PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Luo, CT; Hu, ZM; Zhang, SL; Jiang, ZL				Luo, Changtong; Hu, Zongmin; Zhang, Shao-Liang; Jiang, Zonglin			Adaptive space transformation: An invariant based method for predicting aerodynamic coefficients of hypersonic vehicles	ENGINEERING APPLICATIONS OF ARTIFICIAL INTELLIGENCE			English	Article						Aerodynamic coefficient; Data correlation; Scaling parameter; Genetic programming; Invariant	EVOLUTION	When developing a new hypersonic vehicle, thousands of wind tunnel tests to study its aerodynamic performance are needed. Due to limitations of experimental facilities and/or cost budget, only a part of flight parameters could be replicated. The point to predict might locate outside the convex hull of sample points. This makes it necessary but difficult to predict its aerodynamic coefficients under flight conditions so as to make the vehicle under control and be optimized. Approximation based methods including regression, nonlinear fit, artificial neural network, and support vector machine could predict well within the convex hull (interpolation). But the prediction performance will degenerate very fast as the new point gets away from the convex hull (extrapolation). In this paper, we suggest regarding the prediction not just a mathematical extrapolation, but a mathematics-assisted physical problem, and propose a supervised self-learning scheme, adaptive space transformation (AST), for the prediction. AST tries to automatically detect an underlying invariant relation with the known data under the supervision of physicists. Once the invariant is detected, it will be used for prediction. The result should be valid provided that the physical condition has not essentially changed. The study indicates that AST can predict the aerodynamic coefficient reliably, and is also a promising method for other extrapolation related predictions. (C) 2015 Elsevier Ltd. All rights reserved.	[Luo, Changtong; Hu, Zongmin; Jiang, Zonglin] Chinese Acad Sci, Inst Mech, Beijing 100190, Peoples R China; [Zhang, Shao-Liang] Nagoya Univ, Dept Computat Sci & Engn, Nagoya, Aichi 4648603, Japan	Luo, CT (reprint author), Chinese Acad Sci, Inst Mech, Beijing 100190, Peoples R China.	luo@imech.ac.cn; huzm@imech.ac.cn; zhang@na.cse.nagoya-u.ac.jp; zljiang@imech.ac.cn			Innovation Grant of Chinese Academy of Sciences; National Natural Science Foundation of China [90916028, 11532014]	This research has been supported by Innovation Grant of Chinese Academy of Sciences and the National Natural Science Foundation of China (Grant nos. 90916028 and 11532014).	Anderson J. D., 2006, HYPERSONIC HIGH TEMP; Horn J, 2009, IEEE T NEURAL NETWOR, V20, P686, DOI 10.1109/TNN.2008.2012257; O'Neill M, 2001, IEEE T EVOLUT COMPUT, V5, P349, DOI 10.1109/4235.942529; Bechikh S, 2011, SOFT COMPUT, V15, P1807, DOI 10.1007/s00500-011-0694-3; De Jesus O, 2007, IEEE T NEURAL NETWOR, V18, P14, DOI 10.1109/TNN.2006.882371; TSIEN HS, 1946, J AERONAUT SCI, V13, P653; Luo CT, 2012, ENG APPL ARTIF INTEL, V25, P1182, DOI 10.1016/j.engappai.2012.05.015; Bird G.A., 1970, AIAA J, V8, P1998, DOI 10.2514/3.6037; Chang C-C, 2011, ACM T INTEL SYST TEC, V2, P3, DOI DOI 10.1145/1961189.1961199; Cheng H.K., 1961, P HEAT TRANSFER FLUI, P161; Koza J.R., 1992, GENETIC PROGRAMMING; Lee J.-H., 2009, WORLD ACAD SCI ENG T, V58, P843; Lophaven Soren N., 2002, IMMREP200212, P1; Luo C., 2011, 7 E AS SIAM C RIMS W, P52; Macrossan M.N., 2006, P 25 INT S RAR GAS D, P759; Mezura-Montes E, 2011, SWARM EVOL COMPUT, V1, P173, DOI 10.1016/j.swevo.2011.10.001; Morelli E.A., 2003, 20030653 AIAA; Nicoll A., 2006, 20063829 AIAA; Norgaard M., 1997, 112197 NASA; Peterson Jr J.B., 1980, 1515 NASA TP; Rajkumar T., 2002, P 15 INT FLOR ART IN, P242; Ravikiran N., 2004, P 7 INT C SIGN PROC, V2, P1435, DOI 10.1109/ICOSP.2004.1441596	22	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0952-1976	1873-6769		ENG APPL ARTIF INTEL	Eng. Appl. Artif. Intell.	NOV	2015	46		A				93	103		10.1016/j.engappai.2015.09.001		11	Automation & Control Systems; Computer Science, Artificial Intelligence; Engineering, Multidisciplinary; Engineering, Electrical & Electronic	Automation & Control Systems; Computer Science; Engineering	CX0EG	WOS:000365369100009		
J	Kanemura, H; Sano, F; Ohyama, T; Sugita, K; Aihara, M				Kanemura, Hideaki; Sano, Fumikazu; Ohyama, Tetsuo; Sugita, Kanji; Aihara, Masao			Correlation between perceived stigma and EEG paroxysmal abnormality in childhood epilepsy	EPILEPSY & BEHAVIOR			English	Article						Stigma; EEG paroxysmal abnormalities; Epilepsy; Frontal; Quality of life	QUALITY-OF-LIFE; CLINICAL SEIZURES; CHILDREN; ASYMMETRY; VALPROATE; DISORDER; EMOTION; GROWTH; IMPACT; ADHD	Aims: We investigated the relationship between abnormal electroencephalogram (EEG) findings such as localized EEG paroxysmal abnormality (PA) and the perception of stigma to determine EEG factors associated with perceived stigma in childhood epilepsy. Methods: Participants comprised 40 patients (21 boys, 19 girls; mean age, 14.6 years) with epilepsy at enrollment. The criteria for inclusion were as follows: 1) age of 12-18 years, inclusive; 2) >= 6 months after epilepsy onset; 3) the ability to read and speak Japanese; and 4) the presence of EEG PA. Fifteen healthy seizure-free children were included as a control group. Participants were asked to rate how often they felt or acted in the ways described in the items of the Child Stigma Scale using a 5-point scale. Electroencephalogram paroxysms were classified based on the presence of spikes, sharp waves, or spike-wave complexes, whether focal or generalized. Results: Participants showed significantly higher stigma scores than healthy subjects (p < 0.01). A higher score reflects a greater perception of stigma. The average total scores of patients presenting with EEGPA at generalized, frontal, RD, midtemporal, and occipital regions were 2.3, 4.0, 2.4, 3.2, and 2.2, respectively. The scores of all questions were higher in the frontal group than those in other regions (p < 0.01). Children presenting with frontal EEG PA perceived a greater stigma than children presenting with nonfrontal EEG PA (p < 0.01). Conclusion: A relationship was identified between frontal EEG PA and a greater perception of stigma. Further studies are needed to confirm whether frontal EEG PA may function as a mediator of emotional responses such as perceived stigma in childhood epilepsy. (C) 2015 Elsevier Inc. All rights reserved.	[Kanemura, Hideaki; Sano, Fumikazu; Ohyama, Tetsuo; Sugita, Kanji] Univ Yamanashi, Dept Paediat, Fac Med, Yamanashi 4093898, Japan; [Aihara, Masao] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Yamanashi 4093898, Japan	Kanemura, H (reprint author), Univ Yamanashi, Dept Paediat, Fac Med, Chuo Ku, Yamanashi 4093898, Japan.	ykimu@yamanashi.ac.jp			Japan Epilepsy Research Foundation [22591123]; National Center of Neurology and Psychiatry (NCNP) [25-6]	This research was supported in part by The Japan Epilepsy Research Foundation, Grants-in-Aid for Scientific Research (22591123), and Intramural Research Grant (25-6) for Neurological and Psychiatric Disorders of National Center of Neurology and Psychiatry (NCNP).	Abraham Anisha, 1999, Indian Journal of Pediatrics, V66, P447, DOI 10.1007/BF02845539; Aicardi J., 1993, EUR J PAEDIATR NEURO, V3, P197; Anderson V, 2002, PRINCIPLES FRONTAL L, P504; Taylor J, 2011, EPILEPSY BEHAV, V21, P255, DOI 10.1016/j.yebeh.2011.04.002; Aydemir N, 2011, SEIZURE-EUR J EPILEP, V20, P679, DOI 10.1016/j.seizure.2011.06.017; Bourgeois BFD, 1998, EPILEPSIA, V39, P913, DOI 10.1111/j.1528-1157.1998.tb01440.x; Kanemura H, 2013, EPILEPSY BEHAV, V27, P443, DOI 10.1016/j.yebeh.2013.03.014; Kanemura H, 2013, EUR J PAEDIATR NEURO, V17, P232, DOI 10.1016/j.ejpn.2012.10.002; Wolff M, 2005, EPILEPSIA, V46, P1661, DOI 10.1111/j.1528-1167.2005.00255.x; Kanemura H, 2014, EUR J PAEDIATR NEURO, V18, P482, DOI 10.1016/j.ejpn.2014.03.007; Miyazaki M, 2006, BRAIN DEV-JPN, V28, P470, DOI 10.1016/j.braindev.2006.01.005; JACOBY A, 1993, EPILEPSY RES, V16, P83, DOI 10.1016/0920-1211(93)90042-6; Gordon K, 1996, J CHILD NEUROL, V11, P41; Kanemura H, 2011, BRAIN DEV-JPN, V33, P106, DOI 10.1016/j.braindev.2010.03.005; Kanemura H, 2012, BRAIN DEV-JPN, V34, P175, DOI 10.1016/j.braindev.2011.04.009; Suurmeijer TPBM, 2001, EPILEPSIA, V42, P1160, DOI 10.1046/j.1528-1157.2001.37000.x; Austin JK, 2004, EPILEPSY BEHAV, V5, P472, DOI 10.1016/j.yebeh.2004.04.008; Smith G, 2009, EPILEPSY BEHAV, V16, P484, DOI 10.1016/j.yebeh.2009.08.028; Devinsky O, 1999, EPILEPSIA, V40, P1715, DOI 10.1111/j.1528-1157.1999.tb01588.x; Allen JJB, 2004, BIOL PSYCHOL, V67, P1, DOI 10.1016/j.biopsycho.2004.03.001; Coan JA, 2004, BIOL PSYCHOL, V67, P7, DOI 10.1016/j.biopsycho.2004.03.002; de Boer HM, 2010, SEIZURE-EUR J EPILEP, V19, P630, DOI 10.1016/j.seizure.2010.10.017; Ronen GM, 2000, DEV MED CHILD NEUROL, V42, P751, DOI 10.1017/S0012162200001390; Coan JA, 2003, THE ASYMMETRICAL BRA, P565; Espinola-Nadurille M, 2014, EPILEPSY BEHAV, V32, P162, DOI 10.1016/j.yebeh.2013.12.007; Goldberg E, 1987, FRONTAL LOBES REVISI, P159; Kanemura H, 2014, J PEDIAT EPILEPSY, V3, P85; World Health Organization, 2006, NEUR DIS PUBL HLTH C; World Health Organization International League Against Epilepsy International Bureau for Epilepsy, 1997, GLOB CAMP EP OUT SHA	29	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	NOV	2015	52		A				44	48		10.1016/j.yebeh.2015.08.021		5	Behavioral Sciences; Clinical Neurology; Psychiatry	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	CW4UH	WOS:000364990000010		
J	Al-Eryani, B; Saied, KG; Alddin, RS; Al-Sobaihi, S; Lutf, W; Al-Taiar, A				Al-Eryani, Bilguis; Saied, Khaled Ghilan; Alddin, Reem Sharaf; Al-Sobaihi, Saber; Lutf, Wesam; Al-Taiar, Abdullah			Knowledge of, attitudes toward, and perceptions of epilepsy among university students in Yemen	EPILEPSY & BEHAVIOR			English	Article						Epilepsy; Knowledge; Attitudes; Perceptions; Yemen; University students	SECONDARY-SCHOOL STUDENTS; BATIBO HEALTH DISTRICT; PUBLIC KNOWLEDGE; TEACHERS KNOWLEDGE; AWARENESS; CHILDREN; STIGMA; QUESTIONNAIRE; BELIEFS; ZAMBIA	This cross-sectional study aimed to describe the knowledge and perceptions about epilepsy and the attitudes toward people with epilepsy (PWEs) among university students in Yemen. A self-administered questionnaire was completed by 1155 students. Approximately 23% thought that epilepsy is a form of insanity, and 18% thought that it is a form of mental retardation. About 22% and 10% believed that evil spirits and an evil eye cause epilepsy, respectively. Similarly, 12% believed that children with epilepsy (CWEs) should be isolated from other children, while 12% and 14% thought that PWEs should not get married and should not have children, respectively. Approximately 23% of the students would not allow their child to play with CWEs, and 37% would not employ PWEs in a clerical job. Furthermore, 64% of the students would not agree to marry PWEs. Some misconceptions were strongly linked to attitudes toward PWEs. In conclusion, the negative attitudes toward PWEs among university students in Yemen were slightly more common compared with other settings in the Middle East and showed significant differences between genders which may warrant consideration when designing educational campaigns. (C) 2015 Elsevier Inc. All rights reserved.	[Al-Eryani, Bilguis] Sanaa Univ, Fac Med & Hlth Sci, Dept Paediat, Sanaa, Yemen; [Saied, Khaled Ghilan; Alddin, Reem Sharaf] Sanaa Univ, Fac Med & Hlth Sci, Dept Community Med, Sanaa, Yemen; [Al-Sobaihi, Saber] Tokyo Med & Dent Univ, Div Publ Hlth, Dept Global Hlth Promot, Tokyo, Japan; [Al-Taiar, Abdullah] Kuwait Univ, Dept Community Med & Behav Sci, Fac Med, Safat 13110, Kuwait	Al-Taiar, A (reprint author), Kuwait Univ, Dept Community Med & Behav Sci, Fac Med, Box 24923, Safat 13110, Kuwait.	altaiar@hsc.edu.kw					Al-Adawi S H, 2000, Neurosciences (Riyadh), V5, P18; Goel D, 2011, ANN INDIAN ACAD NEUR, V14, P116, DOI 10.4103/0972-2327.82799; Santosh D, 2007, EPILEPSIA, V48, P1007, DOI 10.1111/j.1528-1167.2007.01040.x; Abulhamail AS, 2014, SEIZURE-EUR J EPILEP, V23, P280, DOI 10.1016/j.seizure.2013.12.010; Al-Rashed H, 2009, EPILEPSY BEHAV, V14, P367, DOI 10.1016/j.yebeh.2008.11.015; McLaughlin DP, 2008, SEIZURE-EUR J EPILEP, V17, P281, DOI 10.1016/j.seizure.2007.09.001; Oguz A, 2002, J CHILD NEUROL, V17, P37, DOI 10.1177/088307380201700109; Yoo JK, 2009, EPILEPSY BEHAV, V16, P260, DOI 10.1016/j.yebeh.2009.07.025; Doughty J, 2003, EPILEPSIA, V44, P115, DOI 10.1046/j.1528-1157.2003.34402.x; Ndoye NF, 2005, SEIZURE-EUR J EPILEP, V14, P106, DOI 10.1016/j.seizure.2004.11.003; Al-Adawi S, 2003, SEIZURE-EUR J EPILEP, V12, P11, DOI 10.1016/S1059-1311(02)00150-4; Benamer HTS, 2009, EPILEPSIA, V50, P2301, DOI 10.1111/j.1528-1167.2009.02058.x; Gelineau AC, 2008, REV NEUROL-FRANCE, V164, P156, DOI 10.1016/j.neurol.2007.10.005; Neni SW, 2010, SEIZURE-EUR J EPILEP, V19, P280, DOI 10.1016/j.seizure.2010.04.006; Chung K, 2010, EPILEPSY BEHAV, V17, P221, DOI 10.1016/j.yebeh.2009.11.023; Hijazeen JK, 2014, EPILEPSY BEHAV, V41, P238, DOI 10.1016/j.yebeh.2014.10.010; Ngugi AK, 2010, EPILEPSIA, V51, P883, DOI 10.1111/j.1528-1167.2009.02481.x; Ezeala-Adikaibe BA, 2013, SEIZURE-EUR J EPILEP, V22, P299, DOI 10.1016/j.seizure.2013.01.016; Thacker AK, 2008, SEIZURE-EUR J EPILEP, V17, P684, DOI 10.1016/j.seizure.2008.04.007; Njamnshi AK, 2010, EPILEPSY BEHAV, V18, P247, DOI 10.1016/j.yebeh.2010.03.013; Chomba EN, 2007, EPILEPSY BEHAV, V10, P111, DOI 10.1016/j.yebeh.2006.08.012; Saengsuwan J, 2013, EPILEPSY BEHAV, V27, P257, DOI 10.1016/j.yebeh.2013.01.014; Birbeck G, 2007, LANCET NEUROL, V6, P39, DOI 10.1016/S1474-4422(06)70629-9; Young GB, 2002, EPILEPSIA, V43, P652, DOI 10.1046/j.1528-1157.2002.01002.x; Bener A, 1998, SEIZURE-EUR J EPILEP, V7, P219, DOI 10.1016/S1059-1311(98)80039-3; Bagic D, 2012, EPILEPSY BEHAV, V25, P200, DOI 10.1016/j.yebeh.2012.06.030; Bishop M, 2004, EPILEPSY BEHAV, V5, P308, DOI 10.1016/j.yebeb.2004.01.011; Njamnshi AK, 2010, EPILEPSY BEHAV, V17, P381, DOI 10.1016/j.yebeh.2009.12.027; Al-Adawi S, 2001, EPILEPSIA, V42, P1476, DOI 10.1046/j.1528-1157.2001.05599.x; Austin JK, 2002, EPILEPSY BEHAV, V3, P368, DOI 10.1016/S1525-5050(02)00042-2; Maiga Y, 2014, EPILEPSY BEHAV, V33, P115, DOI 10.1016/j.yebeh.2014.02.031; Aydin K, 2007, EPILEPSY BEHAV, V10, P286, DOI 10.1016/j.yebeh.2006.09.012; Gzirishvili N, 2013, EPILEPSY BEHAV, V27, P315, DOI 10.1016/j.yebeh.2013.02.011; Pandian JD, 2006, EPILEPSY BEHAV, V9, P492, DOI 10.1016/j.yebeh.2006.07.009; HOARE P, 1994, J PSYCHOSOM RES, V38, P859, DOI 10.1016/0022-3999(94)90073-6; Birbeck GL, 2008, AM J TROP MED HYG, V79, P168; Panda SB, 2011, EPILEPSY BEHAV, V20, P447, DOI 10.1016/j.yebeh.2010.12.024; Alkhamra H, 2012, EPILEPSY BEHAV, V24, P430, DOI 10.1016/j.yebeh.2012.05.004; Daoud A, 2007, SEIZURE-EUR J EPILEP, V16, P521, DOI 10.1016/j.seizure.2007.04.011; Njamnshi AK, 2009, EPILEPSY BEHAV, V14, P83, DOI 10.1016/j.yebeh.2008.09.012; Long L, 2000, EPILEPSIA, V41, P727, DOI 10.1111/j.1528-1157.2000.tb00235.x; Youssef FF, 2009, EPILEPSY BEHAV, V15, P160, DOI 10.1016/j.yebeh.2009.01.027; Awad A, 2008, EPILEPSIA, V49, P564, DOI 10.1111/j.1528-1167.2007.01433.x; Millogo A, 2004, EPILEPTIC DISORD, V6, P21; Dantas FG, 2001, ARQ NEURO-PSIQUIAT, V59, P712, DOI 10.1590/S0004-282X2001000500011; Kankirawatana P, 1999, EPILEPSIA, V40, P497, DOI 10.1111/j.1528-1157.1999.tb00747.x; El Sharkawy G, 2006, EPILEPSY BEHAV, V8, P201, DOI 10.1016/j.yebeh.2005.09.011; Obeid T, 2012, SEIZURE-EUR J EPILEP, V21, P245, DOI 10.1016/j.seizure.2012.01.001; Pupillo E, 2014, EPILEPSY BEHAV, V34, P42, DOI 10.1016/j.yebeh.2014.02.025; Bishop M, 2006, EPILEPSY BEHAV, V8, P397, DOI 10.1016/j.yebeh.2005.11.008; Mameniskiene R, 2015, EPILEPSY BEHAV, V46, P192, DOI 10.1016/j.yebeh.2015.03.002; AbRahman AF, 2005, SEIZURE-EUR J EPILEP, V14, P593, DOI 10.1016/j.seizure.2005.09.005; Jacoby A, 2004, EPILEPSIA, V45, P1405, DOI 10.1111/j.0013-9580.2004.02904.x; Piazzini A, 2001, EPILEPSY BEHAV, V2, P481, DOI 10.1006/ebeh.2001.0247; Gazibara T, 2014, EPILEPSY BEHAV, V41, P210, DOI 10.1016/j.yebeh.2014.09.062; Mecarelli O, 2007, SEIZURE-EUR J EPILEP, V16, P313, DOI 10.1016/j.seizure.2007.01.005; Njamnshi AK, 2009, EPILEPSIA, V50, P1262, DOI 10.1111/j.1528-1167.2008.01809.x; Babikar Haydar E, 2011, J Family Community Med, V18, P17, DOI 10.4103/1319-1683.78633; Dyken JJ, 2013, DIVINE DEFAULT WHY F; Ghanean Helia, 2013, Glob Health Action, V6, P21618, DOI 10.3402/gha.v6i0.21618; Hounsossou CH, 2015, EPILEPSY BEHAV, V42, P153, DOI 10.1016/j.yebeh.2014.10.022; Kassie Gizat Molla, 2014, N Am J Med Sci, V6, P383, DOI 10.4103/1947-2714.139288; Otte WM, 2013, EPILEPSY BEHAV, V29, P28; Shafiq M, 2007, SEIZURE-EUR J EPILEP, V16, P330, DOI 10.1016/j.seizure.2007.02.002; UNICEF, 2012, AT A GLANC YEM; Vancini RL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000919; WHO, 2012, EP FACT SHEET; Zanni KP, 2012, EPILEPSY RES TREAT	68	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	NOV	2015	52		A				102	107		10.1016/j.yebeh.2015.08.011		6	Behavioral Sciences; Clinical Neurology; Psychiatry	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	CW4UH	WOS:000364990000019		
J	Nakajima, K; Hirai, S; Morio, T; Okado, H				Nakajima, Keisuke; Hirai, Shinobu; Morio, Tomohiro; Okado, Haruo			Benzodiazepines induce sequelae in immature mice with inflammation-induced status epilepticus	EPILEPSY & BEHAVIOR			English	Article						Status epilepticus; Children; Inflammation; Benzodiazepine; GABA-A receptor	WORKING-MEMORY; EPILEPSY; SEIZURES; PARVALBUMIN; EXCITATION; INFECTION; CHILDREN; SINGLE	Objective: Since benzodiazepines (BZPs) became clinically available for the treatment of status epilepticus (SE) in children, the incidence of neurological sequelae has increased. However, the cause-effect relationship is poorly understood. In this paper, we examined the effect of BZPs on an inflammation-induced SE (iSE) animal model. Method: Inflammation was induced by injecting poly(I:C) (pIC 10 mg/kg, postnatal day 12-14), seizure was induced by injecting pilocarpine hydrochloride (PILO 200 mg/kg, postnatal day 15) into C57BL/6J mice, and the pIC + PILO mice were used as the iSE model (miSE). The GABA-A receptor agonist midazolam (MDL 0.5 mg/kg) was used to inhibit seizures. Sequelae were evaluated by performing behavior and immunohistochemical analyses in the chronic phase. Result: The exploratory activity of mice in the miSE plus MDL group increased significantly, indicating that hyperactivity was newly induced by MDL in miSE mice. The contextual fear memory of the miSE mice was also significantly increased and that of miSE treated with MDL returned to the normal level. The parvalbumin-positive GABA neurons were decreased in number by pIC + PILO which was rescued by MDL. Apoptosis marker ssDNA-positive cells were increased by pIC + PILO which could not be rescued by MDL. Therefore, we propose that BZP-dependent therapy for SE needs to be rethought from the perspective of using other treatment approaches. (C) 2015 Elsevier Inc. All rights reserved.	[Nakajima, Keisuke; Hirai, Shinobu; Okado, Haruo] Tokyo Metropolitan Inst Med Sci, Dept Brain Dev & Neural Regenerat, Neural Dev Project, Tokyo, Japan; [Nakajima, Keisuke; Morio, Tomohiro] Tokyo Med & Dent Univ, Dept Pediat & Dev Biol, Tokyo, Japan	Okado, H (reprint author), Tokyo Metropolitan Inst Med Sci, Dept Brain Dev & Neural Regenerat, Neural Dev Project, Setagaya Ku, 2-1-6 Kamikitazavya, Tokyo, Japan.	okado-hr@igakuken.or.jp					Suh HS, 2007, J VIROL, V81, P9838, DOI 10.1128/JVI.00792-07; Deeb TZ, 2012, EPILEPSIA, V53, P79, DOI 10.1111/epi.12037; Giovanoli S, 2014, BRAIN BEHAV IMMUN, V40, P48, DOI 10.1016/j.bbi.2014.04.005; Zhang SY, 2013, CURR OPIN IMMUNOL, V25, P19, DOI 10.1016/j.coi.2012.11.001; Nabbout R, 2011, LANCET NEUROL, V10, P99, DOI 10.1016/S1474-4422(10)70214-3; Chang YC, 2001, NEUROLOGY, V57, P37; Fil D, 2011, METAB BRAIN DIS, V26, P49, DOI 10.1007/s11011-010-9231-9; Nagase H, 2014, PEDIATR NEUROL, V51, P78, DOI 10.1016/j.pediatrneurol.2014.02.021; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; Koyama R, 2012, NAT MED, V18, P1271, DOI 10.1038/nm.2850; Dube CM, 2009, BRAIN DEV-JPN, V31, P366, DOI 10.1016/j.braindev.2008.11.010; Richetto J, 2013, BRAIN BEHAV IMMUN, V33, P190, DOI 10.1016/j.bbi.2013.07.006; Shin R, 2013, BIPOLAR DISORD, V15, P405, DOI 10.1111/bdi.12064; Ibi D, 2009, NEUROSCI RES, V64, P297, DOI 10.1016/j.neures.2009.03.015; Ikegaya Y, 2000, NEUROSCIENCE, V98, P647, DOI 10.1016/S0306-4522(00)00188-3; Komatsu M, 2010, BRAIN DEV-JPN, V32, P472, DOI 10.1016/j.braindev.2009.09.012; Riss J, 2008, ACTA NEUROL SCAND, V118, P69, DOI 10.1111/j.1600-0404.2008.01004.x; Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Cornejo BJ, 2008, EPILEPSY BEHAV, V13, P585, DOI 10.1016/j.yebeh.2008.07.002; Cunningham C, 2007, BRAIN BEHAV IMMUN, V21, P490, DOI 10.1016/j.bbi.2006.12.007; Appleton R, 2008, COCHRANE DATABASE SY, V3; Kirchman LT, 2011, METAB BRAIN DIS, V26, P91; Vezzani A, 2011, BRAIN BEHAV IMMUN, V7, P1281; Yamada J, 2004, J PHYSIOL-LONDON, V557, P829, DOI 10.1113/jphysiol.2004.062471; Yi F, 2015, EPILEPSIA, V56, P297, DOI 10.1111/epi.12883	25	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	NOV	2015	52		A				180	186		10.1016/j.yebeh.2015.08.012		7	Behavioral Sciences; Clinical Neurology; Psychiatry	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	CW4UH	WOS:000364990000032		
J	Otsuki, T; Kumagai, J; Kohari, Y; Okuyama, Y; Kwon, E; Seki, C; Uwai, K; Mawatari, Y; Kobayashi, N; Iwasa, T; Tokiwa, M; Takeshita, M; Maeda, A; Hashimoto, A; Turuga, K; Nakano, H				Otsuki, Teppei; Kumagai, Jun; Kohari, Yoshihito; Okuyama, Yuko; Kwon, Eunsang; Seki, Chigusa; Uwai, Koji; Mawatari, Yasuteru; Kobayashi, Nagao; Iwasa, Tatsuo; Tokiwa, Michio; Takeshita, Mitsuhiro; Maeda, Atushi; Hashimoto, Akihiko; Turuga, Kana; Nakano, Hiroto			Silyloxy Amino Alcohol Organocatalyst for Enantioselective 1,3-Dipolar Cycloaddition of Nitrones to alpha,beta-Unsaturated Aldehydes	EUROPEAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						Organocatalysis; Cycloaddition; Enantioselectivity; Diastereoselectivity; Nitrogen heterocycles; Amino alcohols	DIELS-ALDER REACTION; SUPPORTED IMIDAZOLIDINONE CATALYST; ALPHA-ACYLOXYACROLEINS; ORGANIC-SYNTHESIS; DOMINO REACTIONS; HYBRID DIAMINES; ONE-POT; DERIVATIVES; COMPLEXES; ISOXAZOLIDINES	The catalytic activity of a simple amino alcohol that contains a bulky super silyl group [i.e., tris(trimethylsilyl)silyl (TTMSS)] bonded to the oxygen atom at the gamma-position along with a primary amine moiety was examined in the enantioselective 1,3-dipolar cycloaddition of nitrones to alpha,beta-unsaturated aldehydes. The organocatalyst successfully provided optically active isoxazolidines in good chemical yields (up to 86%) with excellent diastereoselectivities (endo/exo, up to 96: 4) and enantioselectivities (up to 97% ee). Furthermore, the obtained isoxazolidines were easily converted into gamma-amino diols that contain three contiguous stereogenic centers.	[Otsuki, Teppei; Kumagai, Jun; Kohari, Yoshihito; Seki, Chigusa; Uwai, Koji; Mawatari, Yasuteru; Nakano, Hiroto] Muroran Inst Technol, Grad Sch Engn, Dept Bioengn, Muroran, Hokkaido 0508585, Japan; [Okuyama, Yuko] Tohoku Pharmaceut Univ, Aoba Ku, Sendai, Miyagi 9818558, Japan; [Kwon, Eunsang] Tohoku Univ, Grad Sch Sci, Res & Analyt Ctr Giant Mol, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Kobayashi, Nagao] Tohoku Univ, Grad Sch Sci, Dept Chem, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Iwasa, Tatsuo] Muroran Inst Technol, Div Engn Composite Funct, Grad Sch Engn, Muroran, Hokkaido 0508585, Japan; [Tokiwa, Michio; Takeshita, Mitsuhiro] Tokiwakai Grp, Iwaki, Fukushima 9738053, Japan; [Maeda, Atushi] Shin Nihon Kogyo Co Ltd, Asahikawa, Hokkaido 0700028, Japan; [Hashimoto, Akihiko; Turuga, Kana] Technos Hokkaido Co Ltd, Asahikawa, Hokkaido 0708044, Japan	Kwon, E (reprint author), Tohoku Univ, Grad Sch Sci, Res & Analyt Ctr Giant Mol, Aoba Ku, 6-3 Aoba, Sendai, Miyagi 9808578, Japan.	catanaka@mmm.muroran-it.ac.jp			Japan Science and Technology Agency (JST) [AS231Z01382G, AS221Z01186D]	This research was partially supported by Japan Science and Technology Agency (JST) (Adaptable & Seamless Technology Transfer Program through Target-driven R&D, grant numbers AS231Z01382G and AS221Z01186D).	Alba M., 2011, CHEM REV, V111, P4703; Casadei MA, 2000, J ORG CHEM, V65, P4759, DOI 10.1021/jo0002386; Jen WS, 2000, J AM CHEM SOC, V122, P9874, DOI 10.1021/ja005517p; Rios R, 2007, TETRAHEDRON LETT, V48, P5701, DOI 10.1016/j.tetlet.2007.05.176; Gothelf KV, 1998, CHEM REV, V98, P863, DOI 10.1021/cr970324e; Frederickson M, 1997, TETRAHEDRON, V53, P403, DOI 10.1016/S0040-4020(96)01095-2; Pagoti S, 2013, ADV SYNTH CATAL, V355, P3532, DOI 10.1002/adsc.201300624; NOYORI R, 1991, ANGEW CHEM INT EDIT, V30, P49, DOI 10.1002/anie.199100491; Kohari Y, 2014, J ORG CHEM, V79, P9500, DOI 10.1021/jo501433c; Gothelf KV, 1996, J AM CHEM SOC, V118, P59, DOI 10.1021/ja952726e; Evans DA, 2006, ORG LETT, V8, P3351, DOI 10.1021/ol061223i; Tessier A, 2008, J ORG CHEM, V73, P3970, DOI 10.1021/jo800562x; Karlsson S, 2002, TETRAHEDRON-ASYMMETR, V13, P923, DOI 10.1016/S0957-4166(02)00231-8; Lait SM, 2007, CHEM REV, V107, P767, DOI 10.1021/cr050065q; Bertelsen S, 2009, CHEM SOC REV, V38, P2178, DOI 10.1039/b903816g; Cordero FM, 2000, J AM CHEM SOC, V122, P8075, DOI 10.1021/ja000108e; Moran A, 2013, J AM CHEM SOC, V135, P9091, DOI 10.1021/ja404784t; Ishihara K, 2005, J AM CHEM SOC, V127, P10504, DOI 10.1021/ja053368a; Alba AN, 2009, CURR ORG CHEM, V13, P1432; BRAVO P, 1992, TETRAHEDRON, V48, P9775, DOI 10.1016/S0040-4020(01)81194-7; Hatano M, 2012, CHEM COMMUN, V48, P4273, DOI 10.1039/c2cc00046f; Sakakura A, 2006, ORG LETT, V8, P2229, DOI 10.1021/ol060490l; Chow SS, 2007, TETRAHEDRON LETT, V48, P277, DOI 10.1016/j.tetlet.2006.11.029; Seebach D, 2010, HELV CHIM ACTA, V93, P603; Vesely J, 2008, CHEM-EUR J, V14, P2693, DOI 10.1002/chem.200701918; KAMETANI T, 1985, J ORG CHEM, V50, P2327, DOI 10.1021/jo00213a025; Ishihara K, 2008, ORG LETT, V10, P2893, DOI 10.1021/ol8011277; Suga H, 2005, ORG LETT, V7, P1431, DOI 10.1021/ol050397h; Soucy C, 1998, TETRAHEDRON LETT, V39, P9117, DOI 10.1016/S0040-4039(98)02060-7; Stanley LM, 2008, CHEM REV, V108, P2887, DOI 10.1021/cr078371m; Shen ZL, 2012, CHEM COMMUN, V48, P5856, DOI 10.1039/c2cc31830j; KITAMURA M, 1994, J PHYS CHEM-US, V98, P12776, DOI 10.1021/j100099a048; Lemay M, 2007, TETRAHEDRON, V63, P11644, DOI 10.1016/j.tet.2007.08.110; WANG F, 1990, AGR BIOL CHEM TOKYO, V54, P2989; Nakano H, 2010, CHEM COMMUN, V46, P4827, DOI 10.1039/c0cc00110d; de Oliveira LF, 2004, TETRAHEDRON-ASYMMETR, V15, P2583, DOI 10.1016/j.tetasy.2004.07.027; Yamaoka Y, 2010, J AM CHEM SOC, V132, P5354, DOI 10.1021/ja101076q; Erkkila A, 2007, CHEM REV, V107, P5416, DOI 10.1021/cr068388p; Sakakura A, 2012, ORG LETT, V14, P2972, DOI 10.1021/ol300921f; Mukherjee S, 2007, CHEM REV, V107, P5471, DOI 10.1021/cr0684016; Notz W, 2004, ACCOUNTS CHEM RES, V37, P580, DOI 10.1021/ar0300468; Enders D, 2007, ANGEW CHEM INT EDIT, V46, P1570, DOI 10.1002/anie.200603129; Boxer MB, 2005, ORG LETT, V7, P3127, DOI 10.1021/ol0512334; Pellissier H, 2007, TETRAHEDRON, V63, P3235, DOI 10.1016/j.tet.2007.01.009; Suttibut C, 2011, TETRAHEDRON LETT, V52, P4745, DOI 10.1016/j.tetlet.2011.06.109; Nie X, 2014, J MOL CATAL A-CHEM, V393, P171, DOI 10.1016/j.molcata.2014.06.015; SOAI K, 1992, CHEM REV, V92, P833, DOI 10.1021/cr00013a004; Gothelf KV, 1996, J ORG CHEM, V61, P346, DOI 10.1021/jo951204e; Najera C, 2010, J BRAZIL CHEM SOC, V21, P377, DOI 10.1590/S0103-50532010000300002; Berkessel A, 2005, ASYMMETRIC ORGANOCATALYSIS: FROM BIOMIMETIC CONCEPTS TO APPLICATIONS IN ASYMMETRIC SYNTHESIS, P1, DOI 10.1002/3527604677; Dalko P. I., 2004, ANGEW CHEM INT EDIT, V37, P580; Dalko P. I., 2007, ENANTIOSELECTIVE ORG; Ender D., 2007, ANGEW CHEM, V119, P1590, DOI DOI 10.1002/ange.200603129; Gothelf K. V., 2002, SYNTHESIS-STUTTGART, P211; Grigor'ev IA, 2008, NITRILE OXIDES, NITRONES, AND NITRONATES IN ORGANIC SYNTHESIS: NOVEL STRATEGIES IN SYNTHESIS, 2ND EDITION, P129; HAYASHI M, 1991, J CHEM SOC CHEM COMM, P1752, DOI 10.1039/c39910001752; Jen W. S., 2004, THESIS, P9; Kametani T., 1982, J ORG CHEM, V47, P2329; Karlsson S, 2003, EUR J ORG CHEM, P2782, DOI 10.1002/ejoc.200300172; Karlsson S., 2001, ORG PREP PROCED INT, V33, P103; List B, 2001, SYNLETT, P1675, DOI 10.1055/s-2001-18074; Seayad J, 2005, ORG BIOMOL CHEM, V3, P719, DOI 10.1039/b415217b; Martin J. N., 2003, SYNTHETIC APPL 1 3 D, P1; Noyori R., 1991, ANGEW CHEM, V103, P34, DOI 10.1002/ange.19911030106; Pellissier H., 2010, RECENT DEV ASYMMETRI; Puglisi A, 2004, EUR J ORG CHEM, P567, DOI 10.1002/ejoc.200300571; Sakuta Y., 2010, HETEROCYCLES, V86, P1379; Torssell K. B. G., 1998, NITRILE OXIDES NITRO; TUFARIELLO JJ, 1979, ACCOUNTS CHEM RES, V12, P396, DOI 10.1021/ar50143a003; Viciano M., 2008, ANGEW CHEM INT EDIT, V47, P4638; Weselinski L, 2011, TETRAHEDRON LETT, V52, P381, DOI 10.1016/j.tetlet.2010.11.015; Weselinski L, 2009, SYNLETT, P2261, DOI 10.1055/s-0029-1217808; Yang H, 2010, SYNLETT, P2827, DOI 10.1055/s-0030-1259020	73	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1434-193X	1099-0690		EUR J ORG CHEM	Eur. J. Org. Chem.	NOV	2015		33					7292	7300		10.1002/ejoc.201500926		9	Chemistry, Organic	Chemistry	CW4NQ	WOS:000364968800011		
J	Hirokane, T; Ikeuchi, K; Yamada, H				Hirokane, Tsukasa; Ikeuchi, Kazutada; Yamada, Hidetoshi			Total Syntheses of Laevigatins A and E	EUROPEAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						Total synthesis; Natural products; Carbohydrates; Glycosylation; Biaryls; Aryl ethers	ROSACEOUS MEDICINAL-PLANTS; ELLAGITANNIN CHEMISTRY; BIOLOGICAL-PROPERTIES; DIMERIC ELLAGITANNIN; INHIBITORY-ACTIVITY; O-GLYCOSYLATION; RECENT PROGRESS; ROSA-LAEVIGATA; CORILAGIN; POLYPHENOLS	We describe the first total syntheses of two ellagitannins, laevigatins A and E. Laevigatin A comprises a 2,3-O-(S)-hexahydroxydiphenoyl-alpha-D-glucose unit, whose anomeric oxygen atom forms a dehydrodigalloyl ester. Laevigatin E is a dimeric ellagitannin with structural motifs similar to those of laevigatin A. A recently developed method for synthesizing C-O digallates allowed the synthesis of more than 1 g of laevigatin A. The abundant supply allowed the synthesis of laevigatin E, an achievement that implies that more complex ellagitannins could be accessible.	[Hirokane, Tsukasa; Ikeuchi, Kazutada; Yamada, Hidetoshi] Kwansei Gakuin Univ, Sch Sci & Technol, Sanda 6691337, Japan	Yamada, H (reprint author), Kwansei Gakuin Univ, Sch Sci & Technol, 2-1 Gakuen, Sanda 6691337, Japan.	hidetosh@kwansei.ac.jp			Ministry of Education, Culture, Sports Science & Technology in Japan through the Strategic Research Foundation at Private Universities [S1311046]; Mizutani Foundation for Glycoscience; Science Research Promotion Fund of the Mutual Aid Corporation	We thank Osaka Synthetic Chemical Laboratories for their provision of EDCI. This work was supported by the Ministry of Education, Culture, Sports Science & Technology in Japan through the Strategic Research Foundation at Private Universities (S1311046), the Mizutani Foundation for Glycoscience, and the Science Research Promotion Fund of the Mutual Aid Corporation.	Youn K, 2013, PLANTA MED, V79, P1038, DOI 10.1055/s-0032-1328769; Zheng SJ, 2012, ORG BIOMOL CHEM, V10, P2590, DOI 10.1039/c2ob25065a; Takeuchi H, 2015, ANGEW CHEM INT EDIT, V54, P6177, DOI 10.1002/anie.201500700; Feldman KS, 1999, BIOORG MED CHEM LETT, V9, P985, DOI 10.1016/S0960-894X(99)00110-9; Li H, 2007, CHEM PHARM BULL, V55, P1325, DOI 10.1248/cpb.55.1287; Yamada H, 2008, J AM CHEM SOC, V130, P7566, DOI [10.1021/ja803111z, 10.1021/ja803111]; YOSHIDA T, 1989, CHEM PHARM BULL, V37, P920; Yoshida T, 2010, INT J MOL SCI, V11, P79, DOI 10.3390/ijms11010079; Wang Z, 2014, INT J MOL SCI, V15, P9762, DOI 10.3390/ijms15069762; Yamaguchi S, 2013, J ORG CHEM, V78, P5410, DOI 10.1021/jo400562k; Li N, 2013, PHYTOTHER RES, V27, P1517, DOI 10.1002/ptr.4891; Jensen HH, 2004, J AM CHEM SOC, V126, P9205, DOI 10.1021/ja047578j; MIYAMOTO K, 1987, CHEM PHARM BULL, V35, P814; Boons GJ, 1996, TETRAHEDRON, V52, P1095, DOI 10.1016/0040-4020(95)00897-7; Xiao HT, 2013, J NAT PROD, V76, P2120, DOI 10.1021/np4006772; Ascacio-Valdes JA, 2011, J MED PLANTS RES, V5, P4696; Quideau S, 1996, CHEM REV, V96, P475, DOI 10.1021/cr940716a; Malik G, 2012, CHEM-EUR J, V18, P9063, DOI 10.1002/chem.201200517; Michihata N, 2013, J ORG CHEM, V78, P4319, DOI 10.1021/jo4003135; KRAUS GA, 1980, J ORG CHEM, V45, P4825, DOI 10.1021/jo01312a004; LINDGREN BO, 1973, ACTA CHEM SCAND, V27, P888, DOI 10.3891/acta.chem.scand.27-0888; Feldman KS, 2000, J AM CHEM SOC, V122, P7396, DOI 10.1021/ja001013f; Su XB, 2008, ORG LETT, V10, P2593, DOI 10.1021/ol8009545; BANOUB J, 1979, CAN J CHEM, V57, P2091, DOI 10.1139/v79-335; Li FJ, 2013, J AGR FOOD CHEM, V61, P9697, DOI 10.1021/jf403710b; BAL BS, 1981, TETRAHEDRON, V37, P2091, DOI 10.1016/S0040-4020(01)97963-3; Kasai Y, 2012, ANGEW CHEM INT EDIT, V51, P8026, DOI 10.1002/anie.201203305; Quideau S, 2011, ANGEW CHEM INT EDIT, V50, P586, DOI 10.1002/anie.201000044; Shioe K, 2013, CHEM PHARM BULL, V61, P1308; Feldman KS, 2005, PHYTOCHEMISTRY, V66, P1984, DOI 10.1016/j.phytochem.2004.11.015; Saha RK, 2010, ANTIVIR RES, V88, P10, DOI 10.1016/j.antiviral.2010.06.008; Monobe M, 2010, CYTOTECHNOLOGY, V62, P201, DOI 10.1007/s10616-010-9280-2; Gambari R, 2014, PHYTOTHER RES, V28, P781, DOI 10.1002/ptr.5049; YOSHIDA T, 1989, PHYTOCHEMISTRY, V28, P2451, DOI 10.1016/S0031-9422(00)98003-8; Yamada H, 2013, EUR J ORG CHEM, V2013, P7872, DOI 10.1002/ejoc.201301219; Feldman KS, 2000, J ORG CHEM, V65, P8011, DOI 10.1021/jo0010936; Sundararaju B, 2012, CHEM SOC REV, V41, P4467, DOI 10.1039/c2cs35024f; Satoh H, 2013, CHEM SOC REV, V42, P4297, DOI 10.1039/c3cs35457a; Pouysegu L, 2011, NAT PROD REP, V28, P853, DOI 10.1039/c0np00058b; Buckingham J., 1994, DICT NATURAL PRODUCT; Chen GH, 2015, J FOOD DRUG ANAL, V23, P116, DOI 10.1016/j.jfda.2014.07.007; Deffieux D, 2011, CHEM COMMUN, V47, P1629, DOI 10.1039/c0cc04007j; Demchenko AV, 2003, SYNLETT, P1225, DOI 10.1055/s-2003-40349; Goodman L, 1967, Adv Carbohydr Chem Biochem, V22, P109; Gross G., 1999, COMPREHENSIVE NATURA, V3, P799; Gross G. G., 1999, PLANT POLYPHENOLS 2; Guibe F, 1998, TETRAHEDRON, V54, P2967, DOI 10.1016/S0040-4020(97)10383-0; Hirokane T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4478; Jensen Henrik Helligsø, 2006, Acc Chem Res, V39, P259, DOI 10.1021/ar050189p; Jensen KJ, 2002, J CHEM SOC PERK T 1, P2219, DOI 10.1039/b110071h; Kasai Y., 2012, ANGEW CHEM, V124, P8150; Khanbabaee K, 2001, SYNTHESIS-STUTTGART, P1585; Kim YH, 2014, BIOCHEM BIOPH RES CO, V450, P824, DOI 10.1016/j.bbrc.2014.06.069; Quideau S., 2009, CHEM BIOL ELLAGITANN; Quideau S., 2011, ANGEW CHEM, V123, P610, DOI 10.1002/ange.201000044; Takeuchi H., 2015, ANGEW CHEM, V127, P6275; TOSHIMA K, 1993, CHEM REV, V93, P1503, DOI 10.1021/cr00020a006; Yoshida T., 2000, STUDIES NATURAL PROD, V23, P395	58	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1434-193X	1099-0690		EUR J ORG CHEM	Eur. J. Org. Chem.	NOV	2015		33					7352	7359		10.1002/ejoc.201501037		8	Chemistry, Organic	Chemistry	CW4NQ	WOS:000364968800018		
J	Morimoto, H; Harada, T				Morimoto, Haruki; Harada, Toshiro			Catalytic Enantioselective Synthesis of Trisubstituted Secondary Allylic Alcohols Starting from Terminal Alkynes and Aldehydes	EUROPEAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						Asymmetric catalysis; Asymmetric synthesis; Nucleophilic addition; Allylic compounds; Aluminium; Titanium	GRIGNARD-REAGENTS; ASYMMETRIC ALKYLATION; TITANIUM COMPLEX; TRIALKYLALUMINUM ADDITION; ARYLATION; ARYL; CARBOALUMINATION; HYDROALUMINATION; CARBOMETALATION; ORGANOZIRCONIUM	A general one-pot method for the enantioselective synthesis of beta,beta-disubstituted allylic alcohols has been developed starting from readily available terminal alkynes and aldehydes. Trisubstituted (E)-vinylaluminium reagents, generated regioand stereoselectively by the Zr-catalyzed carboalumination of the alkynes with Me3Al, was used in subsequent enantioselective addition reactions with aldehydes using a DPP-H-8-BINOL-derived titanium catalyst system at low catalyst loading (5 mol-%).	[Morimoto, Haruki; Harada, Toshiro] Kyoto Inst Technol, Fac Mol Chem & Engn, Sakyo Ku, Kyoto 6068585, Japan	Harada, T (reprint author), Kyoto Inst Technol, Fac Mol Chem & Engn, Sakyo Ku, Kyoto 6068585, Japan.	harada-t@kit.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan [24550118]	This work was supported by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan (KAKENHI, grant number 24550118) from.	Nicolaou KC, 2010, ANGEW CHEM INT EDIT, V49, P5875, DOI 10.1002/anie.201003500; DALE JA, 1969, J ORG CHEM, V34, P2543, DOI 10.1021/jo01261a013; Harada T, 2007, TETRAHEDRON-ASYMMETR, V18, P2499, DOI 10.1016/j.tetasy.2007.10.012; Lumbroso A, 2013, ANGEW CHEM INT EDIT, V52, P1890, DOI 10.1002/anie.201204579; Gao F, 2010, J AM CHEM SOC, V132, P10961, DOI 10.1021/ja104896b; MARRON BE, 1989, J ORG CHEM, V54, P5522, DOI 10.1021/jo00284a025; Wu KH, 2006, J AM CHEM SOC, V128, P14808, DOI 10.1021/ja062080y; Muramatsu Y, 2010, B CHEM SOC JPN, V83, P19, DOI 10.1246/bcsj.20090232; Spino C, 2000, ANGEW CHEM INT EDIT, V39, P1930, DOI 10.1002/1521-3773(20000602)39:11<1930::AID-ANIE1930>3.0.CO;2-J; Fernandez-Mateos E, 2012, TETRAHEDRON-ASYMMETR, V23, P789, DOI 10.1016/j.tetasy.2012.05.007; Fan XY, 2010, CHEM-EUR J, V16, P7988, DOI 10.1002/chem.201000974; Kumar R, 2013, ORG LETT, V15, P4198, DOI 10.1021/ol4019248; WIPF P, 1993, ANGEW CHEM INT EDIT, V32, P1068, DOI 10.1002/anie.199310681; Harada T, 2006, ORG LETT, V8, P3817, DOI 10.1021/ol061407x; BOECKMAN RK, 1989, TETRAHEDRON LETT, V30, P3271, DOI 10.1016/S0040-4039(00)99219-0; ZWEIFEL G, 1967, J AM CHEM SOC, V89, P2753, DOI 10.1021/ja00987a054; Pellissier H, 2008, TETRAHEDRON, V64, P7041, DOI 10.1016/j.tet.2008.04.079; Biradar DB, 2009, ORG LETT, V11, P499, DOI 10.1021/ol801999u; Kinoshita Y, 2013, CHEM-EUR J, V19, P3311, DOI 10.1002/chem.201204346; Donohoe TJ, 2002, J ORG CHEM, V67, P7946, DOI 10.1021/jo026161y; Muramatsu Y, 2008, ANGEW CHEM INT EDIT, V47, P1088, DOI 10.1002/anie.200704963; Lu JF, 2000, TETRAHEDRON-ASYMMETR, V11, P2531, DOI 10.1016/S0957-4166(00)00214-7; NEGISHI E, 1994, ACCOUNTS CHEM RES, V27, P124, DOI 10.1021/ar00041a002; Zhou SL, 2009, TETRAHEDRON-ASYMMETR, V20, P1407, DOI 10.1016/j.tetasy.2009.05.018; Chan ASC, 1997, J AM CHEM SOC, V119, P4080, DOI 10.1021/ja970135d; Negishi E, 1999, CHEM-EUR J, V5, P411, DOI 10.1002/(SICI)1521-3765(19990201)5:2<411::AID-CHEM411>3.0.CO;2-H; Shono T, 2010, ORG LETT, V12, P5270, DOI 10.1021/ol1023213; Muramatsu Y, 2008, CHEM-EUR J, V14, P10560, DOI 10.1002/chem.200801612; Lipshutz BH, 2007, ORG LETT, V9, P3737, DOI 10.1021/ol701469e; VANHORN DE, 1978, J AM CHEM SOC, V100, P2252, DOI 10.1021/ja00475a058; Liang B, 2008, ORG LETT, V10, P193, DOI 10.1021/ol702272d; Uenishi A, 2013, CHEM-EUR J, V19, P4896, DOI 10.1002/chem.201203946; Mata Y, 2006, J ORG CHEM, V71, P8159, DOI 10.1021/jo0613535; Kumar R, 2013, CHEM-EUR J, V19, P17707, DOI 10.1002/chem.201303619; Negishi E, 1996, J AM CHEM SOC, V118, P9577, DOI 10.1021/ja9538039; OHTANI I, 1991, J AM CHEM SOC, V113, P4092, DOI 10.1021/ja00011a006; Biswas K, 2005, ANGEW CHEM INT EDIT, V44, P2232, DOI 10.1002/anie.200462569; Zhou SL, 2009, J ORG CHEM, V74, P3500, DOI 10.1021/jo900348p; Biswas K., 2005, ANGEW CHEM, V117, P2272, DOI 10.1002/ange.200462569; Eisch J. J., 1991, COMPREHENSIVE ORGANI, V8, P733; Hernandez-Toribio J, 2011, ORG LETT, V13, P6094, DOI 10.1021/ol202588g; Itakura D, 2011, SYNLETT, P2875, DOI 10.1055/s-0031-1289854; Lumbroso A., 2013, ANGEW CHEM, V125, P1942; Muramatsu Y., 2008, ANGEW CHEM, V120, P1104, DOI 10.1002/ange.200704963; Nakagawa Y, 2010, EUR J ORG CHEM, P6535, DOI 10.1002/ejoc.201001254; Negishi E, 2005, DALTON T, P827, DOI 10.1039/b417134a; Nicolaou K. C., 2010, ANGEW CHEM, V122, P6011; Pagenkopf BL, 1998, TETRAHEDRON LETT, V39, P9593, DOI 10.1016/S0040-4039(98)02332-6; Rebe S., 2001, CHEM COMMUN, P299; SHARPLES.KB, 1973, J AM CHEM SOC, V95, P6136, DOI 10.1021/ja00799a061; Spino C., 2000, ANGEW CHEM, V112, P2006, DOI 10.1002/1521-3757(20000602)112:11<2006::AID-ANGE2006>3.0.CO;2-8; Ukon T, 2008, EUR J ORG CHEM, P4405, DOI 10.1002/ejoc.200800561; Wipf P., 1993, ANGEW CHEM, V105, P1095, DOI 10.1002/ange.19931050720; You JS, 2001, CHEM COMMUN, P1546, DOI 10.1039/b103618c; Zwifel G., 1984, ORG REACTIONS, V32, P375	55	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1434-193X	1099-0690		EUR J ORG CHEM	Eur. J. Org. Chem.	NOV	2015		33					7378	7383		10.1002/ejoc.201500910		6	Chemistry, Organic	Chemistry	CW4NQ	WOS:000364968800021		
J	Smorra, C; Blaum, K; Bojtar, L; Borchert, M; Franke, KA; Higuchi, T; Leefer, N; Nagahama, H; Matsuda, Y; Mooser, A; Niemann, M; Ospelkaus, C; Quint, W; Schneider, G; Sellner, S; Tanaka, T; Van Gorp, S; Walz, J; Yamazaki, Y; Ulmer, S				Smorra, C.; Blaum, K.; Bojtar, L.; Borchert, M.; Franke, K. A.; Higuchi, T.; Leefer, N.; Nagahama, H.; Matsuda, Y.; Mooser, A.; Niemann, M.; Ospelkaus, C.; Quint, W.; Schneider, G.; Sellner, S.; Tanaka, T.; Van Gorp, S.; Walz, J.; Yamazaki, Y.; Ulmer, S.			BASE - The Baryon Antibaryon Symmetry Experiment	EUROPEAN PHYSICAL JOURNAL-SPECIAL TOPICS			English	Review							PENNING TRAP TECHNIQUE; ELECTRON MASS-RATIO; MAGNETIC-MOMENT; BOHR MAGNETONS; SINGLE PROTON; ATOMIC MASS; ANTIPROTON; SPECTROSCOPY; IONS; CPT	The Baryon Antibaryon Symmetry Experiment (BASE) aims at performing a stringent test of the combined charge parity and time reversal (CPT) symmetry by comparing the magnetic moments of the proton and the antiproton with high precision. Using single particles in a Penning trap, the proton/antiproton g-factors, i.e. the magnetic moment in units of the nuclear magneton, are determined by measuring the respective ratio of the spin-precession frequency to the cyclotron frequency. The spin precession frequency is measured by non-destructive detection of spin quantum transitions using the continuous Stern-Gerlach effect, and the cyclotron frequency is determined from the particle*s motional eigenfrequencies in the Penning trap using the invariance theorem. By application of the double Penning-trap method we expect that in our measurements a fractional precision of delta g/g 10(-9) can be achieved. The successful application of this method to the antiproton will consist a factor 1000 improvement in the fractional precision of its magnetic moment. The BASE collaboration has constructed and commissioned a new experiment at the Antiproton Decelerator (AD) of CERN. This article describes and summarizes the physical and technical aspects of this new experiment.	[Smorra, C.; Higuchi, T.; Nagahama, H.; Mooser, A.; Sellner, S.; Ulmer, S.] RIKEN, Ulmer Initiat Res Unit, Wako, Saitama 3510198, Japan; [Smorra, C.; Bojtar, L.] CERN, CH-1211 Geneva 23, Switzerland; [Blaum, K.; Franke, K. A.] Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; [Borchert, M.; Niemann, M.; Ospelkaus, C.] Leibniz Univ Hannover, Inst Quantum Opt, D-30167 Hannover, Germany; [Higuchi, T.; Nagahama, H.; Matsuda, Y.; Tanaka, T.; Yamazaki, Y.] Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo 1538902, Japan; [Leefer, N.; Walz, J.] Helmholtz Inst Mainz, D-55099 Mainz, Germany; [Schneider, G.] Johannes Gutenberg Univ Mainz, Inst Phys, D-55099 Mainz, Germany; [Ospelkaus, C.] Phys Tech Bundesanstalt, D-38116 Braunschweig, Germany; [Quint, W.] GSI Helmholtzzentrum Schwerionenforsch, D-64291 Darmstadt, Germany; [Quint, W.] Heidelberg Univ, D-69047 Heidelberg, Germany; [Van Gorp, S.; Yamazaki, Y.] RIKEN, Atom Phys Lab, Wako, Saitama 3510198, Japan	Smorra, C (reprint author), RIKEN, Ulmer Initiat Res Unit, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	Christian.Smorra@cern.ch			RIKEN Initiative Research Unit Program; RIKEN President Funding; RIKEN Pioneering Project Funding; RIKEN FPR program; RIKEN JRA program; Max-Planck Society; CERN fellowship program; BMBF; Helmholtz-Gemeinschaft; EU (ERC) [290870-MEFUCO, 337154-QLEDS]; Marie Curie International Incoming Fellowship; CERN; AD group; engineering department; vacuum-group; rf-group; integration service; HSE department; magnet group; survey group of CERN	We acknowledge financial support of RIKEN Initiative Research Unit Program, RIKEN President Funding, RIKEN Pioneering Project Funding, RIKEN FPR program, RIKEN JRA program, the Max-Planck Society, the CERN fellowship program, the BMBF, the Helmholtz-Gemeinschaft, and the EU (ERC Advanced Grant No. 290870-MEFUCO and ERC Starting Grant No. 337154-QLEDS). N.L. was supported by a Marie Curie International Incoming Fellowship within the 7th European Community Framework Programme. We acknowledge support from CERN, in particular, the AD group, the engineering department, the vacuum-group, the rf-group, the integration service, the HSE department, the magnet group and the survey group of CERN. We would like to express our gratitude towards F. Butin for his strong support regarding integration of the experiment into the AD hall.	Deslauriers L, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.103007; Brown KR, 2011, NATURE, V471, P196, DOI 10.1038/nature09721; Thompson JK, 2004, NATURE, V430, P58, DOI 10.1038/nature02682; GABRIELSE G, 1989, PHYS REV LETT, V63, P1360, DOI 10.1103/PhysRevLett.63.1360; Daniilidis N, 2009, J PHYS B-AT MOL OPT, V42, DOI 10.1088/0953-4075/42/15/154012; Chou CW, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.070802; Schmidt PO, 2005, SCIENCE, V309, P749, DOI 10.1126/science.1114375; Van Dyck RS, 1999, REV SCI INSTRUM, V70, P1665, DOI 10.1063/1.1149649; Haffner H, 2003, EUR PHYS J D, V22, P163, DOI 10.1140/epjd/e2003-00012-2; PHILLIPS WD, 1977, METROLOGIA, V13, P179, DOI 10.1088/0026-1394/13/4/005; Mooser A, 2013, PHYS LETT B, V723, P78, DOI 10.1016/j.physletb.2013.05.012; Davoudiasl H, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.095006; GABRIELSE G, 1986, PHYS REV LETT, V57, P2504, DOI 10.1103/PhysRevLett.57.2504; Mooser A, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.140405; Ulmer S, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3271537; Ziegler JF, 1999, J APPL PHYS, V85, P1249, DOI 10.1063/1.369844; Hori M, 2011, NATURE, V475, P484, DOI 10.1038/nature10260; VANDYCK RS, 1992, PHYS SCRIPTA, V46, P257; Bennett GW, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.091602; Safavi-Naini A, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.023412; Hite DA, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.103001; FLOWERS JL, 1993, METROLOGIA, V30, P75, DOI 10.1088/0026-1394/30/2/004; WINELAND DJ, 1975, J APPL PHYS, V46, P919, DOI 10.1063/1.321602; DiSciacca J, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.130801; HOLZSCHEITER MH, 1992, PHYS SCRIPTA, V46, P272, DOI 10.1088/0031-8949/46/3/011; Ulmer S, 2014, J PHYS CONF SER, V488, DOI 10.1088/1742-6596/488/1/012033; FEI X, 1987, REV SCI INSTRUM, V58, P2197, DOI 10.1063/1.1139325; Hite DA, 2013, MRS BULL, V38, P826, DOI 10.1557/mrs.2013.207; DiSciacca J, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.153001; SCHWINGENHEUER B, 1995, PHYS REV LETT, V74, P4376, DOI 10.1103/PhysRevLett.74.4376; GABRIELSE G, 1995, PHYS REV LETT, V74, P3544, DOI 10.1103/PhysRevLett.74.3544; BROWN LS, 1982, PHYS REV A, V25, P2423, DOI 10.1103/PhysRevA.25.2423; CORNELL EA, 1990, PHYS REV A, V41, P312, DOI 10.1103/PhysRevA.41.312; BROWN LS, 1984, PHYS REV LETT, V52, P2013, DOI 10.1103/PhysRevLett.52.2013; Amole C, 2012, NATURE, V483, P439, DOI 10.1038/nature10942; MACALPINE WW, 1959, P IRE, V47, P2099, DOI 10.1109/JRPROC.1959.287128; D'Urso B, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.113002; Djekic S, 2004, EUR PHYS J D, V31, P451, DOI 10.1140/epjd/e2004-00168-1; Myers EG, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.013003; ESSEN L, 1971, NATURE, V229, P110, DOI 10.1038/229110a0; VANDYCK RS, 1987, PHYS REV LETT, V59, P26, DOI 10.1103/PhysRevLett.59.26; Bluhm R, 1998, PHYS REV D, V57, P3932, DOI 10.1103/PhysRevD.57.3932; Gabrielse G, 2006, INT J MASS SPECTROM, V251, P273, DOI 10.1016/j.ijms.2006.02.013; Van Dyck RS, 1999, AIP CONF PROC, V457, P101; CORNELL EA, 1989, PHYS REV LETT, V63, P1674, DOI 10.1103/PhysRevLett.63.1674; Ulmer S, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.253001; Blaum K, 2006, PHYS REP, V425, P1, DOI 10.1016/j.physrep.2005.10.011; Haffner H, 2000, PHYS REV LETT, V85, P5308, DOI 10.1103/PhysRevLett.85.5308; Sturm S, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.143003; Bennett GW, 2006, PHYS REV D, V73, DOI 10.1103/PhysRevD.73.072003; Amole C, 2014, NUCL INSTRUM METH A, V735, P319, DOI 10.1016/j.nima.2013.09.043; Gabrielse G, 1999, PHYS REV LETT, V82, P3198, DOI 10.1103/PhysRevLett.82.3198; GABRIELSE G, 1989, PHYS REV A, V40, P481, DOI 10.1103/PhysRevA.40.481; Harlander M, 2011, NATURE, V471, P200, DOI 10.1038/nature09800; Parthey CG, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.203001; Ulmer S, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.103002; Turchette QA, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.063418; Wineland DJ, 1998, J RES NATL INST STAN, V103, P259, DOI 10.6028/jres.103.019; Sturm S, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.030501; Olive KA, 2014, CHINESE PHYS C, V38, DOI 10.1088/1674-1137/38/9/090001; Pask T, 2009, PHYS LETT B, V678, P55, DOI 10.1016/j.physletb.2009.05.038; Rodegheri CC, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/6/063011; GABRIELSE G, 1989, INT J MASS SPECTROM, V88, P319, DOI 10.1016/0168-1176(89)85027-X; Ulmer S, 2015, NATURE, V524, P196, DOI 10.1038/nature14861; Solders A, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.012514; Mavadia S, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.032502; Verdu J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.093002; Mooser A, 2014, NATURE, V509, P596, DOI 10.1038/nature13388; D'Urso B, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.043001; Cesar CL, 1996, PHYS REV LETT, V77, P255, DOI 10.1103/PhysRevLett.77.255; Bluhm R, 1997, PHYS REV LETT, V79, P1432, DOI 10.1103/PhysRevLett.79.1432; Mohr PJ, 2012, REV MOD PHYS, V84, P1527, DOI 10.1103/RevModPhys.84.1527; Dehmelt H, 1999, PHYS REV LETT, V83, P4694, DOI 10.1103/PhysRevLett.83.4694; BROWN LS, 1986, REV MOD PHYS, V58, P233, DOI 10.1103/RevModPhys.58.233; GRAFF G, 1980, Z PHYS A-HADRON NUCL, V297, P35, DOI 10.1007/BF01414243; Ulmer S, 2013, NUCL INSTRUM METH A, V705, P55, DOI 10.1016/j.nima.2012.12.071; Arkani-Hamed N, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.015014; Benedikt M., 2004, CERN2004003V3 LHC; BROWN LS, 1985, ANN PHYS-NEW YORK, V159, P62, DOI 10.1016/0003-4916(85)90192-7; Chupp T., 2013, COMMUNICATION; Colladay A., 1998, PHYS REV D, V58; Cornejo J.M., 2012, ADV HIGH ENERGY PHYS, V2012; Dehmelt H., 1973, B AM PHYS SOC, V18, P72; DEHMELT H, 1986, P NATL ACAD SCI USA, V83, P5761, DOI 10.1073/pnas.83.16.5761; DIFILIPPO F, 1995, PHYS SCRIPTA, VT59, P144, DOI 10.1088/0031-8949/1995/T59/018; Eliseev S, 2014, APPL PHYS B-LASERS O, V114, P107, DOI 10.1007/s00340-013-5621-0; Gabrielse G., 1986, J APPL PHYS, V63, P15; Goodwin J.F., 2014, ARXIV14076121PHYSICS; Grange J., 2015, ARXIV150106858PHYSIC; Hanneke D, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.120801; Kostelecky A., 1998, PHYS REV LETT, V80, P1818; Kuroda N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4089; Maury S, 1997, HYPERFINE INTERACT, V109, P43, DOI 10.1023/A:1012632812327; Mibe T, 2010, CHINESE PHYS C, V34, P745, DOI 10.1088/1674-1137/34/6/022; Nikiel A, 2014, EUR PHYS J D, V68, DOI 10.1140/epjd/e2014-50401-3; Repp J, 2012, APPL PHYS B-LASERS O, V107, P983, DOI 10.1007/s00340-011-4823-6; Smorra C, 2014, HYPERFINE INTERACT, V228, P31, DOI 10.1007/s10751-014-1018-7; Smorra C., 2015, INT J MASS IN PRESS; Stahl S, 2005, J PHYS B-AT MOL OPT, V38, P297, DOI 10.1088/0953-4075/38/3/013; Streubel S, 2014, APPL PHYS B-LASERS O, V114, P137, DOI 10.1007/s00340-013-5669-x; Thompson J., 1977, J SCI VAC TECHNOL, V14, P643; HEINZEN DJ, 1990, PHYS REV A, V42, P2977, DOI 10.1103/PhysRevA.42.2977; Wineland D.J., 2001, P 2001 FREQ STAND ME, P361; WINKLER PF, 1972, PHYS REV A, V5, P83, DOI 10.1103/PhysRevA.5.83	104	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1951-6355	1951-6401		EUR PHYS J-SPEC TOP	Eur. Phys. J.-Spec. Top.	NOV	2015	224	16					3055	3108		10.1140/epjst/e2015-02607-4		54	Physics, Multidisciplinary	Physics	CX1TK	WOS:000365478300001		
J	Hamazaki, K; Natori, T; Kurihara, S; Murata, N; Cui, ZG; Kigawa, M; Morozumi, R; Inadera, H				Hamazaki, K.; Natori, T.; Kurihara, S.; Murata, N.; Cui, Z-G.; Kigawa, M.; Morozumi, R.; Inadera, H.			Fish consumption and depressive symptoms in undergraduate students: A cross-sectional analysis	EUROPEAN PSYCHIATRY			English	Article						Fish consumption; Depressive symptoms; Cross-sectional study; Undergraduate students	POLYUNSATURATED FATTY-ACIDS; NATIONAL NUTRITION; MENTAL-DISORDERS; YOUNG-ADULTS; METAANALYSIS; HEALTH; ASSOCIATIONS; FOLATE; COHORT; OMEGA-3-FATTY-ACIDS	Background: Emerging evidence suggests that fish consumption may have beneficial effects on mood disorders. However, no study has been reported on this issue in young adults to date. The aim of this study was to investigate the relationship between fish consumption and depressive symptoms in Japanese undergraduate students. Methods: The 20-item Center for Epidemiologic Studies Depression Scale was used to measure depressive symptoms with a cut-off score of 16. A total of 4190 completed questionnaires (from 2124 men and 2066 women) were received for analysis. Results: Multivariate logistic analysis showed that fish intake was inversely associated with risk of depressive symptoms in undergraduate students. After adjustment for possible confounders, the odds-ratios (95% confidence intervals) for fish intake 1-2 times/month, 1-2 times/week, 3-4 times/week, and almost every day (compared with "almost never'') were 0.78 (0.62-0.99), 0.70 (0.56-0.87), 0.67 (0.53-0.85) and 0.65 (0.46-0.92), respectively. This association tended to be stronger in women than in men. Conclusions: Frequent fish consumption in undergraduate students seems to moderate depressive symptoms. Further research is warranted to clarify the causality. (C) 2015 Elsevier Masson SAS. All rights reserved.	[Hamazaki, K.; Natori, T.; Kurihara, S.; Murata, N.; Cui, Z-G.; Kigawa, M.; Inadera, H.] Toyama Univ, Dept Publ Hlth, Fac Med, Toyama, Toyama 9300194, Japan; [Morozumi, R.] Toyama Univ, Fac Econ, Toyama, Toyama 9308555, Japan	Hamazaki, K (reprint author), Toyama Univ, Dept Publ Hlth, Fac Med, 2630 Sugitani, Toyama, Toyama 9300194, Japan.	keihama@med.u-toyama.ac.jp			National Center of Neurology and Psychiatry; Japan Society for the Promotion of Science; Polyene Project, Inc.; Otsuka Pharmaceutical Co., Ltd; DHA & EPA Association	K.H. received support via an Intramural Research Grant for Neurological and Psychiatric Disorders from the National Center of Neurology and Psychiatry and a grant from the Japan Society for the Promotion of Science; consultant fees from Polyene Project, Inc. and scholarship donations from Otsuka Pharmaceutical Co., Ltd; and speaker fees from DHA & EPA Association.	Albanese E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038879; Almeida OP, 2015, INT PSYCHOGERIATR, P1; Hunt J, 2010, J ADOLESCENT HEALTH, V46, P3, DOI 10.1016/j.jadohealth.2009.08.008; Barberger-Gateau P, 2005, EUR J CLIN NUTR, V59, P817, DOI 10.1038/sj.ejcn.1602145; Lin PY, 2010, BIOL PSYCHIAT, V68, P140, DOI 10.1016/j.biopsych.2010.03.018; Weich S, 1998, BRIT MED J, V317, P115; Ju SY, 2013, J NUTR HEALTH AGING, V17, P447, DOI 10.1007/s12603-012-0418-0; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Bountziouka V, 2009, J AGING HEALTH, V21, P864, DOI 10.1177/0898264309340693; Lewis G, 1998, LANCET, V352, P605, DOI 10.1016/S0140-6736(98)04494-8; Tanskanen A, 2001, PSYCHIATR SERV, V52, P529, DOI 10.1176/appi.ps.52.4.529; Harris WS, 2012, ATHEROSCLEROSIS, V225, P425, DOI 10.1016/j.atherosclerosis.2012.05.030; Celentano DD, 2008, J ADDICT MED, V2, P66, DOI 10.1097/ADM.0b013e31816c60c1; Li YF, 2011, PSYCHIAT RES, V190, P103, DOI 10.1016/j.psychres.2011.05.012; Blanco C, 2008, ARCH GEN PSYCHIAT, V65, P1429, DOI 10.1001/archpsyc.65.12.1429; Appleton KM, 2007, J AFFECT DISORDERS, V104, P217, DOI 10.1016/j.jad.2007.03.012; Sanchez-Villegas A, 2007, EUR J NUTR, V46, P337, DOI 10.1007/s00394-007-0671-x; Murakami K, 2008, NUTRITION, V24, P140, DOI 10.1016/j.nut.2007.10.013; Smith KJ, 2014, AM J EPIDEMIOL, V179, P1228, DOI 10.1093/aje/kwu050; Rethorst CD, 2009, SPORTS MED, V39, P491, DOI 10.2165/00007256-200939060-00004; Meyer BJ, 2013, NUTRITION, V29, P1042, DOI 10.1016/j.nut.2013.02.006; Hamazaki-Fujita N, 2011, BRAIN RES, V1397, P38, DOI 10.1016/j.brainres.2011.04.044; Yamada T, 2012, PSYCHIAT RES, V200, P1038, DOI 10.1016/j.psychres.2012.04.023; Hoffmire CA, 2012, PROSTAG LEUKOTR ESS, V86, P155, DOI 10.1016/j.plefa.2012.03.003; Pawlosky RJ, 1999, ALCOHOL CLIN EXP RES, V23, P311, DOI 10.1097/00000374-199902000-00017; Pipingas A, 2014, NUTRIENTS, V6, P1956, DOI 10.3390/nu6051956; Tiemeier H, 2002, AM J PSYCHIAT, V159, P2099, DOI 10.1176/appi.ajp.159.12.2099; Freeman MP, 2006, J CLIN PSYCHIAT, V67, P1954; Zeman M, 2012, NEUROENDOCRINOL LETT, V33, P736; Timonen M, 2004, J AFFECT DISORDERS, V82, P447, DOI 10.1016/j.jad.2004.02.002; Gilbody S, 2007, J EPIDEMIOL COMMUN H, V61, P631, DOI 10.1136/jech.2006.050385; Silvers KM, 2002, PUBLIC HEALTH NUTR, V5, P427, DOI 10.1079/PHN2001308; Chrysohoou C, 2011, CARDIOL RES PRACT, V2011; Gowda U, 2015, NUTRITION, V31, P421, DOI 10.1016/j.nut.2014.06.017; Grosso G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096905; Katzman MA, 2015, PSYCHIAT RES; Ministry of Health Labour and Welfare, 2012, NAT HLTH NUTR SURV; Ministry of Health Labour and Welfare, 2003, NAT HLTH NUTR SURV; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Shima S, 1985, CLIN PSYCHIATR, V27, P717; Suominen-Taipale AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010530; Vavakova M, 2015, OXID MED CELL LONGEV, DOI 10.1155/2015/898393; World Health Organization, 2012, WHO SUICIDE DATA 201	43	0	0	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS	23 RUE LINOIS, 75724 PARIS, FRANCE	0924-9338	1778-3585		EUR PSYCHIAT	Eur. Psychiat.	NOV	2015	30	8					983	987		10.1016/j.eurpsy.2015.09.010		5	Psychiatry	Psychiatry	CW7EF	WOS:000365160100019		
J	Ito, S; Nemoto, T; Tsujino, N; Ohmuro, N; Matsumoto, K; Matsuoka, H; Tanaka, K; Nishiyama, S; Suzuki, M; Kinoshita, H; Ozawa, H; Fujita, H; Shimodera, S; Kishimoto, T; Matsumoto, K; Hasegawa, T; Mizuno, M				Ito, S.; Nemoto, T.; Tsujino, N.; Ohmuro, N.; Matsumoto, K.; Matsuoka, H.; Tanaka, K.; Nishiyama, S.; Suzuki, M.; Kinoshita, H.; Ozawa, H.; Fujita, H.; Shimodera, S.; Kishimoto, T.; Matsumoto, K.; Hasegawa, T.; Mizuno, M.			Differential impacts of duration of untreated psychosis (DUP) on cognitive function in first-episode schizophrenia according to mode of onset	EUROPEAN PSYCHIATRY			English	Article						Cognitive function; Duration of untreated psychosis (DUP); First-episode; Mode of onset; Prospective follow-up; Schizophrenia	SOCIAL DETERMINANTS; ASSOCIATION; SYMPTOMS; PATHWAYS; EPISODE; SCALE; INTERVENTION; SERVICES; CARE	Background: The mode of onset and the course of schizophrenia illness exhibit substantial individual variations. Previous studies have pointed out that the mode of onset affects the duration of untreated psychosis (DUP) and clinical outcomes, such as cognitive and social functioning. This study attempted to clarify the association between the DUP and clinical features, taking the different modes of onset into consideration, in a prospective longitudinal study examining patients with first-episode schizophrenia. Methods: This study was conducted in six areas of Japan. Patients with first-episode schizophrenia were followed for over 18 months. Cognitive function, psychopathology, and social functioning were assessed at baseline and at 6, 12, and 18-month follow-up points. Results: We identified 168 patients and sufficient information was available to determine the DUP and the mode of onset for 156 patients (92.9%): 79 had an acute onset, and 77 had an insidious onset. The DUP was significantly associated with quality of life (QOL), social functioning, and cognitive function at most of the follow-up points in the insidious-onset group. The DUP and negative symptoms at baseline were significant predictors of cognitive function at the 18-month follow-up in the insidious-onset group. Conclusions: The present results further support the hypothesis that the DUP affects QOL, social functioning, and cognitive function over the course of illness, especially in patients with an insidious onset. Effective strategies for detecting and caring for individuals with insidious onset early during the course of schizophrenia will be essential for achieving a full patient recovery. (C) 2015 Elsevier Masson SAS. All rights reserved.	[Ito, S.; Matsumoto, K.; Hasegawa, T.] Toho Univ, Sch Med, Dept Social Med, Tokyo 1438541, Japan; [Nemoto, T.; Tsujino, N.; Mizuno, M.] Toho Univ, Sch Med, Dept Neuropsychiat, Tokyo 1438541, Japan; [Ohmuro, N.; Matsumoto, K.; Matsuoka, H.] Toho Univ, Grad Sch Med, Dept Psychiat, Tokyo 1438541, Japan; [Tanaka, K.; Nishiyama, S.; Suzuki, M.] Toyama Univ, Dept Neuropsychiat, Grad Sch Med & Pharmaceut Sci, Toyama 930, Japan; [Kinoshita, H.; Ozawa, H.] Nagasaki Univ, Dept Neuropsychiat, Unit Translat Med, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Fujita, H.; Shimodera, S.] Kochi Univ, Dept Neuropsychiat, Kochi Med Sch, Kochi 780, Japan; [Kishimoto, T.] Nara Med Univ, Dept Psychiat, Nara, Japan	Nemoto, T (reprint author), Toho Univ, Sch Med, Dept Neuropsychiat, Ota Ku, 6-11-1 Omori Nishi, Tokyo 1438541, Japan.	takahiro.nemoto@med.toho-u.ac.jp			Ministry of Health Labor and Welfare, Japan [H23-SEISHIN-IPPAN-009]	This study was partially supported by a grant to Masafumi Mizuno for Comprehensive Research on Disability Health and Welfare (H23-SEISHIN-IPPAN-009) from the Ministry of Health Labor and Welfare, Japan.	ANDREASEN NC, 1992, ARCH GEN PSYCHIAT, V49, P615; Matsuoka K, 2006, PSYCHIAT CLIN NEUROS, V60, P332, DOI 10.1111/j.1440-1819.2006.01510.x; Morgan C, 2006, BRIT J PSYCHIAT, V189, P446, DOI 10.1192/bjp.bp.106.021303; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261; Harrison G, 1996, PSYCHOL MED, V26, P697; LINCOLN CV, 1995, PSYCHIATR SERV, V46, P1166; Marshall M, 2005, ARCH GEN PSYCHIAT, V62, P975, DOI 10.1001/archpsyc.62.9.975; Cuesta MJ, 2012, SCHIZOPHR RES, V141, P222, DOI 10.1016/j.schres.2012.08.019; Goldberg TE, 2009, SCHIZOPHR RES, V107, P262, DOI 10.1016/j.schres.2008.11.003; Birchwood M, 2013, BRIT J PSYCHIAT, V203, P58, DOI 10.1192/bjp.bp.112.125500; Chang WC, 2013, PSYCHOL MED, V43, P1883, DOI 10.1017/S0033291712002838; Green MF, 2000, SCHIZOPHRENIA BULL, V26, P119; Yamazawa R, 2004, PSYCHIAT CLIN NEUROS, V58, P76, DOI 10.1111/j.1440-1819.2004.01196.x; Keefe RSE, 2006, AM J PSYCHIAT, V163, P426, DOI 10.1176/appi.ajp.163.3.426; Farooq S, 2009, SCHIZOPHR RES, V109, P15, DOI 10.1016/j.schres.2009.01.008; Nishii H, 2010, EARLY INTERV PSYCHIA, V4, P182, DOI 10.1111/j.1751-7893.2010.00179.x; Perkins DO, 2005, AM J PSYCHIAT, V162, P1785, DOI 10.1176/appi.ajp.162.10.1785; Rapp C, 2013, SCHIZOPHR RES, V145, P43, DOI 10.1016/j.schres.2012.12.016; Verdoux H, 2001, SCHIZOPHR RES, V49, P231, DOI 10.1016/S0920-9964(00)00072-4; Green MF, 2004, SCHIZOPHR RES, V72, P41, DOI 10.1016/j.schres.2004.09.009; Yamazawa R, 2008, AUST NZ J PSYCHIAT, V42, P159, DOI 10.1080/00048670701787537; Association. AP, 1994, DIAGN STAT MAN DIS; BIRCHWOOD M, 1990, BRIT J PSYCHIAT, V157, P853, DOI 10.1192/bjp.157.6.853; Guy W, 1976, EARLY CLIN DRUG EVAL; Ito S, 2011, SEISHIN IGAKU, V53, P559; Jablensky A, 1992, Psychol Med Monogr Suppl, V20, P1; Kanecla Y, 2010, SEISHIN IGAKU, V52, P1027; Nakane M, 1997, WHOQOL MANUAL; Nelson H. E., 1982, NATL ADULT READING T; Nemoto T, 2008, JPN B SOC PSYCHIAT, V17, P188; Okazaki Y, 1994, CASH; Organization WH, 1996, PERS PSYCH HIST SCHE; Yamada H, 1991, POSITIVE NEGATIVE SY	33	0	0	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS	23 RUE LINOIS, 75724 PARIS, FRANCE	0924-9338	1778-3585		EUR PSYCHIAT	Eur. Psychiat.	NOV	2015	30	8					995	1001		10.1016/j.eurpsy.2015.08.004		7	Psychiatry	Psychiatry	CW7EF	WOS:000365160100021		
J	Hattori, M; Yokoyama, Y; Hattori, T; Motegi, S; Amano, H; Hatada, I; Ishikawa, O				Hattori, Mai; Yokoyama, Yoko; Hattori, Tomoyasu; Motegi, Sei-ichiro; Amano, Hiroo; Hatada, Izuho; Ishikawa, Osamu			Global DNA hypomethylation and hypoxia-induced expression of the ten eleven translocation (TET) family, TET1, in scleroderma fibroblasts	EXPERIMENTAL DERMATOLOGY			English	Article						DNA methylation; epigenetics; fibroblasts; systemic sclerosis; ten eleven translocation	CD4+ T-CELLS; SYSTEMIC-SCLEROSIS; METHYLATION; PROTEINS; GENE; 5-HYDROXYMETHYLCYTOSINE; 5-METHYLCYTOSINE; PATHOGENESIS; CONVERSION; FLI1	The precise mechanisms of tissue fibrosis have not yet been elucidated in systemic sclerosis (SSc). However, studies of the regulation of DNA methylation, the most widely studied epigenetic mechanism, have confirmed the involvement of the TET family proteins, recently identified DNA demethylases, in the pathogenesis of SSc. The mRNA levels of TET family members were compared in normal and SSc fibroblasts. The effects of hypoxia and siRNA specific to HIF-1 alpha on TET expression were also examined. Global methylation status was analysed by LUMA. The presence of 5-hydroxymethylcytosine (5hmC) in SSc was examined by immunohistochemistry. The level of TET1 mRNA in SSc fibroblasts was elevated by 1.68 fold compared with that of normal fibroblasts, but the expression levels of TET2 and TET3 were comparable between both cell types. The expression levels of DNMT1 and DNMT3B mRNA have a tendency to elevate in SSc fibroblasts. Among TET family members, the expression of TET1 was exclusively induced by hypoxia via HIF-1 alpha-independent pathways in SSc fibroblasts, but not in normal fibroblasts. The methylation level was decreased in SSc fibroblasts relative to normal fibroblasts, and 5hmC was present in dermal fibroblasts of skin sections from patients with SSc. TET1 expression in SSc fibroblasts was abnormally regulated in the hypoxic environment and accompanied by global DNA hypomethylation, suggesting the involvement of aberrant DNA methylation in the pathogenesis of SSc.	[Hattori, Mai; Yokoyama, Yoko; Hattori, Tomoyasu; Motegi, Sei-ichiro; Amano, Hiroo; Ishikawa, Osamu] Gunma Univ, Grad Sch Med, Dept Dermatol, Maebashi, Gumma 3718511, Japan; [Hattori, Tomoyasu] Hattori Dermatol Clin, Takasaki, Gumma, Japan; [Hatada, Izuho] Gunma Univ, Inst Mol & Cellular Regulat, Biosignal Genome Resource Ctr, Lab Genome Sci, Maebashi, Gumma 3718511, Japan	Amano, H (reprint author), Gunma Univ, Grad Sch Med, Dept Dermatol, 3-39-22 Showa Machi, Maebashi, Gumma 3718511, Japan.	hamano@gunma-u.ac.jp					Altorok N, 2015, RHEUMATOLOGY, V54, P1759, DOI 10.1093/rheumatology/keu155; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Lei W, 2009, SCAND J RHEUMATOL, V38, P369, DOI 10.1080/03009740902758875; Qi Q, 2009, J EUR ACAD DERMATOL, V23, P160, DOI 10.1111/j.1468-3083.2008.03016.x; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Selmi C, 2012, CLIN EXP IMMUNOL, V169, P253, DOI 10.1111/j.1365-2249.2012.04621.x; Motegi S, 2014, EXP DERMATOL, V23, P664, DOI 10.1111/exd.12500; Fan SC, 2009, BIOCHEM BIOPH RES CO, V383, P421, DOI 10.1016/j.bbrc.2009.04.023; Luo YY, 2013, J AUTOIMMUN, V41, P161, DOI 10.1016/j.jaut.2013.01.012; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Lian XR, 2012, ARTHRITIS RHEUM-US, V64, P2338, DOI 10.1002/art.34376; Asano Y, 2010, J DERMATOL SCI, V59, P153, DOI 10.1016/j.jdermsci.2010.06.008; Abe M, 2003, J BIOL CHEM, V278, P47707, DOI 10.1074/jbc.M306228200; Tan L, 2012, DEVELOPMENT, V139, P1895, DOI 10.1242/dev.070771; Distler JHW, 2004, ARTHRITIS RHEUM, V50, P10, DOI 10.1002/art.11425; Jiang HY, 2012, CLIN IMMUNOL, V143, P39, DOI 10.1016/j.clim.2012.01.005; Kubo M, 2003, AM J PATHOL, V163, P571, DOI 10.1016/S0002-9440(10)63685-1; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Williams K, 2012, EMBO REP, V13, P28, DOI 10.1038/embor.2011.233; Bohm M, 2014, EXP DERMATOL, V23, P679, DOI 10.1111/exd.12497; Wang YQ, 2006, ARTHRITIS RHEUM, V54, P2271, DOI 10.1002/art.21948; Beyer C, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2598; Mimura Imari, 2011, J Pharmacol Sci, V115, P453; Quintero-Ronderos P, 2012, AUTOIMMUNE DIS, V2012	25	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0906-6705	1600-0625		EXP DERMATOL	Exp. Dermatol.	NOV	2015	24	11					841	846		10.1111/exd.12767		6	Dermatology	Dermatology	CX0RL	WOS:000365404300007		
J	Tagami-Nagata, N; Serada, S; Fujimoto, M; Tanemura, A; Nakatsuka, R; Ohkawara, T; Murota, H; Kishimoto, T; Katayama, I; Naka, T				Tagami-Nagata, Naoko; Serada, Satoshi; Fujimoto, Minoru; Tanemura, Atsushi; Nakatsuka, Rie; Ohkawara, Tomoharu; Murota, Hiroyuki; Kishimoto, Tadamitsu; Katayama, Ichiro; Naka, Tetsuji			Suppressor of cytokine signalling-1 induces significant preclinical antitumor effect in malignant melanoma cells	EXPERIMENTAL DERMATOLOGY			English	Article						apoptosis; JAK/STAT; malignant melanoma; p53; suppressor of cytokine signalling-1	METASTATIC MELANOMA; THERAPEUTIC TARGET; CUTANEOUS MELANOMA; TYROSINE KINASE; SOCS-1 GENE; PROTEIN; P53; INTERLEUKIN-6; INHIBITION; CANCER	Malignant melanoma is the most aggressive form of skin cancer, responsible for the majority of skin cancer-related deaths. Metastatic melanoma is resistant to surgery, radiation or chemotherapy, and an effective therapy has not yet been established. Our study investigated the therapeutic potential of the suppressor of cytokine signalling-1 (SOCS-1), an endogenous inhibitor of the intracellular cytokine signalling pathway, for treating melanoma. Adenovirus vectors encoding the SOCS-1 gene were used to overexpress SOCS-1 in three melanoma cell lines (G361, SK-MEL5 and SK-MEL28). In G361 and SK-MEL5, overexpression of SOCS-1 significantly reduced cell proliferation and induced apoptosis in vitro and in vivo. Furthermore, we indicated that the antiproliferative effect of SOCS-1 correlated not only with decreased levels of the activation of signal transducer and activator of transcription (STAT) 3 but also with increased levels of p53 expression and phosphorylation. These findings indicate the potential for clinical use of SOCS-1 for melanoma treatment.	[Tagami-Nagata, Naoko; Serada, Satoshi; Fujimoto, Minoru; Nakatsuka, Rie; Ohkawara, Tomoharu; Naka, Tetsuji] Natl Inst Biomed Innovat, Lab Immune Signal, Ibaraki, Osaka 5670085, Japan; [Tagami-Nagata, Naoko; Tanemura, Atsushi; Murota, Hiroyuki; Katayama, Ichiro] Osaka Univ, Grad Sch Med, Dept Dermatol, Suita, Osaka, Japan; [Nakatsuka, Rie] Osaka Univ, Grad Sch Med, Dept Surg, Suita, Osaka, Japan; [Kishimoto, Tadamitsu] Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Lab Immune Regulat, Suita, Osaka, Japan	Naka, T (reprint author), Natl Inst Biomed Innovat, Lab Immune Signal, 7-6-8 Saito Asagi, Ibaraki, Osaka 5670085, Japan.	tnaka@nibio.go.jp			Ministry of Health, Labour and Welfare, Japan	This study was supported by a Grant-in-Aid from the Ministry of Health, Labour and Welfare, Japan (T. Naka). The authors are grateful to E. Harada for experimental assistance and to Y. Kanazawa and J. Yamagishi for secretarial assistance.	Narazaki M, 1998, P NATL ACAD SCI USA, V95, P13130, DOI 10.1073/pnas.95.22.13130; Masuhara M, 1997, BIOCHEM BIOPH RES CO, V239, P439, DOI 10.1006/bbrc.1997.7484; Margolin K, 2005, CANCER, V104, P1045, DOI 10.1002/cncr.21265; Larkin J, 2014, LANCET ONCOL, V15, P436, DOI 10.1016/S1470-2045(14)70051-8; TARTOUR E, 1994, BRIT J CANCER, V69, P911, DOI 10.1038/bjc.1994.175; Meier F, 2005, FRONT BIOSCI, V10, P2986, DOI 10.2741/1755; Jensen TO, 2012, CANCER-AM CANCER SOC, V118, P2476, DOI 10.1002/cncr.26511; Naka T, 1997, NATURE, V387, P924; Liu L, 2011, CANCER RES, V71, P3972, DOI 10.1158/0008-5472.CAN-10-3852; Calabrese V, 2009, MOL CELL, V36, P754, DOI 10.1016/j.molcel.2009.09.044; Souma Y, 2012, INT J CANCER, V131, P1287, DOI 10.1002/ijc.27350; Parrillas V, 2013, CELL MOL LIFE SCI, V70, P545, DOI 10.1007/s00018-012-1145-8; Iwahori K, 2013, INT J CANCER, V132, P459, DOI 10.1002/ijc.27611; Endo TA, 1997, NATURE, V387, P921; Brose MS, 2002, CANCER RES, V62, P6997; Mouawad R, 1996, CLIN CANCER RES, V2, P1405; Imada K, 2000, MOL IMMUNOL, V37, P1, DOI 10.1016/S0161-5890(00)00018-3; Schlegel J, 2013, J CLIN INVEST, V123, P2257, DOI 10.1172/JCI67816; Fukushima N, 2003, BRIT J CANCER, V89, P338, DOI 10.1038/sj.bjc.6601039; Bhattacharya S, 2005, BIOCHEM J, V392, P335, DOI 10.1042/BJ20050465; Dahl C, 2007, APMIS, V115, P1161, DOI 10.1111/j.1600-0463.2007.apm_855.xml.x; Yoshimura A, 2012, IMMUNITY, V36, P157, DOI 10.1016/j.immuni.2012.01.010; Chin L, 2003, NAT REV CANCER, V3, P559, DOI 10.1038/nrc1145; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; Starr R, 1997, NATURE, V387, P917; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Sun C, 2014, NATURE, V508, P118, DOI 10.1038/nature13121; Khodadoust MS, 2009, CANCER RES, V69, P6405, DOI 10.1158/0008-5472.CAN-09-1063; Marini A, 2006, J INVEST DERMATOL, V126, P422, DOI 10.1038/sj.jid.5700073; Shimada K, 2013, CANCER SCI, V104, P1483, DOI 10.1111/cas.12266; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Gembarska A, 2012, NAT MED, V18, P1239, DOI 10.1038/nm.2863; Zhuang LQ, 2007, MODERN PATHOL, V20, P416, DOI 10.1038/modpathol.3800750; Lopez-Bergami P, 2008, PHOTOCHEM PHOTOBIOL, V84, P289, DOI 10.1111/j.1751-1097.2007.00254.x; Tas F, 2005, MED ONCOL, V22, P241, DOI 10.1385/MO:22:3:241; Yoshikawa H, 2001, NAT GENET, V28, P29, DOI 10.1038/ng0501-29; Houben R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022096; Philips G K, 2015, INT IMMUNOL, V27, P29; Robinson GW, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-258; Shahar OD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078472; Thangasamy T, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-282	43	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0906-6705	1600-0625		EXP DERMATOL	Exp. Dermatol.	NOV	2015	24	11					864	871		10.1111/exd.12802		8	Dermatology	Dermatology	CX0RL	WOS:000365404300011		
J	Iinuma, S; Kishibe, M; Saito, N; Igawa, S; Honma, M; Takahashi, H; Bando, Y; Yoshida, S; Iizuka, H; Ishida-Yamamoto, A				Iinuma, Shin; Kishibe, Mari; Saito, Nao; Igawa, Satomi; Honma, Masaru; Takahashi, Hidetoshi; Bando, Yoshio; Yoshida, Shigetaka; Iizuka, Hajime; Ishida-Yamamoto, Akemi			Klk8 is required for microabscess formation in a mouse imiquimod model of psoriasis	EXPERIMENTAL DERMATOLOGY			English	Letter						KLK; kallikrein-related peptidase; Klk; mouse kallikrein-related peptidase	SKIN INFLAMMATION; EXPRESSION; AXIS; MICE		[Iinuma, Shin; Kishibe, Mari; Saito, Nao; Igawa, Satomi; Honma, Masaru; Takahashi, Hidetoshi; Iizuka, Hajime; Ishida-Yamamoto, Akemi] Asahikawa Med Univ, Dept Dermatol, Asahikawa, Hokkaido 0788510, Japan; [Bando, Yoshio; Yoshida, Shigetaka] Asahikawa Med Univ, Dept Funct Anat & Neurosci, Asahikawa, Hokkaido 0788510, Japan	Iinuma, S (reprint author), Asahikawa Med Univ, Dept Dermatol, Midorigaoka Higashi 2-1-1-1, Asahikawa, Hokkaido 0788510, Japan.	iinuma@asahikawa-med.ac.jp					Johnston A, 2011, J IMMUNOL, V186, P2613, DOI 10.4049/jimmunol.1003162; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Perera GK, 2012, ANNU REV PATHOL-MECH, V7, P385, DOI 10.1146/annurev-pathol-011811-132448; Tortola L, 2012, J CLIN INVEST, V122, P3965, DOI 10.1172/JCI63451; Komatsu N, 2005, BRIT J DERMATOL, V153, P274, DOI 10.1111/j.1365-2133.2005.06754.x; Lowes MA, 2013, TRENDS IMMUNOL, V34, P174, DOI 10.1016/j.it.2012.11.005; Muhr P, 2011, BRIT J DERMATOL, V165, P189, DOI 10.1111/j.1365-2133.2011.10302.x; Yoshida S, 2010, BIOL CHEM, V391, P375, DOI 10.1515/BC.2010.034; Frenzel DF, 2015, EXP DERMATOL, V24, P305, DOI 10.1111/exd.12649	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0906-6705	1600-0625		EXP DERMATOL	Exp. Dermatol.	NOV	2015	24	11					887	889		10.1111/exd.12794		4	Dermatology	Dermatology	CX0RL	WOS:000365404300017		
J	Takada, S; Kinugawa, S; Matsushima, S; Takemoto, D; Furihata, T; Mizushima, W; Fukushima, A; Yokota, T; Ono, Y; Shibata, H; Okita, K; Tsutsui, H				Takada, Shingo; Kinugawa, Shintaro; Matsushima, Shouji; Takemoto, Daisuke; Furihata, Takaaki; Mizushima, Wataru; Fukushima, Arata; Yokota, Takashi; Ono, Yoshiko; Shibata, Hiroshi; Okita, Koichi; Tsutsui, Hiroyuki			Sesamin prevents decline in exercise capacity and impairment of skeletal muscle mitochondrial function in mice with high-fat diet-induced diabetes	EXPERIMENTAL PHYSIOLOGY			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; LOWER AEROBIC CAPACITY; OXIDATIVE STRESS; ANGIOTENSIN-II; METABOLIC SYNDROME; RAT-LIVER; ANTIOXIDATIVE METABOLITES; NAD(P)H OXIDASE; ACID OXIDATION; HEART-FAILURE	New Findings What is the central question of this study? Our aim was to examine whether sesamin can prevent a decline in exercise capacity in high-fat diet-induced diabetic mice. Our hypothesis was that maintenance of mitochondrial function and attenuation of oxidative stress in the skeletal muscle would contribute to this result. What is the main finding and its importance? The new findings are that sesamin prevents the diabetes-induced decrease in exercise capacity and impairment of mitochondrial function through the inhibition of NAD(P)H oxidase-dependent oxidative stress in the skeletal muscle. Sesamin may be useful as a novel agent for the treatment of diabetes mellitus. AbstractWe previously reported that exercise capacity and skeletal muscle mitochondrial function in diabetic mice were impaired, in association with the activation of NAD(P)H oxidase. It has been reported that sesamin inhibits NAD(P)H oxidase-induced superoxide production. Therefore, we examined whether the antioxidant sesamin could prevent a decline in exercise capacity in mice with high-fat diet (HFD)-induced diabetes. C57BL/6J mice were fed a normal diet (ND) or HFD, then treated or not with sesamin (0.2%) to yield the following four groups: ND, ND+Sesamin, HFD and HFD+Sesamin (n=10 each). After 8 weeks, body weight, fat weight, blood glucose, insulin, triglyceride, total cholesterol and fatty acid were significantly increased in HFD compared with ND mice. Sesamin prevented the increases in blood insulin and lipid levels in HFD-fed mice, but did not affect the plasma glucose. Exercise capacity determined by treadmill tests was significantly reduced in HFD mice, but almost completely recovered in HFD+Sesamin mice. Citrate synthase activity was significantly decreased in the skeletal muscle of HFD mice, and these decreases were also inhibited by sesamin. Superoxide anion and NAD(P)H oxidase activity were significantly increased in HFD mice compared with the ND mice and were ameliorated by sesamin. Sesamin prevented the decline in exercise capacity in HFD-induced diabetic mice via maintenance of mitochondrial function, fat oxidation and attenuation of oxidative stress in the skeletal muscle. Our data suggest that sesamin may be useful as a novel agent for the treatment of diabetes mellitus.	[Takada, Shingo; Kinugawa, Shintaro; Matsushima, Shouji; Furihata, Takaaki; Mizushima, Wataru; Fukushima, Arata; Yokota, Takashi; Tsutsui, Hiroyuki] Hokkaido Univ, Grad Sch Med, Dept Cardiovasc Med, Sapporo, Hokkaido 0608638, Japan; [Takemoto, Daisuke; Ono, Yoshiko; Shibata, Hiroshi] Suntory Wellness Ltd, Inst Hlth Care Sci, Osaka, Japan; [Okita, Koichi] Hokusho Univ, Dept Sport Educ, Ebetsu, Hokkaido, Japan	Kinugawa, S (reprint author), Hokkaido Univ, Grad Sch Med, Dept Cardiovasc Med, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0608638, Japan.	tuckahoe@med.hokudai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [24390192, 25893005, 26350879, 26750331, 15K01625, 15K09115, 15K19358, 15H04815]	This study was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology (24390192, 25893005, 26350879, 26750331, 15K01625, 15K09115, 15K19358 and 15H04815).	Nakano D, 2006, J PHARMACOL EXP THER, V318, P328, DOI 10.1124/jpet.105.100149; Mogensen M, 2007, DIABETES, V56, P1592, DOI 10.2337/db06-0981; Takada S, 2014, EUR J PHARMACOL, V740, P690, DOI 10.1016/j.ejphar.2014.06.008; Ide T, 2009, J NUTR SCI VITAMINOL, V55, P31, DOI 10.3177/jnsv.55.31; Nakano D, 2008, CLIN EXP PHARMACOL P, V35, P324, DOI 10.1111/j.1440-1681.2007.04817.x; Regensteiner JG, 2005, DIABETES CARE, V28, P2877, DOI 10.2337/diacare.28.12.2877; Ide T, 2001, BBA-MOL CELL BIOL L, V1534, P1, DOI 10.1016/S1388-1981(01)00167-6; Doughan AK, 2008, CIRC RES, V102, P488, DOI 10.1161/CIRCRESAHA.107.162800; Morten KJ, 2006, J BIOL CHEM, V281, P3354, DOI 10.1074/jbc.M509261200; Ono T, 2015, EXP PHYSIOL, V100, P1052, DOI 10.1113/EP085049; Inoue N, 2012, AM J PHYSIOL-HEART C, V302, pH1202, DOI 10.1152/ajpheart.00534.2011; Yokota T, 2013, DIABETES CARE, V36, P1341, DOI 10.2337/dc12-1161; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Ashakumary L, 1999, METABOLISM, V48, P1303, DOI 10.1016/S0026-0495(99)90272-X; Suga T, 2014, ENDOCRINOLOGY, V155, P68, DOI 10.1210/en.2013-1382; Kanatous SB, 1999, J APPL PHYSIOL, V86, P1247; Park SY, 2014, AM J PHYSIOL-HEART C, V307, pH346, DOI 10.1152/ajpheart.00227.2014; Nishikawa M, 2015, NEPHROL DIAL TRANSPL, V30, P934, DOI 10.1093/ndt/gfv103; Kinugawa S, 2005, CIRCULATION, V111, P1480, DOI 10.1161/01.CIR.0000159261.11520.63; Yokota T, 2011, HYPERTENS RES, V34, P1029, DOI 10.1038/hr.2011.78; Yang M, 2006, AM J HYPERTENS, V19, P587, DOI 10.1016/j.amjhyper.2005.11.017; Wei M, 2000, ANN INTERN MED, V132, P605; Urata H, 2008, CHEM PHARM BULL, V56, P1611, DOI 10.1248/cpb.56.1611; Takada S, 2013, J APPL PHYSIOL, V114, P844, DOI 10.1152/japplphysiol.00053.2012; Roberts CK, 2006, METABOLISM, V55, P928, DOI 10.1016/j.metabol.2006.02.022; Okita K, 1998, CIRCULATION, V98, P1886; Yokota T, 2009, AM J PHYSIOL-HEART C, V297, pH1069, DOI 10.1152/ajpheart.00267.2009; MacDougall JD, 1998, J APPL PHYSIOL, V84, P2138; FUKUDA Y, 1986, J AM OIL CHEM SOC, V63, P1027, DOI 10.1007/BF02673792; Fukushima A, 2014, AM J PHYSIOL-ENDOC M, V307, pE503, DOI 10.1152/ajpendo.00449.2013; Hong Lei, 2013, J Sci Food Agric, V93, P1833, DOI 10.1002/jsfa.5974; Ide T, 2001, CIRC RES, V88, P529; Kadoguchi T, 2015, EXP PHYSIOL, V100, P312, DOI 10.1113/expphysiol.2014.084095; Kinugawa S, 2015, INT HEART J; Nakai M, 2003, J AGR FOOD CHEM, V51, P1666, DOI 10.1021/jf0258961; Roghani M., 2011, International Journal of Endocrinology and Metabolism, V9, P248; Shimoda H., 2006, BMC COMPLEM ALTERN M, V17, P6, DOI DOI 10.1186/1472-6882-6-9; Tomimori N, 2013, BIOPHARM DRUG DISPOS, V34, P462, DOI 10.1002/bdd.1862	39	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0958-0670	1469-445X		EXP PHYSIOL	Exp. Physiol.	NOV 1	2015	100	11					1319	1330		10.1113/EP085251		12	Physiology	Physiology	CW6OQ	WOS:000365117400012		
J	Moon, S; Komada, K; Sato, K; Yokohata, H; Wada, Y; Yasuda, N				Moon, Seoksu; Komada, Keisuke; Sato, Kiyotaka; Yokohata, Hideaki; Wada, Yoshitaka; Yasuda, Nobuhiro			Ultrafast X-ray study of multi-hole GDI injector sprays: Effects of nozzle hole length and number on initial spray formation	EXPERIMENTAL THERMAL AND FLUID SCIENCE			English	Article						Gasoline direct injection; Multi-hole injector; Spray formation; Nozzle hole geometry; X-ray phase-contrast imaging	DIESEL INJECTOR; VORTEX FLOW; PRESSURE; CAVITATION	Nozzle hole design factors, such as length, diameter, position and number of nozzle holes, significantly alter the near-field jet flow and following spray formation of fuel injection nozzles. This study investigates the effects of various nozzle hole design factors on near-field jet flow and spray formation of the multi-hole injectors for gasoline direct-injection (GDI) engines. The novelty of this study lies in intensive analysis in the near-field jet breakup, dynamics and droplet formation process that have rarely been characterized from previous studies by exploiting the potentials of synchrotron X-ray for near-field spray analysis. Among several nozzle hole design factors, the effects of the length and number of nozzle holes are investigated in the current paper as the first part. Four prototype injection nozzles, which have different lengths and numbers of nozzle holes with a substantially low needle lift of 35 pm, were used for this fundamental study. Single- and multi-exposed X-ray phase-contrast images were used to characterize the jet breakup, dynamics and droplet formation process from the nozzle exit to 30 mm downstream. The emerging jet flows from the multi-hole GDI injectors were highly turbulent and perturbed immediately from the nozzle exit. The decrease in nozzle hole length increased the axial and radial flow velocity of the emerging jet flow with an increased void fraction inside the nozzle hole at the nozzle exit. It promoted the jet breakup with formation of smaller and more circular liquid ligaments/droplets in the near-field when the nozzle hole length decreased, which accompanied the higher velocity decrease rate and turbulence strength along the spray axis. On the other hand, the increase in the number of nozzle holes decreased the axial and radial flow velocity of the emerging jet flow. It led to a slower breakup of the jet flow with a lower velocity decrease rate along the spray axis at larger number of nozzle holes. (C) 2015 Elsevier Inc. All rights reserved.	[Moon, Seoksu; Komada, Keisuke] Natl Inst Adv Ind Sci & Technol, Tokyo, Japan; [Sato, Kiyotaka; Yokohata, Hideaki; Wada, Yoshitaka] MAZDA Motor Corp, Tokyo, Japan; [Yasuda, Nobuhiro] Japan Synchrotron Radiat Res Inst SPring 8, Tokyo, Japan	Moon, S (reprint author), 1-2-1 Namiki, Tsukuba 3058564, Ibaraki, Japan.	ss.moon@aist.go.jp					Wilkins SW, 1996, NATURE, V384, P335, DOI 10.1038/384335a0; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62; Lee WG, 2010, J ENG GAS TURB POWER, V132, DOI 10.1115/1.4000145; Zeng W, 2012, EXP THERM FLUID SCI, V40, P81, DOI 10.1016/j.expthermflusci.2012.02.003; Som S, 2010, J ENG GAS TURB POWER, V132, DOI 10.1115/1.3203146; Moon S, 2014, INT J ENGINE RES, V15, P504, DOI 10.1177/1468087413497951; Lee S, 2014, INT J HEAT FLUID FL, V45, P14, DOI 10.1016/j.ijheatfluidflow.2013.11.005; Andriotis A, 2009, ATOMIZATION SPRAY, V19, P247; DAVIS TJ, 1995, NATURE, V373, P595, DOI 10.1038/373595a0; MIESSE CC, 1955, IND ENG CHEM, V47, P1690, DOI 10.1021/ie50549a013; Moon S, 2014, FUEL, V133, P299, DOI 10.1016/j.fuel.2014.05.024; Kim HJ, 2014, OPTIK, V125, P2763, DOI 10.1016/j.ijleo.2013.11.030; Andriotis A, 2008, J FLUID MECH, V610, P195, DOI 10.1017/S0022112008002668; Befrui B., 20102011011211 SAE; Hayashi T., 2012, 12 TRIENN INT C LIQ; Lai MC, 2011, SAE INT J ENGINES, V4, P703; Lai M.C., 20112011011881 SAE; Lin K.C., 2009, 11 TRIENN INT C LIQ; Liu Z., 2009, 11 TRIENN INT C LIQ; Mitroglou N., 20072007011417 SAE; Mitroglou N., 2006, International Journal of Engine Research, V7, DOI 10.1243/146808705X62922; Moon S., 2010, 22 ANN C LIQ AT SPRA; Moon S., 2012, 12 TRIENN INT C LIQ; Shost M.A., 201420140401 SAE; Skogsberg M., 20052005010097 SAE; Sou A., 2007, JSME INT J B-FLUID T, V49, P1253; Yamamoto S., 20092009011497 SAE; Zhao F., 2002, AUTOMOTIVE GASOLINE	28	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0894-1777	1879-2286		EXP THERM FLUID SCI	Exp. Therm. Fluid Sci.	NOV	2015	68						68	81		10.1016/j.expthermflusci.2015.03.027		14	Thermodynamics; Engineering, Mechanical; Physics, Fluids & Plasmas	Thermodynamics; Engineering; Physics	CX0BL	WOS:000365361800007		
J	Wang, JH; Yu, SB; Zhang, M; Jin, W; Huang, ZH; Chen, S; Kobayashi, H				Wang, Jinhua; Yu, Senbin; Zhang, Meng; Jin, Wu; Huang, Zuohua; Chen, Shuang; Kobayashi, Hideaki			Burning velocity and statistical flame front structure of turbulent premixed flames at high pressure up to 1.0 MPa	EXPERIMENTAL THERMAL AND FLUID SCIENCE			English	Article						Turbulent burning velocity; Flame front structure; Flame surface density; High pressure	HIGH-TEMPERATURE; ELEVATED PRESSURES; COMBUSTION; SCALE; CO2	Statistical flame front structure of turbulent premixed flames at high pressure up to 1.0 MPa was measured on a nozzle-type Bunsen burner with OH-PLIF technique. Turbulent burning velocity, flame surface density and flame brush thickness, as well as the local curvature and radius of curvature were derived from the experimental OH-PLIF images. Turbulence-flame interaction was analyzed based on the geometric parameters combined with laminar flame properties and turbulence length scales. Results show that the flame wrinkles at high pressure are dominated by small scale cusps superimposed with large scale flame branches which is a general characteristic of the turbulent premixed flames at high pressure. S-T/S-L increases remarkably with u'/S-L, and the influence of elevated pressure on S-T/S-L is significant. This is mainly due to the increase of flame front area caused by the turbulence wrinkling. Flame surface density significantly increases with the increase of pressure indicating that there is a large amount of fine cusps and small wrinkles in the flame front at high pressure. This would be due to the enhancement of the flame instability represented by effective Lewis number Le(eff) and flame intrinsic instability scale l(i). With the increase of turbulence intensity, the Sigma at high pressure increases while slightly decreases at normal pressure. The most frequent length scale of the flame front moves to smaller value and the possibility increases with the increase of u'/S-L for all pressures. The effect of flame intrinsic instability on finer flame front at high pressure is mainly on the formation of a large number of convex structures which enlarge the effective contact surface between flame front and unburned reactants, resulting in the increase of S-T/S-L. (C) 2015 Elsevier Inc. All rights reserved.	[Wang, Jinhua; Yu, Senbin; Zhang, Meng; Jin, Wu; Huang, Zuohua] Xi An Jiao Tong Univ, State Key Lab Multiphase Flow Power Engn, Xian 710049, Peoples R China; [Chen, Shuang] China Aerodynam Res & Dev Ctr, Mianyang 621000, Peoples R China; [Kobayashi, Hideaki] Tohoku Univ, Inst Fluid Sci, Sendai, Miyagi 9808577, Japan	Wang, JH (reprint author), Xi An Jiao Tong Univ, State Key Lab Multiphase Flow Power Engn, Xian 710049, Peoples R China.	jinhuawang@mail.xjtu.edu.cn	Huang, Zuohua/G-6403-2011	Huang, Zuohua/0000-0002-8932-5842	National Natural Science Foundation of China [51376004]; National Basic Research Program of China [2013CB228406]; State Key Laboratory of Engines at Tianjin University [K2014-4]; Fundamental Research Funds for the Central Universities	This study is supported by National Natural Science Foundation of China (No. 51376004), the National Basic Research Program of China (2013CB228406) and the State Key Laboratory of Engines at Tianjin University (No. K2014-4). The support from the Fundamental Research Funds for the Central Universities is also appreciated.	BRAY KNC, 1991, P ROY SOC LOND A MAT, V434, P217, DOI 10.1098/rspa.1991.0090; Cohe C, 2007, P COMBUST INST, V31, P1345, DOI 10.1016/j.proci.2006.07.181; Bechtold JK, 2001, COMBUST FLAME, V127, P1906, DOI 10.1016/S0010-2180(01)00297-8; Kobayashi H, 2002, P COMBUST INST, V29, P1793, DOI 10.1016/S1540-7489(02)80217-6; Wang JH, 2013, COMBUST FLAME, V160, P2434, DOI 10.1016/j.combustflame.2013.06.008; Lipatnikov AN, 2002, PROG ENERG COMBUST, V28, P1, DOI 10.1016/S0360-1285(01)00007-7; Kobayashi H, 1997, COMBUST FLAME, V108, P104, DOI 10.1016/S0010-2180(96)00103-4; Wang JH, 2013, EXP THERM FLUID SCI, V50, P90, DOI 10.1016/j.expthermflusci.2013.05.008; Zhang M, 2013, INT J HYDROGEN ENERG, V38, P11421, DOI 10.1016/j.ijhydene.2013.05.051; LEE TW, 1992, COMBUST SCI TECHNOL, V84, P121, DOI 10.1080/00102209208951848; SMALLWOOD GJ, 1995, COMBUST FLAME, V101, P461, DOI 10.1016/0010-2180(94)00226-I; Dagaut P, 2012, COMBUST FLAME, V159, P2531, DOI 10.1016/j.combustflame.2012.05.007; Kobayashi H, 2007, P COMBUST INST, V31, P1451, DOI 10.1016/j.proci.2006.07.159; Wang GH, 2004, EXP FLUIDS, V37, P194, DOI 10.1007/s00348-004-0801-7; Yuan J, 2007, P COMBUST INST, V31, P1267, DOI 10.1016/j.proci.2006.07.180; Lee GG, 2000, COMBUST FLAME, V122, P43, DOI 10.1016/S0010-2180(00)00102-4; Bell JB, 2007, P COMBUST INST, V31, P1299, DOI 10.1016/j.proci.2006.07.186; Kobayashi H, 2002, EXP THERM FLUID SCI, V26, P375, DOI 10.1016/S0894-1777(02)00149-8; Wang JH, 2013, P COMBUST INST, V34, P1429, DOI 10.1016/j.proci.2012.06.154; Shim Y, 2011, P COMBUST INST, V33, P1455, DOI 10.1016/j.proci.2010.09.002; Driscoll JF, 2008, PROG ENERG COMBUST, V34, P91, DOI 10.1016/j.pecs.2007.04.002; Zhang M, 2014, EXP THERM FLUID SCI, V52, P288, DOI 10.1016/j.expthermflusci.2013.10.002; Chen YC, 2003, EXP THERM FLUID SCI, V27, P409, DOI 10.1016/S0894-1777(02)00254-6; Veynante D, 2002, PROG ENERG COMBUST, V28, P193, DOI 10.1016/S0360-1285(01)00017-X; Zhang M, 2014, INT J HYDROGEN ENERG, V39, P5176, DOI 10.1016/j.ijhydene.2014.01.038; Buschmann A., 1996, P COMBUST INST, V26, P437; Kee R.J., 1993, SAND898009B SAND NAT; Kee RJ, 1985, SAND858240 SAND NAT; Kobayashi H., 1996, P COMBUST INST, V26, P389; Peters N., 2000, TURBULENT COMBUSTION; Peters N., 1986, P COMBUST INST, V21, P1231; Shepherd I.G., 1992, P COMBUST INST, V24, P485	32	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0894-1777	1879-2286		EXP THERM FLUID SCI	Exp. Therm. Fluid Sci.	NOV	2015	68						196	204		10.1016/j.expthermflusci.2015.04.015		9	Thermodynamics; Engineering, Mechanical; Physics, Fluids & Plasmas	Thermodynamics; Engineering; Physics	CX0BL	WOS:000365361800019		
J	Iwana, T; Suenaga, K; Shirai, K; Kameya, Y; Motosuke, M; Honami, S				Iwana, T.; Suenaga, K.; Shirai, K.; Kameya, Y.; Motosuke, M.; Honami, S.			Heat transfer and fluid flow characteristics of impinging jet using combined device with triangular tabs and synthetic jets	EXPERIMENTAL THERMAL AND FLUID SCIENCE			English	Article						Impinging jet; Heat transfer; Combined device; Hot wire anemometry; Thermosensitive liquid crystal method	IMPINGEMENT; DYNAMICS	The fluid flow and heat transfer characteristics of an impinging jet with a combined active passive device were investigated. The combined device consisted of triangular tabs and a synthetic jet array that provided periodic disturbance to the jet's shear layer. The Reynolds number based on the nozzle diameter (D) was 3.9 x 10(4), and the nozzle-to-wall spacing (L/D) was 2. Four triangular tabs were attached to the nozzle outlet. The synthetic jets were issued at an angle of 30 degrees against the primary jet. Under the triangular tab operation, the longitudinal vortices were generated and the transverse vortex of the primary jet collapsed. Moreover, the velocity of the primary jet increased because of contracted flow. Under the synthetic jet operation, the development of the transverse vortex was promoted due to the increased instability of the shear layer. The jet's periodic disturbances strengthened because of the use of synthetic jets. The combined device operation led to increased velocity magnitude and periodic disturbance of the primary jet; thus, the peak RMS value of the velocity fluctuation was enhanced and the peak local Nusselt number near the stagnation point increased by 35% compared with cases where the device was not used. Additionally, the area-averaged Nusselt number was 10% larger than that obtained without the device. The heat transfer was governed by the jet's velocity, RMS, and periodic velocity fluctuation. These results indicate that the fluid flow and heat transfer characteristics of an impinging jet could be controlled by optimizing the actuation conditions of the combined active-passive device. (C) 2015 Elsevier Inc. All rights reserved.	[Iwana, T.; Suenaga, K.; Shirai, K.; Kameya, Y.; Motosuke, M.; Honami, S.] Tokyo Univ Sci, Dept Mech Engn, Katsushika Ku, Tokyo 1258585, Japan; [Kameya, Y.; Motosuke, M.] Tokyo Univ Sci, Res Inst Sci & Technol, Katsushika Ku, Tokyo 1258585, Japan	Motosuke, M (reprint author), Tokyo Univ Sci, Dept Mech Engn, Katsushika Ku, 6-3-1 Niijuku, Tokyo 1258585, Japan.	mot@rs.tus.ac.jp			JSPS [24360074, 25709013]	A part of the present work was supported by JSPS KAKENHI Grant Numbers 24360074 and 25709013.	LAU JC, 1972, J SOUND VIB, V22, P379, DOI 10.1016/0022-460X(72)90451-8; DIDDEN N, 1985, J FLUID MECH, V160, P235, DOI 10.1017/S0022112085003469; Travnicek Z, 2012, INT J HEAT MASS TRAN, V55, P1279, DOI 10.1016/j.ijheatmasstransfer.2011.09.015; Carlomagno GM, 2014, EXP THERM FLUID SCI, V58, P15, DOI 10.1016/j.expthermflusci.2014.06.010; Carlomagno GM, 2014, SENSORS-BASEL, V14, P21065, DOI 10.3390/s141121065; Violato D, 2012, INT J HEAT FLUID FL, V37, P22, DOI 10.1016/j.ijheatfluidflow.2012.06.003; Smith BL, 1998, PHYS FLUIDS, V10, P2281, DOI 10.1063/1.869828; O'Donovan TS, 2007, INT J HEAT MASS TRAN, V50, P3291, DOI 10.1016/j.ijheatmasstransfer.2007.01.044; ZAMAN KBMQ, 1980, J FLUID MECH, V101, P449, DOI 10.1017/S0022112080001760; Tamburello DA, 2008, INT J HEAT FLUID FL, V29, P967, DOI 10.1016/j.ijheatfluidflow.2008.02.017; Pavlova A, 2006, J HEAT TRANS-T ASME, V128, P897, DOI 10.1115/1.2241889; Gao N, 2003, INT J HEAT MASS TRAN, V46, P2557, DOI 10.1016/S0017-9310(03)00034-6; Dyke M.V., 1982, ALBUM FLUID MOTION; Hayashi T., 2009, JSME J FLUID SCI TEC, V4, P292; HUSSAIN AKMF, 1981, J FLUID MECH, V110, P39, DOI 10.1017/S0022112081000608; Kataoka K., 1987, J HEAT MASS TRANSFER, V39, P559; Liu T S, 1996, J HEAT MASS TRANSFER, V39, P3695; Tesar1 V., 2014, C FLUID DYN; ZAMAN KBMQ, 1994, PHYS FLUIDS, V6, P778, DOI 10.1063/1.868316	19	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0894-1777	1879-2286		EXP THERM FLUID SCI	Exp. Therm. Fluid Sci.	NOV	2015	68						322	329		10.1016/j.expthermflusci.2015.05.007		8	Thermodynamics; Engineering, Mechanical; Physics, Fluids & Plasmas	Thermodynamics; Engineering; Physics	CX0BL	WOS:000365361800031		
J	Terashima, O; Sakai, Y; Goto, Y; Onishi, K; Nagata, K; Ito, Y				Terashima, Osamu; Sakai, Yasuhiko; Goto, Yusuke; Onishi, Kazuhiro; Nagata, Kouji; Ito, Yasumasa			On the turbulent energy transport related to the coherent structures in a planar jet	EXPERIMENTAL THERMAL AND FLUID SCIENCE			English	Article						Proper orthogonal decomposition; Multiple quantity measurement; Plane turbulent jet; Turbulent energy transport	MULTIPOINT SIMULTANEOUS MEASUREMENT; PROPER ORTHOGONAL DECOMPOSITION; SIMILARITY REGION; VELOCITY; EDDIES; MOTION; MODEL	In this study, the turbulent energy transport related to the coherent vortex structures in the self-similarity region of a turbulent planar jet is investigated experimentally. First, two velocity components and the pressure are measured at multiple points simultaneously through the use of a "combined probe" comprising of a pressure probe and an X-type hot-wire probe. Then, proper orthogonal decomposition (POD) is applied to obtained velocity and pressure field data to extract the coherent vortex structures in the jet. A complementary technique combining POD and linear stochastic estimation is then used to reconstruct the spatiotemporal velocity and pressure field for the dominant POD modes. In the reconstructed velocity and pressure field, a coherent vortex structures which have counter-rotating vortices staggered with respect to the jet centerline are observed. This structure contained approximately 42% of the total energy. Finally, the turbulent energy transport related to the coherent vortex structure is evaluated from the reconstructed velocity and pressure field. This estimation shows that the production and pressure diffusion of the turbulent energy in the jet strongly depend on the discussed coherent vortex structures. (C) 2015 Elsevier Inc. All rights reserved.	[Terashima, Osamu; Sakai, Yasuhiko; Goto, Yusuke; Onishi, Kazuhiro; Nagata, Kouji; Ito, Yasumasa] Nagoya Univ, Grad Sch Engn, Mech Engn & Sci, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Terashima, O (reprint author), Nagoya Univ, Grad Sch Engn, Mech Engn & Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan.				Ono Acoustic Research Fund; Takahashi Industrial and Economic Research Foundation;  [23760155]	The authors express their gratitude for partial financial support of this study by the Ono Acoustic Research Fund, Takahashi Industrial and Economic Research Foundation, and the Grant-in-Aids for scientific research (No. 23760155). The Authors also express their gratitude to Mr. Yuichi Shouji, Mr. Kensuke Miura, and Mr. Mamoru Takahashi for performing the experiment with the authors.	Adrian R.J., 1977, TURBULENCE LIQUIDS, P323; Gordeyev SV, 2000, J FLUID MECH, V414, P145, DOI 10.1017/S002211200000848X; TOWNSEND AA, 1949, AUST J SCI RES SER A, V2, P451; MUMFORD JC, 1982, J FLUID MECH, V118, P241, DOI 10.1017/S0022112082001062; ANTONIA RA, 1983, J FLUID MECH, V134, P49, DOI 10.1017/S0022112083003213; Durgesh V, 2010, EXP FLUIDS, V49, P571, DOI 10.1007/s00348-010-0821-4; Sakai Y, 2006, JSME INT J B-FLUID T, V49, P722, DOI 10.1299/jsmeb.49.722; OLER JW, 1982, J FLUID MECH, V123, P523, DOI 10.1017/S0022112082003188; BONNET JP, 1994, EXP FLUIDS, V17, P307, DOI 10.1007/BF01874409; Terashima O, 2012, EXP FLUIDS, V53, P1149, DOI 10.1007/s00348-012-1351-z; ADRIAN RJ, 1979, PHYS FLUIDS, V22, P2065, DOI 10.1063/1.862515; EVERITT KW, 1978, J FLUID MECH, V88, P563, DOI 10.1017/S0022112078002281; THOMAS FO, 1986, PHYS FLUIDS, V29, P1788, DOI 10.1063/1.865606; Tanaka N, 2006, JSME INT J B-FLUID T, V49, P899, DOI 10.1299/jsmeb.49.899; DIMOTAKIS PE, 1983, PHYS FLUIDS, V26, P3185, DOI 10.1063/1.864090; Gordeyev SV, 2002, J FLUID MECH, V460, P349, DOI 10.1017/S0022112002008364; GOLDSCHM.VW, 1973, PHYS FLUIDS, V16, P354, DOI 10.1063/1.1694348; Gortari J.C., 1981, ASME J FLUID ENG, V103, P119; Lumley J., 1967, ATMOSPHERIC TURBULEN, P166; Rajaratnam N., 1976, TURBULENT JETS; Sakai Y, 2007, J FLUID SCI TECHNOL, V2, P611, DOI 10.1299/jfst.2.611; Terashima O, 2014, MEAS SCI TECHNOL, V25, DOI 10.1088/0957-0233/25/5/055301; WYGNANSK.I, 1971, PHYS FLUIDS, V14, P1309, DOI 10.1063/1.1693606	23	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0894-1777	1879-2286		EXP THERM FLUID SCI	Exp. Therm. Fluid Sci.	NOV	2015	68						697	710		10.1016/j.expthermflusci.2015.07.009		14	Thermodynamics; Engineering, Mechanical; Physics, Fluids & Plasmas	Thermodynamics; Engineering; Physics	CX0BL	WOS:000365361800066		
J	Chigwechokha, PK; Tabata, M; Shinyoshi, S; Oishi, K; Araki, K; Komatsu, M; Itakura, T; Shiozaki, K				Chigwechokha, Petros Kingstone; Tabata, Mutsumi; Shinyoshi, Sayaka; Oishi, Kazuki; Araki, Kyosuke; Komatsu, Masaharu; Itakura, Takao; Shiozaki, Kazuhiro			Recombinant sialidase NanA (rNanA) cleaves alpha 2-3 linked sialic acid of host cell surface N-linked glycoprotein to promote Edwardsiella tarda infection	FISH & SHELLFISH IMMUNOLOGY			English	Article						Edwardsiella tarda; NanA; Infection; Sialidase; alpha 2-3 sialo-glycoprotein; Mannose	MEDAKA ORYZIAS-LATIPES; STREPTOCOCCUS-PNEUMONIAE; EPITHELIAL-CELLS; MOLECULAR-CLONING; ESCHERICHIA-COLI; BIOCHEMICAL-CHARACTERIZATION; OREOCHROMIS-NILOTICUS; BACTERIAL SIALIDASES; BIOFILM FORMATION; NEU3 SIALIDASES	Edwardsiella tarda is one of the major pathogenic bacteria affecting both marine and freshwater fish species. Sialidase NanA expressed endogenously in E. tarda is glycosidase removing sialic acids from glycoconjugates. Recently, the relationship of NanA sialidase activity to E. tarda infection has been reported, however, the mechanism with which sialidase NanA aids the pathogenicity of E. tarda remained unclear. Here, we comprehensively determined the biochemical properties of NanA towards various substrates in vitro to provide novel insights on the potential NanA target molecule at the host cell. GAKS cell pretreated with recombinant NanA showed increased susceptibility to E. tarda infection. Moreover, sialidase inhibitor treated E. tarda showed a significantly reduced ability to infect GAKS cells. These results indicate that NanA-induced desialylation of cell surface glycoconjugates is essential for the initial step of E. tarda infection. Among the natural substrates, NanA exhibited the highest activity towards 3-sialyllactose, alpha 2-3 linked sialic acid carrying sialoglycoconjugates. Supporting this finding, intact GAKS cell membrane exposed to recombinant NanA showed changes of glycoconjugates only in alpha 2-3 sialo-linked glycoproteins, but not in glycolipids and alpha 2-6 sialo-linked glycoproteins. Lectin staining of cell surface glycoprotein provided further evidence that alpha 2-3 sialo-linkage of the N-linked glycoproteins was the most plausible target of NanA sialidase. To confirm the significance of alpha 2-3 sialo-linkage desialylation for E. tarda infection, HeLa cells which possessed lower amount of alpha 2-3 sialo-linkage glycoprotein were used for infection experiment along with GAKS cells. As a result, infection of HeLa cells by E. tarda was significantly reduced when compared to GAMS cells. Furthermore, E. tarda infection was significantly inhibited by mannose pretreatment suggesting that the bacterium potentially recognizes and binds to mannose or mannose containing chains following desialylation. Together, these results suggest that E. tarda may employ endogenous NanA to desialylate alpha 2-3 glycoproteins on host cells, thus revealing one of the potential binding molecules during infection. (C) 2015 Elsevier Ltd. All rights reserved.	[Chigwechokha, Petros Kingstone; Araki, Kyosuke; Komatsu, Masaharu; Itakura, Takao; Shiozaki, Kazuhiro] Kagoshima Univ, United Grad Sch Agr Sci, Kagoshima 890, Japan; [Chigwechokha, Petros Kingstone] Mzuzu Univ, Dept Fisheries, Mzuzu, Malawi; [Tabata, Mutsumi; Shinyoshi, Sayaka; Oishi, Kazuki; Araki, Kyosuke; Komatsu, Masaharu; Itakura, Takao; Shiozaki, Kazuhiro] Kagoshima Univ, Fac Fisheries, Kagoshima 890, Japan	Shiozaki, K (reprint author), 4-50-20 Shimo Arata, Kagoshima 8900056, Japan.	shiozaki@fish.kagoshima-u.ac.jp					KRIVAN HC, 1988, P NATL ACAD SCI USA, V85, P6157, DOI 10.1073/pnas.85.16.6157; Li GY, 2011, LETT APPL MICROBIOL, V52, P213, DOI 10.1111/j.1472-765X.2010.02984.x; OFEK I, 1977, NATURE, V265, P623, DOI 10.1038/265623a0; Gut H, 2008, FEBS LETT, V582, P3348, DOI 10.1016/j.febslet.2008.08.026; Park KH, 1996, AQUACULTURE, V143, P135, DOI 10.1016/0044-8486(95)01224-9; Matsuyama T, 2005, FISH PATHOL, V40, P133; CRENNELL SJ, 1993, P NATL ACAD SCI USA, V90, P9852, DOI 10.1073/pnas.90.21.9852; Soong G, 2006, J CLIN INVEST, V116, P2297, DOI 10.1172/JCI27920; KARLSSON KA, 1989, ANNU REV BIOCHEM, V58, P309; Chigwechokha PK, 2014, GENE, V552, P155, DOI 10.1016/j.gene.2014.09.029; Tsai B, 2003, EMBO J, V22, P4346, DOI 10.1093/emboj/cdg439; Li JH, 2014, INFECT IMMUN, V82, P4620, DOI 10.1128/IAI.02322-14; Parker P, 2010, GLYCOCONJUGATE J, V27, P89, DOI 10.1007/s10719-009-9269-2; Shiozaki K, 2014, FISH PHYSIOL BIOCHEM, V40, P1461, DOI 10.1007/s10695-014-9940-9; CAMARA M, 1994, INFECT IMMUN, V62, P3688; Rottner K, 2005, DEV CELL, V9, P3, DOI 10.1016/j.devcel.2005.06.002; Xu T, 2014, J APPL MICROBIOL, V116, P236, DOI 10.1111/jam.12357; Wang C, 2013, INFECT IMMUN, V81, P3527, DOI 10.1128/IAI.00503-13; Yamasaki M, 2013, VET IMMUNOL IMMUNOP, V153, P83, DOI 10.1016/j.vetimm.2013.02.004; Kuroiwa A, 2009, BIOCHEM BIOPH RES CO, V379, P754, DOI 10.1016/j.bbrc.2008.12.120; Jin RP, 2012, FISH SHELLFISH IMMUN, V33, P514, DOI 10.1016/j.fsi.2012.06.002; Xu TT, 2014, AQUACULTURE, V431, P129, DOI 10.1016/j.aquaculture.2013.12.001; PARKKINEN J, 1983, BIOCHEM BIOPH RES CO, V111, P456, DOI 10.1016/0006-291X(83)90328-5; Tong HH, 2000, INFECT IMMUN, V68, P921, DOI 10.1128/IAI.68.2.921-924.2000; Chisada S, 2013, FEMS MICROBIOL LETT, V341, P18, DOI 10.1111/1574-6968.12082; Ryan PA, 2001, INFECT IMMUN, V69, P7402, DOI 10.1128/IAI.69.12.7402-7412.2001; Muratori MCS, 2000, AQUAC RES, V31, P481, DOI 10.1046/j.1365-2109.2000.00448.x; ROSENBERG M, 1986, ADV MICROB ECOL, V9, P353; King SJ, 2006, MOL MICROBIOL, V59, P961, DOI 10.1111/j.1365-2958.2005.04984.x; Honma K, 2011, INFECT IMMUN, V79, P393, DOI 10.1128/IAI.00629-10; MEYER FP, 1973, APPL MICROBIOL, V25, P155; CORFIELD AP, 1983, BIOCHIM BIOPHYS ACTA, V744, P121, DOI 10.1016/0167-4838(83)90080-8; KODAMA H, 1991, CARBOHYD RES, V218, P111, DOI 10.1016/0008-6215(91)84090-2; Vimr ER, 2004, MICROBIOL MOL BIOL R, V68, P132, DOI 10.1128/MMBR.68.1.132-153.2004; Buschiazzo A, 2008, CURR OPIN CHEM BIOL, V12, P565, DOI 10.1016/j.cbpa.2008.06.017; CORFIELD T, 1992, GLYCOBIOLOGY, V2, P509, DOI 10.1093/glycob/2.6.509; Xiao JF, 2008, AQUAC RES, V40, P13, DOI 10.1111/j.1365-2109.2008.02101.x; Pratt LA, 1999, CURR OPIN MICROBIOL, V2, P598, DOI 10.1016/S1369-5274(99)00028-4; Varki A, 2012, ANN NY ACAD SCI, V1253, P16, DOI 10.1111/j.1749-6632.2012.06517.x; Shiozaki K, 2013, BIOCHIMIE, V95, P280, DOI 10.1016/j.biochi.2012.09.026; Wang C, 2013, FISH SHELLFISH IMMUN, V35, P858, DOI 10.1016/j.fsi.2013.06.021; BEACHEY EH, 1981, J INFECT DIS, V143, P325; Fantini J, 2000, GLYCOCONJUGATE J, V17, P173, DOI 10.1023/A:1026580905156; CIAVAGLIA MD, 1993, BIOCHEM BIOPH RES CO, V193, P718, DOI 10.1006/bbrc.1993.1684; Barthelson R, 1998, INFECT IMMUN, V66, P1439; Ueno S, 2006, J BIOL CHEM, V281, P7756, DOI 10.1074/jbc.M509668200; Minami A, 2013, FEBS OPEN BIO, V3, P231, DOI 10.1016/j.fob.2013.05.002; Baum L G, 1990, Acta Histochem Suppl, V40, P35; Chokhawala HA, 2007, CHEMBIOCHEM, V8, P194, DOI 10.1002/cbic.200600410; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136; Li JH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002429; Matsunaga N, 2011, FISHERIES SCI, V77, P583, DOI 10.1007/s12562-011-0350-y; Miyagi T., 2007, COMPREHENSIVE GLYCOS, V3, P297; Mohanty B R, 2007, J Biosci, V32, P1331, DOI 10.1007/s12038-007-0143-8; Nadirah M., 2012, International Food Research Journal, V19, P1247; Thune Ronald L., 1993, Annual Review of Fish Diseases, V3, P37, DOI 10.1016/0959-8030(93)90028-A; WARREN L, 1959, J BIOL CHEM, V234, P1971; Westerlund-Wikstrom B, 2005, INT J MED MICROBIOL, V295, P479, DOI 10.1016/j.ijmm.2005.06.010	58	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1050-4648	1095-9947		FISH SHELLFISH IMMUN	Fish Shellfish Immunol.	NOV	2015	47	1					34	45		10.1016/j.fsi.2015.08.015		12	Fisheries; Immunology; Marine & Freshwater Biology; Veterinary Sciences	Fisheries; Immunology; Marine & Freshwater Biology; Veterinary Sciences	CW5RC	WOS:000365053300005		
J	Visetnan, S; Supungul, P; Tang, S; Hirono, I; Tassanakajon, A; Rimphanitchayakit, V				Visetnan, Suwattana; Supungul, Premruethai; Tang, Sureerat; Hirono, Ikuo; Tassanakajon, Anchalee; Rimphanitchayakit, Vichien			YHV-responsive gene expression under the influence of PmRelish regulation	FISH & SHELLFISH IMMUNOLOGY			English	Article						Relish; Suppression subtractive hybridization; Yellow head virus; Penaeus monodon; Antimicrobial proteins	SHRIMP FENNEROPENAEUS-CHINENSIS; IMMUNE-DEFICIENCY HOMOLOG; BLACK TIGER SHRIMP; NF-KAPPA-B; PENAEUS-MONODON; LITOPENAEUS-VANNAMEI; INNATE IMMUNITY; PROTEIN; RELISH; VIRUS	In animals, infection by Gram-negative bacteria and certain viruses activates the Imd signaling pathway wherein the a NF-kappa B transcription factor, Relish, is a key regulatory protein for the synthesis of antimicrobial proteins. Infection by yellow head virus (YHV) activates the Imd pathway. To investigate the expression of genes involved in YHV infection and under the influence of PmRelish regulation, RNA interference and suppression subtractive hybridization (SSH) are employed. The genes in forward library expressed in shrimp after YHV infection and under the activity of PmRelish were obtained by subtracting the cDNAs from YHV-infected and PmRelish-knockdown shrimp with cDNAs from YHV-infected shrimp. Opposite subtraction gave a reverse library whereby an alternative set of genes under YHV infection and no PmRelish expression were obtained. Nucleotide sequences of 252 and 99 cDNA clones from the forward and reverse libraries, respectively, were obtained and annotated through blast search against the GenBank sequences. Genes involved in defense and homeostasis were abundant in both libraries, 31% and 23% in the forward and reverse libraries, respectively. They were predominantly antimicrobial proteins, proteinases and proteinase inhibitors. The expression of antimicrobial protein genes, ALFPm3, crustinPm1, penaeidin3 and penaeidin5 were tested under PmRelish silencing and Gram-negative bacterium Vibrio harveyi infection. Together with the results using YHV infection previously reported, the expression of penaeidin5 and also penaeidin3 but not ALFPm3 and crustinPm1 were under the regulation of PmRelish in the Imd pathway. (c) 2015 Elsevier Ltd. All rights reserved.	[Visetnan, Suwattana; Supungul, Premruethai; Tang, Sureerat; Tassanakajon, Anchalee; Rimphanitchayakit, Vichien] Chulalongkorn Univ, Fac Sci, Dept Biochem, Ctr Excellence Mol Biol & Genom Shrimp, Bangkok 10330, Thailand; [Supungul, Premruethai; Tang, Sureerat] NSTDA, Natl Ctr Genet Engn & Biotechnol BIOTEC, Pathum Thani 10120, Thailand; [Hirono, Ikuo] Tokyo Univ Marine Sci & Technol, Lab Genome Sci, Minato Ku, Tokyo 1088477, Japan	Rimphanitchayakit, V (reprint author), Chulalongkorn Univ, Fac Sci, Dept Biochem, Ctr Excellence Mol Biol & Genom Shrimp, Phyathai Rd, Bangkok 10330, Thailand.	kpvr2@yahoo.com			90th Anniversary of Chulalongkorn University Fund; NRCT-JSPS ASIAN CORE Program in Fishery Science; Japan International Cooperation Agency (JICA); Thailand Research Fund [RTA5880004]; Chulalongkorn University; Ratchadaphisek Somphot Endowment	This project was supported by the 90th Anniversary of Chulalongkorn University Fund, the NRCT-JSPS ASIAN CORE Program in Fishery Science, the Japan International Cooperation Agency (JICA) and the TRF Senior Research Scholar (No. RTA5880004), Thailand Research Fund. We thank Chulalongkorn University for the 60/40 Support for Tuition Fee to Suwattana Visetnan and the support under the Ratchadaphisek Somphot Endowment to the Center of Excellence for Molecular Biology and Genomics of Shrimp.	Arts JAJ, 2007, FISH SHELLFISH IMMUN, V23, P504, DOI 10.1016/j.fsi.2006.08.018; Huang XD, 2009, FISH SHELLFISH IMMUN, V27, P230, DOI 10.1016/j.fsi.2009.05.003; Tassanakajon A, 2013, FISH SHELLFISH IMMUN, V34, P954, DOI 10.1016/j.fsi.2012.09.021; Wen R, 2013, FISH SHELLFISH IMMUN, V34, P574, DOI 10.1016/j.fsi.2012.11.034; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Khanobdee K, 2002, DIS AQUAT ORGAN, V48, P79, DOI 10.3354/dao048079; Qiu W, 2014, DEV COMP IMMUNOL, V45, P156, DOI 10.1016/j.dci.2014.02.016; Wang DD, 2013, DEV COMP IMMUNOL, V39, P352, DOI 10.1016/j.dci.2012.12.005; Li FH, 2009, DEV COMP IMMUNOL, V33, P1093, DOI 10.1016/j.dci.2009.06.001; Prapavorarat A, 2010, J BIOL CHEM, V285, P21467, DOI 10.1074/jbc.M110.130526; Wang PH, 2009, MOL IMMUNOL, V46, P1897, DOI 10.1016/j.molimm.2009.01.005; Wang DD, 2013, DEV COMP IMMUNOL, V41, P209, DOI 10.1016/j.dci.2013.06.003; Prapavorarat A, 2010, DEV COMP IMMUNOL, V34, P611, DOI 10.1016/j.dci.2010.01.002; Li FH, 2013, DEV COMP IMMUNOL, V39, P11, DOI 10.1016/j.dci.2012.03.016; Huang XD, 2010, DEV COMP IMMUNOL, V34, P107, DOI 10.1016/j.dci.2009.08.009; Wang PH, 2012, DEV COMP IMMUNOL, V36, P359, DOI 10.1016/j.dci.2011.07.007; Pongsomboon S, 2011, FISH SHELLFISH IMMUN, V30, P439, DOI 10.1016/j.fsi.2010.10.015; Tanji T, 2005, TRENDS IMMUNOL, V26, P193, DOI 10.1016/j.it.2005.02.006; Lan JF, 2013, DEV COMP IMMUNOL, V41, P608, DOI 10.1016/j.dci.2013.07.004; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Shibata T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003970	21	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1050-4648	1095-9947		FISH SHELLFISH IMMUN	Fish Shellfish Immunol.	NOV	2015	47	1					572	581		10.1016/j.fsi.2015.09.053		10	Fisheries; Immunology; Marine & Freshwater Biology; Veterinary Sciences	Fisheries; Immunology; Marine & Freshwater Biology; Veterinary Sciences	CW5RC	WOS:000365053300064		
J	Fujita, K; Watanabe, T; Ito, M; Tokai, T				Fujita, Kaoru; Watanabe, Toshihiro; Ito, Masaki; Tokai, Tadashi			Variation in snow crab entry ratio among sections of footrope and its effect on trawl net catching efficiency	FISHERIES SCIENCE			English	Article						Catching efficiency; Entry ratio; Footrope; Red queen crab; Snow crab; Trawl net; Underwater video camera	VIDEO MONITORING-SYSTEM; CHIONOECETES-OPILIO; TOWED SLEDGE; BOTTOM-TRAWL; FISHING EFFICIENCY; NORTHERN HONSHU; PACIFIC COAST; GROUNDROPE; JAPAN	When evaluating catching efficiency of trawl nets for snow crabs, assessing crab behavior around the footrope is crucial. Using two underwater video cameras, we captured footage at three sections of footrope with different thicknesses and attack angles in relation to the towing direction: the belly, the lower wing gusset, and the wing sections. Based on the footage, we calculated the entry ratio (ratio of snow crabs entering the trawl net to the overall number of snow crabs in contact with the footrope). Our results indicated that the entry ratio was 0.122 at both the belly and the lower wing gusset sections and 0.530 at the wing section, suggesting that footrope thickness and/or attack angle in relation to towing direction affects the entry ratio. The total number of crabs that entered was estimated using these entry ratios and corresponded well to the number of individuals captured at the cod end. Considering the variation among entry sections, the catching efficiency of the trawl net used was estimated to range from 0.311 to 0.361. These results demonstrate that calculating the entry ratio at each section of the footrope separately allows for a more accurate estimation of catching efficiency.	[Fujita, Kaoru; Watanabe, Toshihiro] Fisheries Res Agcy, Natl Res Inst Fisheries Engn, Kamisu, Ibaraki 3140408, Japan; [Ito, Masaki] Fisheries Res Agcy, Tohoku Natl Fisheries Res Inst, Hachinohe Stn, Hachinohe, Aomori 0310841, Japan; [Tokai, Tadashi] Tokyo Univ Marine Sci & Technol, Grad Sch Marine Sci & Technol, Minato Ku, Tokyo 1088477, Japan	Fujita, K (reprint author), Fisheries Res Agcy, Natl Res Inst Fisheries Engn, Kamisu, Ibaraki 3140408, Japan.	duke@fra.affrc.go.jp					ANDREW NL, 1991, ICES J MAR SCI, V48, P201, DOI 10.1093/icesjms/48.2.201; Watanabe T, 1999, NIPPON SUISAN GAKK, V65, P503; Hattori T, 2014, NIPPON SUISAN GAKK, V80, P178; Watanabe T, 2004, NIPPON SUISAN GAKK, V70, P297, DOI 10.2331/suisan.70.297; Takahashi H, 2005, NIPPON SUISAN GAKK, V71, P542, DOI 10.2331/suisan.71.542; Fujita K, 2007, NIPPON SUISAN GAKK, V73, P495, DOI 10.2331/suisan.73.495; Choi Jung Hwa, 2012, Fisheries and Aquatic Sciences, V15, P337, DOI 10.5657/FAS.2012.0337; Somerton D, 1999, ICES J MAR SCI, V56, P299, DOI 10.1006/jmsc.1999.0443; Weinberg KL, 1999, ICES J MAR SCI, V56, P266, DOI 10.1006/jmsc.1999.0442; Dawe EG, 2010, FISH RES, V101, P70, DOI 10.1016/j.fishres.2009.09.008; Fujita K, 2006, NIPPON SUISAN GAKK, V72, P695, DOI 10.2331/suisan.72.695; Weinberg KL, 2004, FISH B-NOAA, V102, P740; Somerton DA, 1999, FISH B-NOAA, V97, P617; Ueda Y, 2006, NIPPON SUISAN GAKK, V72, P201, DOI 10.2331/suisan.72.201; Watanabe T, 2001, NIPPON SUISAN GAKK, V67, P640; Naya M, 2010, NIPPON SUISAN GAKK, V76, P658, DOI 10.2331/suisan.76.658; FUWA S, 1989, Memoirs of Faculty of Fisheries Kagoshima University, V38, P103; Inoue Y, 1998, TECH REPT NAT RES I, V20, P23; Ishida T, 2003, B FUKUSHIMA PREF FIS, V11, P49; Kitagawa D, 1998, B JPN SOC FISH OCEAN, V62, P32; Kitagawa D, 1997, TOHOKU SOKOUO KENKYU, V17, P69; Main J., 1981, SCOTT FISH RES REP, V23, P23; Main J., 1985, SCOTTISH FISHERIES R, V34, P1; NEWLAND PL, 1989, FISH RES, V8, P63, DOI 10.1016/0165-7836(89)90041-6; Rose CS, 1995, SOLVING BYCATCH CONS, P235; Suzuki Y, 2000, CONTRIBUTIONS FISHER, V40, P1; Tokai T., 1997, B JPN FISH OCEANOGRA, V61, P288; Walsh Stephen J., 1992, North American Journal of Fisheries Management, V12, P625, DOI 10.1577/1548-8675(1992)012<0625:SDSATF>2.3.CO;2; Winger Paul D., 2010, P67	29	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0919-9268	1444-2906		FISHERIES SCI	Fish. Sci.	NOV	2015	81	6					1013	1024		10.1007/s12562-015-0924-1		12	Fisheries	Fisheries	CW4QR	WOS:000364977100002		
J	Yatsuya, K; Kiyomoto, S; Yoshimura, T				Yatsuya, Kousuke; Kiyomoto, Setuo; Yoshimura, Taku			Seasonal changes in dietary composition of the herbivorous fish Kyphosus bigibbus in southwestern Japan	FISHERIES SCIENCE			English	Article						Browsing; Diet; Herbivorous fish; Kyphosus bigibbus; Macroalgae; Sargassum	NORTHEASTERN NEW-ZEALAND; MICROBIAL DIGESTION; SARGASSUM; FUCALES; SEA; BAY	Kyphosus bigibbus is an herbivorous fish, and its relatively large body size and schooling behavior may have a significant effect on macroalgae in southwestern Japan. However, the feeding habits of K. bigibbus are poorly understood. We investigated seasonal changes in stomach contents of K. bigibbus in Nishisonogi Peninsula, Nagasaki Prefecture, in southwestern Japan. In this area, large brown algae (i.e., Sargassum and annual kelp) grow abundantly only in spring and early summer; thereafter, from late summer to winter, its biomass becomes negligible. Dietary analyses revealed that K. bigibbus consumed exclusively benthic macroalgae, regardless of the depletion of large macroalgae for a half-year, and that carnivory or detritivory was not evident in any season. When large brown algae were abundant, K. bigibbus fed primarily on these algae, and to the lesser extent on some species of small brown algae (Scytosiphonaceae). During summer to winter, when large brown algae were absent, the main diet consisted of Padina arborescens and Zonaria diesingiana, and even the holdfast of Eckloniopsis radicosa was ingested. Scytosiphonacean species and fleshy red algae were important diets in late winter to early spring, when large sized brown algae were juveniles.	[Yatsuya, Kousuke; Kiyomoto, Setuo; Yoshimura, Taku] Fisheries Res Agcy, Seikai Natl Fisheries Res Inst, 1551-8 Taira, Nagasaki 8512213, Japan	Yatsuya, K (reprint author), Fisheries Res Agcy, Tohoku Natl Fisheries Res Inst, 4-9-1 Sakiyama, Miyako, Iwate 2070097, Japan.	yatsuya@affrc.go.jp					Clements KD, 2008, NEW ZEAL J MAR FRESH, V42, P47; Clements KD, 1997, MAR BIOL, V127, P579, DOI 10.1007/s002270050048; Yamaguchi Atsuko, 2010, Bulletin of Fisheries Research Agency, P89; Noda M, 2011, NIPPON SUISAN GAKK, V77, P1008; Terazono Y, 2012, MAR ECOL PROG SER, V464, P209, DOI 10.3354/meps09873; RIMMER DW, 1986, MAR BIOL, V92, P443, DOI 10.1007/BF00392685; Fujita Daisuke, 2010, Bulletin of Fisheries Research Agency, P33; RIMMER DW, 1987, J FISH BIOL, V31, P229, DOI 10.1111/j.1095-8649.1987.tb05228.x; Murase N, 2000, FISHERIES SCI, V66, P270, DOI 10.1046/j.1444-2906.2000.00044.x; Yatsuya Kousuke, 2011, Japanese Journal of Phycology, V59, P139; Shimabukuro H, 2007, NIPPON SUISAN GAKK, V73, P244, DOI 10.2331/suisan.73.244; Choat JH, 2002, MAR BIOL, V140, P613, DOI 10.1007/s00227-001-0715-3; Horn M.H., 1989, Oceanography and Marine Biology an Annual Review, V27, P167; Inoue K, 2006, THESIS; Kiriyama T., 2002, AQUACULTURE, V50, P295; Kiriyama Takanari, 2005, Suisan Zoshoku, V53, P355; Kiriyama Takanari, 2001, Suisan Zoshoku, V49, P431; Kiyomoto S, 2000, B SEIKAI NATL FISH R, V78, P57; Kuwahara H, 2015, FISH ENG, V51, P253; Noda M, 2002, FISH ENG, V39, P5; RUSSELL BC, 1983, NEW ZEAL J MAR FRESH, V17, P121; Sakai K, 2004, ICHTHYOL RES, V51, P121; Verges A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0846; Yatsuya K, 2014, ALGAL RESOUR, V7, P79; Yatsuya K, 2014, ALGAL RESOUR, V7, P67; Yoshimura T, 2015, FISH ENG, V51, P39; Yoshimura T, 2009, MON KAIYO, V41, P629	27	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0919-9268	1444-2906		FISHERIES SCI	Fish. Sci.	NOV	2015	81	6					1025	1033		10.1007/s12562-015-0919-y		9	Fisheries	Fisheries	CW4QR	WOS:000364977100003		
J	Makino, H; Masuda, R; Tanaka, M				Makino, Hirona; Masuda, Reiji; Tanaka, Masaru			Environmental stimuli improve learning capability in striped knifejaw juveniles: the stage-specific effect of environmental enrichment and the comparison between wild and hatchery-reared fish	FISHERIES SCIENCE			English	Article						Behavioral ontogeny; Critical period; Environmental enrichment; Habitat complexity; Oplegnathus fasciatus; Reward conditioning; Stock enhancement; Y-maze	SALMON SALMO-SALAR; ONTOGENIC CHANGES; PARALICHTHYS-OLIVACEUS; ONCORHYNCHUS-MYKISS; JAPANESE FLOUNDER; STOCK ENHANCEMENT; RAINBOW-TROUT; BEHAVIOR; BRAIN; EXPERIENCE	Hatchery-reared fish often show different behavioral traits from their wild counterparts, possibly due to the lack of environmental stimuli. Here, we aimed to reveal the stage-specific effect of environmental stimuli on the development of learning capability in striped knifejaw Oplegnathus fasciatus. The fish were raised for 15 days (50-65 days post-hatch) or 30 days (50-80 or 90-120 days post-hatch) in either conventional rearing tanks (control) or in a structurally enriched tank containing bricks, artificial sea grass, and plastic pipes (enriched environment), and were examined for learning capability using Y-maze reward conditioning. The learning capability of wild juveniles was also examined, and their scores were compared with those of hatchery-reared fish (which we previously reported). Only fish in the 50-80 days post-hatch enriched-rearing group showed significantly better scores than those in the control group, and wild fish performed better than hatchery-reared ones. The present results indicate that, although the learning capability of hatchery-reared fish is inferior to that of wild fish, exposure to a highly structured environment at an appropriate stage promotes the development of learning capability. Such environmental enrichment can potentially improve the viability of hatchery-reared fish when they are released into the wild.	[Masuda, Reiji] Kyoto Univ, Field Sci Educ & Res Ctr, Maizuru Fisheries Res Stn, Kyoto 6250086, Japan; [Makino, Hirona; Tanaka, Masaru] Kyoto Univ, Field Sci Educ & Res Ctr, Lab Estuarine Ecol, Sakyo Ku, Kyoto 6068502, Japan	Masuda, R (reprint author), Kyoto Univ, Field Sci Educ & Res Ctr, Maizuru Fisheries Res Stn, Kyoto 6250086, Japan.	reiji@kais.kyoto-u.ac.jp			 [15780133]	The authors thank Drs. Barry Berejikian (Northwest Fisheries Science Center, National Oceanic and Atmospheric Administration, USA), Takashi Yokota (Fisheries Research Agency), Kohji Takahashi (Nagasaki University), and Sanshiro Kaneko (MFRS) for their constructive comments on earlier drafts of the manuscript. Dr. Keiichi Fukaya (The Institute of Statistical Mathematics) gave excellent advice for the statistical analysis. Comments from Dr. Yutaka Kurita and two anonymous reviewers are also greatly acknowledged. This work was supported in part by a Grant-in-Aid for Scientific Research (15780133) given to R.M.	Naslund J, 2012, CAN J FISH AQUAT SCI, V69, P1481, DOI [10.1139/F2012-074, 10.1139/f2012-074]; Brydges NM, 2009, APPL ANIM BEHAV SCI, V118, P137, DOI 10.1016/j.applanim.2009.02.017; Makino H, 2006, FISHERIES SCI, V72, P1177, DOI 10.1111/j.1444-2906.2006.01274.x; Marchetti MP, 2003, ENVIRON BIOL FISH, V66, P9, DOI 10.1023/A:1023269221678; Kempermann G, 1998, J NEUROSCI, V18, P3206; Spence R, 2011, ANIM COGN, V14, P607, DOI 10.1007/s10071-011-0391-8; Takahashi K, 2010, J FISH BIOL, V77, P2315, DOI 10.1111/j.1095-8649.2010.02812.x; Yasumuro H, 2011, MAR FRESHW BEHAV PHY, V44, P143, DOI 10.1080/10236244.2011.598643; Masuda R, 1999, BRAIN BEHAV EVOLUT, V53, P173, DOI 10.1159/000006592; Sneddon LU, 2003, J FISH BIOL, V62, P971, DOI 10.1046/j.1095-8649.2003.00084.x; Tanaka M, 1998, B MAR SCI, V62, P551; Furuta S, 1998, NIPPON SUISAN GAKK, V64, P393; Dickel L, 2000, DEV PSYCHOBIOL, V36, P101, DOI 10.1002/(SICI)1098-2302(200003)36:2<101::AID-DEV2>3.0.CO;2-L; Takahashi K, 2013, FISHERIES SCI, V79, P55, DOI 10.1007/s12562-012-0572-7; Masuda R, 2010, FISH B-NOAA, V108, P162; Berejikian BA, 2000, CAN J FISH AQUAT SCI, V57, P628; Masuda R, 2000, J FISH BIOL, V56, P1239, DOI 10.1006/jfbi.2000.1249; Masuda R, 1998, B MAR SCI, V62, P337; Naslund J, 2013, CAN J FISH AQUAT SCI, V70, P585, DOI 10.1139/cjfas-2012-0302; Kihslinger RL, 2006, J EXP BIOL, V209, P504, DOI 10.1242/jeb.02019; Kawabata Y, 2011, FISHERIES SCI, V77, P345, DOI 10.1007/s12562-011-0351-x; KAWAMURA G, 1983, B JPN SOC SCI FISH, V49, P55; Strand DA, 2010, MAR ECOL PROG SER, V412, P273, DOI 10.3354/meps08682; Hyvarinen P, 2013, CAN J FISH AQUAT SCI, V70, P1386, DOI 10.1139/cjfas-2013-0147; Batzina A, 2014, COMP BIOCHEM PHYS A, V169, P25, DOI 10.1016/j.cbpa.2013.12.001; Burke JS, 2010, BEHAV QUALITY FLATFI, P303; Burns JG, 2009, ETHOLOGY, V115, P123; D'Anna G, 2012, AQUACULTURE, V356-357, P91; Naslund J, 2014, FISH FISH, DOI [10.1111/faf.12088, DOI 10.1111/FAF.12088]; Rosenzweig MR, 1996, BEHAV BRAIN RES, V78, P57, DOI 10.1016/0166-4328(95)00216-2; Salvanes AGV, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1331; Young RJ, 2003, ENV ENRICHMENT CAPTI	32	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0919-9268	1444-2906		FISHERIES SCI	Fish. Sci.	NOV	2015	81	6					1035	1042		10.1007/s12562-015-0917-0		8	Fisheries	Fisheries	CW4QR	WOS:000364977100004		
J	Tsutsui, S; Yoshinaga, T; Watanabe, S; Aoyama, J; Tsukamoto, K; Nakamura, O				Tsutsui, Shigeyuki; Yoshinaga, Tatsuki; Watanabe, Shun; Aoyama, Jun; Tsukamoto, Katsumi; Nakamura, Osamu			Skin mucus C-type lectin genes from all 19 Anguilla species/subspecies	FISHERIES SCIENCE			English	Article						Anguilla species; C-type lectin; Genomic structure; Molecular evolution	FRESH-WATER EELS; CARBOHYDRATE-RECOGNITION DOMAINS; JAPANESE EEL; MOLECULAR PHYLOGENY; GENUS ANGUILLA; ANIMAL LECTINS; LUZON ISLAND; EVOLUTION; PROTEINS; JAPONICA	Fish skin and its corresponding mucus are important defenses against infections from pathogenic organisms, and several types of defensive molecules, particularly lectins, are often found in mucus. Freshwater eels of the genus Anguilla are widely distributed throughout the world, and the genus currently contains 16 species plus 3 subspecies. In this work, genomic sequences of skin mucus C-type lectin-encoding genes from all 19 presently known species/subspecies of the genus Anguilla were determined. The nucleotide sequences were approximately 2 kbp long, and the genomic structure of five exons and four introns was common in all species. All of the encoded C-type lectins were considered functional because of the presence of calcium ion-binding and sugar-binding motifs as well as conserved cysteine residues. Phylogenetic analysis of the genus indicated that the C-type lectins in freshwater eels might be divided into two clusters, corresponding to their temperate and tropical growth habitats, suggesting that Anguilla species C-type lectin has evolved to adapt to microflora in each environment. This study is the first to comprehensively describe the immune-related genes in a complete fish genus.	[Tsutsui, Shigeyuki; Yoshinaga, Tatsuki; Nakamura, Osamu] Kitasato Univ, Sch Marine Biosci, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520373, Japan; [Watanabe, Shun; Tsukamoto, Katsumi] Nihon Univ, Coll Bioresource Sci, Fujisawa, Kanagawa 2520880, Japan; [Aoyama, Jun] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778564, Japan	Tsutsui, S (reprint author), Kitasato Univ, Sch Marine, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520373, Japan.	tsutsui@kitasato-u.ac.jp					Alexander John B., 1992, Annual Review of Fish Diseases, V2, P249, DOI 10.1016/0959-8030(92)90066-7; Aoyama J, 2001, MOL PHYLOGENET EVOL, V20, P450, DOI 10.1006/mpev.2001.0959; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0; DRICKAMER K, 1988, J BIOL CHEM, V263, P9557; Tasumi S, 2002, J BIOL CHEM, V277, P27305, DOI 10.1074/jbc.M202648200; SHARON N, 1972, SCIENCE, V177, P949, DOI 10.1126/science.177.4053.949; Schmidt J., 1922, Philosophical Transactions of the Royal Society London B, V211, P179; TSUKAMOTO K, 1992, NATURE, V356, P789, DOI 10.1038/356789a0; Inoue JG, 2010, BIOL LETTERS, V6, P363, DOI 10.1098/rsbl.2009.0989; Tsutsui S, 2007, MOL IMMUNOL, V44, P691, DOI 10.1016/j.molimm.2006.04.023; INGRAM GA, 1980, J FISH BIOL, V16, P23, DOI 10.1111/j.1095-8649.1980.tb03685.x; DRICKAMER K, 1993, PROG NUCLEIC ACID RE, V45, P207, DOI 10.1016/S0079-6603(08)60870-3; Minegishi Y, 2005, MOL PHYLOGENET EVOL, V34, P134, DOI 10.1016/j.ympev.2004.09.003; Suzuki Y, 2003, COMP BIOCHEM PHYS B, V136, P723, DOI 10.1016/S1096-4959(03)00178-7; Lin YS, 2001, MOL PHYLOGENET EVOL, V20, P252, DOI 10.1006/mpev.2001.0969; Tasumi S, 2004, DEV COMP IMMUNOL, V28, P325, DOI 10.1016/j.dci.2003.08.006; BARONDES SH, 1988, TRENDS BIOCHEM SCI, V13, P480, DOI 10.1016/0968-0004(88)90235-6; Watanabe S, 2009, FISHERIES SCI, V75, P387, DOI 10.1007/s12562-009-0087-z; Teng HY, 2009, ZOOL STUD, V48, P808; SEIF I, 1979, NUCLEIC ACIDS RES, V6, P3387, DOI 10.1093/nar/6.10.3387; Aoyama J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088759; Aoyama Jun, 2009, Aqua-Bioscience Monographs, V2, P1; CASTLE PHJ, 1974, COPEIA, P569; DRICKAMER K, 1993, CURR OPIN STRUC BIOL, V3, P393, DOI 10.1016/S0959-440X(05)80112-5; Ege V, 1939, DANA REP, V16, P1; Tanaka C, 2014, ZOOL STUD, V53, DOI 10.1186/s40555-014-0057-8; Tesch FW, 1977, THE EEL; Tsukamoto K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1174; Tsukamoto K, 2014, ENVIRON BIOL FISH, V97, P1377, DOI 10.1007/s10641-014-0228-9; Yoshinaga T, 2014, ZOOL STUD, V53, DOI 10.1186/1810-522X-53-13	31	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0919-9268	1444-2906		FISHERIES SCI	Fish. Sci.	NOV	2015	81	6					1043	1051		10.1007/s12562-015-0922-3		9	Fisheries	Fisheries	CW4QR	WOS:000364977100005		
J	Miyachi, S; Mayahara, T; Tsushima, K; Sasada, K; Kohno, E; Ogawa, NO; Chikaraishi, Y; Ohkouchi, N				Miyachi, Shunsaku; Mayahara, Takeyuki; Tsushima, Kouji; Sasada, Katsuhiro; Kohno, Eiichi; Ogawa, Nanako O.; Chikaraishi, Yoshito; Ohkouchi, Naohiko			Approach to determine individual trophic level and the difference in food sources of Japanese anchovy Engraulis japonicus in Sagami Bay, based on compound-specific nitrogen stable isotope analysis of amino acids	FISHERIES SCIENCE			English	Article						AA method; delta C-13; delta N-15; Food web structure; Isotopic baseline; Migratory fish; Stable isotope analysis; TLGlu/Phe	GEOGRAPHICAL VARIATIONS; RATIOS; CARBON; WEB; DELTA-N-15; FRACTIONATION; DELTA-C-13; POSITION; PLANKTON; ANIMALS	Compound-specific stable isotope analysis of amino acids (AA method) has recently been used to estimate the trophic level (TL) of animals. The individual TL (TLGlu/Phe) of Japanese anchovy Engraulis japonicus was precisely determined using the AA method without sampling or analysis of primary producers. Previously, TLs of organisms were determined using bulk nitrogen stable isotopic composition (delta N-15(bulk)) of tissues (bulk method). The delta N-15(bulk) for Japanese anchovies varied widely because of their migratory behavior, and the TL of anchovies in Sagami Bay remained ambiguous. We showed that the TLGlu/Phe of anchovy was almost 3 and that food-web structures differed between inshore and offshore waters. Furthermore, there was little difference in TLGlu/Phe for representative Japanese anchovies in Sagami Bay, despite the large intra-sample variation in delta N-15(bulk) for anchovies ranging over a trophic shift of 3-4 aEuro degrees in Sagami Bay. We speculated that this variation in delta N-15(bulk) resulted from differences in food sources among the different food webs. Estimation of individual TLs in some simple food chains using the AA method may enable the determination of the food-web structure of migratory fishes, which is difficult to determine using the traditional bulk method.	[Miyachi, Shunsaku; Mayahara, Takeyuki; Tsushima, Kouji; Sasada, Katsuhiro; Kohno, Eiichi] Nihon Univ, Grad Sch Bioresource Sci, 1866 Kameino, Fujisawa, Kanagawa 2520880, Japan; [Ogawa, Nanako O.; Chikaraishi, Yoshito; Ohkouchi, Naohiko] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Dept Biogeochem, Yokosuka, Kanagawa 2370061, Japan	Miyachi, S (reprint author), Nihon Univ, Grad Sch Bioresource Sci, 1866 Kameino, Fujisawa, Kanagawa 2520880, Japan.	miyachi@brs.nihon-u.ac.jp					McClelland JW, 2002, ECOLOGY, V83, P2173, DOI 10.1890/0012-9658(2002)083[2173:TRATNI]2.0.CO;2; Wada E, 2013, ECOL RES, V28, P173, DOI 10.1007/s11284-012-1024-7; Needoba JA, 2003, MAR ECOL PROG SER, V255, P81, DOI 10.3354/meps255081; Pinnegar JK, 1999, FUNCT ECOL, V13, P225, DOI 10.1046/j.1365-2435.1999.00301.x; Takai N, 2007, FISHERIES SCI, V73, P593, DOI 10.1111/j.1444-2906.2007.01372.x; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; YOSHIOKA T, 1994, ECOLOGY, V75, P835, DOI 10.2307/1941739; Tsuda A, 2004, FISH OCEANOGR, V13, P10, DOI 10.1111/j.1365-2419.2004.00315.x; Yoshii K, 1999, LIMNOL OCEANOGR, V44, P502; Tanaka H, 2008, MAR BIOL, V154, P557, DOI 10.1007/s00227-008-0949-4; Chikaraishi Y, 2007, MAR ECOL PROG SER, V342, P85, DOI 10.3354/meps342085; Lindsay DJ, 1998, FISHERIES SCI, V64, P403; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Garcia SM, 2012, SCIENCE, V335, P1045, DOI 10.1126/science.1214594; Wada Eitaro, 2009, Japanese Journal of Ecology (Otsu), V59, P259; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Chikaraishi Y, 2008, ORG GEOCHEM, V39, P510, DOI 10.1016/j.orggeochem.2007.08.010; Takai N, 2000, J MAR BIOL ASSOC UK, V80, P675, DOI 10.1017/S0025315400002502; Makino M, 2014, NIPPON SUISAN GAKK, V80, P254; O'Reilly CM, 2002, LIMNOL OCEANOGR, V47, P306; Aita MN, 2011, J PLANKTON RES, V33, P1629, DOI 10.1093/plankt/fbr070; MITANI I, 1988, NIPPON SUISAN GAKK, V54, P1859; Rolff C, 2000, MAR ECOL PROG SER, V203, P47, DOI 10.3354/meps203047; Chikaraishi Y, 2010, EARTH LIFE ISOTOPES, P367; Chikaraishi Y, 2010, EARTH LIFE ISOTOPES, P415; Chikaraishi Y, 2011, ECOL RES, V26, P835, DOI 10.1007/s11284-011-0844-1; Chikaraishi Y, 2009, LIMNOL OCEANOGR-METH, V7, P740; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Hobson KA, 1992, ECOL PROG SER, V84, P9; Ishikawa FN, 2014, OECOLOGIA, V175, P911; Kawasaki T., 1983, FAO FISH REP, V291, P1065; Kawasaki T, 1988, INT S LONG TERM CHAN, P37; Mihara Yukio, 2000, Bulletin of the Japanese Society of Fisheries Oceanography, V64, P10; Miller TW, 2011, INTERDISCIPLINARY ST, P125; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Miyachi S, 2013, PAP ENV INF SCI, V27, P27; Sugisaki H, 2013, J FISH TECHNOL, V6, P57; Tominaga O, 2008, FISHERIES SCI SERIES, P9; Uotani I, 1985, NIPPON SUISAN GAKK, V51, P197; UOTANI I, 1985, Nippon Suisan Gakkaishi, V51, P1057; Yamaji I, 1991, ILLUSTRATIONS MARINE, P538; YOSHIOKA T, 1989, Japanese Journal of Limnology, V50, P313	42	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0919-9268	1444-2906		FISHERIES SCI	Fish. Sci.	NOV	2015	81	6					1053	1062		10.1007/s12562-015-0923-2		10	Fisheries	Fisheries	CW4QR	WOS:000364977100006		
J	Shikata, T; Matsubara, T; Yoshida, M; Sakamoto, S; Yamaguchi, M				Shikata, Tomoyuki; Matsubara, Tadashi; Yoshida, Makoto; Sakamoto, Setsuko; Yamaguchi, Mineo			Effects of temperature, salinity, and photosynthetic photon flux density on the growth of the harmful diatom Asteroplanus karianus in the Ariake Sea, Japan	FISHERIES SCIENCE			English	Article						Ariake Sea; Asteroplanus karianus; Harmful algal blooms; Light; Nori cultivation; Pennate diatom; Photosynthesis; Temperature	SETO INLAND SEA; LIGHT-LIMITED GROWTH; LONG-TERM CHANGES; ENVIRONMENTAL-FACTORS; HARIMA-NADA; COSCINODISCUS-WAILESII; POPULATION-DYNAMICS; CAUSATIVE ORGANISM; EUCAMPIA-ZODIACUS; PORPHYRA-THALLI	Winter blooms of the diatom Asteroplanus karianus cause bleaching of cultivated Pyropia. We examined the effects of temperature, salinity, and photosynthetic photon flux density (PPFD) on the growth of A. karianus, using culture strains from the Ariake Sea. The maximum growth rate occurred at 20 A degrees C and a salinity of 20, and growth rates at 15-25 A degrees C and salinities of 15-33 were > 70 % of this maximum. However, A. karianus could not survive at 30 A degrees C. The threshold PPFD for growth was approximately 1 mu mol photons m(-2) s(-1); this value was lower than that for other coastal diatoms. The half-saturation PPFD was 41.3 mu mol photons m(-2) s(-1) at 15 A degrees C and 30.5 mu mol photons m(-2) s(-1) at 25 A degrees C. The photosynthetic activity (Fv/Fm) of A. karianus was saturated at 50 mu mol photons m(-2) s(-1), which is similar to or lower than surface PPFDs on cloudy days. We found that A. karianus is eurythermal and euryhaline and can photosynthesize and grow in very low light but not at high temperature. These physiological characteristics may partly explain why this diatom blooms in winter, when temperature and PPFD are at their lowest during the year in the Ariake Sea.	[Shikata, Tomoyuki; Sakamoto, Setsuko; Yamaguchi, Mineo] Fisheries Res Agcy, Natl Res Inst Fisheries & Environm Inland Sea, 2-17-5 Hatsukaichi, Hiroshima 7390452, Japan; [Matsubara, Tadashi] Saga Prefectural Ariake Fisheries Res & Dev Ctr, Ogi, Saga 8490313, Japan; [Yoshida, Makoto] Kagawa Prefectural Govt, Ban Chou 4-1-10, Takamatsu, Kagawa 7600017, Japan	Shikata, T (reprint author), Fisheries Res Agcy, Natl Res Inst Fisheries & Environm Inland Sea, 2-17-5 Hatsukaichi, Hiroshima 7390452, Japan.	shikatat@affrc.go.jp			Japanese Fisheries Agency; Japan Society for the Promotion of Science [26450253]	This work was partially supported by a Japanese Fisheries Agency-aided project addressing red tides and oxygen-depleted water masses and by a grant to Tomoyuki Shikata (26450253) from the Japan Society for the Promotion of Science.	Shikata T, 2008, LIMNOL OCEANOGR, V53, P2503, DOI 10.4319/lo.2008.53.6.2503; Tada K, 2010, BUNSEKI KAGAKU, V59, P945, DOI 10.2116/bunsekikagaku.59.945; Marshall HG, 2009, J COASTAL RES, P59; BAKKER C, 1990, J PLANKTON RES, V12, P947, DOI 10.1093/plankt/12.5.947; Hori Yutaka, 2008, Bulletin of the Japanese Society of Fisheries Oceanography, V72, P107; Nishikawa Tetsuya, 2011, Plankton & Benthos Research, V6, P26; Shikata T, 2011, NIPPON SUISAN GAKK, V77, P40, DOI 10.2331/suisan.77.40; HENDEY NI, 1954, J MAR BIOL ASSOC UK, V33, P537; Kaeriyama H, 2011, EUR J PHYCOL, V46, P113, DOI 10.1080/09670262.2011.565128; Oyama K, 2008, NIPPON SUISAN GAKK, V74, P660, DOI 10.2331/suisan.74.660; YAMAGUCHI M, 1989, NIPPON SUISAN GAKK, V55, P2029; Mather L., 2010, Canadian Technical Report of Fisheries and Aquatic Sciences, V2881, P1; HEATH MR, 1988, J PLANKTON RES, V10, P1251, DOI 10.1093/plankt/10.6.1251; Tada K, 2000, FISHERIES SCI, V66, P509, DOI 10.1046/j.1444-2906.2000.00080.x; ERGA SR, 1984, J PLANKTON RES, V6, P67, DOI 10.1093/plankt/6.1.67; Ishii Mitsuhiro, 2008, Bulletin of the Japanese Society of Fisheries Oceanography, V72, P22; Shikata T, 2010, NIPPON SUISAN GAKK, V76, P34; Nishikawa T, 2006, HARMFUL ALGAE, V5, P141, DOI 10.1016/j.hal.2005.06.007; CHEN LCM, 1969, J PHYCOL, V5, P211, DOI 10.1111/j.1529-8817.1969.tb02605.x; Nishikawa T, 2008, HARMFUL ALGAE, V7, P561, DOI 10.1016/j.hal.2007.12.021; HAIGH R, 1992, MAR ECOL PROG SER, V89, P117, DOI 10.3354/meps089117; Yamaguchi H, 2014, MAR ECOL PROG SER, V517, P51, DOI 10.3354/meps11014; Zhang J, 2004, ANAL SCI, V20, P37, DOI 10.2116/analsci.20.37; LEDERMAN TC, 1981, BOT MAR, V24, P125, DOI 10.1515/botm.1981.24.3.125; HITCHCOCK GL, 1977, LIMNOL OCEANOGR, V22, P126; CADEE GC, 1986, MAR BIOL, V93, P281, DOI 10.1007/BF00508265; PARSONS TR, 1973, LIMNOL OCEANOGR, V18, P511; Matsubara T, 2014, NIPPON SUISAN GAKK, V80, P222; Wen Lixia, 2007, Journal of Ocean University of China, V6, P40, DOI 10.1007/s11802-006-0040-7; THIMIJAN RW, 1983, HORTSCIENCE, V18, P818; Chihara M, 1997, ILLUSTRATED GUIDE MA, P1574; Crawford RM, 1997, NOVA HEDWIGIA, V65, P1; Guillard RRL, 1973, HDB PHYCOLOGICAL MET, P289; Hallfors G, 2004, BALTIC SEA ENV P; Kawaguchi O, 2004, OCEANOGR JAPAN, V13, P173; Koga H, 1990, B SAGA PREFECT ARIAK, V12, P67; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; Matsuoka S, 2005, B COAST OCEANOGR, V43, P77; Tanaka K, 2004, OCEANOGR JAPAN, V13, P163; Yokouchi K, 2005, UMI TO SORA, V80, P1	40	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0919-9268	1444-2906		FISHERIES SCI	Fish. Sci.	NOV	2015	81	6					1063	1069		10.1007/s12562-015-0930-3		7	Fisheries	Fisheries	CW4QR	WOS:000364977100007		
J	Riyanto, M; Arimoto, T				Riyanto, Mochammad; Arimoto, Takafumi			Heart rate and muscle performance during forced swimming of jack mackerel Trachurus japonicus at different temperatures	FISHERIES SCIENCE			English	Article						Jack mackerel; Heart rate; Temperature effect; ECG; EMG; Ordinary muscle; Index of power output	MELANOGRAMMUS-AEGLEFINUS; FISH; EXERCISE; ENDURANCE; HADDOCK; SPEEDS	The physiological condition of jack mackerel [18.3 +/- A 1.2 cm fork length (FL), n = 24] was simultaneously monitored using electrocardiography (ECG) and electromyography (EMG) techniques during swimming exercise in a flume tank at different temperatures of 10, 15 and 22 C-A degrees. To monitor the effect of temperature on the threshold level of the maximum sustainable speed, EMG demonstrated that the initiation of ordinary muscle activity at the lowest temperature (10 C-A degrees) occurred at swimming speeds of 3.2-3.5 FL/s, which was slower than the activation speeds at 15 and 22 C-A degrees of 4.0-5.4 FL/s. Ordinary muscle became active with increasing swimming speed which subsequently resulted in the frequency, amplitude and duration of burst discharge. ECG and EMG monitoring showed that the heart rate started to increase at the sustained speed level before the threshold and markedly increased up to the maximum level of heart rate at the higher speed. The index of ordinary muscle power output at the lowest temperature of 10 C-A degrees was lower than at higher temperatures of 15 and 22 C-A degrees. The heart rate increased with the increasing power output of ordinary muscle for all temperatures.	[Riyanto, Mochammad; Arimoto, Takafumi] Tokyo Univ Marine Sci & Technol, Grad Sch Appl Marine Biosci, Minato Ku, Tokyo 1088477, Japan; [Riyanto, Mochammad] Bogor Agr Univ, Fac Fisheries & Marine Sci, Kampus IPB Dramaga, Bogor 16680, Indonesia	Riyanto, M (reprint author), Tokyo Univ Marine Sci & Technol, Grad Sch Appl Marine Biosci, Minato Ku, Tokyo 1088477, Japan.	mh_ryn@yahoo.com; tarimoto@kaiyodai.ac.jp					Amornpiyakrit T, 2007, AM FISH SOC S, V49, P587; An YI, 1994, NIPPON SUISAN GAKKAS, V63, P3; ALTRINGHAM JD, 1990, J EXP BIOL, V148, P395; HANYU I, 1979, B JPN SOC SCI FISH, V45, P1261; Ito H, 2003, NIPPON SUISAN GAKK, V69, P192; BONE Q, 1978, FISH B-NOAA, V76, P691; ALTRINGHAM JD, 1993, J EXP BIOL, V182, P191; BONE Q, 1966, J MAR BIOL ASSOC UK, V46, P321; XU G, 1993, NIPPON SUISAN GAKK, V59, P745; Ozbilgin H, 2002, FISH RES, V58, P323, DOI 10.1016/S0165-7836(01)00394-0; XU G, 1993, ICES MAR SC, V196, P117; BAINBRIDGE R, 1960, J EXP BIOL, V37, P129; JOHNSTON IA, 1977, J COMP PHYSIOL, V114, P203; WEIHS D, 1974, J THEOR BIOL, V48, P215, DOI 10.1016/0022-5193(74)90192-1; Breen M, 2004, ICES J MAR SCI, V61, P1071, DOI 10.1016/j.icesjms.2004.06.014; JOHNSTON IA, 1980, J COMP PHYSIOL, V135, P147; Arimoto T, 1993, NIPPON SUISAN GAKKAS, V57, P1225; Brett JR, 1964, FISH RES BOARD CAN, V21, P1183; Coull K. A., 1989, SCOTT FISH RES REP, V43, P81; Johnston IA, 1981, S ZOOL SOC LONDON, V48, P71; Nofrizal Yanase K, 2009, FISHERIES SCI, V75, P1369; Riyanto M, 2014, FISHERIES SCI, V80, P53, DOI 10.1007/s12562-013-0686-6; Riyanto M, 2014, FISHERIES SCI, V80, P1241, DOI 10.1007/s12562-014-0811-1; TSUKAMOTO K, 1984, Nippon Suisan Gakkaishi, V50, P2031; TSUKAMOTO K, 1984, Nippon Suisan Gakkaishi, V50, P2025; WEBB PW, 1994, ADV VET SCI COMP MED, V38, P1	26	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0919-9268	1444-2906		FISHERIES SCI	Fish. Sci.	NOV	2015	81	6					1083	1090		10.1007/s12562-015-0932-1		8	Fisheries	Fisheries	CW4QR	WOS:000364977100009		
J	Kawanago, M; Takemura, S; Ishizuka, R; Shioya, I				Kawanago, Makoto; Takemura, Shuhei; Ishizuka, Risa; Shioya, Itaru			Effects of dietary branched-chain amino acid supplementation on growth and skeletal muscle cellularity in Japanese amberjack Seriola quinqueradiata	FISHERIES SCIENCE			English	Article						Branched-chain amino acid; Growth; Muscle fiber diameter; Japanese amberjack Seriola quinqueradiata	TROUT ONCORHYNCHUS-MYKISS; MYOGENIC REGULATORY FACTORS; MESSENGER-RNA EXPRESSION; CARPIO VAR. JIAN; RAINBOW-TROUT; GENE-EXPRESSION; ATLANTIC SALMON; CHANNEL CATFISH; JUVENILE JIAN; IGF-I	The present study investigated a determination method for skeletal muscle fiber diameters in Japanese amberjack Seriola quinqueradiata. We also investigated the effects of two supplements, a mixture of branched-chain amino acids (BCAAs) and valine alone, on body growth and skeletal muscle cellularity. The minor distances between two points on randomly selected individual fibers were measured and termed fiber diameters. Using growing fish (ranging from 4.8 g to 194.0 g in body weight), body weights and median fiber diameters were significantly correlated. A BCAA-supplemented diet (valine:leucine:isoleucine, 1:2:1) significantly increased the body weight after 105 days. The distribution frequency of fiber diameters between 61 and 81 mu m was significantly higher in the 1 % BCAA group (P < 0.05) than in the control. However, dietary valine supplementation (1 %) had no effect on growth or skeletal muscle cellularity. These results indicated that hypertrophic growth occurred in the skeletal muscle of Japanese amberjack and was affected by dietary supplementation with a BCAA mixture.	[Kawanago, Makoto; Takemura, Shuhei; Ishizuka, Risa; Shioya, Itaru] Nippon Suisan Kaisha Ltd, Cent Res Lab, Aquaculture Fundamental Res Grp, 1-32-3 Nanakuni, Hachioji, Tokyo 1920991, Japan	Kawanago, M (reprint author), Nippon Suisan Kaisha Ltd, Cent Res Lab, Aquaculture Fundamental Res Grp, 1-32-3 Nanakuni, Hachioji, Tokyo 1920991, Japan.	mako-k@nissui.co.jp					Li P, 2009, AMINO ACIDS, V37, P43, DOI 10.1007/s00726-008-0171-1; Fuentes EN, 2013, GEN COMP ENDOCR, V192, P136, DOI 10.1016/j.ygcen.2013.06.009; Fukada H, 2012, DOMEST ANIM ENDOCRIN, V42, P220, DOI 10.1016/j.domaniend.2011.12.005; KIESSLING A, 1989, AQUACULTURE, V79, P169, DOI 10.1016/0044-8486(89)90458-4; Picha ME, 2008, N AM J AQUACULT, V70, P196, DOI 10.1577/AO7-038.1; Kawanago M, 2015, AQUACULT NUTR, V21, P63, DOI 10.1111/anu.12141; Pohlenz C, 2013, COMP BIOCHEM PHYS A, V166, P215, DOI 10.1016/j.cbpa.2013.06.016; Dong M, 2013, AQUACULT NUTR, V19, P1, DOI 10.1111/j.1365-2095.2011.00926.x; Alami-Durante H, 2010, COMP BIOCHEM PHYS A, V156, P561, DOI 10.1016/j.cbpa.2010.04.015; Chauvigne F, 2003, GEN COMP ENDOCR, V132, P209, DOI 10.1016/S0016-6480(03)00081-9; Yamamoto T, 2004, AQUACULTURE, V232, P539, DOI 10.1016/s0044-8486(03)00543-x; Chen NS, 2012, GEN COMP ENDOCR, V179, P121, DOI 10.1016/j.ygcen.2012.08.004; Silva P, 2009, J MUSCLE RES CELL M, V30, P29, DOI 10.1007/s10974-009-9167-z; WEATHERLEY AH, 1988, J FISH BIOL, V33, P851, DOI 10.1111/j.1095-8649.1988.tb05532.x; Kuradomi RY, 2011, TRANSGENIC RES, V20, P513, DOI 10.1007/s11248-010-9429-y; WILSON RP, 1980, J NUTR, V110, P627; Alami-Durante H, 2011, J NUTR, V141, P2146, DOI 10.3945/jn.111.146118; Fukada H, 2014, AQUACULTURE, V426, P264, DOI 10.1016/j.aquaculture.2014.02.012; Zhao J, 2012, AQUACULTURE, V368, P117, DOI 10.1016/j.aquaculture.2012.09.019; Ahmed I, 2006, BRIT J NUTR, V96, P450, DOI 10.1079/BJN20061845; Fauconneau B, 1997, J FISH BIOL, V50, P296, DOI 10.1006/jfbi.1996.0293; JOHNSTON IA, 1980, MAR BIOL LETT, V1, P323; Johnston IA, 1999, J EXP BIOL, V202, P1991; Hevroy EM, 2007, GEN COMP ENDOCR, V152, P39, DOI 10.1016/j.ygcen.2007.02.015; Castillo J, 2004, AM J PHYSIOL-REG I, V286, pR935, DOI 10.1152/ajpregu.00459.2003; Hugres SG, 1983, T AM FISH SOC, V112, P812; Kawanago M, 2015, N AM J AQUACULT, V76, P415; Kimball S. R., 2006, AM J CLIN NUTR, V83, P500; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Rathore RM, 2010, AQUAC RES, V41, pe751, DOI 10.1111/j.1365-2109.2010.02576.x; Rodehutscord M, 1997, J NUTR, V127, P1166	31	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0919-9268	1444-2906		FISHERIES SCI	Fish. Sci.	NOV	2015	81	6					1091	1097		10.1007/s12562-015-0931-2		7	Fisheries	Fisheries	CW4QR	WOS:000364977100010		
J	Nakase, G; Eguchi, M				Nakase, Gentoku; Eguchi, Mitsuru			Influence of seasonal solar ultraviolet radiation on microbial mineralization activity in tidal flats in Osaka Bay, Japan	FISHERIES SCIENCE			English	Article						C-14-labeled glucose; Mineralization activity; Summer; Tidal flat; Ultraviolet radiation	DISSOLVED ORGANIC-MATTER; UV-B RADIATION; COASTAL WATERS; MARINE BACTERIOPLANKTON; BACTERIAL-ACTIVITY; FRESH-WATER; SEDIMENTS; OXYGEN; SENSITIVITY; IRRADIANCE	We investigated the influence of solar ultraviolet radiation (UVR) on microbial mineralization activity in three tidal flats located in Osaka Bay, Japan. Within each sampling site, two experimental areas were defined: one area was covered with a transparent acrylic resin board (area without solar UVR) and the other was set as the control area (not manipulated, area with solar UVR). At low tide, UVR and sediment surface temperature were measured in situ and the top 10 mm of the sediment (oxic layer) was core sampled in summer, autumn, and winter in 2003, 2004, and 2005. Each core sample was then examined for potential microbial mineralization activity using C-14-labeled glucose. In the summer, mineralization rates in the areas without solar UVR were significantly higher (by a factor of 1.6-2.2) than those in the areas with solar UVR (t-test, p < 0.05). A reduction in the mineralization activity caused by solar UVR was either not observed or not significant (t-test, p > 0.05) in autumn and winter. Our results could contribute to revealing the potential effects of solar UVR on biogeochemical cycles.	[Eguchi, Mitsuru] Kinki Univ, Fac Agr, Dept Fisheries, Nara 6318505, Japan; [Nakase, Gentoku] Kinki Univ, Fisheries Lab, Wakayama 6492211, Japan	Eguchi, M (reprint author), Kinki Univ, Fac Agr, Dept Fisheries, Nara 6318505, Japan.	eguchi@nara.kindai.ac.jp					Sasaki M, 2002, OPT ENG, V41, P3062, DOI 10.1117/1.1516823; Middelburg JJ, 1996, MAR ECOL PROG SER, V132, P157, DOI 10.3354/meps132157; Sommaruga R, 1997, APPL ENVIRON MICROB, V63, P4178; TAYLOR DI, 1995, MAR ECOL PROG SER, V120, P263, DOI 10.3354/meps120263; RASMUSSEN H, 1992, MAR ECOL PROG SER, V81, P289, DOI 10.3354/meps081289; Glud RN, 2005, DEEP-SEA RES PT I, V52, P1974, DOI 10.1016/j.dsr.2005.05.004; MCKINLEY VL, 1983, APPL ENVIRON MICROB, V45, P255; Sasaki A, 2012, LANDSC ECOL ENG, V8, P107, DOI 10.1007/s11355-011-0157-0; Gustavson K, 2000, J PLANKTON RES, V22, P1501, DOI 10.1093/plankt/22.8.1501; Pakulski JD, 1998, AQUAT MICROB ECOL, V14, P137, DOI 10.3354/ame014137; Hader DP, 2003, PHOTOCH PHOTOBIO SCI, V2, P39, DOI 10.1039/b211160h; MOPPER K, 1991, NATURE, V353, P60, DOI 10.1038/353060a0; Berninger UG, 1995, AQUAT MICROB ECOL, V9, P229, DOI 10.3354/ame009229; Kuwae T, 1999, APPL ENVIRON MICROB, V65, P3407; Wetzel RG, 1995, LIMNOL OCEANOGR, V40, P1369; Douki T, 2000, J BIOL CHEM, V275, P11678, DOI 10.1074/jbc.275.16.11678; Santos AL, 2014, FEMS MICROBIOL ECOL, V87, P517, DOI 10.1111/1574-6941.12239; Alonso-Saez L, 2006, APPL ENVIRON MICROB, V72, P5806, DOI 10.1128/AEM.00597-06; Moran MA, 1997, LIMNOL OCEANOGR, V42, P1307; Vincent WF, 2002, ECOL STU AN, V153, P137; Hortnagl P, 2011, AQUAT ECOL, V45, P125, DOI 10.1007/s10452-010-9341-9; Luna GM, 2002, APPL ENVIRON MICROB, V68, P3509, DOI 10.1128/AEM.68.7.3509-3513.2002; Joux F, 1999, APPL ENVIRON MICROB, V65, P3820; HERNDL GJ, 1993, NATURE, V361, P717, DOI 10.1038/361717a0; Forster S, 1996, MAR ECOL PROG SER, V143, P173, DOI 10.3354/meps143173; Ruiz-Gonzalez C, 2012, FEMS MICROBIOL ECOL, V79, P661, DOI 10.1111/j.1574-6941.2011.01247.x; Friedberg EC, 1995, DNA REPAIR MUTAGENES, P91; Kaiser E, 1997, APPL ENVIRON MICROB, V63, P4026; KARENTZ S, 1991, NATURE, V350, P28, DOI 10.1038/350028b0	29	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0919-9268	1444-2906		FISHERIES SCI	Fish. Sci.	NOV	2015	81	6					1099	1104		10.1007/s12562-015-0927-y		6	Fisheries	Fisheries	CW4QR	WOS:000364977100011		
J	Teng, F; Tanioka, Y; Hamaguchi, N; Bito, T; Takenaka, S; Yabuta, Y; Watanabe, F				Teng, Fei; Tanioka, Yuri; Hamaguchi, Natsumi; Bito, Tomohiro; Takenaka, Shigeo; Yabuta, Yukinori; Watanabe, Fumio			Determination and characterization of vitamin B-12 compounds in edible sea snails, ivory shell Babylonia japonica and turban shell Turdo Batillus cornutus	FISHERIES SCIENCE			English	Article						Edible sea snails; Ivory shell; Pseudovitamin B-12; Turban shell; Vitamin B-12	FOOD	In this study, we characterized and quantified vitamin B-12 compounds in popular edible snails Babylonia japonica and Turdo Batillus cornutus using a microbiological assay based on Lactobacillus delbrueckii subsp. lactis ATCC 7830. The meat and viscera of B. japonica contained 27.2 +/- A 9.1 and 92.8 +/- A 25.8 mu g of vitamin B-12 per 100 g, respectively. However, the meat and viscera of T. cornutus contained extremely low amounts of vitamin B-12 (3.0 +/- A 1.5 and 15.1 +/- A 8.3 mu g of vitamin B-12 per 100 g, respectively). We identified the vitamin B-12 compounds from the edible portions (meat and viscera) of B. japonica and T. cornutus using liquid chromatography-electrospray ionization/tandem mass spectrometry. We found that B. japonica contained substantial amounts of true vitamin B-12, while pseudovitamin B-12 was the predominant corrinoid in T. cornutus. These results indicate that the meat and viscera of B. japonica are excellent sources of vitamin B-12 for humans.	[Teng, Fei; Bito, Tomohiro; Yabuta, Yukinori; Watanabe, Fumio] Tottori Univ, United Grad Sch Agr Sci, Div Appl Bioresources Chem, Tottori 6808553, Japan; [Tanioka, Yuri] Tokyo Univ Agr, Jr Coll, Dept Nutr, Setagaya Ku, Tokyo 1568502, Japan; [Hamaguchi, Natsumi; Yabuta, Yukinori; Watanabe, Fumio] Tottori Univ, Sch Agr, Dept Agr Biol & Environm Sci, Tottori 6808553, Japan; [Takenaka, Shigeo] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Dept Vet Sci, Osaka 5988531, Japan	Watanabe, F (reprint author), Tottori Univ, United Grad Sch Agr Sci, Div Appl Bioresources Chem, Tottori 6808553, Japan.	watanabe@muses.tottori-u.ac.jp			JSPS KAKENHI [25450168]	This work was supported by JSPS KAKENHI Grant number 25450168 (FW).	Yamada S, 1996, J NUTR SCI VITAMINOL, V42, P497; Yoshino K, 2005, J EPIDEMIOL, V15, P29, DOI 10.2188/jea.15.29; Shibata K, 2013, J NUTR SCI VITAMINOL, V59, pS67; Watanabe F, 2007, EXP BIOL MED, V232, P1266, DOI 10.3181/0703-MR-67; Miyamoto E, 2006, J AGR FOOD CHEM, V54, P9604, DOI 10.1021/jf062300r; Watanabe F, 2001, INT J FOOD SCI NUTR, V52, P263, DOI 10.1080/713671784; Watanabe F, 1999, J AGR FOOD CHEM, V47, P4736, DOI 10.1021/jf990541b; Watanabe F, 1998, J AGR FOOD CHEM, V46, P1433, DOI 10.1021/jf970807j; Herbert V, 1996, VITAMIN B12 PRESENT, P191; Ministry of Education Culture Sports Science and Technology, 2010, STAND TABL FOOD COMP, P170; Tanioka Y, 2014, FISHERIES SCI, V80, P1065, DOI 10.1007/s12562-014-0787-x	11	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0919-9268	1444-2906		FISHERIES SCI	Fish. Sci.	NOV	2015	81	6					1105	1111		10.1007/s12562-015-0920-5		7	Fisheries	Fisheries	CW4QR	WOS:000364977100012		
J	Wang, H; Ura, K; Takagi, Y				Wang, Heng; Ura, Kazuhiro; Takagi, Yasuaki			The major yolk protein in sea urchin egg yolk granules is a glycoprotein complex	FISHERIES SCIENCE			English	Article						Strongylocentrotus intermedius; Mesocentrotus nudus; Major yolk protein; Yolk granules; Protein complex	PSEUDOCENTROTUS-DEPRESSUS; ELECTRON-MICROSCOPY; 23S GLYCOPROTEIN; CELOMIC FLUID; EMBRYOS; OVARY; ELECTROPHORESIS; VITELLOGENESIS; PURIFICATION; EXPRESSION	Major yolk protein (MYP) is the most abundant protein found in the yolk granules of sea urchin eggs. The structure of MYPs stored in the eggs of two sea urchin species from Strongylocentrotus intermedius and Mesocentrotus nudus were investigated. Egg-localized major yolk protein (EGMYP) extracted from the eggs of two species of sea urchins was assessed using disc-polyacrylamide gel electrophoresis and immunoelectrophoresis. The molecular weight of native EGMYP was 595 in S. intermedius eggs and 625 kDa in M. nudus eggs. The use of sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western blotting analysis under reducing conditions revealed that the EGMYP of S. intermedius separated into four bands (approximately 172, 116, 74 and 68 kDa), while the EGMYP of M. nudus resolved as a set of bands ranging from 175 to 58 kDa (approximately 175, 165, 153, 115, 102, 90, 78, 65 and 58 kDa). Yolk granules from eggs were isolated using sucrose density ultracentrifugation and examined using electron microscopy. The structures of purified EGMYP extracted from eggs and from yolk granules were similar in both species. The EGMYP stored in the eggs of the sea urchins was a glycoprotein complex, the protein structure of which, however, varied between the two species.	[Wang, Heng; Ura, Kazuhiro; Takagi, Yasuaki] Hokkaido Univ, Grad Sch Fisheries Sci, 3-1-1 Minato Cho, Hakodate, Hokkaido 0418611, Japan	Wang, H (reprint author), Hokkaido Univ, Grad Sch Fisheries Sci, 3-1-1 Minato Cho, Hakodate, Hokkaido 0418611, Japan.	hengwang0422@gmail.com			Ministry of Education, Culture, Science, and Technology, Japan	We wish to express our deep gratitude to Dr. Noriko Azuma for her invaluable help and the comments that greatly improved the manuscript. This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Science, and Technology, Japan.	Agatsuma Y, 1995, MANUAL TRANSPLANTATI; Agatsuma Y, 2013, SEA URCHINS BIOL ECO, P438; HARRINGTON FE, 1982, DEV BIOL, V94, P505, DOI 10.1016/0012-1606(82)90367-0; Unuma T, 2003, J EXP BIOL, V206, P365, DOI 10.1242/jeb.00102; SCOTT LB, 1989, DEV BIOL, V132, P91, DOI 10.1016/0012-1606(89)90208-X; OZAKI H, 1980, DEV GROWTH DIFFER, V22, P365; Brooks JM, 2004, BIOL REPROD, V71, P705, DOI 10.1095/biolreprod.104.027730; GIGA Y, 1985, J BIOCHEM-TOKYO, V98, P19; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; NOLL H, 1985, P NATL ACAD SCI USA, V82, P8062, DOI 10.1073/pnas.82.23.8062; Unuma T, 2007, FEBS J, V274, P4985, DOI 10.1111/j.1742-4658.2007.06014.x; Dev S, 2014, DEV GROWTH DIFFER, V56, P480, DOI 10.1111/dgd.12148; Perera A, 2004, DEV GROWTH DIFFER, V46, P201; Unuma T, 2010, MOL REPROD DEV, V77, P59, DOI 10.1002/mrd.21103; OZAKI H, 1986, ROUX ARCH DEV BIOL, V195, P74, DOI 10.1007/BF00444043; Sewell MA, 2008, PROTEOMICS, V8, P2531, DOI 10.1002/pmic.200700995; Unuma T, 1998, BIOL BULL, V194, P92, DOI 10.2307/1542517; YOKOTA Y, 1988, CELL DIFFER DEV, V23, P191, DOI 10.1016/0045-6039(88)90071-1; Zhadan PM, 2015, J EXP MAR BIOL ECOL, V465, P11, DOI 10.1016/j.jembe.2014.12.017; MALKIN LI, 1965, DEV BIOL, V12, P520, DOI 10.1016/0012-1606(65)90013-8; Unuma T, 2009, MOL REPROD DEV, V76, P142, DOI 10.1002/mrd.20939; Sullivan CV, 2003, FISH PHYSIOL BIOCHEM, V28, P481, DOI 10.1023/B:FISH.0000030635.92568.0a; Unuma T, 2001, ZOOL SCI, V18, P559, DOI 10.2108/zsj.18.559; KARI BE, 1985, DEV BIOL, V108, P18, DOI 10.1016/0012-1606(85)90004-1; SCOTT LB, 1990, DEV BIOL, V137, P368, DOI 10.1016/0012-1606(90)90261-G; ARMANT DR, 1986, DEV BIOL, V113, P342, DOI 10.1016/0012-1606(86)90169-7; SHYU AB, 1986, P NATL ACAD SCI USA, V83, P3865, DOI 10.1073/pnas.83.11.3865; GIGA Y, 1985, J BIOCHEM-TOKYO, V98, P237; Nakakoshi M, 2011, J ELECTRON MICROSC, V60, P401, DOI 10.1093/jmicro/dfr084; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; Decher GL, 1979, J CELL BIOL, V81, P92; FAO, 1996, FISHST PLUS DAT TOT; FUJI AKIRA, 1960, BULL FAC FISH HOKKAIDO UNIV, V11, P43; Fukui prefectural fisheries experimental station, 2003, REP FUK PREF FISH EX; Garber P, 1953, BIOCHIM BIOPHYS ACTA, V10, P193; Hiramatsu N, 2005, BIOCH MOLEC, V6, P431; Hokkaido institute of mariculture, 1992, MAN ART SEEDS PROD S; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Okazaki K, 1975, B FUKUSHIMA PREF FIS, V3, P51; Otaki K, 1984, B FUKUSHIMA PREF FIS, V1, P1; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Yamamoto T, 2006, INVESTIGATION INSTRU; ZACHARIU.RM, 1969, ANAL BIOCHEM, V30, P148, DOI 10.1016/0003-2697(69)90383-2	44	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0919-9268	1444-2906		FISHERIES SCI	Fish. Sci.	NOV	2015	81	6					1127	1134		10.1007/s12562-015-0929-9		8	Fisheries	Fisheries	CW4QR	WOS:000364977100014		
J	Tanimoto, S; Kitabayashi, K; Fukusima, C; Sugiyama, S; Hashimoto, T				Tanimoto, Shota; Kitabayashi, Kaori; Fukusima, Chihiro; Sugiyama, Sumi; Hashimoto, Tatsuyuki			Effect of storage period before reheating on the volatile compound composition and lipid oxidation of steamed meat of yellowtail Seriola quinqueradiata	FISHERIES SCIENCE			English	Article						Volatile compounds; Lipid oxidation; Cooked fish; Reheating; Storage; Yellowtail; Dark muscle; Ordinary muscle	WARMED-OVER FLAVOR; FISH MUSCLE; AROMA COMPOUNDS; DARK MUSCLES; ICE STORAGE; COMPONENTS; PROXIMATE; TIME	The effect of storage period before reheating on the volatile composition and lipid oxidation of steamed yellowtail fish muscle samples [ordinary muscle (OM) and dark muscle (DM)] was studied to evaluate the quality of fish meat in the cook-chill process. In OM and DM samples that were reheated on day 7 of storage, the levels of 26 compounds and most volatiles (47), respectively, were significantly higher than in samples that were steamed only once. In DM steamed only once and in DM reheated after 7 days of storage, values of nine and 32 compounds, respectively, were significantly higher than in OM under identical conditions. In both muscle types, the peroxide values (PVs) and thiobarbituric acid-reactive substances (TBARS) values significantly increased when the meat was stored for 7 days before reheating. Reheated DM showed significantly lower values and significantly lower tendency for PV except for day 1 of storage and significantly higher TBARS values at day 7 of storage compared to those in reheated OM. In reheated muscle of both types, the fatty acid composition was not significantly different from that of samples steamed only once, except for 20:5n-3 of DM. Sensory evaluation showed that at days 3 and 7 of storage, the odor of reheated fish slices had deteriorated. Therefore, steamed yellowtail meat reheated after refrigerated storage of up to 3 days could be consumed without deterioration of its odor and nutritive value.	[Tanimoto, Shota; Fukusima, Chihiro; Sugiyama, Sumi] Prefectural Univ Hiroshima, Fac Human Culture & Sci, Hiroshima 7348558, Japan; [Kitabayashi, Kaori] Hijiyama Univ, Fac Hlth & Nutr, Hiroshima 7328509, Japan; [Hashimoto, Tatsuyuki] Natl Hosp Org Headquarters, Chugokushikoku Off, Higashihiroshima 7390041, Japan	Tanimoto, S (reprint author), Prefectural Univ Hiroshima, Fac Human Culture & Sci, Hiroshima 7348558, Japan.	s-tanimoto@pu-hiroshima.ac.jp					Song X, 2000, NIPPON SUISAN GAKK, V66, P282; Moreira N, 2013, FOOD CHEM, V138, P2365, DOI 10.1016/j.foodchem.2012.11.135; Sohn JH, 2007, FOOD CHEM, V104, P962, DOI 10.1016/j.foodchem.2006.12.062; JOSEPHSON DB, 1986, ACS SYM SER, V317, P201; Weber J, 2008, FOOD CHEM, V106, P140, DOI 10.1016/j.foodchem.2007.05.052; Prost C, 2004, J FOOD SCI, V69, pS198; Wu W, 2014, EUR FOOD RES TECHNOL, V238, P237, DOI 10.1007/s00217-013-2098-3; STANGELO AJ, 1987, J FOOD SCI, V52, P1163, DOI 10.1111/j.1365-2621.1987.tb14034.x; Tanimoto S, 2011, J FOOD SCI, V76, pC974, DOI 10.1111/j.1750-3841.2011.02307.x; ANG CYW, 1990, J FOOD SCI, V55, P644, DOI 10.1111/j.1365-2621.1990.tb05197.x; Funaki J, 2010, J FOOD SCI, V75, pS527, DOI 10.1111/j.1750-3841.2010.01840.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Liu JK, 2009, FISHERIES SCI, V75, P1067, DOI 10.1007/s12562-009-0116-y; Cayhan GG, 2011, J AGR FOOD CHEM, V59, P654, DOI 10.1021/jf103471h; Chung H, 2011, EUR J LIPID SCI TECH, V113, P1481, DOI 10.1002/ejlt.201000510; Iglesias J, 2008, J CHROMATOGR A, V1192, P9, DOI 10.1016/j.chroma.2008.03.028; Aro T, 2003, EUR FOOD RES TECHNOL, V216, P483, DOI 10.1007/s00217-003-0678-3; Sohn JH, 2005, J FOOD SCI, V70, pS490, DOI 10.1111/j.1365-2621.2005.tb11497.x; Tokur B, 2007, FOOD CHEM, V104, P754, DOI 10.1016/j.foodchem.2006.12.033; POSTE LM, 1986, J FOOD SCI, V51, P886, DOI 10.1111/j.1365-2621.1986.tb11192.x; JOSEPHSON DB, 1984, J AGR FOOD CHEM, V32, P1347, DOI 10.1021/jf00126a032; AKASAKA K, 1992, BIOSCI BIOTECH BIOCH, V56, P605; Karlsdottir MG, 2014, FOOD CHEM, V164, P476, DOI 10.1016/j.foodchem.2014.05.068; AOCS, 1960, OFF TENT METH AM OIL, VI; AOCS, 1960, OFF TENT METH AM OIL, VII; Castro FAF, 2007, FOOD CHEM, V103, P1080; Department of Health Great Britain, 1989, CHILL FROZ GUID COOK; Domiszewski Z, INT J FOOD SCI TECHN, V48, P786; Kawai T, 1996, FOOD SCI NUTR, V36, P257; Kovats E., 1965, ADV CHROMATOGR, V1, P229; Niki E., 2001, Journal of Oleo Science, V50, P313; Shimomura M, 1971, J HOME ECON, V22, P106; Stone H, 1992, SENSORY EVALUATION P; Tanimoto S, 2015, J AQUAT FOOD PROD T, DOI [10.1080/10498850.2013.840349, DOI 10.1080/10498850.2013.840349]; WITTE V C, 1970, Journal of Food Science, V35, P582, DOI 10.1111/j.1365-2621.1970.tb04815.x	35	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0919-9268	1444-2906		FISHERIES SCI	Fish. Sci.	NOV	2015	81	6					1145	1155		10.1007/s12562-015-0921-4		11	Fisheries	Fisheries	CW4QR	WOS:000364977100016		
J	Ebitani, K; Sugawara, A; Konno, K				Ebitani, Kohji; Sugawara, Akira; Konno, Kunihiko			A quick loss of myosin cross-linking ability of Arabesque greenling dorsal muscle during its refrigerated storage	FISHERIES SCIENCE			English	Article						Arabesque greenling; Myosin cross-linking; Setting effect; Thermal gel formation; Transglutaminase	WALLEYE POLLACK; ALBUMIN POWDER; SURIMI PASTE; TRANSGLUTAMINASE	Arabesque greenling in rigor state was used in this study. Meat from the fish was ground with 3 % NaCl and incubated at 25 A degrees C. Significant myosin cross-linking and monodansylcadaverine incorporation into myosin heavy chains were both observed. These events were easily lost upon storage of the fish for a few days at 5 A degrees C, indicating a quick inactivation of transglutaminase (TGase) during the storage. Crude TGase extracted from the meat of fish in rigor state also lost the activity upon its storage at 5 A degrees C. The loss of activity seemed not due to degradation of the enzyme by endogenous proteinases from an inhibitor addition test. Storage of fish meat with sorbitol suppressed TGase inactivation during the storage. A similar stabilizing effect of sorbitol on the enzyme was confirmed with crude enzyme. AG meat from the fish in rigor state showed a setting effect with a clear increase in the breaking force and strain upon preheating at 25 A degrees C. Such setting effect was not detectable for commercial AG surimi. Thus, it was suggested that no setting effect found with commercial AG surimi is due to significantly decreased TGase activity in it.	[Ebitani, Kohji; Konno, Kunihiko] Hokkaido Univ, Fac Fisheries Sci, Hakodate, Hokkaido 0418611, Japan; [Ebitani, Kohji] Hokkaido Res Org, Abashiri Fisheries Res Inst, Mombetsu, Hokkaido 0940011, Japan; [Sugawara, Akira] Hokkaido Res Org, Cent Fisheries Res Inst, Yoichi, Hokkaido 0468455, Japan	Konno, K (reprint author), Hokkaido Univ, Fac Fisheries Sci, Hakodate, Hokkaido 0418611, Japan.	konno@fish.hokudai.ac.jp					Konno K, 2000, NIPPON SUISAN GAKK, V66, P869; ARAKI H, 1993, NIPPON SUISAN GAKK, V59, P711; Ni SW, 1998, FISHERIES SCI, V64, P434; Kato N, 2010, J JPN SOC FOOD SCI, V57, P414; OOIZUMI T, 1981, B JPN SOC SCI FISH, V47, P901; WAN JR, 1994, FISHERIES SCI, V60, P107; Suzuki Jun, 2008, Journal of the School of Marine Science and Technology Tokai University, V6, P27; Hashimoto K, 1981, J HOKKAIDO FISH EXP, V38, P176; Kitagami S, 1997, FOOD PRESERV SCI, V23, P145; Kunimoto M., 2014, Nippon Shokuhin Kagaku Kogaku Kaishi = Journal of the Japanese Society for Food Science and Technology, V61, P19, DOI 10.3136/nskkk.61.19; Miyazaki A, 2010, ANN REP ABASHIRI FIS, V2010, P7; Motohiro T., 1976, Refrigeration [Reito], V51, P559; NUMAKURA T, 1985, Nippon Suisan Gakkaishi, V51, P1559; SHIMIZU Y, 1981, B JPN SOC SCI FISH, V47, P95; Uno T, 1958, B HOKKAIDO REG FISH, V18, P45	15	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0919-9268	1444-2906		FISHERIES SCI	Fish. Sci.	NOV	2015	81	6					1169	1176		10.1007/s12562-015-0937-9		8	Fisheries	Fisheries	CW4QR	WOS:000364977100018		
J	Kasada, R; Ishii, D; Ando, M; Tanigawa, H; Ohata, M; Konishi, S				Kasada, Ryuta; Ishii, Daiki; Ando, Masami; Tanigawa, Hiroyasu; Ohata, Mitsuru; Konishi, Satoshi			Dynamic tensile properties of reduced-activation ferritic steel F82H	FUSION ENGINEERING AND DESIGN			English	Article						Dynamic tensile properties; High-speed tensile test; Reduced-activation ferritic steel; Deformation	DEFORMATION; METALS	The dynamic tensile properties of reduced-activation ferritic steel F82H was characterized by high-speed tensile tests over a strain-rate range of 0.01-1400 s(-1) at temperatures of 296 and 423 K. As a result, the tensile strength of the F82H steel appears to be sensitive to strain-rate. This is explained by the activation volume of gliding dislocation. The uniform elongation is also sensitive to strain-rate but true fracture strain is considered to be less sensitive. Zerilli-Armstrong bcc model is found adequate to describe the dependence of yield stress of F82H on temperature and strain-rate tested in the present study. (C) 2015 Elsevier B.V. All rights reserved.	[Kasada, Ryuta; Ishii, Daiki; Konishi, Satoshi] Kyoto Univ, Inst Adv Energy, Uji, Kyoto 6110011, Japan; [Ando, Masami; Tanigawa, Hiroyasu] Japan Atom Energy Agcy, Aomori 0393212, Japan; [Ohata, Mitsuru] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan	Kasada, R (reprint author), Kyoto Univ, Inst Adv Energy, Uji, Kyoto 6110011, Japan.	r-kasada@iae.lcyoto-u.ac.jp					American Society of Mechanical Engineers, 2010, RUL CONSTR NUCL FAC; Shiba K, 2006, FUSION ENG DES, V81, P1051, DOI 10.1016/j.fusengdes.2005.07.030; Wang YM, 2004, ACTA MATER, V52, P1699, DOI 10.1016/j.actamat.2003.12.022; Byun TS, 2004, ACTA MATER, V52, P1597, DOI 10.1016/j.actamat.2003.12.023; Kotulski JD, 2008, FUSION ENG DES, V83, P1068, DOI 10.1016/j.fusengdes.2008.08.039; [Anonymous], 2007, 4206 JEAC; Goto T, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/7/075006; Kytka M, 2011, J NUCL MATER, V409, P147, DOI 10.1016/j.jnucmat.2010.09.016; Caillard D, 2010, ACTA MATER, V58, P3493, DOI 10.1016/j.actamat.2010.02.023; Cadoni E, 2011, J NUCL MATER, V414, P360, DOI 10.1016/j.jnucmat.2011.05.002; Liang RQ, 1999, INT J PLASTICITY, V15, P963, DOI 10.1016/S0749-6419(99)00021-2; Tanigawa H, 2011, FUSION ENG DES, V86, P2549, DOI 10.1016/j.fusengdes.2011.04.047; Spatig P, 1999, J NUCL MATER, V275, P324, DOI 10.1016/S0022-3115(99)00121-X; Gao Y., 2011, J ENG MATER-T ASME, V133; Hashimoto N., 2001, MATER RES SOC S P, V650; Lindholm U.S., 1971, TECHN MET RES, V5; Takii T., 2003, KENSA GIJUTSU, V8, P51; Tanigawa H., 2012, P 24 IAEA FUS EN C S; Ueda Y., 2014, THESIS; Uytdenhouwen I, 2009, ADV MAT RES, V59, P319, DOI 10.4028/www.scientific.net/AMR.59.319	20	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	NOV	2015	100						146	151		10.1016/j.fusengdes.2015.05.001		6	Nuclear Science & Technology	Nuclear Science & Technology	CW5RZ	WOS:000365055600014		
J	Zhou, QL; Gao, Y; Liu, K; Xue, LH; Yan, YW				Zhou, Qilai; Gao, Yue; Liu, Kai; Xue, Lihong; Yan, Youwei			Fabrication of Li2TiO3 pebbles by a selective laser sintering process	FUSION ENGINEERING AND DESIGN			English	Article						Lithium titanate; SLS; Tritium breeder; Ceramic pebbles; 3D printing	RESEARCH-AND-DEVELOPMENT; LITHIUM-TITANATE; WET PROCESS; ITER; BLANKET; PARTS	Lithium titanate, Li2TiO3, is an important tritium breeding material for deuterium (D)-tritium (T) fusion reactor. In test blanket module (TBM) design of China, Li2TiO3 is considered as one candidate material of tritium breeders. In this study, selective laser sintering (SLS) technology was introduced to fabricate Li2TiO3 ceramic pebbles. This fabrication process is computer assisted and has a high level of flexibility. Li2TiO3 powder with a particle size of 1-3 mu m was used as the raw material, whilst epoxy resin E06 was adopted as a binder. Green Li2TiO3 pebbles with certain strengths were successfully prepared via SLS. Density of the green pebbles was subsequently increased by cold isostatic pressing (CIP) process. Li2TiO3 pebbles with a diameter of about 2 mm were obtained after high temperature sintering. Density of the pebbles reaches 80% of theoretical density (TD) with a comparable crush load of 43 N. This computer assisted approach provides a new efficient route for the production of Li2TiO3 ceramic pebbles. (C) 2015 Elsevier B.V. All rights reserved.	[Zhou, Qilai; Xue, Lihong; Yan, Youwei] Huazhong Univ Sci & Technol, State Key Lab Mat Proc & Die & Mould Technol, Wuhan 430074, Peoples R China; [Gao, Yue] Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan; [Liu, Kai] Wuhan Univ Technol, Sch Mat Sci & Engn, Wuhan 430070, Peoples R China	Xue, LH (reprint author), Huazhong Univ Sci & Technol, State Key Lab Mat Proc & Die & Mould Technol, Wuhan 430074, Peoples R China.	xuelh@mail.hust.edu.cn			Chinese National Fusion Project [2013GB110004, 2013GB110005]; National Natural Scheme Foundation of China [51272079]	This work is supported by Chinese National Fusion Project for ITER (2013GB110004, 2013GB110005) and the National Natural Scheme Foundation of China (51272079).	Mandal D, 2010, FUSION ENG DES, V85, P819, DOI 10.1016/j.fusengdes.2010.06.018; Hoshino T, 2011, FUSION ENG DES, V86, P2172, DOI 10.1016/j.fusengdes.2011.01.065; Blackburn S, 2005, ADV APPL CERAM, V104, P97, DOI 10.1179/174367605X16644; KOPASZ JP, 1994, J NUCL MATER, V212, P927, DOI 10.1016/0022-3115(94)90971-7; Giancarli L, 2007, J NUCL MATER, V367, P1271, DOI 10.1016/j.jnucmat.2007.03.234; Ying A, 2007, J NUCL MATER, V367, P1281, DOI 10.1016/j.jnucmat.2007.03.240; Shahzad K, 2012, CERAM INT, V38, P1241, DOI 10.1016/j.ceramint.2011.08.055; Feng YJ, 2012, FUSION ENG DES, V87, P753, DOI 10.1016/j.fusengdes.2012.02.016; Lulewicz JD, 2002, J NUCL MATER, V307, P803, DOI 10.1016/S0022-3115(02)00981-9; Tsuchiya K, 1998, J NUCL MATER, V258, P1985, DOI 10.1016/S0022-3115(98)00229-3; Hong M, 2013, J NUCL MATER, V441, P390, DOI 10.1016/j.jnucmat.2013.06.024; Bertrand P, 2007, APPL SURF SCI, V254, P989, DOI 10.1016/j.apsusc.2007.08.085; Knitter R, 2013, J NUCL MATER, V442, pS420, DOI 10.1016/j.jnucmat.2013.02.060; Kruth JP, 2007, CIRP ANN-MANUF TECHN, V56, P730, DOI 10.1016/j.cirp.2007.10.004; JOHNSON CE, 1989, FUSION ENG DES, V8, P145, DOI 10.1016/S0920-3796(89)80099-7; van der Laan JG, 2000, J NUCL MATER, V283, P99, DOI 10.1016/S0022-3115(00)00352-4; Shikama T, 2008, FUSION ENG DES, V83, P976, DOI 10.1016/j.fusengdes.2008.07.034; Roux N, 1998, FUSION ENG DES, V41, P31, DOI 10.1016/S0920-3796(97)00140-3; Tsuchiya K, 2000, J NUCL MATER, V283, P1380, DOI 10.1016/S0022-3115(00)00099-4; Tsuchiya K, 2005, J NUCL MATER, V345, P239, DOI 10.1016/j.jnucmat.2005.06.005; Hoshino T, 2013, FUSION ENG DES, V88, P2264, DOI 10.1016/j.fusengdes.2013.05.025; Garin P, 2011, FUSION ENG DES, V86, P611, DOI 10.1016/j.fusengdes.2011.01.109; Tang HH, 2015, J EUR CERAM SOC, V35, P981, DOI 10.1016/j.jeurceramsoc.2014.10.019; Liu K, 2014, CERAM INT, V40, P7099, DOI 10.1016/j.ceramint.2013.12.043; Shahzad K, 2013, J MATER PROCESS TECH, V213, P1484, DOI 10.1016/j.jmatprotec.2013.03.014; Shahzad K, 2014, J EUR CERAM SOC, V34, P87, DOI 10.1016/j.jeurceramsoc.2013.07.023	26	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	NOV	2015	100						166	170		10.1016/j.fusengdes.2015.05.061		5	Nuclear Science & Technology	Nuclear Science & Technology	CW5RZ	WOS:000365055600017		
J	Urano, H; Fujita, T; Ide, S; Miyata, Y; Matsunaga, G; Matsukawa, M				Urano, H.; Fujita, T.; Ide, S.; Miyata, Y.; Matsunaga, G.; Matsukawa, M.			Development of operation scenarios for plasma breakdown and current ramp-up phases in JT-60SA tokamak	FUSION ENGINEERING AND DESIGN			English	Article						Breakdown; Conducting elements; Current ramp-up; Divertor configuration; TOSCA; JT-60SA	CHAPTER 8; START-UP; ITER; DESIGN	The operation scenarios for plasma breakdown and current ramp-up phases in JT-60SA tokamak have been developed and verified in simulation using the TOSCA code. The induced current in the conducting elements such as vacuum vessel and stabilizing plate increases to the comparable level of plasma current of similar to 600 kA during the breakdown phase and thus enhances the strength of stray field. The optimized scenarios for half and full pre-magnetization cases satisfied the conditions required for the plasma initiation. At the initial plasma, the vertical magnetic field required to sustain the plasma position was controlled by the outer equilibrium field (EF) coil currents which compensate for a vertical field due to a large eddy current. The condition for the formation of divertor configurations given by the combination of the magnetic flux for plasma and the plasma current has been satisfied which enables us to develop the operational scenarios with a smooth transition from a limiter to a divertor configuration. (C) 2015 Elsevier B.V. All rights reserved.	[Urano, H.; Ide, S.; Miyata, Y.; Matsunaga, G.; Matsukawa, M.] Japan Atom Energy Agcy, Naka Fus Inst, Naka, Ibaraki 3110193, Japan; [Fujita, T.] Nagoya Univ, Grad Sch Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Urano, H (reprint author), Japan Atom Energy Agcy, Naka Fus Inst, 801-1 Oaza Mukouyama, Naka, Ibaraki 3110193, Japan.	urano.hajime@jaea.go.jp					TANI K, 1992, J COMPUT PHYS, V98, P332, DOI 10.1016/0021-9991(92)90146-P; Lampasi A, 2014, FUSION ENG DES, V89, P342, DOI 10.1016/j.fusengdes.2014.02.080; Lloyd B, 1996, PLASMA PHYS CONTR F, V38, P1627, DOI 10.1088/0741-3335/38/9/007; Yoshino R, 1997, PLASMA PHYS CONTR F, V39, P205, DOI 10.1088/0741-3335/39/1/012; Ishida S, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/9/094018; Yamauchi K, 2013, PLASMA SCI TECHNOL, V15, P148, DOI 10.1088/1009-0630/15/2/14; Bareyt B, 2002, FUSION ENG DES, V60, P127, DOI 10.1016/S0920-3796(01)00606-8; Gribov Y, 2007, NUCL FUSION, V47, pS385, DOI 10.1088/0029-5515/47/6/S08; EJIMA S, 1982, NUCL FUSION, V22, P1313, DOI 10.1088/0029-5515/22/10/006; Senda I, 1998, FUSION ENG DES, V42, P395, DOI 10.1016/S0920-3796(98)00165-3; Kamada Y, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/7/073011; Stober J, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/8/083031; Ide S., 2012, J PLASMA FUSION RES, V7; ITER Physics Expert Group on Disruptions, 1999, NUCL FUSION, V39, P2577; Kobayashi T., 2014, P 25 IAEA FUS EN C I; Matsukawa M., 2010, J PLASMA FUSION RES, V9, P264; Matsunaga G., P 28 S FUS TECHN SOF; Miyata Y., 2013, J PLASMA FUSION RES, V8; Miyata Y., 2014, J PLASMA FUSION RES, V9; Shimada K., 2010, J PLASMA FUSION RES, V9, P163; Shinya K., 2000, J PLASMA FUSION RES, V76, P479	21	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	NOV	2015	100						345	356		10.1016/j.fusengdes.2015.06.138		12	Nuclear Science & Technology	Nuclear Science & Technology	CW5RZ	WOS:000365055600042		
J	Nitti, FS; Ibarra, A; Ida, M; Favuzza, P; Furukawa, T; Groeschel, F; Heidinger, R; Kanemura, T; Knaster, J; Kondo, H; Micchiche, G; Sugimoto, M; Wakai, E				Nitti, F. S.; Ibarra, A.; Ida, M.; Favuzza, P.; Furukawa, T.; Groeschel, F.; Heidinger, R.; Kanemura, T.; Knaster, J.; Kondo, H.; Micchiche, G.; Sugimoto, M.; Wakai, E.			The design status of the liquid lithium target facility of IFMIF at the end of the engineering design activities	FUSION ENGINEERING AND DESIGN			English	Article						IFMIF; Lithium target; Neutron source	LOOP; LI	The International Fusion Material Irradiation Facility (IFMIF) is an experimental facility conceived for qualifying and characterizing structural materials for nuclear fusion applications. The Engineering Validation and Engineering Design Activity (EVEDA) is a fundamental step towards the final design. It presented two mandates: the Engineering Validation Activities (EVA), still on-going, and the Engineering Design Activities (EDA) accomplished on schedule in June 2013. Five main facilities are identified in IFMIF, among which the Lithium Target Facility constituted a technological challenge overcome thanks to the success of the main validation challenges impacting the design. The design of the liquid Lithium Target Facility at the end of the EDA phase is here detailed. (C) 2015 Elsevier B.V. All rights reserved.	[Nitti, F. S.; Knaster, J.] IFMIF EVEDA Project Team, Rokkasho, Japan; [Ibarra, A.] CIEMAT, E-28040 Madrid, Spain; [Ida, M.] IHI Corp, Tokyo, Japan; [Favuzza, P.] ENEA, Res Ctr, Rome, Italy; [Furukawa, T.; Kanemura, T.; Kondo, H.; Wakai, E.] JAEA, Res Ctr, Ibaraki, Japan; [Groeschel, F.] KIT, Res Ctr, Karlsruhe, Germany; [Heidinger, R.] F4E, Res Ctr, Garching, Germany; [Micchiche, G.] ENEA, Res Ctr, Brasimone, Italy; [Sugimoto, M.] JAEA, Res Ctr, Rokkasho, Japan	Nitti, FS (reprint author), IFMIF EVEDA Project Team, Rokkasho, Japan.	francesco.nitti@enea.it					Alekseev V.K., 1980, FIZ KHIM MEKH MATER, V16, P83; Fukada S, 2014, FUSION ENG DES, V89, P1346, DOI 10.1016/j.fusengdes.2014.02.030; Knaster J, 2014, FUSION ENG DES, V89, P1709, DOI 10.1016/j.fusengdes.2014.01.011; Kato Y, 1998, J NUCL MATER, V258, P394, DOI 10.1016/S0022-3115(98)00405-X; CHOPRA OK, 1986, J NUCL MATER, V141, P584, DOI 10.1016/0022-3115(86)90058-9; Kondo H, 2014, FUSION ENG DES, V89, P1688, DOI 10.1016/j.fusengdes.2014.02.022; Tian K, 2013, FUSION ENG DES, V88, P635, DOI 10.1016/j.fusengdes.2013.03.055; Kinoshita M, 2006, FUSION ENG DES, V81, P567, DOI 10.1016/j.fusengdes.2005.04.003; Hirakane S, 2005, FUSION ENG DES, V75-79, P721, DOI 10.1016/j.fusengdes.2005.06.080; Loginov N, 2009, J NUCL MATER, V386-88, P958, DOI 10.1016/j.jnucmat.2008.12.257; Yagi J, 2011, J NUCL MATER, V417, P710, DOI 10.1016/j.jnucmat.2010.12.136; CREFFIELD GK, 1974, J CHEM SOC DALTON, P2325, DOI 10.1039/dt9740002325; IFMIF International Team, 2004, IFMIF COMPR DES REP; Kanemura T., 2015, FUSION ENG IN PRESS; Kondo H., 2011, FUSION ENG DES, V89, P2437; Nitti F.S., THESIS; Simakov SP, 2004, J NUCL MATER, V329, P213, DOI 10.1016/j.jnucmat.2004.04.024	17	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	NOV	2015	100						425	430		10.1016/j.fusengdes.2015.07.012		6	Nuclear Science & Technology	Nuclear Science & Technology	CW5RZ	WOS:000365055600049		
J	Yatsuka, E; Hatae, T; Bassan, M; Vayakis, G; Walsh, M; Itami, K				Yatsuka, Eiichi; Hatae, Takaki; Bassan, Michele; Vayakis, George; Walsh, Michael; Itami, Kiyoshi			Enhancement of resistance against high energy laser pulse injection with chevron beam dump	FUSION ENGINEERING AND DESIGN			English	Article						ITER; Thomson scattering; Laser beam dump; Laser-induced damage threshold; Thermal fatigue	INDUCED DAMAGE THRESHOLD; MIRRORS; MO	The laser beam dump of the Edge Thomson scattering (ETS) in ITER is being developed and a new type of beam dump called the chevron beam dump was proposed recently. The laser-induced damage on the surface is one of the most severe issues to be overcome. The key concept of the chevron beam dump is to reduce the laser energy absorption per unit area and to absorb the laser beam gradually. The laser irradiation tests onto flat-mirror-molybdenum sample were carried out. It was clarified that the absorbed (rather than incident) energy density of the laser pulses should be the correct figure of merit for the laser-induced damage. Therefore, the concept of the chevron beam dump design, that minimizes the absorbed laser energy density per unit area, was validated experimentally. The chevron beam dump enables us to extend its lifetime drastically relative to conventional beam dumps. Potential methods to improve the laser-induced damage threshold (LIDT) are also discussed in this paper. (C) 2015 Elsevier B.V. All rights reserved.	[Yatsuka, Eiichi; Hatae, Takaki; Itami, Kiyoshi] Japan Atom Energy Agcy, Naka, Ibaraki 3110193, Japan; [Bassan, Michele; Vayakis, George; Walsh, Michael] ITER Org, F-13067 Provence, France	Yatsuka, E (reprint author), Japan Atom Energy Agcy, Naka, Ibaraki 3110193, Japan.						Yatsuka E, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4824141; LEE CS, 1983, J APPL PHYS, V54, P5727, DOI 10.1063/1.331794; Kajita S, 2013, OPT EXPRESS, V21, P17275, DOI 10.1364/OE.21.017275; ORDAL MA, 1988, APPL OPTICS, V27, P1203, DOI 10.1364/AO.27.001203; Gorshkov A, 2003, FUSION ENG DES, V66-68, P865, DOI 10.1016/S0920-3796(03)00367-3; Sato M, 2013, OPT EXPRESS, V21, P9333, DOI 10.1364/OE.21.009333; FURUYA K, 1984, J NUCL MATER, V122, P754, DOI 10.1016/0022-3115(84)90694-9; Hatae T, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4738658; Becker M., 1990, LASER INDUCED DAMAGE, P174; BENNETT HE, 1961, J OPT SOC AM, V51, P123, DOI 10.1364/JOSA.51.000123; Bohm P, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3460450; Donne AJH, 2007, NUCL FUSION, V47, pS337, DOI 10.1088/0029-5515/47/6/S07; Furuya K., 1981, J NUCL MATER, V103-104, P937; Naylor G.A., 2012, J INSTRUM, V7; Yatsuka E., 2010, 27 ANN M JPN SOC PLA; Yatsuka E, 2013, J INSTRUM, V8, DOI 10.1088/1748-0221/8/12/C12001; Yatsuka E., 2011, Japanese patent application, Patent No. [2011-110374, 2011110374]	17	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	NOV	2015	100						461	467		10.1016/j.fusengdes.2015.07.018		7	Nuclear Science & Technology	Nuclear Science & Technology	CW5RZ	WOS:000365055600054		
J	Kim, JH; Nakamichi, M				Kim, Jae-Hwan; Nakamichi, Masaru			Reactivity of plasma-sintered beryllium in dry air and moisture at high temperature	FUSION ENGINEERING AND DESIGN			English	Article						Oxidation kinetic; Plasma-sintered Be; Activation energy; Parabolic oxidation	INTERMETALLIC COMPOUNDS; CHEMICAL-REACTIVITY; OXIDATION; OXYGEN; STEAM	Beryllium (Be) metal is a candidate material of not only neutron-multiplier for fusion reactors but also a water-cooled target material for an accelerator-based boron neutron capture therapy. To investigate its reactivity in dry air and 1% H2O/Ar at 873-1273K, Be samples were fabricated by a novel plasma-sintering method proposed herein. Because of its reactivity in dry atmosphere, parabolic oxidation of Be along grain boundaries was predominant up to 1173 K at an activation energy of 52 kJ/mol, while catastrophic oxidation occurred at 1273 K. The introduction of H2O facilitated breakaway in Be oxidation. Hence, the weight and H-2 concentration of Be tested in 1% H2O/Ar dramatically increased from 973 K, while samples tested for 24h were completely oxidized in appearance. (C) 2015 Elsevier B.V. All rights reserved.	[Kim, Jae-Hwan; Nakamichi, Masaru] Japan Atom Energy Agcy, Breeding Funct Mat Dev Grp, Dept Blanket Syst Res, Rokkasho Fus Inst,Sect Fus Res & Dev, Rokkasho, Aomori 0393212, Japan	Kim, JH (reprint author), Japan Atom Energy Agcy, Breeding Funct Mat Dev Grp, Dept Blanket Syst Res, Rokkasho Fus Inst,Sect Fus Res & Dev, 2-166 Aza Obuchi Aza Omotedate, Rokkasho, Aomori 0393212, Japan.	kim.jaehwan@jaea.go.jp					Haugsrud R, 2003, CORROS SCI, V45, P211, DOI 10.1016/S0010-938X(02)00085-9; Kim JH, 2014, FUSION ENG DES, V89, P1440, DOI 10.1016/j.fusengdes.2013.12.037; AITKEN EA, 1962, J NUCL MATER, V6, P119, DOI 10.1016/0022-3115(62)90220-9; ERVIN G, 1964, J NUCL MATER, V12, P30, DOI 10.1016/0022-3115(64)90104-7; McCarthy KA, 1997, FUSION ENG DES, V37, P543, DOI 10.1016/S0920-3796(97)00095-1; AYLMORE DW, 1960, J NUCL MATER, V2, P169, DOI 10.1016/0022-3115(60)90044-1; Petti DA, 2000, J NUCL MATER, V283, P1390, DOI 10.1016/S0022-3115(00)00299-3; Kim JH, 2013, J NUCL MATER, V438, P218, DOI 10.1016/j.jnucmat.2013.02.066; Kim JH, 2014, J NUCL MATER, V453, P22, DOI 10.1016/j.jnucmat.2014.06.019; Blackburn BW, 1998, MED PHYS, V25, P1967, DOI 10.1118/1.598370; AYLMORE DW, 1961, J NUCL MATER, V3, P190, DOI 10.1016/0022-3115(61)90006-X; Zhu YF, 2006, METALL MATER TRANS A, V37A, P1231	12	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	NOV	2015	100						614	618		10.1016/j.fusengdes.2015.08.012		5	Nuclear Science & Technology	Nuclear Science & Technology	CW5RZ	WOS:000365055600073		
J	Cho, Y; Tsuchiya, S; Yoshioka, R; Omura, T; Konoki, K; Oshima, Y; Yotsu-Yamashita, M				Cho, Yuko; Tsuchiya, Shigeki; Yoshioka, Renpei; Omura, Takuo; Konoki, Keiichi; Oshima, Yasukatsu; Yotsu-Yamashita, Mari			The presence of 12 beta-deoxydecarbamoylsaxitoxin in the Japanese toxic dinoflagellate Alexandrium determined by simultaneous analysis for paralytic shellfish toxins using HILIC-LC-MS/MS	HARMFUL ALGAE			English	Article						Alexandrium tamarense; Alexandrium catenella; Paralytic shellfish toxins; Dinoflagellate; 12 beta-Deoxydecarbamoylsaxitoxin; LC-MS/MS	CHROMATOGRAPHY-MASS SPECTROMETRY; SOLID-PHASE EXTRACTION; LIQUID-CHROMATOGRAPHY; SAXITOXIN ANALOGS; GYMNODINIUM-CATENATUM; SQUID AXON; TAMARENSE; DERIVATIZATION; IDENTIFICATION; CYANOBACTERIA	A differential screening study using high-resolution (HR)-hydrophilic interaction chromatography (HILIC)-electrospray ionization (ESI)-quadrupole time-of-flight mass spectrometry (Q-TOF MS) was conducted to identify saxitoxin (SIX) analogues in the marine dinoflagellate toxic sub-clone Alexandrium tamarense Axat-2 and the non-toxic sub-clone UAT-014-009 derived from the same Japanese isolate. One unknown compound was identified only in the toxic sub-clone and was found to have the molecular formula C9H16N6O2. This structure differed from that of decarbamoyl STX (dcSTX; C9H16N6O3) by the loss of a single oxygen. A 12-deoxy-dcSTX standard (a mixture of 12 alpha- and beta-deoxy-dcSTX) was chemically prepared from dcSTX by reduction with sodium borohydride. The unknown compound in the toxic strain of A. tamarense was identified as 12 beta-deoxy-dcSTX by comparison of its HR-HILIC-LC-MS retention time and HR-MS/MS spectrum with those of the chemically prepared standard, and the identification was confirmed by high-sensitivity HPLC analysis with post-column fluorescent derivatization. Moreover, two Japanese isolates of A. catenella showing toxin profiles different from that of A. tamarense were also found to contain 12 beta-deoxy-dcSTX. Previously, 12 beta-deoxy-dcSTX was isolated from the freshwater cyanobacterium Lyngbya wollei, which produces a unique set of SIX analogues. This study is the first evidence of the presence of 12 beta-deoxy-dcSTX in marine dinoflagellates. (C) 2015 Elsevier B.V. All rights reserved.	[Cho, Yuko; Tsuchiya, Shigeki; Yoshioka, Renpei; Konoki, Keiichi; Yotsu-Yamashita, Mari] Tohoku Univ, Grad Sch Agr Sci, Aoba Ku, Sendai, Miyagi 9818555, Japan; [Omura, Takuo] Lab Aquat Sci Consultant Co Ltd, Ota Ku, Tokyo 1440031, Japan; [Oshima, Yasukatsu] Tohoku Univ, Grad Sch Life Sci, Aoba Ku, Sendai, Miyagi 9808577, Japan	Cho, Y (reprint author), Tohoku Univ, Grad Sch Agr Sci, Aoba Ku, Tsutsumidori Amamiyamachi 1-1, Sendai, Miyagi 9818555, Japan.	choyuko@m.tohoku.ac.jp			Funding Program for Next-Generation World-Leading Researchers [LS012]; KAKENHI [26292057, 24580295, 15K07569]; SUNBOR scholarship from the Suntory Institute for Bioorganic Research	This work was supported by grants from the Funding Program for Next-Generation World-Leading Researchers (LS012) to M.Y.Y. and by KAKENHI Grants-in-Aid for Scientific Research to M.Y.Y. (no. 26292057) and Y.C. (no. 24580295 and 15K07569). S.T. was the recipient of a SUNBOR scholarship from the Suntory Institute for Bioorganic Research and S.T. is a research fellow of Japan Society for the Promotion of Science (DC2) (no. 15J00480) JSPS (DC2) (no. 15J00480). We thank Dr. T. Ishimaru of Tokyo University of Marine Science and Technology, who kindly donated the A. tamarense clonal culture strains Axat-2 and UAT-014-009, and we thank Dr. K. Koike of Hiroshima University for the A. catenella clonal culture strains 120518KureAC and 0807KureAC.[SS]	Epstein-Barash H, 2009, P NATL ACAD SCI USA, V106, P7125, DOI 10.1073/pnas.0900598106; OSHIMA Y, 1995, J AOAC INT, V78, P528; Ichimi K, 2002, J EXP MAR BIOL ECOL, V273, P51, DOI 10.1016/S0022-0981(02)00137-5; Boundy MJ, 2015, J CHROMATOGR A, V1387, P1, DOI 10.1016/j.chroma.2015.01.086; Zhang Y, 2014, MAR DRUGS, V12, P5698, DOI 10.3390/md12115698; SCHANTZ EJ, 1957, J AM CHEM SOC, V79, P5230, DOI 10.1021/ja01576a044; Sawayama Y, 2011, ANGEW CHEM INT EDIT, V50, P7176, DOI 10.1002/anie.201102494; Turrell E, 2008, J AOAC INT, V91, P1372; Negri AP, 2007, HARMFUL ALGAE, V6, P774, DOI 10.1016/j.hal.2007.04.001; Lagos N, 1999, TOXICON, V37, P1359, DOI 10.1016/S0041-0101(99)00080-X; Cho Y, 2008, HARMFUL ALGAE, V7, P740, DOI 10.1016/j.hal.2008.02.008; Dell'Aversano C, 2005, J CHROMATOGR A, V1081, P190, DOI 10.1016/j.chroma.2005.05.056; Kellmann R, 2008, APPL ENVIRON MICROB, V74, P4044, DOI 10.1128/AEM.00353-08; STRICHARTZ GR, 1995, TOXICON, V33, P723, DOI 10.1016/0041-0101(95)00031-G; Thottumkara AP, 2014, ANGEW CHEM INT EDIT, V53, P5760, DOI 10.1002/anie.201308235; Wiese M, 2010, MAR DRUGS, V8, P2185, DOI 10.3390/md8072185; Vale P, 2008, J CHROMATOGR A, V1195, P85, DOI 10.1016/j.chroma.2008.04.073; Suzuki T, 2013, FOOD ADDIT CONTAM A, V30, P1358, DOI 10.1080/19440049.2013.790085; Ma YY, 2015, TETRAHEDRON, V71, P1145, DOI 10.1016/j.tet.2014.11.056; Anderson DM, 2012, HARMFUL ALGAE, V14, P10, DOI 10.1016/j.hal.2011.10.012; Trainer VL, 2010, PROG OCEANOGR, V85, P33, DOI 10.1016/j.pocean.2010.02.003; Orr RJS, 2013, MAR DRUGS, V11, P2814, DOI 10.3390/md11082814; ROGERS RS, 1980, J AM CHEM SOC, V102, P7335, DOI 10.1021/ja00544a030; SCHANTZ EJ, 1975, J AM CHEM SOC, V97, P1238, DOI 10.1021/ja00838a045; Orr RJS, 2013, APPL ENVIRON MICROB, V79, P2128, DOI 10.1128/AEM.03279-12; Lim PT, 2007, HARMFUL ALGAE, V6, P321, DOI 10.1016/j.hal.2006.04.004; KAO CY, 1966, PHARMACOL REV, V18, P997; BATES HA, 1975, J AGR FOOD CHEM, V23, P237, DOI 10.1021/jf60198a016; KAO CY, 1985, TOXICON, V23, P647, DOI 10.1016/0041-0101(85)90369-1; Tsuchiya S, 2015, CHEM-EUR J, V21, P7835, DOI 10.1002/chem.201500064; SHIMIZU Y, 1982, PURE APPL CHEM, V54, P1973, DOI 10.1351/pac198254101973; Dell'Aversano C, 2008, J NAT PROD, V71, P1518, DOI 10.1021/np800066r; Tsuchiya S, 2014, ORG BIOMOL CHEM, V12, P3016, DOI 10.1039/c4ob00071d; Watanabe R, 2010, TOXICON, V56, P589, DOI 10.1016/j.toxicon.2010.06.002; Cho Y, 2014, HARMFUL ALGAE, V32, P64, DOI 10.1016/j.hal.2013.12.007; Cho YK, 2013, HARMFUL ALGAE, V25, P47, DOI 10.1016/j.hal.2013.02.005; Hallegraeff GM, 2010, J PHYCOL, V46, P220, DOI 10.1111/j.1529-8817.2010.00815.x; Llewellyn LE, 2006, NAT PROD REP, V23, P200, DOI 10.1039/b501296c; Vale P, 2010, PHYTOCHEM REV, V9, P525, DOI 10.1007/s11101-010-9196-7; MAHAR J, 1991, TOXICON, V29, P53, DOI 10.1016/0041-0101(91)90039-T; Smayda TJ, 2007, HARMFUL ALGAE, V6, P601, DOI 10.1016/j.hal.2007.02.003; BORDNER J, 1975, J AM CHEM SOC, V97, P6008, DOI 10.1021/ja00854a009; OGATA T, 1987, TOXICON, V25, P923, DOI 10.1016/0041-0101(87)90154-1; Hackett JD, 2013, MOL BIOL EVOL, V30, P70, DOI 10.1093/molbev/mss142; Hamasaki K, 2001, J PLANKTON RES, V23, P271, DOI 10.1093/plankt/23.3.271; SHIMIZU Y, 1981, J AM CHEM SOC, V103, P605, DOI 10.1021/ja00393a017; KOEHN FE, 1981, BIOORG CHEM, V10, P412, DOI 10.1016/0045-2068(81)90053-5; Bricelj M., 1995, TECHNIQUE ET DOCUMEN, P413; Cho Y., 2006, P 12 INT C HARMF ALG, P59; Harwood DT, 2014, TOXICON, V90, P213, DOI 10.1016/j.toxicon.2014.08.058; KAO CY, 1982, J PHYSIOL-LONDON, V323, P619; Mihali TK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014657; Omura T., 2003, LA MER, V41, P86; Onodera Hideyuki, 1997, Natural Toxins, V5, P146; OSHIMA Y, 1990, TOXIC MARINE PHYTOPLANKTON, P391; Oshima Y., 1979, P377; Oshima Y., 1993, TOXIC PHYTOPLANKTON, P903; STRICHARTZ GR, 1981, BIOPHYS J, V33, pA209; Stuken A., 2011, PLOS ONE, V6, P5; Yoshida Takashi, 2001, Phycological Research, V49, P13	60	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1568-9883	1878-1470		HARMFUL ALGAE	Harmful Algae	NOV	2015	49						58	67		10.1016/j.hal.2015.09.003		10	Marine & Freshwater Biology	Marine & Freshwater Biology	CW5TB	WOS:000365058400007		
J	Wells, ML; Trainer, VL; Smayda, TJ; Karlson, BSO; Trick, CG; Kudela, RM; Ishikawa, A; Bernard, S; Wulff', A; Anderson, DM; Cochlan, WP				Wells, Mark L.; Trainer, Vera L.; Smayda, Theodore J.; Karlson, Bengt S. O.; Trick, Charles G.; Kudela, Raphael M.; Ishikawa, Akira; Bernard, Stewart; Wulff, Angela; Anderson, Donald M.; Cochlan, William P.			Harmful algal blooms and climate change: Learning from the past and present to forecast the future	HARMFUL ALGAE			English	Article						Harmful algal blooms; HAB; Climate change	DOMOIC ACID PRODUCTION; DINOFLAGELLATE GYMNODINIUM-CATENATUM; PHYTOPLANKTON COMMUNITY STRUCTURE; PSEUDO-NITZSCHIA-MULTISERIES; PARALYTIC SHELLFISH TOXINS; HETEROSIGMA-AKASHIWO RAPHIDOPHYCEAE; CO2 CONCENTRATING MECHANISMS; INORGANIC CARBON ACQUISITION; NORTHERN BALTIC SEA; SETO INLAND SEA	Climate change pressures will influence marine planktonic systems globally, and it is conceivable that harmful algal blooms may increase in frequency and severity. These pressures will be manifest as alterations in temperature, stratification, light, ocean acidification, precipitation-induced nutrient inputs, and grazing, but absence of fundamental knowledge of the mechanisms driving harmful algal blooms frustrates most hope of forecasting their future prevalence. Summarized here is the consensus of a recent workshop held to address what currently is known and not known about the environmental conditions that favor initiation and maintenance of harmful algal blooms. There is expectation that harmful algal bloom (HAB) geographical domains should expand in some cases, as will seasonal windows of opportunity for harmful algal blooms at higher latitudes. Nonetheless there is only basic information to speculate upon which regions or habitats HAB species may be the most resilient or susceptible. Moreover, current research strategies are not well suited to inform these fundamental linkages. There is a critical absence of tenable hypotheses for how climate pressures mechanistically affect HAB species, and the lack of uniform experimental protocols limits the quantitative cross-investigation comparisons essential to advancement. A HAB "best practices" manual would help foster more uniform research strategies and protocols, and selection of a small target list of model HAB species or isolates for study would greatly promote the accumulation of knowledge. Despite the need to focus on keystone species, more studies need to address strain variability within species, their responses under multifactorial conditions, and the retrospective analyses of long-term plankton and cyst core data; research topics that are departures from the norm. Examples of some fundamental unknowns include how larger and more frequent extreme weather events may break down natural biogeographic barriers, how stratification may enhance or diminish HAB events, how trace nutrients (metals, vitamins) influence cell toxicity, and how grazing pressures may leverage, or mitigate HAB development. There is an absence of high quality time-series data in most regions currently experiencing HAB outbreaks, and little if any data from regions expected to develop HAB events in the future. A subset of observer sites is recommended to help develop stronger linkages among global, national, and regional climate change and HAB observation programs, providing fundamental datasets for investigating global changes in the prevalence of harmful algal blooms. Forecasting changes in HAB patterns over the next few decades will depend critically upon considering harmful algal blooms within the competitive context of plankton communities, and linking these insights to ecosystem, oceanographic and climate models. From a broader perspective, the nexus of HAB science and the social sciences of harmful algal blooms is inadequate and prevents quantitative assessment of impacts of future HAB changes on human wellbeing. These and other fundamental changes in HAB research will be necessary if HAB science is to obtain compelling evidence that climate change has caused alterations in HAB distributions, prevalence or character, and to develop the theoretical, experimental, and empirical evidence explaining the mechanisms underpinning these ecological shifts. (C) 2015 Elsevier B.V. All rights reserved.	[Wells, Mark L.] Univ Maine, Sch Marine Sci, Orono, ME 04469 USA; [Trainer, Vera L.] NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Marine Biotoxins Program, Seattle, WA 98112 USA; [Smayda, Theodore J.] Univ Rhode Isl, Grad Sch Oceanog, Kingston, RI 02881 USA; [Karlson, Bengt S. O.] SMHI Res & Dev, Oceanog, S-42671 Vastra Frolunda, Sweden; [Trick, Charles G.] Univ Western Ontario, Dept Biol, London, ON N6A 5B7, Canada; [Kudela, Raphael M.] Univ Calif Santa Cruz, Ocean Sci, Santa Cruz, CA 95064 USA; [Ishikawa, Akira] Mie Univ, Grad Sch Bioresources, Lab Biol Oceanog, Tsu, Mie 5148507, Japan; [Bernard, Stewart] CSIR NRE Ctr High Performance Comp, Earth Syst Earth Observat, ZA-7700 Cape Town, South Africa; [Wulff, Angela] Univ Gothenburg, Dept Biol & Environm Sci, SE-40530 Gothenburg, Sweden; [Anderson, Donald M.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Cochlan, William P.] San Francisco State Univ, Romberg Tiburon Ctr Environm Studies, Tiburon, CA 94920 USA	Wells, ML (reprint author), Univ Maine, Sch Marine Sci, Orono, ME 04469 USA.	mlwells@maine.edu; vera.l.trainer@noaa.gov; tsmayda@uri.edu; Bengt.Karlson@smhi.se; trick@uwo.ca; kudela@ucsc.edu; ishikawa@bio.mie-u.ac.jp; sbernard@csir.co.za; angela.wulff@bioenv.gu.se; danderson@whoi.edu; cochlan@sfsu.edu			PICES; GEOHAB; U.S. National Office for Marine Biotoxins and Harmful Algal Blooms, Woods Hole Oceanographic Institution; SCOR-IOC GEOHAB; National Science Foundation (NSF) [OCE-1131657, OCE 1130748, OCE-1128041, OCE-1314642]; NOAA NCCOS grants [NA10NOS4780161, NA10NOS4780160]; Woods Hole Center for Oceans and Human Health; National Institute of Environmental Health Sciences (NIEHS) [1-P50-ES021923-01]; California Sea Grant; California Ocean Protection Council [R/OPCCONT-12 A 10]; National Aeronautics and Space Administration grant [NNX13AL28G]; NOAA award [NA11NOS4780030]	Support for the workshop organized under the auspices of PICES and GEOHAB and endorsed by ICES was provided by the North Pacific Marine Science Organization (PICES), the U.S. National Office for Marine Biotoxins and Harmful Algal Blooms, Woods Hole Oceanographic Institution and SCOR-IOC GEOHAB. Additional support for MLW, CGT, and WPC was from the National Science Foundation (NSF) Grants OCE-1131657 and OCE 1130748 and NOAA NCCOS grants NA10NOS4780161 and NA10NOS4780160, respectively. Support for DMA was provided through the Woods Hole Center for Oceans and Human Health, National Science Foundation (NSF) Grants OCE-1128041 and OCE-1314642; and National Institute of Environmental Health Sciences (NIEHS) Grant 1-P50-ES021923-01. Support for RMK was provided through California Sea Grant and California Ocean Protection Council award R/OPCCONT-12 A 10, National Aeronautics and Space Administration grant NNX13AL28G, and the NOAA award NA11NOS4780030. We express our sincere appreciation to G. Hallegraeff, S. Moore, and an anonymous reviewer for their contributions that improved this work. This is ECOHAB Contribution ECO829.; [SS]	Acker J.G., 2007, EOS T AGU, V88, P14, DOI DOI 10.1029/2007E0020003; Anderson D.M., 2013, IMPROVING ACCURACY U; Beardall J, 2004, PHYCOLOGIA, V43, P26, DOI 10.2216/i0031-8884-43-1-26.1; Sullivan JM, 2010, CONT SHELF RES, V30, P1, DOI 10.1016/j.csr.2009.09.001; Etheridge SM, 2005, DEEP-SEA RES PT II, V52, P2491, DOI 10.1016/j.dsr2.2005.06.026; Kudela RM, 2008, HARMFUL ALGAE, V7, P278, DOI 10.1016/j.hal.2007.12.016; Karentz D, 1998, J PLANKTON RES, V20, P145, DOI 10.1093/plankt/20.1.145; HARGRAVES PE, 1993, HYDROBIOLOGIA, V269, P207, DOI 10.1007/BF00028019; Evens TJ, 2001, J PLANKTON RES, V23, P1177, DOI 10.1093/plankt/23.11.1177; Moore MN, 2013, MICROB ECOL, V65, P889, DOI 10.1007/s00248-013-0204-5; Giordano M, 2005, ANNU REV PLANT BIOL, V56, P99, DOI 10.1146/annurev.arplant.56.032604.144052; Scholin CA, 1995, PHYCOLOGIA, V34, P472, DOI 10.2216/i0031-8884-34-6-472.1; Farrell H, 2012, HARMFUL ALGAE, V15, P36, DOI 10.1016/j.hal.2011.11.003; Shumway SE, 2003, HARMFUL ALGAE, V2, P1, DOI 10.1016/S1568-9883(03)00002-7; Naustvoll LJ, 2012, FOOD ADDIT CONTAM A, V29, P1605, DOI 10.1080/19440049.2012.714908; Fu FX, 2012, MAR ECOL PROG SER, V470, P207, DOI 10.3354/meps10047; Pattanaik B, 2010, HARMFUL ALGAE, V10, P30, DOI 10.1016/j.hal.2010.06.001; Smayda TJ, 2010, PROG OCEANOGR, V85, P92, DOI 10.1016/j.pocean.2010.02.006; Thessen AE, 2009, HARMFUL ALGAE, V8, P792, DOI 10.1016/j.hal.2009.01.003; Martin JL, 2009, J SEA RES, V61, P76, DOI 10.1016/j.seares.2008.05.011; Roy EG, 2011, MAR CHEM, V127, P115, DOI 10.1016/j.marchem.2011.08.006; Ekstrom JA, 2015, NAT CLIM CHANGE, V5, P207, DOI 10.1038/NCLIMATE2508; Fehling J, 2004, J PHYCOL, V40, P622, DOI 10.1111/j.1529-8817.2004.03200.x; GARCIAPICHEL F, 1993, APPL ENVIRON MICROB, V59, P163; Taylor M, 2013, MAR DRUGS, V11, P1669, DOI 10.3390/md11051669; Collos Y, 2009, J SEA RES, V61, P68, DOI 10.1016/j.seares.2008.05.008; MacIntyre HL, 2004, HARMFUL ALGAE, V3, P403, DOI 10.1016/j.hal.2004.05.005; Nishikawa Tetsuya, 2011, Plankton & Benthos Research, V6, P26; Bergkvist J, 2008, OECOLOGIA, V156, P147, DOI 10.1007/s00442-008-0981-6; De Boer MK, 2005, J PLANKTON RES, V27, P47, DOI 10.1093/plankt/fbh149; Belgrano A, 1999, P ROY SOC B-BIOL SCI, V266, P425; Ryan JP, 2008, MAR ECOL PROG SER, V354, P21, DOI 10.3354/meps07222; Mengelt C, 2005, MAR ECOL PROG SER, V301, P81, DOI 10.3354/meps301081; Sun J, 2011, LIMNOL OCEANOGR, V56, P829, DOI 10.4319/lo.2011.56.3.0829; Guerrini F, 2007, HARMFUL ALGAE, V6, P707, DOI 10.1016/j.hal.2007.02.006; Perez CC, 1998, J PHYCOL, V34, P242, DOI 10.1046/j.1529-8817.1998.340242.x; Perez FF, 2010, GLOBAL CHANGE BIOL, V16, P1258, DOI 10.1111/j.1365-2486.2009.02125.x; Greer AT, 2013, J PLANKTON RES, V35, P939, DOI 10.1093/plankt/fbt056; Jeffrey SW, 1999, MAR ECOL PROG SER, V189, P35, DOI 10.3354/meps189035; Teegarden GJ, 2001, MAR ECOL PROG SER, V218, P213, DOI 10.3354/meps218213; Tortell PD, 2000, LIMNOL OCEANOGR, V45, P744; Itakura S, 2002, FISHERIES SCI, V68, P77, DOI 10.1046/j.1444-2906.2002.00392.x; John EH, 2000, EUR J PHYCOL, V35, P11, DOI 10.1017/S0967026200002572; HEIN M, 1995, MAR ECOL PROG SER, V118, P247, DOI 10.3354/meps118247; Dyhrman ST, 2003, LIMNOL OCEANOGR, V48, P647; Byrne M, 2011, OCEANOGR MAR BIOL, V49, P1; Beardall J, 2009, PLANT ECOL DIVERS, V2, P191, DOI 10.1080/17550870903271363; Okolodkov YB, 2005, HARMFUL ALGAE, V4, P351, DOI 10.1016/j.hal.2004.06.016; Karlberg M, 2013, MAR BIOL, V160, P2063, DOI 10.1007/s00227-012-2078-3; Rabalais NN, 2010, BIOGEOSCIENCES, V7, P585; Alheit J, 2005, ICES J MAR SCI, V62, P1205, DOI 10.1016/j.icejms.2005.04.024; Trainer VL, 2003, J SHELLFISH RES, V22, P213; Fehling J, 2006, MAR ECOL PROG SER, V323, P91, DOI 10.3354/meps323091; Jiang XD, 2010, OECOLOGIA, V164, P455, DOI 10.1007/s00442-010-1695-0; Hallegraeff GM, 2007, HARMFUL ALGAE, V6, P461, DOI 10.1016/j.hal.2007.02.001; Rongo T, 2011, HARMFUL ALGAE, V10, P345, DOI 10.1016/j.hal.2010.11.005; Rost B, 2006, PLANT CELL ENVIRON, V29, P810, DOI 10.1111/j.1365-3040.2005.01450.x; Klisch M, 2008, MAR DRUGS, V6, P147, DOI 10.3390/md20080008; Hajdu S, 2000, INT REV HYDROBIOL, V85, P561; Dason JS, 2004, CAN J BOT, V82, P515, DOI [10.1139/B04-023, 10.1139/b04-023]; Gomez F, 2007, J SEA RES, V58, P283, DOI 10.1016/j.seares.2007.08.002; Singh A, 2014, HARMFUL ALGAE, V34, P29, DOI 10.1016/j.hal.2014.02.006; Hallegraeff GM, 2012, HARMFUL ALGAE, V14, P130, DOI 10.1016/j.hal.2011.10.018; Feng YY, 2009, MAR ECOL PROG SER, V388, P13, DOI 10.3354/meps08133; Raven JA, 2014, AQUAT BOT, V118, P24, DOI 10.1016/j.aquabot.2014.05.008; Bonachela JA, 2011, P NATL ACAD SCI USA, V108, P20633, DOI 10.1073/pnas.1118012108; Peacock MB, 2014, LIMNOL OCEANOGR, V59, P660, DOI 10.4319/lo.2014.59.3.0660; Collos Y, 2014, HARMFUL ALGAE, V37, P84, DOI 10.1016/j.hal.2014.05.008; Leu E, 2013, BIOGEOSCIENCES, V10, P1143, DOI 10.5194/bg-10-1143-2013; Laabir M, 2011, J PLANKTON RES, V33, P1550, DOI 10.1093/plankt/fbr050; Smayda TJ, 1998, ICES J MAR SCI, V55, P562, DOI 10.1006/jmsc.1998.0385; Fu FX, 2010, AQUAT MICROB ECOL, V59, P55, DOI 10.3354/ame01396; KAMYKOWSKI D, 1986, J PLANKTON RES, V8, P275, DOI 10.1093/plankt/8.2.275; Stock CA, 2005, DEEP-SEA RES PT II, V52, P2715, DOI 10.1016/j.dsr2.2005.06.022; Monteith DT, 2007, NATURE, V450, P537, DOI 10.1038/nature06316; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Schultz M, 2009, J PLANKTON RES, V31, P553, DOI 10.1093/plankt/fbp010; Fan CL, 2003, HARMFUL ALGAE, V2, P283, DOI 10.1016/S1568-9883(03)00047-7; Wells ML, 2005, LIMNOL OCEANOGR, V50, P1908; Trainer VL, 2013, MAR DRUGS, V11, P1815, DOI 10.3390/md11061815; Rines JEB, 2002, MAR ECOL PROG SER, V225, P123, DOI 10.3354/meps225123; Lundholm N, 2004, MAR ECOL PROG SER, V273, P1, DOI 10.3354/meps273001; Ruiz GM, 1997, AM ZOOL, V37, P621; Rost B, 2003, LIMNOL OCEANOGR, V48, P55; CEMBELLA AD, 1994, J EXP MAR BIOL ECOL, V180, P1, DOI 10.1016/0022-0981(94)90075-2; Turner JT, 2009, MAR ECOL PROG SER, V376, P103, DOI 10.3354/meps07783; Wu ZX, 2013, CONT SHELF RES, V59, P10, DOI 10.1016/j.csr.2013.03.014; Strom SL, 2013, J PHYCOL, V49, P20, DOI 10.1111/jpy.12013; Al-Azri A, 2012, AQUAT ECOSYST HEALTH, V15, P56, DOI 10.1080/14634988.2012.672151; Flynn KJ, 1996, J PLANKTON RES, V18, P2093, DOI 10.1093/plankt/18.11.2093; Teegarden GJ, 1999, MAR ECOL PROG SER, V181, P163, DOI 10.3354/meps181163; Baek SH, 2008, HARMFUL ALGAE, V7, P163, DOI 10.1016/j.ha1.2007.06.006; Maldonado MT, 2002, LIMNOL OCEANOGR, V47, P515; Boyd PW, 2012, MAR ECOL PROG SER, V470, P125, DOI 10.3354/meps10121; Moncheva S, 2001, ESTUAR COAST SHELF S, V53, P281, DOI 10.1006/ecss.2001.0767; Hinga KR, 2002, MAR ECOL PROG SER, V238, P281, DOI 10.3354/meps238281; Okolodkov YB, 1999, GRANA, V38, P162, DOI 10.1080/00173139908559224; Tang DL, 2006, HYDROBIOLOGIA, V568, P245, DOI 10.1007/s10750-006-0108-1; McGillicuddy DJ, 2005, DEEP-SEA RES PT II, V52, P2843, DOI 10.1016/j.dsr2.2005.06.020; Loureiro C, 2011, ECOTOXICOLOGY, V20, P139, DOI 10.1007/s10646-010-0565-1; McGillicuddy DJ, 2011, LIMNOL OCEANOGR, V56, P2411, DOI 10.4319/lo.2011.56.6.2411; MANSON MD, 1977, P NATL ACAD SCI USA, V74, P3060, DOI 10.1073/pnas.74.7.3060; Kudela RM, 2010, PROG OCEANOGR, V85, P122, DOI 10.1016/j.pocean.2010.02.008; Berdalet E, 2014, DEEP-SEA RES PT II, V101, P4, DOI 10.1016/j.dsr2.2013.09.042; Kim H, 2013, HARMFUL ALGAE, V26, P1, DOI 10.1016/j.hal.2013.03.004; HIMMELMAN JH, 1975, J EXP MAR BIOL ECOL, V20, P199, DOI 10.1016/0022-0981(75)90024-6; Trainer VL, 2012, HARMFUL ALGAE, V14, P271, DOI 10.1016/j.hal.2011.10.025; Smayda TJ, 1997, LIMNOL OCEANOGR, V42, P1132; Herndon J, 2007, HARMFUL ALGAE, V6, P260, DOI 10.1016/j.hal.2006.08.006; Matsuoka K, 2010, HARMFUL ALGAE, V9, P548, DOI 10.1016/j.hal.2010.04.003; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Boberg F, 2010, CLIM DYNAM, V35, P1509, DOI 10.1007/s00382-009-0683-8; Anderson DM, 2012, HARMFUL ALGAE, V14, P10, DOI 10.1016/j.hal.2011.10.012; HONJO T, 1985, LIMNOL OCEANOGR, V30, P653; Laglera LM, 2009, LIMNOL OCEANOGR, V54, P610, DOI 10.4319/lo.2009.54.2.0610; Sun Y, 2007, J CLIMATE, V20, P4801, DOI 10.1175/JCLI4263.1; Hattenrath TK, 2010, HARMFUL ALGAE, V9, P402, DOI 10.1016/j.hal.2010.02.003; Ajani PA, 2014, LIMNOL OCEANOGR, V59, P519, DOI 10.4319/lo.2014.59.2.0519; Bissinger JE, 2008, LIMNOL OCEANOGR, V53, P487, DOI 10.4319/lo.2008.53.2.0487; Hinder SL, 2012, NAT CLIM CHANGE, V2, P271, DOI [10.1038/nclimatei388, 10.1038/NCLIMATE1388]; Magana HA, 2006, HARMFUL ALGAE, V5, P192, DOI 10.1016/j.hal.2005.07.003; Auro ME, 2013, J PHYCOL, V49, P156, DOI 10.1111/jpy.12033; Smayda TJ, 2008, HARMFUL ALGAE, V8, P140, DOI 10.1016/j.hal.2008.08.018; Lonnstedt OM, 2013, ECOL EVOL, V3, P3565, DOI 10.1002/ece3.684; Davidson K, 2012, ESTUAR COAST SHELF S, V115, P399, DOI 10.1016/j.ecss.2012.09.019; Widdicombe CE, 2010, J PLANKTON RES, V32, P643, DOI 10.1093/plankt/fbp127; Fu FX, 2008, HARMFUL ALGAE, V7, P76, DOI 10.1016/j.hal.2007.05.006; Van de Waal DB, 2011, ISME J, V5, P1438, DOI 10.1038/ismej.2011.28; Mohlin M, 2009, MICROB ECOL, V57, P675, DOI 10.1007/s00248-008-9427-2; Harrison PJ, 2011, CHIN J OCEANOL LIMN, V29, P807, DOI 10.1007/s00343-011-0510-z; Moore SK, 2010, LIMNOL OCEANOGR, V55, P2262, DOI 10.4319/lo.2010.55.6.2262; Mohlin M, 2012, MICROB ECOL, V63, P736, DOI 10.1007/s00248-011-9964-y; Bricelj VM, 2005, NATURE, V434, P763, DOI 10.1038/nature03415; Jester R, 2009, HARMFUL ALGAE, V8, P291, DOI 10.1016/j.hal.2008.07.001; Ryan JP, 2010, CONT SHELF RES, V30, P7, DOI 10.1016/j.csr.2009.10.017; Anderson DM, 2002, ESTUARIES, V25, P704, DOI 10.1007/BF02804901; Cripps G, 2014, GLOBAL CHANGE BIOL, V20, P3377, DOI 10.1111/gcb.12582; KARENTZ D, 1984, MAR ECOL PROG SER, V18, P277, DOI 10.3354/meps018277; Yoshimatsu T, 2014, HARMFUL ALGAE, V35, P29, DOI 10.1016/j.hal.2014.03.007; Brownlee EF, 2005, HARMFUL ALGAE, V4, P593, DOI 10.1016/j.hal.2004.08.009; Hubbart B, 2012, HARMFUL ALGAE, V20, P30, DOI 10.1016/j.hal.2012.07.005; Chen YW, 2003, J PLANKTON RES, V25, P445, DOI 10.1093/plankt/25.4.445; Hansen PJ, 1997, LIMNOL OCEANOGR, V42, P687; SMETACEK V, 1981, MAR BIOL, V63, P1, DOI 10.1007/BF00394657; Martinez R, 2010, J PLANKTON RES, V32, P529, DOI 10.1093/plankt/fbp135; Maguer JF, 2007, J PHYCOL, V43, P295, DOI 10.1111/j.1529-8817.2007.00334.x; Hutchins DA, 2009, OCEANOGRAPHY, V22, P128; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Leong SCY, 2004, TOXICON, V43, P407, DOI 10.1016/j.toxicon.2004.01.015; Trainer VL, 2009, LIMNOL OCEANOGR, V54, P289, DOI 10.4319/lo.2009.54.1.0289; HANSEN PJ, 1991, MAR ECOL PROG SER, V73, P253, DOI 10.3354/meps073253; Moore SK, 2009, HARMFUL ALGAE, V8, P463, DOI 10.1016/j.hal.2008.10.003; Shi DL, 2010, SCIENCE, V327, P676, DOI 10.1126/science.1183517; Fu FX, 2007, J PHYCOL, V43, P485, DOI 10.1111/j.1529-8817.2007.00355.x; Suikkanen S, 2007, ESTUAR COAST SHELF S, V71, P580, DOI 10.1016/j.ecss.2006.09.004; FIEDLER PC, 1982, LIMNOL OCEANOGR, V27, P961; Ratti S, 2007, J PHYCOL, V43, P693, DOI 10.1111/j.1529-8817.2007.00368.x; Caron DA, 2013, J PLANKTON RES, V35, P235, DOI 10.1093/plankt/fbs091; WALSBY AE, 1995, EUR J PHYCOL, V30, P87, DOI 10.1080/09670269500650851; Teegarden GJ, 1996, J EXP MAR BIOL ECOL, V196, P145, DOI 10.1016/0022-0981(95)00128-X; Trainer VL, 2007, HARMFUL ALGAE, V6, P449, DOI 10.1016/j.hal.2006.12.001; Anderson DM, 2006, LIMNOL OCEANOGR, V51, P860; Nimer NA, 1997, J PHYCOL, V33, P625, DOI 10.1111/j.0022-3646.1997.00625.x; Waldbusser GG, 2015, NAT CLIM CHANGE, V5, P273, DOI 10.1038/NCLIMATE2479; Tester PA, 2010, TOXICON, V56, P698, DOI 10.1016/j.toxicon.2010.02.026; Koski M, 1999, ICES J MAR SCI, V56, P131, DOI 10.1006/jmsc.1999.0621; Azanza RV, 2001, AMBIO, V30, P356, DOI 10.1639/0044-7447(2001)030[0356:APBITS]2.0.CO;2; Coats DW, 2002, J PHYCOL, V38, P520, DOI 10.1046/j.1529-8817.2002.t01-1-01200.x; Ha SY, 2014, DIATOM RES, V29, P399, DOI 10.1080/0269249X.2014.894945; Brand LE, 2007, HARMFUL ALGAE, V6, P232, DOI 10.1016/j.hal.2006.08.005; GOSSELIN S, 1989, MAR ECOL PROG SER, V57, P1, DOI 10.3354/meps057001; Collins S, 2014, EVOL APPL, V7, P140, DOI 10.1111/eva.12120; Sterner RW, 2008, LIMNOL OCEANOGR, V53, P1169, DOI 10.4319/lo.2008.53.3.1169; Carreto JI, 2011, MAR DRUGS, V9, P387, DOI 10.3390/md9030387; Paerl HW, 2014, ESTUAR COAST, V37, P243, DOI 10.1007/s12237-014-9773-x; Raine R, 2014, DEEP-SEA RES PT II, V101, P21, DOI 10.1016/j.dsr2.2013.06.021; Garcia-Mendoza E, 2009, HARMFUL ALGAE, V8, P493, DOI 10.1016/j.hal.2008.10.002; Sunda WG, 2012, MAR ECOL PROG SER, V447, P31, DOI 10.3354/meps09482; Eberlein T, 2014, PHYSIOL PLANTARUM, V151, P468, DOI 10.1111/ppl.12137; Glibert PM, 2008, MAR POLLUT BULL, V56, P1049, DOI 10.1016/j.marpolbul.2008.03.010; HUNTLEY M, 1986, MAR ECOL PROG SER, V28, P105, DOI 10.3354/meps028105; Zhang YH, 2006, HARMFUL ALGAE, V5, P310, DOI 10.1016/j.hal.2005.09.001; Pitcher GC, 2000, S AFR J MARINE SCI, V22, P255; Lewis J, 1999, J PLANKTON RES, V21, P343, DOI 10.1093/plankt/21.2.343; Kremp A, 2000, J PLANKTON RES, V22, P1311, DOI 10.1093/plankt/22.7.1311; Berge T, 2010, MAR ECOL PROG SER, V416, P79, DOI 10.3354/meps08780; Hansen PJ, 2002, AQUAT MICROB ECOL, V28, P279, DOI 10.3354/ame028279; Jeong Hae Jin, 2010, Ocean Science Journal, V45, P65, DOI 10.1007/s12601-010-0007-2; Grigorov I, 2014, DEEP-SEA RES PT I, V93, P1, DOI 10.1016/j.dsr.2014.07.008; Tatters AO, 2013, EVOLUTION, V67, P1879, DOI 10.1111/evo.12029; Moore SK, 2011, HARMFUL ALGAE, V10, P521, DOI 10.1016/j.hal.2011.04.004; RHODES LL, 1994, J PLANKTON RES, V16, P69, DOI 10.1093/plankt/16.1.69; PITCHER GC, 1993, S AFR J SCI, V89, P512; Anderson DM, 2005, DEEP-SEA RES PT II, V52, P2522, DOI 10.1016/j.dsr2.2005.06.014; Lee CK, 2013, HARMFUL ALGAE, V30, pS3, DOI 10.1016/j.hal.2013.10.002; Roemmich D, 2012, NAT CLIM CHANGE, V2, P425, DOI 10.1038/NCLIMATE1461; Rensel JEJ, 2010, HARMFUL ALGAE, V10, P98, DOI 10.1016/j.hal.2010.07.005; Kremp A, 2012, ECOL EVOL, V2, P1195, DOI 10.1002/ece3.245; Ryan JP, 2014, DEEP-SEA RES PT II, V101, P63, DOI 10.1016/j.dsr2.2013.01.017; Selina MS, 2014, HARMFUL ALGAE, V32, P1, DOI 10.1016/j.hal.2013.11.005; Borkman DG, 2014, HARMFUL ALGAE, V32, P73, DOI 10.1016/j.hal.2013.12.005; Buskey EJ, 2001, ESTUARIES, V24, P337, DOI 10.2307/1353236; Gutowski WJ, 2007, J HYDROMETEOROL, V8, P1382, DOI 10.1175/2007JHM817.1; Marinov I, 2010, BIOGEOSCIENCES, V7, P3941, DOI 10.5194/bg-7-3941-2010; Edwards M, 2006, LIMNOL OCEANOGR, V51, P820; Borkman DG, 2012, HARMFUL ALGAE, V19, P92, DOI 10.1016/j.hal.2012.06.004; Koski M, 2002, LIMNOL OCEANOGR, V47, P878; Tatters AO, 2013, HARMFUL ALGAE, V30, P37, DOI 10.1016/j.hal.2013.08.007; JAHNKE J, 1989, NETH J SEA RES, V23, P15, DOI 10.1016/0077-7579(89)90038-0; Trimborn S, 2008, PHYSIOL PLANTARUM, V133, P92, DOI 10.1111/j.1399-3054.2007.01038.x; Collos Y, 2006, AFR J MAR SCI, V28, P313, DOI 10.2989/18142320609504169; Smayda TJ, 2007, HARMFUL ALGAE, V6, P601, DOI 10.1016/j.hal.2007.02.003; Campbell L, 2010, J PHYCOL, V46, P66, DOI 10.1111/j.1529-8817.2009.00791.x; Ralston DK, 2014, LIMNOL OCEANOGR, V59, P1112, DOI 10.4319/lo.2014.59.4.1112; MARCHANT HJ, 1991, MAR BIOL, V109, P391, DOI 10.1007/BF01313504; BINDER BJ, 1987, J PHYCOL, V23, P99; Lincoln JA, 2001, HYDROBIOLOGIA, V453, P107, DOI 10.1023/A:1013163816771; McManus MA, 2008, ESTUAR COAST, V31, P396, DOI 10.1007/s12237-007-9025-4; Anderson CR, 2010, J MARINE SYST, V83, P127, DOI 10.1016/j.jmarsys.2010.04.003; Edwards KF, 2013, ECOL LETT, V16, P56, DOI 10.1111/ele.12012; BRAND LE, 1983, LIMNOL OCEANOGR, V28, P1182; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Trainer VL, 2002, LIMNOL OCEANOGR, V47, P1438; Anderson DM, 2014, DEEP-SEA RES PT II, V103, P6, DOI 10.1016/j.dsr2.2013.10.002; Hama T, 2012, J OCEANOGR, V68, P183, DOI 10.1007/s10872-011-0084-6; Guisande C, 2002, MAR ECOL PROG SER, V225, P169, DOI 10.3354/meps225169; Geider RJ, 2002, EUR J PHYCOL, V37, P1, DOI 10.1017/S0967026201003456; Nishikawa T, 2014, J OCEANOGR, V70, P153, DOI 10.1007/s10872-014-0219-7; Hamasaki K, 2001, J PLANKTON RES, V23, P271, DOI 10.1093/plankt/23.3.271; Hare CE, 2007, MAR ECOL PROG SER, V352, P9, DOI 10.3354/meps07182; Ishimatsu A, 1996, FISHERIES SCI, V62, P836; Aoki K, 2014, MAR POLLUT BULL, V81, P131, DOI 10.1016/j.marpolbul.2014.02.005; Thornton Jeffrey A., 2013, Lakes & Reservoirs Research and Management, V18, P298, DOI 10.1111/lre.12044; Lelong A, 2012, PHYCOLOGIA, V51, P168, DOI 10.2216/11-37; Hallegraeff GM, 1998, MAR FRESHWATER RES, V49, P415, DOI 10.1071/MF97264; Tortell PD, 2002, MAR ECOL PROG SER, V236, P37, DOI 10.3354/meps236037; Kaczmarska I, 2007, HARMFUL ALGAE, V6, P861, DOI 10.1016/j.hal.2007.05.001; BRAVO I, 1994, J PLANKTON RES, V16, P513, DOI 10.1093/plankt/16.5.513; Bates S.S., 2006, ECOLOGY HARMFUL ALGA, P81; Bednarsek N., 2014, PLOS ONE, V9; Berdalet E., 2012, GLOBAL ECOLOGY OCEAN, P64; Bernard S., 2014, OCEANS SOC BLUE PLAN, P46; Boyd P.W., 2013, PLOS ONE, V8; Bricelj V. Monica, 1998, Reviews in Fisheries Science, V6, P315, DOI 10.1080/10641269891314294; Brusle J., 1995, IFREMER REPERES OCEA, P1; Burkholder H.M., 2009, HARMFUL ALGAE, V8, P744; Carignan M.O., 2002, ACTES C, V34, P191; Castenholz R.W., 2005, ECOLOGY CYANOBACTERI, P591; Cho E. S., 2001, KOREA ALGAE, V16, P275; Colin Sean P., 2002, Harmful Algae, V1, P113, DOI 10.1016/S1568-9883(02)00007-0; Djavidnia S., 2014, OCEANS SOC BLUE PLAN; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; EPPLEY RW, 1972, FISH B-NOAA, V70, P1063; Fernandes LDD, 2012, J PLANKTON RES, V34, P236, DOI 10.1093/plankt/fbr106; Figueras F.G., 2006, ECOLOGY HARMFUL ALGA, P127; Fraga S., 1989, P281; GEOHAB, 2006, GLOB EC OC HARMF ALG; GEOHAB, 2013, WORKSH ADV CHALL UND; GEOHAB, 2010, GLOB EC OC HARMF ALG; GEOHAB, 2005, GLOB EC OC HARMF ALG; GEOHAB, 2012, GLOB EC OC HARMF ALG; Gilbert PM, 2006, BIOGEOCHEMISTRY, V77, P441; Hader D.P., 2010, 2010 ASSESSMENTUNEP, P113; Hakansson B, 2002, SWEDISH NATL REPORT; Hallegraeff G., 2012, MARINE CLIMAGE CHANG, P240; Hansson LA, 2013, NAT CLIM CHANGE, V3, P228, DOI 10.1038/NCLIMATE1689; Hattenrath-Lehmann K.T., 2013, HARMFUL ALGAE, V26, P33; Hattenrath-Lehmann TK, 2015, LIMNOL OCEANOGR, V60, P198, DOI 10.1002/lno.10012; Hernandez-Farinas T., 2013, ICES J MAR SCI, V71, P821; HITCHCOCK GL, 1982, J PLANKTON RES, V4, P363, DOI 10.1093/plankt/4.2.363; HONJO T, 1987, Bulletin of Plankton Society of Japan, V34, P119; Huisman J.M., 2005, HARMFUL CYANOBACTERI; Itakura S., 2005, PLANKTON BIOL ECOLOG, V57, P85; Jeong H.J., 2013, HARMFUL ALGAE S, V30S, P541; Jessup D.A., 2009, PLOS ONE, V4, P8; Jorgensen C.B., 1966, BIOL SUSPENSION FEED; Kaebernick M, 2000, APPL ENVIRON MICROB, V66, P3387, DOI 10.1128/AEM.66.8.3387-3392.2000; Kahru M, 2015, DEEP-SEA RES PT II, V112, P91, DOI 10.1016/j.dsr2.2013.07.023; Kahru M., 2004, EOS, V85, P465, DOI 10.1029/2004EO450002; Kraberg A., 2012, ICES PHYTOPLANKTON M, P70; Lasker R., 1978, SPATIAL PATTERN PLAN, P329; Last J.M., 1980, FOOD 20 SPECIES FISH, P1; Levasseur Maurice, 1995, P463; Lewis N.I., 1993, TEMPERATURE EFFECTS; Li W.K.W., 1980, PRIMARY PRODUCTIVITY; Li Yaqin, 2000, Plankton Biology and Ecology, V47, P80; Locarnini R.A., 2006, WORLD OCEAN ATLAS 20, V1; Longhurst AR, 1998, ECOLOGICAL GEOGRAPHY; Lopez C.B., 2008, SCI ASSESSMENT FRESH; Maclntyre H.L., 2011, J PLANKTON RES, V33, P273; Marshall J.A., 2001, HARMFUL ALGAL BLOOMS, P316; McKenzie R.L., 2010, EFFECTS SOLAR UV RAD, P1; Montresor M., 2006, Algal cultures, analogues of blooms and applications, Volume 1, P91; Moran S.A.G., 2010, GLOBAL CHANGE BIOL, V16, P1137; Nishikawa T., 2009, ESTUAR COAST, V33, P417; Ogata T., 1989, P423; Pettersson L.H., 2013, BIOL ECOLOGY HARMFUL, P25; Pfiester LA, 1987, BIOL DINOFLAGELLATES, P611; Preston C.M., 2011, PLOS ONE, V6, P12; Raven J.A., 1988, NEW PHYTOL, V110, P411; Riebesell U., 2010, GUIDE BEST PRACTICES, P260; Ruiz S., 2005, PHYCOLOGIA, V44, P49; Salomon P., 2006, ECOLOGY HARMFUL ALGA, P271; Samson J.C., 2008, J FISH BIOL, V72; Seneviratne S. I., 2012, MANAGING RISKS EXTRE, P109; Shimizu Yuzuru, 1995, P351; SHUMWAY S E, 1990, Journal of the World Aquaculture Society, V21, P65, DOI 10.1111/j.1749-7345.1990.tb00529.x; Smayda Theodore J., 2002, Harmful Algae, V1, P95, DOI 10.1016/S1568-9883(02)00010-0; Smayda T.J., 1996, HARMFUL TOXIC ALGAL, P331; Smayda T.J., 2008, SCI ECOSYSTEM BASED, P423; Smayda T.J., 1992, FOOD CHAINS YIELDS M, P275; Smayda T.J., 2004, ECOLOGICAL EFFECTS C; STARR M, 1990, SCIENCE, V247, P1071, DOI 10.1126/science.247.4946.1071; Stocker T.F., 2013, CONTRIBUTION WORKING; STOECKER DK, 1985, MAR ECOL PROG SER, V25, P159, DOI 10.3354/meps025159; Strom Z., 2002, HYDROBIOLOGIA, V180, P41; Sunda W., 1989, BIOL OCEANOGR, V6, P411; Tang E.P.Y., 1996, J PHYCOL, V32, P80; Tatters A.O., 2012, PLOS ONE, V7; Tatters AO, 2013, PHILOS T R SOC B, V368, P1627; Trainer V., 2014, PICES SCI REP, P85; Trainer Vera L., 2005, Oceanography, V18, P228; Turner J.T, 2006, ECOLOGY HARMFUL ALGA, P259; Uye S.I., 1990, MAR ECOL PROG SER, V49, P97; White A.W., 1989, RED TIDES BIOL ENV S, P3; YAMOCHI S, 1986, Journal of the Oceanographical Society of Japan, V42, P266, DOI 10.1007/BF02114525	327	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1568-9883	1878-1470		HARMFUL ALGAE	Harmful Algae	NOV	2015	49						68	93		10.1016/j.hal.2015.07.009		26	Marine & Freshwater Biology	Marine & Freshwater Biology	CW5TB	WOS:000365058400008		
J	Toyoda, M; Kaira, K; Shino, M; Sakakura, K; Takahashi, K; Takayasu, Y; Tominaga, H; Oriuchi, N; Nikkuni, O; Suzuki, M; Iijima, M; Tsukamoto, N; Nagamori, S; Kanai, Y; Oyama, T; Chikamatsu, K				Toyoda, Miroru; Kaira, Kyoichi; Shino, Masato; Sakakura, Koichi; Takahashi, Katsumasa; Takayasu, Yukihiro; Tominaga, Hideyuki; Oriuchi, Noboru; Nikkuni, Osamu; Suzuki, Masami; Iijima, Misa; Tsukamoto, Norifumi; Nagamori, Shushi; Kanai, Yoshikatsu; Oyama, Tetsunari; Chikamatsu, Kazuaki			CD98 as a novel prognostic indicator for patients with stage III/IV hypopharyngeal squamous cell carcinoma	HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK			English	Article						hypopharynx; L-type amino acid transporter 1 (LAT1); CD98; immunohistochemistry; prognostic factor	ACID TRANSPORTER 1; LUNG-CANCER; HEAVY-CHAIN; EXPRESSION; LAT1; RISK	Background. Both L-type amino acid transporter 1 (LAT1) and CD98 are strongly expressed in primary human cancer and play essential roles in tumor growth. We studied the clinicopathological significance of LAT1 and CD98 expression in hypopharyngeal squamous cell carcinoma (SCC). Methods. A total of 70 patients with stage III/IV disease were retrospectively reviewed. Immunohistochemical staining of tumor sections was used to examine LAT1, CD98, Ki-67, CD34, and p53. Results. High LAT1 and CD98 expression were noted in 60.0% and 47.1%, respectively (p = .174). A statistically significant correlation was recognized between LAT1 and CD98 expression and both expressions were closely associated with tumor cell proliferation. Although LAT1 expression was not significantly associated with poor survival, multivariate analysis revealed high CD98 expression to be an independent prognostic factor for predicting a poor outcome. Conclusion. CD98 is a promising prognostic marker for predicting outcomes after surgical treatment in patients with advanced hypopharyngeal SCC. (C) 2014 Wiley Periodicals, Inc.	[Toyoda, Miroru; Shino, Masato; Sakakura, Koichi; Takahashi, Katsumasa; Takayasu, Yukihiro; Nikkuni, Osamu; Chikamatsu, Kazuaki] Gunma Univ, Dept Otolaryngol Head & Neck Surg, Grad Sch Med, Maebashi, Gunma 3718511, Japan; [Toyoda, Miroru; Kaira, Kyoichi; Shino, Masato; Sakakura, Koichi; Takahashi, Katsumasa; Takayasu, Yukihiro; Tominaga, Hideyuki; Nikkuni, Osamu; Tsukamoto, Norifumi; Chikamatsu, Kazuaki] Gunma Univ Hosp, Ctr Oncol, Maebashi, Gunma 3718511, Japan; [Kaira, Kyoichi; Oyama, Tetsunari] Gunma Univ, Dept Diagnost Pathol, Grad Sch Med, Gunma Univ Hosp, Maebashi, Gunma 3718511, Japan; [Oriuchi, Noboru] Gunma Univ, Dept Diagnost Radiol & Nucl Med, Grad Sch Med, Maebashi, Gunma 3718511, Japan; [Tominaga, Hideyuki] Gunma Univ, Dept Mol Imaging, Grad Sch Med, Maebashi, Gunma 3718511, Japan; [Nikkuni, Osamu; Suzuki, Masami] Gunma Prefectural Canc Ctr, Dept Head & Neck Surg, Gunma, Japan; [Iijima, Misa] Gunma Prefectural Canc Ctr, Dept Pathol & Clin Labs, Gunma, Japan; [Nagamori, Shushi; Kanai, Yoshikatsu] Osaka Univ, Grad Sch Med, Div Biosyst Pharmacol, Osaka, Japan	Kaira, K (reprint author), Gunma Univ, Dept Diagnost Pathol, Grad Sch Med, Maebashi, Gunma 3718511, Japan.	kkaira1970@yahoo.co.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [23591750, 23592523]; National Hospital Organization Policy Based Medical Services	Contract grant sponsor: This work was supported in part by grant 23591750 (K. K.) and grant 23592523 (K. C.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and National Hospital Organization Policy Based Medical Services.	Yanagida O, 2001, BBA-BIOMEMBRANES, V1514, P291, DOI 10.1016/S0005-2736(01)00384-4; Kaira K, 2009, ANN SURG ONCOL, V16, P3473, DOI 10.1245/s10434-009-0685-0; Martens-de Kemp SR, 2013, STEM CELL RES, V10, P477, DOI 10.1016/j.scr.2013.02.004; Feral CC, 2005, P NATL ACAD SCI USA, V102, P355, DOI 10.1073/pnas.0404852102; Kanai Y, 1998, J BIOL CHEM, V273, P23629, DOI 10.1074/jbc.273.37.23629; Kaira K, 2011, AM J TRANSL RES, V3, P468; Ichinoe M, 2011, PATHOL INT, V61, P281, DOI 10.1111/j.1440-1827.2011.02650.x; Park NS, 2008, ANTICANCER RES, V28, P2649; Kobayashi H, 2005, J SURG ONCOL, V90, P233, DOI 10.1002/jso.20257; MCGIVAN JD, 1994, BIOCHEM J, V299, P321; Deves R, 2000, J MEMBRANE BIOL, V173, P165, DOI 10.1007/s002320001017; Kaira K, 2008, CANCER SCI, V99, P2380, DOI 10.1111/j.1349-7006.2008.00969.x; Nawashiro H, 2006, INT J CANCER, V119, P484, DOI 10.1002/ijc.21866; Furuya M, 2012, CANCER SCI, V103, P382, DOI 10.1111/j.1349-7006.2011.02151.x; Kaira K, 2009, LUNG CANCER, V66, P120, DOI 10.1016/j.lungcan.2008.12.015; Sakata T, 2009, PATHOL INT, V59, P7, DOI 10.1111/j.1440-1827.2008.02319.x; CHRISTENSEN HN, 1990, PHYSIOL REV, V70, P43; Nakanishi K, 2007, VIRCHOWS ARCH, V451, P681, DOI 10.1007/s00428-007-0457-9; Kim CH, 2006, ANTICANCER RES, V26, P2943; Cantor JM, 2012, J CELL SCI, V125, P1373, DOI 10.1242/jcs.096040; Kaira K, 2012, BRIT J CANCER, V107, P632, DOI 10.1038/bjc.2012.310; Kaira K, 2008, BRIT J CANCER, V98, P742, DOI 10.1038/sj.bjc.6604235; Ragin CCR, 2007, J DENT RES, V86, P104; Rietbergen MM, 2014, EUR J CANCER, V50, P765, DOI 10.1016/j.ejca.2013.11.010; Thephamongkhol K, 2004, MEMBERS HEAD NECK CA, V5-7	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1043-3074	1097-0347		HEAD NECK-J SCI SPEC	Head Neck-J. Sci. Spec. Head Neck	NOV	2015	37	11					1569	1574		10.1002/hed.23797		6	Otorhinolaryngology; Surgery	Otorhinolaryngology; Surgery	CX0SD	WOS:000365406100011		
J	Maruse, Y; Kawano, S; Kiyoshima, T; Goto, Y; Matsubara, R; Chikui, T; Yoshiga, D; Nakamura, S				Maruse, Yasuyuki; Kawano, Shintaro; Kiyoshima, Tamotsu; Goto, Yuichi; Matsubara, Ryota; Chikui, Toru; Yoshiga, Daigo; Nakamura, Seiji			Case of mucoepidermoid carcinoma of the sublingual gland accompanied with extensive dystrophic calcification and intratumoral bone formation	HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK			English	Article						mucoepidermoid carcinoma; bone formation; sublingual gland; salivary gland tumor; calcification	PALATE	Background. Mucoepidermoid carcinoma (MEC) is the most common salivary gland malignancy. Although the histopathological findings are diverse, no case of salivary MEC accompanied with bone formation has been reported. Herein, we present the first case of MEC with intratumoral bone formation. Methods and Results. A case of a 75-year-old female patient with an asymptomatic mass of the oral floor is presented. Enhanced CT revealed a tumorous mass with radiopaque materials in the oral floor. A pathological diagnosis of MEC was obtained by biopsy. Radical surgery was performed with the patient under general anesthesia. The resected specimen was finally diagnosed as MEC. Histopathologically, hyalinization, and dystrophic calcification were conspicuous within the stromal components of the tumor. Interestingly, ectopic bone formation was also found in the tumor tissues. Bony materials with osteocyte-like cells were also observed in a series of dystrophic calcification. Conclusion. These findings suggest that bony materials are associated with dystrophic calcification. (C) 2015 Wiley Periodicals, Inc.	[Maruse, Yasuyuki; Kawano, Shintaro; Goto, Yuichi; Matsubara, Ryota; Yoshiga, Daigo; Nakamura, Seiji] Kyushu Univ, Fac Dent Sci, Div Maxillofacial Diagnost & Surg Sci, Sect Oral & Maxillofacial Oncol, Fukuoka 8128582, Japan; [Kiyoshima, Tamotsu] Kyushu Univ, Fac Dent Sci, Div Maxillofacial Diagnost & Surg Sci, Lab Oral Pathol, Fukuoka 8128582, Japan; [Chikui, Toru] Kyushu Univ, Fac Dent Sci, Dept Oral & Maxillofacial Radiol, Fukuoka 8128582, Japan	Kawano, S (reprint author), Kyushu Univ, Fac Dent Sci, Div Maxillofacial Diagnost & Surg Sci, Sect Oral & Maxillofacial Oncol,Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	skawano@dent.kyushu-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology of Japan [26463014, 25870492]	The work was supported by a Grants-in-Aid (No. 26463014, 25870492) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology of Japan.	do Prado RF, 2007, ORAL SURG ORAL MED O, V104, pE40, DOI 10.1016/j.tripleo.2007.06.001; Yoon JH, 2005, INT J ORAL MAX SURG, V34, P927, DOI 10.1016/j.ijom.2005.03.012; YATES PO, 1952, J PATHOL BACTERIOL, V64, P881, DOI 10.1002/path.1700640419; Kurabayashi T, 1997, DENTOMAXILLOFAC RAD, V26, P16, DOI 10.1038/sj.dmfr.4600200; LEE KC, 1992, J LARYNGOL OTOL, V106, P50, DOI 10.1017/S0022215100118596; Yang SD, 2010, ORAL SURG ORAL MED O, V109, P274, DOI 10.1016/j.tripleo.2009.08.012; SIAR CH, 1987, ORAL SURG ORAL MED O, V63, P468, DOI 10.1016/0030-4220(87)90260-X; Gnepp DR, 2005, WHO CLASSIFICATION T; Gonzalez-Arriagada WA, 2007, ORAL SURG ORAL MED O, V111, P482; Takeda Yasunori, 1996, Journal of Nihon University School of Dentistry, V38, P102	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1043-3074	1097-0347		HEAD NECK-J SCI SPEC	Head Neck-J. Sci. Spec. Head Neck	NOV	2015	37	11					E161	E164		10.1002/hed.24036		4	Otorhinolaryngology; Surgery	Otorhinolaryngology; Surgery	CX0SD	WOS:000365406100007		
J	Ikenaga, H; Kurisu, S; Watanabe, N; Shimonaga, T; Higaki, T; Iwasaki, T; Utsunomiya, H; Mitsuba, N; Ishibashi, K; Dohi, Y; Imai, K; Sueda, T; Kihara, Y				Ikenaga, Hiroki; Kurisu, Satoshi; Watanabe, Noriaki; Shimonaga, Takashi; Higaki, Tadanao; Iwasaki, Toshitaka; Utsunomiya, Hiroto; Mitsuba, Naoya; Ishibashi, Ken; Dohi, Yoshihiro; Imai, Katsuhiko; Sueda, Taijiro; Kihara, Yasuki			Effects of the topographical extent of coronary artery ectasia on coronary blood flow in patients with aortic aneurysms	HEART AND VESSELS			English	Article						Aortic aneurysms; Coronary artery ectasia; Thrombolysis in myocardial infarction frame count	TIMI FRAME COUNT; ENDOVASCULAR REPAIR; DISEASE; SURVEILLANCE	Aortic aneurysms are associated with coronary artery ectasia (CAE). However, the relation between the extent of CAE and coronary blood flow in patients with aortic aneurysms is not fully understood. This study was undertaken to assess the angiographic characteristics and effects of the topographical extent of CAE on coronary blood flow in patients with aortic aneurysms. This study consisted of 93 consecutive patients with aortic aneurysms (AA group) and 79 patients without aortic aneurysms who had angiographically normal coronary arteries as the control group (Control group). Coronary flow velocity was determined using the thrombolysis in myocardial infarction frame count (TFC) and the topographical extent of CAE was assessed. In the AA group, 43 patients (46.2 %) had significant coronary artery stenosis and 37 patients (40.2 %) had diffuse CAE. TFC was significantly higher in the AA group than in the control group in all 3 coronary arteries. Furthermore, mean corrected TFC (CTFC) was significantly higher in the AA group than in the control group (40.1 +/- A 10.7 vs. 25.8 +/- A 6.5, p < 0.001). In the AA group, mean CTFC in patients with diffuse CAE was significantly higher than that in patients with segmental CAE (50.2 +/- A 8.7 vs. 33.6 +/- A 5.2, p < 0.001). The mean CTFC correlated positively with the topographical extent of CAE. Many patients with aortic aneurysms were accompanied with angiographic coronary artery stenosis and CAE. Furthermore, patients with aortic aneurysms had higher CTFC than those without aortic aneurysms and it was primarily driven by more frequent prevalence of diffuse CAE.	[Ikenaga, Hiroki; Kurisu, Satoshi; Watanabe, Noriaki; Shimonaga, Takashi; Higaki, Tadanao; Iwasaki, Toshitaka; Utsunomiya, Hiroto; Mitsuba, Naoya; Ishibashi, Ken; Dohi, Yoshihiro; Kihara, Yasuki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Cardiovasc Med, Minami Ku, Hiroshima 7348551, Japan; [Imai, Katsuhiko; Sueda, Taijiro] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Cardiovasc Surg, Hiroshima 7348551, Japan	Kurisu, S (reprint author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Cardiovasc Med, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	skurisu@nifty.com					Kosar F, 2005, HEART VESSELS, V20, P199, DOI 10.1007/s00380-005-0831-y; VIRMANI R, 1986, HUM PATHOL, V17, P575, DOI 10.1016/S0046-8177(86)80129-0; Nakayama A, 2014, HEART VESSELS, V29, P65, DOI 10.1007/s00380-012-0319-5; Tanedo JS, 2001, CATHETER CARDIO INTE, V53, P459, DOI 10.1002/ccd.1203; MARKIS JE, 1976, AM J CARDIOL, V37, P217, DOI 10.1016/0002-9149(76)90315-5; Papadakis MC, 2001, AM J CARDIOL, V88, P1030, DOI 10.1016/S0002-9149(01)01984-1; Lamblin N, 2002, J AM COLL CARDIOL, V40, P43, DOI 10.1016/S0735-1097(02)01909-5; Demopoulos VP, 1997, HEART, V78, P136; DOLLERY CM, 1995, CIRC RES, V77, P863; Brady AR, 2002, NEW ENGL J MED, V346, P1445; Zografos TA, 2013, INT J CARDIOL, V167, P1536, DOI 10.1016/j.ijcard.2012.04.098; SWAYE PS, 1983, CIRCULATION, V67, P134; Papadakis MC, 2004, AM J CARDIOL, V94, P1433, DOI 10.1016/j.amjcard.2004.08.019; Cao P, 2011, EUR J VASC ENDOVASC, V41, P13, DOI 10.1016/j.ejvs.2010.08.026; Gibson CM, 1996, CIRCULATION, V93, P879; Shin S, 2013, WORLD J SURG, V37, P2965, DOI 10.1007/s00268-013-2200-9; Ouriel K, 2010, J VASC SURG, V51, P1081, DOI 10.1016/j.jvs.2009.10.113; STAJDUHAR KC, 1993, AM HEART J, V125, P86, DOI 10.1016/0002-8703(93)90060-M; Lederle FA, 2002, NEW ENGL J MED, V346, P1437, DOI 10.1056/NEJMoa012573; Bub GL, 2011, J VASC SURG, V53, P21, DOI 10.1016/j.jvs.2010.07.053; Thompson RW, 2002, CARDIOVASC SURG, V10, P389, DOI 10.1016/S0967-2109(02)00042-X; Elefteriades JA, 2013, PROG CARDIOVASC DIS, V56, P57, DOI 10.1016/j.pcad.2013.06.002; HIROSE Y, 1992, RADIOLOGY, V185, P249; JOHNSTON KW, 1991, J VASC SURG, V13, P452; Beckman JA, 2006, VASCULAR MED; Nakayama A, 2015, HEART VESSELS, V30, P304, DOI 10.1007/s00380-014-0488-5; SCOTT RAP, 1995, BRIT J SURG, V82, P1066, DOI 10.1002/bjs.1800820821; Thompson Robert W, 2002, Curr Probl Surg, V39, P110, DOI 10.1067/msg.2002.121421	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	NOV	2015	30	6					712	718		10.1007/s00380-014-0540-5		7	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CW8AW	WOS:000365221900002		
J	Gamou, T; Sakata, K; Matsubara, T; Yasuda, T; Miwa, K; Inoue, M; Kanaya, H; Konno, T; Hayashi, K; Kawashiri, M; Yamagishi, M				Gamou, Tadatsugu; Sakata, Kenji; Matsubara, Takao; Yasuda, Toshihiko; Miwa, Kenji; Inoue, Masaru; Kanaya, Honin; Konno, Tetsuo; Hayashi, Kenshi; Kawashiri, Masaaki; Yamagishi, Masakazu			Impact of thin-cap fibroatheroma on predicting deteriorated coronary flow during interventional procedures in acute as well as stable coronary syndromes: insights from optical coherence tomography analysis	HEART AND VESSELS			English	Article						No-reflow phenomenon; Acute coronary syndrome; Stable angina; Optical coherence tomography; Percutaneous coronary intervention	ACUTE MYOCARDIAL-INFARCTION; NO-REFLOW PHENOMENON; ELECTIVE STENT IMPLANTATION; INTRAVASCULAR ULTRASOUND; DISTAL EMBOLIZATION; CLINICAL-SIGNIFICANCE; VIRTUAL HISTOLOGY; ATTENUATED PLAQUE; LESION MORPHOLOGY; PROTECTION DEVICE	The occurrence of deteriorated coronary flow associated with distal embolization during percutaneous coronary intervention results in impaired myocardial perfusion and worsens the clinical prognosis. This study aimed to examine the impact of optical coherence tomography (OCT)-determined coronary plaque morphology on the prediction of deteriorated coronary flow after stent implantation in acute as well as stable coronary syndromes (ACS and SAP, respectively). We studied 126 patients who underwent OCT during stenting for ACS (n = 44) and SAP (n = 82) with a de novo lesion. Angiographic deteriorated coronary flow was defined as the deterioration of TIMI flow grade after mechanical dilatation in the absence of a mechanical obstruction on angiograms. Patients could be divided into the deteriorated flow group (n = 21) and the reflow group (n = 105). Under these conditions, the presence of thin-cap fibroatheroma (TCFA) was more frequently observed in the deteriorated flow group than in the reflow group in both ACS and SAP. A multivariable logistic regression model revealed that TCFA was an independent predictor of deteriorated coronary flow (hazard ratio: 12.32; 95 % confidence interval: 3.02-50.31; p = 0.0005). These results demonstrate that TCFA detected by OCT could be a strong predictor of the occurrence of deteriorated coronary flow during stent implantation in ACS as well as SAP.	[Gamou, Tadatsugu; Sakata, Kenji; Konno, Tetsuo; Hayashi, Kenshi; Kawashiri, Masaaki; Yamagishi, Masakazu] Kanazawa Univ, Grad Sch Med, Div Cardiovasc Med, Kanazawa, Ishikawa 9208640, Japan; [Matsubara, Takao; Yasuda, Toshihiko; Miwa, Kenji; Inoue, Masaru; Kanaya, Honin] Ishikawa Prefectural Cent Hosp, Dept Cardiol, Kanazawa, Ishikawa, Japan	Yamagishi, M (reprint author), Kanazawa Univ, Grad Sch Med, Div Cardiovasc Med, 13-1 Takara Machi, Kanazawa, Ishikawa 9208640, Japan.	myamagi@med.kanazawa-u.ac.jp					Jaffe R, 2008, CIRCULATION, V117, P3152, DOI 10.1161/CIRCULATIONAHA.107.742312; Umeda H, 2006, CIRC J, V70, P232, DOI 10.1253/circj.70.232; Ndrepepa G, 2010, J AM COLL CARDIOL, V55, P2383, DOI 10.1016/j.jacc.2009.12.054; Lee SY, 2009, JACC-CARDIOVASC INTE, V2, P65, DOI 10.1016/j.jcin.2008.08.022; McEntegart MB, 2012, J AM COLL CARDIOL, V59, P1745, DOI 10.1016/j.jacc.2012.02.019; Takarada S, 2010, CATHETER CARDIO INTE, V75, P202, DOI 10.1002/ccd.22273; Hong YJ, 2011, EUR HEART J, V32, P2059, DOI 10.1093/eurheartj/ehp034; Watanabe T, 2003, CIRC J, V67, P667; De Luca G, 2007, AM HEART J, V153, P343, DOI 10.1016/j.ahj.2006.11.020; Kusama I, 2007, J AM COLL CARDIOL, V50, P1230, DOI 10.1016/j.jacc.2007.07.004; Henriques JPS, 2002, EUR HEART J, V23, P1112, DOI 10.1053/euhj.2001.3035; Porto I, 2006, INT J CARDIOL, V109, P53, DOI 10.1016/j.ijcard.2005.05.071; Bae JH, 2008, HEART, V94, P1559, DOI 10.1136/hrt.2007.135822; Lee T, 2011, CIRC-CARDIOVASC INTE, V4, P378, DOI 10.1161/CIRCINTERVENTIONS.111.962506; Mizote I, 2005, CIRCULATION, V112, P1001, DOI 10.1161/CIRCULATIONAHA.104.532820; Lee T, 2011, JACC-CARDIOVASC INTE, V4, P483, DOI 10.1016/j.jcin.2010.12.013; Singh M, 2001, AM J CARDIOL, V88, P1091, DOI 10.1016/S0002-9149(01)02040-9; Yabushita H, 2002, CIRCULATION, V106, P1640, DOI 10.1161/01.CIR.0000029927.92825.F6; Kubo T, 2007, J AM COLL CARDIOL, V50, P933, DOI 10.1016/j.jacc.2007.04.082; BRAUNWALD E, 1994, CIRCULATION, V89, P1545; Kimura S, 2009, CIRC-CARDIOVASC INTE, V2, P444, DOI 10.1161/CIRCINTERVENTIONS.108.821124; Hiro T, 2009, J AM COLL CARDIOL, V54, P293, DOI 10.1016/j.jacc.2009.04.033; Chan W, 2012, AM J CARDIOL, V109, P478, DOI 10.1016/j.amjcard.2011.09.037; Tanaka A, 2002, CIRCULATION, V105, P2148, DOI 10.1161/01.CIR.0000015697.59592.07; Kodama T, 2012, JACC-CARDIOVASC INTE, V5, P636, DOI 10.1016/j.jcin.2012.02.016; Porto I, 2011, EUROINTERVENTION, V7, P955, DOI 10.4244/EIJV7I8A151; Fukuda D, 2003, AM J CARDIOL, V91, P403, DOI 10.1016/S0002-9149(02)03233-2; Sakata K, 2015, HEART VESSELS, V30, P406, DOI 10.1007/s00380-014-0477-8; Sakata K, 2012, HEART VESSELS, V5, P443; Yundai C, 2012, HEART VESSELS, V27, P243	30	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	NOV	2015	30	6					719	727		10.1007/s00380-014-0542-3		9	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CW8AW	WOS:000365221900003		
J	Komiyama, M; Wada, H; Ura, S; Yamakage, H; Satoh-Asahara, N; Shimada, S; Akao, M; Koyama, H; Kono, K; Shimatsu, A; Takahashi, Y; Hasegawa, K				Komiyama, Maki; Wada, Hiromichi; Ura, Shuichi; Yamakage, Hajime; Satoh-Asahara, Noriko; Shimada, Sayaka; Akao, Masaharu; Koyama, Hiroshi; Kono, Koichi; Shimatsu, Akira; Takahashi, Yuko; Hasegawa, Koji			The effects of weight gain after smoking cessation on atherogenic alpha 1-antitrypsin-low-density lipoprotein	HEART AND VESSELS			English	Article						Smoking cessation; Obesity; Oxiditive stresss; Atherosclerosis; Prevention	CORONARY-ARTERY-DISEASE; CARDIOVASCULAR-DISEASE; LIPID-PEROXIDATION; METABOLIC SYNDROME; LDL; MEN; ALPHA(1)-ANTITRYPSIN; INTERVENTION; INFLAMMATION; ASSOCIATION	Although cardiovascular risks decrease after quitting smoking, body weight often increases in the early period after smoking cessation. We have previously reported that the serum level of the alpha 1-antitrypsin-low-density lipoprotein complex (AT-LDL)-an oxidatively modified low-density lipoprotein that accelerates atherosclerosis-is high in current smokers, and that the level rapidly decreases after smoking cessation. However, the effects of weight gain after smoking cessation on this cardiovascular marker are unknown. In 183 outpatients (134 males, 49 females) who had successfully quit smoking, serum AT-LDL levels were measured using an enzyme-linked immunosorbent assay. For all persons who had successfully quit smoking, body mass index (BMI) significantly increased 12 weeks after the first examination (p < 0.01). Among patients with a BMI increase smaller than the median, a significant decrease (p < 0.01) in serum AT-LDL values was found, but no significant changes in serum AT-LDL values were found in patients with a BMI increase greater than the median. The findings suggest that the decrease in serum AT-LDL levels after quitting smoking is influenced by weight gain after smoking cessation.	[Komiyama, Maki; Koyama, Hiroshi] Natl Hosp Org Kyoto Med Ctr, Dept Gen Internal Med, Kyoto 6128555, Japan; [Komiyama, Maki; Wada, Hiromichi; Ura, Shuichi; Shimada, Sayaka; Hasegawa, Koji] Natl Hosp Org Kyoto Med Ctr, Div Translat Res, Fushimi Ku, Kyoto 6128555, Japan; [Komiyama, Maki; Kono, Koichi] Osaka Med Coll, Dept Hyg & Publ Hlth, Osaka, Japan; [Yamakage, Hajime; Satoh-Asahara, Noriko; Shimatsu, Akira] Natl Hosp Org Kyoto Med Ctr, Clin Res Inst, Kyoto 6128555, Japan; [Akao, Masaharu] Natl Hosp Org Kyoto Med Ctr, Dept Cardiol, Kyoto 6128555, Japan; [Takahashi, Yuko] Nara Womens Univ, Hlth Care Ctr, Nara 630, Japan	Hasegawa, K (reprint author), Natl Hosp Org Kyoto Med Ctr, Div Translat Res, Fushimi Ku, 1-1 Mukaihata Cho, Kyoto 6128555, Japan.	koj@kuhp.kyoto-u.ac.jp			National Hospital Organization; Pfizer Health Research Foundation	We thank Yuko Iida and Sachiko Terashima for technical assistance, and Noa Nagaoka for secretarial assistance. This work was supported in part by a Grant-in-Aid for Clinical Research from the National Hospital Organization and the Pfizer Health Research Foundation (to KH). The funders played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Satoh N, 2008, CIRC J, V72, P932, DOI 10.1253/circj.72.932; Kotani K, 2013, HEART VESSELS, V28, P461, DOI 10.1007/s00380-012-0265-2; Helmersson J, 2005, ATHEROSCLEROSIS, V181, P201, DOI 10.1016/j.atherosclerosis.2004.11.026; Iso H, 2005, AM J EPIDEMIOL, V161, P170, DOI 10.1093/aje/kwi027; FLEGAL KM, 1995, NEW ENGL J MED, V333, P1165, DOI 10.1056/NEJM199511023331801; Ohmori K, 2005, ANN EPIDEMIOL, V15, P80, DOI 10.1016/j.annepidem.2004.04.001; van Berkel TFM, 1999, EUR HEART J, V20, P1773, DOI 10.1053/euhj.1999.1658; FREI B, 1991, BIOCHEM J, V277, P133; Komiyama M, 2014, INTERNAL MED, V53, P817, DOI 10.2169/internalmedicine.53.2020; Wada H, 2012, J ATHEROSCLER THROMB, V19, P47; Kotani K, 2009, ATHEROSCLEROSIS, V204, P526, DOI 10.1016/j.atherosclerosis.2008.09.017; Clair C, 2013, JAMA-J AM MED ASSOC, V309, P1014, DOI 10.1001/jama.2013.1644; McManus RJ, 2003, BRIT J GEN PRACT, V53, P953; Frohlich M, 2003, EUR HEART J, V24, P1365, DOI 10.1016/S0195-668X(03)00260-4; Hald J, 2003, ACTA ONCOL, V42, P154, DOI 10.1080/02841860310005020; WILLIAMSON DF, 1991, NEW ENGL J MED, V324, P739, DOI 10.1056/NEJM199103143241106; Shin DI, 2012, CIRC J, V76, P2681, DOI 10.1253/circj.CJ-12-0586; Tobaru T, 2013, HEART VESSELS, V28, P39, DOI 10.1007/s00380-012-0243-8; Mashiba S, 2001, ARTERIOSCL THROM VAS, V21, P1801, DOI 10.1161/hq1101.098232; Wannamethee SG, 2005, EUR HEART J, V26, P1765, DOI 10.1093/eurheartj/ehi183; Moraga F, 2000, J BIOL CHEM, V275, P7693, DOI 10.1074/jbc.275.11.7693; Yanbaeva DG, 2007, CHEST, V131, P1557, DOI 10.1378/chest.06-2179; Kadowaki T, 2006, J OCCUP HEALTH, V48, P402, DOI 10.1539/joh.48.402; Thorndike AN, 2008, ARCH INTERN MED, V168, P186, DOI 10.1001/archinternmed.2007.60; Ridker PM, 2008, J PERIODONTOL, V79, P1544, DOI 10.1902/jop.2008.080249; Eberhard J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055265; Hasegawa K., 2008, SMOKING CONTROL SCI, V2, P23; PRYOR WA, 1993, ANN NY ACAD SCI, V686, P12, DOI 10.1111/j.1749-6632.1993.tb39148.x; SEPPER R, 1995, J CLIN IMMUNOL, V15, P27, DOI 10.1007/BF01489487; Tsimikas Sotirios, 2006, Curr Atheroscler Rep, V8, P55, DOI 10.1007/s11883-006-0065-1; Wada H, 2008, SMOKING CONTROL SCI, V2, P4	31	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	NOV	2015	30	6					734	739		10.1007/s00380-014-0549-9		6	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CW8AW	WOS:000365221900005		
J	Naito, R; Miyauchi, K; Konishi, H; Tsuboi, S; Ogita, M; Kasai, T; Tamura, H; Okazaki, S; Daida, H				Naito, Ryo; Miyauchi, Katsumi; Konishi, Hirokazu; Tsuboi, Shuta; Ogita, Manabu; Kasai, Takatoshi; Tamura, Hiroshi; Okazaki, Shinya; Daida, Hiroyuki			Comparison of long-term clinical outcomes between sirolimus- and paclitaxel-eluting stents in real-world clinical practice	HEART AND VESSELS			English	Article						Sirolimus-eluting stent; Paclitaxel-eluting stent; Long-term clinical outcomes; All-cause mortality; Acute coronary syndrome	CORONARY-ARTERY-DISEASE; RANDOMIZED-TRIALS; METAANALYSIS; REVASCULARIZATION; IMPLANTATION; THROMBOSIS; EFFICACY; SAFETY; RISK	Advances in percutaneous coronary intervention (PCI) have improved the outcomes of patients with coronary artery diseases. The advent of drug-eluting stents (DES) has dramatically reduced the rate of revascularization. The first-generation DES has yielded the main role of PCI to the second-generation DES; however, many patients had been implanted with the first-generation DES, sirolimus-eluting stents (SES) and paclitaxel-eluting stents (PES). Therefore, it is of importance to detect the long-term clinical outcomes in patients who underwent PCI with SES or PES. We analyzed data from our PCI cohort who underwent PCI with first-generation DES at Juntendo University Hospital between August 2004 and June 2010. The index procedure was analyzed when patients underwent multiple PCIs. Patients who were implanted with both SES and PES were excluded from this study. The study ended on December 31, 2011. The primary outcome was a composite of all-cause mortality and acute coronary syndrome (ACS). The secondary outcome was the rate of target lesion revascularization (TLR) and stent thrombosis. We analyzed data from 861 consecutive patients who underwent implantation of SES or PES. The median follow-up period was 1671 days (interquartile range 1081 and 2105). Kaplan-Meier curves for the primary endpoint did not significantly differ between the two groups (p = 0.8). The incidence of stent thrombosis was 1.4 and 1.8 per 1,000 person-years in the SES and PES groups, respectively (p = 0.9). The rate of TLR was significantly lower in the SES, than the PES group (12.6 and 38.3 per 1,000 person-years, p = 0.03). The rate of TLR was lower in the group treated with SES than PES, but the primary outcome comprising all-cause mortality and ACS was comparable between the two groups.	[Naito, Ryo; Miyauchi, Katsumi; Konishi, Hirokazu; Tsuboi, Shuta; Ogita, Manabu; Kasai, Takatoshi; Tamura, Hiroshi; Okazaki, Shinya; Daida, Hiroyuki] Juntendo Univ, Grad Sch Med, Dept Cardiol, Bunkyo Ku, Tokyo 1138421, Japan	Miyauchi, K (reprint author), Juntendo Univ, Grad Sch Med, Dept Cardiol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	ktmmy@juntendo.ac.jp			Ministry of Health, Labour and Welfare [23591063]	This study was supported by a grant-in aid for scientific research from the Ministry of Health, Labour and Welfare (23591063). The authors thank Yumi Nozawa and Ayako Onodera for secretarial assistance.	Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Kastrati A, 2005, JAMA-J AM MED ASSOC, V294, P819, DOI 10.1001/jama.294.7.819; Mrdovic I, 2013, HEART VESSELS, V28, P424, DOI 10.1007/s00380-012-0276-z; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Mehilli J, 2006, EUR HEART J, V27, P260, DOI 10.1093/eurheartj/ehi721; Eisenberg MJ, 2006, AM J CARDIOL, V98, P375, DOI 10.1016/j.amjcard.2006.02.042; Schomig A, 2007, J AM COLL CARDIOL, V50, P1373, DOI 10.1016/j.jacc.2007.06.047; Buja P, 2012, HEART VESSELS, V27, P553, DOI 10.1007/s00380-011-0194-5; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Colombo A, 2003, CIRCULATION, V108, P788, DOI 10.1161/01.CIR.0000086926.62288.A6; Kimura T, 2009, CIRCULATION, V119, P987, DOI 10.1161/CIRCULATIONAHA.108.808311; Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193; Ellis SG, 2005, J AM COLL CARDIOL, V45, P1193, DOI 10.1016/j.jacc.2004.11.063; Cosgrave J, 2007, J AM COLL CARDIOL, V49, P2320, DOI 10.1016/j.jacc.2007.02.057; Pfisterer M, 2006, J AM COLL CARDIOL, V48, P2584, DOI 10.1016/j.jacc.2006.10.026; Babapulle MN, 2004, LANCET, V364, P583, DOI 10.1016/S0140-6736(04)16850-5; Gurm HS, 2008, AM HEART J, V155, P630, DOI 10.1016/j.ahj.2007.11.021; Windecker S, 2005, NEW ENGL J MED, V353, P653, DOI 10.1056/NEJMoa051175; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Nakano Yosuke, 2014, Cardiovasc Interv Ther, V29, P93	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	NOV	2015	30	6					746	751		10.1007/s00380-014-0560-1		6	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CW8AW	WOS:000365221900007		
J	Nakamura, A; Miura, S; Shiga, Y; Norimatsu, K; Miyase, Y; Suematsu, Y; Mitsutake, R; Saku, K				Nakamura, Ayumi; Miura, Shin-ichiro; Shiga, Yuhei; Norimatsu, Kenji; Miyase, Yuiko; Suematsu, Yasunori; Mitsutake, Ryoko; Saku, Keijiro			Is pentraxin 3 a biomarker, a player, or both in the context of coronary atherosclerosis and metabolic factors?	HEART AND VESSELS			English	Article						Pentraxin-3; Inflammation; Metabolic factors; C-reactive protein; Adiponectin; Coronary artery disease; Coronary computed tomography angiography	C-REACTIVE PROTEIN; VISCERAL FAT ACCUMULATION; ABDOMINAL OBESITY; ANGINA-PECTORIS; ARTERY-DISEASE; MARKER; INFLAMMATION; MEN	The objective of this study is to determine whether pentraxin-3 (PTX-3) is clinically a biomarker of inflammation, a player in anti-inflammation, or both with regard to coronary atherosclerosis, we compared levels of PTX-3 with levels of adiponectin in addition to high-sensitivity C-reactive protein (hs-CRP). We enrolled 693 patients (51 % male; mean age 64 +/- A 12 years) at Fukuoka University Hospital. They were clinically suspected to have coronary artery disease (CAD) or had at least one cardiac risk factor and had undergone coronary computed tomography angiography (CTA). We evaluated the levels of PTX-3, hs-CRP, and adiponectin, the presence of CAD or metabolic factors, subcutaneous fat area, visceral fat area (VFA) and lipid profiles. The presence of CAD was independently associated with aging (p = 0.010) and the prevalence of hypertension (p < 0.0001), but not the levels of PTX-3, hs-CRP and adiponectin by a multivariate analysis. Although the number of significantly stenosed coronary vessels (VD) was not associated with PTX-3 or adiponectin, hs-CRP tended to increase as the number of VD increased. In addition, PTX-3 decreased as the number of metabolic factors increased, whereas hs-CRP increased as the number of metabolic factors increased. Interestingly, PTX-3 did not correlate with hs-CRP, but was positively correlated with adiponectin. In a multiple regression analysis, adiponectin (p = 0.003) and VFA (p = 0.008) were significant predictors of PTX-3 levels. In conclusion, PTX-3 and adiponectin showed similar associations with metabolic factors, whereas PTX-3 and hs-CRP showed opposite trends. Adiponectin and VFA were significant predictors of PTX-3 levels. PTX-3 might have an atheroprotective role as well as serving as a simple biomarker, like adiponectin.	[Nakamura, Ayumi; Miura, Shin-ichiro; Shiga, Yuhei; Norimatsu, Kenji; Miyase, Yuiko; Suematsu, Yasunori; Mitsutake, Ryoko; Saku, Keijiro] Fukuoka Univ, Sch Med, Dept Cardiol, Jonan Ku, Fukuoka 8140180, Japan; [Miura, Shin-ichiro; Saku, Keijiro] Fukuoka Univ, Sch Med, Dept Mol Cardiovasc Therapeut, Fukuoka 8140180, Japan	Miura, S (reprint author), Fukuoka Univ, Sch Med, Dept Cardiol, Jonan Ku, 7-45-1 Nanakuma, Fukuoka 8140180, Japan.	miuras@cis.fukuoka-u.ac.jp			MSD, Co. LTD.	K.S. is a Chief Director and S.M. is a Director of NPO Clinical and Applied Science, Fukuoka, Japan. K.S. is the Chairman of an Endowed Department, the "Department of Molecular Cardiovascular Therapeutics", supported by MSD, Co. LTD. S.M. belongs to the Department of Molecular Cardiovascular Therapeutics, supported by MSD, Co. LTD.	Zebrack JS, 2002, J AM COLL CARDIOL, V39, P632, DOI 10.1016/S0735-1097(01)01804-6; Lee YH, 2010, ATHEROSCLEROSIS, V213, P592, DOI 10.1016/j.atherosclerosis.2010.09.012; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Meuwissen M, 2003, AM J CARDIOL, V92, P702, DOI 10.1016/S0002-9149(03)00830-0; Osorio-Conles O, 2011, AM J PHYSIOL-ENDOC M, V301, pE1254, DOI 10.1152/ajpendo.00163.2011; Miyaki A, 2012, APPL PHYSIOL NUTR ME, V37, P907, DOI [10.1139/h2012-069, 10.1139/H2012-069]; Asayama K, 2003, OBES RES, V11, P1072, DOI 10.1038/oby.2003.147; Kumada M, 2003, ARTERIOSCL THROM VAS, V23, P85, DOI 10.1161/01.ATV.0000048856.22331.50; Norata GD, 2008, ARTERIOSCL THROM VAS, V28, P925, DOI 10.1161/ATVBAHA.107.160606; Miyamoto T, 2011, CLIN J AM SOC NEPHRO, V6, P2785, DOI 10.2215/CJN.02320311; Ogawa T, 2010, OBESITY, V18, P1871, DOI 10.1038/oby.2009.507; Patel SS, 2002, SEMIN NEPHROL, V22, P449, DOI 10.1053/snep.2002.35973; Ohashi N, 2009, ATHEROSCLEROSIS, V202, P192, DOI 10.1016/j.atherosclerosis.2008.04.019; Tommasi S, 1999, AM J CARDIOL, V83, P1595, DOI 10.1016/S0002-9149(99)00162-9; Inoue K, 2007, ARTERIOSCL THROM VAS, V27, P161, DOI 10.1161/01.ATV.0000252126.48375.d5; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Matsuura Y, 2012, J ATHEROSCLER THROMB, V19, P837; Mitsutake R, 2009, CIRC J, V73, P132; Norata GD, 2009, CIRCULATION, V120, P699, DOI 10.1161/CIRCULATIONAHA.108.806547; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131; Arao K, 2015, HEART VESSELS, V30, P211, DOI 10.1007/s00380-014-0470-2; Knoflach M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031474; Mantovani A, 2003, VACCINE S2, V21, P43; Nishida M, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-27; Parfyonova Y, 2014, HEART VESSELS, V29, P611, DOI 10.1007/s00380-013-0407-1; Soeki T, 2014, HEART VESSELS, V29, P653, DOI 10.1007/s00380-013-0400-8	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	NOV	2015	30	6					752	761		10.1007/s00380-014-0553-0		10	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CW8AW	WOS:000365221900008		
J	Tani, S; Takahashi, A; Nagao, K; Hirayama, A				Tani, Shigemasa; Takahashi, Atsuhiko; Nagao, Ken; Hirayama, Atsushi			Contribution of apolipoprotein A-I to the reduction in high-sensitivity C-reactive protein levels by different statins: comparative study of pitavastatin and atorvastatin	HEART AND VESSELS			English	Article						Atherosclerosis; Apolipoprotein A-I; High-sensitivity C-reactive protein; Inflammation; Statin	HIGH-DENSITY-LIPOPROTEIN; CARDIOVASCULAR-DISEASE; CORONARY EVENTS; HDL; CHOLESTEROL; EXPRESSION; RISK; MECHANISMS; INTERVENTION; METAANALYSIS	Recently, investigation may have focused on modification of apolipoprotein A-I (apoA-I) associated with anti-inflammatory effect for the potential prevention of cardiovascular events. The purpose of this study was to evaluate the effects of atorvastatin and pitavastatin on serum apoA-I levels and to investigate the role of apoA-I in the anti-inflammatory effect of statin. We conducted a 6-month, prospective, randomized, open-label study in which we assigned hypercholesterolemic patients to a pitavastatin group (n = 52; 2 mg/day) or an atorvastatin group (n = 52; 10 mg/day) to investigate the effects of these two statins on the serum apoA-I levels and serum high-sensitivity C-reactive protein (hs-CRP) levels. There were no significant differences between the two groups in the changes in the low-density lipoprotein cholesterol, high-density lipoprotein cholesterol (HDL-C), or hs-CRP levels, but the change in apoA-I in the pitavastatin group was significantly greater than in the atorvastatin group (5.3 vs. 1.4 %; p = 0.0001). A stepwise regression analysis revealed that the percent change in (Delta) serum apoA-I level was an independent predictor of the Delta serum hs-CRP (standard correlation coefficient = -0.198; p = 0.047). However, there was a significant negative correlation between the Delta apoA-I levels and Delta hs-CRP levels in the pitavastatin group (r = -0.283, p = 0.042), but not the atorvastatin group (r = -0.133, p = 0.356). The results suggest that the contribution of apoA-I to the reduction in serum hs-CRP levels by these two statins may be different. A decrease in hs-CRP level accompanied by an increase in apoA-I level may be involved in the pleiotropic effects of pitavastatin.	[Tani, Shigemasa; Takahashi, Atsuhiko] Nihon Univ, Sch Med, Hlth Planning Ctr, Chiyoda Ku, Tokyo 1010062, Japan; [Tani, Shigemasa; Takahashi, Atsuhiko; Nagao, Ken; Hirayama, Atsushi] Nihon Univ, Sch Med, Div Cardiol, Dept Med, Tokyo 1010062, Japan	Tani, S (reprint author), Nihon Univ, Sch Med, Hlth Planning Ctr, Chiyoda Ku, 1-7-3 Kandasurugadai, Tokyo 1010062, Japan.	tani.shigemasa@nihon-u.ac.jp					Kobayashi M, 2011, EUR J PHARMACOL, V662, P9, DOI 10.1016/j.ejphar.2011.04.043; Yin K, 2012, J ATHEROSCLER THROMB, V19, P823; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Tani S, 2012, HEART VESSELS, V27, P143, DOI 10.1007/s00380-011-0130-8; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Ashby DT, 1998, ARTERIOSCL THROM VAS, V18, P1450; Sasaki J, 2006, CIRC J, V70, P810, DOI 10.1253/circj.70.810; Sasaki J, 2008, CLIN THER, V30, P1089, DOI 10.1016/j.clinthera.2008.05.017; Yousuf O, 2013, J AM COLL CARDIOL, V62, P397, DOI 10.1016/j.jacc.2013.05.016; Poolsup N, 2012, J CLIN PHARM THER, V37, P166, DOI 10.1111/j.1365-2710.2011.01274.x; Yokote K, 2008, ATHEROSCLEROSIS, V201, P345, DOI 10.1016/j.atherosclerosis.2008.02.008; Zhang B, 2013, CIRC J, V77, P2651, DOI 10.1253/circj.CJ-12-1584; Chyu KY, 2011, CURR ATHEROSCLER REP, V13, P405, DOI 10.1007/s11883-011-0189-9; Maruyama T, 2011, CIRC J, V75, P1951, DOI 10.1253/circj.CJ-10-1163; Navab M, 2011, NAT REV CARDIOL, V8, P222, DOI 10.1038/nrcardio.2010.222; Teramoto T, 2012, EXPERT OPIN PHARMACO, V13, P859, DOI 10.1517/14656566.2012.660525; McQueen MJ, 2008, LANCET, V372, P224, DOI 10.1016/S0140-6736(08)61076-4; Yamashita S, 2010, J ATHEROSCLER THROMB, V17, P436; Dimayuga P, 1999, BIOCHEM BIOPH RES CO, V264, P465, DOI 10.1006/bbrc.1999.1278; Sniderman AD, 2003, CLIN BIOCHEM, V36, P499, DOI 10.1016/S0009-9120(03)00117-6; Miyamoto-Sasaki M, 2013, J ATHEROSCLER THROMB, V20, P708; CHIESA G, 1993, METABOLISM, V42, P229, DOI 10.1016/0026-0495(93)90041-L; COCKERILL GW, 1995, ARTERIOSCL THROM VAS, V15, P1987; Ogita M, 2014, HEART VESSELS, V29, P35, DOI 10.1007/s00380-013-0330-5; Okumura K, 2015, HEART VESSELS, V30, P154, DOI 10.1007/s00380-013-0466-3	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	NOV	2015	30	6					762	770		10.1007/s00380-014-0554-z		9	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CW8AW	WOS:000365221900009		
J	Sueda, S; Kohno, H; Miyoshi, T; Sakaue, T; Sasaki, Y; Habara, H				Sueda, Shozo; Kohno, Hiroaki; Miyoshi, Toru; Sakaue, Tomoki; Sasaki, Yasuhiro; Habara, Hirokazu			Maximal acetylcholine dose of 200 mu g into the left coronary artery as a spasm provocation test: comparison with 100 mu g of acetylcholine	HEART AND VESSELS			English	Article						ACh 200 mu g; Maximal ACh dose in LCA; Positive spasm	LONG-TERM PROGNOSIS; VARIANT ANGINA; INTRACORONARY INJECTION; CLINICAL CHARACTERISTICS; VASOSPASTIC ANGINA; INDUCTION; HYPERVENTILATION; ARTERIOGRAPHY; ERGONOVINE; FREQUENCY	As a spasm provocation test of acetylcholine (ACH), incremental dose up (20/50/100 mu g) into the left coronary artery (LCA) is recommended in the guidelines established by Japanese Circulation Society. Recently, Ong et al. reported the ACOVA study which maximal ACH dose was 200 mu g in the LCA. We compared the angiographic findings between ACH 100 mu g and ACH 200 mu g in the LCA and also examined the usefulness and safety of ACH 200 mu g in Japanese patients without variant angina. As a spasm provocation test, we performed intracoronary injection of ACH 200 mu g after ACH 100 mu g in 88 patients (55 males, 68.4 +/- A 11.7 years old) including 59 ischemic heart disease (IHD) patients and 29 non-IHD patients. Positive spasm was defined as > 99 % transient stenosis (focal spasm) or 90 % severe diffuse vasoconstriction (diffuse spasm). Positive spasm by ACH 200 mu g was significantly higher than that by ACH 100 mu g (36 pts: 40.9 % vs. 17 pts: 19.3 %, p < 0.01). Diffuse distal spasm on the left anterior descending artery was more recognized in ACH 200 mu g than in ACH 100 mu g (30.7 vs. 13.6 %, p < 0.01). In 29 rest angina patients, positive spasm by ACH 200 mu g (19 pts) was significantly higher than that by ACH 100 mu g (7 pts) (65.5 vs. 24.1 %, p < 0.01). No serious irreversible complications were found during ACH 200 mu g. Administration of ACH 200 mu g into the LCA was safe and useful. We may reexamine the maximal ACH dose into the LCA.	[Sueda, Shozo; Kohno, Hiroaki; Miyoshi, Toru; Sakaue, Tomoki; Sasaki, Yasuhiro; Habara, Hirokazu] Ehime Niihama Prefectural Hosp, Dept Cardiol, Niihama City, Ehime 7920042, Japan	Sueda, S (reprint author), Ehime Niihama Prefectural Hosp, Dept Cardiol, Hongou 3 Choume 1-1, Niihama City, Ehime 7920042, Japan.	EZF03146@nifty.com					Sueda S, 2003, CHEST, V124, P2074, DOI 10.1378/chest.124.6.2074; OKUMURA K, 1988, CIRCULATION, V77, P535; OKUMURA K, 1988, J AM COLL CARDIOL, V12, P883; Sueda S, 2002, JPN HEART J, V43, P307, DOI 10.1536/jhj.43.307; Sueda S, 2001, CORONARY ARTERY DIS, V12, P295, DOI 10.1097/00019501-200106000-00005; KIMURA E, 1981, CIRCULATION, V63, P844; Sueda S, 1999, AM J CARDIOL, V83, P1186, DOI 10.1016/S0002-9149(99)00057-0; SHIMOKAWA H, 1988, INT J CARDIOL, V18, P331, DOI 10.1016/0167-5273(88)90052-6; Sueda S, 2001, CHEST, V119, P155, DOI 10.1378/chest.119.1.155; Sueda S, 2004, CORONARY ARTERY DIS, V15, P491, DOI 10.1097/00019501-200412000-00006; YASUE H, 1988, CIRCULATION, V78, P1; BERTRAND ME, 1982, CIRCULATION, V65, P1299; Sueda S, 2001, AM J CARDIOL, V88, P570, DOI 10.1016/S0002-9149(01)01744-1; Sueda S, 2000, AM J CARDIOL, V85, P391, DOI 10.1016/S0002-9149(99)00754-7; YASUE H, 1986, CIRCULATION, V74, P955; Seo SM, 2013, HEART VESSELS, V28, P301, DOI 10.1007/s00380-012-0249-2; Sueda S, 2009, J CARDIOL, V54, P452, DOI 10.1016/j.jjcc.2009.07.007; Yasue H, 2008, J AM COLL CARDIOL, V51, P1742, DOI 10.1016/j.jacc.2007.12.049; Sueda S, 1999, JPN CIRC J, V63, P85, DOI 10.1253/jcj.63.85; Sueda S, 2002, CORONARY ARTERY DIS, V13, P231, DOI 10.1097/00019501-200206000-00005; NAKAMURA M, 1987, CIRCULATION, V75, P1110; Ong P, 2012, J AM COLL CARDIOL, V59, P655, DOI 10.1016/j.jacc.2011.11.015; Nishino M, 2014, HEART VESSELS, V29, P186, DOI 10.1007/s00380-013-0346-x; CURRY RC, 1979, CIRCULATION, V59, P307; Austen W G, 1975, Circulation, V51, P5; Ogawa H, 2010, CIRC J, V74, P1745, DOI 10.1253/circj.CJ-10-74-0802; Sueda S, 2013, J JPN CORON ASS, V19, P322; Sueda S, 1998, J Cardiol, V32, P155	28	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	NOV	2015	30	6					771	778		10.1007/s00380-014-0563-y		8	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CW8AW	WOS:000365221900010		
J	Sano, M; Satoh, H; Suwa, K; Nobuhara, M; Saitoh, T; Saotome, M; Urushida, T; Katoh, H; Shimoyama, K; Suzuki, D; Ogawa, N; Takehara, Y; Sakahara, H; Hayashi, H				Sano, Makoto; Satoh, Hiroshi; Suwa, Kenichiro; Nobuhara, Mamoru; Saitoh, Takeji; Saotome, Masao; Urushida, Tsuyoshi; Katoh, Hideki; Shimoyama, Kumiko; Suzuki, Daisuke; Ogawa, Noriyoshi; Takehara, Yasuo; Sakahara, Harumi; Hayashi, Hideharu			Characteristics and clinical relevance of late gadolinium enhancement in cardiac magnetic resonance in patients with systemic sclerosis	HEART AND VESSELS			English	Article						Electrocardiography; Conduction disturbance; Cardiac function; Systemic scleroderma; Late gadolinium enhancement	HYPERTROPHIC CARDIOMYOPATHY; PULMONARY-HYPERTENSION; DELAYED ENHANCEMENT; DOPPLER-ECHOCARDIOGRAPHY; DILATED CARDIOMYOPATHY; MYOCARDIAL INVOLVEMENT; HEART-FAILURE; FIBROSIS; DYSFUNCTION; SCLERODERMA	Cardiac involvement in systemic sclerosis (SSc) is considerably frequent in autopsy, but the early identification is clinically difficult. Recent advantages in cardiac magnetic resonance (CMR) enabled to detect myocardial fibrotic scar as late gadolinium enhancement (LGE). We aimed to examine the prevalence and distribution of LGE in patients with SSc, and associate them with clinical features, electrocardiographic abnormalities and cardiac function. Forty patients with SSc (58 +/- A 14 years-old, 35 females, limited/diffuse 25/15, disease duration 106 +/- A 113 months) underwent serological tests, 12-lead electrocardiogram (ECG) and CMR. Seven patients (17.5 %) showed LGE in 26 segments of left ventricle (LV). LGE distributed mainly in the basal to mid inter-ventricular septum and the right ventricular (RV) insertion points, but involved all the myocardial regions. More patients with LGE showed NYHA functional class II and more (71 vs. 21 %, p < 0.05), bundle branch blocks (57 vs. 6 %, p < 0.05), LV ejection fraction (LVEF) < 50 % (72 vs. 6 %, p < 0.01), LV asynergy (43 vs. 0 %, p < 0.01) and RVEF < 40 % (100 vs. 39 %, p < 0.01). There was no difference in disease duration, disease types, or prevalence of positive autoimmune antibodies or high serum NT-proBNP level (> 125 pg/ml). When cardiac involvement of SSc was defined as low LVEF, ECG abnormalities or high NT-proBNP, the sensitivity, specificity positive and negative predictive values of LGE were 36, 92, 71 and 72 %, respectively. We could clarify the prevalence and distribution of LGE in Japanese patients with SSc. The presence of LGE was associated with cardiac symptom, conduction disturbance and impaired LV/RV contraction.	[Sano, Makoto; Satoh, Hiroshi; Suwa, Kenichiro; Nobuhara, Mamoru; Saotome, Masao; Urushida, Tsuyoshi; Katoh, Hideki; Hayashi, Hideharu] Hamamatsu Univ Sch Med, Internal Med 3, Div Cardiol, Higashi Ward, Hamamatsu, Shizuoka 4313192, Japan; [Saitoh, Takeji] Hamamatsu Univ Sch Med, Dept Emergency Med, Hamamatsu, Shizuoka 4313192, Japan; [Shimoyama, Kumiko; Suzuki, Daisuke; Ogawa, Noriyoshi] Hamamatsu Univ Sch Med, Internal Med 3, Div Rheumatol & Immunol, Hamamatsu, Shizuoka 4313192, Japan; [Takehara, Yasuo; Sakahara, Harumi] Hamamatsu Univ Sch Med, Dept Radiol, Hamamatsu, Shizuoka 4313192, Japan	Satoh, H (reprint author), Hamamatsu Univ Sch Med, Internal Med 3, Div Cardiol, Higashi Ward, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	satoh36@hama-med.ac.jp					LEROY EC, 1988, J RHEUMATOL, V15, P202; Feng DL, 2011, CIRCULATION, V124, P1830, DOI 10.1161/CIRCULATIONAHA.111.026070; Steen VD, 2005, SEMIN ARTHRITIS RHEU, V35, P35, DOI 10.1016/j.semarthrit.2005.03.005; Flett AS, 2010, CIRCULATION, V122, P138, DOI 10.1161/CIRCULATIONAHA.109.930636; DANGELO WA, 1969, AM J MED, V46, P428, DOI 10.1016/0002-9343(69)90044-8; Kim RJ, 2000, NEW ENGL J MED, V343, P1445, DOI 10.1056/NEJM200011163432003; de Cobelli F, 2006, J AM COLL CARDIOL, V47, P1649, DOI 10.1016/j.jacc.2005.11.067; Saji M, 2013, HEART VESSELS, V28, P672, DOI 10.1007/s00380-012-0317-7; Allanore Y, 2009, ANN RHEUM DIS, V68, P1885, DOI 10.1136/ard.2008.098087; Liangos O, 2000, RHEUMATOLOGY, V39, P674, DOI 10.1093/rheumatology/39.6.674; BULKLEY BH, 1976, CIRCULATION, V53, P483; de Groote P, 2008, ANN RHEUM DIS, V67, P31, DOI 10.1136/ard.2006.057760; McCann GP, 2007, AM J ROENTGENOL, V188, P349, DOI 10.2214/AJR.05.1259; Hesselstrand R, 2011, SCAND J RHEUMATOL, V40, P133, DOI 10.3109/03009742.2010.507217; Meune C, 2008, ARTHRITIS RHEUM-US, V58, P1803, DOI 10.1002/art.23463; Tzelepis GE, 2007, ARTHRITIS RHEUM, V56, P3827, DOI 10.1002/art.22971; Hen Y, 2013, HEART VESSELS, V28, P742, DOI 10.1007/s00380-012-0300-3; Fernandes F, 2003, J CARD FAIL, V9, P311, DOI 10.1054/jcaf.2003.51; Poanta L, 2009, EUR J INTERN MED, V20, P378, DOI 10.1016/j.ejim.2008.10.011; Matoh F, 2007, J CARD FAIL, V13, P372, DOI 10.1016/j.cardfail.2007.02.001; Moon JCC, 2003, J AM COLL CARDIOL, V41, P1561, DOI 10.1016/S0735-1097(03)00189-X; Patel MR, 2009, CIRCULATION, V120, P1969, DOI 10.1161/CIRCULATIONAHA.109.851352; FOLLANSBEE WP, 1985, AM J MED, V79, P183, DOI 10.1016/0002-9343(85)90008-7; Assomull RG, 2006, J AM COLL CARDIOL, V48, P1977, DOI 10.1016/j.jacc.2006.07.049; Hachulla AL, 2009, ANN RHEUM DIS, V68, P1878, DOI 10.1136/ard.2008.095836; Ioannidis JPA, 2005, AM J MED, V118, P2, DOI 10.1016/j.amjmed.2004.04.031; Spethmann S, 2012, EUR HEART J-CARD IMG, V13, P863, DOI 10.1093/ehjci/jes047; PFISTERER ME, 1985, EUR HEART J, V6, P647; Bogaert J, 2007, EUR RADIOL, V17, P2572, DOI 10.1007/s00330-007-0627-9; Kanno H, 2011, MOD RHEUMATOL, V21, P423, DOI 10.1007/s10165-011-0413-z; Nagai Y, 2007, J DERMATOL, V34, P769, DOI 10.1111/j.1346-8138.2007.00381.x; Satoh H, 2009, J CARD FAIL, V15, P419, DOI 10.1016/j.cardfail.2008.11.014; Di Cesare E, 2013, EUR J RADIOL, V82, pE268, DOI 10.1016/j.ejrad.2013.02.014; STEEN VD, 1988, ARTHRITIS RHEUM, V31, P196, DOI 10.1002/art.1780310207; Allanore Y, 2010, ANN RHEUM DIS, V69, P218, DOI 10.1136/ard.2008.103382; Kahan A, 2006, RHEUMATOLOGY, V45, P14, DOI 10.1093/rheumatology/kel312; Blyth KG, 2005, EUR HEART J, V26, P1993, DOI 10.1093/eurheartj/ehi328; Zemrak F, 2011, PROG CARDIOVASC DIS, V54, P215, DOI 10.1016/j.pcad.2011.07.003; Plastiras SC, 2012, HELL J CARDIOL, V53, P287; Lehrke S, 2011, HEART, V97, P727, DOI 10.1136/hrt.2010.205542; D'Andrea Antonello, 2005, Eur J Echocardiogr, V6, P407, DOI 10.1016/j.euje.2005.01.002; Freed BH, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-11; Takehara K, 2007, GUIDELINE DIAGNOSIS, P1	43	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	NOV	2015	30	6					779	788		10.1007/s00380-014-0539-y		10	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CW8AW	WOS:000365221900011		
J	Nishida, J; Kouzu, H; Hashimoto, A; Fujito, T; Kawamukai, M; Mochizuki, A; Muranaka, A; Kokubu, N; Shimoshige, S; Yuda, S; Hase, M; Tsuchihashi, K; Miura, T				Nishida, Junichi; Kouzu, Hidemichi; Hashimoto, Akiyoshi; Fujito, Takefumi; Kawamukai, Mina; Mochizuki, Atsushi; Muranaka, Atsuko; Kokubu, Nobuaki; Shimoshige, Shinya; Yuda, Satoshi; Hase, Mamoru; Tsuchihashi, Kazufumi; Miura, Tetsuji			"Ballooning" patterns in takotsubo cardiomyopathy reflect different clinical backgrounds and outcomes: a BOREAS-TCM study	HEART AND VESSELS			English	Article						Midventricular obstruction; Prognosis; Recurrence; Takotsubo cardiomyopathy	TAKO-TSUBO CARDIOMYOPATHY; CORONARY-ARTERY STENOSIS; MYOCARDIAL-INFARCTION; PSYCHOLOGICAL STRESS; NATURAL-HISTORY; PHEOCHROMOCYTOMA; ADIPOSITY; PATIENT; VARIANT; SAMPLE	Whether different patterns of ventricular ballooning in takotsubo cardiomyopathy (TCM) reflect differences in trigger mechanisms or clinical outcomes is unclear. Here we examined differences in the clinical characteristics of typical and atypical forms of TCM. TCM patients (n = 251) in the BOREAS Registry were enrolled for comparison of TCM with apical ballooning (type A, n = 217) and TCM with non-apical ballooning (type non-A, n = 34). The percentage of females was significantly lower in the type non-A group (58.8 vs. 75.6 %), while other demographic parameters and triggers of TCM were similar in the two groups. Rate of mid-ventricular obstruction (MVO) was lower (2.9 vs. 14.3 %) in the type non-A group than in the type A group, though left ventricular ejection fractions in the two groups were comparable. During a follow-up period of 2.6 +/- A 2.8 years, TCM recurred in 2.9 % of the patients and cardiac death occurred in 4.0 %. Cox proportional hazard analysis indicated that body mass index (hazard ratio [HR]: 0.75, 95 % confidence interval [CI] 0.54-0.99) and MVO (HR: 14.71, CI 1.87-304.66) were determinants of TCM recurrence and that advanced age (HR: 1.09, CI 1.02-1.17) and cardiogenic shock (HR: 4.27, CI 1.07-18.93) were significantly associated with cardiac death. In conclusion, approximately 20 % of TCM patients show non-apical left ventricular ballooning, and female sex and MVO are less frequent in this type than in apical ballooning type TCM. Low body mass index and MVO are risk factors of recurrence, and advanced age and cardiogenic shock are risk factors of cardiac death in TCM.	[Nishida, Junichi; Kouzu, Hidemichi; Hashimoto, Akiyoshi; Fujito, Takefumi; Kawamukai, Mina; Mochizuki, Atsushi; Muranaka, Atsuko; Kokubu, Nobuaki; Shimoshige, Shinya; Miura, Tetsuji] Sapporo Med Univ, Sch Med, Dept Cardiovasc Renal & Metab Med, Chuo Ku, Sapporo, Hokkaido 0608543, Japan; [Yuda, Satoshi] Sapporo Med Univ, Sch Med, Dept Clin Lab Med, Chuo Ku, Sapporo, Hokkaido 0608543, Japan; [Hase, Mamoru] Sapporo Med Univ, Sch Med, Dept Emergency Med, Chuo Ku, Sapporo, Hokkaido 0608543, Japan; [Tsuchihashi, Kazufumi] Sapporo Med Univ, Sch Med, Div Hlth Care Adm & Management, Chuo Ku, Sapporo, Hokkaido 0608543, Japan	Miura, T (reprint author), Sapporo Med Univ, Sch Med, Dept Cardiovasc Renal & Metab Med, Chuo Ku, South 1,West 16, Sapporo, Hokkaido 0608543, Japan.	miura@sapmed.ac.jp			Sapporo Medical University	This study was supported by Sapporo Medical University Education and Research Grants. There is no relationship with industry and no conflict of interest in this study.	Sharkey SW, 2010, J AM COLL CARDIOL, V55, P333, DOI 10.1016/j.jacc.2009.08.057; Carroll D, 2008, PSYCHOSOM MED, V70, P653, DOI 10.1097/PSY.0b013e31817b9382; Bonnemeier H, 2006, EUR HEART J, V27, P2246, DOI 10.1093/eurheartj/ehi820; FRUSTACI A, 1991, CHEST, V99, P382, DOI 10.1378/chest.99.2.382; Tsuchihashi K, 2001, J AM COLL CARDIOL, V38, P11, DOI 10.1016/S0735-1097(01)01316-X; Iio K, 2013, HEART VESSELS, V28, P255, DOI 10.1007/s00380-012-0247-4; Parodi G, 2011, CHEST, V139, P887, DOI 10.1378/chest.10-1041; Song BG, 2011, CLIN CARDIOL, V34, P693, DOI 10.1002/clc.20953; Sanchez-Recalde A, 2006, CIRCULATION, V113, pE738, DOI 10.1161/CIRCULATIONAHA.105.581108; Previtali M, 2011, AM J CARDIOL, V107, P120, DOI 10.1016/j.amjcard.2010.08.055; Omerovic E, 2011, SCAND CARDIOVASC J, V45, P67, DOI 10.3109/14017431.2011.565794; Kim S, 2010, CLIN CARDIOL, V33, P200, DOI 10.1002/clc.20680; Phillips AC, 2012, PSYCHOSOM MED, V74, P699, DOI 10.1097/PSY.0b013e31825e3b91; Brinjikji W, 2012, AM HEART J, V164, P215, DOI 10.1016/j.ahj.2012.04.010; Murakami T, 2014, J CARDIOL, V63, P269, DOI 10.1016/j.jjcc.2013.09.003; Kurowski V, 2007, CHEST, V132, P809, DOI 10.1378/chest.07-0608; Kyuma M, 2002, CIRC J, V66, P1181, DOI 10.1253/circj.66.1181; Hurst RT, 2006, J AM COLL CARDIOL, V48, P579, DOI 10.1016/j.jacc.2006.06.015; Eitel I, 2011, JAMA-J AM MED ASSOC, V306, P277, DOI 10.1001/jama.2011.992; Spes C, 2006, CLIN RES CARDIOL, V95, P307, DOI 10.1007/s00392-006-0374-y; Akashi YJ, 2008, CIRCULATION, V118, P2754, DOI 10.1161/CIRCULATIONAHA.108.767012; Vidi V, 2009, AM J CARDIOL, V104, P578, DOI 10.1016/j.amjcard.2009.04.028; Elesber AA, 2007, J AM COLL CARDIOL, V50, P448, DOI 10.1016/j.jacc.2007.03.050; Nef HM, 2007, EUR HEART J, V28, P2456, DOI 10.1093/eurheartj/ehl570; Bybee KA, 2004, ANN INTERN MED, V141, P858; Pirzer R, 2012, HEART VESSELS, V27, P186, DOI 10.1007/s00380-011-0132-6; Cacciotti L, 2012, BMJ OPEN, V2; Dote K, 1991, J Cardiol, V21, P203; Ghadri JR, 2014, HEART, V100, P1804, DOI 10.1136/heartjnl-2013-304691; Otsuka M, 2006, Heart, V92, P1837, DOI 10.1136/hrt.2006.088385; Park Jae-Hyeong, 2011, J Cardiovasc Ultrasound, V19, P76, DOI 10.4250/jcu.2011.19.2.76; Ramaraj Radhakrishnan, 2010, Congest Heart Fail, V16, P284, DOI 10.1111/j.1751-7133.2010.00188.x; Wiswell J G, 1969, Trans Am Clin Climatol Assoc, V80, P185; Wittstein IS, 2005, NEW ENGL J MED, V352, P539, DOI 10.1056/NEJMoa043046; Yoshioka T, 2008, AM HEART J, V155, DOI 10.1016/j.ahj.2007.10.042	35	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	NOV	2015	30	6					789	797		10.1007/s00380-014-0548-x		9	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CW8AW	WOS:000365221900012		
J	Hatano, M; Yamada, H; Fukuda, K; Yoshioka, K; Funauchi, M; Kuwana, M; Sata, M; Taniguchi, M; Nakanishi, N; Saito, T; Saji, T; Sasayama, S				Hatano, Masaru; Yamada, Hidehiro; Fukuda, Keiichi; Yoshioka, Koichiro; Funauchi, Masanori; Kuwana, Masataka; Sata, Masataka; Taniguchi, Mitsugu; Nakanishi, Norifumi; Saito, Takefumi; Saji, Tsutomu; Sasayama, Shigetake			Effects of the endothelin receptor antagonist bosentan on hemodynamics and exercise capacity in Japanese patients with mildly symptomatic pulmonary arterial hypertension	HEART AND VESSELS			English	Article						Bosentan; Endothelin receptor antagonist; Pulmonary arterial hypertension; Hemodynamics; World Health Organization functional class	SYSTEMIC-SCLEROSIS; REVEAL REGISTRY; SURVIVAL	Pulmonary arterial hypertension (PAH) trial has mostly enrolled patients with World Health Organization functional class (WHO FC) III or IV. However, PAH is rapidly progressive in nature even in patients with less severe forms at diagnosis. Following the recent studies in Western population, here we assessed the efficacy of bosentan in Japanese patients with WHO FCII PAH. In this open-label trial, bosentan 125 mg twice daily was administered for 12 weeks in 16 patients, and a hemodynamic evaluation was performed. Treatment was continued for a further 12 weeks, where the effect on exercise capacity was assessed in 13 patients. In 16 patients, mean pulmonary arterial pressure decreased from 40.4 +/- A 10.4 to 35.6 +/- A 12.6 mmHg (p = 0.018) and cardiac index increased from 2.54 +/- A 0.73 to 2.96 +/- A 0.82 L/min/m(2) (p = 0.023). Thus, pulmonary vascular resistance decreased from 792 +/- A 565 to 598 +/- A 558 dyn center dot sec/cm(5) (p = 0.006). In 13 patients followed up for 24 weeks, 6-min walking distance increased from baseline at Week 12 (p = 0.003) and Week 24 (p = 0.011). All patients were mildly symptomatic at baseline with dyspnea index (Borg scale) of 2.50 +/- A 1.58 and the specific activity scale (SAS) of 5.0 +/- A 1.4 METs. These values remained unchanged throughout the study. These results suggest that bosentan treatment was beneficial for Japanese patients with WHO FC II PAH and treatment should be started in the early stage of the disease.	[Hatano, Masaru] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138655, Japan; [Yamada, Hidehiro] St Marianna Univ, Sch Med, Dept Internal Med, Div Rheumatol & Allergy, Miyamae, Kanagawa, Japan; [Fukuda, Keiichi] Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan; [Yoshioka, Koichiro] Tokai Univ, Sch Med, Dept Cardiovasc Med, Hiratsuka, Kanagawa 25912, Japan; [Funauchi, Masanori] Kinki Univ, Fac Med, Dept Hematol & Rheumatol, Osaka, Japan; [Kuwana, Masataka] Keio Univ, Sch Med, Dept Internal Med, Div Rheumatol, Tokyo, Japan; [Sata, Masataka] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Cardiovasc Med, Tokushima 770, Japan; [Taniguchi, Mitsugu] Kinki Univ, Fac Med, Div Cardiol, Osaka, Japan; [Nakanishi, Norifumi] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Div Pulm Circulat, Osaka, Japan; [Saito, Takefumi] Natl Hosp Org Ibaraki Higashi Natl Hosp, Dept Resp Med, Ibaraki, Japan; [Saji, Tsutomu] Toho Univ, Omori Med Ctr, Dept Pediat, Tokyo, Japan; [Sasayama, Shigetake] Kyoto Univ, Kyoto, Japan	Hatano, M (reprint author), Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	hatanoma@pg8.so-net.ne.jp			Actelion Pharmaceuticals Japan Ltd.	This study was funded and supported by Actelion Pharmaceuticals Japan Ltd.	RICH S, 1987, ANN INTERN MED, V107, P216; Brown LM, 2011, CHEST, V140, P19, DOI 10.1378/chest.10-1166; Hachulla E, 2005, ARTHRITIS RHEUM, V52, P3792, DOI 10.1002/art.21433; Benza RL, 2011, J HEART LUNG TRANSPL, V30, P982, DOI 10.1016/j.healun.2011.03.011; DALONZO GE, 1991, ANN INTERN MED, V115, P343; Sasayama S, 2005, CIRC J, V69, P131, DOI 10.1253/circj.69.131; MURATA I, 1992, JPN CIRC J, V56, P983; Humbert M, 2010, CIRCULATION, V122, P156, DOI 10.1161/CIRCULATIONAHA.109.911818; Taguchi H, 2012, CIRC J, V76, P1494, DOI 10.1253/circj.CJ-11-1223; McLaughlin VV, 2002, CIRCULATION, V106, P1477, DOI 10.1161/01.CIR.0000029100.82385.58; Jing ZC, 2007, CHEST, V132, P373, DOI 10.1378/chest.06-2913; Galie N, 2008, LANCET, V371, P2093, DOI 10.1016/S0140-6736(08)60919-8; Hoeper MM, 2013, INT J CARDIOL, V168, P871, DOI 10.1016/j.ijcard.2012.10.026; [Anonymous], 2009, J AM COLL CARDIOL, DOI DOI 10.1016/J.JACC.2009.01.004; Badesch DB, 2010, CHEST, V137, P376, DOI 10.1378/chest.09-1140; Hachulla E, 2010, RHEUMATOLOGY, V49, P940, DOI 10.1093/rheumatology/kep449; [Anonymous], 2009, EUR RESPIR J, DOI DOI 10.1183/09031936.00139009; Humbert Marc, 2012, Eur Respir Rev, V21, P306, DOI 10.1183/09059180.00005112; Metabolic Equivalent Task, 2014, CALC YOUR WEEKL EN E; Sasayama S, 2012, PHARM MED, V30, P141	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	NOV	2015	30	6					798	804		10.1007/s00380-014-0544-1		7	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CW8AW	WOS:000365221900013		
J	Momomura, S; Seino, Y; Kihara, Y; Adachi, H; Yasumura, Y; Yokoyama, H				Momomura, Shin-ichi; Seino, Yoshihiko; Kihara, Yasuki; Adachi, Hitoshi; Yasumura, Yoshio; Yokoyama, Hiroyuki			Adaptive servo-ventilation therapy using an innovative ventilator for patients with chronic heart failure: a real-world, multicenter, retrospective, observational study (SAVIOR-R)	HEART AND VESSELS			English	Article						Adaptive servo-ventilation; Chronic heart failure; Noninvasive positive pressure ventilation; Cardiac function; Sleep-disordered breathing	CHEYNE-STOKES RESPIRATION; POSITIVE AIRWAY PRESSURE; CARDIAC RESYNCHRONIZATION THERAPY; SYMPATHETIC-NERVE ACTIVITY; END-EXPIRATORY PRESSURE; SLEEP-APNEA; SERVOVENTILATION; CARVEDILOL; MORBIDITY; MORTALITY	Adaptive servo-ventilation (ASV) therapy using an innovative ventilator-originally developed to treat sleep-disordered breathing (SDB)-is a novel modality of noninvasive positive pressure ventilation and is gaining acceptance among Japanese cardiologists in expectation of its applicability to treat patients with chronic heart failure (CHF) based on its acute beneficial hemodynamic effects. We conducted a multicenter, retrospective, real-world observational study in 115 Japanese patients with CHF, who had undergone home ASV therapy for the first time from January through December 2009, to examine their profile and the effects on their symptoms and hemodynamics. Medical records were used to investigate New York Heart Association (NYHA) class, echocardiographic parameters including left ventricular ejection fraction (LVEF), cardiothoracic ratio (CTR), brain natriuretic peptide (BNP), and other variables. Most of the patients were categorized to NYHA classes II (44.4 %) and III (40.7 %). SDB severity was not determined in 44 patients, and SDB was not detected or was mild in 27 patients. In at least 71 patients (61.7 %), therefore, ASV therapy was not applied for the treatment of SDB. CHF was more severe, i.e., greater NYHA class, lower LVEF, and higher CTR, in 87 ASV-continued patients (75.7 %) than in 28 ASV-discontinued patients (24.3 %). However, SDB severity was not related to continuity of ASV. The combined proportion of NYHA classes III and IV (P = 0.012) and LVEF (P = 0.009) improved significantly after ASV therapy. CTR and BNP did not improve significantly after ASV therapy but showed significant beneficial changes in their time-course analysis (P < 0.05, respectively). Improvements in LVEF and NYHA class after ASV therapy were not influenced by SDB severity at onset. The present study suggests that ASV therapy would improve the symptoms and hemodynamics of CHF patients, regardless of SDB severity. A randomized clinical study to verify these effects is warranted.	[Momomura, Shin-ichi] Jichi Med Univ, Saitama Med Ctr, Cardiovasc Med, Omiya Ku, Saitama 3308503, Japan; [Seino, Yoshihiko] Chiba Hokusoh Hosp, Nippon Med Sch, Ctr Cardiovasc, Chiba, Japan; [Kihara, Yasuki] Hiroshima Univ, Dept Cardiovasc Med, Hiroshima, Japan; [Adachi, Hitoshi] Gunma Prefectural Cardiovasc Ctr, Div Cardiol, Gunma, Japan; [Yasumura, Yoshio] Osaka Natl Hosp, Div Cardiovasc, Osaka, Japan; [Yokoyama, Hiroyuki] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Osaka, Japan	Momomura, S (reprint author), Jichi Med Univ, Saitama Med Ctr, Cardiovasc Med, Omiya Ku, 1-847 Amanuma Cho, Saitama 3308503, Japan.	momochan-tky@umin.ac.jp			Teijin Pharma Limited	The authors thank Satoshi Sakima, MD, for the critical review of the manuscript. The research fund was provided to Comprehensive Support Project for Clinical Research of Lifestyle-Related Disease (CSP-LD) of Public Health Research Foundation (PHRF) by Teijin Pharma Limited.	Go AS, 2013, CIRCULATION, V127, P143, DOI 10.1161/CIR.0b013e318282ab8f; Koyama T, 2012, CIRC J, V76, P2606, DOI 10.1253/circj.CJ-12-0328; TAKANO T, 1986, JPN CIRC J, V50, P359; Harada D, 2011, AUTON NEUROSCI-BASIC, V161, P95, DOI 10.1016/j.autneu.2010.12.001; Azevedo ER, 2000, CIRCULATION, V101, P2053; Hastings PC, 2010, INT J CARDIOL, V139, P17, DOI 10.1016/j.ijcard.2008.08.022; Hori M, 2004, AM HEART J, V147, P324, DOI 10.1016/j.ahj.2003.07.023; Philippe C, 2006, HEART, V92, P337, DOI 10.1136/hrt.2005.060038; Haruki N, 2011, EUR J HEART FAIL, V13, P1140, DOI 10.1093/eurjhf/hfr103; Takama N, 2011, CIRC J, V75, P1164, DOI 10.1253/circj.CJ-10-0831; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; NAUGHTON MT, 1995, CIRCULATION, V91, P1725; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Oldenburg O, 2011, CLIN RES CARDIOL, V100, P107, DOI 10.1007/s00392-010-0216-9; Yoshihisa A, 2012, CIRC J, V76, P2153, DOI 10.1253/circj.CJ-12-0453; Momomura S, 2012, CIRC J, V76, P1911, DOI 10.1253/circj.CJ-11-1341; Mansfield DR, 2004, AM J RESP CRIT CARE, V169, P361, DOI 10.1164/rccm.200306-752OC; Halter JM, 2003, AM J RESP CRIT CARE, V167, P1620, DOI 10.1164/rccm.200205-435OC; YUSUF S, 1991, NEW ENGL J MED, V325, P293; Yamada S, 2013, CIRC J, V77, P1214, DOI 10.1253/circj.CJ-12-1088; Acosta B, 2000, CHEST, V118, P1004, DOI 10.1378/chest.118.4.1004; Oldenburg O, 2008, EUR J HEART FAIL, V10, P581, DOI 10.1016/j.ejheart.2008.04.007; Oldenburg O, 2012, CIRC J, V76, P2305, DOI 10.1253/circj.CJ-12-0689; Koyama T, 2013, EUR J HEART FAIL, V15, P902, DOI 10.1093/eurjhf/hft049; Maurer MS, 2009, CIRC-HEART FAIL, V2, P189, DOI 10.1161/CIRCHEARTFAILURE.108.806240; Joho S, 2012, J CARD FAIL, V18, P769, DOI 10.1016/j.cardfail.2012.08.360; Adabag S, 2011, J AM COLL CARDIOL, V58, P935, DOI 10.1016/j.jacc.2011.05.022; Mehta S, 2001, AM J RESP CRIT CARE, V163, P540; Michelet P, 2005, BRIT J ANAESTH, V95, P267, DOI 10.1093/bja/aei178; HO KKL, 1993, J AM COLL CARDIOL, V22, pA6; JCS Joint Working Group, 2013, CIRC J, V77, P2157; Koyama T, 2010, CIRC J, V74, P2056; Shiba Nobuyuki, 2008, Vasc Health Risk Manag, V4, P103, DOI 10.2147/vhrm.2008.04.01.103; Teschler H, 2001, AM J RESP CRIT CARE, V164, P614	34	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	NOV	2015	30	6					805	817		10.1007/s00380-014-0558-8		13	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CW8AW	WOS:000365221900014		
J	Yamawaki, M; Onuma, Y; Nakano, M; Muramatsu, T; Nakatani, S; Ishibashi, Y; Ishimori, H; Hirano, K; Ito, Y; Tsukahara, R; Muramatsu, T				Yamawaki, Masahiro; Onuma, Yoshinobu; Nakano, Masatsugu; Muramatsu, Takashi; Nakatani, Shimpei; Ishibashi, Yuki; Ishimori, Hiroshi; Hirano, Keisuke; Ito, Yoshiaki; Tsukahara, Reiko; Muramatsu, Toshiya			Simultaneous occlusion of left anterior descending and left circumflex arteries by very late stent thrombosis: vascular response to drug-eluting stents assessed by intravascular ultrasound	HEART AND VESSELS			English	Article						Acute myocardial infarction; Drug-eluting stent; Very late stent thrombosis; Intravascular ultrasound	OPTICAL COHERENCE TOMOGRAPHY; MALAPPOSITION; IMPLANTATION; RISK; HYPERSENSITIVITY; RESTENOSIS	Very late stent thrombosis (VLST) is a catastrophic complication after implantation of a drug-eluting stent (DES). It has been reported that VLST is associated with pathological changes, which often include late acquired incomplete stent apposition (LAISA) with thrombus formation. In addition, the vascular response to the stent (evaginations, neointimal growth, and thrombosis) and the incidence of LAISA are reported to vary among the different types of DES. We experienced a patient with cardiogenic shock induced by simultaneous VLST of both the left anterior descending artery (LAD) and the left circumflex artery (LCX) at 3 years after implantation of two sirolimus-eluting stents. Intravascular ultrasound (IVUS) showed LAISA of both arteries. A paclitaxel-eluting stent, which had been implanted in the right coronary artery 3 years earlier, did not show such a finding. IVUS revealed "different vascular reactions" to "different types of DES" in this patient.	[Yamawaki, Masahiro; Nakano, Masatsugu; Ishimori, Hiroshi; Hirano, Keisuke; Ito, Yoshiaki; Tsukahara, Reiko; Muramatsu, Toshiya] Saiseikai Yokohama City Eastern Hosp, Dept Cardiol, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Onuma, Yoshinobu; Muramatsu, Takashi; Nakatani, Shimpei; Ishibashi, Yuki] Erasmus MC, Thoraxctr, Dept Intervent Cardiol, Rotterdam, Netherlands	Yamawaki, M (reprint author), Saiseikai Yokohama City Eastern Hosp, Dept Cardiol, Tsurumi Ku, 3-6-1 Shimosueyoshi, Yokohama, Kanagawa, Japan.	m_yamawaki@tobu.saiseikai.or.jp					Hayashi T, 2014, HEART VESSELS, V29, P273, DOI 10.1007/s00380-013-0350-1; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; van der Hoeven BL, 2008, JACC-CARDIOVASC INTE, V1, P192, DOI 10.1016/j.jcin.2008.02.003; Hassan AKM, 2010, EUR HEART J, V31, P1172, DOI 10.1093/eurheartj/ehn553; Otsuka Y, 2012, HEART VESSELS, V27, P110, DOI 10.1007/s00380-011-0145-1; Hong MK, 2007, J AM COLL CARDIOL, V50, P1515, DOI 10.1016/j.jacc.2007.07.038; Raber L, 2012, JACC-CARDIOVASC INTE, V5, P946, DOI 10.1016/j.jcin.2012.05.012; Hong MK, 2004, CIRCULATION, V109, P881, DOI 10.1161/01.CIR.0000116751.88818.10; Murakami D, 2009, CIRC J, V73, P1627; Alfonso F, 2012, HEART, V98, P1213, DOI 10.1136/heartjnl-2012-302183; Virmani R, 2004, CORONARY ARTERY DIS, V15, P313, DOI 10.1097/00019501-200409000-00003; Virmani R, 2004, CIRCULATION, V109, P701, DOI 10.1161/01.CIR.0000116202.41966.D4; Karalis I, 2012, HEART, V98, P1529, DOI 10.1136/heartjnl-2011-301220; Watanabe Y, 2009, HEART VESSELS, V24, P308, DOI 10.1007/s00380-008-1124-z; Cook S, 2009, CIRCULATION, V120, P391, DOI 10.1161/CIRCULATIONAHA.109.854398; Narasimhan S, 2012, TEX HEART I J, V39, P630; Hong MK, 2006, CIRCULATION, V113, P414, DOI 10.1161/CIRCULATIONAHA.105.563403; Kang SJ, 2013, JACC-CARDIOVASC IMAG, V6, P695, DOI 10.1016/j.jcmg.2013.02.006; de la Torre Hernandez JM, 2009, EUROINTERVENTION SD, V5, pD112; Prasad Sandhir B, 2009, Cardiovasc Revasc Med, V10, P188, DOI 10.1016/j.carrev.2008.07.005; Puri A, 2013, J INVASIVE CARDIOL, V25, pE48; Sakata K, 2015, HEART VESSELS, V30, P406, DOI 10.1007/s00380-014-0477-8; Silva Joana, 2011, J Invasive Cardiol, V23, pE128	23	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	NOV	2015	30	6					824	829		10.1007/s00380-014-0545-0		6	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CW8AW	WOS:000365221900016		
J	Yano, M; Saito, N; Watanabe, S; Watanabe, H; Nishikawa, R; Fujino, T; Bao, BY; Yamamoto, E; Watanabe, H; Nakatsuma, K; Imai, M; Makiyama, T; Sakata, Y; Kimura, T; Inoue, K				Yano, Mariko; Saito, Naritatsu; Watanabe, Shin; Watanabe, Hirotoshi; Nishikawa, Ryusuke; Fujino, Takeshi; Bao, Bingyuan; Yamamoto, Erika; Watanabe, Hiroki; Nakatsuma, Kenji; Imai, Masao; Makiyama, Takeru; Sakata, Yoshihito; Kimura, Takeshi; Inoue, Kanji			First clinical experience of the looped Inoue balloon technique for antegrade percutaneous balloon aortic valvuloplasty	HEART AND VESSELS			English	Article						Balloon aortic valvuloplasty; Aortic valve stenosis; Structural heart disease	VALVE-REPLACEMENT; STENOSIS; RETROGRADE	Balloon aortic valvuloplasty (BAV) has played a limited role in the management of patients with severe aortic stenosis. However, BAV is being performed more frequently these days with the emergence of transcatheter aortic valve implantation (TAVI). We previously described a technique named "looped Inoue balloon technique" to simplify the antegrade transvenous BAV by making a loop in the left atrium using two stylets. We present a case in which the looped Inoue balloon technique was successfully applied. The patient was an 83-year-old woman with progressive dyspnea due to severe aortic stenosis. The aortic valve area was 0.39 cm(2) with a mean transvalvular gradient of 46 mmHg. The patient was deemed high risk for surgical aortic valve replacement or TAVI in view of the multiple comorbidities and frailty. Antegrade BAV using the looped Inoue balloon technique was performed. The procedure was successful without any complications. The post procedural aortic valve area increased to 1.15 cm(2) with a mean pressure gradient of 23 mmHg. This is the first report of clinical use of the looped Inoue balloon technique for antegrade BAV.	[Yano, Mariko; Saito, Naritatsu; Watanabe, Shin; Watanabe, Hirotoshi; Nishikawa, Ryusuke; Fujino, Takeshi; Bao, Bingyuan; Yamamoto, Erika; Watanabe, Hiroki; Nakatsuma, Kenji; Imai, Masao; Makiyama, Takeru; Kimura, Takeshi] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Sakyo Ku, Kyoto 6068507, Japan; [Sakata, Yoshihito] Ikegami Gen Hosp, Ctr Heart, Tokyo, Japan; [Inoue, Kanji] PTMC Inst, Kyoto, Japan	Saito, N (reprint author), Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	naritatu@kuhp.kyoto-u.ac.jp					Cubeddu RJ, 2009, CATHETER CARDIO INTE, V74, P225, DOI 10.1002/ccd.22085; Eisenhauer AC, 2000, CATHETER CARDIO INTE, V50, P484, DOI 10.1002/1522-726X(200008)50:4<484::AID-CCD25>3.0.CO;2-W; Ben-Dor I, 2013, CATHETER CARDIO INTE, V82, P632, DOI 10.1002/ccd.24682; Bao BY, 2013, CATHETER CARDIO INTE, V82, pE564, DOI 10.1002/ccd.24908; Maekawa Y, 2012, HEART VESSELS, V27, P528, DOI 10.1007/s00380-011-0208-3; CRIBIER A, 1986, LANCET, V1, P63; Furuta A, 2013, HEART VESSELS, V28, P397, DOI 10.1007/s00380-012-0268-z; Sakata Y, 2005, CATHETER CARDIO INTE, V64, P314, DOI 10.1002/ccd.20300; Sack S, 2008, CLIN RES CARDIOL, V97, P288, DOI 10.1007/s00392-008-0650-0; Hara H, 2007, CIRCULATION, V115, pE334, DOI 10.1161/CIRCULATIONAHA.106.657098; Inoue K, 1988, J AM COLL CARDIOL, V11, p1A	11	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	NOV	2015	30	6					830	834		10.1007/s00380-014-0552-1		5	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CW8AW	WOS:000365221900017		
J	Arakawa, J; Hamabe, A; Aiba, T; Nagai, T; Yoshida, M; Touya, T; Ishigami, N; Hisadome, H; Katsushika, S; Tabata, H; Miyamoto, Y; Shimizu, W				Arakawa, Junko; Hamabe, Akira; Aiba, Takeshi; Nagai, Tomoo; Yoshida, Mikoto; Touya, Takumi; Ishigami, Norio; Hisadome, Hideki; Katsushika, Shuichi; Tabata, Hirotsugu; Miyamoto, Yoshihiro; Shimizu, Wataru			A novel cardiac ryanodine receptor gene (RyR2) mutation in an athlete with aborted sudden cardiac death: a case of adult-onset catecholaminergic polymorphic ventricular tachycardia	HEART AND VESSELS			English	Article						Sudden cardiac death; Catecholaminergic polymorphic ventricular tachycardia; Cardiac ryanodine receptor	LONG-QT SYNDROME; AMERICAN-COLLEGE; ABNORMALITIES; ASSOCIATION; ARRHYTHMIAS; VARIABILITY; MANAGEMENT; RELATIVES	Sudden cardiac death (SCD) in athletes < 35 years of age are mostly due to congenital or acquired cardiac malformations or hypertrophic cardiomyopathy. However, ion channelopathies such as catecholaminergic polymorphic ventricular tachycardia (CPVT) or long-QT syndromes, which are less frequently observed, are also potential pathogenesis of SCD in young athletes. CPVT is an inherited arrhythmia that is induced by physical or emotional stress and may lead to ventricular fibrillation syncope or SCD. Here, we report a case of athlete woman with adult-onset CPVT and aborted SCD who has a novel missense mutation (K4392R) in the cardiac RyR2 gene.	[Arakawa, Junko; Hamabe, Akira; Nagai, Tomoo; Yoshida, Mikoto; Touya, Takumi; Ishigami, Norio; Katsushika, Shuichi; Tabata, Hirotsugu] Japan Self Def Forces Cent Hosp, Dept Cardiol, Setagaya Ku, Tokyo 1548532, Japan; [Arakawa, Junko; Hamabe, Akira; Nagai, Tomoo; Yoshida, Mikoto; Touya, Takumi; Ishigami, Norio; Hisadome, Hideki; Katsushika, Shuichi; Tabata, Hirotsugu] KKR Mishuku Hosp, Dept Cardiol, Tokyo, Japan; [Aiba, Takeshi; Shimizu, Wataru] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Osaka, Japan; [Miyamoto, Yoshihiro] Natl Cerebral & Cardiovasc Ctr, Mol Genet Lab, Osaka, Japan; [Shimizu, Wataru] Nippon Med Sch, Dept Cardiovasc Med, Tokyo 113, Japan	Arakawa, J (reprint author), Japan Self Def Forces Cent Hosp, Dept Cardiol, Setagaya Ku, Ikejiri 1-2-24, Tokyo 1548532, Japan.	junko_k1981@yahoo.co.jp			Ministry of Health, Labor and Welfare of Japan [2010-145]; MEXT of Japan [22136011 A02, 24591086]; Ministry of Health, Labor and Welfare, Japan [H24-033]	The authors thank Naotaka Ohta, Toshiko Shibata, Hiromi Fujiyama, Miyuki Hozan and Akihiro Fujiwara for excellent technical supports. This work was supported by grants from the Ministry of Health, Labor and Welfare of Japan (2010-145); a Grant-in-Aid for Scientific Research on Innovative Areas (22136011 A02, Aiba), a Grant-in-Aid for Scientific Research (C) (24591086 Aiba) from MEXT of Japan, and a Research Grant for Cardiovascular Diseases (H24-033 Shimizu, Aiba) from the Ministry of Health, Labor and Welfare, Japan.	Tincello DG, 1997, CLIN ENDOCRINOL, V46, P497, DOI 10.1046/j.1365-2265.1997.1140927.x; LEENHARDT A, 1995, CIRCULATION, V91, P1512; Sumitomo N, 2011, HEART RHYTHM, V8, P872, DOI 10.1016/j.hrthm.2011.02.019; Medeiros-Domingo A, 2009, J AM COLL CARDIOL, V54, P2065, DOI 10.1016/j.jacc.2009.08.022; Laitinen PJ, 2001, CIRCULATION, V103, P485; Beery TA, 2009, BIOL RES NURS, V11, P66, DOI 10.1177/1099800409333369; Swan H, 1999, J AM COLL CARDIOL, V34, P2035, DOI 10.1016/S0735-1097(99)00461-1; van der Werf C, 2012, CIRC-ARRHYTHMIA ELEC, V5, P748, DOI 10.1161/CIRCEP.112.970517; Lahat H, 2001, AM J HUM GENET, V69, P1378, DOI 10.1086/324565; Kimura H, 2012, CIRC-CARDIOVASC GENE, V5, P344, DOI 10.1161/CIRCGENETICS.111.962316; Meli AC, 2011, CIRC RES, V109, P281, DOI 10.1161/CIRCRESAHA.111.244970; Marjamaa A, 2011, INT J CARDIOL, V147, P246, DOI 10.1016/j.ijcard.2009.08.041; Priori SG, 2001, CIRCULATION, V103, P196; Watanabe H, 2009, NAT MED, V15, P380, DOI 10.1038/nm.1942; Chen B, 2012, CIRC-ARRHYTHMIA ELEC, V5, P841, DOI 10.1161/CIRCEP.111.969733; Kawamura M, 2013, CIRC J, V77, P1705, DOI 10.1253/circj.CJ-12-1460; van der Werf C, 2011, J AM COLL CARDIOL, V57, P2244, DOI 10.1016/j.jacc.2011.01.026; Maron BJ, 2007, CIRCULATION, V115, P1643, DOI 10.1161/CIRCULATIONAHA.107.181423; Blayney LM, 2009, PHARMACOL THERAPEUT, V123, P151, DOI 10.1016/j.pharmthera.2009.03.006; Caldwell J, 2012, HEART, V98, P631, DOI 10.1136/heartjnl-2011-300924; Shimizu W, 2003, J AM COLL CARDIOL, V41, P633, DOI 10.1016/S0735-1097(02)02850; Sy RW, 2011, HEART RHYTHM, V8, P864, DOI 10.1016/j.hrthm.2011.01.048; Coumel P., 1978, BRIT HEART J       S, V40, P28; JCS Joint Working Group, 2013, CIRC J, V77, P249; Kawashiri M, 2014, HEART VESSELS, V29, P129, DOI 10.1007/s00380-013-0391-5; Miyazaki A, 2015, HEART VESSELS, V30, P70, DOI 10.1007/s00380-013-0444-9; Nyegaard M, 2013, AM J HUM GENET, V91, P703; Priori SG, 2013, HEART RHYTHM, pe75; Saha Paban, 2012, Curr Treat Options Cardiovasc Med, V14, P81, DOI 10.1007/s11936-011-0160-7; Zipes DP, 2006, CIRCULATION, V114, pE385, DOI 10.1161/CIRCULATIONAHA.106.178233	30	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	NOV	2015	30	6					835	840		10.1007/s00380-014-0555-y		6	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CW8AW	WOS:000365221900018		
J	Yano, T; Ishimura, S; Furukawa, T; Koyama, M; Tanaka, M; Shimoshige, S; Hashimoto, A; Miura, T				Yano, Toshiyuki; Ishimura, Shutaro; Furukawa, Tetsuaki; Koyama, Masayuki; Tanaka, Marenao; Shimoshige, Shinya; Hashimoto, Akiyoshi; Miura, Tetsuji			Cardiac tamponade leading to the diagnosis of eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome): a case report and review of the literature	HEART AND VESSELS			English	Review						Eosinophilic granulomatosis with polyangiitis; Churg-Strauss syndrome; Cardiac tamponade; Pericarditis		Eosinophilic granulomatosis with polyangiitis (EGPA), which was previously called Churg-Strauss syndrome, is a necrotizing systemic vasculitis of unknown cause accompanied by prominent eosinophilia. Cardiovascular complications, including eosinophilic myocarditis, are a major cause of mortality in this disorder. Acute pericarditis with slight pericardial effusion is a typical manifestation in EGPA, though hemodynamically significant pericardial effusion has been reported in a few cases. We report a case that initially presented with isolated cardiac tamponade, which was followed by systemic manifestations of EGPA over 3 weeks. Including the present case, previous EGPA cases with cardiac tamponade are reviewed to delineate its clinical characteristics.	[Yano, Toshiyuki; Ishimura, Shutaro; Furukawa, Tetsuaki; Koyama, Masayuki; Tanaka, Marenao; Shimoshige, Shinya; Hashimoto, Akiyoshi; Miura, Tetsuji] Sapporo Med Univ, Dept Cardiovasc Renal & Metab Med, Sch Med, Chuo Ku, Sapporo, Hokkaido 0608543, Japan	Yano, T (reprint author), Sapporo Med Univ, Dept Cardiovasc Renal & Metab Med, Sch Med, Chuo Ku, South 1,West 16, Sapporo, Hokkaido 0608543, Japan.	tyano@sapmed.ac.jp					Gerlach RM, 2013, CAN J ANESTH, V60, P803, DOI 10.1007/s12630-013-9968-9; Wassmuth R, 2008, J CARD FAIL, V14, P856, DOI 10.1016/j.cardfail.2008.07.227; Agard C, 2007, SEMIN ARTHRITIS RHEU, V36, P386, DOI 10.1016/j.semarthrit.2006.12.002; HASLEY PB, 1990, AM HEART J, V120, P996, DOI 10.1016/0002-8703(90)90227-O; Lenders G, 2011, ACTA CARDIOL, V66, P383, DOI 10.2143/AC.66.3.2114142; Minai K, 2013, HEART VESSELS, V28, P510, DOI 10.1007/s00380-012-0278-x; SHARMA A, 1993, CAN J CARDIOL, V9, P329; Ovadia S, 2009, CLIN RHEUMATOL, V28, pS35, DOI 10.1007/s10067-009-1119-x; UREN NG, 1991, TEX HEART I J, V18, P127; Comarmond C, 2013, ARTHRITIS RHEUM-US, V65, P270, DOI 10.1002/art.37721; Sablé-Fourtassou Régis, 2005, Ann Intern Med, V143, P632; Suganuma Kazuki, 2011, Case Rep Neurol, V3, P274, DOI 10.1159/000334127; Wang Shiuan-Jenn, 2000, Journal of Microbiology Immunology and Infection, V33, P263	13	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	NOV	2015	30	6					841	844		10.1007/s00380-014-0556-x		4	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CW8AW	WOS:000365221900019		
J	Fujisawa, T; Nakayama, C				Fujisawa, Taro; Nakayama, Chikara			Geometric log Hodge structures on the standard log point	HIROSHIMA MATHEMATICAL JOURNAL			English	Article						Hodge theory; log geometry; log deformation; log Hodge structure	VARIETIES; COHOMOLOGY	We construct natural polarized log Hodge structures associated to a projective log deformation over the standard log point.	[Fujisawa, Taro] Tokyo Denki Univ, Sch Engn, Dept Math, Tokyo 1208551, Japan; [Nakayama, Chikara] Hitotsubashi Univ, Dept Econ, Kunitachi, Tokyo 1868601, Japan	Fujisawa, T (reprint author), Tokyo Denki Univ, Sch Engn, Dept Math, 5 Senju Asahi, Tokyo 1208551, Japan.	fujisawa@mail.dendai.ac.jp; c.nakayama@r.hit-u.ac.jp			JSPS, Kakenhi [23540058, 22540011, 23340008]	The first author is partially supported by JSPS, Kakenhi (C) No. 23540058.; The second author is partially supported by JSPS, Kakenhi (C) No. 22540011 and (B) No. 23340008.	STEENBRINK J, 1976, INVENT MATH, V31, P229, DOI 10.1007/BF01403146; Kajiwara T, 2008, J MATH SCI-U TOKYO, V15, P69; Kajiwara T, 2008, J MATH SCI-U TOKYO, V15, P291; Kajiwara T, 2008, NAGOYA MATH J, V191, P149; STEENBRINK JHM, 1995, MATH ANN, V301, P105, DOI 10.1007/BF01446621; Fujisawa T, 2003, REND SEMIN MAT U PAD, V110, P221; Nakayama C, 1997, MATH ANN, V308, P365, DOI 10.1007/s002080050081; Banica C., 1977, METHODES ALGEBRIQUES, V1; CATTANI E, 1986, ANN MATH, V123, P457, DOI 10.2307/1971333; Deligne P., 1968, PUBL MATH-PARIS, V35, P107, DOI 10.1007/BF02698925; Deligne P., 1970, LECT NOTES MATH, V163; Fujisawa T., 2014, J SINGULARITIES, V8, P146; Illusie L., 2005, J MATH SCI-U TOKYO, V12, P1; Iversen B., 1986, COHOMOLOGY SHEAVES; Kato K., 2009, ANN MATH STUD, V169; Kato K., 1989, ALGEBRAIC ANAL GEOME, P191; Kato K., 1999, KODAI MATH J, V22, P161, DOI 10.2996/kmj/1138044041; Kato K., 2000, ADV STUD PURE MATH, V36, P269; Matsubara T., 1998, KODAI MATH J, V21, P81, DOI 10.2996/kmj/1138043866; Mumford D., 1970, ABELIAN VARIETIES; SIEBENMA.LC, 1972, COMMENT MATH HELV, V47, P123, DOI 10.1007/BF02566793	21	0	0	HIROSHIMA UNIV, GRAD SCH SCI	HIGASHI	DEPT MATH, 1-3-1 KAGAMIYAMA, HIGASHI, HIROSHIMA 739-8526, JAPAN	0018-2079			HIROSHIMA MATH J	Hiroshima Math. J.	NOV	2015	45	3					231	266				36	Mathematics	Mathematics	CX3EZ	WOS:000365580100001		
J	Kobayashi, Y; Tanaka, N; Tomizawa, Y				Kobayashi, Yoshikazu; Tanaka, Naoki; Tomizawa, Yukino			Nonautonomous differential equations and Lipschitz evolution operators in Banach spaces	HIROSHIMA MATHEMATICAL JOURNAL			English	Article						Lipschitz evolution operator; infinitesimal generator; sub-tangential condition; quasi-dissipative condition; metric-like functional; connectedness condition	CLOSED SUBSETS	A new class of Lipschitz evolution operators is introduced and a characterization of continuous infinitesimal generators of such evolution operators is given. It is shown that a continuous mapping A from a subset Omega of [a, b) x X into X, where [a, b) is a real half-open interval and X is a real Banach space, is the infinitesimal generator of a Lipschitz evolution operator if and only if it satisfies a sub-tangential condition, a general type of quasi-dissipative condition with respect to a metric-like functional and a connectedness condition. An application of the results to the initial value problem for the quasilinear wave equation with dissipation is also given.	[Kobayashi, Yoshikazu; Tomizawa, Yukino] Chuo Univ, Fac Sci & Engn, Dept Math, Tokyo 1128551, Japan; [Tanaka, Naoki] Shizuoka Univ, Fac Sci, Dept Math, Shizuoka 4228529, Japan	Kobayashi, Y (reprint author), Chuo Univ, Fac Sci & Engn, Dept Math, Tokyo 1128551, Japan.	kobayashi@math.chuo-u.ac.jp; tanaka.naoki@shizuoka.ac.jp; tomizawa@gug.math.chuo-u.ac.jp			 [25400145];  [254001234]	The first author is supported by Grant-in-aid for Science Research, No. 25400145.; The second author is supported by Grant-in-aid for Science Research, No. 254001234.	Agarwal R. P., 1993, SERIES REAL ANAL, V6; YAMADA Y, 1981, NAGOYA MATH J, V84, P31; MARTIN RH, 1973, T AM MATH SOC, V179, P399, DOI 10.2307/1996511; LAKSHMIKANTHAM V, 1976, T AM MATH SOC, V220, P103; ARDITO A, 1974, ATTI ACCAD NAZ LIN, V57, P511; Bacciotti A., 2005, COMMUNICATIONS CONTR; Carja O, 2007, N-HOLLAND M, V207, P1; Iwamiya T., 1983, HIROSHIMA MATH J, V13, P65; Kato S., 1976, FUNKC EKVACIOJ-SER I, V19, P239; KATO S, 1981, NONLINEAR ANAL-THEOR, V5, P81, DOI 10.1016/0362-546X(81)90073-0; Kenmochi N., 1980, Nonlinear Analysis Theory, Methods & Applications, V4, DOI 10.1016/0362-546X(80)90020-6; Kobayashi Y., 2001, ADV DIFFERENTIAL EQU, V6, p[613, 640]; Lakshmikantham V., 1969, MATH SCI ENG, V55- I; Lakshmikantham V., 1969, DIFFERENTIAL INTEGRA, V1; Martin Jr R. H., 1976, PURE APPL MATH; Martin R. H.  Jr., 1973, Mathematical Systems Theory, V7, DOI 10.1007/BF01824808; Matsumura A., 1977, PUBL RIMS KYOTO U, V13, P349, DOI 10.2977/prims/1195189813; Murakami H., 1966, FUNKC EKVACIOJ-SER I, V9, P151; Nagumo M., 1942, P PHYS-MATH SOC JPN, V24, P551; Okamura H., 1942, MEM COLL SCI KYOTO A, V24, P21; Pavel N. H., 1984, RES NOTES MATH, V113; Pavel N. H., 1979, LECT NOTES MATH, V737, P236; Ricciardi P., 1973, B UMI, V8, P306; Szarski J., 1965, MONOGRAFIE MATEMATYC, V43; Yoshizawa T., 1966, PUBLICATIONS MATH SO, V9	25	0	0	HIROSHIMA UNIV, GRAD SCH SCI	HIGASHI	DEPT MATH, 1-3-1 KAGAMIYAMA, HIGASHI, HIROSHIMA 739-8526, JAPAN	0018-2079			HIROSHIMA MATH J	Hiroshima Math. J.	NOV	2015	45	3					267	307				41	Mathematics	Mathematics	CX3EZ	WOS:000365580100002		
J	Sakano, Y; Akama, Y				Sakano, Yudai; Akama, Yohji			Anisohedral spherical triangles and classification of spherical tilings by congruent kites, darts and rhombi	HIROSHIMA MATHEMATICAL JOURNAL			English	Article						anisohedral tile; continuous deformation; Archimedean dual; isohedral tiling; glide; spherical monohedral deltoidal tiling; spherical monohedral rhombus-faced tiling		We classify all spherical monohedral (kite/dart/rhombus)-faced tilings, as follows: The set of spherical monohedral rhombus-faced tilings consists of (1) the central projection of the rhombic dodecahedron, (2) the central projection of the rhombic triacontahedron, (3) a series of non-isohedral tilings, and (4) a series of tilings which are topologically trapezohedra (here a trapezohedron is the dual of an antiprism.). The set of spherical tilings by congruent kites consists of (1) the central projection T of the tetragonal icosikaitetrahedron, (2) the central projection of the tetragonal hexacontahedron, (3) a non-isohedral tiling obtained from T by gliding a hemisphere of T with pi/4 radian, and (4) a continuously deformable series of tilings which are topologically trapezohedra. The set of spherical tilings by congruent darts is a continuously deformable series of tilings which are topologically trapezohedra. In the above explanation, unless otherwise stated, the tilings we have enumerated are isohedral and admit no continuous deformation. We prove that if a spherical (kite/dart/rhombus) admits an edge-to-edge spherical monohedral tiling, then it also does a spherical isohedral tiling. We also prove that the set of anisohedral, spherical triangles (i.e., spherical triangles admitting spherical monohedral triangular tilings but not any spherical isohedral triangular tilings) consists of a certain, infinite series of isosceles triangles I, and an infinite series of right scalene triangles which are the bisections of I.	[Sakano, Yudai; Akama, Yohji] Tohoku Univ, Grad Sch Sci, Math Inst, Sendai, Miyagi 9800845, Japan	Sakano, Y (reprint author), Tohoku Univ, Grad Sch Sci, Math Inst, Sendai, Miyagi 9800845, Japan.	akama@m.tohoku.ac.jp					Alekseevskij D. V., 1993, ENCYCL MATH SCI, V29, P1; Akama Y, 2013, HIROSHIMA MATH J, V43, P285; GRUNBAUM B, 1980, B AM MATH SOC, V3, P951, DOI 10.1090/S0273-0979-1980-14827-2; Bollobas B., 1963, ANN U SCI BUDAP, V6, P117; Conway J. H., 2008, SYMMETRIES THINGS; Cotton F. A., 1990, CHEM APPL GROUP THEO; Coxeter H. S. M., 1973, REGULAR POLYTOPES; Davis C., 1981, GEOMETRIC VEIN COXET; Delgado-Friedrichs O, 2003, THEOR COMPUT SCI, V303, P431, DOI 10.1016/S0304-3975(02)00500-5; Heesch H., 1963, FLACHENSCHLUSS SYSTE; JOHNSON NW, 1966, CANADIAN J MATH, V18, P169, DOI 10.4153/CJM-1966-021-8; Lando S.K., 2004, ENCY MATH SCI, V141; Ueno Y., 2002, HIROSHIMA MATH J, V32, P463; Ueno Y., 2001, MATH INFORM SCI HI 4, V27; Wilson P. M. H., 2008, CURVED SPACES CLASSI; Zalgaller V. A., 1969, SEMINARS MATH, V2	16	0	0	HIROSHIMA UNIV, GRAD SCH SCI	HIGASHI	DEPT MATH, 1-3-1 KAGAMIYAMA, HIGASHI, HIROSHIMA 739-8526, JAPAN	0018-2079			HIROSHIMA MATH J	Hiroshima Math. J.	NOV	2015	45	3					309	339				31	Mathematics	Mathematics	CX3EZ	WOS:000365580100003		
J	Suzuki, K				Suzuki, Kosuke			WAFOM over abelian groups for quasi-Monte Carlo point sets	HIROSHIMA MATHEMATICAL JOURNAL			English	Article						numerical integration; Quasi-Monte Carlo; WAFOM; Dick weight; digital net; MacWilliams-type identity	SMOOTH FUNCTIONS; DIGITAL NETS; CONSTRUCTION; WEIGHT; RULES; ORDER	In this paper, we study quasi-Monte Carlo (QMC) rules for numerical integration. J. Dick proved a Koksma-Hlawka type inequality for alpha-smooth integrands and gave an explicit construction of QMC rules achieving the optimal rate of convergence in that function class. From this inequality, Matsumoto, Saito and Matoba introduced the Walsh figure of merit (WAFOM) WF(P) for an F-2-digital net P as a quickly computable quality criterion for P as a QMC point set. The key ingredient for obtaining WAFOM is the Dick weight, a generalization of the Hamming weight and the Niederreiter-Rosenbloom-Tsfasman (NRT) weight. We extend the notions of the Dick weight and WAFOM over a general finite abelian group G, and show that this version of WAFOM satisfies Koksma-Hlawka type inequality when G is cyclic. We give a MacWilliams-type identity on weight enumerator polynomials for the Dick weight, by which we can compute the minimum Dick weight as well as WAFOM. We give a lower bound on WAFOM of order N-C'G(log N)/s and an upper bound on lowest WAFOM of order N-CG(log N)/s for given (G, N, s) if (log N)/s is suffciently large, where C'(G) and C-G are constants depending only on the cardinality of G and N is the cardinality of quadrature rules in [0, 1)(s). These bounds generalize the bounds given by Yoshiki and others given for G = F-2.	[Suzuki, Kosuke] Univ Tokyo, Grad Sch Math Sci, Meguro Ku, Tokyo 1538914, Japan	Suzuki, K (reprint author), Univ Tokyo, Grad Sch Math Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538914, Japan.	ksuzuki@ms.u-tokyo.ac.jp			Program for Leading Graduate Schools, MEXT, Japan	The work of the first author was supported by the Program for Leading Graduate Schools, MEXT, Japan.	Dick J, 2013, SIAM J DISCRETE MATH, V27, P1335, DOI 10.1137/120893677; Dick J, 2009, B AUST MATH SOC, V80, P430, DOI 10.1017/S0004972709000392; NIEDERREITER H, 1986, MONATSH MATH, V102, P155, DOI 10.1007/BF01490206; Larcher G, 1996, MONATSH MATH, V121, P231, DOI 10.1007/BF01298952; Suzuki K, 2014, J COMPLEXITY, V30, P347, DOI 10.1016/j.jco.2013.12.002; Baldeaux J, 2012, NUMER ALGORITHMS, V59, P403, DOI 10.1007/s11075-011-9497-y; Matsumoto M, 2014, MATH COMPUT, V83, P1233; Dick J, 2008, SIAM J NUMER ANAL, V46, P1519, DOI 10.1137/060666639; Chen W. W. L., 2002, ST PETERSB MATH J, V545, p[67, 301]; Dick J., 2010, DIGITAL NETS SEQUENC; MacWilliams F. J., 1977, THEORY ERROR CORRECT, V16; Matousek Jiri, 1998, INVITATION DISCRETE; Matsumoto Makoto, 2013, MONTE CARLO QUASIMON, V2012, P569; Niederreiter H., 2001, LONDON MATH SOC LECT, V285; Niederreiter Harald, 1992, CBMS NSF REGIONAL C, V63; Rozenblyum M. Yu., 1997, PROBL PEREDACHI INF, V33, P55; Serre Jean-Pierre, 1977, GRADUATE TEXTS MATH, V42; Skriganov M. M., 2001, ALGEBRA ANAL, V13, P191; Yoshiki T, 2014, HIROSHIMA MATH J, V44, P261	19	0	0	HIROSHIMA UNIV, GRAD SCH SCI	HIGASHI	DEPT MATH, 1-3-1 KAGAMIYAMA, HIGASHI, HIROSHIMA 739-8526, JAPAN	0018-2079			HIROSHIMA MATH J	Hiroshima Math. J.	NOV	2015	45	3					341	364				24	Mathematics	Mathematics	CX3EZ	WOS:000365580100004		
J	Lin, WC; Lin, YC; Esashi, M; Seshia, AA				Lin, Wei-Chih; Lin, Yu-Ching; Esashi, Masayoshi; Seshia, Ashwin A.			In-Situ Hydrothermal Synthesis of Zinc Oxide Nanostructures Using Microheaters	IEEE TRANSACTIONS ON NANOTECHNOLOGY			English	Article						Hydrothermal synthesis and UV photodetector; local nanostructure synthesis; microheaters; Zinc oxide nanostructures	NANOWIRES	A technique for in-situ hydrothermal synthesis of transversely suspended zinc oxide nanowires (ZnO NWs) using microfabricated heaters is presented. A number of issues relating to seed layer preparation, directed alignment, local heating control, and the concentration of the synthesis solution are investigated for this method. It is shown that ZnO NWs can be synthesized and aligned from the ZnO seed surface to bridge two adjacent microheater elements. Moreover, hybrid ZnO nanotubes and nanorods are also synthesized by controlling the concentration of the synthesis solution employed. The crystalline structure of synthesized ZnO nanostructures are characterized by the transmission electron microscope and selective area electron diffraction. Finally, ZnO NW devices based on proposed microheater synthesis approach are characterised for UV photoresponsivity demonstrating the potential of this approach to address practical device applications.	[Lin, Wei-Chih] Natl Sun Yat Sen Univ, Dept Mech & Electromech Engn, Kaohsiung 80424, Taiwan; [Lin, Yu-Ching; Esashi, Masayoshi] Tohoku Univ, WPI Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Seshia, Ashwin A.] Univ Cambridge, Dept Engn, Nanosci Ctr, Cambridge CB3 0FF, England	Lin, WC (reprint author), Natl Sun Yat Sen Univ, Dept Mech & Electromech Engn, Kaohsiung 80424, Taiwan.	wc.lin@mail.nsysu.edu.tw; yclin@mems.mech.tohoku.ac.jp; esashi@mems.mech.tohoku.ac.jp; aas41@cam.ac.uk			WPI-AIMR, Tohoku University; Royal Society	This work was supported by the WPI-AIMR, Tohoku University and by the Royal Society. The review of this paper was arranged by Associate Editor S. Islam.	Alim K. A., 2005, J APPL PHYS, V97; Alaca BE, 2009, INT MATER REV, V54, P245, DOI 10.1179/174328009X411190; Hwang JK, 2009, ACS APPL MATER INTER, V1, P2843, DOI 10.1021/am900580v; Li MW, 2008, NAT NANOTECHNOL, V3, P88, DOI 10.1038/nnano.2008.26; Pachauri V, 2010, SMALL, V6, P589, DOI 10.1002/smll.200900876; Wang MCP, 2009, MATER TODAY, V12, P34, DOI 10.1016/S1369-7021(09)70158-0; Hirate T, 2005, THIN SOLID FILMS, V487, P35, DOI 10.1016/j.tsf.2005.01.031; Nayak AP, 2012, NANOSCI NANOTECH LET, V4, P977, DOI 10.1166/nnl.2012.1443; Baruah S., 2009, SCI TECHNOL ADV MAT, V10; Conley J. F., 2005, APPL PHYS LETT, V87; Khaderbad MA, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/2/025501; Kim Y. J., 2010, NANOTECHNOLOGY, V21; Liao Z. M., 2008, APPL PHYS LETT, V93, P1; Lin W. C., 2012, P IEEE 25 INT C MICR, P452; Sosnowchik B. D., 2010, J APPL PHYS, V107; Wang ZL, 2004, J PHYS-CONDENS MAT, V16, pR829, DOI 10.1088/0953-8984/16/25/R01; Weichih Lin, 2011, Proceedings of the 2011 6th IEEE International Conference on Nano/Micro Engineered and Molecular Systems (NEMS 2011), DOI 10.1109/NEMS.2011.6017498; Wei-Chih Lin, 2006, Sensors and Actuators A (Physical), V130-131, DOI 10.1016/j.sna.2006.03.029	18	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1536-125X	1941-0085		IEEE T NANOTECHNOL	IEEE Trans. Nanotechnol.	NOV	2015	14	6					1046	1053		10.1109/TNANO.2015.2468076		8	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Science & Technology - Other Topics; Materials Science; Physics	CW4UR	WOS:000364992600013		
J	Tanaka, H; Ohno, Y; Tadokoro, Y				Tanaka, Hiroya; Ohno, Yutaka; Tadokoro, Yukihiro			Angular Sensitivity of VHF-Band CNT Antenna	IEEE TRANSACTIONS ON NANOTECHNOLOGY			English	Article						Antenna; angular sensitivity; carbon nanotube; nano-mechanical resonator	NANOMECHANICAL MASS SENSOR; CARBON NANOTUBES; RADIO; PERFORMANCE; OSCILLATOR; RESOLUTION	A carbon nanotube (CNT)-based antenna detects incoming electromagnetic waves based on electrically induced mechanical vibration. In this study, we perform an analysis of the angular sensitivity of a CNT-based antenna. To analyze the mechanical vibration, we introduce a simple model using the image charge method. The analysis shows that the angular sensitivity depends on |sin(2)theta|, where. is the angle of arrival. This is clearly different from the traditional Hertzian dipole detector, whose sensitivity varies with |sin theta|. In addition, the full width at half maximum of the angular sensitivity distribution for the CNT-based antenna is 0.36 pi, which is smaller than the value of 0.5 pi for a Hertzian dipole detector.	[Tanaka, Hiroya; Tadokoro, Yukihiro] Toyota Cent Res & Dev Labs Inc, Nagakute, Aichi 4801192, Japan; [Ohno, Yutaka] Nagoya Univ, EcoTopia Sci Inst, Nagoya, Aichi 4648603, Japan	Tanaka, H (reprint author), Toyota Cent Res & Dev Labs Inc, Nagakute, Aichi 4801192, Japan.	tanak@mosk.tytlabs.co.jp; yohno@nagoya-u.jp; tadokoro@mosk.tytlabs.co.jp					Akyildiz I. F., 2010, NANO COMMUNICATION N, V1, P3; Wang Y, 2004, APPL PHYS LETT, V85, P2607, DOI 10.1063/1.1797559; Sazonova V, 2004, NATURE, V431, P284, DOI 10.1038/nature02905; Rutherglen C, 2007, NANO LETT, V7, P3296, DOI 10.1021/nl0714839; Rutherglen C, 2009, SMALL, V5, P884, DOI 10.1002/smll.200800527; [Anonymous], 2014, COMS MULT US GUID; Jensen K, 2008, NAT NANOTECHNOL, V3, P533, DOI 10.1038/nnano.2008.200; Eom K, 2011, PHYS REP, V503, P115, DOI 10.1016/j.physrep.2011.03.002; Gouttenoire V, 2010, SMALL, V6, P1060, DOI 10.1002/smll.200901984; Aleman BJ, 2011, J PHYS CONF SER, V302, DOI 10.1088/1742-6596/302/1/012001; Jensen K, 2007, NANO LETT, V7, P3508, DOI 10.1021/nl0721113; Lee SW, 2004, NANO LETT, V4, P2027, DOI 10.1021/nl049053v; Deshpande VV, 2006, NANO LETT, V6, P1092, DOI 10.1021/nl052513f; Sun DM, 2011, NAT NANOTECHNOL, V6, P156, DOI [10.1038/nnano.2011.1, 10.1038/NNANO.2011.1]; Burke PJ, 2006, IEEE T NANOTECHNOL, V5, P314, DOI 10.1109/TNANO.2006.877430; Chaste J, 2012, NAT NANOTECHNOL, V7, P300, DOI [10.1038/nnano.2012.42, 10.1038/NNANO.2012.42]; Dujardin E., 2005, APPL PHYS LETT, V87; Kaul AB, 2006, NANO LETT, V6, P942, DOI 10.1021/nl052552r; Rodriguez-Morales F., 2006, APPL PHYS LETT, V89; da Costa MR, 2009, MICROELECTRON J, V40, P776, DOI 10.1016/j.mejo.2008.11.016; Smythe W. R., 1950, STATIC DYNAMIC ELECT	21	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1536-125X	1941-0085		IEEE T NANOTECHNOL	IEEE Trans. Nanotechnol.	NOV	2015	14	6					1112	1116		10.1109/TNANO.2015.2477813		5	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Science & Technology - Other Topics; Materials Science; Physics	CW4UR	WOS:000364992600019		
J	Setsuhara, Y; Uchida, G; Kawabata, K; Nakajima, A; Takenaka, K				Setsuhara, Yuichi; Uchida, Giichiro; Kawabata, Kazufumi; Nakajima, Atsushi; Takenaka, Kosuke			Analysis of Dynamic Discharge Characteristics of Plasma Jet Based on Voltage and Current Measurements Using a Metal Plate	IEEE TRANSACTIONS ON PLASMA SCIENCE			English	Article						Plasma jet; potential structure	ATMOSPHERIC-PRESSURE; SURFACE MODIFICATION; MEDICINE; NEEDLE	We present here the analysis of the dynamic discharge characteristics of the plasma jet, where we set the metal plate in the downstream region and measure its voltage and current induced by the plasma-jet contact. The voltage of the metal plate is as high as 1.9 kV at a distance of 15 mm from the plasma source under the high discharge voltage condition of 9 kV. The metal-plate voltage measured at a distance of 40 mm from the plasma source decreases markedly to 0.5 kV, which is still high enough for causing chemical reactions induced by accelerated ions in the potential. The metal-plate voltage also changes in the wide range of 0.3-1.9 kV with various discharge-voltage conditions, where the metal plate is set to a distance of 20 mm from the plasma source. Our experiments demonstrate that the voltage and current measurements using the metal plate could be used as one of the effective protocols to evaluate the plasma-jet irradiation condition in the plasma-jet process.	[Setsuhara, Yuichi; Uchida, Giichiro; Kawabata, Kazufumi; Nakajima, Atsushi; Takenaka, Kosuke] Osaka Univ, Joining & Welding Res Inst, Osaka 5670047, Japan	Uchida, G (reprint author), Osaka Univ, Joining & Welding Res Inst, Osaka 5670047, Japan.	setsuhara@jwri.osaka-u.ac.jp; uchida@jwri.osaka-u.ac.jp; k-kawabata@jwri.osaka-u.ac.jp; a.nakajima@jwri.osaka-u.ac.jp; k_takenaka@jwri.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [24108003]	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas through the Ministry of Education, Culture, Sports, Science and Technology, Japan, within the Plasma Medical Innovation Project under Grant 24108003. (Corresponding author: Giichiro Uchida.)	Teschke M, 2005, IEEE T PLASMA SCI, V33, P310, DOI 10.1109/TPS.2005.845377; Goree J, 2006, IEEE T PLASMA SCI, V34, P1317, DOI 10.1109/TPS.2006.878431; van Gessel AFH, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/26/265202; Yousfi M, 2012, PLASMA SOURCES SCI T, V21, DOI 10.1088/0963-0252/21/4/045003; Tresp H, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/43/435401; Dowling DP, 2011, PLASMA PROCESS POLYM, V8, P718, DOI 10.1002/ppap.201000145; Dobrynin D, 2012, IEEE T PLASMA SCI, V40, P2163, DOI 10.1109/TPS.2012.2204780; Reuter S, 2009, PLASMA SOURCES SCI T, V18, DOI 10.1088/0963-0252/18/1/015006; Reuter S, 2012, PLASMA SOURCES SCI T, V21, DOI 10.1088/0963-0252/21/3/034015; Fricke K, 2011, PLASMA PROCESS POLYM, V8, P51, DOI 10.1002/ppap.201000093; van Gils CAJ, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/17/175203; Lu X, 2006, J APPL PHYS, V100, DOI 10.1063/1.2349475; Uchida G, 2015, J APPL PHYS, V117, DOI 10.1063/1.4918546; Kong MG, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115012; Stoffels E, 2002, PLASMA SOURCES SCI T, V11, P383, DOI 10.1088/0963-0252/11/4/304; Yonemori S, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/22/225202; Boeuf JP, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/1/015201; Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154; Laroussi M, 2009, IEEE T PLASMA SCI, V37, P714, DOI 10.1109/TPS.2009.2017267; Walsh JL, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/7/075201; Jeong JY, 1999, J VAC SCI TECHNOL A, V17, P2581, DOI 10.1116/1.581999; Lu X, 2014, PHYS REP, V540, P123, DOI 10.1016/j.physrep.2014.02.006; Shi JJ, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2828551; Lukes P, 2014, PLASMA SOURCES SCI T, V23, DOI 10.1088/0963-0252/23/1/015019; Takemura Y, 2008, JPN J APPL PHYS, V47, P5644, DOI 10.1143/JJAP.47.5644; Cheng C, 2006, SURF COAT TECH, V200, P6659, DOI 10.1016/j.surfcoat.2005.09.033; Lieberman M. A., 1994, PRINCIPLES PLASMA DI, P161; Naidis GV, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/21/215203; Norberg SA, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/47/475203; Takenaka K, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.11NE04; Tanaka H, 2014, IEEE T PLASMA SCI, V42, P3760, DOI 10.1109/TPS.2014.2353659; Uchida G, 2015, IEEE T PLASMA SCI, V43, P737, DOI 10.1109/TPS.2014.2387064	32	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0093-3813	1939-9375		IEEE T PLASMA SCI	IEEE Trans. Plasma Sci.	NOV	2015	43	11					3821	3826		10.1109/TPS.2015.2482998		6	Physics, Fluids & Plasmas	Physics	CW3EW	WOS:000364875800006		
J	Qin, P; Nishii, R				Qin, Pan; Nishii, Ryuei			Statistical Prediction of Dst Index by Solar Wind Data and t-Distributions	IEEE TRANSACTIONS ON PLASMA SCIENCE			English	Article						Autoregressive models with exogenous variables (ARX) model; solar wind plasma; statistical modeling; stochastic dynamical system	MODEL; MAGNETOSPHERE; ARRIVALS; EARTH	The disturbance storm time (Dst) index is a measure of the geomagnetic storm strength that can be caused by solar wind plasma ejecta and/or high-speed streams. The research aims to predict the Dst index hours ahead using statistical regression models based on solar wind measurements. It is shown that the distribution of Dst index data has heavy tails. This implies that the data cannot be well approximated with Gaussian distribution. Instead, we use t-distributions to model the Dst index data. By considering the Sun-earth plasma coupling process as a stochastic dynamical system, we construct t-distribution-based autoregressive models with the solar wind proton density, solar wind speed, and interplanetary magnetic field Bz as exogenous variables. The Dst index is also regressed to the solar wind measurements as well as the past observations of the Dst index. Furthermore, the scale and degree of freedom of the t-distributions are regressed using generalized linear models. The Bayesian information criterion is used to select the optimal model structures. The results for real data indicate that the proposed model is very effective at describing the time-dependent features of the Dst index.	[Qin, Pan] Dalian Univ Technol, Fac Elect Informat & Elect Engn, Dalian 116024, Peoples R China; [Nishii, Ryuei] Kyushu Univ, Inst Math Ind, Fukuoka 8190395, Japan	Qin, P (reprint author), Dalian Univ Technol, Fac Elect Informat & Elect Engn, Dalian 116024, Peoples R China.	qp112cn@dlut.edu.cn; nishii@imi.kyushu-u.ac.jp			Japan Society for the Promotion of Science through the KAKENHI Program [25540013, 23300106]; Chinese Fundamental Research Funds through the Central Universities [DTU14RC(3)036]; International Center for Space Weather Science and Education, IMI Joint Research Project, Kyushu University, Fukuoka, Japan	This work was supported in part by the Japan Society for the Promotion of Science through the KAKENHI Program under Grant 25540013 and Grant 23300106, in part by the Chinese Fundamental Research Funds through the Central Universities under Grant DTU14RC(3)036, and in part by the International Center for Space Weather Science and Education, IMI Joint Research Project, Kyushu University, Fukuoka, Japan.	Rigby RA, 2005, J ROY STAT SOC C-APP, V54, P507, DOI 10.1111/j.1467-9876.2005.00510.x; NISHII R, 1984, ANN STAT, V12, P758, DOI 10.1214/aos/1176346522; Metallinou FA, 2004, IEEE T PLASMA SCI, V32, P1455, DOI 10.1109/TPS.2004.831734; Smith ZK, 2004, IEEE T PLASMA SCI, V32, P1498, DOI 10.1109/TPS.2004.832509; Wei HL, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2003JA010332; Fry CD, 2004, IEEE T PLASMA SCI, V32, P1489, DOI 10.1109/TPS.2004.833398; Boynton RJ, 2011, ANN GEOPHYS-GERMANY, V29, P965, DOI 10.5194/angeo-29-965-2011; Temerin M, 2006, J GEOPHYS RES-SPACE, V111, DOI 10.1029/2005JA011257; Wei X, 2010, IEEE T PLASMA SCI, V38, P2922, DOI 10.1109/TPS.2010.2061867; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Qin P, 2012, NONLINEAR DYNAM, V70, P1831, DOI 10.1007/s11071-012-0576-y; Doxas I, 2004, IEEE T PLASMA SCI, V32, P1443, DOI 10.1109/TPS.2004.833388; Weigel RS, 2004, IEEE T PLASMA SCI, V32, P1506, DOI 10.1109/TPS.2004.830992; Pallocchia G, 2006, ANN GEOPHYS-GERMANY, V24, P989; Hastie T.J., 1990, GEN ADDITIVE MODELS; Ji EY, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2011JA016872; McCullagh P., 1989, GEN LINEAR MODELS; Newell P. T., 2007, J GEOPHYS RES, V112; Nishii R., 2014, MATH IND, V5, P249; Siscoe G. L., 2002, J GEOPHYS RES, V107; Spencer E, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2011JA016780; Sugiura M., 1964, ANN INT GEOPHYS YR, V35, P7; Temerin M., 2002, J GEOPHYS RES, V107	23	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0093-3813	1939-9375		IEEE T PLASMA SCI	IEEE Trans. Plasma Sci.	NOV	2015	43	11					3908	3915		10.1109/TPS.2015.2485661		8	Physics, Fluids & Plasmas	Physics	CW3EW	WOS:000364875800017		
J	Sukegawa, AM; Okuno, K				Sukegawa, Atsuhiko M.; Okuno, Koichi			Comparison Between Simulations Using the PHITS Code and Activated Material Analysis	IEEE TRANSACTIONS ON PLASMA SCIENCE			English	Article						DCHAIN-SP 2001; foil-activation technique: induced-activity; JT-60; Particle and Heavy Ion Transport code System (PHITS); radiation safety; tokamak fusion device		In this study, a comparison between simulations using the Particle and Heavy Ion Transport code System (PHITS) code and activated material analysis of JT-60U have been performed. Neutron transport has been simulated using the Monte Carlo method PHITS to determine the neutron fluency at the irradiation position. The activated analysis has been complemented by the foil-activation technique. The preliminary accuracy assessment of these PHITS simulations has been confirmed by comparing the reaction rates of gold, cobalt, and nickel foil activation. The simulation results by PHITS consistent with the measured reaction rate of each foil near the device.	[Sukegawa, Atsuhiko M.] Japan Atom Energy Agcy, Naka, Ibaraki 3110193, Japan; [Okuno, Koichi] Ando Hazama, Tsukuba, Ibaraki 3050801, Japan	Sukegawa, AM (reprint author), Japan Atom Energy Agcy, Naka, Ibaraki 3110193, Japan.	morioka.atsuhiko@jaea.go.jp					Ishida S, 2010, FUSION ENG DES, V85, P2070, DOI 10.1016/j.fusengdes.2010.07.027; Shibata K, 2002, J NUCL SCI TECHNOL, V39, P1125, DOI 10.3327/jnst.39.1125; NISHITANI T, 1992, REV SCI INSTRUM, V63, P5270, DOI 10.1063/1.1143439; Hoek M., 1994, 94002 JAERIM; Ikeda Y., 1992, 92073 JAERIM, P250; Nishitani T., 1989, 89138 JAERIM; Pashchenko A. B., 1996, IAEANDS173; Sukegawa A. M., 2011, PROG NUCL SCI TECHNO, V1, P36; Sukegawa A.M., 2011, PROG NUCL SCI TECHNO, V2, P375	9	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0093-3813	1939-9375		IEEE T PLASMA SCI	IEEE Trans. Plasma Sci.	NOV	2015	43	11					3916	3920		10.1109/TPS.2015.2478902		5	Physics, Fluids & Plasmas	Physics	CW3EW	WOS:000364875800018		
J	Bulgarevich, DS; Shiwa, M; Niehues, G; Tani, M				Bulgarevich, Dmitry S.; Shiwa, Mitsuharu; Niehues, Gudrun; Tani, Masahiko			Linear Dichroism Detection and Analysis in Terahertz Spectral Range	IEEE TRANSACTIONS ON TERAHERTZ SCIENCE AND TECHNOLOGY			English	Article						Birefringence; nondestructive testing; optical polarization; polymers; spectroscopy		Two simple experimental techniques of quantitative linear dichroism analysis were developed with Jones calculus for polarization-sensitive terahertz time-domain spectroscopy. Both of them involve the optical measurements at only three angles of rotation for sample or polarizer setup. Such non-destructive evaluation techniques could be a useful addition for quality control of polymer or composite materials. As an example, the production-induced linear dichroism in polytetrafluoroethylene was detected, analyzed, and interpreted as a result of the well-aligned macromolecular arrangement within optical volume probed by terahertz beam.	[Bulgarevich, Dmitry S.; Shiwa, Mitsuharu] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan; [Niehues, Gudrun; Tani, Masahiko] Res Ctr Dev Far Infrared Reg, Fukui 9108507, Japan	Bulgarevich, DS (reprint author), Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan.	DMITRY.Bulgarevich@nims.go.jp; SHIWA.Mitsuharu@nims.go.jp; niehues@fir.u-fukui.ac.jp; tani@fir.u-fukui.ac.jp					Wietzke S, 2011, J MOL STRUCT, V1006, P41, DOI 10.1016/j.molstruc.2011.07.036; Castro-Camus E, 2012, J INFRARED MILLIM TE, V33, P418, DOI 10.1007/s10762-011-9856-8; Dragoman D, 2004, PROG QUANT ELECTRON, V28, P1, DOI [10.1016/S0079-6727(03)00058-2, 10.1016/S0079-6727(03)0058-2]; Wiesauer K, 2013, J INFRARED MILLIM TE, V34, P663, DOI 10.1007/s10762-013-9976-4; Nagashima T, 2013, J INFRARED MILLIM TE, V34, P740, DOI 10.1007/s10762-013-0020-5; Dong H, 2009, OPT COMMUN, V282, P3671, DOI 10.1016/j.optcom.2009.06.035; TASUMI M, 1965, J CHEM PHYS, V43, P1245, DOI 10.1063/1.1696911; Rudd JV, 2000, OPT LETT, V25, P1556, DOI 10.1364/OL.25.001556; Tanabe T, 2010, NDT&E INT, V43, P329, DOI 10.1016/j.ndteint.2010.03.001; Bulgarevich D. S., 2012, NEW J PHYS, V14; Castro-Camus E., 2009, J OPT A-PURE APPL OP, V11; Kim Y., 2011, JPN J APPL PHYS, V50	12	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2156-342X			IEEE T THZ SCI TECHN	IEEE Trans. Terahertz Sci. Technol.	NOV	2015	5	6					1097	1099		10.1109/TTHZ.2015.2465180		3	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CW9FJ	WOS:000365303800030		
J	Toriyama, K; Hirose, A; Kukutsu, N; Nagatsuma, T				Toriyama, Kazushige; Hirose, Akira; Kukutsu, Naoya; Nagatsuma, Tadao			Introduction to Special Issue on Advanced Terahertz Technologies and Efforts Toward Practical Applications	IEEE TRANSACTIONS ON TERAHERTZ SCIENCE AND TECHNOLOGY			English	Editorial Material									[Toriyama, Kazushige] IBM Japan Ltd, Kawasaki, Kanagawa 2120032, Japan; [Hirose, Akira] Univ Tokyo, Tokyo 1138656, Japan; [Kukutsu, Naoya] NTT Device Technol Labs, Atsugi, Kanagawa 2430198, Japan; [Nagatsuma, Tadao] Osaka Univ, Osaka 5608531, Japan	Toriyama, K (reprint author), IBM Japan Ltd, 7-7 Shin Kawasaki, Kawasaki, Kanagawa 2120032, Japan.						[Anonymous], 2014, J IEICE, V97, P917	1	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2156-342X			IEEE T THZ SCI TECHN	IEEE Trans. Terahertz Sci. Technol.	NOV	2015	5	6					1101	1103				3	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CW9FJ	WOS:000365303800032		
J	Minamide, H				Minamide, Hiroaki			Development of High-Power Terahertz-Wave Sources for Finding Novel Applications	IEEE TRANSACTIONS ON TERAHERTZ SCIENCE AND TECHNOLOGY			English	Article						High-power THz-wave source; non-destructive inspection; nonlinear optical wavelength-conversion; real-time THz-wave imaging; THz-wave nonlinear response	GENERATION; TEMPERATURE; LINBO3	Development of terahertz (THz)-wave technology has accelerated in various application fields in which higher output, wider spectral generation, and smaller systems are necessary for THz-wave sources. Novel THz-wave applications and interesting discoveries have been reported along with development of unique THz-wave measurement methods. This review presents aspects of the recent development of intense THz-wave sources. Particularly, a tunable THz-wave source and a method of attaining high output power are reported along with evidence of their performance. Future prospects of high-power THz-wave applications are described.	[Minamide, Hiroaki] RIKEN, RIKEN Ctr Adv Photon RAP, Sendai, Miyagi 9800845, Japan	Minamide, H (reprint author), RIKEN, RIKEN Ctr Adv Photon RAP, Sendai, Miyagi 9800845, Japan.	minamide@riken.jp			Collaborative Research Based on Industrial Demand of the Japan Science and Technology Agency (JST); JSPS KAKENHI [26246046, 26620162, 15K18080, 25220606, 26287067, 26390106, 15K18079]	Research results of the author in this paper were supported in part by Collaborative Research Based on Industrial Demand of the Japan Science and Technology Agency (JST), and JSPS KAKENHI Grants 26246046, 26620162, 15K18080, 25220606, 26287067, 26390106, and 15K18079.	Bratman V, 2009, IEEE T PLASMA SCI, V37, P36, DOI 10.1109/TPS.2008.2004787; Kovacs K, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.193903; Taira T, 2011, OPT MATER EXPRESS, V1, P1040; Fan SZ, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4868134; Kawase K, 2002, APPL PHYS LETT, V80, P195, DOI 10.1063/1.1429299; Saito T, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.4729316; Knyazev BA, 2010, MEAS SCI TECHNOL, V21, DOI 10.1088/0957-0233/21/5/054017; Glyavin MY, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4757290; Shikata J, 1999, ELECTRON COMM JPN 2, V82, P46, DOI 10.1002/(SICI)1520-6432(199905)82:5<46::AID-ECJB6>3.3.CO;2-J; Hirori H, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3560062; Clerici M, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.253901; Fulop JA, 2012, OPT LETT, V37, P557, DOI 10.1364/OL.37.000557; Wu ZR, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4790427; Hirori H, 2013, IEEE J SEL TOP QUANT, V19, DOI 10.1109/JSTQE.2012.2221685; Ito H, 2014, IEEE PHOTONICS J, V6, DOI 10.1109/JPHOT.2014.2309648; Kawase K, 1997, APPL PHYS LETT, V71, P753, DOI 10.1063/1.119635; Palfalvi L, 2005, J APPL PHYS, V97, DOI 10.1063/1.1929859; Hebling J, 2008, IEEE J SEL TOP QUANT, V14, P345, DOI 10.1109/JSTQE.2007.914602; Hayashi S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05045; Hebling J., 2011, OPTICAL MANIPULATION; Hoffmann MC, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/8/083001; Laman N., 2009, INTENSE BROADBAND TH; Langer F., 2014, CLEO QELS FUNDAMENTA; Oda N, 2010, CR PHYS, V11, P496, DOI 10.1016/j.crhy.2010.05.001	24	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2156-342X			IEEE T THZ SCI TECHN	IEEE Trans. Terahertz Sci. Technol.	NOV	2015	5	6					1104	1109				6	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CW9FJ	WOS:000365303800033		
J	Otsuji, T				Otsuji, Taiichi			Trends in the Research of Modern Terahertz Detectors: Plasmon Detectors	IEEE TRANSACTIONS ON TERAHERTZ SCIENCE AND TECHNOLOGY			English	Article						Semiconductor photodetectors; plasmons; submillimeter wave devices; submillimeter wave integrated circuits	MILLIMETER-WAVE DETECTORS; FIELD-EFFECT TRANSISTORS; SCHOTTKY-BARRIER DIODE; HOT-ELECTRON BOLOMETER; ROOM-TEMPERATURE; INTEGRATED-CIRCUITS; MICROWATT-LEVEL; GRAPHENE; RADIATION; ARRAY	Terahertz (THz) wave detectors include Golay cells, bolometers, pyroelectric detectors, superconductor tunnel junction detectors (STJs), and Schottky-barrier diodes (SBDs). Of these, most (except STJs and SBDs) are of the thermoelectric type; they are highly sensitive, but the response speed is low. On the other hand, in SBDs operating at room temperature, the response is fast, but the sensitivity is rather low at high frequencies; this is due to the carrier transit-time effect. Therefore, a nonlinearity of the two-dimensional plasmons, quanta of collective excitation of electronic charge density waves, has attracted attention as a mechanism of fast and sensitive THz-wave rectification and detection. In this paper, technological trends in the research of modern THz detectors are reviewed, with an emphasis on plasmon-type detectors.	[Otsuji, Taiichi] Tohoku Univ, Elect Commun Res Inst, Sendai, Miyagi 9808577, Japan	Otsuji, T (reprint author), Tohoku Univ, Elect Commun Res Inst, Sendai, Miyagi 9808577, Japan.	otsuji@riec.tohoku.ac.jp					An ZH, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.085417; Vicarelli L, 2012, NAT MATER, V11, P865, DOI [10.1038/nmat3417, 10.1038/NMAT3417]; Andrews DH, 1942, REV SCI INSTRUM, V13, P281, DOI 10.1063/1.1770037; Balandin AA, 2011, NAT MATER, V10, P569, DOI [10.1038/nmat3064, 10.1038/NMAT3064]; KINCH MA, 1963, BRIT J APPL PHYS, V14, P672, DOI 10.1088/0508-3443/14/10/317; Reese MO, 2007, IEEE T APPL SUPERCON, V17, P403, DOI 10.1109/TASC.2007.898195; Xia FN, 2009, NAT NANOTECHNOL, V4, P839, DOI [10.1038/nnano.2009.292, 10.1038/NNANO.2009.292]; Ariyoshi S, 2006, JPN J APPL PHYS 2, V45, pL1004, DOI 10.1143/JJAP.45.L1004; WEINGARTEN KJ, 1988, IEEE J QUANTUM ELECT, V24, P198, DOI 10.1109/3.115; VALDMANIS JA, 1982, APPL PHYS LETT, V41, P211, DOI 10.1063/1.93485; PROBER DE, 1993, APPL PHYS LETT, V62, P2119, DOI 10.1063/1.109445; Komiyama S, 2000, NATURE, V403, P405, DOI 10.1038/35000166; Guillet B, 2008, J LOW TEMP PHYS, V151, P570, DOI 10.1007/s10909-007-9694-1; Ryzhii V, 2012, OPTO-ELECTRON REV, V20, P15, DOI 10.2478/s11772-012-0009-y; INOUE T, 1987, IEEE T INSTRUM MEAS, V36, P623; Zak A, 2014, NANO LETT, V14, P5834, DOI 10.1021/nl5027309; Jin N, 2005, IEEE ELECTR DEVICE L, V26, P575, DOI 10.1109/LED.2005.852738; Ariyoshi S, 2005, IEEE T APPL SUPERCON, V15, P920, DOI 10.1109/TASC.2005.850119; Lee AWM, 2006, IEEE PHOTONIC TECH L, V18, P1415, DOI 10.1109/LPT.2006.877220; Meyers RG, 2004, IEEE ELECTR DEVICE L, V25, P4, DOI 10.1109/LED.2003.821601; Yan J, 2012, NAT NANOTECHNOL, V7, P472, DOI [10.1038/nnano.2012.88, 10.1038/NNANO.2012.88]; Otsuji T, 2006, OPT EXPRESS, V14, P4815, DOI 10.1364/OE.14.004815; Vostokov NV, 2014, TECH PHYS+, V59, P1036, DOI 10.1134/S1063784214070287; Zmuidzinas J, 2004, P IEEE, V92, P1597, DOI 10.1109/JPROC.2004.833670; NAKAGAWA Y, 1970, JPN J APPL PHYS, V9, P125, DOI 10.1143/JJAP.9.125; Watanabe T, 2012, SOLID STATE ELECTRON, V78, P109, DOI 10.1016/j.sse.2012.05.047; Siegel PH, 2002, IEEE T MICROW THEORY, V50, P910, DOI 10.1109/22.989974; IRWIN KD, 1995, APPL PHYS LETT, V66, P1998, DOI 10.1063/1.113674; Tonouchi M, 2007, NAT PHOTONICS, V1, P97, DOI 10.1038/nphoton.2007.3; Mueller T, 2010, NAT PHOTONICS, V4, P297, DOI 10.1038/NPHOTON.2010.40; Lemme MC, 2011, NANO LETT, V11, P4134, DOI 10.1021/nl2019068; Steiger A, 2013, OPT EXPRESS, V21, P14466, DOI 10.1364/OE.21.014466; Boppel S, 2012, IEEE T MICROW THEORY, V60, P3834, DOI 10.1109/TMTT.2012.2221732; Graf M, 2004, APPL PHYS LETT, V84, P475, DOI 10.1063/1.1641165; Otani C, 2005, IEEE T APPL SUPERCON, V15, P591, DOI 10.1109/TASC.2005.849950; Semenov AD, 2000, J APPL PHYS, V88, P6758, DOI 10.1063/1.1323531; Liu L, 2010, IEEE MICROW WIREL CO, V20, P504, DOI 10.1109/LMWC.2010.2055553; Tohme L, 2014, ELECTRON LETT, V50, P323, DOI 10.1049/el.2013.3702; Nahata A, 1996, APPL PHYS LETT, V69, P2321, DOI 10.1063/1.117511; Yasui T, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2206770; Hargreaves S, 2007, J MATER SCI-MATER EL, V18, pS299, DOI 10.1007/s10854-007-9220-x; GOLAY MJE, 1947, REV SCI INSTRUM, V18, P357, DOI 10.1063/1.1740949; GERSHENZON EM, 1991, IEEE T MAGN, V27, P1317, DOI 10.1109/20.133427; Nguyen DT, 2012, IEEE T THZ SCI TECHN, V2, P299, DOI 10.1109/TTHZ.2012.2188395; AUSTON DH, 1984, APPL PHYS LETT, V45, P284, DOI 10.1063/1.95174; Iida H, 2014, OPT LETT, V39, P1609, DOI 10.1364/OL.39.001609; Graf M, 2009, INFRARED PHYS TECHN, V52, P289, DOI 10.1016/j.infrared.2009.05.034; WIESENFELD JM, 1990, IBM J RES DEV, V34, P141; Knap W, 2009, J INFRARED MILLIM TE, V30, P1319, DOI 10.1007/s10762-009-9564-9; KOLNER BH, 1983, ELECTRON LETT, V19, P574, DOI 10.1049/el:19830391; Ito H, 2008, JPN J APPL PHYS, V47, P6256, DOI 10.1143/JJAP.47.6256; Knap W, 2004, APPL PHYS LETT, V85, P675, DOI 10.1063/1.1775034; HWANG TL, 1979, APPL PHYS LETT, V34, P773, DOI 10.1063/1.90669; Otsuji T, 2013, IEEE T THZ SCI TECHN, V3, P63, DOI 10.1109/TTHZ.2012.2235911; Liu HC, 2004, APPL PHYS LETT, V84, P4068, DOI 10.1063/1.1751620; Brown ER, 2007, IEEE MICROW MAG, V8, P54, DOI 10.1109/MMW.2007.365059; Ashida M, 2008, JPN J APPL PHYS, V47, P8221, DOI 10.1143/JJAP.47.8221; Shiba S, 2012, IEEE T THZ SCI TECHN, V2, P22, DOI 10.1109/TTHZ.2011.2177704; SMITH PR, 1988, IEEE J QUANTUM ELECT, V24, P255, DOI 10.1109/3.121; Jazbinsek M, 2008, IEEE J SEL TOP QUANT, V14, P1298, DOI 10.1109/JSTQE.2008.921407; Oden J, 2013, OPT EXPRESS, V21, P4817, DOI 10.1364/OE.21.004817; Knap W, 2011, J INFRARED MILLIM TE, V32, P618, DOI 10.1007/s10762-010-9647-7; Komiyama S, 2011, IEEE J SEL TOP QUANT, V17, P54, DOI 10.1109/JSTQE.2010.2048893; Dyakonov M, 1996, IEEE T ELECTRON DEV, V43, P380, DOI 10.1109/16.485650; Dobroiu A, 2004, APPL OPTICS, V43, P5637, DOI 10.1364/AO.43.005637; Sengupta DL, 1998, P IEEE, V86, P235, DOI 10.1109/5.658775; Han SP, 2013, OPT EXPRESS, V21, P25874, DOI 10.1364/OE.21.025874; AUSTON DH, 1988, IEEE J QUANTUM ELECT, V24, P184, DOI 10.1109/3.114; Ariyoshi S., 2006, APPL PHYS LETT, V88; Boubanga-Tombet S., 2010, APPL PHYS LETT, V97; Breusing M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.086809; Burrus C.A.  Jr., 1963, IEEE Transactions on Microwave Theory and Techniques, VMTT-11, DOI 10.1109/TMTT.1963.1125675; Cai X, 2014, NAT NANOTECHNOL, V9, P814, DOI [10.1038/nnano.2014.182, 10.1038/NNANO.2014.182]; Du X., 2014, GRAPHENE 2D MAT, V1, P1; Getterman H. R., 1978, APPL PHYS LETT, V33, P151; Hubers HW, 2008, IEEE J SEL TOP QUANT, V14, P378, DOI 10.1109/JSTQE.2007.913964; Iida H., 2014, P IRMMW THZ 2014 MAI; Ikushima K., 2006, APPL PHYS LETT, V88; Irwin KD, 2005, TOP APPL PHYS, V99, P63; Ito H., 2015, P INT C INFR MILL ME; Kajihara Y., 2013, J APPL PHYS, V113; Knap W., 2009, J INFRARED MILLIM TH, V30, P1243; Knap W., 2013, NANOTECHNOLOGY, V24; Koppens FHL, 2014, NAT NANOTECHNOL, V9, P780, DOI [10.1038/nnano.2014.215, 10.1038/NNANO.2014.215]; Kubler C., 2004, APPL PHYS LETT, V85; Kurita Y., 2014, APPL PHYS LETT, V104; Lee A. W. M., 2006, APPL PHYS LETT, V89; Lisauskas A., 2009, J APPL PHYS, V105; Mass S. A., 1987, IEEE T MICROW THEORY, V35, P425; Mittendorff M., 2013, APPL PHYS LETT, V103; Oda N., 2013, P SOC PHOTO-OPT INS, V8012; Otsuji T., 2014, OPT ENG, V53; Popov V. V., 2013, APPL PHYS LETT, V102; Richards P. L., 1979, APPL PHYS LETT, V36, P480; Ryzhii M., 2011, JPN J APPL PHYS, V50; Ryzhii V., 2007, INT J HIGH SPEED ELE, V17, P521, DOI 10.1142/S0129156407004710; Ryzhii V, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.245311; Ryzhii V., 2013, J PHYS D, V46; Ryzhii V., 2008, J APPL PHYS, V103; Ryzhii V., 2009, J APPL PHYS, V106; Ryzhii V., 2008, APPL PHYS EXPRESS, V1; Sakhno M., 2013, J APPL PHYS, V114; Sakowicz M., 2011, J APPL PHYS, V110; Satou A., 2011, JPN J APPL PHYS, V50; Sherry H., 2012, IEEE INT SOL STAT CI, P252; Sizov S., 2011, OPTO-ELECTRON REV, V19, P79; Spirito D., 2014, APPL PHYS LETT, V104; Tanigawa T., 2010, DEV RES C DRC S BEND, P167; Tauk R., 2006, APPL PHYS LETT, V89; Ting D. Z.-Y., 2007, APPL PHYS LETT, V91; Tredicucci A., 2014, IEEE J SEL TOP QUANT, V20; Werner L, 2009, METROLOGIA, V46, pS160, DOI 10.1088/0026-1394/46/4/S05; Whatmore RW, 1986, IEEE T ULTRASON FERR, V49, P1335; Young A. C., 2005, APPL PHYS LETT, V87; Zhang W., 2010, J APPL PHYS, V108; Zhang Z, 2011, IEEE MICROW WIREL CO, V21, P267, DOI 10.1109/LMWC.2011.2123878	116	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2156-342X			IEEE T THZ SCI TECHN	IEEE Trans. Terahertz Sci. Technol.	NOV	2015	5	6					1110	1120				11	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CW9FJ	WOS:000365303800034		
J	Fukasawa, R				Fukasawa, Ryoichi			Terahertz Imaging: Widespread Industrial Application in Non-destructive Inspection and Chemical Analysis	IEEE TRANSACTIONS ON TERAHERTZ SCIENCE AND TECHNOLOGY			English	Article						Imaging; terahertz camera; terahertz wave; terahertz wave microscope; tomography	INTEGRATED-CIRCUITS; ROOM-TEMPERATURE; TIME; SPECTROSCOPY; TOMOGRAPHY; COMPOSITES; RADIATION; THICKNESS; FILM	Terahertz imaging is being applied to non-destructive inspection and chemical analysis. The main advantage of this approach is that electromagnetic waves at terahertz frequencies can penetrate non-conductive materials and also provide the material's spectral response. The application of terahertz imaging is rapidly spreading to fields such as the evaluation of industrial materials and pharmaceutical products, examination of works of art, investigation of cultural assets, quality control in manufacturing processes, diagnosis of buildings, detection of dangerous objects, biomedical diagnostics and more. This paper describes imaging methods which use terahertz pulses and terahertz camera technology. In addition, interesting applications are introduced from the view point of practical use.	[Fukasawa, Ryoichi] Spectra Design Ltd, Ohtawara, Tochigi 3240403, Japan	Fukasawa, R (reprint author), Spectra Design Ltd, Ohtawara, Tochigi 3240403, Japan.	r.fukasawa@spectra-dsn.co.jp					Doi A, 2010, OPT EXPRESS, V18, P18419, DOI 10.1364/OE.18.018419; Herrmann M, 2002, J APPL PHYS, V91, P1247, DOI 10.1063/1.1429772; May RK, 2011, J PHARM SCI-US, V100, P1535, DOI 10.1002/jps.22359; Woodward RM, 2003, J INVEST DERMATOL, V120, P72, DOI 10.1046/j.1523-1747.2003.12013.x; Stoik CD, 2008, OPT EXPRESS, V16, P17039, DOI 10.1364/OE.16.017039; Yasui T, 2005, APPL OPTICS, V44, P6849, DOI 10.1364/AO.44.006849; Yamashita M, 2005, OPT EXPRESS, V13, P115, DOI 10.1364/OPEX.13.000115; Chan WL, 2007, REP PROG PHYS, V70, P1325, DOI 10.1088/0034-4885/70/8/R02; Usami M, 2002, PHYS MED BIOL, V47, P3749, DOI 10.1088/0031-9155/47/21/311; Banerjee D, 2008, OPT EXPRESS, V16, P9060, DOI 10.1364/OE.16.009060; Tonouchi M, 2007, NAT PHOTONICS, V1, P97, DOI 10.1038/nphoton.2007.3; Huber AJ, 2008, NANO LETT, V8, P3766, DOI 10.1021/nl802086x; Kawase K, 2003, OPT EXPRESS, V11, P2549, DOI 10.1364/OE.11.002549; Ogawa Y, 2008, OPT EXPRESS, V16, P22083, DOI 10.1364/OE.16.022083; Popov VV, 2012, NANOSCI NANOTECH LET, V4, P1015, DOI 10.1166/nnl.2012.1442; Zhong H, 2005, IEEE SENS J, V5, P203, DOI 10.1109/JSEN.2004.841341; Kiwa T, 2003, OPT LETT, V28, P2058, DOI 10.1364/OL.28.002058; Oden J, 2013, OPT EXPRESS, V21, P4817, DOI 10.1364/OE.21.004817; Shen YC, 2005, P SOC PHOTO-OPT INS, V5727, P24, DOI 10.1117/12.591472; Ashworth PC, 2009, OPT EXPRESS, V17, P12444, DOI 10.1364/OE.17.012444; Schuster F, 2011, OPT EXPRESS, V19, P7827, DOI 10.1364/OE.19.007827; Yamashita M, 2005, APPL OPTICS, V44, P5198, DOI 10.1364/AO.44.005198; Hsu DK, 2012, INT J PRECIS ENG MAN, V13, P1183, DOI 10.1007/s12541-012-0157-5; Fukasawa R., 2011, NEW TERAHERTZ IND, P11; Fukasawa R., 2013, THZ TECHNOLOGY CHEM, P147; Fukuchi T., 2013, IEEJ T FUNDAM MAT A, V133, P395; Fukunaga K., 2012, OYO BUTURI, V81, P329; Fuse N., 2011, H11002 CRIEPI; Hu BB, 1995, J SCI OPT LETT, V20, P1716, DOI DOI 10.1364/0L.20.001716; Ikari T., 2013, INSPECTION ENG, V18, P23; Ikari T., 2014, 39 INT C INFR MILL T; Imamura Motoki, 2012, Review of Laser Engineering, V40; Jiang Z., 2003, SENSING TERAHERTZ RA, V85, P155; Jordens C., 2008, OPTICAL ENG, V47; Kiwa T., 2012, OYO BUTURI, V81, P298; Marchese L., 2013, P SOC PHOTO-OPT INS, V8900; Muravev V., 2013, INT WORKSH OPT THZ S; Nakanishi H., 2012, APPL PHYS EXPRESS, V5; Oda N., 2012, OYO BUTURI, V81, P321; Sakai K., 2005, TOPICS APPL PHYS; Serita Kazunori, 2012, Review of Laser Engineering, V40; Shibuya Takayuki, 2010, Review of Laser Engineering, V38; Takahashi N., 2014, 61 JSAP SPRING M; Takayanagi J., 2012, J JPN SOC COLOUR MAT, V85, P459; Wang S, 2004, J PHYS D APPL PHYS, V37, pR1, DOI 10.1088/0022-3727/37/4/R01; Yin XX, 2012, TERAHERTZ IMAGING FOR BIOMEDICAL APPLICATIONS: PATTERN RECOGNITION AND TOMOGRAPHIC RECONSTRUCTION, P1, DOI 10.1007/978-1-4614-1821-4; Zimdars D., 2005, REV PROGR QUANTITA A, V24, P570; Zimdars D., 2010, REV QUANTITAT NONDES, V29, P564	48	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2156-342X			IEEE T THZ SCI TECHN	IEEE Trans. Terahertz Sci. Technol.	NOV	2015	5	6					1121	1127				7	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CW9FJ	WOS:000365303800035		
J	Hirata, A; Yaita, M				Hirata, Akihiko; Yaita, Makoto			Ultrafast Terahertz Wireless Communications Technologies	IEEE TRANSACTIONS ON TERAHERTZ SCIENCE AND TECHNOLOGY			English	Article						Antenna; broadband wireless communications; MMIC; terahertz	DATA-TRANSMISSION; 300 GHZ; BAND; SYSTEM	Terahertz wireless communications technologies are attracting a great deal of attention because of their potential to considerably surpass 10 Gb/s. In recent years, progress in semiconductor integrated circuits has enabled indoor transmission experiments of 100-Gb/s-grade terahertz wireless links and outdoor transmission experiment over distances of more than 1 km. In this paper, trends in the research and development of the domestic and foreign terahertz wireless communications technology and the standardization are presented.	[Hirata, Akihiko; Yaita, Makoto] NTT Corp, NTT Device Technol Labs, Atsugi, Kanagawa 2430198, Japan	Hirata, A (reprint author), NTT Corp, NTT Device Technol Labs, Atsugi, Kanagawa 2430198, Japan.	hirata.akihiko@lab.ntt.co.jp					Takeuchi J, 2014, IEICE T ELECTRON, VE97C, P101, DOI 10.1587/transele.E97.C.101; Ishigaki K, 2012, ELECTRON LETT, V48, P582, DOI 10.1049/el.2012.0849; Tajima T, 2013, EUR MICROW CONF, P231; Koenig S, 2013, NAT PHOTONICS, V7, P977, DOI [10.1038/nphoton.2013.275, 10.1038/NPHOTON.2013.275]; Kanaya H, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.124101; Song HJ, 2012, ELECTRON LETT, V48, P953, DOI 10.1049/el.2012.1708; Nagatsuma T, 2014, IEEE PHOTONICS J, V6, DOI 10.1109/JPHOT.2014.2309643; Song HJ, 2012, IEEE MICROW WIREL CO, V22, P363, DOI 10.1109/LMWC.2012.2201460; Kosugi T, 2003, IEEE MTT-S, P129, DOI 10.1109/MWSYM.2003.1210899; Kim D, 2014, IEEE T ANTENN PROPAG, V62, P1507, DOI 10.1109/TAP.2013.2296318; Hirata A, 2012, IEEE T MICROW THEORY, V60, P881, DOI 10.1109/TMTT.2011.2178256; Deal WR, 2011, IEEE MICROW WIREL CO, V21, P368, DOI 10.1109/LMWC.2011.2143701; Song HJ, 2013, IEEE T THZ SCI TECHN, V3, P445, DOI 10.1109/TTHZ.2013.2252954; Fujimoto R., 2010, 2010 IEEE AS SOL STA, P1, DOI 10.1109/ASSCC.2010.5716610; Kanno A., 2011, ECOC 2011 18 22 SEPT, P1; Minotani T., 2002, AS PAC MICR C; Sengupta K., 2012, 2012 IEEE International Solid-State Circuits Conference (ISSCC), DOI 10.1109/ISSCC.2012.6176999; Shiode T., 2012, P AS PAC MICR PHOT 2; Takahashi H., 2014, IEICE ELECTRON EXPR, V11, P1; Tsumochi J., 2014, IEICE GEN C; Tsuruda K., 2013, 2013 IEEE INT TOP M	21	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2156-342X			IEEE T THZ SCI TECHN	IEEE Trans. Terahertz Sci. Technol.	NOV	2015	5	6					1128	1132				5	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CW9FJ	WOS:000365303800036		
J	Nakagawa, T				Nakagawa, Takao			Observations of the Universe in the Terahertz Range: From AKARI to SPICA	IEEE TRANSACTIONS ON TERAHERTZ SCIENCE AND TECHNOLOGY			English	Article						Astronomy; satellites; terahertz	SPACE; MISSION; TELESCOPE; PERFORMANCE; ASTRONOMY	One of the biggest challenges for the current astrophysics research is to reveal the history of the evolution of the universe. To achieve the goal, sensitive observations in the Terahertz range are essential since significant fraction of the the total energy is emitted in the range. However, the atmosphere of the earth is opaque mostly in the range, and space telescopes are required for sensitive observations. We discuss examples of the Terahertz observations of the universe using space telescopes, focusing on Japan-related infrared astronomical satellites AKARI (launched in 2006) and SPICA (expected to be launched in the 2020s).	[Nakagawa, Takao] Japan Aerosp Explorat Agcy Sagamihara, Inst Space & Astronautial Sci, Dept Space Astron & Astrophys, Kanagawa 2525210, Japan	Nakagawa, T (reprint author), Japan Aerosp Explorat Agcy Sagamihara, Inst Space & Astronautial Sci, Dept Space Astron & Astrophys, Kanagawa 2525210, Japan.	nakagawa@ir.isas.jaxa.jp					Kessler MF, 1996, ASTRON ASTROPHYS, V315, pL27; BOGGESS NW, 1992, ASTROPHYS J, V397, P420, DOI 10.1086/171797; Bennett CL, 2003, ASTROPHYS J, V583, P1, DOI 10.1086/345346; [Anonymous], 2010, ASTRONOMY ASTROPHYS, V514; [Anonymous], 2008, PUBL ASTRON SOC JPN, V60, pSP2; SPINOGLIO L, 1992, ASTROPHYS J, V399, P504, DOI 10.1086/171943; Siegel PH, 2007, IEEE T ANTENN PROPAG, V55, P2957, DOI 10.1109/TAP.2007.908557; [Anonymous], 2007, PUBL ASTRON SOC JPN, V59, p[S369, SP2]; Werner MW, 2004, ASTROPHYS J SUPPL S, V154, P1, DOI 10.1086/422992; Murakami H, 2007, PUBL ASTRON SOC JPN, V59, pS369; Murakami H, 1996, PUBL ASTRON SOC JPN, V48, pL41; THRONSON HA, 1995, PUBL ASTRON SOC PAC, V107, P1099, DOI 10.1086/133666; Clampin M, 2014, PROC SPIE, V9143, DOI 10.1117/12.2057537; David J. H., 2015, ASTROPHYS J, V806; Doi Y, 2015, PUBL ASTRON SOC JPN, V67, DOI 10.1093/pasj/psv022; Leinert C., 1997, A AS, V127, P1; Matsumoto T, 2011, ASTROPHYS J, V742, DOI 10.1088/0004-637X/742/2/124; Mori TI, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/1/53; Nakagawa T., 2014, P SOC PHOTO-OPT INS, V9143, P9143; Nakagawa T, 2007, PUBL ASTRON SOC JPN, V59, pS377; Neugebauer G., 1984, AP J, V278, pL1; Pilbratt GL, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014759; Planck Collaboration, 2011, ASTRON ASTROPHYS, V536, pA1; Rho J, 2012, ASTROPHYS J LETT, V747, DOI 10.1088/2041-8205/747/1/L6; Roelfsema P., 2014, P SOC PHOTO-OPT INS, V9143, P9143; Shinozaki K, 2014, CRYOGENICS, V64, P228, DOI 10.1016/j.cryogenics.2014.03.011; Suzuki T., 2015, J LOW TEMP PHY UNPUB	27	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2156-342X			IEEE T THZ SCI TECHN	IEEE Trans. Terahertz Sci. Technol.	NOV	2015	5	6					1133	1139				7	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CW9FJ	WOS:000365303800037		
J	Ajito, K				Ajito, Katsuhiro			Terahertz Spectroscopy for Pharmaceutical and Biomedical Applications	IEEE TRANSACTIONS ON TERAHERTZ SCIENCE AND TECHNOLOGY			English	Article						Cocrystal; crystal polymorphism; medical diagnostic; molecular interaction; THz spectroscopy	TIME-DOMAIN SPECTROSCOPY; AMINO-ACIDS; PULSED SPECTROSCOPY; ABSORPTION-SPECTRA; THZ; POLYPEPTIDES; SENSITIVITY; COCRYSTALS; CANCER	Terahertz (THz) spectroscopy can detect molecular interactions in compounds formed by hydrogen bonds and hydration reactions. Although improvements are required in many respects, we are seeing encouraging progress in quantitative analyses based on THz spectra, and promising directions in the application of THz imaging to pharmaceuticals, the life sciences, and medical diagnostics.	[Ajito, Katsuhiro] NTT Corp, NTT Device Technol Labs, Atsugi, Kanagawa 2430198, Japan	Ajito, K (reprint author), NTT Corp, NTT Device Technol Labs, Atsugi, Kanagawa 2430198, Japan.	ajito.katsuhiro@lab.ntt.co.jp					Rungsawang R, 2006, OPT EXPRESS, V14, P5765, DOI 10.1364/OE.14.005765; Oh SJ, 2009, OPT EXPRESS, V17, P3469, DOI 10.1364/OE.17.003469; Zhang CF, 2004, J PHYS CHEM B, V108, P10077, DOI 10.1021/jp049933y; Ueno Y, 2006, ANAL CHEM, V78, P5424, DOI 10.1021/ac060520y; Tewari P, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.4.040503; Markelz AG, 2000, CHEM PHYS LETT, V320, P42, DOI 10.1016/S0009-2614(00)00227-X; Wallace VP, 2006, APPL SPECTROSC, V60, P1127, DOI 10.1366/000370206778664635; Brock D, 2013, EUR J PHARM BIOPHARM, V85, P1122, DOI 10.1016/j.ejpb.2013.07.004; Zeitler JA, 2007, INT J PHARMACEUT, V334, P78, DOI 10.1016/j.ijpharm.2006.10.027; Siegrist K, 2006, J AM CHEM SOC, V128, P5764, DOI 10.1021/ja058176u; Yamaguchi M, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1857080; Ueno Y, 2008, ANAL SCI, V24, P185, DOI 10.2116/analsci.24.185; Yamamoto K, 2005, J OPT SOC AM B, V22, P2417, DOI 10.1364/JOSAB.22.002417; Charron DM, 2013, ANAL CHEM, V85, P1980, DOI 10.1021/ac302852n; Kim JY, 2014, J LIGHTWAVE TECHNOL, V32, P3768, DOI 10.1109/JLT.2014.2314139; Walther M, 2003, CHEM PHYS, V288, P261, DOI 10.1016/S0301-0104(03)00031-4; Korter TM, 2006, CHEM PHYS LETT, V418, P65, DOI 10.1016/j.cplett.2005.10.097; Ajito K, 2014, J ELECTROCHEM SOC, V161, pB171, DOI 10.1149/2.0201409jes; Yamamoto K, 2005, BIOPHYS J, V89, pL22, DOI 10.1529/biophysj.105.067447; Ajito K, 2011, IEEE T THZ SCI TECHN, V1, P293, DOI 10.1109/TTHZ.2011.2159562; Chen H, 2011, OPT EXPRESS, V19, P21552, DOI 10.1364/OE.19.021552; Zeitler JA, 2005, THERMOCHIM ACTA, V436, P71, DOI 10.1016/j.tca.2005.07.006; Matei A, 2005, CHEM PHYS, V316, P61, DOI 10.1016/j.chemphys.2005.04.033; Kim JY, 2014, OPT EXPRESS, V22, P1735, DOI 10.1364/OE.22.001735; Kutteruf MR, 2003, CHEM PHYS LETT, V375, P337, DOI 10.1016/S0009-2614(03)00856-X; Brock D, 2013, J PHARM SCI-US, V102, P1813, DOI 10.1002/jps.23521; Haaser M, 2013, EUR J PHARM BIOPHARM, V85, P1095, DOI 10.1016/j.ejpb.2013.03.019; Rungsawang R, 2006, J PHYS CHEM B, V110, P21259, DOI 10.1021/jp060495n; Ueno Y, 2011, ANAL SCI, V27, P351; Fitzgerald AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099291; Nakajima S., 2007, APPL PHYS LETT, V90, P107	31	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2156-342X			IEEE T THZ SCI TECHN	IEEE Trans. Terahertz Sci. Technol.	NOV	2015	5	6					1140	1145				6	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CW9FJ	WOS:000365303800038		
J	Tabata, H				Tabata, Hitoshi			Application of Terahertz Wave Technology in the Biomedical Field	IEEE TRANSACTIONS ON TERAHERTZ SCIENCE AND TECHNOLOGY			English	Article						Terahertz (THz) spectroscopy; biosensors; THz wave surface Plasmon; label-free detection; metal mesh filters	SUBWAVELENGTH HOLE ARRAYS; REFLECTION SPECTROSCOPY; OPTICAL-TRANSMISSION; METALLIC MESH; FREQUENCY; FILTERS	This paper introduces a sensing technology that utilizes terahertz (THz) wave with metal mesh resonant filters in the biomedical field. Due to the consistency of energy regions, it is expected to bring about the non-labeling detection of hydrogen bonding and/or intermolecular recognition, as well as antibody responses, etc. Regularly arranged metallic mesh can also be used to make effective use of the THz wave anomalous propagation and absorption characteristics (spoof surface plasmon) of specimens for biopolymer systems, which do not indicate characteristic absorption in the THz band. This paper introduces the THz wave absorption and propagation characteristics in metallic meshes designed for the THz sensing and for application to biomedical related specimens.	[Tabata, Hitoshi] Univ Tokyo, Sch Engn, Bunkyo Ku, Hongo 1138656, Japan	Tabata, H (reprint author), Univ Tokyo, Sch Engn, Bunkyo Ku, Hongo 1138656, Japan.	tabata@bioeng.t.u-tokyo.ac.jp					Fischer BM, 2002, PHYS MED BIOL, V47, P3807, DOI 10.1088/0031-9155/47/21/319; Siegel PH, 2004, IEEE T MICROW THEORY, V52, P2438, DOI [10.1109/TMTT.2004.835916, 10.1109/TMTT.2004.83516]; Nagel M, 2002, APPL PHYS LETT, V80, P154, DOI 10.1063/1.1428619; Lezec HJ, 2004, OPT EXPRESS, V12, P3629, DOI 10.1364/OPEX.12.003629; Kawabe S, 2014, J APPL PHYS, V115, DOI 10.1063/1.4870954; Fan ST, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/37/374009; Wilmink GJ, 2011, J INFRARED MILLIM TE, V32, P1074, DOI 10.1007/s10762-011-9794-5; Globus TR, 2003, J BIOL PHYS, V29, P89, DOI 10.1023/A:1024420104400; Brun MA, 2010, PHYS MED BIOL, V55, P4615, DOI 10.1088/0031-9155/55/16/001; Bolivar PH, 2002, PHYS MED BIOL, V47, P3815, DOI 10.1088/0031-9155/47/21/320; Fitzgerald AJ, 2002, PHYS MED BIOL, V47, pR67, DOI 10.1088/0031-9155/47/7/201; Yoshida H, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2825411; KAATZE U, 1989, J CHEM ENG DATA, V34, P371, DOI 10.1021/je00058a001; Moller U, 2009, J OPT SOC AM B, V26, pA113, DOI 10.1364/JOSAB.26.00A113; LAMARRE JM, 1981, INT J INFRARED MILLI, V2, P273, DOI 10.1007/BF01007035; Kawase K, 2003, OPT EXPRESS, V11, P2549, DOI 10.1364/OE.11.002549; Yoshida S, 2009, J MOL SPECTROSC, V256, P146, DOI 10.1016/j.jms.2009.04.009; Hasebe T, 2011, BIOCHEM BIOPH RES CO, V414, P192, DOI 10.1016/j.bbrc.2011.09.055; Liu R, 2010, BIOCHEM BIOPH RES CO, V391, P862, DOI 10.1016/j.bbrc.2009.11.153; Hasebe T, 2012, J APPL PHYS, V112, DOI 10.1063/1.4761966; Mickan SP, 2002, PHYS MED BIOL, V47, P3789, DOI 10.1088/0031-9155/47/21/317; Arikawa T, 2008, CHEM PHYS LETT, V457, P12, DOI 10.1016/j.cplett.2008.03.062; Ebbesen TW, 1998, NATURE, V391, P667, DOI 10.1038/35570; Melo AM, 2008, APPL OPTICS, V47, P6064, DOI 10.1364/AO.47.006064; Humphreys K., 2004, P 26 ANN INT C IEEE, V1, P1302; Koch M., 2003, BIOMEDICAL APPL THZ, P295; Melo A. M., 2012, ADV OPTICAL TECHNOLO, V2012; Michan S. P., 2002, PHYS MED BIOL, V47, P3789; Norizawa K., 2006, ANN REP OSAKA U, V135; Park G.-S., 2012, CONVERGENCE TERAHERT; Rostami A., 2011, TERAHERTZ TECHNOLOGY; Saeedkia D., 2013, HDB THZ TECHNOLOGY I, P222; Son J.-H., 2014, TERAHERTZ BIOMEDICAL; Sun Yiwen, 2011, World J Radiol, V3, P55, DOI 10.4329/wjr.v3.i3.55; Ulrich R., 1963, IEEE Transactions on Microwave Theory and Techniques, VMTT-11, DOI 10.1109/TMTT.1963.1125676; Yeoa W.-G., 2014, INFRARED MILLIM THZ, P1; Yin XX, 2012, TERAHERTZ IMAGING FOR BIOMEDICAL APPLICATIONS: PATTERN RECOGNITION AND TOMOGRAPHIC RECONSTRUCTION, P1, DOI 10.1007/978-1-4614-1821-4; Yoshida H., 2009, ILLUM ENG I JPN, V93, P487; Yu Calvin, 2012, Quant Imaging Med Surg, V2, P33, DOI 10.3978/j.issn.2223-4292.2012.01.04	39	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2156-342X			IEEE T THZ SCI TECHN	IEEE Trans. Terahertz Sci. Technol.	NOV	2015	5	6					1146	1153				8	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CW9FJ	WOS:000365303800039		
J	Irimajiri, Y; Kawakami, A; Morohashi, I; Kumagai, M; Sekine, N; Nagano, S; Ochiai, S; Tanaka, S; Hanado, Y; Uzawa, Y; Hosako, I				Irimajiri, Yoshihisa; Kawakami, Akira; Morohashi, Isao; Kumagai, Motohiro; Sekine, Norihiko; Nagano, Shigeo; Ochiai, Satoshi; Tanaka, Shukichi; Hanado, Yuko; Uzawa, Yoshinori; Hosako, Iwao			Development of a Superconducting Low-Noise 3.1-THz Hot Electron Bolometer Receiver	IEEE TRANSACTIONS ON TERAHERTZ SCIENCE AND TECHNOLOGY			English	Article						Atmospheric and astronomical observations; hot electron bolometer (HEB) mixer; THz quantum cascade laser (QCL)		We have developed a hot electron bolometer mixer (HEBM) at 3.1 THz with a terahertz quantum cascade laser (THz-QCL) as a local oscillator. Both the HEBM and the THz-QCL device are fabricated in our laboratory. NbN film with 3 nm thickness was deposited on MgO substrate. The output power of the metal-metal waveguide type 3.1 THz-QCL was about 100 mu W at a heat sink temperature of 15 K. The lowest uncorrected receiver noise temperature of the HEBM was 1200 K (DSB). The corrected receiver noise temperature was 810 K (DSB). The measured IF noise bandwidth was about 3 GHz. The spectroscopic Allan time was 10 s. We have also demonstrated detection of emission line spectra of methanol [CH3OH].	[Irimajiri, Yoshihisa] Natl Inst Informat & Commun Technol, Commun Res Lab, Tokyo 1848795, Japan; [Kawakami, Akira; Morohashi, Isao; Sekine, Norihiko; Tanaka, Shukichi; Hanado, Yuko] Natl Inst Informat & Commun Technol, Tokyo 1848795, Japan; [Kumagai, Motohiro; Nagano, Shigeo] Natl Inst Informat & Commun Technol, Atom Frequency Standard Project, Tokyo 1848795, Japan; [Ochiai, Satoshi] Natl Inst Informat & Commun Technol, Radiat Res Lab, Tokyo 1848795, Japan; [Uzawa, Yoshinori] Natl Inst Informat & Commun Technol, NICT, Commun Res Lab, Minist Posts & Telecommun, Tokyo 1848795, Japan; [Hosako, Iwao] Natl Inst Informat & Commun Technol, ICT Res Inst, Tokyo 1848795, Japan	Irimajiri, Y (reprint author), Natl Inst Informat & Commun Technol, Commun Res Lab, Tokyo 1848795, Japan.	irimaji@nict.go.jp					Kumar S, 2004, APPL PHYS LETT, V84, P2494, DOI 10.1063/1.1695099; Wiedner MC, 2006, ASTRON ASTROPHYS, V454, pL33, DOI 10.1051/0004-6361:20065341; Siegel PH, 2002, IEEE T MICROW THEORY, V50, P910, DOI 10.1109/22.989974; Buchel D, 2015, IEEE T THZ SCI TECHN, V5, P207, DOI 10.1109/TTHZ.2014.2382434; Meledin D, 2009, IEEE T MICROW THEORY, V57, P89, DOI 10.1109/TMTT.2008.2008946; Kerr AR, 1999, IEEE T MICROW THEORY, V47, P325, DOI 10.1109/22.750234; Shiba S, 2012, IEEE T THZ SCI TECHN, V2, P22, DOI 10.1109/TTHZ.2011.2177704; Cherednichenko S, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2890099; De Graauw T, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014698; Gao J. R., 2005, APPL PHYS LETT, V86; Hayton D. J., 2014, P 39 INT C INFR MILL; Kawakami A., 2013, P 24 INT S SPAC THZ; Khosropanah P., 2007, APPL PHYS LETT, V91; Khosropanah P., 2008, J APPL PHYS, V104; Kikuchi K, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD014379; Kloosterman J. L., 2013, APPL PHYS LETT, V102; Ochiai S., 2015, P SOC PHOTO-OPT INS, V9639; Putz P., 2014, P 39 INT C INFR MILL; Putz P, 2012, ASTRON ASTROPHYS, V542, DOI 10.1051/0004-6361/201218916; Richter H., 2015, IEEE T THZ SCI TECHN, V5; Risacher C., 2014, P 39 INT C INFR MILL; Saily J., 2003, S258 HELS U TECHN DE; Tong C.-Y. E., 2006, P SOC PHOTO-OPT INS, V6373, P19	23	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2156-342X			IEEE T THZ SCI TECHN	IEEE Trans. Terahertz Sci. Technol.	NOV	2015	5	6					1154	1159				6	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CW9FJ	WOS:000365303800040		
J	Nishina, S				Nishina, Shigeki			Industrial Development of High-Throughput Terahertz Time-Domain Spectroscopy	IEEE TRANSACTIONS ON TERAHERTZ SCIENCE AND TECHNOLOGY			English	Article						Optical sampling and high speed sweeping; terahertz; time-domain spectroscopy (TDS)		Considering measurement throughput is important for developing practical devices for nondestructive examinations that use terahertz waves. In the optical communications field, optical sampling technology is used to measure optical time division multiplexing, high-speed sweeping technology in terahertz wave spectroscopic devices, high throughput measurement, and other ultra-high-speed optical signals. In this study, we introduce terahertz wave analysis systems that utilize the terahertz optical sampling method. Furthermore, we provide measurement examples and describe industrial applications for terahertz waves.	[Nishina, Shigeki] Advantest Corp, Terahertz Syst Business Div, Technol Dev SE Sect, Sendai, Miyagi 9893124, Japan	Nishina, S (reprint author), Advantest Corp, Terahertz Syst Business Div, Technol Dev SE Sect, Sendai, Miyagi 9893124, Japan.	shigeki.nishina@advantest.com					FATTINGER C, 1988, APPL PHYS LETT, V53, P1480, DOI 10.1063/1.99971; Kim GJ, 2007, JPN J APPL PHYS 1, V46, P7332, DOI 10.1143/JJAP.46.7332; Nguyen KL, 2006, OPT EXPRESS, V14, P2123, DOI 10.1364/OE.14.002123; Kim Y, 2010, OPT LETT, V35, P3715, DOI 10.1364/OL.35.003715; Ferguson B, 2002, OPT LETT, V27, P1312, DOI 10.1364/OL.27.001312; Janke C, 2005, OPT LETT, V30, P1405, DOI 10.1364/OL.30.001405; Adachi S, 1996, APPL PHYS LETT, V68, P964, DOI 10.1063/1.116113; Blakeman P., 2003, 2003013753 SAE; Dekorsy T., 2011, 2011 30 URSI GEN ASS; Irisawa A., 2013, U.S. Patent, Patent No. [8 378 703, 8378703]; Nakazawa M., 2001, ECOC 2001; Nishina S., 2012, 2011012064 SAE; Nishina S., 2007, 2007 GEN C I EL INF; Radon J., 1917, BER VERH SACHS AK MN, V69, P262; Shibuya T., 2011, J INFRARED MILLIM TH, V32, P715; Song H. J., 2015, HDB TERAHERTZ TECHNO; Strzelec A., 2009, 2009012735 SAE; Watanabe S., 2004, ECOC 2004; Yamashita T., 2012, U.S. Patent, Patent No. [8306078B2, 8306078]; Yamashita T., 2014, U.S. Patent, Patent No. [8718108B2, 8718108]	20	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2156-342X			IEEE T THZ SCI TECHN	IEEE Trans. Terahertz Sci. Technol.	NOV	2015	5	6					1160	1165				6	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CW9FJ	WOS:000365303800041		
J	Shimada, Y; Iida, H; Kinoshita, M				Shimada, Yozo; Iida, Hitoshi; Kinoshita, Moto			Recent Research Trends of Terahertz Measurement Standards	IEEE TRANSACTIONS ON TERAHERTZ SCIENCE AND TECHNOLOGY			English	Article						Calorimeter; measurement standards; metrological traceability; power measurement; terahertz	TIME-DOMAIN SPECTROMETERS; FREQUENCY CALIBRATION; POWER MEASUREMENTS; THZ-TDS; DETECTORS; SPECTROSCOPY; RADIATION; TECHNOLOGY; RADIOMETRY; METROLOGY	Terahertz (THz) technology has developed into a new research field in the frequency gap (THz gap) between infrared waves and microwaves. Recent innovation in THz technology has brought a wide variety of applications through advances in detection and emission techniques in the THz range. In order to use THz technology safely, the importance of quality control for measurements in the THz range is increasing in terms of regulation for electromagnetic compatibility or non-ionizing radiation protection of humans. Because of this, measurement standards for the accuracy control of THz measurement have been aggressively developed in leading national metrology institutes. We provide an overview of the current status of THz measurement standards.	[Shimada, Yozo; Iida, Hitoshi; Kinoshita, Moto] Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058563, Japan	Shimada, Y (reprint author), Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058563, Japan.	yozo.shimada@aist.go.jp; h-iida@aist.go.jp; moto-ki-noshita@aist.go.jp			JSPS KAKENHI [25420428]	This work was supported in part by JSPS KAKENHI under Grant 25420428.	Advantest Corp, TER SPECTR IM SYST; Yasui T, 2010, OPT LETT, V35, P1689, DOI 10.1364/OL.35.001689; Gutschwager B, 2009, METROLOGIA, V46, pS165, DOI 10.1088/0026-1394/46/4/S06; Iida H, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.128004; Lehman JH, 2011, APPL OPTICS, V50, P4099, DOI 10.1364/AO.50.004099; Dietz RJB, 2014, OPT LETT, V39, P6482, DOI 10.1364/OL.39.006482; Steiger A, 2010, OPT EXPRESS, V18, P21804, DOI 10.1364/OE.18.021804; Usami M, 2002, PHYS MED BIOL, V47, P3749, DOI 10.1088/0031-9155/47/21/311; Tonouchi M, 2007, NAT PHOTONICS, V1, P97, DOI 10.1038/nphoton.2007.3; Muller R, 2011, J INFRARED MILLIM TE, V32, P742, DOI 10.1007/s10762-011-9785-6; Steiger A, 2013, OPT EXPRESS, V21, P14466, DOI 10.1364/OE.21.014466; Iida H, 2013, IEEE T INSTRUM MEAS, V62, P1801, DOI 10.1109/TIM.2012.2225927; Svetlitza A, 2014, IEEE T THZ SCI TECHN, V4, P347, DOI 10.1109/TTHZ.2014.2309003; Iida H, 2014, OPT LETT, V39, P1609, DOI 10.1364/OL.39.001609; Yasui T, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2209718; Naftaly M, 2009, OPT LETT, V34, P674, DOI 10.1364/OL.34.000674; Popovic Z, 2011, IEEE T THZ SCI TECHN, V1, P133, DOI 10.1109/TTHZ.2011.2159553; [Anonymous], 2008, 1002008 JCGM; Naftaly M, 2009, J OPT SOC AM B, V26, P1357, DOI 10.1364/JOSAB.26.001357; Naftaly M, 2010, OPT COMMUN, V283, P1849, DOI 10.1016/j.optcom.2009.12.025; Muller R, 2014, J INFRARED MILLIM TE, V35, P659, DOI 10.1007/s10762-014-0066-z; Oden J, 2013, OPT EXPRESS, V21, P4817, DOI 10.1364/OE.21.004817; Ehara K., 2014, J IEICE, V97, P324; Grischkowsky D, 1990, J OPT SOC AM B, V7, P10; Hu BB, 1995, J SCI OPT LETT, V20, P1716, DOI DOI 10.1364/0L.20.001716; Iida H., 2013, 38 INT C INFR MILL T; Iida H., 2012, 7 AS PAC MICR PHOT C, VPB-1; Iida H., 2012, 37 INT C INFR MILL T, VThu-Pos-47; Inaba Hajime, 2014, Synthesiology (English Edition), V7; Inoue T., 2000, Bulletin of the Electrotechnical Laboratory, V64; Inoue T., 1992, B ELECTROTECH LAB, V56, P1259; Kinoshita M., 2014, 39 INT C INFR MILL T; Kinoshita M., 2014, 61 JSAP SPRING M MAR, V19p-F5-2; Kinoshita M., 2014, IEEE T THZ SCI TECHN, V4, P756; Kitagshi K., 2013, INT WORKSH OPT TER S, P243; Kleine-Ostmann T, 2014, IEEE T THZ SCI TECHN, V4, P12, DOI 10.1109/TTHZ.2013.2293115; Kleine-Ostmann T., 2005, FREQUENZ, V59; Naftaly M., 2013, IEEE SENSORS J, V13; Naftaly M., 2009, OPT LETT, V34; NEC Co, TER IM; NIST Boulder CO USA, 2007, NIST SPEC PUBL; Notake T, 2014, IEEE T THZ SCI TECHN, V4, P110, DOI 10.1109/TTHZ.2013.2284862; Werner L, 2009, METROLOGIA, V46, pS160, DOI 10.1088/0026-1394/46/4/S05; Withayachumnankul W, 2014, J INFRARED MILLIM TE, V35, P610, DOI 10.1007/s10762-013-0042-z; Withayachumnankul W., 2007, P SOC PHOTO-OPT INS, V6593	45	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2156-342X			IEEE T THZ SCI TECHN	IEEE Trans. Terahertz Sci. Technol.	NOV	2015	5	6					1166	1172				7	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CW9FJ	WOS:000365303800042		
J	De Jesus, M; Rodriguez, AE; Yagita, H; Ostroff, GR; Mantis, NJ				De Jesus, Magdia; Rodriguez, Adam E.; Yagita, Hideo; Ostroff, Gary R.; Mantis, Nicholas J.			Sampling of Candida albicans and Candida tropicalis by Langerin-positive dendritic cells in mouse Peyer's patches	IMMUNOLOGY LETTERS			English	Article						Peyer's patch; Dendritic cells; Langerin; C-type lectins; Diphtheria toxin	FOLLICLE-ASSOCIATED EPITHELIUM; MICROFOLD M CELLS; LYMPHOID-TISSUES; CROHNS-DISEASE; CHOLERA-TOXIN; IN-VIVO; DC-SIGN; COLONIZATION; MIGRATION; INFLAMMATION	Members of the Candida genus, including C. albicans and C. tropicalis are opportunistic fungal pathogens that are increasingly associated with gastrointestinal infections and inflammatory bowel diseases. In healthy populations, however, C. albicans and C tropicalis are considered benign members of the mycobiome, and are presumably kept in check by the mucosal immune system. In this study, we demonstrate in mice that C albicans and C tropicalis are sampled by Peyer's patch (PP) dendritic cells (DCs). Uptake into gut-associated lymphoid tissues occurred rapidly and was at least partly M cell-dependent. C albicans and C tropicalis preferentially localized in (and persisted within) a recently identified sub- population of Peyer's patch DCs distinguished by their expression of the C-type lectin receptor, Langerin. This study is the first to identify a subset of PP DCs capable of sampling Candida species. (C) 2015 Elsevier B.V. All rights reserved.	[De Jesus, Magdia; Mantis, Nicholas J.] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY 12222 USA; [De Jesus, Magdia; Rodriguez, Adam E.; Mantis, Nicholas J.] New York State Dept Hlth, Wadsworth Ctr, Div Infect Dis, Albany, NY 12208 USA; [Rodriguez, Adam E.] Dutchess Community Coll, Poughkeepsie, NY USA; [Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 113, Japan; [Ostroff, Gary R.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	De Jesus, M (reprint author), New York State Dept Hlth, Wadsworth Ctr, Div Infect Dis, 120 New Scotland Ave, Albany, NY 12208 USA.	magdia.dejesus@health.ny.gov		Mantis, Nicholas/0000-0002-5083-8640	Life Sciences Research Foundation postdoctoral fellowship - Howard Hughes Medical Institute (HHMI); Wadsworth Center's Research Experience for Undergraduates (REU) program from the National Science Foundation (NSF) [1062963, 1359413]; NIH [HD061916]	We thank Dr. Stuart M. Levitz (University of Massachusetts Medical School) for the helpful discussions. We thank Dr. Sudha Chaturvedi and Xiaojiang Li of the Wadsworth Center's Mycology Laboratory for the C albicans and C tropicalis strains and for assistance with MALDI-TOF analysis. We thank Dr. Aaron Mitchell (Carnegie Mellon University) for providing the C. albicans strain SC5314. We thank Dr. Sandrine Henri and Bernard Malissen at Centre d'Immunologie Marseille Luminy, INSERM U1104, Marseille, France for the genotyping protocol and helpful discussion on the depletion of Langerin DCs. We thank Richard Cole of the Wadsworth Center's Advanced Light Microscopy facility for assistance with measuring MFI of Langerin DCs. We thank Renjie Song of the Wadsworth Center Immunology Core for assistance with the flow cytometry analysis. We thank Yannick David of the Wadsworth Center's Research Experience for Undergraduates (REU) program in assisting with the LPS, Candida enumeration experiment. M.D.J. was supported by the Life Sciences Research Foundation postdoctoral fellowship sponsored by the Howard Hughes Medical Institute (HHMI). A.E.R. and Y.D. were supported in part by the Wadsworth Center's Research Experience for Undergraduates (REU) program grants 1062963 and 1359413 from the National Science Foundation (NSF). This work was supported in part by NIH grant HD061916 to N.J.M.	Rescigno M, 2009, J CLIN INVEST, V119, P2441, DOI 10.1172/JCI39134; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Kumamoto CA, 2011, CURR OPIN MICROBIOL, V14, P386, DOI 10.1016/j.mib.2011.07.015; Lelouard H, 2012, GASTROENTEROLOGY, V142, P592, DOI 10.1053/j.gastro.2011.11.039; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; GIANNASCA PJ, 1994, AM J PHYSIOL-GASTR L, V267, pG1108; Tateno H, 2010, J BIOL CHEM, V285, P6390, DOI 10.1074/jbc.M109.041863; Neutra MR, 2001, NAT IMMUNOL, V2, P1004, DOI 10.1038/ni1101-1004; Cashman SB, 2009, MOL IMMUNOL, V47, P365, DOI 10.1016/j.molimm.2009.09.007; Underhill DM, 2014, NAT REV IMMUNOL, V14, P405, DOI [10.1038/nri3684, 10.1038/nn3684]; Shreedhar VK, 2003, INFECT IMMUN, V71, P504, DOI 10.1128/IAI.71.1.504-509.2003; Wozniak Karen L., 2009, V470, P71, DOI 10.1007/978-1-59745-204-5_7; Anosova NG, 2008, MUCOSAL IMMUNOL, V1, P59, DOI 10.1038/mi.2007.7; Gow NAR, 2012, NAT REV MICROBIOL, V10, P112, DOI 10.1038/nrmicro2711; Chabot S, 2006, J IMMUNOL, V176, P4275; Bonifazi P, 2009, MUCOSAL IMMUNOL, V2, P362, DOI 10.1038/mi.2009.17; Montagnoli C, 2003, EUR J IMMUNOL, V33, P1193, DOI 10.1002/eji.200323790; Rochereau N, 2011, VACCINE, V29, P3655, DOI 10.1016/j.vaccine.2011.03.012; Ahlawat S, 2014, MICROSC MICROANAL, V20, P198, DOI 10.1017/S1431927613013640; Negri M, 2012, EUR J CLIN MICROBIOL, V31, P1399, DOI 10.1007/s10096-011-1455-z; Brandtzaeg P, 2010, NAT REV GASTRO HEPAT, V7, P380, DOI 10.1038/nrgastro.2010.80; Standaert-Vitse A, 2009, AM J GASTROENTEROL, V104, P1745, DOI 10.1038/ajg.2009.225; Chang SY, 2010, IMMUNOL REV, V234, P233, DOI 10.1111/j.0105-2896.2009.00878.x; Hopkins SA, 2000, CELL MICROBIOL, V2, P59; Jawhara S, 2008, J INFECT DIS, V197, P972, DOI 10.1086/528990; Standaert-Vitse A, 2006, GASTROENTEROLOGY, V130, P1764, DOI 10.1053/j.gastro.2006.02.009; Cambi A, 2003, EUR J IMMUNOL, V33, P532, DOI 10.1002/immu.200310029; Mabbott NA, 2013, MUCOSAL IMMUNOL, V6, P666, DOI 10.1038/mi.2013.30; Knoop KA, 2009, J IMMUNOL, V183, P5738, DOI 10.4049/jimmunol.0901563; Takahara K, 2004, INT IMMUNOL, V16, P819, DOI 10.1093/intimm/dxh084; Iwasaki A, 2001, J IMMUNOL, V166, P4884; Williams JM, 2013, DIS MODEL MECH, V6, P1388, DOI 10.1242/dmm.013284; Westermark L, 2012, MICROB PATHOGENESIS, V53, P154, DOI 10.1016/j.micpath.2012.06.004; de Jong MAWP, 2010, TRENDS IMMUNOL, V31, P452, DOI 10.1016/j.it.2010.08.002; Bonnardel J., 2015, CELL REP; Casadevall A., 2015, HUMAN FUNGAL PATHOGE; Chadwick S., 2009, ADV DRUG DELIV REV, V62, P394; De Jesus M, 2013, JOVE-J VIS EXP, DOI 10.3791/50167; De Jesus M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091002; De Jesus M., 2013, J VIS EXP; Frykman PK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124172; Gerard R., 2013, CRIT REV MICROBIOL; Gonzalez-Hernandez MB, 2014, J VIROL, V88, P6934, DOI 10.1128/JVI.00204-14; Gouba N, 2015, MED MALADIES INFECT, V45, P9, DOI 10.1016/j.medmal.2015.01.007; Hall R.A., 2015, MOL MICROBIOL; Iliev ID, 2012, SCIENCE, V336, P1314; Kanaya Takashi, 2014, Biosci Microbiota Food Health, V33, P91, DOI [10.12938/bmfh.33.91, 10.12938/bmfh.2013-024]; Kujala P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002449; Lelouard H., 2010, GASTROENTEROLOGY, V138, pe171; Mantis N.J., 2011, MUCOSAL IMMUNOL; Marakalala MJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003315; Praneenararat Surat, 2014, Case Rep Gastroenterol, V8, P199, DOI 10.1159/000363566; Schulz O., 2012, TRENDS IMMUNOL; Tomura M, 2014, SCI REP-UK, V4, DOI 10.1038/srep06030	55	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-2478	1879-0542		IMMUNOL LETT	Immunol. Lett.	NOV	2015	168	1					64	72		10.1016/j.imlet.2015.09.008		9	Immunology	Immunology	CX0DR	WOS:000365367600009		
J	Kawakami, K; Takai-Kawakami, K				Kawakami, Kiyobumi; Takai-Kawakami, Kiyoko			Teaching, caring, and altruistic behaviors in toddlers	INFANT BEHAVIOR & DEVELOPMENT			English	Article						Toddlers; Peer-directed behaviors; Caring	PROSOCIAL BEHAVIOR; COOPERATION; CHIMPANZEES; ORIGINS; INFANCY	Peer-directed behaviors of toddlers were longitudinally recorded in a naturalistic preschool setting. An observer (0, the first author) recorded children's behaviors during play sessions with an IC recorder. One-year-old children (N = 13) and children under the age of 12 months (N = 8) were observed for 15 mm, 6 times in a year. Their teaching, caring, and altruistic behaviors were analyzed in detail. Results indicated that peer-directed behaviors of one-year-olds increased dramatically. It is concluded that toddlers are sophisticated social being. (C) 2015 Elsevier Inc. All rights reserved.	[Kawakami, Kiyobumi] Univ Cattolica Sacro Cuore, Shibuya Ku, Tokyo 1508938, Japan; [Takai-Kawakami, Kiyoko] Japan Womens Univ, Bunkyo Ku, Tokyo 1128681, Japan	Kawakami, K (reprint author), Univ Cattolica Sacro Cuore, Shibuya Ku, 4-3-1 Hiroo, Tokyo 1508938, Japan.	kawakami@u-sacred-heart.ac.jp					Brownell CA, 2009, INFANCY, V14, P117, DOI 10.1080/15250000802569868; Liszkowski U, 2009, PSYCHOL SCI, V20, P654, DOI 10.1111/j.1467-9280.2009.02346.x; Brownell CA, 2006, CHILD DEV, V77, P803, DOI 10.1111/j.1467-8624.2006.00904.x; Kawakami K, 2014, INFANT BEHAV DEV, V37, P174, DOI 10.1016/j.infbeh.2014.01.001; Warneken F, 2006, SCIENCE, V311, P1301, DOI 10.1126/science.1121448; Warneken F, 2007, INFANCY, V11, P271; Svetlova M, 2010, CHILD DEV, V81, P1814, DOI 10.1111/j.1467-8624.2010.01512.x; Spinrad TL, 2006, INFANCY, V10, P97, DOI 10.1207/s15327078in1002_1; Thornton A, 2008, ANIM BEHAV, V75, P1823, DOI 10.1016/j.anbehav.2007.12.014; Cote SM, 2006, J ABNORM CHILD PSYCH, V34, P71, DOI 10.1007/s10802-005-9001-z; Thornton A, 2006, SCIENCE, V313, P227, DOI 10.1126/science.1128727; Dunfield K, 2011, INFANCY, V16, P227, DOI 10.1111/j.1532-7078.2010.00041.x; Kawakami K, 2011, INFANT BEHAV DEV, V34, P264, DOI 10.1016/j.infbeh.2011.01.001; BROWNELL CA, 1990, CHILD DEV, V61, P1164, DOI 10.1111/j.1467-8624.1990.tb02850.x; Kawakami F., 2015, KAGAKU, V85, P606; Lewis M., 1975, FRIENDSHIP PEER RELA, P27; Rosenblum L. A., 1974, EFFECT INFANT ITS CA	17	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0163-6383	1879-0453		INFANT BEHAV DEV	Infant Behav. Dev.	NOV	2015	41						108	112		10.1016/j.infbeh.2015.08.007		5	Psychology, Developmental	Psychology	CX0GO	WOS:000365375100013		
J	Grando, SA; Kawashima, K; Kirkpatrick, CJ; Kummer, W; Wessler, I				Grando, Sergei A.; Kawashima, Koichiro; Kirkpatrick, Charles J.; Kummer, Wolfgang; Wessler, Ignaz			Recent progress in revealing the biological and medical significance of the non-neuronal cholinergic system	INTERNATIONAL IMMUNOPHARMACOLOGY			English	Editorial Material						Acetylcholine	ANTIGEN-SPECIFIC IGG(1); EPITHELIAL-CELLS; RECEPTOR LIGANDS; CLINICAL-ASPECTS; CANCER-THERAPY; MESSENGER-RNA; KNOCKOUT MICE; T-CELLS; ACETYLCHOLINE; EXPRESSION	This special issue of International Immunopharmacology is the proceedings of the Fourth International Symposium on Non-neuronal Acetylcholine that was held on August 28-30, 2014 at the Justus Liebig University of Giessen in Germany. It contains original contributions of meeting participants covering the significant progress in understanding of the biological and medical significance of the non-neuronal cholinergic system extending from exciting insights into molecular mechanisms regulating this system via miRNAs over the discovery of novel cholinergic cellular signaling circuitries to clinical implications in cancer, wound healing, immunity and inflammation, cardiovascular, respiratory and other diseases. (C) 2015 Elsevier B.V. All rights reserved.	[Grando, Sergei A.] Univ Calif Irvine, Dept Dermatol, Irvine, CA 92697 USA; [Kawashima, Koichiro] Kitasato Univ, Sch Pharm, Dept Mol Pharmacol, Tokyo 1088641, Japan; [Kirkpatrick, Charles J.; Wessler, Ignaz] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Pathol, D-55101 Mainz, Germany; [Kummer, Wolfgang] Univ Giessen, Inst Anat & Cell Biol, D-35385 Giessen, Germany	Grando, SA (reprint author), Univ Calif Irvine, Dept Dermatol, Irvine, CA 92697 USA.						Abramochkin DV, 2012, LIFE SCI, V91, P1023, DOI 10.1016/j.lfs.2012.03.031; Alessandrini F, 2015, INT IMMUNOPHARMACOL, V29, P105, DOI 10.1016/j.intimp.2015.05.032; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Wu CH, 2011, CLIN CANCER RES, V17, P3533, DOI 10.1158/1078-0432.CCR-10-2434; Kawashima K, 2007, LIFE SCI, V80, P2314, DOI 10.1016/j.lfs.2007.02.036; Dale HH, 1929, J PHYSIOL-LONDON, V68, P97; Schuller HM, 2007, LIFE SCI, V80, P2274, DOI 10.1016/j.lfs.2007.03.006; Nizri E, 2009, J IMMUNOL, V183, P6681, DOI 10.4049/jimmunol.0902212; Lee CH, 2010, J NATL CANCER I, V102, P1322, DOI 10.1093/jnci/djq300; Hollenhorst MI, 2012, BRIT J PHARMACOL, V166, P1388, DOI 10.1111/j.1476-5381.2012.01883.x; FUJII T, 1995, P JPN ACAD B-PHYS, V71, P231, DOI 10.2183/pjab.71.231; [Anonymous], 2007, LIFE SCI; Borovikova LV, 2000, NATURE, V405, P458; Rana OR, 2010, AUTON NEUROSCI-BASIC, V156, P82, DOI 10.1016/j.autneu.2010.04.011; Wessler I, 2008, BRIT J PHARMACOL, V154, P1558, DOI 10.1038/bjp.2008.185; Song P, 2008, J PHARMACOL SCI, V106, P180, DOI 10.1254/jphs.FM0070091; Grando SA, 2008, J PHARMACOL SCI, V106, P174, DOI 10.1254/jphs.FM0070087; Yamamoto K, 2011, J PLANT PHYSIOL, V168, P1987, DOI 10.1016/j.jplph.2011.06.001; [Anonymous], 2003, LIFE SCI; Rinner I, 1998, J NEUROIMMUNOL, V81, P31, DOI 10.1016/S0165-5728(97)00155-0; Qian J, 2011, GENES IMMUN, V12, P222, DOI 10.1038/gene.2010.72; Arredondo J, 2007, BIOCHEM PHARMACOL, V74, P1315, DOI 10.1016/j.bcp.2007.06.026; Pochini L, 2012, BBA-BIOMEMBRANES, V1818, P559, DOI 10.1016/j.bbamem.2011.12.014; Kummer W, 2014, CURR OPIN PHARMACOL, V16, P43, DOI 10.1016/j.coph.2014.03.001; Reinheimer T, 2000, AM J RESP CRIT CARE, V162, P534; Arredondo J, 2005, J INVEST DERMATOL, V125, P1236, DOI 10.1111/j.0022-202X.2005.23973.x; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Kirkpatrick CJ, 2003, LIFE SCI, V72, P2111, DOI 10.1016/S0024-3205(03)00069-9; Moriwaki Y, 2007, LIFE SCI, V80, P2365, DOI 10.1016/j.lfs.2006.12.028; Chen YM, 2015, J BIOL CHEM, V290, P23826, DOI 10.1074/jbc.M115.668061; Fujii YX, 2007, J NEUROIMMUNOL, V189, P69, DOI 10.1016/j.jneuroim.2007.07.003; Fujii T, 1996, J NEUROSCI RES, V44, P66, DOI 10.1002/(SICI)1097-4547(19960401)44:1<66::AID-JNR9>3.0.CO;2-G; Sato KZ, 1999, NEUROSCI LETT, V266, P17, DOI 10.1016/S0304-3940(99)00259-1; Nordstrom P, 2013, EUR HEART J, V34, P2585, DOI 10.1093/eurheartj/eht182; Skok MV, 2007, LIFE SCI, V80, P2334, DOI 10.1016/j.lfs.2007.02.005; Calzetta L, 2014, AM J RESP CELL MOL, V50, P493, DOI 10.1165/rcmb.2013-0119OC; Horiuchi Y, 2003, LIFE SCI, V72, P1745, DOI 10.1016/S0024-3205(02)02478-5; Fujii YX, 2007, J NEUROIMMUNOL, V188, P80, DOI 10.1016/j.jneuroim.2007.05.017; Chimienti F, 2003, HUM MOL GENET, V12, P3017, DOI 10.1093/hmg/ddg320; Besedovsky HO, 1996, ENDOCR REV, V17, P64, DOI 10.1210/er.17.1.64; Tsuji H, 2003, GENOMICS, V81, P26, DOI 10.1016/S0888-7543(02)00025-3; [Anonymous], 2012, LIFE SCI; Kakinuma Y, 2009, FEBS J, V276, P5111, DOI 10.1111/j.1742-4658.2009.07208.x; Grainge CL, 2011, NEW ENGL J MED, V364, P2006, DOI 10.1056/NEJMoa1014350; Bamel E.A., 2015, INT IMMUNOPHARMACOL, V29, P231; Castillo-Gonzalez AC, 2015, INT IMMUNOPHARMACOL, V29, P81, DOI 10.1016/j.intimp.2015.05.011; Chemyavsky A.I., 2015, INT IMMUNOPHARMACOL, V29, P15; Chernyavsky A, 2015, INT IMMUNOPHARMACOL, V29, P76, DOI 10.1016/j.intimp.2015.04.046; Chernyavsky AI, 2015, INT IMMUNOPHARMACOL, V29, P36, DOI 10.1016/j.intimp.2015.05.033; Darby M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004636; Deckmann K, 2015, INT IMMUNOPHARMACOL, V29, P51, DOI 10.1016/j.intimp.2015.05.038; Espanol AJ, 2015, INT IMMUNOPHARMACOL, V29, P87, DOI 10.1016/j.intimp.2015.03.018; Forsgren S, 2015, INT IMMUNOPHARMACOL, V29, P195, DOI 10.1016/j.intimp.2015.04.055; Fu XW, 2015, INT IMMUNOPHARMACOL, V29, P93, DOI 10.1016/j.intimp.2015.05.022; Fujii T, 2014, J NEUROIMMUNOL, V267, P43, DOI 10.1016/j.jneuroim.2013.12.003; Gergalova G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031361; Hainke S, 2015, INT IMMUNOPHARMACOL, V29, P135, DOI 10.1016/j.intimp.2015.05.010; Haupt M, 2015, INT IMMUNOPHARMACOL, V29, P208, DOI 10.1016/j.intimp.2015.06.029; Kakinuma Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050761; Kakinuma Y, 2015, INT IMMUNOPHARMACOL, V29, P185, DOI 10.1016/j.intimp.2015.05.029; Kalantari-Dehaghi M, 2015, INT IMMUNOPHARMACOL, V29, P99, DOI 10.1016/j.intimp.2015.04.041; Kalantari-Dehaghi M, 2012, LIFE SCI, V91, P1122, DOI 10.1016/j.lfs.2012.02.004; Kawashima K, 2015, INT IMMUNOPHARMACOL, V29, P127, DOI 10.1016/j.intimp.2015.04.015; Kishibe M, 2015, INT IMMUNOPHARMACOL, V29, P63, DOI 10.1016/j.intimp.2015.05.047; Kistemaker LEM, 2015, TRENDS PHARMACOL SCI, V36, P164, DOI 10.1016/j.tips.2014.11.005; Krasteva-Christ G, 2015, INT IMMUNOPHARMACOL, V29, P158, DOI 10.1016/j.intimp.2015.05.028; Lips KS, 2015, INT IMMUNOPHARMACOL, V29, P201, DOI 10.1016/j.intimp.2015.05.012; Lykhmus O, 2015, INT IMMUNOPHARMACOL, V29, P148, DOI 10.1016/j.intimp.2015.04.007; Michel-Schmidt R, 2015, INT IMMUNOPHARMACOL, V29, P115, DOI 10.1016/j.intimp.2015.04.005; Moriwaki Y, 2015, INT IMMUNOPHARMACOL, V29, P71, DOI 10.1016/j.intimp.2015.05.030; Nadorp B, 2015, INT IMMUNOPHARMACOL, V29, P8, DOI 10.1016/j.intimp.2015.04.058; Nassenstein C, 2015, INT IMMUNOPHARMACOL, V29, P173, DOI 10.1016/j.intimp.2015.08.007; Oikawa S, 2015, INT IMMUNOPHARMACOL, V29, P31, DOI 10.1016/j.intimp.2015.04.057; Panneck AR, 2014, CELL TISSUE RES, V358, P737, DOI 10.1007/s00441-014-2002-x; Pinheiro NM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120441; Pochini L, 2015, INT IMMUNOPHARMACOL, V29, P21, DOI 10.1016/j.intimp.2015.04.040; Roy A, 2014, MOL MED, V20, P527, DOI 10.2119/molmed.2014.00125; Slebos D.J, 2014, EUR RESP J S58, V44, P1774; Sloniecka M, 2015, INT IMMUNOPHARMACOL, V29, P57, DOI 10.1016/j.intimp.2015.05.039; Soultanova A, 2015, INT IMMUNOPHARMACOL, V29, P143, DOI 10.1016/j.intimp.2015.06.005; Spang C, 2015, INT IMMUNOPHARMACOL, V29, P189, DOI 10.1016/j.intimp.2015.05.053; Tjiu JW, 2011, BRIT J DERMATOL, V164, P47, DOI 10.1111/j.1365-2133.2010.10059.x; Wessler I, 2015, INT IMMUNOPHARMACOL, V29, P27, DOI 10.1016/j.intimp.2015.04.039; Wessler I, 2001, JPN J PHARMACOL, V85, P2, DOI 10.1254/jjp.85.2; Wiederhold S, 2015, INT IMMUNOPHARMACOL, V29, P45, DOI 10.1016/j.intimp.2015.06.027	85	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-5769	1878-1705		INT IMMUNOPHARMACOL	Int. Immunopharmacol.	NOV	2015	29	1			SI		1	7		10.1016/j.intimp.2015.08.023		7	Immunology; Pharmacology & Pharmacy	Immunology; Pharmacology & Pharmacy	CX0CW	WOS:000365365500001		
J	Oikawa, S; Mano, A; Iketani, M; Kakinuma, Y				Oikawa, Shino; Mano, Asuka; Iketani, Mitsue; Kakinuma, Yoshihiko			Nicotinic receptor-dependent and -independent effects of galantamine, an acetylcholinesterase inhibitor, on the non-neuronal acetylcholine system in C2C12 cells	INTERNATIONAL IMMUNOPHARMACOLOGY			English	Article						C2C12 cells; Non-neuronal acetylcholine; Acetylcholinesterase inhibitor; Galantamine; VEGF	SATELLITE CELLS; CARDIOMYOCYTES; ANGIOGENESIS; ISCHEMIA; STRATEGY; DISEASE; ATROPHY; HEART	We previously reported that satellite cells possess the ability to produce angiogenic factors, including fibroblast growth factor (FGF)-2 and vascular endothelial growth factor (VEGF) in vivo. However, whether C2C12 cells possess a non-neuronal cholinergic system (NNCS) or non-neuronal ACh (NNA) remains to be studied; therefore, we investigated the system using C2C12 cells and its regulatory mechanisms. C2C12 cells synthesized ACh, the level of which was comparable with that of cardiomyocytes, and the synthesis was augmented by the acetylcholinesterase inhibitor galantamine. The ChAT promoter activity was upregulated by nicotine or galantamine, partly through nicotinic receptors for both agents as well as through a non-nicotinic receptor pathway for galantamine. Further, VEGF secretion by C2C12 cells was also increased by nicotine or galantamine through nicotinic receptors as well as partly through non-nicotinic pathways in the case of galantamine. These results suggest that C2C12 cells are equipped with NNCS or NNA, which is positively regulated through nicotinic or non-nicotinic pathways, particularly in the case of galantamine. These results provide a novel concept that myogenic cells expressing NNA can be a therapeutic target for regulating angiogenic factor synthesis. (C) 2015 Elsevier B.V. All rights reserved.	[Oikawa, Shino; Mano, Asuka; Iketani, Mitsue; Kakinuma, Yoshihiko] Nippon Med Sch, Grad Sch Med, Dept Physiol, Bunkyo Ku, Tokyo 1138602, Japan	Kakinuma, Y (reprint author), Nippon Med Sch, Grad Sch Med, Dept Physiol, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	k12417853@nms.ac.jp			Smoking Research Foundation	This research was supported by a grant from the Smoking Research Foundation.	Noguchi T, 2014, CIRC J, V78, P2317, DOI 10.1253/circj.CJ-14-0095; Rhoads RP, 2009, AM J PHYSIOL-CELL PH, V296, pC1321, DOI 10.1152/ajpcell.00391.2008; Kakinuma Y, 2014, TRANSL RES, V164, P32, DOI 10.1016/j.trsl.2014.02.005; Kawashima K, 2012, ANN NY ACAD SCI, V1261, P7, DOI 10.1111/j.1749-6632.2012.06516.x; Hamann M, 1995, J PHYSIOL-LONDON, V489, P791; Rana OR, 2010, AUTON NEUROSCI-BASIC, V156, P82, DOI 10.1016/j.autneu.2010.04.011; Samochocki M, 2003, J PHARMACOL EXP THER, V305, P1024, DOI 10.1124/jpet.102.045773; Ten Broek RW, 2010, J CELL PHYSIOL, V224, P7, DOI 10.1002/jcp.22127; Kakinuma Y, 2010, J MOL CELL CARDIOL, V48, P680, DOI 10.1016/j.yjmcc.2009.11.010; Roy A, 2013, FASEB J, V27, P5072, DOI 10.1096/fj.13-238279; Coyle JT, 2007, J ALZHEIMERS DIS, V11, P491; Maelicke A, 2000, EUR J PHARMACOL, V393, P165, DOI 10.1016/S0014-2999(00)00093-5; Kawashima K, 2008, J PHARMACOL SCI, V106, P167, DOI 10.1254/jphs.FM0070073; Rocha-Resende C, 2012, J MOL CELL CARDIOL, V53, P206, DOI 10.1016/j.yjmcc.2012.05.003; Kuwabara M, 2006, J PHYSIOL SCI, V56, P95, DOI 10.2170/physiolsci.RP002305; Kakinuma Y, 2005, FEBS LETT, V579, P2111, DOI 10.1016/j.febslet.2005.02.065; Hao CN, 2015, INT J CARDIOL, V178, P253, DOI 10.1016/j.ijcard.2014.10.048; Kakinuma Y, 2009, FEBS J, V276, P5111, DOI 10.1111/j.1742-4658.2009.07208.x; Klapproth H, 1997, N-S ARCH PHARMACOL, V355, P515, DOI 10.1007/PL00004977; Beckmann J., 2014, PHARMACOLOGY, V92, P286; Shimizu-Motohashi Y, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00050; Wessler I, 2003, LIFE SCI, V72, P2055, DOI 10.1016/S0024-3205(03)00083-3	22	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-5769	1878-1705		INT IMMUNOPHARMACOL	Int. Immunopharmacol.	NOV	2015	29	1			SI		31	35		10.1016/j.intimp.2015.04.057		5	Immunology; Pharmacology & Pharmacy	Immunology; Pharmacology & Pharmacy	CX0CW	WOS:000365365500006		
J	Moriwaki, Y; Takada, K; Tsuji, S; Kawashima, K; Misawa, H				Moriwaki, Yasuhiro; Takada, Kiyoko; Tsuji, Shoutaro; Kawashima, Koichiro; Misawa, Hidemi			Transcriptional regulation of SLURP2, a psoriasis-associated gene, is under control of IL-22 in the skin: A special reference to the nested gene LYNX1	INTERNATIONAL IMMUNOPHARMACOLOGY			English	Article						Acetylcholine receptor; IL-22; Keratinocyte; LYNX1; SLURP	EXPRESSION; MELEDA; KERATINOCYTES; IL-17; STAT3	A novel nicotinic acetylcholine (ACh) receptor (nAChR)-mediated transduction pathway, regulating keratinocyte function, has been elucidated in studies of secreted mammalian Ly6/urokinase plasminogen activator receptor-related protein (SLURP)-1 and -2. SLURPs are members of Ly6/neurotoxin superfamily (Ly6SF) of proteins containing the unique three-finger domain in their three-dimensional structure. Some endogenously expressed Ly6SF proteins (such as LYNX1, SLURP-1, and SLURP-2) modulate the function of nAChR, either as allosteric and/or orthosteric modulators, or as antagonists. Although the expression and functions of SLURP-1 and SLURP-2 in keratinocytes are well documented, the expression and the modes of action of LYNX1 in keratinocytes are unknown. Additionally, a particular hybrid transcript, LYNX1-SLURP2, which contains both LYNX1 and SLURP-2 sequences, with unknown function, has been reported. Furthermore, although SLURP2 is a gene strongly induced in psoriatic skin lesions, the mechanisms controlling SLURP2 expression are largely unknown. To better understand the function of nAChRs in keratinocytes, we investigated the expression profiles of LYNX1, LYNX1-SLURP-2, and SLURP-2 in keratinocytes under various inflammatory conditions. We found that keratinocytes express LYNX1 and SLURP2, but not LYNX1-SLURP2, at mRNA and protein levels. IL-22 treatment increased SLURP2 expression in keratinocytes, but this effect was completely abolished by IFN-gamma. Furthermore, the IL-22-induced up-regulation of SLURP2 was completely suppressed by the inhibitor or siRNA for STAT3, a major transcriptional factor downstream of IL-22. These findings provide new insights into the nAChR-mediated regulatory mechanism of SLURP-2 expression in keratinocytes. (C) 2015 Elsevier B.V. All rights reserved.	[Moriwaki, Yasuhiro; Takada, Kiyoko; Misawa, Hidemi] Keio Univ, Dept Pharmacol, Fac Pharm, Tokyo 1058512, Japan; [Tsuji, Shoutaro] Kanagawa Canc Ctr, Res Inst, Mol Diagnost Project, Yokohama, Kanagawa, Japan; [Kawashima, Koichiro] Kitasato Univ, Sch Pharm, Dept Mol Pharmacol, Tokyo, Japan	Moriwaki, Y (reprint author), Keio Univ, Dept Pharmacol, Fac Pharm, Minato Ku, 1-5-30 Shibakoen, Tokyo 1058512, Japan.	moriwaki-ys@pha.keio.ac.jp; misawa-hd@pha.keio.ac.jp			JSPS KAKENHI [23111006, 26460692]; MEXT KAKENHI [25293020, 24590120]; MEXT-Supported Program for the Strategic Research Foundation at Private Universities; Smoking Research Foundation; Naito Foundation; Hoansha Foundation	We would like to thank Editage (www.editage.jp) for English language editing. This work was supported in part by JSPS KAKENHI Grant Number 23111006 (H.M.) and 26460692 (S.T.), MEXT KAKENHI Grant Number 25293020 (H.M.) and 24590120 (K.K.), MEXT-Supported Program for the Strategic Research Foundation at Private Universities 2014-2016 (H.M.), Smoking Research Foundation (KK. and H.M.), The Naito Foundation (H.M.) and Hoansha Foundation (H.M.).	Grando SA, 2006, J INVEST DERMATOL, V126, P1948, DOI 10.1038/sj.jid.5700151; Moriwaki Y, 2009, NEUROSCI RES, V64, P403, DOI 10.1016/j.neures.2009.04.014; Miyoshi K, 2011, J INVEST DERMATOL, V131, P108, DOI 10.1038/jid.2010.255; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; Arredondo J, 2005, J INVEST DERMATOL, V125, P1236, DOI 10.1111/j.0022-202X.2005.23973.x; Mastrangeli R, 2003, EUR J DERMATOL, V13, P560; Li BS, 2014, J INVEST DERMATOL, V134, P1828, DOI 10.1038/jid.2014.28; Arredondo J, 2006, J CELL PHYSIOL, V208, P238, DOI 10.1002/jcp.20661; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Galat A, 2008, CELL MOL LIFE SCI, V65, P3481, DOI 10.1007/s00018-008-8473-8; Chimienti F, 2003, HUM MOL GENET, V12, P3017, DOI 10.1093/hmg/ddg320; Tsuji H, 2003, GENOMICS, V81, P26, DOI 10.1016/S0888-7543(02)00025-3; Kiuchi N, 1999, J EXP MED, V189, P63, DOI 10.1084/jem.189.1.63; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2009, J MOL MED-JMM, V87, P523, DOI 10.1007/s00109-009-0457-0; Fischer J, 2001, HUM MOL GENET, V10, P875, DOI 10.1093/hmg/10.8.875; Boniface K, 2007, CLIN EXP IMMUNOL, V150, P407, DOI 10.1111/j.1365-2249.2007.03511.x; Tsetlin VI, 2015, TRENDS PHARMACOL SCI, V36, P109, DOI 10.1016/j.tips.2014.11.003	19	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-5769	1878-1705		INT IMMUNOPHARMACOL	Int. Immunopharmacol.	NOV	2015	29	1			SI		71	75		10.1016/j.intimp.2015.05.030		5	Immunology; Pharmacology & Pharmacy	Immunology; Pharmacology & Pharmacy	CX0CW	WOS:000365365500012		
J	Kawashima, K; Fujii, T; Moriwaki, Y; Misawa, H; Horiguchi, K				Kawashima, Koichiro; Fujii, Takeshi; Moriwaki, Yasuhiro; Misawa, Hidemi; Horiguchi, Kazuhide			Non-neuronal cholinergic system in regulation of immune function with a focus on alpha 7 nAChRs	INTERNATIONAL IMMUNOPHARMACOLOGY			English	Article						Acetylcholine (ACh); Choline acetyltransferase (ChAT); Cytokine; Nicotinic ACh receptor (nAChR); SLURP; Spleen	MUSCARINIC ACETYLCHOLINE-RECEPTOR; ACETYLTRANSFERASE MESSENGER-RNA; HUMAN MONONUCLEAR LEUKOCYTES; ANTIGEN-SPECIFIC IGG(1); T-CELL LINES; INFLAMMATORY REFLEX; ALLEGED OCCURRENCE; CLINICAL-ASPECTS; NERVOUS-SYSTEM; KNOCKOUT MICE	In 1929, Dale and Dudley described the first reported natural occurrence of acetylcholine (ACh) in an animal's body. They identified this ACh in the spleens of horses and oxen, which we now know suggests possible involvement of ACh in the regulation of lymphocyte activity and immune function. However, the source and function of splenic ACh were left unexplored for several decades. Recent studies on the source of ACh in the blood revealed ACh synthesis catalyzed by choline acetyltransferase (ChAT) in CD4(+) T cells. T and B cells, macrophages and dendritic cells (DCs) all express all five muscarinic ACh receptor subtypes (mAChRs) and several subtypes of nicotinic AChRs (nAChRs), including alpha 7 nAChRs. Stimulation of these mAChRs and nAChRs by their respective agonists causes functional and biochemical changes in the cells. Using AChR knockout mice, we found that M-1/M-5 mAChR signaling up-regulates IgG(1) and pro-inflammatory cytokine production, while a7 nAChR signaling has the opposite effect. These findings suggest that ACh synthesized by T cells acts in an autocrine/paracrine fashion at AChRs on various immune cells to modulate immune function. In addition, an endogenous allosteric and/or orthosteric alpha 7 nAChR ligand, SLURP-1, facilitates functional development of T cells and increases ACh synthesis via up-regulation of ChAT mRNA expression. SLURP-1 is expressed in CD205(+) DCs residing in the tonsil in close proximity to T cells, macrophages and B cells. Collectively, these findings suggest that ACh released from T cells along with SLURP-1 regulates cytokine production by activating alpha 7 nAChRs on various immune cells, thereby facilitating T cell development and/or differentiation, leading to immune modulation. (C) 2015 The Authors. Published by Elsevier B.V.	[Kawashima, Koichiro] Kitasato Univ, Sch Pharmaceut Sci, Dept Mol Pharmacol, Tokyo 1088641, Japan; [Fujii, Takeshi] Doshisha Womens Coll Liberal Arts, Fac Pharmaceut Sci, Dept Pharmacol, Kyotanabe, Kyoto 6100395, Japan; [Moriwaki, Yasuhiro; Misawa, Hidemi] Keio Univ, Dept Pharmacol, Fac Pharm, Tokyo 1058512, Japan; [Horiguchi, Kazuhide] Univ Fukui, Fac Med Sci, Dept Anat, Matsuoka, Fukui 9101193, Japan	Kawashima, K (reprint author), Kitasato Univ, Sch Pharmaceut Sci, Dept Mol Pharmacol, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan.	koichiro-jk@piano.ocn.ne.jp			Ministry of Education, Science, Sports and Culture (C) of Japan [20590096, 23590121, 24590120]; Astellas Foundation for Research on Metabolic Disorders; Mochida Memorial Foundation for Medical and Pharmaceutical Research; SRF	We would like to thank Professor Shiro Ono, Laboratory of Immunology, Faculty of Pharmacy, Osaka Ohtani University, for his valuable advice and suggestions on the role of alpha 7 nAChRs in the regulation of immune function. This manuscript was supported in part by a Grant-in-Aid for Scientific Research (20590096, 23590121, 24590120) from the Ministry of Education, Science, Sports and Culture (C) of Japan (KK, TF, KH), by the Astellas Foundation for Research on Metabolic Disorders (TF), the Mochida Memorial Foundation for Medical and Pharmaceutical Research (TF), and funding from SRF (KK, TF, KH).	KAWASHIMA K, 1989, NEUROSCI LETT, V104, P336, DOI 10.1016/0304-3940(89)90599-5; Kapfhammer J, 1930, H-S Z PHYSIOL CHEM, V191, P179, DOI 10.1515/bchm2.1930.191.3-4.179; TUCEK S, 1982, J PHYSIOL-LONDON, V322, P53; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Tesmer LA, 2008, IMMUNOL REV, V223, P87, DOI 10.1111/j.1600-065X.2008.00628.x; Loach JV, 1934, J PHYSIOL-LONDON, V82, P118; Kimura R, 2003, LIFE SCI, V72, P2155, DOI 10.1016/S0024-3205(03)00077-8; Kawashima K, 2007, LIFE SCI, V80, P2314, DOI 10.1016/j.lfs.2007.02.036; Fujii T, 2000, N-S ARCH PHARMACOL, V362, P14, DOI 10.1007/s002100000251; Dale HH, 1929, J PHYSIOL-LONDON, V68, P97; Olofsson PS, 2012, MOL MED, V18, P539, DOI 10.2119/molmed.2011.00405; BURGEN ASV, 1995, LIFE SCI, V56, P801, DOI 10.1016/0024-3205(95)00013-V; Fujii T, 1997, NEUROSCI LETT, V227, P21, DOI 10.1016/S0304-3940(97)00287-5; Bischoff C, 1931, H-S Z PHYSIOL CHEM, V200, P153, DOI 10.1515/bchm2.1931.200.4-6.153; Kawashima K, 2003, LIFE SCI, V74, P675, DOI 10.1016/j.lfs.2003.09.037; FUJII T, 1995, P JPN ACAD B-PHYS, V71, P231, DOI 10.2183/pjab.71.231; Fujii T, 2012, J NEUROIMMUNOL, V244, P16, DOI 10.1016/j.jneuroim.2011.12.022; Kawashima K, 2012, ANN NY ACAD SCI, V1261, P7, DOI 10.1111/j.1749-6632.2012.06516.x; Wessler I, 2008, BRIT J PHARMACOL, V154, P1558, DOI 10.1038/bjp.2008.185; Fujii T, 2012, LIFE SCI, V91, P981, DOI 10.1016/j.lfs.2012.04.031; Todman D, 2008, J CLIN NEUROSCI, V15, P972, DOI 10.1016/j.jocn.2008.01.001; Fujii T, 2003, NEUROCHEM RES, V28, P423, DOI 10.1023/A:1022840416292; Smyth HF, 1916, J EXP MED, V23, P265, DOI 10.1084/jem.23.3.265; Yamada S, 1997, NEUROSCI LETT, V225, P25, DOI 10.1016/S0304-3940(97)00188-2; RINNER I, 1993, J NEUROSCI RES, V35, P188, DOI 10.1002/jnr.490350209; Ravishankar B, 2014, P NATL ACAD SCI USA, V111, P4215, DOI 10.1073/pnas.1320924111; McClory S, 2012, J CLIN INVEST, V122, P1403, DOI 10.1172/JCI46125; Fujii T, 1998, J NEUROIMMUNOL, V82, P101, DOI 10.1016/S0165-5728(97)00195-1; Kawashima K, 2000, PHARMACOL THERAPEUT, V86, P29, DOI 10.1016/S0163-7258(99)00071-6; Dunant Y, 2009, ANN NY ACAD SCI, V1152, P100, DOI 10.1111/j.1749-6632.2008.04000.x; Zimring JC, 2005, J NEUROIMMUNOL, V164, P66, DOI 10.1016/j.jneuroim.2005.03.018; Rinner I, 1998, J NEUROIMMUNOL, V81, P31, DOI 10.1016/S0165-5728(97)00155-0; Fujii T, 2008, J PHARMACOL SCI, V106, P186, DOI 10.1254/jphs.FM0070109; Qian J, 2011, GENES IMMUN, V12, P222, DOI 10.1038/gene.2010.72; Dudley HW, 1933, J PHYSIOL-LONDON, V79, P249; FONNUM F, 1975, J NEUROCHEM, V24, P407, DOI 10.1111/j.1471-4159.1975.tb11895.x; Verbitsky M, 2000, NEUROPHARMACOLOGY, V39, P2515, DOI 10.1016/S0028-3908(00)00124-6; Naruse TK, 2002, TISSUE ANTIGENS, V59, P512, DOI 10.1034/j.1399-0039.2002.590608.x; Grando SA, 2012, LIFE SCI, V91, P969, DOI 10.1016/j.lfs.2012.10.004; KAWASHIMA K, 1980, J PHARMACOL METHOD, V3, P115, DOI 10.1016/0160-5402(80)90022-4; Kawashima K, 2004, FRONT BIOSCI, V9, P2063, DOI 10.2741/1390; Fujii T, 1995, NEUROSCI LETT, V201, P207, DOI 10.1016/0304-3940(95)12180-3; KAWASHIMA K, 1993, BIOGENIC AMINES, V9, P251; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Adermann K, 1999, PROTEIN SCI, V8, P810; Moriwaki Y, 2007, LIFE SCI, V80, P2365, DOI 10.1016/j.lfs.2006.12.028; Kawashima K, 2008, J PHARMACOL SCI, V106, P167, DOI 10.1254/jphs.FM0070073; Fujii YX, 2007, J NEUROIMMUNOL, V189, P69, DOI 10.1016/j.jneuroim.2007.07.003; Fujii T, 1996, J NEUROSCI RES, V44, P66, DOI 10.1002/(SICI)1097-4547(19960401)44:1<66::AID-JNR9>3.0.CO;2-G; Kawashima K, 2012, LIFE SCI, V91, P1027, DOI [10.1016/j.lfs.2012.05.006, 10.1016/j.lfs2012.05.006]; Sato KZ, 1999, NEUROSCI LETT, V266, P17, DOI 10.1016/S0304-3940(99)00259-1; Dale HH, 1914, J PHARMACOL EXP THER, V6, P147; Skok MV, 2007, LIFE SCI, V80, P2334, DOI 10.1016/j.lfs.2007.02.005; Horiuchi Y, 2003, LIFE SCI, V72, P1745, DOI 10.1016/S0024-3205(02)02478-5; Fujii T, 1999, NEUROSCI LETT, V259, P71, DOI 10.1016/S0304-3940(98)00921-5; Fujii YX, 2007, J NEUROIMMUNOL, V188, P80, DOI 10.1016/j.jneuroim.2007.05.017; Ewins AJ, 1914, BIOCHEM J, V8, P44; Chimienti F, 2003, HUM MOL GENET, V12, P3017, DOI 10.1093/hmg/ddg320; Dudley HW, 1929, BIOCHEM J, V23, P1064; Chernyavsky AI, 2014, BIOMED RES INT, DOI 10.1155/2014/609086; PLAUT M, 1987, ANNU REV IMMUNOL, V5, P621, DOI 10.1146/annurev.immunol.5.1.621; Fischer J, 2001, HUM MOL GENET, V10, P875, DOI 10.1093/hmg/10.8.875; Bray C, 2005, MOL HUM REPROD, V11, P881, DOI 10.1093/molehr/gah245; Vezys V, 2007, LIFE SCI, V80, P2330, DOI 10.1016/j.lfs.2007.01.001; Moser N, 2007, J NEUROCHEM, V102, P479, DOI 10.1111/j.1471-4159.2007.04498.x; Arredondo J., 2005, J INVEST DERMATOL, V125, P1326; Barnes S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116023; Chemyavsky A.I., 2010, AM J PHYSIOL-CELL PH, V299, pC903; DALE HENRY, 1935, PROC ROY SOC MED, V28, P319; Dale H.H., 1934, J PHYSIOL-LONDON, V80, P10; Danchakoff V., 1919, J EXP MED, V27, P87; Fujii T, 2014, J NEUROIMMUNOL, V267, P43, DOI 10.1016/j.jneuroim.2013.12.003; Fukuya T., 2012, P NATL ACAD SCI USA, V109, P11288; Homo-Delarche F., 1994, IMMUNOPHARMACOLOGY L, P169; Hunt R., 1906, BRIT MED J, V2, P1788; Kajiyama K., 1991, JPN J PHARM S1, V55, p194P; Kajiyama K., 1992, JAPANESE J PHARM S1, V58, p59P; Kawashima K., 1987, NEUROSCI LETT, V80, P209; LOEWI O., 1926, PFLUGER S ARCH GES PHYSIOL, V214, P678, DOI 10.1007/BF01741946; Loewi O, 1921, PFLUG ARCH GES PHYS, V189, P239, DOI 10.1007/BF01738910; MASLINSKI W, 1989, Brain Behavior and Immunity, V3, P1; Mott F W, 1899, Br Med J, V1, P1082; Nordberg A., 1992, BRAIN METAB REV, V4, P303; Razani-Boroujerdi S, 2007, J IMMUNOL, V179, P2889; Tjiu JW, 2011, BRIT J DERMATOL, V164, P47, DOI 10.1111/j.1365-2133.2010.10059.x	86	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-5769	1878-1705		INT IMMUNOPHARMACOL	Int. Immunopharmacol.	NOV	2015	29	1			SI		127	134		10.1016/j.intimp.2015.04.015		8	Immunology; Pharmacology & Pharmacy	Immunology; Pharmacology & Pharmacy	CX0CW	WOS:000365365500022		
J	Oikawa, S; Mano, A; Takahashi, R; Kakinuma, Y				Oikawa, Shino; Mano, Asuka; Takahashi, Rina; Kakinuma, Yoshihiko			Remote ischemic preconditioning with a specialized protocol activates the non-neuronal cardiac cholinergic system and increases ATP content in the heart	INTERNATIONAL IMMUNOPHARMACOLOGY			English	Article						Non-neuronal cardiac cholinergic system; Remote ischemic preconditioning; ATP; Energy metabolism	SIRTUIN 6 PROTECTS; CARDIOPROTECTION; METABOLISM; CARDIOMYOCYTES; MYOCARDIUM; MECHANISMS	Ischemic preconditioning (IPC) renders the targeted organ resistant to prolonged ischemic insults, leading to organoprotection. Among several means to achieve IPC, we reported that remote ischemic preconditioning (RIPC) activates the non-neuronal cardiac cholinergic system (NNCCS) to accelerate de novo ACh synthesis in cardiomyocytes. In the current study, we aimed to optimize a specific protocol to most efficiently activate NNCCS using RIPC. In this study, we elucidated that the protocol with 3 min of ischemia repeated three times increased cardiac ChAT expression (139.2 +/- 0.4%; P < 0.05) as well as ACh (142 +/- 2.0 x 10(-8) M; P < 0.05) and ATP content (2.13 +/- 0.19 mu mol/g tissue; P < 0.05) in the heart. Moreover, in the specific protocol, several characteristic responses against energy starvation and for obtaining adequate energy were observed; therefore, it is suggested that RIPC evokes a robust response by the heart to activate NNCCS through the modification of energy metabolism. (C) 2015 Elsevier B.V. All rights reserved.	[Oikawa, Shino; Mano, Asuka; Takahashi, Rina; Kakinuma, Yoshihiko] Nippon Med Sch, Grad Sch Med, Dept Physiol, Tokyo 1138602, Japan	Kakinuma, Y (reprint author), Nippon Med Sch, Grad Sch Med, Dept Physiol, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	k12417853@nms.ac.jp			Vehicle Racing Commemorative Foundation; Japan Society for the Promotion of Science [25460333]	We would like to thank Mitsue Iketani for her patient and diligent work and help. This research was supported by The Vehicle Racing Commemorative Foundation, and partly by a grant-in-aid from the Japan Society for the Promotion of Science (25460333).	Wu PF, 2000, ARCH BIOCHEM BIOPHYS, V381, P1, DOI 10.1006/abbi.2000.1946; Fillmore N, 2013, BBA-MOL CELL RES, V1833, P857, DOI 10.1016/j.bbamcr.2012.08.014; PRZYKLENK K, 1993, CIRCULATION, V87, P893; Mastitskaya S, 2012, CARDIOVASC RES, V95, P487, DOI 10.1093/cvr/cvs212; Donato M, 2013, EXP PHYSIOL, V98, P425, DOI 10.1113/expphysiol.2012.066217; Basalay M, 2012, EXP PHYSIOL, V97, P908, DOI 10.1113/expphysiol.2012.064923; Zhao GX, 2008, AM J PHYSIOL-HEART C, V294, pH936, DOI 10.1152/ajpheart.00870.2007; Kakinuma Y, 2009, FEBS J, V276, P5111, DOI 10.1111/j.1742-4658.2009.07208.x; Webster KA, 2012, NAT MED, V18, P1617, DOI 10.1038/nm.2983; Kakinuma Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050761; Maksin-Matveev A, 2015, EXP CELL RES, V330, P81, DOI 10.1016/j.yexcr.2014.07.013; McCafferty K, 2014, DIS MODEL MECH, V7, P1321, DOI 10.1242/dmm.016741; Oikawa S, 2014, CELL PHYSIOL BIOCHEM, V34, P781, DOI 10.1159/000363042; Randhawa PK, 2015, EUR J PHARMACOL, V746, P317, DOI 10.1016/j.ejphar.2014.08.016; Yu SS, 2013, BRIT J PHARMACOL, V168, P117, DOI 10.1111/j.1476-5381.2012.01903.x	15	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-5769	1878-1705		INT IMMUNOPHARMACOL	Int. Immunopharmacol.	NOV	2015	29	1			SI		181	184		10.1016/j.intimp.2015.06.004		4	Immunology; Pharmacology & Pharmacy	Immunology; Pharmacology & Pharmacy	CX0CW	WOS:000365365500030		
J	Kakinuma, Y				Kakinuma, Yoshihiko			Future perspectives of a cardiac non-neuronal acetylcholine system targeting cardiovascular diseases as an adjunctive tool for metabolic intervention	INTERNATIONAL IMMUNOPHARMACOLOGY			English	Article						Cardiomyocytes; Non-neuronal ACh; Energy metabolism; Angiogenesis; Ischemia resistance	VAGUS NERVE-STIMULATION; HEART-FAILURE; VAGAL-STIMULATION; SATELLITE CELLS; CARDIOMYOCYTES; ARRHYTHMIAS; ISCHEMIA; THERAPY; ATROPHY; HUMANS	It has been several years since the function of the non-neuronal cholinergic system was independently reported in cardiomyocytes by several research groups. Although these findings initially seemed to be negligible and insignificant, extraordinary findings about cardiomyocytes were subsequently reported in studies involving the knockdown of the non-neuronal cholinergic system. These studies provide the evidence that this system may be indispensable for maintaining principal cardiac functions. Despite the absence of an appropriate and reliable technology to detect cellular ACh in real time in cardiomyocytes, studies of this system have progressed, albeit very slowly, to gradually consolidate the significance of this system. Based on the many significant findings regarding this system, these will be critical to develop adjunctive intervention therapy against cardiovascular diseases, including peripheral artey disease and heart failure. In this study, previous studies focusing on the non-neuronal cholinergic system are reviewed along with our studies, both indicating the biologically significant roles of the cardiac non-neuronal acetylcholine system from a clinical perspective. (C) 2015 Elsevier B.V. All rights reserved.	[Kakinuma, Yoshihiko] Nippon Med Sch, Grad Sch Med, Dept Physiol, Bunkyo Ku, Tokyo 1138602, Japan	Kakinuma, Y (reprint author), Nippon Med Sch, Grad Sch Med, Dept Physiol, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	k12417853@nms.ac.jp					Noguchi T, 2014, CIRC J, V78, P2317, DOI 10.1253/circj.CJ-14-0095; Inanaga K, 2010, ATHEROSCLEROSIS, V213, P52, DOI 10.1016/j.atherosclerosis.2010.07.027; Tateno K, 2006, CIRC RES, V98, P1194, DOI 10.1161/01.RES.0000219901.13974.15; Kakinuma Y, 2014, TRANSL RES, V164, P32, DOI 10.1016/j.trsl.2014.02.005; Dicarlo L, 2013, J CARD FAIL, V19, P655, DOI 10.1016/j.cardfail.2013.07.002; Borovikova LV, 2000, NATURE, V405, P458; Hamann M, 1995, J PHYSIOL-LONDON, V489, P791; Rana OR, 2010, AUTON NEUROSCI-BASIC, V156, P82, DOI 10.1016/j.autneu.2010.04.011; Kakinuma Y, 2010, J MOL CELL CARDIOL, V48, P680, DOI 10.1016/j.yjmcc.2009.11.010; Roy A, 2013, FASEB J, V27, P5072, DOI 10.1096/fj.13-238279; Wessler I, 1998, PHARMACOL THERAPEUT, V77, P59, DOI 10.1016/S0163-7258(97)00085-5; ZUANETTI G, 1987, CIRC RES, V61, P429; Kawano H, 2003, HEART VESSELS, V18, P32, DOI 10.1007/s003800300005; Nordstrom P, 2013, EUR HEART J, V34, P2585, DOI 10.1093/eurheartj/eht182; Heeschen C, 2002, J CLIN INVEST, V110, P527, DOI 10.1172/JCI200214676; Rocha-Resende C, 2012, J MOL CELL CARDIOL, V53, P206, DOI 10.1016/j.yjmcc.2012.05.003; Kuwabara M, 2006, J PHYSIOL SCI, V56, P95, DOI 10.2170/physiolsci.RP002305; Kakinuma Y, 2005, FEBS LETT, V579, P2111, DOI 10.1016/j.febslet.2005.02.065; Sabino JPJ, 2013, AUTON NEUROSCI-BASIC, V173, P58, DOI 10.1016/j.autneu.2012.11.007; Schwartz PJ, 2008, EUR J HEART FAIL, V10, P884, DOI 10.1016/j.ejheart.2008.07.016; Hoover DB, 2004, CARDIOVASC RES, V62, P112, DOI 10.1016/j.cardiores.2004.01.012; Kakinuma Y, 2009, FEBS J, V276, P5111, DOI 10.1111/j.1742-4658.2009.07208.x; Kato K, 1999, NEUROSCI LETT, V260, P5, DOI 10.1016/S0304-3940(98)00943-4; De Ferrari GM, 2014, EUR J HEART FAIL, V16, P692, DOI 10.1002/ejhf.80; Lataro RM, 2013, AM J PHYSIOL-REG I, V305, pR908, DOI 10.1152/ajpregu.00102.2013; Arikawa M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020629; Clancy JA, 2014, BRAIN STIMUL, V7, P871, DOI 10.1016/j.brs.2014.07.031; Gavioli M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100179; Kakinuma Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050761; Kakinuma Y, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.004887; Oikawa S, 2014, CELL PHYSIOL BIOCHEM, V34, P781, DOI 10.1159/000363042; Santos-Almeida FM, 2015, AM J PHYSIOL-HEART C, V308, pH101, DOI 10.1152/ajpheart.00591.2014	32	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-5769	1878-1705		INT IMMUNOPHARMACOL	Int. Immunopharmacol.	NOV	2015	29	1			SI		185	188		10.1016/j.intimp.2015.05.029		4	Immunology; Pharmacology & Pharmacy	Immunology; Pharmacology & Pharmacy	CX0CW	WOS:000365365500031		
J	Kobayashi, S; Tanaka, T; Moue, M; Ohashi, S; Nishikawa, T				Kobayashi, Shunsuke; Tanaka, Toru; Moue, Masamitsu; Ohashi, Sachiyo; Nishikawa, Taishi			YB-1 gene expression is kept constant during myocyte differentiation through replacement of different transcription factors and then falls gradually under the control of neural activity	INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY			English	Article						Skeletal muscle cells; Differentiation; YB-1 gene; Transcription factors	MOUSE SKELETAL-MUSCLE; MESSENGER-RNA; PROMOTER; PROTEIN; MICE	We have previously reported that translation of acetylcholine receptor alpha-subunit (AChR alpha) mRNA in skeletal muscle cells is regulated by Y-box binding protein 1 (YB-1) in response to neural activity, and that in the postnatal mouse developmental changes in the amount of YB-1 mRNA are similar to those of AChR a mRNA, which is known to be regulated by myogenic transcription factors. Here, we examined transcriptional regulation of the YB-1 gene in mouse skeletal muscle and differentiating C2C12 myocytes. Although neither YB-1 nor AChR alpha was detected at either the mRNA or protein level in adult hind limb muscle, YB-1 expression was transiently activated in response to denervation of the sciatic nerve and completely paralleled that of AChR a, suggesting that these genes are regulated by the same transcription factors. However, during differentiation of C2C12 cells to myotubes, the level of YB-1 remained constant even though the level of AChR a increased markedly. Reporter gene, gel mobility shift and ChIP assays revealed that in the initial stage of myocyte differentiation, transcription of the YB-1 gene was regulated by E2F1 and Spl, and was then gradually replaced under the control of both MyoD and myogenin through an E-box sequence in the proximal region of the YB-1 gene promoter. These results suggest that transcription factors for the YB-1 gene are exchanged during skeletal muscle cell differentiation, perhaps playing a role in translational control of mRNAs by YB-1 in both myotube formation and the response of skeletal muscle tissues to neural stimulation. (C) 2015 Elsevier Ltd. All rights reserved.	[Kobayashi, Shunsuke; Tanaka, Toru; Moue, Masamitsu; Ohashi, Sachiyo; Nishikawa, Taishi] Nihon Univ, Sch Pharm, Dept Biochem, Funabashi, Chiba 2748555, Japan	Kobayashi, S (reprint author), Nihon Univ, Sch Pharm, Dept Biochem, 7-7-1 Narashinodai, Funabashi, Chiba 2748555, Japan.	kobayashi.shunsuke@nihon-u.ac.jp			Nihon University Multidisciplinary Research Grants [14-023/15-019]	This work was supported in part by Nihon University Multidisciplinary Research Grants (Grant no. 14-023/15-019).	REIKOFSKI J, 1992, BIOTECHNOL ADV, V10, P535, DOI 10.1016/0734-9750(92)91451-J; DUCLERT A, 1995, PHYSIOL REV, V75, P339; VANDEKLUNDERT FAJM, 1994, J BIOL CHEM, V269, P220; EFTIMIE R, 1991, P NATL ACAD SCI USA, V88, P1349, DOI 10.1073/pnas.88.4.1349; Tanaka T, 2012, BBA-GEN SUBJECTS, V1820, P1035, DOI 10.1016/j.bbagen.2012.04.005; Shiota M, 2008, CANCER RES, V68, P98, DOI 10.1158/0008-5472.CAN-07-2981; Biesiada E, 1999, MOL CELL BIOL, V19, P2577; PRODY CA, 1991, J BIOL CHEM, V266, P22588; Eliseeva IA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1402, DOI 10.1134/S0006297911130049; Skabkin MA, 2004, NUCLEIC ACIDS RES, V32, P5621, DOI 10.1093/nar/gkh889; Lyabin DN, 2014, WIRES RNA, V5, P95, DOI 10.1002/wrna.1200; Higuchi T, 2008, BBA-GEN SUBJECTS, V1780, P274, DOI 10.1016/j.bbagen.2007.11.005; Ohashi S, 2009, MOL CELL BIOCHEM, V327, P267, DOI 10.1007/s11010-009-0065-x; Tanaka T, 2010, CELL MOL NEUROBIOL, V30, P1089, DOI 10.1007/s10571-010-9541-9; Ohashi S, 2011, BIOCHEM BIOPH RES CO, V414, P647, DOI 10.1016/j.bbrc.2011.09.086; Evdokimova VM, 1999, INT J BIOCHEM CELL B, V31, P139, DOI 10.1016/S1357-2725(98)00137-X; Miwa A, 2006, BBA-GEN SUBJECTS, V1760, P1675, DOI 10.1016/j.bbagen.2006.08.027; FONTAINE B, 1988, EMBO J, V7, P603; WANG J, 1995, CELL GROWTH DIFFER, V6, P1299; MERLIE JP, 1989, NEURON, V2, P1295, DOI 10.1016/0896-6273(89)90067-6; Yokoyama H, 2003, BIOCHEM BIOPH RES CO, V303, P140, DOI 10.1016/S0006-291X(03)00296-1	21	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1357-2725	1878-5875		INT J BIOCHEM CELL B	Int. J. Biochem. Cell Biol.	NOV	2015	68						1	8		10.1016/j.biocel.2015.08.008		8	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CW3HU	WOS:000364883500001		
J	Shimizu, S; Yonezawa, R; Negoro, T; Yamamoto, S; Numata, T; Ishii, M; Mori, Y; Toda, T				Shimizu, Shunichi; Yonezawa, Ryo; Negoro, Takaharu; Yamamoto, Shinichiro; Numata, Tomohiro; Ishii, Masakazu; Mori, Yasuo; Toda, Takahiro			Sensitization of H2O2-induced TRPM2 activation and subsequent interleukin-8 (CXCL8) production by intracellular Fe2+ in human monocytic U937 cells	INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY			English	Article						TRPM2 channel; Hydrogen peroxide; Ferrous iron; CXCL8; U937 cells	POTENTIAL MELASTATIN 2; POLY(ADP-RIBOSE) POLYMERASE; OXIDATIVE STRESS; ADP-RIBOSE; INTRACEREBRAL HEMORRHAGE; INSULIN-SECRETION; HYDROGEN-PEROXIDE; CALCIUM-CHANNELS; BRAIN-INJURY; CA2+ INFLUX	Transient receptor potential melastatin 2 (TRPM2) is an oxidative stress-sensitive Ca2+-permeable channel. In monocytes/macrophages, H2O2-induced TRPM2 activation causes cell death and/or production of chemokines that aggravate inflammatory diseases. However, relatively high concentrations of H2O2 are required for activation of TRPM2 channels in vitro. Thus, in the present study, factors that sensitize TRPM2 channels to H2O2 were identified and subsequent physiological responses were examined in U937 human monocytes. Temperature increase from 30 degrees C to 37 degrees C enhanced H2O2-induced TRPM2-mediated increase in intracellular free Ca2+ ([Ca2+](i)) in TRPM2-expressing HEK 293 cells (TRPM2/HEK cells). The H2O2-induced TRPM2 activation enhanced by the higher temperature was dramatically sensitized by intracellular Fe2+-accumulation following pretreatment with FeSO4. Thus intracellular Fe2+-accumulation sensitizes H2O2-induced TRPM2 activation at around body temperature. Moreover, intracellular Fe2+-accumulation increased poly(ADP-ribose) levels in nuclei by H2O2 treatment, and the sensitization of H2O2-induced TRPM2 activation were almost completely blocked by poly(ADP-ribose) polymerase inhibitors, suggesting that intracellular Fe2+-accumulation enhances H2O2-induced TRPM2 activation by increase of ADP-ribose production through poly(ADP-ribose) polymerase pathway. Similarly, pretreatment with FeSO4 stimulated H2O2-induced TRPM2 activation at 37 degrees C in U937 cells and enhanced H2O2-induced ERK phosphorylation and interleukin-8 (CXCL8) production. Although the addition of H2O2 to cells under conditions of intracellular Fe2*-accumulation caused cell death, concentration of H2O2 required for CXCL8 production was lower than that resulting in cell death. These results indicate that intracellular Fe2+-accumulation sensitizes TRPM2 channels to H2O2 and subsequently produces CXCL8 at around body temperature. It is possible that sensitization of H2O2-induced TRPM2 channels by Fe2+ may implicated in hemorrhagic brain injury via aggravation of inflammation, since Fe2+ is released by heme degradation under intracerebral hemorrhage. (C) 2015 Elsevier Ltd. All rights reserved.	[Shimizu, Shunichi; Toda, Takahiro] Yokohama Coll Pharm, Pharmacol Lab, Dept Clin Pharm, Yokohama, Kanagawa 2450066, Japan; [Shimizu, Shunichi] Teikyo Heisei Univ, Div Pharmacol, Fac Pharmaceut Sci, Nakano Ku, Tokyo 1648530, Japan; [Yonezawa, Ryo; Ishii, Masakazu] Showa Univ, Sch Pharm, Div Physiol & Pathol, Dept Pharmacol Toxicol & Therapeut, Tokyo 1428555, Japan; [Negoro, Takaharu] Showa Univ, Sch Pharm, Dept Pharmacogen, Tokyo 1428555, Japan; [Yamamoto, Shinichiro] Univ Tokushima, Grad Sch, Dept Mol Cell Biol & Med, Inst Hlth Biosci, Tokushima 7708505, Japan; [Numata, Tomohiro; Mori, Yasuo] Kyoto Univ, Dept Synthet Chem & Biol Chem, Grad Sch Engn, Kyoto 6158510, Japan	Shimizu, S (reprint author), Teikyo Heisei Univ, Div Pharmacol, Fac Pharmaceut Sci, Nakano Ku, 4-21-2 Nakano, Tokyo 1648530, Japan.	s.shimizu@thu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24590124]	We thank Sayaka Yukimoto, who is a student in the Showa University School of Pharmacy, for technical assistance. This work was supported in part by KAKENHI [Grant-in-Aid for Scientific Research (C), 24590124] from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The authors would like to thank Enago (www.enago.jp) for the English language review.	Yamamoto S, 2008, NAT MED, V14, P738, DOI 10.1038/nm1758; Uchida K, 2011, ENDOCR J, V58, P1021; Zhang W, 2003, J BIOL CHEM, V278, P16222, DOI 10.1074/jbc.M300298200; Okauchi M, 2009, STROKE, V40, P1858, DOI 10.1161/STROKEAHA.108.535765; Wehrhahn J, 2010, J IMMUNOL, V184, P2386, DOI 10.4049/jimmunol.0902474; TANUMA SI, 1985, ARCH BIOCHEM BIOPHYS, V237, P38, DOI 10.1016/0003-9861(85)90251-6; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Cohausz O, 2008, CELL MOL LIFE SCI, V65, P644, DOI 10.1007/s00018-008-7516-5; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Fonfria E, 2004, BRIT J PHARMACOL, V143, P186, DOI 10.1038/sj.bjp.0705914; Kheradpezhouh E, 2014, P NATL ACAD SCI USA, V111, P3176, DOI 10.1073/pnas.1322657111; Wang JA, 2010, PROG NEUROBIOL, V92, P463, DOI 10.1016/j.pneurobio.2010.08.001; Fonfria E, 2005, J NEUROCHEM, V95, P715, DOI 10.1111/j.1471-4159.2005.03396.x; Wehage E, 2002, J BIOL CHEM, V277, P23150, DOI 10.1074/jbc.M112096200; Yang KT, 2006, CELL DEATH DIFFER, V13, P1815, DOI 10.1038/sj.cdd.4401813; Hiroi T, 2013, CARDIOVASC RES, V97, P271, DOI 10.1093/cvr/cvs332; Perraud AL, 2003, CELL CALCIUM, V33, P519, DOI 10.1016/S0143-4160(03)00057-5; Wu H, 2011, J CEREBR BLOOD F MET, V31, P1243, DOI 10.1038/jcbfm.2010.209; Kashio M, 2012, P NATL ACAD SCI USA, V109, P6745, DOI 10.1073/pnas.1114193109; Ishii M, 2006, CELL CALCIUM, V39, P487, DOI 10.1016/j.ceca.2006.01.013; Wu H, 2012, NEUROBIOL DIS, V45, P388, DOI 10.1016/j.nbd.2011.08.028; Togashi K, 2006, EMBO J, V25, P1804, DOI 10.1038/sj.emboj.7601083; Zhang WY, 2006, AM J PHYSIOL-CELL PH, V290, pC1146, DOI 10.1152/ajpcell.00205.2005.; Hegedus C, 2014, REDOX BIOL, V2, P978, DOI 10.1016/j.redox.2014.08.003; Wu JM, 2003, STROKE, V34, P2964, DOI 10.1161/01.STR.0000103140.52838.45; Oliver FJ, 1999, EMBO J, V18, P4446, DOI 10.1093/emboj/18.16.4446; DEMURCIA G, 1994, TRENDS BIOCHEM SCI, V19, P172, DOI 10.1016/0968-0004(94)90280-1; Zou J, 2013, AM J PHYSIOL-CELL PH, V305, pC61, DOI 10.1152/ajpcell.00390.2012; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Naziroglu M, 2012, PHYSIOL BEHAV, V105, P683, DOI 10.1016/j.physbeh.2011.10.005; Akpinar A, 2014, J MEMBRANE BIOL, V247, P451, DOI 10.1007/s00232-014-9652-1; Buelow Ben, 2008, J Biol Chem, V283, P24571, DOI 10.1074/jbc.M802673200; Naziroglu M, 2014, J MEMBRANE BIOL, V247, P253, DOI 10.1007/s00232-014-9630-7; Shimizu S, 2014, HANDB EXP PHARMACOL, V223, P767, DOI 10.1007/978-3-319-05161-1_3; Shimizu S, 2014, EUR J PHARMACOL, V742, P22, DOI 10.1016/j.ejphar.2014.08.023	35	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1357-2725	1878-5875		INT J BIOCHEM CELL B	Int. J. Biochem. Cell Biol.	NOV	2015	68						119	127		10.1016/j.biocel.2015.09.005		9	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CW3HU	WOS:000364883500015		
J	Sato, M; Narukawa, M				Sato, Masahiko; Narukawa, Mamoru			Factors affecting intrasubject variability in PK exposure: Absolute oral bioavailability and the acidic nature of drugs	INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS			English	Article						bioequivalence; intrasubject variability; absolute bioavailability; acidic drugs	HIGHLY VARIABLE DRUGS; BIOPHARMACEUTICAL CLASSIFICATION-SYSTEM; BIOEQUIVALENCE; DISSOLUTION; FDA; PHARMACOKINETICS; PREDICTION; ABSORPTION; BIOWAIVERS; SIMULATION	Objectives: The aim of the present study is to investigate factors affecting intrasubject variability of pharmacokinetic (PK) exposure, which affect the results of bioequivalence (BE) studies. We focused on two factors: absolute oral bioavailability (BA) and acidic nature of drugs. Methods: Intrasubject coefficient of variation (CV) for C-max and AUC was estimated based on the 90% confidence intervals (CIs) and the number of subjects from fasting BE study results for our investigation. Relationships between the intrasubject CV and, the absolute oral BA as well as the acidic nature of the drugs were investigated. Results: First, the relationship between absolute oral BA and intrasubject variability of PK exposure (C-max and AUC) showed negative log-linear relationship in the BE studies following oral administration of 65 immediate-release drugs under fasted condition. Drugs with poor absolute oral BA of less than 5% showed high intrasubject CV in the range of 30 - 65%. In contrast, drugs with high absolute oral BA of more than 80% showed low intrasubject CV of less than 20%. Second, acidic drugs with pKa < 6 had higher intrasubject CV of C-max than AUC compared to other types of drugs. The intrasubject CV ratios of C-max to AUC for acidic drugs with pKa < 6 were significantly higher than those for other types of drugs. Conclusion: Results show that absolute oral BA is one of the major factors that predict the extent of intrasubject variability of PK exposure. Acidic nature of drugs is thought to be an additional factor increasing intrasubject variability of C-max as compared to AUC.	[Sato, Masahiko; Narukawa, Mamoru] Kitasato Univ, Grad Sch Pharmaceut Sci, Dept Clin Med Pharmaceut Med, Tokyo 1088641, Japan	Sato, M (reprint author), Kitasato Univ, Grad Sch Pharmaceut Sci, Dept Clin Med Pharmaceut Med, Pharm,Minato Ku, Shirokane 5-9-1, Tokyo 1088641, Japan.	masahiko.sato@novartis.com					Bullingham R, 1996, J CLIN PHARMACOL, V36, P315; Kortejarvi H, 2007, EUR J PHARM SCI, V30, P155, DOI 10.1016/j.ejps.2006.10.011; Haidar SH, 2008, PHARM RES, V25, P237, DOI 10.1007/s11095-007-9434-x; Cushing DJ, 2012, CLIN EXP PHARMACOL P, V39, P3, DOI 10.1111/j.1440-1681.2011.05616.x; Tsume Y, 2012, BIOPHARM DRUG DISPOS, V33, P366, DOI 10.1002/bdd.1800; Tubic-Grozdanis M, 2008, AAPS J, V10, P213, DOI 10.1208/s12248-008-9023-x; Davit BM, 2008, AAPS J, V10, P148, DOI 10.1208/s12248-008-9015-x; Rinaki E, 2004, PHARM RES, V21, P1567, DOI 10.1023/B:PHAM.0000041450.25106.c8; Rescigno A, 1996, PHARMACOL RES, V34, P149, DOI 10.1006/phrs.1996.0080; STEINIJANS VW, 1995, INT J CLIN PHARM TH, V33, P427; Karalis V, 2012, PHARM RES-DORDR, V29, P1066, DOI 10.1007/s11095-011-0651-y; Yazdanian M, 2004, PHARM RES, V21, P293, DOI 10.1023/B:PHAM.0000016242.48642.71; Basmenji S, 2011, ARZNEIMITTEL-FORSCH, V61, P566, DOI 10.1055/s-0031-1300554; Biernacka J, 2013, ACTA POL PHARM, V70, P877; DRESSMAN JB, 1990, PHARMACEUT RES, V7, P756, DOI 10.1023/A:1015827908309; Flores-Murrieta Francisco J, 2007, Proc West Pharmacol Soc, V50, P64; Tanguay M, 2002, AAPS PHARM SCI, V4	17	0	0	DUSTRI-VERLAG DR KARL FEISTLE	DEISENHOFEN-MUENCHEN	BAHNHOFSTRASSE 9 POSTFACH 49, D-82032 DEISENHOFEN-MUENCHEN, GERMANY	0946-1965			INT J CLIN PHARM TH	Int. J. Clin. Pharmacol. Ther.	NOV	2015	53	11					955	962		10.5414/CP202399		8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CX1ML	WOS:000365460200007		
J	Quartieri, F; Shinohara, R				Quartieri, Federico; Shinohara, Ryusuke			Coalition-proofness in a class of games with strategic substitutes	INTERNATIONAL JOURNAL OF GAME THEORY			English	Article						Coalition-proof Nash equilibrium; Pareto dominance; Strategic substitutes; Externalities; Generalized aggregative games	COMPARATIVE STATICS; AGGREGATIVE GAMES; NASH EQUILIBRIA; PUBLIC GOOD; COMPLEMENTS; EXISTENCE; DOMINANCE; OLIGOPOLY; SET	We examine the coalition-proofness and Pareto properties of Nash equilibria in pure strategy -interactive games with strategic substitutes and increasing/decreasing externalities. For this class of games: (i) we prove the equivalence among the set of Nash equilibria, the set of coalition-proof Nash equilibria under strong Pareto dominance and the set of Nash equilibria that are not strongly Pareto dominated by other Nash equilibria; (ii) we prove that the fixpoints of some " extremal" selections from the joint best reply correspondence are both coalition-proof Nash equilibria under weak Pareto dominance and not weakly Pareto dominated by other Nash equilibria. We also provide an order-theoretic characterization of the set of Nash equilibria and show various applications of our results.	[Quartieri, Federico] Univ Naples Federico II, Dipartimento Sci Econ & Stat, Naples, Italy; [Shinohara, Ryusuke] Hosei Univ, Fac Econ, Machida, Tokyo 1940298, Japan	Shinohara, R (reprint author), Hosei Univ, Fac Econ, 4342 Aihara Machi, Machida, Tokyo 1940298, Japan.	quartieri.f@alice.it; ryusukes@hosei.ac.jp			Japan Society for Promotion of Science [21730156, 24730165]	The present version of this paper considerably benefited from discerning comments and remarks of two anonymous reviewers. The second author gratefully acknowledges financial support from Grant-in-Aid for Young Scientists (21730156, 24730165) from the Japan Society for Promotion of Science.	Acemoglu D, 2013, GAME ECON BEHAV, V81, P27, DOI 10.1016/j.geb.2013.03.009; Konishi H, 1999, J ECON THEORY, V85, P122, DOI 10.1006/jeth.1998.2481; Jensen MK, 2010, ECON THEOR, V43, P45, DOI 10.1007/s00199-008-0419-8; Furusawa T, 2011, THEOR ECON, V6, P219, DOI 10.3982/TE567; Kukushkin NS, 1997, ECON LETT, V57, P269, DOI 10.1016/S0165-1765(97)00232-2; Yi SS, 1999, GAME ECON BEHAV, V26, P353, DOI 10.1006/game.1998.0656; Quartieri F, 2013, SOC CHOICE WELFARE, V40, P553, DOI 10.1007/s00355-011-0618-2; Bramoulle Y, 2007, J ECON THEORY, V135, P478, DOI 10.1016/j.jet.2006.06.006; Shinohara R, 2005, ECON LETT, V89, P174, DOI 10.1016/j.econlet.2005.05.023; Kerschbamer R, 1998, J ECON, V68, P175, DOI 10.1007/BF01237190; Alos-Ferrer C, 2005, ECON THEOR, V26, P497, DOI 10.1007/s00199-004-0474-8; MILGROM P, 1990, ECONOMETRICA, V58, P1255, DOI 10.2307/2938316; Milgrom P, 1996, GAME ECON BEHAV, V17, P113, DOI 10.1006/game.1996.0096; KUKUSHKIN NS, 1994, ECON LETT, V46, P23, DOI 10.1016/0165-1765(94)90072-8; Amir R, 1996, GAME ECON BEHAV, V15, P132, DOI 10.1006/game.1996.0062; Roy S, 2008, ECON THEOR, V37, P161, DOI 10.1007/s00199-007-0285-9; Dubey P, 2006, GAME ECON BEHAV, V54, P77, DOI 10.1016/j.geb.2004.10.007; CORCHON LC, 1994, MATH SOC SCI, V28, P151, DOI 10.1016/0165-4896(94)90001-9; Bernheim D., 1987, J ECON THEORY, V42, P1; BULOW JI, 1985, J POLIT ECON, V93, P488, DOI 10.1086/261312; Dacic RM, 1979, PUB I MATH, V40, P83; Jackson MO, 2014, HDB GAME THEORY, V4; Jensen MK, 2012, AGGREGATIVE GAMES BE; Jensen MK, 2006, WORKING PAPER; Kukushkin NS, 2005, STRATEGIC SUPPLEMENT; Newton J, 2010, WORKING PAPER; NOVSHEK W, 1985, REV ECON STUD, V52, P85, DOI 10.2307/2297471; Quartieri F, 2012, COALITION PROOFNESS	28	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0020-7276	1432-1270		INT J GAME THEORY	Int. J. Game Theory	NOV	2015	44	4					785	813		10.1007/s00182-014-0452-8		29	Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods; Statistics & Probability	Business & Economics; Mathematics; Mathematical Methods In Social Sciences	CW7LL	WOS:000365180200001		
J	Sekiguchi, T				Sekiguchi, Tadashi			Multimarket contact under demand fluctuations	INTERNATIONAL JOURNAL OF GAME THEORY			English	Article						Collusion; Demand fluctuations; Multimarket contact; Repeated games	COLLUSION	The present paper studies repeated Bertrand oligopoly with multiple markets. The markets are subject to independent, stochastic fluctuations in demands. According to the literature, the demand fluctuations generally hinder collusion, while the multimarket contact sometimes facilitates it. We show that when only partial collusion is sustainable under a single market, the per-market expected profit under the most collusive equilibrium increases with the number of markets. Further, the difference between the total expected profit under full collusion and that under the most collusive equilibrium vanishes, if the number of markets goes to infinity. Thus the collusion-deterrence effects of fluctuated demands completely disappear in the limit.	[Sekiguchi, Tadashi] Kyoto Univ, Inst Econ Res, Sakyo Ku, Kyoto 6068501, Japan	Sekiguchi, T (reprint author), Kyoto Univ, Inst Econ Res, Sakyo Ku, Kyoto 6068501, Japan.	sekiguchi@kier.kyoto-u.ac.jp			Murata Science Foundation; Tokyo Center for Economic Research;  [20530153];  [23000001]	An early version of the present paper has been circulated as Sekiguchi (2013). The author thanks Makoto Hanazono, Jin Li, Katsunori Ohta, Michael Powell, Dan Sasaki, Giulio Seccia, and two anonymous referees for very helpful comments. Financial supports from the Murata Science Foundation, the Tokyo Center for Economic Research, and the Grants-in-Aid for Scientific Research (20530153, 23000001) are gratefully acknowledged.	Kobayashi H, 2012, GAME ECON BEHAV, V76, P636, DOI 10.1016/j.geb.2012.08.003; Matsushima H, 2001, J ECON THEORY, V98, P158, DOI 10.1006/jeth.2000.2708; ROTEMBERG JJ, 1986, AM ECON REV, V76, P390; Bernheim D., 1990, RAND J ECON, V21, P1; Li J, 2013, NOTE LIMITS MU UNPUB; Sekiguchi T, 2013, E52 TOK CTR EC RES	6	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0020-7276	1432-1270		INT J GAME THEORY	Int. J. Game Theory	NOV	2015	44	4					1033	1048		10.1007/s00182-015-0464-z		16	Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods; Statistics & Probability	Business & Economics; Mathematics; Mathematical Methods In Social Sciences	CW7LL	WOS:000365180200011		
J	Shurrab, M; Mohanna, R; Shurrab, S; Mandahawi, N				Shurrab, Mohammed; Mohanna, Reem; Shurrab, Shorouq; Mandahawi, Nabeel			Experimental design to evaluate the influence of anthropometric factors on the grip force and hand force exertion	INTERNATIONAL JOURNAL OF INDUSTRIAL ERGONOMICS			English	Article						Grip force; Borg scale; Handedness; Wrist position; Subjective rating; Hand positions	ANGULAR VELOCITY; WRIST POSITION; SELF-REPORT; POWER GRIP; STRENGTH; PERCEPTION; RESPONSES; DIRECTION; RATINGS; POSTURE	Many industrial operations require gripping of tools. Therefore, it is essential to determine the grip force for labors (i.e. operators). Ratings of perceived exertion is an indirect measure method of the grip force. It is an efficient and low cost method. This method is convenient for large sample numbers as well. In this study, a Borg Category Ratio (CR10) scale is used to measure and estimate the exertion in a physical oriented way. Forty six subjects were evaluated on two scales (i.e. levels) of the CR10 scale (2 and 10 CR10 scales) under different positions. This study also investigates the effect of gender, smoking status, hand dominance, hand positions (90 degrees and 180 degrees) and wrist positions (45 degrees flexion, and 45 degrees extension) under the two Borg scales. The grip force between males and females was significant at both CR10 scale levels. The grip force was neglected between the dominant and the non-dominant hands when level 2 of CR10 was used. Moreover, the grip force was significantly different between the two positions of the hand (90 degrees and 180 degrees) at Borg scale level 10. Conversely, the grip force was not significantly different between the two hand positions at level 2. Same results were found for the wrist positions (45 degrees flexion and 45 degrees extension). The mean force at 45 degrees extension position is greater than that at 45 degrees flexion position. Three regression models were conducted for the purpose of this study. The first regression model was conducted to quantify the grip force for males and females based on hand dominance, hand positions, wrist positions, and CR10 scale. The second regression model was also conducted to predict the Maximum Voluntary Contraction (MVC) value based on gender, age, smoking status, hand dominance, hand length, hand breadth and Body Mass Index (BMI). The third regression model was conducted to estimate the endurance time value based on gender, smoking status, hand dominance, hand position, wrist position, Borg scale exertion, and MVC. Significant R-2 values were shown by the regression models. (C) 2015 Elsevier B.V. All rights reserved.	[Shurrab, Mohammed; Shurrab, Shorouq] Kyushu Univ, Dept Mech Engn, Fukuoka, Japan; [Mohanna, Reem] Islamic Univ Gaza, Dept Ind Engn, Gaza, Palestine, Israel; [Mandahawi, Nabeel] Hashemite Univ, Dept Ind Engn, Amman, Jordan	Shurrab, M (reprint author), 744 Motooka,Nishi Ku, Fukuoka 8190395, Japan.	mshurrab@live.com		Shurrab, Mohammed/0000-0002-3364-2304			Buchholz B, 2008, ERGONOMICS, V51, P1064, DOI 10.1080/00140130801915220; Jaber R, 2012, MED ENG PHYS, V34, P1356, DOI 10.1016/j.medengphy.2012.07.001; Tsaousidis N, 1998, INT J IND ERGONOM, V21, P353, DOI 10.1016/S0169-8141(96)00086-8; HJELM EW, 1995, J OCCUP ENVIRON MED, V37, P1210, DOI 10.1097/00043764-199510000-00012; Li KW, 2011, APPL ERGON, V42, P929, DOI 10.1016/j.apergo.2011.03.001; Chi CF, 2012, INT J IND ERGONOM, V42, P113, DOI 10.1016/j.ergon.2011.08.008; Bao S, 2009, INT J IND ERGONOM, V39, P333, DOI 10.1016/j.ergon.2008.03.005; Koley S, 2010, ANTHROPOLOGIST, V12, P13; Cohen DD, 2010, ACTA PAEDIATR, V99, P1065, DOI 10.1111/j.1651-2227.2010.01723.x; Deeb JM, 1999, INT J IND ERGONOM, V24, P223, DOI 10.1016/S0169-8141(98)00031-6; Mathur K, 2004, J HAND SURG-BRIT EUR, V29B, P390, DOI 10.1016/j.jhsb.2004.02.012; Morse JL, 2006, APPL ERGON, V37, P737, DOI 10.1016/j.apergo.2005.11.008; Eksioglu M, 2011, INT J IND ERGONOM, V41, P401, DOI 10.1016/j.ergon.2011.05.006; Jung MC, 2002, INT J IND ERGONOM, V29, P133, DOI 10.1016/S0169-8141(01)00058-0; Chkeir A, 2013, MED ENG PHYS, V35, P1698, DOI 10.1016/j.medengphy.2013.05.003; McGorry RW, 2010, J OCCUP ENVIRON HYG, V7, P298, DOI 10.1080/15459621003711360; Li KW, 2007, APPL ERGON, V38, P259, DOI 10.1016/j.apergo.2006.06.006; Li KW, 2009, INT J IND ERGONOM, V39, P422, DOI 10.1016/j.ergon.2008.08.004; Park D, 1996, COMPUT IND ENG, V31, P675, DOI 10.1016/S0360-8352(96)00253-7; Koppelaar E, 2005, ERGONOMICS, V48, P983, DOI 10.1080/00140130500120841; Spielholz P, 2001, ERGONOMICS, V44, P588; Wang MJJ, 2000, HUM FACTORS, V42, P553, DOI 10.1518/001872000779698079; Fong PWK, 2001, AM J OCCUP THER, V55, P212; BORG G, 1990, SCAND J WORK ENV HEA, V16, P55; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Incel Nurgul Arinci, 2002, SMJ Singapore Medical Journal, V43, P234; Koley S, 2009, J LIFE SCI, V1, P57; Mandahawi N., 2008, INT J IND ERGONOM, V38, P66; McGarry R., 2004, J OCCUP REHABIL, V14, P255; Moore S. J., 1995, AM IND HYG ASSOC J, V56, P443; NASA, 1978, ANTHR SOURC BOOK, V1; National Institute for Occupational Safety and Health (NIOSH), 1997, DHHS NIOSH PUB, V97-141; Rohmert W., 1986, APPL PSYCHOLINGUIST, V35, P159, DOI 10.1111/j.1464-0597.1986.tb00911.x; Romero V., 2008, J HAND SURG, V33, P378; SILVERSTEIN BA, 1986, BRIT J IND MED, V43, P779; Smet L, 1996, ACTA ORTHOP BELG, V62, P26; Spielholz P, 2006, APPL ERGON, V37, P615	37	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-8141	1872-8219		INT J IND ERGONOM	Int. J. Ind. Ergon.	NOV	2015	50						9	16		10.1016/j.ergon.2015.09.005		8	Engineering, Industrial; Ergonomics	Engineering	CX0DV	WOS:000365368000002		
J	Uematsu, A; Kurita, Y; Inoue, K; Okuno, K; Hortobagyi, T; Suzuki, S				Uematsu, A.; Kurita, Y.; Inoue, K.; Okuno, K.; Hortobagyi, T.; Suzuki, S.			A 200-m All-out Front-crawl Swim Modifies Competitive Swimmers' Shoulder Joint Position Sense	INTERNATIONAL JOURNAL OF SPORTS MEDICINE			English	Article						proprioception; position matching error; error variation; competitive swimming	MUSCLE FATIGUE; LIMB POSITION; EXERCISE; VELOCITY; STROKE; PROPRIOCEPTION; KNEE; RACE; ARMS	We tested the hypothesis that an all-out-effort 200-m front-crawl swim trial affects competitive swimmers' shoulder joint position sense. On Day 1, we measured shoulder joint position sense before and after the swim trial, and on Day 2 before and after 2 min of seated rest. On both days, shoulder joint position sense was measured in the seated position using electromagnetic movement sensors in a position-matching paradigm. An investigator abducted participants' left (reference) shoulder joint in the frontal plane to test angles of 90 degrees, 135 degrees, and 180 degrees. Participants then actively abducted the right (indicator) shoulder joint to match the position of the left, reference arm. After the 200-m all-out front-crawl swim trial, the indicator relative to the reference angle differed by 4.4 degrees toward adduction at the 180 degrees (vertical) testing position (P < 0.05). Variation in absolute matching error was 3.2 degrees or 2.2 times greater after swim compared with the no-swim control trial. An all-out 200-m front-crawl swim trial can selectively increase competitive swimmers' shoulder joint position sense error and increase variation in matching error in horizontal arm position.	[Uematsu, A.] Dokkyo Med Univ, Dept Sport Sci, Tokyo 3210293, Japan; [Kurita, Y.] Waseda Univ, Grad Sch Sport Sci, Tokorozawa, Saitama, Japan; [Inoue, K.] Kagawa Univ, Fac Engn, Takamatsu, Kagawa 760, Japan; [Okuno, K.] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan; [Hortobagyi, T.] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Hortobagyi, T.] Northumbria Univ, Fac Hlth & Life Sci, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [Suzuki, S.] Waseda Univ, Fac Human Sci, Tokorozawa, Saitama, Japan	Uematsu, A (reprint author), Dokkyo Med Univ, Dept Sport Sci, 880 Kitakobayashi, Tokyo 3210293, Japan.	azusa.uematsu@gmail.com					Proske U, 2005, MUSCLE NERVE, V31, P780, DOI 10.1002/mus.20330; Alberty M, 2005, INT J SPORTS MED, V26, P471, DOI 10.1055/s-2004-821110; Harriss DJ, 2013, INT J SPORTS MED, V34, P1025, DOI 10.1055/s-0033-1358756; Allen TJ, 2006, EXP BRAIN RES, V170, P30, DOI 10.1007/s00221-005-0174-z; Chollet D, 1997, PERCEPT MOTOR SKILL, V85, P167; Suito H, 2008, J APPL BIOMECH, V24, P316; de Toledo JM, 2013, PHYSIOTHER THEOR PR, V29, P124, DOI 10.3109/09593985.2012.699606; Figueiredo P, 2013, INT J SPORTS MED, V34, P49, DOI 10.1055/s-0032-1321889; Vuillerme N, 2008, GAIT POSTURE, V28, P521, DOI 10.1016/j.gaitpost.2008.03.005; Figueiredo P, 2011, EUR J APPL PHYSIOL, V111, P767, DOI 10.1007/s00421-010-1696-z; Givoni NJ, 2007, J PHYSIOL-LONDON, V584, P111, DOI 10.1113/jphysiol.2007.134411; Figueiredo P, 2013, APPL PHYSIOL NUTR ME, V38, P716, DOI 10.1139/apnm-2012-0263; Toussaint HM, 2006, MED SCI SPORT EXER, V38, P1635, DOI 10.1249/01.mss.0000230209.53333.31; Carpenter JE, 1998, AM J SPORT MED, V26, P262; CRAIG AB, 1985, MED SCI SPORT EXER, V17, P625, DOI 10.1249/00005768-198512000-00001; Panics G, 2008, BRIT J SPORT MED, V42, P472, DOI 10.1136/bjsm.2008.046516; Ikuta Y, 2012, EUR J APPL PHYSIOL, V112, P3417, DOI 10.1007/s00421-012-2321-0; Allen TJ, 2010, J PHYSIOL-LONDON, V588, P1369, DOI 10.1113/jphysiol.2010.187732; Deschodt VJ, 1999, EUR J APPL PHYSIOL O, V80, P192, DOI 10.1007/s004210050581; Aujouannet YA, 2006, APPL PHYSIOL NUTR ME, V31, P150, DOI 10.1139/H05-012; Brady LT, 2009, J ATHL TRAINING, V44, P617; Halasi T, 2010, ACTA PHYSL HUNG, V97, P183; Montgomery J, 2009, MASTERING SWIMMING; Russell C, 2014, J INT SOC SPORT NUTR, V11, DOI 10.1186/1550-2783-11-26	24	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0172-4622	1439-3964		INT J SPORTS MED	Int. J. Sports Med.	NOV	2015	36	13					1081	1086		10.1055/s-0035-1554698		6	Sport Sciences	Sport Sciences	CW9WH	WOS:000365348400009		
J	Ayabe, M; Kumahara, H; Morimura, K; Tanaka, H				Ayabe, M.; Kumahara, H.; Morimura, K.; Tanaka, H.			Effects of Exercise Intervention on Habitual Physical Activity Above Lactate Threshold Under Free-living Conditions: A Randomized Controlled Trial	INTERNATIONAL JOURNAL OF SPORTS MEDICINE			English	Article						exercise prescription; lifestyle; adherence	ENERGY-EXPENDITURE; JAPANESE MEN; WEIGHT-GAIN; ADULTS; INTENSITY; FITNESS; OLDER; VALIDATION; PREVENTION; STEPS/DAY	The purpose of the present investigation was to examine the effects of an exercise-based intervention on the daily physical activity (PA) above the lactate threshold under free-living conditions. A total of 81 middle-aged to older males (51 +/- 7 years) were randomly assigned into one of 2 groups. The subjects' body weight, visceral fat area, lactate threshold (LT), and PA levels were measured before and after the 8-week lifestyle intervention. The PA levels were assessed using a pedometer with a uni-axial accelerometer (Lifecorder, Kenz, Nagoya). During the intervention, 300 min/week of exercise at LT was targeted in the exercise group. The LT was determined by the log-log transformation method. The subjects in the control group were instructed to maintain their usual lifestyles. In the exercise group, the body weight, visceral fat area and LT significantly improved after the intervention. In contrast, the duration of PA at an intensity of LT, >3 METs and >6 METs did not differ significantly. The present investigation did not find significant changes in the PA at LT under free-living conditions as a result of an 8-week exercise-based intervention, although the participants successfully improved their aerobic capacity and body composition.	[Ayabe, M.] Okayama Prefectural Univ, Fac Comp Sci & Syst Engn, Okayama, Japan; [Ayabe, M.; Kumahara, H.; Morimura, K.; Tanaka, H.] Fukuoka Univ, Fac Hlth & Sports Sci, Fukuoka 81401, Japan; [Kumahara, H.] Nakamura Gakuen Univ, Fac Nutr Sci, Fukuoka, Japan	Ayabe, M (reprint author), Okayama Prefectural Univ, Fac Comp Sci & Syst Engn, 111 Kuboki, Soja, Okayama 7191197, Japan.	ayabe@ss.oka-pu.ac.jp			Fukuoka University (Global FU program); Fukuoka University (Fukuoka University Institute for Physical Activity)	Part of this study was supported by Fukuoka University (Global FU program and Fukuoka University Institute for Physical Activity).	Ayabe M, 2008, CIRC J, V72, P299, DOI 10.1253/circj.72.299; Ishikawa-Takata K, 2007, J EPIDEMIOL, V17, P177; Harriss DJ, 2013, INT J SPORTS MED, V34, P1025, DOI 10.1055/s-0033-1358756; Ekkekakis P, 2008, ANN BEHAV MED, V35, P136, DOI 10.1007/s12160-008-9025-z; Kumahara H, 2004, BRIT J NUTR, V91, P235, DOI 10.1079/BJN20031033; Rejeski WJ, 2011, ARCH INTERN MED, V171, P880, DOI 10.1001/archinternmed.2010.522; Tanaka H, 1997, MED SCI SPORT EXER, V29, P503, DOI 10.1097/00005768-199704000-00012; Binder RK, 2008, EUR J CARDIOV PREV R, V15, P726, DOI 10.1097/HJR.0b013e328304fed4; Suzukamo Y, 2011, J CLIN EPIDEMIOL, V64, P301, DOI 10.1016/j.jclinepi.2010.04.017; Aoyagi Y, 2010, QUAL LIFE RES, V19, P333, DOI 10.1007/s11136-010-9588-6; Ayabe M, 2009, J PHYS ACT HEALTH, V6, P419; Dasilva SG, 2011, MED SCI SPORT EXER, V43, P1114, DOI 10.1249/MSS.0b013e318205874c; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Aoyagi Y, 2009, GERONTOLOGY, V55, P523, DOI 10.1159/000236326; Donnelly JE, 2009, MED SCI SPORT EXER, V41, P459, DOI 10.1249/MSS.0b013e3181949333; Sawada SS, 2010, J PHYS ACT HEALTH, V7, P627; BEAVER WL, 1985, J APPL PHYSIOL, V59, P1936; Wadden TA, 2011, OBESITY, V19, P1987, DOI 10.1038/oby.2011.230; Pescatello LS, 2004, MED SCI SPORT EXER, V36, P533, DOI 10.1249/01.MSS.0000115224.88514.3A; Brubaker PH, 2011, CIRCULATION, V123, P1010, DOI 10.1161/CIRCULATIONAHA.110.940577; Ayabe M, 2010, J CARDIOPULM REHABIL, V30, P111, DOI 10.1097/HCR.0b013e3181be7c80; Ayabe M, 2003, INT J SPORT HLTH SCI, V1, P207, DOI 10.5432/ijshs.1.207; Hayashi Y, 2008, JAP J PHYS ED HLTH S, V53, P99; Hofmann P, 2011, CARDIOL RES PRACT, V2011, P209; Levine JA, 2008, DIABETES, V57, P548, DOI 10.2337/db07-0815; Matsubara T, 2011, JAP J PHYS ED HLTH S, V56, P105; Novak CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005869; Ozemek C, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-53; Rafamantanantsoa HH, 2002, J NUTR SCI VITAMINOL, V48, P517; Saris W H M, 2003, Obes Rev, V4, P101, DOI 10.1046/j.1467-789X.2003.00101.x; Tudor-Locke C, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-79	31	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0172-4622	1439-3964		INT J SPORTS MED	Int. J. Sports Med.	NOV	2015	36	13					1106	1111		10.1055/s-0035-1548767		6	Sport Sciences	Sport Sciences	CW9WH	WOS:000365348400013		
J	Qin, YW; Xiao, XM; Dong, JW; Zhang, GL; Shimada, M; Liu, JY; Li, CG; Kou, WL; Moore, B				Qin, Yuanwei; Xiao, Xiangming; Dong, Jinwei; Zhang, Geli; Shimada, Masanobu; Liu, Jiyuan; Li, Chungan; Kou, Weili; Moore, Berrien, III			Forest cover maps of China in 2010 from multiple approaches and data sources: PALSAR, Landsat, MODIS, FRA, and NFI	ISPRS JOURNAL OF PHOTOGRAMMETRY AND REMOTE SENSING			English	Article						Forest; PALSAR; MODIS; FRA; NLCD; China	ALOS PALSAR; TROPICAL FOREST; RUBBER PLANTATIONS; GREEN PROGRAM; BIOMASS; SCALE; SAR; BACKSCATTER; IMAGERY; CONSEQUENCES	Forests and their changes are important to the regional and global carbon cycle, biodiversity and ecosystem services. Some uncertainty about forest cover area in China calls for an accurate and updated forest cover map. In this study, we combined ALOS PALSAR orthorectified 50-m mosaic images (FED mode with HH and HV polarization) and MODIS time series data in 2010 to map forests in China. We used MODIS-based NDVI dataset (MOD13Q1, 250-m spatial resolution) to generate a map of annual maximum NDVI and used it to mask out built-up lands, barren lands, and sparsely vegetated lands. We developed a decision tree classification algorithm to identify forest and non-forest land cover, based on the signature analysis of PALSAR backscatter coefficient data. The PALSAR-based algorithm was then applied to produce a forest cover map in China in 2010. The resulting forest/non-forest classification map has an overall accuracy of 96.2% and a Kappa Coefficient of 0.91. The resultant 50-m PALSAR-based forest cover map was compared to five forest cover databases. The total forest area (2.02 x 10(6) km(2)) in China from the PALSAR-based forest map is close to the forest area estimates from China National Forestry Inventory (1.95 x 10(6) km(2)), JAXA (2.00 x 10(6) km(2)), and FAO FRA (2.07 x 10(6) km(2)). There are good linear relationships between the PALSAR-based forest map and the forest maps from the JAXA, MCD12Q1, and NLCD-China datasets at the province and county scales. All the forest maps have similar spatial distributions of forest/non-forest at pixel scale. Our PALSAR-based forest map recognizes well the agro-forests in China. The results of this study demonstrate the potential of integrating PALSAR and MODIS images to map forests in large areas. The resultant map of forest cover in China in 2010 can be used for many studies such as forest carbon cycle and ecological restoration. (C) 2015 International Society for Photogrammetry and Remote Sensing, Inc. (ISPRS). Published by Elsevier B.V. All rights reserved.	[Qin, Yuanwei; Xiao, Xiangming; Dong, Jinwei; Zhang, Geli] Univ Oklahoma, Ctr Spatial Anal, Dept Microbiol & Plant Biol, Norman, OK 73019 USA; [Xiao, Xiangming] Fudan Univ, Inst Biodivers Sci, Shanghai 200433, Peoples R China; [Shimada, Masanobu] Japan Aerosp Explorat Agcy, Earth Observat Res Ctr, Tsukuba, Ibaraki 3058505, Japan; [Liu, Jiyuan] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing 100101, Peoples R China; [Li, Chungan] Guangxi Forest Inventory & Planning Inst, Nanning 530000, Guangxi, Peoples R China; [Kou, Weili] Southwest Forestry Univ, Kunming 650224, Yunnan, Peoples R China; [Moore, Berrien, III] Univ Oklahoma, Coll Atmospher & Geog Sci, Norman, OK 73019 USA	Xiao, XM (reprint author), Univ Oklahoma, Ctr Spatial Anal, Norman, OK 73019 USA.	xiangming.xiao@ou.edu			National Aeronautics and Space Administration (NASA) Land Cover and Land Use Change program [NNX11AJ35G, NNX14AD78G]; US National Science Foundation (NSF) EPSCoR program [IIA-1301789]; National Institutes of Health (NIH) NIAID [1R01AI101028-01A1]	This study was supported in part by the research grants from the National Aeronautics and Space Administration (NASA) Land Cover and Land Use Change program (NNX11AJ35G and NNX14AD78G), the US National Science Foundation (NSF) EPSCoR program (IIA-1301789), and the National Institutes of Health (NIH) NIAID (1R01AI101028-01A1). We thank Sarah Xiao for English editing of the manuscript.	Achard F., 2012, GLOBAL EST MONITO; Xiao JF, 2014, J GEOPHYS RES-BIOGEO, V119, P2261, DOI 10.1002/2014JG002820; Yu GR, 2014, P NATL ACAD SCI USA, V111, P4910, DOI 10.1073/pnas.1317065111; Lambin EF, 2011, P NATL ACAD SCI USA, V108, P3465, DOI 10.1073/pnas.1100480108; Rakwatin P, 2012, INT J REMOTE SENS, V33, P7727, DOI 10.1080/01431161.2012.701349; Hansen MC, 2013, SCIENCE, V342, P850, DOI 10.1126/science.1244693; Hansen MC, 2008, P NATL ACAD SCI USA, V105, P9439, DOI 10.1073/pnas.0804042105; Hansen MC, 2000, INT J REMOTE SENS, V21, P1331, DOI 10.1080/014311600210209; Zhang ZX, 2014, REMOTE SENS ENVIRON, V149, P142, DOI 10.1016/j.rse.2014.04.004; Rosenqvist A, 2000, INT J REMOTE SENS, V21, P1375, DOI 10.1080/014311600210227; Sheldon S, 2012, ISPRS J PHOTOGRAMM, V74, P34, DOI 10.1016/j.isprsjprs.2012.07.003; Shimada M, 2010, IEEE J-STARS, V3, P637, DOI 10.1109/JSTARS.2010.2077619; Lehmann EA, 2012, IEEE T GEOSCI REMOTE, V50, P55, DOI 10.1109/TGRS.2011.2171495; Gong P, 2013, INT J REMOTE SENS, V34, P2607, DOI 10.1080/01431161.2012.748992; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Peregon A, 2013, REMOTE SENS ENVIRON, V137, P139, DOI 10.1016/j.rse.2013.06.012; Shimada M, 2009, IEEE T GEOSCI REMOTE, V47, P3915, DOI 10.1109/TGRS.2009.2023909; Dong JW, 2013, REMOTE SENS ENVIRON, V134, P392, DOI 10.1016/j.rse.2013.03.014; Liu JY, 2005, REMOTE SENS ENVIRON, V98, P442, DOI 10.1016/j.rse.2005.08.012; Ni WJ, 2013, IEEE J-STARS, V6, P875, DOI 10.1109/JSTARS.2012.2212701; Potapov P, 2011, REMOTE SENS ENVIRON, V115, P548, DOI 10.1016/j.rse.2010.10.001; Leinenkugel P, 2011, REMOTE SENS ENVIRON, V115, P3007, DOI 10.1016/j.rse.2011.06.004; Longepe N, 2011, IEEE T GEOSCI REMOTE, V49, P2135, DOI 10.1109/TGRS.2010.2102041; Shimada M, 2005, CAN J REMOTE SENS, V31, P132; Kovacs JM, 2013, ISPRS J PHOTOGRAMM, V82, P102, DOI 10.1016/j.isprsjprs.2013.05.004; DEFRIES RS, 1994, INT J REMOTE SENS, V15, P3567; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Dong JW, 2012, REMOTE SENS ENVIRON, V127, P60, DOI 10.1016/j.rse.2012.08.022; Fang JY, 2014, GLOBAL CHANGE BIOL, V20, P2019, DOI 10.1111/gcb.12512; Bagan H, 2012, IEEE T GEOSCI REMOTE, V50, P1318, DOI 10.1109/TGRS.2011.2164806; Liu D, 2014, LANDSCAPE ECOL, V29, P1675, DOI 10.1007/s10980-014-0081-4; IMHOFF ML, 1995, IEEE T GEOSCI REMOTE, V33, P341, DOI 10.1109/36.377934; Gibbs HK, 2010, P NATL ACAD SCI USA, V107, P16732, DOI 10.1073/pnas.0910275107; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Vibrans AC, 2013, REMOTE SENS ENVIRON, V130, P87, DOI 10.1016/j.rse.2012.10.023; Fang JY, 2014, P NATL ACAD SCI USA, V111, P9527, DOI 10.1073/pnas.1402333111; Loveland TR, 2000, INT J REMOTE SENS, V21, P1303, DOI 10.1080/014311600210191; Hoan NT, 2013, INT J REMOTE SENS, V34, P139, DOI 10.1080/01431161.2012.709329; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; Dong JW, 2012, ISPRS J PHOTOGRAMM, V74, P20, DOI 10.1016/j.isprsjprs.2012.07.004; Ban YF, 2010, INT J REMOTE SENS, V31, P1391, DOI 10.1080/01431160903475415; Bartholome E, 2005, INT J REMOTE SENS, V26, P1959, DOI 10.1080/01431160412331291297; Bontemps S., 2011, GLOBCOVER 2009 PRODU; Dong J.W., 2014, PLOS ONE, V9; FAO, 2012, FOR RES ASS FRA 2010; FAQ, 2009, FEED WORLD 2050; Forestry Ministry of China, 1983, TECHN STAND FOR RES; Friedl MA, 2010, REMOTE SENS ENVIRON, V114, P168, DOI 10.1016/j.rse.2009.08.016; Girl C, 2011, GLOBAL ECOL BIOGEOGR, V20, P154, DOI DOI 10.1111/J.1466-8238.2010.00584.X; Jenkins M. D., 2002, WORLD ATLAS BIODIVER; Jensen J. R., 2006, REMOTE SENSING ENV E; Motohka T, 2014, REMOTE SENS ENVIRON, V155, P79, DOI 10.1016/j.rse.2014.04.012; Ohmann J. L, 2014, ISPRS J PHOTOGRAMM, V151, P3; Pantze A, 2014, REMOTE SENS ENVIRON, V155, P120, DOI 10.1016/j.rse.2013.08.050; Pongratz J., 2010, GEOPHYS RES LETT, V37; Shimada M, 2014, REMOTE SENS ENVIRON, V155, P13, DOI 10.1016/j.rse.2014.04.014; Solano R., 2010, MODIS VEGETATION IND; State Forestry Bureau, 2012, CHIN FOR STAT YB; State Forestry Bureau, 2014, BRIEF INTR FOR RES C; State Forestry Bureau, 2003, TECHN REG NAT FOR IN; Zhang Z., 2012, REMOTE SENSING MONIT	61	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0924-2716	1872-8235		ISPRS J PHOTOGRAMM	ISPRS-J. Photogramm. Remote Sens.	NOV	2015	109						1	16		10.1016/j.isprsjprs.2015.08.010		16	Geography, Physical; Geosciences, Multidisciplinary; Remote Sensing; Imaging Science & Photographic Technology	Physical Geography; Geology; Remote Sensing; Imaging Science & Photographic Technology	CW5SI	WOS:000365056500001		
J	EIGharbawi, T; Tamura, M				EIGharbawi, Tamer; Tamura, Masayuki			Estimating deformation due to soil liquefaction in Urayasu city, Japan using permanent scatterers	ISPRS JOURNAL OF PHOTOGRAMMETRY AND REMOTE SENSING			English	Article						2011 Tohoku earthquake; Land deformation measurement; PS-InSAR; Soil liquefaction; Urayasu city	SYNTHETIC-APERTURE RADAR; SAR INTERFEROMETRY; EARTHQUAKE	In Japan, several cities endured severe damage due to soil liquefaction phenomenon, which was developed in association with the massive shaking of the 2011 Tohoku earthquake. Measuring soil liquefaction deformations was not an easy task, mainly because of the total loss of signal coherence in the affected regions. In this paper, we present our approach to estimate the deformations associated with soil liquefaction using interferometric synthetic aperture radar techniques. We use a stack of coseismic inter-ferograms to identify the reliable pixels in the damaged areas using permanent scatterers technique. Then, we estimate and remove the preseismic mean velocity and DEM error components. Finally, we identify the liquefaction deformation component using least squares inversion and spatial phase filtering. We test the performance of the proposed approach using synthetic data, simulating the effects of soil liquefaction. The simulation results show a RMSE of the liquefaction deformation of 5.23 mm. After that, we estimate the deformation associated with soil liquefaction in Urayasu city, Japan, using ALOS-PALSAR data. The proposed approach allows a prompt estimation of the liquefaction deformation by utilizing the SAR images archives with only one postseismic SAR image. (C) 2015 International Society for Photogrammetry and Remote Sensing, Inc. (ISPRS). Published by Elsevier B.V. All rights reserved.	[EIGharbawi, Tamer; Tamura, Masayuki] Kyoto Univ, Kyoto 6158540, Japan	EIGharbawi, T (reprint author), Kyoto Univ, Civil & Earth Resources Engn, Nishikyo Ku, Kyoto 6158540, Japan.	tamer_ib@yahoo.com; tamuram@envinfo.uee.kyoto-u.ac.jp					Guarnieri AM, 1997, IEEE T GEOSCI REMOTE, V35, P660, DOI 10.1109/36.581984; Burgmann R, 2000, ANNU REV EARTH PL SC, V28, P169, DOI 10.1146/annurev.earth.28.1.169; Hooper A, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004763; Lyons S, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001831; GOLDSTEIN RM, 1993, SCIENCE, V262, P1525, DOI 10.1126/science.262.5139.1525; Ferretti A, 2001, IEEE T GEOSCI REMOTE, V39, P8, DOI 10.1109/36.898661; Mora O, 2003, IEEE T GEOSCI REMOTE, V41, P2243, DOI 10.1109/TGRS.2003.814657; Tokimatsu K, 2012, SOILS FOUND, V52, P956, DOI 10.1016/j.sandf.2012.11.014; Goldstein RM, 1998, GEOPHYS RES LETT, V25, P4035, DOI 10.1029/1998GL900033; Liu GX, 2009, IEEE T GEOSCI REMOTE, V47, P2762, DOI 10.1109/TGRS.2009.2016213; MASSONNET D, 1994, NATURE, V369, P227, DOI 10.1038/369227a0; Perissin D, 2012, IEEE T GEOSCI REMOTE, V50, P271, DOI 10.1109/TGRS.2011.2160644; Ferretti A, 2000, IEEE T GEOSCI REMOTE, V38, P2202, DOI 10.1109/36.868878; Bhattacharya S., 2011, SOIL DYN EARTHQ ENG, P1618; Buckley S.M., 2003, J GEOPHYS RES, V108, P8; Costantini M., 1999, P INT GEOSC REM SENS, V1, P267, DOI DOI 10.1109/IGARSS.1999.773467; EIGharbawi T., 2014, ISPRS J PHOTOGRAMM, V88, P156; Hanssen R., 2001, RADAR INTERFEROMETRY; Imakiire T., 2011, B GSI, V59, P21; Ishihara K., 2012, INT S ENG LESS LEARN, P63; Ishitsuka K., 2012, EARTH PLANETS SPACE, P1267; Kampes B.M., 2005, THESIS; Kanto Regional Development Bureau of Ministry of Land. I, 2011, INV SOIL LIQ KANT RE; PAIGE CC, 1982, ACM T MATH SOFTWARE, V8, P43, DOI 10.1145/355984.355989; Tamura M., 2013, AS PAC C SYNTH AP RA; Tokimatsu K., 2012, INT S ENG LESS LEARN, P665; Tsukamoto Y., 2012, SOILS FOUND, P987; Williams S, 1998, J GEOPHYS RES-SOL EA, V103, P27051, DOI 10.1029/98JB02794; Yamaguchi A., 2012, SOILS FOUND, P811; Yasuda S., 2012, SOILS FOUND, P793; Zhang L, 2014, IEEE T GEOSCI REMOTE, V52, P3529, DOI 10.1109/TGRS.2013.2273374	31	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0924-2716	1872-8235		ISPRS J PHOTOGRAMM	ISPRS-J. Photogramm. Remote Sens.	NOV	2015	109						152	164		10.1016/j.isprsjprs.2015.09.002		13	Geography, Physical; Geosciences, Multidisciplinary; Remote Sensing; Imaging Science & Photographic Technology	Physical Geography; Geology; Remote Sensing; Imaging Science & Photographic Technology	CW5SI	WOS:000365056500012		
J	Hecht, HS; Achenbach, S; Kondo, T; Narula, J				Hecht, Harvey S.; Achenbach, Stephan; Kondo, Takeshi; Narula, Jagat			High-Risk Plaque Features on Coronary CT Angiography	JACC-CARDIOVASCULAR IMAGING			English	Editorial Material									[Hecht, Harvey S.; Narula, Jagat] Icahn Sch Med Mt Sinai, Dept Cardiol, New York, NY 10029 USA; [Achenbach, Stephan] Univ Erlangen Nurnberg, Dept Cardiol, D-91054 Erlangen, Germany; [Kondo, Takeshi] Fujita Univ Hlth Sci, Dept Cardiol, Toyoake, Aichi, Japan	Hecht, HS (reprint author), Mt Sinai Med Ctr, One Gustave L Levy Pl,Box 1030, New York, NY 10029 USA.	harvey.hecht@mountsinai.org					Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; Motoyama S, 2009, J AM COLL CARDIOL, V54, P49, DOI 10.1016/j.jacc.2009.02.068; Leipsic J, 2014, J CARDIOVASC COMPUT, V8, P342, DOI 10.1016/j.jcct.2014.07.003	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1936-878X	1876-7591		JACC-CARDIOVASC IMAG	JACC-Cardiovasc. Imag.	NOV	2015	8	11					1336	1339		10.1016/j.jcmg.2014.11.018		4	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	CW7AS	WOS:000365150900015		
J	Sawada, N; Yamada, H; Kusunose, K; Hayashi, S; Lwase, T; Sata, M				Sawada, Naoko; Yamada, Hirotsugu; Kusunose, Kenya; Hayashi, Shuji; Lwase, Takashi; Sata, Masataka			3D Transthoracic Echocardiography Provides Accurate Cross-Sectional Area of the RV Outflow Tract	JACC-CARDIOVASCULAR IMAGING			English	Letter									[Yamada, Hirotsugu] Tokushima Univ Hosp, Dept Cardiovasc Med, Tokushima 7708503, Japan		yamadah@tokushima-u.ac.jp					Izumo M, 2012, CIRC-CARDIOVASC IMAG, V5, P621, DOI 10.1161/CIRCIMAGING.112.974287	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1936-878X	1876-7591		JACC-CARDIOVASC IMAG	JACC-Cardiovasc. Imag.	NOV	2015	8	11					1343	1345		10.1016/j.jcmg.2014.12.018		3	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	CW7AS	WOS:000365150900018		
J	Terui, H; Numata, I; Takata, Y; Ogura, M; Aiba, S				Terui, Hitoshi; Numata, Ikuko; Takata, Yusuke; Ogura, Masaki; Aiba, Setsuya			Pott's Puffy Tumor Caused by Chronic Sinusitis Resulting in Sinocutaneous Fistula	JAMA DERMATOLOGY			English	Letter									[Terui, Hitoshi; Numata, Ikuko] Sendai City Hosp, Dept Dermatol, Sendai, Miyagi, Japan; [Terui, Hitoshi; Aiba, Setsuya] Tohoku Univ, Grad Sch Med, Dept Dermatol, Sendai, Miyagi 9808574, Japan; [Takata, Yusuke; Ogura, Masaki] Sendai City Hosp, Dept Otorhinolaryngol, Sendai, Miyagi, Japan	Aiba, S (reprint author), Tohoku Univ, Grad Sch Med, Dept Dermatol, Aoba Ku, Seriryomachi 1-1, Sendai, Miyagi 9808574, Japan.	saiba@med.tohoku.ac.jp					Kombogiorgas D, 2006, J NEUROSURG, V105, P143; Bellaney GJ, 1997, BRIT J DERMATOL, V136, P145, DOI 10.1111/j.1365-2133.1997.tb08777.x; KOCH SE, 1985, ARCH DERMATOL, V121, P548, DOI 10.1001/archderm.121.4.548; Bannon PD, 2011, J EMERG MED, V41, P616, DOI 10.1016/j.jemermed.2008.04.050; SINGH B, 1995, J LARYNGOL OTOL, V109, P945; Pott P, 1760, OBSERVATIONS NATURE	6	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6068	2168-6084		JAMA DERMATOL	JAMA Dermatol.	NOV	2015	151	11					1261	1263		10.1001/jamadermatol.2015.0874		4	Dermatology	Dermatology	CW9GD	WOS:000365305900027		
J	Chihara, E				Chihara, Etsuo			Myopic Cleavage of Retinal Nerve Fiber Layer Assessed by Split-Spectrum Amplitude-Decorrelation Angiography Optical Coherence Tomography	JAMA OPHTHALMOLOGY			English	Editorial Material									[Chihara, Etsuo] Sensho Kai Eye Inst, Div Glaucoma, Uji, Kyoto 6110043, Japan	Chihara, E (reprint author), Sensho Kai Eye Inst, Minamiyama 50-1, Uji, Kyoto 6110043, Japan.	chihara-oph@umin.net						0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6165	2168-6173		JAMA OPHTHALMOL	JAMA Ophthalmol.	NOV	2015	133	11										1	Ophthalmology	Ophthalmology	CW5KJ	WOS:000365034000004		
J	Iyama, Y; Nakaura, T; Kidoh, M; Kiyota, N; Uemura, S; Harada, K; Yamashita, Y				Iyama, Yuji; Nakaura, Takeshi; Kidoh, Masafumi; Kiyota, Naoto; Uemura, Shouzaburou; Harada, Kazunori; Yamashita, Yasuyuki			Effects of a high-pitch protocol and a hybrid iterative reconstruction algorithm on image quality of cerebral subtracted 3D CT angiography	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Imaging; Head and neck; Hybrid iterative reconstruction; 3D-computed tomography angiography	COMPUTERIZED-TOMOGRAPHY ANGIOGRAPHY; INTRACRANIAL ANEURYSMS; CONVENTIONAL ANGIOGRAPHY; MULTIDETECTOR CT; EXPERIENCE; MANAGEMENT; DIAGNOSIS; STENOSIS; BRAIN	Purpose To evaluate the image quality and the radiation dose of 3D-computed tomography angiography (3D-CTA) with a high-pitch protocol and a hybrid iterative reconstruction (HIR). Materials and methods This was a prospective study and thirty patients were scanned at a 0.51-helical pitch with filtered back-projection (FBP, protocol-A), and 30 patients were scanned at a 0.91-helical pitch with FBP and HIR (protocol-B and C). The mean volume CT dose index (CTDIvol), image noise, and mean cerebral arterial and venous attenuation were compared between the three protocols. Two readers assessed image noise, arterial contrast and venous overlap. Results The mean CTDIvol of protocol-B/C (38.9 mGy) was lower than that of protocol-A (49.7 mGy). Mean image noise of protocol-B [12.6 +/- A 1.3 Hounsfield units (HU)] was higher than that of protocol-A (10.3 +/- A 1.2 HU). There was no significant difference in arterial attenuation between protocol-A (327.5 +/- A 57.5 HU) and C (327.7 +/- A 59.4 HU). Venous attenuation of protocol-C (148.5 +/- A 50.4 HU) was lower than that of protocol-A (185.9 +/- A 50.6 HU). In qualitative analysis, the image noise of protocol-B was higher than that of protocol-A/C. Venous enhancement of protocol-B/C was more inconspicuous than that of protocol-A. Conclusions 3D-CTA with a high-pitch protocol and HIR can reduce radiation dose while decreasing venous enhancement and image noise to an adequate level for diagnosis.	[Iyama, Yuji; Nakaura, Takeshi; Kiyota, Naoto] Amakusa Med Ctr, Diagnost Radiol, Kumamoto 8630046, Japan; [Iyama, Yuji; Nakaura, Takeshi; Kidoh, Masafumi; Yamashita, Yasuyuki] Kumamoto Univ, Grad Sch Med Sci, Dept Diagnost Radiol, Kumamoto, Kumamoto 8608556, Japan; [Uemura, Shouzaburou] Amakusa Med Ctr, Dept Neurosurg, Kumamoto 8630046, Japan; [Harada, Kazunori] Amakusa Med Ctr, Dept Surg, Kumamoto 8630046, Japan	Iyama, Y (reprint author), Amakusa Med Ctr, Diagnost Radiol, Kameba 854-1, Kumamoto 8630046, Japan.	iyamayuuji28@gmail.com; kff00712@nifty.com; masafkidoh@yahoo.co.jp; nkiyo0ctls@yahoo.co.jp; syouzaburouuemura@gmail.com; k-harada@amed.jp; yama@kumamoto-u.ac.jp					Achenbach Stephan, 2009, J Cardiovasc Comput Tomogr, V3, P117, DOI 10.1016/j.jcct.2009.02.008; Anderson GB, 1997, NEUROSURGERY, V41, P7; Silva AC, 2010, AM J ROENTGENOL, V194, P191, DOI 10.2214/AJR.09.2953; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Amacker NA, 2012, EUR J RADIOL, V81, pE392, DOI 10.1016/j.ejrad.2011.12.017; Matsumoto M, 2001, J NEUROSURG, V94, P718, DOI 10.3171/jns.2001.94.5.0718; Machida H, 2013, AM J NEURORADIOL, V34, P971, DOI 10.3174/ajnr.A3320; Komlosi P, 2014, NEURORADIOLOGY, V56, P187, DOI 10.1007/s00234-013-1313-z; Randoux B, 2001, RADIOLOGY, V220, P179; Hu XH, 2012, CLIN RADIOL, V67, P1083, DOI 10.1016/j.crad.2012.03.016; Liang T, 2013, CAN ASSOC RADIOL J, V64, P130, DOI 10.1016/j.carj.2013.02.002; Kidoh M, 2013, EUR RADIOL, V23, P3012, DOI 10.1007/s00330-013-2928-5; Marin D, 2009, RADIOLOGY, V251, P771, DOI 10.1148/radiol.2513081330; Love A, 2013, AM J ROENTGENOL, V201, pW861, DOI 10.2214/AJR.13.10701; Hara AK, 2009, AM J ROENTGENOL, V193, P764, DOI 10.2214/AJR.09.2397; Anderson GB, 1997, NEUROSURGERY, V41, P522, DOI 10.1097/00006123-199709000-00003; Imai E, 2007, AM J KIDNEY DIS, V50, P927, DOI 10.1053/j.ajkd.2007.09.004; Prakash P, 2010, INVEST RADIOL, V45, P202, DOI [10.1097/RLI.ob013e3181dzfeec, 10.1097/RLI.0b013e3181dzfeec]; Karamessini MT, 2004, EUR J RADIOL, V49, P212, DOI 10.1016/S0720-048X(03)00173-6; Tipper G, 2005, CLIN RADIOL, V60, P565, DOI 10.1016/j.crad.2004.09.012; Wintermark M, 2003, J NEUROSURG, V98, P828, DOI 10.3171/jns.2003.98.4.0828; Ren QG, 2012, EUR J RADIOL, V81, P2597, DOI 10.1016/j.ejrad.2011.12.041; Leipsic J, 2012, INT J CARDIOVAS IMAG, V28, P613, DOI 10.1007/s10554-011-9832-3; Teksam M, 2004, AM J NEURORADIOL, V25, P1485; Villablanca JP, 2002, J NEUROSURG, V97, P1322, DOI 10.3171/jns.2002.97.6.1322; Yeh BM, 2009, AM J ROENTGENOL, V193, P47, DOI 10.2214/AJR.09.2592; Sanelli PC, 2004, AM J ROENTGENOL, V183, P1123; Aoki S, 1998, Radiat Med, V16, P263; Ketelsen D, 2012, RADIOL RES PRACT, V2012	29	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	NOV	2015	33	11					687	693		10.1007/s11604-015-0477-3		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CW8WA	WOS:000365278900001		
J	Shindo, D; Shimono, T; Takami, T; Tanaka, S; Tsukamoto, T; Miki, Y				Shindo, Daisuke; Shimono, Taro; Takami, Toshihiro; Tanaka, Sayaka; Tsukamoto, Taro; Miki, Yukio			Spinal hamartoma in an elderly man	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Magnetic resonance imaging; Spinal hamartoma; Spinal cord	TERATOMA	Spinal hamartoma is a very rare, benign spinal lesion, usually occurring in children with either spinal dysraphism or neurofibromatosis type 1. We report a case of thoracic spinal hamartoma in a 75-year-old male without associated lesions. This patient represents the oldest of 19 patients whose cases we found reported in detail and one of only nine reported cases without associated lesions. On magnetic resonance imaging, the current patient showed a well-defined exophytic appearance arising from the dorsal midline surface of the spinal cord. We discuss the radiological and pathological features of spinal hamartoma and review the literature, focusing on magnetic resonance imaging features for diagnosing spinal hamartoma.	[Shindo, Daisuke; Shimono, Taro; Tsukamoto, Taro; Miki, Yukio] Osaka City Univ, Grad Sch Med, Dept Diagnost & Intervent Radiol, Abeno Ku, Osaka 5458585, Japan; [Takami, Toshihiro] Osaka City Univ, Grad Sch Med, Dept Neurosurg, Abeno Ku, Osaka 5458585, Japan; [Tanaka, Sayaka] Osaka City Univ, Grad Sch Med, Dept Diagnost Pathol, Abeno Ku, Osaka 5458585, Japan	Shindo, D (reprint author), Osaka City Univ, Grad Sch Med, Dept Diagnost & Intervent Radiol, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.	daisuke0523shindo@yahoo.co.jp					Seo HS, 2010, AM J NEURORADIOL, V31, P498, DOI 10.3174/ajnr.A1864; Jang WY, 2009, J CLIN NEUROSCI, V16, P851, DOI 10.1016/j.jocn.2008.09.008; Riley K, 1999, NEUROSURGERY, V44, P1125, DOI 10.1097/00006123-199905000-00109; Loder D, 2009, FETAL DIAGN THER, V25, P11, DOI 10.1159/000185606; Ghostine S, 2009, SPINE, V34, pE973, DOI 10.1097/BRS.0b013e3181ba0fe5; Bining HJS, 2006, AM J NEURORADIOL, V27, P810; Davidson L, 2009, PEDIATR NEUROSURG, V45, P244, DOI 10.1159/000224623; Morris GF, 1998, J NEUROSURG, V88, P954, DOI 10.3171/jns.1998.88.6.0954; Castillo M, 1999, AM J NEURORADIOL, V20, P1169; Moon HJ, 2010, J NEUROSURG-SPINE, V13, P283, DOI 10.3171/2010.3.SPINE09461; Lin HC, 2011, KAOHSIUNG J MED SCI, V27, P295, DOI 10.1016/j.kjms.2010.09.007	11	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	NOV	2015	33	11					706	709		10.1007/s11604-015-0475-5		4	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CW8WA	WOS:000365278900003		
J	Sonoda, A; Nitta, N; Ushio, N; Nagatani, Y; Okumura, N; Otani, H; Murata, K				Sonoda, Akinaga; Nitta, Norihisa; Ushio, Noritoshi; Nagatani, Yukihiro; Okumura, Noriaki; Otani, Hideji; Murata, Kiyoshi			Evaluation of the quality of CT images acquired with the single energy metal artifact reduction (SEMAR) algorithm in patients with hip and dental prostheses and aneurysm embolization coils	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Artifact reduction; Metal implants; Noise	RADIATION RISK; VISIBILITY	Purpose We compared the quality of the images acquired with single energy metal artifact reduction (SEMAR) on CT scans of three different human body areas. Materials and methods Our institutional review board approved the study protocol. CT studies of 58 patients (hip prosthesis, n = 20; iliac artery aneurysm embolization, n = 20; dental prosthesis, n = 18) were retrospectively reconstructed using interactive reconstruction (IR) and IR plus SEMAR. Two radiologists independently evaluated the images for the reduction of metal artifacts at three sites, i.e., 0-1, 1-5, and 5-10 cm from their edges, and recorded their findings on a 100-mm-long line that corresponded to the Likert scale and ranged from 0 (invisible) to 100 mm (clearly visible). The standard deviation in Hounsfield units was used as the noise assessment tool. Statistical analysis was performed with the t test and the Wilcoxon signed-rank test. Results The image quality of scans of hip prostheses and metal embolization coils was significantly improved when SEMAR was used (p < 0.05). On scans of dental prostheses, SEMAR did not contribute significantly, especially in the area 1 cm from the edge of the implant. Conclusion Visual subjective evaluation showed that SEMAR improved the image quality.	[Sonoda, Akinaga] Shiga Univ Med Sci, Dept Radiol, Otsu, Shiga 5202192, Japan; [Sonoda, Akinaga; Nitta, Norihisa; Ushio, Noritoshi; Nagatani, Yukihiro; Okumura, Noriaki; Otani, Hideji; Murata, Kiyoshi] Shiga Univ Med Sci, Dept Orthoped Surg, Otsu, Shiga 5202192, Japan	Sonoda, A (reprint author), Shiga Univ Med Sci, Dept Radiol, Setatsukinowa Cho, Otsu, Shiga 5202192, Japan.	akinaga@belle.shiga-med.ac.jp; r34nitta@yahoo.co.jp; ushio@belle.shiga-med.ac.jp; yatsushi@belle.shiga-med.ac.jp; noriaki@belle.shiga-med.ac.jp; otani@belle.shiga-med.ac.jp; murata@belle.shiga-med.ac.jp					Kidoh M, 2014, CLIN RADIOL, V69, pE11, DOI 10.1016/j.crad.2013.08.008; Yamada M, 2012, CIRC J, V76, P1799, DOI 10.1253/circj.CJ-12-0463; Yu LF, 2012, AM J ROENTGENOL, V199, pS9, DOI 10.2214/AJR.12.9121; Albert JM, 2013, AM J ROENTGENOL, V201, pW81, DOI 10.2214/AJR.12.9226; Cheng PM, 2014, J COMPUT ASSIST TOMO, V38, P159, DOI 10.1097/RCT.0b013e3182aac5de; Bal M, 2006, MED PHYS, V33, P2852, DOI 10.1118/1.2218062; Teixeira PAG, 2014, SKELETAL RADIOL, V43, P1237, DOI 10.1007/s00256-014-1923-5; Brook OR, 2012, RADIOLOGY, V263, P696, DOI 10.1148/radiol.12111170; Funama Y, 2015, PHYS MEDICA, V31, P66, DOI 10.1016/j.ejmp.2014.10.003; Joseph P M, 1982, IEEE Trans Med Imaging, V1, P192, DOI 10.1109/TMI.1982.4307572; Westra SJ, 2014, PEDIATR RADIOL, V44, P525, DOI 10.1007/s00247-014-3087-9	11	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	NOV	2015	33	11					710	716		10.1007/s11604-015-0478-2		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CW8WA	WOS:000365278900004		
J	Sonoda, A; Nitta, N; Ushio, N; Nagatani, Y; Okumura, N; Otani, H; Murata, K				Sonoda, Akinaga; Nitta, Norihisa; Ushio, Noritoshi; Nagatani, Yukihiro; Okumura, Noriaki; Otani, Hideji; Murata, Kiyoshi			Evaluation of the quality of CT images acquired with the single energy metal artifact reduction (SEMAR) algorithm in patients with hip and dental prostheses and aneurysm embolization coils (vol 33, pg 710, 2015)	JAPANESE JOURNAL OF RADIOLOGY			English	Correction									[Sonoda, Akinaga; Nitta, Norihisa; Ushio, Noritoshi; Nagatani, Yukihiro; Otani, Hideji; Murata, Kiyoshi] Shiga Univ Med Sci, Dept Radiol, Otsu, Shiga 5202192, Japan; [Okumura, Noriaki] Shiga Univ Med Sci, Dept Orthoped Surg, Otsu, Shiga 5202192, Japan	Sonoda, A (reprint author), Shiga Univ Med Sci, Dept Radiol, Setatsukinowa Cho, Otsu, Shiga 5202192, Japan.	akinaga@belle.shiga-med.ac.jp; r34nitta@yahoo.co.jp; ushio@belle.shiga-med.ac.jp; yatsushi@belle.shiga-med.ac.jp; noriaki@belle.shiga-med.ac.jp; otani@belle.shiga-med.ac.jp; murata@belle.shiga-med.ac.jp					Sonoda A, 2015, JPN J RADIOL, V33, P710, DOI 10.1007/s11604-015-0478-2	1	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	NOV	2015	33	11					717	717		10.1007/s11604-015-0483-5		1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CW8WA	WOS:000365278900005		
J	Takekawa, S; Ueda, Y; Hiramatsu, Y; Komiyama, K; Munechika, H				Takekawa, Shoichi; Ueda, Yoshihiko; Hiramatsu, Yoshihiro; Komiyama, Kihachiro; Munechika, Hirotsugu			History note: tragedy of Thorotrast	JAPANESE JOURNAL OF RADIOLOGY			English	Article							CANCER		[Takekawa, Shoichi; Munechika, Hirotsugu] Southern Tohoku Gen Hosp, Dept Diagnost Radiol, Koriyama, Fukushima 9638563, Japan; [Takekawa, Shoichi; Hiramatsu, Yoshihiro; Komiyama, Kihachiro] Dokkyo Med Univ, Koshigaya Hosp, Dept Radiol, Koshigaya, Saitama 3438555, Japan; [Ueda, Yoshihiko] Dokkyo Med Univ, Dept Pathol, Koshigaya Hosp, Koshigaya, Saitama 3438555, Japan	Takekawa, S (reprint author), Southern Tohoku Gen Hosp, Dept Diagnost Radiol, 7-115 Yatsuyamada, Koriyama, Fukushima 9638563, Japan.	takekawasd@mt.strins.or.jp					Abo M, 1969, Gan No Rinsho, V15, P822; ITO Y, 1988, CANCER, V62, P1153; MORI T, 1967, STRAHLENTHER ONKOL, V134, P229; WEBER E, 1995, POSTGRAD MED J, V71, P367; SADAHIRA Y, 1985, ACTA PATHOL JAPON, V35, P1467; KAPLAN AW, 1984, AM J NEURORADIOL, V5, P323; MACMAHON HE, 1947, AM J PATHOL, V23, P585; JANOWER ML, 1972, RADIOLOGY, V103, P13; BUDIN E, 1956, AMER J ROENTGENOL RA, V75, P1188; Fukumoto M, 2011, PATHOL CLIN, V29, P761; Hirakawa S, 1987, J MUTSU GEN HOSP, V3, P1; Horta da Silvia J, 1965, LANCET, V2, P201; Ishida H, 1982, KANZO LIVER, V23, P297; Kaick Gv, 1999, RADIAT RES, V152, pS64; Kakei H, 1952, NIPPON ACTA RADIOL, V22, P479; Kido Ch, 1989, THOROTRAST CARCINOGE, P1; Mori T, 1966, NIPPON ACTA RADIOL, V25, P1144; PLENGE K, 1954, Zentralbl Allg Pathol, V92, P255; TAKAHASH.S, 1965, TOHOKU J EXP MED, V87, P144	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	NOV	2015	33	11					718	722		10.1007/s11604-015-0479-1		5	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CW8WA	WOS:000365278900006		
J	Mochizuki, S; Liu, DP; Sekijima, T; Lu, J; Wang, C; Ozaki, K; Nagata, H; Murakami, T; Ueno, Y; Yamagishi, S				Mochizuki, Shota; Liu, Dongping; Sekijima, Tsuneo; Lu, Jun; Wang, Chao; Ozaki, Kiyoaki; Nagata, Hisashi; Murakami, Takuhiko; Ueno, Yusuke; Yamagishi, Satoshi			Detecting the nesting suitability of the re-introduced Crested Ibis Nipponia nippon for nature restoration program in Japan	JOURNAL FOR NATURE CONSERVATION			English	Article						Yatsuda ecosystem; Nature restoration; Nest site selection; Satellite remote sensing; Multiple scale analysis	REINTRODUCTION BIOLOGY; HABITAT; LANDSCAPES; FOREST; MODEL; FRAGMENTATION; CONSERVATION; PREDATION; SELECTION; BIRDS	The Crested Ibis, became extinct in the wild in Japan in 1981; however, a captive breeding facility was established on Sado Island, Niigata Prefecture in 1999 in the hope of conserving the species. Following successful breeding at the facility, a group of birds was released on Sado Island on 25th September 2008, with further reintroductions in subsequent years. Habitat restoration is also necessary to facilitate the re-introduction program of this endangered species. The aim of this study was to detect suitable nesting areas for the released ibises on Sado Island for subsequent nature restoration. Since little ibis nesting information was available for Sado Island, the nesting model was constructed from nesting information from China, from which results were extrapolated for Sado Island. Land usage was assessed using LAND-SAT/ETM+ data for China and SPOT/HRG images for Sado Island. In this study, land-use information was used to define the environmental parameters related to nest site selection of the Crested Ibis. For the nesting model, a generalized linear mixed model, with seven environmental factors, was employed. The multi-spatial scale for Crested Ibis nesting was also analyzed. We took the spatial scale into consideration at intervals of 100 m from a buffer size of 100 m to 2500 m. Because nest site selection was influenced by the results of the previous year, nesting location data in 2005 and 2006 were distinguished and models built accordingly. Several important environmental factors were identified for nest site selection: the ratio of broadleaved deciduous forest to coniferous forest; the shape of the forest edge; and, the distance from rice fields and other wetlands. The model's accuracy was verified using the Boyce index, and shows the validity of the model's results. Suitable nesting areas for the Crested Ibis were found mainly on: the Kuninaka plain; the ridgeline between the Kuninaka plain and the Osado or Kosado mountain ranges; the area around Lake Kamo; and, the midwestern area of the Kosado region. Suitable nesting sites for the Crested Ibis were all found to be concentrated in what is known as Yatsuda, a traditional Japanese landscape structure providing a complex mosaic of forest and rice fields with complex ecotones. Eastern Kosado, the region that has been designated by the Ministry of the Environment as the conservation area for the reintroduced birds, was not judged to provide suitable nesting habitat for the Crested Ibis. Unfortunately, no evaluation of habitat suitability was made prior to the release of the first captive-bred Crested Ibis into the wild on Sado Island. Had an evaluation of habitat suitability been performed prior to release, more effective nature restoration could have been planned. (C) 2015 Elsevier GmbH. All rights reserved.	[Mochizuki, Shota; Sekijima, Tsuneo] Niigata Univ, Grad Sch Sci & Technol, Niigata 9502181, Japan; [Liu, Dongping; Lu, Jun] Chinese Acad Forestry, Natl Bird Banding Ctr, Beijing 100091, Peoples R China; [Liu, Dongping; Lu, Jun] Chinese Acad Forestry, Res Inst Forest Ecol Environm & Protect, Key Open Lab Forest Protect State Forestry Adm, Beijing 100091, Peoples R China; [Wang, Chao] Shaanxi Hanzhong Crested Ibis Natl Nat Reserve, Hanzhong 723300, Peoples R China; [Ozaki, Kiyoaki] Yamashina Inst Ornithol, Abiko, Chiba 2701145, Japan; [Nagata, Hisashi] Ctr Toki & Ecol Restorat, Niigata 9520103, Japan; [Murakami, Takuhiko] Niigata Univ, Fac Agr, Niigata 9502181, Japan; [Ueno, Yusuke] Natl Inst Land & Infrastruct Management, Landscape & Ecol Div, Tsukuba, Ibaraki 3050804, Japan	Mochizuki, S (reprint author), Niigata Univ, Grad Sch Sci & Technol, 2-8050 Ikarashi, Niigata 9502181, Japan.	smochi@agr.niigata-u.ac.jp			Department of Wildlife Protection and Nature Reserve Management, State Forestry Administration of China (SFA) [2130211]; Environment Research and Technology Development Fund (ERTDF) [F-072]; JSPS KAKENHI [14534521]	We thank the Ibis monitoring team organized by the staff of the Sado office of Japan's Environment Ministry, the Japan Wildlife Research Center, and Niigata University. Information on the released Crested Ibis was acquired from the Ministry of Environment. I would also like to thank Mark Brazil, Scientific Editing Services, for assistance in the preparation of the final draft of the manuscript. This work was supported by Grant from Department of Wildlife Protection and Nature Reserve Management, State Forestry Administration of China (SFA number 2130211), Grant from the Environment Research and Technology Development Fund (ERTDF) F-072, and Grant-in-Aid for Research Activity Start-up (JSPS KAKENHI Grant number 14534521).	Akaike H., 1973, 2 INT S INF THEOR, P267; Amano T, 2008, BIOL CONSERV, V141, P1704, DOI 10.1016/j.biocon.2008.04.012; Poirazidis K, 2004, BIOL CONSERV, V118, P235, DOI 10.1016/j.biocon.2003.08.016; Li XH, 2006, LANDSCAPE ECOL, V21, P1207, DOI 10.1007/s10980-006-0021-z; Armstrong DP, 2008, TRENDS ECOL EVOL, V23, P20, DOI 10.1016/j.tree.2007.10.003; SMALL MF, 1988, OECOLOGIA, V76, P62; Wiegand T, 2004, BIODIVERS CONSERV, V13, P79, DOI 10.1023/B:BIOC.0000004314.38828.db; ANDERSSON M, 1981, ECOLOGY, V62, P538, DOI 10.2307/1937718; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Sjoasen T, 1997, J APPL ECOL, V34, P1070, DOI 10.2307/2405295; Li XH, 2009, BIODIVERS CONSERV, V18, P2165, DOI 10.1007/s10531-009-9580-z; Li XH, 2002, ECOL RES, V17, P565, DOI 10.1046/j.1440-1703.2002.00515.x; MEAGHER M, 1994, CONSERV BIOL, V8, P645, DOI 10.1046/j.1523-1739.1994.08030645.x; Wiegand T, 2008, ECOL MONOGR, V78, P87, DOI 10.1890/06-1870.1; MOHR CO, 1947, AM MIDL NAT, V37, P223, DOI 10.2307/2421652; Hawrot RY, 1996, AUK, V113, P586; Pearce JL, 2006, J APPL ECOL, V43, P405, DOI 10.1111/j.1365-2664.2005.01112.x; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Duhme F, 1997, LANDSCAPE URBAN PLAN, V37, P73, DOI 10.1016/S0169-2046(96)00371-4; Seddon PJ, 2007, CONSERV BIOL, V21, P303, DOI 10.1111/j.1523-1739.2006.00627.x; Keyser AJ, 1998, CONSERV BIOL, V12, P986, DOI 10.1046/j.1523-1739.1998.97177.x; Yu XP, 2006, BIRD CONSERV INT, V16, P325, DOI 10.1017/S0959270906000499; Kano Y, 2010, ICHTHYOL RES, V57, P180, DOI 10.1007/s10228-009-0146-6; Hansen MJ, 2001, REMOTE SENS ENVIRON, V77, P50, DOI 10.1016/S0034-4257(01)00193-6; TERBORGH J, 1977, ECOLOGY, V58, P1007, DOI 10.2307/1936921; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Natuhara Y, 1999, ECOL RES, V14, P105, DOI 10.1046/j.1440-1703.1999.00287.x; O'Toole L, 2002, BIOL CONSERV, V103, P303, DOI 10.1016/S0006-3207(01)00141-0; Kato N, 2010, WETLANDS, V30, P1171, DOI 10.1007/s13157-010-0103-1; Hubert-Moy L, 2001, REMOTE SENS ENVIRON, V75, P174, DOI 10.1016/S0034-4257(00)00165-6; Buner F, 2005, BIOL CONSERV, V124, P373, DOI 10.1016/j.biocon.2005.01.043; Camarero JJ, 2002, PLANT ECOL, V162, P247, DOI 10.1023/A:1020367918521; Hirzel AH, 2001, ECOL MODEL, V145, P111, DOI 10.1016/S0304-3800(01)00396-9; Asrar G, 1989, THEORY APPL OPTICAL; Beyer H.L, 2004, HAWTHS ANAL TOOLS AR; Burnham KP, 2002, MODEL SELECTION MULT; Cook E. A., 1994, LANDSCAPE PLANNING E; Faraway J. J., 2006, EXTENDING LINEAR MOD; Ichinose T., 2008, Journal of Rural Planning Association, V27, P7; IUCN, 1998, GUID REINTR; Jongman R. H. G., 2004, ECOLOGICAL NETWORKS, P7, DOI 10.1017/CBO9780511606762.004; KACELNIK A, 1984, J ANIM ECOL, V53, P283, DOI 10.2307/4357; Li X.H., 2001, CHINA BIODIVERS, V9, P352; Lu B., 1997, J SHAANXI NORMAL S25, P98; Ma Z. J., 2000, P 4 MAINL TAIW S ORN, P7; Manly B. F. J., 2002, RESOURCE SELECTION A; Ministry of Environment, 2004, CREST IB PROT MULT B; Nakamura S., 2010, REP CHIBA BIODIVERS, V2, P21; Orians G.H., 1979, P155; R Development Core Team, 2008, R LANG ENV STAT COMP; Rothman KJ, 2002, EPIDEMIOLOGY INTRO; Saito G., 2002, APPL REMOTE SENSING, P175; Sakamoto K., 2009, J REMOTE SENS SOC JP, V29, P471; Satoh H., 1978, WING FLAPPING CRESTE; Shi D., 2001, CRESTED IBIS CHINA; Shi Dongchou, 1989, Zoological Research, V10, P327; Shi D. C., 1991, J NW U S, V21, P25; Wang Z. Y., 1995, J HANZHONG NORMAL CO, V13, P54; Yamashina Y., 1983, NIPPONIA NIPPON, P301; Yang County Agriculture Division Office, 1986, REP AGR DIV YANG COU	61	0	0	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	1617-1381	1618-1093		J NAT CONSERV	J. Nat. Conserv.	NOV	2015	28						45	55		10.1016/j.jnc.2015.08.002		11	Biodiversity Conservation; Ecology	Biodiversity & Conservation; Environmental Sciences & Ecology	CX0HR	WOS:000365378000006		
J	Hones, SA				Hones, Sheila A.			Fictions of Speculation	JOURNAL OF AMERICAN STUDIES			English	Editorial Material							CRITICAL-GEOGRAPHY		[Hones, Sheila A.] Univ Tokyo, Tokyo 1138654, Japan	Hones, SA (reprint author), Univ Tokyo, Tokyo 1138654, Japan.						Aalbers Manuel B., 2007, GEOJOURNAL, V67, P137, DOI 10.1007/s10708-007-9041-8; Aalbers Manuel B., 2013, DIALOGUES HUMAN GEOG, V3, P209; Peake L, 2011, SOC CULT GEOGR, V12, P757, DOI 10.1080/14649365.2011.610245; Sidaway JD, 2013, ANN ASSOC AM GEOGR, V103, P984, DOI 10.1080/00045608.2012.660397; Robinson J, 2003, SINGAPORE J TROP GEO, V24, P273, DOI 10.1111/1467-9493.00159; Robinson J, 2008, ENVIRON PLANN A, V40, P74, DOI 10.1068/a39127; Berg LD, 2004, GEOFORUM, V35, P553, DOI 10.1016/j.geoforum.2004.01.005; Garcia-Ramon MD, 2004, GEOFORUM, V35, P523, DOI 10.1016/j.geoforum.2004.01.006; Bender Thomas, 2006, NATION NATIONS AM PL; Best Ulrich, 2009, SOCIAL GEOGRAPHY, V4, P83; Hannah Matthew, 2005, SOCIAL GEOGRAPHY, V1, P3; Hones, 2005, AM Q, V57, P1019; Hones Sheila, 2004, COMP AM STUDIES, V2, P185, DOI 10.1177/1477570004044532; Kitchin Rob, 2011, CODE SPACE SOFTWARE, P68; Massey Doreen, 2005, FOR SPACE, P141; Morin Karen M., 2011, ACME INT E J CRITICA, P58; Peake Linda, 2011, SOC CULT GEOGR, V12, P764; Robinson Jennifer, 2003, SINGAPORE J TROPICAL, V24, P282; Sidaway James, 2013, ANN ASSOC AM GEOGR, V103, P996; Sparke Matthew, 2005, SPACE THEORY POSTFOU, pxiv	20	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0021-8758	1469-5154		J AM STUD	J. Am. Stud.	NOV	2015	49	4			SI		893	901				9	Humanities, Multidisciplinary	Arts & Humanities - Other Topics	CW7HQ	WOS:000365169200028		
J	Kai, Y; Iwata, K; Iba, Y; Mio, Y				Kai, Yoshiteru; Iwata, Kyoko; Iba, Yumiko; Mio, Yasuyuki			Diagnosis of abnormal human fertilization status based on pronuclear origin and/or centrosome number	JOURNAL OF ASSISTED REPRODUCTION AND GENETICS			English	Article						Abnormal fertilization; Monopronuclear (1PN) zygote; Tripronuclear (3PN) zygote; 5-Hydroxymethylcytosine (5hmC); Centrosome	INTRACYTOPLASMIC SPERM INJECTION; TIME-LAPSE CINEMATOGRAPHY; IN-VITRO FERTILIZATION; HUMAN OOCYTES; HUMAN EMBRYOS; DNA METHYLATION; HUMAN ZYGOTES; CHROMOSOMAL CONSTITUTION; TRIPRONUCLEATE ZYGOTES; CYTOGENETIC ANALYSIS	Normally fertilized zygotes generally show two pronuclei (2PN) and the extrusion of the second polar body. Conventional in vitro fertilization (c-IVF) and intracytoplasmic sperm injection (ICSI) often result in abnormal monopronuclear (1PN), tripronuclear (3PN), or other polypronuclear zygotes. In this study, we performed combined analyses of the methylation status of pronuclei (PN) and the number of centrosomes, to reveal the abnormal fertilization status in human zygotes. We used differences in DNA methylation status (5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC)) to discriminate between male and female PN in human zygotes. These results were also used to analyze the centrosome number to indicate how many sperm entered into the oocyte. Immunofluorescent analysis shows that all of the normal 2PN zygotes had one 5mC/5hmC double-positive PN and one 5mC-positive PN, whereas a parthenogenetically activated oocyte had only 5mC staining of the PN. All of the zygotes derived from ICSI (1PN, 3PN) had two centrosomes as did all of the 2PN zygotes derived from c-IVF. Of the 1PN zygotes derived from c-IVF, more than 50 % had staining for both 5mC and 5hmC in a single PN, and one or two centrosomes, indicating fertilization by a single sperm. Meanwhile, most of 3PN zygotes derived from c-IVF had a 5mC-positive PN and two 5mC/5hmC double-positive PNs, and had four or five centrosomes, suggesting polyspermy. We have established a reliable method to identify the PN origin based on the epigenetic status of the genome and have complemented these results by counting the centrosomes of zygotes.	[Kai, Yoshiteru; Mio, Yasuyuki] Mio Fertil Clin, Fertil Res Ctr, Yonago, Tottori 6830008, Japan; [Iwata, Kyoko; Iba, Yumiko; Mio, Yasuyuki] Mio Fertil Clin, Reprod Ctr, Yonago, Tottori 6830008, Japan	Mio, Y (reprint author), Mio Fertil Clin, Fertil Res Ctr, 2-1-1 Kuzumo Minami, Yonago, Tottori 6830008, Japan.	yasmio@mfc.or.jp					SATHANANTHAN AH, 1991, P NATL ACAD SCI USA, V88, P4806, DOI 10.1073/pnas.88.11.4806; Guo HS, 2014, NATURE, V511, P606, DOI 10.1038/nature13544; Zhao XM, 2012, MOL REPROD DEV, V79, P445, DOI 10.1002/mrd.22052; Staessen C, 1997, HUM REPROD, V12, P321, DOI 10.1093/humrep/12.2.321; Iwata K, 2014, J ASSIST REPROD GEN, V31, P421, DOI 10.1007/s10815-014-0195-2; NAGY ZP, 1994, HUM REPROD, V9, P1743; STAESSEN C, 1993, HUM REPROD, V8, P221; BALAKIER H, 1993, HUM REPROD, V8, P402; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; KOLA I, 1987, BIOL REPROD, V37, P395, DOI 10.1095/biolreprod37.2.395; Xu YW, 2005, MOL HUM REPROD, V11, P167, DOI 10.1093/molehr/gah145; Payne D, 1997, HUM REPROD, V12, P532; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; LEVRON J, 1995, BIOL REPROD, V52, P653, DOI 10.1095/biolreprod52.3.653; PALERMO G, 1994, HUM REPROD, V9, P1220; De Munck N, 2015, MOL HUM REPROD, V21, P535, DOI 10.1093/molehr/gav013; Munne S, 1998, HUM REPROD UPDATE, V4, P842, DOI 10.1093/humupd/4.6.842; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Otsu E, 2004, FERTIL STERIL, V81, P723, DOI 10.1016/j.fertnstert.2003.07.042; Rosenbusch B, 2002, HUM REPROD, V17, P2388, DOI 10.1093/humrep/17.9.2388; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Rosenbusch B, 2001, HUM REPROD, V16, P2362; Mio Y, 2012, J ASSIST REPROD GEN, V29, P951, DOI 10.1007/s10815-012-9815-x; TAYLOR AS, 1994, HUM REPROD, V9, P2389; Balakier H, 1997, HUM REPROD, V12, P800, DOI 10.1093/humrep/12.4.800; Beaujean N, 2004, CURR BIOL, V14, pR266, DOI 10.1016/j.cub.2004.03.019; Grossmann M, 1997, HUM REPROD, V12, P2762, DOI 10.1093/humrep/12.12.2762; Mio Y, 2008, AM J OBSTET GYNECOL, V199, P1; Mio Y, 2014, J HLTH MED INFO, V5, P143, DOI [10.4172/2157-7420.1000143, DOI 10.4172/2157-7420.1000143]; Mio Y., 2006, J MAMM OVA RES, V23, P27, DOI 10.1274/jmor.23.27; PALERMO GD, 1995, HUM REPROD, V10, P120; Parelmo G, 1993, FERTIL STERIL, V59, P826; PLACHOT M, 1991, PREIMPLANTATION GENETICS, P103; PLACHOT M, 1989, Human Reproduction (Oxford), V4, P99; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Sathanathan AH, 1996, HUM REPROD, V11, P345; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240	37	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1058-0468	1573-7330		J ASSIST REPROD GEN	J. Assist. Reprod. Genet.	NOV	2015	32	11					1589	1595		10.1007/s10815-015-0568-1		7	Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology	Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology	CW8XN	WOS:000365282800003		
J	Arase, N; Arase, H				Arase, Noriko; Arase, Hisashi			Cellular misfolded proteins rescued from degradation by MHC class II molecules are possible targets for autoimmune diseases	JOURNAL OF BIOCHEMISTRY			English	Review						antigen presentation; molecular chaperon; cryptic epitope; human leukocyte antigen (HLA); rheumatoid arthritis	HLA-DR EXPRESSION; RHEUMATOID-ARTHRITIS; ANTIPHOSPHOLIPID SYNDROME; HEAVY-CHAINS; ENDOPLASMIC-RETICULUM; ANTIGEN PRESENTATION; IMMUNE-RESPONSES; INVARIANT CHAIN; DOMAIN-I; T-CELLS	The major function of major histocompatibility complex (MHC) class II molecules is the presentation of peptide antigens to helper T cells. However, when misfolded proteins are associated with MHC class II molecules in the endoplasmic reticulum, they are transported to the cell surface by MHC class II molecules without processing to peptides. Of note, misfolded proteins complexed with MHC class II molecules are specifically recognized by autoantibodies produced in patients with autoimmune diseases such as rheumatoid arthritis and antiphospholipid syndrome. Furthermore, autoantibody binding to misfolded proteins complexed with MHC class II molecules is associated with the susceptibility to autoimmune diseases conferred by each MHC class II allele. Therefore, misfolded proteins rescued from degradation by MHC class II molecules may be recognized as 'neo-self' antigens by the immune system and be involved in the pathogenicity of autoimmune diseases.	[Arase, Noriko; Arase, Hisashi] Osaka Univ, Microbial Dis Res Inst, Dept Immunochem, Suita, Osaka 565, Japan; [Arase, Noriko] Osaka Univ, Grad Sch Med, Dept Dermatol, Suita, Osaka, Japan; [Arase, Hisashi] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Immunochem, Suita, Osaka, Japan	Arase, H (reprint author), Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Immunochem, Suita, Osaka, Japan.	arase@biken.osaka-u.ac.jp			JSPS KAKENHI [15K15131, 15H02545, 26117714, 24115005]; Practical Research Project for Allergic Diseases and Immunology from Japan Agency for Medical Research and development; AMED; Naito Foundation; Tokyo Biochemical Research Foundation; Uehara Memorial Foundation; Terumo Life Science Foundation	This work was partially supported by JSPS KAKENHI Grant Numbers (15K15131, 15H02545, 26117714 and 24115005), the Practical Research Project for Allergic Diseases and Immunology from Japan Agency for Medical Research and development, AMED, The Naito Foundation, The Tokyo Biochemical Research Foundation, The Uehara Memorial Foundation and Terumo Life Science Foundation.	Sibilio L, 2005, J IMMUNOL, V175, P6651; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; GALLI M, 1993, HAEMATOLOGICA, V78, P1; Ooi JD, 2008, J AUTOIMMUN, V31, P295, DOI 10.1016/j.jaut.2008.04.005; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; SCHNABL E, 1990, J EXP MED, V171, P1431, DOI 10.1084/jem.171.5.1431; Petkova SB, 2006, J EXP MED, V203, P275, DOI 10.1084/jem.20051951; Sokolove J, 2014, ARTHRITIS RHEUMATOL, V66, P813, DOI 10.1002/art.38307; Lleo A, 2010, AUTOIMMUN REV, V9, pA259, DOI 10.1016/j.autrev.2009.12.002; de Laat HB, 2004, CLIN IMMUNOL, V112, P161, DOI 10.1016/j.clim.2004.02.012; Latrofa F, 2013, J CLIN ENDOCR METAB, V98, pE1768, DOI 10.1210/jc.2013-2912; de Laat B, 2011, ARTHRITIS RHEUM-US, V63, P3960, DOI 10.1002/art.30633; Tanimura K, 2015, BLOOD, V125, P2835, DOI 10.1182/blood-2014-08-593624; Matsumoto I, 2002, NAT IMMUNOL, V3, P360, DOI 10.1038/ni772; de Laat B, 2006, BLOOD, V107, P1916, DOI 10.1182/blood-2005-05-1943; Jones EY, 2006, NAT REV IMMUNOL, V6, P271, DOI 10.1038/nri1805; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; Germain RN, 2011, J IMMUNOL, V187, P1073, DOI 10.4049/jimmunol.1101663; Busch R, 1996, EMBO J, V15, P418; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; Agar C, 2010, BLOOD, V116, P1336, DOI 10.1182/blood-2009-12-260976; Aichinger G, 1997, J BIOL CHEM, V272, P29127, DOI 10.1074/jbc.272.46.29127; TODD I, 1985, CLIN EXP IMMUNOL, V61, P265; POBER JS, 1983, J EXP MED, V157, P1339, DOI 10.1084/jem.157.4.1339; Jin H, 2014, P NATL ACAD SCI USA, V111, P3787, DOI 10.1073/pnas.1401105111; STAM NJ, 1986, J IMMUNOL, V137, P2299; BOTTAZZO GF, 1983, LANCET, V2, P1115; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; BALLARDINI G, 1984, LANCET, V2, P1009; Anquetil F, 2015, J IMMUNOL, V194, P3664, DOI 10.4049/jimmunol.1402334; Lessard CJ, 2013, NAT GENET, V45, P1284, DOI 10.1038/ng.2792; JAFFE EA, 1989, J IMMUNOL, V143, P3961; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Castellino F, 1998, J IMMUNOL, V161, P4048; Hinks A, 2013, NAT GENET, V45, P664, DOI 10.1038/ng.2614; Giacomini P, 1997, TISSUE ANTIGENS, V50, P555, DOI 10.1111/j.1399-0039.1997.tb02913.x; DAVENPORT MP, 1995, P NATL ACAD SCI USA, V92, P6567, DOI 10.1073/pnas.92.14.6567; Matsumoto I, 1999, SCIENCE, V286, P1732, DOI 10.1126/science.286.5445.1732; GOTTLIEB AB, 1986, J EXP MED, V164, P1013, DOI 10.1084/jem.164.4.1013; Wilson WA, 1999, ARTHRITIS RHEUM, V42, P1309, DOI 10.1002/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F; Arosa FA, 2007, TRENDS IMMUNOL, V28, P115, DOI 10.1016/j.it.2007.01.002; Griffiths MM, 2001, IMMUNOL REV, V184, P172, DOI 10.1034/j.1600-065x.2001.1840116.x; Okada Y, 2015, NAT GENET, V47, P798, DOI 10.1038/ng.3310; Dorner T, 2004, CURR OPIN RHEUMATOL, V16, P246; Jiang Y, 2013, INT IMMUNOL, V25, P235, DOI 10.1093/intimm/dxs155; Feldmann M, 1988, Scand J Rheumatol Suppl, V76, P39; MCNEIL HP, 1990, P NATL ACAD SCI USA, V87, P4120, DOI 10.1073/pnas.87.11.4120	48	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	NOV	2015	158	5					367	372		10.1093/jb/mvv093		6	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CW6VX	WOS:000365137600002		
J	Fukasawa, R; Iida, S; Tsutsui, T; Hirose, Y; Ohkuma, Y				Fukasawa, Rikiya; Iida, Satoshi; Tsutsui, Taiki; Hirose, Yutaka; Ohkuma, Yoshiaki			Mediator complex cooperatively regulates transcription of retinoic acid target genes with Polycomb Repressive Complex 2 during neuronal differentiation	JOURNAL OF BIOCHEMISTRY			English	Article						chromatin regulation; mediator; neuronal differentiation; PRC2; transcriptional regulation	RNA-POLYMERASE-II; CHROMATIN ARCHITECTURE; EMBRYONAL CARCINOMA; CDK SUBUNITS; GENOME-WIDE; STEM-CELL; EZH2; PHOSPHORYLATION; IDENTIFICATION; H3K27	The Mediator complex (Mediator) plays key roles in transcription and functions as the nexus for integration of various transcriptional signals. Previously, we screened for Mediator cyclin-dependent kinase (CDK)-interacting factors and identified three proteins related to chromatin regulation. One of them, SUZ12 is required for both stability and activity of Polycomb Repressive Complex 2 (PRC2). PRC2 primarily suppresses gene expression through histone H3 lysine 27 trimethylation, resulting in stem cell maintenance and differentiation; perturbation of this process leads to oncogenesis. Recent work showed that Mediator contributes to the embryonic stem cell state through DNA loop formation, which is strongly associated with chromatin architecture; however, it remains unclear how Mediator regulates gene expression in cooperation with chromatin regulators (i.e. writers, readers and remodelers). We found that Mediator CDKs interact directly with the PRC2 subunit EZH2, as well as SUZ12. Known PRC2 target genes were deregulated by Mediator CDK knockdown during neuronal differentiation, and both Mediator and PRC2 complexes co-occupied the promoters of developmental genes regulated by retinoic acid. Our results provide a mechanistic link between Mediator and PRC2 during neuronal differentiation.	[Fukasawa, Rikiya; Iida, Satoshi; Tsutsui, Taiki; Hirose, Yutaka; Ohkuma, Yoshiaki] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Lab Gene Regulat, Toyama 9300194, Japan; [Tsutsui, Taiki] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Ohkuma, Yoshiaki] Nagasaki Univ, Sch Med, Dept Biochem, Nagasaki 8528523, Japan	Ohkuma, Y (reprint author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Lab Gene Regulat, 2630 Sugitani, Toyama 9300194, Japan.	ohkumay@pha.u-toyama.ac.jp			Japan Society for the Promotion of Science (JSPS) (JSPS KAKENHI) [24118003, 25131704]	This work was supported by Grants-in-Aid for Scientific Research on Innovative Areas from Japan Society for the Promotion of Science (JSPS) to Y.O. (JSPS KAKENHI Grant No. 24118003 and 25131704).	Cee VJ, 2009, ANGEW CHEM INT EDIT, V48, P8952, DOI 10.1002/anie.200904778; Mukhopadhyay A, 2010, HUM GENET, V128, P281, DOI 10.1007/s00439-010-0848-x; Kaneko S, 2010, GENE DEV, V24, P2615, DOI 10.1101/gad.1983810; Brookes E, 2012, CELL STEM CELL, V10, P157, DOI 10.1016/j.stem.2011.12.017; Pavri R, 2005, MOL CELL, V18, P83, DOI 10.1016/j.molcel.2005.02.034; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/S0968-0004(96)10050-5; Ding N, 2008, MOL CELL, V31, P347, DOI [10.1016/j.molcel.2008.05.023, 10.1016/i.molcel.2008.05.023]; Chen SA, 2010, NAT CELL BIOL, V12, P1108, DOI 10.1038/ncb2116; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Freemantle SJ, 2002, ONCOGENE, V21, P2880, DOI 10.1038/sj/onc/1205408; Gu W, 1999, MOL CELL, V3, P97, DOI 10.1016/S1097-2765(00)80178-1; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Fukasawa R, 2012, J BIOCHEM, V152, P241, DOI 10.1093/jb/mvs065; Nekrasov M, 2007, EMBO J, V26, P4078, DOI 10.1038/sj.emboj.7601837; Gillespie RF, 2007, J MOL BIOL, V372, P298, DOI 10.1016/j.jmb.2007.06.079; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Li GH, 2011, CURR OPIN GENET DEV, V21, P175, DOI 10.1016/j.gde.2011.01.022; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; Sato S, 2004, MOL CELL, V14, P685, DOI 10.1016/j.molcel.2004.05.006; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Ebmeier CC, 2010, P NATL ACAD SCI USA, V107, P11283, DOI 10.1073/pnas.0914215107; Donner AJ, 2010, NAT STRUCT MOL BIOL, V17, P194, DOI 10.1038/nsmb.1752; Adler AS, 2012, CANCER RES, V72, P2129, DOI 10.1158/0008-5472.CAN-11-3886; Ding N, 2009, J BIOL CHEM, V284, P2648, DOI 10.1074/jbc.M806514200; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kirmizis A, 2003, MOL CANCER THER, V2, P113; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Tsutsui T, 2008, GENES CELLS, V13, P817, DOI 10.1111/j.1365-2443.2008.01208.x; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Porter DC, 2012, P NATL ACAD SCI USA, V109, P13799, DOI 10.1073/pnas.1206906109; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Lehmann L, 2012, J BIOL CHEM, V287, P35784, DOI 10.1074/jbc.M112.397430; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Deb-Rinker P, 2005, J BIOL CHEM, V280, P6257, DOI 10.1074/jbc.C400479200; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Kotake Y, 2011, ONCOGENE, V30, P1956, DOI 10.1038/onc.2010.568; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Wu SC, 2011, J BIOL CHEM, V286, P28511, DOI 10.1074/jbc.M111.240515; Akoulitchev S, 2000, NATURE, V407, P102; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Galbraith MD, 2013, CELL, V153, P1327, DOI 10.1016/j.cell.2013.04.048; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Wei YK, 2011, NAT CELL BIOL, V13, P87, DOI 10.1038/ncb2139; ANDREWS PW, 1988, BIOCHIM BIOPHYS ACTA, V948, P17, DOI 10.1016/0304-419X(88)90003-0; Tsutsui T, 2011, GENES CELLS, V16, P1208, DOI 10.1111/j.1365-2443.2011.01565.x	51	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	NOV	2015	158	5					373	384		10.1093/jb/mvv055		12	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CW6VX	WOS:000365137600003		
J	Kato, T; Shirakawa, Y; Takegawa, K; Kimura, Y				Kato, Takuya; Shirakawa, Yuuki; Takegawa, Kaoru; Kimura, Yoshio			Functional analysis of conserved motifs in a bacterial tyrosine kinase, BtkB, from Myxococcus xanthus	JOURNAL OF BIOCHEMISTRY			English	Article						activation domain; bacterial tyrosine kinase; Myxococcus xanthus; point mutation; poly(Glu, Tyr) kinase activity	ESCHERICHIA-COLI; WZC; INHIBITOR; PHOSPHORYLATION; SPECIFICITY; AUTOKINASE; ACTIVATION; MECHANISM; EVOLUTION	Myxococcus xanthus has two bacterial protein-tyrosine (BY) kinases, BtkA and BtkB. Autophosphorylation in C-terminal tyrosine-rich clusters and poly(Glu, Tyr) kinase activities of cytoplasmic catalytic domains of BtkA and BtkB were activated by the intracellular juxtamembrane regions of the second transmembrane helices. Protein kinase activity against poly(Glu, Tyr) of cytoplasmic fragment of BtkB (CF-BtkB) containing an activator region was not inhibited by serine/threonine protein kinase inhibitors. However, addition of tyrosine protein kinase inhibitors, genistein and 4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo [3,4-d]pyrimidine (PP2), at a concentration of 0.2 mM, inhibited the CF-BtkB kinase activity by 20 and 64%, respectively. A CF-BtkB mutant constructed by replacing all C-terminal tyrosine residues with phenylalanines, did not undergo autophosphorylation. Further, this mutation did not significantly affect poly(Glu, Tyr) kinase activity, suggesting that M. xanthus BtkB kinase activity is not dependent on autophosphorylation in the C-terminal tyrosine cluster. A conserved motif (ExxRxxR) of BY kinases is involved in the self-association of catalytic domains of BY kinases, necessary to accomplish trans-phosphorylation. An ExxRxxR motif mutant of CF-BtkB led to loss of autophosphorylation and poly(Glu, Tyr) kinase activities. These observations provide insights into the regulation mechanism of M. xanthus BY kinase activity.	[Kato, Takuya; Shirakawa, Yuuki; Kimura, Yoshio] Kagawa Univ, Fac Agr, Dept Appl Biol Sci, Miki, Kagawa 76107, Japan; [Takegawa, Kaoru] Kyushu Univ, Dept Biosci & Biotechnol, Higashi Ku, Fukuoka, Japan	Kimura, Y (reprint author), Kagawa Univ, Fac Agr, Dept Appl Biol Sci, Miki, Kagawa 76107, Japan.	kimura@ag.kagawa-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25440087]	This study was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (25440087).	AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; Kimura Y, 2012, FEMS MICROBIOL LETT, V336, P45, DOI 10.1111/j.1574-6968.2012.02651.x; Kimura Y, 2011, J BACTERIOL, V193, P5853, DOI 10.1128/JB.05750-11; Bechet E, 2010, MOL MICROBIOL, V77, P1315, DOI 10.1111/j.1365-2958.2010.07291.x; Shi L, 2014, GENOME BIOL EVOL, V6, P800, DOI 10.1093/gbe/evu056; KEMP BE, 1991, METHOD ENZYMOL, V201, P287; Mori Y, 2012, MICROBIOL-SGM, V158, P2546, DOI 10.1099/mic.0.059824-0; Grangeasse C, 2012, PHILOS T R SOC B, V367, P2640, DOI 10.1098/rstb.2011.0424; Morona JK, 2003, J BACTERIOL, V185, P3009, DOI 10.1128/JB.185.10.3009-3019.2003; EICHHOLTZ T, 1993, J BIOL CHEM, V268, P1982; Grangeasse C, 1997, GENE, V204, P259, DOI 10.1016/S0378-1119(97)00554-4; Mijakovic I, 2003, EMBO J, V22, P4709, DOI 10.1093/emboj/cdg458; Bechet E, 2009, AMINO ACIDS, V37, P499, DOI 10.1007/s00726-009-0237-8; Williams DM, 2000, J BIOL CHEM, V275, P38127, DOI 10.1074/jbc.C000606200; Beebe JA, 2003, J BIOL CHEM, V278, P26810, DOI 10.1074/jbc.M301397200; Paiment A, 2002, J BACTERIOL, V184, P6437, DOI 10.1128/JB.184.23.6437-6447.2002; Collins RF, 2007, P NATL ACAD SCI USA, V104, P2390, DOI 10.1073/pnas.0607763104; Lee DC, 2008, EMBO J, V27, P1758, DOI 10.1038/emboj.2008.97; Doublet P, 2002, J BIOL CHEM, V277, P37339, DOI 10.1074/jbc.M204465200; Grangeasse C, 2002, J BIOL CHEM, V277, P7127, DOI 10.1074/jbc.M110880200; Hanke JH, 1996, J BIOL CHEM, V271, P695; Jelsbak L, 2003, J MICROBIOL METH, V55, P829, DOI 10.1016/.jmimet.2003.08.007; Olivares-Illana V, 2008, PLOS BIOL, V6, P1321, DOI 10.1371/journal.pbio.0060143; Sasaki M., FEBS LETT, V588, P3395; Whitworth DE, 2007, MYXOBACTERIA: MULTICELLULARITY AND DIFFERENTIATION, P1	25	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	NOV	2015	158	5					385	392		10.1093/jb/mvv053		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CW6VX	WOS:000365137600004		
J	Kawakami, T; Yoshikawa, R; Fujiyoshi, Y; Mishima, Y; Hojo, H; Tajima, S; Suetake, I				Kawakami, Toru; Yoshikawa, Ryo; Fujiyoshi, Yuki; Mishima, Yuichi; Hojo, Hironobu; Tajima, Shoji; Suetake, Isao			Synthesis of histone proteins by CPE ligation using a recombinant peptide as the C-terminal building block	JOURNAL OF BIOCHEMISTRY			English	Article						chemical ligation; CPE peptide; histone; post-translational modification	NATIVE CHEMICAL LIGATION; ESTER CPE; AUTOACTIVATING UNIT; THIOESTER METHOD; CYSTEINE; DNA; H3; DESULFURIZATION; CONDENSATION; METHYLATION	The post-translational modification of histones plays an important role in gene expression. We report herein on a method for synthesizing such modified histones by ligating chemically prepared N-terminal peptides and C-terminal recombinant peptide building blocks. Based on their chemical synthesis, core histones can be categorized as two types; histones H2A, H2B and H4 which contain no Cys residues, and histone H3 which contains a Cys residue(s) in the C-terminal region. A combination of native chemical ligation and desulphurization can be simply used to prepare histones without Cys residues. For the synthesis of histone H3, the endogenous Cys residue(s) must be selectively protected, while keeping the N-terminal Cys residue of the C-terminal building block that is introduced for purposes of chemical ligation unprotected. To this end, a phenacyl group was successfully utilized to protect endogenous Cys residue(s), and the recombinant peptide was ligated with a peptide containing a Cys-Pro ester (CPE) sequence as a thioester precursor. Using this approach it was possible to prepare all of the core histones H2A, H2B, H3 and H4 with any modifications. The resulting proteins could then be used to prepare a core histone library of proteins that have been post-translationally modified.	[Kawakami, Toru; Yoshikawa, Ryo; Fujiyoshi, Yuki; Mishima, Yuichi; Hojo, Hironobu; Tajima, Shoji; Suetake, Isao] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Suetake, Isao] JST, CREST, Tokyo, Japan	Kawakami, T (reprint author), Osaka Univ, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	kawa@protein.osaka-u.ac.jp; suetake@protein.osaka-u.ac.jp			JSPS KAKENHI [24550187, 245701530]; CREST, Japan Science and Technology Agency [115201018]	This research was supported, in part, by JSPS KAKENHI Grant Number 24550187 (T.K.) and 245701530 (I.S.), and I.S. was supported by a grant from CREST, Japan Science and Technology Agency (Grant Number 115201018).	Yan LZ, 2001, J AM CHEM SOC, V123, P526, DOI 10.1021/ja003265m; He S, 2003, P NATL ACAD SCI USA, V100, P12033, DOI 10.1073/pnas.2035256100; Ferreira H, 2007, J MOL BIOL, V374, P563, DOI 10.1016/j.jmb.2007.09.059; Kawakami T, 2005, TETRAHEDRON LETT, V46, P5533, DOI 10.1016/j.tetlet.2005.06.039; Kawakami T, 2007, CHEM LETT, V36, P76, DOI 10.1246/cl.2007.76; Rothbart SB, 2014, BBA-GENE REGUL MECH, V1839, P627, DOI 10.1016/j.bbagrm.2014.03.001; Muller MM, 2015, CHEM REV, V115, P2296, DOI 10.1021/cr5003529; Kawakami T, 2009, TETRAHEDRON, V65, P3871, DOI 10.1016/j.tet.2009.03.008; Kawakami T, 2014, TETRAHEDRON LETT, V55, P79, DOI 10.1016/j.tetlet.2013.10.121; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; HOJO H, 1991, B CHEM SOC JPN, V64, P111, DOI 10.1246/bcsj.64.111; Chiang KP, 2009, CHEMBIOCHEM, V10, P2182, DOI 10.1002/cbic.200900238; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Mishima Y, 2013, J MOL BIOL, V425, P54, DOI 10.1016/j.jmb.2012.10.018; Kawakami T, 2001, J PEPT SCI, V7, P474, DOI 10.1002/psc.341; Wan Q, 2007, ANGEW CHEM INT EDIT, V46, P9248, DOI 10.1002/anie.200704195; Shimko JC, 2011, J MOL BIOL, V408, P187, DOI 10.1016/j.jmb.2011.01.003; Asahina Y, 2013, ORG BIOMOL CHEM, V11, P7199, DOI 10.1039/c3ob41565a; Mochizuki M, 2014, ORG LETT, V16, P5740, DOI 10.1021/ol502773v; Rohde H, 2011, CHEMBIOCHEM, V12, P1396, DOI 10.1002/cbic.201100179; ITOH M, 1973, B CHEM SOC JPN, V46, P2219, DOI 10.1246/bcsj.46.2219; Reverter D, 2004, STRUCTURE, V12, P1519, DOI 10.1016/j.str.2004.05.023; Shogren-Knaak MA, 2003, J BIOL CHEM, V278, P15744, DOI 10.1074/jbc.M301445200; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Subiros-Funosas R, 2009, CHEM-EUR J, V15, P9394, DOI 10.1002/chem.200900614; Katayama H, 2013, ORG BIOMOL CHEM, V11, P4405, DOI 10.1039/c3ob40644j; Simon MD, 2012, METHOD ENZYMOL, V512, P57, DOI 10.1016/B978-0-12-391940-3.00003-2; Kawakami T, 1996, B CHEM SOC JPN, V69, P3331, DOI 10.1246/bcsj.69.3331; Hake SB, 2006, P NATL ACAD SCI USA, V103, P6428, DOI 10.1073/pnas.0600803103; Chen ZL, 2014, CHEMBIOCHEM, V15, P2071, DOI 10.1002/cbic.201402313; Kawakami T, 2013, B CHEM SOC JPN, V86, P690, DOI 10.1246/bcsj.20130026; KING DS, 1990, INT J PEPT PROT RES, V36, P255	32	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	NOV	2015	158	5					403	411		10.1093/jb/mvv056		9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CW6VX	WOS:000365137600006		
J	Kawano, S; Maruyama, J; Nagashima, S; Inami, K; Qiu, WZ; Iwasa, H; Nakagawa, K; Ishigami-Yuasa, M; Kagechika, H; Nishina, H; Hata, Y				Kawano, Shodai; Maruyama, Junichi; Nagashima, Shunta; Inami, Kazutoshi; Qiu, Wenzhe; Iwasa, Hiroaki; Nakagawa, Kentaro; Ishigami-Yuasa, Mari; Kagechika, Hiroyuki; Nishina, Hiroshi; Hata, Yutaka			A cell-based screening for TAZ activators identifies ethacridine, a widely used antiseptic and abortifacient, as a compound that promotes dephosphorylation of TAZ and inhibits adipogenesis in C3H10T1/2 cells	JOURNAL OF BIOCHEMISTRY			English	Article						adipogenesis; ethacridine; TAZ	EPITHELIAL-MESENCHYMAL TRANSITION; HIPPO PATHWAY; OSTEOGENIC DIFFERENTIATION; MYOGENIC DIFFERENTIATION; GENE-TRANSCRIPTION; STEM-CELLS; PROLIFERATION; PHORBAKETAL; PROTEINS; MITOSIS	Transcriptional co-activator with PSD-95/Dlg-A/ZO-1 (PDZ)-binding motif (TAZ) regulates in cell proliferation and differentiation. In mesenchymal stem cells it promotes osteogenesis and myogenesis, and suppresses adipogenesis. TAZ activators are expected to prevent osteoporosis, obesity and muscle atrophy. TAZ activation induces epithelial-mesenchymal transition, confers stemness to cancer cells and leads to poor clinical prognosis in cancer patients. In this point of view, TAZ inhibitors should contribute to cancer therapy. Thus, TAZ attracts attention as a two-faced drug target. We screened for TAZ modulators by using human lung cancer A549 cells expressing the fluorescent reporter. Through this assay, we obtained TAZ activator candidates. We unexpectedly found that ethacridine, a widely used antiseptic and abortifacient, enhances the interaction of TAZ and protein phosphatases and increases unphosphorylated and nuclear TAZ. Ethacridine inhibits adipogenesis in mesenchymal C3H10T1/2 cells through the activation of TAZ. This finding suggests that ethacridine is a bona fide TAZ activator and supports that our assay is useful to discover TAZ activators.	[Kawano, Shodai; Maruyama, Junichi; Nagashima, Shunta; Inami, Kazutoshi; Qiu, Wenzhe; Iwasa, Hiroaki; Nakagawa, Kentaro; Hata, Yutaka] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Med Biochem, Tokyo 1138519, Japan; [Ishigami-Yuasa, Mari; Kagechika, Hiroyuki] Tokyo Med & Dent Univ, Chem Biol Screening Ctr, Tokyo 1010062, Japan; [Kagechika, Hiroyuki] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo 1010062, Japan; [Nishina, Hiroshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Dev & Regenerat Biol, Tokyo 1138510, Japan; [Hata, Yutaka] Tokyo Med & Dent Univ, Ctr Brain Integrat Res, Tokyo 1138519, Japan	Hata, Y (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Med Biochem, Tokyo 1138519, Japan.	yuhammch@tmd.ac.jp			Japan Society for the Promotion of Science (JSPS) [26460359, 26293061]; Mitsubishi Foundation	This work was supported by research grants from Japan Society for the Promotion of Science (JSPS) (26460359, 26293061), and the Mitsubishi Foundation.	Park GH, 2014, BRIT J PHARMACOL, V171, P4051, DOI 10.1111/bph.12755; Abe Y, 2006, FEBS LETT, V580, P782, DOI 10.1016/j.febslet.2005.12.096; Byun MR, 2013, EUR J PHARMACOL, V718, P181, DOI [10.1016/j.ejphar.2013.08.035, 10.1016/j.ejphar.2013.03.035]; Murakami M, 2006, BIOCHEM BIOPH RES CO, V339, P533, DOI 10.1016/j.bbrc.2005.10.214; Jang EJ, 2012, BRIT J PHARMACOL, V165, P1584, DOI 10.1111/j.1476-5381.2011.01664.x; Jeong H, 2010, FASEB J, V24, P3310, DOI 10.1096/fj.09-151324; Nishiyama Y, 1999, FEBS LETT, V459, P159, DOI 10.1016/S0014-5793(99)01224-7; Beyer TA, 2013, CELL REP, V5, P1611, DOI 10.1016/j.celrep.2013.11.021; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Byun MR, 2012, BONE, V50, P364, DOI 10.1016/j.bone.2011.10.035; Hirabayashi S, 2008, ONCOGENE, V27, P4281, DOI 10.1038/onc.2008.66; Bao YJ, 2011, J BIOCHEM, V150, P199, DOI 10.1093/jb/mvr063; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Lee MJ, 2014, J INVEST DERMATOL, V134, P518, DOI 10.1038/jid.2013.339; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Nam HS, 2009, CELL STEM CELL, V5, P515, DOI 10.1016/j.stem.2009.08.017; BLUMENTHAL PD, 1991, CURR OPIN OBSTET GYN, V3, P496; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Byun MR, 2012, FEBS LETT, V586, P1086, DOI 10.1016/j.febslet.2012.03.008; Liu CY, 2011, J BIOL CHEM, V286, P5558, DOI 10.1074/jbc.M110.194019; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Byun MR, 2014, CELL DEATH DIFFER, V21, P854, DOI 10.1038/cdd.2014.8; Jung H, 2009, BIOCHEM PHARMACOL, V78, P1323, DOI 10.1016/j.bcp.2009.07.001; Ota M, 2008, DEVELOPMENT, V135, P4059, DOI 10.1242/dev.027151; Yang ZY, 2014, MOL CELL BIOL, V34, P1607, DOI 10.1128/MCB.01346-13; Kodaka M, 2015, CELL MOL LIFE SCI, V72, P285, DOI 10.1007/s00018-014-1742-9; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Byun M.R., 2014, J BIOL CHEM, V289; Hergovich A, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-32; Ikeda M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000300; O'Meara S., 2008, COCHRANE DB SYST REV, V1	32	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	NOV	2015	158	5					413	423		10.1093/jb/mvv051		11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CW6VX	WOS:000365137600007		
J	Endo, S; Noda, M; Ikari, A; Tatematsu, K; El-Kabbani, O; Hara, A; Kitade, Y; Matsunaga, T				Endo, Satoshi; Noda, Misato; Ikari, Akira; Tatematsu, Kenjiro; El-Kabbani, Ossama; Hara, Akira; Kitade, Yukio; Matsunaga, Toshiyuki			Characterization of hamster NAD(+)-dependent 3(17)beta-hydroxysteroid dehydrogenase belonging to the aldo-keto reductase 1C subfamily	JOURNAL OF BIOCHEMISTRY			English	Article						aldo-keto reductase; flavonoid; 3(17)beta-hydroxysteroid dehydrogenase; morphine 6-dehydrogenase; sexually dimorphic expression.	SITE-DIRECTED MUTAGENESIS; RABBIT 20-ALPHA-HYDROXYSTEROID DEHYDROGENASE; 3-BETA-HYDROXYSTEROID DEHYDROGENASE; 3-ALPHA-HYDROXYSTEROID DEHYDROGENASE; SUBSTRATE-SPECIFICITY; HYDROXYSTEROID DEHYDROGENASES; INHIBITOR SENSITIVITY; TISSUE DISTRIBUTION; SUPERFAMILY; IDENTIFICATION	The cDNAs for morphine 6-dehydrogenase (AKR1C34) and its homologous aldo-keto reductase (AKR1C35) were cloned from golden hamster liver, and their enzymatic properties and tissue distribution were compared. AKR1C34 and AKR1C35 similarly oxidized various xenobiotic alicyclic alcohols using NAD+, but differed in their substrate specificity for hydroxysteroids and inhibitor sensitivity. While AKR1C34 showed 3 alpha/17 beta/20 alpha-hydroxysteroid dehydrogenase activities, AKR1C35 efficiently oxidized various 3 beta- and 17 beta-hydroxysteroids, including biologically active 3 beta-hydroxy-5 alpha/beta-dihydro-C-19/C-21-steroids, dehydroepiandrosterone and 17 beta-estradiol. AKR1C35 also differed from AKR1C34 in its high sensitivity to flavonoids, which inhibited competitively with respect to 17 beta-estradiol (K-i 0.11-0.69 mu M). The mRNA for AKR1C35 was expressed liver-specific in male hamsters and ubiquitously in female hamsters, whereas the expression of the mRNA for AKR1C34 displayed opposite sexual dimorphism. Because AKR1C35 is the first 3(17)beta-hydroxysteroid dehydrogenase in the AKR superfamily, we also investigated the molecular determinants for the 3 beta-hydroxysteroid dehydrogenase activity by replacement of Val54 and Cys310 in AKR1C35 with the corresponding residues in AKR1C34, Ala and Phe, respectively. The mutation of Val54Ala, but not Cys310Phe, significantly impaired this activity, suggesting that Val54 plays a critical role in recognition of the steroidal substrate.	[Endo, Satoshi; Noda, Misato; Ikari, Akira; Matsunaga, Toshiyuki] Gifu Pharmaceut Univ, Biochem Lab, Gifu 5011196, Japan; [Tatematsu, Kenjiro] Gifu Pharmaceut Univ, Lab Radiochem, Gifu 5011196, Japan; [El-Kabbani, Ossama] Nagoya Univ, Grad Sch Med, Showa Ku, Nagoya, Aichi 4668550, Japan; [Hara, Akira; Kitade, Yukio] Gifu Univ, Fac Engn, Gifu 5011193, Japan	Matsunaga, T (reprint author), Gifu Pharmaceut Univ, Biochem Lab, Gifu 5011196, Japan.	matsunagat@gifu-pu.ac.jp			Japan Society for the Promotion of Science [26460149]	This work was partly funded by grant-in-aid for Scientific Research (C) from the Japan Society for the Promotion of Science (26460149).	Ishikura S, 2006, J BIOCHEM, V139, P1053, DOI 10.1093/jb/mvj109; Uehara Y, 2002, CARDIOVASC RES, V55, P870, DOI 10.1016/S0008-6363(02)00458-3; Endo S, 2007, ARCH BIOCHEM BIOPHYS, V467, P76, DOI 10.1016/j.abb.2007.08.011; Wu XQ, 2007, MOL CELL ENDOCRINOL, V265, P71, DOI 10.1016/j.mce.2006.12.006; Handa RJ, 2009, J NEUROENDOCRINOL, V21, P351, DOI 10.1111/j.1365-2826.2009.01840.x; Sanai M, 2007, ARCH BIOCHEM BIOPHYS, V464, P122, DOI 10.1016/j.abb.2007.04.003; Qiu W, 2004, MOL ENDOCRINOL, V18, P1798, DOI 10.1210/me.2004-0032; Wang MD, 2002, J NEUROSCI, V22, P3366; OHMURA M, 1990, BIOCHEM J, V266, P583; Baker ME, 2013, STEROIDS, V78, P337, DOI 10.1016/j.steroids.2012.12.011; Zhang B, 2014, CNS NEUROSCI THER, V20, P3, DOI 10.1111/cns.12166; Faucher F, 2007, J MOL BIOL, V369, P525, DOI 10.1016/j.jmb.2007.03.058; Penning TM, 1997, ENDOCR REV, V18, P281, DOI 10.1210/er.18.3.281; BESA EC, 1973, J CLIN INVEST, V52, P2278, DOI 10.1172/JCI107415; Keung WM, 1996, ALCOHOL CLIN EXP RES, V20, P213, DOI 10.1111/j.1530-0277.1996.tb01632.x; Ohno S, 2004, J STEROID BIOCHEM, V88, P175, DOI 10.1016/j.jsbmb.2003.11.007; Penning TM, 1999, J STEROID BIOCHEM, V69, P211, DOI 10.1016/S0960-0760(99)00038-2; Ishikura S, 2004, BIOL PHARM BULL, V27, P1939, DOI 10.1248/bpb.27.1939; Endo S, 2013, BIOL PHARM BULL, V36, P1514; Endo S, 2010, ARCH BIOCHEM BIOPHYS, V503, P230, DOI 10.1016/j.abb.2010.08.010; Jin Y, 2001, BIOCHEMISTRY-US, V40, P10161, DOI 10.1021/bi010919a; Plapp BV, 2003, CHEM-BIOL INTERACT, V143, P183, DOI 10.1016/S0009-2797(02)00202-8; Endo S, 2012, ARCH BIOCHEM BIOPHYS, V527, P23, DOI 10.1016/j.abb.2012.07.012; Simard J, 2005, ENDOCR REV, V26, P525, DOI 10.1210/er.2002-0050; Barski OA, 2008, DRUG METAB REV, V40, P553, DOI 10.1080/03602530802431439 ; Nakajin S, 1998, BIOCHEM J, V334, P553; Rogerson FM, 1998, J MOL ENDOCRINOL, V20, P99, DOI 10.1677/jme.0.0200099; Penning TM, 2000, BIOCHEM J, V351, P67, DOI 10.1042/0264-6021:3510067; Todaka T, 2000, ARCH BIOCHEM BIOPHYS, V374, P189, DOI 10.1006/abbi.1999.1450; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Matsunaga T, 2008, ARCH BIOCHEM BIOPHYS, V477, P339, DOI 10.1016/j.abb.2008.06.002; Couture JF, 2003, J MOL BIOL, V331, P593, DOI 10.1016/S0022-2836(03)00762-9; Reddy DS, 2010, PROG BRAIN RES, V186, P113, DOI 10.1016/B978-0-444-53630-3.00008-7; Couture JF, 2004, J MOL BIOL, V339, P89, DOI 10.1016/j.jmb.2004.03.035; Matsuura K, 1997, BIOCHEM J, V323, P61; Ishikura S, 2001, BIOCHEMISTRY-US, V40, P214, DOI 10.1021/bi001804u; Takenoshita R, 2001, CHEM-BIOL INTERACT, V130, P863, DOI 10.1016/S0009-2797(00)00241-6; Endo S, 2006, BIOL PHARM BULL, V29, P2488, DOI 10.1248/bpb.29.2488; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Endo S., 2012, ARCH BIOCHEM BIOPHYS, V529, P131; Hu G.X., 2010, ASIAN J ANDROL, V4, P519; PLATT KL, 1977, SYNTHESIS-STUTTGART, P449; SAMBROOK J, 1989, MOL CLONING LAB MANU; Steckelbroeck S, 2004, J BIOL CHEM, V279, P10784, DOI 10.1074/jbc.M313308200	44	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	NOV	2015	158	5					425	434		10.1093/jb/mvv057		10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CW6VX	WOS:000365137600008		
J	Motizuki, M; Saitoh, M; Miyazawa, K				Motizuki, Mitsuyoshi; Saitoh, Masao; Miyazawa, Keiji			Maid is a negative regulator of transforming growth factor-beta-induced cell migration	JOURNAL OF BIOCHEMISTRY			English	Article						cell motility; helix-loop-helix protein; Smad; TGF-beta	LOOP-HELIX PROTEIN; EPITHELIAL-CELLS; CARCINOMA CELLS; HUMAN HOMOLOG; CANCER-CELLS; ID PROTEINS; GCIP; EXPRESSION; BREAST; TRANSCRIPTION	Maternal Id-like molecule (Maid) is a dominant negative helix-loop-helix protein that has been implicated in regulating gene expression as well as cell-cycle progression. Overexpressed Maid was previously shown to inhibit certain cellular responses induced by transforming growth factor-beta (TGF-beta), such as TGF-beta-induced cytostasis and cell motility, but not epithelial-mesenchymal transition (EMT). The role of endogenous Maid in regulating TGF-beta signalling, however, has not been elucidated. We have found evidence that endogenous Maid negatively regulates TGF-beta-induced cell motility. Maid knockdown enhanced TGF-beta-induced cell motility as measured by chamber migration and wound healing assays but did not affect cell motility induced by bone morphogenetic protein (BMP)-4. Endogenous Maid does not appear to be involved in regulating TGF-beta-induced cytostasis, resistance to apoptosis or EMT. Notably, Maid expression was induced in the delayed phase (later than 24 h) after TGF-beta stimulation whereas the expression of two other negative feedback regulators, Smad7 and SnoN, was induced as early as 1 h after stimulation. These findings indicate that Maid is a unique negative feedback regulator of TGF-beta signalling in its mode of action as well as the timing of its induction.	[Motizuki, Mitsuyoshi; Saitoh, Masao; Miyazawa, Keiji] Univ Yamanashi, Interdisciplinary Grad Sch Med, Dept Biochem, Kofu, Yamanashi 4093898, Japan	Miyazawa, K (reprint author), Univ Yamanashi, Interdisciplinary Grad Sch Med, Dept Biochem, Kofu, Yamanashi 4093898, Japan.	keiji-miyazawa@umin.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [22390052]; JSPS	This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant 22390052 and JSPS Core-to-Core Program 'Cooperative International Framework in TGF-beta Family Signaling'.	BRAUN L, 1988, P NATL ACAD SCI USA, V85, P1539, DOI 10.1073/pnas.85.5.1539; Lee I, 2010, CANCER RES, V70, P4357, DOI 10.1158/0008-5472.CAN-09-3791; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Chen WC, 2008, HISTOPATHOLOGY, V53, P554, DOI 10.1111/j.1365-2559.2008.03154.x; Ma WB, 2007, J CELL BIOCHEM, V100, P1376, DOI 10.1002/jcb.21140; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; Yao Y, 2000, EXP CELL RES, V257, P22, DOI 10.1006/excr.2000.4884; Xia CZ, 2000, J BIOL CHEM, V275, P20942, DOI 10.1074/jbc.M002598200; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Ma W, 2006, ONCOGENE, V25, P4207, DOI 10.1038/sj.onc.1209450; Seto A, 2009, ACTA CRYSTALLOGR F, V65, P21, DOI 10.1107/S1744309108038219; Chen KY, 2014, ONCOTARGET, V5, P5017; Takami T, 2005, GASTROENTEROLOGY, V128, P1369, DOI 10.1053/j.gastro.2005.03.014; Arase M, 2014, CANCER SCI, V105, P974, DOI 10.1111/cas.12454; Ehata S, 2007, CANCER RES, V67, P9694, DOI 10.1158/0008-5472.CAN-07-1522; Xiang H, 2002, ONCOGENE, V21, P3784, DOI 10.1038/sj/onc/1205455; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; TAIPALE J, 1994, CELL GROWTH DIFFER, V5, P1309; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Hwang SY, 1997, DEV DYNAM, V209, P217, DOI 10.1002/(SICI)1097-0177(199706)209:2<217::AID-AJA7>3.0.CO;2-L; Nagano Y, 2010, J BIOCHEM, V147, P545, DOI 10.1093/jb/mvp202; Ikushima H, 2008, EMBO J, V27, P2955, DOI 10.1038/emboj.2008.218; Chang TW, 2008, ONCOGENE, V27, P332, DOI 10.1038/sj.onc.1210651; Hoshino Y, 2011, J BIOCHEM, V149, P55, DOI 10.1093/jb/mvq114; Ishii R, 2012, EMBO J, V31, P2541, DOI 10.1038/emboj.2012.77; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Motizuki M, 2013, J BIOL CHEM, V288, P18911, DOI 10.1074/jbc.M113.480996; Terai S, 2000, HEPATOLOGY, V32, P357, DOI 10.1053/jhep.2000.9092; Ishii H, 2014, J BIOL CHEM, V289, P27386, DOI 10.1074/jbc.M114.589432; Lasorella A, 2014, NAT REV CANCER, V14, P77, DOI 10.1038/nrc3638; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Nakao A, 1997, NATURE, V389, P631; Sonnenberg-Riethmacher E, 2007, HEPATOLOGY, V45, P404, DOI 10.1002/hep.21461; Su Tao, 2007, J Exp Ther Oncol, V6, P117	35	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	NOV	2015	158	5					435	444		10.1093/jb/mvv054		10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CW6VX	WOS:000365137600009		
J	Thumarat, U; Kawabata, T; Nakajima, M; Nakajima, H; Sugiyama, A; Yazaki, K; Tada, T; Waku, T; Tanaka, N; Kawai, F				Thumarat, Uschara; Kawabata, Takeshi; Nakajima, Maho; Nakajima, Hajime; Sugiyama, Akifumi; Yazaki, Kazufumi; Tada, Tomoko; Waku, Tomonori; Tanaka, Naoki; Kawai, Fusako			Comparison of genetic structures and biochemical properties of tandem cutinase-type polyesterases from Thermobifida alba AHK119	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Thermobifida alba AHK119; Cutinase-type polyesterase; Ca-activated cutinase; Thermostable cutinase; Tandem genes regulation; PET surface hydrolysis	ALIPHATIC-AROMATIC COPOLYESTERS; PROTEIN THERMOSTABILITY; AMINO-ACID; FUSCA; HYDROLASE; PROLINE; DEGRADATION; STABILITY; RESIDUES; LIPASE	This study described the genetic map of tandem genes (est1 and est119) encoding cutinase-type polyesterases in Thermobifida alba AHK119 and comparison of wild type and mutant enzymes of Est1 and Est119. Two genes were independently and constitutively expressed. The activity of Est1 was higher by approximately 1.6-1.7-fold than that of Est119 towards p-nitrophenyl butyrate, although both enzymes shared 95% sequence identity and 98% similarity and possessed similar 3D structures except that several amino acids in the probable substrate-docking loops were different from each other. Calcium ion enhanced the activity and the therinostability of both enzymes. Based on conserved sequences among Thermobifida cutinases, valine, proline and lysine were introduced into Est1 at AIa68, Thr253 and Met256, respectively. Among wild and mutant enzymes of Est119 and Est1, Est1 (A68V/T253P) possessed three prolines in the substrate-docking loops and displayed the highest thermostability that spotlighted the important effect of proline numbers in the loops. Est1 (A68V/T253P) was stable for 1 h below 60 degrees C and even at 65 degrees C, more than 70% and 50% activities were maintained after 30 and 60 min, respectively. Est1 (A68V/T253P) degraded various aliphatic and aliphaticco-aromatic polyesters and hydrophilized an amorphous PET film. The enzyme hydrolyzed a PET trimer model compound, indicating its specificity towards an ester bond between terephthalic acid and ethylene glycol. (C) 2015, The Society for Biotechnology, Japan. All rights reserved.	[Thumarat, Uschara] Prince Songkla Univ, Fac Agroind, Dept Ind Biotechnol, Hat Yai 90112, Songkhla, Thailand; [Kawabata, Takeshi] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Nakajima, Maho] Kyoto Inst Technol, Grad Sch, Dept Mat & Life Sci, Sakyo Ku, Kyoto 6068585, Japan; [Nakajima, Hajime; Kawai, Fusako] Kyoto Inst Technol, Ctr Fiber & Text Sci, Sakyo Ku, Kyoto 6068585, Japan; [Sugiyama, Akifumi; Yazaki, Kazufumi] Kyoto Univ, Res Inst Sustainable Humanosphere, Lab Plant Gene Express, Uji, Kyoto 6110011, Japan; [Tada, Tomoko; Waku, Tomonori; Tanaka, Naoki] Kyoto Inst Technol, Grad Sch Sci & Technol, Dept Biomol Engn, Sakyo Ku, Kyoto 6068585, Japan	Kawai, F (reprint author), Kyoto Inst Technol, Ctr Fiber & Text Sci, Sakyo Ku, Kyoto 6068585, Japan.	fkawai@kit.ac.jp			Institute for Fermentation, Osaka (Japan); JSPS (Japan); NRCT (Thailand)	We acknowledge Prof. Uwe Bornscheuer, Greifswald University, Germany and his group for their advice in mutation of Est1. The study was partially supported by a fund (2012) from the Institute for Fermentation, Osaka (Japan) to F K. that does not restrict or influence the result of the research. LC-IT-TOF-MS was provided by Development and Assessment of Sustainable Humanosphere (DASH) system of RISH and CER, Kyoto University, as a collaborative program. This work is linked with the Asia Core Program supported by JSPS (Japan) and NRCT (Thailand).	Lykidis A, 2007, J BACTERIOL, V189, P2477, DOI 10.1128/JB.01899-06; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; Pack SP, 2004, J BIOTECHNOL, V111, P269, DOI 10.1016/j.jbiotec.2004.01.018; Muslin EH, 2002, PROTEIN ENG, V15, P29, DOI 10.1093/protein/15.1.29; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Hu XP, 2008, J POLYM ENVIRON, V16, P103, DOI 10.1007/s10924-008-0088-5; Van den Burg B, 1998, P NATL ACAD SCI USA, V95, P2056, DOI 10.1073/pnas.95.5.2056; Kleeberg I, 2005, BIOMACROMOLECULES, V6, P262, DOI 10.1021/bm049582t; Sakaguchi M, 2007, J BIOCHEM, V141, P213, DOI 10.1093/jh/mvm025; Xu JA, 1998, PROTEIN SCI, V7, P158; Bustos-Jaimes I, 2010, BBA-PROTEINS PROTEOM, V1804, P2222, DOI 10.1016/j.bbapap.2010.09.001; Yang Y, 2007, BIOTECHNOL BIOENG, V96, P780, DOI 10.1002/bit.21167; Kleeberg I, 1998, APPL ENVIRON MICROB, V64, P1731; Acharya P, 2004, J MOL BIOL, V341, P1271, DOI 10.1016/j.jmb.2004.06.059; Zhu GP, 1999, PROTEIN ENG, V12, P635, DOI 10.1093/protein/12.8.635; Shah AA, 2014, APPL MICROBIOL BIOT, V98, P3437, DOI 10.1007/s00253-014-5558-1; Dresler K, 2006, BIOPROC BIOSYST ENG, V29, P169, DOI 10.1007/s00449-006-0069-9; Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Thumarat U, 2012, APPL MICROBIOL BIOT, V95, P419, DOI 10.1007/s00253-011-3781-6; Kitadokoro K, 2012, POLYM DEGRAD STABIL, V97, P771, DOI 10.1016/j.polymdegradstab.2012.02.003; Chen S, 2010, J MOL CATAL B-ENZYM, V63, P121, DOI 10.1016/j.molcatb.2010.01.001; Hu XP, 2010, APPL MICROBIOL BIOT, V87, P771, DOI 10.1007/s00253-010-2555-x; Vertommen MAME, 2005, J BIOTECHNOL, V120, P376, DOI 10.1016/j.jbiotec.2005.06.015; Sadeghi M, 2006, BIOPHYS CHEM, V119, P256, DOI 10.1016/j.bpc.2005.09.018; Bogin O, 1998, PROTEIN SCI, V7, P1156; Sinsereekul N, 2010, APPL MICROBIOL BIOT, V86, P1775, DOI 10.1007/s00253-010-2465-y; Chen S, 2008, J BIOL CHEM, V283, P25854, DOI 10.1074/jbc.M800848200; Chen S, 2013, BIOTECHNOL ADV, V31, P1754, DOI 10.1016/j.biotechadv.2013.09.005; Arnorsdottir J, 2007, BBA-PROTEINS PROTEOM, V1774, P749, DOI 10.1016/j.bbapap.2007.03.015; Herrero-Acero E., 2011, MACROMOLECULES, V44, P4632; Kawai F, 2013, ACS SYM SER, V1144, P111; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Sambrook J., 2001, MOL CLONING LAB MANU; Wei Y., 1988, STRUCTURE, V6, P511; Zimmermann W., 2010, ADV BIOCHEM ENG BIOT, V125, P97	35	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	NOV	2015	120	5					491	497		10.1016/j.jbiosc.2015.03.006		7	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CX0BQ	WOS:000365362300002		
J	Satake, R; Ichiyanagi, A; Ichikawa, K; Hirokawa, K; Araki, Y; Yoshimura, T; Gomi, K				Satake, Ryoko; Ichiyanagi, Atsushi; Ichikawa, Keiichi; Hirokawa, Kozo; Araki, Yasuko; Yoshimura, Taro; Gomi, Keiko			Novel glucose dehydrogenase from Mucor prainii: Purification, characterization, molecular cloning and gene expression in Aspergillus sojae	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Diabetes; Glucose dehydrogenase; Glucose sensor; Flavin adenine dinucleotide; Substrate specificity	PENICILLIUM-AMAGASAKIENSE; PYRROLOQUINOLINE QUINONE; SENSOR; OVEREXPRESSION; CONSTRUCTION; BIOSENSOR; OXIDASE; ENZYME	Glucose dehydrogenase (GDH) is of interest for its potential applications in the field of glucose sensors. To improve the performance of glucose sensors, GDH is required to have strict substrate specificity. A novel flavin adenine dinucleotide (FAD)-dependent GDH was isolated from Mucor prainii NISL0103 and its enzymatic properties were characterized. This FAD-dependent GDH (MpGDH) exhibited high specificity toward glucose. High specificity for glucose was also observed even in the presence of saccharides such as maltose, galactose and xylose. The molecular masses of the glycoforms of GDH ranged from 90 to 130 KDa. After deglycosylation, a single 80 KDa band was observed. The gene encoding MpGDH was cloned and expressed in Aspergillus sojae. The apparent k(cat) and K-m values of recombinant enzyme for glucose were found to be 749.7 s(-1) and 28.3 mM, respectively. The results indicated that the characteristics of MpGDH were suitable for assaying blood glucose levels. (C) 2015, The Society for Biotechnology, Japan. All rights reserved.	[Satake, Ryoko; Ichiyanagi, Atsushi; Ichikawa, Keiichi; Hirokawa, Kozo; Araki, Yasuko; Yoshimura, Taro; Gomi, Keiko] Kikkoman Foods Inc, Div Res & Dev, Chiba 2780037, Japan	Satake, R (reprint author), Kikkoman Foods Inc, Div Res & Dev, 399 Noda, Chiba 2780037, Japan.	rsatake@mail.kikkoman.co.jp					KATZ E, 1994, J ELECTROANAL CHEM, V368, P165, DOI 10.1016/0022-0728(93)03094-6; Yamazaki T, 2000, ANAL CHEM, V72, P4689, DOI 10.1021/ac000151k; Ogawa M, 2010, FUNGAL GENET BIOL, V47, P10, DOI 10.1016/j.fgb.2009.10.004; Yoshida H, 2000, BIOTECHNOL LETT, V22, P1505, DOI 10.1023/A:1005658316948; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Tsujimura S, 2006, BIOSCI BIOTECH BIOCH, V70, P654, DOI 10.1271/bbb.70.654; Kitamoto N, 1999, APPL ENVIRON MICROB, V65, P20; Takahashi T, 2004, MOL GENET GENOMICS, V272, P344, DOI 10.1007/s00438-004-1062-0; PAULY HE, 1977, BIOCHEMISTRY-US, V16, P4599, DOI 10.1021/bi00640a011; Sode K, 1996, ENZYME MICROB TECH, V19, P82, DOI 10.1016/0141-0229(95)00170-0; Takahashi Y, 2000, ELECTROCHEMISTRY, V68, P907; KOYAMA Y, 1990, AGR BIOL CHEM TOKYO, V54, P1315; Ito K, 2013, BIOSCI BIOTECH BIOCH, V77, P1832, DOI 10.1271/bbb.130151; Laurinavicius V, 2000, TALANTA, V52, P485, DOI 10.1016/S0039-9140(00)00396-9; Fraeyman A, 2010, ANN CLIN BIOCHEM, V47, P494, DOI 10.1258/acb.2010.010091; Wohlfahrt G, 1999, ACTA CRYSTALLOGR D, V55, P969, DOI 10.1107/S0907444999003431; Razumiene J, 2000, ELECTROCHEM COMMUN, V2, P307, DOI 10.1016/S1388-2481(00)00024-2; Witt S, 2000, BIOCHEM J, V347, P553, DOI 10.1042/0264-6021:3470553; DCOSTA EJ, 1986, BIOSENSORS, V2, P71, DOI 10.1016/0265-928X(86)80011-6; Groton L., 2002, REV MOL BIOTECHNOL, V82, P371; Mark D. H., 2009, J DIABETES SCI TECHN, V3, P1219; OGURA YASUYUKI, 1951, JOUR BIOCHEM [TOKYO], V38, P75; Omura K., 2004, Coenzyme-binding glucose dehydrogenase, Patent No. [WO 2004/058958 A1, 2004058958]; PACE CN, 1995, PROTEIN SCI, V4, P2411; Sano S., 2004, PRACTICE, V21, P91; Sygmund C, 2011, MICROBIOL-SGM, V157, P3203, DOI 10.1099/mic.0.051904-0; The International Organization for Standardization, 2013, ISO151972013; Tsuji Y., 2007, Production method of glucose dehydrogenase from Aspergillus oryzae, Patent No. [JP2007-289148A, 2007289148]; WILSON R, 1992, BIOSENS BIOELECTRON, V7, P165, DOI 10.1016/0956-5663(92)87013-F; Ye Ling, 1993, Analytical Chemistry, V65, P238, DOI 10.1021/ac00051a008	30	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	NOV	2015	120	5					498	503		10.1016/j.jbiosc.2015.03.012		6	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CX0BQ	WOS:000365362300003		
J	Dong, JH; Kojima, T; Ohashi, H; Ueda, H				Dong, Jinhua; Kojima, Tomoki; Ohashi, Hiroyuki; Ueda, Hiroshi			Optimal fusion of antibody binding domains resulted in higher affinity and wider specificity	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Antibody binding protein; Affinity tag; Immunoassay; Avidity effect; Linker engineering	STAPHYLOCOCCAL PROTEIN-A; OPEN-SANDWICH ELISA; SINGLE-CHAIN-FV; MONOCLONAL-ANTIBODY; VARIABLE REGION; BREAST-CANCER; AUREUS; FAB; PH; RECEPTORS	Antibody is a very important protein in biotechnological and biomedical fields because of its high affinity and specificity to various antigens. Due to the rise of human antibody therapeutics, its cost-effective purification is an urgent issue for bio-industry. In this study, we made novel fusion proteins PAxPG with a flexible (DDAKK)n linker between the two Ig binding domains derived from Staphylococcus protein A and Streptococcus protein G. The fusion proteins bound human and mouse IgGs and their fragments with up to 58-times higher affinity and wider specificity than the parental binding domains. Interestingly, the optimal linker for human Fab fragment was n = 4, which was close to the modeled distance between the termini of domains bound to heavy chain, implying increased avidity as a possible mechanism. For binding to Fc, the longest n = 6 linker gave the highest affinity, implying longer interchain distance between the two binding sites. The novel fusion protein with optimized interdomain linker length will be a useful tool for the purification and detection of various IgGs including mouse IgG(1) that binds only weakly to natural protein A. (C) 2015, The Society for Biotechnology, Japan. All rights reserved.	[Dong, Jinhua; Ueda, Hiroshi] Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Yokoyama, Kanagawa 2268503, Japan; [Kojima, Tomoki; Ohashi, Hiroyuki] Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan; [Ohashi, Hiroyuki] Ushio Inc, Kawasaki BIOLAB, Kawasaki Ku, Kawasaki, Kanagawa 2100855, Japan	Ueda, H (reprint author), Tokyo Inst Technol, Chem Resources Lab, Midori Ku, 4259-R1-18,Nagatsuta Cho, Yokoyama, Kanagawa 2268503, Japan.	ueda@res.titech.ac.jp	Dong, Jinhua/D-2510-2015	Dong, Jinhua/0000-0002-7417-1932	Japan Society for the Promotion of Science [25123456];  [B24360336]	This study was supported by a Grant-in-Aid for Scientific Research (B24360336), and a Grant-in-Aid for Challenging Exploratory Research (25123456) from Japan Society for the Promotion of Science.	Abe R, 2014, SCI REP-UK, V4, DOI 10.1038/srep04640; FORSGREN A, 1966, J IMMUNOL, V97, P822; Starovasnik MA, 1997, P NATL ACAD SCI USA, V94, P10080, DOI 10.1073/pnas.94.19.10080; KATO K, 1995, STRUCTURE, V3, P79, DOI 10.1016/S0969-2126(01)00136-8; Pabst TM, 2014, J CHROMATOGR A, V1362, P180, DOI 10.1016/j.chroma.2014.08.046; Graille M, 2000, P NATL ACAD SCI USA, V97, P5399, DOI 10.1073/pnas.97.10.5399; Palmer B, 2008, J BIOTECHNOL, V134, P222, DOI 10.1016/j.jbiotec.2007.12.009; BJORCK L, 1984, J IMMUNOL, V133, P969; Evers TH, 2006, BIOCHEMISTRY-US, V45, P13183, DOI 10.1021/bi061288t; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; ROBEN PW, 1995, J IMMUNOL, V154, P6437; LANGONE JJ, 1982, ADV IMMUNOL, V32, P157; NILSSON B, 1987, PROTEIN ENG, V1, P107, DOI 10.1093/protein/1.2.107; Rich RL, 2007, ANAL BIOCHEM, V361, P1, DOI 10.1016/j.ab.2006.10.040; Ueda H, 1996, NAT BIOTECHNOL, V14, P1714, DOI 10.1038/nbt1296-1714; SJOBRING U, 1991, J BIOL CHEM, V266, P399; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639; Starovasnik MA, 1999, PROTEIN SCI, V8, P1423; Suzuki C, 1997, J BIOCHEM-TOKYO, V122, P322; Zhou HH, 2007, J CLIN PHARMACOL, V47, P383, DOI 10.1177/0091270006298188; Carter P, 1997, CURR OPIN BIOTECH, V8, P449, DOI 10.1016/S0958-1669(97)80067-5; Watanabe H, 2009, J BIOL CHEM, V284, P12373, DOI 10.1074/jbc.M809236200; DERRICK JP, 1994, J MOL BIOL, V243, P906, DOI 10.1006/jmbi.1994.1691; PANTOLIANO MW, 1991, BIOCHEMISTRY-US, V30, P10117, DOI 10.1021/bi00106a007; Dong J, 2009, ANAL BIOCHEM, V386, P36, DOI 10.1016/j.ab.2008.11.045; Diessner J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.115; RICHMAN DD, 1982, J IMMUNOL, V128, P2300	27	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	NOV	2015	120	5					504	509		10.1016/j.jbiosc.2015.03.014		6	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CX0BQ	WOS:000365362300004		
J	Hondo, S; Takahashi, M; Osanai, T; Matsuda, M; Hasunuma, T; Tazuke, A; Nakahira, Y; Chohnan, S; Hasegawa, M; Asayama, M				Hondo, Sayaka; Takahashi, Masatoshi; Osanai, Takashi; Matsuda, Mami; Hasunuma, Tomohisa; Tazuke, Akio; Nakahira, Yoichi; Chohnan, Shigeru; Hasegawa, Morifumi; Asayama, Munehiko			Genetic engineering and metabolite profiling for overproduction of polyhydroxybutyrate in cyanobacteria	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Acetyl-CoA; Cyanobacteria; Metabolite analysis; Nitrogen depletion; Polyhydroxybutyrate	POLY-BETA-HYDROXYBUTYRATE; SYNECHOCYSTIS SP PCC-6803; SP STRAIN ABRG5-3; MULTICELLULAR CYANOBACTERIUM; POLYHYDROXYALKANOATES; BIOSYNTHESIS; ACCUMULATION; PHOSPHATE; PCC6803; CO2	Genetic engineering and metabolite profiling for the overproduction of polyhydroxybutyrate (PHB), which is a carbon material in biodegradable plastics, were examined in the unicellular cyanobacterium Synechocystis sp. PCC 6803. Transconjugants harboring cyanobacterial expression vectors that carried the pha genes for PHB biosynthesis were constructed. The overproduction of PHB by the engineering cells was confirmed through microscopic observations using Nile red, transmission electron microscopy (TEM), or nuclear magnetic resonance (NMR). We successfully recovered PHB from transconjugants prepared from nitrogen-depleted medium without sugar supplementation in which PHB reached approximately 7% (w/w) of the dry cell weight, showing a value of 12-fold higher productivity in the transconjugant than that in the control strain. We also measured the intracellular levels of acetyl-CoA, acetoacetyl-CoA, and 3-hydroxybutyryl-CoA (3HB-CoA), which are intermediate products for PHB. The results obtained indicated that these products were absent or at markedly low levels when cells were subjected to the steady-state growth phase of cultivation under nitrogen depletion for the overproduction of bioplastics. Based on these results, efficient factors were discussed for the overproduction of PHB in recombinant cyanobacteria. (C) 2015, The Society for Biotechnology, Japan. All rights reserved.	[Hondo, Sayaka; Takahashi, Masatoshi; Tazuke, Akio; Nakahira, Yoichi; Chohnan, Shigeru; Hasegawa, Morifumi; Asayama, Munehiko] Ibaraki Univ, Coll Agr, Ibaraki 3000393, Japan; [Osanai, Takashi; Matsuda, Mami; Hasunuma, Tomohisa; Asayama, Munehiko] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan; [Osanai, Takashi] RIKEN, Genom Sci Ctr, Yokohama, Kanagawa 2300045, Japan; [Matsuda, Mami; Hasunuma, Tomohisa] Kobe Univ, Org Adv Sci & Technol, Kobe, Hyogo 6578501, Japan	Asayama, M (reprint author), Ibaraki Univ, Coll Agr, 3-21-1 Ami, Ibaraki 3000393, Japan.	asam@mx.ibaraki.ac.jp	Hasunuma, Tomohisa/A-1949-2015; Hasegawa, Morifumi/G-6053-2011	Hasunuma, Tomohisa/0000-0002-8382-2362; Hasegawa, Morifumi/0000-0001-9829-2811	PRESTO (Sakigake project) of Japan Science and Technology Agency	This work was partially supported by PRESTO (Sakigake project) of the Japan Science and Technology Agency (to M.A.).	Akiyama H, 2011, BIORESOURCE TECHNOL, V102, P11039, DOI 10.1016/j.biortech.2011.09.058; Miyake M, 1997, J BACTERIOL, V179, P5009; RIPPKA R, 1988, METHOD ENZYMOL, V167, P3; Chanprateep S, 2010, J BIOSCI BIOENG, V110, P621, DOI 10.1016/j.jbiosc.2010.07.014; Pietrini M, 2007, BIOMACROMOLECULES, V8, P2210, DOI 10.1021/bm0700892; Hein S, 1998, ARCH MICROBIOL, V170, P162, DOI 10.1007/s002030050629; Hasunuma T, 2013, J EXP BOT, V64, P2943, DOI 10.1093/jxb/ert134; Sudesh K, 2002, INT J BIOL MACROMOL, V30, P97, DOI 10.1016/S0141-8130(02)00010-7; Leaf TA, 1996, MICROBIOL-SGM, V142, P1169; Maehara A, 1999, J BACTERIOL, V181, P2914; Ducat DC, 2011, TRENDS BIOTECHNOL, V29, P95, DOI 10.1016/j.tibtech.2010.12.003; Panda B, 2007, LETT APPL MICROBIOL, V44, P194, DOI 10.1111/j.1472-765X.2006.02048.x; Ogata Y, 2014, CAN J MICROBIOL, V60, P297, DOI 10.1139/cjm-2013-0793; Asada Y, 1999, INT J BIOL MACROMOL, V25, P37, DOI 10.1016/S0141-8130(99)00013-6; Jendrossek D, 2002, ANNU REV MICROBIOL, V56, P403, DOI 10.1146/annurev.micro.56.012302.160838; MEYER RJ, 1980, J BACTERIOL, V143, P1362; Nishioka M, 2001, BIOTECHNOL LETT, V23, P1095, DOI 10.1023/A:1010551614648; Kaneko T, 2007, DNA RES, V14, P247, DOI 10.1093/dnares/dsm026; Poomipuk N, 2014, INT J BIOL MACROMOL, V65, P51, DOI 10.1016/j.ijbiomac.2014.01.002; Osanai T, 2013, DNA RES, V20, P525, DOI 10.1093/dnares/dst028; Kitazaki C, 2013, BIOSCI BIOTECH BIOCH, V77, P2339, DOI 10.1271/bbb.130409; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Nishizawa T, 2010, BIOSCI BIOTECH BIOCH, V74, P1827, DOI 10.1271/bbb.100216; Wang B, 2013, METAB ENG, V16, P68, DOI 10.1016/j.ymben.2013.01.001; Asayama M, 2012, APPL MICROBIOL BIOT, V95, P683, DOI 10.1007/s00253-012-3989-0; Zinchenko VV, 1999, RUSS J GENET+, V35, P228; Tian JM, 2005, J BACTERIOL, V187, P3825, DOI 10.1128/JB.187.11.3825.3832.2005; Kaneko T, 1996, DNA Res, V3, P109, DOI 10.1093/dnares/3.3.109; Osanai T, 2006, DNA RES, V13, P185, DOI 10.1093/dnares/ds1010; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766	30	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	NOV	2015	120	5					510	517		10.1016/j.jbiosc.2015.03.004		8	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CX0BQ	WOS:000365362300005		
J	Mori, A; Hara, S; Sugahara, T; Kojima, T; Iwasaki, Y; Kawarasaki, Y; Sahara, T; Ohgiya, S; Nakano, H				Mori, Akihiro; Hara, Shoichi; Sugahara, Tomohiro; Kojima, Takaaki; Iwasaki, Yugo; Kawarasaki, Yasuaki; Sahara, Takehiko; Ohgiya, Satoru; Nakano, Hideo			Signal peptide optimization tool for the secretion of recombinant protein from Saccharomyces cerevisiae	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Signal peptide library; Secretion; SignalP; beta-Galactosidase; Saccharomyces cerevisiae	BACILLUS-SUBTILIS; EXPRESSION; PREDICTION; SYSTEM; GENOME; LEADER	The secretion efficiency of foreign proteins in recombinant microbes is strongly dependent on the combination of the signal peptides (SPs) used and the target proteins; therefore, identifying the optimal SP sequence for each target protein is a crucial step in maximizing the efficiency of protein secretion in both prokaryotes and eukaryotes. In this study, we developed a novel method, named the SP optimization tool (SPOT), for the generation and rapid screening of a library of SP-target gene fusion constructs to identify the optimal SP for maximizing target protein secretion. In contrast to libraries generated in previous studies, SPOT fusion constructs are generated without adding the intervening sequences associated with restriction enzyme digestion sites. Therefore, no extra amino acids are inserted at the N-terminus of the target protein that might affect its function or conformational stability. As a model system, beta-galactosidase (LacA) from Aspergillus oryzae was used as a target protein for secretion from Saccharomyces cerevisiae. In total, 60 SPs were selected from S. cerevisiae secretory proteins and utilized to generate the SP library. While many of the SP-LacA fusions were not secreted, several of the SPs, AGA2, CRH1, PLB1, and MF(alpha)1, were found to enhance LacA secretion compared to the WT sequence. Our results indicate that SPOT is a valuable method for optimizing the bioproduction of any target protein, and could be adapted to many host strains. (C) 2015, The Society for Biotechnology, Japan. All rights reserved.	[Mori, Akihiro; Hara, Shoichi; Sugahara, Tomohiro; Kojima, Takaaki; Iwasaki, Yugo; Nakano, Hideo] Nagoya Univ, Grad Sch Bioagr Sci, Mol Biotechnol Lab, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Kawarasaki, Yasuaki] Univ Shizuoka, Sch Food & Nutr Sci, Biomol Engn Lab, Suruga Ku, Shizuoka 4228526, Japan; [Sahara, Takehiko] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst BPRI, Tsukuba, Ibaraki 3058566, Japan; [Ohgiya, Satoru] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst BPRI, Toyohira Ku, Sapporo, Hokkaido 0628517, Japan	Nakano, H (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Mol Biotechnol Lab, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	hnakano@agr.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) [23656522]	This work was supported in part by a Grant-in Aid (no. 23656522) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT).	Rakestraw JA, 2009, BIOTECHNOL BIOENG, V103, P1192, DOI 10.1002/bit.22338; Degering C, 2010, APPL ENVIRON MICROB, V76, P6370, DOI 10.1128/AEM.01146-10; Celik E, 2012, BIOTECHNOL ADV, V30, P1108, DOI 10.1016/j.biotechadv.2011.09.011; JARVIS DL, 1993, J BIOL CHEM, V268, P16754; DERTZBAUGH MT, 1993, INFECT IMMUN, V61, P384; Brockmeier U, 2006, J MOL BIOL, V362, P393, DOI 10.1016/j.jmb.2006.07.034; Takano K, 1999, EUR J BIOCHEM, V266, P675, DOI 10.1046/j.1432-1327.1999.00918.x; Monroy-Lagos O, 2006, APPL ENVIRON MICROB, V72, P3797, DOI 10.1128/AEM.72.5.3797-3801.2006; Shigemori Y, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni111; Low KO, 2013, APPL MICROBIOL BIOT, V97, P3811, DOI 10.1007/s00253-013-4831-z; Watanabe K, 2009, MICROBIOL-SGM, V155, P741, DOI 10.1099/mic.0.024075-0; Mitaku S, 2002, BIOINFORMATICS, V18, P608, DOI 10.1093/bioinformatics/18.4.608; Kamiya T, 2010, J BIOTECHNOL, V146, P151, DOI 10.1016/j.jbiotec.2010.02.007; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; LI P, 1988, P NATL ACAD SCI USA, V85, P7685, DOI 10.1073/pnas.85.20.7685; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Kojima T, 2011, J BIOSCI BIOENG, V112, P299, DOI 10.1016/j.jbiosc.2011.05.017; Klatt S, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-97; Klee EW, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-256; Mathiesen G, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-425; Sahara T., 2007, Japan Patent, Patent No. [P2007-167062A, 2007167062]; Sambrook J., 2001, MOL CLONING LAB MANU	23	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	NOV	2015	120	5					518	525		10.1016/j.jbiosc.2015.03.003		8	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CX0BQ	WOS:000365362300006		
J	Hayakawa, K; Kajihata, S; Matsuda, F; Shimizu, H				Hayakawa, Kenshi; Kajihata, Shuichi; Matsuda, Fumio; Shimizu, Hiroshi			C-13-metabolic flux analysis in S-adenosyl-L-methionine production by Saccharomyces cerevisiae	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						C-13-based metabolic flux analysis; Crabtree effect; Central carbon metabolism; Redox balance; Saccharomyces cerevisiae	CHEMOSTAT CULTURES; METABOLIC NETWORK; STRESS RESPONSES; PICHIA-PASTORIS; ACID PRODUCTION; ETHANOL STRESS; SAKE YEAST; IDENTIFICATION; FERMENTATION; STRAINS	S-Adenosyl-L-methionine (SAM) is a major biological methyl group donor, and is used as a nutritional supplement and prescription drug. Yeast is used for the industrial production of SAM owing to its high intracellular SAM concentrations. To determine the regulation mechanisms responsible for such high SAM production, C-13-metabolic flux analysis (C-13-MFA) was conducted to compare the flux distributions in the central metabolism between Kyokai no. 6 (high SAM-producing) and S288C (control) strains. C-13-MFA showed that the levels of tricarboxylic acid (TCA) cycle flux in SAM-overproducing strain were considerably increased compared to those in the S228C strain. Analysis of ATP balance also showed that a larger amount of excess ATP was produced in the Kyokai 6 strain because of increased oxidative phosphorylation. These results suggest that high SAM production in Kyokai 6 strains could be attributed to enhanced ATP regeneration with high TCA cycle fluxes and respiration activity. Thus, maintaining high respiration efficiency during cultivation is important for improving SAM production. (C) 2015, The Society for Biotechnology, Japan. All rights reserved.	[Hayakawa, Kenshi; Kajihata, Shuichi; Matsuda, Fumio; Shimizu, Hiroshi] Osaka Univ, Grad Sch Informat Sci & Technol, Dept Bioinformat Engn, Suita, Osaka 5650871, Japan; [Hayakawa, Kenshi] Osaka Univ, Grad Sch Engn, KANEKA Fundamental Technol Res Alliance Labs, Suita, Osaka 5650871, Japan	Shimizu, H (reprint author), Osaka Univ, Grad Sch Informat Sci & Technol, Dept Bioinformat Engn, 1-5 Yamadaoka, Suita, Osaka 5650871, Japan.	Kenshi.Hayakawa@kaneka.co.jp; s-kajihata@ist.osaka-u.ac.jp; fmatsuda@ist.osaka-u.ac.jp; shimizu@ist.osaka-u.ac.jp					Agrimi G, 2014, FEMS YEAST RES, V14, P249, DOI 10.1111/1567-1364.12120; TAKAGI A, 1985, APPL ENVIRON MICROB, V49, P244; Yoshikawa K, 2009, FEMS YEAST RES, V9, P32, DOI 10.1111/j.1567-1364.2008.00456.x; Motomura S, 2012, J I BREWING, V118, P22, DOI 10.1002/jib.7; Stuckrath I, 2002, BIOTECHNOL BIOENG, V77, P61, DOI 10.1002/bit.10123; Frick O, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-30; Wang YL, 2013, BIORESOURCE TECHNOL, V131, P28, DOI 10.1016/j.biortech.2012.10.168; Shobayashi M, 2006, APPL MICROBIOL BIOT, V69, P704, DOI 10.1007/s00253-005-0009-7; Hu XQ, 2008, J BIOTECHNOL, V137, P44, DOI 10.1016/j.jbiotec.2008.04.009; Antoniewicz MR, 2006, METAB ENG, V8, P324, DOI 10.1016/j.ymben.2006.01.004; Sollner S, 2009, BIOCHEMISTRY-US, V48, P8636, DOI 10.1021/bi900734a; Kajihata S, 2014, BIOMED RES INT, DOI 10.1155/2014/627014; Boles E, 1998, J BACTERIOL, V180, P2875; Kanai M, 2013, APPL MICROBIOL BIOT, V97, P1183, DOI 10.1007/s00253-012-4261-3; Kotaka A, 2008, BIOSCI BIOTECH BIOCH, V72, P1376, DOI 10.1271/bbb.70825; SHIOZAKI S, 1989, AGR BIOL CHEM TOKYO, V53, P3269; SHIOZAKI S, 1986, J BIOTECHNOL, V4, P345, DOI 10.1016/0168-1656(86)90048-9; Toya Y, 2013, BIOTECHNOL ADV, V31, P818, DOI 10.1016/j.biotechadv.2013.05.002; Shobayashi M, 2007, BIOSCI BIOTECH BIOCH, V71, P323, DOI 10.1271/bbb.60190; Hu XQ, 2007, ENZYME MICROB TECH, V40, P669, DOI 10.1016/j.enzmictec.2006.05.024; VERDUYN C, 1990, J GEN MICROBIOL, V136, P405; Monschau N, 1997, FEMS MICROBIOL LETT, V150, P55, DOI 10.1016/S0378-1097(97)00096-7; van Winden WA, 2002, BIOTECHNOL BIOENG, V80, P477, DOI 10.1002/bit.10393; Wang LQ, 2006, METAB ENG, V8, P142, DOI 10.1016/j.yinben.2005.11.002; VERDUYN C, 1991, ANTON LEEUW INT J G, V60, P325, DOI 10.1007/BF00430373; Breker M, 2013, J CELL BIOL, V200, P839, DOI 10.1083/jcb.201301120; Toya Y, 2014, J BIOTECHNOL, V179, P42, DOI 10.1016/j.jbiotec.2014.03.025; Akada R, 2002, J BIOSCI BIOENG, V94, P536, DOI 10.1016/S1389-1723(02)80192-X; PIPER PW, 1995, FEMS MICROBIOL LETT, V134, P121, DOI 10.1016/0378-1097(95)00431-9; MORTIMER RK, 1986, GENETICS, V113, P35; Oba T, 2014, FEMS YEAST RES, V14, P789, DOI 10.1111/1567-1364.12170; Gombert AK, 2001, J BACTERIOL, V183, P1441, DOI 10.1128/JB.183.4.1441-1451.2001; Mori E, 2011, BIOTECHNOL J, V6, P1377, DOI 10.1002/biot.201000446; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; DEJONGGUBBELS P, 1995, YEAST, V11, P407, DOI 10.1002/yea.320110503; Kasahara H., 1963, J SOC BREW JAPAN, V58, P583; SHIOZAKI S, 1984, AGR BIOL CHEM TOKYO, V48, P2293; Shiroma S, 2014, APPL ENVIRON MICROB, V80, P1002, DOI 10.1128/AEM.03130-13; Tkach JM, 2012, NAT CELL BIOL, V14, P966, DOI 10.1038/ncb2549; WALKER ME, 1991, BIOCHEM BIOPH RES CO, V176, P1210, DOI 10.1016/0006-291X(91)90414-3; van Winden WA, 2005, FEMS YEAST RES, V5, P559, DOI 10.1016/j.femsyr.2004.10.007	41	1	1	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	NOV	2015	120	5					532	538		10.1016/j.jbiosc.2015.03.010		7	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CX0BQ	WOS:000365362300008		
J	Jumhawan, U; Putri, SP; Yusianto; Bamba, T; Fukusaki, E				Jumhawan, Udi; Putri, Sastia Prama; Yusianto; Bamba, Takeshi; Fukusaki, Eiichiro			Application of gas chromatography/flame ionization detector-based metabolite fingerprinting for authentication of Asian palm civet coffee (Kopi Luwak)	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Civet coffee; Kopi Luwak; Gas chromatography/flame ionization detector; Metabolite fingerprinting; Industrial routine	MASS SPECTROMETRY; METABOLOMICS; IDENTIFICATION; DISCRIMINATION; ROBUSTA; BEANS; CLASSIFICATION; CHEMOMETRICS; SPECTROSCOPY; PREDICTION	Development of authenticity screening for Asian palm civet coffee, the world-renowned priciest coffee, was previously reported using metabolite profiling through gas chromatography/mass spectrometry (GC/MS). However, a major drawback of this approach is the high cost of the instrument and maintenance. Therefore, an alternative method is needed for quality and authenticity evaluation of civet coffee. A rapid, reliable and cost-effective analysis employing a universal detector, GC coupled with flame ionization detector (FID), and metabolite fingerprinting has been established for discrimination analysis of 37 commercial and non-commercial coffee beans extracts, gas chromatography/flame ionization detector (GC/FID) provided higher sensitivity over a similar range of detected compounds than GC/MS. In combination with multivariate analysis, GC/FID could successfully reproduce quality prediction from GC/MS for differentiation of commercial civet coffee, regular coffee and coffee blend with 50 wt % civet coffee content without prior metabolite details. Our study demonstrated that GC/FID-based metabolite fingerprinting can be effectively actualized as an alternative method for coffee authenticity screening in industries. (C) 2015, The Society for Biotechnology, Japan. All rights reserved.	[Jumhawan, Udi; Putri, Sastia Prama; Bamba, Takeshi; Fukusaki, Eiichiro] Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka 5650871, Japan; [Yusianto] Indonesian Coffee & Cocoa Res Inst, Jember 68118, East Java, Indonesia	Fukusaki, E (reprint author), Osaka Univ, Grad Sch Engn, Dept Biotechnol, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	fukusaki@bio.eng.osaka-u.ac.jp					Agresti PDCM, 2008, FOOD CHEM, V106, P787, DOI 10.1016/j.foodchem.2007.06.019; Kobayashi S, 2012, J BIOSCI BIOENG, V114, P232, DOI 10.1016/j.jbiosc.2012.03.022; Yeh TF, 2006, TREE PHYSIOL, V26, P1497; De Livera AM, 2012, ANAL CHEM, V84, P10768, DOI 10.1021/ac302748b; El-Abassy RM, 2011, FOOD CHEM, V126, P1443, DOI 10.1016/j.foodchem.2010.11.132; Marcone MF, 2004, FOOD RES INT, V37, P901, DOI 10.1016/j.foodres.2004.05.008; Wei FF, 2012, J AGR FOOD CHEM, V60, P10118, DOI 10.1021/jf3033057; Kobayashi S, 2012, J BIOSCI BIOENG, V114, P86, DOI 10.1016/j.jbiosc.2012.02.015; Campo E, 2006, ANAL CHIM ACTA, V563, P180, DOI 10.1016/j.aca.2005.10.035; Lundstedt T, 1998, CHEMOMETR INTELL LAB, V42, P3, DOI 10.1016/S0169-7439(98)00065-3; Moco S, 2007, TRAC-TREND ANAL CHEM, V26, P855, DOI 10.1016/j.trac.2007.08.003; Hawkins DM, 2004, J CHEM INF COMP SCI, V44, P1, DOI 10.1021/ci0342472; Wermelinger T, 2011, J AGR FOOD CHEM, V59, P9074, DOI 10.1021/jf201918a; Ibanez AJ, 2013, P NATL ACAD SCI USA, V110, P8790, DOI 10.1073/pnas.1209302110; Eriksson L, 2014, J CHEMOMETR, V28, P332, DOI 10.1002/cem.2581; Dieterle F, 2006, ANAL CHEM, V78, P3551, DOI 10.1021/ac0518351; Briandet R, 1996, J AGR FOOD CHEM, V44, P170, DOI 10.1021/jf950305a; Jumtee K, 2009, J SEP SCI, V32, P2296, DOI 10.1002/jssc.200900096; Anderson KA, 2002, J AGR FOOD CHEM, V50, P2068, DOI 10.1021/jf011056v; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Shiga K, 2014, J AGR FOOD CHEM, V62, P7317, DOI 10.1021/jf501173r; Taguchi K, 2014, J CHROMATOGR A, V1362, P270, DOI 10.1016/j.chroma.2014.08.003; Eriksson L, 2003, ENVIRON HEALTH PERSP, V111, P1361, DOI 10.1289/ehp.5758; Ma CF, 2008, J CHROMATOGR A, V1186, P412, DOI 10.1016/j.chroma.2007.09.023; Yamamoto S, 2014, J BIOSCI BIOENG, V118, P56, DOI 10.1016/j.jbiosc.2013.12.019; Mendonca JCF, 2008, FOOD CHEM, V111, P490, DOI 10.1016/j.foodchem.2008.03.080; Wei FF, 2012, J AGR FOOD CHEM, V60, P1005, DOI 10.1021/jf205315r; Garrett R., 2012, J AGR FOOD CHEM, V60, P4255; Jumhawan U, 2013, J AGR FOOD CHEM, V61, P7994, DOI 10.1021/jf401819s; Li SZ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003123; Mimura N, 2014, J BIOSCI BIOENG, V118, P406, DOI 10.1016/j.jbiosc.2014.04.006; Setoyama D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070098; Wang ZF, 2014, ANAL CHEM, V86, P9050, DOI 10.1021/ac501658k; Wildund S., 2008, ANAL CHEM, V80, P115; Zenobi R., 2013, SCIENCE, V342, P6163	35	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	NOV	2015	120	5					555	561		10.1016/j.jbiosc.2015.03.005		7	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CX0BQ	WOS:000365362300012		
J	Sato, S; Nakazawa, M; Kihara, Y; Kubo, Y; Sato, Y; Kikuchi, T; Nonaka, A; Sasaki, A; Iwashita, J; Murata, J; Hosaka, M; Kobayashi, M				Sato, Shiori; Nakazawa, Masato; Kihara, Yumi; Kubo, Yusuke; Sato, Yuki; Kikuchi, Takahiro; Nonaka, Asumi; Sasaki, Akira; Iwashita, Jun; Murata, Jun; Hosaka, Masahiro; Kobayashi, Masayuki			Partial inhibition of differentiation associated with elevated protein levels of pluripotency factors in mouse embryonic stem cells expressing exogenous EGAM1N homeoprotein	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						CRXOS1 isoform c; Crxos tv3; Differentiation; EGAM1N; Embryonic stem cells; Inhibition; Pluripotency factor	TRANSCRIPTION FACTOR OCT-4; SELF-RENEWAL; ES CELLS; ENDODERM; NANOG; LINEAGES; GENES; STAT3; ESTABLISHMENT; HOMEODOMAIN	We previously reported that transcripts encoding the homeoprotein EGAM1N are expressed in preimplantation mouse embryos and embryonic stem (ES) cells, and the exogenous expression of EGAM1N inhibits the differentiation of ES cells. In order to clarify the relationship between the inhibition of differentiation and EGAM1N, we generated mouse MG1.19 ES cells stably expressing EGAM1N. Control transfectants with an empty vector formed relatively flattened cell colonies similar to those observed in parental MG1.19 cells. In contrast, Egam1n transfectants formed tightly aggregated cell colonies with increased localization of CDH1 at cell-to-cell interfaces. The protein levels of pluripotency factors, including TBX3 and SOX2, were also increased. The expression of Tbx3 transcripts was induced, although the level of Sox2 transcripts was almost unchanged. The expression of EGAM1N resulted in no obvious changes in the expression of genes encoding receptors, protein kinases, transcription factors, and their encoded proteins involved in the LIF-STAT3 signaling pathway. Alkaline phosphatase activity, a marker for the undifferentiated state, in Egam1n transfectants was exhibited in a clonal proliferation assay. When differentiation of Egam1n transfectants was induced, progression was prevented with increases in transcript levels of Pou5f1, Sox2, Nanog, K1f4, Tbx3, and their encoded proteins. However, Egam1n transfectants formed relatively flattened-cell layers as observed in the control, indicating that the expression of EGAM1N could not maintain LIF-independent self-renewal of ES cells. Overall, we suggest that expression of EGAM1N could inhibit differentiation, at least in part, by elevating the protein levels of pluripotency factors in MG1.19 ES cells. (C) 2015, The Society for Biotechnology, Japan. All rights reserved.	[Sato, Shiori; Nakazawa, Masato; Kihara, Yumi; Kubo, Yusuke; Sato, Yuki; Kikuchi, Takahiro; Nonaka, Asumi; Sasaki, Akira; Iwashita, Jun; Murata, Jun; Hosaka, Masahiro; Kobayashi, Masayuki] Akita Prefectural Univ, Grad Sch Bioresource Sci, Akita 0100195, Japan; [Sasaki, Akira] Akita Res Inst Food & Brewing, Akita 0101623, Japan	Kobayashi, M (reprint author), Akita Prefectural Univ, Grad Sch Bioresource Sci, 241-438 Kaidohbatanishi, Akita 0100195, Japan.	makoba@akita-pu.ac.jp			Japan Society for the Promotion of Science (JSPS KAKENHI) [24580413]; Akita Prefectural University President's Research Project [173, 108, 240]	We thank Dr. Hitoshi Niwa (RIKEN Center for Developmental Biology, Kobe, Japan) for providing the human LIF-expressing vector. We thank Dr. Max Gassmann (University of Zurich, Switzerland) for providing the pMGD20neo vector and MG1.19 cells. This work was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS KAKENHI No. 24580413) and the Akita Prefectural University President's Research Project to M. K. (H24Kendai-ken No. 173 and H25Kendai-ken No. 108) and to M. H. (H24Kendai-ken No. 240).	Kunath T, 2005, DEVELOPMENT, V132, P1649, DOI 10.1242/dev.01715; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; NIWA H, 1991, GENE, V108, P193; Soma M, 2012, J BIOSCI BIOENG, V114, P342, DOI 10.1016/j.jbiosc.2012.04.012; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; RIETHMACHER D, 1995, P NATL ACAD SCI USA, V92, P855, DOI 10.1073/pnas.92.3.855; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Zhang ZH, 2007, FASEB J, V21, P3042, DOI 10.1096/fj.06-6914com; PALMIERI SL, 1994, DEV BIOL, V166, P259, DOI 10.1006/dbio.1994.1312; Moretto-Zita M, 2010, P NATL ACAD SCI USA, V107, P13312, DOI 10.1073/pnas.1005847107; Hanna LA, 2002, GENE DEV, V16, P2650, DOI 10.1101/gad.1020502; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Soma M, 2011, BIOTECHNOL BIOTEC EQ, V25, P2679, DOI 10.5504/BBEQ.2011.0094; PEDERSEN RA, 1986, DEV BIOL, V117, P581, DOI 10.1016/0012-1606(86)90327-1; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Bourillot PY, 2009, STEM CELLS, V27, P1760, DOI 10.1002/stem.110; Saito K, 2011, REPRODUCTION, V141, P259, DOI 10.1530/REP-10-0355; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Saito K, 2010, BIOL REPROD, V82, P687, DOI 10.1095/biolreprod.108.075697; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Abe H, 2011, BIOTECHNOL BIOTEC EQ, V25, P2301, DOI 10.5504/BBEQ.2011.0013; GASSMANN M, 1995, P NATL ACAD SCI USA, V92, P1292, DOI 10.1073/pnas.92.5.1292; Saito R, 2009, BIOCHEM BIOPH RES CO, V390, P1129, DOI 10.1016/j.bbrc.2009.09.118; Liu Y, 2008, STEM CELLS, V26, P2475, DOI 10.1634/stemcells.2008-0269; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Larue L, 1996, DEVELOPMENT, V122, P3185; Martello G, 2013, EMBO J, V32, P2561, DOI 10.1038/emboj.2013.177; Iha M, 2012, REPRODUCTION, V143, P477, DOI 10.1530/REP-11-0379; FLEMING TP, 1987, DEV BIOL, V119, P520, DOI 10.1016/0012-1606(87)90055-8; Fujikura J, 2002, GENE DEV, V16, P784, DOI 10.1101/gad.968802; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; GEHRING WJ, 1994, ANNU REV BIOCHEM, V63, P487, DOI 10.1146/annurev.biochem.63.1.487; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Xu HM, 2004, J BIOL CHEM, V279, P23495, DOI 10.1074/jbc.M400516200; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Iha M, 2012, BIOSCI BIOTECH BIOCH, V76, P1410; Musch T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010726; Plank J. L., 2013, STEM CELL RES, V12, P233; Rao S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-230; Sato S, 2013, J BIOSCI BIOENG, V116, P141, DOI 10.1016/j.jbiosc.2013.02.007; Smith A., 1991, J TISSUE CULTURE MET, V13, P89, DOI 10.1007/BF01666137	43	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	NOV	2015	120	5					562	569		10.1016/j.jbiosc.2015.03.001		8	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CX0BQ	WOS:000365362300013		
J	Akiyama, H; Kobayashi, A; Ichimura, M; Tone, H; Nakatani, M; Inoue, M; Tojo, A; Kagami, H				Akiyama, Hirokazu; Kobayashi, Asako; Ichimura, Masaki; Tone, Hiroshi; Nakatani, Masaru; Inoue, Minoru; Tojo, Arinobu; Kagami, Hideaki			Comparison of manual and automated cultures of bone marrow stromal cells for bone tissue engineering	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Automated cell culture system; Bone marrow stromal cells; Osteogenic potential; Bone tissue engineering; Regenerative medicine	MESENCHYMAL STEM-CELLS; RANDOMIZED PHASE-1 TRIAL; IN-VITRO; EXPANSION; RECONSTRUCTION; TRANSFORMATION; SYSTEM	The development of an automated cell culture system would allow stable and economical cell processing for wider clinical applications in the field of regenerative medicine. However, it is crucial to determine whether the cells obtained by automated culture are comparable to those generated by manual culture. In the present study, we focused on the primary culture process of bone marrow stromal cells (BMSCs) for bone tissue engineering and investigated the feasibility of its automation using a commercially available automated cell culture system in a clinical setting. A comparison of the harvested BMSCs from manual and automated cultures using clinically acceptable protocols showed no differences in cell yields, viabilities, surface marker expression profiles, and in vivo osteogenic abilities. Cells cultured with this system also did not show malignant transformation and the automated process was revealed to be safe in terms of microbial contamination. Taken together, the automated procedure described in this report provides an approach to clinical bone tissue engineering. (C) 2015, The Society for Biotechnology, Japan. All rights reserved.	[Akiyama, Hirokazu; Ichimura, Masaki; Nakatani, Masaru] Kaneka Corp, Med Device Dev Labs, Takasago, Hyogo 6768688, Japan; [Kobayashi, Asako; Inoue, Minoru; Tojo, Arinobu; Kagami, Hideaki] Univ Tokyo, Inst Med Sci, Div Mol Therapy, Tissue Engn Res Grp,Minato Ku, Tokyo 1088639, Japan; [Tone, Hiroshi] Kaneka Corp, Div Med Devices, Technol Management Dept, Kita Ku, Osaka 5308288, Japan; [Kagami, Hideaki] Matsumoto Dent Univ, Sch Dent, Dept Oral & Maxillofacial Surg, Shiojiri, Nagano 3990781, Japan	Kagami, H (reprint author), Univ Tokyo, Inst Med Sci, Div Mol Therapy, Tissue Engn Res Grp,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	kagami@ims.u-tokyo.ac.jp			Kaneka Corporation; Health Labor Sciences Research Grants from Ministry of Health, Labour and Welfare of Japan; Translational Research Network Program of Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)	This work was supported in part by a research grant from the Kaneka Corporation, Health Labor Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan, and the Translational Research Network Program of the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT). Hirokazu Akiyama, Masaki Ichimura, Hiroshi Tone, and Masaru Nakatani are employees of the Kaneka Corporation. Asako Kobayashi, Minoru Inoue, Arinobu Tojo, and Hideaki Kagami declare that there is no conflict of interest regarding the work described herein.	Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Seto I, 2006, PLAST RECONSTR SURG, V117, P902, DOI 10.1097/01.prs.0000200069.81973.49; Kato R, 2010, TISSUE ENG PART C-ME, V16, P947, DOI 10.1089/ten.TEC.2009.0305; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; Thomas RJ, 2009, BIOTECHNOL LETT, V31, P1167, DOI 10.1007/s10529-009-9989-1; Sawa Y, 2012, SURG TODAY, V42, P181, DOI 10.1007/s00595-011-0106-4; Yamada Y, 2013, STEM CELLS, V31, P572, DOI 10.1002/stem.1300; Rojewski MT, 2013, CELL TRANSPLANT, V22, P1981, DOI 10.3727/096368912X657990; Siddappa R, 2007, J ORTHOP RES, V25, P1029, DOI 10.1002/jor.20402; Kagami H, 2014, TISSUE ENG PART B-RE, V20, P229, DOI [10.1089/ten.TEB.2013.0578, 10.1089/ten.teb.2013.0578]; Vilalta M, 2008, STEM CELLS DEV, V17, P993, DOI 10.1089/scd.2007.0201; Kino-Oka M, 2009, J BIOSCI BIOENG, V108, P267, DOI 10.1016/j.jbiosc.2009.04.007; Bernardo ME, 2007, CANCER RES, V67, P9142, DOI 10.1158/0008-5472.CAN-06-4690; Tarte K, 2010, BLOOD, V115, P1549, DOI 10.1182/blood-2009-05-219907; Liu Y, 2010, J TISSUE ENG REGEN M, V4, P45, DOI 10.1002/term.217; Adachi N, 2014, KNEE SURG SPORT TR A, V22, P1241, DOI 10.1007/s00167-013-2521-0; Thomas RJ, 2009, BIOTECHNOL BIOENG, V102, P1636, DOI 10.1002/bit.22187; Owaki T, 2014, BIOTECHNOL J, V9, P904, DOI 10.1002/biot.201300432; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Urbano N, 2013, NUCL MED BIOL, V40, P104, DOI 10.1016/j.nucmedbio.2012.09.002; Agata H, 2010, TISSUE ENG PT A, V16, P663, DOI 10.1089/ten.TEA.2009.0500; Kami Daisuke, 2013, BMC Biotechnol, V13, P102, DOI 10.1186/1472-6750-13-102; Serra Marta, 2015, Methods Mol Biol, V1283, P161, DOI 10.1007/7651_2014_104	23	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	NOV	2015	120	5					570	576		10.1016/j.jbiosc.2015.03.011		7	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CX0BQ	WOS:000365362300014		
J	Takei, T; Aokawa, R; Shigemitsu, T; Kawakami, K; Yoshida, M				Takei, Takayuki; Aokawa, Ryuta; Shigemitsu, Takamasa; Kawakami, Koei; Yoshida, Masahiro			Fabrication of uniformly cell-laden porous scaffolds using a gas-in-liquid templating technique	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Scaffold; Gas foaming; Gelatin; Alginate; Tissue engineering	MICROBIAL TRANSGLUTAMINASE; TISSUE; REGENERATION; FOAMS	Design of porous scaffolds in tissue engineering field was challenging. Uniform immobilization of cells in the scaffolds with high porosity was essential for homogeneous tissue formation. The present study was aimed at fabricating uniformly cell-laden porous scaffolds with porosity >74% using the gas-in-liquid foam templating technique. To this end, we used gelatin, microbial transglutaminase and argon gas as a scaffold material, cross-linker of the protein and porogen of scaffold, respectively. We confirmed that a porosity of >74% could be achieved by increasing the gas volume delivered to a gelatin solution. Pore size in the scaffold could be controlled by stirring speed, stirring time and the pore size of the filter through which the gas passed. The foaming technique enabled us to uniformly immobilize a human hepatoblastoma cell line in scaffold. Engraftment efficiency of the cell line entrapped within the scaffold in nude mice was higher than that of cells in free-form. These results showed that the uniformly cell-laden porous scaffolds were promising for tissue engineering. (C) 2015, The Society for Biotechnology, Japan. All rights reserved.	[Takei, Takayuki; Shigemitsu, Takamasa; Yoshida, Masahiro] Kagoshima Univ, Grad Sch Sci & Engn, Dept Chem Engn, Kagoshima 8900065, Japan; [Aokawa, Ryuta; Kawakami, Koei] Kyushu Univ, Grad Sch Engn, Dept Chem Engn, Nishi Ku, Fukuoka 8190385, Japan	Takei, T (reprint author), Kagoshima Univ, Grad Sch Sci & Engn, Dept Chem Engn, 1-21-40 Korimoto, Kagoshima 8900065, Japan.	takei@cen.kagoshima-u.ac.jp; breeze21.1220@hotmail.co.jp; k7918268@kadai.jp; jjdjq118@ybb.ne.jp; myoshida@cen.kagoshima-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [25820383, 2013]	The authors gratefully acknowledge Dr. Yoshiyuki Kumazawa at Ajinomoto Co., Inc. for provision of MTG. This work was partially supported by a Grant-in-Aid for Young Scientists (B), 25820383, 2013, from Japan Society for the Promotion of Science (JSPS).	Liu J, 2013, ACTA BIOMATER, V9, P4688, DOI 10.1016/j.actbio.2012.08.009; Gong YH, 2010, TISSUE ENG PT A, V16, P3611, DOI 10.1089/ten.TEA.2010.0219; Barbetta A, 2010, SOFT MATTER, V6, P1785, DOI 10.1039/b920049e; Sakai S, 2008, BIOMACROMOLECULES, V9, P2036, DOI 10.1021/bm800286v; Lu LC, 2000, BIOMATERIALS, V21, P1595, DOI 10.1016/S0142-9612(00)00048-X; Chen PY, 2014, ACTA BIOMATER, V10, P912, DOI 10.1016/j.actbio.2013.11.009; Muthutantri A, 2008, J MATER SCI-MATER M, V19, P1485, DOI 10.1007/s10856-008-3379-4; Yung CW, 2007, J BIOMED MATER RES A, V83A, P1039, DOI 10.1002/jbm.a.31431; Li B, 2009, BIOMATERIALS, V30, P6768, DOI 10.1016/j.biomaterials.2009.08.038; Lau TT, 2013, BIOMATERIALS, V34, P6659, DOI 10.1016/j.biomaterials.2013.05.034; Whang K, 2000, BIOMATERIALS, V21, P2545, DOI 10.1016/S0142-9612(00)00122-8; Sultana N, 2008, J MATER SCI-MATER M, V19, P2555, DOI 10.1007/s10856-007-3214-3; Barbetta A, 2010, SOFT MATTER, V6, P5213, DOI 10.1039/c0sm00616e; Danielsson C, 2006, BIOMATERIALS, V27, P1410, DOI 10.1016/j.biomaterials.2005.08.026; Moriyama K, 2011, J BIOSCI BIOENG, V111, P650, DOI 10.1016/j.jbiosc.2011.02.002; Barbetta A, 2009, BIOMACROMOLECULES, V10, P3188, DOI 10.1021/bm901051c; Whang K, 1999, TISSUE ENG, V5, P35, DOI 10.1089/ten.1999.5.35; Ajioka I, 2001, TISSUE ENG, V7, P335, DOI 10.1089/10763270152044198; Dehghani F, 2011, CURR OPIN BIOTECH, V22, P661, DOI 10.1016/j.copbio.2011.04.005; Wei GB, 2008, ADV FUNCT MATER, V18, P3568, DOI 10.1002/adfm.200800662; FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689; Hwang CM, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/3/035003	22	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	NOV	2015	120	5					577	581		10.1016/j.jbiosc.2015.03.017		5	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CX0BQ	WOS:000365362300015		
J	Sasaki, K; Miyata, H; Sasaki, H; Kang, S; Yuasa, T; Kato, R				Sasaki, Kei; Miyata, Hirofumi; Sasaki, Hiroto; Kang, Siu; Yuasa, Tetsuya; Kato, Ryuji			Image-based focused counting of dividing cells for non-invasive monitoring of regenerative medicine products	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Image processing; Cell proliferation; Dividing cells; Sarcoma; Fibroblast	MESENCHYMAL STEM-CELLS; HUMAN FIBROBLASTS; IN-VITRO; TRACKING; SEGMENTATION; MICROSCOPY; CONTEXT	Despite the growing numbers of successful applications in regenerative medicine, biotechnologies for evaluating the quality of cells remain limited. To evaluate the cultured cells non-invasively, image-based cellular assessment method holds great promise. However, although there are various image-processing algorithms, very few studies have focused to prove the effectiveness of phase contrast images with risk assessment example that reflects actual difficulties in regenerative medicine products. In this study, we developed a simple image-processing method to recognize the number of dividing cells in time-course phase-contrast microscopic images, and applied this method to assess the irregular proliferation behavior in normal cells. Practically, as a model, rapid proliferating human fibrosarcoma cells were mixed in normal human fibroblasts in the same culture dish, and their sarcoma existence was evaluated. As a result, the existence of sarcoma population in normal cell sample could be feasibly detected within earliest period of cell culture by their irregular rise of accumulated counts of dividing cells. Our image-processing technique also illustrates the technical effectiveness of combining intra-frame and inter-frame image processing to accurately count only the dividing cells. Our concept of focused counting of dividing cells shows a successful example of image-based analysis to quickly and non-invasively monitor the regular state of regenerative medicine products. (C) 2015, The Society for Biotechnology, Japan. All rights reserved.	[Sasaki, Kei; Miyata, Hirofumi; Kang, Siu; Yuasa, Tetsuya] Yamagata Univ, Grad Sch Sci & Engn, Yonezawa, Yamagata 9928510, Japan; [Sasaki, Hiroto] Nagoya Univ, Grad Sch Engn, Chikusa Ku, Aichi 4668602, Japan; [Kato, Ryuji] Nagoya Univ, Grad Sch Pharmaceut Sci, Chikusa Ku, Aichi 4668601, Japan	Kato, R (reprint author), Nagoya Univ, Grad Sch Pharmaceut Sci, Chikusa Ku, Aichi 4668601, Japan.	kato-r@ps.nagoya-u.ac.jp			New Energy and Industrial Technology Development Organization (NEDO) via Grant for Industrial Technology Research [09C46036a]; Japan Society for the Promotion of Science [23650286, 26630427]	This work was supported by the New Energy and Industrial Technology Development Organization (NEDO) via a Grant for Industrial Technology Research (Financial Support to Young Researchers, 09C46036a), and by a Grant-in-Aid for Challenging Exploratory Research from the Japan Society for the Promotion of Science (Nos. 23650286 and 26630427). We also thank Yurika Nonogaki and Wakana Yamamoto for conducting image acquisition and data preparation.	Li K, 2008, MED IMAGE ANAL, V12, P546, DOI 10.1016/j.media.2008.06.001; Yang FX, 2005, LECT NOTES COMPUT SC, V3749, P302; Ebisawa K, 2011, J BIOSCI BIOENG, V111, P255, DOI 10.1016/j.jbiosc.2010.11.014; Ren ZH, 2011, EXP CELL RES, V317, P2950, DOI 10.1016/j.yexcr.2011.09.008; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; PREWITT JMS, 1966, ANN NY ACAD SCI, V128, P1035; Smith DM, 2012, REGEN MED, V7, P721, DOI [10.2217/rme.12.40, 10.2217/RME.12.40]; Debeir O, 2005, IEEE T MED IMAGING, V24, P697, DOI 10.1109/TMI.2005.846851; Harrison RG, 1907, ANAT REC, V1, P116, DOI 10.1002/ar.1090010503; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; PRESTON K, 1976, COMPUTER, V9, P54, DOI 10.1109/C-M.1976.218587; Matsuoka F, 2014, BIOTECHNOL BIOENG, V111, P1430, DOI 10.1002/bit.25189; McGuire MK, 2005, J PERIODONTOL, V76, P867, DOI 10.1902/jop.2005.76.6.867; Meijering E, 2012, IEEE SIGNAL PROC MAG, V29, P140, DOI 10.1109/MSP.2012.2204190; Bunyak F, 2006, I S BIOMED IMAGING, P1040; Harder N, 2009, GENOME RES, V19, P2113, DOI 10.1101/gr.092494.109; Jones TR, 2009, P NATL ACAD SCI USA, V106, P1826, DOI 10.1073/pnas.0808843106; Bailey A. M., 2012, SCI TRANSL MED, V4; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Kanade T., 2011, 2011 IEEE WORKSH APP, P374, DOI 10.1109/WACV.2011.5711528; Matsuoka F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055082; Misselwitz B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-30; Pan Q., 2013, EXP BIOL MED, V239, P105; Sasaki H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093952; Sasaki H, 2013, TISSUE ENG BIOMATER, V10, P207; Watson D, 1999, Arch Facial Plast Surg, V1, P165, DOI 10.1001/archfaci.1.3.165; Werahera P. N., 2011, PROSTATE CANC, V2011; Wu Q., 2010, MICROSCOPE IMAGE PRO	28	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	NOV	2015	120	5					582	590		10.1016/j.jbiosc.2015.03.002		9	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CX0BQ	WOS:000365362300016		
J	Tsukuda, M; Nakashima, N; Miyazaki, K				Tsukuda, Miyuki; Nakashima, Nobutaka; Miyazaki, Kentaro			Counterselection method based on conditional silencing of antitoxin genes in Escherichia coli	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Counterselection; Escherichia coli; Antitoxin; Toxin-antitoxin; Antisense RNA; MqsA; RnlB; MqsR/MqsA; RnlA/RnlB]	MESSENGER-RNA INTERFERASES; BACTERIAL GENETICS; STRESS-RESPONSE; ANTISENSE RNAS; TOXIN; TRANSLATION; SYSTEM; CONSTRUCTION; EFFICIENCY; CHROMOSOME	Counterselection is a genetic engineering technique to eliminate specific genetic fragments containing selectable marker genes. Although the technique is widely used in bacterial genome engineering and plasmid curing experiments, the repertoire of the markers usable in Escherichia coil is limited. Here we developed a novel counterselection method in E. coli based on antisense RNA (asRNA) technology directed against toxin-antitoxin (TA) modules. Under normal conditions, excess antitoxin neutralizes its cognate toxin and thus the module is stably maintained in the genome. We hypothesised that repression of an antitoxin gene would perturb cell growth due to the toxin being released. We designed asRNAs corresponding to all 19 type II antitoxins encoded in the E. coli genome. asRNAs were then conditionally expressed; repression of MqsA in the MqsR/MqsA module had the greatest inhibitory effect, followed by RnlB in the RnlA/RnlB module. The utility of asRNA(MqsA) as a counterselection marker was demonstrated by efficient plasmid curing and strain improvement experiments. (C) 2015, The Society for Biotechnology, japan. All rights reserved.	[Tsukuda, Miyuki; Miyazaki, Kentaro] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Sapporo, Hokkaido 0628517, Japan; [Tsukuda, Miyuki; Miyazaki, Kentaro] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki 3058566, Japan; [Nakashima, Nobutaka] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Informat, Meguro Ku, Tokyo 1528550, Japan	Miyazaki, K (reprint author), Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Toyohira Ku, 2-17-2-1 Tsukisamu Higashi, Sapporo, Hokkaido 0628517, Japan.	miyazaki-kentaro@aist.go.jp			Japan Society for the Promotion of Science (JSPS) [26292048, 26670219, 26-7760]	The authors thank Shoko Kamada for technical assistance. This work was supported in part by the Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (B) 26292048 (to K.M.), Grant-in-Aid for Scientific Research on Innovative Areas 26670219 (to K.M.), Grant-in-Aid for JSPS Fellows 26-7760 (to T.M.).	Jorgensen MG, 2009, J BACTERIOL, V191, P1191, DOI 10.1128/JB.01013-08; Zhang YL, 2009, J BIOL CHEM, V284, P25522, DOI 10.1074/jbc.M109.036624; Korch SB, 2003, MOL MICROBIOL, V50, P1199, DOI 10.1046/j.1365-2958.2003.03779.x; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; BERNARD P, 1995, GENE, V162, P159, DOI 10.1016/0378-1119(95)00314-V; Schmidt O, 2007, J MOL BIOL, V372, P894, DOI 10.1016/j.jmb.2007.07.016; Nakashima N, 2012, METHODS MOL BIOL, V815, P307, DOI 10.1007/978-1-61779-424-7_23; Bergler H, 1996, EUR J BIOCHEM, V242, P689, DOI 10.1111/j.1432-1033.1996.0689r.x; Christensen SK, 2004, MOL MICROBIOL, V51, P1705, DOI 10.1046/j.1365-2958.2003.03941.x; Yamaguchi Y, 2011, NAT REV MICROBIOL, V9, P779, DOI 10.1038/nrmicro2651; Mizoguchi H, 2007, BIOSCI BIOTECH BIOCH, V71, P2905, DOI 10.1271/bbb.70274; Zhang YL, 2011, MOL MICROBIOL, V79, P1418, DOI 10.1111/j.1365-2958.2010.07506.x; Zhang YL, 2005, J BIOL CHEM, V280, P26080, DOI 10.1074/jbc.M502050200; Wang XX, 2011, NAT CHEM BIOL, V7, P359, DOI [10.1038/nchembio.560, 10.1038/NCHEMBIO.560]; Sato K, 2009, NUCLEIC ACIDS RES, V37, pW277, DOI 10.1093/nar/gkp367; Sugai R, 2001, J BACTERIOL, V183, P5523, DOI 10.1128/JB.183.19.5523-5528.2001; Tan QA, 2011, MOL MICROBIOL, V79, P109, DOI 10.1111/j.1365-2958.2010.07433.x; Takagi H, 2005, NAT STRUCT MOL BIOL, V12, P327, DOI 10.1038/nsmb911; Nakashima N, 2014, INT J MOL SCI, V15, P2773, DOI 10.3390/ijms15022773; KAST P, 1991, J MOL BIOL, V222, P99, DOI 10.1016/0022-2836(91)90740-W; Domka J, 2007, ENVIRON MICROBIOL, V9, P332, DOI 10.1111/j.1462-2920.2006.01143.x; Wang XX, 2012, NAT CHEM BIOL, V8, P855, DOI 10.1038/NCHEMBIO.1062; Cheng HY, 2014, ENVIRON MICROBIOL, V16, P1741, DOI 10.1111/1462-2920.12373; Williams JJ, 2012, TRENDS MICROBIOL, V20, P291, DOI 10.1016/j.tim.2012.02.005; Hashimoto M, 2005, MOL MICROBIOL, V55, P137, DOI 10.1111/j.1365-2958.2004.04386.x; Miyazaki K, 2010, J BIOSCI BIOENG, V110, P372, DOI 10.1016/j.jbiosc.2010.02.016; Yamaguchi Y, 2009, J BIOL CHEM, V284, P28746, DOI 10.1074/jbc.M109.032904; Reyrat JM, 1998, INFECT IMMUN, V66, P4011; Kim Y, 2010, ENVIRON MICROBIOL, V12, P1105, DOI 10.1111/j.1462-2920.2009.02147.x; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7; Schweizer HP, 2008, BIOTECHNIQUES, V44, P633, DOI 10.2144/000112807; Masuda H, 2012, MOL MICROBIOL, V84, P979, DOI 10.1111/j.1365-2958.2012.08068.x; Tsukuda M, 2013, J BIOSCI BIOENG, V116, P540, DOI 10.1016/j.jbiosc.2013.05.013; Prysak MH, 2009, MOL MICROBIOL, V71, P1071, DOI 10.1111/j.1365-2958.2008.06572.x; Ren D, 2004, APPL MICROBIOL BIOT, V64, P515, DOI 10.1007/s00253-003-1517-y; STEINMETZ M, 1983, MOL GEN GENET, V191, P138, DOI 10.1007/BF00330901; Koga M, 2011, GENETICS, V187, P123, DOI 10.1534/genetics.110.121798; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Baba Tomoya, 2006, Mol Syst Biol, V2; Brown BL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000706; Burke C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060964; Caspi R, 2014, NUCLEIC ACIDS RES, V42, pD459, DOI 10.1093/nar/gkt1103; Christensen-Dalsgaard M, 2010, MOL MICROBIOL, V75, P333, DOI 10.1111/j.1365-2958.2009.06969.x; DeVito JA, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1084; Gonzalez B. A., 2006, J BACTERIOL, V188, P305, DOI [10.1128/JB.188.1.305-316.2006, DOI 10.1128/JB.188.1.305-316.2006]; Kato JI, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100174; Miyazaki K, 2015, BIOTECHNIQUES, V58, P86, DOI 10.2144/000114257; Nakashima N, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl697; Schweizer H., 2008, BIOTECHNIQUES, V44, P636; Tashiro Y, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1070	51	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	NOV	2015	120	5					591	595		10.1016/j.jbiosc.2015.03.008		5	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CX0BQ	WOS:000365362300017		
J	Nakashima, T; Boonsnongcheep, P; Kimura, T; Iwatsuki, M; Sato, N; Nonaka, K; Prathanturarug, S; Takahashi, Y; Omura, S				Nakashima, Takuji; Boonsnongcheep, Panitch; Kimura, Toru; Iwatsuki, Masato; Sato, Noriko; Nonaka, Kenichi; Prathanturarug, Sompop; Takahashi, Yoko; Omura, Satoshi			New compounds, nanaomycin F and G, discovered by physicochemical screening from a culture broth of Streptomyces rosa subsp notoensis OS-3966	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Nanaomycin F; Nanaomycin G; Physicochemical screening; Streptomyces sp.; Nanaomycin analogs	LECHEVALIERIA-AEROCOLONIGENES K10-0216; STRAIN; FERMENTATION; ACTINOMYCETE; MANGROMICINS; TAXONOMY; AGENTS; OXYGEN; MODE	Two new compounds, nanaomycin F and G, were isolated by physicochemical screening method from cultured broth of Streptomyces rosa subsp. notoensis OS-3966, which is known to produce nanaomycin A, B, C, D, and E. Nanaomycin F is a new nanaomycin analog, a 4a-hydroxyl analog of nanaomycin B. Nanaomycin G has a unique skeleton with 1-indanone infused with a tetrahydropyran ring. Nanaomycin A possesses broad antimicrobial activity but nanaomycin F and G demonstrated no bioactivity against all bacteria and fungi tested in this study. In addition, in both nanaomycin F and G, the production of superoxide radicals was majorly decreased in comparison to nanaomycin A. It was considered that the antimicrobial properties were lost as a result of the decrease in production of the superoxide radicals. (C) 2015, The Society for Biotechnology, Japan. All rights reserved.	[Nakashima, Takuji; Iwatsuki, Masato; Nonaka, Kenichi; Takahashi, Yoko; Omura, Satoshi] Kitasato Univ, Kitasato Inst Life Sci, Minato Ku, Tokyo 1088641, Japan; [Boonsnongcheep, Panitch; Prathanturarug, Sompop] Mahidol Univ, Fac Pharm, Dept Pharmaceut Bot, Bangkok 10400, Thailand; [Kimura, Toru; Iwatsuki, Masato; Nonaka, Kenichi] Kitasato Univ, Grad Sch Infect Control Sci, Minato Ku, Tokyo 1088641, Japan; [Sato, Noriko] Kitasato Univ, Grad Sch Pharmaceut Sci, Minato Ku, Tokyo 1088641, Japan	Nakashima, T (reprint author), Kitasato Univ, Kitasato Inst Life Sci, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan.	takuji@lisci.kitasato-u.ac.jp			Institute for Fermentation, Osaka (IFO), Japan	This study was supported by funds from the Institute for Fermentation, Osaka (IFO), Japan. We thank Kenichiro Nagai, School of Pharmacy, Kitasato University, for measurement of MS spectra.	HAYASHI M, 1982, J ANTIBIOT, V35, P1078; MISRA HP, 1972, J BIOL CHEM, V247, P188; CADENAS E, 1977, ARCH BIOCHEM BIOPHYS, V180, P248, DOI 10.1016/0003-9861(77)90035-2; OMURA S, 1977, J ANTIBIOT, V30, P275; MARUMO H, 1980, J ANTIBIOT, V33, P885; OMURA S, 1979, J ANTIBIOT, V32, P255; Nakashima T, 2013, J ANTIBIOT, V66, P311, DOI 10.1038/ja.2013.17; KITAO C, 1980, J ANTIBIOT, V33, P711; Nakashima T, 2014, J ANTIBIOT, V67, P533, DOI 10.1038/ja.2014.34; KASAI M, 1979, J ANTIBIOT, V32, P442; TANAKA H, 1975, J ANTIBIOT, V28, P925; Nakashima T, 2010, J BIOSCI BIOENG, V110, P304, DOI 10.1016/j.jbiosc.2010.03.003; BURG RW, 1979, ANTIMICROB AGENTS CH, V15, P361; Nakashima T, 2014, J ANTIBIOT, V67, P253, DOI 10.1038/ja.2013.129; TANAKA H, 1975, J ANTIBIOT, V28, P860; Nakashima T, 2015, J ANTIBIOT, V68, P220, DOI 10.1038/ja.2014.134; Omura S., 1976, S CHEM NAT PROD, V20, P9; Ueda H., 1999, BIOSCI BIOTECH BIOCH, V3, P485	18	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	NOV	2015	120	5					596	600		10.1016/j.jbiosc.2015.03.018		5	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CX0BQ	WOS:000365362300018		
J	Isokawa, N; Fueda, K; Miyagawa, K; Kanno, K				Isokawa, Naho; Fueda, Kazuki; Miyagawa, Korin; Kanno, Kenichi			Demonstration of the Coagulation and Diffusion of Homemade Slime Prepared Under Acidic Conditions without Borate	JOURNAL OF CHEMICAL EDUCATION			English	Article						High School/Introductory Chemistry; Polymer Chemistry; Problem Solving/Decision Making Applications of Chemistry		Poly(vinyl alcohol) (PVA) precipitates in many kinds of aqueous salt solutions. While sodium sulfate, a coagulant for PVA fiber, precipitates PVA to yield a white rigid gel, coagulation of PVA with aluminum sulfate, a coagulant for water treatment, yields a slime-like viscoelastic fluid. One type of homemade slime is prepared under basic conditions with borate. The method reported in this paper is carried out under acidic conditions with materials that are used for water treatment. Through this demonstration, students can learn about chemical interactions through the coagulation and diffusion of slime. This demonstration can be carried out in 30 min.	[Isokawa, Naho; Fueda, Kazuki; Miyagawa, Korin] Kinki Univ, Fukuoka High Sch, Fukuoka 8208555, Japan; [Kanno, Kenichi] Kinki Univ, Dept Biol & Environm Chem, Fukuoka 8208555, Japan	Kanno, K (reprint author), Kinki Univ, Dept Biol & Environm Chem, 11-6 Iizuka, Fukuoka 8208555, Japan.	kanno@fuk.kindai.ac.jp					GRANT GT, 1973, FEBS LETT, V32, P195, DOI 10.1016/0014-5793(73)80770-7; Sun JY, 2012, NATURE, V489, P133, DOI 10.1038/nature11409; SHIBAYAMA M, 1988, POLYMER, V29, P336, DOI 10.1016/0032-3861(88)90343-6; CASASSA EZ, 1986, J CHEM EDUC, V63, P57; Droste R L., 1997, THEORY PRACTICE WATE, P385; Lopez-Maldonado EA, 2014, J HAZARD MATER, V279, P1, DOI 10.1016/j.jhazmat.2014.06.025; Shibayama M, 1996, POLYM MAT ENCY SYNTH, V9, P7020; Wang L. K., 2005, HDB ENV ENG, V3, P111	8	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0021-9584	1938-1328		J CHEM EDUC	J. Chem. Educ.	NOV	2015	92	11					1886	1888		10.1021/acs.jchemed.5b00272		3	Chemistry, Multidisciplinary; Education, Scientific Disciplines	Chemistry; Education & Educational Research	CW4RN	WOS:000364979900020		
J	Nakamura, N				Nakamura, Nobuhiro			Pin(-)(2)-MONOPOLE INVARIANTS	JOURNAL OF DIFFERENTIAL GEOMETRY			English	Article							SEIBERG-WITTEN INVARIANTS; THOM CONJECTURE; 4-MANIFOLDS; SURFACES	We introduce a diffeomorphism invariant of 4-manifolds, the Pin(-)(2)-monopole invariant, defined by using the Pin(-)( 2)-monopole equations. We compute the invariants of several 4-manifolds, and prove gluing formulae. By using the invariants, we construct exotic smooth structures on the connected sum of an elliptic surface E(n) with arbitrary number of the 4-manifolds of the form of S-2 x Sigma or S-1 x Y where Sigma is a compact Riemann surface with positive genus and Y is a closed 3-manifold. As another application, we give an estimate of the genus of surfaces embedded in a 4-manifold X representing a class alpha is an element of H-2(X; l), where l is a local coefficient on X.	[Nakamura, Nobuhiro] Gakushuin Univ, Dept Math, Toshima Ku, Tokyo 1718588, Japan	Nakamura, N (reprint author), Gakushuin Univ, Dept Math, Toshima Ku, 1-5-1 Mejiro, Tokyo 1718588, Japan.	nobuhiro@math.gakushuin.ac.jp					Ozsvath P, 2000, J DIFFER GEOM, V55, P385; Nakamura N, 2002, J KOREAN MATH SOC, V39, P103; Ruan YB, 2000, COMMUN ANAL GEOM, V8, P477; OKONEK C, 1988, TOPOLOGY, V27, P415, DOI 10.1016/0040-9383(88)90021-3; Morgan JW, 1996, J DIFFER GEOM, V44, P706; Kotschick D, 1995, MATH RES LETT, V2, P119; Nakamura N, 2013, MATH ANN, V357, P915, DOI 10.1007/s00208-013-0924-3; Fintushel R, 1998, INVENT MATH, V134, P363, DOI 10.1007/s002220050268; Bauer S, 2004, INVENT MATH, V155, P1, DOI 10.1007/s00222-003-0288-5; Ozsvath P, 2000, ANN MATH, V151, P93, DOI 10.2307/121113; Morgan JW, 1997, MATH RES LETT, V4, P17; TAUBES CH, 1987, J DIFFER GEOM, V25, P363; Atiyah M. F., ANN MATH, V93, P119; Donaldson S. K., 1990, OXFORD MATH MONOGRAP; Donaldson S. K., 2002, CAMBRIDGE TRACTS MAT, V147; Fintushel R., 1995, TURKISH J MATH, V19, P145; Froyshov K. A., 2008, GEOMETRY TOPOLOGY MO, V15; Gompf R., 1999, GRADUATE STUDIES MAT, V20; Kirby R., 1989, LECT NOTES MATH, V1374; Kronheimer PB, 1994, MATH RES LETT, V1, P797; Kronheimer P. B., 2007, NEW MATH MONOGRAPHS, V10; Nicolaescu L. I., 2000, GRADUATE STUDIES MAT, V28; Wall C. T. C., 1964, J LOND MATH SOC, Vs1-39, P131	23	0	0	INT PRESS BOSTON, INC	SOMERVILLE	PO BOX 43502, SOMERVILLE, MA 02143 USA	0022-040X	1945-743X		J DIFFER GEOM	J. Differ. Geom.	NOV	2015	101	3					507	549				43	Mathematics	Mathematics	CW7CF	WOS:000365154800004		
J	Ishida, T; Tayasu, I; Takenaka, C				Ishida, Takuya; Tayasu, Ichiro; Takenaka, Chisato			Quantitative Reconstruction of Sulfur Deposition Using a Mixing Model Based on Sulfur Isotope Ratios in Tree Rings	JOURNAL OF ENVIRONMENTAL QUALITY			English	Article							STABLE SULFUR; NORWAY SPRUCE; ATMOSPHERIC DEPOSITION; CENTRAL-EUROPE; FOREST SOILS; SULFATE; ARCHIVES; JAPAN; METABOLISM; STAND	Quantification of sulfur (S) deposition is critical to deciphering the environmental archive of S in terrestrial ecosystems. Here we propose a mixing model that quantifies S deposition based on the S isotope ratio (delta S-34) in tree rings. We collected samples from Japanese cedar (Cryptomeria japonica D. Don) stumps from two sites: one near Yokkaichi City (YOK), which is well known for having the heaviest S air pollution in the world, and one at Inabucho (INA) in central Japan, which has been much less affected by air pollution. The delta S-34 profiles at both sites are consistent with S air pollution and contributions of anthropogenic S. The minimum value in YOK is lower than the delta S-34 values of anthropogenic S or any other possible source. Because the delta S-34 in the tree rings is affected by fractionation in the forest ecosystems, we used a mixing model to account for the isotope effects and to distinguish the sources of S. Based on the model results, we infer that the peak of S emissions at YOK occurred sometime between the late 1960s and early 1970s (489 mmol m(-2) yr(-1)). This estimated value is comparable with the highest reported values in Europe. This is the first quantitative estimate of anthropogenic input of S in forest systems based on delta S-34 in tree rings. Our results suggest that tree ring data can be used when monitoring stations of atmospheric S are lacking and that estimates of S deposition using delta S-34 in tree rings will advance our understanding of the local-scale S dynamics and the effect of human activities on it.	[Ishida, Takuya; Takenaka, Chisato] Nagoya Univ, Dept Biosphere Resources Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Tayasu, Ichiro] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan; [Ishida, Takuya; Tayasu, Ichiro] Natl Inst Humanities, Res Inst Humanity & Nat, Kita Ku, Kyoto 6038047, Japan	Ishida, T (reprint author), Nagoya Univ, Dept Biosphere Resources Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	tishida@chikyu.ac.jp	Tayasu, Ichiro/A-9924-2009	Tayasu, Ichiro/0000-0002-3006-7973	Joint Research Grant for the Environmental Isotope Study of Research Institute for Humanity and Nature; Center for Ecological Research, Kyoto University [2014-A-2]	This study was supported by a Joint Research Grant for the Environmental Isotope Study of Research Institute for Humanity and Nature and a Joint Usage (2014-A-2)/Research Grant from the Center for Ecological Research, Kyoto University. The authors thank Dr. Y. Yamada (Nagoya University), G. Furuhashi, and H. Kuroda for providing the ring sample; Dr. H. Yamamoto, Dr. H. Yokochi, and N. Yamaguchi (Nagoya University) for support during the sample preparation; and Drs. T. Nakano, Y. Tada (Research Institute for Humanity and Nature), and J. Matsubayashi (Kyoto University) for IRMS measurement.	Barrelet T, 2008, ENVIRON POLLUT, V156, P1007, DOI 10.1016/j.envpol.2008.05.004; Tcherkez G, 2013, NEW PHYTOL, V200, P44, DOI 10.1111/nph.12314; Mann JL, 2009, RAPID COMMUN MASS SP, V23, P1116, DOI 10.1002/rcm.3977; Wynn PM, 2008, GEOCHIM COSMOCHIM AC, V72, P2465, DOI 10.1016/j.gca.2008.03.002; WIGLEY TML, 1984, J CLIM APPL METEOROL, V23, P201, DOI 10.1175/1520-0450(1984)023<0201:OTAVOC>2.0.CO;2; Akata N, 2010, GEOCHEM J, V44, P571; Novak M, 2001, ENVIRON SCI TECHNOL, V35, P255, DOI 10.1021/es0000753; Wynn PM, 2013, BIOGEOCHEMISTRY, V114, P255, DOI 10.1007/s10533-012-9807-z; Thomas RB, 2013, P NATL ACAD SCI USA, V110, P15319, DOI 10.1073/pnas.1308115110; Yang WB, 1996, GEOCHIM COSMOCHIM AC, V60, P3015, DOI 10.1016/0016-7037(96)00149-4; Mukai H, 2001, ENVIRON SCI TECHNOL, V35, P1064, DOI 10.1021/es001399u; CALHOUN JA, 1991, GEOPHYS RES LETT, V18, P1877, DOI 10.1029/91GL02304; MAYER B, 1995, BIOGEOCHEMISTRY, V30, P31, DOI 10.1007/BF02181039; SCHUPP R, 1992, BOT ACTA, V105, P180; Shutou K, 2004, ECOL RES, V19, P233, DOI 10.1111/j.1440-1703.2003.00628.x; Wynn PM, 2014, ENVIRON POLLUT, V187, P98, DOI 10.1016/j.envpol.2013.12.017; Ohizumi T, 1997, ATMOS ENVIRON, V31, P1339, DOI 10.1016/S1352-2310(96)00278-6; Monaghan JM, 1999, PLANT CELL ENVIRON, V22, P831, DOI 10.1046/j.1365-3040.1999.00445.x; SCHNEIDER A, 1994, J EXP BOT, V45, P457, DOI 10.1093/jxb/45.4.457; Houle D, 2014, GEOCHIM COSMOCHIM AC, V126, P18, DOI 10.1016/j.gca.2013.10.038; KROUSE HR, 1977, NATURE, V265, P45, DOI 10.1038/265045a0; Maruyama T, 2000, NIPPON KAGAKU KAISHI, P45, DOI 10.1246/nikkashi.2000.45; Novak M, 1996, ENVIRON SCI TECHNOL, V30, P3473, DOI 10.1021/es960106n; Kawamura H, 2006, ENVIRON SCI TECHNOL, V40, P5750, DOI 10.1021/es060321w; Smith SJ, 2011, ATMOS CHEM PHYS, V11, P1101, DOI 10.5194/acp-11-1101-2011; Zhao FJ, 2003, J ENVIRON QUAL, V32, P33; Rennenberg H, 2007, PLANT BIOLOGY, V9, P620, DOI 10.1055/s-2007-965248; Novak M, 2000, GEOCHIM COSMOCHIM AC, V64, P367, DOI 10.1016/S0016-7037(99)00298-7; REES CE, 1978, GEOCHIM COSMOCHIM AC, V42, P377, DOI 10.1016/0016-7037(78)90268-5; Inagaki Y, 2004, FOREST ECOL MANAG, V202, P107, DOI 10.1016/j.foreco.2004.07.029; SALTZMAN ES, 1983, GEOPHYS RES LETT, V10, P513, DOI 10.1029/GL010i007p00513; Novak M, 2001, BIOGEOCHEMISTRY, V53, P23, DOI 10.1023/A:1010792205756; Fairchild IJ, 2009, ENVIRON SCI TECHNOL, V43, P1310, DOI 10.1021/es8029297; Wynn PM, 2010, CHEM GEOL, V271, P101, DOI 10.1016/j.chemgeo.2010.01.001; Bottrell SH, 2003, CHEM GEOL, V201, P185, DOI 10.1016/S0009-2541(03)00163-3; Campbell JL, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2006JG000208; DEVISSER PHB, 1992, CAN J FOREST RES, V22, P1824; Forest Agency of Japan, 1997, REP FOR DAM MON PROJ; Ichikawa T., 2006, Journal of the Japanese Forest Society, V88, P525, DOI 10.4005/jjfs.88.525; Ishida T, 2014, WATER AIR SOIL POLL, V225, DOI 10.1007/s11270-014-2061-3; IVENS W, 1990, Tellus Series B Chemical and Physical Meteorology, V42, P294, DOI 10.1034/j.1600-0889.1990.t01-2-00008.x; Kawamura H., 2002, CHIKYUKAGAKU GEOCHEM, V36, P127; Krouse H. R., 1991, SCOPE, V43; Nagamine K., 1997, CHIKYUKAGAKU, V31, P235; Nakai N., 1967, GEOCHEM J, V1, P199, DOI 10.2343/geochemj.1.199; Nakai N., 1991, SCOPE, V43, P352; National Greenhouse Gas Inventory Office of Japan, 2014, NAT GREENH GAS INV R; Newman L., 1991, STABLE ISOTOPES NATU, V43, P133; Nielsen B. H., 1974, TELLUS, V26, P213, DOI [10.1111/j.2153-3490.1974.tb01969.x, DOI 10.1111/J.2153-3490.1974.TB01969.X]; Novak M, 2009, GEOCHEM J, V43, pE1; Okita T., 1997, SANSEIU CHIKYUKANKYO, P21; Omori T., 2014, J JPN SOC ATMOSPHERI, V49, pA7; Owada M., 1994, ATMOSPHERIC ENV ISE, P147; Robinson B. W., 1995, REFERENCE INTERCOMPA, P39; Thode H. G., 1991, SCOPE, P1	55	0	0	AMER SOC AGRONOMY	MADISON	677 S SEGOE RD, MADISON, WI 53711 USA	0047-2425	1537-2537		J ENVIRON QUAL	J. Environ. Qual.	NOV-DEC	2015	44	6					1800	1808		10.2134/jeq2014.11.0506		9	Environmental Sciences	Environmental Sciences & Ecology	CW3SO	WOS:000364912300012		
J	Nakata, T; Liu, H; Bomphrey, RJ				Nakata, Toshiyuki; Liu, Hao; Bomphrey, Richard J.			A CFD-informed quasi-steady model of flapping-wing aerodynamics	JOURNAL OF FLUID MECHANICS			English	Article						biological fluid dynamics; computational methods; swimming/flying	HOVERING INSECT FLIGHT; HAWKMOTH MANDUCA-SEXTA; LEADING-EDGE VORTICES; LIFT; MECHANISMS; KINEMATICS; ROTATION; VORTEX; OPTIMIZATION; GENERATION	Aerodynamic performance and agility during flapping flight are determined by the combination of wing shape and kinematics, The degree of morphological and kinematic optimization is unknown and depends upon a large parameter space. Aimed at providing an accurate and computationally inexpensive modelling tool for flapping-wing aerodynamics, we propose a novel CID (computational fluid dynamics)-informed quasi-steady model (CIQSM), which assumes that the aerodynamic forces on a flapping wing can be decomposed into quasi-steady forces and parameterized based on CFD results, Using least-squares fitting, we determine a set of proportional coefficients for the quasi-steady model relating wing kinematics to instantaneous aerodynamic force and torque; we calculate power as the product. of quasi steady torques and angular velocity. With the quasi steady model fully and independently parameterized on the basis of high-fidelity CUD modelling, it is capable of predicting flapping-wing aerodynamic forces and power more accurately than the conventional blade element model (BEM) does. The improvement can be attributed to, for instance, taking into account the effects of the induced downwash and the wing tip vortex on the force generation and power consumption. Our model is validated by comparing the aerodynamics of a CFD model and the present quasi-steady model using the example case of a hovering hawkmoth. This demonstrates that the CIQSM outperforms the conventional BEM while remaining computationally cheap, and hence can be an effective tool for revealing the mechanisms of optimization and control of kinematics and morphology in flapping-wing flight for both bio-flyers and unmanned aerial systems.	[Nakata, Toshiyuki; Bomphrey, Richard J.] Univ London, Royal Vet Coll, Struct & Mot Lab, Hatfield AL9 7TA, Herts, England; [Liu, Hao] Chiba Univ, Grad Sch Engn, Inage Ku, Chiba 2638522, Japan; [Liu, Hao] Shanghai Jiao Tong Univ, Shanghai 200240, Peoples R China; [Liu, Hao] Chiba Univ, Int Cooperat Res Ctr, Shanghai 200240, Peoples R China	Bomphrey, RJ (reprint author), Univ London, Royal Vet Coll, Struct & Mot Lab, Hawkshead Lane, Hatfield AL9 7TA, Herts, England.	rbomphrey@rvc.ac.uk			EPSRC grant [EP/H004025/1]; BBSRC grant [BB/J001244/1]; EPSRC Career Acceleration Fellowship; JSPS [24120007]	This work was supported by EPSRC grant (EP/H004025/1), BBSRC grant (BB/J001244/1) and an EPSRC Career Acceleration Fellowship to R.J.B., and by a Grant-in-Aid for Scientific Research on Innovative Areas (24120007, JSPS) to H.L. The authors would like to acknowledge the use of the University of Oxford Advanced Research Computing (ARC) facility in carrying out this work (http://dx.doi.org/10.5281/zenodo.22558).	Sun M, 2002, J EXP BIOL, V205, P55; Ramamurti R, 2002, J EXP BIOL, V205, P1507; Berman GJ, 2007, J FLUID MECH, V582, P153, DOI 10.1017/S0022112007006209; JEONG J, 1995, J FLUID MECH, V285, P69, DOI 10.1017/S0022112095000462; Dickinson MH, 1999, SCIENCE, V284, P1954, DOI 10.1126/science.284.5422.1954; Hedrick TL, 2009, SCIENCE, V324, P252, DOI 10.1126/science.1168431; Queipo NV, 2005, PROG AEROSP SCI, V41, P1, DOI 10.1016/j.paerosci.2005.02.001; Le TQ, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0312; Hedrick TL, 2006, J EXP BIOL, V209, P3114, DOI 10.1242/jeb.02363; Heathcote S, 2007, AIAA J, V45, P1066, DOI 10.2514/1.25431; Cheng B, 2011, IEEE T ROBOT, V27, P849, DOI 10.1109/TRO.2011.2156170; Kim JK, 2014, BIOINSPIR BIOMIM, V9, DOI 10.1088/1748-3182/9/1/016011; Nabawy MRA, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1197; Srygley RB, 2002, NATURE, V420, P660, DOI 10.1038/nature01223; Liu H, 2009, BIOINSPIR BIOMIM, V4, DOI 10.1088/1748-3182/4/1/015002; Bomphrey RJ, 2005, J EXP BIOL, V208, P1079, DOI 10.1242/jeb.01471; Lentink D, 2009, J EXP BIOL, V212, P2705, DOI 10.1242/jeb.022269; Zheng LX, 2013, J FLUID MECH, V721, P118, DOI 10.1017/jfm.2013.46; Usherwood JR, 2002, J EXP BIOL, V205, P1547; Sane SP, 2002, J EXP BIOL, V205, P1087; WEISFOGH T, 1973, J EXP BIOL, V59, P169; Lua KB, 2010, EXP FLUIDS, V49, P1263, DOI 10.1007/s00348-010-0873-5; Young J, 2009, SCIENCE, V325, P1549, DOI 10.1126/science.1175928; Dai H, 2012, J FLUID MECH, V693, P473, DOI 10.1017/jfm.2011.543; Bergou AJ, 2007, J FLUID MECH, V591, P321, DOI 10.1017/S0022112007008440; Whitney JP, 2010, J FLUID MECH, V660, P197, DOI 10.1017/S002211201000265X; Nabawy MRA, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1196; Liu H, 2009, J COMPUT PHYS, V228, P439, DOI 10.1016/j.jcp.2008.09.020; Dickson WB, 2008, AIAA J, V46, P2150, DOI 10.2514/1.29862; Heathcote S, 2008, J FLUID STRUCT, V24, P183, DOI [10.1016/j.jfluidstructs.2007.08.003, 10.1016/jjfluidstructs.2007.08.003]; MAXWORTHY T, 1979, J FLUID MECH, V93, P47, DOI 10.1017/S0022112079001774; Chimakurthi SK, 2009, AIAA J, V47, P1865, DOI 10.2514/1.38845; Nakata T, 2012, J COMPUT PHYS, V231, P1822, DOI 10.1016/j.jcp.2011.11.005; Bomphrey RJ, 2012, EVOL BIOL, V39, P1, DOI 10.1007/s11692-011-9134-7; GRODNITSKY DL, 1993, J EXP BIOL, V182, P11; Aono H., 2006, J BIOMECH SCI ENG, V1, P234, DOI DOI 10.1299/JBSE.1.234; Ellington CP, 1996, NATURE, V384, P626, DOI 10.1038/384626a0; ELLINGTON CP, 1984, PHILOS T ROY SOC B, V305, P1, DOI 10.1098/rstb.1984.0049; Grodnier R. E., 2013, J FLUID STRUCT, V40, P86; Kang CK, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0933; Sun M, 2003, ACTA MECH SINICA, V19, P458; Wan H., 2015, J R SOC INTERFACE, V12; Willmott AP, 1997, J EXP BIOL, V200, P2705	43	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0022-1120	1469-7645		J FLUID MECH	J. Fluid Mech.	NOV	2015	783						323	343		10.1017/jfm.2015.537		21	Mechanics; Physics, Fluids & Plasmas	Mechanics; Physics	CW5BF	WOS:000365009700014		
J	Inoue, T; Fuse, C; Hara, S				Inoue, Toshiya; Fuse, Chiaki; Hara, Shoji			Synthesis of trifluoromethyl ethers and difluoro(methylthio)methyl ethers by the reaction of dithiocarbonates with IF5-pyridine-HF	JOURNAL OF FLUORINE CHEMISTRY			English	Article						Trifluoromethyl ether; Difluoro(methylthio)methyl ether; IF5-pyridine-HF	SUPRAMOLECULAR CHEMISTRY; HALOGEN BOND; HYDROGEN	Trifluoromethyl ether and difluoro(methylthio)methyl ether of phenols and aliphatic alcohols were selectively synthesized from the corresponding dithiocarbonates. When IF5-pyridine-HF was used alone in the reaction of the dithiocarbonate, the difluoro(methylthio)methyl ether was selectively formed. On the other hand, by the additional use of Et3N-6HF with IF5-pyridine-HF, trifluoromethyl ether was formed selectively. Various functional groups such as ester, ether, amide, and acetonide could tolerate the reaction conditions, and various functionalized difluoro(methylthio)methyl ethers and trifluoromethyl ethers were synthesized. (C) 2015 Elsevier B.V. All rights reserved.	[Inoue, Toshiya; Fuse, Chiaki; Hara, Shoji] Hokkaido Univ, Grad Sch Engn, Sapporo, Hokkaido 0608628, Japan	Hara, S (reprint author), Hokkaido Univ, Grad Sch Engn, Sapporo, Hokkaido 0608628, Japan.	shara@eng.hokudai.ac.jp			Office of Basic Energy Sciences of the U.S. Department of Energy [DE-FG02-13ER16369]	D.A.V. thanks the Office of Basic Energy Sciences of the U.S. Department of Energy (DE-FG02-13ER16369) for support of this work.	Allen F. H., 1987, PERKIN T, pS1; ZEFIROV NS, 1982, CHEM REV, V82, P615, DOI 10.1021/cr00052a004; Cardillo P, 2000, TETRAHEDRON, V56, P5535, DOI 10.1016/S0040-4020(00)00476-2; Politzer P, 2007, J MOL MODEL, V13, P305, DOI 10.1007/s00894-006-0154-7; Minkwitz R, 1997, Z ANORG ALLG CHEM, V623, P613, DOI 10.1002/zaac.19976230196; Priimagi A, 2013, ACCOUNTS CHEM RES, V46, P2686, DOI 10.1021/ar400103r; Minkwitz R, 1997, Z ANORG ALLG CHEM, V623, P151, DOI 10.1002/zaac.19976230125; Mukherjee A, 2014, ACCOUNTS CHEM RES, V47, P2514, DOI 10.1021/ar5001555; Metrangolo P, 2001, CHEM-EUR J, V7, P2511, DOI 10.1002/1521-3765(20010618)7:12<2511::AID-CHEM25110>3.0.CO;2-T; Metrangolo P, 2012, CRYST GROWTH DES, V12, P5835, DOI 10.1021/cg301427a; Metrangolo P, 2008, ANGEW CHEM INT EDIT, V47, P6114, DOI 10.1002/anie.200800128; Minkwitz R, 1996, Z ANORG ALLG CHEM, V622, P1749, DOI 10.1002/zaac.19966221020; Metrangolo P, 2002, J FLUORINE CHEM, V114, P27, DOI 10.1016/S0022-1139(01)00558-9; Erdelyi M, 2012, CHEM SOC REV, V41, P3547, DOI 10.1039/c2cs15292d; Metrangolo P, 2008, SCIENCE, V321, P918, DOI 10.1126/science.1162215; Farina A, 1999, ANGEW CHEM INT EDIT, V38, P2433, DOI 10.1002/(SICI)1521-3773(19990816)38:16<2433::AID-ANIE2433>3.0.CO;2-D; Desiraju GR, 2013, PURE APPL CHEM, V85, P1711, DOI 10.1351/PAC-REC-12-05-10; Politzer P, 2010, PHYS CHEM CHEM PHYS, V12, P7748, DOI 10.1039/c004189k; Metrangolo P, 2013, CHEM COMMUN, V49, P1783, DOI 10.1039/c3cc37596j; Chu QL, 2001, J AM CHEM SOC, V123, P11069, DOI 10.1021/ja015786v; Legon AC, 2010, PHYS CHEM CHEM PHYS, V12, P7736, DOI 10.1039/c002129f	21	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-1139	1873-3328		J FLUORINE CHEM	J. Fluor. Chem.	NOV	2015	179				SI		48	55		10.1016/j.jfluchem.2015.04.016		8	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	CW3GW	WOS:000364881000007		
J	Sakaguchi, Y; Nakazaki, Y; Moriyasu, K; Konno, T				Sakaguchi, Yukiho; Nakazaki, Yoshitomo; Moriyasu, Kazuki; Konno, Tsutomu			Selective synthesis of fluoroalkyl-containing multisubstituted benzenes through Co-mediated [2+2+2] cycloaddition reaction with fluoroalkylated alkynes	JOURNAL OF FLUORINE CHEMISTRY			English	Article						[2+2+2] Cycloaddition reaction; Dicobalt octacarbonyl; Fluoroalkylated alkynes; Alkyne-cobalt complex; Multisubstituted benzenes	MEDICINAL CHEMISTRY; CATALYZED TRIFLUOROMETHYLATION; FLUORINE; FACILE; CYCLOTRIMERIZATION; DERIVATIVES; CONVENIENT; SYSTEM	The reaction of various fluoroalkylated alkynes with 1.2 equiv of Co-2(CO)(8) in toluene at room temperature for 30 mm took place smoothly to give the corresponding alkyne-cobalt complex quantitatively. Without its purification, treatment of the in situ-generated complex with 6.0 equiv of various nonfluorinated alkynes at 130 degrees C for 4 h provided monofluoroallcylated multisubstituted benzenes in moderate to good yields. (C) 2015 Elsevier B.V. All rights reserved.	[Sakaguchi, Yukiho; Nakazaki, Yoshitomo; Moriyasu, Kazuki; Konno, Tsutomu] Kyoto Inst Technol, Dept Chem & Mat Technol, Sakyo Ku, Kyoto 6068585, Japan	Konno, T (reprint author), Kyoto Inst Technol, Dept Chem & Mat Technol, Sakyo Ku, Kyoto 6068585, Japan.	konno@kit.ac.jp					YAMAZAKI T, 1995, J ORG CHEM, V60, P6046, DOI 10.1021/jo00124a013; WESSEL J, 1986, CHEM BER-RECL, V119, P453, DOI 10.1002/cber.19861190208; Cho EJ, 2010, SCIENCE, V328, P1679, DOI 10.1126/science.1190524; Konno T, 2003, TETRAHEDRON, V59, P7571, DOI 10.1016/S0040-4020(03)01199-2; Kizirian JC, 2010, ORG LETT, V12, P5620, DOI 10.1021/ol102283c; Hagmann WK, 2008, J MED CHEM, V51, P4359, DOI 10.1021/jm800219f; Purser S, 2008, CHEM SOC REV, V37, P320, DOI 10.1039/b610213c; Wang J, 2014, CHEM REV, V114, P2432, DOI 10.1021/cr4002879; Kawatsura M, 2011, ORG LETT, V13, P1001, DOI 10.1021/ol1030734; Chu LL, 2010, ORG LETT, V12, P5060, DOI 10.1021/ol1023135; Senecal TD, 2011, J ORG CHEM, V76, P1174, DOI 10.1021/jo1023377; Aiguabella N, 2013, ANGEW CHEM INT EDIT, V52, P5355, DOI 10.1002/anie.201300907; Minakawa M, 2014, RSC ADV, V4, P41353, DOI 10.1039/c4ra06973k; Kirk KL, 2008, ORG PROCESS RES DEV, V12, P305, DOI 10.1021/op700134j; Konno T, 2012, J FLUORINE CHEM, V144, P147, DOI 10.1016/j.jfluchem.2012.08.006; UMEMOTO T, 1993, J AM CHEM SOC, V115, P2156, DOI 10.1021/ja00059a009; URATA H, 1991, TETRAHEDRON LETT, V32, P91, DOI 10.1016/S0040-4039(00)71226-3; Weng ZQ, 2011, ORGANOMETALLICS, V30, P3229, DOI 10.1021/om200204y; Konno T, 2010, ORG BIOMOL CHEM, V8, P1718, DOI 10.1039/b926192c; Muller C, 2002, ORGANOMETALLICS, V21, P1975, DOI 10.1021/om0110989; Kieltsch I, 2007, ANGEW CHEM INT EDIT, V46, P754, DOI 10.1002/anie.200603497; Nagib DA, 2011, NATURE, V480, P224, DOI 10.1038/nature10647; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Meanwell NA, 2011, J MED CHEM, V54, P2529, DOI 10.1021/jm1013693; HIYAMA T, 1989, B CHEM SOC JPN, V62, P1352, DOI 10.1246/bcsj.62.1352; Garcia JJ, 1996, TETRAHEDRON LETT, V37, P6097, DOI 10.1016/0040-4039(96)01301-9; Furuya T, 2011, NATURE, V473, P470, DOI 10.1038/nature10108; Bazter R.J, 1999, ORGANOMETALLICS, V18, P206; Begue J.-P., 2008, BIOORGANIC MED CHEM; Dickson R.S., 1974, ADV ORGANOMET CHEM, V12, P323, DOI 10.1016/S0065-3055(08)60454-2; DICKSON RS, 1972, J CHEM SOC DALTON, P2278, DOI 10.1039/dt9720002278; Gladysz J.A., 2004, HDB FLUOROUS CHEM; Hamper B.C., 1992, ORG SYNTH, V70, P246; Kemmitt R.D.W., 1982, COMPREHENSIVE ORGANO, V5, P1; Kirsch P., 2004, MODERN FLUOROORGANIC; Konno T, 2008, SYNTHESIS-STUTTGART, P564, DOI 10.1055/s-2008-1032143; Liu T., 2013, ORG LETT, V13, P2342; Ojima I., 2009, FLUORINE MED CHEM CH; Petrov V.A., 2009, FLUORINATED HETEROCY	39	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-1139	1873-3328		J FLUORINE CHEM	J. Fluor. Chem.	NOV	2015	179				SI		64	70		10.1016/j.jfluchem.2015.06.013		7	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	CW3GW	WOS:000364881000009		
J	Hiraoka, Y; Kawasaki-Takasuka, T; Morizawa, Y; Yamazaki, T				Hiraoka, Yuya; Kawasaki-Takasuka, Tomoko; Morizawa, Yoshitomi; Yamazaki, Takashi			Synthetic utility of 2,3,3,3-tetrafluoroprop-1-ene (HFO-1234yf)	JOURNAL OF FLUORINE CHEMISTRY			English	Article						Addition-elimination reactions; Vinyl ethers; Trifluoromethyl group; Acetals	STEREOSELECTIVE-SYNTHESIS; CLAISEN REARRANGEMENT; GAS-PHASE; ACID; SUBSTITUTION	2,3,3,3-Tetrafluoroprop-1-ene, known as the environmentally benign fluorinated olefin recently employed for the car air-conditioning system, was proved to follow the addition-elimination sequence at its C-2 position by the reaction of a variety of alkoxides, forming CF3-containing vinyl ethers in excellent yields. (C) 2015 Elsevier B.V. All rights reserved.	[Hiraoka, Yuya; Kawasaki-Takasuka, Tomoko; Yamazaki, Takashi] Tokyo Univ Agr & Technol, Inst Engn, Div Appl Chem, Koganei, Tokyo 1848588, Japan; [Morizawa, Yoshitomi] Asahi Glass Co Ltd, Res Ctr, Kanagawa Ku, Yokohama, Kanagawa 2218755, Japan	Yamazaki, T (reprint author), Tokyo Univ Agr & Technol, Inst Engn, Div Appl Chem, 2-24-16 Nakamachi, Koganei, Tokyo 1848588, Japan.	tyamazak@cc.tuat.ac.jp					Amin-Sanayei R, 2012, PCT Int. Appl., Patent No. [WO 2012112840, 2012112840]; Konno T, 2014, TETRAHEDRON, V70, P2455, DOI 10.1016/j.tet.2014.02.015; Rulev AY, 2011, J FLUORINE CHEM, V132, P945, DOI 10.1016/j.jfluchem.2011.07.015; Ueki H, 2004, J ORG CHEM, V69, P7616, DOI 10.1021/jo049025x; Goldberg AA, 2010, J FLUORINE CHEM, V131, P384, DOI 10.1016/j.jfluchem.2009.12.004; Essers M, 2002, J ORG CHEM, V67, P4715, DOI 10.1021/jo015917a; Borisov YA, 2002, J STRUCT CHEM+, V43, P734, DOI 10.1023/A:1022856703749; Nielsen OJ, 2007, CHEM PHYS LETT, V439, P18, DOI 10.1016/j.cplett.2007.03.053; Ichikawa J, 2003, J ORG CHEM, V68, P7800, DOI 10.1021/jo03718j; GAJEWSKI JJ, 1990, J ORG CHEM, V55, P1813, DOI 10.1021/jo00293a027; FUJII S, 1987, J FLUORINE CHEM, V35, P437, DOI 10.1016/S0022-1139(00)81992-2; KENDRICK DA, 1989, J FLUORINE CHEM, V45, P265, DOI 10.1016/S0022-1139(00)84151-2; Patil Y, 2013, MACROMOLECULES, V46, P3092, DOI 10.1021/ma400304u; SIMMONS HE, 1960, J AM CHEM SOC, V82, P2288, DOI 10.1021/ja01494a047; Annamalai VR, 2009, ORG LETT, V11, P621, DOI 10.1021/ol8026945; Konno T, 2013, J FLUORINE CHEM, V156, P144, DOI 10.1016/j.jfluchem.2013.09.010; Hirotaki K, 2013, ORG LETT, V15, P1226, DOI 10.1021/ol400141y; Feng K, 2014, PCT Int. Appl., Patent No. [WO 2014046908, 2014046908]; Frisch MJ, 2009, GAUSSIAN 09 REVISION; HASZELDINE RN, 1952, J CHEM SOC, P3490, DOI 10.1039/jr9520003490; Imahori Y, 2011, PCT Int. Appl., Patent No. [WO 2011125740, 2011125740]; Jiang BA, 2003, CHEM COMMUN, P536, DOI 10.1039/b210642f; KUBOTA T, 1988, CHEM LETT, P1987, DOI 10.1246/cl.1988.1987; Lu C-Q., 2014, PCT Int. Appl., Patent No. [WO 2014186138, 2014186138]; Lu C-Q., 2014, PCT Int. Appl., Patent No. [WO 2014099508, 2014099508]; Morikawa T, 2013, Jpn. Kokai Tokkyo Koho, Patent No. [JP 2013216915, 2013216915]; Samuels GJ., 2008, U.S. Pat. Appl. Publ., Patent No. [US 20080153977, 20080153977]; Samuels GJ., 2008, PCT Int. Appl., Patent No. [WO 2008079986, 2008079986]; Takahashi M, 2012, Jpn. Kokai Tokkyo Koho, Patent No. [JP 2012092164, 2012092164]; Wang CC, 2013, RENEW SUST ENERG REV, V19, P444, DOI 10.1016/j.rser.2012.11.049	30	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-1139	1873-3328		J FLUORINE CHEM	J. Fluor. Chem.	NOV	2015	179				SI		71	76		10.1016/j.jfluchem.2015.05.006		6	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	CW3GW	WOS:000364881000010		
J	Shibatomi, K; Kawasaki, Y; Iwasa, S				Shibatomi, Kazutaka; Kawasaki, Yohei; Iwasa, Seiji			Organocatalytic enantioselective Diels-Alder reaction of 4,4,4-trifluorocrotonaldehyde	JOURNAL OF FLUORINE CHEMISTRY			English	Article						Asymmetric catalysis; Organocatalyst; Diels-Alder reaction; Trifluoromethyl compounds; Conjugate addition	CARBON QUATERNARY STEREOCENTERS; FRIEDEL-CRAFTS ALKYLATION; SELF-DISPROPORTIONATION; CONJUGATE ADDITION; BETA,BETA-DISUBSTITUTED ENONES; 1,3-DIPOLAR CYCLOADDITION; STEREOGENIC CENTERS; MICHAEL ADDITION; CONSTRUCTION; ENANTIOMERS	A highly enantioselective Diels-Alder reaction of 4,4,4-trifluorocrotonaldehyde and dienes was performed with a diarylprolinol silyl ether catalyst. The reaction with cyclopentadiene, 1,3-cyclohexadiene, and 2-substituted 1,3-butadienes yielded the corresponding cycloadducts bearing a trifluoromethylated chiral carbon center with up to 97% ee, whereas the reaction with furan yielded the corresponding Friedel-Crafts adduct with high enantioselectivity. (C) 2015 Elsevier B.V. All rights reserved.	[Shibatomi, Kazutaka; Kawasaki, Yohei; Iwasa, Seiji] Toyohashi Univ Technol, Dept Environm & Life Sci, Toyohashi, Aichi 4418580, Japan	Shibatomi, K (reprint author), Toyohashi Univ Technol, Dept Environm & Life Sci, 1-1 Hibarigaoka,Tempaku Cho, Toyohashi, Aichi 4418580, Japan.	shiba@ens.tut.ac.jp			Central Glass Co., Ltd.; MEXT, Japan	This study was supported by Central Glass Co., Ltd. and a Grant-in-Aid for Scientific Research on Innovative Areas "Advanced Molecular Transformations by Organocatalysts" from MEXT, Japan.	Dong N, 2013, ORG LETT, V15, P4896, DOI 10.1021/ol402346c; Zhu W, 2014, J FLUORINE CHEM, V167, P37, DOI 10.1016/j.jfluchem.2014.06.026; Zhang W, 2012, ANGEW CHEM INT EDIT, V51, P10069, DOI 10.1002/anie.201205872; Wen LL, 2013, ACS CATAL, V3, P502, DOI 10.1021/cs300806w; Morigaki A, 2013, ORG BIOMOL CHEM, V11, P586, DOI 10.1039/c2ob26708j; Wang X, 2013, J ORG CHEM, V78, P3429, DOI 10.1021/jo400115r; Chen Q, 2014, ORG LETT, V16, P1394, DOI 10.1021/ol500157b; Wu H, 2014, SYNLETT, V25, P457, DOI 10.1055/s-0033-1340318; Li QH, 2012, TETRAHEDRON LETT, V53, P3650, DOI 10.1016/j.tetlet.2012.05.021; Wang J, 2014, CHEM REV, V114, P2432, DOI 10.1021/cr4002879; Grassi D, 2012, CHEM COMMUN, V48, P11404, DOI 10.1039/c2cc36513h; Hayashi Y, 2008, ANGEW CHEM INT EDIT, V47, P6634, DOI 10.1002/anie.200801408; Ueki H, 2010, TETRAHEDRON-ASYMMETR, V21, P1396, DOI 10.1016/j.tetasy.2010.04.040; Kawai H, 2012, ANGEW CHEM INT EDIT, V51, P4959, DOI 10.1002/anie.201201278; Li Q, 2012, SYNTHESIS-STUTTGART, V44, P265, DOI 10.1055/s-0031-1289653; Gao JR, 2013, J AM CHEM SOC, V135, P2983, DOI 10.1021/ja400650m; Zhao Y, 2014, TETRAHEDRON, V70, P2523, DOI 10.1016/j.tet.2014.02.062; Shibatomi K, 2012, CHEM COMMUN, V48, P7380, DOI 10.1039/c2cc32757k; Ahrendt KA, 2000, J AM CHEM SOC, V122, P4243, DOI 10.1021/ja000092s; Kawai H, 2012, CHEM COMMUN, V48, P4067, DOI 10.1039/c2cc18049a; Nie J, 2011, CHEM REV, V111, P455, DOI 10.1021/cr100166a; Blay G, 2012, SYNTHESIS-STUTTGART, V44, P3590, DOI 10.1055/s-0032-1317161; Soloshonok VA, 2012, CHEM SOC REV, V41, P4180, DOI 10.1039/c2cs35006h; Deng HP, 2012, ADV SYNTH CATAL, V354, P783, DOI 10.1002/adsc.201101012; Shibatomi K, 2012, CHEM COMMUN, V48, P413, DOI 10.1039/c1cc15889a; Sanz-Marco A, 2014, CHEM COMMUN, V50, P2275, DOI 10.1039/c3cc48508k; Boz E, 2014, ORGANOMETALLICS, V33, P5111, DOI 10.1021/om401112f; Yang KS, 2013, J AM CHEM SOC, V135, P16050, DOI 10.1021/ja409012q; Kawai H, 2012, CHEM COMMUN, V48, P3632, DOI 10.1039/c2cc18052a; Han JL, 2011, CURR ORG SYNTH, V8, P310, DOI 10.2174/157017911794697303; Soloshonok VA, 2007, J AM CHEM SOC, V129, P12112, DOI 10.1021/ja065603a; Harada S, 2013, ORG LETT, V15, P5314, DOI [10.1021/ol402559z, 10.1021/oI402559z]; Davies AT, 2013, J ORG CHEM, V78, P9243, DOI 10.1021/jo401433q; Kawai H, 2013, ANGEW CHEM INT EDIT, V52, P5575, DOI 10.1002/anie.201301123; Gouverneur V., 2012, FLUORINE PHARM MED C; Kwiatkowski P, 2014, ORG LETT, V16, P5930, DOI 10.1021/ol502941d; Li L, 2014, ORG LETT, V16, P6032, DOI 10.1021/ol503067g; Merino P, 2010, SYNTHESIS-STUTTGART, P1, DOI 10.1055/s-0029-1217130; Ojima I., 2009, FLUORINE MED CHEM CH; Soloshonok VA, 2006, ANGEW CHEM INT EDIT, V45, P766, DOI 10.1002/anie.200503373; Wu H., 2015, ORG CHEM FRONT, P124; Zhao M.-X., 2014, EUR J ORG CHEM, P644	42	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-1139	1873-3328		J FLUORINE CHEM	J. Fluor. Chem.	NOV	2015	179				SI		77	82		10.1016/j.jfluchem.2015.05.011		6	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	CW3GW	WOS:000364881000011		
J	Asano, M; Tomita, R; Koike, T; Akita, M				Asano, Masashi; Tomita, Ren; Koike, Takashi; Akita, Munetaka			Trifluoromethylation of aromatic alkenes by visible-light-driven photoredox catalysis: Direct conversion of alkenes to 3-trifluoromethyl-1-propenyl and 1,3-bis(trifluoromethyl)-1-propenyl derivatives	JOURNAL OF FLUORINE CHEMISTRY			English	Article						Trifluoromethylation; Transition metal catalyst; Allyl compound; Electrophilic CF3 reagent; Photoredox catalysis; Step-economical process	TRANSITION-METAL CATALYSIS; ELECTROPHILIC TRIFLUOROMETHYLATION; PERFLUOROALKYLATION REACTIONS; ASYMMETRIC FLUORINATION; COMBINING PHOTOREDOX; FUNCTIONAL-GROUPS; TERMINAL ALKENES; RECENT PROGRESS; BOND FORMATION; SALT SYSTEM	Photoredox-catalyzed trifluoromethylation of alkenes using Umemoto's reagent as a CF3 source under visible light irradiation has been developed. A Ru photocatalyst, [Ru(bpy)(3)](PF6)(2) (bpy = 2,2'-bipyridine), is useful for the present trifluoromethylation and preferable formation of 3-trifluoromethy1-1-propenyl derivatives is observed. Use of an excess amount of Umemoto's reagent readily induces double trifluoromethylation of electron-rich alkenes, resulting in 1,3-bis(trifluoromethyl)-1-propenyl skeleton. (C) 2015 Elsevier B.V. All rights reserved.	[Tomita, Ren; Koike, Takashi; Akita, Munetaka] Tokyo Inst Technol, Chem Resources Lab, Tokyo, Japan; [Asano, Masashi] Tokyo Univ Sci, Dept Chem, Tokyo 162, Japan	Koike, T (reprint author), R1-27,4259 Nagatsuta,Midori Ku, Yokohama, Kanagawa 2268503, Japan.	koike.t.ad@m.titech.ac.jp; makita@res.titech.ac.jp	Koike, Takashi/H-8045-2012	Koike, Takashi/0000-0002-3737-7093			Koike T, 2014, INORG CHEM FRONT, V1, P562, DOI 10.1039/c4qi00053f; JACOBS RT, 1994, J MED CHEM, V37, P1282, DOI 10.1021/jm00035a008; Xuan J, 2012, ANGEW CHEM INT EDIT, V51, P6828, DOI 10.1002/anie.201200223; UMEMOTO T, 1990, TETRAHEDRON LETT, V31, P3579; Eisenberger P, 2006, CHEM-EUR J, V12, P2579, DOI 10.1002/chem.200501052; Hopkinson MN, 2014, CHEM-EUR J, V20, P3874, DOI 10.1002/chem.201304823; Zhang C, 2014, ORG BIOMOL CHEM, V12, P6580, DOI 10.1039/c4ob00671b; Yasu Y, 2013, ORG LETT, V15, P2136, DOI 10.1021/ol4006272; Lerch MM, 2014, ANGEW CHEM INT EDIT, V53, P8654, DOI 10.1002/anie.201404712; Mizuta S, 2012, CHEM-EUR J, V18, P8583, DOI 10.1002/chem.201201707; Xu J, 2011, J AM CHEM SOC, V133, P15300, DOI 10.1021/ja206330m; Liang T, 2013, ANGEW CHEM INT EDIT, V52, P8214, DOI 10.1002/anie.201206566; Chu LL, 2012, ORG LETT, V14, P2106, DOI 10.1021/ol300639a; Wang DS, 2012, J MED CHEM, V55, P3827, DOI 10.1021/jm300015m; Besset T, 2012, ANGEW CHEM INT EDIT, V51, P5048, DOI 10.1002/anie.201201012; Mayer SC, 2008, J MED CHEM, V51, P7348, DOI 10.1021/jm801252w; Yasu Y, 2013, CHEM COMMUN, V49, P2037, DOI 10.1039/c3cc39235j; Ma JA, 2004, CHEM REV, V104, P6119, DOI 10.1021/cr030143e; Wang CJ, 2005, ANGEW CHEM INT EDIT, V44, P4933, DOI 10.1002/anie.200501332; Yasu Y, 2012, ANGEW CHEM INT EDIT, V51, P9567, DOI 10.1002/anie.201205071; Koike T, 2013, SYNLETT, V24, P2492, DOI 10.1055/s-0033-1339874; Umemoto T, 1996, CHEM REV, V96, P1757, DOI 10.1021/cr941149u; Xu J, 2014, TETRAHEDRON LETT, V55, P585, DOI 10.1016/j.tetlet.2013.11.108; Alonso C, 2015, CHEM REV, V115, P1847, DOI 10.1021/cr500368h; UMEMOTO T, 1993, J AM CHEM SOC, V115, P2156, DOI 10.1021/ja00059a009; Alimardanov A, 2008, ORG PROCESS RES DEV, V12, P424, DOI 10.1021/op700259d; Narayanam JMR, 2011, CHEM SOC REV, V40, P102, DOI 10.1039/b913880n; Koike T, 2014, TOP CATAL, V57, P967, DOI 10.1007/s11244-014-0259-7; Kieltsch I, 2007, ANGEW CHEM INT EDIT, V46, P754, DOI 10.1002/anie.200603497; Parsons AT, 2011, ANGEW CHEM INT EDIT, V50, P9120, DOI 10.1002/anie.201104053; Yoon TP, 2010, NAT CHEM, V2, P527, DOI [10.1038/nchem.687, 10.1038/NCHEM.687]; Yasu Y, 2014, ORG LETT, V16, P780, DOI 10.1021/ol403500y; Wang X, 2011, J AM CHEM SOC, V133, P16410, DOI 10.1021/ja207775a; Zhang MS, 2007, BIOORG MED CHEM LETT, V17, P2401, DOI 10.1016/j.bmcl.2007.02.041; Merino E, 2014, CHEM SOC REV, V43, P6598, DOI 10.1039/c4cs00025k; Prier CK, 2013, CHEM REV, V113, P5322, DOI 10.1021/cr300503r; Ma JA, 2008, CHEM REV, V108, pPR1, DOI 10.1021/cr800221v; Liu H, 2013, ADV SYNTH CATAL, V355, P617, DOI 10.1002/adsc.201200764; Ma JA, 2007, J FLUORINE CHEM, V128, P975, DOI 10.1016/j.jfluchem.2007.04.026; Tomashenko OA, 2011, CHEM REV, V111, P4475, DOI 10.1021/cr1004293; Mizuta S, 2013, ORG LETT, V15, P1250, DOI 10.1021/ol400184t; Tomita R, 2014, ANGEW CHEM INT EDIT, V53, P7144, DOI 10.1002/anie.201403590; Furuya T, 2011, NATURE, V473, P470, DOI 10.1038/nature10108; Barata-Vallejo S, 2014, CHEM-EUR J, V20, P16806, DOI 10.1002/chem.201404005; Besset T, 2014, CHEM-EUR J, V20, P16830, DOI 10.1002/chem.201404537; Charpentier J, 2015, CHEM REV, V115, P650, DOI 10.1021/cr500223h; Egami H, 2014, ANGEW CHEM INT EDIT, V53, P8294, DOI 10.1002/anie.201309260; Hari DP, 2013, ANGEW CHEM INT EDIT, V52, P4734, DOI 10.1002/anie.201210276; Hollingworth C, 2012, CHEM COMMUN, V48, P2929, DOI 10.1039/c2cc16158c; Hu JB, 2009, CHEM COMMUN, P7465, DOI 10.1039/b916463d; Koike T, 2014, J FLUORINE CHEM, V167, P30, DOI 10.1016/j.jfluchem.2014.06.025; Liu X, 2015, CHEM REV, V115, P683, DOI 10.1021/cr400473a; Mace Y, 2012, EUR J ORG CHEM, P2479, DOI 10.1002/ejoc.201101535; Ni CF, 2015, CHEM REV, V115, P765, DOI 10.1021/cr5002386; Shimizu M, 2005, ANGEW CHEM INT EDIT, V44, P214, DOI 10.1002/anie.200460441; Shimizu R, 2012, ANGEW CHEM INT EDIT, V51, P4577, DOI 10.1002/anie.201201095; Studer A, 2012, ANGEW CHEM INT EDIT, V51, P8950, DOI 10.1002/anie.201202624; Tomita R, 2014, BEILSTEIN J ORG CHEM, V10, P1099, DOI 10.3762/bjoc.10.108	58	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-1139	1873-3328		J FLUORINE CHEM	J. Fluor. Chem.	NOV	2015	179				SI		83	88		10.1016/j.jfluchem.2015.07.020		6	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	CW3GW	WOS:000364881000012		
J	Fuchibe, K; Morikawa, T; Ueda, R; Okauchi, T; Ichikawa, J				Fuchibe, Kohei; Morikawa, Toshiyuki; Ueda, Ryu; Okauchi, Tatsuo; Ichikawa, Junji			Pinpoint-fluorinated phenanthrene synthesis based on C-F bond activation of difluoroalkenes	JOURNAL OF FLUORINE CHEMISTRY			English	Article						Catalyst; Fluoroalkenes; Packing; Palladium; Polycyclic aromatic hydrocarbons; Semiconductors	EXCHANGE HALEX REACTION; GEM-DIFLUOROOLEFINATION; ARYL FLUORIDES; PHENANTHROQUINOLIZIDINE ALKALOIDS; ELECTROPHILIC FLUORINATION; NUCLEOPHILIC FLUORINATION; CATALYZED FLUORINATION; TRANSISTOR APPLICATION; FUNCTIONALIZED ARYL; CARBONYL-COMPOUNDS	Treatment with a cationic palladium(II) catalyst promoted the Friedel-Crafts-type cyclization of 1,1-difluoro-1-alkenes bearing a biphenyl skeleton to afford regioselectively fluorinated (pinpoint-fluorinated) phenanthrenes via C-F bond activation. The obtained pinpoint-fluorinated phenanthrenes were observed to be organized by pi-pi and C-H center dot center dot center dot F interactions to exhibit columnar and layer structures in the solid state. (C) 2015 Elsevier B.V. All rights reserved.	[Fuchibe, Kohei; Morikawa, Toshiyuki; Ueda, Ryu; Ichikawa, Junji] Univ Tsukuba, Fac Pure & Appl Sci, Div Chem, Tsukuba, Ibaraki 3058571, Japan; [Okauchi, Tatsuo] Kyushu Inst Technol, Dept Appl Chem, Kitakyushu, Fukuoka 8048550, Japan	Ichikawa, J (reprint author), Univ Tsukuba, Fac Pure & Appl Sci, Div Chem, Tsukuba, Ibaraki 3058571, Japan.	junji@chem.tsukuba.ac.jp			JSPS KAKENHI [25288016, 2562015]; Asahi Glass Foundation	This research is supported by JSPS KAKENHI (grant nos. 25288016 and 2562015) and Asahi Glass Foundation. Central Glass Co., Ltd. ((CF<INF>3</INF>)<INF>2</INF>CHOH (HFIP) and Tf<INF>2</INF>O) and Tosoh-F-Tech, Inc. (CBr<INF>2</INF>F<INF>2</INF>) are acknowledged for the generous gifts of the reagents.	Ahrens T, 2015, CHEM REV, V115, P931, DOI 10.1021/cr500257c; Tian HK, 2006, CHEM COMMUN, P3498, DOI 10.1039/b606759j; Sakamoto Y, 2004, J AM CHEM SOC, V126, P8138, DOI 10.1021/ja0476258; Gao B, 2014, CHEM-EUR J, V20, P7803, DOI 10.1002/chem.201402183; Mamane V, 2004, CHEM-EUR J, V10, P4556, DOI 10.1002/chem.200400220; Matsumoto A, 2011, J AM CHEM SOC, V133, P6557, DOI 10.1021/ja201931e; Wei LY, 2006, BIOORGAN MED CHEM, V14, P6560, DOI 10.1016/j.bmc.2006.06.009; Wang CY, 2010, J AM CHEM SOC, V132, P14006, DOI 10.1021/ja106130r; Worrell BT, 2012, ANGEW CHEM INT EDIT, V51, P11791, DOI 10.1002/anie.201204979; Yoshida H, 2013, ANGEW CHEM INT EDIT, V52, P8629, DOI 10.1002/anie.201302783; Yoon MH, 2006, J AM CHEM SOC, V128, P5792, DOI 10.1021/ja060016a; Hashimoto H, 2002, J MED CHEM, V45, P1511, DOI 10.1021/jm010484p; KELLY TR, 1990, TETRAHEDRON LETT, V31, P161; Li Q, 2014, J FLUORINE CHEM, V163, P38, DOI 10.1016/j.jfluchem.2014.04.011; Shimizu M, 2008, ANGEW CHEM INT EDIT, V47, P8096, DOI 10.1002/anie.200803213; FINGER GC, 1956, J AM CHEM SOC, V78, P6034, DOI 10.1021/ja01604a022; Wang XS, 2009, J AM CHEM SOC, V131, P7520, DOI 10.1021/ja901352k; Brooks AF, 2014, CHEM SCI, V5, P4545, DOI 10.1039/c4sc02099e; Ichiishi N, 2013, ORG LETT, V15, P5134, DOI 10.1021/ol4025716; Wang F, 2014, BEILSTEIN J ORG CHEM, V10, P344, DOI 10.3762/bjoc.10.32; Entani S, 2009, J PHYS CHEM C, V113, P6202, DOI 10.1021/jp808861y; Kitazawa K, 2011, CHEM LETT, V40, P300, DOI 10.1246/cl.2011.300; Ichitsuka T, 2014, ANGEW CHEM INT EDIT, V53, P7564, DOI 10.1002/anie.201402695; Mazzotti AR, 2013, J AM CHEM SOC, V135, P14012, DOI 10.1021/ja405919z; Wang BJ, 2010, ORG LETT, V12, P3352, DOI 10.1021/ol101154h; BURTON DJ, 1973, J AM CHEM SOC, V95, P8467, DOI 10.1021/ja00806a055; PETRICEK V, 1990, ACTA CRYSTALLOGR B, V46, P830, DOI 10.1107/S0108768190007510; FLOYD AJ, 1976, CHEM REV, V76, P509, DOI 10.1021/cr60303a001; WILSON S, 1993, J PHARM SCI, V82, P571, DOI 10.1002/jps.2600820605; WOOD CS, 1964, J ORG CHEM, V29, P3373, DOI 10.1021/jo01034a059; Furuya T, 2008, ANGEW CHEM INT EDIT, V47, P5993, DOI 10.1002/anie.200802164; DEY AS, 1974, J MED CHEM, V17, P1095, DOI 10.1021/jm00256a015; Yamada S, 2010, ANGEW CHEM INT EDIT, V49, P2215, DOI 10.1002/anie.200905052; Wang J, 2014, CHEM REV, V114, P2432, DOI 10.1021/cr4002879; Li Y, 2014, ADV SYNTH CATAL, V356, P1412, DOI 10.1002/adsc.201400101; Salomon P, 2014, ORG LETT, V16, P2926, DOI 10.1021/ol501063a; Anbarasan P, 2010, ANGEW CHEM INT EDIT, V49, P2219, DOI 10.1002/anie.200905855; Huang XS, 2008, J FLUORINE CHEM, V129, P1076, DOI 10.1016/j.jfluchem.2008.06.028; Tang PP, 2011, J AM CHEM SOC, V133, P11482, DOI 10.1021/ja2048072; Fuchibe K, 2015, ORG LETT, V17, P1126, DOI 10.1021/ol503759d; Kuehnel MF, 2013, ANGEW CHEM INT EDIT, V52, P3328, DOI 10.1002/anie.201205260; Saito A, 2010, J ORG CHEM, V75, P6980, DOI 10.1021/jo1013993; ZUPAN M, 1975, J ORG CHEM, V40, P3794, DOI 10.1021/jo00913a045; [Anonymous], 2014, ORG CHEM, DOI DOI 10.1021/JO501489C; LAPOUYADE R, 1982, ANGEW CHEM INT EDIT, V21, P766, DOI 10.1002/anie.198207661; Ichikawa J, 2000, J FLUORINE CHEM, V105, P257, DOI 10.1016/S0022-1139(99)00268-7; Walker ER, 2005, TETRAHEDRON LETT, V46, P6537, DOI 10.1016/j.tetlet.2005.07.084; Nishiwaki N, 2010, TETRAHEDRON LETT, V51, P3590, DOI 10.1016/j.tetlet.2010.05.014; Thalladi VR, 1998, J AM CHEM SOC, V120, P8702, DOI 10.1021/ja981198e; Saito A, 2007, ANGEW CHEM INT EDIT, V46, P3931, DOI 10.1002/anie.200605162; Amii H, 2009, CHEM REV, V109, P2119, DOI 10.1021/cr800388c; Adams DJ, 1999, CHEM SOC REV, V28, P225, DOI 10.1039/a808707e; Saito M, 2011, CHEM COMMUN, V47, P3410, DOI 10.1039/c1cc10215j; Clot E, 2011, ACCOUNTS CHEM RES, V44, P333, DOI 10.1021/ar100136x; Jones SB, 2006, ORG LETT, V8, P3757, DOI 10.1021/ol0613564; Fier PS, 2012, J AM CHEM SOC, V134, P5524, DOI 10.1021/ja301013h; Lee HG, 2014, J AM CHEM SOC, V136, P3792, DOI 10.1021/ja5009739; SEN A, 1981, J AM CHEM SOC, V103, P4627, DOI 10.1021/ja00405a077; ZUPAN M, 1995, B CHEM SOC JPN, V68, P1655, DOI 10.1246/bcsj.68.1655; Shuklov IA, 2007, SYNTHESIS-STUTTGART, P2925, DOI 10.1055/s-2007-983902; Lacour MA, 2008, ADV SYNTH CATAL, V350, P2677, DOI 10.1002/adsc.200800428; Zheng J, 2013, CHEM COMMUN, V49, P7513, DOI 10.1039/c3cc44271c; Cho DM, 2005, ORG LETT, V7, P1067, DOI 10.1021/ol050019c; ICHIKAWA J, 1995, J ORG CHEM, V60, P2320, DOI 10.1021/jo00113a005; Truong T, 2013, J AM CHEM SOC, V135, P9342, DOI 10.1021/ja4047125; Anthony JE, 2001, J AM CHEM SOC, V123, P9482, DOI 10.1021/ja0162459; NEWMAN MS, 1979, J ORG CHEM, V44, P1347, DOI 10.1021/jo01322a035; Fuchibe K, 2013, ANGEW CHEM INT EDIT, V52, P7825, DOI 10.1002/anie.201302740; VINSON WA, 1983, J ORG CHEM, V48, P4661, DOI 10.1021/jo00172a042; Berkessel A, 2006, J AM CHEM SOC, V128, P13412, DOI 10.1021/ja0620181; Schmidt BM, 2013, CHEM-EUR J, V19, P13872, DOI 10.1002/chem.201301910; Furuya T, 2009, ORG LETT, V11, P2860, DOI 10.1021/ol901113t; Watson DA, 2009, SCIENCE, V325, P1661, DOI 10.1126/science.1178239; Takachi M, 2010, ANGEW CHEM INT EDIT, V49, P8717, DOI 10.1002/anie.201004543; Balz G, 1927, BER DTSCH CHEM GES, V60, P1186, DOI 10.1002/cber.19270600539; Tang PP, 2010, J AM CHEM SOC, V132, P12150, DOI 10.1021/ja105834t; Dai WP, 2014, J ORG CHEM, V79, P10537, DOI 10.1021/jo5022234; Grushin VV, 2008, ORGANOMETALLICS, V27, P4825, DOI 10.1021/om800520e; Fujita T, 2011, CHEM LETT, V40, P986, DOI 10.1246/cl.2011.986; Laali KK, 1998, J FLUORINE CHEM, V91, P185, DOI 10.1016/S0022-1139(98)00224-3; Hull KL, 2006, J AM CHEM SOC, V128, P7134, DOI 10.1021/ja061943k; Yokota M, 2007, ORG LETT, V9, P4639, DOI 10.1021/ol702279w; Wang Y, 2006, J ORG CHEM, V71, P7780, DOI 10.1021/jo061305k; Tanabe H, 2010, CHEM LETT, V39, P248, DOI 10.1246/cl.2010.248; Kirsch P, 2013, BEILSTEIN J ORG CHEM, V9, P2367, DOI 10.3762/bjoc.9.272; Sundar VC, 2004, SCIENCE, V303, P1644, DOI 10.1126/science.1094196; Okamoto T, 2011, CHEM MATER, V23, P1646, DOI 10.1021/cm200356y; Okamoto H, 2008, J AM CHEM SOC, V130, P10470, DOI 10.1021/ja803291a; Campeau LC, 2006, J AM CHEM SOC, V128, P581, DOI 10.1021/ja055819x; Dohi T, 2010, TETRAHEDRON, V66, P5775, DOI 10.1016/j.tet.2010.04.116; Furuya T, 2011, NATURE, V473, P470, DOI 10.1038/nature10108; Banwell MG, 2006, BIOORG MED CHEM LETT, V16, P181, DOI 10.1016/j.bmcl.2005.09.032; Babudri F, 2007, CHEM COMMUN, P1003, DOI 10.1039/b611336b; Banks R. E., 1994, ORGANOFLUORINE CHEM; Baudoux J., 2007, ORG REACTIONS, V69, P347; Begue J.-P., 2008, BIOORGANIC MED CHEM; Begue JP, 2004, SYNLETT, P18, DOI 10.1055/s-2003-44973; Campbell MG, 2015, CHEM REV, V115, P612, DOI 10.1021/cr500366b; Champagne P.A., 2015, CHEM REV IN PRESS; Fuchibe K, 2014, B CHEM SOC JPN, V87, P942, DOI 10.1246/bcsj.20140128; Furuya T, 2010, SYNTHESIS-STUTTGART, P1804, DOI 10.1055/s-0029-1218742; Grushin VV, 2010, ACCOUNTS CHEM RES, V43, P160, DOI 10.1021/ar9001763; Grushin W., 2007, U.S. Patent, Patent No. [7,202,388, 7202388]; HAYASHI S, 1979, CHEM LETT, P983, DOI 10.1246/cl.1979.983; Hollingworth C, 2012, CHEM COMMUN, V48, P2929, DOI 10.1039/c2cc16158c; Ichikawa J., 2014, Jpn. Kokai Toklcyo Koho, Patent No. [JP 2014136700 A 20140728, 2014136700]; Janiak C, 2000, J CHEM SOC DALTON, P3885, DOI 10.1039/b003010o; Kirsch P., 2004, MODERN FLUOROORGANIC; Kubozono Y, 2014, EUR J INORG CHEM, P3806, DOI 10.1002/ejic.201402168; Lail K.K., 2001, J FLUORINE CHEM, V107, P31; Li ZG, 2001, SYNTHESIS-STUTTGART, P2365; Mallory F.B., 2004, ORG REACTIONS, V30, P1; Noel T, 2011, ANGEW CHEM INT EDIT, V50, P8900, DOI 10.1002/anie.201104652; Okamoto H, 2014, SCI REP-UK, V4, DOI 10.1038/srep05048; Okazaki T., 2006, ADV ORG SYNTH, V2, P353; Roe A., 1949, ORG REACTIONS, V5, P193; Sakoda K, 2005, CHEM COMMUN, P4684, DOI 10.1039/b510039a; Sasson Y, 1996, CHEM COMMUN, P297, DOI 10.1039/cc9960000297; Tang M.L., 2010, CHEM MATER, V23, P446; Uneyama K, 2006, ORGANOFLUORINE CHEM; Yamada S, 2010, SYNTHESIS-STUTTGART, P2490, DOI 10.1055/s-0029-1218816	121	1	1	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-1139	1873-3328		J FLUORINE CHEM	J. Fluor. Chem.	NOV	2015	179				SI		106	115		10.1016/j.jfluchem.2015.06.008		10	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	CW3GW	WOS:000364881000016		
J	Egami, H; Usui, Y; Kawamura, S; Shimizu, R; Nagashima, S; Sodeoka, M				Egami, Hiromichi; Usui, Yoshihiko; Kawamura, Shintaro; Shimizu, Ryo; Nagashima, Sayoko; Sodeoka, Mikiko			Mechanistic study on a unique S(N)2 '-type reaction of allylic alcohols with organolithium reagent accelerated by a proximal trifluoromethyl group	JOURNAL OF FLUORINE CHEMISTRY			English	Article						Trifluoromethyl; Organolithium reagent; Proximal effect; Allylic alcohol	COPPER-CATALYZED TRIFLUOROMETHYLATION; BENZYLIC ORGANOZINC HALIDES; ENANTIOSELECTIVE CARBOLITHIATION; BOND FORMATION; FUNCTIONALIZED 1,1-DIFLUORO-1-ALKENES; ISOLABLE 2,2-DIFLUOROVINYLSILANES; INTRAMOLECULAR CARBOLITHIATION; CONFIGURATIONAL STABILITY; TERTIARY ALKYLLITHIUMS; CINNAMYL DERIVATIVES	We previously found that treatment of (Z)-trifluoromethylated-2-aryl allylic alcohols with organolithium provided the S(N)2'-type product through C-O bond cleavage. Interestingly, no additive was required to enhance the nucleophilicity of the organolithium, and the free hydroxyl group served as a leaving group. The mechanistic studies of the unique transformation indicated that chelation of alkoxide and fluorine of the trifluoromethyl group to the lithium ion play a crucial role in controlling the reactivity and selectivity. Furthermore, theoretical investigation supported this interpretation. (C) 2015 Elsevier B.V. All rights reserved.	[Egami, Hiromichi; Usui, Yoshihiko; Kawamura, Shintaro; Shimizu, Ryo; Sodeoka, Mikiko] RIKEN, Synthet Organ Chem Lab, Wako, Saitama 3510198, Japan; [Egami, Hiromichi; Kawamura, Shintaro; Sodeoka, Mikiko] Japan Sci & Technol Agcy, ERATO, Sodeoka Live Cell Chem Project, Wako, Saitama 3510198, Japan; [Usui, Yoshihiko; Shimizu, Ryo; Nagashima, Sayoko; Sodeoka, Mikiko] Saitama Univ, Grad Sch Sci & Engn, Sakura Ku, Saitama 3388570, Japan; [Kawamura, Shintaro; Sodeoka, Mikiko] RIKEN, Ctr Sustainable Resource Sci, Wako, Saitama 3510198, Japan; [Egami, Hiromichi] Univ Shizuoka, Sch Pharmaceut Sci, Suruga Ku, Shizuoka 4228526, Japan	Sodeoka, M (reprint author), RIKEN, Synthet Organ Chem Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	sodeoka@riken.jp	Sodeoka, Mikiko/A-9952-2008; 	Sodeoka, Mikiko/0000-0002-1344-364X; Egami, Hiromichi/0000-0002-7784-4987	RIKEN; Japan Science and Technology Agency	This work was supported by RIKEN and Japan Science and Technology Agency. All calculations were conducted on the RIKEN Integrated Cluster of Clusters (RICC). We are grateful to Dr. Ryo Takita (Tokyo University, RIKEN CSRS) and Prof. Teiji Chihara (Saitama University) for helpful discussions.	Amii H, 2011, J SYN ORG CHEM JPN, V69, P752; KLEIN S, 1994, J ORG CHEM, V59, P2925, DOI 10.1021/jo00090a005; Dalpozzo R, 1998, J ORG CHEM, V63, P9559, DOI 10.1021/jo981130h; Hogan AML, 2007, J ORG CHEM, V72, P9557, DOI 10.1021/jo7017679; Egami H, 2013, ANGEW CHEM INT EDIT, V52, P7841, DOI 10.1002/anie.201303350; Mizuta S, 2012, CHEM-EUR J, V18, P8583, DOI 10.1002/chem.201201707; CRANDALL JK, 1972, J ORG CHEM, V37, P4236, DOI 10.1021/jo00799a002; PARHAM WE, 1959, J AM CHEM SOC, V81, P2146, DOI 10.1021/ja01518a032; Ichikawa J, 2003, TETRAHEDRON LETT, V44, P707, DOI 10.1016/S0040-4039(02)02652-7; BEGUE JP, 1995, TETRAHEDRON LETT, V36, P5003, DOI 10.1016/0040-4039(95)00933-4; KITAZUME T, 1989, J ORG CHEM, V54, P5630, DOI 10.1021/jo00284a047; Hagmann WK, 2008, J MED CHEM, V51, P4359, DOI 10.1021/jm800219f; Egami H, 2013, CHEM COMMUN, V49, P7346, DOI 10.1039/c3cc43936d; DORIS E, 1994, TETRAHEDRON LETT, V35, P7943, DOI 10.1016/S0040-4039(00)78391-2; Egami H, 2012, TETRAHEDRON LETT, V53, P5503, DOI 10.1016/j.tetlet.2012.07.134; Breit B, 2008, CHEM REV, V108, P2928, DOI 10.1021/cr078352c; Hogan AML, 2008, J ORG CHEM, V73, P6041, DOI 10.1021/jo800941h; Roy S, 2011, TETRAHEDRON, V67, P2161, DOI 10.1016/j.tet.2011.01.002; SODERQUIST JA, 1991, TETRAHEDRON LETT, V32, P6305, DOI 10.1016/0040-4039(91)80153-W; Kawamura S, 2015, J AM CHEM SOC, V137, P4865, DOI 10.1021/jacs.5b02046; FUCHIKAMI T, 1986, TETRAHEDRON LETT, V27, P3173, DOI 10.1016/S0040-4039(00)84746-2; Norsikian S, 2000, TETRAHEDRON LETT, V41, P6575, DOI 10.1016/S0040-4039(00)01091-1; Norsikian S, 1999, CHEM-EUR J, V5, P2055, DOI 10.1002/(SICI)1521-3765(19990702)5:7<2055::AID-CHEM2055>3.3.CO;2-0; Brisdon AK, 2003, ANGEW CHEM INT EDIT, V42, P2399, DOI 10.1002/anie.200250756; BARTLETT PD, 1969, J AM CHEM SOC, V91, P6362, DOI 10.1021/ja01051a030; EBERHARDT GG, 1964, J ORG CHEM, V29, P2928, DOI 10.1021/jo01033a029; Shimizu R, 2010, TETRAHEDRON LETT, V51, P5947, DOI 10.1016/j.tetlet.2010.09.027; Hogan AML, 2006, ORG LETT, V8, P3769, DOI 10.1021/ol061348n; Cottineau B, 2007, TETRAHEDRON, V63, P10354, DOI 10.1016/j.tet.2007.07.028; Strohmann C, 2007, J AM CHEM SOC, V129, P8952, DOI 10.1021/ja072970t; Amii H, 2009, CHEM REV, V109, P2119, DOI 10.1021/cr800388c; Liu W, 2013, SYNTHESIS-STUTTGART, V45, P2051, DOI 10.1055/s-0033-1339176; Jeschke P, 2004, CHEMBIOCHEM, V5, P570, DOI 10.1002/cbic.200300833; Luitjes H, 1997, TETRAHEDRON, V53, P9977, DOI 10.1016/S0040-4020(97)00340-2; Kimura M, 2004, ORG LETT, V6, P4651, DOI 10.1021/ol0481941; Ichikawa J, 2003, J ORG CHEM, V68, P7800, DOI 10.1021/jo03718j; MULVANEY JE, 1965, J ORG CHEM, V30, P917, DOI 10.1021/jo01014a063; KLEIN S, 1995, J AM CHEM SOC, V117, P8853, DOI 10.1021/ja00139a020; Scommoda M, 1996, J ORG CHEM, V61, P4379, DOI 10.1021/jo960027u; Yamazaki T, 1995, J ORG CHEM, V60, P8140, DOI 10.1021/jo00130a012; Castagnolo D, 2013, ORG LETT, V15, P2116, DOI 10.1021/ol400570r; Hartwig JF, 2010, ACCOUNTS CHEM RES, V43, P1461, DOI 10.1021/ar100047x; Tsuchida S, 2008, ORG LETT, V10, P3635, DOI 10.1021/ol801397v; Tait M, 2013, ORG LETT, V15, P34, DOI 10.1021/ol3029324; Tang SC, 2008, TETRAHEDRON LETT, V49, P1348, DOI 10.1016/j.tetlet.2007.12.085; Norsikian S, 1997, TETRAHEDRON LETT, V38, P7523, DOI 10.1016/S0040-4039(97)10022-3; Alexakis A, 2008, CHEM REV, V108, P2796, DOI 10.1021/cr0683515; Egami H, 2013, ANGEW CHEM INT EDIT, V52, P4000, DOI 10.1002/anie.201210250; Fournier AM, 2012, ORG LETT, V14, P142, DOI 10.1021/ol2029355; Egami H, 2013, J FLUORINE CHEM, V152, P51, DOI 10.1016/j.jfluchem.2013.03.009; Barluenga J, 2002, ORG LETT, V4, P2225, DOI 10.1021/ol026078x; Bailey WF, 2008, ORG LETT, V10, P1071, DOI 10.1021/ol702862d; MARUMOTO S, 1993, J AM CHEM SOC, V115, P9021, DOI 10.1021/ja00073a018; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Hogan AML, 2006, J AM CHEM SOC, V128, P10360, DOI 10.1021/ja060076g; Pratt LM, 2008, TETRAHEDRON, V64, P5314, DOI 10.1016/j.tet.2008.03.022; Merino E, 2014, CHEM SOC REV, V43, P6598, DOI 10.1039/c4cs00025k; Wu XF, 2012, CHEM-ASIAN J, V7, P1744, DOI 10.1002/asia.201200211; Gessner VH, 2009, CHEM-EUR J, V15, P3320, DOI 10.1002/chem.200900041; Wei XD, 1996, TETRAHEDRON LETT, V37, P4209, DOI 10.1016/0040-4039(96)00797-6; BARTLETT PD, 1969, J AM CHEM SOC, V91, P7425, DOI 10.1021/ja01054a034; MAGID RM, 1968, J AM CHEM SOC, V90, P5211, DOI 10.1021/ja01021a025; Harutyunyan SR, 2008, CHEM REV, V108, P2824, DOI 10.1021/cr068424k; Clayden J, 2010, J AM CHEM SOC, V132, P6624, DOI 10.1021/ja1007992; Gessner VH, 2011, CHEM-EUR J, V17, P2996, DOI 10.1002/chem.201000814; Zheng Y, 2010, ADV SYNTH CATAL, V352, P2745, DOI 10.1002/adsc.201000545; Tomashenko OA, 2011, CHEM REV, V111, P4475, DOI 10.1021/cr1004293; Isanbor C, 2006, J FLUORINE CHEM, V127, P303, DOI 10.1016/j.jfluchem.2006.01.011; Sundararaju B, 2012, CHEM SOC REV, V41, P4467, DOI 10.1039/c2cs35024f; Egami H, 2014, CHEM-EUR J, V20, P12061, DOI 10.1002/chem.201403447; Unkelbach C, 2009, J AM CHEM SOC, V131, P17044, DOI 10.1021/ja9076167; Furuya T, 2011, NATURE, V473, P470, DOI 10.1038/nature10108; Miyazaki A, 2012, HETEROCYCLES, V86, P979, DOI 10.3987/COM-12-S(N)101; Bande R. J., 2008, ORG LETT, V10, P4017; Barata-Vallejo S, 2014, CHEM-EUR J, V20, P16806, DOI 10.1002/chem.201404005; Bartoli G, 2000, EUR J ORG CHEM, P99; Begue J.-P., 2008, BIOORGANIC MED CHEM; Charpentier J, 2015, CHEM REV, V115, P650, DOI 10.1021/cr500223h; COLLUM DB, 1992, ACCOUNTS CHEM RES, V25, P448, DOI 10.1021/ar00022a003; CRANDALL JK, 1969, TETRAHEDRON LETT, P325; DIMMEL DR, 1973, J ORG CHEM, V38, P2756, DOI 10.1021/jo00956a003; Egami H, 2014, J FLUORINE CHEM, V167, P172, DOI 10.1016/j.jfluchem.2014.05.009; Egami H, 2014, ANGEW CHEM INT EDIT, V53, P8294, DOI 10.1002/anie.201309260; FELKIN H, 1969, TETRAHEDRON LETT, P707; Frisch M.J., 2013, GAUSSIAN 09 REVISION; Gomez-SanJuan A., 2013, B J ORG CHEM, V9, P313; Gouverneur V., 2012, FLUORINE PHARM MED C; Groth U, 2008, SYNLETT, P1301, DOI 10.1055/s-2008-1072630; Helmchen G., 2010, CATALYTIC ASYMMETRIC, P497; Hogan AML, 2008, CHEM COMMUN, P3839, DOI 10.1039/b805595e; Hoppe D., 1997, ANGEW CHEM INT EDIT, V36, P2282, DOI DOI 10.1002/ANIE.199722821; Houk N. K., 1985, J AM CHEM SOC, V107, P2821; Krisch P., 2004, MODERN FLUOROORGANIC; Legault C. Y., 2009, CYLVIEW V 1 0 561 BE; Luisi R, 2014, LITHIUM COMPOUNDS IN ORGANIC SYNTHESIS: FROM FUNDAMENTALS TO APPLICATIONS, P1, DOI 10.1002/9783527667512; Mace Y, 2012, EUR J ORG CHEM, P2479, DOI 10.1002/ejoc.201101535; MIYAKE H, 1989, CHEM LETT, P981, DOI 10.1246/cl.1989.981; Ojima I., 2009, FLUORINE MED CHEM CH; Schlosser M, 2006, ANGEW CHEM INT EDIT, V45, P5432, DOI 10.1002/anie.200600449; Shimizu M, 2005, ANGEW CHEM INT EDIT, V44, P214, DOI 10.1002/anie.200460441; Shimizu R, 2012, ANGEW CHEM INT EDIT, V51, P4577, DOI 10.1002/anie.201201095; Studer A, 2012, ANGEW CHEM INT EDIT, V51, P8950, DOI 10.1002/anie.201202624; Wang B, 2009, EUR J ORG CHEM, P3688, DOI 10.1002/ejoc.200900538; Wei XD, 2000, J CHEM SOC PERK T 1, P1109, DOI 10.1039/a910195k; YAMAZAKI T, 1991, CHEM LETT, P2171, DOI 10.1246/cl.1991.2171; Yang XY, 2015, CHEM REV, V115, P826, DOI 10.1021/cr500277b; Ye YD, 2012, SYNLETT, P2005, DOI 10.1055/s-0032-1316988	107	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-1139	1873-3328		J FLUORINE CHEM	J. Fluor. Chem.	NOV	2015	179				SI		121	128		10.1016/j.jfluchem.2015.07.024		8	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	CW3GW	WOS:000364881000018		
J	Kagawa, T; Shigehiro, D; Kawada, K				Kagawa, Takumi; Shigehiro, Daiki; Kawada, Kosuke			Trifluoroethoxy group as a leaving group for regioselective sequential substitution reactions of 5-trifluoromethylpyrimidine derivative with heteroatom nucleophiles	JOURNAL OF FLUORINE CHEMISTRY			English	Article						Trifluoromethyl; Pyrimidine; 2,2,2-Trifluoroethoxy; Regioselective	KINASE INHIBITORS; DISCOVERY; POTENT; CANCER; DESIGN	Highly regioselective substitution reaction of 2,4-bis(2,2,2-trifluoroethoxy)-5-(trifluoromethyl)pyrimidine (TFEFP) with aniline derivatives smoothly proceeded firstly at the 2-postion. For the subsequent nucleophilic substitution at the 4-position with alkoxides, trifluoroethoxy group at the 4-position serves as a practically efficient leaving group. (C) 2015 Elsevier B.V. All rights reserved.	[Kagawa, Takumi; Shigehiro, Daiki; Kawada, Kosuke] TOSOH F TECH Inc, Res Lab, Yamaguchi 7460006, Japan	Kagawa, T (reprint author), TOSOH F TECH Inc, Res Lab, 4988 Kaisei Cho, Yamaguchi 7460006, Japan.	kagawa@f-techinc.co.jp					Lucking U, 2013, CHEMMEDCHEM, V8, P1067, DOI 10.1002/cmdc.201300096; Ward RA, 2015, J MED CHEM, V58, P4790, DOI 10.1021/acs.jmedchem.5b00466; Chen HF, 2012, J MED CHEM, V55, P5536, DOI 10.1021/jm300452p; Richter DT, 2013, TETRAHEDRON LETT, V54, P4610, DOI 10.1016/j.tetlet.2013.06.025; Walker DP, 2009, BIOORG MED CHEM LETT, V19, P3253, DOI 10.1016/j.bmcl.2009.04.093; CHARTON M, 1975, J AM CHEM SOC, V97, P1552, DOI 10.1021/ja00839a047; Yang EH, 2013, B KOREAN CHEM SOC, V34, P3129, DOI 10.5012/bkcs.2013.34.10.3129; MACPHEE JA, 1978, TETRAHEDRON, V34, P3553, DOI 10.1016/0040-4020(78)88431-2; Curtin ML, 2012, BIOORG MED CHEM LETT, V22, P4750, DOI 10.1016/j.bmcl.2012.05.067; Walker DP, 2008, BIOORG MED CHEM LETT, V18, P6071, DOI 10.1016/j.bmcl.2008.10.030; Mollard A, 2011, ACS MED CHEM LETT, V2, P907, DOI 10.1021/ml200198x; Estrada AA, 2012, J MED CHEM, V55, P9416, DOI 10.1021/jm301020q; Song X, 2012, MEDCHEMCOMM, V3, P238, DOI 10.1039/c1md00219h; Bunker KD, 2010, ACTA CRYSTALLOGR E, V66, pO1448, DOI 10.1107/S1600536810018854; Charles J., [No title captured], Patent No. [W02005023780 (A1), 2005023780, WO 2,005,023,780]; Crew A.P., 2013, US Patent Application Publication, Patent No. [2013/0231306 (A1), 20130231306]; Guenter L., [No title captured], Patent No. [W02011018518 (A1), 2011018518]; Hirsch J.A., 1967, TOP STEREOCHEM, V1, P199, DOI 10.1002/9780470147108.ch4; Kandeel M. M., 2012, DER PHARM CHEM, V4, P1704; Lee HJ, 2014, ARCH PHARM RES, V37, P1130, DOI 10.1007/s12272-013-0323-z	20	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-1139	1873-3328		J FLUORINE CHEM	J. Fluor. Chem.	NOV	2015	179				SI		150	158		10.1016/j.jfluchem.2015.07.016		9	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	CW3GW	WOS:000364881000022		
J	Kikuchi, Y; Nakatsukasa, M; Nakano, Y; Kunimatsu, Y; Shimizu, D; Ogihara, N; Tsujikawa, H; Takano, T; Ishida, H				Kikuchi, Yasuhiro; Nakatsukasa, Masato; Nakano, Yoshihiko; Kunimatsu, Yutaka; Shimizu, Daisuke; Ogihara, Naomichi; Tsujikawa, Hiroshi; Takano, Tomo; Ishida, Hidemi			Morphology of the thoracolumbar spine of the middle Miocene hominoid Nacholapithecus kerioi from northern Kenya	JOURNAL OF HUMAN EVOLUTION			English	Article						Vertebra; Fossil apes; Spinous process; Dorsostability; Evolution	LUMBAR VERTEBRAL BODIES; FUNCTIONAL-MORPHOLOGY; GREAT-APE; BODY-MASS; MORPHOMETRIC-ANALYSIS; POSITIONAL BEHAVIOR; PROCONSUL-NYANZAE; MFANGANO ISLANDS; PARTIAL SKELETON; AFRICAN APES	A new caudal thoracic and a new lumbar vertebra of Nacholapithecus kerioi, a middle Miocene hominoid from northern Kenya, are reported. The caudal thoracic vertebral body of N. kerioi has a rounded median ventral keel and its lateral sides are moderately concave. The lumbar vertebral body has an obvious median ventral keel. Based on a comparison of vertebral body cranial articular surface size between the caudal thoracic vertebrae in the present study and one discussed in a previous study (KNM-BG 35250BO, a diaphragmatic vertebra), N. kerioi has at least two post-diaphragmatic vertebrae (rib-bearing lumbar-type thoracic vertebrae), unlike extant hominoids. It also has thick, rounded, and moderately long metapophyses on the lumbar vertebra that project dorsolaterally. The spinous process bases of its caudal thoracic and lumbar vertebrae originate caudally between the postzygapophyses, as described previously in the KNM-BG 35250 holotype specimen. In other words, the postzygapophyses of N. kerioi do not project below the caudal border of the spinous processes, similar to those of extant great apes, and unlike small apes and monkeys, which have more caudally projecting postzygapophyses. Nacholapithecus kerioi has a craniocaudally expanded spinous process in relation to vertebral body length, also similar to extant great apes. Both these spinous process features of N. kerioi differ from those of Proconsul nyanzae. The caudal thoracic vertebra of N. kerioi has a caudally-directed spinous process, whose tip is tear-drop shaped. These features resemble those of extant apes. The morphology of the spinous process tips presumably helps vertebral stability by closely stacking adjacent spinous process tips as seen in extant hominoids. The morphology of the spinous process and postzygapophyses limits the intervertebral space and contributes to the stability of the functional lumbar region as seen in extant great apes, suggesting that antipronograde activity was included in the positional behavior of N. kerioi. (C) 2015 Elsevier Ltd. All rights reserved.	[Kikuchi, Yasuhiro] Saga Univ, Fac Med, Dept Anat & Anthropol, Div Human Anat & Biol Anthropol, Saga 8498501, Japan; [Nakatsukasa, Masato; Shimizu, Daisuke] Kyoto Univ, Grad Sch Sci, Lab Phys Anthropol, Kyoto 6068502, Japan; [Nakano, Yoshihiko] Osaka Univ, Grad Sch Human Sci, Lab Biol Anthropol, Osaka 5650871, Japan; [Kunimatsu, Yutaka] Ryukoku Univ, Fac Business Adm, Dept Business Adm, Kyoto 6128577, Japan; [Ogihara, Naomichi] Keio Univ, Fac Sci & Technol, Dept Mech Engn, Lab Evolutionary Biomech, Yokohama 2238522, Kanagawa, Japan; [Tsujikawa, Hiroshi] Tohoku Bunka Gakuen Univ, Fac Med Sci & Welf, Dept Rehabil, Sendai 9818551, Miyagi, Japan; [Takano, Tomo] Japan Monkey Ctr, Aichi 4840081, Japan; [Ishida, Hidemi] Kyoto Univ, Kyoto 6068502, Japan	Kikuchi, Y (reprint author), Saga Univ, Fac Med, Dept Anat & Anthropol, Div Human Anat & Biol Anthropol, Saga 8498501, Japan.	kikuchiy@cc.saga-u.ac.jp; nakatsuk@anthro.zool.kyoto-u.ac.jp; nakano@hus.osaka-u.ac.jp; kunimats@biz.ryukoku.ac.jp; Ishida-h@seisen.ac.jp			Japan Society for Promotion of Science, Nairobi Research Station; JSPS KAKENHI [20247033, 24000015, 15K14621]; Sumitomo Foundation [140080]	We thank Sarah Elton (Editor), an Associate Editor, and two anonymous referees for reviewing our paper, using their precious time and giving us helpful comments. We extend our gratitude to the Office of the President of the Republic of Kenya, especially, Ahmed Yassin, Stephen Rucina Mathai, Idle Farah, and Emma Mbua (now of Mount Kenya University), and the staff of the National Museums of Kenya for permission to carry out research in Kenya. We thank the curators of the Division of Osteology of the National Museums of Kenya; Christoph Zollikofer, and Marcia Ponce de Leon of the Anthropological Institute and Museum, Universitat Zurich-Irchel; Christiane Funk of the Museum fur Naturkunde Berlin; and Emmanuel Gilissen and Wim Wendelen of the Department of African Zoology at the Royal Museum for Central Africa for access to collections under their care. The Japan Society for Promotion of Science, Nairobi Research Station provided us with support to conduct research in Kenya. This study was supported by JSPS KAKENHI Grant Numbers 20247033, 24000015, and 15K14621, and by a fiscal 2014 Grant-in-Aid for Scientific Research and a Grant for Basic Science Research Projects from the Sumitomo Foundation, grant number 140080.	Moya-Sola S, 2009, P NATL ACAD SCI USA, V106, P9601, DOI 10.1073/pnas.0811730106; Nakatsukasa M, 2009, EVOL ANTHROPOL, V18, P103, DOI 10.1002/evan.20208; Smith RJ, 1997, J HUM EVOL, V32, P523, DOI 10.1006/jhev.1996.0122; Shapiro LJ, 2007, AM J PRIMATOL, V69, P86, DOI 10.1002/ajp.20329; Williams SA, 2012, AM J PHYS ANTHROPOL, V148, P111, DOI 10.1002/ajpa.22049; FEIBEL CS, 1991, J HUM EVOL, V21, P221, DOI 10.1016/0047-2484(91)90063-2; Ward S, 1999, SCIENCE, V285, P1382, DOI 10.1126/science.285.5432.1382; Lovejoy CO, 2009, SCIENCE, V326, P100, DOI 10.1126/science.1175833; Schultz AH, 1953, AM J PHYS ANTHROP-NE, V11, P277, DOI 10.1002/ajpa.1330110308; Mccollum MA, 2010, J EXP ZOOL PART B, V314B, P123, DOI 10.1002/jez.b.21316; MoyaSola S, 1996, NATURE, V379, P156, DOI 10.1038/379156a0; Shapiro LJ, 2002, J HUM EVOL, V42, P753, DOI 10.1006/jhev.2002.0560; Pickford M, 2003, CR PALEVOL, V2, P649, DOI 10.1016/j.crpv.2003.10.001; Haeusler M, 2002, J HUM EVOL, V43, P621, DOI 10.1006/jhev.2002.0595; Nakatsukasa M, 2003, PRIMATES, V44, P371, DOI 10.1007/s10329-003-0051-y; SHAPIRO LJ, 1988, AM J PHYS ANTHROPOL, V77, P201, DOI 10.1002/ajpa.1330770208; Maclatchy L, 2004, EVOL ANTHROPOL, V13, P90, DOI 10.1002/evan.10133; Jungers WL, 1995, YEARB PHYS ANTHROPOL, V38, P137; Nakatsukasa M, 2007, J HUM EVOL, V52, P347, DOI 10.1016/j.jhevol.2006.08.008; Rockwell H, 1938, J MORPHOL, V63, P87, DOI 10.1002/jmor.1050630105; Gebo DL, 1997, SCIENCE, V276, P401, DOI 10.1126/science.276.5311.401; CLAUSER DA, 1975, FOLIA PRIMATOL, V23, P308, DOI 10.1159/000155679; SHAPIRO L, 1995, AM J PHYS ANTHROPOL, V98, P323, DOI 10.1002/ajpa.1330980306; Kohler M, 1997, P NATL ACAD SCI USA, V94, P11747, DOI 10.1073/pnas.94.21.11747; Johnson SE, 1998, AM J PHYS ANTHROPOL, V105, P333, DOI 10.1002/(SICI)1096-8644(199803)105:3<333::AID-AJPA4>3.0.CO;2-S; Shapiro LJ, 2005, AM J PHYS ANTHROPOL, V128, P823, DOI 10.1002/ajpa.20122; Moya-Sola S, 2004, SCIENCE, V306, P1339, DOI 10.1126/science.1103094; WALKER A, 1968, NATURE, V217, P980, DOI 10.1038/217980a0; Kikuchi Y, 2012, J HUM EVOL, V62, P677, DOI 10.1016/j.jhevol.2012.03.002; WARD CV, 1993, AM J PHYS ANTHROPOL, V90, P77, DOI 10.1002/ajpa.1330900106; Granatosky MC, 2014, J MORPHOL, V275, P313, DOI 10.1002/jmor.20216; CARTMILL M, 1977, AM J PHYS ANTHROPOL, V47, P249, DOI 10.1002/ajpa.1330470206; Young NM, 2004, J HUM EVOL, V46, P163, DOI 10.1016/j.jhevol.2003.11.002; DRAKE RE, 1988, J GEOL SOC LONDON, V145, P479, DOI 10.1144/gsjgs.145.3.0479; Williams SA, 2012, J EXP ZOOL PART B, V318B, P134, DOI 10.1002/jezb.21451; Nakatsukasa M, 2008, J HUM EVOL, V55, P581, DOI 10.1016/j.jhevol.2008.04.009; Sherwood RJ, 2002, J HUM EVOL, V42, P63, DOI 10.1006/jhev.2001.0502; RUFF CB, 1989, J HUM EVOL, V18, P515, DOI 10.1016/0047-2484(89)90016-X; ROSE MD, 1975, J HUM EVOL, V4, P21, DOI 10.1016/0047-2484(75)90087-1; MacLatchy L, 2000, J HUM EVOL, V39, P159, DOI 10.1006/jhev.2000.0407; Schultz AH, 1938, AM J PHYS ANTHROPOL, V24, P1, DOI 10.1002/ajpa.1330240124; MOSIMANN JE, 1970, J AM STAT ASSOC, V65, P930, DOI 10.2307/2284599; Sawada Y, 1998, CR ACAD SCI II A, V326, P445, DOI 10.1016/S1251-8050(98)80069-4; Susanna I, 2014, J HUM EVOL, V73, P15, DOI 10.1016/j.jhevol.2014.05.009; WALKER A, 1993, J HUM EVOL, V25, P43, DOI 10.1006/jhev.1993.1037; LARSON SG, 1988, AM J PHYS ANTHROPOL, V76, P449, DOI 10.1002/ajpa.1330760405; Ruff CB, 2003, AM J PHYS ANTHROPOL, V120, P16, DOI 10.1002/ajpa.10118; Sargis EJ, 2001, J ZOOL, V253, P473, DOI 10.1017/S0952836901000437; [Anonymous], 1999, AM J PHYS ANTHR S; Badoux D.M., 1974, P1; Benton R. S., 1967, BABOON MED RES, VII, P201; Benton R. S., 1974, YEARB PHYS ANTHROPOL, V18, P65; Buettner-Janusch J., 1952, AM J PHYS ANTHROPOL, V10, P251; Clauser D. A., 1980, THESIS; Delson Eric, 2000, Anthropological Papers of the American Museum of Natural History, V83, P1; ERIKSON G. E., 1963, SYMP ZOOL SOC LONDON, V10, P135; HARRISON T, 1986, J HUM EVOL, V15, P541, DOI 10.1016/S0047-2484(86)80073-2; Harrison Terry, 1997, P327; Hofer H., 1961, HDB PRIMATENKUNDE, V4, P1; Ishida H., 2004, J HUM EVOL, V46, P67; Jenkins F.A. Jr., 1974, P85; Jungers W.L., 1984, P146; Kelley J., 1986, THESIS; Kohler Meike, 1999, P91; Kohler M., 1995, SPAIN J HUM EVOL, V29, P101, DOI DOI 10.1006/JHEV.1995.1049; Pickford Martin, 1998, Annales de Paleontologie, V84, P275, DOI 10.1016/S0753-3969(99)80003-2; Pickford Martin, 1999, P27; Preuschoft H., 1979, P327; Rose Michael D., 1996, African Study Monographs Supplementary Issue, V24, P3; SANDERS WJ, 1994, J HUM EVOL, V26, P203, DOI 10.1006/jhev.1994.1012; Sanders W. J, 1995, THESIS; Shapiro Liza, 1993, P121; Slijper E. J., 1946, Verh K nod Akad Wet Amsterdam (2), V42, P1; Susanna I, 2010, J HUM EVOL, V30, P311; Walker A.C., 1983, P325; Ward C. V., 1991, THESIS; WARD CV, 1993, AM J PHYS ANTHROPOL, V92, P291, DOI 10.1002/ajpa.1330920306; Ward C.V., 2007, HDB PALEOANTHROPOLOG, V2, P1011; Williams S.A, 2011, THESIS; Williams SA, 2015, EVOL ANTHROPOL, V24, P15, DOI 10.1002/evan.21437; Young J. Z., 1962, LIFE VERTEBRATES	81	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0047-2484			J HUM EVOL	J. Hum. Evol.	NOV	2015	88						25	42		10.1016/j.jhevol.2015.09.003		18	Anthropology; Evolutionary Biology	Anthropology; Evolutionary Biology	CX0FP	WOS:000365372600003		
J	Ye, QH; Bolch, T; Naruse, R; Wang, YZ; Zong, JB; Wang, ZY; Zhao, R; Yang, DQ; Kang, SC				Ye, Qinghua; Bolch, Tobias; Naruse, Renji; Wang, Yuzhe; Zong, Jibiao; Wang, Zhongyan; Zhao, Rui; Yang, Daqing; Kang, Shichang			Glacier mass changes in Rongbuk catchment on Mt. Qomolangma from 1974 to 2006 based on topographic maps and ALOS PRISM data	JOURNAL OF HYDROLOGY			English	Article						ALOS/PRISM; Digital elevation model (DEM); Mt. Qomolangma (Mt. Everest MQ); Rongbuk Catchment (RC); Glacier mass changes; Topographic maps	DEBRIS-COVERED GLACIERS; TIBETAN PLATEAU; HIMALAYAN GLACIERS; NEPAL-HIMALAYA; WESTERN HIMALAYA; STEREO IMAGERY; EVEREST REGION; MOUNT EVEREST; VOLUME CHANGE; BALANCE	Elevation changes of glacier surfaces were investigated in Rongbuk Catchment (RC) on the northern slopes of Mt. Qomolangma in the central Himalayas, by comparing a digital elevation model (DEM) generated from the 2006 ALOS/PRISM imageries with the base DEM1974 derived from the 1:50,000 topographic maps. The average elevation change rate of glacier surfaces in RC was estimated at -0.47 +/- 0.23 m a(-1) between 1974 and 2006. Such surface lowering rates varied significantly with glaciers and altitudes. One of the notable results is that the debris-covered ice thinned much more rapidly than the exposed ice at higher altitudes. Overall, glaciers in RC have lost mass of -0.06 +/- 0.04 Gt a(-1) during 1974-2006. Glacier imbalance constitutes about 50% or more of the Rongbuk runoff. (C) 2015 Elsevier B.V. All rights reserved.	[Ye, Qinghua; Zong, Jibiao; Wang, Zhongyan; Zhao, Rui] Chinese Acad Sci, Key Lab Tibetan Environm Changes & Land Surface P, Inst Tibetan Plateau Res, Beijing 100101, Peoples R China; [Bolch, Tobias] Univ Zurich, Geog Inst, CH-8057 Zurich, Switzerland; [Bolch, Tobias] Tech Univ Dresden, Inst Kartog, D-01069 Dresden, Germany; [Naruse, Renji] Glacier & Cryospher Environm Res Lab, Tottori 6800011, Japan; [Wang, Yuzhe; Kang, Shichang] Chinese Acad Sci, State Key Lab Cryospher Sci, Cold & Arid Reg Environm & Engn Res Inst, Lanzhou 730000, Peoples R China; [Yang, Daqing] Natl Hydrol Res Ctr, Saskatoon, SK S7N 3H5, Canada; [Kang, Shichang] Chinese Acad Sci, CAS Ctr Excellence Tibetan Plateau Earth Sci, Beijing 100101, Peoples R China	Ye, QH (reprint author), Chinese Acad Sci, Key Lab Tibetan Environm Changes & Land Surface P, Inst Tibetan Plateau Res, Beijing 100101, Peoples R China.	yeqh@itpcas.ac.cn			Special Basic Research Project of MST [2013FY111400-2]; NSF of China [41120114001, 41125003, 40971048, 41071254]; Foundation Program for outstanding Young Scholar of CAS [KZCX2-EW-QN104]; Open Research Fund of TEL in CAS; State Key Laboratory of Remote Sensing Science; DFG [BO 3199/2-1, BU 949/20-1]; ESA [4000101778/10/I-AM]	The research results have been obtained through the cooperation between the research organization (Institute of Tibetan Plateau Research, CAS) and JAXA (JAXA/METI for PALSAR) in JAXA's ALOS RA. The work is supported by the Special Basic Research Project of MST (2013FY111400-2), by NSF of China (41120114001, 41125003, 40971048, 41071254), by Foundation Program for outstanding Young Scholar of CAS (KZCX2-EW-QN104). The project was also supported by Open Research Fund of TEL in CAS, by Open Fund of State Key Laboratory of Remote Sensing Science and by in-situ investigated data from QOMORS. T.B. was funded by DFG (Codes: BO 3199/2-1 and BU 949/20-1) and ESA within the Glaciers_cci Project (4000101778/10/I-AM).	Yao TD, 2012, NAT CLIM CHANGE, V2, P663, DOI 10.1038/NCLIMATE1580; Luedeling E, 2007, ISPRS J PHOTOGRAMM, V62, P283, DOI 10.1016/j.isprsjprs.2007.05.004; Gardner AS, 2013, SCIENCE, V340, P852, DOI 10.1126/science.1234532; Bajracharya SR, 2009, ANN GLACIOL, V50, P81, DOI 10.3189/172756410790595895; Gardelle J, 2013, CRYOSPHERE, V7, P1885, DOI 10.5194/tc-7-1885-2013; Neckel N, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/1/014009; Berthier E, 2010, NAT GEOSCI, V3, P92, DOI 10.1038/NGEO737; Tian LD, 2014, J GLACIOL, V60, P879, DOI 10.3189/2014JoG14J022; Liu WG, 2010, J MT SCI-ENGL, V7, P146, DOI 10.1007/s11629-010-1069-4; Bolch T, 2012, SCIENCE, V336, P310, DOI 10.1126/science.1215828; Pieczonka T, 2013, REMOTE SENS ENVIRON, V130, P233, DOI 10.1016/j.rse.2012.11.020; Bolch T, 2011, CRYOSPHERE, V5, P349, DOI 10.5194/tc-5-349-2011; Azam MF, 2012, J GLACIOL, V58, P315, DOI 10.3189/2012JoG11J123; Fujita K, 2011, P NATL ACAD SCI USA, V108, P14011, DOI 10.1073/pnas.1106242108; Bolch T, 2008, NAT HAZARD EARTH SYS, V8, P1329; Wang PY, 2014, GLOBAL PLANET CHANGE, V114, P14, DOI 10.1016/j.gloplacha.2014.01.001; Nuth C, 2011, CRYOSPHERE, V5, P271, DOI 10.5194/tc-5-271-2011; Kaab A, 2015, CRYOSPHERE, V9, P557, DOI 10.5194/tc-9-557-2015; Nuimura T, 2012, J GLACIOL, V58, P648, DOI 10.3189/2012JoG11J061; Yang W, 2013, J GEOPHYS RES-ATMOS, V118, P9579, DOI 10.1002/jgrd.50760; Ren JW, 2004, CHINESE SCI BULL, V49, P65, DOI 10.1360/03wd0148; Berthier E, 2007, REMOTE SENS ENVIRON, V108, P327, DOI 10.1016/j.rse.2006.11.017; Huss M, 2013, CRYOSPHERE, V7, P877, DOI 10.5194/tc-7-877-2013; Li Z, 2012, INT J DIGIT EARTH, V5, P516, DOI 10.1080/17538947.2011.594099; Cogley JG, 2012, NATURE, V488, P468, DOI 10.1038/488468a; Ma LL, 2010, CHINESE SCI BULL, V55, P2088, DOI 10.1007/s11434-010-3211-7; Lei YB, 2012, J GLACIOL, V58, P177, DOI 10.3189/2012JoG11J025; Kaab A, 2012, NATURE, V488, P495, DOI 10.1038/nature11324; Sakai A, 2002, ARCT ANTARCT ALP RES, V34, P12, DOI 10.2307/1552503; Kaser G, 2010, P NATL ACAD SCI USA, V107, P20223, DOI 10.1073/pnas.1008162107; Fujita K, 2013, NAT HAZARD EARTH SYS, V13, P1827, DOI 10.5194/nhess-13-1827-2013; Quincey DJ, 2009, J GLACIOL, V55, P596; Zhang YS, 2012, J MT SCI-ENGL, V9, P343, DOI 10.1007/s11629-009-2296-4; Li X, 2008, GLOBAL PLANET CHANGE, V62, P210, DOI 10.1016/j.gloplacha.2008.02.001; Osti R, 2011, NAT HAZARDS, V58, P1209, DOI 10.1007/s11069-011-9723-x; Molg T, 2014, NAT CLIM CHANGE, V4, P68, DOI [10.1038/nclimate2055, 10.1038/NCLIMATE2055]; MILLER MM, 1965, J GEOPHYS RES, V70, P3885, DOI 10.1029/JZ070i016p03885; Sakai A, 2010, J GLACIOL, V56, P177; Vincent C, 2013, CRYOSPHERE, V7, P569, DOI 10.5194/tc-7-569-2013; Ye QH, 2009, J MT SCI-ENGL, V6, P211, DOI 10.1007/s11629-009-1016-4; Yang XG, 2011, ARCT ANTARCT ALP RES, V43, P147, DOI 10.1657/1938-4246-43.1.147; Yin YH, 2013, J GEOGR SCI, V23, P195, DOI 10.1007/s11442-013-1003-0; Immerzeel WW, 2010, SCIENCE, V330, P585, DOI 10.1126/science.330.6004.585-a; Benn D.I., 2012, EARTH SCI REV; Dobhal DP, 2008, B GLACIOL RES, V25, P9; Gardelle J., 1999, CRYOSPHERE DISCUSS, P975; Holzer N., 2015, CRYOSPHERE DISCUSS, V9, P1811; Kaspar S, 2008, J GLACIOL, V54, P343, DOI 10.3189/002214308784886126; Kaspari S.D., 2011, GEOPHYS RES LETT, V38; Liu Z., 1962, ACTA GEOGRAPHICA SIN, V01, P19; Paul F., 2008, GEOPHYS RES LETT, V35; Racoviteanu A, 2014, CRYOSPHERE DISCUSS, V8, P3949, DOI [10.5194/tcd-8-3949-2014, DOI 10.5194/TCD-8-3949-2014]; Shi Y., 1991, B CHINESE ACAD SCI, V6, P287; The Tibetan Scientific Expedition Team in Chinese Academy of Sciences (TSETCAS), 1962, REP SCI EXP MT; The Tibetan Scientific Expedition Team in Chinese Academy of Sciences (TSETCAS), 1975, REP SCI EXP MT; Xie Z.C., 1975, GLACIER DEV QUANTITY, P95; Zemp M., 2013, CRYOSPHERE, V7; [张通 Zhang Tong], 2012, [冰川冻土, Journal of Glaciology and Geocryology], V34, P1059	58	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-1694	1879-2707		J HYDROL	J. Hydrol.	NOV	2015	530						273	280		10.1016/j.jhydrol.2015.09.014		8	Engineering, Civil; Geosciences, Multidisciplinary; Water Resources	Engineering; Geology; Water Resources	CW5QD	WOS:000365050600022		
J	Nikaido, T; Tanino, Y; Wang, X; Sato, S; Misa, K; Fukuhara, N; Sato, Y; Fukuhara, A; Uematsu, M; Suzuki, Y; Kojima, T; Tanino, M; Endo, Y; Tsuchiya, K; Kawamura, I; Frevert, CW; Munakata, M				Nikaido, Takefumi; Tanino, Yoshinori; Wang, Xintao; Sato, Suguru; Misa, Kenichi; Fukuhara, Naoko; Sato, Yuki; Fukuhara, Atsuro; Uematsu, Manabu; Suzuki, Yasuhito; Kojima, Tetsuhito; Tanino, Mishie; Endo, Yuichi; Tsuchiya, Kohsuke; Kawamura, Ikuo; Frevert, Charles W.; Munakata, Mitsuru			Serum Syndecan-4 as a Possible Biomarker in Patients With Acute Pneumonia	JOURNAL OF INFECTIOUS DISEASES			English	Article						syndecan-4; acute bacterial pneumonia; S. pneumoniae; survival; biomarker	HEPARAN-SULFATE PROTEOGLYCANS; ACUTE LUNG INJURY; PULMONARY INFLAMMATION; MYOCARDIAL-INFARCTION; NEUTROPHIL MIGRATION; UP-REGULATION; A-DROP; MICE; BINDING; CELLS	Background. Syndecan-4 is a transmembrane heparan sulfate proteoglycan expressed in a variety of cells, and glycosaminoglycan side chains of syndecan-4 bind to several proteins, suggesting several biological functions. However, the role of syndecan-4 in acute bacterial pneumonia has not yet been elucidated. Methods. Serumsyndecan-4 levels were measured in patients with acute pneumonia, and the relationships between serum syndecan-4 levels and clinical parameters were analyzed. Next, we treated wild-type and syndecan-4-deficient mice with Streptococcus pneumoniae intranasally and analyzed the phenotype of syndecan-4-deficient mice. Results. In the patients with acute pneumonia, serumsyndecan-4 levels were significantly higher than in the healthy volunteers and correlated negatively with the pneumonia severity score. In addition, in patients who improved with short-term antibiotic therapy, serum syndecan-4 levels were higher on admission and gradually increased during antibiotic therapy. Furthermore, in syndecan-4-deficient mice, the survival rate was significantly worse, and total neutrophil counts in bronchoalveolar lavage fluid, bacterial counts in blood, and plasma levels of inflammatory cytokines were significantly higher than in wild-type mice. Conclusions. These results suggest that syndecan-4 has an anti-inflammatory function in acute pneumonia and could serve as a useful biomarker in these patients.	[Nikaido, Takefumi; Tanino, Yoshinori; Wang, Xintao; Sato, Suguru; Misa, Kenichi; Fukuhara, Naoko; Sato, Yuki; Fukuhara, Atsuro; Uematsu, Manabu; Suzuki, Yasuhito; Munakata, Mitsuru] Fukushima Med Univ, Sch Med, Dept Pulm Med, Fukushima 9601295, Japan; [Endo, Yuichi] Fukushima Med Univ, Sch Med, Dept Immunol, Fukushima 9601295, Japan; [Kojima, Tetsuhito] Nagoya Univ, Sch Hlth Sci, Dept Med Technol, Nagoya, Aichi 4648601, Japan; [Tanino, Mishie] Hokkaido Univ, Grad Sch Med, Dept Canc Pathol, Sapporo, Hokkaido, Japan; [Tsuchiya, Kohsuke; Kawamura, Ikuo] Kyoto Univ, Grad Sch Med, Dept Microbiol, Kyoto, Japan; [Frevert, Charles W.] Univ Washington, Sch Med, Dept Med, Div Pulm Crit Care Med, Seattle, WA 98195 USA; [Frevert, Charles W.] Univ Washington, Sch Med, Dept Comparat Med, Comparat Pathol Program, Seattle, WA 98195 USA; [Frevert, Charles W.] Univ Washington, Sch Med, Ctr Lung Biol, Seattle, WA USA	Tanino, Y (reprint author), Fukushima Med Univ, Sch Med, Dept Pulm Med, 1 Hikarigaoka, Fukushima 9601295, Japan.	ytanino@fmu.ac.jp			Ministry of Health, Labour and Welfare, Japan	This work was supported by the Ministry of Health, Labour and Welfare, Japan (grant to the Diffuse Lung Diseases Research Group).	Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI13530; Segel GB, 2011, J LEUKOCYTE BIOL, V89, P359, DOI 10.1189/jlb.0910538; Saphire ACS, 2001, J VIROL, V75, P9187, DOI 10.1128/JVI.75.19.9187-9200.2001; BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365; Bartlett AH, 2007, MOL CELLS, V24, P153; Brule S, 2006, GLYCOBIOLOGY, V16, P488, DOI 10.1093/glycob/cwj098; Okuyama E, 2013, J BIOCHEM, V154, P41, DOI 10.1093/jb/mvt024; Gill S, 2010, ANAT REC, V293, P968, DOI 10.1002/ar.21094; Kohno S, 2011, INTERNAL MED, V50, P1183, DOI 10.2169/internalmedicine.50.4651; Xu J, 2005, J IMMUNOL, V174, P5758; Ishiguro K, 2001, LAB INVEST, V81, P509; Cevikbas F, 2008, MATRIX BIOL, V27, P42, DOI 10.1016/j.matbio.2007.07.003; Endo Y, 2012, J IMMUNOL, V189, P5860, DOI 10.4049/jimmunol.1200836; Pittet JF, 1997, AM J RESP CRIT CARE, V155, P1187; Smith MF, 2006, GLYCOBIOLOGY, V16, P221, DOI 10.1093/glycob/cwj061; Parish CR, 2006, NAT REV IMMUNOL, V6, P633, DOI 10.1038/nri1918; Gotte M, 2003, FASEB J, V17, P575, DOI 10.1096/fj.02-0739rev; Kasamatsu Y, 2012, RESPIROLOGY, V17, P330, DOI 10.1111/j.1440-1843.2011.02101.x; Tonnaer ELGM, 2006, MICROBES INFECT, V8, P316, DOI 10.1016/j.micinf.2005.06.028; Tanino Y, 2010, J IMMUNOL, V184, P2677, DOI 10.4049/jimmunol.0903274; Tanino Y, 2012, AM J RESP CELL MOL, V47, P196, DOI 10.1165/rcmb.2011-0294OC; Pruessmeyer J, 2010, J BIOL CHEM, V285, P555, DOI 10.1074/jbc.M109.059394; Ishiguro K, 2001, J BIOL CHEM, V276, P47483, DOI 10.1074/jbc.M106268200; Muramatsu T, 2006, METHOD ENZYMOL, V416, P263, DOI 10.1016/S0076-6879(06)16017-6; Inokoshi Y, 2013, RESPIROLOGY, V18, P1236, DOI 10.1111/resp.12144; Kon S, 2008, J EXP MED, V205, P25, DOI 10.1084/jem.20071324; Frevert CW, 2003, AM J RESP CELL MOL, V28, P464, DOI 10.1165/rcmb.2002-0084OC; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Chuang KH, 2013, AM J RESP CELL MOL, V49, P1110, DOI 10.1165/rcmb.2013-0022OC; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Alexopoulou AN, 2007, INT J BIOCHEM CELL B, V39, P505, DOI 10.1016/j.biocel.2006.10.014; Ishiguro K, 2000, J BIOL CHEM, V275, P5249, DOI 10.1074/jbc.275.8.5249; Matsui Y, 2011, CIRC RES, V108, P1328, DOI 10.1161/CIRCRESAHA.110.235689; Ramnath R, 2014, FASEB J, V28, P4686, DOI 10.1096/fj.14-252221; Xie J, 2012, J MOL CELL CARDIOL, V53, P250, DOI 10.1016/j.yjmcc.2012.04.014; Tanino Y, 2002, AM J PHYSIOL-LUNG C, V283, pL156, DOI 10.1152/ajplung.00155.2001; Echtermeyer F, 2001, J CLIN INVEST, V107, pR9, DOI 10.1172/JCI10559; Kaneider NC, 2001, BIOCHEM BIOPH RES CO, V287, P42, DOI 10.1006/bbrc.2001.5534; Celie JWAM, 2009, FRONT BIOSCI-LANDMRK, V14, P4932, DOI 10.2741/3578; Wang XT, 2008, AM J IND MED, V51, P548, DOI 10.1002/ajim.20587; Hagiwara S, 2008, CRIT CARE, V12, DOI 10.1186/cc6851; Iba T, 2008, CRIT CARE, V12, DOI 10.1186/cc6943; Kono S, 2013, RESPIRATION, V85, P27; Severin IC, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00293; Tan Xiahui, 2012, Am J Physiol Lung Cell Mol Physiol, V302, pL700, DOI 10.1152/ajplung.00167.2011; World Health Organization, TOP 10 CAUSES DEATH	46	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-1899	1537-6613		J INFECT DIS	J. Infect. Dis.	NOV 1	2015	212	9					1500	1508		10.1093/infdis/jiv234		9	Immunology; Infectious Diseases; Microbiology	Immunology; Infectious Diseases; Microbiology	CW1QX	WOS:000364767500019		
J	Fujii, T; Yamamoto, M; Nakano, R; Nirazawa, T; Rong, Y; Dong, SL; Ishikawa, Y				Fujii, Takeshi; Yamamoto, Masanobu; Nakano, Ryo; Nirazawa, Takuya; Rong, Yu; Dong, Shuang-Lin; Ishikawa, Yukio			Alkenyl sex pheromone analogs in the hemolymph of an arctiid Eilema japonica and several non-arctiid moths	JOURNAL OF INSECT PHYSIOLOGY			English	Article						Eilema japonica; Type-I and type-II sex pheromones; Hemolymph	JAPANESE GIANT LOOPER; LICHEN MOTH; ASCOTIS-SELENARIA; BORER MOTH; HYDROCARBONS; EPOXIDATION; TRANSPORT; IDENTIFICATION; BIOSYNTHESIS; LEPIDOPTERA	The majority of moth species utilize compounds derived from de novo synthesized fatty acids as their sex pheromones (type I). In contrast, species belonging to two recently diverged moth families, Arctiidae and Geometridae, utilize alkenes and their epoxides, which are derived from dietary essential fatty acids (EFAs), as their sex pheromones (type II). In the latter species, EFAs are considered to be converted into alkenes, often after chain elongation, in specialized cells called oenocytes. These alkenes are transported through the hemolymph to the pheromone gland, from which they are secreted with or without further modifications. We confirmed that the appearance of EFA-derived alkenes in the hemolymph was closely associated with the completion of pheromone gland formation in an arctiid moth Eilema japonica. Analyses of the hemolymph of several moth species utilizing type-I sex pheromones demonstrated the occurrence of (ZZZ)-3,6,9-tricosatriene (T23), a typical type-II component, in the hemolymph of a noctuid Mamestra brassicae and two crambids Ostrinia furnacalis and Ostrinia scapulalis. Our results demonstrated that moths utilizing type-I pheromones have the ability to synthesize type-II sex pheromones, and suggested that recently diverged groups of moths may have secondarily exploited EFA-derived alkenes as sex pheromones. (C) 2015 Elsevier Ltd. All rights reserved.	[Fujii, Takeshi; Yamamoto, Masanobu; Nakano, Ryo; Nirazawa, Takuya; Rong, Yu; Ishikawa, Yukio] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan; [Dong, Shuang-Lin] Nanjing Agr Univ, Coll Plant Protect, Nanjing 210095, Jiangsu, Peoples R China	Fujii, T (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan.	takeshi.f0405@gmail.com			JSPS KAKENHI [23248008]	This work was supported by JSPS KAKENHI Grant Number 23248008 to Y.I.	Cabrera A, 2001, J CHEM ECOL, V27, P2097, DOI 10.1023/A:1012299021967; Gibb AR, 2007, J CHEM ECOL, V33, P579, DOI 10.1007/s10886-006-9221-x; Miyamoto T, 1999, INSECT BIOCHEM MOLEC, V29, P63, DOI 10.1016/S0965-1748(98)00105-2; Takanashi T, 2005, BIOL J LINN SOC, V84, P143, DOI 10.1111/j.1095-8312.2005.00421.x; Fujii T, 2007, J INSECT PHYSIOL, V53, P312, DOI 10.1016/j.jinsphys.2006.12.005; Fujii T, 2010, J INSECT PHYSIOL, V56, P1986, DOI 10.1016/j.jinsphys.2010.08.024; Qian SG, 2011, INSECT BIOCHEM MOLEC, V41, P22, DOI 10.1016/j.ibmb.2010.09.008; Rong Y, 2014, INSECT BIOCHEM MOLEC, V54, P122, DOI 10.1016/j.ibmb.2014.09.009; Jurenka R, 2004, TOP CURR CHEM, V239, P97, DOI 10.1007/b95450; Millar JG, 2000, ANNU REV ENTOMOL, V45, P575, DOI 10.1146/annurev.ento.45.1.575; Namiki S, 2012, NEUROREPORT, V23, P857, DOI 10.1097/WNR.0b013e3283582007; Schal C, 1998, NATURWISSENSCHAFTEN, V85, P339, DOI 10.1007/s001140050511; Ando T, 2004, TOP CURR CHEM, V239, P51, DOI 10.1007/b95449; Matsuoka K, 2006, INSECT BIOCHEM MOLEC, V36, P576, DOI 10.1016/j.ibmb.2006.04.006; Yan Q, 2014, J CHEM ECOL, V40, P590, DOI 10.1007/s10886-014-0446-9; Xiao W, 2012, J CHEM ECOL, V38, P1143, DOI 10.1007/s10886-012-0176-9; El-Sayed AM, 2013, CHEMOECOLOGY, V23, P93, DOI 10.1007/s00049-012-0123-9; Millar JG, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P390, DOI 10.1017/CBO9780511711909.019; Wei W, 2003, INSECT BIOCHEM MOLEC, V33, P397, DOI 10.1016/S0965-1748(03)00002-X; Wei W, 2004, INSECT BIOCHEM MOLEC, V34, P1215, DOI 10.1016/j.ibmb.2004.08.004; Fujii T, 2013, BIOCHEM BIOPH RES CO, V441, P849, DOI 10.1016/j.bbrc.2013.10.143; Chino H., 1985, COMPREHENSIVE INSECT, V10, P115; Daimon T., 2012, J INSECT SCI, V12, P1, DOI DOI 10.1673/031.012.4901; Nakano R, 2013, SCI REP-UK, V3, DOI 10.1038/srep02003; Romer F, 1991, OENOCYTE INSECTS DIF, P542	25	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-1910	1879-1611		J INSECT PHYSIOL	J. Insect Physiol.	NOV	2015	82						109	113		10.1016/j.jinsphys.2015.09.006		5	Entomology; Physiology; Zoology	Entomology; Physiology; Zoology	CW5RJ	WOS:000365054000014		
J	Robertson, AJ; Pandey, MK; Marsh, A; Nishiyama, Y; Brown, SP				Robertson, Aiden J.; Pandey, Manoj Kumar; Marsh, Andrew; Nishiyama, Yusuke; Brown, Steven P.			The use of a selective saturation pulse to suppress t(1) noise in two-dimensional H-1 fast magic angle spinning solid-state NMR spectroscopy	JOURNAL OF MAGNETIC RESONANCE			English	Article						H-1 two-dimensional solid-state NMR; DNA based analogue; Selective saturation pulse; t(1) noise; Fast MAS	HIGH-RESOLUTION H-1; NUCLEAR-MAGNETIC-RESONANCE; CHEMICAL-SHIFT STANDARDS; X-RAY-DIFFRACTION; 100 KHZ MAS; H-1-NMR SPECTROSCOPY; DOUBLE-QUANTUM; INTERMOLECULAR INTERACTIONS; SOLVENT SUPPRESSION; HYDROGEN-BOND	A selective saturation pulse at fast magic angle spinning (MAS) frequencies (60+ kHz) suppresses t(1) noise in the indirect dimension of two-dimensional H-1 MAS NMR spectra. The method is applied to a synthetic nucleoside with an intense methyl H-1 signal due to triisopropylsilyl (TIPS) protecting groups. Enhanced performance in terms of suppressing the methyl signal while minimising the loss of signal intensity of nearby resonances of interest relies on reducing spin diffusion - this is quantified by comparing two-dimensional H-1 NOESY-like spin diffusion spectra recorded at 30-70 kHz MAS. For a saturation pulse centred at the methyl resonance, the effect of changing the nutation frequency at different MAS frequencies as well as the effect of changing the pulse duration is investigated. By applying a pulse of duration 30 ms and nutation frequency 725 Hz at 70 kHz MAS, a good compromise of significant suppression of the methyl resonance combined with the signal intensity of resonances greater than 5 ppm away from the methyl resonance being largely unaffected is achieved. The effectiveness of using a selective saturation pulse is demonstrated for both homonuclear H-1-H-1 double quantum (DQ)/single quantum (SQ) MAS and N-14-H-1 heteronuclear multiple quantum coherence (HMQC) two-dimensional solid-state NMR experiments. (C) 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).	[Robertson, Aiden J.; Brown, Steven P.] Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England; [Robertson, Aiden J.; Marsh, Andrew] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England; [Pandey, Manoj Kumar; Nishiyama, Yusuke] RIKEN CLST JEOL Collaborat Ctr, Yokohama, Kanagawa 2300045, Japan; [Nishiyama, Yusuke] JEOL RESONANCE Inc, Akishima, Tokyo 1968558, Japan	Brown, SP (reprint author), Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England.	S.P.Brown@warwick.ac.uk	Brown, Steven/F-8765-2014	Brown, Steven/0000-0003-2069-8496	EPSRC	We thank EPSRC for funding (PhD studentship to AJR). We also thank scientists from JEOL resonance for their help with the 1.0 mm fast MAS probe. Helpful discussions with Matthias Ernst (ETH Zurich) concerning rf-driven spin diffusion are acknowledged. All experimental NMR data for this study are provided as a supporting dataset from WRAP, the Warwick Research Archive Portal at http://wrap.warwick.ac.uk/71829.	Agarwal V, 2014, ANGEW CHEM INT EDIT, V53, P12253, DOI 10.1002/anie.201405730; Maruyoshi K, 2012, CHEM COMMUN, V48, P10844, DOI 10.1039/c2cc36094b; Cademartiri L, 2015, NAT MATER, V14, P2, DOI 10.1038/nmat4184; HAYASHI S, 1991, B CHEM SOC JPN, V64, P685, DOI 10.1246/bcsj.64.685; Steiner T, 2002, ANGEW CHEM INT EDIT, V41, P48, DOI 10.1002/1521-3773(20020104)41:1<48::AID-ANIE48>3.0.CO;2-U; MORRIS GA, 1978, J MAGN RESON, V29, P433, DOI 10.1016/0022-2364(78)90003-3; Schaller T, 2007, J AM CHEM SOC, V129, P1293, DOI 10.1021/ja0666351; Schnell I, 2001, J MAGN RESON, V151, P153, DOI 10.1006/jmre.2001.2336; Pileio G, 2008, CHEM PHYS LETT, V456, P116, DOI 10.1016/j.cplett.2008.03.021; Shimada J, 2012, CHEM COMMUN, V48, P6226, DOI 10.1039/c2cc30618b; Chevelkov V, 2003, J AM CHEM SOC, V125, P7788, DOI 10.1021/ja029354b; Brinkmann A, 2006, J AM CHEM SOC, V128, P14758, DOI 10.1021/ja065415k; EMSLEY L, 1990, J MAGN RESON, V90, P214, DOI 10.1016/0022-2364(90)90381-I; Carignani E, 2013, J PHYS CHEM C, V117, P17731, DOI 10.1021/jp4044946; Torring T, 2011, CHEM SOC REV, V40, P5636, DOI 10.1039/c1cs15057j; Xu J, 2015, CHEM MATER, V27, P3306, DOI 10.1021/acs.chemmater.5b00360; Samoson A, 2001, SOLID STATE NUCL MAG, V20, P130, DOI 10.1006/snmr.2001.0037; Fischbach I, 2003, J MAGN RESON, V165, P102, DOI 10.1016/j.jmr.2003.07.002; Schnell I, 1998, J AM CHEM SOC, V120, P11784, DOI 10.1021/ja982766t; Kuzyk A, 2012, NATURE, V483, P311, DOI 10.1038/nature10889; Cadars S, 2006, J PHYS CHEM B, V110, P16982, DOI 10.1021/jp062920v; Granwehr J, 2007, APPL MAGN RESON, V32, P113, DOI 10.1007/s00723-007-0006-3; Tatton AS, 2012, Z PHYS CHEM, V226, P1187, DOI 10.1524/zpch.2012.0308; Baias M, 2015, ANGEW CHEM INT EDIT, V54, P5971, DOI 10.1002/anie.201500518; Brown SP, 2012, SOLID STATE NUCL MAG, V41, P1, DOI 10.1016/j.ssnmr.2011.11.006; Mifsud N, 2006, PHYS CHEM CHEM PHYS, V8, P3418, DOI 10.1039/b605227d; Pham TN, 2010, MOL PHARMACEUT, V7, P1667, DOI 10.1021/mp100205g; HAYASHI S, 1991, B CHEM SOC JPN, V64, P688, DOI 10.1246/bcsj.64.688; Cutajar M, 2007, CHEM PHYS LETT, V449, P86, DOI 10.1016/j.cplett.2007.10.021; BODENHAUSEN G, 1976, J MAGN RESON, V23, P171, DOI 10.1016/0022-2364(76)90150-5; Griffin JM, 2007, ANGEW CHEM INT EDIT, V46, P8036, DOI 10.1002/anie.200702582; Dudenko DV, 2013, J PHYS CHEM C, V117, P12258, DOI 10.1021/jp4041106; Khan M, 2010, J AM CHEM SOC, V132, P5254, DOI 10.1021/ja100146f; Brissac C, 1995, J BIOMOL NMR, V6, P361, DOI 10.1007/BF00197635; Paulson EK, 2003, J AM CHEM SOC, V125, P15831, DOI 10.1021/ja037315+; Cavadini S, 2006, J MAGN RESON, V182, P168, DOI 10.1016/j.jmr.2006.06.003; Li YL, 2015, J AM CHEM SOC, V137, P4320, DOI 10.1021/jacs.5b01196; Ishii Y, 2001, J AM CHEM SOC, V123, P2921, DOI 10.1021/ja015505j; GIBBS A, 1993, J MAGN RESON SER A, V101, P351, DOI 10.1006/jmra.1993.1058; Lesage A, 2009, PHYS CHEM CHEM PHYS, V11, P6876, DOI 10.1039/b907733m; ROBYR P, 1989, CHEM PHYS LETT, V162, P417, DOI 10.1016/0009-2614(89)87001-0; Reddy GNM, 2015, SOLID STATE NUCL MAG, V65, P41, DOI 10.1016/j.ssnmr.2015.01.001; Harris RK, 2008, PURE APPL CHEM, V80, P59, DOI 10.1351/pac200880010059; Metzroth T, 2011, CHEM SCI, V2, P69, DOI 10.1039/c0sc00292e; Dumez JN, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3505455; Brinkmann A, 2007, MAGN RESON CHEM, V45, pS231, DOI 10.1002/mrc.2159; Vogt FG, 2009, CRYST GROWTH DES, V9, P921, DOI 10.1021/cg8007014; Tatton AS, 2013, MOL PHARMACEUT, V10, P999, DOI 10.1021/mp300423r; Lamley JM, 2014, J AM CHEM SOC, V136, P16800, DOI 10.1021/ja5069992; Kweon JJ, 2015, J PHYS CHEM C, V119, P5013, DOI 10.1021/jp512127x; Mafra L, 2012, J AM CHEM SOC, V134, P71, DOI 10.1021/ja208647n; SOMMER W, 1995, J MAGN RESON SER A, V113, P131, DOI 10.1006/jmra.1995.1068; Bradley JP, 2011, CRYST GROWTH DES, V11, P3463, DOI 10.1021/cg200277a; Sardo M, 2015, SOLID STATE NUCL MAG, V65, P49, DOI 10.1016/j.ssnmr.2014.12.005; Tatton AS, 2012, CRYSTENGCOMM, V14, P2654, DOI 10.1039/c2ce06547a; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Fritzsche M, 2011, ANGEW CHEM INT EDIT, V50, P3030, DOI 10.1002/anie.201007437; Poulding S, 2007, J MAGN RESON, V189, P190, DOI 10.1016/j.jmr.2007.09.004; Schnell I, 1998, J MAGN RESON, V133, P61, DOI 10.1006/jmre.1998.1432; Saalwachter K, 2011, J MAGN RESON, V212, P204, DOI 10.1016/j.jmr.2011.07.001; Brown SP, 2001, CHEM REV, V101, P4125, DOI 10.1021/cr990132e; Peters GM, 2015, J AM CHEM SOC, V137, P5819, DOI 10.1021/jacs.5b02753; Zorin VE, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2357602; Kobayashi T, 2013, ANGEW CHEM INT EDIT, V52, P14108, DOI 10.1002/anie.201305475; Salager E, 2009, PHYS CHEM CHEM PHYS, V11, P2610, DOI 10.1039/b821018g; Nishiyama Y, 2011, J MAGN RESON, V208, P44, DOI 10.1016/j.jmr.2010.10.001; Lewandowski JR, 2011, J PHYS CHEM LETT, V2, P2205, DOI 10.1021/jz200844n; Baias M, 2013, PHYS CHEM CHEM PHYS, V15, P8069, DOI 10.1039/c3cp41095a; Zhang YG, 2013, NAT NANOTECHNOL, V8, P865, DOI [10.1038/nnano.2013.209, 10.1038/NNANO.2013.209]; Gan ZH, 2007, CHEM PHYS LETT, V435, P163, DOI 10.1016/j.cplett.2006.12.066; Brown SP, 2007, PROG NUCL MAG RES SP, V50, P199, DOI 10.1016/j.pnmrs.2006.10.002; MARION D, 1989, J MAGN RESON, V85, P393, DOI 10.1016/0022-2364(89)90152-2; Zhou DH, 2008, J MAGN RESON, V192, P167, DOI 10.1016/j.jmr.2008.01.012; Cavadini S, 2010, PROG NUCL MAG RES SP, V56, P46, DOI 10.1016/j.pnmrs.2009.08.001; Albert SK, 2014, ANGEW CHEM INT EDIT, V53, P8352, DOI 10.1002/anie.201403455; Hu B, 2009, J MAGN RESON, V198, P41, DOI 10.1016/j.jmr.2009.01.002; Webber AL, 2011, J AM CHEM SOC, V133, P19777, DOI 10.1021/ja206516u; Li J, 2015, J AM CHEM SOC, V137, P1412, DOI [10.1021/ja512293f, 10.1021/ja5122931]; Zhao MQ, 2014, NANOSCALE, V6, P9339, DOI 10.1039/c4nr00271g; FREEMAN R, 1991, CHEM REV, V91, P1397, DOI 10.1021/cr00007a006; Chierotti MR, 2013, CRYSTENGCOMM, V15, P8599, DOI 10.1039/c3ce41026a; Marsh A, 2003, TETRAHEDRON, V59, P5595, DOI 10.1016/S0040-4020(03)00708-7; HUNTER CA, 1990, J AM CHEM SOC, V112, P5525, DOI 10.1021/ja00170a016; Martin GE, 2000, J NAT PROD, V63, P543, DOI 10.1021/np9903191; GEEN H, 1994, CHEM PHYS LETT, V227, P79, DOI 10.1016/0009-2614(94)00789-6; Desiraju GR, 2007, ANGEW CHEM INT EDIT, V46, P8342, DOI 10.1002/anie.200700534; Miao XJ, 1996, J MAGN RESON SER A, V119, P90, DOI 10.1006/jmra.1996.0055; Tian C., 2014, ANGEW CHEM, V126, P8179	88	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1090-7807	1096-0856		J MAGN RESON	J. Magn. Reson.	NOV	2015	260						89	97		10.1016/j.jmr.2015.09.005		9	Biochemical Research Methods; Physics, Atomic, Molecular & Chemical; Spectroscopy	Biochemistry & Molecular Biology; Physics; Spectroscopy	CW4SK	WOS:000364982200011		
J	Tsunoda, T; Chaves, LF; Nguyen, GTT; Nguyen, YT; Takagi, M				Tsunoda, Takashi; Fernando Chaves, Luis; Giang Thi Tra Nguyen; Yen Thi Nguyen; Takagi, Masahiro			Winter Activity and Diapause of Aedes albopictus (Diptera: Culicidae) in Hanoi, Northern Vietnam	JOURNAL OF MEDICAL ENTOMOLOGY			English	Article						bet hedging; photoperiod; subtropic; hatchability	GOLDENROD GALL FLY; OVERWINTERING SURVIVAL; EUROSTA-SOLIDAGINIS; POTENTIAL FECUNDITY; EGGS; OVIPOSITION; STRATEGIES; DORMANCY; AEGYPTI; STORAGE	We studied the winter activity of Aedes albopictus (Skuse) from November 2008 to April 2009 in Bat Trang village of Hanoi, Vietnam. We selected 12 houses and collected: 1) adults with BG sentinel traps, 2) pupae from household water containers, and 3) eggs with ovitraps. Aedes albopictus adults, pupae, and eggs were not collected from early January to early February. Though the egg hatching probability tended to be initially high at longer day length, the maximum probability gradually shifted to shorter day length, as the observation period elapsed. When females were reared under long day length and their eggs were immersed 1 or 5 wk after oviposition, >50% of eggs hatched within 20 days. However, when females were reared under short day length and their eggs were immersed after 1 wk, hatching was suppressed for 60 days. When females were reared under short day length, the median hatching day occurred earlier in eggs kept dry for 5 and 10 wk after oviposition than in those dried for only 1 wk. This indicates that the extended dry periods accelerate egg hatching. Our results showed that hatchability gradually changed with day length, suggesting that selection for overwintering is not as strong relative to Ae. albopictus living in the temperate zone, where winter conditions are less favorable than in tropical and subtropical areas.	[Tsunoda, Takashi; Fernando Chaves, Luis; Takagi, Masahiro] Nagasaki Univ, Inst Trop Med NEKKEN, Dept Vector Ecol & Environm, Nagasaki 8528523, Japan; [Fernando Chaves, Luis] Univ Nacl, Escuela Med Vet, PIET, Heredia, Costa Rica; [Giang Thi Tra Nguyen; Yen Thi Nguyen] Natl Inst Hyg & Epidemiol, Dept Med Entomol & Zool, Hanoi, Vietnam	Tsunoda, T (reprint author), Nagasaki Univ, Inst Trop Med NEKKEN, Dept Vector Ecol & Environm, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.	tsunoda@nagasaki-u.ac.jp			Nagasaki University (Program for Nurturing Global Leaders in Tropical and Emerging Communicable Diseases); Center for Infectious Disease Research in Asia and Africa, Vietnam Research Station, Nagasaki University; Program of Japan Initiative for Global Research Network on Infectious Diseases (J-GRID), MEXT, Japan	K. Tanaka (Ecological Laboratory, General Education, Miyagi Gakuin Women's College) provided stimulating discussion on many topics. We appreciate N. Minakawa (Department of Vector Ecology and Environment, Institute of Tropical Medicine, Nagasaki University) for various suggestions. We are very grateful to the Public Health Center staff in Bat Trang commune, Hanoi, for support of mosquito collection in the field. L.F.C. was funded by Nagasaki University (Program for Nurturing Global Leaders in Tropical and Emerging Communicable Diseases). This work was supported by the Center for Infectious Disease Research in Asia and Africa, Vietnam Research Station, Nagasaki University, and the Program of Japan Initiative for Global Research Network on Infectious Diseases (J-GRID), MEXT, Japan.	FONTES EG, 1995, J ECON ENTOMOL, V88, P1256; Higa Yukiko, 2007, Medical Entomology and Zoology, V58, P1; Ripa J, 2010, P ROY SOC B-BIOL SCI, V277, P1153, DOI 10.1098/rspb.2009.2023; Evans MEK, 2005, Q REV BIOL, V80, P431, DOI 10.1086/498282; HAWLEY WA, 1989, J MED ENTOMOL, V26, P122; GROETERS FR, 1994, ECOGRAPHY, V17, P221, DOI 10.1111/j.1600-0587.1994.tb00097.x; Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395; BRADFORD MJ, 1993, ECOLOGY, V74, P1129, DOI 10.2307/1940482; DENLINGER DL, 1986, ANNU REV ENTOMOL, V31, P239; Irwin JT, 2000, J INSECT PHYSIOL, V46, P655, DOI 10.1016/S0022-1910(99)00153-5; Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206; Denlinger DL, 2014, ANNU REV ENTOMOL, V59, P73, DOI 10.1146/annurev-ento-011613-162023; HAWLEY WA, 1987, SCIENCE, V236, P1114, DOI 10.1126/science.3576225; COHEN D, 1970, AM NAT, V104, P389, DOI 10.1086/282672; Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814; Khatchikian CE, 2010, EVOL ECOL, V24, P1159, DOI 10.1007/s10682-010-9359-4; Hahn DA, 2007, J INSECT PHYSIOL, V53, P760, DOI 10.1016/j.jinsphys.2007.03.018; Knox TB, 2007, J MED ENTOMOL, V44, P192, DOI 10.1603/0022-2585(2007)44[192:CEOQSM]2.0.CO;2; PHILIPPI T, 1989, TRENDS ECOL EVOL, V4, P41, DOI 10.1016/0169-5347(89)90138-9; LIVDAHL TP, 1979, AM NAT, V113, P835, DOI 10.1086/283439; Reiter P, 2006, LANCET INFECT DIS, V6, P463, DOI 10.1016/S1473-3099(06)70531-X; Hopper KR, 1999, ANNU REV ENTOMOL, V44, P535, DOI 10.1146/annurev.ento.44.1.535; Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003; Irwin JT, 2003, OIKOS, V100, P71, DOI 10.1034/j.1600-0706.2003.11738.x; WALKER TJ, 1980, OECOLOGIA, V47, P291, DOI 10.1007/BF00398519; Chen C. S., 1988, YUSHANIA, V5, P1; Christophers S.R, 1960, AEDES AEGYPTI L YELL; COHEN D, 1966, J THEOR BIOL, V12, P119, DOI 10.1016/0022-5193(66)90188-3; Faraway J. J., 2006, EXTENDING LINEAR MOD; Lees A. D., 1968, PHOTOPHYSIOLOGY, P47; Levins R, 1968, EVOLUTION CHANGING E; Mangel M, 2006, THEORETICAL BIOLOGIST'S TOOLBOX: QUANTITATIVE METHODS FOR ECOLOGY AND EVOLUTIONARY BIOLOGY, P1, DOI 10.2277/ 0521537487; Morales V. R. E., 2013, INFECT GENET EVOL, V13, P242; MORI A, 1978, Tropical Medicine, V20, P29; MORI A, 1981, Tropical Medicine, V23, P79; Seger J., 1987, Oxford Surveys in Evolutionary Biology, V4, P182; SMITH C E G, 1956, J Trop Med Hyg, V59, P243; Stojanovich C. J., 1966, ILLUSTRATED KEY MOSQ; Suwonkerd Wannapa, 1996, Tropical Medicine, V38, P101; Tsunoda T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095606; Venables W. N., 2002, MODERN APPL STAT S; Weatherbase, 2013, WEATH HAN VIETN TRAV	42	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-2585	1938-2928		J MED ENTOMOL	J. Med. Entomol.	NOV	2015	52	6					1203	1212		10.1093/jme/tjv122		10	Entomology; Veterinary Sciences	Entomology; Veterinary Sciences	CW7SH	WOS:000365199000003		
J	Oshiro, S; Tada, T; Kameoka, Y; Suzuki, K; Ohmagari, N; Miyoshi-Akiyama, T; Kirikae, T				Oshiro, Satoshi; Tada, Tatsuya; Kameoka, Yousuke; Suzuki, Kazuo; Ohmagari, Norio; Miyoshi-Akiyama, Tohru; Kirikae, Teruo			Development and evaluation of immunochromatography to detect Gram-negative bacteria producing ArmA 16S rRNA methylase responsible for aminoglycoside resistance	JOURNAL OF MICROBIOLOGICAL METHODS			English	Article						Immunochromatography; ArmA; 16S rRNA methylase; Rapid test; Aminoglycoside resistance	HIGH-LEVEL RESISTANCE; PSEUDOMONAS-AERUGINOSA; METHYLTRANSFERASE; ISOLATE; RMTF	Rapid and reliable detection of aminoglycoside-resistant bacteria is an important infection-control measure and a crucial aspect of antimicrobial chemotherapy. The enzyme 16S rRNA methylase has been shown to mediate aminoglycoside resistance in bacteria. This study describes a newly developed immunochromatographic assay using novel monoclonal antibodies (mAbs) that recognize ArmA 16S rRNA methylase. Epitope mapping showed that these mAbs recognized amino acids 1-93 of ArmA, which consists of 257 amino acids. Evaluation of the assay using ArmA producing and non-producing bacterial species, as well as bacteria producing other types of 16S rRNA methylases, indicated that immunochromatographic detection of the ArmA-type 16S rRNA methylase was fully consistent with PCR analysis for armA genes, with all immunochromatographically positive strains being resistant to aminoglycosides (MIC >= 128 mu g/mL). The detection limit of the assay was 12 ng ArmA. These findings indicate that this assay can be used for the rapid and reliable detection of the production of ArmA 16S rRNA methylase by Gram-negative bacteria, including Acinetobacter baumannii and Escherichia coli. (C) 2015 Elsevier B.V. All rights reserved.	[Oshiro, Satoshi; Miyoshi-Akiyama, Tohru] Natl Ctr Global Hlth & Med, Res Inst, Pathogen Microbe Lab, Shinjuku Ku, Tokyo 1628655, Japan; [Tada, Tatsuya; Kirikae, Teruo] Natl Ctr Global Hlth & Med, Res Inst, Dept Infect Dis, Shinjuku Ku, Tokyo 1628655, Japan; [Kameoka, Yousuke; Suzuki, Kazuo] A CLIP Inst, Chio Ku, Chiba 2600856, Japan; [Ohmagari, Norio] Natl Ctr Global Hlth & Med, Dis Control & Prevent Ctr, Shinjuku Ku, Tokyo 1628655, Japan	Miyoshi-Akiyama, T (reprint author), Natl Ctr Global Hlth & Med, Res Inst, Pathogen Microbe Lab, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	takiyam@ri.ncgm.go.jp			Japan Agency for Medical Research and Development (J-GRID); JSPS [15H05280]; Grant for International Health Research from the Ministry of Health, Labour and Welfare of Japan [27A-3]	This study was supported by a grant from the Japan Agency for Medical Research and Development (J-GRID). Teruo Kirikae was supported by JSPS KAKENHI Grant Number 15H05280. Tatsuya Tada was supported by a Grant for International Health Research (27A-3) from the Ministry of Health, Labour and Welfare of Japan. We thank Mrs. Mayumi Komiya and Mrs. Nobuko Saito for preparation of the antibodies and Mrs. Kayo Shimada for testing the kits.	KISHIRO Y, 1995, CELL STRUCT FUNCT, V20, P151; Doi Y, 2007, ANTIMICROB AGENTS CH, V51, P852, DOI 10.1128/AAC.01345-06; Galimand M, 2003, ANTIMICROB AGENTS CH, V47, P2565, DOI 10.1128/AAC.47.8.2565-2571.2003; Davis MA, 2010, ANTIMICROB AGENTS CH, V54, P2666, DOI 10.1128/AAC.01743-09; Galimand M, 2012, ANTIMICROB AGENTS CH, V56, P3960, DOI 10.1128/AAC.00660-12; Wachino JI, 2006, ANTIMICROB AGENTS CH, V50, P178, DOI 10.1128/AAC.50.1.178-184.2006; Doi Y, 2004, ANTIMICROB AGENTS CH, V48, P491, DOI 10.1128/AAC.48.2.491-496.2004; Hatakeyama S, 2008, VIROLOGY, V380, P99, DOI 10.1016/j.virol.2008.07.012; Wachino JI, 2007, ANTIMICROB AGENTS CH, V51, P4401, DOI 10.1128/AAC.00926-07; Kitao T, 2010, J ANTIMICROB CHEMOTH, V65, P1382, DOI 10.1093/jac/dkq148; Tada T, 2013, INT J ANTIMICROB AG, V42, P372, DOI 10.1016/j.ijantimicag.2013.06.014; Yokoyama K, 2003, LANCET, V362, P1888, DOI 10.1016/S0140-6736(03)14959-8; Doi Y, 2007, CLIN INFECT DIS, V45, P88, DOI 10.1086/518605; Hidalgo J., 2013, J ANTIMICROB CHEMOTH, V68, P1543; Tada T, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-251	15	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-7012	1872-8359		J MICROBIOL METH	J. Microbiol. Methods	NOV	2015	118						159	163		10.1016/j.mimet.2015.09.005		5	Biochemical Research Methods; Microbiology	Biochemistry & Molecular Biology; Microbiology	CW3KX	WOS:000364892300026		
J	Hayano, S; Takefuji, M; Maeda, K; Noda, T; Ichimiya, H; Kobayashi, K; Enomoto, A; Asai, N; Takahashi, M; Murohara, T				Hayano, Shinji; Takefuji, Mikito; Maeda, Kengo; Noda, Tomonori; Ichimiya, Hitoshi; Kobayashi, Koichi; Enomoto, Atsushi; Asai, Naoya; Takahashi, Masahide; Murohara, Toyoaki			Akt-dependent Girdin phosphorylation regulates repair processes after acute myocardial infarction	JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY			English	Article						Girdin; Akt; Cardiac fibroblast; Myocardial infarction; Cardiac tissue rupture	ACTIN-BINDING PROTEIN; CARDIAC FIBROBLASTS; SIGNALING PATHWAYS; PI3K/AKT PATHWAY; ANGIOTENSIN-II; HEART-FAILURE; CELL; RUPTURE; AKT/PKB; CANCER	Myocardial infarction is a leading cause of death, and cardiac rupture following myocardial infarction leads to extremely poor prognostic feature. A large body of evidence suggests that Akt is involved in several cardiac diseases. We previously reported that Akt-mediated Girdin phosphorylation is essential for angiogenesis and neointima formation. The role of Girdin expression and phosphorylation in myocardial infarction, however, is not understood. Therefore, we employed Girdin-deficient mice and Girdin S1416A knock-in (Girdin(SA/SA)) mice, replacing the Akt phosphorylation site with alanine, to address this question. We found that Girdin was expressed and phosphorylated in cardiac fibroblasts in vitro and that its phosphorylation was crucial for the proliferation and migration of cardiac fibroblasts. In vivo, Girdin was localized in non-cardiomyocyte interstitial cells and phosphorylated in a-smooth muscle actin-positive cells, which are likely to be cardiac myofibroblasts. In an acute myocardial infarction model, Girdin(SA/SA) suppressed the accumulation and proliferation of cardiac myofibroblasts in the infarcted area. Furthermore, lower collagen deposition in Girdin(SA/SA) mice impaired cardiac repair and resulted in increased mortality attributed to cardiac rupture. These findings suggest an important role of Girdin phosphorylation at serine 1416 in cardiac repair after acute myocardial infarction and provide insights into the complex mechanism of cardiac rupture through the Akt/Girdin-mediated regulation of cardiac myofibroblasts. (C) 2015 Elsevier Ltd. All rights reserved.	[Hayano, Shinji; Takefuji, Mikito; Maeda, Kengo; Noda, Tomonori; Ichimiya, Hitoshi; Kobayashi, Koichi; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4668550, Japan; [Enomoto, Atsushi; Asai, Naoya; Takahashi, Masahide] Nagoya Univ, Grad Sch Med, Dept Pathol, Nagoya, Aichi 4668550, Japan	Takefuji, M (reprint author), Nagoya Univ, Grad Sch Med, Dept Cardiol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	takefuji@med.nagoya-u.ac.jp	Murohara, Toyoaki/M-4958-2014		Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Foundation for Aging and Health	This work was supported by a Grant-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (M.T. and K.M.) and by Japan Foundation for Aging and Health (M.T.).	Matsusaka H, 2006, CARDIOVASC RES, V70, P457, DOI 10.1016/j.cardiores.2006.02.001; Hofmann U, 2012, AM J PATHOL, V180, P113, DOI 10.1016/j.ajpath.2011.09.033; Sun Y, 2000, CARDIOVASC RES, V46, P250, DOI 10.1016/S0008-6363(00)00032-8; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Gavras H, 2001, HYPERTENSION, V37, P342; Diez C, 2001, CARDIOVASC RES, V49, P731, DOI 10.1016/S0008-6363(00)00296-0; Pouleur AC, 2010, CIRCULATION, V122, P597, DOI 10.1161/CIRCULATIONAHA.110.940619; Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020; Schreiner CE, 2011, CARDIOVASC RES, V90, P140, DOI 10.1093/cvr/cvq355; Kobayashi K, 2009, NAT CELL BIOL, V11, P46, DOI 10.1038/ncb1811; Figueras J, 2008, CIRCULATION, V118, P2783, DOI 10.1161/CIRCULATIONAHA.108.776690; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Chen W, 2013, BBA-MOL CELL RES, V1833, P945, DOI 10.1016/j.bbamcr.2012.08.023; Gao XM, 2005, CARDIOVASC RES, V65, P469, DOI 10.1016/j.cardiores.2004.10.014; Chaanine AH, 2011, EUR J HEART FAIL, V13, P825, DOI 10.1093/eurjhf/hfr080; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; van den Borne SWM, 2009, CARDIOVASC RES, V84, P273, DOI 10.1093/cvr/cvp207; Wang YS, 2014, J MOL CELL CARDIOL, V66, P94, DOI 10.1016/j.yjmcc.2013.08.007; Tamaoki M, 2005, AM J PATHOL, V167, P71, DOI 10.1016/S0002-9440(10)62954-9; Ramachandran V, 2008, CANCER RES, V68, P7811, DOI 10.1158/0008-5472.CAN-08-1320; Mishina H, 2014, CIRC RES, V114, P493, DOI 10.1161/CIRCRESAHA.114.302319; Huynh T, 2009, CIRCULATION, V119, P3101, DOI 10.1161/CIRCULATIONAHA.108.793745; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Miyachi H, 2014, J VASC SURG, V60, P479, DOI 10.1016/j.jvs.2013.06.080; Chung CC, 2014, INT J CARDIOL, V176, P386, DOI 10.1016/j.ijcard.2014.07.077; Kitamura T, 2008, NAT CELL BIOL, V10, P329, DOI 10.1038/ncb1695; Dobaczewski M, 2010, J MOL CELL CARDIOL, V48, P504, DOI 10.1016/j.yjmcc.2009.07.015; Okada M, 2015, EUR J PHARMACOL, V750, P20, DOI 10.1016/j.ejphar.2015.01.019; Shimazaki M, 2008, J EXP MED, V205, P295, DOI 10.1084/jem.20071297; Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809; Korf-Klingebiel M, 2011, CIRCULATION, V123, P504, DOI 10.1161/CIRCULATIONAHA.110.989665; Yamamura Y, 2015, CANCER RES, V75, P813, DOI 10.1158/0008-5472.CAN-14-1317; Enomoto A, 2006, ANN NY ACAD SCI, V1086, P169, DOI 10.1196/annals.1377.016; Miyake H, 2011, CIRC RES, V108, P1170, DOI 10.1161/CIRCRESAHA.110.236174; Aridgides D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057450; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Sanchez I, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5451; Nishioka T., 2010, AM J PHYSIOL-HEART C, V298, P1072; Ohara K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036681; Wang HH, 2015, J AM SOC NEPHROL, V26, P314, DOI 10.1681/ASN.2013090985	41	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0022-2828	1095-8584		J MOL CELL CARDIOL	J. Mol. Cell. Cardiol.	NOV	2015	88						55	63		10.1016/j.yjmcc.2015.09.012		9	Cardiac & Cardiovascular Systems; Cell Biology	Cardiovascular System & Cardiology; Cell Biology	CW5TK	WOS:000365059300005		
J	Meten, M; Bhandary, NP; Yatabe, R				Meten, Matebie; Bhandary, Netra Prakash; Yatabe, Ryuichi			GIS-based frequency ratio and logistic regression modelling for landslide susceptibility mapping of Debre Sina area in central Ethiopia	JOURNAL OF MOUNTAIN SCIENCE			English	Article						Landslide susceptibility; GIS; Frequency Ratio; Logistic Regression; Debre Sina; Ethiopia	HAZARD; VALIDATION; VERIFICATION; APENNINES; BIVARIATE; REGION; TURKEY; SLOPE; SCALE; KOREA	Ethiopia has a mountainous landscape which can be divided into the Northwestern and Southeastern plateaus by the Main Ethiopian Rift and Afar Depression. Debre Sina area is located in Central Ethiopia along the escarpment where landslide problem is frequent due to steep slope, complex geology, rift tectonics, heavy rainfall and seismicity. In order to tackle this problem, preparing a landslide susceptibility map is very important. For this, GIS-based frequency ratio (FR) and logistic regression (LR) models have been applied using landslide inventory and the nine landslide factors (i.e. lithology, land use, distance from river & fault, slope, aspect, elevation, curvature and annual rainfall). Database construction, weighting each factor classes or factors, preparing susceptibility map and validation were the major steps to be undertaken. Both models require a rasterized landslide inventory and landslide factor maps. The former was classified into training and validation landslides. Using FR model, weights for each factor classes were calculated and assigned so that all the weighted factor maps can be added to produce a landslide susceptibility map. In the case of LR model, the entire study area is firstly divided into landslide and non-landslide areas using the training landslides. Then, these areas are changed into landslide and non-landslide points so as to extract the FR maps of the nine landslide factors. Then a linear relationship is established between training landslides and landslide factors in SPSS. Based on this relationship, the final landslide susceptibility map is prepared using LR equation. The success-rate and prediction-rate of FR model were 74.8% and 73.5%, while in case of LR model these were 75.7% and 74.5% respectively. A close similarity in the prediction and validation rates showed that the model is acceptable. Accuracy of LR model is slightly better in predicting the landslide susceptibility of the area compared to FR model.	[Meten, Matebie; Bhandary, Netra Prakash; Yatabe, Ryuichi] Ehime Univ, Grad Sch Sci & Engn, Geodisaster Res Lab, Matsuyama, Ehime 7908577, Japan	Meten, M (reprint author), Ehime Univ, Grad Sch Sci & Engn, Geodisaster Res Lab, 3 Bunkyo, Matsuyama, Ehime 7908577, Japan.	matebe21@gmail.com; netra@ehime-u.ac.jp; yatabe@cee.ehime-u.ac.jp			Japanese Government for Scholarship through Ministry of Education, culture, Science & Technology (MEXT)	The first author would like to thank the Japanese Government for the Scholarship grant through the Ministry of Education, culture, Science & Technology (MEXT). We express our deep gratitude to Prof. Ranjan Kumar Dahal, Dr. Ngadisih Asih and Dr. Manita Timilsina for their support and suggestions during the initial phase of this research.	Abay A, 2012, J EARTH SCI ENG, V2, P133; Alkhasawneh MS, 2013, SCI WORLD J, DOI 10.1155/2013/415023; Allison PD, 2001, LOGISTIC REGRESSION, P28; Gerscovich DMS, 2006, ENG GEOL, V88, P23, DOI 10.1016/j.enggeo.2006.07.008; Chung CJF, 2003, NAT HAZARDS, V30, P451, DOI 10.1023/B:NHAZ.0000007172.62651.2b; Yilmaz I, 2009, COMPUT GEOSCI-UK, V35, P1125, DOI 10.1016/j.cageo.2008.08.007; Abebe B, 2010, J AFR EARTH SCI, V56, P131, DOI 10.1016/j.jafrearsci.2009.06.006; [Anonymous], 2007, ENG GEOL; Akgun A, 2007, ENVIRON GEOL, V51, P1377, DOI 10.1007/s00254-006-0435-6; Atkinson PM, 1998, COMPUT GEOSCI-UK, V24, P373, DOI 10.1016/S0098-3004(97)00117-9; Temesgen B, 2001, PHYS CHEM EARTH PT C, V26, P665, DOI 10.1016/S1464-1917(01)00065-4; Lee S, 2006, ENVIRON GEOL, V50, P847, DOI 10.1007/s00254-006-0256-7; Lee S, 2005, ENVIRON GEOL, V47, P982, DOI 10.1007/s00254-005-1228-z; Ohlmacher GC, 2003, ENG GEOL, V69, P331, DOI 10.1016/S0013-7952(03)00069-3; Pradhan AMS, 2014, NAT HAZARDS, V72, P1189, DOI 10.1007/s11069-014-1065-z; Lee S, 2007, LANDSLIDES, V4, P33, DOI 10.1007/s10346-006-0047-y; Bai SB, 2010, GEOMORPHOLOGY, V115, P23, DOI 10.1016/j.geomorph.2009.09.025; Lee S, 2005, INT J REMOTE SENS, V26, P1477, DOI 10.1080/01431160412331331012; Yilmaz I, 2009, B ENG GEOL ENVIRON, V68, P459, DOI 10.1007/s10064-009-0188-z; Lee S, 2005, GEOSCI J, V9, P63, DOI 10.1007/BF02910555; Lee S, 2007, LANDSLIDES, V4, P327, DOI 10.1007/s10346-007-0088-x; Pradhan B, 2011, ENVIRON ECOL STAT, V18, P471, DOI 10.1007/s10651-010-0147-7; Lee S, 2001, ENVIRON GEOL, V40, P1095, DOI 10.1007/s002540100310; Yesilnacar E, 2005, ENG GEOL, V79, P251, DOI 10.1016/j.enggeo.2005.02.002; Guzzetti F, 1999, GEOMORPHOLOGY, V31, P181, DOI 10.1016/S0169-555X(99)00078-1; Lee S, 2007, ENVIRON GEOL, V52, P615, DOI 10.1007/s00254-006-0491-y; Shahabi H, 2014, CATENA, V115, P55, DOI 10.1016/j.catena.2013.11.014; Clerici A, 2006, ENVIRON GEOL, V50, P941, DOI 10.1007/s00254-006-0264-7; Ayalew L, 2005, GEOMORPHOLOGY, V65, P15, DOI 10.1016/j.geomorph.2004.06.010; Ruff M, 2008, GEOMORPHOLOGY, V94, P314, DOI 10.1016/j.geomorph.2006.10.032; Regmi AD, 2014, ARAB J GEOSCI, V7, P725, DOI 10.1007/s12517-012-0807-z; Dai FC, 2002, GEOMORPHOLOGY, V42, P213, DOI 10.1016/S0169-555X(01)00087-3; Pradhan B, 2010, J INDIAN SOC REMOT, V38, P301, DOI 10.1007/s12524-010-0020-z; Yalcin A, 2011, CATENA, V85, P274, DOI 10.1016/j.catena.2011.01.014; Schicker R, 2012, GEOMORPHOLOGY, V161, P40, DOI 10.1016/j.geomorph.2012.03.036; Ayalew L, 1999, B ENG GEOL ENVIRON, V58, P9, DOI 10.1007/s100640050065; Carrara A, 1983, PREDICTION PERCEPTIO, P101; CARSON M. A., 1972, Hillslope Form and Process.; Chen, 2013, P INT ARCH PHOT REM; Geographic Information Technology Training Alliance GITTA, 2011, CLASS DAT; Ibrahim J, 2011, THESIS, P1; Meinhardt M, 2015, GEOMORPHOLOGY, V234, P80, DOI 10.1016/j.geomorph.2014.12.042; Menard S, 1995, SAGE U PAPER SERIES, V106, P98; Mezughi T. H., 2012, Asian Journal of Earth Sciences, V5, P13, DOI 10.3923/ajes.2012.13.24; Bui DT, 2012, MATH PROBL ENG, DOI 10.1155/2012/974638; Wilson J.P., 2000, TERRAIN ANAL PRINCIP; Woldearegay K, 2008, GEOPH RES ABSTR, V10; Zhu Lei, 2006, Journal of Zhejiang University (Science), V7, DOI 10.1631/jzus.2006.A2007	48	0	0	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1672-6316	1993-0321		J MT SCI-ENGL	J Mt. Sci.	NOV	2015	12	6					1355	1372		10.1007/s11629-015-3464-3		18	Environmental Sciences	Environmental Sciences & Ecology	CW8SJ	WOS:000365269200002		
J	Hotta, N; Tsunetaka, H; Suzuki, T				Hotta, Norifumi; Tsunetaka, Haruka; Suzuki, Takuro			Interaction between topographic conditions and entrainment rate in numerical simulations of debris flow	JOURNAL OF MOUNTAIN SCIENCE			English	Article						Debris flow; Entrainment rate equation; Numerical simulation; Topographic condition	MODEL	Debris flow simulations are useful for predicting the sediment supplied to watersheds from upstream areas. However, the topographic conditions upstream are more complicated than those downstream and the relationship between the topographic conditions and debris flow initiation is not well understood. This study compared the use of several entrainment rate equations in numerical simulations of debris flows to examine the effect of topographic conditions on the flow. One-dimensional numerical simulations were performed based on the shallow water equations and three entrainment rate equations were tested. These entrainment rate equations were based on the same idea that erosion and the deposition of debris flows occur via the difference between the equilibrium and current conditions of debris flows, while they differed in the expression of the concentration, channel angle, and sediment amount. The comparison was performed using a straight channel with various channel angles and a channel with a periodically undulating surface. The three entrainment rate equations gave different amounts of channel bed degradation and hydrographs for a straight channel with a channel angle greater than 21A degrees when water was supplied from upstream at a steady rate. The difference was caused by the expression of the entrainment rate equations. For channels with little undulation, the numerical simulations gave results almost identical to those for straight channels with the same channel angle. However, for channels with large undulations, the hydrographs differed from those for straight channels with the same channel angle when the channel angle was less than 21A degrees. Rapid erosion occurred and the hydrograph showed a significant peak, especially in cases using the entrainment equation expressed by channel angle. This was caused by the effects of the steep undulating sections, since the effect increased with the magnitude of the undulation, suggesting that a debris flow in an upstream area develops differently according to the topographic conditions. These results also inferred that numerical simulations of debris flow can differ depending on the spatial resolution of the simulation domain, as the resolution determines the reproducibility of the undulations.	[Hotta, Norifumi; Tsunetaka, Haruka] Univ Tsukuba, Fac Life & Environm Sci, Ibaraki 3058577, Japan; [Suzuki, Takuro] Forestry & Forest Prod Res Inst, Ibaraki 3058687, Japan	Hotta, N (reprint author), Univ Tsukuba, Fac Life & Environm Sci, Ibaraki 3058577, Japan.	hotta.norifumi.ge@u.tsukuba.ac.jp; tsunetakaharuka@gmail.com; takurosuzuki@ffpri.affrc.go.jp			Ministry of Education, Science, Sports, and Culture of Japan [26292077]; River Fund in charge of the River Foundation, Japan	We sincerely thank Prof. Kuniaki Miyamoto (University of Tsukuba) and Prof. Shinji Egashira (International Center of Excellence for Water Hazard and Risk Management, Japan) for their insightful comments on this study. This research was partially supported by Grant-in-Aid for Scientific Research 26292077, 2014, from the Ministry of Education, Science, Sports, and Culture of Japan, and by the River Fund in charge of the River Foundation, Japan.	McCoy SW, 2012, J GEOPHYS RES-EARTH, V117, DOI 10.1029/2011JF002278; Tsai YF, 2007, J MT SCI, V4, P193, DOI 10.1007/s11629-007-0193-2; Imaizumi F, 2005, CAN GEOTECH J, V42, P919, DOI 10.1139/T05-019; Hsu SM, 2010, NAT HAZARD EARTH SYS, V10, P535; Armanini A, 2009, COMPUT GEOSCI-UK, V35, P993, DOI 10.1016/j.cageo.2007.11.008; Zhou GGD, 2015, ENG GEOL, V194, P52, DOI 10.1016/j.enggeo.2014.10.021; Tai YC, 2008, ACTA MECH, V199, P71, DOI 10.1007/s00707-007-0560-7; Osti R, 2009, HYDROL PROCESS, V23, P2943, DOI 10.1002/hyp.7405; Liu JF, 2012, J MT SCI-ENGL, V9, P529, DOI 10.1007/s11629-012-2225-9; Imaizumi F, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026250; Iverson RM, 2012, J GEOPHYS RES-EARTH, V117, DOI 10.1029/2011JF002189; Denlinger RP, 2001, J GEOPHYS RES-SOL EA, V106, P553, DOI 10.1029/2000JB900330; Peng H, 2011, J MT SCI-ENGL, V8, P757, DOI 10.1007/s11629-011-2043-5; Egashira S, 1997, P 1 INT C DEBR FLOW, P340; Egashira S, 1988, P JAP C HYDR JAP SOC, V32, P485; Hungr D, 2004, GEOL SOC AM BULL, V116, P1240, DOI 10.1130/B25362.1; Ikeda A, 2011, P 5 INT C DEBR FLOW, P91; Itoh T, 2002, JSCE, V46, P671; Miyamoto K, 2002, J JAPAN SOC EROSION, V55, P24; Nakagawa H, 1997, P 1 INT C DEBR FLOW, P64; Nakagawa H., 1996, ANN DISASTER PREVENT, V39B-2, P347; O'Brien J.S., 1993, J HYDRAUL ENG, V119, P244; Suzuki T, 2011, P 5 INT C DEBR FLOW, P615; Suzuki T, 2009, J JAPAN SOC EROSION, V62, P14; Suzuki T, 2013, J JAPAN SOC EROSION, V65, P21; Takahama J, 2000, P HYDRAULIC ENG JAPA, V44, P687; Takahama J, 2002, P HYDRAULIC ENG JSCE, V46, P683; TAKAHASHI T, 1980, J HYDR ENG DIV-ASCE, V106, P381; Takahashi T, 2007, DEBRIS FLOW MECH PRE, P448; Takahashi T., 2000, ANN J HYDRAULIC ENG, V44, P717; Takahashi T., 1991, J JAPAN SOC EROSION, V44, P12; Takahashi T, 1986, ANN DISASTER PREVENT, V29, P345; Takahashi T, 1977, ANN DISASTER PREVENT, V20, P405; Takahashi T., 1988, ANN DISASTER PREVENT, V31, P655; TSUBAKI T., 1982, P JAPAN SOC CIVIL EN, V317, P79; Tsunetaka H, 2015, J JAPAN SOC EROSION, V68, P3; Wu YH, 2012, J MT SCI-ENGL, V10, P293	37	0	0	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1672-6316	1993-0321		J MT SCI-ENGL	J Mt. Sci.	NOV	2015	12	6					1383	1394		10.1007/s11629-014-3352-2		12	Environmental Sciences	Environmental Sciences & Ecology	CW8SJ	WOS:000365269200004		
J	Hu, MJ; Pan, HL; Zhu, CQ; Wang, FW				Hu Ming-jian; Pan Hua-li; Zhu Chang-qi; Wang Fa-wu			High-speed ring shear tests to study the motion and acceleration processes of the Yingong landslide	JOURNAL OF MOUNTAIN SCIENCE			English	Article						Yigong landslide; Ring shear tests; Shear zone; Liquefaction; Strength		In this paper, the motion and acceleration process, as well as the mechanism of a high speed and long run landslide are investigated by adopting high speed ring shear test and taking the landslide occurred at Yigong River in Bomi, Tibet on April 9, 2000 as the background. According to the motion characteristics of high-speed and long distance motion landside, the mechanism is studied under different conditions such as shear speed, consolidated drained and consolidated undrained status. Results show that high speed shearing process hinders and delays the dissipation of pore pressure, and drives pore water migrating to shear zone slowly. Both of water content and fine particle content at shear zone are obviously higher than those in other layers; and soil liquefaction occurs at shear zone in the saturated consolidated undrained ring shear tests. The effective internal friction angle of the consolidated undrained soil is much lower than that of the consolidated drained soil under ring shearing. The results also indicate that the shearing speed affecting the strength of soil to some extent. The higher the ring shearing speed is, the lower the strength of soil is. This investigation provides a preliminary interpretation of the mechanism of the motion and acceleration process of the Yigong landslide, occurred in Tibet in 2000.	[Hu Ming-jian; Zhu Chang-qi] State Key Lab Geomech & Geotech Engn, Wuhan 430071, Peoples R China; [Hu Ming-jian; Zhu Chang-qi] Chinese Acad Sci, Inst Rock & Soil Mech, Wuhan 430071, Peoples R China; [Pan Hua-li] Key Lab Mt Hazards & Earth Surface Proc, Chengdu 610041, Peoples R China; [Pan Hua-li] Chinese Acad Sci, Inst Mt Hazards & Environm, Chengdu 610041, Peoples R China; [Wang Fa-wu] Shimane Univ, Res Ctr Nat Disaster Reduct, Matsue, Shimane 6908504, Japan	Pan, HL (reprint author), Key Lab Mt Hazards & Earth Surface Proc, Chengdu 610041, Peoples R China.	mjhu@whrsm.ac.cn; hlpan@imde.ac.cn; cqzhu@whrsm.ac.cn; wangfw@riko.shimane-u.ac.jp			National Basic Research Program of China [2012CB026103]; National Natural Science Foundation of China [41172283, 41372313]	This work was financial aided by the National Basic Research Program of China (2012CB026103) and the National Natural Science Foundation of China (Grant Nos. 41172283, 41372313).	Chen GQ, 2013, J MT SCI-ENGL, V10, P532, DOI 10.1007/s11629-013-2367-4; Chai HJ, 2001, J GEOLOGICAL HAZARDS, V12, P1; Chai HJ, 2001, J GEOLOGICAL HAZARDS, V12, P82; Chen GQ, 2012, DISASTER ADV, V5, P1719; 郭广猛, 2005, [地学前缘, Earth science frontiers], V12, P276; Iverson RM, 1997, ANNU REV EARTH PL SC, V25, P85, DOI 10.1146/annurev.earth.25.1.85; Liu GQ, 2000, TIBETS SCI TECHNOLOG, V4, P15; Liu GQ, 2001, WATER RESOURCES HYDR, V19, P26; [刘伟 Liu Wei], 2002, [中国地质灾害与防治学报, The Chinese Journal of Geological Hazard and Control], V13, P9; [吕杰堂 Lu Jietang], 2002, [地球学报, Acta Geoscientia Sinica], V23, P363; Ren J., 2001, GEOLOGY COMMENT, V47, P642; Sassa K, 1984, P 4 INT S LANDSL TOR, V2, P349; Sassa K, 1998, LANDSLIDES, V1, P37; [Wang Fawu 汪发武], 2005, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V24, P1654; Wang FW, 2002, ENG GEOL, V63, P169, DOI 10.1016/S0013-7952(01)00080-1; Wang ZH, 2001, J REMOTE SENSING, V5, P312; Yin YP, 2000, HYDROGEOLOGY ENG GEO, V4, P8; 朱博勤, 2001, 自然灾害学报, V10, P103	18	0	0	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1672-6316	1993-0321		J MT SCI-ENGL	J Mt. Sci.	NOV	2015	12	6					1534	1541		10.1007/s11629-014-3059-4		8	Environmental Sciences	Environmental Sciences & Ecology	CW8SJ	WOS:000365269200016		
J	Yoshino, M; Naka, A; Sakamoto, Y; Shibasaki, A; Toh, M; Tsukamoto, S; Kondo, K; Iida, K				Yoshino, Makiko; Naka, Ayano; Sakamoto, Yuri; Shibasaki, Ayako; Toh, Mariko; Tsukamoto, Sakuka; Kondo, Kazuo; Iida, Kaoruko			Dietary isoflavone daidzein promotes Tfam expression that increases mitochondrial biogenesis in C2C12 muscle cells	JOURNAL OF NUTRITIONAL BIOCHEMISTRY			English	Article						Daidzein; Mitochondria; Muscles; PGC1 alpha; Sirtuin-1	ACTIVATED PROTEIN-KINASE; TRANSCRIPTION FACTOR-I; INSULIN-RESISTANCE; GENE-EXPRESSION; OXIDATIVE-PHOSPHORYLATION; SKELETAL-MUSCLE; SIRT1; NUCLEAR; PHYTOESTROGENS; DYSFUNCTION	Mitochondrial dysfunction in muscles leads to a wide range of metabolic and age-related disorders. Recently, it has been reported that a natural polyphenol, resveratrol, affects mitochondrial biogenesis. This study aimed to identify other natural polyphenolic compounds that regulate mitochondrial biogenesis in muscles. For this purpose, we used the C2C12 murine muscle cell line. Screening involved a reporter assay based on the promoter of mitochondrial transcription factor A (Tfam). We found that several polyphenols exhibited the ability to increase Tfam promoter activity and that the soy isoflavone daidzein was a most potent candidate that regulated mitochondrial biogenesis. When C2C12 myotubes were treated with 25-50 mu M daidzein for 24 h, there were significant increases in the expression of Tfam and mitochondrial genes such as COX1 and Cytb as well as the mitochondrial content. Using several mutant Tfam promoter fragments, we found that the transcription factor, nuclear respiratory factor (NRF) and its coactivator, PGC1 alpha, were necessary for the effect of daidzein on Tfam expression. Finally, silencing of sirtuin-1 (SIRT1) by shRNA resulted in inhibition of the daidzein effects on mitochondrial gene expression. In conclusion, daidzein regulates mitochondrial biogenesis in muscle cells by regulating transcriptional networks through a SIRT1-associated pathway. These results suggest that daidzein would be beneficial to protect against a wide range of diseases caused by muscle mitochondrial dysfunction. (C) 2015 Elsevier Inc. All rights reserved.	[Yoshino, Makiko; Sakamoto, Yuri; Shibasaki, Ayako; Toh, Mariko; Tsukamoto, Sakuka; Iida, Kaoruko] Ochanomizu Univ, Grad Sch Humanities & Sci, Dept Nutr & Food Sci, Bunkyo Ku, Tokyo 1128610, Japan; [Naka, Ayano; Kondo, Kazuo] Ochanomizu Univ, Inst Environm Sci Human Life, Bunkyo Ku, Tokyo 1128610, Japan	Iida, K (reprint author), Ochanomizu Univ, Grad Sch Humanities & Sci, Dept Nutr & Food Sci, Bunkyo Ku, 2-1-1 Otsuka, Tokyo 1128610, Japan.	iida.kaoruko@ocha.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24300254, 26750037]	This study was supported in part by Grants-in-Aid for Scientific Research (Grant No. 24300254 and 26750037) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; FISHER RP, 1988, MOL CELL BIOL, V8, P3496; Cederroth CR, 2008, DIABETES, V57, P1176, DOI 10.2337/db07-0630; Feng Y, 2009, ANAL BIOCHEM, V395, P205, DOI 10.1016/j.ab.2009.08.011; Wisloff U, 2005, SCIENCE, V307, P418, DOI 10.1126/science.1108177; Setchell KDR, 2003, J NUTR, V133, P1027; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Brasnyo P, 2011, BRIT J NUTR, V106, P383, DOI 10.1017/S0007114511000316; VIRBASIUS JV, 1993, GENE DEV, V7, P380, DOI 10.1101/gad.7.3.380; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Mai A, 2009, J MED CHEM, V52, P5496, DOI 10.1021/jm9008289; Sreekumar R, 2002, DIABETES, V51, P1913, DOI 10.2337/diabetes.51.6.1913; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zang MW, 2006, DIABETES, V55, P2180, DOI 10.2337/db05-1188; Arunkumar E, 2012, NUTR RES, V32, P617, DOI 10.1016/j.nutres.2012.06.002; Fernandez-Silva P, 2003, EXP PHYSIOL, V88, P41, DOI 10.1113/eph8802514; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Morino K, 2006, DIABETES, V55, pS9, DOI 10.2337/db06-S002; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Sakamoto Y, 2014, MOL NUTR FOOD RES, V58, P718, DOI 10.1002/mnfr.201300482; King RA, 1998, AM J CLIN NUTR, V67, P867; Suetsugi M, 2003, MOL CANCER RES, V1, P981; Kraft CS, 2006, AM J PHYSIOL-CELL PH, V290, pC1119, DOI 10.1152/ajpcell.00463.2005.; Rasbach KA, 2008, J PHARMACOL EXP THER, V325, P536, DOI 10.1124/jpet.107.134882; Freyer C, 2010, NUCLEIC ACIDS RES, V38, P6577, DOI 10.1093/nar/gkq527; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Bhathena SJ, 2002, AM J CLIN NUTR, V76, P1191; Scarpulla RC, 2002, GENE, V286, P81, DOI 10.1016/S0378-1119(01)00809-5; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Choi YS, 2002, BBA-GENE STRUCT EXPR, V1574, P200, DOI 10.1016/S0167-4781(01)00361-X; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; CLAYTON DA, 1991, ANNU REV CELL BIOL, V7, P453; Ayissi VBO, 2014, MOL NUTR FOOD RES, V58, P22, DOI 10.1002/mnfr.201300195; Marzetti E, 2013, AM J PHYSIOL-HEART C, V305, pH459, DOI 10.1152/ajpheart.00936.2012; Davis JM, 2009, AM J PHYSIOL-REG I, V296, pR1071, DOI 10.1152/ajpregu.90925.2008; PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027; Hirasaka K, 2013, J NUTR SCI VITAMINOL, V59, P317, DOI 10.3177/jnsv.59.317; Hwang JT, 2009, NEW BIOTECHNOL, V26, P17, DOI 10.1016/j.nbt.2009.03.005; Lorenz M, 2013, AM J CLIN NUTR, V98, p1642S, DOI 10.3945/ajcn.113.058230; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3; Urn J.H., 2010, DIABETES, V59, P554	47	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0955-2863	1873-4847		J NUTR BIOCHEM	J. Nutr. Biochem.	NOV	2015	26	11					1193	1199		10.1016/j.jnutbio.2015.05.010		7	Biochemistry & Molecular Biology; Nutrition & Dietetics	Biochemistry & Molecular Biology; Nutrition & Dietetics	CW4RK	WOS:000364979600010		
J	Nakanishi, A; Tsukamoto, I				Nakanishi, Atsuko; Tsukamoto, Ikuyo			n-3 polyunsaturated fatty acids stimulate osteoclastogenesis through PPAR gamma-mediated enhancement of c-Fos expression, and suppress osteoclastogenesis through PPAR gamma-dependent inhibition of NFkB activation	JOURNAL OF NUTRITIONAL BIOCHEMISTRY			English	Article						Osteoclastogenesis; Bone marrow-derived monocytes/macrophage precursor cells (BMMs); Eicosapentaenoic acid (EPA); Docosahexaenoic acid (DHA); c-fos; PPAR gamma	BONE-MINERAL DENSITY; RECEPTOR-GAMMA; TRANSCRIPTION FACTOR; METABOLIC DISEASE; FISH-OIL; ROSIGLITAZONE; DIFFERENTIATION; CELLS; DECREASES; MICE	n-3 polyunsaturated fatty acids (PUFAs), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) have been reported to suppress osteoclastogenesis in vivo. In this study, the effect of PUFAs on receptor for activation of nuclear factor-kappa B ligand (RANKL)-induced osteoclastogenesis was examined using bone marrow-derived monocytes/macrophage precursor cells (BMMs) or-bone marrow cells (BMCs) in vitro. EPA and DHA stimulated the osteoclastic differentiation of BMMs, but n-6 PUFAs, linoleic acid and arachidonic acid had no effect. The stimulation of osteoclastogenesis of BMMs by EPA and DHA was associated with enhancement of the gene expressions of c-Fos, tartrate-resistant acid phosphatase, cathepsin K and peroxisome proliferator-activated receptor-gamma (PPAR gamma) and the protein levels of c-Fos, PPAR gamma and nuclear factor of activated T cells, cytoplasmic, calcineurin-dependent-1 (NFATc1). The PPAR gamma agonists, rosiglitazone and GW1929, also stimulated the osteoclastogenesis of BMMs. The PPAR gamma antagonists, T0070907 and GW9662, inhibited the stimulations of osteoclastogenesis and c-Fos expression by EPA or DHA. However, EPA and DHA inhibited the osteoclastogenesis in BMCs including BMMs and mesenchymal stem cells (MSCs). This inhibition was associated with suppression of the expression of RANKL and nuclear factor-kappa B (NF kappa B)-regulating genes, cyclooxygenase 2, TNF alpha and IL-6 in BMCs and MSCs. The agonists and antagonists of PPAR gamma showed that the inhibitions of NF kappa B transcriptional activity and osteoclastogenesis by EPA and DHA were PPAR gamma-dependent. These results suggest that EPA and DHA directly act on BMMs and stimulate osteoclastogenesis through enhancing c-Fos expression mediated by PPAR gamma but suppress osteoclastogenesis through the PPAR gamma-dependent inhibition of NF kappa B activation of MSCs in BMCs. (C) 2015 Elsevier Inc. All rights reserved.	[Nakanishi, Atsuko; Tsukamoto, Ikuyo] Nara Womens Univ, Dept Food Sci & Nutr, Nara 6308506, Japan; [Tsukamoto, Ikuyo] Hiroshima Int Univ, Fac Clin Nutr, Kure, Hiroshima 7370112, Japan	Tsukamoto, I (reprint author), Nara Womens Univ, Dept Food Sci & Nutr, Nara 6308506, Japan.	itsuka@cc.nara-wu.ac.jp					Okazaki R, 1999, ENDOCRINOLOGY, V140, P5060, DOI 10.1210/en.140.11.5060; Rahman M, 2008, J CELL PHYSIOL, V214, P201, DOI 10.1002/jcp.21188; FROST HM, 1968, AM J PHYS ANTHROPOL, V29, P183, DOI 10.1002/ajpa.1330290212; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Moerman EJ, 2004, AGING CELL, V3, P379, DOI 10.1111/j.1474-9728.2004.00127.x; Calder PC, 2010, NUTRIENTS, V2, P355, DOI 10.3390/nu2030355; Ali AA, 2005, ENDOCRINOLOGY, V146, P1226, DOI 10.1210/en.2004-0735; Sun DX, 2003, J BONE MINER RES, V18, P1206, DOI 10.1359/jbmr.2003.18.7.1206; Hie M, 2011, BONE, V49, P1152, DOI 10.1016/j.bone.2011.08.019; Willson TM, 2001, ANNU REV BIOCHEM, V70, P341, DOI 10.1146/annurev.biochem.70.1.341; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Brun RP, 1996, GENE DEV, V10, P974, DOI 10.1101/gad.10.8.974; Schwartz AV, 2006, J CLIN ENDOCR METAB, V91, P3349, DOI 10.1210/jc.2005-2226; Wei W, 2010, CELL METAB, V11, P503, DOI 10.1016/j.cmet.2010.04.015; Sugii S, 2011, FEBS LETT, V585, P2121, DOI 10.1016/j.febslet.2011.05.007; Bhattacharya A, 2007, J NUTR BIOCHEM, V18, P372, DOI 10.1016/j.jnutbio.206.07.002; Kahn SE, 2008, DIABETES CARE, V31, P845, DOI 10.2337/dc07-2270; Lazarenko OP, 2007, ENDOCRINOLOGY, V148, P2669, DOI 10.1210/en.2006-1587; Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Poulsen RC, 2007, EXP BIOL MED, V232, P1275, DOI 10.3181/0704-MR-100; Wan YH, 2007, NAT MED, V13, P1496, DOI 10.1038/nm1672; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Nakanishi A, 2013, INT J MOL MED, V31, P874, DOI 10.3892/ijmm.2013.1258; Gruntmanis U, 2010, CALCIFIED TISSUE INT, V86, P343, DOI 10.1007/s00223-010-9352-5; Berberoglu Z, 2007, J CLIN ENDOCR METAB, V92, P3523, DOI 10.1210/jc.2007-0431; Yanai R, 2014, P NATL ACAD SCI USA, V111, P9603, DOI 10.1073/pnas.1401191111; Grey A, 2007, J CLIN ENDOCR METAB, V92, P1305, DOI 10.1210/jc.2006-2646; Zinman B, 2010, J CLIN ENDOCR METAB, V95, P134, DOI 10.1210/jc.2009-0572; Hie M, 2009, EUR J PHARMACOL, V621, P1, DOI 10.1016/j.ejphar.2009.08.025; Cho ES, 2012, MOL CELLS, V33, P173, DOI 10.1007/s10059-012-2240-z; Rzonca SO, 2004, ENDOCRINOLOGY, V145, P401, DOI 10.1210/en.2003-0746; Chapkin RS, 2009, PROSTAG LEUKOTR ESS, V81, P187, DOI 10.1016/j.plefa.2009.05.010; Hie M, 2011, J NUTR BIOCHEM, V22, P164, DOI 10.1016/j.jnutbio.2010.01.002; Wei W, 2011, MOL CELL BIOL, V31, P4692, DOI 10.1128/MCB.05979-11; Ross FP, 2006, J CLIN INVEST, V116, P1140, DOI 10.1172/JCI28605; Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Wan YH, 2010, TRENDS ENDOCRIN MET, V21, P722, DOI 10.1016/j.tem.2010.08.006; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; UDAGAWA N, 1990, P NATL ACAD SCI USA, V87, P7260, DOI 10.1073/pnas.87.18.7260; Kruger MC, 2010, PROG LIPID RES, V49, P438, DOI 10.1016/j.plipres.2010.06.002; Rahman MM, 2009, J CELL MOL MED, V13, P1833, DOI 10.1111/j.1582-4934.2009.00649.x; Wu HC, 2013, J CELL BIOCHEM, V114, P1969, DOI 10.1002/jcb.24534; Nakashima T, 2012, TRENDS ENDOCRIN MET, V23, P582, DOI 10.1016/j.tem.2012.05.005; Nakanishi A, 2013, MOL MED REP, V7, P1896, DOI 10.3892/mmr.2013.1446; Fukunaga Tomohiro, 2015, J Bone Miner Res, V30, P481, DOI 10.1002/jbmr.2364; Lecka-Czernik Beata, 2006, PPAR Res, V2006, P27489; Salari P, 2008, MED SCI MONITOR, V14, pRA37; Zhao DF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102706	52	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0955-2863	1873-4847		J NUTR BIOCHEM	J. Nutr. Biochem.	NOV	2015	26	11					1317	1327		10.1016/j.jnutbio.2015.06.007		11	Biochemistry & Molecular Biology; Nutrition & Dietetics	Biochemistry & Molecular Biology; Nutrition & Dietetics	CW4RK	WOS:000364979600022		
J	Ono, S; Ishimaru, M; Matsui, H; Fushimi, K; Yasunaga, H				Ono, Sachiko; Ishimaru, Miho; Matsui, Hiroki; Fushimi, Kiyohide; Yasunaga, Hideo			Effect of Hospital Volume on Outcomes of Surgery for Cleft Lip and Palate	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article							CHILDREN; CENTRALIZATION; EXPERIENCE; SERVICES; ENGLAND	Purpose: Cleft lip and cleft palate are the most common craniofacial anomalies. However, the effect of hospital volume on outcomes of surgery for cleft lip and palate is unknown. Materials and Methods: The Japanese Diagnosis Procedure Combination database was searched to identify patients who underwent surgery for cleft lip and palate from July 2010 through March 2013. Hospital volume was divided into tertiles (<= 28, 29 to 82, and >= 83 admissions/yr). Outcomes included total cost, length of hospital stay, duration of anesthesia, and length of antibiotic use. The relation between hospital volume and surgical outcomes was analyzed by multivariable regression analyses. Results: The authors identified 7,405 admissions for cleft lip alone, cleft palate alone, or cleft lip and palate during the study period. Compared with the reference low-volume hospital category, a shorter duration of anesthesia was seen in the medium-volume group (-15 minutes; 95% confidence interval, -37 to 7 minutes) and high-volume group (-22 minutes; 95% confidence interval, -65 to 3 minutes). No statistical associations were observed between hospital volume and total cost or length of stay. Although not statistically important, a higher hospital volume was associated with a shorter length of antibiotic use after adjusting for duration of anesthesia. Conclusion: In the present study of surgical outcomes for cleft lip and palate, hospital volume was inversely associated with duration of anesthesia and length of antibiotic use, but was not statistically associated with length of hospital stay or total cost. (C) 2015 American Association of Oral and Maxillofacial Surgeons	[Ono, Sachiko; Ishimaru, Miho; Matsui, Hiroki; Yasunaga, Hideo] Univ Tokyo, Dept Clin Epidemiol & Hlth Econ, Sch Publ Hlth, Tokyo 1130033, Japan; [Fushimi, Kiyohide] Tokyo Med & Dent Univ, Grad Sch Med, Dept Hlth Policy & Informat, Tokyo, Japan	Yasunaga, H (reprint author), Univ Tokyo, Dept Clin Epidemiol & Hlth Econ, Sch Publ Hlth, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	yasunagah-tky@umin.ac.jp		Yasunaga, Hideo/0000-0002-6017-469X	Ministry of Health, Labour and Welfare, Japan [H26-Policy-011, H26-Special-047]	This work was supported by grants from the Ministry of Health, Labour and Welfare, Japan (grants H26-Policy-011 and H26-Special-047).	Hathorn IS, 2006, CLEFT PALATE-CRAN J, V43, P401; MacIsaac ZM, 2012, PLAST RECONSTR SURG, V130, P625, DOI 10.1097/PRS.0b013e31825dcb75; Shaw WC, 2001, J CRANIO MAXILL SURG, V29, P131, DOI 10.1054/jcms.2001.0217; Williams AC, 2003, PLAST RECONSTR SURG, V111, P586, DOI 10.1097/01.PRS.0000041946.98451.FB; Al-Nawas B, 2013, J CRANIO MAXILL SURG, V41, P135, DOI 10.1016/j.jcms.2012.06.005; Mossey PA, 2009, LANCET, V374, P1773, DOI 10.1016/S0140-6736(09)60695-4; Masuda K, 2012, SPINE J, V12, P1029, DOI 10.1016/j.spinee.2012.10.020; Witt PD, 1998, PLAST RECONSTR SURG, V102, P1375, DOI 10.1097/00006534-199810000-00009; Phua YS, 2009, INT J PEDIATR OTORHI, V73, P307, DOI 10.1016/j.ijporl.2008.10.026; Fitzsimons KJ, 2013, ARCH DIS CHILD, V98, P970, DOI 10.1136/archdischild-2013-304271; Fitzsimons KJ, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-148; Sandy J, 1998, Br J Orthod, V25, P21; SHAW WC, 1992, CLEFT PALATE-CRAN J, V29, P413, DOI 10.1597/1545-1569(1992)029<0413:ASCISO>2.3.CO;2; Tremlett M, 2004, CURR ANAESTH CRIT CA, V15, P309, DOI 10.1016/j.cacc.2004.09.003; Trussler AP, 2012, PLAST RECONSTR SURG, V130, p470E, DOI 10.1097/PRS.0b013e31825dc349; World Health Organization, ADDR GLOB CHALL CRAN	16	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-2391	1531-5053		J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	NOV	2015	73	11					2219	2224		10.1016/j.joms.2015.04.003		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CW9VW	WOS:000365347300021		
J	Koike, T				Koike, Tatsuya			Treatment of rheumatoid arthritis by molecular-targeted agents: efficacy and limitations	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							ALPHA MONOCLONAL-ANTIBODY; MODIFYING ANTIRHEUMATIC DRUGS; ADALIMUMAB PLUS METHOTREXATE; DISEASE-ACTIVITY SCORE; DOUBLE-BLIND; EULAR RECOMMENDATIONS; CLINICAL-TRIAL; 2013 UPDATE; CERTOLIZUMAB PEGOL; FUSION PROTEIN	Rheumatoid arthritis (RA) is characterized by chronic synovial inflammation due to unknown causes. Conventional synthetic disease-modifying antirheumatic drugs (csDMARDs), biological DMARDs (bDMARDs), and tofacitinib, a targeted sDMARD, can be used to treat RA. In clinical trials, molecular-targeted therapies showed a significant reduction in RA symptoms and provided pain relief for patients with active RA. Even if patients did not show clinical improvement with combination therapy with a bDMARD and methotrexate (MTX), some patients showed a significant inhibition in structural damage. The clinical efficacies of tofacitinib were shown to be equivalent to adalimumab, a bDMARD, in patients with RA treated with MTX. MTX is the first-line agent for the treatment of RA. Higher doses of MTX might be needed to maintain the effects of bDMARDs. Patients receiving some bDMARDs have been shown to have a higher risk for serious infections; thus, pre-screening for infections is important before beginning treatment with bDMARDs. The rates of patients maintaining targeted levels of disease activity after stopping bDMARDs are relatively low. It is uncertain whether remission or low disease activity can be maintained after stopping molecular-targeted therapies. The development of bDMARDs and targeted-molecular sDMARDs has provided a wide range of treatment options for RA. Patients with active RA should be treated with a treat-to-target strategy after assessment of risks and benefits.	[Koike, Tatsuya] Osaka City Univ, Sch Med, Ctr Senile Degenerat Disorders, Abeno Ku, Osaka 5458585, Japan; [Koike, Tatsuya] Shirahama Fdn Hlth & Welf, Search Inst Bone & Arthrit Dis SINBAD, Wakayama 6492211, Japan	Koike, T (reprint author), Osaka City Univ, Sch Med, Ctr Senile Degenerat Disorders, Abeno Ku, Asahimachi 1-4-3, Osaka 5458585, Japan.	tatsuya@med.osaka-cu.ac.jp			AbbVie; Astellas Pharma Inc.; Bristol-Myers Squibb; Chugai Pharmaceutical; Daiichi Sankyo; Eisai; Janssen; Mitsubishi Tanabe Pharma; MSD; Ono Pharmaceutical; Pfizer; Sanofi; Santen Pharmaceutical; Taisho Pharmaceutical; Takeda Pharmaceutical; Teijin Pharma; UCB Pharma	The author has received research grants and consulting fees or other remuneration from and served on speakers' bureaus on behalf of AbbVie, Astellas Pharma Inc., Bristol-Myers Squibb, Chugai Pharmaceutical, Daiichi Sankyo, Eisai, Janssen, Mitsubishi Tanabe Pharma, MSD, Ono Pharmaceutical, Pfizer, Sanofi, Santen Pharmaceutical, Taisho Pharmaceutical, Takeda Pharmaceutical, Teijin Pharma, and UCB Pharma.	Smolen JS, 2013, LANCET, V381, P918, DOI 10.1016/S0140-6736(12)61811-X; Smolen JS, 2005, ARTHRITIS RHEUM, V52, P1020, DOI 10.1002/art.20982; Emery P, 2011, ARTHRITIS RHEUM-US, V63, P1200, DOI 10.1002/art.30263; Rau R, 2002, ANN RHEUM DIS, V61, P70; Smolen JS, 2012, CLIN EXP RHEUMATOL, V30, pS2; Yoshida K, 2014, ANN RHEUM DIS, V73, P595, DOI 10.1136/annrheumdis-2013-203302; van Vollenhoven RF, 2012, NEW ENGL J MED, V367, P508, DOI 10.1056/NEJMoa1112072; Pincus T, 2003, ARTHRITIS RHEUM, V48, P625, DOI 10.1002/art.10824; Dougados M, 2014, ANN RHEUM DIS, V73, P62, DOI 10.1136/annrheumdis-2013-204223; Moreland LW, 1997, NEW ENGL J MED, V337, P141, DOI 10.1056/NEJM199707173370301; Ramiro S, 2014, ANN RHEUM DIS, V73, P529, DOI 10.1136/annrheumdis-2013-204575; Kremer JM, 2011, ANN RHEUM DIS, V70, P1826, DOI 10.1136/ard.2010.139345; Breedveld FC, 2006, ARTHRITIS RHEUM, V54, P26, DOI 10.1002/art.21519; Kaur K, 2014, CLIN THER, V36, P1074, DOI 10.1016/j.clinthera.2014.06.018; Bathon JM, 2000, NEW ENGL J MED, V343, P1586, DOI 10.1056/NEJM200011303432201; Burmester GR, 2015, ANN RHEUM DIS, V74, P1037, DOI 10.1136/annrheumdis-2013-204769; O'Dell JR, 2013, NEW ENGL J MED, V369, P307, DOI 10.1056/NEJMoa1303006; Emery P, 2008, LANCET, V372, P375, DOI 10.1016/S0140-6736(08)61000-4; Visser K, 2009, ANN RHEUM DIS, V68, P1086, DOI 10.1136/ard.2008.094474; Maini RN, 2006, ARTHRITIS RHEUM, V54, P2817, DOI 10.1002/art.22033; Weinblatt ME, 1999, NEW ENGL J MED, V340, P253, DOI 10.1056/NEJM199901283400401; Conaghan PG, 2011, CLIN RHEUMATOL, V30, pS41, DOI 10.1007/s10067-010-1639-4; Schiff M, 2014, ANN RHEUM DIS, V73, P86, DOI 10.1136/annrheumdis-2013-203843; ELLIOTT MJ, 1994, LANCET, V344, P1125, DOI 10.1016/S0140-6736(94)90632-7; VANDERHEIJDE DMFM, 1990, ANN RHEUM DIS, V49, P916, DOI 10.1136/ard.49.11.916; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Smolen JS, 2009, LANCET, V374, P210, DOI 10.1016/S0140-6736(09)60506-7; Maini RN, 1998, ARTHRITIS RHEUM, V41, P1552, DOI 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W; ELLIOTT MJ, 1994, LANCET, V344, P1105, DOI 10.1016/S0140-6736(94)90628-9; Winthrop KL, 2012, RHEUM DIS CLIN N AM, V38, P727, DOI 10.1016/j.rdc.2012.08.019; Nam JL, 2014, ANN RHEUM DIS, V73, P516, DOI 10.1136/annrheumdis-2013-204577; Smolen JS, 2009, ANN RHEUM DIS, V68, P823, DOI 10.1136/ard.2008.090019; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Scarsi M, 2014, CLIN EXP RHEUMATOL, V32, P204; Emery P, 2009, ARTHRITIS RHEUM, V60, P2272, DOI 10.1002/art.24638; Keystone E, 2008, ARTHRITIS RHEUM, V58, P3319, DOI 10.1002/art.23964; Burmester GR, 2009, LANCET, V374, P210; Smolen JS, 2014, LANCET, V383, P321, DOI 10.1016/S0140-6736(13)61751-1; Smolen JS, 2015, ANN RHEUM DIS, V74, P843, DOI 10.1136/annrheumdis-2013-204632; St Clair E William, 2004, Arthritis Rheum, V50, P3432, DOI 10.1002/art.20568; Winthrop KL, 2014, ARTHRITIS RHEUMATOL, V66, P2675, DOI 10.1002/art.38745	41	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	NOV	2015	20	6					951	957		10.1007/s00776-015-0766-9		7	Orthopedics	Orthopedics	CX0XT	WOS:000365421500001		
J	Ushida, T				Ushida, Takahiro			Burdensome problems of chronic musculoskeletal pain and future prospects	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							LOW-BACK-PAIN; LUMBAR DISC HERNIATION; MANAGEMENT; SURGERY; SPINE; VERTEBROPLASTY; SCIATICA; EXERCISE	According to a recent survey, about 15 % of the Japanese population suffers from moderate-severe chronic musculoskeletal pain persisting for at least 6 months. Social factors and related psychological factors (including depression) thus appear to greatly affect chronic musculoskeletal pain. This suggests the need for measures that take these factors into account. Treatment for musculoskeletal pain at present is generally based on a biomedical model that has been used for many years in this field, and modern medical imaging technologies have been a high priority to support this model and treatment strategy. Under the concept of the biomedical model, nonsteroidal antiinflammatory drugs, channel blockers and opioid analgesics are generally used as pharmacotherapy to alleviate chronic pain. However, these drugs are commonly associated with problems such as adverse effects, drug dependency and drug abuse, and they must be used with care. Surgery may also be effective in treating certain diseases, but studies have shown that many patients suffer residual chronic pain even after such treatment. Besides, exercise therapy has been found to be effective in treating many different types of chronic pain. Lately, various countries have been launching interdisciplinary pain centers that use a multidisciplinary approach to treat chronic musculoskeletal pain. Treatment in these centers is provided by a team of specialists in anesthesiology, psychiatry and orthopedics as well as the relevant paramedical professionals. The therapeutic strategy is based on a cognitive-behavioral approach, and patients are taught about methods for restoring physical function and coping with pain, mostly with drugs and exercise therapy, so that any pain present does not impair function and the patient can reintegrate into society.	[Ushida, Takahiro] Aichi Med Univ, Ctr Multidisciplinary Pain, Nagakute, Aichi 48011, Japan; [Ushida, Takahiro] Aichi Med Univ, Inst Phys Fitness Sports Med & Rehabil, Nagakute, Aichi 48011, Japan	Ushida, T (reprint author), Aichi Med Univ, Ctr Multidisciplinary Pain, Nagakute, Aichi 48011, Japan.	ushidat-koc@umin.ac.jp					Yoshimura N, 2009, J BONE MINER METAB, V27, P620, DOI 10.1007/s00774-009-0080-8; Kawaguchi Y, 1996, SPINE, V21, P941, DOI 10.1097/00007632-199604150-00007; FINE PG, 1994, PAIN, V56, P235, DOI 10.1016/0304-3959(94)90099-X; Peul WC, 2007, NEW ENGL J MED, V356, P2245, DOI 10.1056/NEJMoa064039; Atlas SJ, 2005, SPINE, V30, P927, DOI 10.1097/01.brs.0000158954.68522.2a; Osterman H, 2006, SPINE, V31, P2409; Nakano M, 2005, J NEUROSURG-SPINE, V2, P27, DOI 10.3171/spi.2005.2.1.0027; Longo UG, 2012, J BONE JOINT SURG BR, V94B, P152, DOI 10.1302/0301-620X.94B2.26894; Nakamura M, 2011, J ORTHOP SCI, V16, P424, DOI 10.1007/s00776-011-0102-y; Lingard EA, 2006, J BONE JOINT SURG AM, V88A, P1201, DOI 10.2106/JBJS.E.00147; Taylor NF, 2007, AUST J PHYSIOTHER, V53, P7; Uchida K, 2010, J NEUROSURG-SPINE, V13, P612, DOI 10.3171/2010.5.SPINE09813; Zhang W, 2008, OSTEOARTHR CARTILAGE, V16, P137, DOI 10.1016/j.joca.2010.01.013; Hayden JA, 2005, ANN INTERN MED, V142, P765; Sakai T, 2009, SPINE, V34, P2346, DOI 10.1097/BRS.0b013e3181b4abbe; Finnerup NB, 2010, PAIN, V150, P573, DOI 10.1016/j.pain.2010.06.019; DEYO RA, 1992, JAMA-J AM MED ASSOC, V268, P760, DOI 10.1001/jama.268.6.760; Inoue M, 2014, PAIN RES MANAG, V19, P302; Inoue S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060079; Inoue S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129262; Nicholas M, 2012, MANAGE YOUR PAIN PRA; Ohtori Seiji, 2009, Spine (Phila Pa 1976), V34, P1345, DOI 10.1097/BRS.0b013e3181a401bf; Schatman ME, 2012, PAIN CLIN UPDAT, V20; Shibata M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090984; Yamamoto H, 1985, GERIATR MED JPN, V23, P587; Yoshimura N, 2008, RIUMACHI KA, V39, P465	26	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	NOV	2015	20	6					958	966		10.1007/s00776-015-0753-1		9	Orthopedics	Orthopedics	CX0XT	WOS:000365421500002		
J	Kobayashi, K; Imagama, S; Ito, Z; Ando, K; Shinjo, R; Yagi, H; Hida, T; Ito, K; Ishikawa, Y; Ishiguro, N				Kobayashi, Kazuyoshi; Imagama, Shiro; Ito, Zenya; Ando, Kei; Shinjo, Ryuichi; Yagi, Hideki; Hida, Tetsuro; Ito, Kenyu; Ishikawa, Yoshimoto; Ishiguro, Naoki			Hyperamylasemia and pancreatitis following posterior spinal surgery	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							CEREBRAL-PALSY; FUSION; SCOLIOSIS; INSTRUMENTATION; ANTERIOR	Postoperative pancreatitis has primarily been reported as a complication of abdominal surgery, but there are some case reports of postoperative pancreatitis after spinal surgery. The objective of this study was to investigate a case series of hyperamylasemia and pancreatitis following posterior spinal surgery. The serum amylase level was measured following posterior spinal surgery in the prone position. Patients were divided into groups with a normal serum amylase level (0-125 IU/L) and with hyperamylasemia (> 125 IU/L), based on the upper limit of normal of 125 IU/L in our institution. Relationships among preoperative factors, perioperative factors, and the serum amylase level were investigated. Hyperamylasemia (serum amylase > 125 IU/L) following posterior spinal surgery was found in 92 cases (35 %). Among perioperative factors, intraoperative estimated blood loss (EBL) and operating time were significantly higher in patients with high serum amylase than in patients with normal serum amylase (P < 0.01). In a multivariate regression model, intraoperative EBL (OR 1.001, 95 % CI 1.000-1.002; P = 0.001) and operation time (OR 1.006, 95 % CI 1.003-1.009; P = 0.006) were significantly associated with postoperative pancreatitis. Serum amylase levels of a parts per thousand yen5 times the upper limit of normal were found in six cases. Five of these cases were asymptomatic and one was caused by severe pancreatitis. In our case series, intraoperative blood loss caused a rise in the serum amylase level following posterior spinal surgery. Thus, this level should be carefully monitored after spinal surgery with significant blood loss. Clinical symptoms of pancreatitis, such as abdominal pain and vomiting, should also be monitored following spinal surgery.	[Kobayashi, Kazuyoshi; Imagama, Shiro; Ito, Zenya; Ando, Kei; Shinjo, Ryuichi; Yagi, Hideki; Hida, Tetsuro; Ito, Kenyu; Ishikawa, Yoshimoto; Ishiguro, Naoki] Nagoya Univ, Grad Sch Med, Dept Orthopaed Surg, Showa Ku, Nagoya, Aichi 4668560, Japan	Imagama, S (reprint author), Nagoya Univ, Grad Sch Med, Dept Orthopaed Surg, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668560, Japan.	imagama@med.nagoya-u.ac.jp					BELL DF, 1989, SPINE, V14, P1301, DOI 10.1097/00007632-198912000-00006; LEICHTNER AM, 1991, J PEDIATR ORTHOPED, V11, P594; STEINBERG WM, 1985, ANN INTERN MED, V102, P576; BROE PJ, 1982, SURGERY, V91, P377; JEVSEVAR DS, 1993, J BONE JOINT SURG AM, V75A, P880; Rajaraman V, 2000, EUR SPINE J, V9, P171, DOI 10.1007/s005860050230; Farley FA, 2001, J SPINAL DISORD, V14, P268, DOI 10.1097/00002517-200106000-00015; PATEL NJ, 1985, J BONE JOINT SURG AM, V67A, P1384; MANDELBAUM BR, 1988, CLIN ORTHOP RELAT R, P5; Borkhuu B, 2009, J PEDIATR ORTHOPED, V29, P256, DOI 10.1097/BPO.0b013e31819bcf0a; Gallucci F, 2010, ADV MED SCI-POLAND, V55, P143, DOI 10.2478/v10039-010-0049-9; WARSHAW AL, 1978, ANN SURG, V188, P197, DOI 10.1097/00000658-197808000-00012; STEINBERG W, 1994, NEW ENGL J MED, V330, P1198, DOI 10.1056/NEJM199404283301706; Korovessis PG, 1996, J SPINAL DISORD, V9, P347; Burden S, 2013, BMJ CASE REP, V2013, P16; Castillo CF, 1991, NEW ENGL J MED, V325, P382, DOI 10.1056/NEJM199108083250602; CURTIN WA, 1993, CLIN ORTHOP RELAT R, P142; Frulloni Luca, 2005, JOP, V6, P536; RELTON J E, 1963, Can Anaesth Soc J, V10, P603, DOI 10.1007/BF03002093; Sasaki H, 2005, SEKITSUI SEKIZUI, V18, P237; Tauchi R, 2014, EUR J ORTHOP SURG TR, V24, P305; White M T, 1970, Am J Surg, V120, P132	22	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	NOV	2015	20	6					967	972		10.1007/s00776-015-0754-0		6	Orthopedics	Orthopedics	CX0XT	WOS:000365421500003		
J	Seki, S; Kawaguchi, Y; Nakano, M; Yasuda, T; Hori, T; Noguchi, K; Kimura, T				Seki, Shoji; Kawaguchi, Yoshiharu; Nakano, Masato; Yasuda, Taketoshi; Hori, Takeshi; Noguchi, Kyo; Kimura, Tomoatsu			Clinical significance of high intramedullary signal on T2-weighted cervical flexion-extension magnetic resonance imaging in cervical myelopathy	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							SPONDYLOTIC MYELOPATHY; SPINAL-CORD; COMPRESSION MYELOPATHY; RELIABILITY; LESIONS; IMAGES	In cervical myelopathy, significant findings are seen in flexion-extension MRI due to the increased likelihood of cord compression during neck extension. In addition, a high intramedullary signal on T2-weighted MR images has been reported to be a prognostic factor in this condition. However, the relationship between Japanese Orthopaedic Association (JOA) scores and the signal intensity in preoperative cervical flexion-extension T2-weighted images has not been evaluated. The purpose of this study was to evaluate whether preoperative flexion-extension MRI may be used to predict surgical outcomes in patients with cervical myelopathy. A total of 121 patients who underwent surgery for cervical myelopathy were included. All patients underwent preoperative cervical flexion-extension MRI followed by cervical decompression surgery, with or without spinal fusion, and postoperative follow-up for at least 2 years. Pre- and postoperative (2 years after surgery) JOA scores were recorded, and the degree of postoperative improvement was calculated. The relationship between intramedullary signal intensity on preoperative cervical dynamic MRI findings and degree of clinical recovery was examined. Patients with a high intramedullary signal on the extension MRI had significantly better neurological recovery than those with a high signal on the flexion MRI (p < 0.000005). There was no significant difference in neurological recovery between patients with and without a high intramedullary signal on extension MRI. A preoperative high intramedullary signal on flexion MRI was associated with a poor surgical outcome, while no such association was seen with extension MRI.	[Seki, Shoji; Kawaguchi, Yoshiharu; Yasuda, Taketoshi; Hori, Takeshi; Kimura, Tomoatsu] Toyama Univ, Fac Med, Dept Orthopaed Surg, Toyama, Toyama 9300194, Japan; [Nakano, Masato] Takaoka City Hosp, Dept Orthopaed Surg, Takaoka, Toyama 9338550, Japan; [Noguchi, Kyo] Toyama Univ, Fac Med, Dept Radiol, Toyama, Toyama 9300194, Japan	Seki, S (reprint author), Toyama Univ, Fac Med, Dept Orthopaed Surg, 2630 Sugitani, Toyama, Toyama 9300194, Japan.	seki@med.u-toyama.ac.jp					Fei ZQ, 2011, J CLIN NEUROSCI, V18, P232, DOI 10.1016/j.jocn.2010.04.035; Chen CJ, 2001, RADIOLOGY, V221, P789, DOI 10.1148/radiol.2213010365; OHSHIO I, 1993, SPINE, V18, P1140, DOI 10.1097/00007632-199307000-00005; Karanicolas PJ, 2009, J BONE JOINT SURG AM, V91A, P99, DOI 10.2106/JBJS.H.01624; Mizuno J, 2003, J NEUROSURG, V99, P162, DOI 10.3171/spi.2003.99.2.0162; OKADA Y, 1993, SPINE, V18, P2024, DOI 10.1097/00007632-199310001-00016; Zhang L, 2011, SPINE, V36, pE1134, DOI 10.1097/BRS.0b013e3181f822c7; Morio Y, 2001, SPINE, V26, P1238, DOI 10.1097/00007632-200106010-00012; Wada E, 1999, SPINE, V24, P455, DOI 10.1097/00007632-199903010-00009; RAMANAUSKAS WL, 1989, J COMPUT ASSIST TOMO, V13, P399, DOI 10.1097/00004728-198905000-00005; Ito T, 1996, SPINE, V21, P827, DOI 10.1097/00007632-199604010-00010; Machino M, 2011, SPINE, V36, P399, DOI 10.1097/BRS.0b013e3181d2510b; Gerigk L, 2012, Clin Neuroradiol, V22, P93, DOI 10.1007/s00062-011-0121-2; Sim J, 2005, PHYS THER, V85, P257; YONE K, 1992, SPINE, V17, pS388, DOI 10.1097/00007632-199210001-00008	15	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	NOV	2015	20	6					973	977		10.1007/s00776-015-0757-x		5	Orthopedics	Orthopedics	CX0XT	WOS:000365421500004		
J	Enyo, Y; Yoshimura, N; Yamada, H; Hashizume, H; Yoshida, M				Enyo, Yoshio; Yoshimura, Noriko; Yamada, Hiroshi; Hashizume, Hiroshi; Yoshida, Munehito			Radiographic natural course of lumbar degenerative spondylolisthesis and its risk factors related to the progression and onset in a 15-year community-based cohort study: the Miyama study	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							LOW-BACK-PAIN; SAGITTAL BALANCE; FACET JOINTS; SPINE; ASSOCIATION; ORIENTATION; ETIOLOGY; SEX; AGE	The natural history and risk factors for lumbar degenerative spondylolisthesis (DS) remain unclear. Because it is important for physicians to take these factors into account to ensure accurate decisions regarding surgical methods, this study aimed to elucidate the natural course and risk factors for the progression of DS. This is a prospective observation and case control study of 15-year follow-up in a rural mountainous cohort in Wakayama, Japan. In 1990 and 2005, a total of 200 participants (baseline age, range 40-75) were subjected to anteroposterior and lateral radiographs of the lumbar spine, which were acquired with patients in a standing position. The prevalence of DS (slip a parts per thousand yen3 mm) at baseline and the incidence of DS at 15-year follow-up were recorded. Risk factors at baseline for progression of L4 slip (a parts per thousand yen3 mm) over the 15-year period were determined by multiple logistic regression analysis. The overall prevalence of DS in 1990 was 10 % (20/200), and by spinal level was as follows: one case at L3, 14 cases at L4, and five at L5. In 2005, the overall prevalence of DS had risen to 22.5 % (45/200). Thus the incidence of de novo DS during the 15-year period was estimated at 14 % (25/180). Progression of the L4 slip (a parts per thousand yen3 mm), regardless of baseline condition, was observed in 23 participants after 15 years. In multiple regression analysis, significant risk factors for L4 slip progression were identified as age less than 60 years, female sex, lumbar axis sacral distance, facet sagittalization, and existence of slip at baseline. We successfully elucidated the risk factors for the progression of DS in a general population. Moreover, the results of this study identified preventive factors as well as risk factors for slip progression. This study provides useful information for physicians treating DS.	[Enyo, Yoshio; Yamada, Hiroshi; Hashizume, Hiroshi; Yoshida, Munehito] Wakayama Med Univ, Dept Orthoped Surg, Wakayama 6418509, Japan; [Yoshimura, Noriko] Univ Tokyo, Grad Sch Med, Dept Joint Dis Res, 22nd Century Med & Res Ctr, Tokyo, Japan	Enyo, Y (reprint author), Wakayama Med Univ, Dept Orthoped Surg, 811-1 Kimiidera, Wakayama 6418509, Japan.	yoshio19721220@gmail.com					Kalichman L, 2009, SPINE, V34, P199, DOI 10.1097/BRS.0b013e31818edcfd; Boden SD, 1996, J BONE JOINT SURG AM, V78A, P403; MACNAB I, 1950, J BONE JOINT SURG BR, V32, P325; MATSUNAGA S, 1990, SPINE, V15, P1204, DOI 10.1097/00007632-199011010-00021; Matsunaga S, 2000, J NEUROSURG, V93, P194, DOI 10.3171/spi.2000.93.2.0194; Yoshimura N, 2002, OSTEOPOROSIS INT, V13, P803, DOI 10.1007/s001980200111; Denard PJ, 2010, SPINE, V35, P1072, DOI 10.1097/BRS.0b013e3181bd9e19; Love TW, 1999, J BONE JOINT SURG BR, V81B, P670, DOI 10.1302/0301-620X.81B4.9682; NATHAN H, 1962, J BONE JOINT SURG AM, V44, P243; Kawakami M, 2002, SPINE, V27, P59, DOI 10.1097/00007632-200201010-00014; [Anonymous], 1982, CLIN ORTHOPAEDICS; Toyone T, 2009, SPINE, V34, P2259, DOI 10.1097/BRS.0b013e3181b20158; Aono K, 2010, SPINE, V35, P887, DOI 10.1097/BRS.0b013e3181cdd1aa; Vogt MT, 1998, SPINE, V23, P2640, DOI 10.1097/00007632-199812010-00020; Barrey C, 2007, EUR SPINE J, V16, P1459, DOI 10.1007/s00586-006-0294-6; Jacobsen S, 2007, SPINE, V32, P120, DOI 10.1097/01.brs.0000250979.12398.96; Berlemann U, 1998, Eur Spine J, V7, P376, DOI 10.1007/s005860050093; Farfan HF., 1973, MECH DISORDERS LOW B, P37; Fischgrund JS, 1997, SPINE, V22, P2807, DOI 10.1097/00007632-199712150-00003; GENANT HK, 1993, J BONE MINER RES, V8, P1137; JACKSON RP, 1994, SPINE, V19, P1611, DOI 10.1097/00007632-199407001-00010; Junghanns H, 1930, ARCH ORTHOP UNFALLCH, V29, P118; Kasamatsu T, 1991, J BONE MINER METAB S, V9, P50, DOI 10.1007/BF02375934; Kauppila LI, 1998, SPINE, V23, P1868, DOI 10.1097/00007632-199809010-00014; Ministry of Health and Welfare of Japan, 1990, RES NAT NUTR SURV 19; NEWMAN PH, 1963, J BONE JOINT SURG BR, V45, P39; SATO K, 1989, SPINE, V14, P1265, DOI 10.1097/00007632-198911000-00022; Weinstein JN, 2007, NEW ENGL J MED, V356, P2257, DOI 10.1056/NEJMoa070302; WILTSE LL, 1983, J BONE JOINT SURG AM, V65, P768; Yoshimura N, 1995, J EPIDEMIOL, V5, P171	30	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	NOV	2015	20	6					978	984		10.1007/s00776-015-0759-8		7	Orthopedics	Orthopedics	CX0XT	WOS:000365421500005		
J	Kikuchi, N; Matsudaira, K; Sawada, T; Oka, H				Kikuchi, Norimasa; Matsudaira, Ko; Sawada, Takayuki; Oka, Hiroyuki			Psychometric properties of the Japanese version of the Tampa Scale for Kinesiophobia (TSK-J) in patients with whiplash neck injury pain and/or low back pain	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							FEAR-AVOIDANCE-BELIEFS; QUESTIONNAIRE; RELIABILITY; ADAPTATION; VALIDATION; MOVEMENT; VALIDITY; PEOPLE; WORK	Although the Tampa Scale for Kinesiophobia (TSK) is useful for measuring fear of movement in patients with musculoskeletal pain, no psychometrically validated Japanese version is available. We evaluated the reliability and validity of the Japanese version of the TSK-J (original 17-item version and shorter 11-item version). The data subset used in this psychometric testing was derived from a survey previously conducted to collect information on musculoskeletal pain due to motor vehicle accident. For reliability, internal consistency was assessed via Cronbach's alpha coefficient. For concurrent validity, Pearson correlation coefficients of the TSK-J with the pain catastrophizing scale (PCS), euroqol 5 dimension (EQ-5D), and numerical rating scales (NRSs) for pain in the neck and back were calculated. For known-group validity, the relationship between variables (e.g., depression, somatic symptoms, treatment period) and the TSK-J score was examined. Data from 956 persons who had suffered from a motor vehicle accident were used in this analysis. For reliability, internal consistency was demonstrated, with Cronbach's alpha statistics of 0.850 (TSK-J17) and 0.919 (TSK-J11). For concurrent validity, significantly strong correlations were demonstrated between the TSK-J versions and PCS total score and subscales (r = 0.602-0.680). For known-group validity, as hypothesized, significantly higher TSK-J scores were observed in persons with depressive mood, somatic symptoms, and longer treatment period. The present analysis showed that the Japanese versions of the TSK-J17 and TSK-J11 were psychometrically reliable and valid for detecting fear of movement in the Japanese population suffering from neck to back pain due to a motor vehicle accident.	[Kikuchi, Norimasa; Sawada, Takayuki] Clin Study Support Inc, Naka Ku, Nagoya, Aichi 4600858, Japan; [Kikuchi, Norimasa; Sawada, Takayuki] Aichi Med Univ, Sch Med, Dept Publ Hlth, Nagakute, Aichi 48011, Japan; [Matsudaira, Ko; Oka, Hiroyuki] Univ Tokyo, Dept Med Res & Management Musculoskeletal Pain, 22nd Century Med & Res Ctr, Fac Med, Tokyo, Japan	Kikuchi, N (reprint author), Clin Study Support Inc, Naka Ku, Daiei Bldg,2F 1-11-20 Nishiki, Nagoya, Aichi 4600858, Japan.	norimasa_kikuchi@jp-css.com			JA Kyosai Research Institute; Japan Labor Health and Welfare Organization	This study was supported by grants from JA Kyosai Research Institute and the Japan Labor Health and Welfare Organization.	Bunketorp L, 2005, J REHABIL MED, V37, P330, DOI 10.1080/16501970510036411; Chou R, 2010, JAMA-J AM MED ASSOC, V303, P1295, DOI 10.1001/jama.2010.344; Koes BW, 2010, EUR SPINE J, V19, P2075, DOI 10.1007/s00586-010-1502-y; Fritz JM, 2001, PAIN, V94, P7, DOI 10.1016/S0304-3959(01)00333-5; Wong WS, 2010, J REHABIL MED, V42, P620, DOI 10.2340/16501977-0575; de Souza FS, 2008, SPINE, V33, P1028, DOI 10.1097/BRS.0b013e31816c8329; [Anonymous], 1951, PSYCHOMETRIKA; Visscher CM, 2010, PAIN, V150, P492, DOI 10.1016/j.pain.2010.06.002; Leeuw M, 2007, J BEHAV MED, V30, P77, DOI 10.1007/s10865-006-9085-0; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1037, DOI 10.1016/S0895-4356(98)00095-X; Vowles KE, 2003, PAIN, V101, P291, DOI 10.1016/S0304-3959(02)00337-8; Hapidou EG, 2012, PHYSIOTHER CAN, V64, P235, DOI 10.3138/ptc.2011-10; Dionne CE, 2008, SPINE, V33, P95, DOI 10.1097/BRS.0b013e31815e7f94; Mintken PE, 2010, ARCH PHYS MED REHAB, V91, P1128, DOI 10.1016/j.apmr.2010.04.009; Haugen AJ, 2008, SPINE, V33, pE595, DOI 10.1097/BRS.0b013e31817c6c4b; Burwinkle T, 2005, J PAIN, V6, P384, DOI 10.1016/j.jpain.2005.01.355; Askary-Ashtiani A, 2014, SPINE, V39, pE1095, DOI 10.1097/BRS.0000000000000438; Woby SR, 2005, PAIN, V117, P137, DOI 10.1016/j.pain.2005.05.029; Walton DM, 2009, J ORTHOP SPORT PHYS, V39, P334, DOI 10.2519/jospt.2009.2765; Larsson C, 2014, PHYSIOTHER THEOR PR, V30, P421, DOI 10.3109/09593985.2013.877546; Cohen J., 1988, STAT POWER ANAL BEHA; Devellis RF, 1991, SCALE DEV THEORY APP; EuroQol Group, 1990, Health Policy, V16, P199; Koho P, 2014, PHYSIOTHERAPY, V100, P356, DOI 10.1016/j.physio.2013.11.007; Matsudaira K, 2012, SEIKEI GEKA, V63, P149; Matsudaira K, 2013, SEIKEI GEKA, V48, P13; Matsuoka H, 2007, JPN J PSYCHOSOM MED, V47, P95; Rusu AC, 2014, BMC MUSCULOSKEL DIS, V19, P280; Swinkels-Meewisse EJCM, 2003, MANUAL THER, V8, P29, DOI 10.1054/math.2002.484; Yamazaki Shin, 2005, Health Qual Life Outcomes, V3, P48, DOI 10.1186/1477-7525-3-48	30	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	NOV	2015	20	6					985	992		10.1007/s00776-015-0751-3		8	Orthopedics	Orthopedics	CX0XT	WOS:000365421500006		
J	Kataoka, T; Moritomo, H; Omori, S; Iida, A; Omokawa, S; Suzuki, D; Fujimiya, M; Wada, T; Aoki, M; Yoshikawa, H				Kataoka, Toshiyuki; Moritomo, Hisao; Omori, Shinsuke; Iida, Akio; Omokawa, Shohei; Suzuki, Daisuke; Fujimiya, Mineko; Wada, Takuro; Aoki, Mitsuhiro; Yoshikawa, Hideki			Pressure and tendon strain in the sixth extensor compartment of the wrist during simulated provocative maneuvers for diagnosing extensor carpi ulnaris tendinitis	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							MOTION	Various provocative maneuvers for diagnosing extensor carpi ulnaris (ECU) tendinitis have been reported; however, it remains unclear which maneuver is the most sensitive to detect ECU tendinitis. To clarify this, we investigated and compared the extratendinous pressure and ECU tendon strain in the sixth extensor compartment of the wrist during various provocative maneuvers for diagnosing ECU tendinitis. Nine upper extremities from nine fresh-frozen cadavers were examined. We investigated extratendinous pressure in the ECU fibro-osseous tunnel of the distal ulna and ECU tendon strain during eight forearm positions-neutral rotation, pronation, supination, pronation with wrist flexion, supination with wrist flexion, supination with wrist extension, both hand and forearm supination, and supination with ECU full loading-to simulate provocative maneuvers reported to detect ECU tendinitis. Pressure was significantly higher during both hand and forearm supination (carpal supination test) and during supination with wrist extension (prayer's hand supination test) than during neutral rotation. The pressure during the carpal supination test was 3 times higher than that during the prayer's hand supination test and 27 times higher than that during the neutral position. Strain was significantly higher during the carpal supination test and during supination with ECU full loading (the ECU synergy test) than during other maneuvers. Both pressure and tendon strain increased most notably during the carpal supination test compared to the other maneuvers, which suggests that the carpal supination test is the most sensitive for the detection of ECU tendinitis.	[Kataoka, Toshiyuki] Hoshigaoka Med Ctr, Dept Orthoped Surg, Hirakata, Osaka, Japan; [Moritomo, Hisao] Osaka Yukioka Coll Hlth Sci, Yukioka Hosp Hand Ctr, Kita Ku, Osaka, Osaka 5300021, Japan; [Omori, Shinsuke; Yoshikawa, Hideki] Osaka Univ, Dept Orthoped Surg, Grad Sch Med, Suita, Osaka, Japan; [Iida, Akio] Hanna Cent Hosp, Dept Orthoped Surg, Nara, Japan; [Omokawa, Shohei] Nara Med Univ, Dept Orthoped Surg, Kashihara, Nara 634, Japan; [Suzuki, Daisuke; Fujimiya, Mineko] Sapporo Med Univ, Dept Anat Sect 2, Sch Hlth Sci, Sapporo, Hokkaido, Japan; [Suzuki, Daisuke; Fujimiya, Mineko] Hokkaido Univ, Sch Med, Sapporo, Hokkaido 060, Japan; [Wada, Takuro] Sapporo Med Univ, Dept Orthoped Surg, Sch Med, Sapporo, Hokkaido, Japan; [Aoki, Mitsuhiro] Sapporo Daiichi Hosp, Dept Orthoped Surg, Sapporo, Hokkaido, Japan	Moritomo, H (reprint author), Osaka Yukioka Coll Hlth Sci, Yukioka Hosp Hand Ctr, Kita Ku, Osaka, Osaka 5300021, Japan.	hisao-moritomo@yukioka-u.ac.jp					TALEISNIK J, 1987, HAND CLIN, V3, P51; Aoki M, 2005, J BONE JOINT SURG AM, V87A, P2508, DOI 10.2106/JBJS.D.02989; Takasaki H, 2008, J ORTHOP SPORT PHYS, V38, P257, DOI 10.2519/jospt.2008.2672; Takasaki H, 2007, J SHOULDER ELB SURG, V16, P854, DOI 10.1016/j.jse.2007.03.022; Poca MA, 2002, J NEUROTRAUM, V19, P439, DOI 10.1089/08977150252932398; Kobayashi M, 1997, J BIOMECH, V30, P1165, DOI 10.1016/S0021-9290(97)00080-8; Ruland RT, 2008, J HAND SURG-AM, V33A, P1777, DOI 10.1016/j.jhsa.2008.08.018; Aso K, 2000, J JPN SOC SURG HAND, V17, P280; Aso K, 2006, J JPN SOC SURG HAND, V23, P393; Futami T, 1989, J JPN SOC SURG HAND, V6, P499; Kaplan EB, 1965, FUNCTIONAL SURG ANAT, P191; Kotwica Z, 1992, Neurol Neurochir Pol, V26, P671; Nagaoka M, 1994, J JPN SOC SURG HAND, V11, P252; Yoshida T, 2010, J JPN SOC SURG HAND, V26, P383	14	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	NOV	2015	20	6					993	998		10.1007/s00776-015-0772-y		6	Orthopedics	Orthopedics	CX0XT	WOS:000365421500007		
J	Tanaka, Y; Gotani, H; Yano, K; Sasaki, K; Miyashita, M; Hamada, Y				Tanaka, Yoshitaka; Gotani, Hiroyuki; Yano, Koichi; Sasaki, Kosuke; Miyashita, Masahiro; Hamada, Yoshitaka			Sonographic evaluation of effects of the volar plate on trigger finger	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							1ST ANNULAR PULLEY; A1 PULLEY; TENDON; ULTRASOUND; APPEARANCE	We evaluated trigger fingers ultrasonographically and clarified differences between fingers with and without continuous locking or snapping symptoms according to the thicknesses of the A1 pulley, flexor tendon and volar plate. We evaluated 26 trigger fingers, divided into two groups: Group 1, 14 fingers with locking or snapping; and Group 2, 12 fingers without such symptoms. We also evaluated 26 contralateral fingers as controls (Control 1 and 2 groups). We compared each group to the respective control group according to thickness of the A1 pulley and volar plate, and cross-sectional area of the flexor tendon. In addition, nine fingers with locking or snapping and treated using corticosteroid injection were evaluated according to symptoms and sonographic findings 3-4 weeks after treatment. Thickness of the A1 pulley and cross-sectional area of the flexor tendon were greater in both Groups 1 and 2 than in controls. Thickness of the volar plate was greater in Group 1 than in Control 1, although no significant difference was seen between Group 2 and Control 2. In Group 1, eight of the nine fingers showed an alleviation of locking or snapping symptoms with corticosteroid injection, and sonographic findings showed that thickness of the volar plate was significantly decreased with corticosteroid injection, in addition to reduced thickness of the A1 pulley. In addition to thickening of the A1 pulley, thickening of the volar plate may represent an important contributor to continuous snapping or locking symptoms.	[Tanaka, Yoshitaka; Gotani, Hiroyuki; Sasaki, Kosuke; Miyashita, Masahiro; Hamada, Yoshitaka] Osaka Ekisaikai Hosp, Dept Orthopaed Hand, Nishi Ku, Osaka, Osaka 5500022, Japan; [Tanaka, Yoshitaka; Gotani, Hiroyuki; Sasaki, Kosuke; Miyashita, Masahiro; Hamada, Yoshitaka] Osaka Ekisaikai Hosp, Microsurg Ctr, Nishi Ku, Osaka, Osaka 5500022, Japan; [Yano, Koichi] Seikeikai Hosp, Dept Orthopaed Hand, Sakai Ku, Sakai, Osaka 5900024, Japan; [Yano, Koichi] Seikeikai Hosp, Microsurg Ctr, Sakai Ku, Sakai, Osaka 5900024, Japan	Tanaka, Y (reprint author), Osaka Ekisaikai Hosp, Dept Orthopaed Hand, Nishi Ku, 2-1-10 Honden, Osaka, Osaka 5500022, Japan.	yoshi1869@paw.hi-ho.ne.jp					Yoshii Y, 2009, J BONE JOINT SURG AM, V91A, P2922, DOI 10.2106/JBJS.H.01653; Guerini H, 2008, J ULTRAS MED, V27, P1407; Ekizos A, 2013, J ELECTROMYOGR KINES, V23, P1278, DOI 10.1016/j.jelekin.2013.08.004; Serafini G, 1996, J ULTRAS MED, V15, P213; Fortin M, 2012, PHYS THER, V92, P853, DOI 10.2522/ptj.20110380; Miyamoto H, 2011, J HAND SURG-AM, V36A, P1486, DOI 10.1016/j.jhsa.2011.05.038; Sato J, 2012, J HAND SURG-AM, V37A, P2012, DOI 10.1016/j.jhsa.2012.06.027; Lee DH, 2011, J ULTRAS MED, V30, P197; Gruber H, 2011, ULTRASOUND MED BIOL, V37, P688, DOI 10.1016/j.ultrasmedbio.2011.01.019; Bodor M, 2009, J ULTRAS MED, V28, P737; KETCHUM LD, 1967, PLAST RECONSTR SURG, V40, P89, DOI 10.1097/00006534-196707000-00016; Liu KJ, 2013, J HAND SURG-AM, V38A, P1933, DOI 10.1016/j.jhsa.2013.06.033; Ryzewicz M, 2006, J HAND SURG-AM, V31A, P135, DOI 10.1016/j.jhsa.2005.10.013; Godey Shashi Kanth, 2006, Acta Orthop Belg, V72, P633; Kim HR, 2010, RHEUMATOL INT, V30, P1455, DOI 10.1007/s00296-009-1165-3; Vuillemin V, 2012, J Ultrasound, V15, P20, DOI 10.1016/j.jus.2012.02.002	16	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	NOV	2015	20	6					999	1004		10.1007/s00776-015-0752-2		6	Orthopedics	Orthopedics	CX0XT	WOS:000365421500008		
J	Shirato, R; Wada, T; Aoki, M; Iba, K; Kanaya, K; Fujimiya, M; Yamashita, T				Shirato, Rikiya; Wada, Takuro; Aoki, Mitsuhiro; Iba, Kousuke; Kanaya, Kohei; Fujimiya, Mineko; Yamashita, Toshihiko			Effect of simultaneous stretching of the wrist and finger extensors for lateral epicondylitis: a gross anatomical study of the tendinous origins of the extensor carpi radialis brevis and extensor digitorum communis	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							RANDOMIZED CONTROLLED-TRIAL; TERM-FOLLOW-UP; TENNIS ELBOW; MUSCLE; DEBRIDEMENT	Pulling the wrist into flexion with the elbow in extension and forearm in pronation has been used as the stretching technique of wrist extensors for lateral epicondylitis. Simultaneous stretching of the fingers in addition to the wrist flexion has also been applied. However, the mechanism of this simultaneous stretching has not been clarified. This study is designed to clarify the mechanism underlying this simultaneous stretching technique based on the anatomical features of the origins of the extensor carpi radialis brevis (ECRB) and extensor digitorum communis (EDC). Thirty-nine arms from formalin-embalmed Japanese human specimens were dissected. The features of the origins of the ECRB and EDC were macroscopically observed, and the locations of each origin on the lateral epicondyle were measured. The ECRB had a long and wide, purely tendinous origin which originated from the anterior slope of the lateral epicondyle. The tendinous origin of the index finger of the EDC (EDC-IF) arose from the posterior aspect of the ECRB tendinous origin, with a coexisting muscular portion observed at the level of the proximal forearm. The middle finger of the EDC (EDC-MF) had a short tendinous origin with an associated muscular portion and originated proximo-laterally to the origin of the ECRB on the lateral epicondyle. In addition, the muscular origin of the EDC-MF arose on the superficial and posterior aspect of the ECRB tendinous origin. In contrast, the ring and little fingers of the EDC originated from the tendinous septum of the extensor digiti minimi and extensor carpi ulnaris, and had no connection with the ECRB tendinous origin. On the basis of our anatomical findings, simultaneous stretching of the wrist extensors by wrist, index and middle fingers flexion could provide stretching force to both the tendinous origins of the ECRB and EDC through the EDC-IF and EDC-MF.	[Shirato, Rikiya; Iba, Kousuke; Kanaya, Kohei; Yamashita, Toshihiko] Sapporo Med Univ, Dept Orthopaed Surg, Chuo Ku, Sapporo, Hokkaido 0608556, Japan; [Wada, Takuro] Saiseikai Otaru Hosp, Dept Orthopaed Surg, Otaru, Hokkaido, Japan; [Aoki, Mitsuhiro] Hlth Sci Univ Hokkaido, Sch Rehabil Sci, Dept Orthoped, Ishikari, Hokkaido 06102, Japan; [Fujimiya, Mineko] Sapporo Med Univ, Dept Anat 2, Sapporo, Hokkaido, Japan	Shirato, R (reprint author), Sapporo Med Univ, Dept Orthopaed Surg, Chuo Ku, South 1,West 16, Sapporo, Hokkaido 0608556, Japan.	rshirato@sapmed.ac.jp					Allman Jr FL, 1995, UPPER EXTREMITY SPOR, P335; STOECKART R, 1989, CLIN BIOMECH, V4, P210, DOI 10.1016/0268-0033(89)90004-1; KELLETT J, 1986, MED SCI SPORT EXER, V18, P489; Cyriax JH, 1936, J BONE JOINT SURG, V18, P921; Wilke HJ, 1996, J BIOMECH, V29, P1629, DOI 10.1016/0021-9290(96)00085-1; Brach P, 2006, J HAND THER, V19, P228, DOI 10.1197/j.jht.2006.02.013; Smidt N, 2002, LANCET, V359, P657, DOI 10.1016/S0140-6736(02)07811-X; Takasaki H, 2007, J SHOULDER ELB SURG, V16, P854, DOI 10.1016/j.jse.2007.03.022; Zingg PO, 2006, J SHOULDER ELB SURG, V15, P347, DOI 10.1016/j.jse.2005.07.002; Cohen MS, 2008, J SHOULDER ELB SURG, V17, P954, DOI 10.1016/j.jse.2008.02.021; MacDermid JC, 2010, J HAND THER, V23, P18, DOI 10.1016/j.jht.2009.09.009; Lattermann C, 2010, J SHOULDER ELB SURG, V19, P651, DOI 10.1016/j.jse.2010.02.008; Bisset LM, 2014, J ORTHOP SPORT PHYS, V44, P120, DOI 10.2519/jospt.2014.4744; Fairbank SM, 2002, J HAND SURG-BRIT EUR, V27B, P405, DOI 10.1054/jhsb.2002.0761; Pienimaki T, 1998, SCAND J REHABIL MED, V30, P159; LABELLE H, 1992, J BONE JOINT SURG BR, V74, P646; Sharma P, 2005, J BONE JOINT SURG AM, V87A, P187, DOI 10.2106/JBJS.D.01850; NIRSCHL RP, 1979, J BONE JOINT SURG AM, V61, P832; Bunata RE, 2007, J BONE JOINT SURG AM, V89A, P1955, DOI 10.2106/JBJS.F.00727; Solveborn SA, 1997, SCAND J MED SCI SPOR, V7, P229; Boyer MI, 1999, J SHOULDER ELB SURG, V8, P481, DOI 10.1016/S1058-2746(99)90081-2; Braybon W, 1995, SPORTS PHYSIOTHERAPY, P407; BRIGGS CA, 1985, ANAT CLIN, V7, P149, DOI 10.1007/BF01654635; Kushner S, 1986, J Orthop Sports Phys Ther, V7, P264; Martinez-Silvestrini Julio A, 2005, J Hand Ther, V18, P411, DOI 10.1197/j.jht.2005.07.007; Nagrale Amit V, 2009, J Man Manip Ther, V17, P171; Nirschl R P, 1973, Orthop Clin North Am, V4, P787; Oatis CA, 2004, KINESIOLOGY MECH PAT; Palastanga N, 2012, ANATOMY HUMAN MOVEME	29	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	NOV	2015	20	6					1005	1011		10.1007/s00776-015-0758-9		7	Orthopedics	Orthopedics	CX0XT	WOS:000365421500009		
J	Niki, Y; Takeda, Y; Harato, K; Suda, Y				Niki, Yasuo; Takeda, Yuki; Harato, Kengo; Suda, Yasunori			Factors affecting the achievement of Japanese-style deep knee flexion after total knee arthroplasty using posterior-stabilized prosthesis with high-flex knee design	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							CONDYLAR OFFSET; JOINT GAP; FLUOROSCOPIC ANALYSIS; TIBIAL SLOPE; REPLACEMENT; KINEMATICS; IMPLANT; SYSTEM; RANGE; RATIO	Achievement of very deep knee flexion after total knee arthroplasty (TKA) can play a critical role in the satisfaction of patients who demand a floor-sitting lifestyle and engage in high-flexion daily activities (e.g., seiza-sitting). Seiza-sitting is characterized by the knees flexed > 145A(0) and feet turned sole upwards underneath the buttocks with the tibia internally rotated. The present study investigated factors affecting the achievement of seiza-sitting after TKA using posterior-stabilized total knee prosthesis with high-flex knee design. Subjects comprised 32 patients who underwent TKA with high-flex knee prosthesis and achieved seiza-sitting (knee flexion > 145A(0)) postoperatively. Another 32 patients served as controls who were capable of knee flexion > 145A(0) preoperatively, but failed to achieve seiza-sitting postoperatively. Accuracy of femoral and tibial component positions was assessed in terms of deviation from the ideal position using a two-dimensional to three-dimensional matching technique. Accuracies of the component position, posterior condylar offset ratio and intraoperative gap length were compared between the two groups. The proportion of patients with > 3A(0) internally rotated tibial component was significantly higher in patients who failed at seiza-sitting (41 %) than among patients who achieved it (13 %, p = 0.021). Comparison of intraoperative gap length between patient groups revealed that gap length at 135A(0) flexion was significantly larger in patients who achieved seiza-sitting (4.2 +/- A 0.4 mm) than in patients who failed at it (2.7 +/- A 0.4 mm, p = 0.007). Conversely, no significant differences in gap inclination were seen between the groups. From the perspective of surgical factors, accurate implant positioning, particularly rotational alignment of the tibial component, and maintenance of a sufficient joint gap at 135A(0) flexion appear to represent critical factors for achieving > 145A(0) of deep knee flexion after TKA.	[Niki, Yasuo; Takeda, Yuki; Harato, Kengo; Suda, Yasunori] Keio Univ, Dept Orthopaed Surg, Shinjuku Ku, Tokyo 1608582, Japan	Niki, Y (reprint author), Keio Univ, Dept Orthopaed Surg, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	y.niki@lib.bekkoame.ne.jp					FIGGIE HE, 1986, J BONE JOINT SURG AM, V68A, P1035; Bellemans J, 2002, J BONE JOINT SURG BR, V84B, P50, DOI 10.1302/0301-620X.84B1.12432; Matsumoto T, 2006, J BIOMECH ENG-T ASME, V128, P867, DOI 10.1115/1.2354201; Fujimoto E, 2013, KNEE SURG SPORT TR A, V21, P2704, DOI 10.1007/s00167-012-2059-6; Fu PL, 2009, KNEE, V16, P280, DOI 10.1016/j.knee.2008.12.012; Matsuda Y, 2005, J BONE JOINT SURG BR, V87B, P804, DOI 10.1302/0301-620X.87B6.15256; Dennis DA, 1998, CLIN ORTHOP RELAT R, P47; Nakayama K, 2005, J BONE JOINT SURG BR, V87B, P483, DOI 10.1302/0301-620X.87B4; Unitt L, 2008, J BONE JOINT SURG BR, V90B, P159, DOI 10.1302/0301-620X.90B2.19327; Massin P, 2006, J ARTHROPLASTY, V21, P889, DOI 10.1016/j.arth.2005.10.019; Ranawat CS, 1997, J BONE JOINT SURG AM, V79A, P342; Shi XJ, 2013, KNEE SURG SPORT TR A, V21, P2696, DOI 10.1007/s00167-012-2058-7; Acker SM, 2011, J ARTHROPLASTY, V26, P319, DOI 10.1016/j.arth.2010.08.003; Sharkey PF, 2011, J ARTHROPLASTY, V26, P1427, DOI 10.1016/j.arth.2010.10.009; Matsumoto T, 2007, KNEE SURG SPORT TR A, V15, P1013, DOI 10.1007/s00167-007-0331-y; Devers BN, 2011, J ARTHROPLASTY, V26, P178, DOI 10.1016/j.arth.2010.02.008; Niki Y, 2011, KNEE SURG SPORT TR A, V19, P973, DOI 10.1007/s00167-010-1323-x; Higuchi H, 2009, INT ORTHOP, V33, P997, DOI 10.1007/s00264-009-0772-7; Watanabe T, 2013, CLIN ORTHOP RELAT R, V471, P1326, DOI 10.1007/s11999-012-2755-z; Soda Y, 2007, ARCH ORTHOP TRAUM SU, V127, P167, DOI 10.1007/s00402-007-0295-x; Hanratty BM, 2007, J BONE JOINT SURG BR, V89B, P915, DOI 10.1302/0301-620X.89B7.18920; Niki Y, 2010, J ARTHROPLASTY, V25, P381, DOI 10.1016/j.arth.2009.01.004; Scuderi GR, 2005, J ARTHROPLASTY, V20, P23, DOI 10.1016/j.arth.2005.03.014; Meneghini RM, 2006, J ARTHROPLASTY, V21, P116, DOI 10.1016/j.arth.2006.04.014; [Anonymous], 2003, CLIN ORTHOP REALT RE, DOI 10.1097/01.blo.0000092986.12414.b5; Wyss T, 2008, ARCH ORTHOP TRAUM SU, V128, P129, DOI 10.1007/s00402-007-0541-2; Boldt JG, 2006, INT ORTHOP, V30, P420, DOI 10.1007/s00264-006-0085-z; Ritter MA, 2003, J BONE JOINT SURG AM, V85A, P1278; Niki Y, 2013, BONE JOINT J, V95B, P782, DOI 10.1302/0301-620X.95B6.30757; Gejo R, 2008, CLIN ORTHOP RELAT R, V466, P946, DOI 10.1007/s11999-008-0154-2; Ayers DC, 2005, CLIN ORTHOP RELAT R, P157, DOI 10.1097/01.blo.0000185447.43622.93; Bhimji Safia, 2008, J Knee Surg, V21, P315; Kim Jong-Heon, 2013, Knee Surg Relat Res, V25, P54, DOI 10.5792/ksrr.2013.25.2.54; Niki Y., 2011, KNEE SURG SPORT TR A, V19, P1610; Niki Y, 2010, J ARTHROPLASTY, V25	35	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	NOV	2015	20	6					1012	1018		10.1007/s00776-015-0769-6		7	Orthopedics	Orthopedics	CX0XT	WOS:000365421500010		
J	Shima, H; Okuda, R; Yasuda, T; Jotoku, T; Hida, T; Mori, K; Neo, M				Shima, Hiroaki; Okuda, Ryuzo; Yasuda, Toshito; Jotoku, Tsuyoshi; Hida, Takashi; Mori, Katsunori; Neo, Masashi			Surgical reduction and ligament reconstruction for chronic dorsal dislocation of the lesser metatarsophalangeal joint associated with hallux valgus	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							PROXIMAL METATARSAL OSTEOTOMY; STANDARD RATING SYSTEM; SOFT-TISSUE PROCEDURE; PLANTAR PLATE; 2ND TOE; OUTCOME MEASUREMENT; INSTABILITY; REPAIR; DEFORMITIES; DISORDERS	Hallux valgus (HV) is occasionally associated with chronic dislocation of the lesser metatarsophalangeal (MTP) joints. We have developed a novel surgical procedure to treat dislocation of the lesser MTP joints. This study aimed to describe our procedure and investigate the outcomes of surgical intervention in the treatment of HV with dislocation of the lesser MTP joints. Twenty-three patients (27 feet, average age: 63.6 years, average follow-up: 49.5 months; a minimum follow-up of 24 months) underwent surgical intervention for HV and dislocation of the lesser MTP joints. Twenty-three feet had dislocation (10 feet) or subluxation (13 feet) of the second MTP joint, whereas 4 feet had dislocation of the second and third MTP joints. The surgical procedure included a distal soft-tissue procedure combined with proximal osteotomy for correction of the HV, and reconstruction of the collateral ligaments (CL) following open reduction with complete release of the capsule and the CL at the metatarsal head for dislocation of the lesser MTP joints. Outcomes were assessed using the Japanese Society for Surgery of the Foot (JSSF) scale and radiological examinations. The JSSF score improved significantly from an average of 49.7 points preoperatively to 93.1 points postoperatively. The average HV angle and intermetatarsal angle decreased significantly from 44.6A degrees and 18.1A degrees preoperatively to 7.9A degrees and 6.0A degrees postoperatively, respectively. The average extension and flexion of the second MTP joint was 53.1A degrees and 13.8A degrees at the most recent follow-up, respectively. Postoperatively, no feet had dislocation of the second or third MTP joint, three had subluxation of the second MTP joint, and one had subluxation of the third MTP joint. Osteoarthritis of the lesser MTP joint had developed in two feet (7.4 %) at the time of the most recent follow-up. Our surgical procedure achieved significant correction of HV, a low rate of postoperative re-dislocation of the lesser MTP joints, and significant improvement of pain and function for symptomatic moderate-to-severe HV with dislocation of the lesser MTP joints. Level IV, retrospective case series.	[Shima, Hiroaki; Yasuda, Toshito; Jotoku, Tsuyoshi; Hida, Takashi; Mori, Katsunori; Neo, Masashi] Osaka Med Coll, Dept Orthoped Surg, Takatsuki, Osaka 569, Japan; [Okuda, Ryuzo] Shimizu Hosp, Dept Orthopaed Surg, Nishikyou Ku, Kyoto, Japan	Shima, H (reprint author), Osaka Med Coll, Dept Orthoped Surg, 2-7 Daigaku Machi, Takatsuki, Osaka 569, Japan.	ort125@poh.osaka-med.ac.jp; ort071@poh.osaka-med.ac.jp; ort028@poh.osaka-med.ac.jp; ort032@poh.osaka-med.ac.jp; ort153@poh.osaka-med.ac.jp; fb76cat@gmail.com; neo@poh.osaka-med.ac.jp					Chow FYH, 2008, FOOT ANKLE INT, V29, P29, DOI 10.3113/FAI.2008.0029; COUGHLIN MJ, 1987, FOOT ANKLE, V8, P29; Gazdag A, 1998, FOOT ANKLE INT, V19, P137; HELAL B, 1975, J BONE JOINT SURG BR, V57, P187; THOMPSON FM, 1987, ORTHOPEDICS, V10, P83; Barg A, 2012, FOOT ANKLE INT, V33, P877, DOI 10.3113/FAI.2012.0877; Barouk LS, 1996, ORTHOPADE, V25, P338, DOI 10.1007/s001320050034; Myerson MS, 2005, FOOT ANKLE INT, V26, P675; BHATIA D, 1994, J BONE JOINT SURG AM, V76A, P1371; Niki H, 2005, J ORTHOP SCI, V10, P466, DOI 10.1007/s00776-005-0937-1; Okuda R, 2001, FOOT ANKLE INT, V22, P203; MANN RA, 1992, J BONE JOINT SURG AM, V74A, P124; Shima H, 2009, J BONE JOINT SURG AM, V91A, P1369, DOI 10.2106/JBJS.H.00483; CRACCHIOLO A, 1988, FOOT ANKLE, V9, P10; Watson TS, 2014, FOOT ANKLE INT, V35, P730, DOI 10.1177/1071100714536540; Niki H, 2005, J ORTHOP SCI, V10, P457, DOI 10.1007/s00776-005-0936-2; COUGHLIN MJ, 1987, ORTHOPEDICS, V10, P63; Kaz AJ, 2007, FOOT ANKLE INT, V28, P1223, DOI 10.3113/FAI.2007.1223; Okuda R, 2000, CLIN ORTHOP RELAT R, P209; Peck CN, 2012, FOOT ANKLE INT, V33, P565, DOI [10.3113/FAI.2012.0001, 10.3113/FAI.2012.0565]; SCHECK M, 1968, J BONE JOINT SURG AM, VA 50, P727; Bouche RT, 2008, J FOOT ANKLE SURG, V47, P125, DOI [10.1053/j.jfas.2007.12.008, 10.1053/j.fas.2007.12.008]; Branch HE, 1937, J BONE JOINT SURG, V19, P978; Deland J T, 1992, Foot Ankle, V13, P391; Devos Bevernage B, 2010, FOOT ANKLE SURG, V16, P153; Ford L A, 1998, J Foot Ankle Surg, V37, P217; HATTRUP SJ, 1988, CLIN ORTHOP RELAT R, P182; Nery C, 2014, FOOT ANKLE INT, V35, P876, DOI 10.1177/1071100714539659; Okuda R, 2004, CENT JPN J ORTHOP TR, V47, P1037; Okuda R., 2009, J JOINT SURG JPN, V28, P851	30	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	NOV	2015	20	6					1019	1029		10.1007/s00776-015-0756-y		11	Orthopedics	Orthopedics	CX0XT	WOS:000365421500011		
J	Takahashi, A; Sugita, T; Aizawa, T; Chiba, D; Kamimura, M; Aki, T; Itoi, E				Takahashi, Atsushi; Sugita, Takehiko; Aizawa, Toshimi; Chiba, Daisuke; Kamimura, Masayuki; Aki, Takashi; Itoi, Eiji			Potential risk of excising the femoral insertion of the popliteus tendon during primary total knee arthroplasty: a biometric study	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							POPLITEOFIBULAR LIGAMENT; RECONSTRUCTION; STABILITY; RESECTION; RELEASE; ANATOMY; FEMUR	During total knee arthroplasty (TKA), excision of the popliteus tendon leads to extensive static gaps and reduced mobility. The purpose of this study was to determine the positional relationship between the femoral insertion of the popliteus tendon and the bone cutting lines of various TKA systems. This study included 21 cadaveric right femurs presenting no macroscopic deformity. The lateral image of the femur and the template of the femoral component were overlaid to determine the preservation/excision of the popliteus tendon insertion. TKA systems used were Genesis II, NexGen, low contact stress (LCS), PFC I pound, Scorpio, and Vanguard. The knees in which the insertion was preserved in all implants or excised in at least one implant were classified into intact or the high-risk groups, respectively. The popliteus tendon was preserved in all specimens with the LCS system. In contrast, the popliteus tendon insertion was excised in a parts per thousand yen1/3 of the specimens with the other systems. The anteroposterior diameter was significantly larger in the intact group than that in the high-risk group (58.1 +/- A 4.5 mm vs. 53.7 +/- A 2.7 mm; p = 0.018). The high-risk group included more knees from female cadavers than the intact group (70 vs. 9 %; p = 0.008). During primary TKA, the femoral insertion of the popliteus tendon could be inevitably excised, regardless of technical problems. We demonstrate that the unique design of the LCS system preserves the popliteus tendon insertion. In addition, small knees and females may be risk factors for excision of the insertion.	[Takahashi, Atsushi; Aizawa, Toshimi; Chiba, Daisuke; Kamimura, Masayuki; Aki, Takashi; Itoi, Eiji] Tohoku Univ, Sch Med, Dept Orthopaed Surg, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Sugita, Takehiko] Tohoku Orthopaed Clin, Izumiku Ku, Sendai, Miyagi 9813121, Japan	Takahashi, A (reprint author), Tohoku Univ, Sch Med, Dept Orthopaed Surg, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	a-takahashi@med.tohoku.ac.jp					Fok AWM, 2014, AM J SPORT MED, V42, P394, DOI 10.1177/0363546513510388; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Peters CL, 2008, J BONE JOINT SURG AM, V90A, P40, DOI 10.2106/JBJS.H.00687; Jung GH, 2010, ARCH ORTHOP TRAUM SU, V130, P1027, DOI [10.1007/s00402-010-1123-2, 10.1007/s00402-010-1077-4]; TRIA AJ, 1989, J BONE JOINT SURG AM, V71A, P714; Tantavisut S, 2012, KNEE, V19, P597, DOI 10.1016/j.knee.2011.06.017; LaPrade RF, 2003, AM J SPORT MED, V31, P854; Lustig S, 2008, KNEE SURG SPORT TR A, V16, P674, DOI 10.1007/s00167-008-0551-9; YOSHIOKA Y, 1987, J BONE JOINT SURG AM, V69A, P873; Nyland J, 2005, J ORTHOP SPORT PHYS, V35, P165; de Simone V, 2012, INT ORTHOP, V36, P2061, DOI 10.1007/s00264-012-1631-5; Pietrini SD, 2009, AM J SPORT MED, V37, P542, DOI 10.1177/0363546508328117; LaPrade RF, 2010, AM J SPORT MED, V38, P543, DOI 10.1177/0363546509349493; Kanamiya T, 2002, CLIN ORTHOP RELAT R, P24, DOI 10.1097/01.blo.0000030519.43495.85; Yang JH, 2011, KNEE SURG SPORT TR A, V19, P1669, DOI 10.1007/s00167-011-1442-z; Pasque C, 2003, J BONE JOINT SURG BR, V85B, P292, DOI 10.1302/0301-620X.85B2.12857; Kamath GV, 2010, AM J SPORT MED, V38, P570, DOI 10.1177/0363546509350066; Kesman TJ, 2011, CLIN ORTHOP RELAT R, V469, P76, DOI 10.1007/s11999-010-1525-z; BASMAJIA.JV, 1971, J BONE JOINT SURG AM, VA 53, P557; Takeda S, 2015, KNEE SURG SPORT TR A, V23, P3049, DOI 10.1007/s00167-014-3059-5	20	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	NOV	2015	20	6					1030	1035		10.1007/s00776-015-0773-x		6	Orthopedics	Orthopedics	CX0XT	WOS:000365421500012		
J	Otsuka, A; Morita, M; Yamada, H				Otsuka, Akiyo; Morita, Mitsuhiro; Yamada, Harumoto			Clinical characteristics of Japanese patients with axial spondyloarthritis, and short-term efficacy of adalimumab	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							NECROSIS-FACTOR-ALPHA; ANKYLOSING-SPONDYLITIS; 2010 UPDATE; BACK-PAIN; HLA-B; DISEASE; RECOMMENDATIONS; MULTICENTER; SEVERITY; ANTIGENS	Ankylosing spondylitis (AS) is rarer in Japan than in Europe, probably because the European criteria, not well known by Japanese general physicians, regard AS as a progressive stage of axial spondyloarthritis (SpA). HLA-B27 is an important diagnostic marker of SpA; however, the incidence of the HLA-B27 allele is as low as 0.4 % in Japan. For Japanese SpA patients, other HLA alleles and clinical findings are required for earlier definitive diagnosis, for determining appropriate treatment timing, and for disease monitoring. We investigated the HLA-B alleles of 36 patients clinically diagnosed with SpA. For 8 axial SpA patients we evaluated the short-term efficacy of subcutaneous adalimumab injections (40 mg every other week for a parts per thousand yen11 months). Treatment efficacy was evaluated by use of the Bath Ankylosing Spondylitis Activity Index (BASDAI) score, and serum TNF-alpha and IL-6 levels were measured pre and post-treatment. Among the 36 Japanese SpA patients, the HLA-B27 allele occurred infrequently (5.6 %) whereas the HLA-B44 and 61 alleles were the most frequently detected (25.0 %). We also detected severe bamboo spine on radiography in the absence of the HLA-B27 allele. All 8 patients with axial SpA experienced significant symptom improvement after adalimumab treatment; the HLA-B27 allele was absent from these patients. Serum TNF-alpha and IL-6 levels were elevated in cases with remarkable inflammatory pain and high disease activity. These cytokines decreased after therapy, however. Most patients with normal cytokine levels at baseline retained these low levels. The findings reveal the short-term efficacy of adalimumab. The remarkably low incidence of HLA-B27 among our patients indicates that HLA-B distribution is different from that in other countries. Serum TNF-alpha and IL-6 levels were not effective as biomarkers for cases without high disease activity, and further research with larger samples is needed. The efficacy of TNF blockers, however, suggested a potential localized TNF effect was present among SpA patients.	[Otsuka, Akiyo; Morita, Mitsuhiro; Yamada, Harumoto] Fujita Hlth Univ, Dept Orthopaed Surg, Toyoake, Aichi 4701192, Japan	Otsuka, A (reprint author), Fujita Hlth Univ, Dept Orthopaed Surg, 1-98 Dengakugakubo,Kutsukake Cho, Toyoake, Aichi 4701192, Japan.	akiyo-y@yc4.so-net.ne.jp					Shichikawa K, 1999, ANN RHEUM DIS, V58, P751, DOI 10.1136/ard.58.12.751; Braun J, 2011, ANN RHEUM DIS, V70, P896, DOI 10.1136/ard.2011.151027; Hukuda S, 2001, J RHEUMATOL, V28, P554; Boyer GS, 1997, J RHEUMATOL, V24, P500; Reveille JD, 2013, AM J MED SCI, V345, P431, DOI 10.1097/MAJ.0b013e318294457f; Rudwaleit M, 2004, ANN RHEUM DIS, V63, P535, DOI 10.1136/ard.2003.011247; Sieper J, 2013, ANN RHEUM DIS, V72, P815, DOI 10.1136/annrheumdis-2012-201766; Haibel H, 2008, ARTHRITIS RHEUM, V58, P1981, DOI 10.1002/art.23606; Francois RJ, 2006, ANN RHEUM DIS, V65, P713, DOI 10.1136/ard.2005.037465; Maksymowych WP, 2010, J RHEUMATOL, V37, P385, DOI 10.3899/jrheum.090242; van der Heijde D, 2011, ANN RHEUM DIS, V70, P905, DOI 10.1136/ard.2011.151563; [Anonymous], 2006, ANN RHEUM DIS; Molto A, 2014, ARTHRITIS RHEUMATOL, V66, P1734, DOI 10.1002/art.38613; Kobayashi S, 2012, MOD RHEUMATOL, V22, P589, DOI 10.1007/s10165-011-0557-x; Kchir MM, 2010, RHEUMATOL INT, V30, P933, DOI 10.1007/s00296-009-1079-0; Brandt J, 2000, ARTHRITIS RHEUM, V43, P1346, DOI 10.1002/1529-0131(200006)43:6<1346::AID-ANR18>3.0.CO;2-E; Chen JM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004524.pub4; BRAUN J, 1995, ARTHRITIS RHEUM, V38, P499, DOI 10.1002/art.1780380407; van der Linden S, 1998, RHEUM DIS CLIN N AM, V24, P663, DOI 10.1016/S0889-857X(05)70036-3; Vargas-Alarcon G, 2002, ANN RHEUM DIS, V61, P714, DOI 10.1136/ard.61.8.714; Shima Y, 2011, MOD RHEUMATOL, V21, P436, DOI 10.1007/s10165-011-0416-9; Haibel H, 2010, CURR OPIN RHEUMATOL, V22, P388, DOI 10.1097/BOR.0b013e32833aaf93; GRATACOS J, 1994, BRIT J RHEUMATOL, V33, P927; Canoui-Poitrine F, 2014, ARTHRIT CARE RES, V66, P1395, DOI 10.1002/acr.22330; Chou CT., 2013, CLIN DEV IMMUNOL, V2013, DOI [10.1155/2013/369202., DOI 10.1155/2013/369202]; Sieper J, 2013, ARTHRITIS RHEUM-US, V65, P543, DOI 10.1002/art.37803; Tanaka H, 1996, CLIN TRANSPL, V10, P139; Tikly M, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-014-0421-z; Urano F., 2008, SPONDYLARTHRITIS ANK, P18; Weiss A, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4464	30	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	NOV	2015	20	6					1070	1077		10.1007/s00776-015-0755-z		8	Orthopedics	Orthopedics	CX0XT	WOS:000365421500017		
J	Ito, S; Hashimoto, M; Aduma, S; Yasumura, S				Ito, Shinya; Hashimoto, Mari; Aduma, Saori; Yasumura, Seiji			Effectiveness of locomotion training in a home visit preventive care project: one-group pre-intervention versus post-intervention design study	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							RANDOMIZED CONTROLLED-TRIAL; ELDERLY INDIVIDUALS; BALANCE; EXERCISE; FALLS	Locomotion training in a home visit-type preventive-care program has been reported elsewhere. However, continuation of appropriate exercises in a home setting is difficult, and few reports are available on locomotion training in a home setting. The objective of this study was to evaluate the effectiveness of locomotion training over 3 months in a home visit-type preventive-care program for improvement of motor function among elderly people. Nine hundred and fifty-eight elderly people in Tendo City in Japan who were not currently attending any preventive-care program were invited to participate in the study, and 87 were enrolled. In the pre-intervention and post-intervention assessments, we administered an interview survey (the Kihon Checklist), the timed one-leg standing test with eyes open and the sit-to-stand test, at the participants' homes. The intervention involved one set of training exercises with the participants standing on each leg for 1 min and squatting five or six times. The participants were asked to repeat one set of the exercises three times a day at home. In addition, the participants were regularly asked over the telephone about their performance of the exercises. Physical strength, cognitive function, and total scores of the Kihon Checklist were significantly lower after the intervention than before. In addition, the one-leg standing test time was significantly longer after the intervention (mean +/- A SD, 23.9 +/- A 35.4) than before (15.7 +/- A 20.5), and the sit-to-stand test time was significantly shorter after the intervention (13.0 +/- A 6.2) than before (14.8 +/- A 8.3). Locomotion training in a home-visit preventive-care program with telephone support effectively improved the motor function of elderly people who were not currently attending any preventive-care program organized by the long-term care insurance system.	[Ito, Shinya; Hashimoto, Mari; Aduma, Saori; Yasumura, Seiji] Fukushima Med Univ, Sch Med, Dept Publ Hlth, Fukushima, Fukushima 9601295, Japan	Ito, S (reprint author), Fukushima Med Univ, Sch Med, Dept Publ Hlth, Hikariga Oka 1, Fukushima, Fukushima 9601295, Japan.	Shinyai@fmu.ac.jp					Seichi A, 2012, J ORTHOP SCI, V17, P163, DOI 10.1007/s00776-011-0193-5; Lord SR, 2002, J GERONTOL A-BIOL, V57, pM539; Kita K, 2007, OSTEOPOROSIS INT, V18, P611, DOI 10.1007/s00198-006-0288-6; Yoshimura N, 2011, J ORTHOP SCI, V16, P768, DOI 10.1007/s00776-011-0160-1; Nakamura K, 2008, J ORTHOP SCI, V13, P1, DOI 10.1007/s00776-007-1202-6; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Fukutomi E, 2013, GERIATR GERONTOL INT, V13, P654, DOI 10.1111/j.1447-0594.2012.00959.x; Michikawa T, 2009, J ORTHOP SCI, V14, P675, DOI 10.1007/s00776-009-1371-6; Yamashita F, 2012, J MUSCULOSKEL NEURON, V12, P74; Sakamoto K, 2006, J ORTHOP SCI, V11, P467, DOI 10.1007/s00776-006-1057-2; Hashimoto Mari, 2012, Nihon Ronen Igakkai Zasshi, V49, P476; Ishibashi H, 2011, IGAKU NO AYUMI, V236, P353; Kato Chikako, 2013, Nihon Ronen Igakkai Zasshi, V50, P804	13	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	NOV	2015	20	6					1078	1084		10.1007/s00776-015-0760-2		7	Orthopedics	Orthopedics	CX0XT	WOS:000365421500018		
J	Iizuka, Y; Iizuka, H; Mieda, T; Tajika, T; Yamamoto, A; Takagishi, K				Iizuka, Yoichi; Iizuka, Haku; Mieda, Tokue; Tajika, Tsuyoshi; Yamamoto, Atsushi; Takagishi, Kenji			Population-based study of the association of osteoporosis and chronic musculoskeletal pain and locomotive syndrome: the Katashina study	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							QUALITY-OF-LIFE; LOW-BACK-PAIN; SUPER-AGED SOCIETY; QUANTITATIVE ULTRASOUND; KNEE OSTEOARTHRITIS; JAPANESE WOMEN; HEALTH; DISABILITY; ROAD; PREVALENCE	"Locomotive syndrome", a concept proposed by the Japanese Orthopaedic Association (JOA), refers to risk conditions among the elderly population that may lead to the need for nursing care services. The association between osteoporosis (OP) or chronic musculoskeletal pain (CMSP) and the screening results of locomotive dysfunction identified by the GLFS-25 (a 25-question geriatric locomotive function scale) has not yet been adequately investigated. Two hundred eighty-seven Japanese subjects were evaluated for locomotive dysfunction using the GLFS-25 and were also evaluated for their bone status by a quantitative ultrasound (QUS) assessment of the bone status (i.e., the measurement of the speed of sound (SOS) of the calcaneus). Furthermore, a questionnaire survey concerning CMSP persisting for 3 months or longer was given to those subjects. Statistical analyses were conducted to clarify the association between the bone status or CMSP and the screening results for locomotive dysfunction. The % young adult mean (%YAM) of the SOS was significantly lower among the 43 subjects with locomotive dysfunction identified by the GLFS-25 than in the 244 subjects without locomotive dysfunction (p < 0.001). Moreover, low back pain (p < 0.01), shoulder pain (p < 0.05) and knee pain (p < 0.001) were significantly more frequently observed in the 43 subjects with locomotive dysfunction than the 244 subjects without locomotive dysfunction. The screening results of the %YAM of the SOS was significantly associated with the population demonstrating locomotive dysfunction screened by the GLFS-25 based on the age-, gender- and BMI-adjusted analysis (OR 0.95, 95 % CI 0.91-0.98). Furthermore, the %YAM of SOS correlated with the GLFS-25 score (beta = -0.212, p = 0.001). Furthermore, low back pain (OR 2.60, 95 % CI 1.29-5.24), shoulder pain (OR 2.16, 95 % CI 1.00-4.66), and knee pain (OR 2.97, 95 % CI 1.41-6.28) were found to be associated with locomotive dysfunction based on the results of the age-, gender- and a BMI-adjusted analysis. The %YAM of the SOS was associated with the population demonstrating locomotive dysfunction which was identified using the GLFS-25, and the severity of locomotive dysfunction evaluated by the GLFS-25 was found to correlate with the %YAM of the SOS. Furthermore, low back pain, shoulder pain and knee pain were found to be associated with the screening results for locomotive dysfunction by the GLFS-25.	[Iizuka, Yoichi; Iizuka, Haku; Mieda, Tokue; Tajika, Tsuyoshi; Yamamoto, Atsushi; Takagishi, Kenji] Gunma Univ, Grad Sch Med, Dept Orthopaed Surg, Maebashi, Gumma 3718511, Japan	Mieda, T (reprint author), Gunma Univ, Grad Sch Med, Dept Orthopaed Surg, 3-39-22 Showa, Maebashi, Gumma 3718511, Japan.	tmieda@gunma-u.ac.jp					Yoshimura N, 2009, J BONE MINER METAB, V27, P620, DOI 10.1007/s00774-009-0080-8; Muramoto A, 2012, J ORTHOP SCI, V17, P782, DOI 10.1007/s00776-012-0283-z; Nemoto O, 2013, EUR SPINE J, V22, P453, DOI 10.1007/s00586-012-2488-4; Seichi A, 2012, J ORTHOP SCI, V17, P163, DOI 10.1007/s00776-011-0193-5; Yoshimura N, 2014, J BONE MINER METAB, V32, P524, DOI 10.1007/s00774-013-0522-1; [Anonymous], 2014, GRAPH REV JAP HOUS C; Lawrence RC, 1998, ARTHRITIS RHEUM, V41, P778, DOI 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V; FELSON DT, 1993, J BONE MINER RES, V8, P567; Muraki S, 2011, SPINE, V36, P1312, DOI 10.1097/BRS.0b013e3181fa60d1; [Anonymous], 1986, PAIN S, V3, pS1; Laugier P, 2004, INT CONGR SER, V1274, P23, DOI 10.1016/j.ics.2004.07.034; Sasaki E, 2013, J ORTHOP SCI, V18, P121, DOI 10.1007/s00776-012-0329-2; Hirano K, 2013, MOD RHEUMATOL, V23, P939, DOI 10.1007/s10165-012-0770-2; Nakamura M, 2011, J ORTHOP SCI, V16, P424, DOI 10.1007/s00776-011-0102-y; Yoshimura N, 2011, J ORTHOP SCI, V16, P768, DOI 10.1007/s00776-011-0160-1; Muraki S, 2009, ANN RHEUM DIS, V68, P1401, DOI 10.1136/ard.2007.087296; Muramoto A, 2013, J ORTHOP SCI, V18, P618, DOI 10.1007/s00776-013-0382-5; Muraki S, 2010, OSTEOARTHR CARTILAGE, V18, P1227, DOI 10.1016/j.joca.2010.06.001; Muraki S, 2011, ARTHRITIS RHEUM-US, V63, P3859, DOI 10.1002/art.30641; Nakamura K, 2008, J ORTHOP SCI, V13, P1, DOI 10.1007/s00776-007-1202-6; Trimpou P, 2010, EUR J RADIOL, V73, P360, DOI 10.1016/j.ejrad.2008.11.024; Hirano K, 2014, J ORTHOP SCI, V19, P164, DOI 10.1007/s00776-013-0476-0; Oka H, 2006, J BONE MINER METAB, V24, P307, DOI 10.1007/s00774-006-0688-x; Nakamura K, 2009, J ORTHOP SCI, V14, P1, DOI 10.1007/s00776-008-1302-y; Ohtori S, 2010, J ORTHOP SCI, V15, P86, DOI 10.1007/s00776-009-1426-8; Fujiwara S, 2005, OSTEOPOROSIS INT, V16, P2107, DOI 10.1007/s00198-005-2008-z; Muraki S, 2010, MOD RHEUMATOL, V20, P444, DOI 10.1007/s10165-010-0307-5; Gluer CC, 1997, J BONE MINER RES, V12, P1280, DOI 10.1359/jbmr.1997.12.8.1280; Collinge CA, 2010, J ORTHOP TRAUMA, V24, P176, DOI 10.1097/BOT.0b013e3181b8b036; Nakamura K, 2011, J ORTHOP SCI, V16, P489, DOI 10.1007/s00776-011-0108-5; Kitahara H, 2013, OSTEOPOROSIS INT, V24, P907, DOI 10.1007/s00198-012-2038-2; Iizuka Y, 2014, J ORTHOP SCI, V19, P786, DOI 10.1007/s00776-014-0602-7; Kanis JA, 2007, ASSESSMENT OSTEOPORO; Ministry of Health Labour and Welfare, OUTL NAT HLTH NUTR S; Ministry of Health Labour and Welfare, OUTL RES NAT LIV SUR; Muraki S, 2014, MOD RHEUMATOL, V24, P966, DOI 10.3109/14397595.2014.883055; Nakamura M, 2014, J ORTHOP SCI, V19, P339, DOI 10.1007/s00776-013-0525-8; Orimo Hajime, 2012, Arch Osteoporos, V7, P3	38	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	NOV	2015	20	6					1085	1089		10.1007/s00776-015-0774-9		5	Orthopedics	Orthopedics	CX0XT	WOS:000365421500019		
J	Ogura, K; Uehara, K; Akiyama, T; Iwata, S; Shinoda, Y; Kobayashi, E; Saita, K; Yonemoto, T; Kawano, H; Chuman, H; Davis, AM; Kawai, A				Ogura, Koichi; Uehara, Kosuke; Akiyama, Toru; Iwata, Shintaro; Shinoda, Yusuke; Kobayashi, Eisuke; Saita, Kazuo; Yonemoto, Tsukasa; Kawano, Hirotaka; Chuman, Hirokazu; Davis, Aileen M.; Kawai, Akira			Cross-cultural adaptation and validation of the Japanese version of the Toronto Extremity Salvage Score (TESS) for patients with malignant musculoskeletal tumors in the lower extremities	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							QUESTIONNAIRE; GUIDELINES; SARCOMA	Before this work a Japanese version of the Toronto Extremity Salvage Score (TESS), a disease-specific patient-completed questionnaire widely used to assess the physical function of patients with musculoskeletal tumors, had not been developed. The purpose of this study was cross-cultural adaptation and validation of the English-language version of the TESS to facilitate international comparisons of treatment results. The TESS was translated into Japanese, back-translated into English, and reviewed by a committee to develop a consensus Japanese version of the TESS. One hundred and two patients were assessed by use of this Japanese version to examine its reliability and validity. Test-retest reliability and internal consistency determined by using the intraclass correlation coefficient (0.941) and Cronbach's alpha test (0.978), respectively, were excellent. Factor analysis showed that the structure consisted of a three-item cluster; the Akaike information criterion (AIC) network also demonstrated that the items could be divided into three domains in accordance with their content. The Japanese version of the TESS correlated with the Musculoskeletal Tumor Society rating scale (r = 0.811; P < 0.001) and the Short Form-36 physical component summary (r = 0.785; P < 0.001). Our study suggested that the Japanese version of the TESS is a reliable and valid instrument for measuring patient-reported functional outcome for patients with lower extremity sarcoma, and that it enables international comparisons of treatment results. The spatial association of each item demonstrated by using the AIC network also suggested that the underlying structure of the TESS reflected its coverage of a wide range of physical functions.	[Ogura, Koichi; Kobayashi, Eisuke; Chuman, Hirokazu; Kawai, Akira] Natl Canc Ctr, Dept Musculoskeletal Oncol, Chuo Ku, Tokyo 1040045, Japan; [Ogura, Koichi; Uehara, Kosuke; Shinoda, Yusuke; Kawano, Hirotaka] Tokyo Univ Hosp, Dept Orthopaed Surg, Tokyo 113, Japan; [Akiyama, Toru; Saita, Kazuo] Jichi Med Univ, Saitama Med Ctr, Dept Orthopaed Surg, Saitama, Japan; [Iwata, Shintaro; Yonemoto, Tsukasa] Chiba Canc Ctr, Div Orthopaed Surg, Chiba 2608717, Japan; [Davis, Aileen M.] Univ Hlth Network, Toronto Western Res Inst, Hlth Care & Outcomes Res, Toronto, ON, Canada; [Davis, Aileen M.] Univ Toronto, Inst Rehabil, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada	Ogura, K (reprint author), Natl Canc Ctr, Dept Musculoskeletal Oncol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	ogura-tky@umin.ac.jp			Ministry of Education and Science [22390296]; National Cancer Center Research and Development Fund [23-A-10]	This study was funded by a Grant-in-Aid for Scientific Research from the Ministry of Education and Science (B, no. 22390296), and by the National Cancer Center Research and Development Fund (23-A-10). The authors would like to acknowledge Misuzu Mori, Yoko Kato, and Keiko Hishiki for administrative support with data collection.	Akaika H., 1973, P 2 INT S INF THEOR, P267; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Seichi A, 2012, J ORTHOP SCI, V17, P163, DOI 10.1007/s00776-011-0193-5; Saraiva D, 2008, PEDIATR BLOOD CANCER, V50, P1039, DOI 10.1002/pbc.21392; ENNEKING WF, 1993, CLIN ORTHOP RELAT R, P241; Saebye C, 2014, DAN MED J, V61; Davis AM, 1996, QUAL LIFE RES, V5, P508, DOI 10.1007/BF00540024; BRAZIER JE, 1992, BRIT MED J, V305, P160; Fletcher CDM, 2013, WHO CLASSIFICATION T; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; Sakamoto Y, 1991, CATEGORICAL DATA ANA, P163	12	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	NOV	2015	20	6					1098	1105		10.1007/s00776-015-0767-8		8	Orthopedics	Orthopedics	CX0XT	WOS:000365421500021		
J	Okano, T; Koike, T; Tada, M; Sugioka, Y; Mamoto, K; Inui, K; Okihana, H; Ebihara, K; Nakao, K; Nakamura, H				Okano, Tadashi; Koike, Tatsuya; Tada, Masahiro; Sugioka, Yuko; Mamoto, Kenji; Inui, Kentaro; Okihana, Hiroyuki; Ebihara, Ken; Nakao, Kazuwa; Nakamura, Hiroaki			Hyperleptinemia suppresses aggravation of arthritis of collagen-antibody-induced arthritis in mice	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							RHEUMATOID-ARTHRITIS; IMMUNE-RESPONSES; DISEASE-ACTIVITY; SERUM LEPTIN; OBESE GENE; INFLAMMATION; PLASMA; FAT; ABNORMALITIES; MACROPHAGES	Leptin is an adipocytokine produced by adipocytes and controlling body weight. It is unclear whether leptin works as a proinflammatory or an anti-inflammatory cytokine. We investigated the effects of hyperleptinemia on leptin transgenic (LepTg) mice in terms of cartilage destruction, bone destruction, joint synovitis, and serum cytokine levels by using a mouse model of collagen-antibody-induced arthritis (CAIA). CAIA was induced for female age-matched 6- to 8-week-old C57BL/6 J control mice and LepTg mice. Mice were injected intraperitoneally with 5 mg of a combination of monoclonal antibody specific for type II collagen on day 0 and 12.5 mg of lipopolysaccharide (LPS) on day 3. Clinical evaluation of arthritis was monitored for 14 days, and hind paws were examined clinically and histologically. Serum cytokine levels of interleukin (IL)-1 beta, IL-6, IL-10, and IL-17 and tumor necrosis factor alpha (TNF-alpha) were also analyzed on days 0 and 5. Moreover, THP-1 cells, which are human monocytic cell line derived from an acute monocytic leukemia patient, were cultured and differentiated into macrophages. The effects of leptin on messenger RNA (mRNA) expression of IL-6 were examined by real-time quantitative polymerase chain reaction (RT-PCR). Serum leptin concentrations were approximately ninefold higher in LepTg mice (62.0 +/- A 20.7 ng/ml) than in control mice (7.2 +/- A 0.5 ng/ml). Severity of clinical paw swelling, arthritis score, synovial hyperplasia, and cartilage damage were suppressed in LepTg mice with CAIA. Although serum cytokine levels of IL-1 beta, IL-17, and IL-10 and TNF-alpha showed no significant changes in two mice, serum levels of IL-6 in LepTg mice were suppressed at day 5. Moreover, in vitro study showed that IL-6 elevation following LPS exposure in THP-1 cells was suppressed with high leptin concentrations. Our finding suggests that hyperleptinemia suppress IL-6 responses and progression of joint inflammation. Leptin may play an anti-inflammatory role under hyperleptinemia.	[Okano, Tadashi; Tada, Masahiro; Mamoto, Kenji; Inui, Kentaro; Nakamura, Hiroaki] Osaka City Univ, Sch Med, Dept Orthopaed Surg, Abeno Ku, Osaka 5458585, Japan; [Koike, Tatsuya; Sugioka, Yuko; Okihana, Hiroyuki] Osaka City Univ, Sch Med, Ctr Senile Degenerat Disorders, Abeno Ku, Osaka 5458585, Japan; [Koike, Tatsuya] Shirahama Hlth & Welf Fdn, Search Inst Bone & Arthrit Dis SINBAD, Wakayama 6492211, Japan; [Ebihara, Ken] Kyoto Univ, Sch Med, Kyoto Univ Hosp, Translat Res Ctr,Sakyo Ku, Kyoto 6068507, Japan; [Nakao, Kazuwa] Kyoto Univ, Grad Sch Med, Dept Med & Clin Sci, Sakyo Ku, Kyoto 6068507, Japan	Koike, T (reprint author), Osaka City Univ, Sch Med, Ctr Senile Degenerat Disorders, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.	tatsuya@med.osaka-cu.ac.jp			Takeda Pharmaceutical Co., Ltd.; Mitsubishi Tanabe Pharma Co.; Chugai Pharmaceutical Co., Ltd.; Eisai; Abbvie GK; Teijin Pharma; MSD K.K.; Ono Pharmaceutical; Astellas Pharma Inc.; Eisai Co., Ltd.; Bristol-Myers K.K.; Janssen Pharmaceutical K.K.; Chugai Pharmaceutical; Astellas Pharma; Janssen Pharmaceutica; GlaxoSmithKline; Pfizer; Daiichi Sankyo	Dr. Koike has received research grants and/or speaking fees from Takeda Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Co., Chugai Pharmaceutical Co., Ltd., Eisai, Abbvie GK, Teijin Pharma, MSD K.K. and Ono Pharmaceutical. Dr. Inui has received research grants and/or speaking fees from Chugai Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Co., Astellas Pharma Inc., Abbvie GK, Eisai Co., Ltd., MSD K.K., Bristol-Myers K.K., Takeda Pharmaceutical Co., Ltd. and Janssen Pharmaceutical K.K. Dr. Nakamura has received research grants and/or speaking fees from Chugai Pharmaceutical, Astellas Pharma, Janssen Pharmaceutica, GlaxoSmithKline, Pfizer, Daiichi Sankyo and Ono Pharmaceutical. The other authors have no conflicts of interest to disclose.	Anandacoomarasamy A, 2008, INT J OBESITY, V32, P211, DOI 10.1038/sj.ijo.0803715; Janik JE, 1997, J CLIN ENDOCR METAB, V82, P3084, DOI 10.1210/jc.82.9.3084; Sugioka Y, 2012, CLIN EXP RHEUMATOL, V30, P707; Toyoda T, 2008, OBESITY, V16, P1199, DOI 10.1038/oby.2008.62; Tian G, 2014, CLIN EXP IMMUNOL, V177, P557, DOI 10.1111/cei.12372; Ogawa Y, 1999, DIABETES, V48, P1822, DOI 10.2337/diabetes.48.9.1822; Bokarewa M, 2003, ANN RHEUM DIS, V62, P952, DOI 10.1136/ard.62.10.952; Gabay C, 2001, J CLIN ENDOCR METAB, V86, P783, DOI 10.1210/jc.86.2.783; Hizmetli S, 2007, RHEUMATOL INT, V27, P335, DOI 10.1007/s00296-006-0264-7; Nowell MA, 2009, J IMMUNOL, V182, P613; Lee FYJ, 1999, AM J PHYSIOL-CELL PH, V276, pC386; Faggioni R, 1999, AM J PHYSIOL-REG I, V276, pR136; TERATO K, 1992, J IMMUNOL, V148, P2103; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Otero M, 2005, FEBS LETT, V579, P295, DOI 10.1016/j.febslet.2004.11.024; Popa C, 2005, ANN RHEUM DIS, V64, P1195, DOI 10.1136/ard.2004.032243; Fantuzzi G, 2000, J LEUKOCYTE BIOL, V68, P437; Deng J, 2012, ARTHRITIS RHEUM-US, V64, P3564, DOI 10.1002/art.34637; Su JM, 2007, CELL SIGNAL, V19, P1596, DOI 10.1016/j.cellsig.2007.02.009; MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523; Loffreda S, 1998, FASEB J, V12, P57; FELSON DT, 1988, ANN INTERN MED, V109, P18; Otero M, 2006, ANN RHEUM DIS, V65, P1198, DOI 10.1136/ard.2005.046540; Hultgren OH, 2001, ARTHRITIS RES, V3, P389, DOI 10.1186/ar332; Rho YH, 2009, ARTHRITIS RHEUM, V60, P1906, DOI 10.1002/art.24626; Baker JF, 2014, ANN RHEUM DIS, V73, P1923, DOI 10.1136/annrheumdis-2014-205544; Bernotiene E, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2004; Kim Sung-Jo, 2010, J Periodontal Implant Sci, V40, P119, DOI 10.5051/jpis.2010.40.3.119; Muraoka S, 2013, CLIN EXP RHEUMATOL, V31, P589; Wisiowska M, 2007, RHEUMATOL INT, V27, P947, DOI 10.1007/s00296-007-0335-4; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	31	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	NOV	2015	20	6					1106	1113		10.1007/s00776-015-0768-7		8	Orthopedics	Orthopedics	CX0XT	WOS:000365421500022		
J	Kodama, N; Ishida, M; Ueba, H; Imai, S; Matsusue, Y				Kodama, Narihito; Ishida, Mitsuaki; Ueba, Hiroaki; Imai, Shinji; Matsusue, Yoshitaka			Florid reactive periostitis of the forearm with pronation and supination contracture	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							PAROSTEAL OSTEOCHONDROMATOUS PROLIFERATION; RADIOULNAR SYNOSTOSIS; FAT GRAFT; LESION; BONES; HANDS; FLAP; MOBILIZATION; PHALANGES; EROSION		[Kodama, Narihito; Ueba, Hiroaki; Imai, Shinji; Matsusue, Yoshitaka] Shiga Univ Med Sci, Dept Orthopaed Surg, Otsu, Shiga 5202192, Japan; [Ishida, Mitsuaki] Shiga Univ Med Sci, Clin Lab Med, Otsu, Shiga 52021, Japan; [Ishida, Mitsuaki] Shiga Univ Med Sci, Div Diagnost Pathol, Otsu, Shiga 52021, Japan	Kodama, N (reprint author), Shiga Univ Med Sci, Dept Orthopaed Surg, Otsu, Shiga 5202192, Japan.	koda62@belle.shiga-med.ac.jp					Abramovici L, 2002, HUM PATHOL, V33, P1205, DOI 10.1053/hupa.2002.130103; Funakoshi T, 2004, J SHOULDER ELB SURG, V13, P230, DOI 10.1016/j.jse.2003.09.009; YUEN M, 1992, SKELETAL RADIOL, V21, P301; NORA FE, 1983, AM J SURG PATHOL, V7, P245, DOI 10.1097/00000478-198304000-00003; MENESES MF, 1993, AM J SURG PATHOL, V17, P691, DOI 10.1097/00000478-199307000-00006; BRAUN RM, 1995, J HAND SURG-AM, V20A, P915, DOI 10.1016/S0363-5023(05)80137-6; Kanaya F, 1998, J BONE JOINT SURG AM, V80A, P1186; Brien EW, 1999, J BONE JOINT SURG AM, V81A, P1002; WEINZWEIG N, 1994, PLAST RECONSTR SURG, V94, P675, DOI 10.1097/00006534-199410000-00016; Jambhekar NA, 2004, SKELETAL RADIOL, V33, P663, DOI 10.1007/s00256-004-0760-3; PORTER AR, 1985, AM J ROENTGENOL, V144, P617; Mathew SE, 2011, J BONE JOINT SURG BR, V93B, P418, DOI 10.1302/0301-620X.93B3.24955; CALLAHAN DJ, 1985, J BONE JOINT SURG AM, V67A, P968; CHANG SM, 1990, PLAST RECONSTR SURG, V85, P150, DOI 10.1097/00006534-199001000-00053; DUPREE WB, 1986, CANCER, V58, P2103, DOI 10.1002/1097-0142(19861101)58:9<2103::AID-CNCR2820580923>3.0.CO;2-C; SPJUT HJ, 1981, AM J SURG PATHOL, V5, P423, DOI 10.1097/00000478-198107000-00002; Howard RF, 1996, J HAND SURG-AM, V21A, P501, DOI 10.1016/S0363-5023(96)80370-4; Ting BL, 2013, J HAND SURG-AM, V38A, P2381, DOI 10.1016/j.jhsa.2013.09.024; Gao ZH, 2013, J HAND SURG-AM, V38A, P2134, DOI 10.1016/j.jhsa.2013.08.115; Dorfman HD, 1998, BONE TUMORS, P1120; Porcel Lopez MT, 2008, ORTHOPEDICS, V31, P286; Weiss SW, 2001, SOFT TISSUE TUMORS, P1389	22	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	NOV	2015	20	6					1122	1126		10.1007/s00776-014-0596-1		5	Orthopedics	Orthopedics	CX0XT	WOS:000365421500024		
J	Osada, R; Zukawa, M; Kimura, T				Osada, Ryusuke; Zukawa, Mineyuki; Kimura, Tomoatsu			Atypical ulnar fracture associated with long-term bisphosphonate use	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							SUPPRESSED BONE TURNOVER; ALENDRONATE THERAPY; FEMORAL-SHAFT; COMPLICATION; FEMUR		[Osada, Ryusuke; Zukawa, Mineyuki; Kimura, Tomoatsu] Toyama Univ, Fac Med, Dept Orthopaed Surg, Toyama 9300194, Japan	Osada, R (reprint author), Toyama Univ, Fac Med, Dept Orthopaed Surg, 2630 Sugitani, Toyama 9300194, Japan.	osa97@med.u-toyama.ac.jp					Giusti A, 2010, BONE, V47, P169, DOI 10.1016/j.bone.2010.05.019; Carvalho NNC, 2011, J CLIN ENDOCR METAB, V96, P2675, DOI 10.1210/jc.2011-0593; Aspenberg P, 2010, ACTA ORTHOP, V81, P460, DOI 10.3109/17453674.2010.492766; Stathopoulos KD, 2011, J MUSCULOSKEL NEURON, V11, P208; Schilcher J, 2011, NEW ENGL J MED, V364, P1728, DOI 10.1056/NEJMoa1010650; Somford MP, 2009, J BONE MINER RES, V24, P1736, DOI [10.1359/jbmr.090408, 10.1359/JBMR.090408]; Ang BFH, 2013, OSTEOPOROSIS INT, V24, P1523, DOI 10.1007/s00198-012-2118-3; Odvina CV, 2005, J CLIN ENDOCR METAB, V90, P1294, DOI 10.1210/jc.2004-0952; Visekruna M, 2008, J CLIN ENDOCR METAB, V93, P2948, DOI 10.1210/jc.2007-2803; Tjhia CK, 2011, BONE, V49, P1279, DOI 10.1016/j.bone.2011.09.042; Black DM, 2010, NEW ENGL J MED, V362, P1761, DOI 10.1056/NEJMoa1001086; Bjorgul K, 2011, ACTA ORTHOP, V82, P761, DOI 10.3109/17453674.2011.636676; Kwek EBK, 2008, INJURY, V39, P224, DOI 10.1016/j.injury.2007.08.036; RECKER RR, 1988, J BONE MINER RES, V3, P133; Park-Wyllie LY, 2011, JAMA-J AM MED ASSOC, V305, P783, DOI 10.1001/jama.2011.190; Tang ZH, 2011, J ORTHOP SURG-HONG K, V19, P37022	16	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	NOV	2015	20	6					1132	1135		10.1007/s00776-014-0589-0		4	Orthopedics	Orthopedics	CX0XT	WOS:000365421500026		
J	Mori, K; Imai, S; Nishizawa, K; Matsusue, Y				Mori, Kanji; Imai, Shinji; Nishizawa, Kazuya; Matsusue, Yoshitaka			Cervical myelopathy due to calcification of the posterior atlantoaxial membrane associated with generalized articular deposition of calcium pyrophosphate dihydrate: a case report and review of the literature	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							LIGAMENTUM-FLAVUM; CRYSTAL DEPOSITION; RADICULOMYELOPATHY; SPINE; PSEUDOGOUT; MYELORADICULOPATHY; OSSIFICATION; SECONDARY; DISEASE		[Mori, Kanji; Imai, Shinji; Nishizawa, Kazuya; Matsusue, Yoshitaka] Shiga Univ Med Sci, Dept Orthopaed Surg, Otsu, Shiga 5202192, Japan	Mori, K (reprint author), Shiga Univ Med Sci, Dept Orthopaed Surg, Tsukinowa Cho, Otsu, Shiga 5202192, Japan.	kanchi@belle.shiga-med.ac.jp			Health and Labour Science Research Grants	This study was supported by Health and Labour Science Research Grants. No other financial associations were relevant or may be seen as relevant to the submitted manuscript. The authors thank Dr. Mitsuaki Ishida, Department of Clinical Laboratory Medicine, Shiga University of Medical Science, for histopathological assistance.	AKINO M, 1983, Neurological Surgery, V11, P173; NAGASHIMA C, 1984, J NEUROSURG, V60, P69, DOI 10.3171/jns.1984.60.1.0069; ELLMAN MH, 1978, ARTHRITIS RHEUM, V21, P611; KAWANO N, 1980, J NEUROSURG, V52, P279, DOI 10.3171/jns.1980.52.2.0279; Inoue H, 2013, EUR SPINE J, V22, pS416, DOI 10.1007/s00586-012-2521-7; IMAI S, 1994, J SPINAL DISORD, V7, P513; Ugarriza LF, 2001, NEUROSURGERY, V48, P673, DOI 10.1097/00006123-200103000-00047; IWASAKI Y, 1983, J NEUROSURG, V59, P531, DOI 10.3171/jns.1983.59.3.0531; KUBOTA T, 1987, SPINE, V12, P317, DOI 10.1097/00007632-198705000-00002; Haraguchi K, 1996, NEUROL SURG TOKYO, V24, P69; Yamagami T, 2000, NEUROL MED-CHIR, V40, P234, DOI 10.2176/nmc.40.234; Sato K, 1989, BRIT J NEUROSURG, V3, P597, DOI 10.3109/02688698909002852; KAMAKURA K, 1979, ANN NEUROL, V5, P193, DOI 10.1002/ana.410050214; NAKAJIMA K, 1984, SURG NEUROL, V21, P479, DOI 10.1016/0090-3019(84)90454-3; MIYASAKA K, 1983, AM J NEURORADIOL, V4, P629; OGATA M, 1984, J BONE JOINT SURG AM, V66A, P1301; Mwaka ES, 2009, CLIN EXP RHEUMATOL, V27, P430; GOMEZ H, 1989, NEUROSURGERY, V25, P298; Cabre P, 2001, JOINT BONE SPINE, V68, P158, DOI 10.1016/S1297-319X(00)00246-3; OKADA G, 1993, SKELETAL RADIOL, V22, P211; Guesmi H, 2005, NEUROCHIRURGIE, V51, P591, DOI 10.1016/S0028-3770(05)83634-3; HANKEY GJ, 1988, AUST NZ J SURG, V58, P247, DOI 10.1111/j.1445-2197.1988.tb01046.x; Yabuki S, 2008, J SPINAL DISORD TECH, V21, P518, DOI 10.1097/BSD.0b013e31815a6151; BABA H, 1993, SPINE, V18, P2174, DOI 10.1097/00007632-199311000-00005; KAWANO N, 1988, J NEUROSURG, V68, P613, DOI 10.3171/jns.1988.68.4.0613; Muthukumar N, 2003, NEUROSURGERY, V53, P103, DOI 10.1227/01.NEU.0000068861.47199.A8; BERGHAUSEN EJ, 1987, CLIN ORTHOP RELAT R, P217; FUJIWARA M, 1982, Neurological Surgery, V10, P769; Higashi S, 1997, Ryumachi, V37, P794; Hirano H, 1985, CENT JPN J ORTHOP TR, V28, P447; Jyotoku Z, 1980, RINSHO SEIKEI GEKA, V15, P708; Kida H, 1981, RINSHO SEIKEI GEKA, V16, P310; KOYAMA S, 1988, Neurological Surgery, V16, P1179; Nagashima C, 1981, J SAITAMA MED SCH, V8, P33; Nanko S, 1976, SHINKEINAIKA, V4, P205; Ohnishi H, 1992, SEIKEIGEKA, V43, P655; RAMSEY R. H., 1966, CLIN ORTHO RELAT RESIN HISTORICAL ORTHOPAEDICS, V44, P129; Takayama S, 1993, No To Shinkei, V45, P859	38	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	NOV	2015	20	6					1136	1141		10.1007/s00776-014-0631-2		6	Orthopedics	Orthopedics	CX0XT	WOS:000365421500027		
J	Watanabe, H; Takahashi, K; Takenouchi, K; Sato, A; Kawaji, H; Nakamura, H; Takai, S				Watanabe, Hiroshi; Takahashi, Kenji; Takenouchi, Kenji; Sato, Akiko; Kawaji, Hidemi; Nakamura, Hiroshi; Takai, Shinro			Pseudotumor and deep venous thrombosis due to crevice corrosion of the head-neck junction in metal-on-polyethylene total hip arthroplasty	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							FRETTING CORROSION; TISSUE-REACTIONS; TAPER; PROSTHESES; RETRIEVAL; TRIBOCORROSION; REPLACEMENTS; OSTEOLYSIS; LESION; ALLOY		[Watanabe, Hiroshi; Takahashi, Kenji; Takenouchi, Kenji; Sato, Akiko; Kawaji, Hidemi; Nakamura, Hiroshi; Takai, Shinro] Nippon Med Sch, Dept Orthopaed Surg, Bunkyo Ku, Tokyo 1138603, Japan	Takahashi, K (reprint author), Nippon Med Sch, Dept Orthopaed Surg, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan.	t-keji@mbox.kyoto-inet.or.jp					Pandit H, 2008, J BONE JOINT SURG BR, V90B, P847, DOI 10.1302/0301-620X.90B7.20213; Gill IPS, 2012, J BONE JOINT SURG BR, V94B, P895, DOI 10.1302/0301-620X.94B7.29122; Licausi MP, 2013, J MECH BEHAV BIOMED, V20, P137, DOI 10.1016/j.jmbbm.2013.01.019; de Smet K, 2008, J BONE JOINT SURG AM, V90A, P202, DOI 10.2106/JBJS.H.00672; Goldberg JR, 2002, CLIN ORTHOP RELAT R, P149; Cooper HJ, 2012, J BONE JOINT SURG AM, V94A, P1655, DOI 10.2106/JBJS.K.01352; Cooper HJ, 2013, J BONE JOINT SURG AM, V95A, P865, DOI 10.2106/JBJS.L.01042; Wiley KF, 2013, J ARTHROPLASTY, V28, P1238, DOI 10.1016/j.arth.2013.03.027; Johnson AJ, 2013, J ARTHROPLASTY, V28, P1235, DOI 10.1016/j.arth.2013.03.015; Rodrigues DC, 2009, J BIOMED MATER RES B, V88B, P206, DOI 10.1002/jbm.b.31171; Kobayashi A, 1997, J BONE JOINT SURG BR, V79B, P844, DOI 10.1302/0301-620X.79B5.7602; Sierra JM, 2011, ARCH ORTHOP TRAUM SU, V131, P1357, DOI 10.1007/s00402-011-1307-4; MATHIESEN EB, 1991, J BONE JOINT SURG BR, V73, P569; Boardman DR, 2006, J BONE JOINT SURG BR, V88B, P402, DOI 10.1302/0301-620X.88B3.16748; Campbell P, 2010, CLIN ORTHOP RELAT R, V468, P2321, DOI 10.1007/s11999-010-1372-y; Daniel J, 2012, J BONE JOINT SURG AM, V94A, P86, DOI 10.2106/JBJS.J.01612; Kop AM, 2009, J ARTHROPLASTY, V24, P1019, DOI 10.1016/j.arth.2008.09.009; Gruber FW, 2007, J ARTHROPLASTY, V22, P923, DOI 10.1016/j.arth.2006.10.002; Pansard E, 2012, ORTHOP TRAUMATOL-SUR, V98, P247, DOI 10.1016/j.otsr.2011.05.018; Kop AM, 2012, CLIN ORTHOP RELAT R, V470, P1885, DOI 10.1007/s11999-011-2155-9; Cook RB, 2013, J ARTHROPLASTY, V28, P1430, DOI 10.1016/j.arth.2013.02.009; Mroczkowski ML, 2006, J ORTHOP RES, V24, P271, DOI 10.1002/jor.20048; Kurtz SM, 2013, CLIN ORTHOP RELAT R, V471, P3270, DOI 10.1007/s11999-013-3096-2; Griffin Justin W, 2012, World J Orthop, V3, P70, DOI 10.5312/wjo.v3.i6.70; Grupp TM, 2010, BMC MUSCULOSKEL DIS, V4, P3; Hsu Andrew R, 2012, Am J Orthop (Belle Mead NJ), V41, P422; Scully William F, 2013, Orthopedics, V36, pe666, DOI 10.3928/01477447-20130426-33; Sugano N, 2014, J ORTHOP SCI, V19, P85, DOI 10.1007/s00776-013-0490-2	28	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	NOV	2015	20	6					1142	1147		10.1007/s00776-014-0623-2		6	Orthopedics	Orthopedics	CX0XT	WOS:000365421500028		
J	Iwanami, A; Kobayashi, Y; Takano, M; Mikami, S; Toyama, Y; Nakamura, M				Iwanami, Akio; Kobayashi, Yoshiomi; Takano, Morito; Mikami, Shuji; Toyama, Yoshiaki; Nakamura, Masaya			Invasive dumbbell spinal meningiomas: report of four cases and a review of the literature	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							BENIGN MENINGIOMAS; CORD MENINGIOMA; EN-PLAQUE; FEATURES		[Iwanami, Akio; Kobayashi, Yoshiomi; Takano, Morito; Toyama, Yoshiaki; Nakamura, Masaya] Keio Univ, Sch Med, Dept Orthopaed Surg, Shinjuku Ku, Tokyo 1608582, Japan; [Mikami, Shuji] Keio Univ, Sch Med, Dept Pathol, Shinjuku Ku, Tokyo 1608582, Japan	Nakamura, M (reprint author), Keio Univ, Sch Med, Dept Orthopaed Surg, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	masa@a8.keio.jp					SIMPSON D, 1957, J NEUROL NEUROSUR PS, V20, P22, DOI 10.1136/jnnp.20.1.22; Sato N, 1997, NEURORADIOLOGY, V39, P450; GAMBARDELLA G, 1990, ACTA NEUROCHIR, V107, P70, DOI 10.1007/BF01402617; Fujimoto T, 2011, NEUROL MED-CHIR, V51, P415; STERN J, 1980, SURG NEUROL, V14, P155; Abramovich CM, 1998, HUM PATHOL, V29, P1420, DOI 10.1016/S0046-8177(98)90010-7; Achari G, 2000, NEUROL RES, V22, P351; LEVY WJ, 1982, J NEUROSURG, V57, P804, DOI 10.3171/jns.1982.57.6.0804; Gezen F, 2000, SPINE, V25, P727, DOI 10.1097/00007632-200003150-00013; BAIRD M, 1989, CLIN NEUROPATHOL, V8, P41; Cohen-Gadol AA, 2003, J NEUROSURG, V98, P258, DOI 10.3171/spi.2003.98.3.0258; Nakamura M, 2012, SPINE, V37, pE617, DOI 10.1097/BRS.0b013e31824167f1; Ozaki M, 2013, J ORTHOP SCI, V18, P1042, DOI 10.1007/s00776-012-0252-6; CALOGERO JA, 1972, J NEUROSURG, V37, P442, DOI 10.3171/jns.1972.37.4.0442; Messori A, 2002, NEURORADIOLOGY, V44, P256, DOI 10.1007/s00234-001-0709-3; SOLERO CL, 1989, NEUROSURGERY, V25, P153; King AT, 1998, BRIT J NEUROSURG, V12, P521, DOI 10.1080/02688699844367; KUMAR S, 1980, J NEUROSURG, V52, P728, DOI 10.3171/jns.1980.52.5.0728; Condra KS, 1997, INT J RADIAT ONCOL, V39, P427, DOI 10.1016/S0360-3016(97)00317-9; Clarke M J, 2006, J Neurosurg Sci, V50, P41; Engenhart-Cabillic R, 2006, STRAHLENTHER ONKOL, V182, P641, DOI 10.1007/s00066-006-1555-3; GOLDSMITH BJ, 1994, J NEUROSURG, V80, P195, DOI 10.3171/jns.1994.80.2.0195; Heald JB, 2014, ACTA NEUROCHIR, V156, P383, DOI 10.1007/s00701-013-1923-6; Krishnan K L, 1978, Int Surg, V63, P42; Martínez R, 1988, J Neurosurg Sci, V32, P179; Rao S B, 1970, Neurol India, V18, P126; Setzer Matthias, 2007, Neurosurg Focus, V23, pE14, DOI 10.3171/FOC-07/10/E14; Suzuki Akinobu, 2002, Spine (Phila Pa 1976), V27, pE193, DOI 10.1097/00007632-200204010-00021; Zevgaridis Dimitris, 2002, Spine (Phila Pa 1976), V27, pE403, DOI 10.1097/00007632-200209150-00021	29	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	NOV	2015	20	6					1148	1154		10.1007/s00776-014-0638-8		7	Orthopedics	Orthopedics	CX0XT	WOS:000365421500029		
J	Okada, S; Orito, K				Okada, Shoichi; Orito, Kensuke			Tugging force: A new objective index for evaluating acute changes in neuromuscular function in mice	JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS			English	Article						Grip strength; Methods; Mouse; Muscle relaxant; Muscle; Neuromuscular function; Pancuronium; Suxamethonium; Tugging force; Vecuronium		Introduction: Many agents, including muscle relaxants, influence neuromuscular function. Although in vitro and in situ measurement systems of skeletal muscular contractility have been developed and in use for years, no convenient device and parameter are available to examine the time course of the acute effects of such agents on neuromuscular function in conscious mice. Methods: We created a two-compartment device consisting of a transparent, wide, acrylic chamber with a foot shock grid, and an attached, opaque narrow tunnel to measure neuromuscular performance. A mouse placed into the wide chamber, quickly enters the narrow tunnel. We attached a string to the tail of the mouse to measure the developed tugging force when the mouse entered the narrow tunnel. Results: After administering the muscle relaxants suxamethonium, vecuronium, and pancuronium, the peak tugging force decreased maximally at 3 or 5min after administration, and recovered within 20 min. These responses to the muscle relaxants were dose-dependent. Discussion: Tugging force is an objective and reproducible parameter for examining the time course of an acute change in neuromuscular function. (C) 2015 Elsevier Inc. All rights reserved.	[Okada, Shoichi; Orito, Kensuke] Azabu Univ, Sch Vet Med, Lab Physiol 2, Chuo Ku, Sagamihara, Kanagawa 2525201, Japan	Orito, K (reprint author), Azabu Univ, Chuo Ku, 1-17-71 Fuchinobe, Sagamihara, Kanagawa 2525201, Japan.	oritok@azabu-u.ac.jp			Azabu University	The authors thank Yutaro Ono for his technical assistance. This research was supported by a research project grant awarded by the Azabu University.	Maurissen JPJ, 2003, NEUROTOXICOL TERATOL, V25, P543, DOI 10.1016/S0892-0362(03)00073-4; Bruckert E, 2005, CARDIOVASC DRUG THER, V19, P403, DOI 10.1007/s10557-005-5686-z; Olson SC, 2012, PEDIATR INFECT DIS J, V31, P1307, DOI 10.1097/INF.0b013e3182700e34; Lewis RL, 2004, SEMIN NEUROL, V24, P175, DOI 10.1055/s-2004-830904; NEVINS ME, 1993, PSYCHOPHARMACOLOGY, V110, P92, DOI 10.1007/BF02246955; Deichmann RE, 2012, PHYSICIAN SPORTSMED, V40, P88, DOI 10.3810/psm.2012.11.1991; Nouette-Gaulain K, 2009, ANESTHESIOLOGY, V111, P1120, DOI 10.1097/ALN.0b013e3181bbc949; Stodieck LS, 2012, MUSCLE NERVE, V45, P536, DOI 10.1002/mus.22294; Hira Harmanjit Singh, 2012, J Neurosci Rural Pract, V3, P36, DOI 10.4103/0976-3147.91928; Lovering R. M., 2014, J BIOL METHODS, pe8; Shah Syed Sajid Hussain, 2014, J Ayub Med Coll Abbottabad, V26, P406	11	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1056-8719	1873-488X		J PHARMACOL TOX MET	J. Pharmacol. Toxicol. Methods	NOV-DEC	2015	76						23	26		10.1016/j.vascn.2015.07.003		4	Pharmacology & Pharmacy; Toxicology	Pharmacology & Pharmacy; Toxicology	CW6JJ	WOS:000365103400004		
J	Uematsu, M; Mohamed, YH; Onizuka, N; Ueki, R; Inoue, D; Fujikawa, A; Kitaoka, T				Uematsu, Masafumi; Mohamed, Yasser Helmy; Onizuka, Naoko; Ueki, Ryotaro; Inoue, Daisuke; Fujikawa, Azusa; Kitaoka, Takashi			A novel in vivo corneal trans-epithelial electrical resistance measurement device	JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS			English	Article						Corneal epithelium; Toxicity; Barrier function	BENZALKONIUM CHLORIDE; PENETRATION ENHANCERS; BARRIER FUNCTION; OCULAR IRRITATION; RABBIT CORNEAS; EYE TEST; DRY-EYE; TOXICITY; VITRO; PERMEABILITY	Purpose: To develop a device that is capable of easily measuring corneal transepithelial electrical resistance (TER) and changes in the corneal barrier function. Methods: We had previously developed an in vivo method for measuring corneal TER using intraocular electrode. This method can be used to precisely measure the decline of the corneal barrier function after instillation of benzalkonium chloride (BAC). In order to lessen the invasiveness of that procedure, we further refined the method for measuring the corneal TER by developing electrodes that could be placed on the cornea and in the conjunctival sac instead of inserting them into the anterior chamber. TER was then calculated by subtracting the electrical resistance, which lacked the corneal epithelial input, from the whole electrical resistance that was measured between the electrodes. Slit lamp examination and scanning electron microscopy (SEM) were used to determine safety of the new device. Corneal TER changes after exposure to 0.02% BAC were determined using the new device as well as SEM and transmission electron microscopy (TEM). Results: Slit lamp examination before and after exposure of rabbits' corneas to the sensor confirmed safety of the device. SEM examination revealed no difference of the corneal epithelium which exposed to the new device with normal corneas. SEM and TEM pictures revealed damaged microvilli and tight junctions after instillation of 0.02% BAC. TER change after treatment with 0.02% BAC was similar to those determined by the established anterior chamber method. Conclusion: We succeeded to develop a less invasive device for corneal TER measurement in vivo in animals. This new device may be applicable in the future for clinical use in humans. (C) 2015 Elsevier Inc. All rights reserved.	[Uematsu, Masafumi; Mohamed, Yasser Helmy; Onizuka, Naoko; Ueki, Ryotaro; Inoue, Daisuke; Fujikawa, Azusa; Kitaoka, Takashi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Ophthalmol & Visual Sci, Nagasaki, Nagasaki 8528501, Japan; [Mohamed, Yasser Helmy] El Minia Univ Hosp, Dept Ophthalmol, El Minia, Egypt	Uematsu, M (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Ophthalmol & Visual Sci, 1-7-1 Sakamoto, Nagasaki, Nagasaki 8528501, Japan.	uematsu1124@outlook.jp					DONN A, 1959, ARCH OPHTHALMOL-CHIC, V62, P741; Ishibashi T, 2003, J GLAUCOMA, V12, P486, DOI 10.1097/00061198-200312000-00008; ROJANASAKUL Y, 1990, INT J PHARM, V63, P1, DOI 10.1016/0378-5173(90)90094-K; JORDAN A, 1980, OPHTHALMOLOGY, V87, P920; Furrer P, 2000, INT J PHARM, V207, P89, DOI 10.1016/S0378-5173(00)00540-8; Blikslager AT, 2007, PHYSIOL REV, V87, P545, DOI 10.1152/physrev.00012.2006; Alarcon I, 2011, INVEST OPHTH VIS SCI, V52, P1368, DOI 10.1167/iovs.10-6125; Baudouin C, 2010, PROG RETIN EYE RES, V29, P312, DOI 10.1016/j.preteyeres.2010.03.001; Monti D, 2002, INT J PHARM, V232, P139, DOI 10.1016/S0378-5173(01)00907-3; Yee RW, 2006, ADV THER, V23, P511, DOI 10.1007/BF02850039; Nakashima M, 2008, J OCUL PHARMACOL TH, V24, P43, DOI 10.1089/jop.2007.0006; ROJANASAKUL Y, 1990, INT J PHARM, V66, P131, DOI 10.1016/0378-5173(90)90392-H; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Kinoshita S, 2001, PROG RETIN EYE RES, V20, P639, DOI 10.1016/S1350-9462(01)00007-6; Pflugfelder SC, 2005, AM J PATHOL, V166, P61, DOI 10.1016/S0002-9440(10)62232-8; Draize JH, 1944, J PHARMACOL EXP THER, V82, P377; Balda MS, 1996, J CELL BIOL, V134, P1031, DOI 10.1083/jcb.134.4.1031; Miyoshi J, 2008, BBA-BIOMEMBRANES, V1778, P670, DOI 10.1016/j.bbamem.2007.12.014; Sasaki H, 1999, CRIT REV THER DRUG, V16, P85; YOKOI N, 1995, CORNEA, V14, P485; [Anonymous], 2005, 606011 IEC; Chetoni P, 2003, TOXICOL IN VITRO, V17, P497, DOI 10.1016/S0887-2333(03)00052-3; POTTS AM, 1957, AM J OPHTHALMOL, V44, P284; Uematsu M, 2007, OPHTHAL RES, V39, P308, DOI 10.1159/000109986; Moyes SM, 2007, INT J PHARM, V337, P133, DOI 10.1016/j.ijpharm.2006.12.036; Kusano M, 2010, CORNEA, V29, P80, DOI 10.1097/ICO.0b013e3181a3c3e6; York M, 1998, J APPL TOXICOL, V18, P233, DOI 10.1002/(SICI)1099-1263(199807/08)18:4<233::AID-JAT496>3.0.CO;2-Y; BURSTEIN NL, 1980, INVEST OPHTH VIS SCI, V19, P308; TONJUM AM, 1975, ACTA OPHTHALMOL, V53, P358; Joshi A, 1996, INVEST OPHTH VIS SCI, V37, P1008; Saettone MF, 1996, INT J PHARM, V142, P103, DOI 10.1016/0378-5173(96)04663-7; Prinsen MK, 1996, FOOD CHEM TOXICOL, V34, P291, DOI 10.1016/0278-6915(95)00115-8; Kruszewski FH, 1997, FUND APPL TOXICOL, V36, P130, DOI 10.1006/faat.1997.2289; Denoyer A, 2008, OPHTHALMIC RES, V40, P298, DOI 10.1159/000134928; Onizuka N, 2014, CORNEA, V33, P521, DOI 10.1097/ICO.0000000000000086; Pellinen P, 2009, OPHTHAL RES, V41, P118, DOI 10.1159/000192082; Biermann H, 1991, Fortschr Ophthalmol, V88, P17; Chen WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040893; Fukuda Masamichi, 2012, Clin Ophthalmol, V6, P585, DOI 10.2147/OPTH.S30935; Jurgens I, 1996, PHYSIOL MEAS, V17, P187; Kojima D., 2014, CURRENT TISSUE ENG, V3, P102; GOBBELS M, 1989, GRAEF ARCH CLIN EXP, V227, P139, DOI 10.1007/BF02169786; Watanabe Makio, 1993, Nippon Ganka Gakkai Zasshi, V97, P569	43	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1056-8719	1873-488X		J PHARMACOL TOX MET	J. Pharmacol. Toxicol. Methods	NOV-DEC	2015	76						65	71		10.1016/j.vascn.2015.08.153		7	Pharmacology & Pharmacy; Toxicology	Pharmacology & Pharmacy; Toxicology	CW6JJ	WOS:000365103400009		
J	Yamaoka, T; Kitamura, Y				Yamaoka, Toshikazu; Kitamura, Yoshiaki			Characterization of a highly sensitive and selective novel trapping reagent, stable isotope labeled glutathione ethyl ester, for the detection of reactive metabolites	JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS			English	Article						Bioactivation; Glutathione trapping assay; Idiosyncratic toxicity; Reactive intermediate; Stable isotope	TANDEM MASS-SPECTROMETRY; INDUCED-LIVER-INJURY; IN-VITRO; COVALENT BINDING; DRUG BIOACTIVATION; RAPID DETECTION; NEUTRAL LOSS; IDENTIFICATION; HEPATOTOXICITY; INTERMEDIATE	Introduction: Glutathione (GSH) trapping assays are widely used to predict the post-marketing risk for idiosyncratic drug reactions (IDRs) in the pharmaceutical industry. Although several GSH derivatives have been introduced as trapping reagents for reactive intermediates, more sensitive and selective reagents are desired to prevent the generation of erroneous results. In this study, stable isotope labeled GSH ethyl ester (GSHEE-d(5)) was designed and its detection capability was evaluated. Methods: GSHEE-d(5) was synthesized and its detection potential was compared with stable isotope labeled GSH ([C-13(2),N-15] GSH) as a reference trapping reagent. The trapping reagents were added to human liver microsomes as a 1:1 mixture with GSHEE or GSH, respectively, and incubated with seven IDR positive drugs and three IDR negative drugs. The adducts formed between the reagents and reactive metabolites were analyzed by unit resolution mass spectrometer (MS) using isotope pattern-dependent scan with neutral loss filtering. Results: A single-step reaction of GSHand ethanol-d(6) produced GSHEE-d(5) with a yield of 85%. The GSHEE-d(5) assay detected adducts with all seven IDR positive drugs, and no adducts were detected with the three IDR negative drugs. In contrast, the [C-13(2),N-15] GSH assay failed to detect adducts with three of the IDR positive drugs. In the case of diclofenac, the GSHEE-d(5) assay showed a 4-times greater signal intensity than the [C-13(2),N-15] GSH assay. Discussion: GSHEE-d5 enabled the detection of reactive metabolites with greater sensitivity and selectivity than [C-13(2),N-15] GSH. These results demonstrate that GSHEE-d(5) would be a useful trapping reagent for evaluating the risk of IDRs with unit resolution MS. (C) 2015 Elsevier Inc. All rights reserved.	[Yamaoka, Toshikazu; Kitamura, Yoshiaki] Kyorin Pharmaceut Co Ltd, DMPK Res Lab, Watarase Res Ctr, Nogi Machi, Tochigi 3290114, Japan	Yamaoka, T (reprint author), Kyorin Pharmaceut Co Ltd, DMPK Res Lab, Watarase Res Ctr, 1848 Nogi, Nogi Machi, Tochigi 3290114, Japan.	toshikazu.yamaoka@mb.kyorin-pharm.co.jp; yoshiaki.kitamura@mb.kyorin-pharm.co.jp					Ikeda T, 2015, CURR MED CHEM, V22, P528; Miura M, 2010, J PHARMACOL TOX MET, V61, P44, DOI 10.1016/j.vascn.2009.10.005; Ma L, 2008, CHEM RES TOXICOL, V21, P1477, DOI 10.1021/tx8001115; Usui T, 2009, DRUG METAB DISPOS, V37, P2383, DOI 10.1124/dmd.109.028860; Huang K, 2015, ANAL CHEM, V87, P3646, DOI 10.1021/ac504737x; Evans DC, 2004, CHEM RES TOXICOL, V17, P3, DOI 10.1021/tx034170b; Lim HK, 2008, RAPID COMMUN MASS SP, V22, P1295, DOI 10.1002/rcm.3504; Zheng J, 2007, CHEM RES TOXICOL, V20, P757, DOI 10.1021/tx600277y; Zhu XC, 2011, ANAL CHEM, V83, P9516, DOI 10.1021/ac202280f; Sawamura R, 2010, DRUG METAB DISPOS, V38, P1857, DOI 10.1124/dmd.110.034173; Buchard A, 2012, CLIN TOXICOL, V50, P27, DOI 10.3109/15563650.2011.639713; Walgren JL, 2005, CRIT REV TOXICOL, V35, P325, DOI 10.1080/10408440590935620; [Anonymous], 1998, PHYS DESK REFERENCE; Masubuchi N, 2007, CHEM RES TOXICOL, V20, P455, DOI 10.1021/tx060234h; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; Obach RS, 2008, CHEM RES TOXICOL, V21, P1814, DOI 10.1021/tx800161s; Defoy D, 2011, CHEM RES TOXICOL, V24, P412, DOI 10.1021/tx1003694; [Anonymous], 2014, FULL PRESCR INF STRI; Gan JP, 2005, CHEM RES TOXICOL, V18, P896, DOI 10.1021/tx0496791; Nakayama S, 2009, DRUG METAB DISPOS, V37, P1970, DOI 10.1124/dmd.109.027797; Lucena MI, 2008, HEPATOLOGY, V48, P588, DOI 10.1002/hep.22370; Zhu MS, 2007, ANAL CHEM, V79, P8333, DOI 10.1021/ac071119u; Lammert C, 2008, HEPATOLOGY, V47, P2003, DOI 10.1002/hep.22272; Mutlib A, 2005, RAPID COMMUN MASS SP, V19, P3482, DOI 10.1002/rcm.2223; Argoti D, 2005, CHEM RES TOXICOL, V18, P1537, DOI 10.1021/tx0501637; Soglia JR, 2004, J PHARMACEUT BIOMED, V36, P105, DOI 10.1016/j.jpba.2004.04.019; Yan ZY, 2004, ANAL CHEM, V76, P6835, DOI 10.1021/ac040159k; Castro-Perez J, 2005, RAPID COMMUN MASS SP, V19, P798, DOI 10.1002/rcm.1855; [Anonymous], 2014, PACK INS DORM INJ 10; Rousu T, 2009, RAPID COMMUN MASS SP, V23, P843, DOI 10.1002/rcm.3953; Zhou SF, 2005, DRUG METAB REV, V37, P41, DOI 10.1081/DMR-200028812; Yan ZY, 2005, RAPID COMMUN MASS SP, V19, P3322, DOI 10.1002/rcm.2195; Kalgutkar AS, 2015, ANNU REV PHARMACOL, V55, P35, DOI 10.1146/annurev-pharmtox-010814-124720	33	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1056-8719	1873-488X		J PHARMACOL TOX MET	J. Pharmacol. Toxicol. Methods	NOV-DEC	2015	76						83	95		10.1016/j.vascn.2015.08.157		13	Pharmacology & Pharmacy; Toxicology	Pharmacology & Pharmacy; Toxicology	CW6JJ	WOS:000365103400012		
J	Ma, L; Perrier, P; Dang, JW				Ma, Liang; Perrier, Pascal; Dang, Jianwu			Strength of syllabic influences on articulation in Mandarin Chinese and French: Insights from a motor control approach	JOURNAL OF PHONETICS			English	Article						Speech production; Syllable; Coarticulation; Speech units; Cross-linguistic study	VOCAL-TRACT CONSTRICTIONS; TO-VOWEL COARTICULATION; LANGUAGE PRODUCTION; SPEECH PRODUCTION; LEXICAL ACCESS; REACTION-TIME; SEQUENCE; ENGLISH; MODEL; SEGMENTATION	This paper investigates how strong the influences of syllables are on the organization of speech movements in Mandarin Chinese and French. More specifically, we evaluate the strength of these influences by measuring the extent of anticipatory coarticulation in V1CV2 sequences, within and across the boundaries of the CV2 syllable. In line with motor control studies that have investigated serial-order motor tasks such as speech production, we consider that the extent of anticipatory motor planning reveals information about the units of planning, their boundaries and their strengths. For V-1/t/V-2 and V-1/k/V-2 sequences, where V-1 and V-2 are either /i/, /a/ or /u/, we used an electromagnetic magnetometer to record articulatory data from three native speakers of Mandarin Chinese and three native speakers of French. We labeled key articulatory configurations for V-1, C and V-2 based on general articulatory criteria. Our two major findings are: (1) Within CV2 boundaries, coarticulation is strong for both groups of speakers; in French, the coarticulation patterns can be fully explained by anticipatory behavior, while in Mandarin Chinese other strategies might also be involved. (2) Across CV2 boundaries, anticipatory coarticulation is observed in numerous cases in French, while no significant anticipation can be noted in Mandarin Chinese. We conclude that these measures provide evidence for the hypothesis that the strength of the syllable as a unit of speech planning is more important in Mandarin Chinese than in French. Finally, we propose potential explanations for these differences. (C) 2015 Elsevier Ltd. All rights reserved.	[Ma, Liang] Fudan Univ, Dept Chinese Language & Literature, Shanghai 200433, Peoples R China; [Perrier, Pascal] Univ Grenoble Alpes, GIPSA Lab, F-38000 Grenoble, France; [Perrier, Pascal] CNRS, GIPSA Lab, F-38000 Grenoble, France; [Dang, Jianwu] Japanese Adv Inst Sci & Technol, Nomi, Ishikawa, Japan	Ma, L (reprint author), Fudan Univ, Dept Chinese Language & Literature, Room 701,Guanghua West Bldg,220,Handan Rd, Shanghai 200433, Peoples R China.	liangma@fudan.edu.cn; pascal.perrier@gipsa-lab.grenoble-inp.fr; jdang@jaist.ac.jp			French Ministry of Higher Education and Research; French "Agence Nationale de la Recherche" [DOCVACIM - ANR-07-CORP-0018]; National Basic Research Program of China [2013CB329301]; National Natural Science Foundation of China [61233009]	Special thanks are due to Noel Nguyen for insightful suggestions and comments during the conduct of the study. This work was in large part supported by a Grant from the French Ministry of Higher Education and Research to Liang Ma. This work was also supported by a grant from the French "Agence Nationale de la Recherche" (DOCVACIM - ANR-07-CORP-0018 - PI: Rudolph Sock, Strasbourg University), by the National Basic Research Program of China (No. 2013CB329301), and by the National Natural Science Foundation of China under Contract no. 61233009.	Gaskell MG, 2002, MEM COGNITION, V30, P798, DOI 10.3758/BF03196435; Chen JY, 1999, APPL PSYCHOLINGUIST, V20, P289; Klapp ST, 2003, J MOTOR BEHAV, V35, P135; Guenther FH, 2012, J NEUROLINGUIST, V25, P408, DOI 10.1016/j.jneuroling.2009.08.006; Arvaniti A, 2012, J PHONETICS, V40, P351, DOI 10.1016/j.wocn.2012.02.003; Content A, 2001, LANG COGNITIVE PROC, V16, P609; Engel KC, 1997, EXP BRAIN RES, V113, P189, DOI 10.1007/BF02450317; Marin S, 2010, MOTOR CONTROL, V14, P380; Menezes C, 2003, SPEECH COMMUN, V40, P71, DOI 10.1016/S0167-6393(02)00076-6; Recasens D, 1997, J ACOUST SOC AM, V102, P544, DOI 10.1121/1.419727; O'Seaghdha PG, 2010, COGNITION, V115, P282, DOI 10.1016/j.cognition.2010.01.001; Content A, 2001, J MEM LANG, V45, P177, DOI 10.1006/jmla.2000.2775; Xu Y, 1998, PHONETICA, V55, P179, DOI 10.1159/000028432; DELATTRE P, 1969, LINGUA, V22, P160, DOI 10.1016/0024-3841(69)90051-5; BELLBERTI F, 1982, J ACOUST SOC AM, V71, P449, DOI 10.1121/1.387466; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; MANUEL SY, 1990, J ACOUST SOC AM, V88, P1286, DOI 10.1121/1.399705; Fujimura O, 2000, PHONETICA, V57, P128, DOI 10.1159/000028467; DELL GS, 1986, PSYCHOL REV, V93, P283, DOI 10.1037//0033-295X.93.3.283; Guenther FH, 1998, PSYCHOL REV, V105, P611; Chen BL, 2002, IEEE T SPEECH AUDI P, V10, P303, DOI 10.1109/TSA.2002.802541; Ramus F, 1999, COGNITION, V73, P265, DOI 10.1016/S0010-0277(99)00058-X; LUBKER J, 1981, PHONETICA, V38, P51; Fougeron C, 1997, J ACOUST SOC AM, V101, P3728, DOI 10.1121/1.418332; Grimme B, 2011, MOTOR CONTROL, V15, P5; O'Seaghdha PG, 2013, P NATL ACAD SCI USA, V110, pE3, DOI 10.1073/pnas.1217032110; SCHMIDT RA, 1968, PSYCHOL BULL, V70, P631, DOI 10.1037/h0026740; Chen JY, 2002, J MEM LANG, V46, P751, DOI 10.1006/jmla.2001.2825; Qu QQ, 2012, P NATL ACAD SCI USA, V109, P14265, DOI 10.1073/pnas.1200632109; Orliaguet JP, 1997, PERCEPTION, V26, P905, DOI 10.1068/p260905; Qu QQ, 2013, P NATL ACAD SCI USA, V110, pE4, DOI 10.1073/pnas.1217601110; MEYER AS, 1990, J MEM LANG, V29, P524, DOI 10.1016/0749-596X(90)90050-A; BROWMAN CP, 1988, PHONETICA, V45, P140; MEYER AS, 1991, J MEM LANG, V30, P69, DOI 10.1016/0749-596X(91)90011-8; HARSHMAN R, 1977, J ACOUST SOC AM, V62, P693, DOI 10.1121/1.381581; Dell GS, 1999, COGNITIVE SCI, V23, P517; GAY T, 1991, J PHONETICS, V19, P445; HULSTIJN W, 1983, ACTA PSYCHOL, V54, P23, DOI 10.1016/0001-6918(83)90021-5; LEVELT WJM, 1994, COGNITION, V50, P239, DOI 10.1016/0010-0277(94)90030-2; Guenther FH, 2006, BRAIN LANG, V96, P280, DOI 10.1016/j.bandl.2005.06.001; Fowler CA, 2000, LANG SPEECH, V43, P1; BENGUERE.AP, 1974, PHONETICA, V30, P41; Browman C. P., 2000, B COMMUNICATION PARL, V5, P25; Browman Catherine, 1986, PHONOLOGY YB, V3, P219; Browman CP, 1989, PHONOLOGY, V6, P201, DOI 10.1017/S0952675700001019; Calliope, 1989, PAR SON TRAIT AUT; Chao Y.-R., 1968, GRAMMAR SPOKEN CHINE; Cheng C. C., 1973, SYNCHRONIC PHONOLOGY; Chistovich L., 1965, SPEECH ARTICULATION, P104; Cholin J, 2011, BRILL HANDB LINGUIST, V1, P225; Dang J., 2007, ADV CHINESE SPOKEN L, P3; Daniloff R. G., 1973, J PHONETICS, V1, P239; Duanmu S., 2002, PHONOLOGY STANDARD C; Fujimura O., 1992, Journal of the Acoustical Society of Japan (E), V13; Gafos A., 2014, P 10 INT SEM SPEECH, P61; Gao M., 2008, THESIS; GAY T, 1992, J ACOUST SOC AM, V92, P1301, DOI 10.1121/1.403924; Hermes A, 2013, SPEECH PRODUCTION PE, V2; Hyman L. M., 2010, UC BERKELEY PHONOLOG, P95; Kent R. D., 1977, J PHONETICS, V5, P115; Lallouache T M., 1995, P ICPHS STOCKH SUED, V4, P152; Levelt W. J. M., 1993, SPEAKING INTENTION A; LINDBLOM B, 1990, NATO ADV SCI I D-BEH, V55, P403; Ma L, 2008, THESIS; Mann S., 2011, P 9 INT SEM SPEECH P, P179; MEHLER J, 1981, J VERB LEARN VERB BE, V20, P298, DOI 10.1016/S0022-5371(81)90450-3; Mok P. K. P., 2010, J ACOUSTICAL SOC AM; Noiray A., 2011, J ACOUST SOC AM, V129, P40; Pastatter M., 2014, P 10 INT SEM SPEECH, P312; PERKELL JS, 1990, NATO ADV SCI I D-BEH, V55, P263; Pouplier M., 2011, LAB PHONOLOGY, V2, P243, DOI DOI 10.1515/LABPHON.2011.009; Pouplier Marianne, 2012, SPEECH PLANNING DYNA, P63; Shattuck-Hufnagel S, 2011, BRILL HANDB LINGUIST, V1, P197; Straka G., 1965, ALBUM PHONETIQUE; Vaxelaire B., 2007, P 16 INT C PHON SCI, P525; Verwey W. B, 1996, J EXPT PSYCHOL HUMAN, V22, P554; WHALEN DH, 1990, J PHONETICS, V18, P3; Wu Z. J., 1989, GEN INTRO EXPT PHONE	78	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0095-4470			J PHONETICS	J. Phon.	NOV	2015	53				SI		101	124		10.1016/j.wocn.2015.09.005		24	Linguistics; Language & Linguistics	Linguistics	CX0IA	WOS:000365378900010		
J	Yamamoto, Y; Turkiewicz, A; Wingstrand, H; Englund, M				Yamamoto, Yuri; Turkiewicz, Aleksandra; Wingstrand, Hans; Englund, Martin			Fragility Fractures in Patients with Rheumatoid Arthritis and Osteoarthritis Compared with the General Population	JOURNAL OF RHEUMATOLOGY			English	Article						RHEUMATOID ARTHRITIS; OSTEOARTHRITIS; FRACTURES; EPIDEMIOLOGY; OSTEOPOROSIS	BONE-MINERAL DENSITY; KNEE OSTEOARTHRITIS; HIP OSTEOARTHRITIS; RISK; OSTEOPOROSIS; ASSOCIATION; REGISTER	Objective. To determine the rate ratios of hip and distal radius fractures in patients with rheumatoid arthritis (RA), hip osteoarthritis (OA), and knee OA. Methods. Cohort study using healthcare data (1998-2012) covering the entire population of the Skane region of Sweden. Results. We found an increased rate of hip fracture in both female [standardized fracture rate ratio (SFR) 1.54, 95% CI 1.40-1.70] and male patients with RA (SFR 1.81, 95% CI 1.51-2.17). The hip fracture rate in female OA was reduced by 10-20%, and trochanteric fracture tended to have a higher rate ratio compared with the cervical. Conclusion. The 50-80% increased rate of hip fracture adds to the total burden of RA while the shifted distribution of cervical/trochanteric fractures in OA is in support of subchondral bone alterations.	[Yamamoto, Yuri] Nagoya Univ Hosp, Dept Rehabil, Nagoya, Aichi, Japan; [Turkiewicz, Aleksandra; Wingstrand, Hans; Englund, Martin] Lund Univ, Dept Clin Sci, Orthoped, Lund, Sweden; [Englund, Martin] Skane Univ Hosp, Epidemiol & Register Ctr South, Lund, Sweden; [Englund, Martin] Boston Univ, Sch Med, Clin Epidemiol Res & Training Unit, Boston, MA 02118 USA	Englund, M (reprint author), Clin Epidemiol Unit, Orthoped, Klinikgatan 22 Wigerthuset, SE-22185 Lund, Sweden.	martin.englund@med.lu.se		Turkiewicz, Aleksandra/0000-0003-1460-2275	Swedish Research Council; Swedish Rheumatism Association; Kock Foundations; Region Skane; Governmental Funding of Clinical Research within National Health Service; Faculty of Medicine, Lund University, Sweden	Supported by the Swedish Research Council, the Swedish Rheumatism Association, Kock Foundations, Region Skane, Governmental Funding of Clinical Research within National Health Service, and the Faculty of Medicine, Lund University, Sweden.	Chan MY, 2014, OSTEOARTHR CARTILAGE, V22, P1251, DOI 10.1016/j.joca.2014.07.004; Chudyk AM, 2012, CLIN RHEUMATOL, V31, P749, DOI 10.1007/s10067-012-1970-z; Arden NK, 1999, ARTHRITIS RHEUM, V42, P1378, DOI 10.1002/1529-0131(199907)42:7<1378::AID-ANR11>3.0.CO;2-I; Kaz HK, 2004, RHEUMATOLOGY, V43, P1267, DOI 10.1093/rheumatology/keh304; Haugen IK, 2007, ANN RHEUM DIS, V66, P1594, DOI 10.1136/ard.2006.068940; van den Bergh JP, 2012, NAT REV RHEUMATOL, V8, P163, DOI 10.1038/nrrheum.2011.217; Haugeberg G, 2000, ARTHRITIS RHEUM, V43, P2776, DOI 10.1002/1529-0131(200012)43:12<2776::AID-ANR18>3.3.CO;2-E; Haugeberg G, 2000, ARTHRITIS RHEUM, V43, P522, DOI 10.1002/1529-0131(200003)43:3<522::AID-ANR7>3.0.CO;2-Y; Englund M, 2010, RHEUMATOLOGY, V49, P1563, DOI 10.1093/rheumatology/keq127; Rosengren Björn E, 2015, J Bone Miner Res, V30, P535, DOI 10.1002/jbmr.2370; CUMMING RG, 1993, ANN RHEUM DIS, V52, P707, DOI 10.1136/ard.52.10.707; HART DJ, 1994, ANN RHEUM DIS, V53, P158, DOI 10.1136/ard.53.3.158; van Staa TP, 2006, ARTHRITIS RHEUM, V54, P3104, DOI 10.1002/art.22117; Arden NK, 2006, ARTHRIT RHEUM-ARTHR, V55, P610, DOI 10.1002/art.22088; Calderazzi F, 2014, HIP INT, V24, P231, DOI [10.530/hipint.5000116, 10.5301/hipint.5000116]; Franklin J, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-274; Kim SY, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3107; Lofvendahl S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098024; Tang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055077; Turkiewicz A, 2014, OSTEOARTHR CARTILAGE, V22, P1826, DOI 10.1016/j.joca.2014.07.015	20	0	0	J RHEUMATOL PUBL CO	TORONTO	365 BLOOR ST E, STE 901, TORONTO, ONTARIO M4W 3L4, CANADA	0315-162X	1499-2752		J RHEUMATOL	J. Rheumatol.	NOV	2015	42	11					2055	2058		10.3899/jrheum.150325		4	Rheumatology	Rheumatology	CW8AS	WOS:000365221400009		
J	Asano, J; Watanabe, T; Oguchi, T; Kanai, K; Maruyama, M; Ito, T; Muraki, T; Hamano, H; Arakura, N; Matsumoto, A; Kawa, S				Asano, Junpei; Watanabe, Takayuki; Oguchi, Takaya; Kanai, Keita; Maruyama, Masahiro; Ito, Tetsuya; Muraki, Takashi; Hamano, Hideaki; Arakura, Norikazu; Matsumoto, Akihiro; Kawa, Shigeyuki			Association Between Immunoglobulin G4-related Disease and Malignancy within 12 Years after Diagnosis: An Analysis after Longterm Followup	JOURNAL OF RHEUMATOLOGY			English	Article						IMMUNOGLOBULIN G4-RELATED DISEASE; AUTOIMMUNE PANCREATITIS; MALIGNANCIES; ACTIVITY MARKER	PANCREATIC DUCTAL ADENOCARCINOMA; AUTOIMMUNE PANCREATITIS; IGG4-RELATED DISEASE; HEPATOCELLULAR-CARCINOMA; SCLEROSING PANCREATITIS; CANCER; RISK; CRITERIA; IMMUNOSURVEILLANCE; GUIDELINES	Objective. Because it is uncertain whether immunoglobulin G4-related disease (IgG4-RD) is associated with malignancy, we evaluated the incidence of cancer development in a large cohort of patients with IgG4-RD. Methods. The study enrolled 158 patients diagnosed as having IgG4-RD between 1992 and 2012. We calculated the standardized incidence ratio (SIR) and cumulative rate of malignancies in this group and searched for risk factors associated with the occurrence of tumors. Results. A total of 34 malignancies were observed in the patients with IgG4-RD over a mean followup period of 5.95 +/- 4.48 years. The overall SIR of malignancies was 2.01 (95% CI 1.34-2.69). The SIR of patients who exhibited a tumor within 1 year after IgG4-RD diagnosis was 3.53 (95% CI 1.23-5.83), while that of subjects forming a malignancy in subsequent years was 1.48 (95% CI 0.99-1.98). The cumulative rate of malignancy development was significantly higher in patients with IgG4-RD within 12 years after diagnosis than in the Japanese general population. Comparable results were obtained for an autoimmune pancreatitis subgroup. The serum concentrations of several disease activity markers at diagnosis were significantly higher in patients with malignancies than in those without. Conclusion. We identified a close association between IgG4-RD and malignancy formation within 12 years after diagnosis, particularly during the first year. An active IgG4-RD state is presumed to be a strong risk factor for malignancy development.	[Asano, Junpei; Watanabe, Takayuki; Oguchi, Takaya; Kanai, Keita; Maruyama, Masahiro; Ito, Tetsuya; Muraki, Takashi; Hamano, Hideaki; Matsumoto, Akihiro] Shinshu Univ, Sch Med, Dept Gastroenterol, Matsumoto, Nagano 3908621, Japan; [Arakura, Norikazu] Shinshu Univ, Sch Med, Endoscop Examinat Ctr, Matsumoto, Nagano 3908621, Japan; Shinshu Univ, Sch Med, Ctr Hlth Safety & Environm Management, Matsumoto, Nagano 3908621, Japan; [Kawa, Shigeyuki] Shinshu Univ, Ctr Hlth Safety & Environm Management, Matsumoto, Nagano 3908621, Japan	Kawa, S (reprint author), Shinshu Univ, Ctr Hlth Safety & Environm Management, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	skawapc@shinshu-u.ac.jp			Ministry of Health, Labor, and Welfare of Japan; Ministry of Education, Science, Sports, and Culture of Japan [23591012]	Supported partially by the Research Program of Intractable Disease provided by the Ministry of Health, Labor, and Welfare of Japan and in part by Grants-in-aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture of Japan (23591012).	Hussain SP, 2007, INT J CANCER, V121, P2373, DOI 10.1002/ijc.23173; Nishino T, 2006, INTERNAL MED, V45, P497, DOI 10.2169/internalmedicine.45.1565; Witkiewicz AK, 2008, HUM PATHOL, V39, P1548, DOI 10.1016/j.humpath.2008.01.021; Seino Y, 2010, J DIABETES INVEST, V1, P212, DOI 10.1111/j.2040-1124.2010.00074.x; Zitvogel L, 2006, NAT REV IMMUNOL, V6, P715, DOI 10.1038/nri1936; Kamisawa T, 2006, WORLD J GASTROENTERO, V12, P6225; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Umehara H, 2012, MOD RHEUMATOL, V22, P21, DOI 10.1007/s10165-011-0571-z; Uchida K, 2009, J GASTROENTEROL, V44, P726, DOI 10.1007/s00535-009-0049-3; Matsuda A, 2014, JPN J CLIN ONCOL, V44, P388, DOI 10.1093/jjco/hyu003; Sandanayake NS, 2009, CLIN GASTROENTEROL H, V7, P1089, DOI 10.1016/j.cgh.2009.03.021; Hart PA, 2013, GUT, V62, P1771, DOI 10.1136/gutjnl-2012-303617; Kamisawa T, 2009, PANCREAS, V38, P890, DOI 10.1097/MPA.0b013e3181b65a1c; Kawano M, 2011, CLIN EXP NEPHROL, V15, P615, DOI 10.1007/s10157-011-0521-2; Yoshimura Y, 2006, INTERNAL MED, V45, P897, DOI 10.2169/internalmedicine.45.1752; Senovilla L, 2012, SCIENCE, V337, P1678, DOI 10.1126/science.1224922; Nakazawa T, 2012, J GASTROENTEROL, V47, P79, DOI 10.1007/s00535-011-0465-z; Shiokawa M, 2013, AM J GASTROENTEROL, V108, P610, DOI 10.1038/ajg.2012.465; SIMONETTI RG, 1992, ANN INTERN MED, V116, P97; Yoneda M, 2013, J CYTOL, V30, P46, DOI 10.4103/0970-9371.107513; Racanelli V, 2008, AUTOIMMUN REV, V7, P352, DOI 10.1016/j.autrev.2008.02.001; Kamisawa T, 2014, J GASTROENTEROL, V49, P961, DOI 10.1007/s00535-014-0945-z; Hart PA, 2014, PANCREAS, V43, P417, DOI 10.1097/MPA.0000000000000053; LOWENFELS AB, 1993, NEW ENGL J MED, V328, P1433, DOI 10.1056/NEJM199305203282001; Kiyosawa K, 2004, GASTROENTEROLOGY, V127, pS17, DOI 10.1053/j.gastro.2004.09.012; Kobayashi H, 2007, J THORAC IMAG, V22, P360; Yamamoto M, 2012, MOD RHEUMATOL, V22, P414, DOI 10.1007/s10165-011-0520-x; Yoshizawa K, 2012, HEPATOLOGY, V56, P668, DOI 10.1002/hep.25658; Hamano H, 2001, NEW ENGL J MED, V344, P732, DOI 10.1056/NEJM200103083441005; Naschitz JE, 1999, SEMIN ARTHRITIS RHEU, V29, P43, DOI 10.1016/S0049-0172(99)80037-7; Hamano H, 2002, LANCET, V359, P1403, DOI 10.1016/S0140-6736(02)08359-9; Shimosegawa T, 2011, PANCREAS, V40, P352, DOI 10.1097/MPA.0b013e3182142fd2; Cohen IR, 2014, J AUTOIMMUN, V54, P112, DOI 10.1016/j.jaut.2014.05.002; HENDERSO.BE, 1974, CANCER RES, V34, P1045; Hirano K, 2014, INTERNAL MED, V53, P171, DOI 10.2169/internalmedicine.53.1342; Kawa S, 2013, AUTOIMMUNE DIS, P935; Maruyama M, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-77; Ohnishi S, 2013, OXID MED CELL LONGEV, V2013; Sugiyama Toshiro, 2004, Medical Electron Microscopy, V37, P149; Sugumar Aravind, 2009, Expert Rev Gastroenterol Hepatol, V3, P197, DOI 10.1586/egh.09.2; Yamamoto M, 2006, MOD RHEUMATOL, V16, P335	41	0	0	J RHEUMATOL PUBL CO	TORONTO	365 BLOOR ST E, STE 901, TORONTO, ONTARIO M4W 3L4, CANADA	0315-162X	1499-2752		J RHEUMATOL	J. Rheumatol.	NOV	2015	42	11					2135	2142		10.3899/jrheum.150436		8	Rheumatology	Rheumatology	CW8AS	WOS:000365221400019		
J	Bruyn, GA; Naredo, E; Iagnocco, A; Balint, PV; Backhaus, M; Gandjbakhch, F; Gutierrez, M; Filer, A; Finzel, S; Ikeda, K; Kaeley, GS; Manzoni, SM; Ohrndorf, S; Pineda, C; Richards, B; Roth, J; Schmidt, WA; Terslev, L; D'Agostino, MA				Bruyn, George A.; Naredo, Esperanza; Iagnocco, Annamaria; Balint, Peter V.; Backhaus, Marina; Gandjbakhch, Frederique; Gutierrez, Marwin; Filer, Andrew; Finzel, Stephanie; Ikeda, Kei; Kaeley, Gurjit S.; Manzoni, Silvia Magni; Ohrndorf, Sarah; Pineda, Carlos; Richards, Bethan; Roth, Johannes; Schmidt, Wolfgang A.; Terslev, Lene; D'Agostino, Maria Antonietta		OMERACT Ultrasound Task Force	The OMERACT Ultrasound Working Group 10 Years On: Update at OMERACT 12	JOURNAL OF RHEUMATOLOGY			English	Article						JOINT EROSIONS; OUTCOME ASSESSMENT; ULTRASONOGRAPHY	RHEUMATOID-ARTHRITIS; MUSCULOSKELETAL ULTRASONOGRAPHY; INTEROBSERVER RELIABILITY; DEFINITIONS; PERSPECTIVES; SYNOVITIS; VALIDITY; DISEASE; JOINTS; RA	Musculoskeletal ultrasound (US) now thrives as an established imaging modality for the investigation and management of chronic inflammatory arthritis. We summarize here results of the Outcome Measures in Rheumatology (OMERACT) US working group (WG) projects of the last 2 years. These results were reported at the OMERACT 12 meeting at the plenary session and discussed during breakout sessions. Topics included standardization of US use in rheumatic disease over the last decade and its contribution to understanding musculoskeletal diseases. This is the first update report of WG activities in validating US as an outcome measure in musculoskeletal inflammatory and degenerative diseases, including pediatric arthritis, since the OMERACT 11 meeting.	[Bruyn, George A.] MC Groep, Dept Rheumatol, Lelystad, Netherlands; [Naredo, Esperanza] Hosp Gen Univ Gregorio Maranon, Dept Rheumatol, Madrid, Spain; [Balint, Peter V.] Natl Inst Rheumatol & Rehabil, Dept Rheumatol, Budapest, Hungary; [Iagnocco, Annamaria] Univ Roma La Sapienza, Dept Rheumatol, I-00185 Rome, Italy; [Filer, Andrew] Univ Birmingham, Rheumatol Res Grp, Birmingham, W Midlands, England; [Finzel, Stephanie] Univ Clin Erlangen Nuremberg, Dept Internal Med 3, Erlangen, Germany; [Gutierrez, Marwin] Univ Politecn Marche, Clin Reumatol, Ancona, Italy; [Gandjbakhch, Frederique] Hop La Pitie Salpetriere, Serv Rhumatol, Paris, France; [Terslev, Lene] Copenhagen Univ Hosp Glostrup, Dept Rheumatol, Copenhagen, Denmark; [Pineda, Carlos] Inst Nacl Rehabil, Dept Rheumatol, Mexico City, DF, Mexico; [Kaeley, Gurjit S.] Univ Florida, Coll Med, Div Rheumatol, Jacksonville, FL USA; [Ikeda, Kei] Chiba Univ Hosp, Dept Allergy & Clin Immunol, Chiba, Japan; [Manzoni, Silvia Magni] IRCCS Osped Pediat Bambino Gesu, Pediat Rheumatol Unit, Rome, Italy; Royal Prince Alfred Hosp, Inst Rheumatol & Orthopaed, Camperdown, NSW 2050, Australia; [Roth, Johannes] Childrens Hosp Eastern Ontario, Div Pediat Rheumatol, Ottawa, ON K1H 8L1, Canada; [Schmidt, Wolfgang A.] Med Ctr Rheumatol Berlin Buch, Berlin, Germany; [Backhaus, Marina; Ohrndorf, Sarah] Humboldt Univ, Charite Univ Hosp, D-10099 Berlin, Germany; [D'Agostino, Maria Antonietta] Univ Paris Ouest Versailles St Quentin En Yveline, Hop Ambroise Pare, AP HP, Dept Rheumatol, Boulogne, France	Bruyn, GA (reprint author), MC Groep Hosp, Dept Rheumatol, NL-8233 AA Lelystad, Netherlands.	gawbruyn@wxs.nl					Alcalde M, 2012, RHEUMATOLOGY, V51, P1246, DOI 10.1093/rheumatology/kes018; D'Agostino M, 2012, ANN RHEUM DIS, V71, P186; Joshua F, 2007, J RHEUMATOL, V34, P839; Naredo E, 2006, ANN RHEUM DIS, V65, P14, DOI 10.1136/ard.2005.037382; Roth J, 2015, ARTHRIT CARE RES, V67, P136, DOI 10.1002/acr.22410; Bruyn GAW, 2012, RHEUMATOLOGY, V51, P1655, DOI 10.1093/rheumatology/kes103; Scheel AK, 2005, ANN RHEUM DIS, V64, P1043, DOI 10.1136/ard.2004.030387; Naredo E, 2013, ANN RHEUM DIS, V72, P1328, DOI 10.1136/annrheumdis-2012-202092; Bakewell CJ, 2013, J RHEUMATOL, V40, P1951, DOI 10.3899/jrheum.130643; Bruyn GAW, 2009, ANN RHEUM DIS, V68, P357, DOI 10.1136/ard.2008.089243; Chowalloor PV, 2013, ANN RHEUM DIS, V72, P638, DOI 10.1136/annrheumdis-2012-202301; Bruyn GAW, 2010, ARTHRIT CARE RES, V62, P1079, DOI 10.1002/acr.20175; Mathiessen A, 2013, ANN RHEUM DIS, V72, P51, DOI 10.1136/annrheumdis-2011-201195; Wakefield RJ, 2007, J RHEUMATOL, V34, P848; Wakefield RJ, 2005, J RHEUMATOL, V32, P2485; Iagnocco A, 2014, J RHEUMATOL, V41, P379, DOI 10.3899/jrheum.131084; Iagnocco A, 2012, OSTEOARTHR CARTILAGE, V20, P1142, DOI 10.1016/j.joca.2012.07.003; Naredo E, 2011, J RHEUMATOL, V38, P2063, DOI 10.3899/jrheum.110425; Bruyn GAW, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13893; Bruyn GAW, 2014, ANN RHEUM DIS, V73, P1929, DOI 10.1136/annrheumdis-2013-203596; Gutierrez M, RHEUMATOLOG IN PRESS; Terslev L, 2015, J RHEUMATOL, V42, P2177, DOI 10.3899/jrheum.141294	22	0	0	J RHEUMATOL PUBL CO	TORONTO	365 BLOOR ST E, STE 901, TORONTO, ONTARIO M4W 3L4, CANADA	0315-162X	1499-2752		J RHEUMATOL	J. Rheumatol.	NOV	2015	42	11					2172	2176		10.3899/jrheum.141462		5	Rheumatology	Rheumatology	CW8AS	WOS:000365221400026		
J	Ueta, I; Onikata, M; Mochizuki, S; Fujimura, K; Sasaki, T; Aoki, J; Maeda, T				Ueta, Ikuo; Onikata, Moe; Mochizuki, Suguru; Fujimura, Koji; Sasaki, Tomohiro; Aoki, Junji; Maeda, Tsuneaki			Partitioning sample collection/solvent extraction cartridge packed with octadecyl-derivatized macroporous silica particles for the analysis of sesquiterpenes in air samples	JOURNAL OF SEPARATION SCIENCE			English	Article						Gas chromatography with mass spectroscopy; Partitioning extraction; Sample Preparation; Sesquiterpenes	POLYCYCLIC AROMATIC-HYDROCARBONS; CHROMATOGRAPHY-MASS SPECTROMETRY; VOLATILE ORGANIC-COMPOUNDS; GAS-CHROMATOGRAPHY; MICRO-EXTRACTION; INDOOR AIR; DEVICE; MICROEXTRACTION	A novel sampling device based on the partition of target analytes to the extraction medium was developed for the determination of sesquiterpenes in air samples. The extraction medium was prepared by the chemical derivatization of a specially prepared macroporous silica, with a specific surface area of 2.0 m(2)/g. Taking advantage of the sample extraction, which was mainly based on the partition of sesquiterpenes between air and a C-18-bonded phase, the extracted analytes were rapidly and quantitatively desorbed just by passing a small amount of desorption solvent for subsequent analysis by gas chromatography with mass spectrometry. Several experimental conditions, such as the sampling volume and temperature, were systematically evaluated. Under optimized conditions, desorption of the extracted analytes was completed within 1 min with a desorption efficiency of more than 99.9%, achieved using 5 mL of acetone for all the evaluated sesquiterpenes. The applicability of the developed device was confirmed by the determination of several sesquiterpenes from coniferous trees. Although further improvements of the device are required for collecting large volumes or high-temperature air samples, the potential of the developed sampling device was confirmed by determining traces of semivolatile organic compounds in air samples.	[Ueta, Ikuo; Onikata, Moe; Mochizuki, Suguru] Univ Yamanashi, Dept Appl Chem, Kofu, Yamanashi 4008511, Japan; [Fujimura, Koji] Shinwa Chem Ind Ltd, Fushimi Ku, Kyoto, Japan; [Sasaki, Tomohiro; Aoki, Junji] HORIBA STEC Co Ltd, Minami Ku, Kyoto, Japan; [Maeda, Tsuneaki] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan	Ueta, I (reprint author), Univ Yamanashi, Dept Appl Chem, 4-3-11 Takeda, Kofu, Yamanashi 4008511, Japan.	iueta@yamanashi.ac.jp	Ueta, Ikuo/F-7879-2010		JSPS KAKENHI	This work was supported by JSPS KAKENHI. One of the authors (I. Ueta) acknowledges support from Prof. Y. Saito, Toyohashi University of Technology, S. Kawakubo, and Y. Suzuki of the University of Yamanashi.	Marlet C, 2010, TALANTA, V82, P1230, DOI 10.1016/j.talanta.2010.06.044; Krol S, 2010, TRAC-TREND ANAL CHEM, V29, P1101, DOI 10.1016/j.trac.2010.05.010; Parshintsev J, 2008, ANAL BIOANAL CHEM, V390, P913, DOI 10.1007/s00216-007-1755-4; Parida SK, 2006, ADV COLLOID INTERFAC, V121, P77, DOI 10.1016/j.cis.2006.05.028; Saito Y, 2009, ANAL BIOANAL CHEM, V393, P861, DOI 10.1007/s00216-008-2400-6; Bouvier-Brown NC, 2007, J CHROMATOGR A, V1161, P113, DOI 10.1016/j.chroma.2007.05.094; Inoue M, 2013, ANAL SCI, V29, P519; Calfapietra C, 2013, ENVIRON POLLUT, V183, P71, DOI 10.1016/j.envpol.2013.03.012; Ueta I, 2012, ANAL CHIM ACTA, V746, P77, DOI 10.1016/j.aca.2012.08.014; Boy M, 2004, ATMOS CHEM PHYS, V4, P657; Li K, 2007, J CHROMATOGR A, V1154, P74, DOI 10.1016/j.chroma.2007.03.129; King AJ, 2003, ENVIRON GEOCHEM HLTH, V25, P69, DOI 10.1023/A:1021248932084; [Anonymous], 2010, PAWLISZYN J ANAL CHI, DOI DOI 10.1016/J.ACA.2010.06.020; Son HH, 2012, ANAL CHIM ACTA, V751, P86, DOI 10.1016/j.aca.2012.09.023; Ueta I, 2014, ANAL SCI, V30, P105; Trefz P, 2012, J CHROMATOGR A, V1219, P29, DOI 10.1016/j.chroma.2011.10.077; Clausen P. A., 1997, J HIGH RES CHROMATOG, V20, P99, DOI 10.1002/jhrc.1240200210; Goncalves J, 2012, J SEP SCI, V35, P2282, DOI 10.1002/jssc.201200244; Petronilho S, 2014, ANAL CHIM ACTA, V846, P8, DOI 10.1016/j.aca.2014.05.049; US Environmental Protection Agency, 2009, INT SCI ASS PART MAT; World Health Organization (WHO), 2006, REG OFF EUR HLTH RIS; World Health Organization (WHO), 2013, REG OFF EUR HLTH EFF	22	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1615-9306	1615-9314		J SEP SCI	J. Sep. Sci.	NOV	2015	38	22					3891	3896		10.1002/jssc.201500629		6	Chemistry, Analytical	Chemistry	CW9LS	WOS:000365320800011		
J	Komatsuzaki, M; Wagger, MG				Komatsuzaki, M.; Wagger, M. G.			Nitrogen recovery by cover crops in relation to time of planting and growth termination	JOURNAL OF SOIL AND WATER CONSERVATION			English	Article						black oat; nitrogen leaching; planting time; rye; triticale; wheat	NO-TILL CORN; FERTILIZER NITROGEN; SOIL-WATER; KILL DATE; MANAGEMENT; RYE; CONSERVATION; TRITICALE; CEREALS; VETCH	Residual fertilizer nitrogen (N) in soil represents a potential environmental contaminant because of the risk of nitrate (NO3) leaching into ground water. Winter annual grass cover crops can conserve residual soil N; however, their ability to recover N greatly varies with management. A two-year field experiment in the North Carolina Coastal Plain on a State fine sandy loam (fine-loamy, mixed, thermic Typic Hapludult) compared dry matter (DM), N accumulation, and soil inorganic N following rye (Secale cereale L.), winter wheat (Triticum aestivum L.), triticale (Triticum secale L.), black oats (Avena strigosa L.), and fallow (native weeds) in relation to planting (October, November, and December) and growth termination (early March, early April, and late April/early May) dates and levels of residual soil N. Cover crop DM and N accumulations decreased with successive planting date delays (November and December) for each growth termination date in the following spring. In 2000, cumulative DM yields of October-and November-planted cover crops were 3.17 Mg ha(-1) (1.41 tn ac(-1)) and 3.74 Mg ha(-1) (1.66 tn ac(-1)), respectively, which were significantly greater than those of December-planted cover crops (1.90 Mg ha(-1) [0.84 tn ac(-1)]) at the second growth termination date (early April). Cover crop N accumulation increased with a delay in growth termination, although the interaction between cover crop species and the planting date varied. October planting of rye and triticale showed greater N accumulation at a March growth termination date, averaging 37.8 kg N ha(-1) (33.7 lb N ac(-1)) for rye and 37.6 kg N ha(-1) (33.5 lb N ac(-1)) for triticale; these values were 7.8% and 14.1% higher than those of black oat and wheat, respectively, at the same planting and growth termination dates. November-planted wheat showed in the highest N accumulation (average, 57.9 kg N ha(-1) [51.7 lb N ac(-1)]) at the late April/early May termination date; this was 3.8% to 7.9% higher than that of other species. In contrast, black oat showed a greater ability to scavenge soil residual N with a late planting and growth termination date combination (average, 58.7 kg N ha(-1) [52.4 lb N ac(-1)]). The cover crop planting date affected soil inorganic N distribution at each termination date, with an October planting date resulting in lower soil profile inorganic N levels than November and December planting dates. Lower soil inorganic N concentrations were strongly associated with increases in cover crop DM and N accumulation for each growth termination date. These results should help growers identify the best niche for a cover crop with respect to recovering residual soil N in their various rotations.	[Komatsuzaki, M.] Ibaraki Univ, Coll Agr, Ibaraki, Japan; [Wagger, M. G.] N Carolina State Univ, Dept Soil Sci, Raleigh, NC 27695 USA	Komatsuzaki, M (reprint author), Ibaraki Univ, Coll Agr, Ibaraki, Japan.						MCCRACKEN DV, 1994, SOIL SCI SOC AM J, V58, P1476; Sainju UM, 1998, AGRON J, V90, P511; PEREZ FJ, 1993, WEED RES, V33, P115, DOI 10.1111/j.1365-3180.1993.tb01924.x; HAUCK RD, 1976, ADV AGRON, V28, P219, DOI 10.1016/S0065-2113(08)60556-8; DITSCH DC, 1991, J FERT ISSUES, V8, P6; Monks CD, 1997, J PROD AGRIC, V10, P289; Clark AJ, 1997, AGRON J, V89, P427; Di HJ, 2002, NUTR CYCL AGROECOSYS, V64, P237, DOI 10.1023/A:1021471531188; CLARK AJ, 1994, AGRON J, V86, P1065; BOURGET SJ, 1966, CAN J SOIL SCI, V46, P213; Ranells NN, 1997, AGR ECOSYST ENVIRON, V65, P23, DOI 10.1016/S0167-8809(97)00054-6; MUNAWAR A, 1990, AGRON J, V82, P773; Bauer PJ, 1999, CROP SCI, V39, P1824; SHIPLEY PR, 1992, AGRON J, V84, P869; Vaughan JD, 1998, AGRON J, V90, P536; Rodrigues MA, 2002, EUR J AGRON, V17, P155, DOI 10.1016/S1161-0301(02)00003-5; SHENG Q, 1991, CAN J PLANT SCI, V71, P41; Odhiambo JJO, 2001, AGRON J, V93, P299; Strock JS, 2004, J ENVIRON QUAL, V33, P1010; Osmond D, 2012, J SOIL WATER CONSERV, V67, p122A, DOI 10.2489/jswc.67.5.122A; Clark A, 1998, MANAGING COVER CROPS; HERBERT S J, 1986, Applied Agricultural Research, V1, P91; Keeney D.R., 1982, ASA MONOGR, V9; Lachat Instruments, 1990, METH MAN QUICKCHEM A; Martin J.H., 1976, RYE TRITICALE PRINCI; Osmond Deanna L., 2001, TheScientificWorldJOURNAL, V1, P777; Osmond D.L., 2011, DELINEATION AGR NEUS; SAS Institute, 1989, SAS STAT US GUID VER; USDA ARS NSDL (National Soil Dynamics Laboratory), 2014, COV CROP COSTS; WAGGER MG, 1989, AGRON J, V81, P533; Wagger M.G., 1996, REDUCTION NITRATE LE, P1; Wagger M.G., 1988, CROPPING STRATEGIES, V51, P115	32	1	1	SOIL WATER CONSERVATION SOC	ANKENY	945 SW ANKENY RD, ANKENY, IA 50023-9723 USA	0022-4561	1941-3300		J SOIL WATER CONSERV	J. Soil Water Conserv.	NOV-DEC	2015	70	6					385	398		10.2489/jswc.70.6.385		14	Ecology; Soil Science; Water Resources	Environmental Sciences & Ecology; Agriculture; Water Resources	CW3UO	WOS:000364917700011		
J	Uchida, N; Yoshimura, N; Takayanagi, M				Uchida, Naruya; Yoshimura, Norio; Takayanagi, Masao			Variation of the Near-Infrared Spectrum of Water from Dissolved Salts	JOURNAL OF SOLUTION CHEMISTRY			English	Article						Aqueous solutions; Salts; Hydrogen-bonded network; Near-infrared spectroscopy; Principal component analysis (PCA)	AQUEOUS-SOLUTIONS; ABSORPTION-BANDS; LIQUID WATER; IONS; SPECTROSCOPY; TEMPERATURE; DYNAMICS; BONDS; ACIDS	In order to investigate the effect of dissolution of salts on the hydrogen-bonded network in liquid water, near-infrared absorption spectra of aqueous solutions of 16 salts, containing Na+ as common cation, were measured in the region where the first overtone of the -OH stretching mode of water is observed. Although the spectral variations of water resulting from dissolution of a salt is dependent on the kind of salt, principal component analysis of the observed spectra revealed that all spectral variations for the 16 salts were almost reproducible with only three components. The first component corresponds to the average of the observed spectra, while the other two components are responsible for the variations. The second component, which almost coincides with the component of the spectral variation of water from changes in temperature, was found to explain mainly the spectral changes by salts that destroy the hydrogen-bonded network. On the other hand, the third component, which includes the spectral changes at a lower wavenumber region than the second component, was found to mainly explain the spectral variation from the salts that expand the hydrogen-bonded network. These results suggest that observed spectral variations are not due to direct interaction between ions and water molecules, but due to the change of the hydrogen-bonded network because all variations produced by these 16 salts can be explained by only two components. The results suggest also that the mechanisms of destruction and expansion of the hydrogen-bonded network by the anions may be different.	[Uchida, Naruya] Tokyo Univ Agr & Technol, Grad Sch Agr, Fuchu, Tokyo 1838509, Japan; [Yoshimura, Norio; Takayanagi, Masao] Tokyo Univ Agr & Technol, United Grad Sch Agr Sci, Fuchu, Tokyo 1838509, Japan	Takayanagi, M (reprint author), Tokyo Univ Agr & Technol, United Grad Sch Agr Sci, 3-5-8 Saiwai Cho, Fuchu, Tokyo 1838509, Japan.	masaot@cc.tuat.ac.jp					Marcus Y, 2009, CHEM REV, V109, P1346, DOI 10.1021/cr8003828; Marcus Y, 2010, PURE APPL CHEM, V82, P1889, DOI 10.1351/PAC-CON-09-07-02; Waluyo I, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3597606; Omar AF, 2012, MOLECULES, V17, P7440, DOI 10.3390/molecules17067440; Zhang YJ, 2006, CURR OPIN CHEM BIOL, V10, P658, DOI 10.1016/j.cbpa.2006.09.020; LIN J, 1994, TRAC-TREND ANAL CHEM, V13, P320, DOI 10.1016/0165-9936(94)87004-7; Sebe F, 2012, PHYS CHEM CHEM PHYS, V14, P4433, DOI 10.1039/c2cp23255c; Smith JD, 2007, J AM CHEM SOC, V129, P13847, DOI 10.1021/ja071933z; Saitow K, 2004, J SOLUTION CHEM, V33, P689, DOI 10.1023/B:JOSL.0000043633.79708.7f; Chang K, 2014, J MOL STRUCT, V1069, P122, DOI 10.1016/j.molstruc.2013.12.005; Mancinelli R, 2007, J PHYS CHEM B, V111, P13570, DOI 10.1021/jp075913v; Pegau WS, 1997, APPL OPTICS, V36, P6035, DOI 10.1364/AO.36.006035; Davidian AG, 2014, J NEAR INFRARED SPEC, V22, P27, DOI 10.1255/jnirs.1090; Kunz W, 2010, CURR OPIN COLLOID IN, V15, P34, DOI 10.1016/j.cocis.2009.11.008; Heiman A, 1999, ANAL CHIM ACTA, V394, P135, DOI 10.1016/S0003-2670(99)00312-8; Lin J, 1996, APPL SPECTROSC, V50, P444, DOI 10.1366/0003702963906096; Omta AW, 2003, SCIENCE, V301, P347, DOI 10.1126/science.1084801; Bruni F, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3684633; Frost VJ, 1997, J MOL STRUCT, V410, P573, DOI 10.1016/S0022-2860(96)09707-4; OHTAKI H, 1993, CHEM REV, V93, P1157, DOI 10.1021/cr00019a014; Bakker HJ, 2008, CHEM REV, V108, P1456, DOI 10.1021/cr0206622; Gowen AA, 2013, ANAL CHIM ACTA, V759, P8, DOI 10.1016/j.aca.2012.10.007; Kondoh M, 2014, CHEM PHYS LETT, V591, P317, DOI 10.1016/j.cplett.2013.11.055; Czarnik-Matusewicz B, 2006, VIB SPECTROSC, V40, P235, DOI 10.1016/j.vibspec.2005.10.002; Davidian AG, 2014, RUSS J GEN CHEM+, V84, P1877, DOI 10.1134/S1070363214100028; Gowena A.A., 2015, TALANTA, V31, P609; Hasegawa T., 2015, INTRO EXPT INFRARED, P97; Murrell J.N., 1994, PROPERTIES LIQUIDS S; Sobina EP, 2011, RUSS J PHYS CHEM A+, V85, P1168, DOI 10.1134/S0036024411070326	29	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0095-9782	1572-8927		J SOLUTION CHEM	J. Solut. Chem.	NOV	2015	44	11					2167	2178		10.1007/s10953-015-0399-9		12	Chemistry, Physical	Chemistry	CW7NZ	WOS:000365187400005		
J	Aoki, T; Murakami, M; Koizumi, T; Kusano, T; Fujimori, A; Enami, Y; Matsuda, K; Goto, S; Watanabe, M; Otsuka, K				Aoki, Takeshi; Murakami, Masahiko; Koizumi, Tomotake; Kusano, Tomokazu; Fujimori, Akira; Enami, Yuta; Matsuda, Kazuhiro; Goto, Satoru; Watanabe, Makoto; Otsuka, Koji			Preoperative Tattooing for Precise and Expedient Localization of Landmark in Laparoscopic Liver Resection	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article							LEFT LATERAL SEGMENTECTOMY; METASTASES; HEPATECTOMY; MARGIN; RECURRENCE; EXPERIENCE; TUMORS		[Aoki, Takeshi; Murakami, Masahiko; Koizumi, Tomotake; Kusano, Tomokazu; Fujimori, Akira; Enami, Yuta; Matsuda, Kazuhiro; Goto, Satoru; Watanabe, Makoto; Otsuka, Koji] Showa Univ, Sch Med, Dept Gastroenterol & Gen Surg, Tokyo 1428666, Japan	Aoki, T (reprint author), Showa Univ, Sch Med, Dept Gastroenterol & Gen Surg, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428666, Japan.	takejp@wb4.so-net.ne.jp					Nuzzo G, 2008, SURGERY, V143, P384, DOI 10.1016/j.surg.2007.09.038; Kokudo N, 2002, ARCH SURG-CHICAGO, V137, P833, DOI 10.1001/archsurg.137.7.833; Figueras J, 2007, ANN ONCOL, V18, P1190, DOI 10.1093/annonc/mdm106; MAKUUCHI M, 1985, SURG GYNECOL OBSTET, V161, P346; Hamady ZZR, 2014, ANN SURG, V259, P543, DOI 10.1097/SLA.0b013e3182902b6e; Muratore A, 2010, ANN SURG ONCOL, V17, P1324, DOI 10.1245/s10434-009-0770-4; Shafaee Z, 2011, J AM COLL SURGEONS, V212, P171, DOI 10.1016/j.jamcollsurg.2010.10.012; SAKAIRI T, 1991, SURGERY, V110, P903; Ishizawa T, 2012, ANN SURG, V256, P959, DOI 10.1097/SLA.0b013e31825ffed3; Oldhafer KJ, 2009, LANGENBECK ARCH SURG, V394, P489, DOI 10.1007/s00423-009-0469-9; Berardi G, 2015, LIVER TRANSPLANT, V21, P738, DOI 10.1002/lt.24119; REICH H, 1991, OBSTET GYNECOL, V78, P956; Kazaryan AM, 2010, ANN SURG, V252, P1005, DOI 10.1097/SLA.0b013e3181f66954; Postriganova N, 2014, HPB, V16, P822, DOI 10.1111/hpb.12204; Newman NA, 2010, SURGERY, V148, P371, DOI 10.1016/j.surg.2010.04.008; Kaneko H, 1996, SURGERY, V120, P468, DOI 10.1016/S0039-6060(96)80065-1; MAKUUCHI M, 1981, JPN J CLIN ONCOL, V11, P367; Gigot JF, 2002, ANN SURG, V236, P90, DOI 10.1097/01.SLA.0000018658.57709.09; Azagra JS, 1996, SURG ENDOSC-ULTRAS, V10, P758, DOI 10.1007/BF00193052; Araki K, 2014, J AM COLL SURGEONS, V218, P37; Dagher I, 2014, J HEPATO-BIL-PAN SCI, V21, P732, DOI 10.1002/jhbp.140; Ferrero A, 2015, SURG ENDOSC, V29, P1002, DOI 10.1007/s00464-014-3762-9; Hüscher C G, 1998, Semin Laparosc Surg, V5, P204; Montalti R, 2014, SURG ENDOSC; Takayama T, 1994, J Am Coll Surg, V179, P72; Vigano L, 2013, BRIT J SURG, V100, P535, DOI 10.1002/bjs.9025; Wakabayashi G, 2015, ANN SURG, V261, P619, DOI 10.1097/SLA.0000000000001180	27	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1072-7515	1879-1190		J AM COLL SURGEONS	J. Am. Coll. Surg.	NOV	2015	221	5					E97	E101		10.1016/j.jamcollsurg.2015.07.444		5	Surgery	Surgery	CW9VK	WOS:000365346100004		
J	Baba, Y; Akiyama, T; Kosumi, K; Harada, K; Shigaki, H; Iwatsuki, M; Sakamoto, Y; Yoshida, N; Watanabe, M; Baba, H				Baba, Yoshifumi; Akiyama, Takahiko; Kosumi, Keisuke; Harada, Kazuto; Shigaki, Hironobu; Iwatsuki, Masaaki; Sakamoto, Yasuo; Yoshida, Naoya; Watanabe, Masayuki; Baba, Hideo			Esophageal Bypass Using a Y-Shaped Gastric Tube for Advanced Esophageal Cancer: Transabdominal Placement of the Decompression Tube	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article							COMPLICATIONS		[Baba, Yoshifumi; Akiyama, Takahiko; Kosumi, Keisuke; Harada, Kazuto; Shigaki, Hironobu; Iwatsuki, Masaaki; Sakamoto, Yasuo; Yoshida, Naoya; Baba, Hideo] Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Kumamoto, Kumamoto 8608556, Japan; [Watanabe, Masayuki] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Surg Gastroenterol, Ariake, Koto, Japan	Baba, H (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, 1-1-1 Honjo, Kumamoto, Kumamoto 8608556, Japan.	hdobaba@kumamoto-u.ac.jp					Yoshida N, 2015, J AM COLL SURGEONS, V220, pE13, DOI 10.1016/j.jamcollsurg.2014.10.015; Seto Y, 2007, AM J SURG, V193, P792, DOI 10.1016/j.amjsurg.2006.07.023; MANNELL A, 1988, BRIT J SURG, V75, P283, DOI 10.1002/bjs.1800750332; Kang Hyoun Woo, 2015, Clin Endosc, V48, P187, DOI 10.5946/ce.2015.48.3.187; Kosumi K, 2012, J AM COLL SURGEONS, V214, pE31, DOI 10.1016/j.jamcollsurg.2012.01.048; Nishimura Y, 2003, INT J RADIAT ONCOL, V56, P1327, DOI 10.1016/S0360-3016(03)00198-6; POSTLETHWAIT RW, 1979, ANN SURG, V189, P673, DOI 10.1097/00000658-197906000-00001; Yakami Masahiro, 2003, Int J Clin Oncol, V8, P395, DOI 10.1007/s10147-003-0356-2	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1072-7515	1879-1190		J AM COLL SURGEONS	J. Am. Coll. Surg.	NOV	2015	221	5					E87	E90		10.1016/j.jamcollsurg.2015.07.445		4	Surgery	Surgery	CW9VK	WOS:000365346100002		
J	Kawaguchi, Y; Tanaka, N; Nagai, M; Nomura, Y; Fuks, D; Gayet, B; Kokudo, N				Kawaguchi, Yoshikuni; Tanaka, Nobutaka; Nagai, Motoki; Nomura, Yukihiro; Fuks, David; Gayet, Brice; Kokudo, Norihiro			Usefulness of Intraoperative Real-Time Tissue Elastography During Laparoscopic Hepatectomy	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article							HEPATOCELLULAR-CARCINOMA; INDOCYANINE-GREEN; LIVER RESECTION; US ELASTOGRAPHY; ULTRASONOGRAPHY; DIAGNOSIS; IDENTIFICATION; HEPATOBILIARY; EXPERIENCE; SURGERY		[Kawaguchi, Yoshikuni; Kokudo, Norihiro] Univ Tokyo, Dept Surg, Hepatobiliary Pancreat Surg Div, Grad Sch Med, Tokyo 1138655, Japan; [Kawaguchi, Yoshikuni; Tanaka, Nobutaka; Nagai, Motoki; Nomura, Yukihiro] Asahi Gen Hosp, Dept Surg, Chiba, Japan; [Kawaguchi, Yoshikuni; Fuks, David; Gayet, Brice] Univ Paris 05, Inst Mutualiste Montsouris, Dept Digest Dis, Paris, France	Kawaguchi, Y (reprint author), Univ Tokyo, Dept Surg, Hepatobiliary Pancreat Surg Div, Grad Sch Med,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	yokawaguchi-tky@umin.ac.jp					Kaneko H, 2005, AM J SURG, V189, P190, DOI 10.1016/j.amjsurg.2004.09.010; Arita J, 2011, ANN SURG, V254, P992, DOI 10.1097/SLA.0b013e31822518be; Gotoh K, 2009, J SURG ONCOL, V100, P75, DOI 10.1002/jso.21272; Lyshchik A, 2005, RADIOLOGY, V237, P202, DOI 10.1148/radiol.2363041248; Buell JF, 2008, ANN SURG, V248, P475, DOI 10.1097/SLA.0b013e318185e647; Tsutsumi M, 2007, INT J CLIN ONCOL, V12, P250, DOI 10.1007/s10147-007-0669-7; Garra BS, 1997, RADIOLOGY, V202, P79; Ishizawa T, 2012, ANN SURG, V256, P959, DOI 10.1097/SLA.0b013e31825ffed3; Takahashi M, 2012, BRIT J SURG, V99, P1271, DOI 10.1002/bjs.8844; Kudo H, 2014, SURG ENDOSC, V28, P2504, DOI 10.1007/s00464-014-3468-z; Kawaguchi Y, 2014, J HEPATO-BIL-PAN SCI, V21, P78, DOI 10.1002/jhbp.33; Inoue Y, 2010, SURGERY, V148, P1000, DOI 10.1016/j.surg.2010.02.009; Ishizawa T, 2009, CANCER, V115, P2491, DOI 10.1002/cncr.24291; Kawaguchi Y, 2013, J GASTROEN HEPATOL, V28, P587, DOI 10.1111/jgh.12095; Bryant R, 2009, ANN SURG, V250, P103, DOI 10.1097/SLA.0b013e3181ad6660; Kawaguchi Y, 2013, J HEPATOL, V58, P247, DOI 10.1016/j.jhep.2012.09.028; Itoh A, 2006, RADIOLOGY, V239, P341, DOI 10.1148/radiol.2391041676; Vibert E, 2006, BRIT J SURG, V93, P67, DOI 10.1002/bjs.5150; Kawaguchi Y, 2011, J AM COLL SURGEONS, V212, pE33, DOI 10.1016/j.jamcollsurg.2011.03.006; Araki K, 2014, J AM COLL SURGEONS, V218, pE37, DOI 10.1016/j.jamcollsurg.2013.10.022; Arita J, 2015, ANN SURG; Koffron AJ, 2007, ANN SURG, V246, P392; Koffron AJ, 2007, ANN SURG, V246, P385, DOI 10.1097/SLA.0b013e318146996c; Makuuchi M, 1983, Ultrasound Med Biol, VSuppl 2, P493; Omichi K, 2015, BRIT J SURG, V102, P246, DOI 10.1002/bjs.9728; Sandulescu Larisa, 2012, Curr Health Sci J, V38, P32; Shiina T, 2002, J MED ULTRASON, V29, P119, DOI 10.1007/BF02481234	27	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1072-7515	1879-1190		J AM COLL SURGEONS	J. Am. Coll. Surg.	NOV	2015	221	5					E103	E111		10.1016/j.jamcollsurg.2015.07.453		9	Surgery	Surgery	CW9VK	WOS:000365346100005		
J	Uchiyama, H; Morita, K; Itoh, S; Harimoto, N; Ikegami, T; Yoshizumi, T; Shirabe, K; Takenaka, K; Maehara, Y				Uchiyama, Hideaki; Morita, Kazutoyo; Itoh, Shinji; Harimoto, Norifumi; Ikegami, Toru; Yoshizumi, Tomoharu; Shirabe, Ken; Takenaka, Kenji; Maehara, Yoshihiko			Pancreatic Transection Using Tape Sling and Ultrasonic Aspirator Dissection Technique in Pancreaticoduodenectomy and Distal Pancreatectomy	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article							FISTULA; CLOSURE; TRIAL		[Uchiyama, Hideaki; Morita, Kazutoyo; Itoh, Shinji; Takenaka, Kenji] Fukuoka City Hosp, Dept Hepatobiliary Pancreat Surg, Fukuoka 8120046, Japan; [Uchiyama, Hideaki; Itoh, Shinji; Harimoto, Norifumi; Ikegami, Toru; Yoshizumi, Tomoharu; Shirabe, Ken; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan	Uchiyama, H (reprint author), Fukuoka City Hosp, Dept Hepatobiliary Pancreat Surg, Hakata Ku, Yoshizuka Honmachi 13-1, Fukuoka 8120046, Japan.	huchi@surg2.med.kyushu-u.ac.jp					Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Jimenez RE, 2012, SURGERY, V152, pS64, DOI 10.1016/j.surg.2012.05.024; Diener MK, 2011, LANCET, V377, P1514, DOI 10.1016/S0140-6736(11)60237-7; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; Makino I, 2013, SURG TODAY, V43, P595, DOI 10.1007/s00595-012-0370-y; Kawai M, 2008, J HEPATO-BILIARY-PAN, V15, P366, DOI 10.1007/s00534-008-1330-1; Soejima Y, 2013, J AM COLL SURGEONS, V216, pE23, DOI 10.1016/j.jamcollsurg.2012.10.021; Okano K, 2008, J HEPATO-BILIARY-PAN, V15, P353, DOI 10.1007/s00534-008-1328-8; Suzuki Y, 1999, BRIT J SURG, V86, P608; Zhou W, 2010, AM J SURG, V200, P529, DOI 10.1016/j.amjsurg.2009.12.022; Ikegami T, 2010, J GASTROINTEST SURG, V15, P690; Kakita A, 2001, J Hepatobiliary Pancreat Surg, V8, P230, DOI 10.1007/s005340170022; Zhang H, 2015, BRIT J SURG, V102, P4, DOI 10.1002/bjs.9653	13	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1072-7515	1879-1190		J AM COLL SURGEONS	J. Am. Coll. Surg.	NOV	2015	221	5					E91	E95		10.1016/j.jamcollsurg.2015.08.005		5	Surgery	Surgery	CW9VK	WOS:000365346100003		
J	Yamasaki, T; Balakrishnan, SN; Takano, H; Yamaguchi, I				Yamasaki, Takeshi; Balakrishnan, S. N.; Takano, Hiroyuki; Yamaguchi, Isao			Sliding mode-based intercept guidance with uncertainty and disturbance compensation	JOURNAL OF THE FRANKLIN INSTITUTE-ENGINEERING AND APPLIED MATHEMATICS			English	Article							IMPACT ANGLE CONSTRAINTS; ACKERMANNS FORMULA; MISSILE GUIDANCE; TIME; AUTOPILOT; DIFFERENTIATION	This paper presents a missile intercept guidance law that can account for uncertainty and disturbance. The proposed guidance law is developed based on a novel second order sliding surface, along with an uncertainty and disturbance estimator. The proposed sliding surface is invariant for the non-impact angle constraint case as well as the impact angle constraint case. The sliding surface guarantees finite time convergence of the line-of-sight (LOS) rate and (if specified) the LOS angle error, characterized by a simple function of time-to-go. Furthermore, the proposed strategy is also effective against a maneuvering target. The line-of-sight rate convergence property can be adjusted using only one parameter that makes the design process simple. Potential of the proposed guidance laws is demonstrated with some simulations. (C) 2015 The Franklin Institute. Published by Elsevier Ltd. All rights reserved.	[Yamasaki, Takeshi; Takano, Hiroyuki; Yamaguchi, Isao] Natl Def Acad Japan, Dept Aerosp Engn, Yokosuka, Kanagawa 2398686, Japan; [Balakrishnan, S. N.] Missouri Univ Sci & Technol, Dept Mech & Aerosp Engn, Rolla, MO 65409 USA	Yamasaki, T (reprint author), Natl Def Acad Japan, Dept Aerosp Engn, Yokosuka, Kanagawa 2398686, Japan.	ymski@nda.ac.jp; bala@mst.edu; htakano0@nda.ac.jp; isymgt@nda.ac.jp					Kim BS, 1998, IEEE T AERO ELEC SYS, V34, P277; Levant A, 2003, INT J CONTROL, V76, P924, DOI 10.1080/0020717031000099029; ACKERMANN J, 1994, IEEE DECIS CONTR P, P3622, DOI 10.1109/CDC.1994.411715; Shtessel YB, 2007, AUTOMATICA, V43, P1470, DOI 10.1016/j.automatica.2007.01.008; Zhang ZX, 2013, AEROSP SCI TECHNOL, V31, P30, DOI 10.1016/j.ast.2013.09.003; RUSNAK I, 1990, IEEE T AERO ELEC SYS, V26, P618, DOI 10.1109/7.55555; Yamasaki T, 2013, J GUID CONTROL DYNAM, V36, P25, DOI 10.2514/1.58259; Zhang ZX, 2013, T I MEAS CONTROL, V35, P764, DOI 10.1177/0142331213478327; Tahk MJ, 2002, IEEE T AERO ELEC SYS, V38, P13; Phadke SB, 2012, IEEE T AERO ELEC SYS, V48, P3331, DOI 10.1109/TAES.2012.6324711; Harl N, 2012, IEEE T CONTR SYST T, V20, P1436, DOI 10.1109/TCST.2011.2169795; Shima T, 2006, J GUID CONTROL DYNAM, V29, P250, DOI 10.2514/1.14951; Ryoo CK, 2006, IEEE T CONTR SYST T, V14, P483, DOI 10.1109/TCST.2006.872525; Ackermann J, 1998, IEEE T AUTOMAT CONTR, V43, P234, DOI 10.1109/9.661072; Levant A, 1998, AUTOMATICA, V34, P379; Kumar SR, 2014, J GUID CONTROL DYNAM, V37, P1114, DOI 10.2514/1.62737; Bryson Jr A.E., APPL OPTIMAL CONTROL, P154; Edwards C., SLIDING MODE CONTROL; Harl N, 2010, J GUID CONTROL DYNAM, V33, P186, DOI 10.2514/1.42654; Harl N., 2010, P AIAA GNC C TOR; Kuroda T., 1989, P 1989 AIAA GUID NAV, P176; Lee CH, 2012, P IMECHE G, V227, P235, DOI DOI 10.1177/0954410011433732; Machol R.E., 1965, SYSTEM ENG HDB; Rao S., 2012, P 12 IEEE WORKSH VAR, P325; Shinar J., 1988, Proceedings of the 27th IEEE Conference on Decision and Control (IEEE Cat. No.88CH2531-2), DOI 10.1109/CDC.1988.194562; Shtessel YB, 2009, IEEE T AERO ELEC SYS, V45, P110, DOI 10.1109/TAES.2009.4805267; Youcef-Toumi K., 1987, Proceedings of the 1987 American Control Conference; YOUCEFTOUMI K, 1990, J DYN SYST-T ASME, V112, P133, DOI 10.1115/1.2894130; YOUCEFTOUMI K, 1989, AMER CONTR CONF CONF, P1912; Zarchan P., 2007, PROGR ASTRONAUTICS A, P219; Zhong Q.-C., COMMENTS TIME DELAY; Zipfel P., 2007, AIAA ED SERIES	32	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0016-0032	1879-2693		J FRANKLIN I	J. Frankl. Inst.-Eng. Appl. Math.	NOV	2015	352	11					5145	5172		10.1016/j.jfranklin.2015.08.014		28	Automation & Control Systems; Engineering, Multidisciplinary; Engineering, Electrical & Electronic; Mathematics, Interdisciplinary Applications	Automation & Control Systems; Engineering; Mathematics	CW3JV	WOS:000364889500024		
J	Saijo, H; Hayashida, K; Morooka, S; Fujioka, M				Saijo, Hiroto; Hayashida, Kenji; Morooka, Shin; Fujioka, Masaki			Combined treatment with artificial dermis and basic fibroblast growth factor for cranial bone-exposing wounds	JOURNAL OF TISSUE VIABILITY			English	Article						Basic fibroblast growth factor; Artificial dermis; Free skin grafting; Cranial bone	QUALITY	Aim of the study: Cranial bone-exposing wounds should be resurfaced as soon as possible using flaps. However, early one-stage wound closure is sometimes difficult due to the poor general condition of the patient or equipment shortages. Artificial dermis composed of atelocollagen sponge is useful for reconstructing bone-exposing wounds. In addition, the treatment of wounds with basic fibroblast growth factor helps more severe wounds to heal faster. We employed combined treatment with artificial dermis and basic fibroblast growth factor to treat cranial bone-exposing wounds in 2 cases, and we describe these cases here. Materials and methods: Case 1: A 56-year-old man suffered severe burns, which exposed the occipital bone and mandible, after attempting suicide. Case 2: A 79-year-old woman suffered a full-thickness skin defect on her forehead due to a fall, which resulted in her frontal bone being exposed. Both patients underwent combined treatment with artificial dermis and basic fibroblast growth factor, followed by free skin grafting. Results: The combined treatment promoted the formation of granulation tissue, which acted as a wound bed for the subsequent skin grafting. The free skin grafting resulted in the complete resurfacing of the patients' wounds. Conclusion: Combined treatment with artificial dermis and bFGF is an easy, fast-acting, and effective way of preparing a favorable wound bed for skin grafting, and hence, is useful for the treatment of cranial bone-exposing wounds. (C) 2015 Published by Elsevier Ltd on behalf of Tissue Viability Society.	[Saijo, Hiroto; Hayashida, Kenji; Morooka, Shin; Fujioka, Masaki] Natl Hosp Org, Nagasaki Med Ctr, Dept Plast & Reconstruct Surg, Ohmura City 8560835, Japan	Saijo, H (reprint author), Natl Hosp Org, Nagasaki Med Ctr, Dept Plast & Reconstruct Surg, 1001-1 Kubara,2, Ohmura City 8560835, Japan.	saijo@nagasaki-mc.com					Muneuchi G, 2005, BURNS, V31, P514, DOI 10.1016/j.burns.2004.11.016; Akita S, 2005, BURNS, V31, P855, DOI 10.1016/j.burns.2005.04.008; Akita S, 2008, J TRAUMA, V64, P809, DOI 10.1097/TA.0b013e31802c8247; Ito K, 2005, PLAST RECONSTR SURG, V115, P567, DOI 10.1097/01.PRS.0000149485.60638.30; Kanematsu A, 2004, J CONTROL RELEASE, V99, P281, DOI 10.1016/j.jconrel.2004.07.008; Akita S, 2008, WOUND REPAIR REGEN, V16, P635, DOI 10.1111/j.1524-475X.2008.00414.x; Fujioka M, 2009, DERMATOL SURG, V35, P1422, DOI 10.1111/j.1524-4725.2009.01251.x; Hayashida K, 2012, OSTOMY WOUND MANAG, V58, P32; Rizzi SC, 2010, EXPERT REV MED DEVIC, V7, P143, DOI [10.1586/erd.09.57, 10.1586/ERD.09.57]; Fujioka M, 1997, CLEFT PALATE-CRAN J, V34, P297, DOI 10.1597/1545-1569(1997)034<0297:MGFAIO>2.3.CO;2; Burd Andrew, 2010, Semin Plast Surg, V24, P262, DOI 10.1055/s-0030-1263068	11	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0965-206X			J TISSUE VIABILITY	J. Viab.	NOV	2015	24	4					173	179		10.1016/j.jtv.2015.08.002		7	Dermatology; Nursing	Dermatology; Nursing	CX0EJ	WOS:000365369400006		
J	Fujita, S; Sakurai, M; Baba, H; Abe, K; Tominaga, R				Fujita, Satoshi; Sakurai, Masahiro; Baba, Hironori; Abe, Koji; Tominaga, Ryuji			Autophagy-mediated stress response in motor neurons after hypothermic spinal cord ischemia in rabbits	JOURNAL OF VASCULAR SURGERY			English	Article							HEAT-SHOCK-PROTEIN; CELL-DEATH; INDUCTION; BECLIN-1; BCL-2; SURVIVAL; DISEASE	Objective: The development of spinal cord injury is believed to be related to the vulnerability of spinal motor neurons to ischemia. However, the mechanisms underlying this vulnerability have not been fully investigated. Previously, we reported that spinal motor neurons are lost likely due to autophagy and that local hypothermia prevents such spinal motor neuron death. Therefore, we investigated the role of autophagy in normothermic and hypothermic spinal cord ischemia using an immunohistochemical analysis of Beclin 1 (BCLN1; B-cell leukemia 2 protein [Bcl-2] interacting protein), Bcl-2, and g-aminobutyric acid type-A receptor-associated protein (GABARAP), which are considered autophagy-related proteins. Methods: We used rabbit normothermic and hypothermic transient spinal cord ischemia models using a balloon catheter. Neurologic function was assessed according to the Johnson score, and the spinal cord was removed at 8 hours and 1, 2, and 7 days after reperfusion, and morphologic changes were examined using hematoxylin and eosin staining. A Western blot analysis and histochemical study of BCLN1, Bcl-2, and GABARAP, and double-labeled fluorescent immunocytochemical studies were performed. Results: There were significant differences in the physiologic function between the normothermic model and hypothermic model after the procedure (P <.05). In the normothermic model, most of the motor neurons were selectively lost at 7 days of reperfusion (P <.001 compared with the sham group), and they were preserved in the hypothermic model (P =.574 compared with the sham group). The Western blot analysis revealed that the sustained expression of the autophagy markers, BCLN1 and GABARAP, was observed (P <.001 compared with the sham group) and was associated with neuronal cell death in normothermic ischemic conditions. In hypothermic ischemic conditions, the autophagy inhibitory protein Bcl-2 was powerfully induced (P <.001 compared with the sham group) and was associated with blunted expression of BCLN1 and GABARAP and neuronal cell survival. The double-label fluorescent immunocytochemical study revealed that immunoreactivitiy for BCLN1, Bcl-2, and GABARAP was induced in the same motor neurons. Conclusions: These data suggest that the prolonged induction of autophagy might be a potential factor responsible for delayed motor neuron death, and the induction of the autophagy inhibitory protein Bcl-2 using hypothermia might limit autophagy and protect against delayed motor neuron death.	[Fujita, Satoshi; Baba, Hironori; Tominaga, Ryuji] Kyushu Univ, Grad Sch Med, Dept Cardiovasc Surg, Fukuoka 8128582, Japan; [Sakurai, Masahiro] Natl Hosp Org, Sendai Med Ctr, Dept Clin Res, Sendai, Miyagi, Japan; [Abe, Koji] Okayama Univ, Grad Sch Med, Dept Neurol, Okayama 7008530, Japan	Fujita, S (reprint author), Kyushu Univ, Grad Sch Med, Dept Cardiovasc Surg, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	sfujita.heart.med@gmail.com					Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Cambria RP, 2002, ANN SURG, V236, P471, DOI 10.1097/01.SLA.0000031240.26001.E2; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Liang XH, 1999, NATURE, V402, P672; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Rami A, 2008, NEUROBIOL DIS, V29, P132, DOI 10.1016/j.nbd.2007.08.005; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Zhang H, 2010, NEUROL RES, V32, P384, DOI 10.1179/016164110X12670144526228; MATSUI Y, 1994, J THORAC CARDIOV SUR, V107, P1519; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Walensky LD, 2006, CELL DEATH DIFFER, V13, P1339, DOI 10.1038/sj.cdd.4401992; Baba H, 2009, J VASC SURG, V50, P381, DOI 10.1016/j.jvs.2009.03.042; Pan TH, 2008, BRAIN, V131, P1969, DOI 10.1093/brain/awm318; JOHNSON SH, 1993, STROKE, V24, P1547; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Sakurai M, 2003, J THORAC CARDIOV SUR, V125, P370, DOI 10.1067/mtc.2003.112; Motoyoshi N, 2001, J THORAC CARDIOV SUR, V122, P351, DOI 10.1067/mtc.2001.113935; Cheng BC, 2013, INT J CARDIOL, V168, P2064, DOI 10.1016/j.ijcard.2013.01.162; Sakurai M, 1997, J THORAC CARDIOV SUR, V113, P159, DOI 10.1016/S0022-5223(97)70411-2	23	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0741-5214			J VASC SURG	J. Vasc. Surg.	NOV	2015	62	5					1312	1319		10.1016/j.jvs.2014.03.297		8	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	CW8IF	WOS:000365242000030		
J	Sueyoshi, E; Nagayama, H; Eishi, K; Uetani, M				Sueyoshi, Eijun; Nagayama, Hiroki; Eishi, Kiyoyuki; Uetani, Masataka			Rapidly progressive calcification of the false lumen in aortic dissection	JOURNAL OF VASCULAR SURGERY			English	Editorial Material									[Sueyoshi, Eijun; Nagayama, Hiroki; Uetani, Masataka] Nagasaki Univ, Sch Med, Dept Radiol, Nagasaki 852, Japan; [Eishi, Kiyoyuki] Nagasaki Univ, Sch Biomed Sci, Dept Cardiovasc Surg, Nagasaki 852, Japan	Sueyoshi, E (reprint author), Nagasaki Univ, Sch Med, Dept Radiol, Nagasaki 852, Japan.	sueyo@nagasaki-u.ac.jp					HACHIYA J, 1993, J COMPUT ASSIST TOMO, V17, P374, DOI 10.1097/00004728-199305000-00006; Hachiya Junichi, 1994, Nippon Acta Radiologica, V54, P258	2	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0741-5214			J VASC SURG	J. Vasc. Surg.	NOV	2015	62	5					1328	1329		10.1016/j.jvs.2014.05.011		2	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	CW8IF	WOS:000365242000034		
J	Kita, T; Yamamoto, N				Kita, Tomohiro; Yamamoto, Naokatsu			Quantum dots and silicon photonics combine in broadband tunable laser	LASER FOCUS WORLD			English	Article								A new wavelength-tunable laser diode combines quantum-dot (QD) technology and silicon photonics with large optical gains around the 1310 nm telecom window and is amenable to integration of other passive and active components towards a truly integrated photonic platform.	[Kita, Tomohiro] Tohoku Univ, Dept Elect Engn, Sendai, Miyagi 980, Japan; [Yamamoto, Naokatsu] Natl Inst Informat & Commun, Lightwave Device Lab, Tokyo, Japan	Kita, T (reprint author), Tohoku Univ, Dept Elect Engn, Sendai, Miyagi 980, Japan.	tkita@ecei.tohoku.ac.jp; naokatsu@nict.go.jp			Strategic Information and Communications R&D Promotion Program (SCOPE) of Japan's Ministry of Internal Affairs and Communications; Japan Society for the Promotion of Science	This research was partially supported by the Strategic Information and Communications R&D Promotion Program (SCOPE), of Japan's Ministry of Internal Affairs and Communications and a Grant-in-Aid for Scientific Research of the Japan Society for the Promotion of Science.	Kobayashi N, 2015, J LIGHTWAVE TECHNOL, V33, P1241, DOI 10.1109/JLT.2014.2385106; Jalali B, 2006, J LIGHTWAVE TECHNOL, V24, P4600, DOI 10.1109/JLT.2006.885782; SOREF RA, 1993, P IEEE, V81, P1687, DOI 10.1109/5.248958; Kita T, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4915306; Huffaker DL, 1998, APPL PHYS LETT, V73, P2564, DOI 10.1063/1.122534; Kita T, 2015, APPL PHYS EXPRESS, V8, DOI 10.7567/APEX.8.062701; ARAKAWA Y, 1982, APPL PHYS LETT, V40, P939, DOI 10.1063/1.92959; Yamamoto N, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.02BG08; Yamamoto N., 2015, P OFC	9	0	0	PENNWELL PUBL CO	NASHUA	98 SPIT BROOK RD, NASHUA, NH 03062-2801 USA	1043-8092			LASER FOCUS WORLD	Laser Focus World	NOV	2015	51	11					45	48				4	Optics	Optics	CW6ZT	WOS:000365148300014		
J	Nakajima, S; Onza, N; Nakagawa, H				Nakajima, Sadahiko; Onza, Nanako; Nakagawa, Hiroya			Relapse of generalized bait shyness in rats after constant and graded extinction procedures (vol 51, pg 62, 2015)	LEARNING AND MOTIVATION			English	Correction									[Nakajima, Sadahiko; Onza, Nanako; Nakagawa, Hiroya] Kwansei Gakuin Univ, Dept Psychol Sci, Nishinomiya, Hyogo 6628501, Japan	Nakajima, S (reprint author), Kwansei Gakuin Univ, Dept Psychol Sci, Nishinomiya, Hyogo 6628501, Japan.	nakajia@kwansei.ac.jp					Nakajima S, 2015, LEARN MOTIV, V51, P62, DOI 10.1016/j.lmot.2015.06.001	1	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0023-9690	1095-9122		LEARN MOTIV	Learn. Motiv.	NOV	2015	52						83	83		10.1016/j.lmot.2015.08.001		1	Psychology, Biological; Psychology, Experimental	Psychology	CX0GK	WOS:000365374700010		
J	Miyashita, K; Tomita, N; Taguri, M; Suzuki, T; Ishiyama, Y; Ishii, Y; Nakajima, Y; Numata, A; Hattori, Y; Yamamoto, W; Miyazaki, T; Tachibana, T; Takasaki, H; Matsumoto, K; Hashimoto, C; Takemura, S; Yamazaki, E; Fujimaki, K; Sakai, R; Motomura, S; Ishigatsubo, Y				Miyashita, Kazuho; Tomita, Naoto; Taguri, Masataka; Suzuki, Taisei; Ishiyama, Yasufumi; Ishii, Yoshimi; Nakajima, Yuki; Numata, Ayumi; Hattori, Yukako; Yamamoto, Wataru; Miyazaki, Takuya; Tachibana, Takayoshi; Takasaki, Hirotaka; Matsumoto, Kenji; Hashimoto, Chizuko; Takemura, Sachiya; Yamazaki, Etsuko; Fujimaki, Katsumichi; Sakai, Rika; Motomura, Shigeki; Ishigatsubo, Yoshiaki			Beta-2 microglobulin is a strong prognostic factor in patients with DLBCL receiving R-CHOP therapy	LEUKEMIA RESEARCH			English	Article						Diffuse large B-cell lymphoma; Non-hodgkin lymphoma; Beta 2-microglobulin; R-CHOP; Progression-free survival	B-CELL LYMPHOMA; SOLUBLE INTERLEUKIN-2-RECEPTOR; SERUM BETA-2-MICROGLOBULIN; MULTIPLE-MYELOMA; HODGKIN-LYMPHOMA; ELDERLY-PATIENTS; PLUS RITUXIMAB; CYCLOPHOSPHAMIDE; REARRANGEMENTS; CHEMOTHERAPY	Useful prognostic markers for patients with diffuse large B cell lymphoma (DLBCL) have been reported. To identify which biomarker best predicts the prognosis of patients with DLBCL, we performed a retrospective study that included 319 DLBCL patients who had received rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone (R-CHOP) therapy between 2003 and 2012. We assessed the prognostic significance of six biomarkers [lactate dehydrogenase, soluble interleukin-2 receptor, thymidine kinase activity, beta-2 microglobulin (B2M), C-reactive protein, and ferritin] and representative clinical characteristics using progression-free survival (PFS) as the endpoint. The study group included 181 men and 138 women with a median age of 63 years (range, 22-89 years). In a multivariate analysis, the serum B2M level most strongly correlated with PFS (hazard ratio, 2.11;P=0.04). In a univariate analysis, patients with serum B2M levels >1.75 mu g/mL (n = 210) had a worse 3-year PFS rate (71.2%) than those with B2M levels <= 1.75 mu g/mL (n = 109; 90.0%). Therefore, serum B2M level at the time of diagnosis is a useful prognostic indicator in DLBCL patients receiving R-CHOP. (C) 2015 Elsevier Ltd. All rights reserved.	[Miyashita, Kazuho; Tomita, Naoto; Nakajima, Yuki; Miyazaki, Takuya; Tachibana, Takayoshi; Yamazaki, Etsuko; Ishigatsubo, Yoshiaki] Yokohama City Univ, Grad Sch Med, Dept Internal Med & Clin Immunol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Taguri, Masataka] Yokohama City Univ, Grad Sch Med, Dept Biostat & Epidemiol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Suzuki, Taisei] Yokosuka City Hosp, Dept Hematol, Yokosuka, Kanagawa 2400195, Japan; [Ishiyama, Yasufumi; Hattori, Yukako; Takasaki, Hirotaka; Sakai, Rika; Motomura, Shigeki] Kanagawa Canc Ctr, Dept Med Oncol, Asahi Ku, Yokohama, Kanagawa 2418515, Japan; [Ishii, Yoshimi; Numata, Ayumi; Yamamoto, Wataru; Matsumoto, Kenji] Yokohama City Univ, Med Ctr, Dept Hematol, Minami Ku, Yokohama, Kanagawa 2320024, Japan; [Hashimoto, Chizuko] Yamato Municipal Hosp, Dept Hematol Oncol, Yamato 2428602, Japan; [Takemura, Sachiya] Yokohama Ekisaikai Hosp, Dept Internal Med, Naka Ku, Yokohama, Kanagawa 2310036, Japan; [Fujimaki, Katsumichi] Fujisawa City Hosp, Dept Hematol Immunol, Fujisawa, Kanagawa 2518550, Japan	Tomita, N (reprint author), Yokohama City Univ, Grad Sch Med, Dept Internal Med & Clin Immunol, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	cavalier@ch-yamate.dlenet.com					Shi CM, 2009, DRUG DISCOV TODAY, V14, P25, DOI 10.1016/j.drudis.2008.11.001; Watanabe R, 2014, EUR J HAEMATOL, V92, P204, DOI 10.1111/ejh.12221; Akyurek N, 2012, CANCER-AM CANCER SOC, V118, P4173, DOI 10.1002/cncr.27396; Feugier P, 2005, J CLIN ONCOL, V23, P4117, DOI 10.1200/JCO.2005.09.131; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Kramer MHH, 1998, BLOOD, V92, P3152; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Pfreundschuh M, 2011, LANCET ONCOL, V12, P1013, DOI 10.1016/S1470-2045(11)70235-2; Tomita N, 2013, BRIT J HAEMATOL, V161, P383, DOI 10.1111/bjh.12281; Tomita N, 2012, CANCER SCI, V103, P1518, DOI 10.1111/j.1349-7006.2012.02331.x; Ennishi D, 2009, ANN ONCOL, V20, P526, DOI 10.1093/annonc/mdn677; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; SHIPP MA, 1993, NEW ENGL J MED, V329, P987; Cao Y, 2012, TUMOR BIOL, V33, P1039, DOI 10.1007/s13277-012-0337-z; CONSTANTINDES IP, 1985, CANCER, V55, P2384, DOI 10.1002/1097-0142(19850515)55:10<2384::AID-CNCR2820551014>3.0.CO;2-3; Decaux O, 2012, CL LYMPH MYELOM LEUK, V12, P418, DOI 10.1016/j.clml.2012.06.003; Nakajima Y, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0185-3; Suzuki K, 2013, LEUKEMIA LYMPHOMA, V54, P2412, DOI 10.3109/10428194.2013.779690; Tomita Naoto, 2013, J Clin Exp Hematop, V53, P121; Vaidya R., 2014, ANN ONCOL, V11, P2124; Wu L, 2014, ONCOLOGY-BASEL, V87, P40, DOI 10.1159/000362670; Yoh KA, 2014, CL LYMPH MYELOM LEUK, V14, P43, DOI 10.1016/j.clml.2013.09.008; Yoo Changhoon, 2014, Blood Res, V49, P148, DOI 10.5045/br.2014.49.3.148	24	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0145-2126	1873-5835		LEUKEMIA RES	Leuk. Res.	NOV	2015	39	11					1187	1191		10.1016/j.leukres.2015.08.016		5	Oncology; Hematology	Oncology; Hematology	CW9RE	WOS:000365335100010		
J	Shazia, JR; Harlov, DE; Suzuki, K; Kim, SW; Girish-Kumar, M; Hayasaka, Y; Ishwar-Kumar, C; Windley, BF; Sajeev, K				Shazia, J. R.; Harlov, D. E.; Suzuki, K.; Kim, S. W.; Girish-Kumar, M.; Hayasaka, Y.; Ishwar-Kumar, C.; Windley, B. F.; Sajeev, K.			Linking monazite geochronology with fluid infiltration and metamorphic histories: Nature and experiment	LITHOS			English	Article						Monazite; Coupled dissolution-reprecipitation; Experimental petrology; Migmatitic metapelite; Electron microprobe CHIME method	ULTRAHIGH-TEMPERATURE METAMORPHISM; SAPPHIRINE-BEARING GRANULITES; PLUS QUARTZ ASSEMBLAGE; KERALA KHONDALITE BELT; RARE-EARTH-ELEMENTS; CAUVERY SHEAR ZONE; SOUTHERN INDIA; CRUSTAL EVOLUTION; ORTHO-PYROXENE; MADURAI BLOCK	Migmatised metapelites from the Kodaikanal region, central Madurai Block, southern India have undergone ultrahigh-temperature metamorphism (950-1000 degrees C; 7-8 kbar). In-situ electron microprobe Th-U-Pb isochron (CHIME) dating of monazites in a leucosome and surrounding silica-saturated and silica-poor restites from the same outcrop indicates three principal ages that can be linked to the evolutionary history of these rocks. Monazite grains from the silica-saturated restite have well-defined, inherited cores with thick rims that yield an age of ca. 1684 Ma. This either dates the metamorphism of the original metapelite or is a detrital age of inherited monazite. Monazite grains from the silica-poor restite, thick rims from the silica-saturated restite, and monazite cores from the leucosome have ages ranging from 520 to 540 Ma suggesting a mean age of 530 Ma within the error bars. In the leucosome the altered rim of the monazite gives an age of ca. 502 Ma. Alteration takes the form of Th-depleted lobes of monazite with sharp curvilinear boundaries extending from the monazite grain rim into the core. We have replicated experimentally these altered rims in a monazite-leucosome experiment at 800 degrees C and 2 kbar. This experiment, coupled with earlier published monazite-fluid experiments involving high pH alkali-bearing fluids at high P-T, helps to confirm the idea that alkali-bearing fluids, in the melt and along grain boundaries during crystallization, were responsible for the formation of the altered monazite grain rims via the process of coupled dissolution-reprecipitation. (C) 2015 Elsevier B.V. All rights reserved.	[Shazia, J. R.; Ishwar-Kumar, C.; Sajeev, K.] Indian Inst Sci, Ctr Earth Sci, Bangalore 560012, Karnataka, India; [Harlov, D. E.] Geoforschungszentrum Potsdam, D-14473 Potsdam, Germany; [Harlov, D. E.] Univ Johannesburg, Dept Geol, ZA-2006 Auckland Pk, South Africa; [Suzuki, K.] Nagoya Univ, Ctr Chronol Res, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Kim, S. W.] Korea Inst Geosci & Mineral Resources, Div Geol Res, Daejeon 305350, South Korea; [Girish-Kumar, M.] Geol Survey India, Bangalore, Karnataka, India; [Hayasaka, Y.] Hiroshima Univ, Dept Earth & Planetary Syst Sci, Higashihiroshima 7398526, Japan; [Windley, B. F.] Univ Leicester, Dept Geol, Leicester LE1 7RH, Leics, England	Sajeev, K (reprint author), Indian Inst Sci, Ctr Earth Sci, Bangalore 560012, Karnataka, India.	sajeev@ceas.iisc.ernet.in			CSIR, Government of India project [24(0327) /13-EMR-II]	We acknowledge support from a CSIR (24(0327) /13-EMR-II), Government of India project. Julien Allaz is thanked for performing some of the EMP analyses of the experimentally metasomatised monazite grains.	Buick IS, 2004, J PETROL, V45, P1777, DOI 10.1093/petrology/egh033; Braun I, 2003, GEOL SOC SPEC PUBL, P169; Budzyn B, 2011, AM MINERAL, V96, P1547, DOI 10.2138/am.2011.3741; SANTOSH M, 1992, LITHOS, V29, P107, DOI 10.1016/0024-4937(92)90036-X; KRETZ R, 1983, AM MINERAL, V68, P277; Santosh M, 2008, GONDWANA RES, V13, P86, DOI 10.1016/j.gr.2007.07.003; Sriramguru K, 2002, J GEOL SOC INDIA, V59, P103; Kelsey DE, 2008, J METAMORPH GEOL, V26, P199, DOI 10.1111/j.1525-1314.2007.00757.x; Shazia JR, 2012, J ASIAN EARTH SCI, V58, P88, DOI 10.1016/j.jseaes.2012.06.020; Braun I, 2004, INT J EARTH SCI, V93, P13, DOI 10.1007/s00531-003-0376-1; TOURET JLR, 1992, TERRA NOVA, V4, P87, DOI 10.1111/j.1365-3121.1992.tb00453.x; Chetty TRK, 2006, GONDWANA RES, V10, P77, DOI 10.1016/j.gr.2005.11.017; Braun I, 1998, CHEM GEOL, V146, P65, DOI 10.1016/S0009-2541(98)00005-9; Brown M, 1996, J GEOL SOC LONDON, V153, P819, DOI 10.1144/gsjgs.153.6.0819; Clark C, 2009, PRECAMBRIAN RES, V174, P129, DOI 10.1016/j.precamres.2009.07.003; Rajesh VJ, 2004, GONDWANA RES, V7, P961, DOI 10.1016/S1342-937X(05)71078-9; Tateishi K, 2004, GONDWANA RES, V7, P899, DOI 10.1016/S1342-937X(05)71073-X; Williams ML, 2011, CHEM GEOL, V283, P218, DOI 10.1016/j.chemgeo.2011.01.019; Harlov DE, 2010, AM MINERAL, V95, P1105, DOI 10.2138/am.2010.3525; Prakash D, 1999, GONDWANA RES, V2, P95, DOI 10.1016/S1342-937X(05)70130-1; MEEN JK, 1989, NATURE, V340, P301, DOI 10.1038/340301a0; Tsunogae T, 2006, LITHOS, V92, P524, DOI 10.1016/j.lithos.2006.03.060; NEWTON RC, 1992, J METAMORPH GEOL, V10, P383, DOI 10.1111/j.1525-1314.1992.tb00091.x; Santosh M, 2009, GONDWANA RES, V16, P321, DOI 10.1016/j.gr.2008.12.012; Van den Kerkhof AM, 2001, LITHOS, V55, P27, DOI 10.1016/S0024-4937(00)00037-2; Santosh M, 2003, GONDWANA RES, V6, P29, DOI 10.1016/S1342-937X(05)70643-2; Santosh M, 2003, J GEOL, V111, P1, DOI 10.1086/344578; Sajeev K, 2006, LITHOS, V92, P465, DOI 10.1016/j.lithos.2006.03.059; Ghosh JG, 2004, TECTONICS, V23, DOI 10.1029/2002TC001444; Sajeev K, 2006, GEOL MAG, V143, P923, DOI 10.1017/S0016756806002470; HARRIS NBW, 1982, J GEOL, V90, P509; Watt GR, 1995, MINERAL MAG, V59, P735, DOI 10.1180/minmag.1995.059.397.14; Hetherington CJ, 2010, MINER PETROL, V99, P165, DOI 10.1007/s00710-010-0110-1; TOURET J, 1983, J GEOL SOC LONDON, V140, P635, DOI 10.1144/gsjgs.140.4.0635; NEWTON RC, 1980, NATURE, V288, P45, DOI 10.1038/288045a0; SUZUKI K, 1991, GEOCHEM J, V25, P357; Touret JLR, 2009, RUSS GEOL GEOPHYS+, V50, P1052, DOI 10.1016/j.rgg.2009.11.004; Harlov DE, 2011, CONTRIB MINERAL PETR, V162, P329, DOI 10.1007/s00410-010-0599-7; Suzuki K, 2008, GONDWANA RES, V14, P569, DOI 10.1016/j.gr.2008.01.005; Prakash D, 2007, J ASIAN EARTH SCI, V29, P41, DOI 10.1016/j.jseaes.2006.01.002; Mohan A, 1999, GONDWANA RES, V2, P251, DOI 10.1016/S1342-937X(05)70149-0; Tropper P, 2011, CHEM GEOL, V282, P58, DOI 10.1016/j.chemgeo.2011.01.009; Raith M, 1997, J METAMORPH GEOL, V15, P379, DOI 10.1111/j.1525-1314.1997.00027.x; WATT GR, 1993, CONTRIB MINERAL PETR, V114, P550, DOI 10.1007/BF00321759; Touret JLR, 2001, LITHOS, V55, P1, DOI 10.1016/S0024-4937(00)00036-0; Plavsa D, 2012, PRECAMBRIAN RES, V198, P77, DOI 10.1016/j.precamres.2011.12.013; Santosh M, 2006, GONDWANA RES, V10, P128, DOI 10.1016/j.gr.2005.12.005; Collins AS, 2007, PRECAMBRIAN RES, V155, P125, DOI 10.1016/j.precamres.2007.01.006; Collins AS, 2007, TERRA NOVA, V19, P141, DOI 10.1111/j.1365-3121.2007.00729.x; Tadokoro H, 2007, INT GEOL REV, V49, P1050, DOI 10.2747/0020-6814.49.11.1050; Bartlett JM, 1998, CONTRIB MINERAL PETR, V131, P181, DOI 10.1007/s004100050387; PATTAN JN, 1995, CHEM GEOL, V121, P201, DOI 10.1016/0009-2541(94)00112-L; DRURY SA, 1980, TECTONOPHYSICS, V65, pT1, DOI 10.1016/0040-1951(80)90073-6; Plavsa D, 2014, GEOL SOC AM BULL, V126, P791, DOI 10.1130/B30977.1; Sajeev K, 2004, CONTRIB MINERAL PETR, V148, P29, DOI 10.1007/s00410-004-0592-0; MOHAN A, 1993, J METAMORPH GEOL, V11, P867, DOI 10.1111/j.1525-1314.1993.tb00196.x; Prakash D, 2010, J GEOL SOC INDIA, V76, P371, DOI 10.1007/s12594-010-0107-8; Brandt S, 2014, PRECAMBRIAN RES, V246, P91, DOI 10.1016/j.precamres.2014.01.007; Bartlett J.M., 1995, MEM GEOLOGICAL SOC I, V34, P391; Coolen, 1980, SO TANZANIA GUA PA 1, V1; Anto KF, 1997, CURR SCI INDIA, V73, P792; GREW ES, 1984, J GEOL SOC INDIA, V25, P116; Ishwar-Kumar C., 2013, PRECAMBRIAN RES, V236, P227; Jayananda M., 1995, MEMOIR GEOLOGICAL SO, V34, P378; Miller JS, 1996, J SOUTHE ASIAN EARTH, V14, P127, DOI 10.1016/S0743-9547(96)00051-7; Mohan A., 2005, METAMORPHISM CRUSTAL, P314; Patino Douce A.E., 1998, J PETROL, V39, P689, DOI [DOI 10.1093/PETROJ/39.4.689, 10.1093/petroj/39.4.689]; Prakash D., 2003, POLAR GEOSCI, V16, P149; Roedder E, 1984, REV MINERAL, V12, P644; Sawyer, 1986, CHEM GEOL, V55, P77; Shaw, 1956, GEOLOGICAL SOC AM B, V67, P919; Sun S. S., 1989, GEOL SOC SPEC PUBL, V42, P313, DOI DOI 10.1144/GSL.SP.1989.042.01.19; Suzuki K., 1991, J EARTH SCI-NAGOYA U, V38, P11; Tamashiro T., 2004, J MINERALOGICAL PETR, V99, P279; Taylor S.R., 1985, CONTINENTAL CRUST IT, P312; Touret J., 1971, LITHOS, V4, P423, DOI DOI 10.1016/0024-4937(71)90125-3; Touret J., 1981, MINERALOGICAL ASS CA, V6, P182; Tropper P., 2013, GEOFLUIDS, V13, P272; Tsunogae T., 2003, GONDWANA RES, V6, P925, DOI 10.1016/S1342-937X(05)71037-6; VIELZEUF D, 1994, CONTRIB MINERAL PETR, V117, P375, DOI 10.1007/BF00307272	80	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0024-4937	1872-6143		LITHOS	Lithos	NOV	2015	236						1	15		10.1016/j.lithos.2015.08.008		15	Geochemistry & Geophysics; Mineralogy	Geochemistry & Geophysics; Mineralogy	CW3KP	WOS:000364891500001		
J	dos Santos, SR; Branco, N; Franco, RMB; Paterniani, JES; Katsumata, M; Barlow, PW; Gallep, CD				dos Santos, Samuel Ricardo; Branco, Nilson; Bueno Franco, Regina Maura; Stipp Paterniani, Jose Euclides; Katsumata, Masakazu; Barlow, Peter W.; Gallep, Cristiano de Mello			Fluorescence decay of dyed protozoa: differences between stressed and non-stressed cysts	LUMINESCENCE			English	Article						fluorescence decay; Giardia lamblia; Cryptosporidium parvum; carboxyfluorescein-diacetate-succinimidyl-ester; dyes	CRYPTOSPORIDIUM-PARVUM VIABILITY; ANIMAL INFECTIVITY; GIARDIA CYSTS; OOCYSTS; DIACETATE; OZONE; EXCYSTATION; PHYSIOLOGY; SURVIVAL; CELLS	Several series of tests have shown that fresh, intact samples of Giardia duodenalis and Cryptosporidium parvum (oo) cysts are not marked by fluorescent probes such as carboxyfluorcein-succinimidyl-diacetate-ester (CFDA-SE), C12-resazurin and SYTOX (R) Green, probably because of their robust cell walls. These dyes fail to indicate the viability of such protozoa and allow negative responses to be recorded from living and infectious samples. Cryptosporidium parvum showed stronger isolation from chemicals, with living oocysts remaining unstained by the probe for up to 90 days after extraction. However, in further fluorescence decay (FD) experiments run with G. duodenalis samples stained using CFDA-SE (comprising living, non-stressed but aged cysts, heat-killed samples and UV-C-stressed samples) each showed a different FD decay profile, here studied in seven series of tests of five replicates each. The FD profiles were fitted by double-exponential decay kinetics, with the decay constant k(2) being five times higher than k(1). This FD procedure is fast and can be easily reproduced in 10 steps, taking similar to 1 h of laboratory work for already purified samples. Copyright (C) 2015 John Wiley & Sons, Ltd.	[dos Santos, Samuel Ricardo; Gallep, Cristiano de Mello] Univ Estadual Campinas, Sch Technol, Limeira, SP, Brazil; [dos Santos, Samuel Ricardo; Stipp Paterniani, Jose Euclides] Univ Estadual Campinas, Sch Agr Engn, Campinas, SP, Brazil; [Branco, Nilson; Bueno Franco, Regina Maura] Univ Estadual Campinas, Inst Biol, Campinas, SP, Brazil; [Katsumata, Masakazu] Hamamatsu Photon KK, Cent Res Labs, Hamamatsu, Shizuoka, Japan; [Barlow, Peter W.] Univ Bristol, Sch Biol Sci, Bristol BS8 1TH, Avon, England	Gallep, CD (reprint author), Univ Estadual Campinas, Sch Technol, Limeira, SP, Brazil.	gallep@ft.unicamp.br			Hamamatsu Photonics K.K.; FAPESP [11/10763-6, 10/07792-1, 13/01501-3]	The authors are thankful for the partial support from Hamamatsu Photonics K.K. and for useful discussions with Dr Shinji Izumiyama (National Institute of Infectious Diseases - NIID) Japan, and FAPESP (grants #11/10763-6, #10/07792-1 and #13/01501-3). Special acknowledgement is given to Anjaina Albuquerque, Josiane Vendemiatti, Joao Viana, Jessica Maise and Geyna Souza for technical support at FT/UNICAMP.	Neumann NF, 2000, APPL ENVIRON MICROB, V66, P406; King BJ, 2007, PARASITOLOGY, V134, P309, DOI 10.1017/S0031182006001491; KORICH DG, 1990, APPL ENVIRON MICROB, V56, P1423; Castro-Hermida JA, 2009, WATER RES, V43, P4133, DOI 10.1016/j.watres.2009.06.020; Garcia A, 2002, WATER ENVIRON RES, V74, P541, DOI 10.2175/106143002X140341; LABATIUK CW, 1991, APPL ENVIRON MICROB, V57, P3187; SCHUPP DG, 1987, APPL ENVIRON MICROB, V53, P704; Bridle H, 2012, WATER RES, V46, P1641, DOI 10.1016/j.watres.2012.01.010; Hammes F, 2011, ADV BIOCHEM ENG BIOT, V124, P123, DOI 10.1007/10_2010_95; Grit GH, 2012, VET PARASITOL, V184, P330, DOI 10.1016/j.vetpar.2011.08.021; SMITH AL, 1989, PARASITOLOGY, V99, P329; Kvac M, 2007, PARASITOL RES, V100, P213, DOI 10.1007/s00436-006-0272-2; Iturriaga R, 2001, J MICROBIOL METH, V46, P19, DOI 10.1016/S0167-7012(01)00249-4; Brescia CC, 2009, APPL ENVIRON MICROB, V75, P6856, DOI 10.1128/AEM.00540-09; Cronin UP, 2008, J IND MICROBIOL BIOT, V35, P1695, DOI 10.1007/s10295-008-0461-3; Bukhari Z, 2000, APPL ENVIRON MICROB, V66, P2972, DOI 10.1128/AEM.66.7.2972-2980.2000; Scheid PL, 2011, PARASITOL RES, V109, P499, DOI 10.1007/s00436-011-2287-6; Wang XQ, 2005, ACTA BIOCH BIOPH SIN, V37, P379, DOI 10.1111/j.1745-7270.2005.00051.x; Gajadhar AA, 2004, VET PARASITOL, V126, P3, DOI 10.1016/j.vetpar.2004.09.009; Hilpert F, 2005, SCAND J IMMUNOL, V62, P399, DOI 10.1111/j.1365-3083.2005.01677.x; AWWA, 2012, 9711 AWWA; Barbosa Joana, 2008, Travel Med Infect Dis, V6, P234, DOI 10.1016/j.tmaid.2008.01.004; Bertogna E., 2011, 2011 SBMO/IEEE MTT-S International Microwave and Optoelectronics Conference (IMOC), DOI 10.1109/IMOC.2011.6169247; Koehler AV, 2014, BIOTECHNOL ADV, V32, P280, DOI 10.1016/j.biotechadv.2013.10.009; Lee C., 2004, J INT SOC LIFE INF S, V22, P445; OriginLab, FIT EXP; OriginLab, BOLTZM FUNCT APP 3 B; Robertson LJ, 2014, J MICROBIOL METH, V96, P68, DOI 10.1016/j.mimet.2013.11.001; Smith H, 2003, HDB WATER WASTEWATER, P695, DOI 10.1016/B978-012470100-7/50041-8; Smith HV, 2009, GIARDIA AND CRYPTOSPORIDIUM: FROM MOLECULES TO DISEASE, P179, DOI 10.1079/9781845933913.0179; United States Environmental Protection Agency (EPA), 2012, 16231 USEPA, P83; WHO, 2002, PROT PAR CRYPT GIARD, P70	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1522-7235	1522-7243		LUMINESCENCE	Luminescence	NOV	2015	30	7					1139	1147		10.1002/bio.2872		9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CX0LW	WOS:000365389200030		
J	Lee, H; Wei, HW; Takahashi, J				Lee, Hooseok; Wei, Haowen; Takahashi, Jun			The influence of plasma in various atmospheres on the adhesion properties of recycled carbon fiber	MACROMOLECULAR RESEARCH			English	Article						plasma; surface treatment; recycled carbon fiber	INTERFACIAL PROPERTIES; NITRIC-ACID; SHEAR-STRENGTH; OXYGEN PLASMA; SURFACE; COMPOSITES; MATRIX; CHEMISTRY; OXIDATION; NANOTUBES	We studied the effects of the plasma surface treatment of recycled carbon fiber (RCF) for adhesion of the fiber to polymers after various plasma conditions. RCF was treated in dry air and CO2 by the plasma surface treatment to compare its surface and adhesive properties depended on treatment conditions. The changes in surface morphology of RCF were examined using scanning electron microscopy (SEM). Surface functionalization was quantified by X-ray photoelectron spectroscopy (XPS). The efficiency of the modification for adhesion properties by the plasma surface treatment depends on the gas used as well as on the exposure time. The micro-droplet test for adhesion properties and the surface change after performing an interfacial shear stress (IFSS) of carbon fiber-reinforced plastics (CFRP) were also investigated.	[Lee, Hooseok; Wei, Haowen; Takahashi, Jun] Univ Tokyo, Dept Syst Innovat, Tokyo 1138654, Japan	Lee, H (reprint author), Univ Tokyo, Dept Syst Innovat, Tokyo 1138654, Japan.	lee-hooseok@cfrtp.t.u-tokyo.ac.jp					PROCTOR A, 1983, CARBON, V21, P53, DOI 10.1016/0008-6223(83)90156-2; Zhang GX, 2008, CARBON, V46, P196, DOI 10.1016/j.carbon.2007.11.002; Montes-Moran MA, 2002, CARBON, V40, P845, DOI 10.1016/S0008-6223(01)00212-3; Lee H, 2015, APPL SURF SCI, V328, P241, DOI 10.1016/j.apsusc.2014.12.012; Pimenta S, 2012, COMPOS STRUCT, V94, P3669, DOI 10.1016/j.compstruct.2012.05.024; Pisanova E, 2001, COMPOS PART A-APPL S, V32, P435, DOI 10.1016/S1359-835X(00)00054-3; Meredith J, 2012, COMPOS SCI TECHNOL, V72, P688, DOI 10.1016/j.compscitech.2012.01.017; Brondsted P, 2005, ANNU REV MATER RES, V35, P505, DOI 10.1146/annurev.matsci.35.100303.110641; Liu HM, 2010, CARBON, V48, P721, DOI 10.1016/j.carbon.2009.10.018; Ho KKC, 2008, COMPOS PART A-APPL S, V39, P364, DOI 10.1016/j.compositesa.2007.10.008; Hou YP, 2012, J MATER SCI, V47, P4775, DOI 10.1007/s10853-012-6317-2; Fu XL, 1998, CARBON, V36, P1337, DOI 10.1016/S0008-6223(98)00115-8; Pittman CU, 1998, CARBON, V36, P25, DOI 10.1016/S0008-6223(97)00147-4; Lindsay B, 2007, CARBON, V45, P2433, DOI 10.1016/j.carbon.2007.04.017; Gardner SD, 1996, SURF INTERFACE ANAL, V24, P311, DOI 10.1002/(SICI)1096-9918(199605)24:5<311::AID-SIA120>3.3.CO;2-Q; Boudou JP, 2003, CARBON, V41, P41, DOI 10.1016/S0008-6223(02)00270-1; Banerjee S, 2005, ADV MATER, V17, P17, DOI 10.1002/adma.200401340; Zielke U, 1996, CARBON, V34, P983, DOI 10.1016/0008-6223(96)00032-2; Paiva MC, 2000, CARBON, V38, P1323, DOI 10.1016/S0008-6223(99)00266-3; SMILEY RJ, 1993, J MATER SCI, V28, P3601, DOI 10.1007/BF01159843; Wong KH, 2012, COMPOS SCI TECHNOL, V72, P835, DOI 10.1016/j.compscitech.2012.02.013; Greco A, 2013, J COMPOS MATER, V47, P369, DOI 10.1177/0021998312440133; Pittman CU, 1997, CARBON, V35, P317, DOI 10.1016/S0008-6223(97)89608-X; Jeong JY, 2000, J PHYS CHEM A, V104, P8027, DOI 10.1021/jp0012449; Wang YQ, 1999, CHEM MATER, V11, P2573, DOI 10.1021/cm9902772; KOWBEL W, 1990, CARBON, V28, P287, DOI 10.1016/0008-6223(90)90003-H; Chen J, 1998, SCIENCE, V282, P95, DOI 10.1126/science.282.5386.95; Montes-Moran MA, 2001, CARBON, V39, P1057, DOI 10.1016/S0008-6223(00)00220-7; Park SJ, 2000, J MATER SCI, V35, P1901, DOI 10.1023/A:1004754100310; de Darwent B., 1970, NATL STANDARD REFERE, V31, P52; Fukui R., 2005, P 9 JAP INT SAMPE S, P44; Jianfei Xie, 2011, Surface & Coatings Technology, V206, DOI 10.1016/j.surfcoat.2011.04.016; Kozarsky R., 2012, STRONGER LIGHTER FAS; Montes-Moran MA, 2001, COMPOS PART A-APPL S, V32, P361, DOI 10.1016/S1359-835X(00)00109-3; Nakagawa M., 2009, P 5 INT S FEEDST REC, P241; PONCINEPAILLARD F, 1990, EUR POLYM J, V26, P333, DOI 10.1016/0014-3057(90)90250-8; Suzuki T., 2005, P 9 JAP INT SAMPE S, P14; Suzuki T., 2004, P 29 S JAP SOC COMP, P195; Tang LG, 1997, POLYM COMPOSITE, V18, P100, DOI 10.1002/pc.10265; Vicari A., 2013, STRONGER LIGHTER FAS; Yu Z.R., 1999, CARBON, V37, P1785	41	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1598-5032	2092-7673		MACROMOL RES	Macromol. Res.	NOV	2015	23	11					1026	1033		10.1007/s13233-015-3141-y		8	Polymer Science	Polymer Science	CW9FK	WOS:000365303900007		
J	Ho, S				Ho, Shirun			Design of Aggregate Structures and Molecular Capture by Using Molecular-Cluster-Assembly Method	MACROMOLECULAR THEORY AND SIMULATIONS			English	Article						aggregate structure; molecular capture; simulation method	LI-ION BATTERIES; MONTE-CARLO; FORCE-FIELD; PROTEINS; POLYMERS; DYNAMICS; BINDERS; COMPLEXATION; SIMULATIONS; ELECTRODES	Technology for designing functional polymers needs to incorporate biomimetic structures for a new functionality. A simulation method, referred to as "molecular-cluster-assembly," is used to design aggregate structures comprised of oligomers in a bottom-up manner and predict the capability of molecular capture. Acrylic acid oligomer forms an arched and syndiotactic structure with minimum energy. In accordance with the degree of aggregation, arched oligomers form a constricted structure with a unique channel width. The aggregate structures capture ethylene carbonates (ECs) inside the constricted channel and produce attractive energy between the ECs in host-guest complexes. The optimum numbers of ECs stably captured are determined when the binding energy at which the guests are captured at the outside wall of the channel exceeds the attractive energy between the guests in the constricted channel.	[Ho, Shirun] Hitachi Ltd, Res & Dev Grp, Kokubunji, Tokyo 1858601, Japan	Ho, S (reprint author), Hitachi Ltd, Res & Dev Grp, Kokubunji, Tokyo 1858601, Japan.	shirun.ho.eh@hitachi.com					Wang LP, 2012, J CHEM THEORY COMPUT, V8, P610, DOI 10.1021/ct200340x; FIELD MJ, 1990, J COMPUT CHEM, V11, P700, DOI 10.1002/jcc.540110605; Kovalenko A, 2005, PHYS CHEM CHEM PHYS, V7, P1785, DOI 10.1039/b416615a; Mayhall NJ, 2011, J CHEM THEORY COMPUT, V7, P1336, DOI 10.1021/ct200033b; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; WARSHEL A, 1976, J MOL BIOL, V103, P227, DOI 10.1016/0022-2836(76)90311-9; Aida T, 2012, SCIENCE, V335, P813, DOI 10.1126/science.1205962; Ogoshi T, 2010, J PHYS CHEM LETT, V1, P817, DOI 10.1021/jz900437r; Magasinski A, 2010, ACS APPL MATER INTER, V2, P3004, DOI 10.1021/am100871y; Komaba S, 2012, J PHYS CHEM C, V116, P1380, DOI 10.1021/jp204817h; Damm W, 1997, J COMPUT CHEM, V18, P1955, DOI 10.1002/(SICI)1096-987X(199712)18:16<1955::AID-JCC1>3.0.CO;2-L; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Komaba S, 2011, J PHYS CHEM C, V115, P13487, DOI 10.1021/jp201691g; GEYER CJ, 1995, J AM STAT ASSOC, V90, P909, DOI 10.2307/2291325; Haino T, 2005, J AM CHEM SOC, V127, P8936, DOI 10.1021/ja0524088; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Kovalenko I, 2011, SCIENCE, V334, P75, DOI 10.1126/science.1209150; MASERAS F, 1995, J COMPUT CHEM, V16, P1170, DOI 10.1002/jcc.540160911; Yamagishi TA, 2005, MACROMOLECULES, V38, P6871, DOI 10.1021/ma0478299; AQVIST J, 1993, CHEM REV, V93, P2523; Gao JL, 2002, ANNU REV PHYS CHEM, V53, P467, DOI 10.1146/annurev.physchem.53.091301.150114; TOMASI J, 1994, CHEM REV, V94, P2027, DOI 10.1021/cr00031a013; Nagaoka M, 2006, J PHYS CHEM A, V110, P4555, DOI 10.1021/jp056115c; Kitaura K, 1999, CHEM PHYS LETT, V313, P701, DOI 10.1016/S0009-2614(99)00874-X; Tozzini V, 2005, CHEM PHYS LETT, V413, P123, DOI 10.1016/j.cplett.2005.07.075; AOKI Y, 1992, J CHEM PHYS, V97, P8432, DOI 10.1063/1.463413; Cacciapaglia R, 2007, J AM CHEM SOC, V129, P12512, DOI 10.1021/ja0737366; ATWOOD JL, 1994, NATURE, V368, P229, DOI 10.1038/368229a0; Hukushima K, 1996, J PHYS SOC JPN, V65, P1604, DOI 10.1143/JPSJ.65.1604; Meinke JH, 2009, J COMPUT CHEM, V30, P1642, DOI 10.1002/jcc.21321; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; Hochgatterer NS, 2008, ELECTROCHEM SOLID ST, V11, pA76, DOI 10.1149/1.2888173; FORESMAN JB, 1996, EXPLORING CHEM ELECT; Frisch M. J., 2010, GAUSSIAN 09 REVISION; Hansmann U. E., 1997, PHYS LETT, V281, P140; Ho S, 2013, MACROMOL THEOR SIMUL, V22, P443, DOI 10.1002/mats.201300101; Ho S., 2014, 10 SPSJ INT POL C, P112; Petsko G., 2008, PROTEIN STRUCTURE FU; Svensson M, 1996, J PHYS CHEM-US, V100, P19357, DOI 10.1021/jp962071j; Tozzini V, 2010, ACCOUNTS CHEM RES, V43, P220, DOI 10.1021/ar9001476; van Schalkwijk W., 2002, ADV LITHIUM ION BATT; White S., MEMBRANE PROTEINS KN	42	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1022-1344	1521-3919		MACROMOL THEOR SIMUL	Macromol. Theory Simul.	NOV	2015	24	6					595	609		10.1002/mats.201500041		15	Polymer Science	Polymer Science	CX2GD	WOS:000365513700005		
J	Goto, KT; Shimoda, G; Anbar, AD; Gordon, GW; Harigane, Y; Senda, R; Suzuki, K				Goto, Kosuke T.; Shimoda, Gen; Anbar, Ariel D.; Gordon, Gwyneth W.; Harigane, Yumiko; Senda, Ryoko; Suzuki, Katsuhiko			Molybdenum isotopes in hydrothermal manganese crust from the Ryukyu arc system: Implications for the source of molybdenum	MARINE GEOLOGY			English	Article						Molybdenum isotope; Hydrothermal manganese crust; Manganophile element; Osmium isotope; Ryukyu arc system	AFANASIY-NIKITIN SEAMOUNT; PLASMA-MASS SPECTROMETRY; PITCAIRN ISLAND HOTSPOT; CENTRAL PACIFIC-OCEAN; MID-ATLANTIC RIDGE; DE-FUCA RIDGE; FERROMANGANESE CRUSTS; OKINAWA TROUGH; GEOCHEMICAL EVIDENCE; SOUTHWEST PACIFIC	A high concentration of molybdenum (Mo) is a striking feature of modern marine hydrothermal manganese (Mn) crusts from both low- and high-temperature hydrothermal systems; however, the origin of that Mo is poorly constrained. In this study, we analyzed Mo isotopic composition (delta Mo-98/95) in a Mn crust collected from the Ryukyu arc system, and assessed the possible use of delta Mo-98/95 to constrain the origin of Mo in hydrothermal Mn crusts. Along with Mo isotope analysis, we also measured the abundance of major and trace elements and the Re-Os isotopic composition. The Mn crust sample had a high Mn content (42%-47%) and was low in Fe (0.2%-0.5%). Among the manganophile elements (Co, Ni, Cu, Zn, and Mo), only Mo showed high concentrations (>550 ppm). We also found low contents of Os (similar to 35 ppt) with an isotopic composition of Os-187/Os-188 = similar to 1.00. These results are consistent with previously reported chemical compositions of hydrothermal Mn crusts. delta Mo-98/95 values in the sample ranged from -0.56 parts per thousand. to -0.66 parts per thousand, which are similar to 2.7 parts per thousand lighter than the present-day sea-water delta Mo-98/95 but similar to those in modem hydrogenous Fe-Mn crusts and Mn nodules. Although current data do not preclude the possible contribution of hydrothermally derived Mo, the light delta Mo-98/95 values can be explained by isotope fractionation associated with a change in coordination number during the adsorption of Mo from seawater onto Mn oxides. We suggest that the delta Mo-98/95 data are useful for constraining the source of Mo in hydrothermal Mn crusts. (C) 2015 Elsevier B.V. All rights reserved.	[Goto, Kosuke T.; Shimoda, Gen; Harigane, Yumiko] AIST, Geol Survey Japan, Tsukuba, Ibaraki 3058567, Japan; [Anbar, Ariel D.; Gordon, Gwyneth W.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Anbar, Ariel D.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Senda, Ryoko] Japan Agcy Marine Earth Sci & Technol, Dept Solid Earth Geochem, Yokosuka, Kanagawa 2370061, Japan; [Senda, Ryoko; Suzuki, Katsuhiko] Japan Agcy Marine Earth Sci & Technol, Res & Dev Ctr Submarine Resources, Yokosuka, Kanagawa 2370061, Japan	Goto, KT (reprint author), Cent 7,1-1-1 Higashi, Tsukuba, Ibaraki 3058567, Japan.	k.goto@aist.go.jp			Hirokawa Research Fund; MEXT [20109006]; JSPS [2034015]	We thank Stephen J. Romaniello, Taichi Sato, Yasuhito Sekine and Eiichi Tajika for fruitful discussions; Takuya Itaki and Ken Ikehara for providing U-Pb data; and the captain and crew of the RN Kaiyoumaru No.7 for helping to collect samples. The bathymetric data used in this study were obtained by the GSJ, AIST. This study was partly supported by the Hirokawa Research Fund, and Grant-In-Aid from MEXT (20109006 to KS) and JSPS (2034015 to KS).	Nakagawa Y, 2012, GEOCHEM J, V46, P131; Hidaka H, 2002, CHEM GEOL, V187, P279, DOI 10.1016/S0009-2541(02)00058-X; Wen X, 1997, MAR GEOL, V136, P277, DOI 10.1016/S0025-3227(96)00064-3; Poulson RL, 2006, GEOLOGY, V34, P617, DOI 10.1130/G22485.1; [Anonymous], 2000, MAR SCI SER; Kuhn T, 2003, CHEM GEOL, V199, P29, DOI 10.1016/S0009-2541(03)00054-8; Glasby GP, 1997, GEOCHIM COSMOCHIM AC, V61, P4583, DOI 10.1016/S0016-7037(97)00262-7; McManus J, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2002GC000356; Wheat CG, 2002, GEOCHIM COSMOCHIM AC, V66, P3693, DOI 10.1016/S0016-7037(02)00894-3; SHIMMIELD GB, 1986, MAR CHEM, V19, P261, DOI 10.1016/0304-4203(86)90027-7; Sharma M, 2000, EARTH PLANET SC LETT, V179, P139, DOI 10.1016/S0012-821X(00)00099-6; GRAMLICH JW, 1973, J RES NBS A PHYS CH, VA 77, P691, DOI 10.6028/jres.077A.040; Iwano H, 2013, ISL ARC, V22, P382, DOI 10.1111/iar.12038; Rajani RP, 2005, J EARTH SYST SCI, V114, P51, DOI 10.1007/BF02702008; Sato T, 2014, EARTH PLANETS SPACE, V66, DOI 10.1186/1880-5981-66-68; Gordon GW, 2009, GEOLOGY, V37, P535, DOI 10.1130/G25186A.1; Hein JR, 1996, MAR GEORESOUR GEOTEC, V14, P177; Wasylenki LE, 2008, GEOCHIM COSMOCHIM AC, V72, P5997, DOI 10.1016/j.gca.2008.08.027; Siebert C, 2003, EARTH PLANET SC LETT, V211, P159, DOI 10.1016/S0012-821X(03)00189-4; Miller CA, 2011, GEOCHIM COSMOCHIM AC, V75, P7146, DOI 10.1016/j.gca.2011.09.005; MOORBY SA, 1984, GEOCHIM COSMOCHIM AC, V48, P433, DOI 10.1016/0016-7037(84)90272-2; Herzig CT, 1998, GEOCHEM J, V32, P21; HIRATA T, 1995, GEOCHIM COSMOCHIM AC, V59, P2491, DOI 10.1016/0016-7037(95)00144-1; HODKINSON RA, 1994, GEOCHIM COSMOCHIM AC, V58, P5011, DOI 10.1016/0016-7037(94)90228-3; Banakar VK, 1997, MAR GEOL, V136, P299, DOI 10.1016/S0025-3227(96)00065-5; Barling J, 2001, EARTH PLANET SC LETT, V193, P447, DOI 10.1016/S0012-821X(01)00514-3; Voegelin AR, 2012, GEOCHIM COSMOCHIM AC, V86, P150, DOI 10.1016/j.gca.2012.02.029; Goldberg T, 2009, GEOCHIM COSMOCHIM AC, V73, P6502, DOI 10.1016/j.gca.2009.08.004; Wasylenki LE, 2011, GEOCHIM COSMOCHIM AC, V75, P5019, DOI 10.1016/j.gca.2011.06.020; Morford JL, 2012, CHEM GEOL, V324, P73, DOI 10.1016/j.chemgeo.2011.12.014; TAKEMATSU N, 1989, MAR CHEM, V26, P41, DOI 10.1016/0304-4203(89)90063-7; ISHIBASHI J, 1988, GEOCHEM J, V22, P107; CRONAN DS, 1982, NATURE, V298, P456, DOI 10.1038/298456a0; EMERSON SR, 1991, MAR CHEM, V34, P177, DOI 10.1016/0304-4203(91)90002-E; Byrne RH, 2002, GEOCHEM T, V3, P11, DOI 10.1039/b109832f; Hein JR, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004286; Rogers TDS, 2001, MAR GEORESOUR GEOTEC, V19, P245, DOI 10.1080/106411901753335326; Burton KW, 1999, EARTH PLANET SC LETT, V171, P185, DOI 10.1016/S0012-821X(99)00139-9; Woodhouse OB, 1999, EARTH PLANET SC LETT, V173, P223, DOI 10.1016/S0012-821X(99)00233-2; Glasby GP, 2003, ORE GEOL REV, V23, P299, DOI 10.1016/j.orgeorev.2003.07.001; Eckhardt JD, 1997, MAR GEORESOUR GEOTEC, V15, P175; TREFRY JH, 1994, J GEOPHYS RES-SOL EA, V99, P4925, DOI 10.1029/93JB02108; KIMURA M, 1988, TECTONOPHYSICS, V145, P319, DOI 10.1016/0040-1951(88)90203-X; Nagler TF, 2011, CHEM GEOL, V289, P1, DOI 10.1016/j.chemgeo.2011.07.001; Goldberg T, 2013, J ANAL ATOM SPECTROM, V28, P724, DOI 10.1039/c3ja30375f; KOIDE M, 1991, GEOCHIM COSMOCHIM AC, V55, P1641, DOI 10.1016/0016-7037(91)90135-R; Yokoyama TD, 2011, ANAL CHEM, V83, P8892, DOI 10.1021/ac2012448; DECARLO EH, 1991, MAR GEOL, V98, P449, DOI 10.1016/0025-3227(91)90116-L; Asael D, 2013, CHEM GEOL, V362, P193, DOI 10.1016/j.chemgeo.2013.08.003; CLAUER N, 1984, NATURE, V311, P743, DOI 10.1038/311743a0; Bau M, 2014, CHEM GEOL, V381, P1, DOI 10.1016/j.chemgeo.2014.05.004; Pearce CR, 2010, EARTH PLANET SC LETT, V295, P104, DOI 10.1016/j.epsl.2010.03.032; USUI A, 1986, MAR GEOL, V73, P311, DOI 10.1016/0025-3227(86)90020-4; Ravizza G, 1996, EARTH PLANET SC LETT, V138, P105, DOI 10.1016/0012-821X(95)00216-Y; Barling J, 2004, EARTH PLANET SC LETT, V217, P315, DOI 10.1016/S0012-821X(03)00608-3; Levasseur S, 1998, SCIENCE, V282, P272, DOI 10.1126/science.282.5387.272; Jiang Xuejun, 2009, Journal of Ocean University of China, V8, P57, DOI [10.1007/s11802-009-0057-1, 10.1109/ICIE.2009.60]; MOORE WS, 1976, EARTH PLANET SC LETT, V29, P349, DOI 10.1016/0012-821X(76)90139-4; Scott MR, 1974, GEOPHYS RES LETT, V1, P355, DOI 10.1029/GL001i008p00355; PALMER MR, 1988, GEOCHIM COSMOCHIM AC, V52, P1197, DOI 10.1016/0016-7037(88)90274-8; Klemm V, 2005, EARTH PLANET SC LETT, V238, P42, DOI 10.1016/j.epsl.2005.07.016; Metz S, 2000, GEOCHIM COSMOCHIM AC, V64, P2267, DOI 10.1016/S0016-7037(00)00354-9; COLLIER RW, 1985, LIMNOL OCEANOGR, V30, P1351; Glasby G.P., 2006, MARINE GEOCHEMISTRY, P371, DOI 10.1007/3-540-32144-6_11; Harigane Y., 2014, AGU 2014 FALL M; IMAI N, 1995, GEOSTANDARD NEWSLETT, V19, P135, DOI 10.1111/j.1751-908X.1995.tb00158.x; Ishikawa A, 2014, CHEM GEOL, V384, P27, DOI 10.1016/j.chemgeo.2014.06.013; Kashiwabara T, 2009, GEOCHEM J, V43, pE31; Kato Y, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2005GC0000920; Koide M., 1986, APPLIED GEOCHEMISTRY, V1, P705, DOI 10.1016/0883-2927(86)90092-2; Letouzey J, 1985, MAR PETROL GEOL, V2, P111, DOI DOI 10.1016/0264-8172(85)90002-9; Minami H., 2014, VOLC SOC JAP FALL M; Sakata S, 2014, GEOSTAND GEOANAL RES, V38, P409, DOI 10.1111/j.1751-908X.2014.00320.x; Siebert C, 2001, GEOCHEM GEOPHY GEOSY, P2, DOI [10.1029/2000GC000124, DOI 10.1029/2000GC000124]	74	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0025-3227	1872-6151		MAR GEOL	Mar. Geol.	NOV 1	2015	369						91	99		10.1016/j.margeo.2015.08.007		9	Geosciences, Multidisciplinary; Oceanography	Geology; Oceanography	CW5VP	WOS:000365065000007		
J	Shinozaki, T; Goto, K; Fujino, S; Sugawara, D; Chiba, T				Shinozaki, Tetsuya; Goto, Kazuhisa; Fujino, Shigehiro; Sugawara, Daisuke; Chiba, Takashi			Erosion of a paleo-tsunami record by the 2011 Tohoku-oki tsunami along the southern Sendai Plain	MARINE GEOLOGY			English	Article						2011 Tohoku-oki tsunami; Erosion; Redeposition; Coastal lake; Sendai Plain	INDIAN-OCEAN TSUNAMI; SANRIKU COAST; HISTORICAL TSUNAMI; GREAT EARTHQUAKES; DEPOSITS; JAPAN; INSIGHTS; DIATOMS; TRENCH; BAY	Erosion of sediment beneath a coastal lake by the 2011 Tohoku-oki tsunami largely removed up to 1100 years of the geologic record of tsunami and tephra deposition. That lost geologic record included the 1611 Keicho tsunami deposit and the 915 To-a tephra, amounting to ca. 1.4 m of lake-bottom sediment, as judged from comparison of stratigraphy at four locations examined before and after the 2011 tsunami. The tsunami replaced the eroded sediment with a 7-15-cm-thick sand sheet and an overlying 20-60-cm-thick layer of black mud. Both 2011 deposit components were likely derived from sediment eroded along the tsunami flow path, including granite rock fragments downstream of the lake basin and mainly reworked lake-floor sediment. Erosion and redeposition of lake floor sediment by tsunami inundation can introduce uncertainty to sandy tsunami deposit age estimation. The 2011 tsunami sand might be dated a few hundred years older than the actual age if one overlooks the reworked muddy tsunami deposit. In its facies, the mud closely resembles mud deposited from the usual environment but is mixed with sediments of various ages. Therefore, it is important to identify the reworked muddy tsunami deposit based on geochemistry and micropaleontology, to avoid misinterpretation of the depositional age of tsunami deposits. Erosion of deposits beneath the lake floor also erases evidence, leaving an incomplete paleo-tsunami history. Reconstructing geological records of tsunamis in coastal lakes requires careful evaluation of the possible effects of tsunami erosion. Identifying sediment sources, mapping stratigraphic unconformities, and constructing detailed age-depth models to test for gaps in sedimentation can produce important insights. (C) 2015 Elsevier B.V. All rights reserved.	[Shinozaki, Tetsuya] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Goto, Kazuhisa; Sugawara, Daisuke] Tohoku Univ, Int Res Inst Disaster Sci, Sendai, Miyagi 9800845, Japan; [Fujino, Shigehiro; Chiba, Takashi] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3050006, Japan	Shinozaki, T (reprint author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tennodai 1-1-1, Tsukuba, Ibaraki 3058572, Japan.	shinozakit@geol.tsukuba.ac.jp	Fujino, Shigehiro /C-8846-2014	Fujino, Shigehiro /0000-0003-2415-9764	JSPS [26242033]; Program to Disseminate Tenure Tracking System, MEXT, Japan	We thank Robert C. Witter and an anonymous reviewer for providing valuable comments. CT image, tephra, and radiocarbon dating analyses were conducted, respectively, at the Center for Advanced Marine Core Research in Kochi University (Accept No. 14A006), the Institute of Tephrochronology for Nature and History Co. Ltd., and the Beta Analytic Radiocarbon Laboratory. This research was supported by JSPS research funds (no. 26242033) and the Program to Disseminate Tenure Tracking System, MEXT, Japan.	Abe T., 2014, INT SED C 19 GEN, P10; Bondevik S, 1997, SEDIMENTOLOGY, V44, P1115, DOI 10.1046/j.1365-3091.1997.d01-63.x; HEMPHILLHALEY E, 1995, NORTHWEST SCI, V69, P29; MINOURA K, 1994, SEDIMENT GEOL, V89, P25, DOI 10.1016/0037-0738(94)90081-7; Putra PS, 2013, SEDIMENT GEOL, V294, P282, DOI 10.1016/j.sedgeo.2013.06.004; Goto T, 2015, MAR GEOL, V367, P105, DOI 10.1016/j.margeo.2015.05.009; Nanayama F, 2003, NATURE, V424, P660, DOI 10.1038/nature01864; Ozawa S, 2011, NATURE, V475, P373, DOI 10.1038/nature10227; Tanaka H, 2014, COAST ENG, V86, P14, DOI 10.1016/j.coastaleng.2014.01.002; Jankaew K, 2008, NATURE, V455, P1228, DOI 10.1038/nature07373; Reimer PJ, 2013, RADIOCARBON, V55, P1869; Shinozaki T, 2015, NAT HAZARDS, V77, P445, DOI 10.1007/s11069-015-1598-9; Goto K, 2011, MAR GEOL, V290, P46, DOI 10.1016/j.margeo.2011.10.004; Tappin DR, 2012, SEDIMENT GEOL, V282, P151, DOI 10.1016/j.sedgeo.2012.09.011; Kelsey HM, 2005, GEOL SOC AM BULL, V117, P1009, DOI 10.1130/B25452.1; Sawai Y, 2008, HOLOCENE, V18, P517, DOI 10.1177/0959683608089206; Arai F., 2000, QUATERNARY RES, V39, P107; Arai F., 2011, ATLAS TEPHRA JAPAN; Chague-Goff C., 2014, TSUNAMI EVENTS LESSO, P193; Goto K, 2014, MAR GEOL, V358, P38; Jackson KL, 2014, GEOLOGY, V42, P859, DOI 10.1130/G35796.1; Ishimura D, 2015, PROG EARTH PLANET SC, V2, DOI 10.1186/s40645-015-0047-4; Nakata T, 1997, J GEOGR, V106, P59, DOI DOI 10.5026/JGEOGRAPHY.106.59; Sawai Y, 2015, GEOPHYS RES LETT, V42, P4795, DOI 10.1002/2015GL064167; Sawai Y., 2012, GEOPHYS RES LETT, V39; Sawai Y, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2007JB005503; Soda T., 1989, Q RES, V27, P297; Soda T., 1996, SUMM RES USING AMS N, V7, P256; Szczucinski W, 2012, SEDIMENT GEOL, V282, P40, DOI 10.1016/j.sedgeo.2012.07.019; Szczucinski W, 2012, NAT HAZARDS, V60, P115, DOI 10.1007/s11069-011-9956-8; Takada K, 2002, CHISHITSU NEWS, V579, P12; The 2011 Tohoku Earthquake Tsunami Joint Survey Group, 2011, J JPN SOC CIV ENG B, V67, P63; Yamaguchi N., 2014, JAP GEOSC UN M 2014	33	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0025-3227	1872-6151		MAR GEOL	Mar. Geol.	NOV 1	2015	369						127	136		10.1016/j.margeo.2015.08.009		10	Geosciences, Multidisciplinary; Oceanography	Geology; Oceanography	CW5VP	WOS:000365065000010		
J	Sakai, T; Tao, T; Somiya, S				Sakai, Takenobu; Tao, Takayuki; Somiya, Satoshi			Estimation of creep and recovery behavior of a shape memory polymer	MECHANICS OF TIME-DEPENDENT MATERIALS			English	Article						Creep; Shape memory polymer; Shape recovery; Time-temperature superposition principle; Viscoelasticity	POLYURETHANE; MODEL; RELAXATION	The shape recovery and shape fixity properties of shape memory polymers (SMPs), advanced functional materials, were investigated in this study. Although the shape recovery behavior of these polymers has been examined from a viscoelastic point of view, questions remain with regard to quantifying the recovery behavior of SMPs. SMPs can recover their shape after the molding process; this recovery occurs via creep recovery and/or shape recovery; an estimation of SMP recovery requires a good understanding of both processes. In this study, the time-temperature superposition principle was applied to the creep and shape recovery behavior of SMPs. The creep behavior was estimated using an experimentally obtained master curve and time-temperature shift factors. Our estimated results were in good agreement with the experimental data. However, the estimation of the creep recovery with changing temperature below or above the glass transition temperature was not successful due to the lack of consideration of the shape recovery behavior. The time and temperature dependency of the shape recovery were confirmed for creep behavior, using the master curve for the recovery ratio and the corresponding shift factors for shape recovery. The values of the shape recovery shift factors differed from those for the time-temperature shift factors obtained for creep behavior. Therefore, these shape recovery shift factors were used in the estimation of creep and shape recovery behavior using the master curve for the creep tests. The estimated results were closer to the results obtained experimentally. Moreover, our results indicated that the recovery behavior above was dominated by shape recovery as a result of polymer viscoelasticity.	[Sakai, Takenobu] Saitama Univ, Grad Sch Sci & Engn, Sakura Ku, Saitama, Saitama 3388570, Japan; [Tao, Takayuki; Somiya, Satoshi] Keio Univ, Fac Sci & Technol, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan	Sakai, T (reprint author), Saitama Univ, Grad Sch Sci & Engn, Sakura Ku, 255 Shimo Okubo, Saitama, Saitama 3388570, Japan.	sakai@mech.saitama-u.ac.jp					Diani J, 2012, INT J SOLIDS STRUCT, V49, P793, DOI 10.1016/j.ijsolstr.2011.11.019; Arrieta S, 2014, MECH MATER, V68, P95, DOI 10.1016/j.mechmat.2013.08.008; Sakai T, 2011, MECH TIME-DEPEND MAT, V15, P293, DOI 10.1007/s11043-011-9136-y; Liu YP, 2006, INT J PLASTICITY, V22, P279, DOI 10.1016/j.ijplas.2005.03.004; Morshedian J, 2005, MACROMOL THEOR SIMUL, V14, P428, DOI 10.1002/mats.200400108; Nguyen TD, 2013, POLYM REV, V53, P130, DOI 10.1080/15583724.2012.751922; Monkman GJ, 2000, MECHATRONICS, V10, P489, DOI 10.1016/S0957-4158(99)00068-9; Azra C, 2011, SMART MATER STRUCT, V20, DOI 10.1088/0964-1726/20/8/082002; Lin JR, 1999, J APPL POLYM SCI, V73, P1305, DOI 10.1002/(SICI)1097-4628(19990815)73:7<1305::AID-APP24>3.0.CO;2-5; Hong SJ, 2007, FIBER POLYM, V8, P377, DOI 10.1007/BF02875826; Lendlein A, 2002, ANGEW CHEM INT EDIT, V41, P2034, DOI 10.1002/1521-3773(20020617)41:12<2034::AID-ANIE2034>3.0.CO;2-M; Xu W, 2010, INT J SOLIDS STRUCT, V47, P1306, DOI 10.1016/j.ijsolstr.2010.01.015; Srivastava V, 2010, J MECH PHYS SOLIDS, V58, P1100, DOI 10.1016/j.jmps.2010.04.004; Heuchel M, 2010, POLYMER, V51, P6212, DOI 10.1016/j.polymer.2010.10.051; Muller WW, 2010, EUR POLYM J, V46, P1745, DOI 10.1016/j.eurpolymj.2010.05.004; Tobushi H, 1997, J INTEL MAT SYST STR, V8, P711; Nguyen TD, 2008, J MECH PHYS SOLIDS, V56, P2792, DOI 10.1016/j.jmps.2008.04.007; Kafka V, 2008, INT J PLASTICITY, V24, P1533, DOI 10.1016/j.ijplas.2007.11.001; Arrieta S., 2014, J APPL POLYM SCI, V131, P39813; Diani J., 2006, POLYM ENG SCI, V46, P484; Lendlein A. S., 2005, ENCY MAT SCI TECHNOL, P1; Nakayama K., 1991, INT POLYM SCI TECHN, V18, pT43; Otsuka K., 1998, SHAPE MEMORY MAT; Sakai T., 2007, J SOLID MECH MAT ENG, V1, P480, DOI 10.1299/jmmp.1.480; Struik L. C. E., 1978, PHYS AGING AMORPHOUS	25	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1385-2000	1573-2738		MECH TIME-DEPEND MAT	Mech. Time-Depend. Mater.	NOV	2015	19	4					569	579		10.1007/s11043-015-9279-3		11	Mechanics; Materials Science, Characterization & Testing	Mechanics; Materials Science	CX0YO	WOS:000365423600007		
J	Saito, D; Takahashi, Y				Saito, Daisuke; Takahashi, Yoshiko			Sympatho-adrenal morphogenesis regulated by the dorsal aorta	MECHANISMS OF DEVELOPMENT			English	Article						Neural crest cells; Dorsal aorta; Sympathetic nervous system; Cell migration; Adrenal gland	NEURAL CREST MIGRATION; SYMPATHETIC-NERVOUS-SYSTEM; ADRENAL CHROMAFFIN CELLS; IN-VIVO; DIFFERENTIATION; NEURONS; GLUCOCORTICOIDS; SPECIFICATION; LINEAGE; EMBRYOS	The autonomic nervous system, composed of sympathetic-and para-sympathetic neurons, plays essential roles in a variety of physiological functions including homeostasis and responses to external stimuli. We here present an overview of recent findings concerning how the sympathetic nervous system is formed during the early development, paying particular attention to the morphogenesis of those tissues derived from migrating neural crest cells. Neural crest cells, originally multipotent, are progressively specified to sympathetic ganglia neurons and adrenomedullary cells during their migration through the body. Importantly, the dorsal aorta, the first-forming blood vessel, acts as a signaling center for their migration and differentiation. BMP signals emanating from the dorsal aorta are essential for establishing environmental cues that directly act on the migrating cells. The mechanisms underlying these early neuro-vascular interactions provide insights into understanding diseases caused by malfunctions and malformations of the autonomic nervous system. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Saito, Daisuke] Tohoku Univ, Frontier Res Inst Interdisciplinary Sci FRIS, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Takahashi, Yoshiko] Kyoto Univ, Grad Sch Sci, Dept Zool, Sakyo Ku, Kyoto 6068502, Japan; [Takahashi, Yoshiko] Japan Agcy Med Res & Dev AMED, AMED Core Res Evolut Sci & Technol AMED CREST, Chiyoda Ku, Tokyo 1000004, Japan	Takahashi, Y (reprint author), Kyoto Univ, Grad Sch Sci, Dept Zool, Sakyo Ku, Kyoto 6068502, Japan.	yotayota@develop.zool.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [22122004]; Mitsubishi Foundation; Takeda Science Foundation	We thank Dr. S. F. Gilbert and the members of Takahashi's lab for reading the manuscript and helpful discussion. This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (Grant Number 22122004) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), The Mitsubishi Foundation, and Takeda Science Foundation.	Gut P, 2005, DEVELOPMENT, V132, P4611, DOI 10.1242/dev.02052; Watanabe T, 2007, DEV BIOL, V305, P625, DOI 10.1016/j.ydbio.2007.01.042; OGAWA M, 1984, NATURE, V307, P66, DOI 10.1038/307066a0; Coffinier C, 2002, MECH DEVELOP, V119, pS179, DOI 10.1016/S0925-4773(03)00113-8; Britsch S, 1998, GENE DEV, V12, P1825, DOI 10.1101/gad.12.12.1825; ANDERSON DJ, 1991, J NEUROSCI, V11, P3507; Kelley R, 2009, J CELL BIOL, V184, P597, DOI 10.1083/jcb.200808064; Kawasaki T, 2002, DEVELOPMENT, V129, P671; Espinosa-Medina I, 2014, SCIENCE, V345, P87, DOI 10.1126/science.1253286; ANDERSON DJ, 1986, CELL, V47, P1079, DOI 10.1016/0092-8674(86)90823-8; Kasemeier-Kulesa JC, 2010, J NEUROSCI, V30, P13078, DOI 10.1523/JNEUROSCI.0892-10.2010; Reissmann E, 1996, DEVELOPMENT, V122, P2079; Jin EJ, 2001, DEV BIOL, V233, P22, DOI 10.1006/dbio.2001.0222; UNSICKER K, 1978, P NATL ACAD SCI USA, V75, P3498, DOI 10.1073/pnas.75.7.3498; Osborne NJ, 2005, DEV DYNAM, V232, P939, DOI 10.1002/dvdy.20258; Morikawa Y, 2009, DEVELOPMENT, V136, P3575, DOI 10.1242/dev.038133; Moser M, 2007, J MOL CELL CARDIOL, V43, P243, DOI 10.1016/j.yjmcc.2007.05.008; DOUPE AJ, 1985, J NEUROSCI, V5, P2119; De Bellard ME, 2003, J CELL BIOL, V162, P269, DOI 10.1083/jcb.200301041; Eickholt BJ, 1999, DEVELOPMENT, V126, P2181; Dyachuk V, 2014, SCIENCE, V345, P82, DOI 10.1126/science.1253281; Sela-Donenfeld D, 1999, DEVELOPMENT, V126, P4749; Coles E, 2004, DEVELOPMENT, V131, P5309, DOI 10.1242/dev.01419; Saito D, 2012, SCIENCE, V336, P1578, DOI 10.1126/science.1222369; Trainor PA, 2005, SEMIN CELL DEV BIOL, V16, P683, DOI 10.1016/j.semcdb.2005.06.007; Schneider C, 1999, NEURON, V24, P861, DOI 10.1016/S0896-6273(00)81033-8; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; TEILLET MA, 1974, ARCH ANAT MICROSC MO, V63, P51; Krull CE, 1997, CURR BIOL, V7, P571, DOI 10.1016/S0960-9822(06)00256-9; Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261; Huber K, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-28; Huber K, 2015, CELL TISSUE RES, V359, P333, DOI 10.1007/s00441-014-1947-0; Le Douarin N, 1999, NEURAL CREST; LEDOUARI.N, 1971, CR ACAD SCI D NAT, V272, P481; SHINODA K, 1995, DEV DYNAM, V204, P22	36	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-4773	1872-6356		MECH DEVELOP	Mech. Dev.	NOV	2015	138		1				2	7		10.1016/j.mod.2015.07.011		6	Developmental Biology	Developmental Biology	CW9MZ	WOS:000365324200002		
J	Rivera-Santiago, RF; Sriswasdi, S; Harper, SL; Speicher, DW				Rivera-Santiago, Roland F.; Sriswasdi, Sira; Harper, Sandra L.; Speicher, David W.			Probing structures of large protein complexes using zero-length cross-linking	METHODS			English	Article						Mass spectrometry; Structure; Chemical cross-linking; Zero-length cross-linking; Cross-link identification; Molecular modeling	MOBILITY-MASS SPECTROMETRY; AMINO-ACID-RESIDUES; PHOSPHOLIPASE A(2) ACTIVITY; WATER-SOLUBLE CARBODIIMIDE; HEREDITARY ELLIPTOCYTOSIS; RADIOLYTIC MODIFICATION; HYDROGEN/DEUTERIUM EXCHANGE; MOLECULAR ARCHITECTURE; PEPTIDE IDENTIFICATION; HYDROGEN-EXCHANGE	Structural mass spectrometry (MS) is a field with growing applicability for addressing complex biophysical questions regarding proteins and protein complexes. One of the major structural MS approaches involves the use of chemical cross-linking coupled with MS analysis (CX-MS) to identify proximal sites within macromolecules. Identified cross-linked sites can be used to probe novel protein-protein interactions or the derived distance constraints can be used to verify and refine molecular models. This review focuses on recent advances of "zero-length" cross-linking. Zero-length cross-linking reagents do not add any atoms to the cross-linked species due to the lack of a spacer arm. This provides a major advantage in the form of providing more precise distance constraints as the cross-linkable groups must be within salt bridge distances in order to react. However, identification of cross-linked peptides using these reagents presents unique challenges. We discuss recent efforts by our group to minimize these challenges by using multiple cycles of LC-MS/MS analysis and software specifically developed and optimized for identification of zero-length cross-linked peptides. Representative data utilizing our current protocol are presented and discussed. (C) 2015 Elsevier Inc. All rights reserved.	[Rivera-Santiago, Roland F.; Sriswasdi, Sira; Harper, Sandra L.; Speicher, David W.] Wistar Inst Anat & Biol, Ctr Syst & Computat Biol, Philadelphia, PA 19104 USA; [Rivera-Santiago, Roland F.; Sriswasdi, Sira; Harper, Sandra L.; Speicher, David W.] Wistar Inst Anat & Biol, Mol & Cellular Oncogenesis Program, Philadelphia, PA 19104 USA; [Rivera-Santiago, Roland F.; Speicher, David W.] Univ Penn, Biochem & Mol Biophys Grad Grp, Philadelphia, PA 19104 USA; [Sriswasdi, Sira] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130032, Japan	Speicher, DW (reprint author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	speicher@wistar.org			US National Institute of Health [R01HL038794, R01DK084188, P30CA010815, T32GM008275]; Philadelphia Health Care Trust Fellowship	The authors gratefully acknowledge the assistance of the Wistar Institute Proteomics Core and the expert assistance of Peter Hembach. This work was supported by the US National Institute of Health Grants R01HL038794 and R01DK084188 (to D.W.S.), P30CA010815 (NCI core Grant to the Wistar Institute), and T32GM008275 as well as a Philadelphia Health Care Trust Fellowship (to R.R.S.).	Pacholarz KJ, 2012, CHEM SOC REV, V41, P4335, DOI 10.1039/c2cs35035a; Back JW, 2001, J AM SOC MASS SPECTR, V12, P222, DOI 10.1016/S1044-0305(00)00212-9; Leitner A, 2010, MOL CELL PROTEOMICS, V9, P1634, DOI 10.1074/mcp.R000001-MCP201; GRABAREK Z, 1990, ANAL BIOCHEM, V185, P131, DOI 10.1016/0003-2697(90)90267-D; Wei H, 2014, DRUG DISCOV TODAY, V19, P95, DOI 10.1016/j.drudis.2013.07.019; Serpa JJ, 2012, EUR J MASS SPECTROM, V18, P251, DOI 10.1255/ejms.1178; Wang LW, 2011, ANAL CHEM, V83, P7234, DOI 10.1021/ac200567u; STAROS JV, 1986, ANAL BIOCHEM, V156, P220, DOI 10.1016/0003-2697(86)90176-4; Nagao R, 2010, PLANT CELL PHYSIOL, V51, P718, DOI 10.1093/pcp/pcq042; Back JW, 2003, J MOL BIOL, V331, P303, DOI 10.1016/S0022-2836(03)00721-6; Hyung SJ, 2012, PROTEOMICS, V12, P1547, DOI 10.1002/pmic.201100520; Young MM, 2000, P NATL ACAD SCI USA, V97, P5802, DOI 10.1073/pnas.090099097; El-Shafey A, 2006, PROTEIN SCI, V15, P429, DOI 10.1110/ps.051685706; Paramelle D, 2013, PROTEOMICS, V13, P438, DOI 10.1002/pmic.201200305; Lepvrier E, 2014, ANAL CHEM, V86, P10524, DOI 10.1021/ac502561e; Harper SL, 2013, BLOOD, V122, P3045, DOI 10.1182/blood-2013-02-487702; Ruotolo BT, 2008, NAT PROTOC, V3, P1139, DOI 10.1038/nprot.2008.78; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099; Monroe EB, 2013, ANAL CHEM, V85, P6185, DOI 10.1021/ac400107c; Kalkhof S, 2005, ANAL CHEM, V77, P495, DOI 10.1021/ac0487294; Singh P, 2008, ANAL CHEM, V80, P8799, DOI 10.1021/ac801646f; Poor TA, 2014, P NATL ACAD SCI USA, V111, pE2596, DOI 10.1073/pnas.1408983111; Gao QX, 2006, J BIOL CHEM, V281, P20404, DOI 10.1074/jbc.M601785200; Greber BJ, 2014, NATURE, V515, P283, DOI 10.1038/nature13895; Xu H, 2009, PROTEOMICS, V9, P1548, DOI 10.1002/pmic.200700322; Li DH, 2010, J BIOL CHEM, V285, P29535, DOI 10.1074/jbc.M110.145573; Walzthoeni T, 2013, CURR OPIN STRUC BIOL, V23, P252, DOI 10.1016/j.sbi.2013.02.008; van den Akker E, 2010, BLOOD CELL MOL DIS, V45, P1, DOI 10.1016/j.bcmd.2010.02.019; Li DH, 2008, J BIOL CHEM, V283, P1553, DOI 10.1074/jbc.M706981200; Zhu WH, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/840518; Nahnsen S, 2013, MOL CELL PROTEOMICS, V12, P549, DOI 10.1074/mcp.R112.025163; Wu Y, 2009, BIOCHEM J, V419, P669, DOI 10.1042/BJ20082061; Frank AM, 2007, J PROTEOME RES, V6, P114, DOI 10.1021/pr060271u; Merkley Eric D., 2013, Journal of Structural and Functional Genomics, V14, P77, DOI 10.1007/s10969-013-9160-z; Schmidt A, 2005, EUR J MASS SPECTROM, V11, P525, DOI 10.1255/ejms.748; Yan YT, 2014, J AM SOC MASS SPECTR, V25, P2084, DOI 10.1007/s13361-014-0993-x; Rahaman H, 2012, BIOCHEMISTRY-US, V51, P5521, DOI 10.1021/bi300380h; Sinz A, 2006, MASS SPECTROM REV, V25, P663, DOI 10.1002/mas.20082; Gotze M, 2012, J AM SOC MASS SPECTR, V23, P76, DOI 10.1007/s13361-011-0261-2; Xu GZ, 2003, ANAL CHEM, V75, P6995, DOI 10.1021/ac035104h; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Kiselar JG, 2010, J MASS SPECTROM, V45, P1373, DOI 10.1002/jms.1808; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Baines AJ, 2009, BIOCHEM SOC T, V37, P796, DOI 10.1042/BST0370796; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Back JW, 2002, ANAL CHEM, V74, P4417, DOI 10.1021/ac0257492; Budayeva HG, 2014, ADV EXP MED BIOL, V806, P263, DOI 10.1007/978-3-319-06068-2_11; Choi I, 2012, CURR TOP MEMBR, V70, P77, DOI 10.1016/B978-0-12-394316-3.00003-X; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Bumpus NN, 2010, J INORG BIOCHEM, V104, P485, DOI 10.1016/j.jinorgbio.2009.12.017; Liu HJ, 2011, P NATL ACAD SCI USA, V108, P18536, DOI 10.1073/pnas.1111597108; Xu GZ, 2005, ANAL CHEM, V77, P2437, DOI 10.1021/ac0484629; Harper SL, 2010, J BIOL CHEM, V285, P11003, DOI 10.1074/jbc.M109.083048; Vahidi S, 2013, ANAL CHEM, V85, P8618, DOI 10.1021/ac401148z; Konermann L, 2011, CHEM SOC REV, V40, P1224, DOI 10.1039/c0cs00113a; Sriswasdi S, 2014, P NATL ACAD SCI USA, V111, P1801, DOI 10.1073/pnas.1317620111; Park CY, 2008, J PROTEOME RES, V7, P3022, DOI 10.1021/pr800127y; GALLAGHER PG, 1992, J CLIN INVEST, V89, P892, DOI 10.1172/JCI115669; Maleknia SD, 2014, CHEM SOC REV, V43, P3244, DOI 10.1039/c3cs60432b; Leitner A, 2012, STRUCTURE, V20, P814, DOI 10.1016/j.str.2012.03.007; GleleKakai C, 1996, BRIT J HAEMATOL, V95, P57, DOI 10.1046/j.1365-2141.1996.d01-1869.x; Hirai T, 2011, BIOCHEM CELL BIOL, V89, P148, DOI [10.1139/o10-160, 10.1139/O10-160]; Sriswasdi S, 2014, J PROTEOME RES, V13, P898, DOI 10.1021/pr400953w; Lanucara F, 2014, NAT CHEM, V6, P281, DOI [10.1038/nchem.1889, 10.1038/NCHEM.1889]; Xu GZ, 2004, ANAL CHEM, V76, P1213, DOI 10.1021/ac035422g; Singh P, 2013, J MOL BIOL, V425, P3378, DOI 10.1016/j.jmb.2013.06.026; Manevich Y, 2007, J LIPID RES, V48, P2306, DOI 10.1194/jlr.M700299-JLR200; Bruce JE, 2012, PROTEOMICS, V12, P1565, DOI 10.1002/pmic.201100516; FASOLD H, 1971, ANGEW CHEM INT EDIT, V10, P795, DOI 10.1002/anie.197107951; Choi HJ, 1998, NAT STRUCT BIOL, V5, P400, DOI 10.1038/nsb0598-400; Konijnenberg A, 2013, BBA-PROTEINS PROTEOM, V1834, P1239, DOI 10.1016/j.bbapap.2012.11.013; Herzog F, 2012, SCIENCE, V337, P1348, DOI 10.1126/science.1221483; Rappsilber J, 2011, J STRUCT BIOL, V173, P530, DOI 10.1016/j.jsb.2010.10.014; Haladova K, 2012, J STRUCT BIOL, V179, P10, DOI 10.1016/j.jsb.2012.04.016; Wang GB, 2013, P NATL ACAD SCI USA, V110, P20087, DOI 10.1073/pnas.1315029110; Chen ZA, 2010, EMBO J, V29, P717, DOI 10.1038/emboj.2009.401; Manevich Y, 2005, FREE RADICAL BIO MED, V38, P1422, DOI 10.1016/j.freeradbiomed.2005.02.011; Hojrup P., 1990, ION FORMATION ORGANI, P61; Kao AH, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002212; Marekov L.N., 2007, CURR PROTOC PROTEIN, V19, P16; Mcllwain S., 2010, J PROTEOME RES, V9, P2488; Olson A.L., 2014, STRUCTURE; Pan C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-118; Petrotchenko E.V., 2011, MOL CELL PROTEOMICS, V10, DOI DOI 10.1074/MCP.M110.001420; Rivera-Santiago R., 2015, BIOCHEM, V1; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Stengel F., 2012, MOL CELL PROTEOMICS, V11, pR111, DOI DOI 10.1074/MCP.R111.014027; Zybailov B. L., 2013, J PROTEOM BIOINFORM, V6, P001	89	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1046-2023	1095-9130		METHODS	Methods	NOV 1	2015	89						99	111		10.1016/j.ymeth.2015.04.031		13	Biochemical Research Methods; Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CW5UT	WOS:000365062800013		
J	Bazhenov, MS; Divashuk, MG; Amagai, Y; Watanabe, N; Karlov, GI				Bazhenov, M. S.; Divashuk, M. G.; Amagai, Y.; Watanabe, N.; Karlov, G. I.			Isolation of the dwarfing Rht-B1p (Rht17) gene from wheat and the development of an allele-specific PCR marker	MOLECULAR BREEDING			English	Article						DELLA protein; Diagnostic PCR marker; GA-insensitive; Reduced height; Rht17; Rht-B1p	HEIGHT GENES; DOMINANT; LENGTH; DELLA	Plant height is one of the most important traits of wheat because it influences lodging resistance, harvest index and yield. Reduced height of wheat is achieved mainly by the introduction of Rht-B1b (Rht1), Rht-B1e (Rht11) or Rht-D1b (Rht2) dwarfing genes, which produce mutant DELLA proteins that constitutively restrain plant growth irrespective of gibberellin hormone level. The exploration of new variations of these genes is necessary for plant breeding purposes. A set of alleles with various degrees of height reduction may be useful for optimization of wheat plant height in different environments. Also, new alleles may give different pleiotropic effects on other important traits, as leaf area, coleoptile length, disease resistance and preharvest sprouting tolerance. In the present work, we discovered a new allelic variation at the Rht-B1 locus in the 'Chris Mutant' bread wheat line that carries the Rht17 gene. The Rht-B1 gene from the Chris Mutant line was cloned and sequenced. The alignment showed an C-to-T substitution at a position 178 nucleotides from the start codon that created a stop codon in the DELLA domain. We designated the new allele as RhtB1p and developed a diagnostic PCR marker for its identification. As a result of crossing and segregation analysis, we showed that Rht-B1p reduced plant height by approximately 30 and 50 % in bread wheat and durum wheat, respectively, under greenhouse conditions. We concluded that Rht-B1p was identical to the earlier identified gene Rht17.	[Bazhenov, M. S.; Divashuk, M. G.; Karlov, G. I.] Russian State Agr Univ MTAA, Ctr Mol Biotechnol, Moscow 127550, Russia; [Amagai, Y.; Watanabe, N.] Ibaraki Univ, Coll Agr, Inashiki, Ibaraki 3000393, Japan	Karlov, GI (reprint author), Russian State Agr Univ MTAA, Ctr Mol Biotechnol, Timiryazevskaya St 49, Moscow 127550, Russia.	karlovg@gmail.com	Karlov, Gennady/F-7403-2013	Karlov, Gennady/0000-0002-9016-103X			Wen W, 2013, J EXP BOT, V64, P3299, DOI 10.1093/jxb/ert183; HEINER RE, 1974, CROP SCI, V14, P342; Pearce S, 2011, PLANT PHYSIOL, V157, P1820, DOI 10.1104/pp.111.183657; Liang D, 2010, EUPHYTICA, V172, P235, DOI 10.1007/s10681-009-0054-x; Ellis MH, 2002, THEOR APPL GENET, V105, P1038, DOI 10.1007/s00122-002-1048-4; Divashuk MG, 2012, RUSS J GENET+, V48, P761, DOI 10.1134/S1022795412050055; Daviere JM, 2013, DEVELOPMENT, V140, P1147, DOI 10.1242/dev.087650; MESSING J, 1983, METHOD ENZYMOL, V101, P20; Li AX, 2012, MOL BREEDING, V30, P1443, DOI 10.1007/s11032-012-9730-y; Srinivasachary, 2008, THEOR APPL GENET, V116, P1145, DOI 10.1007/s00122-008-0742-2; PEPE JF, 1975, CROP SCI, V15, P637; Knopf C, 2008, CEREAL RES COMMUN, V36, P553, DOI 10.1556/CRC.36.2008.4.4; Srinivasachary, 2009, THEOR APPL GENET, V118, P695, DOI 10.1007/s00122-008-0930-0; Rebetzke GJ, 2001, AUST J AGR RES, V52, P1221, DOI 10.1071/AR01042; KING RW, 1983, ANN BOT-LONDON, V51, P201; Ellis MH, 2004, FUNCT PLANT BIOL, V31, P583, DOI 10.1071/FP03207; Divashuk MG, 2013, EUPHYTICA, V190, P137, DOI 10.1007/s10681-012-0789-7; Li YY, 2012, NEW PHYTOL, V196, P282, DOI 10.1111/j.1469-8137.2012.04243.x; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Wu J, 2011, PLANT PHYSIOL, V157, P2120, DOI 10.1104/pp.111.185272; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Gasperini D, 2012, J EXP BOT, V63, P4419, DOI 10.1093/jxb/ers138; Gale M D, 1985, PROGR PLANT BREEDING, V1, P1; Gent M.P., 1997, J CROP PROD, V1, P27, DOI DOI 10.1300/J144V01N01_; Hirsch Sibylle, 2009, Plant Signal Behav, V4, P698; Konzak C. F., 1987, Wheat and wheat improvement., P428; McDonald J. H., 2014, HDB BIOL STAT; Mohd-Yusoff NF, 2015, G3-GENES GENOM GENET, V5, P559, DOI 10.1534/g3.114.014571; Nicholas KB, 1997, GENEDOC TOOL EDITING; Tan MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069690; Zanke CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113287	31	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1380-3743	1572-9788		MOL BREEDING	Mol. Breed.	NOV	2015	35	11							213	10.1007/s11032-015-0407-1		8	Agronomy; Plant Sciences; Genetics & Heredity; Horticulture	Agriculture; Plant Sciences; Genetics & Heredity	CW7ML	WOS:000365183200012		
J	Nakamura, S; Osaka, H; Muramatsu, S; Aoki, S; Jimbo, EF; Yamagata, T				Nakamura, Sachie; Osaka, Hitoshi; Muramatsu, Shinichi; Aoki, Shiho; Jimbo, Eriko F.; Yamagata, Takanori			Mutational and functional analysis of Glucose transporter I deficiency syndrome	MOLECULAR GENETICS AND METABOLISM			English	Article						Glucose transporter I deficiency; syndrome (GLIM-DS); GLUT1; SLC2A1; Functional assay; 2-deoxyglucose uptake	CRYSTAL-STRUCTURE; UPTAKE ASSAY; GLUT1; SPECTRUM	Objective: We investigated a correlation between a mutation in the SLC2A1 gene and functional disorders in Glucose transporter I deficiency syndrome (GLUT1DS). Methods: We performed direct sequence analysis of SLC2A1 in a severe GLUT1DS patient and identified a novel frame shift mutation, c.906_907insG, p.V303fs. We created a plasmid vector carrying the c.906_907insG mutation, as well as A405D or R333W in the SLC2A1, which are found in patients with mild and moderate GLUT1DS severity, respectively. We transiently expressed these mutants and wild type SLC2A1 plasmids in a human embryonic kidney cell line (HEK293), and performed immunoblotting, immunofluorescence, and enzymatic photometric 2-deoxyglucose (2DG) uptake assays. Results: GLUT1 was not detected after transient expression of the SLC2A1 plasmid carrying c.906_907insG by either immunoblotting or immunofluorescence. The degree of glucose transport reduction as determined by enzymatic photometric 2DG assay uptake correlated with disease severity. Conclusions: Enzymatic photometric 2DG uptake study appears to be a suitable functional assay to predict the effect of SLC2A1 mutations on GLUT1 transport. (C) 2015 Elsevier Inc. All rights reserved.	[Nakamura, Sachie; Osaka, Hitoshi; Aoki, Shiho; Jimbo, Eriko F.; Yamagata, Takanori] Jichi Med Univ, Dept Pediat, Shimotsuke, Tochigi, Japan; [Muramatsu, Shinichi] Jichi Med Univ, Div Neurol, Shimotsuke, Tochigi, Japan; [Muramatsu, Shinichi] Univ Tokyo, Inst Med Sci, Ctr Gene & Cell Therapy, Tokyo 1138654, Japan	Osaka, H (reprint author), Jichi Med Sch, Dept Pediat, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	hosaka@jichi.ac.jp			Project for Health Research on Infants, Children, Adolescents, and Young Adults from Agency of Medical Research and Development	This work was supported by a grant for the Project for Health Research on Infants, Children, Adolescents, and Young Adults from the Agency of Medical Research and Development. I would like to thank Keiko Yanagihara for the study of 3-0MG uptake in the patient's erythrocytes.	Klepper J, 2007, DEV MED CHILD NEUROL, V49, P707; Klepper J, 1999, J CLIN LAB ANAL, V13, P116, DOI 10.1002/(SICI)1098-2825(1999)13:3<116::AID-JCLA5>3.0.CO;2-C; Wang D, 2005, ANN NEUROL, V57, P111, DOI 10.1002/ana.20331; Fujii T, 2007, BRAIN DEV-JPN, V29, P92, DOI 10.1016/j.j.braindev.2006.07.007; Wong HY, 2007, MOL GENET METAB, V90, P193, DOI 10.1016/j.ymgme.2006.09.002; Rotstein M, 2010, ANN NEUROL, V68, P955, DOI 10.1002/ana.22088; Wang D, 2001, ANN NEUROL, V50, pS124; Leen WG, 2010, BRAIN, V133, P655, DOI 10.1093/brain/awp336; HELLWIG B, 1991, MOL PHARMACOL, V40, P383; Saito K, 2011, ANAL BIOCHEM, V412, P9, DOI 10.1016/j.ab.2011.01.022; De Giorgis V, 2013, SEIZURE-EUR J EPILEP, V22, P803, DOI 10.1016/j.seizure.2013.07.003; Marin-Valencia I, 2012, NEUROBIOL DIS, V48, P92, DOI 10.1016/j.nbd.2012.04.011; Yang H, 2011, ANN NEUROL, V70, P996, DOI 10.1002/ana.22640; Takahashi S, 2008, EPILEPSY RES, V80, P18, DOI 10.1016/j.eplepsyres.2008.03.010; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; Deng D, 2014, NATURE, V510, P121, DOI 10.1038/nature13306; Ito Y., 2014, BRAIN DEV; Leen WG, 2014, J NEUROL, V261, P589, DOI 10.1007/s00415-014-7240-z; Pearson TS, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0342-7	19	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1096-7192	1096-7206		MOL GENET METAB	Mol. Genet. Metab.	NOV	2015	116	3					157	162		10.1016/j.ymgme.2015.08.006		6	Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental	Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine	CW4TE	WOS:000364984200009		
J	Yamada, K; Kobayashi, H; Bo, R; Takahashi, T; Hasegawa, Y; Nakamura, M; Ishige, N; Yamaguchi, S				Yamada, Kenji; Kobayashi, Hironori; Bo, Ryosuke; Takahashi, Tomoo; Hasegawa, Yuki; Nakamura, Makoto; Ishige, Nobuyuki; Yamaguchi, Seiji			Elevation of pivaloylcarnitine by sivelestat sodium in two children	MOLECULAR GENETICS AND METABOLISM			English	Article						Sivelestat sodium; Antibiotics containing pivalic acid; Pivaloylcarnitine; Isovaleric acidemia; Tandem mass spectrometry; Newborn screening	TANDEM MASS-SPECTROMETRY; SHORT-TERM TREATMENT; PIVALIC ACID; CARNITINE HOMEOSTASIS; PRODRUG	Background: Sivelestat sodium (sivelestat), a neutrophil elastase inhibitor, is used to treat acute respiratory distress syndrome (ARDS). We report two cases that developed elevated C5-acylcarnitine (C5-AC) levels following treatment with sivelestat Case 1 was a 14-day-old female infant born at 25 weeks and 1 day of gestation who was treated with sivelestat for the prophylaxis of Wilson-Mikity syndrome soon after birth. Isovaleric acidemia (WA) was suspected based on a newborn screening using tandem mass spectrometry (MS/MS). Her C5-AC level was elevated to 4.49 mu M (cut-off, <1.0) after treatment with sivelestat Case 2 was a 4-year-old female with pneumocystis pneumonia that developed during chemotherapy for disseminated medulloblastoma. Sivelestat was given for the complication of ARDS. Her C5-AC level increased (1.09 mu M) after eight days of treatment with sivelestat Results: In both cases, IVA was ruled out because isovalerylglycine was not observed in the urinary organic acid analysis. Case 1 was associated with carnitine deficiency (CO 9.16 mu M; reference value, 10-60). Liquid chromatography-MS/MS confirmed elevated pivaloylcarnitine (PVC) in both cases. Discussion: Similar to antibiotics containing pivalic acid (PVA), sivelestat contains PVA, which has the potential to cause secondary camitine deficiency. In addition, elevated PVC can lead to false positive findings of IVA in newborns screened using MS/MS. (C) 2015 Elsevier Inc. All rights reserved.	[Yamada, Kenji; Kobayashi, Hironori; Bo, Ryosuke; Takahashi, Tomoo; Hasegawa, Yuki; Yamaguchi, Seiji] Shimane Univ, Dept Pediat, Fac Med, Izumo, Shimane 6938501, Japan; [Bo, Ryosuke] Kobe Univ, Grad Sch Med, Dept Pediat, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Nakamura, Makoto] Okayama Med Ctr, Dept Neonatol, Kita Ku, Okayama 7011192, Japan; [Ishige, Nobuyuki] Tokyo Hlth Serv Assoc, Shinjuku Ku, Tokyo 1628402, Japan	Yamada, K (reprint author), Shimane Univ, Dept Pediat, Fac Med, 89-1 Enya Cho, Izumo, Shimane 6938501, Japan.	k-yamada@med.shimane-u.ac.jp		Kobayashi, Hironori/0000-0001-9091-3521; Yamada, Kenji/0000-0002-0738-7960	Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labor and Welfare of Japan	This report was partially supported by grants from the Ministry of Education, Culture, Sports, Science and Technology (S.Y. and K.Y.) and the Ministry of Health, Labor and Welfare (S.Y.) of Japan.	Makino Y, 2007, PEDIATRICS, V120, pE739, DOI 10.1542/peds.2007-0339; HOLME E, 1992, SCAND J CLIN LAB INV, V52, P361, DOI 10.3109/00365519209088371; Janzen N, 2013, CLIN CHIM ACTA, V421, P41, DOI 10.1016/j.cca.2013.03.001; Shigematsu Y, 1999, J CHROMATOGR B, V731, P97, DOI 10.1016/S0378-4347(99)00111-5; Boemer F, 2014, MOL GENET METAB, V111, P52, DOI 10.1016/j.ymgme.2013.11.005; ITO T, 1995, TOHOKU J EXP MED, V175, P43, DOI 10.1620/tjem.175.43; Abdenur JE, 1998, J INHERIT METAB DIS, V21, P624, DOI 10.1023/A:1005424331822; Sakuma T, 1998, EUR J PHARMACOL, V353, P273, DOI 10.1016/S0014-2999(98)00412-9; Paglia G, 2008, RAPID COMMUN MASS SP, V22, P3809, DOI 10.1002/rcm.3799; Brass EP, 2003, CLIN PHARMACOL THER, V73, P338, DOI 10.1016/S0009-9236(02)17636-3; HOLME E, 1989, LANCET, V2, P469; Forni S, 2010, MOL GENET METAB, V101, P25, DOI 10.1016/j.ymgme.2010.05.012; Kikuchi Toshihiro, 2006, J Anesth, V20, P355, DOI 10.1007/s00540-006-0435-4; Stiehm ER, 1980, IMMUNOLOGICAL DISORD	14	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1096-7192	1096-7206		MOL GENET METAB	Mol. Genet. Metab.	NOV	2015	116	3					192	194		10.1016/j.ymgme.2015.09.009		3	Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental	Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine	CW4TE	WOS:000364984200014		
J	Komine, O; Yamanaka, K				Komine, Okiru; Yamanaka, Koji			Neuroinflammation in motor neuron disease	NAGOYA JOURNAL OF MEDICAL SCIENCE			English	Review						neuroinflammation; glia; ALS; neurodegenerative disease	AMYOTROPHIC-LATERAL-SCLEROSIS; TRANSGENIC MOUSE MODEL; WILD-TYPE MICROGLIA; FAMILIAL ALS; MUTANT SOD1; EXTEND SURVIVAL; SUPEROXIDE-DISMUTASE; INHERITED ALS; UP-REGULATION; SPINAL-CORDS	Increasing evidence suggests that the pathogenesis of neurodegenerative diseases including amyotrophic lateral sclerosis (ALS) is not restricted to the neurons but attributed to the abnormal interactions of neurons and surrounding glial and lymphoid cells. These findings led to the concept of non-cell autonomous neurodegeneration. Neuroinflammation, which is mediated by activated glial cells and infiltrated lymphocytes and accompanied by the subsequent production of proinflammatory cytokines and neurotoxic or neuroprotective molecules, is characteristic to the pathology in ALS and is a key component for non-cell autonomous neurodegeneration. This review covers the involvement of microglia and astrocytes in the ALS mouse models and human ALS, and it also covers the deregulated pathways in motor neurons, which are involved in initiating the disease. Based on the cell-type specific pathomechanisms of motor neuron disease, targeting of neuroinflammation could lead to future therapeutic strategies for ALS and could be potentially applied to other neurodegenerative diseases.	[Komine, Okiru; Yamanaka, Koji] Nagoya Univ, Environm Med Res Inst, Dept Neurosci & Pathobiol, Nagoya, Aichi 4648601, Japan	Yamanaka, K (reprint author), Nagoya Univ, Environm Med Res Inst, Dept Neurosci & Pathobiol, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	kojiyama@riem.nagoya-u.ac.jp			Ministry for Education, Culture, and Sports, Science and Technology of Japan [23111006, 26293208, 26830046]; Japan Agency for Medical Research and Development; AMED; Daiko Foundation; Uehara Memorial Foundation	This work was partly supported by Grants-in-Aid for Scientific Research on Innovative Areas (23111006), Scientific Research (B) (26293208), and Young Scientists (B) (26830046) and from the Ministry for Education, Culture, and Sports, Science and Technology of Japan, Grant-in-Aid for Research on rare and intractable diseases, the Research Committee on Establishment of Novel Treatments for Amyotrophic Lateral Sclerosis, from Japan Agency for Medical Research and Development, AMED, Daiko Foundation, and Uehara Memorial Foundation.	Zhao WH, 2010, GLIA, V58, P231, DOI 10.1002/glia.20919; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Yoshihara T, 2002, J NEUROCHEM, V80, P158, DOI 10.1046/j.0022-3042.2001.00683.x; Tsuiji H, 2013, EMBO MOL MED, V5, P221, DOI 10.1002/emmm.201202303; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Serio A, 2013, P NATL ACAD SCI USA, V110, P4697, DOI 10.1073/pnas.1300398110; Almer G, 1999, J NEUROCHEM, V72, P2415, DOI 10.1046/j.1471-4159.1999.0722415.x; Yang CX, 2014, P NATL ACAD SCI USA, V111, pE1121, DOI 10.1073/pnas.1322641111; Haidet-Phillips AM, 2011, NAT BIOTECHNOL, V29, P824, DOI [10.1038/nbt.1957, 10.1038/nbt1957]; Vargas MR, 2008, J NEUROSCI, V28, P13574, DOI 10.1523/JNEUROSCI.4099-08.2008; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Hensley K, 2003, NEUROBIOL DIS, V14, P74, DOI 10.1016/S0969-9961(03)00087-1; Jaarsma D, 2008, J NEUROSCI, V28, P2075, DOI 10.1523/JNEUROSCI.5258-07.2008; Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107; Pesiridis GS, 2009, HUM MOL GENET, V18, pR156, DOI 10.1093/hmg/ddp303; Alexianu ME, 2001, NEUROLOGY, V57, P1282; Austin JA, 2014, P NATL ACAD SCI USA, V111, P4309, DOI 10.1073/pnas.1317317111; Pramatarova A, 2001, J NEUROSCI, V21, P3369; Chhor V, 2013, BRAIN BEHAV IMMUN, V32, P70, DOI 10.1016/j.bbi.2013.02.005; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Tong JB, 2013, EMBO J, V32, P1917, DOI 10.1038/emboj.2013.122; Xiao Q, 2007, J NEUROCHEM, V102, P2008, DOI 10.1111/j.1471-4159.2007.04677.x; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Turner MR, 2004, NEUROBIOL DIS, V15, P601, DOI 10.1016/j.ndb.2003.12.012; Beers DR, 2008, P NATL ACAD SCI USA, V105, P15558, DOI 10.1073/pnas.0807419105; Lee EB, 2012, NAT REV NEUROSCI, V13, P38, DOI 10.1038/nrn3121; Koval ED, 2013, HUM MOL GENET, V22, P4127, DOI 10.1093/hmg/ddt261; Benatar M, 2007, NEUROBIOL DIS, V26, P1, DOI 10.1016/j.nbd.2006.12.015; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Marchetto MCN, 2008, CELL STEM CELL, V3, P649, DOI 10.1016/j.stem.2008.10.001; Kang J, 2007, J CELL BIOL, V179, P1219, DOI 10.1083/jcb.200705046; Wang LJ, 2009, NEUROBIOL DIS, V35, P234, DOI 10.1016/j.nbd.2009.05.002; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Ekestern E, 2004, NEURODEGENER DIS, V1, P88, DOI 10.1159/000080049; Lino MM, 2002, J NEUROSCI, V22, P4825; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Frakes AE, 2014, NEURON, V81, P1009, DOI 10.1016/j.neuron.2014.01.013; Miller TM, 2006, P NATL ACAD SCI USA, V103, P19546, DOI 10.1073/pnas.0609411103; ENGELHARDT JI, 1990, ARCH NEUROL-CHICAGO, V47, P1210; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Henkel JS, 2009, J NEUROIMMUNE PHARM, V4, P389, DOI 10.1007/s11481-009-9171-5; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Yamanaka K, 2008, P NATL ACAD SCI USA, V105, P7594, DOI 10.1073/pnas.0802556105; Henkel JS, 2013, EMBO MOL MED, V5, P64, DOI 10.1002/emmm.201201544; Trumbull KA, 2012, NEUROBIOL DIS, V45, P137, DOI 10.1016/j.nbd.2011.07.015; Watanabe S, 2013, J BIOL CHEM, V288, P3641, DOI 10.1074/jbc.M112.433615; Takeuchi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021050; Lepore AC, 2008, NAT NEUROSCI, V11, P1294, DOI 10.1038/nn.2210; Re DB, 2014, NEURON, V81, P1001, DOI 10.1016/j.neuron.2014.01.011; Haidet-Phillips AM, 2013, EXP NEUROL, V250, P250, DOI 10.1016/j.expneurol.2013.10.004; Fray AE, 1998, EUR J NEUROSCI, V10, P2481, DOI 10.1046/j.1460-9568.1998.00273.x; Harraz MM, 2008, J CLIN INVEST, V118, P659, DOI 10.1172/JCI34060; Wang LJ, 2011, HUM MOL GENET, V20, P286, DOI 10.1093/hmg/ddq463; Philips T, 2011, LANCET NEUROL, V10, P253, DOI 10.1016/S1474-4422(11)70015-1; Pehar M, 2004, J NEUROCHEM, V89, P464, DOI 10.1111/j.1471-4159.2004.02357.x; Turner BJ, 2008, PROG NEUROBIOL, V85, P94, DOI 10.1016/j.pneurobio.2008.01.001; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Lobsiger CS, 2009, P NATL ACAD SCI USA, V106, P4465, DOI 10.1073/pnas.0813339106; Swarup V, 2011, J EXP MED, V208, P2429, DOI 10.1084/jem.20111313; Kang SH, 2013, NAT NEUROSCI, V16, P571, DOI 10.1038/nn.3357; Chiu IM, 2008, P NATL ACAD SCI USA, V105, P17913, DOI 10.1073/pnas.0804610105; Endo F, 2015, CELL REP, V11, P592, DOI 10.1016/j.celrep.2015.03.053; ENGELHARDT JI, 1993, ARCH NEUROL-CHICAGO, V50, P30; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Ludolph AC, 2010, AMYOTROPH LATERAL SC, V11, P38, DOI 10.3109/17482960903545334; Elliott JL, 2001, MOL BRAIN RES, V95, P172, DOI 10.1016/S0169-328X(01)00242-X; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Nishihira Y, 2008, ACTA NEUROPATHOL, V116, P169, DOI 10.1007/s00401-008-0385-z; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; D'Ambrosi N, 2009, J IMMUNOL, V183, P4648, DOI 10.4049/jimmunol.0901212; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Banerjee R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002740; Butovsky O, 2015, ANN NEUROL, V77, P75, DOI 10.1002/ana.24304; Lasiene J., 2011, NEUROL RES INT, V2011, DOI DOI 10.1155/2011/718987; Mesci P, 2015, BRAIN, V138, P53, DOI 10.1093/brain/awu312; Watanabe S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.459; Watanabe S, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0062-1	82	0	0	NAGOYA UNIV, SCH MED	NAGOYA	EDITORIAL OFF, NAGOYA UNIV MED LIB, SCH MED, 65 TSURUMAI-CHO SHOWA- KU, NAGOYA, 466-8550, JAPAN	2186-3326	0027-7622		NAGOYA J MED SCI	Nagoya J. Med. Sci.	NOV	2015	77	4					537	549				13	Medicine, Research & Experimental	Research & Experimental Medicine	CX0VP	WOS:000365415600001		
J	Osmani, AK; Reyer, JA; Osmani, AR; Hamajima, N				Osmani, Ahmad Kamran; Reyer, Joshua A.; Osmani, Ahmad Reshad; Hamajima, Nobuyuki			Factors influencing contraceptive use among women in Afghanistan: secondary analysis of Afghanistan Health Survey 2012	NAGOYA JOURNAL OF MEDICAL SCIENCE			English	Article						contraceptive use; family planning; married women; Afghanistan	PAKISTAN; CHOICE; TURKEY	The increase in contraceptive use in Afghanistan has been frustratingly slow from 7.0% in 2003 to 11.3% in 2012. Data on contraceptive use and influencing factors were obtained from Afghanistan Health Survey (AHS) 2012, which had been collected through interview-led questionnaire from 13,654 current married women aged 12-49 years. Odds ratio (OR) and 95% confidence interval (CI) of contraceptive use were estimated by logistic regression analysis. When adjusted for age, residence, region, education, media, and wealth index, significant OR was obtained for parity (OR of 6 or more children relative to 1 child was 3.45, and the 95% CI 2.54-4.69), number of living sons (OR of 5 or more sons relative to no son was 2.48, and the 95% CI 1.86-3.29), wealth index (OR of the richest households relative to the poorest households was 2.14, and the 95% CI 1.72-2.67), antenatal care attendance (OR relative to no attendance was 2.13, and the 95% CI 1.74-2.62), education (OR of secondary education or above relative to no education was 1.62, and the 95% CI 1.26-2.08), media exposure (OR of at least some exposure to electronic media relative to no exposure was 1.15, and the 95% CI 1.01-1.30), and child mortality experience (OR was 0.88, and the 95% CI 0.77-0.99), as well as age, residence (rural/urban), and region. This secondary analysis based on AHS 2012 showed the findings similar to those from the previous studies in other developing countries. Although the unique situation in Afghanistan should be considered to promote contraceptive use, the background may be common among the areas with low contraceptive use.	[Osmani, Ahmad Kamran] Jhpiego, Family Planning Maternal Newborn & Child Hlth Pro, Kabul, Afghanistan; [Reyer, Joshua A.; Hamajima, Nobuyuki] Nagoya Univ, Grad Sch Med, Dept Healthcare Adm, Nagoya, Aichi 4668550, Japan; [Osmani, Ahmad Reshad] Univ Memphis, Fogelman Coll Business & Econ, Hlth Econ, Memphis, TN 38152 USA	Reyer, JA (reprint author), Nagoya Univ, Grad Sch Med, Dept Healthcare Adm, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	reyer@med.nagoya-u.ac.jp					Afghanistan Central Statistics Office, AFGH MULT CLUST IND; Ali AA, BMC PUBLIC HLTH, V201, P102; Jayaraman A, 2009, INT PERSPECT SEX R H, V35, P29, DOI 10.1363/ifpp.35.029.09; Beekle AT, 2006, INT NURS REV, V53, P269, DOI 10.1111/j.1466-7657.2006.00492.x; Casterline JB, 2001, STUD FAMILY PLANN, V32, P95, DOI 10.1111/j.1728-4465.2001.00095.x; Alpu O, 2006, EUR J CONTRACEP REPR, V11, P228, DOI 10.1080/13625180600766032; Saleem A, 2008, EUR J CONTRACEP REPR, V13, P83, DOI 10.1080/01443610701577107; Ertem M, 2001, EUR J CONTRACEP REPR, V6, P1; Fikree F, INT FAM PLANN PERSPE, V27, P130; Hailemariam A, 2011, ETHIOP J HLTH SCI, V121, P121; Mahgoub Y M, 1994, Egypt Popul Fam Plann Rev, V28, P104; Mahmood N, 1996, Pak Dev Rev, V35, P1; Martin E, 2013, AFR J REPROD HEALTH, V17, P91; Ministry of Public Health of Afghanistan, HLTH NUTR SECT STRAT; Ministry of Public Health of Afghanistan, NAT REPR HLTH STRAT; Monitoring and Evaluation Department of Ministry of Public Health John Hopkins University Indian Institute of Health Management Research, AFGH HLTH SURV 2012; Retherford RD, 1997, NATL FAM HLTH SURV B, V7, P1; Taiwan ET, 1997, J BIOSOC SCI, V29, P141; Tehrani FR, 2001, FAM PRACT, V18, P204, DOI 10.1093/fampra/18.2.204; United Nation Department of Economic and Social Affairs Population Division, WRLD CONTR PATT 201; World Health Organization, 2013, FAM PLANN FACT SHEET	21	0	0	NAGOYA UNIV, SCH MED	NAGOYA	EDITORIAL OFF, NAGOYA UNIV MED LIB, SCH MED, 65 TSURUMAI-CHO SHOWA- KU, NAGOYA, 466-8550, JAPAN	2186-3326	0027-7622		NAGOYA J MED SCI	Nagoya J. Med. Sci.	NOV	2015	77	4					551	561				11	Medicine, Research & Experimental	Research & Experimental Medicine	CX0VP	WOS:000365415600002		
J	Sato, K; Kajihara, T; Miki, A; Hirabayashi, E; Shintani, D; Niitsu, M; Ishihara, O; Itakura, A				Sato, Kazuko; Kajihara, Takeshi; Miki, Akinori; Hirabayashi, Eriko; Shintani, Daisuke; Niitsu, Mamoru; Ishihara, Osamu; Itakura, Atsuo			Differential diagnosis of pelvic cystic lesions caused by hemorrhage from inflammatory abscess using CT attenuation in women with acute abdomen	NAGOYA JOURNAL OF MEDICAL SCIENCE			English	Article						abscess; acute abdomen; CT attenuation; hematoma; differential diagnosis	COMPUTED-TOMOGRAPHY; PAIN	To determine the efficacy of computed tomography (CT) attenuation of cystic lesions measured on an image browsing system to distinguish abscess from hematoma in women with acute abdomen. The medical records of female patients of reproductive age with acute abdomen who were treated over a 7-year period in a single center and who had undergone laparotomy or laparoscopic surgery and preoperative pelvic CT scanning were retrospectively analyzed to identify those with hematoma or abscess cyst formation. Nineteen patients with tubo-ovarian abscess (abscess group) and six patients with hematoma (hematoma group) formation in the pelvis were included in the analysis. The preoperative CT images of the tubo-ovarian cyst were retrospectively investigated on the basis of cyst attenuation. CT attenuation of the cyst measured by both two gynecologists could be used to clearly distinguish inflammatory disease with abscess formation from bleeding disease with hematoma. CT attenuation on a picture archiving and communication system can distinguish hematoma from abscess in women with acute abdomen. This may significantly contribute to making differential diagnosis without interpretation by a medical radiologist.	[Sato, Kazuko; Kajihara, Takeshi; Miki, Akinori; Hirabayashi, Eriko; Shintani, Daisuke; Ishihara, Osamu] Saitama Med Univ, Fac Med, Dept Obstet & Gynecol, Iruma, Saitama, Japan; [Niitsu, Mamoru] Saitama Med Univ, Dept Radiol, Iruma, Saitama, Japan; [Itakura, Atsuo] Juntendo Univ, Fac Med, Dept Obstet & Gynecol, Tokyo, Japan	Kajihara, T (reprint author), Saitama Med Univ, Fac Med, Dept Obstet & Gynecol, 38 Morohongo, Iruma, Saitama, Japan.	kajihara@saitama-med.ac.jp					Choi NJ, 2011, J COMPUT ASSIST TOMO, V35, P454, DOI 10.1097/RCT.0b013e31821f4bd2; HAAGA JR, 1977, AM J ROENTGENOL, V128, P465; Allen BC, 2012, AM SURGEON, V78, P185; FERRUCCI JT, 1981, JAMA-J AM MED ASSOC, V246, P2728, DOI 10.1001/jama.246.23.2728; McWilliams GDE, 2008, SURG CLIN N AM, V88, P265, DOI 10.1016/j.suc.2007.12.007; Bennett GL, 2002, RADIOGRAPHICS, V22, P785; Kruszka PS, 2010, AM FAM PHYSICIAN, V82, P141; Bennett GL, 2003, ABDOM IMAGING, V28, P416, DOI 10.1007/s00261-002-0052-0; FEDERLE MP, 1983, RADIOLOGY, V148, P187; Yitta S, 2009, RADIOGRAPHICS, V29, P1987, DOI 10.1148/rg.297095710; Carrino JA, 2003, SEMIN ROENTGENOL, V38, P200, DOI 10.1016/S0037-198X(03)00062-2; Cano Alonso R, 2009, EMERG RADIOL, V16, P453; Jearwattanakanok K, 2014, EMERG MED INT, V2014, DOI [10.1155/2014/320926, DOI 10.1155/2014/320926]; Jung Sung Il, 2011, J Obstet Gynaecol Res, V37, P228, DOI 10.1111/j.1447-0756.2010.01380.x; McNamara MM, EXPERT PANEL GASTROI; Smith MP, EXPERT PANEL GASTROI; Tellis Wyatt M, 2002, J Digit Imaging, V15 Suppl 1, P20, DOI 10.1007/s10278-002-5037-6; Yarmish GM, EXPERT PANEL GASTROI	18	0	0	NAGOYA UNIV, SCH MED	NAGOYA	EDITORIAL OFF, NAGOYA UNIV MED LIB, SCH MED, 65 TSURUMAI-CHO SHOWA- KU, NAGOYA, 466-8550, JAPAN	2186-3326	0027-7622		NAGOYA J MED SCI	Nagoya J. Med. Sci.	NOV	2015	77	4					563	569				7	Medicine, Research & Experimental	Research & Experimental Medicine	CX0VP	WOS:000365415600003		
J	Saito, H; Hayashi, H				Saito, Hiroshi; Hayashi, Hisao			Transformation rate between ferritin and hemosiderin assayed by serum ferritin kinetics in patients with normal iron stores and iron overload	NAGOYA JOURNAL OF MEDICAL SCIENCE			English	Article						transformation among iron stores; ferritin and hemosiderin; serum ferritin kinetics; hereditary hemochromatosis; chronic hepatitis C	PHLEBOTOMY; METABOLISM; HEPCIDIN; LIVER	Ferritin iron, hemosiderin iron, total iron stores and transformation rate were determined by serum ferritin kinetics. The transformation rate between ferritin and hemosiderin is motivated by the potential difference between them. The transformer determines transformation rate according to the potential difference in iron mobilization and deposition. The correlations between transformation rate and iron stores were studied in 11 patients with chronic hepatitis C (CHC), 1 patent with treated iron deficiency anemia (TIDA), 9 patients with hereditary hemochromatosis (HH) and 4 patients with transfusion-dependent anemia (TD). The power regression curve of approximation showed an inverse correlation between transformation rate and ferritin iron, hemosiderin iron in part and total iron stores in HH. Such an inverse correlation between transformation rate and iron stores implies that the larger the amount of iron stores, the smaller the transformation of iron stores. On the other hand, a minimal inverse correlation between transformation rate and ferritin iron and no correlation between transformation rate and hemosiderin iron or total iron stores in CHC indicate the derangement of storage iron metabolism in the cells with CHC. Radio-iron fixation on the iron storing tissue in iron overload was larger than that in normal subjects by ferrokinetics. This is consistent with the inverse correlation between transformation rate and total iron stores in HH. The characteristics of iron turnover between ferritin and hemosiderin were disclosed from the correlation between transformation rate and ferritin iron, hemosiderin iron or total iron stores.	[Saito, Hiroshi] Kawamura Hosp, Dept Internal Med, Gifu, Japan; [Hayashi, Hisao] Aichi Gakuin Univ, Sch Pharm, Dept Med, Nagoya, Aichi 464, Japan	Saito, H (reprint author), 1314 Otokikiyama,Tenpakuku, Nagoya, Aichi 4680063, Japan.	eise@beetle.ocn.ne.jp					Addison SM, 1972, J CLIN PATHOL, V25, P326; COOK JD, 1986, BLOOD, V68, P726; JACOBS A, 1975, NEW ENGL J MED, V292, P951, DOI 10.1056/NEJM197505012921805; ELMLINGER PJ, 1953, ACTA HAEMATOL-BASEL, V9, P73; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Thomson AM, 1999, INT J BIOCHEM CELL B, V31, P1139, DOI 10.1016/S1357-2725(99)00080-1; HUFF RL, 1951, J CLIN INVEST, V30, P1512, DOI 10.1172/JCI102562; Saito H, 2014, NAGOYA J MED SCI, V76, P235; POLLYCOVE M, 1961, J CLIN INVEST, V40, P753, DOI 10.1172/JCI104310; Miyazaki E, 2002, GUT, V50, P413, DOI 10.1136/gut.50.3.413; MILDER MS, 1980, MEDICINE, V59, P34; MILLER LL, 1991, P NATL ACAD SCI USA, V88, P4946, DOI 10.1073/pnas.88.11.4946; COULSON RMR, 1993, P NATL ACAD SCI USA, V90, P7613, DOI 10.1073/pnas.90.16.7613; Fleming RE, 2005, NEW ENGL J MED, V352, P1741, DOI 10.1056/NEJMp048363; WALTERS GO, 1973, J CLIN PATHOL, V26, P770, DOI 10.1136/jcp.26.10.770; Saito H, 2012, NAGOYA J MED SCI, V74, P39; PRIETO J, 1975, GASTROENTEROLOGY, V68, P525; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; SHODEN A, 1953, J BIOL CHEM, V204, P823; MUNRO HN, 1990, J CELL BIOCHEM, V44, P107, DOI 10.1002/jcb.240440205; HAYASHI H, 1994, AM J GASTROENTEROL, V89, P986; VANOOST BA, 1985, AM J HEMATOL, V18, P7, DOI 10.1002/ajh.2830180103; Bothwell TH, 1979, IRON METABOLISM MAN, p[88, 327]; COOK J D, 1970, Journal of Clinical Investigation, V49, P197, DOI 10.1172/JCI106228; Eisenstein Richard S., 1998, Journal of Nutrition, V128, P2295; Michael M, 2006, FEBS J, V273, P3828; Saito H, 2013, NAGOYA J MED SCI, V76, P213; Saito H, 1973, ACTA HAEMATOL JAPON, V36, P109	28	0	0	NAGOYA UNIV, SCH MED	NAGOYA	EDITORIAL OFF, NAGOYA UNIV MED LIB, SCH MED, 65 TSURUMAI-CHO SHOWA- KU, NAGOYA, 466-8550, JAPAN	2186-3326	0027-7622		NAGOYA J MED SCI	Nagoya J. Med. Sci.	NOV	2015	77	4					571	583				13	Medicine, Research & Experimental	Research & Experimental Medicine	CX0VP	WOS:000365415600004		
J	Tamaki, Y; Hieda, Y; Yoshida, R; Yoshizako, T; Fuchiwaki, T; Aoi, N; Sekihara, K; Kitajima, K; Kawauchi, H; Kitagaki, H; Sasaki, R; Inomata, T				Tamaki, Yukihisa; Hieda, Yoko; Yoshida, Rika; Yoshizako, Takeshi; Fuchiwaki, Takafumi; Aoi, Noriaki; Sekihara, Kazumasa; Kitajima, Kazuhiro; Kawauchi, Hideyuki; Kitagaki, Hajime; Sasaki, Ryohei; Inomata, Taisuke			Short treatment time and excellent treatment outcome in accelerated hyperfractionated radiotherapy for T1 glottic cancer	NAGOYA JOURNAL OF MEDICAL SCIENCE			English	Article						glottic cancer; accelerated hyperftactionted radiotherapy; overall treatment time; local control rate; safety	SQUAMOUS-CELL CARCINOMA; DEFINITIVE RADIATION-THERAPY; LOCAL-CONTROL; PROGNOSTIC-FACTORS; FRACTION SIZE; EXPERIENCE; REPOPULATION; LARYNX	Accelerated hyperfractionated radiotherapy was performed as treatment for patients with T1 glottic cancer, and its utility was evaluated based on treatment outcomes and adverse effects. Fifty-eight men who had undergone radiotherapy were retrospectively reviewed. Tumor classification was Tis in 4 patients, T1a in 38, and T1b in 16. Histological examination revealed squamous cell carcinoma in 55 patients. Travel time from home to hospital was 0-1 hour for 24 patients, 1-2 hours for 9, and > 2 hours for 25. Laser vaporization was performed prior to radiotherapy in 38 patients, and 19 patients received concurrent chemotherapy with an agent such as S-1. Patients were irradiated twice daily using an irradiation container. Most patients received a dose of 1.5 Gy/fraction up to a total of 60 Gy. The median overall treatment time was 30 days, with a median observation period of 59.6 months. A complete response was observed in all patients. The 5-year overall survival, disease-free survival, and local control rates were 97.2%, 93.2%, and 97.8%, respectively. Although grade 3 pharyngeal mucositis was observed in 2 patients, there were no other grade 3 or higher acute adverse events. As late toxicity, grade 2 laryngeal edema and grade 1 laryngeal hemorrhage were observed in 1 patient each, but no serious events such as laryngeal necrosis or laryngeal stenosis were observed. In conclusion, this treatment method brings excellent outcome and will substantially reduce the treatment duration among patients who need to stay at nearby hotels while undergoing treatment at hospitals in rural areas.	[Tamaki, Yukihisa; Hieda, Yoko; Inomata, Taisuke] Shimane Univ, Sch Med, Dept Radiat Oncol, Izumo, Shimane 6938501, Japan; [Yoshida, Rika; Yoshizako, Takeshi; Kitagaki, Hajime] Shimane Univ, Sch Med, Dept Radiol, Izumo, Shimane 6938501, Japan; [Fuchiwaki, Takafumi; Aoi, Noriaki; Kawauchi, Hideyuki] Shimane Univ, Sch Med, Dept Otorhinolaryngol, Izumo, Shimane, Japan; [Sekihara, Kazumasa] Effects Res Fdn, Dept Genet, Hiroshima, Japan; [Kitajima, Kazuhiro] Kobe Univ, Grad Sch Med, Dept Radiol, Kobe, Hyogo 657, Japan; [Sasaki, Ryohei] Kobe Univ, Grad Sch Med, Dept Radiat Oncol, Kobe, Hyogo 657, Japan	Tamaki, Y (reprint author), Shimane Univ, Sch Med, Dept Radiat Oncol, 89-1 Enya Cho, Izumo, Shimane 6938501, Japan.	ytamaki@med.shimane-u.ac.jp					Kim TG, 2012, CLIN EXP OTORHINOLAR, V5, P94, DOI 10.3342/ceo.2012.5.2.94; Onimaru R, 2011, JPN J CLIN ONCOL, V41, P103, DOI 10.1093/jjco/hyq153; Marshak G, 1999, INT J RADIAT ONCOL, V43, P1009, DOI 10.1016/S0360-3016(98)00547-1; WITHERS HR, 1995, INT J RADIAT ONCOL, V33, P549, DOI 10.1016/0360-3016(95)00228-Q; Le QTX, 1997, INT J RADIAT ONCOL, V39, P115, DOI 10.1016/S0360-3016(97)00284-8; Reddy SP, 1998, RADIOTHER ONCOL, V47, P161, DOI 10.1016/S0167-8140(97)00196-5; FEIN DA, 1993, INT J RADIAT ONCOL, V25, P605; Hayakawa K, 1996, LARYNGOSCOPE, V106, P1545, DOI 10.1097/00005537-199612000-00020; Trott KR, 1999, ACTA ONCOL, V38, P153; ROBERTS SA, 1993, RADIOTHER ONCOL, V29, P69, DOI 10.1016/0167-8140(93)90175-8; Okubo M, 2010, JPN J CLIN ONCOL, V40, P944, DOI 10.1093/jjco/hyq078; Skladowski K, 1999, INT J RADIAT ONCOL, V43, P101, DOI 10.1016/S0360-3016(98)00375-7; Tateya I, 2006, EUR ARCH OTO-RHINO-L, V263, P144, DOI 10.1007/s00405-005-0978-2; Gultekin M, 2012, HEAD NECK-J SCI SPEC, V34, P1009, DOI 10.1002/hed.21860; Gowda RV, 2003, RADIOTHER ONCOL, V68, P105, DOI 10.1016/S0167-8140(03)00059-8; Canaday DJ, 1999, RADIAT ONCOL INVEST, V7, P42; van der Voet JCM, 1998, INT J RADIAT ONCOL, V42, P247, DOI 10.1016/S0360-3016(98)00226-0; Trotti A, 2014, INT J RADIAT ONCOL, V89, P958, DOI 10.1016/j.ijrobp.2014.04.041; Yamazaki H, 2006, INT J RADIAT ONCOL, V64, P77, DOI 10.1016/j.ijrobp.2005.06.014; Nomiya T, 2008, LARYNGOSCOPE, V118, P1417, DOI 10.1097/MLG.0b013e3181781791; Furusawa M, 1996, Radiat Med, V14, P151; Hayakawa K, 1992, Radiat Med, V10, P199; Hirasawa N, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-122; Khan MK, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-193; Motegi A, 2015, HEAD NECK-J SCI SPEC, V37, P5879	25	0	0	NAGOYA UNIV, SCH MED	NAGOYA	EDITORIAL OFF, NAGOYA UNIV MED LIB, SCH MED, 65 TSURUMAI-CHO SHOWA- KU, NAGOYA, 466-8550, JAPAN	2186-3326	0027-7622		NAGOYA J MED SCI	Nagoya J. Med. Sci.	NOV	2015	77	4					585	594				10	Medicine, Research & Experimental	Research & Experimental Medicine	CX0VP	WOS:000365415600005		
J	Shahram, MS; Hamajima, N; Reyer, JA				Shahram, Muhammad Shuaib; Hamajima, Nobuyuki; Reyer, Joshua A.			Factors affecting maternal healthcare utilization in Afghanistan: secondary analysis of Afghanistan Health Survey 2012	NAGOYA JOURNAL OF MEDICAL SCIENCE			English	Article						maternal healthcare; maternal mortality; skilled birth attendant; antenatal care; Afghanistan	SKILLED BIRTH ATTENDANTS; SERVICE UTILIZATION; MULTILEVEL ANALYSIS; DANGER SIGNS; DETERMINANTS; ETHIOPIA; DELIVERY; PREGNANCY; NIGERIA; INDIA	This study, a secondary analysis of data from Afghanistan Health Survey 2012, aimed to identify factors affecting maternal healthcare utilization in Afghanistan. Subjects were 5,662 women aged 15-49 years who had had one delivery in the two years preceding the survey. Odds ratio (OR) and 95% confidence interval (CI) were estimated by logistic regression analysis. The study found that 54.0% of mothers used antenatal care (ANC) at least one time, and 47.4% of births were assisted by skilled birth attendants (SBA). Adjusted OR of ANC use was 2.74 (95% CI, 2.08-3.60) for urban residency, 1.69 (95% CI, 1.26-2.27) for primary education relative to no education, 3.94 (95% CI, 3.51-4.42) for knowledge on danger signs of pregnancy, and 1.78 (95% CI, 1.47-2.15) for television and radio relative to no exposure. Adjusted OR of SBA utilization was 3.71 (95% CI, 2.65-5.18) for urban residency, 0.67 (95% CI, 0.48-0.91) for age < 20 years relative to age 34-49 years, 1.43 (95% CI, 1.03-1.97) for secondary and higher education relative to no education, 1.83 (95% CI, 1.47-2.27) for para 1 relative to para >= 5, 6.66 (95% CI, 5.43-8.15) for >= 4 ANC visits relative to no visit, 1.37 (95% CI, 1.21-1.57) for knowledge of danger signs of pregnancy, 1.62 (95% CI, 1.38-1.90) for radio relative to no exposure, and 2.71 (95% CI, 2.25-3.27) for rich households relative to poor ones. Since women's education and knowledge about danger signs of pregnancy were significant factors of both ANC and SBA, educating women may be an effective step in promoting safe maternal health.	[Shahram, Muhammad Shuaib] Nagoya Univ, Grad Sch Med, Healthcare Adm, Nagoya, Aichi 4648601, Japan; [Hamajima, Nobuyuki; Reyer, Joshua A.] Nagoya Univ, Grad Sch Med, Dept Healthcare Adm, Nagoya, Aichi 4668550, Japan	Shahram, MS (reprint author), Nagoya Univ, Grad Sch Med, Dept Healthcare Adm, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	shuaibshahram@gmail.com					Abera Mulumebet, 2011, Ethiop J Health Sci, V21, P95; Mayhew M, 2008, AM J PUBLIC HEALTH, V98, P1849, DOI 10.2105/AJPH.2007.123471; Filmer D, 1999, POPUL DEV REV, V25, P85, DOI 10.1111/j.1728-4457.1999.00085.x; Chakraborty N, 2003, HEALTH PROMOT INT, V18, P327, DOI 10.1093/heapro/dag414; Jat TR, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-59; [Anonymous], 2013, AFGH MILL DEV GOAL R; Anderson FWJ, 2007, MATERN CHILD HLTH J, V11, P395, DOI 10.1007/s10995-006-0173-0; Doctor HV, 2013, J HEALTH CARE POOR U, V24, P152, DOI 10.1353/hpu.2013.0032; Mekonnen Y, 2003, J HEALTH POPUL NUTR, V21, P374; Pallikadavath S, 2004, SOC SCI MED, V59, P1147, DOI 10.1016/j.socscimed.2003.11.045; Babalola S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-43; Babalola SO, 2014, REV PANAM SALUD PUBL, V36, P1; Bayou Negalign Berhanu, 2013, Ethiop J Health Sci, V23, P79; Bhandari TR, 2012, N J OBSTET GYNAECOL, V7, P5; Birmeta K, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-256; Central Statistics Organization, 2014, NAT RISK VULN ASS SU, P92; Choulagai B, 2013, BMC INT HEALTH HUM R, V13, DOI 10.1186/1472-698X-13-49; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; Gupta S, 1999, PLOS ONE, V9; Mbalinda SN, 2014, HEALTH RES POLICY SY, V12, DOI 10.1186/1478-4505-12-60; Measure DHS, 2011, MEASURE DHS AFGH MOR; Ministry of Public Health, 2010, BAS PACK HLTH SERV A, P10; Mpembeni Rose Nm, 2007, BMC Pregnancy Childbirth, V7, P29, DOI 10.1186/1471-2393-7-29; Ntambue MLA, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-66; Rashid Mamunur, 2014, J Res Health Sci, V14, P187; Save the children, 2011, STAT WORLDS MOTH 201, P5; Singh PK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031666; Tarekegn SM, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-161; Teferra AS, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-74; The World Bank, LAB FORC PART RAT; United Nations, 2014, MILL DEV GOALS REP 2, P28; United States Agency for International Development, 2014, END PREV MAT MORT US, P6; WHO, 10 FACTS MAT HLTH; World Health Organization, 2014, TRENDS MAT MORT 1990, P1	34	0	0	NAGOYA UNIV, SCH MED	NAGOYA	EDITORIAL OFF, NAGOYA UNIV MED LIB, SCH MED, 65 TSURUMAI-CHO SHOWA- KU, NAGOYA, 466-8550, JAPAN	2186-3326	0027-7622		NAGOYA J MED SCI	Nagoya J. Med. Sci.	NOV	2015	77	4					595	607				13	Medicine, Research & Experimental	Research & Experimental Medicine	CX0VP	WOS:000365415600006		
J	Watson, BM; Chiang, C; Ikerdeu, E; Yatsuya, H; Honjo, K; Mita, T; Cui, R; Madraisau, S; Ngirmang, G; Iso, H; Aoyama, A				Watson, Berry Moon; Chiang, Chifa; Ikerdeu, Edolem; Yatsuya, Hiroshi; Honjo, Kaori; Mita, Takashi; Cui, Renzhe; Madraisau, Sherilynn; Ngirmang, Gregorio; Iso, Hiroyasu; Aoyama, Atsuko			Profile of non-communicable disease risk factors among adults in the Republic of Palau: findings of a national STEPS survey	NAGOYA JOURNAL OF MEDICAL SCIENCE			English	Article						non-communicable disease; WHO STEPS; obesity; hypertension; betel nut and tobacco chewing		Palau, similar to other Pacific island countries, is currently highly burdened with non-communicable diseases (NCDs). The WHO STEPS was launched in 2011 to comprehensively survey indicators for NCDs in the country. This paper aims to describe the prevalence of key NCD risk factors assessed by the survey. The WHO instrument, including behavioral, physical and biochemical measurements, was adopted to the nationwide survey for all residents aged 25 to 64 years. A cluster-based sampling method was performed to obtain a national representative data. Valid data from 2,184 individuals were selected for the analyses, of which 75% were Palauans and 19% were Filipinos. Prevalence of current cigarette smoking was 25% in men and 10% in women. Betel nut chewing with tobacco was prevalent particularly among Palauans (58% in men, 69% in women) compared to the other ethnic groups. In terms of all types of tobacco use, 60% of men and 58% of women were current users. Overweight or obesity was very common among Palauans (84% in men, 86% in women) as well as Filipinos (52% in men, 40% in women). Hypertension was found in 55% of men and 49% of women, with the stage 2 hypertension being 21% and 19%, respectively. The prevalence of diabetic level hyperglycemia was more than 20%. Raised total cholesterol was detected in 16% of men and 20% of women. This survey revealed an alarmingly high prevalence of NCD risk factors, especially tobacco use, obesity, hypertension and raised blood glucose. The data would be useful baseline information to develop effective NCD strategies in Palau.	[Watson, Berry Moon; Ikerdeu, Edolem; Madraisau, Sherilynn; Ngirmang, Gregorio] Minist Hlth, Koror, Palau; [Chiang, Chifa; Yatsuya, Hiroshi; Aoyama, Atsuko] Nagoya Univ, Sch Med, Dept Publ Hlth & Hlth Syst, Nagoya, Aichi 4668550, Japan; [Yatsuya, Hiroshi] Fujita Hlth Univ, Sch Med, Dept Publ Hlth, Toyoake, Aichi 47011, Japan; [Honjo, Kaori; Mita, Takashi] Osaka Univ, Global Collaborat Ctr, Suita, Osaka, Japan; [Mita, Takashi] Osaka Univ, Inst Acad Initiat, Suita, Osaka, Japan; [Cui, Renzhe; Iso, Hiroyasu] Osaka Univ, Grad Sch Med, Publ Hlth, Suita, Osaka, Japan	Chiang, C (reprint author), Nagoya Univ, Sch Med, Dept Publ Hlth & Hlth Syst, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	keihatsu@med.nagoya-u.ac.jp			Ministry of Health, Labour and Welfare, Government of Japan [H24-chikyukibo-ippan-004]	The authors wish to thank staff members of the Bureau of Public Health, Ministry of Health, Republic of Palau for the data collection. Appreciation is also given to the Regional Office for the Western Pacific, WHO for the full financial and technical support during the survey. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Palauan Government or the WHO. Data analysis of this paper is part of a joint research project between Palau and Japan, supported by the Health and Labour Sciences Research Grants for Research on Global Health Issues (H24-chikyukibo-ippan-004) to A. A. from the Ministry of Health, Labour and Welfare, Government of Japan.	American Diabetes Association, 2014, DIABETES CARE S1, V37, pS81, DOI DOI 10.2337/DC14-S081; Singh PN, 2009, B WORLD HEALTH ORGAN, V87, P905, DOI 10.2471/BLT.08.058917; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Chiang CF, 2015, J EPIDEMIOL, V25, P392, DOI 10.2188/jea.JE20140156; [Anonymous], 2015, STEPS COUNTR REP; Chobanian AV, 2003, JAMA-J AM MED ASSOC, V289, P2560, DOI 10.1001/jama.289.19.2560; Griffin MTQ, 2014, INT NURS REV, V61, P148, DOI 10.1111/inr.12082; Cash H, 2012, PALAU EPIDEMIOLOGICA; Department of Health and Social Affairs Federated States of Micronesia, 2008, NCD RISK FACT STEPS; KISH L, 1949, J AM STAT ASSOC, V44, P380, DOI 10.2307/2280236; National Cholesterol Education Program (NCEP), 2002, CIRCULATION, V106, P3143, DOI DOI 10.2215/CJN.04131206; The Word Bank, 2012, EC COSTS NONC DIS PA; The World Bank, 2014, NONC DIS NCD ROADM R; World Health Organization, STEPS MAN; World Health Organization, 2006, DEF DIAGN DIAB MELL; World Health Organization, 2011, WHO GLOB INF; World Health Organization, 2011, WHO REP GLOB TOB EP; World Health Organization, 2012, REV AR BET NUT TOB U; World Health Organization, 2013, GLOB BRIEF HYP SIL K; World Health Organization, WHO STEPWISE APPR SU	20	0	0	NAGOYA UNIV, SCH MED	NAGOYA	EDITORIAL OFF, NAGOYA UNIV MED LIB, SCH MED, 65 TSURUMAI-CHO SHOWA- KU, NAGOYA, 466-8550, JAPAN	2186-3326	0027-7622		NAGOYA J MED SCI	Nagoya J. Med. Sci.	NOV	2015	77	4					609	619				11	Medicine, Research & Experimental	Research & Experimental Medicine	CX0VP	WOS:000365415600007		
J	Tomita, N; Oze, I; Shimizu, H; Yoshida, M; Kimura, K; Takehana, K; Shimizu, A; Makita, C; Tachibana, H; Kodaira, T; Soga, N; Ogura, Y; Hayashi, N				Tomita, Natsuo; Oze, Isao; Shimizu, Hidetoshi; Yoshida, Maiko; Kimura, Kana; Takehana, Keiichi; Shimizu, Arisa; Makita, Chiyoko; Tachibana, Hiroyuki; Kodaira, Takeshi; Soga, Norihito; Ogura, Yuji; Hayashi, Norio			International prostate symptom score (IPSS) change and changing factor in intensity-modulated radiotherapy combined with androgen deprivation therapy for prostate cancer	NAGOYA JOURNAL OF MEDICAL SCIENCE			English	Article						IPSS; prostate cancer; genitourinary toxicity; IMRT; ADT	RADIATION-THERAPY; TOXICITY; RISK; MEN	The purposes of this study on prostate cancer are to demonstrate the time course of International Prostate Symptom Score (IPSS) after intensity-modulated radiation therapy (IMRT) combined with androgen deprivation therapy (ADT) and to examine the factor associated with the IPSS change. This study included 216 patients treated with IMRT between 2006 and 2010. Patients were evaluated in three groups according to baseline IPSS as defined by the American Urological Association classification, where IPSSs of 0 to 7, 8 to 19, and 20 to 35 represent mild (n = 124), moderate (n = 70), and severe (n = 22) symptom groups, respectively. The average IPSSs +/- standard deviation at baseline vs. those at 24 months after IMRT were 3.5 +/- 2.1 vs. 5.1 +/- 3.6 in the mild group (P < 0.001), 12.6 +/- 3.4 vs. 10.0 +/- 6.0 in the moderate group (P = 0.0015), and 23.8 +/- 2.9 vs. 14.4 +/- 9.1 in the severe group (P < 0.001). Among factors of patient and treatment characteristics, age, IPSS classification, pretreatment GU medications, and positive biopsy rates were associated with the IPSS difference between baseline and 24 months (P = 0.023, < 0.001, 0.044, and 0.028, respectively). In conclusion, patients with moderate to severe urinary symptoms can exhibit improvement in urinary function after IMRT, whereas patients with mild symptoms may have slightly worsened functions. Age, baseline IPSS, GU medications, and tumor burden in the prostate can have an effect on the IPSS changes.	[Tomita, Natsuo; Shimizu, Hidetoshi; Yoshida, Maiko; Kimura, Kana; Takehana, Keiichi; Shimizu, Arisa; Makita, Chiyoko; Tachibana, Hiroyuki; Kodaira, Takeshi] Aichi Canc Ctr Hosp, Dept Radiat Oncol, Nagoya, Aichi 4648681, Japan; [Oze, Isao] Aichi Canc Ctr, Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi 464, Japan; [Soga, Norihito; Ogura, Yuji; Hayashi, Norio] Aichi Canc Ctr Hosp, Dept Urol, Nagoya, Aichi 464, Japan	Tomita, N (reprint author), Aichi Canc Ctr Hosp, Dept Radiat Oncol, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	ntomita@aichi-cc.jp			Japan Society for the Promotion of Science (JSPS) [25871226]	This work was supported by a Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research, Grant Number 25871226.	Tomita N, 2012, J CANCER RES CLIN, V138, P1931, DOI 10.1007/s00432-012-1277-0; Malik R, 2011, INT J RADIAT ONCOL, V80, P1080, DOI 10.1016/j.ijrobp.2010.03.040; COX JD, 1995, INT J RADIAT ONCOL, V31, P1341, DOI 10.1016/0360-3016(95)00060-C; Nag S, 1999, INT J RADIAT ONCOL, V44, P789, DOI 10.1016/S0360-3016(99)00069-3; Sridharan S, 2013, CLIN ONCOL-UK, V25, P499, DOI 10.1016/j.clon.2013.04.004; Terk MD, 1998, J UROLOGY, V160, P1379, DOI 10.1016/S0022-5347(01)62542-4; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Feigenberg SJ, 2005, INT J RADIAT ONCOL, V62, P397, DOI 10.1016/j.ijrobp.2004.10.021; Valdagni R, 2012, INT J RADIAT ONCOL, V82, P1957, DOI 10.1016/j.ijrobp.2011.03.028; Mason M, 2013, CLIN ONCOL-UK, V25, P190, DOI 10.1016/j.clon.2012.09.010; Michalski JM, 2010, INT J RADIAT ONCOL, V76, P123; Takeda K, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-105; Yamazaki H, 2014, J RADIAT RES, V55, P1033, DOI 10.1093/jrr/rru061	13	0	0	NAGOYA UNIV, SCH MED	NAGOYA	EDITORIAL OFF, NAGOYA UNIV MED LIB, SCH MED, 65 TSURUMAI-CHO SHOWA- KU, NAGOYA, 466-8550, JAPAN	2186-3326	0027-7622		NAGOYA J MED SCI	Nagoya J. Med. Sci.	NOV	2015	77	4					637	646				10	Medicine, Research & Experimental	Research & Experimental Medicine	CX0VP	WOS:000365415600010		
J	Ito, K; Tsushita, K; Muramoto, A; Kanzaki, H; Nohara, T; Shimizu, H; Nakazawa, T; Harada, A				Ito, Kenyu; Tsushita, Kazuyo; Muramoto, Akiko; Kanzaki, Hiroki; Nohara, Takashi; Shimizu, Hitomi; Nakazawa, Tomoko; Harada, Atsushi			Cross-calibration of pencil-beam (DPX-NT) and fan-beam (QDR-4500C) dual-energy X-ray absorptiometry for sarcopenia	NAGOYA JOURNAL OF MEDICAL SCIENCE			English	Article						sarcopenia; dual-energy X-ray absorptiometry; calibration; pencil-beam; fan-beam	BIOELECTRICAL-IMPEDANCE ANALYSIS; BODY-COMPOSITION; PHOTON ABSORPTIOMETRY; DXA; DENSITY; WOMEN; AGE	Sarcopenia, defined as the loss of muscle mass accompanied by weakness, is an important factor leading to frailty and is a growing concern in the aging Japanese society. Muscle mass can be calculated by dual-energy X-ray absorptiometry (DXA), but results differ between devices produced by different manufactures. Thus, cross-calibration is needed to compare body composition results in multicenter trials or when scanners are replaced. The purpose of this study was to perform an in vivo calibration of total body scans between pencil-beam (DPX-NT, GE Healthcare) and fan-beam (QDR-4500C, Hologic Inc.) DXA units. A total 30 subjects (15 women, 15 men, mean age = 35 years, range 22-49 years) were recruited. The lumbar bone mineral density (BMD), femoral neck BMD, appendicular fat and lean body mass, and the appendicular skeletal muscle mass index (ASMI) were highly correlated (r = 0.979-0.993, r(2) = 0.889-0.977). The conversion formulas were as follows: lumbar BMD, Y = -0.08 + 1.16X (X = QDR-4500C, Y = DPX-NT), femoral neck BMD, Y = -0.015 + 1.11X, and ASMI Y = 0.92 + 0.90X. There is excellent comparability between the DPX-NT and the QDR-4500C DXA units. However, cross-calibration equations are required to assess muscle volume, fat, and ASMI in multicenter studies investigating sarcopenia.	[Ito, Kenyu; Nohara, Takashi; Shimizu, Hitomi; Nakazawa, Tomoko; Harada, Atsushi] Natl Ctr Geriatr & Gerontol, Obu, Japan; [Tsushita, Kazuyo; Muramoto, Akiko; Kanzaki, Hiroki] Aichi Hlth Plaza Comprehens Hlth Sci Ctr, Nagoya, Aichi, Japan; [Ito, Kenyu] Nagoya Univ Hosp, Grad Sch Med, Dept Orthopaed Surg, Nagoya, Aichi, Japan	Ito, K (reprint author), Nagoya Univ Hosp, Grad Sch Med, Dept Orthopaed Surg, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	kenyubankara@yahoo.co.jp			Comprehensive Research on Aging and Health research grant from the Ministry of Health, Labour and Welfare of Japan; Chukyo longevity medical and promotion foundation	This study was funded in 2010 by a Comprehensive Research on Aging and Health research grant from the Ministry of Health, Labour and Welfare of Japan, and Chukyo longevity medical and promotion foundation.	Walsh MC, 2006, OSTEOPOROSIS INT, V17, P61, DOI 10.1007/s00198-005-1900-x; Sanada K, 2010, EUR J APPL PHYSIOL, V110, P57, DOI 10.1007/s00421-010-1473-z; EIKEN P, 1994, BONE, V15, P671, DOI 10.1016/8756-3282(94)90316-6; KALENDER WA, 1995, EUR J RADIOL, V20, P83, DOI 10.1016/0720-048X(95)00631-Y; WANG J, 1989, AM J PHYSIOL, V256, pE829; Sayer AA, 2006, AM J EPIDEMIOL, V164, P665, DOI 10.1093/aje/kwj255; BAUMGARTNER RN, 1995, J GERONTOL A-BIOL, V50, pM307; Kriemler S, 2009, EUR J CLIN NUTR, V63, P619, DOI 10.1038/ejcn.2008.19; Henzell S, 2003, J CLIN DENSITOM, V6, P205, DOI 10.1385/JCD:6:3:205; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Malavolti M, 2003, ANN HUM BIOL, V30, P380, DOI 10.1080/0301446031000095211; Ellis KJ, 1998, J BONE MINER RES, V13, P1613, DOI 10.1359/jbmr.1998.13.10.1613; Blake GM, 1996, CALCIFIED TISSUE INT, V59, P1, DOI 10.1007/s002239900075; Cruz-Jentoft AJ, 2012, AGE AGEING, V39, P412; HEYMSFIELD SB, 1990, AM J CLIN NUTR, V52, P214; Hida T, 2012, GERIATR GERONTOL INT, V13, P413; Pfisterer MHD, 2006, J AM GERIATR SOC, V54, P405, DOI 10.1111/j.1532-5415.2005.00613.x; ROSENBERG IH, 1989, AM J CLIN NUTR, V50, P1231; Sarino JM, 2004, J CLIN DENSIOMETRY, V7, P281	19	0	0	NAGOYA UNIV, SCH MED	NAGOYA	EDITORIAL OFF, NAGOYA UNIV MED LIB, SCH MED, 65 TSURUMAI-CHO SHOWA- KU, NAGOYA, 466-8550, JAPAN	2186-3326	0027-7622		NAGOYA J MED SCI	Nagoya J. Med. Sci.	NOV	2015	77	4					647	652				6	Medicine, Research & Experimental	Research & Experimental Medicine	CX0VP	WOS:000365415600011		
J	Kobayashi, K; Imagama, S; Ito, Z; Ando, K; Yagi, H; Shinjo, R; Hida, T; Ito, K; Ishikawa, Y; Matsuyama, Y; Ishiguro, N				Kobayashi, Kazuyoshi; Imagama, Shiro; Ito, Zenya; Ando, Kei; Yagi, Hideki; Shinjo, Ryuichi; Hida, Tetsuro; Ito, Kenyu; Ishikawa, Yoshimoto; Matsuyama, Yukihiro; Ishiguro, Naoki			Tuberculous meningitis with dementia as the presenting symptom after intramedullary spinal cord tumor resection	NAGOYA JOURNAL OF MEDICAL SCIENCE			English	Article						tuberculous meningitis; dementia; intramedullary spinal cord tumor resection; Vietnam diagnostic rule		Early-stage TB meningitis has no specific symptoms in patients, potentially leading to delayed diagnosis and consequently worsening prognosis. The authors present the fatal case with a delayed diagnosis of tuberculous (TB) meningitis with dementia as the presenting symptom after intramedullary spinal cord tumor resection. The medical records, operative reports, and radiographical imaging studies of a single patient were retrospectively reviewed. A 77-year-old man who underwent thoracic intramedullary hemangioblastoma resection for 2 times. The postoperative course was uneventful, but 1.5 months after surgery, the patient suffered from dementia with memory loss and diminished motivation and speech in the absence of a fever. No abnormalities were detected on blood test, brain computed tomography and cerebrospinal fluid (CSF) analysis. A sputum sample was negative for Mycobacterium tuberculosis in the QuantiFERON (R)-TB Gold (QFT-G) In-Tube Test and the tuberculin skin test was also negative. The patient was diagnosed with senile dementia by a psychiatrist. However, the patient's symptoms progressively worsened. Despite the absence of TB meningitis findings, we suspected TB meningitis from the patient's history, and administered a four-drug regimen. However the patient died 29 days after admission, subsequently M. tuberculosis was detected in the CSF sample. This case is a rare case of TB meningitis initially mistaken for dementia after intramedullary spinal cord tumor resection. Symptoms of dementia after intramedullary spinal cord tumor resection should first be suspected as one of TB meningitis, even if the tests for meningitis are negative. We propose that anti-tuberculosis therapy should be immediately initiated in cases of suspected TB meningitis prior to positive identification on culture.	[Kobayashi, Kazuyoshi; Imagama, Shiro; Ito, Zenya; Ando, Kei; Yagi, Hideki; Shinjo, Ryuichi; Hida, Tetsuro; Ito, Kenyu; Ishikawa, Yoshimoto; Ishiguro, Naoki] Nagoya Univ, Grad Sch Med, Dept Orthopaed Surg, Nagoya, Aichi 4668560, Japan; [Matsuyama, Yukihiro] Hamamatsu Univ, Sch Med, Dept Orthopaed Surg, Hamamatsu, Shizuoka 4312102, Japan	Imagama, S (reprint author), Nagoya Univ, Grad Sch Med, Dept Orthopaed Surg, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668560, Japan.	imagama@med.nagoya-u.ac.jp					Khalil KF, 2013, JCPSP-J COLL PHYSICI, V23, P633, DOI 09.2013/JCPSP.633636; Kotnis R, 2001, J LARYNGOL OTOL, V115, P491; SHELLER JR, 1986, NEUROL CLIN, V4, P143; Garg RK, 1999, POSTGRAD MED J, V75, P133; Thwaites GE, 2002, LANCET, V360, P1287, DOI 10.1016/S0140-6736(02)11318-3; Thwaites GE, 2013, LANCET NEUROL, V12, P999, DOI 10.1016/S1474-4422(13)70168-6; DAIF A, 1992, CLIN NEUROL NEUROSUR, V94, P1, DOI 10.1016/0303-8467(92)90109-G; Brienze V M, 2001, Rev Soc Bras Med Trop, V34, P389; Takahashi T, 2005, NEUROLOGY, V64, P1789, DOI 10.1212/01.WNL.0000162052.13838.B2	9	0	0	NAGOYA UNIV, SCH MED	NAGOYA	EDITORIAL OFF, NAGOYA UNIV MED LIB, SCH MED, 65 TSURUMAI-CHO SHOWA- KU, NAGOYA, 466-8550, JAPAN	2186-3326	0027-7622		NAGOYA J MED SCI	Nagoya J. Med. Sci.	NOV	2015	77	4					653	657				5	Medicine, Research & Experimental	Research & Experimental Medicine	CX0VP	WOS:000365415600012		
J	Ohshima, T; Nagakura, M; Nishizawa, T; Kato, K				Ohshima, Tomotaka; Nagakura, Masamune; Nishizawa, Toshihisa; Kato, Kyozo			Alpha horizontal stent delivery for coil embolization of a broad-necked large basilar apex aneurysm: a case report	NAGOYA JOURNAL OF MEDICAL SCIENCE			English	Article						basilar apex aneurysm; coiling; stent placement	WAFFLE CONE TECHNIQUE; INTRACRANIAL ANEURYSMS; CEREBRAL ANEURYSMS; NEUROFORM STENT; ASSISTED COILING; RECONSTRUCTION; PLACEMENT; BALLOON; COMPLEX	Here we describe a novel technique for single stent horizontal reconstruction and coil embolization for a broad-necked large basilar artery (BA) apex aneurysm. A previously healthy 77-year-old woman presented with a broad-necked large BA apex aneurysm. Due to difficulty accessing the right posterior cerebral artery (PCA), we abandoned the Y-stent technique. Instead, we decided to navigate the stent through the BA to the left PCA making a loop of the stent delivery catheter inside the aneurysm in an "alpha" fashion. The procedure outcome was excellent without any complications. Alpha horizontal stent delivery via an antegrade approach for coil embolization of broad-necked large BA apex aneurysms may provide an effective therapeutic alternative, if other techniques are not feasible.	[Ohshima, Tomotaka; Nagakura, Masamune; Nishizawa, Toshihisa; Kato, Kyozo] Kariya Toyota Gen Hosp, Dept Neurosurg, Kariya, Aichi 4488505, Japan	Ohshima, T (reprint author), Kariya Toyota Gen Hosp, Dept Neurosurg, 5-15 Sumiyoshi Cho, Kariya, Aichi 4488505, Japan.	tomotaka.oshima@toyota-kai.or.jp					Xu F, 2011, ACTA NEUROCHIR, V153, P923, DOI 10.1007/s00701-010-0934-9; Hauck EF, 2011, J NEUROINTERV SURG, V3, P27, DOI 10.1136/jnis.2010.002931; Horowitz M, 2006, NEUROSURGERY, V58, P258, DOI 10.1227/01.NEU.0000204713.24945.D2; Maldonado IL, 2011, AM J NEURORADIOL, V32, P131, DOI 10.3174/ajnr.A2245; Kelly ME, 2007, NEUROSURGERY, V61, P249, DOI [10.1227/01.neu.0000303977.04128.3e, 10.1227/01.NEU.0000280091.91489.D3]; Moret J, 1997, J NEURORADIOLOGY, V24, P30; Cekirge SH, 2007, AM J NEURORADIOL, V28, P1388, DOI 10.3174/ajnr.A0618; Sychra V, 2011, NEURORADIOLOGY, V53, P961, DOI 10.1007/s00234-010-0766-6; Cho YD, 2012, NEUROSURGERY, V70, P244, DOI 10.1227/NEU.0b013e31823bcdc5; Wanke I, 2006, NEURORADIOLOGY, V48, P817, DOI 10.1007/s00234-006-0128-6; Liu W, 2012, INTERV NEURORADIOL, V18, P20; Benitez RP, 2004, NEUROSURGERY, V54, P1359, DOI 10.1227/01.NEU.0000124484.87635.CD; Heller RS, 2011, J NEUROSURG, V115, P624, DOI 10.3171/2011.4.JNS102050; Shapiro M, 2008, AM J NEURORADIOL, V29, P1777, DOI 10.3174/ajnr.A1216; Fiorella D, 2005, NEUROSURGERY, V56, P1191, DOI 10.1227/01.NEU.0000159645.86823.AF; Luo J, 2012, WORLD NEUROSURG, V73, P379; Otani Yoshihiro, 2012, No Shinkei Geka, V40, P1005; Rohde S, 2012, NEURORADIOLOGY, V52, P231	18	0	0	NAGOYA UNIV, SCH MED	NAGOYA	EDITORIAL OFF, NAGOYA UNIV MED LIB, SCH MED, 65 TSURUMAI-CHO SHOWA- KU, NAGOYA, 466-8550, JAPAN	2186-3326	0027-7622		NAGOYA J MED SCI	Nagoya J. Med. Sci.	NOV	2015	77	4					659	665				7	Medicine, Research & Experimental	Research & Experimental Medicine	CX0VP	WOS:000365415600013		
J	Kohyama, K; Yamada, K; Sugiura, H; Hyodo, I; Ozawa, T; Hasegawa, Y; Kato, H; Kamei, Y				Kohyama, Keishi; Yamada, Kenji; Sugiura, Hideshi; Hyodo, Ikuo; Ozawa, Taijiro; Hasegawa, Yasuhisa; Kato, Hisakazu; Kamei, Yuzuru			Salvage surgery and microsurgical reconstruction for recurrence of skull base osteosarcoma after carbon ion radiotherapy	NAGOYA JOURNAL OF MEDICAL SCIENCE			English	Article						carbon ion radiotherapy; salvage surgery; microsurgery; skull base; osteosarcoma	RELATIVE BIOLOGICAL EFFECTIVENESS; TUMORS; COMPLICATIONS; DEFECTS; TRIAL	Carbon ion radiotherapy has recently emerged as an alternative choice of treatment for malignant tumors of the head and neck. However, it is still in the infant stages and its influence on subsequent salvage surgery remains unclear. Here we report the case of a 43-year-old woman who underwent salvage surgery for left frontal bone osteosarcoma recurrence following carbon ion radiotherapy. Tumor resection was performed with a wide margin including the tissue considered to have been damaged by carbon ion radiotherapy. The dural defect was reconstructed using a fascia lata graft and pedicled galeal pericranial flap. The soft tissue defect was reconstructed using an anterolateral thigh flap anastomosed to the ipsilateral neck interposed by the radial forearm flap. As the patient developed no postoperative wound complications, she was able to initiate adjuvant chemotherapy early. Carbon ion radiotherapy is useful for its focused distribution and strong biological effects. Although the affected field may be limited, its high potency may severely damage adjacent normal tissue and lead to serious postoperative complications. Despite these concerns, satisfactory results were achieved in this case.	[Kohyama, Keishi; Kato, Hisakazu] Gifu Univ Hosp, Dept Plast & Reconstruct Surg, Gifu 5011194, Japan; [Kohyama, Keishi; Hyodo, Ikuo] Aichi Canc Ctr Hosp, Dept Plast & Reconstruct Surg, Nagoya, Aichi 464, Japan; [Yamada, Kenji; Sugiura, Hideshi] Aichi Canc Ctr Hosp, Dept Orthopaed Surg, Nagoya, Aichi 464, Japan; [Ozawa, Taijiro; Hasegawa, Yasuhisa] Aichi Canc Ctr Hosp, Dept Head & Neck Surg, Nagoya, Aichi 464, Japan; [Kamei, Yuzuru] Nagoya Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, Nagoya, Aichi 4648601, Japan	Kohyama, K (reprint author), Gifu Univ Hosp, Dept Plast & Reconstruct Surg, 1-1 Yanagido, Gifu 5011194, Japan.	casey_cybercat@yahoo.co.jp					Georgantopoulou A, 2003, BRIT J PLAST SURG, V56, P10, DOI 10.1016/S0007-1226(03)00013-4; Matsumoto T, 2013, BONE JOINT J, V95B, P1392, DOI 10.1302/0301-620X.95B10.31269; Newman J, 2006, ARCH OTOLARYNGOL, V132, P381, DOI 10.1001/archotol.132.4.381; Patel SG, 2003, CANCER, V98, P1179, DOI 10.1002/cncr.11630; Koike S, 2002, J RADIAT RES, V43, P247, DOI 10.1269/jrr.43.247; Akutsu Y, 2012, J SURG ONCOL, V105, P750, DOI 10.1002/jso.22127; Kanai T, 1999, INT J RADIAT ONCOL, V44, P201, DOI 10.1016/S0360-3016(98)00544-6; Chepeha DB, 2004, OTOLARYNG HEAD NECK, V131, P958, DOI 10.1016/j.otohns.2004.05.029; Neligan PC, 1996, PLAST RECONSTR SURG, V98, P1159, DOI 10.1097/00006534-199612000-00005; KRAUS DH, 1994, HEAD NECK-J SCI SPEC, V16, P307, DOI 10.1002/hed.2880160403; Chang DW, 2001, PLAST RECONSTR SURG, V107, P1346, DOI 10.1097/00006534-200105000-00003; Schulz-Ertner D, 2007, INT J RADIAT ONCOL, V67, P171, DOI 10.1016/j.ijrobp.2006.08.027; Kamada T, 2002, J CLIN ONCOL, V20, P4466, DOI 10.1200/JCO.2002.10.050; SMITH IE, 1978, CANCER RES, V38, P390; Shinoto M, 2013, CANCER-AM CANCER SOC, V119, P45, DOI 10.1002/cncr.27723; Suzuki M, 2000, INT J RADIAT ONCOL, V48, P241, DOI 10.1016/S0360-3016(00)00568-X	16	0	0	NAGOYA UNIV, SCH MED	NAGOYA	EDITORIAL OFF, NAGOYA UNIV MED LIB, SCH MED, 65 TSURUMAI-CHO SHOWA- KU, NAGOYA, 466-8550, JAPAN	2186-3326	0027-7622		NAGOYA J MED SCI	Nagoya J. Med. Sci.	NOV	2015	77	4					667	673				7	Medicine, Research & Experimental	Research & Experimental Medicine	CX0VP	WOS:000365415600014		
J	Chonan, M; Saito, R; Shoji, T; Shibahara, I; Kanamori, M; Sonoda, Y; Watanabe, M; Kikuchi, T; Ishii, N; Tominaga, T				Chonan, Masashi; Saito, Ryuta; Shoji, Takuhiro; Shibahara, Ichiyo; Kanamori, Masayuki; Sonoda, Yukihiko; Watanabe, Mika; Kikuchi, Toshiaki; Ishii, Naoto; Tominaga, Teiji			CD40/CD40L expression correlates with the survival of patients with glioblastomas and an augmentation in CD40 signaling enhances the efficacy of vaccinations against glioma models	NEURO-ONCOLOGY			English	Article						CD40; CD40 ligand; glioma; immunotherapy; prognosis	COSTIMULATORY MOLECULE; MONOCLONAL-ANTIBODY; CANCER; CELLS; THERAPY; LIGAND; TRIAL; IDENTIFICATION; TEMOZOLOMIDE; IMMUNITY	The prognosis of glioblastoma (GBM) remains poor; therefore, effective therapeutic strategies need to be developed. CD40 is a costimulatory molecule whose agonistic antibody has been shown to activate antitumor effects. Recently, CD40 has been extensively targeted for immunotherapeutic purposes. Expressions of CD40/CD40L mRNAs were examined in 86 cases of World Health Organization grade IV GBM and 36 cases of grade III gliomas and correlated with outcomes. CD40 signaling was employed to augment the efficacy of immunotherapy against gliomas. The efficacy of FGK45, an agonistic antibody for CD40, was examined by adding it to a tumor lysate-based subcutaneous vaccination against a GL261 glioma model and an NSCL61 glioma-initiating cell-like cell tumor model. We demonstrated for the first time using quantitative PCR that grade III gliomas express higher levels of CD40/CD40L than does grade IV GBM. The higher expression of CD40/CD40L was associated with good prognoses in patients with GBM. Addition of FGK45 to the subcutaneous tumor cell lysate-based vaccination significantly prolonged survival in both tumor models. However, the efficacy was modest in NSCL61-model mice. Therefore, we established combination immunotherapeutic strategies using FGK45 and OX86, an agonistic antibody for OX40. Combination immunotherapy significantly prolonged survival with synergistic effects. Apoptosis increased and proliferation decreased in tumors treated with combination immunotherapy. The high expression of CD40/CD40L can be used as a biomarker for better prognoses in patients with gliomas. Immunotherapy using FGK45 significantly prolonged survival and represents a potential therapeutic strategy for gliomas including glioma-initiating cells.	[Chonan, Masashi; Saito, Ryuta; Shoji, Takuhiro; Shibahara, Ichiyo; Kanamori, Masayuki; Sonoda, Yukihiko; Tominaga, Teiji] Tohoku Univ, Sch Med, Dept Neurosurg, Sendai, Miyagi 9808575, Japan; [Watanabe, Mika] Tohoku Univ Hosp, Div Pathol, Sendai, Miyagi, Japan; [Kikuchi, Toshiaki] Tohoku Univ, Grad Sch Med, Dept Resp Oncol, Sendai, Miyagi 9808575, Japan; [Kikuchi, Toshiaki] Tohoku Univ, Grad Sch Med, Dept Mol Med, Sendai, Miyagi 9808575, Japan; [Ishii, Naoto] Tohoku Univ, Grad Sch Med, Dept Immunol, Sendai, Miyagi 9808575, Japan	Saito, R (reprint author), Tohoku Univ, Sch Med, Dept Neurosurg, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	ryuta@nsg.med.tohoku.ac.jp		Sonoda, Yukihiko/0000-0001-7651-1374			Kosaka A, 2014, CANCER IMMUNOL IMMUN, V63, P847, DOI 10.1007/s00262-014-1561-8; Andarini S, 2004, CANCER RES, V64, P3281, DOI 10.1158/0008-5472.CAN-03-3911; Khong A, 2013, J IMMUNOTHER, V36, P365, DOI 10.1097/CJI.0b013e31829fb856; Shah AH, 2013, NEUROSURGERY, V73, P863, DOI 10.1227/NEU.0000000000000107; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sugamura K, 2004, NAT REV IMMUNOL, V4, P420, DOI 10.1038/nri1371; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Wick W, 2006, CURR PHARM DESIGN, V12, P341, DOI 10.2174/138161206775201901; Shibahara I, 2012, INT J CLIN ONCOL, V17, P551, DOI 10.1007/s10147-011-0323-2; Iizuka Y, 2006, INT J CANCER, V118, P942, DOI 10.1002/ijc.21432; Dougan M, 2009, ANNU REV IMMUNOL, V27, P83, DOI 10.1146/annurev.immunol.021908.132544; Gramaglia I, 1998, J IMMUNOL, V161, P6510; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Wischhusen J, 2005, J NEUROIMMUNOL, V162, P28, DOI 10.1016/j.neuroim.2005.01.005; Hide T, 2009, CANCER RES, V69, P7953, DOI 10.1158/0008-5472.CAN-09-2006; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.immunol.12.1.881; Weiner LM, 2009, LANCET, V373, P1033, DOI 10.1016/S0140-6736(09)60251-8; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Bonavida B, 2007, ONCOGENE, V26, P3592, DOI 10.1038/sj.onc.1210369; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262	21	1	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1522-8517	1523-5866		NEURO-ONCOLOGY	Neuro-Oncology	NOV	2015	17	11					1453	1462		10.1093/neuonc/nov090		10	Oncology; Clinical Neurology	Oncology; Neurosciences & Neurology	CW1WZ	WOS:000364783900005		
J	Morioka, N; Sugimoto, T; Sato, K; Okazaki, S; Saeki, M; Hisaoka-Nakashima, K; Nakata, Y				Morioka, Norimitsu; Sugimoto, Tatsuhiko; Sato, Koichi; Okazaki, Shuji; Saeki, Munenori; Hisaoka-Nakashima, Kazue; Nakata, Yoshihiro			The induction of Pen1 expression by the combined treatment with glutamate, 5-hydroxytriptamine and dopamine initiates a ripple effect on Bmal1 and Cry1 mRNA expression via the ERK signaling pathway in cultured rat spinal astrocytes	NEUROCHEMISTRY INTERNATIONAL			English	Article						Clock gene; Per1; Astrocytes; Spinal cord; Neurotransmitters; Extracellular signal-regulated kinase	CLOCK GENE-EXPRESSION; CIRCADIAN-RHYTHM; TNF-ALPHA; RECEPTOR; CORD; ACTIVATION; SEROTONIN; MICE; PER1; INHIBITION	Clock genes contribute to the regulation of spinal cord astrocytic function. Although it was previously found that noradrenaline has a pivotal role in the regulation of clock genes expression in cultured rat spinal astrocytes, it is still unknown whether other neurotransmitters might affect clock gene expression. Thus, the effect of spinal neurotransmitters glutamate (Glu), 5-hydroxytriptamine (5-HT) and dopamine (DA) on clock genes expression was examined in cultured rat spinal astrocytes. Simultaneous treatment with Glu (100 mu M) 5-HT (10 mu M) and DA (10 mu M) led to a transient induction of Per1 expression, and a delayed increase of Bmal1 expression and a decrease of Cry1 expression. By contrast, treatment with either Glu, 5-HT or DA alone increased only Per1 expression. The increase in Per1 mRNA by simultaneous treatment with Glu, 5-HT and DA was dependent on extracellular signal-regulated kinase (ERK) activation, since pretreatment with ERR inhibitor U0126 (3 mu M) blocked Per1 expression. Second messengers p38 and c-jun N-terminal kinase were not involved in the neurotransmitter effect on Per1 expression, since pretreatment with SB202190 (3 mu M) and SP600125 (10 mu M) a p38 inhibitor and c-jun N-terminal kinase inhibitor, respectively, had no effect. Blockade of ERK signaling also prevented changes in Bmal1 and Cry1 mRNA expression induced by co-treatment with Glu, 5-HT and DA. In addition to modulating clock gene expression, co-treatment with Glu, 5-HT and DA significantly increased ERK1/2 phosphorylation. Per1 expression itself modulates the expression of other clock gene as knockdown of Per1 expression by using short interference RNA significantly blocked the increase of Bmal1 mRNA expression and the decrease of Cry1 mRNA expression. Thus, neurotransmitters Glu, 5-HT and DA regulate spinal astrocytic clock genes mRNA expression through the ERR pathway and Per1 is a key clock gene that likely modulates the oscillation of clock genes thereby regulating astrocytic function. (C) 2015 Elsevier Ltd. All rights reserved.	[Morioka, Norimitsu; Sugimoto, Tatsuhiko; Sato, Koichi; Okazaki, Shuji; Saeki, Munenori; Hisaoka-Nakashima, Kazue; Nakata, Yoshihiro] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Pharmacol, Minami Ku, Hiroshima 7348553, Japan	Morioka, N (reprint author), Kasumi 1-2-3,Minami Ku, Hiroshima 7348553, Japan.	mnori@hiroshima-u.ac.jp			Nakatomi Foundation	This work was supported in part by grant from the Nakatomi Foundation. We wish to thank the Analysis Center of Life Science, and the Research Center for Molecular Medicine, Hiroshima University for the use of their facilities. We also thank Dr. Aldric T. Hama for his careful editing of the manuscript.	HOSLI E, 1986, NEUROSCI LETT, V65, P177, DOI 10.1016/0304-3940(86)90300-9; Imbesi M, 2009, NEUROSCIENCE, V158, P537, DOI 10.1016/j.neuroscience.2008.10.044; Perissin L, 2004, PAIN, V110, P250, DOI 10.1016/j.pain.2004.03.039; Richards J, 2013, AM J PHYSIOL-REG I, V305, pR735, DOI 10.1152/ajpregu.00195.2013; Maxishima M, 2001, BRAIN RES, V889, P270, DOI 10.1016/S0006-8993(00)03150-4; Barros DM, 2001, BEHAV BRAIN RES, V124, P1, DOI 10.1016/S0166-4328(01)00208-X; Hu HJ, 2007, J NEUROSCI, V27, P13181, DOI 10.1523/JNEUROSCI.0269-07.2007; Doly S, 2005, J COMP NEUROL, V490, P256, DOI 10.1002/cne.20667; Kojetin DJ, 2014, NAT REV DRUG DISCOV, V13, P197, DOI 10.1038/nrd4100; Hashiramoto A, 2010, J IMMUNOL, V184, P1560, DOI 10.4049/jimmunol.0903284; Leventhal L, 2007, J PHARMACOL EXP THER, V320, P1178, DOI 10.1124/jpet.106.109728; Spanagel R, 2005, NAT MED, V11, P35, DOI 10.1038/nm1163; Clinckers R, 2004, J NEUROCHEM, V89, P834, DOI 10.1111/j.1471-4159.2004.02355.x; Prolo LM, 2005, J NEUROSCI, V25, P404, DOI 10.1523/JNEUROSCI.4133-04.2005; Shi XD, 2011, PSYCHOPHARMACOLOGY, V214, P653, DOI 10.1007/s00213-010-2068-4; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Sugimoto T, 2014, MOL CELL NEUROSCI, V59, P37, DOI 10.1016/j.mcn.2014.01.003; Norum JH, 2003, J BIOL CHEM, V278, P3098, DOI 10.1074/jbc.M206237200; Domercq M, 2011, J BIOL CHEM, V286, P11825, DOI 10.1074/jbc.M110.153049; Morioka N, 2014, J CELL PHYSIOL, V229, P323, DOI 10.1002/jcp.24452; Minami T, 2001, BRAIN RES, V895, P178, DOI 10.1016/S0006-8993(01)02069-8; Werry EL, 2006, J NEUROCHEM, V99, P924, DOI 10.1111/j.1471-4159.2006.04133.x; Ziak D, 1998, PHYSIOL RES, V47, P365; Hamby ME, 2006, J NEUROSCI METH, V150, P128, DOI 10.1016/j.jneumeth.2005.06.016; Tamaru T, 2000, J NEUROSCI, V20, P7525; Poddar R, 2013, J NEUROCHEM, V124, P558, DOI 10.1111/jnc.12102; Thijssen DHJ, 2011, CHRONOBIOL INT, V28, P146, DOI 10.3109/07420528.2010.540364; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Morioka N, 2012, NEUROCHEM INT, V60, P817, DOI 10.1016/j.neuint.2012.03.005; Hayakawa K, 2010, J CEREBR BLOOD F MET, V30, P871, DOI 10.1038/jcbfm.2009.257; Clemens S, 2005, NEUROSCIENCE, V133, P353, DOI 10.1016/j.neuroscience.2005.03.002; Lamia KA, 2011, NATURE, V480, P552, DOI 10.1038/nature10700; Peirson SN, 2006, BIOCHEM BIOPH RES CO, V351, P800, DOI 10.1016/j.bbrc.2006.10.118; PROSSER RA, 1994, BRAIN RES, V643, P296, DOI 10.1016/0006-8993(94)90036-1; Sugimoto T, 2011, NEUROSCIENCE, V185, P1, DOI 10.1016/j.neuroscience.2011.04.024; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Nicholson KJ, 2012, NEUROSCIENCE, V209, P187, DOI 10.1016/j.neuroscience.2012.02.027; Marinova Z, 2013, PROG NEURO-PSYCHOPH, V44, P64, DOI 10.1016/j.pnpbp.2013.01.017; Duhart JM, 2013, J IMMUNOL, V191, P4656, DOI 10.4049/jimmunol.1300450; Hood S, 2010, J NEUROSCI, V30, P14046, DOI 10.1523/JNEUROSCI.2128-10.2010; Varcoe Tamara J, 2003, Brain Res Mol Brain Res, V119, P192; Yamamoto S, 2001, J COMP NEUROL, V430, P518; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Akiyama M, 2003, FEBS LETT, V542, P109, DOI 10.1016/S0014-5793(03)00360-0; Godinez-Chaparro B, 2012, NEUROSCIENCE, V222, P379, DOI 10.1016/j.neuroscience.2012.07.008; Brewer KL, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00062; Bunney BG, 2015, MOL PSYCHIATR, V20, P48, DOI 10.1038/mp.2014.138; Falcon E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066438; Galbavy W, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-60; Meszaros K, 2014, KIDNEY INT, V86, P915, DOI 10.1038/ki.2014.199; Nakamura Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073640; Setchov T, 2006, CHRONOBIOL INT, V23, P191; Shibata K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023510	53	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	NOV	2015	90						9	19		10.1016/j.neuint.2015.06.013		11	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CX0DH	WOS:000365366600002		
J	Ishii, Y; Yamaizumi, A; Kawakami, A; Islam, A; Choudhury, ME; Takahashi, H; Yano, H; Tanaka, J				Ishii, Yurika; Yamaizumi, Ayaka; Kawakami, Ayu; Islam, Afsana; Choudhury, Mohammed E.; Takahashi, Hisaaki; Yano, Hajime; Tanaka, Junya			Anti-inflammatory effects of noradrenaline on LPS-treated microglial cells: Suppression of NF kappa B nuclear translocation and subsequent STAT1 phosphorylation	NEUROCHEMISTRY INTERNATIONAL			English	Article						Adrenergic receptor; Phenylephrine; cAMP; JAK; IRF; TLR4	BETA-ADRENERGIC-RECEPTORS; NITRIC-OXIDE SYNTHASE; GENE-EXPRESSION; BETA-2-ADRENERGIC RECEPTOR; NADPH OXIDASE; SMOOTH-MUSCLE; SYNAPSIN-I; MAJOR ROLE; GM-CSF; NOREPINEPHRINE	Noradrenaline (NA) has marked anti-inflammatory effects on activated microglial cells. The present study was conducted to elucidate the mechanisms underlying the NA effects using rat primary cultured microglial cells. NA, an alpha 1 agonist, phenylephrine (Phe) and a beta 2 agonist, terbutaline (Ter) suppressed lipopolysaccharide (LPS)-induced nitric oxide (NO) release by microglia and prevented neuronal degeneration in LPS-treated neuron-microglia coculture. The agents suppressed expression of mRNA encoding proinflammatory mediators. Both an alpha 1-selective blocker terazocine and a beta 2-selective blocker butoxamine overcame the suppressive effects of NA. cAMP-dependent kinase (PKA) inhibitors did not abolish the suppressive NA effects. LPS decreased la leading to NF kappa B translocation into nuclei, then induced phosphorylation of signal transducer and activator of transcription 1 (STAT1) and expression of interferon regulatory factor 1 (IRF1). NA inhibited LPS-induced these changes. When NF kappa B expression was knocked down with siRNA, LPS-induced STAT1 phosphorylation and IRF1 expression was abolished. NA did not suppress IL-6 induced STAT1 phosphorylation and IRF1 expression. These results suggest that one of the critical mechanisms underlying the anti-inflammatory effects of NA is the inhibition of NF kappa B translocation. Although inhibitory effects of NA on STAT1 phosphorylation and IRF1 expression may contribute to the overall suppressive effects of NA, these may be the downstream events of inhibitory effects on NF kappa B. Since NA, Phe and Ter exerted almost the same effects and PICA inhibitors did not show significant antagonistic effects, the suppression by NA might not be dependent on specific adrenergic receptors and cAMP-dependent signaling pathway. (C) 2015 Elsevier Ltd. All rights reserved.	[Ishii, Yurika; Yamaizumi, Ayaka; Kawakami, Ayu; Islam, Afsana; Choudhury, Mohammed E.; Takahashi, Hisaaki; Yano, Hajime; Tanaka, Junya] Ehime Univ, Grad Sch Med, Dept Mol & Cellular Physiol, Toon, Ehime 7910295, Japan; [Takahashi, Hisaaki] Asahikawa Med Univ, Ctr Adv Res & Educ, Asahikawa, Hokkaido, Japan	Tanaka, J (reprint author), Ehime Univ, Grad Sch Med, Dept Mol & Cellular Physiol, Toon, Ehime 7910295, Japan.	jtanaka@m.ehime-u.ac.jp			Ehime University [0503003000, 0503003010]; Ministry of Education, Culture, Sports, Science, and Technology, Japan [22390037, 80127894]	We are grateful to the staff of the Animal Center of INCS, Ehime University, for their careful and gentle handling of the animals. This study was partly supported by grants from the Ehime University (0503003000 to JT; 0503003010 to HY) and the Ministry of Education, Culture, Sports, Science, and Technology, Japan (22390037 to JT; 80127894 to YK).	ALEXANDER RW, 1975, P NATL ACAD SCI USA, V72, P1564, DOI 10.1073/pnas.72.4.1564; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; LOWENSTEIN CJ, 1993, P NATL ACAD SCI USA, V90, P9730, DOI 10.1073/pnas.90.20.9730; Morioka N, 2009, NEUROCHEM INT, V55, P226, DOI 10.1016/j.neuint.2009.03.004; Liu K, 2007, FASEB J, V21, P3904, DOI 10.1096/fj.07-8770com; ABERCROMBIE ED, 1989, J NEUROSCI, V9, P4062; Chang JY, 2000, BRAIN RES BULL, V52, P525, DOI 10.1016/S0361-9230(00)00291-4; Markus T, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-94; Sugimoto K, 2014, GLIA, V62, P185, DOI 10.1002/glia.22598; Mori K, 2002, NEUROPHARMACOLOGY, V43, P1026, DOI 10.1016/S0028-3908(02)00211-3; Tanaka KF, 2002, J NEUROSCI RES, V70, P232, DOI 10.1002/jnr.10399; Tanaka J, 1998, GLIA, V24, P198, DOI 10.1002/(SICI)1098-1136(199810)24:2<198::AID-GLIA5>3.0.CO;2-0; Tanaka J, 1999, GLIA, V28, P85, DOI 10.1002/(SICI)1098-1136(199911)28:2<85::AID-GLIA1>3.0.CO;2-Y; Fujita H, 1996, GLIA, V18, P269, DOI 10.1002/(SICI)1098-1136(199612)18:4<269::AID-GLIA2>3.0.CO;2-T; Heinrich PC, 1998, BIOCHEM J, V334, P297; Dello Russo C, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-9; Kong Y, 2010, J NEUROSCI, V30, P11848, DOI 10.1523/JNEUROSCI.2985-10.2010; Heneka MT, 2010, P NATL ACAD SCI USA, V107, P6058, DOI 10.1073/pnas.0909586107; GUSCHIN D, 1995, EMBO J, V14, P1421; Yokoyama A, 2004, GLIA, V45, P96, DOI 10.1002/glia.10306; Fujita H, 1998, NEUROSCI LETT, V242, P37, DOI 10.1016/S0304-3940(98)00003-2; Farmer P, 2000, AM J PHYSIOL-LUNG C, V279, pL675; Jaruga B, 2004, AM J PHYSIOL-GASTR L, V287, pG1044, DOI 10.1152/ajpgi.00184.2004; MINNEMAN KP, 1983, J PHARMACOL EXP THER, V227, P605; GRESCH PJ, 1995, J NEUROCHEM, V65, P111; Zarow C, 2003, ARCH NEUROL-CHICAGO, V60, P337, DOI 10.1001/archneur.60.3.337; Woo MS, 2004, NEUROSCI LETT, V356, P187, DOI 10.1016/j.neulet.2003.11.056; Toku K, 1998, J NEUROSCI RES, V53, P415, DOI 10.1002/(SICI)1097-4547(19980815)53:4<415::AID-JNR3>3.0.CO;2-9; Qian L, 2009, GLIA, V57, P1600, DOI 10.1002/glia.20873; LI LA, 1993, P NATL ACAD SCI USA, V90, P1460, DOI 10.1073/pnas.90.4.1460; Qian L, 2011, J IMMUNOL, V186, P4443, DOI 10.4049/jimmunol.1002449; McNamee EN, 2010, NEUROPHARMACOLOGY, V59, P37, DOI 10.1016/j.neuropharm.2010.03.014; Madrigal JLM, 2005, J NEUROSCI RES, V81, P390, DOI 10.1002/jnr.20481; Zhang B, 2002, NEUROPHARMACOLOGY, V42, P262, DOI 10.1016/S0028-3908(01)00174-5; Qiu J, 2008, J CEREBR BLOOD F MET, V28, P927, DOI 10.1038/sj.jcbfm.9600582; Schoch S, 1996, J BIOL CHEM, V271, P3317; Sasaguri T, 2000, BIOCHEM BIOPH RES CO, V268, P25, DOI 10.1006/bbrc.1999.2066; POYET P, 1986, MOL CELL ENDOCRINOL, V48, P59, DOI 10.1016/0303-7207(86)90166-8; Takahashi H, 2008, BBA-GEN SUBJECTS, V1780, P709, DOI 10.1016/j.bbagen.2007.12.014; Ohmori Y, 2001, J LEUKOCYTE BIOL, V69, P598; Zhong HY, 2000, MOL PHARMACOL, V57, P961; Choudhury ME, 2011, BRAIN BEHAV, V1, P26, DOI 10.1002/brb3.11; Gomes-Leal W, 2012, BRAIN BEHAV, V2, P345, DOI 10.1002/brb3.51; Jiang LL, 2015, GLIA, V63, P1057, DOI 10.1002/glia.22801	44	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	NOV	2015	90						56	66		10.1016/j.neuint.2015.07.010		11	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CX0DH	WOS:000365366600007		
J	Araki, K; Nakanishi, H; Nakamura, T; Atsuta, N; Yamada, S; Hijikata, Y; Hashizume, A; Suzuki, K; Katsuno, M; Sobue, G				Araki, Kunihiko; Nakanishi, Hirotaka; Nakamura, Tomohiko; Atsuta, Naoki; Yamada, Shinichiro; Hijikata, Yasuhiro; Hashizume, Atsushi; Suzuki, Keisuke; Katsuno, Masahisa; Sobue, Gen			Myotonia-like symptoms in a patient with spinal and bulbar muscular atrophy	NEUROMUSCULAR DISORDERS			English	Article						Myotonia; Spinal and bulbar muscular atrophy; Motor neuron; Androgen receptor	MUTANT ANDROGEN RECEPTOR; DISEASE; SBMA; PATHOGENESIS; DIAGNOSIS; DISORDERS; MUTATIONS; PATHOLOGY; MODELS	We describe the case of a 33-year-old man with a 4-year history of worsening muscle stiffness and weakness in his right hand. He showed elevated serum creatine kinase levels at the onset of muscle stiffness that was characterized by delayed muscle relaxation after voluntary contraction. This symptom often occurred during cold exposure, and was partially attenuated by sodium channel blockade. Electrodiagnostic findings in repetitive nerve stimulation, short-exercise, and cooling tests were normal. Electromyography showed chronic denervation potentials in his cranial, cervical, thoracic, and lumbosacral myotomes without myotonic discharge. He exhibited facial and tongue fasciculations, hypernasality, gynecomastia, neurogenic changes in muscle biopsy, and increased serum testosterone levels. Spinal and bulbar muscular atrophy (SBMA) was diagnosed on the basis of the CAG trinucleotide expansion in the gene coding androgen receptor. A myotonia-like symptom without myotonic discharge may present as an early neurological sign of SBMA, which possibly reflects a sodium channel dysfunction in skeletal muscles. (C) 2015 Elsevier B.V. All rights reserved.	[Araki, Kunihiko; Nakanishi, Hirotaka; Nakamura, Tomohiko; Atsuta, Naoki; Yamada, Shinichiro; Hijikata, Yasuhiro; Hashizume, Atsushi; Suzuki, Keisuke; Katsuno, Masahisa; Sobue, Gen] Nagoya Univ, Grad Sch Med, Dept Neurol, Showa Ku, Nagoya, Aichi 4668550, Japan	Sobue, G (reprint author), Nagoya Univ, Grad Sch Med, Dept Neurol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	sobueg@med.nagoya-u.ac.jp					Katsuno M, 2012, PROG NEUROBIOL, V99, P246, DOI 10.1016/j.pneurobio.2012.05.007; Miller TM, 2008, MUSCLE NERVE, V37, P293, DOI 10.1002/mus.20923; Adachi H, 2005, BRAIN, V128, P659, DOI 10.1093/brain/awh381; SOBUE G, 1989, BRAIN, V112, P209, DOI 10.1093/brain/112.1.209; Miller TM, 2005, MUSCLE NERVE, V32, P431, DOI 10.1002/mus.20341; Dejager S, 2002, J CLIN ENDOCR METAB, V87, P3893, DOI 10.1210/jc.87.8.3893; Fournier E, 2006, ANN NEUROL, V60, P356, DOI 10.1002/ana.20905; Atsuta N, 2006, BRAIN, V129, P1446, DOI 10.1093/brain/awl096; Cortes CJ, 2014, NEURON, V82, P295, DOI 10.1016/j.neuron.2014.03.001; Yu Z, 2006, J CLIN INVEST, V116, P2663, DOI 10.1172/JCI28773; Heatwole CR, 2013, MUSCLE NERVE, V47, P632, DOI 10.1002/mus.23683; Iida M, 2015, HUM MOL GENET, V24, P314, DOI 10.1093/hmg/ddu445; Matthews E, 2010, BRAIN, V133, P9, DOI 10.1093/brain/awp294; Orrell RW, 1998, J NEUROL NEUROSUR PS, V65, P569, DOI 10.1136/jnnp.65.4.569; Katsuno M, 2006, EXP NEUROL, V200, P8, DOI 10.1016/j.expneurol.2006.01.021; Fournier E, 2004, ANN NEUROL, V56, P650, DOI 10.1002/ana.20241; Chahin N, 2009, MUSCLE NERVE, V40, P126, DOI 10.1002/mus.21310; Araki A, 2014, NEUROLOGY, V82, P1813, DOI 10.1212/WNL.0000000000000434; Lieberman AP, 2014, CELL REP, V7, P774, DOI 10.1016/j.celrep.2014.02.008; Palazzolo I, 2009, NEURON, V63, P316, DOI 10.1016/j.neuron.2009.07.019; Soraru G, 2008, J NEUROL SCI, V264, P100, DOI 10.1016/j.jns.2007.08.012; Rhodes LE, 2009, BRAIN, V132, P3242, DOI 10.1093/brain/awp258	22	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	NOV	2015	25	11					913	915		10.1016/j.nmd.2015.08.006		3	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CX0BP	WOS:000365362200013		
J	Wu, DZ; Sato, K; Ma, JF				Wu, Dezhi; Sato, Kazuhiro; Ma, Jian Feng			Genome-wide association mapping of cadmium accumulation in different organs of barley	NEW PHYTOLOGIST			English	Article						barley; cadmium (Cd); core collection; genome-wide association (GWA) mapping; genotypic difference; quantitative trait loci (QTL); straw	GENOTYPIC DIFFERENCES; RICE; IDENTIFICATION; TRANSPORTER; CD; TRANSLOCATION; MANGANESE; OSHMA2; TOLERANCE; VARIETIES	The threshold value of cadmium (Cd) concentration in grains of barley (Hordeum vulgare) is the lowest among cereal crops; however, it is poorly understood how Cd accumulation in barley grain is genetically controlled. We investigated genotypic variation in Cd accumulation of different organs in 100 accessions from a subset of the barley core collection using both hydroponic and Cd-contaminated soil culture. We also performed a genome-wide association (GWA) mapping for Cd accumulation in different organs. A large genotypic variation in the Cd concentration was found in all organs. There was a good correlation between shoot Cd of solution and soil culture, the shoot Cd and grain Cd, but no correlation between the root Cd and grain Cd. GWA mapping detected 9 quantitative trait loci (QTL) for root Cd, 21 for shoot Cd, 14 for root-to-shoot translocation and 15 for grain Cd. A common QTL for the shoot Cd and root-to-shoot translocation was found at 132.6 cM on chromosome 5H. Two major QTL for grain Cd were identified on chromosome 2H and chromosome 5H. The genetic variation in Cd accumulation and major QTL detected provide useful information helpful for cloning candidate genes for Cd accumulation and breeding low-Cd barley cultivars in future.	[Wu, Dezhi; Sato, Kazuhiro; Ma, Jian Feng] Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama 7100046, Japan	Ma, JF (reprint author), Okayama Univ, Inst Plant Sci & Resources, Chuo 2-20-1, Kurashiki, Okayama 7100046, Japan.	maj@rib.okayama-u.ac.jp			Ministry of Agriculture, Forestry, and Fisheries of Japan [TRS-1006, Brain 25013A]	This work was supported by a grant from the Ministry of Agriculture, Forestry, and Fisheries of Japan (Genomics-based Technology for Agricultural Improvement, TRS-1006 and Brain 25013A to J.F.M).	Arao T, 2003, PLANT SOIL, V251, P247, DOI 10.1023/A:1023079819086; Ishikawa S, 2012, P NATL ACAD SCI USA, V109, P19166, DOI 10.1073/pnas.1211132109; Cockram J, 2010, P NATL ACAD SCI USA, V107, P21611, DOI 10.1073/pnas.1010179107; Uraguchi S, 2011, P NATL ACAD SCI USA, V108, P20959, DOI 10.1073/pnas.1116531109; Comadran J, 2012, NAT GENET, V44, P1388, DOI 10.1038/ng.2447; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Miyadate H, 2011, NEW PHYTOL, V189, P190, DOI 10.1111/j.1469-8137.2010.03459.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Chen F, 2007, CHEMOSPHERE, V67, P2082, DOI 10.1016/j.chemosphere.2006.10.014; Satoh-Nagasawa N, 2012, PLANT CELL PHYSIOL, V53, P213, DOI 10.1093/pcp/pcr166; Sasaki A, 2014, J EXP BOT, V65, P6013, DOI 10.1093/jxb/eru340; [Anonymous], 2013, 1931995 CODEX STAN; Ueno D, 2009, PLANT CELL PHYSIOL, V50, P2223, DOI 10.1093/pcp/pcp160; Takahashi R, 2012, PLANT CELL ENVIRON, V35, P1948, DOI 10.1111/j.1365-3040.2012.02527.x; Sasaki A, 2012, PLANT CELL, V24, P2155, DOI 10.1105/tpc.112.096925; Pedas P, 2008, PLANT PHYSIOL, V148, P455, DOI 10.1104/pp.108.118851; Komatsuda T, 1998, GENOME, V41, P680, DOI 10.1139/gen-41-5-680; Pasam RK, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-16; Houston K, 2013, P NATL ACAD SCI USA, V110, P16675, DOI 10.1073/pnas.1311681110; Yamaji N, 2013, PLANT PHYSIOL, V162, P927, DOI 10.1104/pp.113.216564; Adams ML, 2004, J ENVIRON QUAL, V33, P532; Ueno D, 2010, P NATL ACAD SCI USA, V107, P16500, DOI 10.1073/pnas.1005396107; Clemens S, 2013, TRENDS PLANT SCI, V18, P92, DOI 10.1016/j.tplants.2012.08.003; Wu FB, 2002, B ENVIRON CONTAM TOX, V69, P219, DOI 10.1007/s00128-002-0050-5; Tiryakioglu M, 2006, J TRACE ELEM MED BIO, V20, P181, DOI 10.1016/j.jtemb.2005.12.004; Chen F, 2008, BIOL TRACE ELEM RES, V121, P171, DOI 10.1007/s12011-007-8042-2; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Chaney RL, 1980, SLUDGE HLTH RISKS LA, P59; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Gawenda I, 2015, PLANT BREEDING, V134, P28, DOI 10.1111/pbr.12237; Ishimaru Y, 2012, SCI REP-UK, V2, DOI 10.1038/srep00286; Knupffer H, 2003, DIVERSITY BARLEY HOR, P259; Mills RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042640; Wu DZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022938; Yamaji N, 2014, TRENDS PLANT SCI, V19, P556, DOI 10.1016/j.tplants.2014.05.007	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0028-646X	1469-8137		NEW PHYTOL	New Phytol.	NOV	2015	208	3					817	829		10.1111/nph.13512		13	Plant Sciences	Plant Sciences	CX0MX	WOS:000365392100019		
J	Hespeels, F; Tonneau, R; Ikeda, T; Lucas, S				Hespeels, F.; Tonneau, R.; Ikeda, T.; Lucas, S.			Comparison of experimental and Monte-Carlo simulation of MeV particle transport through tapered/straight glass capillaries and circular collimators	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS			English	Article						Micro beam; Collimators; Glass capillary; Focusing effect; Ion beam analysis	OPTICS; BEAMS; AIR	This study compares the capabilities of three different passive collimation devices to produce micrometer-sized beams for proton and alpha particle beams (1.7 MeV and 5.3 MeV respectively): classical platinum TEM-like collimators, straight glass capillaries and tapered glass capillaries. In addition, we developed a Monte-Carlo code, based on the Rutherford scattering theory, which simulates particle transportation through collimating devices. The simulation results match the experimental observations of beam transportation through collimators both in air and vacuum. This research shows the focusing effects of tapered capillaries which clearly enable higher transmission flux. Nevertheless, the capillaries alignment with an incident beam is a prerequisite but is tedious, which makes the TEM collimator the easiest way to produce a 50 mu m microbeam. (C) 2015 Elsevier B.V. All rights reserved.	[Hespeels, F.; Tonneau, R.; Lucas, S.] Univ Namur, PMR, B-5000 Namur, Belgium; [Ikeda, T.] RIKEN Nishina Ctr, Wako, Saitama 3510198, Japan	Hespeels, F (reprint author), Univ Namur, PMR, 61 Rue Bruxelles, B-5000 Namur, Belgium.	felicien.hespeels@unamur.be					Dudu D, 2012, ROM J PHYS, V57, P1308; Nebiki T, 2003, J VAC SCI TECHNOL A, V21, P1671, DOI 10.1116/1.1597889; Ikeda T, 2011, SURF COAT TECH, V206, P859, DOI 10.1016/j.surfcoat.2011.03.098; Fujita N, 2013, NUCL INSTRUM METH B, V315, P332, DOI 10.1016/j.nimb.2013.05.079; Lemell C, 2013, PROG SURF SCI, V88, P237, DOI 10.1016/j.progsurf.2013.06.001; Wera AC, 2011, NUCL INSTRUM METH B, V269, P3120, DOI 10.1016/j.nimb.2011.04.104; FLEISCHER RL, 1964, PHYS REV A-GEN PHYS, V133, P1443; Hanot M., 2008, BIOL PHYS; Hasegawa J, 2011, J APPL PHYS, V110, DOI 10.1063/1.3624617; Ikeda T, 2007, J PHYS CONF SER, V88, DOI 10.1088/1742-6596/88/1/012031; Ikeda T, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2362642; Ikeda T, 2012, J PHYS CONF SER, V399, DOI 10.1088/1742-6596/399/1/012007; Iwai Y, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2834695; Kato M, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4714911; Kojima TM, 2007, J PHYS SOC JPN, V76, DOI 10.1143/JPSJ.76.093501; Michelet-Habchi C., 2005, IMAGES PHYS, P166; Nebiki T, 2006, NUCL INSTRUM METH B, V249, P226, DOI 10.1016/j.nimb.2006.04.003; PostnovaAnalytics, 2012, FUS SIL CAP TUB; Rasband W.S., 1997, IMAGEJ; Roussetski AS., 2006, CR 39 TRACK DETECTOR, P274	20	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-583X	1872-9584		NUCL INSTRUM METH B	Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms	NOV 1	2015	362						72	79		10.1016/j.nimb.2015.09.030		8	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Atomic, Molecular & Chemical; Physics, Nuclear	Instruments & Instrumentation; Nuclear Science & Technology; Physics	CW3HW	WOS:000364883800014		
J	Khandaker, MU; Haba, H; Murakami, M; Otuka, N; Abu Kassim, H				Khandaker, Mayeen Uddin; Haba, Hiromitsu; Murakami, Masashi; Otuka, Naohiko; Abu Kassim, Hasan			Excitation functions of deuteron-induced nuclear reactions on natural platinum up to 24 MeV	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS			English	Article						Natural platinum target; Stacked-foil activation; Deuteron-induced reaction cross-sections; Physical thick target yields; TENDL-2013	ACTIVATION CROSS-SECTIONS; DATA SHEETS; CYCLOTRON PRODUCTION; RADIONUCLIDES; THERAPY; AU-199; RADIOISOTOPES; NANOPARTICLES; SEPARATION; PROTON	Excitation functions of the Pt-nat(d,x)Au-192,Au-193,Au-194,Au-195,Au-196m2,Au-196,Au-198m,Au-198,Au-199, Pt-195m,Pt-197 and Ir-190(g+m1+0.086m2),Ir-192(g+m1).194m nuclear reactions were measured from the respective threshold up to 24 MeV deuteron energy by using the stacked foil activation technique combined with HPGe gamma-ray spectrometry. Measured data were critically compared with the available literature data and theoretical data extracted from the TENDL-2013 library, and only partial agreement among them was found. Physical thick target yields for the investigated reaction products were also deduced and compared with the directly measured ones in the literature. The deduced yield curves indicate that a low energy cyclotron (<15 MeV) and a highly enriched 198Pt target could be used to obtain Au-198,Au-199 in no carrier added form. All cross-sections for Ir-190(g+m1+0.086m2),Ir-194m and those for Au-193,Au-194,Au-196m2,Au-196,Au-199 and Pt-195m,Pt- 197 in the lower energy region are reported for the first time. (C) 2015 Elsevier B.V. All rights reserved.	[Khandaker, Mayeen Uddin; Abu Kassim, Hasan] Univ Malaya, Dept Phys, Kuala Lumpur 50603, Malaysia; [Haba, Hiromitsu; Murakami, Masashi] RIKEN, Nishina Ctr Accelerator Based Sci, Wako, Saitama 3510198, Japan; [Otuka, Naohiko] IAEA, Dept Nucl Sci & Applicat, Div Phys & Chem Sci, Nucl Data Sect, A-1400 Vienna, Austria	Khandaker, MU (reprint author), Univ Malaya, Dept Phys, Kuala Lumpur 50603, Malaysia.	mu_khandaker@yahoo.com	Khandaker, Mayeen /F-5376-2011	Khandaker, Mayeen /0000-0003-3772-294X	University of Malaya Research Grant [RP006D-13AFR]	This work was performed at the RI Beam Factory operated by RIKEN Nishina Center and CNS, University of Tokyo. The work was partially supported by the University of Malaya Research Grant (RP006D-13AFR). We are indebted to the anonymous reviewer for his constructive comments and corrections, which have substantially improved the quality of the manuscript.	Akaboshi M., 2003, IAEATECDOC1340, P171; Akhtar M., 1994, RADIOCHIM ACTA, V64, P137; Ananthakrishnan M., 2003, MANUAL REACTOR PRODU, P116; [Anonymous], QTOOL CALC REACT Q V; Khandaker MU, 2008, NUCL INSTRUM METH B, V266, P4877, DOI 10.1016/j.nimb.2008.08.014; Karvat A, 2001, RADIOTHER ONCOL, V59, P153, DOI 10.1016/S0167-8140(00)00334-0; Audi G, 1995, NUCL PHYS A, V595, P409, DOI 10.1016/0375-9474(95)00445-9; HOWELL RW, 1992, MED PHYS, V19, P1371, DOI 10.1118/1.596927; Bouchat V, 2011, SURF COAT TECH, V205, P4934, DOI 10.1016/j.surfcoat.2011.04.077; Huang XL, 2009, NUCL DATA SHEETS, V110, P2533, DOI 10.1016/j.nds.2009.09.002; VOLKERT WA, 1991, J NUCL MED, V32, P174; Khandaker MU, 2010, NUCL INSTRUM METH B, V268, P2303, DOI 10.1016/j.nimb.2010.04.002; Ditroi F, 2006, NUCL INSTRUM METH B, V243, P20, DOI 10.1016/j.nimb.2005.07.206; Tarkanyi F, 2004, RADIOCHIM ACTA, V92, P223, DOI 10.1524/ract.92.4.223.35588; Qaim SM, 2009, APPL RADIAT ISOTOPES, V67, P1074, DOI 10.1016/j.apradiso.2008.11.008; Shivarudrappa V, 2005, B MATER SCI, V28, P325, DOI 10.1007/BF02704244; Ziegler JF, 2004, NUCL INSTRUM METH B, V219, P1027, DOI 10.1016/j.nimb.2004.01.208; Khandaker MU, 2011, NUCL INSTRUM METH B, V269, P1140, DOI 10.1016/j.nimb.2011.02.082; Baglin CM, 2012, NUCL DATA SHEETS, V113, P1871, DOI 10.1016/j.nds.2012.08.001; Hilgers K, 2005, APPL RADIAT ISOTOPES, V63, P93, DOI 10.1016/j.apradiso.2004.12.010; Lahiri S, 1999, J RADIOANAL NUCL CH, V242, P497, DOI 10.1007/BF02345583; Mariani G, 2000, J NUCL MED, V41, P1519; Ekkels P, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/6/065010; Hermanne A, 2002, NUCL INSTRUM METH B, V187, P3, DOI 10.1016/S0168-583X(01)00851-5; Singh B, 2007, NUCL DATA SHEETS, V108, P79, DOI 10.1016/j.nds.2007.01.001; Wheate NJ, 2010, DALTON T, V39, P8113, DOI 10.1039/c0dt00292e; Khandaker MU, 2014, NUCL INSTRUM METH B, V335, P8, DOI 10.1016/j.nimb.2014.05.020; Sanchez FJ, 2013, CAN J CHEM ENG, V91, P1175, DOI 10.1002/cjce.21740; Achterberg E, 2006, NUCL DATA SHEETS, V107, P1, DOI 10.1016/j.nds.2005.12.001; Oppenheimer JR, 1935, PHYS REV, V48, P500, DOI 10.1103/PhysRev.48.500; Singh B, 2006, NUCL DATA SHEETS, V107, P1531, DOI 10.1016/j.nds.2006.05.004; Koning AJ, 2012, NUCL DATA SHEETS, V113, P2841, DOI 10.1016/j.nds.2012.11.002; Uddin MS, 2007, NUCL INSTRUM METH B, V258, P313, DOI 10.1016/j.nimb.2007.02.089; Khandaker MU, 2013, NUCL INSTRUM METH B, V316, P33, DOI 10.1016/j.nimb.2013.08.032; Tarkanyi F, 2004, NUCL INSTRUM METH B, V226, P490, DOI 10.1016/j.nimb.2004.06.043; Huang XL, 2005, NUCL DATA SHEETS, V104, P283, DOI 10.1016/j.nds.2005.01.001; ANDERSON P, 1988, NUCL MED BIOL, V15, P293; HOESCHELE JD, 1982, RADIOCHIM ACTA, V31, P27; Berning DE, 1998, NUCL MED BIOL, V25, P577, DOI 10.1016/S0969-8051(98)00023-7; Neves M, 2005, J RADIOANAL NUCL CH, V266, P377, DOI 10.1007/s10967-005-0920-5; Berglund M, 2011, PURE APPL CHEM, V83, P397, DOI 10.1351/PAC-REP-10-06-02; Wahl U, 2011, NUCL INSTRUM METH B, V269, P3014, DOI 10.1016/j.nimb.2011.04.082; Fazaeli Y, 2014, MAT SCI ENG C-MATER, V45, P196, DOI 10.1016/j.msec.2014.09.019; Das NR, 1999, APPL RADIAT ISOTOPES, V50, P643, DOI 10.1016/S0969-8043(98)00115-8; Chanda N, 2010, NANOMED-NANOTECHNOL, V6, P201, DOI 10.1016/j.nano.2009.11.001; [Anonymous], NUDAT 2 6 SOFTW; HORIUCHI J, 1991, RADIOTHER ONCOL, V21, P29, DOI 10.1016/0167-8140(91)90338-H; Otuka N, 2014, NUCL DATA SHEETS, V120, P272, DOI 10.1016/j.nds.2014.07.065; Correia J.G., 2011, CERNOPEN2014009; Dmitriev P.P., 1982, VOP AT NAUKI TEKH YK, V4, P38; Huang Xiaolong, 2007, DATA SHEETS, V108, P1093; Khandaker M.U., 2013, NUCL INSTRUM METH B, V296, P14; Khandaker M.U., 2012, NUCL INSTRUM METH B, V271, P72; Khandaker M.U., 2009, NUCL INSTRUM METH B, V267, P23; Koning A. J., 2007, P INT C NUCL DAT SCI, P211; Koning A.J., TALYS BASED EVALUATE; Kulko A. A., 2012, Physics of Particles and Nuclei Letters, V9, DOI 10.1134/S154747711206012X; National Institute of Standards and Technology, XRAY MASS ATT COEFF; Otuka N, 2015, RADIOCHIM ACTA, V103, P1, DOI 10.1515/ract-2013-2234; Qaim S.M., 2001, IAEATECDOC1211; Singh B., 2003, Nuclear Data Sheets, V99, DOI 10.1006/ndsh.2003.0009; Zhou Chunmei, 1999, NUCL DATA SHEETS, V86, P645; Ziegler J.F., 2003, SRIM 2003 CODE VERSI	63	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-583X	1872-9584		NUCL INSTRUM METH B	Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms	NOV 1	2015	362						151	162		10.1016/j.nimb.2015.09.045		12	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Atomic, Molecular & Chemical; Physics, Nuclear	Instruments & Instrumentation; Nuclear Science & Technology; Physics	CW3HW	WOS:000364883800024		
J	Minami, M; Kato, T; Horikawa, K; Nakamura, T				Minami, Masayo; Kato, Tomomi; Horikawa, Keiji; Nakamura, Toshio			Seasonal variations of C-14 and delta C-13 for cave drip waters in Ryugashi Cave, Shizuoka Prefecture, central Japan	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS			English	Article						Radiocarbon; Speleothem; Drip water; Dead carbon fraction	SPELEOTHEMS; GEOCHEMISTRY; VARIABILITY	Speleothem C-14 has recently emerged as a potentially powerful proxy for hydrology changes in comparison with atmospheric C-14 calibration curve, rather than as a direct dating tool, apart from a time marker using bomb peak of C-14. Some possible causes for the relationship between speleothem C-14 content (or dead carbon fraction: DCF) and karst hydrology have been proposed, such as changes in temperature, precipitation, drip water flow dynamics, cave air ventilation, soil air pCO(2). In this study, we investigated seasonal variation in C-14 and delta C-13 of drip water in Ryugashi Cave, Shizuoka Prefecture, central Japan, to examine the causes of the C-14 and delta C-13 variations in a speleothem. The results show that different C-14 concentrations and delta C-13 values of drip water from the Ryugashi Cave, were exhibited at different sites of the Caves No. 1, No. 3, and No. 4, which have different temperature, air pCO(2), and flow paths. Further, the C-14 and delta C-13 of drip waters showed seasonal variations at all sites, which were lower in fall and winter, and higher in spring and summer, though the extent of the variations was different among the sites. The C-14 in drip waters tended to be correlated with the drip rates: C-14 tended to be higher in drip waters with higher drip rates, and also correlated with rainfall amount around the Ryugashi Cave, especially for the drip waters in Cave No. 3, which are considered to have simpler flow paths. The increase in rainfall amount could bring the increase in drip rate of drip water, and then the decrease in interaction between solution and karst, resulting in C-14 increase (DCF decrease) in drip water. Accordingly, the reconstruction of precipitation could be performed using C-14 variation in a speleothem formed by drip water with simple flow dynamics. (C) 2015 Elsevier B.V. All rights reserved.	[Minami, Masayo; Nakamura, Toshio] Nagoya Univ, Ctr Chronol Res, Nagoya, Aichi 4648602, Japan; [Kato, Tomomi] Nagoya Univ, Grad Sch Environm Studies, Nagoya, Aichi 4648601, Japan; [Horikawa, Keiji] Toyama Univ, Dept Environm Biol & Chem, Toyama 9308555, Japan	Minami, M (reprint author), Nagoya Univ, Ctr Chronol Res, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan.	minami@nendai.nagoya-u.ac.jp					Fohlmeister J, 2011, RADIOCARBON, V53, P99; Fohlmeister J, 2010, RADIOCARBON, V52, P1529; NIELSEN AE, 1984, J CRYST GROWTH, V67, P278, DOI 10.1016/0022-0248(84)90188-X; Fohlmeister J, 2011, GEOCHIM COSMOCHIM AC, V75, P5219, DOI 10.1016/j.gca.2011.06.023; Minami M, 2013, NUCL INSTRUM METH B, V294, P91, DOI 10.1016/j.nimb.2012.02.036; Wong CI, 2011, GEOCHIM COSMOCHIM AC, V75, P3514, DOI 10.1016/j.gca.2011.03.025; Noronha AL, 2014, EARTH PLANET SC LETT, V394, P20, DOI 10.1016/j.epsl.2014.03.015; Fairchild IJ, 2006, EARTH-SCI REV, V75, P105, DOI 10.1016/j.earscirev.2005.08.003; HENDY CH, 1971, GEOCHIM COSMOCHIM AC, V35, P801, DOI 10.1016/0016-7037(71)90127-X; Karmann I, 2007, CHEM GEOL, V244, P232, DOI 10.1016/j.chemgeo.2007.06.029; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; McDonald J, 2007, CHEM GEOL, V244, P605, DOI 10.1016/j.chemgeo.2007.07.007; HENDY CH, 1968, NATURE, V219, P48, DOI 10.1038/219048a0; Griffiths ML, 2012, QUAT GEOCHRONOL, V14, P81, DOI 10.1016/j.quageo.2012.04.001; Frisia S., 2000, J SEDIMENT RES, V70, P411; Kato T., 2014, SUMMARIES RES USING, V15, P84; MacDermott F., 2004, QUATERNARY SCI REV, V23, P901; Mizutani Y., 1993, J GROUNDWATER HYDROL, V35, P77	18	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-583X	1872-9584		NUCL INSTRUM METH B	Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms	NOV 1	2015	362						202	209		10.1016/j.nimb.2015.05.020		8	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Atomic, Molecular & Chemical; Physics, Nuclear	Instruments & Instrumentation; Nuclear Science & Technology; Physics	CW3HW	WOS:000364883800031		
J	Nakao, M; Yamamoto, H; Nakahashi, O; Ikeda, S; Abe, K; Masuda, M; Ishiguro, M; Iwano, M; Takeda, E; Taketani, Y				Nakao, Mari; Yamamoto, Hironori; Nakahashi, Otoki; Ikeda, Shoko; Abe, Kotaro; Masuda, Masashi; Ishiguro, Mariko; Iwano, Masayuki; Takeda, Eiji; Taketani, Yutaka			Dietary phosphate supplementation delays the onset of iron deficiency anemia and affects iron status in rats	NUTRITION RESEARCH			English	Article						Dietary phosphate; Iron-deficient; Anemia; Gene expression; Rat	ADENOSINE TRIPHOSPHATE CONCENTRATION; PEPTIDE HEPCIDIN; SODIUM-PHOSPHATE; PHOSPHORUS; CALCIUM; GENE; MICE; RESTRICTION; CELL; ERYTHROCYTES	Inorganic phosphate (Pi) plays critical roles in bone metabolism and is an essential component of 2,3-diphosphoglycerate (2,3-DPG). It has been reported that animals fed a low-iron diet modulate Pi metabolism, whereas the effect of dietary Pi on iron metabolism, particularly in iron deficiency anemia (IDA), is not fully understood. In this study, we hypothesized the presence of a link between Pi and iron metabolism and tested the hypothesis by investigating the effects of dietary Pi on iron status and IDA. Wistar rats aged 4 weeks were randomly assigned to 1 of 4 experimental dietary groups: normal iron content (Con Fe) + 0.5% Pi, low-iron (Low Fe) + 0.5% Pi, Con Fe + 1.5% Pi, and Low Fe + 1.5% Pi. Rats fed the 1.5% Pi diet for 14 days, but not for 28 days, maintained their anemia state and plasma erythropoietin concentrations within the reference range, even under conditions of low iron. In addition, plasma concentrations of 2,3-DPG were significantly increased by the 1.5% Pi diets and were positively correlated with plasma Pi concentration (r = 0.779; P < .001). Dietary Pi regulated the messenger RNA expression of iron-regulated genes, including divalent metal transporter 1, duodenal cytochrome B, and hepcidin. Furthermore, iron concentration in liver tissues was increased by the 1.5% Pi in Con Fe diet. These results suggest that dietary Pi supplementation delays the onset of IDA and increases plasma 2,3-DPG concentration, followed by modulation of the expression of iron-regulated genes. (C) 2015 Elsevier Inc. All rights reserved.	[Nakao, Mari; Yamamoto, Hironori; Nakahashi, Otoki; Ikeda, Shoko; Abe, Kotaro; Masuda, Masashi; Takeda, Eiji; Taketani, Yutaka] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Clin Nutr & Food Management, Tokushima 7708503, Japan; [Yamamoto, Hironori; Ishiguro, Mariko] Jin Ai Univ, Fac Human Life, Dept Hlth & Nutr, Echizen City, Fukui 9158586, Japan; [Yamamoto, Hironori; Iwano, Masayuki] Univ Fukui, Fac Med Sci, Dept Gen Med, Div Nephrol, Fukui 9101193, Japan	Yamamoto, H (reprint author), Jin Ai Univ, Fac Human Life, Dept Hlth & Nutr, Ohde Cho 3-1-1, Echizen City, Fukui 9158586, Japan.	yamamoto@jindai.ac.jp			Ministry of Education, Science, Sports and Culture of Japan [22680053, 25282022, 24300256]	This work was supported by grants 22680053, 25282022 (to HY), and 24300256 (to ET) from the Ministry of Education, Science, Sports and Culture of Japan. We thank Y. Takei, S. Tanaka, M. Kozai, and A. Otani for their helpful discussions and comments and R. Mukohara, M. Sogo, T. Kagawa, M. Tajiri, N. Yokoyama, R. Yoshikawa, R. Onishi, S. Fukuda, and K. Fujimoto for their technical assistance. The authors declare that they have no conflict of interest.	Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; SHELDON GF, 1975, ANN SURG, V182, P683, DOI 10.1097/00000658-197512000-00004; HEGSTED DM, 1949, J EXP MED, V90, P147, DOI 10.1084/jem.90.2.147; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Buck CL, 2013, SPORTS MED, V43, P425, DOI 10.1007/s40279-013-0042-0; NARITA H, 1981, J BIOL CHEM, V256, P7059; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; HISHINUMA K, 1989, INT J VITAM NUTR RES, V59, P406; Takeda E, 2004, J CELL MOL MED, V8, P191, DOI 10.1111/j.1582-4934.2004.tb00274.x; MONSEN ER, 1976, AM J CLIN NUTR, V29, P1142; Yamamoto H, 2005, BBA-GENE STRUCT EXPR, V1732, P43, DOI 10.1016/j.bbaexp.2005.11.003; GARDNER GW, 1977, AM J CLIN NUTR, V30, P910; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Nishida Y, 2006, KIDNEY INT, V70, P2141, DOI 10.1038/sj.ki.5002000; LENFANT C, 1970, FED PROC, V29, P1115; ROSE IA, 1966, J BIOL CHEM, V241, P4848; Ebert BL, 1999, BLOOD, V94, P1864; Laroche M, 2005, JOINT BONE SPINE, V72, P376, DOI 10.1016/j.jbspin.2004.07.013; Berndt TJ, 2005, AM J PHYSIOL-RENAL, V289, pF1170, DOI 10.1152/ajprenal.00072.2005; McKie AT, 2001, SCIENCE, V291, P1755, DOI 10.1126/science.1057206; Shuto E, 2009, J AM SOC NEPHROL, V20, P1504, DOI 10.1681/ASN.2008101106; Diaz-Castro J, 2008, NUTRITION, V24, P1167, DOI 10.1016/j.nut.2008.05.012; Farrow EG, 2011, P NATL ACAD SCI USA, V108, pE1146, DOI 10.1073/pnas.1110905108; HISHINUMA K, 1990, INT J VITAM NUTR RES, V60, P372; ARMBRECHT HJ, 1981, ARCH BIOCHEM BIOPHYS, V210, P179, DOI 10.1016/0003-9861(81)90178-8; LICHTMAN MA, 1970, J LAB CLIN MED, V76, P267; Chiba H, 1978, Curr Top Cell Regul, V14, P75; Zhang YJ, 2012, MICROBES INFECT, V14, P863, DOI 10.1016/j.micinf.2012.05.005; LICHTMAN MA, 1971, ANN INTERN MED, V74, P562; Murer H, 2000, PHYSIOL REV, V80, P1373; Yamada S, 2014, AM J PHYSIOL-RENAL, V306, pF1418, DOI 10.1152/ajprenal.00633.2013; Collins JF, 2005, AM J PHYSIOL-GASTR L, V288, pG964, DOI 10.1152/ajpgi.00489.2004; KREIDER RB, 1992, INT J SPORT NUTR, V2, P20; Sato T, 2006, J BONE MINER METAB, V24, P291, DOI 10.1007/s00774-006-0686-z; Nakahashi O, 2014, J CLIN BIOCHEM NUTR, V54, P102, DOI 10.3164/jcbn.13-109; Murer H, 2004, PFLUG ARCH EUR J PHY, V447, P763, DOI 10.1007/s00424-003-1072-5; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Miyamoto KI, 2007, AM J NEPHROL, V27, P503, DOI 10.1159/000107069; Latunde-Dada GO, 2008, J NUTR, V138, P991; Fleming MD, 1997, NAT GENET, V16, P383; Tani Y, 2007, J CLIN BIOCHEM NUTR, V40, P221, DOI 10.3164/jcbn.40.221; Mackenzie B, 2005, AM J PHYSIOL-GASTR L, V289, pG981, DOI 10.1152/ajpgi.00363.2005; Shaikh A, 2008, PEDIATR NEPHROL, V23, P1203, DOI 10.1007/s00467-008-0751-z; JACOB HS, 1971, NEW ENGL J MED, V285, P1446, DOI 10.1056/NEJM197112232852602; Zhang YJ, 2011, NAT MED, V17, P79, DOI 10.1038/nm.2280; Brasse-Lagnel C, 2011, GASTROENTEROLOGY, V140, P1261, DOI 10.1053/j.gastro.2010.12.037; Campos MS, 1998, EXP PHYSIOL, V83, P771; Clinkenbeard EL, 2014, J BONE MINER RES, V29, P361, DOI 10.1002/jbmr.2049; Lutwak K, 1975, ANN CLIN LAB SCI, V5, P185; Reeves P G, 1997, J Nutr, V127, p838S; Sasaki R, 1983, MOL CELL BIOCHEM, V28, P957; Shoko I, 2014, AM J PHYSIOL-RENAL, V306, pF744	52	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0271-5317			NUTR RES	Nutr. Res.	NOV	2015	35	11					1016	1024		10.1016/j.nutres.2015.09.001		9	Nutrition & Dietetics	Nutrition & Dietetics	CW7AN	WOS:000365150400010		
J	Ikeya, Y; Fukuyama, N; Mori, H				Ikeya, Yoshimori; Fukuyama, Naoto; Mori, Hidezo			Importance and proper use of fatty acid levels in vascular events Response	NUTRITION RESEARCH			English	Letter							RED-BLOOD-CELLS; EICOSAPENTAENOIC ACID; HYPERCHOLESTEROLEMIC PATIENTS; PLASMA; TRIAL; JELIS		[Ikeya, Yoshimori; Fukuyama, Naoto; Mori, Hidezo] Tokai Univ, Sch Med, Dept Physiol, Isehara, Kanagawa 2591193, Japan; [Ikeya, Yoshimori] Fureai Machida Hosp, Machida, Tokyo, Japan	Ikeya, Y (reprint author), Tokai Univ, Sch Med, Div Physiol, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.	y.ikey@river.ocn.ne.jp					STANFORD JL, 1991, NUTR CANCER, V16, P183; Valagussa F, 1999, LANCET, V354, P447; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3; THERET N, 1993, METABOLISM, V42, P562, DOI 10.1016/0026-0495(93)90213-8; Tanaka K, 2008, STROKE, V39, P2052, DOI 10.1161/STROKEAHA.107.509455; Rise P, 2007, PROSTAG LEUKOTR ESS, V76, P363, DOI 10.1016/j.plefa.2007.05.003; Ikeya Y, 2015, NUTR RES, V35, P214, DOI 10.1016/j.nutres.2015.01.003	7	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0271-5317			NUTR RES	Nutr. Res.	NOV	2015	35	11					1027	1027		10.1016/j.nutres.2015.09.009		1	Nutrition & Dietetics	Nutrition & Dietetics	CW7AN	WOS:000365150400012		
J	Ohno, Y; Miyazaki, T; Sato, M; Araki, R; Takahashi, S; Takenaka, T; Suzuki, H; Shibazaki, S				Ohno, Yoichi; Miyazaki, Takashi; Sato, Makiko; Araki, Ryuichiro; Takahashi, Sachiko; Takenaka, Tsuneo; Suzuki, Hiromichi; Shibazaki, Satomi			Lifestyle modifications supported by regional health nurses lowered insulin resistance, oxidative stress and central blood pressure in subjects with metabolic syndrome	OBESITY RESEARCH & CLINICAL PRACTICE			English	Article						Lifestyle modifications; Metabolic syndrome; Insulin resistance; Oxidative stress; Blood pressure	CARDIOVASCULAR-DISEASE MORTALITY; JAPANESE MEN; AUGMENTATION INDEX; PHYSICAL-ACTIVITY; WEIGHT-LOSS; INTERVENTION; RISK; HYPERTENSION; INFLAMMATION; OVERWEIGHT	Background: This study was attempted to investigate whether lifestyle modifications supported by regional health nurses should improve cardio-metabolic factors-including adipocytokines, oxidative stress, and arterial stiffness-in subjects with metabolic syndrome. Methods: Thirty-six subjects with metabolic syndrome were enrolled, 28 of whom completed the 6-month lifestyle modifications (male: female = 19: 9). Blood and urine test results were examined in relation to metabolic factors before and after 6-month nutritional and physical activity modifications. In addition, oral glucose tolerance tests were performed and arterial stiffness was measured by brachial-ankle pulse wave velocity and radial augmentation index before and after them. Results: Six-month lifestyle modifications significantly reduced body weight, homeostasis model assessment index, and low-density lipoprotein cholesterol (LDL-C). They significantly attenuated oxidative stress measured by the urinary 8-hydroxy-2-deoxyguanosine/creatinine ratio. They also lowered brachial and central systolic blood pressure. They tended to decrease waist circumferences and the levels of C-reactive protein. However they did not significantly change the levels of adipocytokines, including tumour necrosis factor, soluble tumour necrosis factor receptors, and interleukin 6, or arterial stiffness measured by brachial-ankle pulse wave velocity and radial augmentation index. Conclusions: Six-month lifestyle modifications supported by regional health nurses lowered body weight, insulin resistance, LDL-C, oxidative stress, and peripheral and central blood pressure in subjects with metabolic syndrome. (C) 2015 Asian Oceanian Association for the Study of Obesity. Published by Elsevier Ltd. All rights reserved.	[Ohno, Yoichi; Miyazaki, Takashi; Sato, Makiko; Araki, Ryuichiro; Takahashi, Sachiko; Suzuki, Hiromichi; Shibazaki, Satomi] Saitama Med Univ, Community Hlth Sci Ctr, Saitama, Japan; [Ohno, Yoichi; Suzuki, Hiromichi] Saitama Med Univ, Dept Nephrol, Saitama, Japan; [Takenaka, Tsuneo] Int Univ Hlth & Welf, Clin Res Ctr, Tokyo, Japan	Ohno, Y (reprint author), 38 Moro Hongo, Moroyama, Saitama, Japan.	yo1-ohno@bk2.so-net.ne.jp					Mora S, 2007, CIRCULATION, V116, P2110, DOI 10.1161/CIRCULATIONAHA.107.729939; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Carroll S, 2004, SPORTS MED, V34, P371, DOI 10.2165/00007256-200434060-00004; Selvin E, 2007, ARCH INTERN MED, V167, P31, DOI 10.1001/archinte.167.1.31; Schulze MB, 2005, AM J CLIN NUTR, V82, P675; Takenaka T, 2012, AM J NEPHROL, V35, P416, DOI 10.1159/000338132; Saaristo T, 2010, DIABETES CARE, V33, P2146, DOI 10.2337/dc10-0410; Liu LJ, 2014, AM J CARDIOL, V113, P84, DOI 10.1016/j.amjcard.2013.08.042; Ohno Y, 2008, J HUM HYPERTENS, V22, P144, DOI 10.1038/sj.jhh.1002278; Sakano N, 2009, J CLIN BIOCHEM NUTR, V44, P185, DOI 10.3164/jcbn.08-252; Higashino R, 2013, BLOOD PRESS MONIT, V18, P311, DOI 10.1097/MBP.0000000000000006; Roman MJ, 2007, HYPERTENSION, V50, P197, DOI 10.1161/HYPERTENSIONAHA.107.089078; Ahmed HM, 2012, AM J CARDIOL, V109, P288, DOI 10.1016/j.amjcard.2011.08.042; Sanchez-Muniz FJ, 2012, NUTR HOSP, V27, P31, DOI [10.1590/S0212-16112012000100005, 10.3305/nh.2012.27.1.5560]; Kohro T, 2008, INT HEART J, V49, P193, DOI 10.1536/ihj.49.193; Miyatake N, 2010, INTERNAL MED, V49, P261, DOI 10.2169/internalmedicine.49.2900; Kobayashi K, 2011, CLIN EXP HYPERTENS, V33, P100, DOI 10.3109/10641963.2010.531834; Roberts CK, 2009, LIFE SCI, V84, P705, DOI 10.1016/j.lfs.2009.02.026; Herder C, 2009, DIABETOLOGIA, V52, P433, DOI 10.1007/s00125-008-1243-1; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; Morii T, 2009, BIOMARKERS, V14, P207, DOI 10.1080/13547500902811274; Lu Y, 2014, LANCET, V383, P970, DOI 10.1016/S0140-6736(13)61836-X; Cangemi R, 2007, FREE RADICAL BIO MED, V43, P853, DOI 10.1016/j.freeradbiomed.2007.06.002; Mitjavila MT, 2013, CLIN NUTR, V32, P172, DOI 10.1016/j.clnu.2012.08.002; Eckel RH, 2013, CIRCULATION; Eguchi T, 2014, INT J BIOL MARKER, V29, pE69, DOI 10.5301/jbm.5000049; Health Insurance Bureau, PROT UN HLTH INS SYS; Kujala UM, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000292; Okauchi Y, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-82; Rector RS, 2007, AM J PHYSIOL-ENDOC M, V293, pE500, DOI 10.1152/ajpendo.00116.2007; Rodriguez MP, 2013, NITRIC OXIDE C, V36C, P67; Siqueira-Catania A, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-21; Yamaoka K, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-138	33	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1871-403X	1878-0318		OBES RES CLIN PRACT	Obes. Res. Clin. Pract.	NOV-DEC	2015	9	6					584	591		10.1016/j.orcp.2015.03.003		8	Endocrinology & Metabolism; Nutrition & Dietetics	Endocrinology & Metabolism; Nutrition & Dietetics	CW8HY	WOS:000365241300005		
J	Hamasaki, H; Moriyama, S; Yanai, H				Hamasaki, Hidetaka; Moriyama, Sumie; Yanai, Hidekatsu			A possible difference in the mechanism for postprandial hypoglycemia associated with dumping syndrome between patients with and without type 2 diabetes	OBESITY RESEARCH & CLINICAL PRACTICE			English	Letter						GLP-1; Dumping syndrome; Bariatric surgery; Type 2 diabetes	GLP-1	Dumping syndrome is a complication of gastric surgery including bariatric surgery, and which is induced by rapid gastric emptying and increased intestinal motility. We should note that hypoglycaemia due to dumping syndrome can occur in patients with type 2 diabetes. However, the pathogenesis of dumping syndrome in patients with type 2 diabetes is not fully investigated. We investigated the changes in plasma glucose, serum insulin, plasma glucagon, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) by the 75 g oral glucose tolerance test (OGTT) in 3 patients with and without type 2 diabetes who had gastric surgery. Significant hyperinsulinemia was observed in non-diabetic patients, but not in a diabetic patient. On the other hand, plasma GLP-1 levels significantly increased after glucose intake in a diabetic patient. Increased secretion of GLP-1 may have caused reactive hypoglycaemia in patients with type 2 diabetes undergoing gastric surgery. (C) 2015 Asian Oceanian Association for the Study of Obesity. Published by Elsevier Ltd. All rights reserved.	[Hamasaki, Hidetaka; Moriyama, Sumie; Yanai, Hidekatsu] Natl Ctr Global Hlth & Med Kohnodai Hosp, Dept Internal Med, Chiba 2728516, Japan	Hamasaki, H (reprint author), Natl Ctr Global Hlth & Med Kohnodai Hosp, Dept Internal Med, 1-7-1 Kohnodai, Chiba 2728516, Japan.	hhamasaki78@gmail.com		Hamasaki, Hidetaka/0000-0002-0124-597X			American Diabetes Association, 2010, DIABETES CARE S1, V33, pS11, DOI DOI 10.2337/DC10-S011; Padoin AV, 2009, OBES SURG, V19, P1481, DOI 10.1007/s11695-009-9943-2; Tack J, 2009, NAT REV GASTRO HEPAT, V6, P583, DOI 10.1038/nrgastro.2009.148; CREUTZFELDT W, 1985, DIABETOLOGIA, V28, P565; Toft-Nielsen M, 1998, DIABETOLOGIA, V41, P1180, DOI 10.1007/s001250051049; Scheen AJ, 2009, DIABETES METAB, V35, P537, DOI 10.1016/S1262-3636(09)73463-9; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; ROTH DA, 1965, DIABETES, V14, P526; Patti ME, 2014, GASTROENTEROLOGY, V146, P605, DOI 10.1053/j.gastro.2014.01.038	9	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1871-403X	1878-0318		OBES RES CLIN PRACT	Obes. Res. Clin. Pract.	NOV-DEC	2015	9	6					622	624		10.1016/j.orcp.2015.08.006		3	Endocrinology & Metabolism; Nutrition & Dietetics	Endocrinology & Metabolism; Nutrition & Dietetics	CW8HY	WOS:000365241300011		
J	Langlais, R; Katsumata, A; Naidoo, S; Ogawa, K; Fukui, T; Shimoda, S; Kobayashi, K				Langlais, Robert; Katsumata, Akitoshi; Naidoo, Sudeshni; Ogawa, Koichi; Fukui, Tatsumasa; Shimoda, Shinji; Kobayashi, Kaoru			The cadmium telluride photon counting sensor in panoramic radiology: gray value separation and its potential application for bone density evaluation	ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY			English	Article							CONE-BEAM CT; TOMOSYNTHESIS METHOD; GREY LEVELS; DOSIMETRY; DEVICES	Objective. To investigate whether bone mineral density can be evaluated more accurately using a panoramic device with a new cadmium telluride photon-counting sensor and software than 2 panoramic devices with a conventional semiconductor sensor. Study Design. A fiduciary test object with several known levels of hydroxy apatite mineral concentration was placed in a phantom on the mandibular occlusal plane. Panoramic images were acquired by changing the position of the test object within the dental arch. The gray value, the spectrum deformation index (SDI), and the relative attenuation index (RAI) of the test object were evaluated. The SDI and RAI represent unique energy information as acquired by the QR-Master panoramic machine and the corresponding special QR-MC analysis software. In order to compare the values expressed in the different units (gray, SDI, and RAI values), the percentage discrepancy was calculated. Results. The cadmium telluride photon-counting fitted machine more consistently separated each of the hydroxy apatite concentrations in all of the different positioning configurations and locations. The SDI function of the QR Master machine produced more stable values than the RAI value and the gray values of the 2 conventional panoramic machines. Conclusions. The methodologies as developed for this study can be used to test more sophisticated analyses for the determination of bone density.	[Langlais, Robert] Univ Texas Hlth Sci Ctr San Antonio, Sch Dent, San Antonio, TX 78229 USA; [Langlais, Robert] CEO Emeritus Enterprises, San Antonio, TX USA; [Katsumata, Akitoshi] Asahi Univ, Sch Dent, Dept Oral Radiol, Mizuho, Gifu 5010296, Japan; [Naidoo, Sudeshni] Univ Western Cape, Tygerberg, South Africa; [Ogawa, Koichi] Hosei Univ, Fac Sci & Engn, Dept Appl Informat, Tokyo, Japan; [Fukui, Tatsumasa] Asahi Univ, Sch Dent, Dept Oral Radiol, Mizuho, Gifu 5010296, Japan; [Shimoda, Shinji] Tsurumi Univ, Sch Dent Med, Dept Oral Anat, Yokohama, Kanagawa, Japan; [Kobayashi, Kaoru] Tsurumi Univ, Sch Dent Med, Dept Oral Radiol, Yokohama, Kanagawa, Japan	Katsumata, A (reprint author), Asahi Univ, Sch Dent, Dept Oral Radiol, 1851-1 Hozumi, Mizuho, Gifu 5010296, Japan.	kawamata@dent.asahi-u.ac.jp			Japanese Ministry of Economy, Trade, and Industry	This work was supported by "Grant-in-Aid for subject-solution-type development of medical instrument" by the Japanese Ministry of Economy, Trade, and Industry.	Ludlow JB, 2003, DENTOMAXILLOFAC RAD, V32, P229, DOI 10.1259/dmfr/26310390; Yang J, 2002, DENTOMAXILLOFAC RAD, V31, P313, DOI 10.1038/sj.dmfr.4600715; Mah P, 2010, DENTOMAXILLOFAC RAD, V39, P323, DOI 10.1259/dmfr/19603304; Noujeim M, 2011, DENTOMAXILLOFAC RAD, V40, P42, DOI 10.1259/dmfr/73312141; Katsumata A, 2011, ORAL SURG ORAL MED O, V112, P375, DOI 10.1016/j.tripleo.2011.04.024; Kitai N, 2013, ANGLE ORTHOD, V83, P117, DOI 10.2319/020412-100.1; Reeves TE, 2012, DENTOMAXILLOFAC RAD, V41, P500, DOI 10.1259/dmfr/31640433; Chun KJ, 2011, SEMIN NUCL MED, V41, P220, DOI 10.1053/j.semnuclmed.2010.12.002; Ogawa K, 2012, NUCL INSTRUM METH A, V664, P29, DOI 10.1016/j.nima.2011.10.009; Cakur B, 2008, J INT MED RES, V36, P792; Devlin H, 1998, J PROSTHET DENT, V79, P323, DOI 10.1016/S0022-3913(98)70245-8; Ludlow JB, 2008, ORAL SURG ORAL MED O, V106, P106, DOI 10.1016/j.tripleo.2008.03.018; Ludlow JB, 2008, J AM DENT ASSOC, V139, P1237; Ogawa K, 2010, DENTOMAXILLOFAC RAD, V39, P47, DOI 10.1259/dmfr/12999660; Gulashi A, 2010, DENTOMAXILLOFAC RAD, V39, P284; Hiasa K, 2011, ISRN DENT, V2011; Langland OE, 1982, PRINCIPLES PRACTICE, P37; Langland OE, 2002, PRINCIPLES DENT IMAG, P31; Langland OE, 1989, PANORAMIC RADIOGRAPH, P38; Nakaerts O, 2007, CLIN ORAL INVEST, V11, P225	20	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	2212-4403	1528-395X		OR SURG OR MED OR PA	Oral Surg. Oral Med. Oral Pathol. Oral Radiol.	NOV	2015	120	5					636	643		10.1016/j.oooo.2015.07.002		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CW2OY	WOS:000364833200021		
J	Maeyama, S; Watanabe, T; Idomura, Y; Nakata, M; Nunami, M; Ishizawa, A				Maeyama, Shinya; Watanabe, Tomohiko; Idomura, Yasuhiro; Nakata, Motoki; Nunami, Masanori; Ishizawa, Akihiro			Improved strong scaling of a spectral/finite difference gyrokinetic code for multi-scale plasma turbulence	PARALLEL COMPUTING			English	Article						Gyrokinetics; Computational fluid dynamics application; Parallel scalability; Spectral method; Finite difference	TEMPERATURE-GRADIENT TURBULENCE; K-COMPUTER; SIMULATIONS; IMPLEMENTATION; COMMUNICATION; INTERCONNECT; DYNAMICS; TOFU	Optimization techniques of a plasma turbulence simulation code GKV for improved strong scaling are presented. This work is motivated by multi-scale plasma turbulence extending over multiple spatio-temporal scales of electrons and ions, whose simulations based on the gyrokinetic theory require huge calculations of five-dimensional (5D) computational fluid dynamics by means of spectral and finite difference methods. First, we present the multi-layer domain decomposition of the multi-dimensional and multi-species problem, and segmented MPI-process mapping on 3D torus interconnects, which fully utilizes the bi-section bandwidth for data transpose and reduces the conflicts of simultaneous point-to-point communications. These techniques reduce the inter-node communication cost drastically. Second, pipelined computation-communication overlaps are implemented by using the OpenMP/MPI hybrid parallelization, which effectively mask the communication cost. Careful regulations of the pipeline length and of the thread granularity respectively suppress latencies of MPI, load imbalance and scheduling overheads of OpenMP. Thanks to the above optimizations, GKV achieves excellent strong scaling up to similar to 600k cores with high computational performance 782.4 TFlops (8.29% of the theoretical peak) and high effective parallelization rate similar to 99.99994% on K, which demonstrates its applicability and efficiency toward a million of cores. The optimized code realizes multi-scale plasma turbulence simulations covering electron and ion scales, and reveals cross-scale interactions of electron- and ion-scale turbulence. (C) 2015 Elsevier B.V. All rights reserved.	[Maeyama, Shinya; Idomura, Yasuhiro] Japan Atom Energy Agcy, Kashiwa, Chiba 2778587, Japan; [Maeyama, Shinya; Watanabe, Tomohiko] Nagoya Univ, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Nakata, Motoki] Japan Atom Energy Agcy, Obuchi, Rokkasho 0393212, Japan; [Nunami, Masanori; Ishizawa, Akihiro] Grad Univ Adv Studies, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan	Maeyama, S (reprint author), Nagoya Univ, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	smaeyama@p.phys.nagoya-u.ac.jp			HPCI Strategic Programs [4]; G8 Research Council Initiative (NuFuSE); JAEA-NIFS collaboration program; KAKENHI from the Japanese Ministry of Education, Culture, Sports, Science and Technology [26800283]; RIKEN Advanced Institute for Computational Science through the HPCI System Research project [hp120011]	This work is supported by the HPCI Strategic Programs Field No. 4, the G8 Research Council Initiative (NuFuSE), the JAEA-NIFS collaboration program, and the KAKENHI Grant no. 26800283 from the Japanese Ministry of Education, Culture, Sports, Science and Technology. This research uses computational resources of K at RIKEN Advanced Institute for Computational Science through the HPCI System Research project (Project ID:hp120011). Computations are partially performed on BX900 at Japan Atomic Energy Agency (to check cross-platform versatility) and on Helios at Computational Simulation Centre of International Fusion Energy Research Centre (for linear instability analysis).	Adachi Tomoya, 2013, Computer Science - Research and Development, V28, DOI 10.1007/s00450-012-0211-7; Idomura Y, 2014, INT J HIGH PERFORM C, V28, P73, DOI 10.1177/1094342013490973; FOX DG, 1973, J COMPUT PHYS, V11, P612, DOI 10.1016/0021-9991(73)90141-1; Jenko F, 2000, PHYS PLASMAS, V7, P1904, DOI 10.1063/1.874014; Montagnier J, 2013, INT J NUMER METH FL, V72, P709, DOI 10.1002/fld.3758; Gorler T, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.185002; Mininni PD, 2011, PARALLEL COMPUT, V37, P316, DOI 10.1016/j.parco.2011.05.004; Calvin C, 1996, PARALLEL COMPUT, V22, P1255, DOI 10.1016/S0167-8191(96)00039-7; Candy J, 2007, PLASMA PHYS CONTR F, V49, P1209, DOI 10.1088/0741-3335/49/8/008; Dimits AM, 2000, PHYS PLASMAS, V7, P969, DOI 10.1063/1.873896; Rabenseifner R, 2009, EUROMICRO WORKSHOP P, P427, DOI 10.1109/.42; Candy J, 2006, PHYS PLASMAS, V13, DOI 10.1063/1.2220536; ANTONSEN TM, 1980, PHYS FLUIDS, V23, P1205, DOI 10.1063/1.863121; Brizard AJ, 2007, REV MOD PHYS, V79, P421, DOI 10.1103/RevModPhys.79.421; Ajima Y, 2012, FUJITSU SCI TECH J, V48, P280; Ajima Y, 2009, COMPUTER, V42, P36, DOI 10.1109/MC.2009.370; BEER MA, 1995, PHYS PLASMAS, V2, P2687, DOI 10.1063/1.871232; Frigo M, 2005, P IEEE, V93, P216, DOI 10.1109/JPROC.2004.840301; Maeyama S., 2013, PLASMA FUSION RES, V8; Maeyama S, 2013, COMPUT PHYS COMMUN, V184, P2462, DOI 10.1016/j.cpc.2013.06.014; Watanabe TH, 2006, NUCL FUSION, V46, P24, DOI 10.1088/0029-5515/46/1/003; Yamada S., 2005, P ACM IEEE C SUP SEA, P44	22	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8191	1872-7336		PARALLEL COMPUT	Parallel Comput.	NOV	2015	49						1	12		10.1016/j.parco.2015.06.001		12	Computer Science, Theory & Methods	Computer Science	CW3KZ	WOS:000364892500001		
J	Mishima, T; Fujioka, S; Kurisaki, R; Yanamoto, S; Higuchi, MA; Tsugawa, J; Fukae, J; Neshige, R; Tsuboi, Y				Mishima, Takayasu; Fujioka, Shinsuke; Kurisaki, Ryoichi; Yanamoto, Shozaburo; Higuchi, Masa-aki; Tsugawa, Jun; Fukae, Jiro; Neshige, Ryuji; Tsuboi, Yoshio			Impulse control disorders and punding in Perry syndrome	PARKINSONISM & RELATED DISORDERS			English	Letter						Perry syndrome; Impulse control disorders; Punding; DCTN1; Frontal lobe dysfunction	PARKINSONS-DISEASE		[Mishima, Takayasu; Fujioka, Shinsuke; Yanamoto, Shozaburo; Higuchi, Masa-aki; Tsugawa, Jun; Fukae, Jiro; Tsuboi, Yoshio] Fukuoka Univ, Dept Neurol, Sch Med, Fukuoka, Fukuoka 8140180, Japan; [Kurisaki, Ryoichi] Natl Hosp Org Kumamoto Minami Hosp, Dept Neurol, Kumamoto, Japan; [Neshige, Ryuji] Neshige Neurol Clin, Kurume, Fukuoka, Japan	Tsuboi, Y (reprint author), Fukuoka Univ, Dept Neurol, Johnan Ku, 7-45-1 Nanakuma, Fukuoka, Fukuoka 8140180, Japan.	tsuboi@cis.fukuoka-u.ac.jp					Farrer MJ, 2009, NAT GENET, V41, P163, DOI 10.1038/ng.293; Evans AH, 2004, MOVEMENT DISORD, V19, P397, DOI 10.1002/mds.20045; Chung EJ, 2014, PARKINSONISM RELAT D, V20, P388, DOI 10.1016/j.parkreldis.2014.01.010; Callesen MB, 2014, PARKINSONISM RELAT D, V20, P22, DOI 10.1016/j.parkreldis.2013.09.006; Rodriguez-Violante M, 2014, PARKINSONISM RELAT D, V20, P907, DOI 10.1016/j.parkreldis.2014.05.014	5	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1353-8020	1873-5126		PARKINSONISM RELAT D	Parkinsonism Relat. Disord.	NOV	2015	21	11					1381	1382		10.1016/j.parkreldis.2015.09.037		2	Clinical Neurology	Neurosciences & Neurology	CW5RS	WOS:000365054900018		
J	Funama, Y; Taguchi, K; Utsunomiya, D; Oda, S; Shimonobo, T; Yuki, H; Kidoh, M; Yamashita, Y				Funama, Yoshinori; Taguchi, Katsuyuki; Utsunomiya, Daisuke; Oda, Seitaro; Shimonobo, Toshiaki; Yuki, Hideaki; Kidoh, Masafumi; Yamashita, Yasuyuki			Simultaneous achievement of accurate CT number and image quality improvement for myocardial perfusion CT at 320-MDCT volume scanning	PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS			English	Article						Full-scan reconstruction; Myocardial CT perfusion; Image-to-image variation; Half-scan reconstruction; 320-Detector volume scanner	COMPUTED-TOMOGRAPHY ANGIOGRAPHY; MULTIDETECTOR CT; STRESS; ISCHEMIA; RECONSTRUCTION; ABNORMALITIES; REDUCTION; ARTIFACTS; ALGORITHM; MDCT	Purpose: To investigate differences in image-to-image variations between full- and half-scan reconstruction on myocardial CT perfusion (CTP) study. Methods: Using a cardiac phantom we performed ECG-gated myocardial CTP on a second-generation 320-multidetector CT volume scanner. The heart rate was set at 60 bpm; once per second for a total of 24 s were performed. CT images were acquired at 80- and 120 kVp and subjected to full-and half-scan reconstruction. On images acquired at the same slice level we then measured image-to-image variations, coefficients of variance (CV), and image noise. Results: The image-to-image variations with full-and half-scan reconstruction were 1.3 HU vs. 27.2 HU at 80 kVp (p < 0.001) and 0.70 HU vs. 9.3 HU at 120 kVp (p < 0.001) even though the mean HU value was almost the same for both reconstruction methods. The CV of 80- and 120-kVp images of the left ventricular cavity decreased by 0.16% and 0.17%, respectively, with full-scan reconstruction; with half-scan reconstruction it decreased by 3.34% and 2.30%, respectively. Compared with half-scan reconstruction, the image noise was reduced by 27.2% at 80 kVp and by 28.0% at 120 kVp with full-scan reconstruction. Conclusion: Myocardial CTP with full-scan reconstruction substantially decreased image-to-image variations and provided accurate CT attenuation. (C) 2015 Associazione Italiana di Fisica Medica. Published by Elsevier Ltd. All rights reserved.	[Funama, Yoshinori] Kumamoto Univ, Fac Life Sci, Dept Med Phys, Kumamoto 8620976, Japan; [Taguchi, Katsuyuki] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA; [Utsunomiya, Daisuke; Oda, Seitaro; Yuki, Hideaki; Kidoh, Masafumi; Yamashita, Yasuyuki] Kumamoto Univ, Fac Life Sci, Dept Diagnost Radiol, Kumamoto 8620976, Japan; [Shimonobo, Toshiaki] Kumamoto Univ Hosp, Dept Radiol, Kumamoto, Japan	Funama, Y (reprint author), Kumamoto Univ, Fac Life Sci, Dept Med Phys, 4-24-1 Kuhonji, Kumamoto 8620976, Japan.	funama@kumamoto-u.ac.jp					Ghoshhajra BB, 2011, J CARDIOVASC COMPUT, V5, P459, DOI 10.1016/j.jcct.2011.10.011; Feuchtner G, 2011, CIRC-CARDIOVASC IMAG, V4, P540, DOI 10.1161/CIRCIMAGING.110.961250; Gervaise A, 2012, EUR RADIOL, V22, P295, DOI 10.1007/s00330-011-2271-7; Kitagawa K, 2010, RADIOLOGY, V256, P111, DOI 10.1148/radiol.10091399; George RT, 2009, CIRC-CARDIOVASC IMAG, V2, P174, DOI 10.1161/CIRCIMAGING.108.813766; Fujita M, 2014, EUR RADIOL, V24, P748, DOI 10.1007/s00330-013-3063-z; Rochitte CE, 2014, EUR HEART J, V35, P1120, DOI 10.1093/eurheartj/eht488; Primak AN, 2007, MED PHYS, V34, P4726, DOI 10.1118/1.2805476; Funama Y, 2014, PHYS MEDICA, V30, P385, DOI 10.1016/j.ejmp.2013.10.003; Ko BS, 2011, J CARDIOVASC COMPUT, V5, P345, DOI 10.1016/j.jcct.2011.10.005; Patel AR, 2011, J CARDIOVASC COMPUT, V5, P247, DOI 10.1016/j.jcct.2011.06.004; Bamberg F, 2011, RADIOLOGY, V260, P689, DOI 10.1148/radiol.11110638; Bamberg F, 2010, EUR RADIOL, V20, P1168, DOI 10.1007/s00330-010-1715-9; Bischoff B, 2013, INT J CARDIOVAS IMAG, V29, P435, DOI 10.1007/s10554-012-0080-y; Rief M, 2013, J AM COLL CARDIOL, V62, P1476, DOI 10.1016/j.jacc.2013.03.088; Crossett MP, 2011, J CARDIOVASC COMPUT, V5, P406, DOI 10.1016/j.jcct.2011.10.003; Cury RC, 2011, J CARDIOVASC COMPUT, V5, P443, DOI 10.1016/j.jcct.2011.10.012; Bamberg F, 2014, JACC-CARDIOVASC IMAG, V7, P267, DOI 10.1016/j.jcmg.2013.06.008; Funama Y, 2015, PHYS MEDICA, V31, P66, DOI 10.1016/j.ejmp.2014.10.003; Huber Armin M, 2013, Radiology, V269, P378, DOI 10.1148/radiol.13121441; Linde JJ, 2015, INT J CARDIOVAS IMAG, V31, P171, DOI 10.1007/s10554-014-0530-9; Nikolaou K, 2011, INSIGHTS IMAGING, V2, P9, DOI 10.1007/s13244-010-0049-0; Rossi A, 2014, RADIOLOGY, V270, P24, DOI 10.1148/radiol.13112739	23	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1120-1797	1724-191X		PHYS MEDICA	Phys. Medica	NOV	2015	31	7					702	707		10.1016/j.ejmp.2015.05.018		6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CW5OE	WOS:000365044800007		
J	Hao, Q; Saito, Y; Matsuo, Y; Li, HZ; Tanaka, T				Hao, Qian; Saito, Yoshinori; Matsuo, Yosuke; Li, Hai-Zhou; Tanaka, Takashi			Chalcane-stilbene conjugates and oligomeric flavonoids from Chinese Dragon's Blood produced from Dracaena cochinchinensis	PHYTOCHEMISTRY			English	Article						Dracaena cochinchinensis; Asparagaceae; Chinese Dragon's Blood; Chalcane; Stilbene; Flavonoid	STEROIDAL SAPONINS; DERIVATIVES; CAMBODIANA; NEOLIGNANS; LIGNANS; STEMS; RESIN	A detailed chemical investigation of Chinese Dragon's Blood, which is a traditional medicine produced form the red resin of Dracaena cochinchinensis, yielded two chalcane-stilbene conjugates, named cochinchinenenes G and H, together with 25 known compounds. The structures of these compounds were determined by spectroscopic examination. HPLC analysis of the resin indicated that the major constituents were a complex mixture of oligomeric polyphenols, which were detected as a broad hump on the base line of a HPLC chromatogram. C-13 NMR analysis indicated that the oligomers were mainly composed of oxygenated chalcane units. This suggestion was supported by the results of a thiol degradation experiment with mercaptoethanol, which yielded a thioether of 4-[(4-hydroxyphenyl)propyl]-3-methoxyphenol. Furthermore, methylation followed by electrospray ionization mass spectroscopic analysis of the resulting fractions established the presence of at least one heptamer of chalcane units. (C) 2015 Elsevier Ltd. All rights reserved.	[Hao, Qian; Saito, Yoshinori; Matsuo, Yosuke; Tanaka, Takashi] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 8528521, Japan; [Li, Hai-Zhou] Kunming Univ Sci & Technol, Fac Life Sci & Technol, Yunnan 650500, Peoples R China	Tanaka, T (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, 1-14 Bunkyo Machi, Nagasaki 8528521, Japan.	t-tanaka@nagasaki-u.ac.jp					Xiong L, 2011, J NAT PROD, V74, P1188, DOI 10.1021/np200117y; Wang Q, 2006, TETRAHEDRON, V62, P6107, DOI 10.1016/j.tet.2006.03.111; Zhu YD, 2007, J NAT PROD, V70, P1570, DOI 10.1021/np070260v; Wang XH, 2011, PLANT SCI, V180, P292, DOI 10.1016/j.plantsci.2010.09.007; Zheng QA, 2006, J ASIAN NAT PROD RES, V8, P571, DOI 10.1080/1028602042000204126; Li N, 2014, J ETHNOPHARMACOL, V152, P508, DOI 10.1016/j.jep.2014.01.032; Mei WL, 2013, B KOREAN CHEM SOC, V34, P1791, DOI 10.5012/bkcs.2013.34.6.1791; Wang YH, 2010, HELV CHIM ACTA, V93, P2467, DOI 10.1002/hlca.201000116; Zheng QA, 2004, HELV CHIM ACTA, V87, P1167, DOI 10.1002/hlca.200490106; Mimaki Y, 1996, PHYTOCHEMISTRY, V42, P1609, DOI 10.1016/0031-9422(96)00107-0; Zheng QG, 2012, B KOREAN CHEM SOC, V33, P4204, DOI 10.5012/bkcs.2012.33.12.4204; Kusano R, 2011, J NAT PROD, V74, P119, DOI 10.1021/np100372t; Luo Y, 2011, PLANTA MED, V77, P2053, DOI 10.1055/s-0031-1280086; Zheng QA, 2004, STEROIDS, V69, P111, DOI 10.1016/j.steroids.2003.11.004; Yi T, 2011, J ETHNOPHARMACOL, V133, P796, DOI 10.1016/j.jep.2010.11.008; Orsini F, 2004, J NAT PROD, V67, P421, DOI 10.1021/np0303153; Tobinaga S., 2006, Jpn. Kokai Tokkyo Koho, Patent No. [JP 2006241078 A 20060914, 2006241078]; Tu PengFei, 2003, Chinese Journal of Natural Medicines, V1, P27; Wei H., 1998, CHINA J CHINESE MAT, V23, P616; Zheng QA, 2012, NAT PROD BIOPROSPECT, V2, P111; Zhou Z. H., 2001, CHIN TRAD HERB DRUGS, V32, P484; Zhou ZhiHong, 2001, Acta Pharmaceutica Sinica, V36, P200	22	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0031-9422			PHYTOCHEMISTRY	Phytochemistry	NOV	2015	119						76	82		10.1016/j.phytochem.2015.09.009		7	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	CW3IV	WOS:000364886700009		
J	Aratani, N; Katada, I; Nakayama, K; Terano, M; Taniike, T				Aratani, Naoki; Katada, Ikki; Nakayama, Koyuru; Terano, Minoru; Taniike, Toshiaki			Development of high-throughput chemiluminescence imaging instrument for parallel evaluation of polymer lifetime	POLYMER DEGRADATION AND STABILITY			English	Article						Chemiluminescence imaging; High-throughput; Oxidative degradation; Anti-oxidants; Structure-performance relationship; Polypropylene	ETHYLENE-PROPYLENE ELASTOMERS; ANTIOXIDANT EFFECTIVENESS; PHENOLIC ANTIOXIDANTS; COMBINATORIAL METHODS; THERMAL-STABILITY; HINDERED PHENOLS; POLYPROPYLENE; DEGRADATION; OXIDATION; STABILIZATION	A high-throughput chemiluminescence imaging instrument is developed to realize facile and systematic data accumulation in degradation and stabilization of polymer. The instrument works based on imaging chemiluminescence of 100 oxidatively degrading polymer samples that are placed in a multi-cell with arrayed wells being flushed with atmospheric gas, and thereby enables simultaneous acquisition of 100 chemiluminescence curves. The present study reports validation and demonstrative application of the instrument for the oxidative degradation of stabilized polypropylene with a variety of hindered phenol anti-oxidants. Based on quantitatively accurate and large-volume data on oxidative induction time, not only the feasibility of the new instrument but also a number of useful aspects of stabilizers are demonstrated. (C) 2015 Elsevier Ltd. All rights reserved.	[Aratani, Naoki; Katada, Ikki; Nakayama, Koyuru; Terano, Minoru; Taniike, Toshiaki] Japan Adv Inst Sci & Technol, Sch Mat Sci, Nomi, Ishikawa 9231292, Japan	Taniike, T (reprint author), Japan Adv Inst Sci & Technol, Sch Mat Sci, 1-1 Asahidai, Nomi, Ishikawa 9231292, Japan.	taniike@jaist.ac.jp					Ahlblad G., 1997, POLYM TEST, V16, P59; Hoogenboom R, 2003, MACROMOL RAPID COMM, V24, P16; Hopewell J, 2009, PHILOS T R SOC B, V364, P2115, DOI 10.1098/rstb.2008.0311; Haider N, 2000, BIOMACROMOLECULES, V1, P481, DOI 10.1021/bm0000283; PFAENDNER R, 1995, ANGEW MAKROMOL CHEM, V232, P193, DOI 10.1002/apmc.1995.052320113; Blakey I, 2000, POLYM DEGRAD STABIL, V70, P269, DOI 10.1016/S0141-3910(00)00126-9; ALLEN NS, 1981, POLYM PHOTOCHEM, V1, P111, DOI 10.1016/0144-2880(81)90025-7; Hamskog M, 2003, POLYM TEST, V22, P363, DOI 10.1016/S0142-9418(02)00114-9; Homkhiew C, 2015, J THERMOPLAST COMPOS, V28, P179, DOI 10.1177/0892705712475019; KNIGHT JB, 1985, POLYMER, V26, P1713, DOI 10.1016/0032-3861(85)90291-5; CELINA M, 1995, POLYM DEGRAD STABIL, V47, P311, DOI 10.1016/0141-3910(94)00134-T; Foldes E, 1998, ANGEW MAKROMOL CHEM, V262, P65; Luzuriaga S, 2006, POLYM DEGRAD STABIL, V91, P1226, DOI 10.1016/j.polymdegradstab.2005.09.004; Raquez JM, 2010, PROG POLYM SCI, V35, P487, DOI 10.1016/j.progpolymsci.2010.01.001; Celina MC, 2013, POLYM DEGRAD STABIL, V98, P2419, DOI 10.1016/j.polymdegradstab.2013.06.024; Richaud E, 2011, POLYM DEGRAD STABIL, V96, P1, DOI 10.1016/j.polymdegradstab.2010.11.011; Jansson A, 2003, POLYM DEGRAD STABIL, V82, P37, DOI 10.1016/S0141-3910(03)00160-5; Beissmann S, 2013, POLYM DEGRAD STABIL, V98, P1655, DOI 10.1016/j.polymdegradstab.2013.06.015; Vulic I, 2002, POLYM DEGRAD STABIL, V78, P27, DOI 10.1016/S0141-3910(02)00115-5; Wroczynski RJ, 2004, MACROMOL RAPID COMM, V25, P264, DOI 10.1002/marc.200300167; GEORGE GA, 1991, POLYM DEGRAD STABIL, V34, P37, DOI 10.1016/0141-3910(91)90110-D; Kosa C, 2003, POLYM DEGRAD STABIL, V81, P453, DOI 10.1016/S0141-3910(03)00130-7; Okada M, 2002, PROG POLYM SCI, V27, P87, DOI 10.1016/S0079-6700(01)00039-9; Catalina F, 2002, J POLYM SCI POL CHEM, V40, P3312, DOI 10.1002/pola.10419; Siddique R, 2008, WASTE MANAGE, V28, P1835, DOI 10.1016/j.wasman.2007.09.011; Jipa S, 1999, POLYM INT, V48, P414, DOI 10.1002/(SICI)1097-0126(199905)48:5<414::AID-PI155>3.0.CO;2-#; Celina M, 2005, POLYM DEGRAD STABIL, V90, P395, DOI 10.1016/j.polydegradstab.2005.05.004; Balart R, 2005, EUR POLYM J, V41, P2150, DOI 10.1016/j.eurpolymj.2005.04.001; Potyrailo R, 2011, ACS COMB SCI, V13, P579, DOI 10.1021/co200007w; Serranti S, 2011, WASTE MANAGE, V31, P2217, DOI 10.1016/j.wasman.2011.06.007; Eriksson P, 2002, POLYM DEGRAD STABIL, V78, P183, DOI 10.1016/S0141-3910(02)00132-5; Vilaplana F, 2008, MACROMOL MATER ENG, V293, P274, DOI 10.1002/mame.200700393; Hamskog M, 2003, POLYM DEGRAD STABIL, V82, P181, DOI 10.1016/S0141-3910(03)00182-4; Pfaendner R, 2006, POLYM DEGRAD STABIL, V91, P2249, DOI 10.1016/j.polymdegradstab.2005.10.017; Hagemeyer A, 2001, APPL CATAL A-GEN, V221, P23, DOI 10.1016/S0926-860X(01)00886-9; Zaharescu T, 2002, POLYM TEST, V21, P149, DOI 10.1016/S0142-9418(01)00062-9; Fayolle B, 2002, POLYM DEGRAD STABIL, V77, P515, DOI 10.1016/S0141-3910(02)00110-6; CELINA M, 1993, POLYM DEGRAD STABIL, V42, P335, DOI 10.1016/0141-3910(93)90229-C; BILLINGHAM NC, 1991, POLYM DEGRAD STABIL, V31, P23, DOI 10.1016/0141-3910(91)90093-7; Celina M, 2006, POLYM DEGRAD STABIL, V91, P1036, DOI 10.1016/j.polymdegradstab.2005.07.022; ZAHARESCU T, 1995, POLYM DEGRAD STABIL, V48, P151, DOI 10.1016/0141-3910(95)00008-A; Park D, 2012, J APPL POLYM SCI, V124, P1731, DOI 10.1002/app.35186; Tochacek J, 2004, POLYM DEGRAD STABIL, V86, P385, DOI 10.1016/j.polymdegradstab.2004.05.010; STEP EN, 1994, MACROMOLECULES, V27, P2529, DOI 10.1021/ma00087a022; Kohler DR, 1998, POLYM DEGRAD STABIL, V62, P385, DOI 10.1016/S0141-3910(98)00027-5; Kech-Antoine K., 2009, MULTILAYER FLEXIBLE, P37; Richters P., 1970, MACROMOLECULES, V3, P262, DOI 10.1021/ma60014a027; Taniike T., 2008, MACROMOL S, V260, P42; Taniike T., 2015, JP Patent, Patent No. 114212; Yua L, 2006, PROG POLYM SCI, V31, P576; Zweifel H, 1998, STABILIZATION POLYM	51	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0141-3910	1873-2321		POLYM DEGRAD STABIL	Polym. Degrad. Stabil.	NOV	2015	121						340	347		10.1016/j.polymdegradstab.2015.09.025		8	Polymer Science	Polymer Science	CW5SU	WOS:000365057700037		
J	Yoshida, M; Yoshida-Takashima, Y; Nunoura, T; Takai, K				Yoshida, Mitsuhiro; Yoshida-Takashima, Yukari; Nunoura, Takuro; Takai, Ken			Identification and genomic analysis of temperate Pseudomonas bacteriophage PstS-1 from the Japan trench at a depth of 7000 m	RESEARCH IN MICROBIOLOGY			English	Article						Temperate bacteriophage; Deep sea; Genome sequence; Pseudomonas	DEEP-SEA; MARINE VIRUSES; MICROCYSTIS-AERUGINOSA; TAILED-BACTERIOPHAGES; SEQUENCE; PHAGE; BACTERIAL; STUTZERI; DIVERSITY; PROPHAGE	Viruses play important roles in aquatic ecosystems, but deep-sea bacteriophages remain largely unexplored. A temperate bacteriophage (termed vB_PstS-1) was identified from the psychrotolerant gammaproteobacterium Pseudomonas stutzeri 1-1-1b, which was isolated from hadopelagic water (depth of 7000 m) of the Japan Trench in the Northwest Pacific Ocean. The genome size of PstS-1 was 48,666 bp; its genome displayed a 59.8% G + C content and a total of 79 coding sequences were identified in its genome. The PstS-1 phage belongs to the family Siphoviridae, but its genomic sequence and organization are distinct from those of any other well-known Siphoviridae phage. The mosaic genomic structure of PstS-1 suggests the occurrence of genetic exchange between distinct temperate phages in deep-sea Pseudomonas populations. The PstS-1 genome also harbors three distinct sequence regions corresponding to spacers within a single clustered regularly interspaced short palindromic repeat (CRISPR) locus in the rhizosphere-associated diazotrophic P. stutzeri A1501 genome. The extension of these spacers to the soil environment and the presence of many homologs of both the hadal deep-sea phage PstS-1 and terrestrial Pseudomonas phages suggest the early co-evolution of temperate phages and their host genus Pseudomonas prior to the divergence of their habitational and physiological adaptation. (C) 2015 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.	[Yoshida, Mitsuhiro; Yoshida-Takashima, Yukari; Nunoura, Takuro; Takai, Ken] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Yokosuka, Kanagawa 2370061, Japan	Yoshida, M (reprint author), Japan Agcy Marine Earth Sci & Technol JAMSTEC, 2-15 Natsushima Cho, Yokosuka, Kanagawa 2370061, Japan.	mityoshi@jamstec.go.jp			Japan Society for the Promotion of Science (JSPS) [60565555, 24370015]	We would like to thank the captains and crews of the RN Kairei (JAMSTEC) during the KR12-19 cruise. We also appreciate the operation team of the CTD rosette for their work during the KR12-19 cruise. We are grateful to Dr. Takaaki Kubota and Katsuyuki Uematsu for their technical assistance with bacterial isolation and transmission electron microscopy, respectively. This work was supported in part by a Grant-in-Aid for Young Scientists (B) (no. 60565555) and a Grant-in-Aid for Scientific Research (B) (no. 24370015) from the Japan Society for the Promotion of Science (JSPS).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2012, NUCLEIC ACIDS RES, DOI DOI 10.1093/NAR/GKR1065; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Casjens SR, 2005, J BACTERIOL, V187, P1091, DOI 10.1128/JB.187.3.1091-1104.2005; Brunet-Galmes I, 2012, J BACTERIOL, V194, P6642, DOI 10.1128/JB.01753-12; Bouvier T, 2007, ENVIRON MICROBIOL, V9, P287, DOI 10.1111/j.1462-2920.2006.01137.x; Yoshida M, 2008, APPL ENVIRON MICROB, V74, P3269, DOI 10.1128/AEM.02240-07; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Magiopoulos I, 2012, DEEP-SEA RES PT I, V66, P1, DOI 10.1016/j.dsr.2012.03.009; Kropinski AM, 2000, J BACTERIOL, V182, P6066, DOI 10.1128/JB.182.21.6066-6074.2000; Casjens SR, 2005, CURR OPIN MICROBIOL, V8, P451, DOI 10.1016/j.mib.2005.06.014; Anantharaman K, 2014, SCIENCE, V344, P757, DOI 10.1126/science.1252229; Chen F, 2006, APPL ENVIRON MICROB, V72, P4995, DOI 10.1128/AEM.00056-06; Casas V, 2007, METHOD ENZYMOL, V421, P259, DOI 10.1016/S0076-6879(06)21020-6; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Engelhardt T, 2014, ISME J, V8, P1503, DOI 10.1038/ismej.2013.245; Yau S, 2011, P NATL ACAD SCI USA, V108, P6163, DOI 10.1073/pnas.1018221108; Casjens SR, 2008, RES MICROBIOL, V159, P340, DOI 10.1016/j.resmic.2008.04.005; Canchaya C, 2003, MICROBIOL MOL BIOL R, V67, P238, DOI 10.1128/MMBR.67.2.238-276.2003; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Chen M, 2011, J BACTERIOL, V193, P6095, DOI 10.1128/JB.06061-11; Fukui Y, 2012, J GEN APPL MICROBIOL, V58, P273; Faruque SM, 2005, P NATL ACAD SCI USA, V102, P1702, DOI 10.1073/pnas.0408992102; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Wang F, 2007, J BACTERIOL, V189, P7151, DOI 10.1128/JB.00569-07; Pena A, 2012, J BACTERIOL, V194, P1277, DOI 10.1128/JB.06648-11; Yoshida M, 2014, J OCEANOGR, V70, P115, DOI 10.1007/s10872-013-0216-2; Danovaro R, 2008, NATURE, V454, P1084, DOI 10.1038/nature07268; Wang YQ, 2010, APPL ENVIRON MICROB, V76, P7861, DOI 10.1128/AEM.01270-10; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; KING G, 1995, MOL MICROBIOL, V16, P769, DOI 10.1111/j.1365-2958.1995.tb02438.x; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Muniesa M, 2013, FUTURE MICROBIOL, V8, P739, DOI 10.2217/fmb.13.32; Sandaa RA, 2006, APPL ENVIRON MICROB, V72, P4610, DOI 10.1128/AEM.00168-06; Danovaro R, 2008, CURR BIOL, V18, P1, DOI 10.1016/j.cub.2007.11.056; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Fuhrman JA, 1995, LIMNOL OCEANOGR, V40, P1236; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Meiring TL, 2012, EXTREMOPHILES, V16, P715, DOI 10.1007/s00792-012-0467-7; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; NARAYANA N, 1995, NAT STRUCT BIOL, V2, P1018, DOI 10.1038/nsb1195-1018; Tamegai H, 1997, EXTREMOPHILES, V1, P207, DOI 10.1007/s007920050035; Kropinski AM, 2009, ENVIRON MICROBIOL, V11, P2775, DOI 10.1111/j.1462-2920.2009.01970.x; Tock MR, 2005, CURR OPIN MICROBIOL, V8, P466, DOI 10.1016/j.mib.2005.06.003; Yanagawa K, 2014, FEMS MICROBIOL ECOL, V88, P60, DOI 10.1111/1574-6941.12269; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Yan YL, 2008, P NATL ACAD SCI USA, V105, P7564, DOI 10.1073/pnas.0801093105; ETTER RJ, 1992, NATURE, V360, P576, DOI 10.1038/360576a0; Weinbauer MG, 2004, FEMS MICROBIOL REV, V28, P127, DOI 10.1016/j.femsre.2003.08.001; JIANG SC, 1994, MAR ECOL PROG SER, V104, P163, DOI 10.3354/meps104163; Yoshida M, 2010, MICROBES ENVIRON, V25, P211, DOI 10.1264/jsme2.ME10117; Kormas KA, 2006, ENVIRON MICROBIOL, V8, P909, DOI 10.1111/j.1462-2920.2005.00976.x; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Gorlas A, 2012, ENVIRON MICROBIOL, V14, P503, DOI 10.1111/j.1462-2920.2011.02662.x; Engelhardt T, 2011, ENV MICROBIOL REP, V3, P459, DOI 10.1111/j.1758-2229.2010.00232.x; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Busquets A, 2013, GENOME ANNOUNC, V1; Gage JD, 1991, DEEP SEA BIOL NATURA; Grigoryeva TV, 2013, GENOME ANNOUNC, V1; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Hurwitz BL, 2015, ISME J, V9, P472, DOI 10.1038/ismej.2014.143; King AMQ, 2012, 9 INT COMM TAX VIR, P86; Lalucat J, 2006, MICROBIOL MOL BIOL R, V70, P510, DOI 10.1128/MMBR.00047-05; Nagata T., 2000, MICROBIAL ECOLOGY OC, P121; Nunoura T, 2015, P NATL ACAD SCI USA, V121, pE1230; Ohtsubo Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-376; PENA A, 2013, GENOME ANNOUNCEMENTS, V0001; Ronning CM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-202; Sullivan MB, 2006, PLOS BIOL, V4, P1344, DOI 10.1371/journal.pbio.0040234; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Venieraki A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105837; Yoshida M, 2015, EXTREMOPHILES, V19, P49, DOI 10.1007/s00792-014-0702-5; Yoshida M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057271; Yoshida-Takashima Y, 2013, EXTREMOPHILES, V17, P405, DOI 10.1007/s00792-013-0529-5; Yoshida-Takashima Y, 2012, APPL ENVIRON MICROB, V78, P1311, DOI 10.1128/AEM.06491-11	78	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0923-2508	1769-7123		RES MICROBIOL	Res. Microbiol.	NOV	2015	166	9			SI		668	676		10.1016/j.resmic.2015.05.001		9	Microbiology	Microbiology	CW5RY	WOS:000365055500002		
J	Saito, T; Tanikawa, T; Uchida, Y; Takemae, N; Kanehira, K; Tsunekuni, R				Saito, Takehiko; Tanikawa, Taichiro; Uchida, Yuko; Takemae, Nobuhiro; Kanehira, Katsushi; Tsunekuni, Ryota			Intracontinental and intercontinental dissemination of Asian H5 highly pathogenic avian influenza virus (clade 2.3.4.4) in the winter of 2014-2015	REVIEWS IN MEDICAL VIROLOGY			English	Review							GENETIC-CHARACTERIZATION; MIGRATORY BIRDS; A(H5N8) VIRUS; WILD BIRDS; A VIRUSES; DOMESTIC DUCKS; SUBTYPE H5N1; SOUTH-KOREA; PHYLOGENETIC CHARACTERIZATION; MOLECULAR CHARACTERIZATION	Asian H5 highly pathogenic avian influenza viruses (HPAIVs) that possess the clade 2.3.4.4 HA gene have been identified in wild birds and poultry since late 2014 in both Europe and North America (N. America). Clade 2.3.4.4 H5 HPAIVs of the H5N8 subtype have been isolated in both regions, whereas reassortment viruses with NA N1 and N2 subtypes of the North American (N. American). avian lineage have only been identified in N. America. The HA genes of those isolates were closely related to genes of the HPAIVs that have caused massive outbreaks in poultry in Korea since January 2014. The outbreaks caused by those viruses and the genetic relatedness of their HA and NA genes are reviewed in this study. Although the illegal movement of poultry and poultry products cannot be ruled out as a cause of intercontinental and intracontinental dissemination of clade 2.3.4.4 H5 HPAIVs during the winter of 2014-2015, transmission of the viruses by infected migratory birds appears to be a more plausible mechanism for their dissemination. In particular, the involvement of migratory birds in HPAIV transmission between Asia and N. America is highly likely because of the reassortments between H5N8 HPAIV and the N. American lineage avian influenza viruses. Copyright (c) 2015 John Wiley & Sons, Ltd.	[Saito, Takehiko; Tanikawa, Taichiro; Uchida, Yuko; Takemae, Nobuhiro; Kanehira, Katsushi; Tsunekuni, Ryota] Natl Inst Anim Hlth, Natl Agr & Food Res Org NARO, Influenza & Prion Dis Res Ctr, Tsukuba, Ibaraki 3050856, Japan; [Saito, Takehiko] Gifu Univ, United Grad Sch Vet Sci, Gifu, Japan	Saito, T (reprint author), Natl Inst Anim Hlth, Natl Agr & Food Res Org NARO, Influenza & Prion Dis Res Ctr, 3-1-5 Kannondai, Tsukuba, Ibaraki 3050856, Japan.	taksaito@affrc.go.jp			Ministry of Agriculture, Forestry, and Fisheries of Japan	This work was supported in part by a research project for improving food safety and animal health of the Ministry of Agriculture, Forestry, and Fisheries of Japan. The authors thank the researchers who contributed their sequence data to GISAID's EpiFlu Database to promptly share their sequence data.	Adlhoch C, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.50.20996; Golender N, 2008, VIRUS GENES, V37, P289, DOI 10.1007/s11262-008-0272-7; Van Borm S, 2005, EMERG INFECT DIS, V11, P702; Lee CCD, 2014, J VIROL, V88, P5677, DOI 10.1128/JVI.00139-14; Lee EK, 2015, POULTRY SCI, V94, P650, DOI 10.3382/ps/pev036; Kim HR, 2015, EMERG INFECT DIS, V21, P775, DOI 10.3201/eid2105.141967; de Vries E, 2015, EMERG INFECT DIS, V21, P842, DOI 10.3201/eid2105.141927; Mon PP, 2012, ARCH VIROL, V157, P2113, DOI 10.1007/s00705-012-1411-y; Zhao KK, 2013, VET MICROBIOL, V163, P351, DOI 10.1016/j.vetmic.2012.12.025; Ozawa M, 2015, EUROSURVEILLANCE, V20, P15; Smietanka K, 2010, AVIAN DIS, V54, P335, DOI 10.1637/8782-040109-ResNote.1; Mase M, 2005, VIROLOGY, V332, P167, DOI 10.1016/j.virol.2004.11.016; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Ducatez MF, 2007, J GEN VIROL, V88, P2297, DOI 10.1099/vir.0.82939-0; Lee DH, 2015, J VIROL, V89, P6521, DOI 10.1128/JVI.00728-15; Bouwstra R, 2015, EMERG INFECT DIS, V21, P872, DOI 10.3201/eid2105.141839; Kiss I, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-113; Song BM, 2015, J VET SCI, V16, P237, DOI 10.4142/jvs.2015.16.2.237; Ip HS, 2015, EMERG INFECT DIS, V21, P886, DOI 10.3201/eid2105.142020; Lipatov AS, 2007, EMERG INFECT DIS, V13, P539; Couacy-Hymann E, 2009, ZOONOSES PUBLIC HLTH, V56, P10, DOI 10.1111/j.1863-2378.2008.01167.x; Shen HQ, 2015, EMERG INFECT DIS, V21, P1261, DOI 10.3201/eid2107.140838; Desvaux S, 2009, EMERG INFECT DIS, V15, P475, DOI [10.3201/eid1503.071410, 10.3201/eid1503.081410]; Saito T, 2009, VET MICROBIOL, V133, P65, DOI 10.1016/j.vetmic.2008.06.020; Van Borm S, 2012, ARCH VIROL, V157, P1509, DOI 10.1007/s00705-012-1323-x; Fasina FO, 2009, EPIDEMIOL INFECT, V137, P456, DOI 10.1017/S0950268808000988; Ray K, 2008, VIRUS GENES, V36, P345, DOI 10.1007/s11262-007-0195-8; WEBSTER RG, 1986, VIROLOGY, V149, P165, DOI 10.1016/0042-6822(86)90118-2; Uchida Y, 2008, VIRUS RES, V138, P70, DOI 10.1016/j.virusres.2008.08.007; Ducatez MF, 2006, NATURE, V442, P37, DOI 10.1038/442037a; Alexander DJ, 2010, AVIAN DIS, V54, P194, DOI 10.1637/8833-040209-Reg.1; Weber S, 2007, J GEN VIROL, V88, P554, DOI 10.1099/vir.082300-0; Hanna A, 2015, EMERG INFECT DIS, V21, P879, DOI 10.3201/eid2105.141954; [Anonymous], 2015, VET REC, V176, DOI 10.1136/vr.h198; Ramey AM, 2010, VIROLOGY, V406, P352, DOI 10.1016/j.virol.2010.07.031; Szeleczky Z, 2009, VET MICROBIOL, V139, P24, DOI 10.1016/j.vetmic.2009.04.017; Witt CJ, 2005, LANCET INFECT DIS, V5, P143, DOI 10.1016/S1473-3099(05)01305-8; Ku KB, 2014, EMERG INFECT DIS, V20, P1587, DOI 10.3201/eid2009.140390; Kobasa D, 2001, J VIROL, V75, P11773, DOI 10.1128/JVI.75.23.11773-11780.2001; Fusaro A, 2010, J VIROL, V84, P3239, DOI 10.1128/JVI.02385-09; Nagy A, 2007, VET MICROBIOL, V120, P9, DOI 10.1016/j.vetmic.2006.10.004; [Anonymous], 1998, MMWR MORB MORTAL WKL, V46, P1245; Perk S, 2007, VIRUS GENES, V35, P497, DOI 10.1007/s11262-007-0120-1; Lee YJ, 2014, EMERG INFECT DIS, V20, P1087, DOI 10.3201/eid2006.140233; Wee SH, 2006, VET REC, V158, P341; Swayne DE, 2000, REV SCI TECH OIE, V19, P463; Pabbaraju K, 2014, EMERG INFECT DIS, V20, P887, DOI 10.3201/eid2005.140164; Ramey AM, 2010, VIROLOGY, V401, P179, DOI 10.1016/j.virol.2010.02.006; Kanehira K, 2015, ARCH VIROL, V160, P1629, DOI 10.1007/s00705-015-2428-9; [Anonymous], 1997, MMWR MORB MORTAL WKL, V46, P1204; Harder T, 2015, EMERG INFECT DIS, V21, P860, DOI 10.3201/eid2105.141897; Chen HL, 2006, J VIROL, V80, P5976, DOI 10.1128/JVI.00110-06; Smith GJD, 2006, VIROLOGY, V350, P258, DOI 10.1016/j.virol.2006.03.048; Xu XY, 1999, VIROLOGY, V261, P15, DOI 10.1006/viro.1999.9820; Tee KK, 2009, INT J INFECT DIS, V13, P307, DOI 10.1016/j.ijid.2008.09.005; Hofmann MA, 2008, VIRUS GENES, V37, P407, DOI 10.1007/s11262-008-0285-2; Wu HB, 2014, EMERG INFECT DIS, V20, P1315, DOI 10.3201/eid2008.140339; [Anonymous], 2014, VET REC, V175, P495, DOI 10.1136/vr.g6947; Viseshakul N, 2004, VIROLOGY, V328, P169, DOI 10.1016/j.virol.2004.06.045; Wan XF, 2005, ARCH VIROL, V150, P1257, DOI 10.1007/s00705-004-0474-9; Aly MM, 2008, AVIAN DIS, V52, P269, DOI 10.1637/8166-103007-Reg.1; Bi YH, 2015, J GEN VIROL, V96, P975, DOI 10.1099/vir.0.000056; Shortridge KF, 1998, VIROLOGY, V252, P331, DOI 10.1006/viro.1998.9488; Fink M, 2010, J VIROL, V84, P5815, DOI 10.1128/JVI.01642-09; Salzberg SL, 2007, EMERG INFECT DIS, V13, P713; Gu M, 2011, EMERG INFECT DIS, V17, P1060, DOI [10.3201/eid/1706.101406, 10.3201/eid1706.101406]; Wong FYK, 2015, EMERG INFECT DIS, V21, P511, DOI 10.3201/eid2103.141488; KAWAOKA Y, 1984, VIROLOGY, V139, P303, DOI 10.1016/0042-6822(84)90376-3; KAWAOKA Y, 1985, VIROLOGY, V146, P130, DOI 10.1016/0042-6822(85)90059-5; Wasilenko JL, 2012, VIRUS GENES, V44, P247, DOI 10.1007/s11262-011-0689-2; Liu J, 2005, SCIENCE, V309, P1206, DOI 10.1126/science.1115273; Marinova-Petkova A, 2012, EMERG INFECT DIS, V18, P1596, DOI 10.3201/eid1810.120357; Barral M, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-50; Bouwstra RJ, 2015, EUROSURVEILLANCE, V20, P31; Bragstad K, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-43; Jhung MA, 2015, MMWR-MORBID MORTAL W, V64, P111; Dalby AR, 2015, PEERJ, V3, DOI 10.7717/peerj.934; Donis R. O., 2008, Emerging Infectious Diseases, V14, pe1; Donis RO, 2015, INFLUENZA OTHER RESP, DOI [10.1111/irv.12324, DOI 10.1111/IRV.12324]; Dusek RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092075; Fan ST, 2014, INFLUENZA OTHER RESP, V8, P646, DOI 10.1111/irv.12289; Gall-Reculé Ghislaine Le, 2008, Avian Pathol, V37, P15, DOI 10.1080/03079450701774835; Jeong J, 2014, VET MICROBIOL, V173, P249, DOI 10.1016/j.vetmic.2014.08.002; Krauss S, 2007, PLOS PATHOG, V3, P1684, DOI 10.1371/journal.ppat.0030167; Ma QX, 2014, EMERG INFECT DIS, V20, P2152, DOI 10.3201/eid2012.140733; Nguyen DT, 2014, AVIAN DIS, V58, P599, DOI 10.1637/10814-030814-Reg; Pasick J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09484; Qi X., 2014, GENOME ANNOUNC, V2, P2; Reperant LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000854; Rith S, 2014, J VIROL, V88, P13897, DOI 10.1128/JVI.01887-14; Torchetti MK, 2015, GENOME ANNOUNC, V3, DOI [DOI 10.1128/GENOMEA.00195-15, 10.1128/genomeA.00195-15]; Verhagen JH, 2015, EUROSURVEILLANCE, V20; Xu HY, 2015, VIRUSES-BASEL, V7, P887, DOI 10.3390/v7030887; Yoon Hachung, 2015, Osong Public Health Res Perspect, V6, P106, DOI 10.1016/j.phrp.2015.01.005; Zhang YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009167; Zhao G, 2012, CHINA PLOS ONE, V7, DOI [10.1371/journal.pone.0046183, DOI 10.1371/JOURNAL.PONE.0046183]	96	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1052-9276	1099-1654		REV MED VIROL	Rev. Med. Virol.	NOV	2015	25	6					388	405		10.1002/rmv.1857		18	Virology	Virology	CW9JT	WOS:000365315700006		
J	Gong, QY; Dazzan, P; Scarpazza, C; Kasai, K; Hu, XY; Marques, TR; Iwashiro, N; Huang, XQ; Murray, RM; Koike, S; David, AS; Yamasue, H; Lui, S; Mechelli, A				Gong, Qiyong; Dazzan, Paola; Scarpazza, Cristina; Kasai, Kyioto; Hu, Xinyu; Marques, Tiago R.; Iwashiro, Norichika; Huang, Xiaoqi; Murray, Robin M.; Koike, Shinsuke; David, Anthony S.; Yamasue, Hidenori; Lui, Su; Mechelli, Andrea			A Neuroanatomical Signature for Schizophrenia Across Different Ethnic Groups	SCHIZOPHRENIA BULLETIN			English	Article						schizophrenia; neuroanatomy; ethnicity; magnetic resonance imaging; voxel-based morphometry	VOXEL-BASED MORPHOMETRY; 1ST EPISODE PSYCHOSIS; GRAY-MATTER VOLUME; ULTRA-HIGH-RISK; 1ST-EPISODE SCHIZOPHRENIA; LIKELIHOOD ESTIMATION; SALIENCE NETWORK; ANTERIOR INSULA; BRAIN; ABNORMALITIES	Schizophrenia is a disabling clinical syndrome found across the world. While the incidence and clinical expression of this illness are strongly influenced by ethnic factors, it is unclear whether patients from different ethnicities show distinct brain deficits. In this multicentre study, we used structural Magnetic Resonance Imaging to investigate neuroanatomy in 126 patients with first episode schizophrenia who came from 4 ethnically distinct cohorts (White Caucasians, African-Caribbeans, Japanese, and Chinese). Each patient was individually matched with a healthy control of the same ethnicity, gender, and age (+/- 1 year). We report a reduction in the gray matter volume of the right anterior insula in patients relative to controls (P < .05 corrected); this reduction was detected in all 4 ethnic groups despite differences in psychopathology, exposure to antipsychotic medication and image acquisition sequence. This finding provides evidence for a neuroanatomical signature of schizophrenia expressed above and beyond ethnic variations in incidence and clinical expression. In light of the existing literature, implicating the right anterior insula in bipolar disorder, depression, addiction, obsessive-compulsive disorder, and anxiety, we speculate that the neuroanatomical deficit reported here may represent a transdiagnostic feature of Axis I disorders.	[Gong, Qiyong; Hu, Xinyu; Huang, Xiaoqi; Lui, Su] Sichuan Univ, Dept Radiol, Huaxi MR Res Ctr, West China Hosp, Chengdu 610064, Peoples R China; [Dazzan, Paola; Scarpazza, Cristina; Marques, Tiago R.; Murray, Robin M.; David, Anthony S.; Mechelli, Andrea] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychosis Studies, London SE5 8AF, England; [Kasai, Kyioto; Iwashiro, Norichika; Koike, Shinsuke; Yamasue, Hidenori] Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Koike, Shinsuke] UCL, MRC Unit Lifelong Hlth & Ageing, London, England	Mechelli, A (reprint author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychosis Studies, London SE5 8AF, England.	a.mechelli@kcl.ac.uk	Reis Marques, Tiago/F-2489-2010	Reis Marques, Tiago/0000-0003-0602-7661	Chinese National Natural Science Foundation [81030027, 81227002, 81220108013]; Institute of International Education, USA [F510000/G16916411]; King's College London; NARSAD; Psychiatry Research Trust; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [23118001, 20118004]; Japan Agency for Medical Research and Development [H25-002, H26-012]; UK National Institute of Health Research Biomedical Research Centre at the South London & Maudsley NHS Foundation Trust; Institute of Psychiatry, Psychology & Neuroscience, King's College London; MEXT [23118001, 23118004]	QG was supported by the Chinese National Natural Science Foundation (Grant Nos. 81030027, 81227002 and 81220108013) and a CMB Distinguished Professorship Award by the Institute of International Education, USA (Award No. F510000/G16916411). PD was supported by a King's College London Translational Research Grant, NARSAD and the Psychiatry Research Trust. KK was supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) (23118001, 20118004, CBSN) and the Japan Agency for Medical Research and Development (H25-002, H26-012, Brain/MINDS). PD, CS, TRM, RMM, ASD and AM were supported by the UK National Institute of Health Research Biomedical Research Centre at the South London & Maudsley NHS Foundation Trust and the Institute of Psychiatry, Psychology & Neuroscience, King's College London. The acquisition of the Japanese dataset was carried out under Grants-in-Aid for Scientific Research on Innovative Areas (Comprehensive Brain Science Network and Adolescent Mind & Self-Regulation [23118001 & 23118004]) and "Development of biomarker candidates for social behavior" of the Strategic Research Program for Brain Sciences by the MEXT. RMM and ASD are also supported by the UK National Institute of Health Research Biomedical Research Centre at the South London & Maudsley NHS Foundation Trust and Institute of Psychiatry, Psychology & Neuroscience, King's College London.	Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Koutsouleris N, 2008, NEUROIMAGE, V39, P1600, DOI 10.1016/j.neuroimage.2007.10.029; Amminger GP, 2012, MOL PSYCHIATR, V17, P1150, DOI 10.1038/mp.2011.167; Kalra G, 2012, INT REV PSYCHIATR, V24, P441, DOI 10.3109/09540261.2012.708649; Fischer BA, 2009, NEUROPSYCHOPHARMACOL, V34, P2081, DOI 10.1038/npp.2009.32; Shapleske J, 2002, CEREB CORTEX, V12, P1331, DOI 10.1093/cercor/12.12.1331; Yeo RA, 2014, PSYCHOL MED, V44, P1257, DOI 10.1017/S0033291713001608; Chua SE, 2007, SCHIZOPHR RES, V89, P12, DOI 10.1016/j.schres.2006.09.009; Cascella NG, 2011, SCHIZOPHR RES, V133, P77, DOI 10.1016/j.schres.2011.08.004; Orru G, 2012, NEUROSCI BIOBEHAV R, V36, P1140, DOI 10.1016/j.neubiorev.2012.01.004; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261; Gelernter J, 2014, MOL PSYCHIATR, V19, P41, DOI 10.1038/mp.2013.145; Sheffield JM, 2013, SCHIZOPHR RES, V143, P185, DOI 10.1016/j.schres.2012.10.032; Yassa MA, 2009, NEUROIMAGE, V44, P319, DOI 10.1016/j.neuroimage.2008.09.016; Palaniyappan L, 2012, J PSYCHIATR NEUROSCI, V37, P17, DOI 10.1503/jpn.100176; Mechelli A, 2005, CURR MED IMAGING REV, V1, P105, DOI 10.2174/1573405054038726; Prata D, 2014, NEUROSCI BIOBEHAV R, V45, P134, DOI 10.1016/j.neubiorev.2014.05.010; Lim CS, 2011, EARLY INTERV PSYCHIA, V5, P242, DOI 10.1111/j.1751-7893.2011.00260.x; Cumming G, 2014, PSYCHOL SCI, V25, P7, DOI 10.1177/0956797613504966; Takahashi T, 2009, SCHIZOPHR RES, V108, P49, DOI 10.1016/j.schres.2008.12.029; Chan RCK, 2011, SCHIZOPHRENIA BULL, V37, P177, DOI 10.1093/schbul/sbp073; Hutchinson G, 1999, PSYCHOL MED, V29, P607, DOI 10.1017/S0033291799008430; Smieskova R, 2012, PSYCHOL MED, V42, P1613, DOI 10.1017/S0033291711002716; Suhail K, 2002, INT J SOC PSYCHIATR, V48, P126, DOI 10.1177/002076402128783181; Glahn DC, 2008, BIOL PSYCHIAT, V64, P774, DOI 10.1016/j.biopsych.2008.03.031; Howes OD, 2014, LANCET, V383, P1677, DOI 10.1016/S0140-6736(13)62036-X; Fusar-Poli P, 2012, SCHIZOPHRENIA BULL, V38, P1297, DOI 10.1093/schbul/sbr134; Morgan KD, 2010, PSYCHOL MED, V40, P1137, DOI 10.1017/S0033291709991565; MUFSON EJ, 1981, NEUROSCIENCE, V6, P1231, DOI 10.1016/0306-4522(81)90184-6; Iwashiro N, 2012, SCHIZOPHR RES, V137, P124, DOI 10.1016/j.schres.2012.02.024; Takahashi T, 2009, PROG NEURO-PSYCHOPH, V33, P651, DOI 10.1016/j.pnpbp.2009.03.005; Chen Z, 2014, PSYCHOL MED, V44, P2489, DOI 10.1017/S003329171300319X; Mechelli A, 2011, ARCH GEN PSYCHIAT, V68, P489, DOI 10.1001/archgenpsychiatry.2011.42; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Ford ME, 2005, HEALTH SERV RES, V40, P1658, DOI 10.1111/j.1475-6773.2005.00449.x; Takahashi T, 2009, SCHIZOPHR RES, V111, P94, DOI 10.1016/j.schres.2009.03.024; Fornito A, 2009, SCHIZOPHR RES, V108, P104, DOI 10.1016/j.schres.2008.12.011; Straube T, 2011, NEUROIMAGE, V54, P2534, DOI 10.1016/j.neuroimage.2010.10.010; Fusar-Poli P, 2014, WORLD J BIOL PSYCHIA, V15, P219, DOI 10.3109/15622975.2011.630408; Ellison-Wright I, 2008, AM J PSYCHIAT, V165, P1015, DOI 10.1176/appi.ajp.2008.07101562; Mane A, 2009, SCHIZOPHR RES, V114, P136, DOI 10.1016/j.schres.2009.07.014; Takeuchi H, 2011, HUM BRAIN MAPP, V32, P1497, DOI 10.1002/hbm.21122; Giuliani NR, 2011, NEUROIMAGE, V58, P10, DOI 10.1016/j.neuroimage.2011.06.028; Nenadic I, 2012, NEUROPSYCHOBIOLOGY, V66, P44, DOI 10.1159/000338547; Hasenkamp W, 2011, SCHIZOPHR RES, V125, P169, DOI 10.1016/j.schres.2010.08.041; Bauer CM, 2010, NEUROIMAGE, V52, P508, DOI 10.1016/j.neuroimage.2010.04.255; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Fearon P, 2006, PSYCHOL MED, V36, P1541, DOI 10.1017/S0033291706008774; Tapsell R, 2007, INT J SOC PSYCHIATR, V53, P317, DOI 10.1177/0020764006074525; Palaniyappan L, 2013, NEURON, V79, P814, DOI 10.1016/j.neuron.2013.06.027; Zipursky RB, 2013, SCHIZOPHRENIA BULL, V39, P1363, DOI 10.1093/schbul/sbs135; Jakab A, 2012, BRAIN TOPOGR, V25, P264, DOI 10.1007/s10548-011-0205-y; Radua J, 2012, NEUROSCI BIOBEHAV R, V36, P2325, DOI 10.1016/j.neubiorev.2012.07.012; Pu WD, 2012, SCHIZOPHR RES, V141, P15, DOI 10.1016/j.schres.2012.07.017; Benetti S, 2013, SCHIZOPHR RES, V150, P505, DOI 10.1016/j.schres.2013.08.030; BEBBINGTON P, 1995, INT J METHOD PSYCH, V5, P11; Fusar-Poli P, 2014, ANNU REV CLIN PSYCHO, V10, P155, DOI 10.1146/annurev-clinpsy-032813-153645; Goodkind M, 2015, JAMA PSYCHIAT, V72, P305, DOI 10.1001/jamapsychiatry.2014.2206; Meyer Francisca, 2014, Front Behav Neurosci, V7, P118, DOI 10.3389/fnbeh.2013.00118; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Thomas RH, 2015, J NEUROL NEUROSUR PS, V86, P341, DOI 10.1136/jnnp-2014-307903	62	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0586-7614	1745-1701		SCHIZOPHRENIA BULL	Schizophr. Bull.	NOV	2015	41	6					1266	1275		10.1093/schbul/sbv109		10	Psychiatry	Psychiatry	CW1TR	WOS:000364774900012		
J	Leucht, S; Samara, M; Heres, S; Patel, MX; Furukawa, T; Cipriani, A; Geddes, J; Davis, JM				Leucht, Stefan; Samara, Myrto; Heres, Stephan; Patel, Maxine X.; Furukawa, Toshi; Cipriani, Andrea; Geddes, John; Davis, John M.			Dose Equivalents for Second-Generation Antipsychotic Drugs: The Classical Mean Dose Method	SCHIZOPHRENIA BULLETIN			English	Article						dose; equivalence; schizophrenia; antipsychotic drugs	SCHIZOPHRENIA; METAANALYSIS; TRIALS	The concept of dose equivalence is important for many purposes. The classical approach published by Davis in 1974 subsequently dominated textbooks for several decades. It was based on the assumption that the mean doses found in flexible-dose trials reflect the average optimum dose which can be used for the calculation of dose equivalence. We are the first to apply the method to second-generation antipsychotics. We searched for randomized, double-blind, flexible-dose trials in acutely ill patients with schizophrenia that examined 13 oral second-generation antipsychotics, haloperidol, and chlorpromazine (last search June 2014). We calculated the mean doses of each drug weighted by sample size and divided them by the weighted mean olanzapine dose to obtain olanzapine equivalents. We included 75 studies with 16 555 participants. The doses equivalent to 1 mg/d olanzapine were: amisulpride 38.3 mg/d, aripiprazole 1.4 mg/d, asenapine 0.9 mg/d, chlorpromazine 38.9 mg/d, clozapine 30.6 mg/d, haloperidol 0.7 mg/d, quetiapine 32.3mg/d, risperidone 0.4mg/d, sertindole 1.1 mg/d, ziprasidone 7.9 mg/d, zotepine 13.2 mg/d. For iloperidone, lurasidone, and paliperidone no data were available. The classical mean dose method is not reliant on the limited availability of fixed-dose data at the lower end of the effective dose range, which is the major limitation of "minimum effective dose methods" and "dose-response curve methods." In contrast, the mean doses found by the current approach may have in part depended on the dose ranges chosen for the original trials. Ultimate conclusions on dose equivalence of antipsychotics will need to be based on a review of various methods.	[Leucht, Stefan; Samara, Myrto; Heres, Stephan] Tech Univ Munich, Klinikum Rechts Isar, Dept Psychiat & Psychotherapy, D-81675 Munich, Germany; [Leucht, Stefan; Patel, Maxine X.] Kings Coll London, Dept Psychosis Studies, Inst Psychiat Psychol & Neurosci, London WC2R 2LS, England; [Furukawa, Toshi] Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Hlth Promot & Human Behav, Kyoto, Japan; [Furukawa, Toshi] Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Clin Epidemiol, Kyoto, Japan; [Cipriani, Andrea; Geddes, John] Univ Oxford, Dept Psychiat, Oxford, England; [Davis, John M.] Univ Illinois, Inst Psychiat, Chicago, IL USA	Leucht, S (reprint author), Tech Univ Munich, Klinikum Rechts Isar, Dept Psychiat & Psychotherapy, Ismaningerstr 22, D-81675 Munich, Germany.	Stefan.Leucht@lrz.tum.de			Janssen-Cilag; Sanofi-Aventis; Johnson Johnson; Pfizer; Bristol-Myers Squibb; AstraZeneca; Lundbeck; Novartis; Eli Lilly; Otsuka; Servier; Pierre Fabre; Organon; Roche; Merck; National Institute for Health Research; Janssen; Lilly; Endo; Wyeth; Meiji; Mochida; Merck Sharp Dohme (MSD); Tanabe-Mitsubishi; Sekisui; Takeda Science Foundation; Japanese Ministry of Education, Science, and Technology; Japanese Ministry of Health, Labor and Welfare; Japan Foundation for Neuroscience and Mental Health	We thank Sunovion Pharmaceuticals for replying to our request regarding lurasidone. In the last 3 years, S.L. has received honoraria for lectures from Abbvie, AstraZeneca, Bristol-Myers Squibb, ICON, Eli Lilly, Janssen, Johnson & Johnson, Roche, Sanofi-Aventis, Lundbeck, and Pfizer; for consulting/advisory boards from Roche, Eli Lilly, Medavante, Bristol-Myers Squibb, Alkermes, Janssen, Johnson & Johnson, and Lundbeck. Eli Lilly has provided medication for a study with S.L. as primary investigator. S.H. has received honoraria from Janssen-Cilag, Eli Lilly, Sanofi-Aventis, Lundbeck, and Johnson & Johnson; he has accepted travel or hospitality payment from Janssen-Cilag, Sanofi-Aventis, Johnson & Johnson, Pfizer, Bristol-Myers Squibb, AstraZeneca, Lundbeck, Novartis, and Eli Lilly; he has participated in clinical trials sponsored or supported by Eli Lilly, Janssen-Cilag, Johnson & Johnson, Bristol-Myers Squibb, AstraZeneca, Otsuka, Lundbeck, Novartis, Servier, Pierre Fabre, Pfizer, Organon, Roche, and Merck; and he has participated in advisory activities and boards for Janssen, Johnson & Johnson, Eli Lilly, Lundbeck, Otsuka, and Roche. M.X.P. holds a Clinician Scientist Award supported by the National Institute for Health Research and has also received consultancy fees, lecturing honoraria, and/or research funding from Janssen, Lilly, Endo, Lundbeck, Otsuka, and Wyeth. M.X.P. has previously worked on clinical drug trials for Janssen and Amgen and is currently working on a clinical study supported by Lundbeck. T.F. has received lecture fees from Eli Lilly, Meiji, Mochida, Merck Sharp & Dohme (MSD), Otsuka, Pfizer, and Tanabe-Mitsubishi and consultancy fees from Sekisui and Takeda Science Foundation. He has received royalties from Igaku-Shoin, Seiwa-Shoten, and Nihon Bunka Kagaku-sha publishers. He has received grant or research support from the Japanese Ministry of Education, Science, and Technology, the Japanese Ministry of Health, Labor and Welfare, the Japan Foundation for Neuroscience and Mental Health, Tanabe-Mitsubishi, and Mochida. He is a diplomate of the Academy of Cognitive Therapy. A.C. was expert witness for Accord Healthcare for a patent issue about quetiapine extended release. J.G. is a National Institute for Health Research (NIHR) Senior Investigator. M.S. and J.M.D. have no conflict of interest to declare.	Mace S, 2005, INT J PSYCHIAT CLIN, V9, P124, DOI 10.1080/13651500510028995; Hartling L, 2012, ANN INTERN MED, V157, P498, DOI 10.7326/0003-4819-157-7-201210020-00525; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Gardner DM, 2010, AM J PSYCHIAT, V167, P686, DOI 10.1176/appi.ajp.2009.09060802; Leucht S, 2013, LANCET, V382, P951, DOI 10.1016/S0140-6736(13)60733-3; Leucht S, 2009, MOL PSYCHIATR, V14, P429, DOI 10.1038/sj.mp.4002136; Heres S, 2006, AM J PSYCHIAT, V163, P185, DOI 10.1176/appi.ajp.163.2.185; Leucht S, 2009, AM J PSYCHIAT, V166, P152, DOI 10.1176/appi.ajp.2008.08030368; Leucht S, 2009, LANCET, V373, P31, DOI [10.1016/S0140-6736(08)61764-X, 10.1016/S01406736(08)61764-X]; Ho BC, 2011, ARCH GEN PSYCHIAT, V68, P128, DOI 10.1001/archgenpsychiatry.2010.199; Lehman AF, 2004, AM J PSYCHIAT, V161, P1; Davis JM, 2004, J CLIN PSYCHOPHARM, V24, P192, DOI 10.1097/01.jcp.0000117422.05703.ae; Leucht S, 2014, SCHIZOPHRENIA BULL, V40, P314, DOI 10.1093/schbul/sbu001; MCEVOY JP, 1991, ARCH GEN PSYCHIAT, V48, P739; DAVIS JM, 1974, J PSYCHIAT RES, V11, P65, DOI 10.1016/0022-3956(74)90071-5; Li CB, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007474.pub2; Agid O, 2013, AM J PSYCHIAT, V170, P1335, DOI 10.1176/appi.ajp.2013.12030315; Patel MX, 2013, SCHIZOPHR RES, V149, P141, DOI 10.1016/j.schres.2013.06.030; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663; Ho BC, 2009, BIOL PSYCHIAT, V67, P255; Kane JM, 1996, NEW ENGL J MED, V334, P34; Kane JM, 2003, J CLIN PSYCHIAT S12, V64, P1; Milton J, 1995, PSYCHIAT B, V19, P575, DOI 10.1192/pb.19.9.575-a; Patel MX, 2015, PSYCHOL MED, V45, P467, DOI 10.1017/S0033291714001214; Weiden Peter J, 2012, Clin Schizophr Relat Psychoses, V6, P34, DOI 10.3371/CSRP.6.1.5; WHO Collaborating Centre for Drug Statistics Methodology, 2012, GUID ATC CLASS DDD A; Zhang JP, 2012, INT J NEUROPSYCHOPH, V16, P1205	27	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0586-7614	1745-1701		SCHIZOPHRENIA BULL	Schizophr. Bull.	NOV	2015	41	6					1397	1402		10.1093/schbul/sbv037		6	Psychiatry	Psychiatry	CW1TR	WOS:000364774900025		
J	Wang, LC; Li, GQ; Hu, ZJ				Wang LiChao; Li GuoQiang; Hu ZhenJiang			Constructing format-preserving printing from syntax-directed definitions	SCIENCE CHINA-INFORMATION SCIENCES			English	Article						format-preserving; bidirectional transformation; pretty printing; unparsing; tree matching		Transformations between source codes, such as refactorings and program analysis, are frequently used in software engineering. Typically, transformations are effectively implemented using an abstract syntax tree (AST) on the origin source code. However, a critical limitation of ASTs is the loss of layout information such as whitespace and comments, which can result in poor readability. To overcome this shortcoming, this paper proposes a bidirectional transformation (BX) method that maintains consistency in the layout between the origin and transformed. First, a section of origin source code will be translated to a concrete syntax tree (CST) that includes layout information. Second, to make the BX practical, a new method is constructed that matches an AST with its respective CST. Finally, to get a reasonable CST, a method to amend the CST is also provided. We prove that the BX is well-behaved, which implies that it satisfies both the PutGet and GetPut laws. Furthermore, we illustrate the correctness of the methodology by treating XML language as a case study.	[Wang LiChao; Li GuoQiang] Shanghai Jiao Tong Univ, Sch Software, BASICS, Shanghai 200240, Peoples R China; [Hu ZhenJiang] Natl Inst Informat, Tokyo 1018430, Japan	Li, GQ (reprint author), Shanghai Jiao Tong Univ, Sch Software, BASICS, Shanghai 200240, Peoples R China.	li.g@sjtu.edu.cn			National Natural Science Foundation of China [61472240, 91318301, 61261130589]	This work was supported by National Natural Science Foundation of China (Grant Nos. 61472240, 91318301, 61261130589).	AHO A. V., 2006, COMPILERS PRINCIPLES; Brown C., 2008, THESIS; Danvy O, 1998, J FUNCTIONAL PROGRAM, V8, P621, DOI 10.1017/S0956796898003104; Donnelly C, 2002, BISON MANUAL USING Y; Erdweg S, 2013, LECT NOTES COMPUT SC, V7745, P244; Fischer S, 2012, 201208 GRACETR NAT I; Foster JN, 2007, ACM T PROGR LANG SYS, V29, DOI 10.1145/1232420.1232424; FRITZSON P, 1983, J SYST SOFTWARE, V3, P285, DOI 10.1016/0164-1212(83)90014-6; Fritzson P., 1984, THESIS; Jonge M D, 2012, LECT NOTES COMPUT SC, V6940, P40; Kumar R, 2011, P 22 INT JOINT C ART, P2674; Merijn D J., 2002, P INT C SOFTW MAINT, P550; Neamtiu I., 2005, SIGSOFT SOFTW ENG NO, V30, P1; Sandewall E., 1978, ACM COMPUT SURV, V10, P35, DOI 10.1145/356715.356719; Teltelman W, 1978, INTERLISP REFERENCE; Van De Vanter M. L., 2001, Proceedings First IEEE International Workshop on Source Code Analysis and Manipulation, DOI 10.1109/SCAM.2001.972674; Vaucher J G, 1993, J SYMB COMPUT, V15, P523; VAUCHER JG, 1980, SOFTWARE PRACT EXPER, V10, P553, DOI 10.1002/spe.4380100706; Visser E, 1997, THESIS; Wang L C., 2015, THESIS	20	0	0	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1674-733X	1869-1919		SCI CHINA INFORM SCI	Sci. China-Inf. Sci.	NOV	2015	58	11							112106	10.1007/s11432-015-5368-9		14	Computer Science, Information Systems	Computer Science	CW6TA	WOS:000365129500011		
J	Weinstein, DK; Klaus, JS; Smith, TS				Weinstein, D. K.; Klaus, J. S.; Smith, T. S.			Habitat heterogeneity reflected in mesophotic reef sediments	SEDIMENTARY GEOLOGY			English	Article						Mesophotic coral reefs; Sedimentary facies; US Virgin Islands; Bioerosion; Stable isotopic analysis		Modern reef sediments reflect the physical and chemical characteristics of the environment as well as the local reef fauna. Analysis of sedimentary reef fades can thus provide a powerful tool in interpreting ancient reef deposits. However, few studies have attempted to differentiate sedimentary facies in mesophotic coral ecosystems, low light habitats defined as residing 30-150 m below sea level. The low-angle shelf mesophotic coral ecosystem south of the northern U.S. Virgin Islands (USVI) consists of reefs with different structural characteristics ideal for studying the relationship between habitat variability and sedimentary facies. Textural, compositional, and geochemical analyses of surface sediments were used to identify mesophotic reef subfacies associated with distinct benthic communities and structural habitats. Sediment grain composition and bulk geochemistry were found to broadly record the distribution and abundance of coral and macroalgae communities, foundational mesophotic reef benthic organisms. Overall, sediment composition was found to be a good indicator of specific reef environments in low-angle mesophotic reef habitats. Sedimentological analyses indicate that hydrodynamic forces do not transport a significant amount of allochthonous sediment or potentially harmful terrigenous material to USVI mesophotic reefs. Episodic, maximum current velocities prevented deposition of most silt-size grains and smaller, but biological processes were found to have a greater influence on subfacies partitioning than hydrodynamic processes. Results provide a new analog for studies of ancient mesophotic coral ecosystem geological history and document the relationship between mesophotic reef subfacies, structural complexity, and habitat heterogeneity. They also demonstrate how mesophotic reefs along the same shelf system do not always share similar sedimentary characteristics and thus record a diverse set of ecological and environmental conditions. (C) 2015 Elsevier B.V. All rights reserved.	[Weinstein, D. K.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [Klaus, J. S.] Univ Miami, Dept Geol Sci, Coral Gables, FL 33124 USA; [Smith, T. S.] Univ Virgin Isl, Ctr Marine & Environm Studies, St Thomas, VI 00802 USA	Weinstein, DK (reprint author), Univ Ryukyus, Dept Biol Chem & Marine Sci, 1 Senbaru, Nishihara, Okinawa 9030213, Japan.	dweinstein@rsmas.miami.edu; jklaus@rsmas.miami.edu; tsmith@uvi.edu			National Science Foundation; Sigma Xi; Geological Society of America; ExxonMobil; Academy of Underwater Arts and Sciences; University of Miami Center for Latin American Studies; Leonard and Jayne Abess/Citizens Board; RSMAS Graduate Student Fund	We thank P. Swart for geochemical support and interpretations, P. Reid, R. Ginsburg, and D. McNeill for guidance and early manuscript comments, and A. Shansby, J. Weinstein, and It Cunning for early conceptualization. Technical diving and field support was provided by R. Gomez, E. Kadison, and M. Kammann. Assistance with laboratory analyses was provided by C. Kaiser, R. Thompson, C. Gil, and S. Dowiarz. A. Weinstein provided editorial review. Funding was provided by the National Science Foundation, Sigma Xi, the Geological Society of America, ExxonMobil, the Academy of Underwater Arts and Sciences, the University of Miami Center for Latin American Studies, the Leonard and Jayne Abess/Citizens Board, and the RSMAS Graduate Student Fund. This is contribution # 126 from the Center for Marine and Environmental Studies, UVI.		0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0037-0738	1879-0968		SEDIMENT GEOL	Sediment. Geol.	NOV	2015	329						177	187		10.1016/j.sedgeo.2015.07.003		11	Geology	Geology	CW3HS	WOS:000364883200013		
J	Huang, H; Yan, JW				Huang, Hu; Yan, Jiwang			Possibility for rapid generation of high-pressure phases in single-crystal silicon by fast nanoindentation	SEMICONDUCTOR SCIENCE AND TECHNOLOGY			English	Article						single-crystal silicon; high-pressure phase; nanoindentation; phase transformation; load control	MONOCRYSTALLINE SILICON; GROUP-IV; IN-SITU; III-V; TRANSFORMATIONS; INDENTATION; LOAD; MICROINDENTATION	High-pressure phases of silicon such as Si-XII/Si-III exhibit attractive optical, electrical and chemical properties, but until now, it has been technologically impossible to produce a significant quantity of Si-XII or Si-III. In this study, to explore the possibility of generating high-pressure silicon phases efficiently, comparative nanoindentation experiments were conducted. Effects of the loading rate, unloading rate and maximum indentation load were investigated, and key factors affecting the high-pressure phase formation were identified. A new nanoindentation protocol is proposed that introduces an intermediate holding stage into the unloading process. The resulting end phases under the indent were detected by a laser micro-Raman spectrometer and compared with those formed in conventional nanoindentation. The results indicate that high-pressure phases Si-XII and Si-III were successfully formed during the intermediate holding stage even with a very high loading/unloading rate. This finding demonstrates the possibility of rapid production of high-pressure phases of silicon through fast mechanical loading and unloading.	[Huang, Hu; Yan, Jiwang] Keio Univ, Dept Mech Engn, Yokohama, Kanagawa 2238522, Japan	Huang, H (reprint author), Keio Univ, Dept Mech Engn, Yokohama, Kanagawa 2238522, Japan.	yan@mech.keio.ac.jp	Huang, Hu/A-3650-2012	Huang, Hu/0000-0002-3778-4457	 [26-04048];  [15K13838]	H H is an International Research Fellow of the Japan Society for the Promotion of Science (JSPS). This study has been financially supported by Grant-in-Aid for JSPS Fellows (Grant No. 26-04048) and Grant-in-Aid for Exploratory Research (Grant No. 15K13838).	Auckland GJ, 2001, REP PROG PHYS, V64, P483; Yan JW, 2002, J MATER PROCESS TECH, V121, P363, DOI 10.1016/S0924-0136(01)01218-3; Bradby JE, 2001, J MATER RES, V16, P1500, DOI 10.1557/JMR.2001.0209; Zarudi I, 2004, P I MECH ENG C-J MEC, V218, P591, DOI 10.1243/095440604774202222; Ruffell S, 2007, J MATER RES, V22, P578, DOI 10.1557/JMR.2007.0100; Jasinevicius RG, 2008, MATER LETT, V62, P812, DOI 10.1016/j.matlet.2007.06.071; Zarudi I, 2003, APPL PHYS LETT, V82, P874, DOI 10.1063/1.1544429; Fujisawa N, 2009, J APPL PHYS, V105, DOI 10.1063/1.3130154; Kailer A, 1997, J APPL PHYS, V81, P3057, DOI 10.1063/1.364340; Jang JI, 2005, ACTA MATER, V53, P1759, DOI 10.1016/j.actamat.2004.12.025; Kukushkin SA, 2014, PHYS SOLID STATE+, V56, P792, DOI 10.1134/S1063783414040143; BESSON JM, 1987, PHYS REV LETT, V59, P473, DOI 10.1103/PhysRevLett.59.473; Gogotsi Y, 1999, REV SCI INSTRUM, V70, P4612, DOI 10.1063/1.1150122; Gogotsi Y, 1999, SEMICOND SCI TECH, V14, P936, DOI 10.1088/0268-1242/14/10/310; Zeng ZD, 2014, J APPL PHYS, V115, DOI 10.1063/1.4868156; MIGNOT JM, 1986, PHYS REV B, V34, P3150, DOI 10.1103/PhysRevB.34.3150; Domnich V, 2000, APPL PHYS LETT, V76, P2214, DOI 10.1063/1.126300; Kukushkin SA, 2005, J APPL PHYS, V98, DOI 10.1063/1.1957131; Wippermann S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.046804; Juliano T, 2003, J MATER RES, V18, P1192, DOI 10.1557/JMR.2003.0164; Malone BD, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.161202; Jasinevicius RG, 2007, SEMICOND SCI TECH, V22, P561, DOI 10.1088/0268-1242/22/5/019; Kiriyama T, 2009, SEMICOND SCI TECH, V24, DOI 10.1088/0268-1242/24/2/025014; Gerbig YB, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.205209; MCMAHON MI, 1993, PHYS REV B, V47, P8337, DOI 10.1103/PhysRevB.47.8337; Juliano T, 2004, J MATER RES, V19, P3099, DOI 10.1557/JMR.2004.0403; Malone BD, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.035210; Ruffell S, 2007, J APPL PHYS, V102, DOI 10.1063/1.2781394; PILTZ RO, 1995, PHYS REV B, V52, P4072, DOI 10.1103/PhysRevB.52.4072; Shchennikov VV, 2013, J ELECTRON MATER, V42, P2249, DOI 10.1007/s11664-013-2602-3; Mujica A, 2003, REV MOD PHYS, V75, P863, DOI 10.1103/RevModPhys.75.863; Youn SW, 2004, SCRIPTA MATER, V50, P105, DOI 10.1016/j.scriptamat.2003.09.030; CRAIN J, 1994, PHYS REV B, V50, P13043, DOI 10.1103/PhysRevB.50.13043; Chang L, 2009, ACTA MATER, V57, P2148, DOI 10.1016/j.actamat.2009.01.008; Domnich V., 2002, Reviews on Advanced Materials Science, V3; Kukushkin S. A., 1998, Physics-Uspekhi, V41, DOI 10.1070/PU1998v041n10ABEH000461; Mann AB, 2005, NANOTRIBOLOGY AND NANOMECHANICS, P575, DOI 10.1007/3-540-28248-3_12; Slezov V V, 2009, KINETICS 1 ORDER PHA; Yan JW, 2006, MAT SCI ENG A-STRUCT, V423, P19, DOI 10.1016/j.msea.2005.09.120	39	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0268-1242	1361-6641		SEMICOND SCI TECH	Semicond. Sci. Technol.	NOV	2015	30	11							115001	10.1088/0268-1242/30/11/115001		7	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Condensed Matter	Engineering; Materials Science; Physics	CW8HT	WOS:000365240800018		
J	Vanhellemont, J; Anada, S; Yasuda, H; Van Marcke, P; Bender, H; Rooyackers, R; Vandooren, A				Vanhellemont, Jan; Anada, Satoshi; Yasuda, Hidehiro; Van Marcke, Patricia; Bender, Hugo; Rooyackers, Rita; Vandooren, Anne			In situ UHVEM study of {113}-defect formation in Si nanowires	SEMICONDUCTOR SCIENCE AND TECHNOLOGY			English	Article						silicon; nanowire; 113-defect; in situ; electron irradiation; HVEM; dopant	IRRADIATION-INDUCED DEFECTS; ELECTRON-IRRADIATION; POINT-DEFECTS; SILICON; IMPACT; GROWTH; DISTRIBUTIONS; MICROSCOPE; CLUSTERS	Results are presented of a study of {113}-defect formation in vertical Si nanowire n-type tunnel field effect transistors with nanowire diameters ranging from 40 to 500 nm. The nanowires are etched into an epitaxial moderately As doped n-type layer grown on a heavily As doped n(+) Si substrate. p(+) contacts on the nanowire are created by epitaxial growth of a heavily B doped layer. Using focused ion beam cutting, samples for irradiation are prepared with different thicknesses so that the nanowires are fully or partially embedded in the sample thickness. {113}-defects are created in situ by 2 MeV e-irradiation in an ultra-high voltage electron microscope between room temperature and 375 degrees C. The observations are discussed in the frame of intrinsic point defect properties, taking into account the role of dopants and capping layers. The important impact of the specimen thickness is elucidated.	[Vanhellemont, Jan; Anada, Satoshi; Yasuda, Hidehiro] Osaka Univ, Res Ctr Ultrahigh Voltage Elect Microscopy, Suita, Osaka 565, Japan; [Van Marcke, Patricia; Bender, Hugo; Rooyackers, Rita; Vandooren, Anne] IMEC, B-3001 Leuven, Belgium	Vanhellemont, J (reprint author), Univ Ghent, Dept Solid State Sci, B-9000 Ghent, Belgium.	jan.vanhellemont@ugent.be					Vandooren A, 2012, SOLID STATE ELECTRON, V72, P82, DOI 10.1016/j.sse.2011.12.008; Vanhellemont J, 1995, MATER SCI TECH SER, V11, P1194; BULLOUGH R, 1980, J NUCL MATER, V90, P44, DOI 10.1016/0022-3115(80)90244-5; ASEEV AL, 1991, SOV PHYS SEMICOND+, V25, P352; Vanhellemont J, 2015, PHYS STATUS SOLIDI C, V12, P275, DOI 10.1002/pssc.201400100; BENDER H, 1988, PHYS STATUS SOLIDI A, V107, P455, DOI 10.1002/pssa.2211070202; Sueoka K, 2013, J APPL PHYS, V114, DOI 10.1063/1.4825222; Kube R, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.085206; Fedina LI, 2002, DEFECT DIFFUS FORUM, V210-2, P21; Cowern NEB, 1999, PHYS REV LETT, V82, P4460, DOI 10.1103/PhysRevLett.82.4460; Vanhellemont J, 2012, PHYS STATUS SOLIDI A, V209, P1902, DOI 10.1002/pssa.201200023; Vanhellemont J, 2013, ECS J SOLID STATE SC, V2, pP166, DOI 10.1149/2.024304jss; TAKEDA S, 1991, ULTRAMICROSCOPY, V39, P180, DOI 10.1016/0304-3991(91)90196-D; Vanhellemont J, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1940140; Schulze A, 2013, ULTRAMICROSCOPY, V125, P18, DOI 10.1016/j.ultramic.2012.10.008; KIRITANI M, 1991, ULTRAMICROSCOPY, V39, P135, DOI 10.1016/0304-3991(91)90193-A; Aseev A L, 1994, CLUSTERS INTERSTITIA; Fedina L I, 2014, COMMUNICATION; Fedina L. I., 1990, Soviet Physics - Solid State, V32; Schulze A, 2013, THESIS; TAKEDA S, 1991, JPN J APPL PHYS 2, V30, pL639, DOI 10.1143/JJAP.30.L639; Vanhellemont J, 2015, PHYS STATUS SOLIDI C, V12, P1160, DOI 10.1002/pssc.201400222; VANHELLEMONT J, 1994, APPL PHYS A-MATER, V58, P541, DOI 10.1007/BF00348164; Vanhellemont J, 2014, MATER RES SOC S P, V1713, P895; VANHELLEMONT J, 1993, APPL PHYS A-MATER, V57, P521, DOI 10.1007/BF00331752	25	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0268-1242	1361-6641		SEMICOND SCI TECH	Semicond. Sci. Technol.	NOV	2015	30	11							114013	10.1088/0268-1242/30/11/114013		11	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Condensed Matter	Engineering; Materials Science; Physics	CW8HT	WOS:000365240800014		
J	Fukuda, N; Ikemoto, T				Fukuda, Naohiro; Ikemoto, Tomomi			Scalable and Straightforward Synthesis of a 2-Alkyl-7-Arylbenzo-thiophene as a GPR52 Agonist via a Hemithioindigo Derivative	SYNTHESIS-STUTTGART			English	Article						benzothiophenes; Friedel-Crafts reactions; cyclizations; scalable syntheses; medicinal chemistry	THIN-FILM TRANSISTORS; ONE-POT SYNTHESIS; BENZOTHIOPHENE DERIVATIVES; ELECTROPHILIC CYCLIZATION; ALKYNES; CONVENIENT; ALCOHOLS; HETEROCYCLES; INHIBITOR; DISCOVERY	A simple and efficient procedure has been developed for the synthesis of the GPR52 agonist N-(2-amino-2-oxoethyl)-3-{4-fluoro-2-[3-(trifluoromethyl)benzyl]-1-benzothien-7-yl}benzamide. The benzothiophene unit was directly constructed by reduction of a hemithioindigo derivative prepared by an intramolecular Friedel-Crafts cyclization of (phenylsulfanyl) acetic acid, followed by dehydrative benzylidene formation.	[Fukuda, Naohiro; Ikemoto, Tomomi] Takeda Pharmaceut Co Ltd, Chem Dev Labs, Yodogawa Ku, Osaka 5328686, Japan	Fukuda, N (reprint author), Takeda Pharmaceut Co Ltd, Chem Dev Labs, Yodogawa Ku, Osaka 5328686, Japan.	naohiro.fukuda@takeda.com					Anderson N. G., 2012, PRACTICAL PROCESS RE; Qin ZH, 2007, J MED CHEM, V50, P2682, DOI 10.1021/jm070079j; Larock RC, 2001, TETRAHEDRON LETT, V42, P6011, DOI 10.1016/S0040-4039(01)01149-2; Sawzdargo M, 1999, MOL BRAIN RES, V64, P193, DOI 10.1016/S0169-328X(98)00277-0; Nakamura I, 2006, ANGEW CHEM INT EDIT, V45, P4473, DOI 10.1002/anie.200601178; Setoh M, 2014, J MED CHEM, V57, P5226, DOI 10.1021/jm5002919; Bryan CS, 2009, ANGEW CHEM INT EDIT, V48, P7064, DOI 10.1002/anie.200902843; Rueping M, 2012, ACS CATAL, V2, P2810, DOI 10.1021/cs300604k; Liu KS, 2013, ORG LETT, V15, P2026, DOI 10.1021/ol400719d; BURGER U, 1989, HELV CHIM ACTA, V72, P93, DOI 10.1002/hlca.19890720112; Flynn BL, 2001, ORG LETT, V3, P651, DOI 10.1021/ol0067179; Lin CH, 2013, CHEM-EUR J, V19, P2578, DOI 10.1002/chem.201202704; Varedian M, 2008, TETRAHEDRON LETT, V49, P6033, DOI 10.1016/j.tetlet.2008.07.054; Jung KH, 2010, ORG ELECTRON, V11, P1584, DOI 10.1016/j.orgel.2010.07.008; Duez S, 2012, ORG LETT, V14, P1951, DOI 10.1021/ol300517q; Lyons TW, 2010, CHEM REV, V110, P1147, DOI 10.1021/cr900184e; Hessian KO, 2003, ORG LETT, V5, P4377, DOI 10.1021/ol035663a; Zhou Y, 2007, J AM CHEM SOC, V129, P12386, DOI 10.1021/ja075045f; Lu WD, 2007, TETRAHEDRON, V63, P356, DOI 10.1016/j.tet.2006.10.068; Robbins DW, 2013, ANGEW CHEM INT EDIT, V52, P933, DOI 10.1002/anie.201208203; Ebata H, 2007, ORG LETT, V9, P4499, DOI 10.1021/ol701815j; Hari DP, 2012, ORG LETT, V14, P5334, DOI 10.1021/ol302517n; Wang ZT, 2011, TETRAHEDRON LETT, V52, P6997, DOI 10.1016/j.tetlet.2011.10.098; Horton DA, 2003, CHEM REV, V103, P893, DOI 10.1021/cr020033s; Duan ZY, 2010, ORG LETT, V12, P2430, DOI 10.1021/ol100816g; Fouad I, 2004, J MATER CHEM, V14, P1711, DOI 10.1039/b308779b; CLARK PD, 1995, J ORG CHEM, V60, P1936, DOI 10.1021/jo00112a010; Kuhn M, 2011, ORG LETT, V13, P4100, DOI 10.1021/ol2016093; Berrade L, 2011, J MED CHEM, V54, P3086, DOI 10.1021/jm2000773; Lapointe D, 2009, ORG LETT, V11, P4160, DOI 10.1021/ol901689q; Shrestha S, 2005, B KOR CHEM SOC, V26, P1138; Gabriele B, 2011, J ORG CHEM, V76, P8277, DOI 10.1021/jo201471k; Pinney KG, 1999, BIOORG MED CHEM LETT, V9, P1081, DOI 10.1016/S0960-894X(99)00143-2; JONES CD, 1984, J MED CHEM, V27, P1057, DOI 10.1021/jm00374a021; Godoi B, 2011, CHEM REV, V111, P2937, DOI 10.1021/cr100214d; Imamura M, 2012, BIOORGAN MED CHEM, V20, P3263, DOI 10.1016/j.bmc.2012.03.051; Eggers K, 2001, J ORG CHEM, V66, P2966, DOI 10.1021/jo0056848; Pu SZ, 2009, J MOL STRUCT, V919, P100, DOI 10.1016/j.molstruc.2008.08.023; Kashiki T, 2009, ORG LETT, V11, P2473, DOI 10.1021/ol900809w; Kunz T, 2012, ANGEW CHEM INT EDIT, V51, P1958, DOI 10.1002/anie.201106734; Yu H, 2013, J ORG CHEM, V78, P8898, DOI 10.1021/jo401353w; KUROSAWA K, 1981, B CHEM SOC JPN, V54, P635, DOI 10.1246/bcsj.54.635; Fukuda N, 2013, SYNLETT, V24, P1438, DOI 10.1055/s-0033-1338856; Sun LL, 2011, J ORG CHEM, V76, P7546, DOI 10.1021/jo201081v; Flynn BL, 2002, J MED CHEM, V45, P2670, DOI 10.1021/jm020077t; HSIAO CN, 1992, TETRAHEDRON LETT, V33, P2629, DOI 10.1016/S0040-4039(00)79043-5; Fukuda N, 2015, TETRAHEDRON LETT, V56, P3905, DOI 10.1016/j.tetlet.2015.04.115; Um MC, 2008, J MATER CHEM, V18, P4698, DOI 10.1039/b808438f; BENATI L, 1992, J CHEM SOC PERK T 1, P1659, DOI 10.1039/p19920001659; CAPOZZI G, 1970, J CHEM SOC C, P2621, DOI 10.1039/j39700002621; Inamoto K, 2008, CHEM COMMUN, P5529, DOI 10.1039/b811362a; Komatsu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090134; Newman SG, 2009, CHEM COMMUN, P5236, DOI 10.1039/b912093a; Repic O., 1998, PRINCIPLES PROCESS R; SAINSBURY M, 1975, J CHEM SOC PERK T 1, P289, DOI 10.1039/p19750000289; Setoh M., 2009, [No title captured], Patent No. [WO 2009107391, 2009107391, WO 2009/107391]; Zhang T. Y., 2002, HDB GREEN CHEM TECHN, P312	57	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0039-7881	1437-210X		SYNTHESIS-STUTTGART	Synthesis	NOV	2015	47	22					3467	3472		10.1055/s-0034-1378746		6	Chemistry, Organic	Chemistry	CW9FR	WOS:000365304600004		
J	Inai, M; Ishikawa, R; Yoshida, N; Shirakawa, N; Akao, Y; Kawabe, Y; Asakawa, T; Egi, M; Hamashima, Y; Kan, T				Inai, Makoto; Ishikawa, Ryo; Yoshida, Naoto; Shirakawa, Nana; Akao, Yusuke; Kawabe, Yusuke; Asakawa, Tomohiro; Egi, Masahiro; Hamashima, Yoshitaka; Kan, Toshiyuki			Stereocontrolled Total Syntheses of Optically Active Furofuran Lignans	SYNTHESIS-STUTTGART			English	Article						aldol reaction; natural products; organocatalysts; proline; stereoselective synthesis	STEREOSELECTIVE TOTAL SYNTHESIS; EFFICIENT ASYMMETRIC-SYNTHESIS; METAL RADICAL SOURCE; ENANTIOSELECTIVE SYNTHESIS; REGIOSELECTIVE SYNTHESIS; EPIGALLOCATECHIN GALLATE; PHOTOAFFINITY PROBES; (-)-METHYL PIPERITOL; PRACTICAL SYNTHESIS; ANTAGONIST ACTIVITY	Plant products (+)-sesamin, (+)-sesaminol, (+)-methylpiperitol, (+)-aschantin, and (+)-5'-hydroxymethylpiperitol were synthesized in a highly stereocontrolled manner through L-proline-catalyzed bifunctional-urea-accelerated cross-aldol reaction, followed by biomimetic construction of the furofuran lignan skeleton through a quinomethide intermediate.	[Inai, Makoto; Ishikawa, Ryo; Yoshida, Naoto; Shirakawa, Nana; Akao, Yusuke; Kawabe, Yusuke; Asakawa, Tomohiro; Egi, Masahiro; Hamashima, Yoshitaka; Kan, Toshiyuki] Univ Shizuoka, Sch Pharmaceut Sci, Suruga Ku, Shizuoka 4228526, Japan	Hamashima, Y (reprint author), Univ Shizuoka, Sch Pharmaceut Sci, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	hamashima@u-shizuoka-ken.ac.jp; kant@u-shizuoka-ken.ac.jp			Uehara Memorial Foundation; MEXT/JSPS KAKENHI [23390007, 26860013]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [12045232, 24105530]; Ministry of Education, Culture, Sports, Science and Technology	This work was financially supported by the Uehara Memorial Foundation (Y.H.), MEXT/JSPS KAKENHI Grant Numbers 23390007 and 26860013, Grants-in-Aid for Scientific Research on Priority Areas 12045232 and 24105530 from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, and a grant for Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology.	Kang MH, 2000, LIFE SCI, V66, P161; Rana KK, 2000, TETRAHEDRON LETT, V41, P9337, DOI 10.1016/S0040-4039(00)01698-1; SUGINOME H, 1995, J ORG CHEM, V60, P3052, DOI 10.1021/jo00115a021; Kawabe Y, 2013, SYNLETT, V24, P479, DOI 10.1055/s-0032-1318131; OGIKU T, 1995, J ORG CHEM, V60, P1148, DOI 10.1021/jo00110a016; Ward RS, 1999, NAT PROD REP, V16, P75, DOI 10.1039/a705992b; Hajra S, 2008, J ORG CHEM, V73, P3935, DOI 10.1021/jo8005733; IIDA T, 1982, PHYTOCHEMISTRY, V21, P673, DOI 10.1016/0031-9422(82)83163-4; IWAKAMI S, 1992, CHEM PHARM BULL, V40, P1196; Poe SL, 2009, J ORG CHEM, V74, P1574, DOI 10.1021/jo802461w; Aldous DJ, 2006, ORG BIOMOL CHEM, V4, P2912, DOI 10.1039/b604952d; Aihara Y, 2009, BIOORG MED CHEM LETT, V19, P4171, DOI 10.1016/j.bmcl.2009.05.111; BEROZA M, 1956, J AM CHEM SOC, V78, P1242, DOI 10.1021/ja01587a045; ORITO K, 1991, TETRAHEDRON LETT, V32, P5999, DOI 10.1016/S0040-4039(00)79448-2; Shimokawa J, 2011, J AM CHEM SOC, V133, P17634, DOI 10.1021/ja208617c; Sasaki S, 2014, ORG LETT, V16, P564, DOI 10.1021/ol403434e; Maes D, 2005, TETRAHEDRON, V61, P2505, DOI 10.1016/j.tet.2004.12.061; Furuta T, 2007, BIOORG MED CHEM LETT, V17, P3095, DOI 10.1016/j.bmcl.2007.03.041; Roy SC, 2002, J ORG CHEM, V67, P3242, DOI 10.1021/jo010857u; Ohmizu H, 2000, HETEROCYCLES, V52, P1399; Zhang J, 2014, CHEM BIODIVERS, V11, P1, DOI 10.1002/cbdv.201100433; Brown RCD, 2001, J ORG CHEM, V66, P6719, DOI 10.1021/jo015829q; PAN JX, 1987, PHYTOCHEMISTRY, V26, P1377, DOI 10.1016/S0031-9422(00)81816-6; Asakawa T, 2013, CURR PHARM DESIGN, V19, P6207, DOI 10.2174/1381612811319340012; Kim JC, 2006, TETRAHEDRON-ASYMMETR, V17, P3, DOI 10.1016/j.tetasy.2005.11.007; ICHIKAWA K, 1986, CHEM PHARM BULL, V34, P3514; Morohashi Y, 2006, J BIOL CHEM, V281, P14670, DOI 10.1074/jbc.M513012200; Fuwa H, 2007, ACS CHEM BIOL, V2, P408, DOI 10.1021/cb700073y; Kang MH, 1998, LIPIDS, V33, P1031, DOI 10.1007/s11745-998-0302-y; CHIUNG YM, 1994, J ANTIBIOT, V47, P487; Northrup AB, 2002, J AM CHEM SOC, V124, P6798, DOI 10.1021/ja0262378; Chi YG, 2006, J AM CHEM SOC, V128, P6804, DOI 10.1021/ja061731n; IWAKAMI S, 1990, HETEROCYCLES, V30, P795; Schmidt TJ, 2006, PHYTOCHEM ANALYSIS, V17, P299, DOI 10.1002/pca.918; Yoshida A, 2011, CHEM COMMUN, V47, P1794, DOI 10.1039/c0cc03676e; Kise N, 2003, TETRAHEDRON-ASYMMETR, V14, P2495, DOI 10.1016/S0957-4166(03)00572-X; Ikeuchi K, 2014, ORG BIOMOL CHEM, V12, P3813, DOI 10.1039/c4ob00705k; MATSUI M, 1956, B AGR CHEM SOC JAPAN, V20, P139; KOLLONITSCH J, 1954, NATURE, V173, P125, DOI 10.1038/173125a0; Swain NA, 2004, J ORG CHEM, V69, P122, DOI 10.1021/jo035365r; Kan T, 2007, ORG LETT, V9, P2055, DOI 10.1021/ol070376i; Jan KC, 2009, J AGR FOOD CHEM, V57, P6101, DOI 10.1021/jf901215j; Kawabe Y, 2014, ORG LETT, V16, P1976, DOI 10.1021/ol500524y; Banerjee B, 2005, SYNTHESIS-STUTTGART, P2913, DOI 10.1055/s-2005-872173; Enders D, 2002, SYNTHESIS-STUTTGART, P515; Latip J, 1999, PHYTOCHEMISTRY, V51, P107, DOI 10.1016/S0031-9422(98)00720-1; Hirooka Y, 2008, SYNLETT, P3234, DOI 10.1055/s-0028-1087371; Hiza A., 2013, HETEROCYCLES, V88, P1371; Hoke M., 1972, ARCH PHARM, V33, P305; Hull HM, 1998, J CHEM SOC PERK T 1, P1779, DOI 10.1039/a801667d; Ishikawa R, 2014, CHEM LETT, V43, P1572, DOI 10.1246/cl.140613; Kan T, 2003, CHEM COMMUN, P2244, DOI 10.1039/b306970b; Kan T, 2004, CHEM COMMUN, P353, DOI 10.1039/b311203a; Kan T, 2001, J SYN ORG CHEM JPN, V59, P779; Ku K.-L., 2011, J AGR FOOD CHEM, V59, P3078; Mori N, 2006, SYNTHESIS-STUTTGART, P400, DOI 10.1055/s-2006-926271; SOAI K, 1984, B CHEM SOC JPN, V57, P1948, DOI 10.1246/bcsj.57.1948; PELTER A, 1982, J CHEM SOC PERK T 1, P183, DOI 10.1039/p19820000183; PELTER A, 1982, J CHEM SOC PERK T 1, P175, DOI 10.1039/p19820000175; PELTER A, 1985, J CHEM SOC PERK T 1, P587, DOI 10.1039/p19850000587; SAMIZU K, 1995, CHEM LETT, P543, DOI 10.1246/cl.1995.543; FREEMAN PK, 1988, TETRAHEDRON, V44, P5051, DOI 10.1016/S0040-4020(01)86010-5; TAKANO S, 1988, J CHEM SOC CHEM COMM, P189, DOI 10.1039/c39880000189	63	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0039-7881	1437-210X		SYNTHESIS-STUTTGART	Synthesis	NOV	2015	47	22					3513	3521	UNSP ss-2015-f0330-op	10.1055/s-0034-1378812		9	Chemistry, Organic	Chemistry	CW9FR	WOS:000365304600009		
J	Hirata, Y; Yajima, Y				Hirata, Yasushi; Yajima, Yukinobu			On the D-property of certain products	TOPOLOGY AND ITS APPLICATIONS			English	Article						D-space; DC-like; Subparacompact; Submetacompact; Elementary submodel	DUALLY DISCRETE SPACES; TOPOLOGICAL GAMES	We first point out that the product of a subparacompact DC-like space and a subparacompact D-space is a D-space. As a main result, we use elementary submodels to prove that any countable product of subparacompact DC-like spaces is a D-space. More generally, we prove that any uncountable product of subparacompact DC-like spaces is a D-space if and only if all but countably many of the factors are compact. (C) 2015 Elsevier B.V. All rights reserved.	[Hirata, Yasushi; Yajima, Yukinobu] Kanagawa Univ, Dept Math, Yokohama, Kanagawa 2218686, Japan	Yajima, Y (reprint author), Kanagawa Univ, Dept Math, Yokohama, Kanagawa 2218686, Japan.	hirata-y@kanagawa-u.ac.jp; yajimy01@kanagawa-u.ac.jp			 [24540147]	This research was supported by Grant-in-Aid for Scientific Research (C) 24540147.	Guo HF, 2011, TOPOL APPL, V158, P2111, DOI 10.1016/j.topol.2011.06.053; YAJIMA Y, 1983, FUND MATH, V117, P47; VANDOUWEN EK, 1979, PAC J MATH, V81, P371; Peng LX, 2008, TOPOL APPL, V155, P1867, DOI 10.1016/j.topol.2008.06.005; Alas OT, 2008, TOPOL APPL, V155, P1420, DOI 10.1016/j.topol.2008.04.003; Chaber J, 1998, TOPOL APPL, V82, P71, DOI 10.1016/S0166-8641(97)00058-8; Gruenhage G, 2011, CONTEMP MATH, V533, P13; YAJIMA Y, 1983, FUND MATH, V117, P223; STONE AH, 1948, B AM MATH SOC, V54, P977, DOI 10.1090/S0002-9904-1948-09118-2; VanDouwen EK, 1997, P AM MATH SOC, V125, P1237, DOI 10.1090/S0002-9939-97-03902-6; Borges C.R., 1991, TOPOLOGY P, V16, P7; FITZPATR.B, 1967, DUKE MATH J, V34, P33; GALVIN F, 1986, TOPOL APPL, V22, P51, DOI 10.1016/0166-8641(86)90077-5; Junnila H.J.K., 1978, TOPOLOGY P, V3, P375; Martinez J.C., 2011, TOPOL APPL, V156, P223; Peng LX, 2008, HOUSTON J MATH, V34, P165; Peng L. -Xue, 1996, J BEIJING I TECHNOL, V16, P229; Scott B.M., 1980, TOPOLOGY P, V5, P155; Szeptycki P., 2014, RECENT PROGR GEN TOP, VIII, P801; Tanaka H., 1993, TSUKUBA J MATH, V17, P565; Telgarsky R., 1975, FUND MATH, V88, P193; Telgarsky R., 1971, FUND MATH, V73, P59; Yajima Y., 1989, TOPICS GEN TOPOLOGY, P523	23	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-8641	1879-3207		TOPOL APPL	Topology Appl.	NOV	2015	195				SI		297	311		10.1016/j.topol.2015.09.036		15	Mathematics, Applied; Mathematics	Mathematics	CW3JS	WOS:000364889200025		
J	Yamazaki, K				Yamazaki, Kaori			Insertion theorems for maps to ordered topological vector spaces	TOPOLOGY AND ITS APPLICATIONS			English	Article						Insertion; Semi-continuous; (Extended) ordered topological vector space; (Topological) Riesz space; Countably paracompact; Normal; Paracompact; cb-space; Perfectly normal; Dedekind sigma-complete	CONTINUOUS-SELECTIONS; PARACOMPACT SPACES; OPERATORS	For an ordered topological vector space Y and a, b is an element of Y, we write a << b if b - a is an interior point of the positive cone. Modifying the earlier results of Borwein-Thera, in this paper, << is extended over Y: = Y U {infinity} U {-infinity} and a natural topology on Y: is introduced. For a topological space X, and a non-trivial separable ordered topological vector space Y with an interior point of the positive cone, we show the following: X is normal and countably paracompact if and only if for every lower semi-continuous map f : X -> Y: and every upper semi-continuous map g : X -> Y: with g << f, there exists a continuous map h : X -> Y such that g << h << f. (C) 2015 Elsevier B.V. All rights reserved.	[Yamazaki, Kaori] Takasaki City Univ Econ, Fac Econ, Takasaki, Gumma 3700801, Japan	Yamazaki, K (reprint author), Takasaki City Univ Econ, Fac Econ, 1800 Kaminamie, Takasaki, Gumma 3700801, Japan.	kaori@tcue.ac.jp			KAKENHI [23540100]	Supported by KAKENHI (No. 23540100).	Aliprantis C.D., 2003, LOCALLY SOLID RIESZ, V105; Aliprantis C.D., 2007, CONE DUALITY, V84; BORWEIN JM, 1992, CAN MATH BULL, V35, P463, DOI 10.4153/CMB-1992-061-7; Gutev V, 2003, J MATH SOC JPN, V55, P499, DOI 10.2969/jmsj/1191419128; MACK J, 1965, P AM MATH SOC, V16, P467, DOI 10.2307/2034675; Yamazaki K, 2014, TOPOL APPL, V169, P51, DOI 10.1016/j.topol.2014.02.032; Yamauchi T, 2008, TOPOL APPL, V155, P916, DOI 10.1016/j.topol.2007.02.016; Yamazaki K, 2011, ACTA MATH HUNG, V132, P42, DOI 10.1007/s10474-011-0096-0; BORWEIN JM, 1984, J MATH ANAL APPL, V102, P399, DOI 10.1016/0022-247X(84)90180-X; TONG H, 1952, DUKE MATH J, V19, P289, DOI 10.1215/S0012-7094-52-01928-5; QUINN J, 1975, PAC J MATH, V56, P225; Yamazaki K, 2010, TOPOL APPL, V157, P1955, DOI 10.1016/j.topol.2010.04.009; PENOT JP, 1982, ARCH MATH, V38, P158, DOI 10.1007/BF01304771; DOWKER CH, 1951, CAN J MATH, V3, P219, DOI 10.4153/CJM-1951-026-2; Engelking R., 1989, GEN TOPOLOGY REVISED; Hewitt E., 1975, REAL ABSTRACT ANAL, V25; Horne Jr J.G., 1959, NOT AM MATH SOC, V6, P629; Katetov M., 1953, FUND MATH, V40, P203; Katetov M., 1951, FUND MATH, V38, P85; MACK J, 1967, CANADIAN J MATH, V19, P649, DOI 10.4153/CJM-1967-059-0; MEYER-NIEBERG P., 1991, BANACH LATTICES; MICHAEL E, 1956, ANN MATH, V63, P361, DOI 10.2307/1969615; Morita K., 1962, FUND MATH, V50, P223; Ohta H., 2006, TOPOLOGY P, V30, P557; Rudin M.E., 1984, HDB SET THEORETIC TO, P761; Schaefer H.H., 1999, TOPOLOGICAL VECTOR S, V3	26	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-8641	1879-3207		TOPOL APPL	Topology Appl.	NOV	2015	195				SI		312	326		10.1016/j.topol.2015.09.037		15	Mathematics, Applied; Mathematics	Mathematics	CW3JS	WOS:000364889200026		
J	Fulka, H; Kyogoku, H; Zatsepina, O; Langerova, A; Fulka, J				Fulka, Helena; Kyogoku, Hirohisa; Zatsepina, Olga; Langerova, Alena; Fulka, Josef, Jr.			Can Nucleoli Be Markers of Developmental Potential in Human Zygotes?	TRENDS IN MOLECULAR MEDICINE			English	Review							MOUSE OOCYTES; HETEROCHROMATIN ESTABLISHMENT; PREIMPLANTATION DEVELOPMENT; ELECTRON-MICROSCOPE; MATERNAL NUCLEOLUS; EMBRYO DEVELOPMENT; PREPUBERTAL MOUSE; LIGHT-MICROSCOPE; RIBOSOMAL-RNA; ORGANIZATION	In 1999, Tesarik and Greco reported that they could predict the developmental potential of human zygotes from a single static evaluation of their pronuclei. This was based on the distribution and number of specific nuclear organelles - the nucleoli. Recent studies in mice show that nucleoli play a key role in parental genome restructuring after fertilization, and that interfering with this process may lead to developmental failure. These studies thus support the Tesarik-Greco evaluation as a potentially useful method for selecting high-quality embryos in human assisted reproductive technologies. In this opinion article we discuss recent evidence linking nucleoli to parental genome reprogramming, and ask whether nucleoli can mirror or be used as representative markers of embryonic parameters such as chromosome content or DNA fragmentation.	[Fulka, Helena; Fulka, Josef, Jr.] Inst Anim Sci, Prague, Czech Republic; [Fulka, Helena] Acad Sci Czech Republic, Inst Mol Genet, Prague, Czech Republic; [Kyogoku, Hirohisa] RIKEN, Ctr Dev Biol, Kobe, Hyogo, Japan; [Zatsepina, Olga] Shemyakin Ovchinikov Inst Bioorgan Chem, Moscow, Russia; [Langerova, Alena] GENNET, Prague, Czech Republic	Fulka, J (reprint author), Inst Anim Sci, Prague, Czech Republic.	fulka@vuzv.cz			Czech Science Fondation (GAM) [13-03269S]; Japan Society for the Promotion of Science	The laboratory of J.F. Jr is supported by Czech Science Fondation (GAM) grant 13-03269S. H.K. is supported by a Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science.	Aguirre-Lavin T, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-30; Wakayama T, 1999, P NATL ACAD SCI USA, V96, P14984, DOI 10.1073/pnas.96.26.14984; Fulka H, 2012, J REPROD DEVELOP, V58, P371, DOI 10.1262/jrd.2011-004; Fulka H, 2004, FERTIL STERIL, V82, P486, DOI 10.1016/j.fertnstert.2003.12.042; KAPLAN G, 1982, J EXP ZOOL, V220, P361, DOI 10.1002/jez.1402200311; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Inoue A, 2014, NAT STRUCT MOL BIOL, V21, P609, DOI 10.1038/nsmb.2839; Pombo A, 2015, NAT REV MOL CELL BIO, V16, P245, DOI 10.1038/nrm3965; Kono T, 1996, NAT GENET, V13, P91, DOI 10.1038/ng0596-91; Santenard A, 2010, NAT CELL BIOL, V12, P853, DOI 10.1038/ncb2089; Probst AV, 2011, TRENDS GENET, V27, P177, DOI 10.1016/j.tig.2011.02.002; Ramalho-Santos J, 2000, HUM REPROD, V15, P2610, DOI 10.1093/humrep/15.12.2610; Romanova L, 2006, BIOL REPROD, V74, P807, DOI 10.1095/biolreprod.105.047340; Li JJ, 2012, ZYGOTE, V20, P291, DOI 10.1017/S0967199411000219; Lefevre B, 2008, BIOESSAYS, V30, P613, DOI 10.1002/bies.20774; Kyogoku H, 2014, DEVELOPMENT, V141, P2255, DOI 10.1242/dev.106948; Jachowicz JW, 2013, GENE DEV, V27, P2427, DOI 10.1101/gad.224550.113; Ogushi S, 2008, SCIENCE, V319, P613, DOI 10.1126/science.1151276; Guerif F, 2007, HUM REPROD, V22, P1973, DOI 10.1093/humrep/dem100; Ajduk A, 2006, BIOL REPROD, V75, P442, DOI 10.1095/biolreprod.106.053223; Inoue A, 2010, FASEB J, V24, P485, DOI 10.1096/fj.09-143370; James AN, 2006, HUM REPROD, V21, P1599, DOI 10.1093/humrep/de1013; CHOUINARD LA, 1975, J CELL SCI, V17, P589; Tesarik J, 1999, HUM REPROD, V14, P1318, DOI 10.1093/humrep/14.5.1318; Fulka H, 2014, DEVELOPMENT, V141, P1694, DOI 10.1242/dev.105940; Kurokawa M, 2003, MOL HUM REPROD, V9, P523, DOI 10.1093/molehr/gag072; Wakayama T, 2001, MOL REPROD DEV, V58, P376, DOI 10.1002/1098-2795(20010401)58:4<376::AID-MRD4>3.0.CO;2-L; Fulka J, 2011, J ASSIST REPROD GEN, V28, P385, DOI 10.1007/s10815-011-9565-1; Fulka J, 2003, THERIOGENOLOGY, V59, P1879, DOI 10.1016/S0093-691X(02)01226-8; DEBEY P, 1993, MOL REPROD DEV, V36, P59, DOI 10.1002/mrd.1080360110; Probst AV, 2007, CHROMOSOMA, V116, P403, DOI 10.1007/s00412-007-0106-8; Inoue A, 2008, HUM REPROD, V23, P1377, DOI 10.1093/humrep/den096; Probst AV, 2010, DEV CELL, V19, P625, DOI 10.1016/j.devcel.2010.09.002; CHOUINAR.LA, 1971, J CELL SCI, V9, P637; Cremer T, 2006, EUR J HISTOCHEM, V50, P161; Dang-Nguyen Thanh Quang, 2015, Curr Opin Cell Biol, V34, P9, DOI 10.1016/j.ceb.2015.04.006; Ferrai C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000588; Hyttel P., 2011, OOCYTE MATURATION FE, P1; Lian HY, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.120188; Monti M, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.103887; Ogushi S, 2010, J REPROD DEVELOP, V56, P495, DOI 10.1262/jrd.09-184H; Pederson T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000521; Shishova KV, 2015, DEV BIOL, V397, P267, DOI 10.1016/j.ydbio.2014.11.022; van de Werken C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6868; Vera-Rodriguez M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8601	45	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1471-4914	1471-499X		TRENDS MOL MED	Trends Mol. Med	NOV	2015	21	11					663	672		10.1016/j.molmed.2015.09.005		10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CW5TJ	WOS:000365059200001		
J	Kuboki, S; Shimizu, H; Ohtsuka, M; Kato, A; Yoshitomi, H; Furukawa, K; Takayashiki, T; Takano, S; Okamura, D; Suzuki, D; Sakai, N; Kagawa, S; Miyazaki, M				Kuboki, Satoshi; Shimizu, Hiroaki; Ohtsuka, Masayuki; Kato, Atsushi; Yoshitomi, Hideyuki; Furukawa, Katsunori; Takayashiki, Tsukasa; Takano, Shigetsugu; Okamura, Daiki; Suzuki, Daisuke; Sakai, Nozomu; Kagawa, Shingo; Miyazaki, Masaru			Incidence, risk factors, and management options for portal vein thrombosis after hepatectomy: a 14-year, single-center experience	AMERICAN JOURNAL OF SURGERY			English	Article						Portal vein thrombosis; Major hepatectomy; Right-sided hepatectomy; Caudate lobectomy; Operative thrombectomy	LIVER-TRANSPLANTATION; HEPATOCELLULAR-CARCINOMA; LAPAROSCOPIC SPLENECTOMY; ANTICOAGULANT-THERAPY; CLINICAL PRESENTATION; VENOUS SYSTEM; RESECTION; THROMBECTOMY; CIRRHOSIS; ADULTS	BACKGROUND: Portal vein thrombosis (PVT) after hepatectomy is rare; however, it increases mortality and morbidity. Few studies have been conducted that focused on PVT following major hepatectomy. METHODS: Patients who underwent hepatectomy at a single institution were retrospectively reviewed, and risk factors and management options were evaluated. RESULTS: Of the 1,193 patients undergoing hepatectomy, 25 patients developed PVT. Right-sided hepatectomy, caudate lobectomy, splenectomy, and postoperative bile leakage were independent risk factors for PVT following hepatectomy. PVT occurred more frequently after major hepatectomy compared with minor hepatectomy. Increased instability and reduced portal venous flow caused by kinking was the reason for increasing the risk of PVT after right-sided hepatectomy with caudate lobectomy. The new operative procedure, suturing the posterior wall of the portal vein with the anterior wall of the inferior vena cava, was effective for reducing the risk of PVT following right-sided hepatectomy. Operative thrombectomy showed significant benefits for PVT detected within 5 days after hepatectomy. CONCLUSIONS: PVT frequently occurs following major hepatectomy. Urgent operative thrombectomy is strongly recommended for PVT with early detection. (C) 2015 Elsevier Inc. All rights reserved.	[Kuboki, Satoshi; Shimizu, Hiroaki; Ohtsuka, Masayuki; Kato, Atsushi; Yoshitomi, Hideyuki; Furukawa, Katsunori; Takayashiki, Tsukasa; Takano, Shigetsugu; Okamura, Daiki; Suzuki, Daisuke; Sakai, Nozomu; Kagawa, Shingo; Miyazaki, Masaru] Chiba Univ, Grad Sch Med, Dept Gen Surg, Chuo Ku, Chiba 2600856, Japan	Miyazaki, M (reprint author), Chiba Univ, Grad Sch Med, Dept Gen Surg, Chuo Ku, 1-8-1 Inohana, Chiba 2600856, Japan.	masaru@faculty.chiba-u.jp					TESSLER FN, 1991, AM J ROENTGENOL, V157, P293; Shimada M, 2000, SURG ENDOSC-ULTRAS, V14, P127; Condat B, 2000, HEPATOLOGY, V32, P466, DOI 10.1053/jhep.2000.16597; Sobhonslidsuk A, 2002, AM J GASTROENTEROL, V97, P535, DOI 10.1111/j.1572-0241.2002.05527.x; Amitrano L, 2007, AM J GASTROENTEROL, V102, P2464, DOI 10.1111/j.1572-0241.2007.01477.x; Ganger DR, 1999, AM J GASTROENTEROL, V94, P603; Ushitora Y, 2011, DIGEST SURG, V28, P9, DOI 10.1159/000321886; Kyoden Y, 2008, TRANSPL INT, V21, P1136, DOI 10.1111/j.1432-2277.2008.00752.x; Condat B, 2001, GASTROENTEROLOGY, V120, P490, DOI 10.1053/gast.2001.21209; Smoot RL, 2006, J GASTROINTEST SURG, V10, P1371, DOI 10.1016/j.gassur.2006.09.001; Klempnauer J, 1997, BRIT J SURG, V84, P129; Ikeda M, 2005, ANN SURG, V241, P208, DOI 10.1097/01.sla.0000151794.28392.a6; Dumortier J, 2002, AM J TRANSPLANT, V2, P934, DOI 10.1034/j.1600-6143.2002.21009.x; Bach AM, 1996, RADIOLOGY, V201, P149; Vivarelli M, 2010, WORLD J GASTROENTERO, V16, P2146, DOI 10.3748/wjg.v16.i17.2146; Belghiti J, 2000, J AM COLL SURGEONS, V191, P38, DOI 10.1016/S1072-7515(00)00261-1; Thomas RM, 2010, J GASTROINTEST SURG, V14, P570, DOI 10.1007/s11605-009-0967-7; Ravaioli M, 2011, ANN SURG, V253, P378, DOI 10.1097/SLA.0b013e318206818b; ROUCH DA, 1988, SURG GYNECOL OBSTET, V166, P311; Amitrano L, 2004, J HEPATOL, V40, P736, DOI 10.1016/j.jhep.2004.01.001; Rodriguez-Castro KI, 2012, TRANSPLANTATION, V94, P1145, DOI 10.1097/TP.0b013e31826e8e53; Garcia-Pagan JC, 2008, SEMIN LIVER DIS, V28, P282, DOI 10.1055/s-0028-1085096; Yerdel MA, 2000, TRANSPLANTATION, V69, P1873, DOI 10.1097/00007890-200005150-00023; Hanazaki K, 2000, J AM COLL SURGEONS, V191, P381, DOI 10.1016/S1072-7515(00)00700-6; Ansari D, 2013, WORLD J SURG, V37, P179, DOI 10.1007/s00268-012-1777-8; Darwish MS, 2006, AM J GASTROENTEROL, V101, P83; MERGENTH.FW, 1968, ANN SURG, V167, P106, DOI 10.1097/00000658-196801000-00017; Sogaard KK, 2007, BMC GASTROENTEROL, V7, DOI 10.1186/1471-230X-7-34; Yoshiya S, 2014, WORLD J SURG, V38, P1491, DOI 10.1007/s00268-013-2440-8	29	0	0	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610	1879-1883		AM J SURG	Am. J. Surg.	NOV	2015	210	5					878	+		10.1016/j.amjsurg.2014.11.021		10	Surgery	Surgery	CW6DC	WOS:000365086700014		
J	Takahashi, M; Hasegawa, K; Oba, M; Aoki, T; Sakamoto, Y; Sugawara, Y; Kokudo, N				Takahashi, Michiro; Hasegawa, Kiyoshi; Oba, Masaru; Aoki, Taku; Sakamoto, Yoshihiro; Sugawara, Yasuhiko; Kokudo, Norihiro			Repeat resection leads to long-term survival: analysis of 10-year follow-up of patients with colorectal liver metastases	AMERICAN JOURNAL OF SURGERY			English	Article						Colorectal liver metastases; Long-term survival; Repeat resection; 10-Year survival; Hepatectomy	HEPATIC RESECTION; PULMONARY METASTASECTOMY; RADIOFREQUENCY ABLATION; SURGICAL INDICATIONS; DEFINES CURE; CANCER; SURGERY; HEPATECTOMY; TRENDS; TRIAL	BACKGROUND: Some reports have shown that a significant number of patients experience recurrence, even after 5 or more years after surgery for colorectal liver metastases (CLMs). This study aimed to determine the actual cure rate and identify clinical characteristics among long-term survivors. METHODS: A prospectively maintained database was used to retrospectively review patients who underwent liver resection for CLM between 1994 and 2001. RESULTS: A total of 130 patients underwent liver resection for CLM with a complete 10-year follow-up. The 10-year disease-specific survival rate was 31.1%, and the survival curve reached a plateau after 10 years from the time of hepatic resection. There were 35 actual 10-year survivors. Multivariate analysis revealed that female patients and those with negative surgical margins were independent prognostic factors for disease-specific survival. CONCLUSION: A 10-year survival following initial hepatectomy should be defined as cure. (C) 2015 Elsevier Inc. All rights reserved.	[Takahashi, Michiro; Hasegawa, Kiyoshi; Oba, Masaru; Aoki, Taku; Sakamoto, Yoshihiro; Sugawara, Yasuhiko; Kokudo, Norihiro] Univ Tokyo, Grad Sch Med, Dept Surg, Hepatobiliarypancreat Surg Div,Bunkyo Ku, Tokyo 1138655, Japan	Kokudo, N (reprint author), Univ Tokyo, Grad Sch Med, Dept Surg, Hepatobiliarypancreat Surg Div,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	KOKUDO-2SU@h.u-tokyo.ac.jp					Petrowsky H, 2002, ANN SURG, V235, P863, DOI 10.1097/00000658-200206000-00015; Vigano L, 2008, ANN SURG ONCOL, V15, P2458, DOI 10.1245/s10434-008-9935-9; Iida T, 2013, ANN SURG, V257, P1059, DOI 10.1097/SLA.0b013e31826eda3b; Kulik U, 2013, BRIT J SURG, V100, P926, DOI 10.1002/bjs.9132; Ruers T, 2012, ANN ONCOL, V23, P2619, DOI 10.1093/annonc/mds053; Kokudo N, 2001, AM J SURG, V181, P153, DOI 10.1016/S0002-9610(00)00560-2; Tomlinson JS, 2007, J CLIN ONCOL, V25, P4575, DOI 10.1200/JCO.2007.11.0833; Choti MA, 2002, ANN SURG, V235, P759, DOI 10.1097/00000658-200206000-00002; Chua TC, 2011, J SURG ONCOL, V103, P796, DOI 10.1002/jso.21864; Adair RA, 2012, BRIT J SURG, V99, P1278, DOI 10.1002/bjs.8845; Hamady ZZR, 2006, EJSO, V32, P557, DOI 10.1016/j.ejso.2006.02.001; Portier G, 2006, J CLIN ONCOL, V24, P4976, DOI 10.1200/JCO.2006.06.8353; Hata S, 2011, WORLD J SURG, V35, P2779, DOI 10.1007/s00268-011-1264-7; Giuliante F, 2009, J SURG ONCOL, V100, P538, DOI 10.1002/jso.21393; Minagawa M, 2000, ANN SURG, V231, P487, DOI 10.1097/00000658-200004000-00006; Mise Y, 2010, ANN SURG, V251, P902, DOI 10.1097/SLA.0b013e3181c9868a; Roberts KJ, 2014, BRIT J SURG, V101, P856, DOI 10.1002/bjs.9471; Shimizu Y, 2007, LANGENBECK ARCH SURG, V392, P535, DOI 10.1007/s00423-007-0153-x; Nordlinger B, 2008, LANCET, V371, P1007, DOI 10.1016/S0140-6736(08)60455-9; Wei AC, 2006, ANN SURG ONCOL, V13, P668, DOI 10.1245/ASO.2006.05.039; Blackmon SH, 2012, ANN THORAC SURG, V94, P1802, DOI 10.1016/j.athoracsur.2012.07.014; Rees M, 2008, ANN SURG, V247, P125, DOI 10.1097/SLA.0b013e31815aa2c2; Khajanchee YS, 2011, ARCH SURG-CHICAGO, V146, P1416, DOI 10.1001/archsurg.2011.212; Tanaka K, 2007, ANN SURG ONCOL, V14, P1336, DOI 10.1245/s10434-006-9071-3; Pulitano C, 2010, HPB, V12, P244, DOI 10.1111/j.1477-2574.2010.00155.x; Gold JS, 2008, ANN SURG, V247, P109, DOI 10.1097/SLA.0b013e3181557e47; Andreou A, 2011, HPB, V13, P774, DOI 10.1111/j.1477-2574.2011.00370.x; Sakamoto M, 2010, ANN THORAC SURG, V90, P1766, DOI 10.1016/j.athoracsur.2010.07.054; Cirocchi R, 2012, COCHRANE DB SYST REV, V6; Saiura A, 2014, ANN SURG ONCOL, V21, P4293, DOI 10.1245/s10434-014-3863-7	30	0	0	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610	1879-1883		AM J SURG	Am. J. Surg.	NOV	2015	210	5					904	910		10.1016/j.amjsurg.2015.01.026		7	Surgery	Surgery	CW6DC	WOS:000365086700018		
J	Klochikhin, A; Greil, R; Cohen, E; Vermorken, J; Harrington, K; Tahara, M; Ge, JY; Geib, J; Jin, F; Burtness, B				Klochikhin, A.; Greil, R.; Cohen, E.; Vermorken, J.; Harrington, K.; Tahara, M.; Ge, J. Y.; Geib, J.; Jin, F.; Burtness, B.			Phase 3 trial of pembrolizumab as a first-line treatment in subjects with recurrent/metastatic head and neck squamous cell carcinoma: KEYNOTE-048	ANNALS OF ONCOLOGY			English	Meeting Abstract	Meeting of the European-Society-for-Medical-Oncology (ESMO)	NOV 20-21, 2015	Lausanne, SWITZERLAND	European Soc Med Oncol, Bristol Myers Squibb, MSD, Merck, Pfizer, Roche, Celldex Therapeut					[Klochikhin, A.] State Med Inst, Med Oncol, Yaroslavl, Russia; [Greil, R.] Paracelsus Med Univ Salzburg, Illrd Med Dept, Salzburg, Austria; [Cohen, E.] Univ Calif San Diego, Moores Canc Ctr, Translat Sci, San Diego, CA 92103 USA; [Vermorken, J.] Univ Antwerp Hosp, Med Oncol, Edegem, Belgium; [Harrington, K.] Inst Canc Res, Med Oncol, London, England; [Tahara, M.] Hosp East, Natl Canc Ctr, Med Oncol, Kashiwa, Chiba, Japan; [Ge, J. Y.; Geib, J.; Jin, F.] Merck & Co Inc, Med Oncol, Kenilworth, NJ USA; [Burtness, B.] Yale Univ, Med Oncol, New Haven, CT USA								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			8		11TiP	5	5				1	Oncology	Oncology	CW7EH	WOS:000365160300012		
J	Yoshino, T				Yoshino, Takayuki			SCRUM-Japan GI-SCREEN: The nationwide cancer genome screening projects for gastrointestinal cancer in Japan	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Yoshino, Takayuki] Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		AJ-5	5	5				1	Oncology	Oncology	CW7ED	WOS:000365159900010		
J	Kitano, S				Kitano, Shigehisa			Immue checkpoint inhibitors. Clinical point of views from JSMO	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Kitano, Shigehisa] Natl Canc Ctr, Dept Expt Therapeut, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		EJ-3	7	7				1	Oncology	Oncology	CW7ED	WOS:000365159900016		
J	Inoue, A				Inoue, Akira			How to use EGFR-TKI in clinical practice	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Inoue, Akira] Tohoku Univ, Dept Palliat Med, Sendai, Miyagi 980, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		ISY1-1	8	8				1	Oncology	Oncology	CW7ED	WOS:000365159900018		
J	Fukutomi, A				Fukutomi, Akira			Treatment for locally advanced disease	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Fukutomi, Akira] Shizuoka Canc Ctr, Div Gastrointestinal Oncol, Shizuoka, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		ISY2-3	9	9				1	Oncology	Oncology	CW7ED	WOS:000365159900021		
J	Furuse, J				Furuse, Junji			Treatment for advanced and metastatic disease: Gemcitaine-based therapy	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Furuse, Junji] Kyorin Univ, Sch Med, Dept Med Oncol, Hachioji, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		ISY2-6	9	10				2	Oncology	Oncology	CW7ED	WOS:000365159900024		
J	Ioka, T; Katayama, K; Ashida, R				Ioka, Tatsuya; Katayama, Kazuhiro; Ashida, Reiko			S-1 based chemotherapy for metastatic pancreatic cancer	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Ioka, Tatsuya; Katayama, Kazuhiro; Ashida, Reiko] Osaka Med Ctr Canc & CVD, Pancreat Canc Ctr, Osaka, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		ISY2-4	9	9				1	Oncology	Oncology	CW7ED	WOS:000365159900022		
J	Ozaka, M				Ozaka, Masato			Current status and perspective of FOLFIRINOX for pancreatic cancer	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Ozaka, Masato] JFCR, Canc Inst Hosp, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		ISY2-5	9	9				1	Oncology	Oncology	CW7ED	WOS:000365159900023		
J	Ueno, H; Okusaka, T; Kosuge, T; Motoi, F; Unno, M				Ueno, Hideki; Okusaka, Takuji; Kosuge, Tomoo; Motoi, Fuyuhiko; Unno, Michiaki			Adjuvant and neoadjuvant therapy for resectable pancreatic cancer	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Ueno, Hideki; Okusaka, Takuji] Natl Canc Ctr, Hepatobiliary & Pancreat Oncol Div, Tokyo, Japan; [Kosuge, Tomoo] Natl Canc Ctr, Hepatobiliary & Pancreat Surg Div, Tokyo, Japan; [Motoi, Fuyuhiko; Unno, Michiaki] Tohoku Univ, Grad Sch Med, Dept Surg, Sendai, Miyagi 980, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		ISY2-2	9	9				1	Oncology	Oncology	CW7ED	WOS:000365159900020		
J	Iwata, H				Iwata, Hiroji			The perspective of anti-HER2 therapy for HER2 positive breast cancer	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Iwata, Hiroji] Aichi Canc Ctr Hosp, Dept Breast Oncol, Nagoya, Aichi, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		ISY3-3	11	11				1	Oncology	Oncology	CW7ED	WOS:000365159900028		
J	Hironaka, S				Hironaka, Shuichi			Perspectives of systemic chemotherapy for unresectable and recurrent gastric cancer similar to Cytotoxic agent similar to	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Hironaka, Shuichi] Chiba Canc Ctr, Clin Trial Promot Dept, Chiba, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		ISY4-5	12	12				1	Oncology	Oncology	CW7ED	WOS:000365159900031		
J	Kuboki, Y; Kawazoe, A; Shitara, K; Ushijima, T; Doi, T; Ochiai, A; Ohtsu, A				Kuboki, Yasutoshi; Kawazoe, Akihito; Shitara, Kohei; Ushijima, Toshikazu; Doi, Toshihiko; Ochiai, Atsushi; Ohtsu, Atsushi			What is a useful biomarker for advanced gastric cancer (AGC)?	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Kuboki, Yasutoshi; Doi, Toshihiko] Natl Canc Ctr Hosp East, Dept Expt Therapeut, Tokyo, Japan; [Kawazoe, Akihito; Shitara, Kohei] Natl Canc Ctr Hosp East, Dept GI Oncol, Tokyo, Japan; [Ushijima, Toshikazu; Ochiai, Atsushi] Natl Canc Ctr, Res Inst, Tokyo, Japan; [Ohtsu, Atsushi] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		ISY4-4	12	12				1	Oncology	Oncology	CW7ED	WOS:000365159900030		
J	Muro, K				Muro, Kei			Clinical outcomes in patients with advanced gastric cancer treated with pembrolizumab (MK-3475) in KEYNOTE-012	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Muro, Kei] Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		ISY4-6	12	12				1	Oncology	Oncology	CW7ED	WOS:000365159900032		
J	Sato, Y				Sato, Yasushi			Conversion therapy using docetaxel/CDDP/S-1 (DCS) in inoperable, metastatic gastric cancer patients	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Sato, Yasushi] Sapporo Med Univ, Sch Med, Dept Med Oncol & Hematol, Sapporo, Hokkaido, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		ISY4-7	12	12				1	Oncology	Oncology	CW7ED	WOS:000365159900033		
J	Yamazaki, K				Yamazaki, Kentaro			The current status and a perspective on the future of colorectal cancer treatment in Japan	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Yamazaki, Kentaro] Shizuoka Canc Ctr, Div Gastrointestinal Oncol, Nagaizumi, Shizuoka, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		ISY5-3	13	13				1	Oncology	Oncology	CW7ED	WOS:000365159900035		
J	Kiyota, N				Kiyota, Naomi			JCOG1008: Phase II/III Trial of postoperative chemoradiotherapy comparing 3-weekly cisplatin with weekly cisplatin in high-risk patients with squamous cell carcinoma of head and neck	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Kiyota, Naomi] Kobe Univ Hosp, Dept Med Oncol & Hepatol, Kobe, Hyogo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		ISY6-1	14	14				1	Oncology	Oncology	CW7ED	WOS:000365159900036		
J	Tahara, M				Tahara, Makoto			PEACE trial: A phase 3 trial of paclitaxel, carboplatin and cetuximab vs cisplatin, 5-FU and cetuximab in R/M SCCHN	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Tahara, Makoto] Natl Canc Ctr Hosp East, Dept Head & Neck Med Oncol, Kashiwa, Chiba, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		ISY6-3	14	14				1	Oncology	Oncology	CW7ED	WOS:000365159900037		
J	Koh, Y				Koh, Yasuhiro			Liquid biopsies: noninvasive longitudinal monitoring of lung cancer	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Koh, Yasuhiro] Wakayama Med Univ, Dept Internal Med 3, Wakayama, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		ISY7-4	15	15				1	Oncology	Oncology	CW7ED	WOS:000365159900040		
J	Song, SL; Kaname, T; Sugano, S				Song, Shuolin; Kaname, Tadashi; Sugano, Sumio			Next generation sequencing-based cancer companion diagnostics: the reality and future perspectives	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Song, Shuolin] Roche Diagnost KK, Tokyo, Japan; [Kaname, Tadashi] Univ Ryukyus, Nishihara, Okinawa 90301, Japan; [Sugano, Sumio] Univ Tokyo, Tokyo 1138654, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		ISY7-1	15	15				1	Oncology	Oncology	CW7ED	WOS:000365159900039		
J	Seto, T				Seto, Takashi			New ALK inhibitors	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Seto, Takashi] Kyushu Natl Canc Ctr, Dept Thorac Oncol, Fukuoka, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		ISY8-2	16	16				1	Oncology	Oncology	CW7ED	WOS:000365159900042		
J	Yamamoto, N				Yamamoto, Noboru			New molecular targeted agent for non-small cell lung cancer: miscellaneous or old agents	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Yamamoto, Noboru] Natl Canc Ctr, Dept Thorac Oncol, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		ISY8-5	16	16				1	Oncology	Oncology	CW7ED	WOS:000365159900045		
J	Nakamura, S				Nakamura, Shigeo			EBV-associated lymphoproliferative disorders/lymphomas	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Nakamura, Shigeo] Nagoya Univ Hosp, Dept Pathol & Lab Med, Nagoya, Aichi, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		ISY9-3	17	17				1	Oncology	Oncology	CW7ED	WOS:000365159900047		
J	Tobinai, K				Tobinai, Kensei			Clinical trials for T/NK-cell lymphomas in Japan	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Tobinai, Kensei] Natl Canc Ctr, Dept Hematol, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		ISY9-5	17	17				1	Oncology	Oncology	CW7ED	WOS:000365159900049		
J	Shinohara, N				Shinohara, Nobuo			Clinical usefulness of abiraterone acetate for Japanese patients with castration-resistant prostate cancer	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Shinohara, Nobuo] Hokkaido Univ, Grad Sch Med, Dept Gemitourinary Surg, Sapporo, Hokkaido 060, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		ISY10-2	18	18				1	Oncology	Oncology	CW7ED	WOS:000365159900050		
J	Takahashi, S				Takahashi, Shunji			Chemotherapy for castration resistant prostate cancer: new perspectives	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Takahashi, Shunji] Canc Inst Hosp, JFCR, Dept Med Oncol, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		ISY10-4	18	18				1	Oncology	Oncology	CW7ED	WOS:000365159900051		
J	Yano, S				Yano, Seiji			Circumvention of TKI resistance with HDAC inhibitors in lung cancer	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Yano, Seiji] Kanazawa Univ, Canc Res Inst, Div Med Oncol, Kanazawa, Ishikawa 9201192, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		JS1-5	19	19				1	Oncology	Oncology	CW7ED	WOS:000365159900052		
J	Naoi, Y; Noguchi, S				Naoi, Yasuto; Noguchi, Shinzaburo			Multi-gene classifiers for prediction of recurrence in breast cancer	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Naoi, Yasuto; Noguchi, Shinzaburo] Osaka Univ, Grad Sch Med, Dept Breast & Endocrine Surg, Suita, Osaka 565, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		JS2-2	20	20				1	Oncology	Oncology	CW7ED	WOS:000365159900053		
J	Tsurutani, J				Tsurutani, Junji			Liquid biopsy could revolutionize cancer care	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Tsurutani, Junji] Kinki Univ, Fac Med, Dept Med Oncol, Higashiosaka, Osaka 577, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		JS2-4	20	20				1	Oncology	Oncology	CW7ED	WOS:000365159900054		
J	Muro, K				Muro, Kei			Molecular targeting agents combined with radiation therapy for esophageal cancer	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Muro, Kei] Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		JS3-3	21	21				1	Oncology	Oncology	CW7ED	WOS:000365159900057		
J	Sasaki, T				Sasaki, Tomonari			Progress of clinical research on the combination of radiotherapy and targeted therapy for lung cancer	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Sasaki, Tomonari] Kyushu Univ, Dept Radiol Informat & Network, Fukuoka 812, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		JS3-4	21	21				1	Oncology	Oncology	CW7ED	WOS:000365159900058		
J	Zenda, S				Zenda, Sadamoto			The clinical impact of targeting therapy in head and neck cancer	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Zenda, Sadamoto] Natl Canc Ctr Hosp East, Dept Radiat Oncol, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		JS3-2	21	21				1	Oncology	Oncology	CW7ED	WOS:000365159900056		
J	Nanba, Y				Nanba, Yoshinobu			Development and prospects of a new anti-cancer agent similar to the first anti PD-1 antibody in the world similar to	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Nanba, Yoshinobu] Ono Pharmaceut Co Ltd, Clin Dev, Osaka, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		JS4-4	22	22				1	Oncology	Oncology	CW7ED	WOS:000365159900059		
J	Ohtsu, A				Ohtsu, Atsushi			Activity for new oncology agent development in the clinical trial center	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Ohtsu, Atsushi] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		JS4-5	22	22				1	Oncology	Oncology	CW7ED	WOS:000365159900060		
J	Kanbayashi, Y				Kanbayashi, Yuko			Early palliative care based on guideline -involvement of our palliative care team	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Kanbayashi, Yuko] Kyoto Prefectural Univ Med, Dept Hosp Pharm, Kyoto 602, Japan; [Kanbayashi, Yuko] Kyoto Prefectural Univ Med, Dept Pain Treatment & Palliat Care Unit, Kyoto 602, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		JS5-3	23	23				1	Oncology	Oncology	CW7ED	WOS:000365159900062		
J	Sasaki, J; Hirayama, Y				Sasaki, Jiichiro; Hirayama, Yasuo			Report of results from a survey for oncologists about the established guidelines in supportive or palliative medicine	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Sasaki, Jiichiro] Kitasato Univ, Sch Med, Res & Dev Ctr New Med Frontiers, Div Clin Oncol,Dept Comprehens Med, Tokyo, Japan; [Hirayama, Yasuo] Higashi Sapporo Hosp, Dept Hematol & Oncol, Sapporo, Hokkaido, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		JS5-1	23	23				1	Oncology	Oncology	CW7ED	WOS:000365159900061		
J	Fujimori, M				Fujimori, Maiko			Effect of communication skills training program for oncologists based on patient preferences for communicating bad news	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Fujimori, Maiko] Natl Ctr Neurol & Psychiat, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		JS6-1	24	24				1	Oncology	Oncology	CW7ED	WOS:000365159900063		
J	Takamatsu, H				Takamatsu, Hiroyuki			Prognostic value of minimal residual disease response assessment in multiple myeloma	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Takamatsu, Hiroyuki] Kanazawa Univ, Cellular Transplantat Biol, Kanazawa, Ishikawa 9201192, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		JS7-5	25	25				1	Oncology	Oncology	CW7ED	WOS:000365159900064		
J	Amano, T				Amano, Toraji			Needs of patient-reported outcome: from the perspective of clinical practice	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Amano, Toraji] Hokkaido Univ, Grad Sch Med, Dept Med Oncol, Sapporo, Hokkaido 060, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		SY1-1	26	26				1	Oncology	Oncology	CW7ED	WOS:000365159900065		
J	Kajiyama, H; Shibata, K; Kikkawa, F				Kajiyama, Hiroaki; Shibata, Kiyosumi; Kikkawa, Fumitaka			Long-term prognosis for ovarian cancer based on front-line chemotherapy similar to Is it the same for each histological type?	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Kajiyama, Hiroaki; Shibata, Kiyosumi; Kikkawa, Fumitaka] Nagoya Univ, Dept Obstet & Gynecol, Nagoya, Aichi 4648601, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		SY2-3	27	27				1	Oncology	Oncology	CW7ED	WOS:000365159900069		
J	Kuroda, T; Hirohashi, Y; Torigoe, T; Mariya, T; Asano, T; Tabuchi, Y; Mizuuchi, M; Iwasaki, M; Sato, N; Saito, T				Kuroda, Takafumi; Hirohashi, Yoshihiko; Torigoe, Toshihiko; Mariya, Tasuku; Asano, Takuya; Tabuchi, Yudai; Mizuuchi, Masahito; Iwasaki, Masahiro; Sato, Noriyuki; Saito, Tsuyoshi			The property of ovarian cancer stem-like cells and the prospect for immunotherapy targeted cancer stem-like cells	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Kuroda, Takafumi; Mariya, Tasuku; Asano, Takuya; Tabuchi, Yudai; Mizuuchi, Masahito; Iwasaki, Masahiro; Saito, Tsuyoshi] Sapporo Med Univ, Dept Obstet & Gynecol, Sapporo, Hokkaido, Japan; [Kuroda, Takafumi; Hirohashi, Yoshihiko; Torigoe, Toshihiko; Mariya, Tasuku; Asano, Takuya; Tabuchi, Yudai; Mizuuchi, Masahito; Sato, Noriyuki] Sapporo Med Univ, Dept Pathol, Sapporo, Hokkaido, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		SY2-4	27	27				1	Oncology	Oncology	CW7ED	WOS:000365159900070		
J	Matsumoto, K				Matsumoto, Koji			Novel medical treatments for ovarian cancer; anti-angiogenesis, PARP inhibitors, and more	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Matsumoto, Koji] Hyogo Canc Ctr, Div Med Oncol, Akashi, Hyogo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		SY2-2	27	27				1	Oncology	Oncology	CW7ED	WOS:000365159900068		
J	Takeuchi, S				Takeuchi, Satoshi			Current status and future perspective of PET/CT imaging in clinical oncology	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Takeuchi, Satoshi] Hokkaido Univ, Grad Sch Med, Dept Med Oncol, Sapporo, Hokkaido 060, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		SY3-4	28	28				1	Oncology	Oncology	CW7ED	WOS:000365159900072		
J	Daigo, Y				Daigo, Yataro			Development of therapeutic cancer vaccines and future prospects towards personalized medicine	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Daigo, Yataro] Shiga Univ Med Sci, Dept Med Oncol, Otsu, Shiga, Japan; [Daigo, Yataro] Shiga Univ Med Sci, Ctr Canc, Otsu, Shiga, Japan; [Daigo, Yataro] Univ Tokyo, Res Hosp, Ctr Antibody & Vaccine Therapy, Tokyo 1138654, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		SY5-1	30	30				1	Oncology	Oncology	CW7ED	WOS:000365159900074		
J	Kochin, V; Kanaseki, T; Miyamoto, S; Morooka, D; Moniwa, K; Ikeuchi, Y; Takaya, A; Hirohashi, Y; Torigoe, T; Sato, N				Kochin, Vitaly; Kanaseki, Takayuki; Miyamoto, Sho; Morooka, Daichi; Moniwa, Keigo; Ikeuchi, Yutaro; Takaya, Akari; Hirohashi, Yoshihiko; Torigoe, Toshihiko; Sato, Noriyuki			Human cancer immunopeptidomics for efficient CTL immunotherapy	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Kochin, Vitaly; Kanaseki, Takayuki; Miyamoto, Sho; Morooka, Daichi; Moniwa, Keigo; Ikeuchi, Yutaro; Takaya, Akari; Hirohashi, Yoshihiko; Torigoe, Toshihiko; Sato, Noriyuki] Sapporo Med Univ, Dept Pathol, Sapporo, Hokkaido, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		SY5-2	30	30				1	Oncology	Oncology	CW7ED	WOS:000365159900075		
J	Matsumoto, M; Seya, T				Matsumoto, Misako; Seya, Tsukasa			Development of a non-inflammatory adjuvant for vaccine immunotherapy against cancer	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Matsumoto, Misako; Seya, Tsukasa] Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Sapporo, Hokkaido 060, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		SY5-7	30	30				1	Oncology	Oncology	CW7ED	WOS:000365159900076		
J	Gotoh, N; Tominaga, K; Tojo, A				Gotoh, Noriko; Tominaga, Kana; Tojo, Arinobu			MICAL3 regulates stemness of human breast cancer	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Gotoh, Noriko] Kanazawa Univ, Canc Res Inst, Div Canc Cell Biol, Kanazawa, Ishikawa 9201192, Japan; [Tominaga, Kana; Tojo, Arinobu] Univ Tokyo, Inst Med Sci, Div Mol Therapy, Tokyo 1138654, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		SY6-3	31	31				1	Oncology	Oncology	CW7ED	WOS:000365159900078		
J	Hirohashi, Y; Torigoe, T; Morita, R; Sato, N				Hirohashi, Yoshihiko; Torigoe, Toshihiko; Morita, Rena; Sato, Noriyuki			Establishment of cancer stem cell-targeting immunotherapy	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Hirohashi, Yoshihiko; Torigoe, Toshihiko; Morita, Rena; Sato, Noriyuki] Sapporo Med Univ, Sch Med, Dept Pathol, Sapporo, Hokkaido, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		SY6-4	31	31				1	Oncology	Oncology	CW7ED	WOS:000365159900079		
J	Ochiya, T				Ochiya, Takahiro			Impact of exosomal transfer of microRNAs in cancer stem cell dorman	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Ochiya, Takahiro] Natl Canc Ctr, Div Mol & Cellular Med, Res Inst, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		SY6-2	31	31				1	Oncology	Oncology	CW7ED	WOS:000365159900077		
J	Takahashi, T; Akinaga, S				Takahashi, Takeshi; Akinaga, Shiro			Points to be aware of in the development of antibody drugs-from our experience with mogamulizumab	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Takahashi, Takeshi; Akinaga, Shiro] Kyowa Hakko Kirin Co Ltd, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		SY7-3	32	32				1	Oncology	Oncology	CW7ED	WOS:000365159900080		
J	Shimizu, Y; Taguchi, J; Kinoshita, I; Tsuchiya, K; Shirato, H; Homma, A; Fukuda, S; Akita, H				Shimizu, Yasushi; Taguchi, Jun; Kinoshita, Ichiro; Tsuchiya, Kazuhiko; Shirato, Hiroki; Homma, Akihiro; Fukuda, Satoshi; Akita, Hirotoshi			Induction chemotherapy in locally advanced head and neck cancer	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Shimizu, Yasushi; Taguchi, Jun; Kinoshita, Ichiro; Akita, Hirotoshi] Hokkaido Univ, Grad Sch Med, Dept Med Oncol, Sapporo, Hokkaido 060, Japan; [Tsuchiya, Kazuhiko; Shirato, Hiroki] Hokkaido Univ, Grad Sch Med, Dept Radiat Med, Sapporo, Hokkaido 060, Japan; [Homma, Akihiro; Fukuda, Satoshi] Hokkaido Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Sapporo, Hokkaido 060, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		SY8-2	33	33				1	Oncology	Oncology	CW7ED	WOS:000365159900082		
J	Tahara, M				Tahara, Makoto			The evolving role of immunotherapy in head and neck cancer	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Tahara, Makoto] Natl Canc Ctr Hosp East, Dept Head & Neck Med Oncol, Kashiwa, Chiba, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		SY8-1	33	33				1	Oncology	Oncology	CW7ED	WOS:000365159900081		
J	Takahashi, M				Takahashi, Miyako			Cancer survivorship research and care practice: current status and issues in Japan	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Takahashi, Miyako] Natl Canc Ctr, Ctr Canc Control & Informat Serv, Div Canc Survivorship Res, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		SY9-1	34	34				1	Oncology	Oncology	CW7ED	WOS:000365159900084		
J	Kawai, A				Kawai, Akira			Treatment of soft tissue sarcomas: global trends and the current Japanese situation	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Kawai, Akira] Natl Canc Ctr, Rare Canc Ctr, Musculoskeletal Oncol, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		SY10-1	35	35				1	Oncology	Oncology	CW7ED	WOS:000365159900086		
J	Oda, Y				Oda, Yoshinao			The roles histopathological diagnosis in multidisciplinary therapy for soft tissue sarcoma	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Oda, Yoshinao] Kyushu Univ, Dept Anat Pathol, Fukuoka 812, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		SY10-2	35	35				1	Oncology	Oncology	CW7ED	WOS:000365159900087		
J	Tanaka, K				Tanaka, Kazuhiro			Multicenter clinical studies for soft tissue sarcomas in Japan	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Tanaka, Kazuhiro] Oita Univ, Dept Orthopaed Surg, Oita, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		SY10-3	35	35				1	Oncology	Oncology	CW7ED	WOS:000365159900088		
J	Akiyama, S				Akiyama, Shoko			Medical liaison for medical practitioners in Miyagi prefecture: a questionnaire survey	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Akiyama, Shoko] Sendai Med Ctr, Dept Med Oncol, Sendai, Miyagi, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		SY11-2	36	36				1	Oncology	Oncology	CW7ED	WOS:000365159900090		
J	Okamoto, I; Nakagawa, K; Ohe, Y; Ueno, N; Banno, S; Endo, Y; Ohki, E; Gemma, A				Okamoto, Isamu; Nakagawa, Kazuhiko; Ohe, Yuichiro; Ueno, Naomi; Banno, Shigeo; Endo, Yutaka; Ohki, Emiko; Gemma, Akihiko			Safety of crizotinib in 892 Japanese ALK-positive advanced NSCLC patients: Interim report of post-marketing surveillance	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Okamoto, Isamu] Kyusyu Univ Hosp, Ctr Clin & Transrat Res, Fukuoka, Japan; [Nakagawa, Kazuhiko] Kinki Univ, Fac Med, Dept Med Oncol, Osaka, Japan; [Ohe, Yuichiro] Natl Canc Ctr, Dept Resp Med, Tokyo, Japan; [Ueno, Naomi; Banno, Shigeo; Endo, Yutaka; Ohki, Emiko] Pfizer Japan Inc, Tokyo, Japan; [Gemma, Akihiko] Nippon Med Sch, Grad Sch Med, Dept Pulm Med & Oncol, Tokyo 113, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		SY12-3	37	37				1	Oncology	Oncology	CW7ED	WOS:000365159900091		
J	Fukudo, M				Fukudo, Masahide			Relationships between sorafenib exposure and clinical safety and efficacy	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Fukudo, Masahide] Asahikawa Med Univ, Dept Hosp Pharm & Pharmacol, Asahikawa, Hokkaido, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		SY13-3	38	38				1	Oncology	Oncology	CW7ED	WOS:000365159900093		
J	Imamura, C				Imamura, Chiyo			Tamoxifen and CYP2D6 polymorphism in the treatment of hormone receptor-positive breast cancer	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Imamura, Chiyo] Keio Univ, Sch Med, Dept Clin Pharmacokinet & Pharmacodynam, Tokyo 108, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		SY13-5	38	38				1	Oncology	Oncology	CW7ED	WOS:000365159900094		
J	Miura, M				Miura, Masatomo			Therapeutic drug monitoring of imatinib	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Miura, Masatomo] Akita Univ Hosp, Dept Pharm, Akita, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		SY13-2	38	38				1	Oncology	Oncology	CW7ED	WOS:000365159900092		
J	Kinoshita, I				Kinoshita, Ichiro			Screening for HER2 alterations and HER2-targeted therapy in non-small cell lung cancer	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Kinoshita, Ichiro] Hokkaido Univ, Grad Sch Med, Dept Med Oncol, Sapporo, Hokkaido 060, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		SY15-2	40	40				1	Oncology	Oncology	CW7ED	WOS:000365159900098		
J	Yoh, K				Yoh, Kiyotaka			Nationwide driver mutation analysis in advanced EGFR mutation-negative non-squamous lung cancer: LC-SCRUM-Japan	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Yoh, Kiyotaka] Natl Canc Ctr Hosp East, Div Thorac Oncol, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		SY15-3	40	40				1	Oncology	Oncology	CW7ED	WOS:000365159900099		
J	Sasaki, T				Sasaki, Takaaki			ALK resistance mechanism & TKI selection	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Sasaki, Takaaki] Asahikawa Med Univ, Asahikawa, Hokkaido, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		SY15-4	41	41				1	Oncology	Oncology	CW7ED	WOS:000365159900100		
J	Takahashi, S; Kota, O; Ishioka, C				Takahashi, Shin; Kota, Ouchi; Ishioka, Chikashi			Development of the new biomarker of colorectal cancer using the comprehensive molecular analyses	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Takahashi, Shin; Ishioka, Chikashi] Tohoku Univ, Dept Clin Oncol, IDAC, Sendai, Miyagi 980, Japan; [Takahashi, Shin; Ishioka, Chikashi] Tohoku Univ Hosp, Dept Clin Oncol, Sendai, Miyagi, Japan; [Kota, Ouchi] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		SY16-4	42	42				1	Oncology	Oncology	CW7ED	WOS:000365159900103		
J	Taniguchi, H				Taniguchi, Hiroya			Precision medicine for metastatic colorectal cancer; current status and future perspectives	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Taniguchi, Hiroya] Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		SY16-2	42	42				1	Oncology	Oncology	CW7ED	WOS:000365159900102		
J	Tsuchihara, K				Tsuchihara, Katsuya			Cancer precision medicine directed by next-generation sequencing technologies	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Tsuchihara, Katsuya] Natl Canc Ctr, EPOC, Div Translat Res, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		SY16-1	42	42				1	Oncology	Oncology	CW7ED	WOS:000365159900101		
J	Kashiwazaki, H				Kashiwazaki, Haruhiko			Oral supportive care in cancer therapy at Hokkaido University Hospital	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Kashiwazaki, Haruhiko] Hokkaido Univ Hosp, Ctr Dent Clin, Gerodontol, Sapporo, Hokkaido, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		SY17-3	43	43				1	Oncology	Oncology	CW7ED	WOS:000365159900105		
J	Nakajima, N				Nakajima, Nobuhisa			Oral care in palliative care settings - actual situation of oral problems and issues from the viewpoint of "total pain"	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Nakajima, Nobuhisa] Tohoku Univ, Grad Sch Med, Dept Palliat Med, Sendai, Miyagi 980, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		SY17-5	43	43				1	Oncology	Oncology	CW7ED	WOS:000365159900107		
J	Sumi, N				Sumi, Naomi			Practice of oral care and related issues among nurses in cancer treatment: approach for effective oral management	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Sumi, Naomi] Hokkaido Univ, Fac Hlth Sci, Dept Fundamental Nursing, Sapporo, Hokkaido 060, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		SY17-4	43	43				1	Oncology	Oncology	CW7ED	WOS:000365159900106		
J	Ueno, T				Ueno, Takao			Approach of medical-dental cooperation in National Cancer Center Hospital	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Ueno, Takao] Natl Canc Ctr Hosp, Kashiwa, Chiba, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		SY17-2	43	43				1	Oncology	Oncology	CW7ED	WOS:000365159900104		
J	Azuma, T				Azuma, Teruhisa			Evidence of supportive care for cancer or therapy-related fatigue	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Azuma, Teruhisa] Fukushima Med Univ, Shirakawa Satellite Teaching & Res Gen Med, Fukushima, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		SY18-4	44	44				1	Oncology	Oncology	CW7ED	WOS:000365159900109		
J	Kosho, T				Kosho, Tomoki			A challenge to establish a multidisciplinary team for the management of HBOC in Shinshu University Hospital	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Kosho, Tomoki] Shinshu Univ Hosp, Div Clin & Mol Genet, Matsumoto, Nagano, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		SY19-5	45	45				1	Oncology	Oncology	CW7ED	WOS:000365159900112		
J	Yagata, H				Yagata, Hiroshi			Secondary prevention of hereditary cancer	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Yagata, Hiroshi] Saitama Med Univ, Saitama Med Ctr, Dept Breast Care, Hidaka, Saitama, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		SY19-3	45	45				1	Oncology	Oncology	CW7ED	WOS:000365159900111		
J	Yotsumoto, J				Yotsumoto, Junko			Genetic counseling and genetic testing for hereditary cancer syndromes	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Yotsumoto, Junko] Ochanomizu Univ, Div Nat Sci, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		SY19-2	45	45				1	Oncology	Oncology	CW7ED	WOS:000365159900110		
J	Naito, T; Okayama, T; Aoyama, T; Mori, K; Tanuma, A; Takahashi, T				Naito, Tateaki; Okayama, Taro; Aoyama, Takashi; Mori, Keita; Tanuma, Akira; Takahashi, Toshiaki			The role of exercise intervention in the management of cancer cachexia	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Naito, Tateaki; Takahashi, Toshiaki] Shizuoka Canc Ctr, Div Thorac Oncol, Shizuoka, Japan; [Okayama, Taro; Tanuma, Akira] Shizuoka Canc Ctr, Div Rehabil Med, Shizuoka, Japan; [Aoyama, Takashi] Shizuoka Canc Ctr, Div Nutr, Shizuoka, Japan; [Mori, Keita] Shizuoka Canc Ctr, Clin Trial Coordinat Off, Shizuoka, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		SY20-4	46	46				1	Oncology	Oncology	CW7ED	WOS:000365159900115		
J	Tatematsu, N				Tatematsu, Noriatsu			Exercise therapy for decreased strength and cancer-related fatigue	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Tatematsu, Noriatsu] Natl Canc Ctr Hosp East, Dept Musculoskeletal Oncol, Kashiwa, Chiba, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		SY20-3	46	46				1	Oncology	Oncology	CW7ED	WOS:000365159900114		
J	Tsuji, T				Tsuji, Tetsuya			Management of lymphedema and edema in advanced cancer	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Tsuji, Tetsuya] Keio Univ, Sch Med, Dept Rehabil Med, Tokyo 108, Japan; [Tsuji, Tetsuya] Keio Univ Hosp, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		SY20-5	46	46				1	Oncology	Oncology	CW7ED	WOS:000365159900116		
J	Tsurukawa, T				Tsurukawa, Toshihiro			Cancer rehabilitation for eating, swallowing, speech and articulation dysfunctions on the basis of the guidelines	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Tsurukawa, Toshihiro] NHO Kagoshima Med Ctr, Dept Rehabil Med, Kagoshima, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		SY20-2	46	46				1	Oncology	Oncology	CW7ED	WOS:000365159900113		
J	Takagi, T				Takagi, Tatsuya			Transdiciplinary approach for skeletal metastases in cancer patients	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Takagi, Tatsuya] Junetendo Univ, Orthopaed Surg, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		SY20-6	47	47				1	Oncology	Oncology	CW7ED	WOS:000365159900117		
J	Araki, K; Ito, Y				Araki, Kazuhiro; Ito, Yoshinori			Handling of anti-HER2 antibodies, trastuzumab and pertuzumab, in patients with HER2-positive breast cancer	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Araki, Kazuhiro; Ito, Yoshinori] Japanese Fdn Canc Res, Canc Inst Hosp, Breast Oncol Ctr, Breast Med Oncol, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		WS1-1	48	48				1	Oncology	Oncology	CW7ED	WOS:000365159900118		
J	Naito, Y				Naito, Yoichi			Everolimus	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Naito, Yoichi] Natl Canc Ctr Hosp East, Dept Dev Therapeut, Kashiwa, Chiba, Japan; [Naito, Yoichi] Natl Canc Ctr Hosp East, Dept Breast & Med Oncol, Kashiwa, Chiba, Japan; [Naito, Yoichi] Natl Canc Ctr, Rare Canc Ctr, Singapore, Singapore								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		WS1-4	48	48				1	Oncology	Oncology	CW7ED	WOS:000365159900120		
J	Yamamoto, Y				Yamamoto, Yutaka			How to manage bevacizumab for metastatic breast cancer?	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Yamamoto, Yutaka] Kumamoto Univ, Grad Sch Med, Dept Breast & Endocrine Surg, Kumamoto 860, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		WS1-5	48	48				1	Oncology	Oncology	CW7ED	WOS:000365159900121		
J	Yonemori, K				Yonemori, Kan			How to use small molecule agent for patient with human epidermal growth receptor type 2 positive breast cancer?	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Yonemori, Kan] Natl Canc Ctr, Dept Breast & Med Oncol, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		WS1-3	48	48				1	Oncology	Oncology	CW7ED	WOS:000365159900119		
J	Hamada, T				Hamada, Tamami			Development of guidelines for optimal practices in chemotherapy in oncology nursing - focusing on evidence based nursing	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Hamada, Tamami] Asahikawa Med Univ, Nursing Course, Sch Med, Asahikawa, Hokkaido, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		WS3-1	49	49				1	Oncology	Oncology	CW7ED	WOS:000365159900122		
J	Kabasawa, M				Kabasawa, Minako			Developing of a nursing intervention for promoting self-management of cancer-related fatigue in lung cancer patients	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Kabasawa, Minako] Seirei Christopher Univ, Sch Nursing, Hamamatsu, Shizuoka, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		WS4-2	50	50				1	Oncology	Oncology	CW7ED	WOS:000365159900123		
J	Aogi, K				Aogi, Kenjiro			Clinical problems on constructing the safe handling system of "hazardous drugs" in Japan	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Aogi, Kenjiro] NHO Shikoku Canc Ctr, Div Clin Res Promot, Matsuyama, Ehime, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		WS5-2	51	51				1	Oncology	Oncology	CW7ED	WOS:000365159900125		
J	Ishimaru, H				Ishimaru, Hiromasa			Drug exposure from the viewpoints of pharmacists	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Ishimaru, Hiromasa] St Lukes Int Hosp, Dept Pharm, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		WS5-3	51	51				1	Oncology	Oncology	CW7ED	WOS:000365159900126		
J	Matsuno, Y; Marukaawa, K; Hatanaka, Y				Matsuno, Yoshihiro; Marukaawa, Katsuji; Hatanaka, Yutaka			Pathology quality assurance in companion diagnosis	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Matsuno, Yoshihiro; Marukaawa, Katsuji; Hatanaka, Yutaka] Hokkaido Univ Hosp, Dept Surg Pathol, Sapporo, Hokkaido, Japan; [Matsuno, Yoshihiro; Hatanaka, Yutaka] Hokkaido Univ Hosp, Res Div Compan Diagnost, Sapporo, Hokkaido, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		PD1-4	52	52				1	Oncology	Oncology	CW7ED	WOS:000365159900127		
J	Ito, K; Ono, M; Oba, T; Iesato, A; Hanamura, T; Ito, T; Kanai, T; Maeno, K				Ito, Ken-ichi; Ono, Mayu; Oba, Takaaki; Iesato, Asumi; Hanamura, Toru; Ito, Tokiko; Kanai, Toshiharu; Maeno, Kazuma			Will molecular-targeted agents change clinical practice for advanced thyroid cancer?	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Ito, Ken-ichi; Ono, Mayu; Oba, Takaaki; Iesato, Asumi; Hanamura, Toru; Ito, Tokiko; Kanai, Toshiharu; Maeno, Kazuma] Shinshu Univ, Sch Med, Dept Surg, Div Breast Endocrine & Resp Surg, Matsumoto, Nagano, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		PD2-1	53	53				1	Oncology	Oncology	CW7ED	WOS:000365159900128		
J	Kiyota, N				Kiyota, Naomi			Current status and future perspectives of molecular targeting treatment for thyroid cancer	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Kiyota, Naomi] Kobe Univ Hosp, Dept Med Oncol & Hepatol, Kobe, Hyogo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		PD2-2	53	53				1	Oncology	Oncology	CW7ED	WOS:000365159900129		
J	Ikeda, M				Ikeda, Masafumi			Reactivation of hepatitis B viral infection in patients with solid tumor receiving chemotherapy	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Ikeda, Masafumi] Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		PD4-2	54	54				1	Oncology	Oncology	CW7ED	WOS:000365159900131		
J	Mochida, S				Mochida, Satoshi			Reactivation of HBV in patients with resolved infection during and after antitumor and/or immunosuppressive therapies	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Mochida, Satoshi] Saitama Med Univ, Dept Gastroenterol & Hepatol, Moroyama, Saitama, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		PD4-1	54	54				1	Oncology	Oncology	CW7ED	WOS:000365159900130		
J	Tsushima, T				Tsushima, Takahiro			Prophylactic measure against reactivation of hepatitis B virus in chemotherapy for gastrointestinal cancer	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Tsushima, Takahiro] Shizuoka Canc Ctr, Div Gastrointestinal Oncol, Shizuoka, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		PD4-3	54	54				1	Oncology	Oncology	CW7ED	WOS:000365159900132		
J	Kodaira, M				Kodaira, Makoto			Standards of care for Soft Tissue Sarcoma	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Kodaira, Makoto] Natl Canc Ctr, Dept Breast & Med Oncol, Tokyo 104, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		EL2	56	56				1	Oncology	Oncology	CW7ED	WOS:000365159900134		
J	Yamaguchi, K; Hara, H; Takako, Y; Toko, Y; Masako, A				Yamaguchi, Kensei; Hara, Hiroki; Takako, Yoshii; Toko, Yamada; Masako, Asayama			New evidence and new agent for advanced Colorectal Cancer	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Yamaguchi, Kensei; Hara, Hiroki; Takako, Yoshii; Toko, Yamada; Masako, Asayama] Saitama Canc Ctr, Dept Gastroenterol, Saitama, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		EL4	57	57				1	Oncology	Oncology	CW7ED	WOS:000365159900135		
J	Zenda, S				Zenda, Sadamoto			Supportive care for patients receiving radiotherapy	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Zenda, Sadamoto] Natl Canc Ctr Hosp East, Dept Radiat Oncol, Kashiwa, Chiba, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		EL5	58	58				1	Oncology	Oncology	CW7ED	WOS:000365159900136		
J	Takamatsu, Y				Takamatsu, Yasushi			Prophylaxis of Febrile Neutropenia with granulocyte-colony stimulating factor	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Takamatsu, Yasushi] Fukuoka Univ Hosp, Dept Med, Div Med Oncol Hematol & Infect Dis, Fukuoka, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		EL6	59	59				1	Oncology	Oncology	CW7ED	WOS:000365159900137		
J	Sasaki, J				Sasaki, Jiichiro			Palliative medicine: how to standardize palliative medicine	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Sasaki, Jiichiro] Kitasato Univ, Sch Med, Div Clin Oncol, Dept Comprehens Med,Res & Dev Ctr New Med Frontie, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		EL7	60	60				1	Oncology	Oncology	CW7ED	WOS:000365159900138		
J	Matoba, M				Matoba, Motohiro			Screening for pain in cancer patients and the roles of oncologists	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Matoba, Motohiro] Japanese Red Cross Med Ctr, Dept Palliat Care, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		EL8	61	61				1	Oncology	Oncology	CW7ED	WOS:000365159900139		
J	Takahashi, S				Takahashi, Shunji			New development on bone metastasis treatment	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Takahashi, Shunji] JFCR, Canc Inst Hosp, Dept Med Oncol, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		EL9	62	62				1	Oncology	Oncology	CW7ED	WOS:000365159900140		
J	Nagashima, F; Mizutani, T; Nakamura, K; Hamaguchi, T; Ogawa, A; Furuse, J				Nagashima, Fumio; Mizutani, Tomonori; Nakamura, Kenichi; Hamaguchi, Tetsuya; Ogawa, Asao; Furuse, Junji			Chemotherapy in older patients with cancer (Geriatric Oncology)	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Nagashima, Fumio; Furuse, Junji] Kyorin Univ, Dept Med Oncol, Mitaka, Tokyo, Japan; [Mizutani, Tomonori; Nakamura, Kenichi] Natl Canc Ctr, Operat Off, Japan Clin Oncol Grp, Kashiwa, Chiba, Japan; [Hamaguchi, Tetsuya] Natl Canc Ctr Hosp, Div Gastrointestinal Med Oncol, Kashiwa, Chiba, Japan; [Ogawa, Asao] Natl Canc Ctr East Hosp, Res Ctr Innovat Oncol, Psychooncol Div, Kashiwa, Chiba, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		EL13	63	63				1	Oncology	Oncology	CW7ED	WOS:000365159900141		
J	Nakamura, K				Nakamura, Kenichi			Essence of ethical guideline of medical research for human subjects and influence of clinical research	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Nakamura, Kenichi] Natl Canc Ctr, CRAS, Kashiwa, Chiba, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		EL14	64	64				1	Oncology	Oncology	CW7ED	WOS:000365159900142		
J	Shirato, H				Shirato, Hiroki			Radiotherapy : characteristics of particle therapy and its perspective	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Shirato, Hiroki] Hokkaido Univ, Dept Radiat Oncol, Sapporo, Hokkaido 060, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		EL19	65	65				1	Oncology	Oncology	CW7ED	WOS:000365159900143		
J	Yamane, H				Yamane, Hiromichi			Cancer survivorship - current status in Japan	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Yamane, Hiromichi] Kawasaki Med Univ, Dept Gen Internal Med 4, Kurashiki, Okayama, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		EL20	66	66				1	Oncology	Oncology	CW7ED	WOS:000365159900144		
J	Saji, S				Saji, Shigehira			Principles of endocrine therapy for breast cancer	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Saji, Shigehira] Fukushima Med Univ, Dept Med Oncol, Fukushima, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		EL21	67	67				1	Oncology	Oncology	CW7ED	WOS:000365159900145		
J	Shinohara, N				Shinohara, Nobuo			Molecular-targeted therapy for metastatic renal cell carcinoma	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Shinohara, Nobuo] Hokkaido Univ, Grad Sch Med, Dept Gemitourinary Surg, Sapporo, Hokkaido 060, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		EL22	68	68				1	Oncology	Oncology	CW7ED	WOS:000365159900146		
J	Fujiwara, Y				Fujiwara, Yutaka			Immune-checkpoint Inhibitor in clinical practice	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Fujiwara, Yutaka] Natl Canc Ctr Hosp, Dept Expt Therapeut, Kashiwa, Chiba, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		EL24	69	69				1	Oncology	Oncology	CW7ED	WOS:000365159900147		
J	Hatakeyama, M				Hatakeyama, Masanori			Helicobacter pylori Oncoprotein CagA and gastric cancer	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Hatakeyama, Masanori] Univ Tokyo, Grad Sch Med, Div Microbiol, Tokyo 1138654, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		EL30	70	70				1	Oncology	Oncology	CW7ED	WOS:000365159900148		
J	Torigoe, T; Hirohashi, Y; Sato, N				Torigoe, Toshihiko; Hirohashi, Yoshihiko; Sato, Noriyuki			Immunopathology of cancer stem cells: from basics to therapeutic application	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Torigoe, Toshihiko; Hirohashi, Yoshihiko; Sato, Noriyuki] Sapporo Med Univ, Sch Med, Dept Pathol, Sapporo, Hokkaido, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		EL31	71	71				1	Oncology	Oncology	CW7ED	WOS:000365159900149		
J	Kotani, D; Shitara, K; Fukuoka, S; Bando, H; Okamoto, W; Kojima, T; Doi, T; Yoshino, T				Kotani, Daisuke; Shitara, Kohei; Fukuoka, Shota; Bando, Hideaki; Okamoto, Wataru; Kojima, Takashi; Doi, Toshihiko; Yoshino, Takayuki			Safety and efficacy on TAS-102 monotherapy in clinical practice in patients with metastatic colorectal cancer (mCRC)	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Kotani, Daisuke; Shitara, Kohei; Fukuoka, Shota; Bando, Hideaki; Okamoto, Wataru; Kojima, Takashi; Doi, Toshihiko; Yoshino, Takayuki] Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		ISS1-1-3	72	72				1	Oncology	Oncology	CW7ED	WOS:000365159900152		
J	Nakayama, I; Eiji, S; Takeru, W; Mariko, O; Takashi, I; Daisuke, T; Masato, O; Mitsukuni, S; Keisho, C; Nobuyuki, M				Nakayama, Izuma; Eiji, Shinozaki; Takeru, Wakatsuki; Mariko, Ogura; Takashi, Ichimura; Daisuke, Takahari; Masato, Ozaka; Mitsukuni, Suenaga; Keisho, Chin; Nobuyuki, Mizunuma			The significance of EGFR pathway mutations for the efficacy of bevacizumab in metastatic colorectal cancer	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Nakayama, Izuma; Eiji, Shinozaki; Takeru, Wakatsuki; Mariko, Ogura; Takashi, Ichimura; Daisuke, Takahari; Masato, Ozaka; Mitsukuni, Suenaga; Keisho, Chin; Nobuyuki, Mizunuma] Japanese Fdn Canc Inst, Canc Inst Hosp, Dept Gastroenterol, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		ISS1-1-2	72	72				1	Oncology	Oncology	CW7ED	WOS:000365159900151		
J	Yoshino, T; Shitara, K; Taniguchi, H; Brega, N; Ohkura, M; Ono, C; Suzuki, M; Vermette, J; Muro, K				Yoshino, Takayuki; Shitara, Kohei; Taniguchi, Hiroya; Brega, Nicoletta; Ohkura, Masayuki; Ono, Chiho; Suzuki, Mie; Vermette, Jennifer; Muro, Kei			PF-05212384+irinotecan Phase II study in metastatic colorectal cancer (mCRC): B2151005 Japanese lead-in-cohort (J-LIC)	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Yoshino, Takayuki; Shitara, Kohei] Natl Canc Ctr Hosp East, Dept Gastroenterol & GI Oncol, Kashiwa, Chiba, Japan; [Taniguchi, Hiroya; Muro, Kei] Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi, Japan; [Brega, Nicoletta] Pfizer Oncol, Milan, Italy; [Ohkura, Masayuki; Ono, Chiho; Suzuki, Mie] Pfizer Japan, Tokyo, Japan; [Vermette, Jennifer] Pfizer Oncol, Cambridge, MA USA								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		ISS1-1-1	72	72				1	Oncology	Oncology	CW7ED	WOS:000365159900150		
J	Kozuki, T; Nishio, M; Kiura, K; Seto, T; Nakagawa, K; Maemondo, M; Inoue, A; Hida, T; Tanaka, T; Tamura, T				Kozuki, Toshiyuki; Nishio, Makoto; Kiura, Katsuyuki; Seto, Takashi; Nakagawa, Kazuhiko; Maemondo, Makoto; Inoue, Akira; Hida, Toyoaki; Tanaka, Tomohiro; Tamura, Tomohide			Updates on PFS and safety results of a Phase I/II study (AF-001JP) of alectinib in ALK-rearranged advanced NSCLC	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Kozuki, Toshiyuki] Natl Hosp Org Shikoku Canc Ctr, Clin Res Inst, Matsuyama, Ehime, Japan; [Nishio, Makoto] Japanese Fdn Canc Res, Canc Inst Hosp, Thorac Med Oncol, Tokyo, Japan; [Kiura, Katsuyuki] Okayama Univ Hosp, Allergy & Resp Med, Okayama, Japan; [Seto, Takashi] Kyushu Natl Canc Ctr, Dept Thorac Oncol, Nagoya, Aichi, Japan; [Nakagawa, Kazuhiko] Kinki Univ, Fac Med, Dept Med Oncol, Higashiosaka, Osaka 577, Japan; [Maemondo, Makoto] Miyagi Canc Ctr, Dept Resp Med, Natori, Miyagi, Japan; [Inoue, Akira] Tohoku Univ Hosp, Dept Resp Med, Sendai, Miyagi, Japan; [Hida, Toyoaki] Aichi Canc Ctr, Dept Thorac Oncol, Nagoya, Aichi, Japan; [Tanaka, Tomohiro] Chugai Pharmaceut Co Ltd, Clin Res Planning Dept, Tokyo, Japan; [Tamura, Tomohide] Natl Canc Ctr Hosp, Dept Thorac Oncol, Kashiwa, Chiba, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		ISS1-2-1	73	73				1	Oncology	Oncology	CW7ED	WOS:000365159900153		
J	Togashi, Y; Mizuuchi, H; Sakai, K; Banno, E; Hayashi, H; de Velasco, M; Fujita, Y; Tomida, S; Mitsudomi, T; Nishio, K				Togashi, Yosuke; Mizuuchi, Hiroshi; Sakai, Kazuko; Banno, Eri; Hayashi, Hidetoshi; de Velasco, Marco; Fujita, Yoshihiko; Tomida, Shuta; Mitsudomi, Tetsuya; Nishio, Kazuto			An activating ALK gene mutation in ALK IHC-positive/FISH-negative non-small cell lung cancer	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Togashi, Yosuke; Sakai, Kazuko; Banno, Eri; Hayashi, Hidetoshi; de Velasco, Marco; Fujita, Yoshihiko; Tomida, Shuta; Nishio, Kazuto] Kinki Univ, Fac Med, Dept Genome Biol, Higashiosaka, Osaka 577, Japan; [Mizuuchi, Hiroshi; Mitsudomi, Tetsuya] Kinki Univ, Fac Med, Dept Surg, Higashiosaka, Osaka 577, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		ISS1-2-4	73	73				1	Oncology	Oncology	CW7ED	WOS:000365159900154		
J	Hamamoto, Y; Nagase, M; Egawa, S; Ueno, H; Ohkawa, S; Funakoshi, A; Nakamori, S; Kanai, M; Ohashi, Y; Furuse, J				Hamamoto, Yasuo; Nagase, Michitaka; Egawa, Shinichi; Ueno, Hideki; Ohkawa, Shinichi; Funakoshi, Akihiro; Nakamori, Shoji; Kanai, Masashi; Ohashi, Yasuo; Furuse, Junji			Prognostic index model for overall survival in advanced unresectable pancreatic cancer from GEST study	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Hamamoto, Yasuo] Keio Univ, Sch Med, Keio Canc Ctr, Tokyo 108, Japan; [Nagase, Michitaka] Nagoya Red Cross Daiichi Hosp, Nagoya, Aichi, Japan; [Egawa, Shinichi] Tohoku Univ, Sendai, Miyagi 980, Japan; [Ueno, Hideki] Natl Canc Ctr, Tokyo, Japan; [Ohkawa, Shinichi] Kanagawa Canc Ctr, Kanagawa, Japan; [Funakoshi, Akihiro] Fukuoka Sanno Hosp, Fukuoka, Japan; [Nakamori, Shoji] Osaka Natl Hosp, Osaka, Japan; [Kanai, Masashi] Kyoto Univ, Ctr Canc, Kyoto 6068501, Japan; [Ohashi, Yasuo] Chuo Univ, Tokyo, Japan; [Furuse, Junji] Kyorin Univ, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		ISS1-3-2	74	74				1	Oncology	Oncology	CW7ED	WOS:000365159900155		
J	Ito, T; Okusaka, T; Tori, M; Hashigaki, S; Kimura, N; Ohki, E; Sawaki, A; Nishida, T; Yamao, K; Imamura, M				Ito, Tetsuhide; Okusaka, Takuji; Tori, Masayuki; Hashigaki, Satoshi; Kimura, Nobuyuki; Ohki, Emiko; Sawaki, Akira; Nishida, Toshirou; Yamao, Kenji; Imamura, Masayuki			Final phase II results for sunitinib (SU) in Japanese pts with well-differentiated pancreatic neuroendocrine tumor (NET)	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Ito, Tetsuhide] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Fukuoka 812, Japan; [Okusaka, Takuji] Natl Canc Ctr, Hepatobiliary & Pancreat Oncol Div, Tokyo, Japan; [Tori, Masayuki; Nishida, Toshirou] Osaka Police Hosp, Osaka, Japan; [Hashigaki, Satoshi; Kimura, Nobuyuki; Ohki, Emiko] Pfizer Japan Inc, Tokyo, Japan; [Sawaki, Akira; Yamao, Kenji] Aichi Canc Ctr Hosp, Dept Gastroenterol, Nagoya, Aichi 464, Japan; [Imamura, Masayuki] Kansai Elect Power Co Hosp, Osaka, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		ISS1-3-4	74	74				1	Oncology	Oncology	CW7ED	WOS:000365159900156		
J	Hironaka, S; Yuji, N; Yutaka, K; Keita, U; Katsunori, S; Masanori, M; Miura, Y; Kenichi, Y; Narikazu, B; Ichinosuke, H				Hironaka, Shuichi; Yuji, Negoro; Yutaka, Kimura; Keita, Uchino; Katsunori, Shinozaki; Masanori, Matsuda; Miura, Yuji; Kenichi, Yoshimura; Narikazu, Boku; Ichinosuke, Hyodo			5-weekly S-1 plus cisplatin combined with trastuzumab for HER2-positive gastric cancer (WJOG7212G): a phase II study	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Hironaka, Shuichi] Chiba Canc Ctr, Clin Trial Promot Dept, Chiba, Japan; [Yuji, Negoro] Kochi Hlth Sci Ctr, Med Oncol, Kochi, Japan; [Yutaka, Kimura] Sakai City Hosp, Dept Gastroesophageal Surg, Osaka, Japan; [Keita, Uchino] Kyushu Med Ctr, Dept Med Oncol, Fukuoka, Japan; [Katsunori, Shinozaki] Hiroshima Prefectural Hosp, Dept Clin Oncol, Hiroshima, Japan; [Masanori, Matsuda] Saiseikai Utsunomiya Hosp, Dept Surg, Utsunomiya, Tochigi, Japan; [Miura, Yuji] Toranomon Gen Hosp, Dept Med Oncol, Tokyo, Japan; [Kenichi, Yoshimura] Kanazawa Univ, Innovat Clin Res Ctr, Kanazawa, Ishikawa 9201192, Japan; [Narikazu, Boku] Natl Canc Ctr, Div Gastrointestinal Oncol, Tokyo, Japan; [Ichinosuke, Hyodo] Univ Tsukuba, Dept Gastroenterol, Tsukuba, Ibaraki 305, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		ISS2-1-5	75	75				1	Oncology	Oncology	CW7ED	WOS:000365159900157		
J	Matsumoto, S; Yoh, K; Hosomi, Y; Shukuya, T; Miyata, Y; Kohno, T; Tsuta, K; Ishii, G; Tsuchihara, K; Goto, K				Matsumoto, Shingo; Yoh, Kiyotaka; Hosomi, Yukio; Shukuya, Takehito; Miyata, Yoshihiro; Kohno, Takashi; Tsuta, Koji; Ishii, Genichiro; Tsuchihara, Katsuya; Goto, Koichi			Nationwide genomic screening network for the development of targeted therapies in NSCLC (LC-SCRUM-Japan)	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Matsumoto, Shingo; Kohno, Takashi; Tsuchihara, Katsuya] Natl Canc Ctr, Div Translat Res, Exploratory Oncol Res & Clin Trial Ctr, Tokyo, Japan; [Matsumoto, Shingo; Yoh, Kiyotaka; Goto, Koichi] Natl Canc Ctr Hosp East, Dept Thorac Oncol, Tokyo, Japan; [Yoh, Kiyotaka] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Tokyo, Japan; [Hosomi, Yukio] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Thorac Oncol & Resp Med, Tokyo, Japan; [Shukuya, Takehito] Juntendo Univ, Dept Resp Med, Tokyo, Japan; [Miyata, Yoshihiro] Hiroshima Univ, Dept Surg Oncol, Hiroshima 730, Japan; [Kohno, Takashi] Natl Canc Ctr, Res Inst, Div Genome Biol, Tokyo, Japan; [Tsuta, Koji] Natl Canc Ctr, Div Pathol, Tokyo, Japan; [Tsuta, Koji] Natl Canc Ctr, Clin Labs, Tokyo, Japan; [Ishii, Genichiro] Natl Canc Ctr, Innovat Med Res Ctr, Pathol Div, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		ISS2-2-1	76	76				1	Oncology	Oncology	CW7ED	WOS:000365159900158		
J	Kawaguchi, K; Suzuki, E; Yamaguchi, A; Nishie, M; Toi, M				Kawaguchi, Kosuke; Suzuki, Eiji; Yamaguchi, Ayane; Nishie, Mariko; Toi, Masakazu			Immune signatures may differ between early operable breast cancer and metastatic breast cancer patients	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Kawaguchi, Kosuke; Suzuki, Eiji; Yamaguchi, Ayane; Nishie, Mariko; Toi, Masakazu] Kyoto Univ, Grad Sch Med, Dept Breast Surg, Kyoto 6068501, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		ISS3-1-5	77	77				1	Oncology	Oncology	CW7ED	WOS:000365159900162		
J	Tei, S; Aomatsu, N; Hiramatsu, S; Iwauchi, T; Morimoto, J; Nishii, T; Wang, E; Kosaka, K; Uchima, Y; Takeuchi, K				Tei, Seika; Aomatsu, Naoki; Hiramatsu, Soichiro; Iwauchi, Takehiko; Morimoto, Junya; Nishii, Takafumi; Wang, En; Kosaka, Kinshi; Uchima, Yasutake; Takeuchi, Kazuhiro			Changes in biologic features between primary and recurrent breast cancers	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Tei, Seika; Aomatsu, Naoki; Hiramatsu, Soichiro; Iwauchi, Takehiko; Morimoto, Junya; Nishii, Takafumi; Wang, En; Kosaka, Kinshi; Uchima, Yasutake; Takeuchi, Kazuhiro] Seichokai Fuchu Hosp, Fukuoka, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		ISS3-1-6	77	77				1	Oncology	Oncology	CW7ED	WOS:000365159900163		
J	Asano, Y; Kashiwagi, S; Kurata, K; Noda, S; Kawajiri, H; Takashima, T; Onoda, N; Osawa, M; Hirakawa, K				Asano, Yuka; Kashiwagi, Shinichiro; Kurata, Kento; Noda, Satoru; Kawajiri, Hidemi; Takashima, Tsutomu; Onoda, Naoyoshi; Osawa, Masahiko; Hirakawa, Kosei			Clinical verification of sensitivity to pre-operative chemotherapy androgen in case of receptor expressing positive TNBC	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Asano, Yuka; Kashiwagi, Shinichiro; Kurata, Kento; Noda, Satoru; Kawajiri, Hidemi; Takashima, Tsutomu; Onoda, Naoyoshi; Hirakawa, Kosei] Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Osaka, Japan; [Osawa, Masahiko] Osaka City Univ, Grad Sch Med, Dept Diagnost Pathol, Osaka, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		ISS3-2-3	78	78				1	Oncology	Oncology	CW7ED	WOS:000365159900164		
J	Takada, M; Sugimoto, M; Masuda, N; Iwata, H; Kuroi, K; Yamashiro, H; Ohno, S; Ishiguro, H; Inamoto, T; Toi, M				Takada, Masahiro; Sugimoto, Masahiro; Masuda, Norikazu; Iwata, Hiroji; Kuroi, Katsumasa; Yamashiro, Hiroyasu; Ohno, Shinji; Ishiguro, Hiroshi; Inamoto, Takashi; Toi, Masakazu			Predictions of pathological response after preoperative chemotherapy plus trastuzumab in HER2-positive breast cancer	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Takada, Masahiro; Toi, Masakazu] Kyoto Univ Hosp, Dept Breast Surg, Kyoto, Japan; [Sugimoto, Masahiro] Keio Univ, Inst Adv Biosci, Tokyo 108, Japan; [Masuda, Norikazu] Osaka Natl Hosp, Dept Surg, Breast Oncol, Osaka, Japan; [Iwata, Hiroji] Aichi Canc Ctr, Dept Breast Oncol, Aichi, Japan; [Kuroi, Katsumasa] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Surg, Tokyo, Japan; [Yamashiro, Hiroyasu] Tenri Hosp, Dept Breast Surg, Nairobi, Kenya; [Ohno, Shinji] Kyushu Natl Canc Ctr, Clin Res Inst, Fukuoka, Japan; [Ishiguro, Hiroshi] Kyoto Univ, Grad Sch Med, Dept Target Therapy Oncol, Kyoto 6068501, Japan; [Inamoto, Takashi] Tenri Hlth Care Univ, Fac Hlth Care, Nairobi, Kenya								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		ISS3-2-4	78	78				1	Oncology	Oncology	CW7ED	WOS:000365159900165		
J	Kubo, M; Nakaya, A; Suehira, T; Toguchi, Y; Sameshima, M; Yokoi, T; Yanagimoto, H; Kurata, T				Kubo, Maiko; Nakaya, Aya; Suehira, Tomoko; Toguchi, Yoko; Sameshima, Miku; Yokoi, Takashi; Yanagimoto, Hiroaki; Kurata, Takayasu			Preventive strategy of reactivation of hepatitis B virus at Kansai Medical University Hospital	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol		Reactivation; HBV carrier; de novo B hepatitis			[Kubo, Maiko; Suehira, Tomoko; Toguchi, Yoko; Sameshima, Miku] Kansai Med Univ, Hirakata Hosp, Chemotherapy & Palliat Care Ctr, Hirakata, Osaka, Japan; [Nakaya, Aya; Yokoi, Takashi; Kurata, Takayasu] Kansai Med Univ, Dept Internal Med 1, Hirakata, Osaka, Japan; [Yanagimoto, Hiroaki] Kansai Med Univ, Dept Surg, Hirakata, Osaka, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O1-4-5	79	80				2	Oncology	Oncology	CW7ED	WOS:000365159900169		
J	Nomura, M; Kato, K; Mizusawa, J; Kataoka, K; Ando, N; Muro, K; Ohtsu, A; Igaki, H; Daiko, H; Kitagawa, Y				Nomura, Motoo; Kato, Ken; Mizusawa, Junki; Kataoka, Kozo; Ando, Nobutoshi; Muro, Kei; Ohtsu, Atsushi; Igaki, Hiroyasu; Daiko, Hiroyuki; Kitagawa, Yuko			Comparison between NAC-S and CRT in overall survival for patients with esophageal squamous cell carcinoma (JCOG1406-A)	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Nomura, Motoo] Kyoto Univ, Grad Sch Med, Dept Therapeut Oncol, Kyoto 6068501, Japan; [Kato, Ken] Natl Canc Ctr, Gastrointestinal Oncol Div, Tokyo, Japan; [Mizusawa, Junki; Kataoka, Kozo] JCOG Data Ctr, Tokyo, Japan; [Ando, Nobutoshi] Int Goodwill Hosp, Dept Surg, Tokyo, Japan; [Muro, Kei] Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi, Japan; [Ohtsu, Atsushi] Natl Canc Ctr Hosp East, Gastrointestinal Oncol Div, Dept Gastroenterol, Tokyo, Japan; [Igaki, Hiroyasu] Natl Canc Ctr, Div Esophageal Surg, Tokyo, Japan; [Daiko, Hiroyuki] Natl Canc Ctr Hosp East, Div Esophageal Surg, Tokyo, Japan; [Kitagawa, Yuko] Keio Univ, Sch Med, Dept Surg, Tokyo 108, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O1-3-1	79	79				1	Oncology	Oncology	CW7ED	WOS:000365159900166		
J	Ohba, A; Kato, K; Ito, Y; Katada, C; Ishiyama, H; Yamamoto, S; Ura, T; Kodaira, T; Kudo, S; Nakamura, T				Ohba, Akihiro; Kato, Ken; Ito, Yoshinori; Katada, Chikatoshi; Ishiyama, Hiromichi; Yamamoto, Sachiko; Ura, Takashi; Kodaira, Takeshi; Kudo, Shigehiro; Nakamura, Takayuki			Phase II study of chemoradiotherapy with docetaxel for elderly patients with stage II/III esophageal carcinoma	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Ohba, Akihiro; Kato, Ken] Natl Canc Ctr, Gastrointestinal Med Oncol Div, Tokyo, Japan; [Ito, Yoshinori] Natl Canc Ctr, Div Radiat Oncol, Tokyo, Japan; [Katada, Chikatoshi] Kitasato Univ, Dept Gastroenterol, Sch Med, Tokyo, Japan; [Ishiyama, Hiromichi] Kitasato Univ, Dept Radiol, Sch Med, Tokyo, Japan; [Yamamoto, Sachiko] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Gastroenterol, Osaka, Japan; [Ura, Takashi] Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi, Japan; [Kodaira, Takeshi] Aichi Canc Ctr Hosp, Dept Therapeut Radiat Oncol, Nagoya, Aichi, Japan; [Kudo, Shigehiro] Gunma Prefectural Canc Ctr, Div Radiat Oncol, Gunma, Japan; [Nakamura, Takayuki] Gunma Prefectural Canc Ctr, Dept Surg, Gunma, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O1-3-2	79	79				1	Oncology	Oncology	CW7ED	WOS:000365159900167		
J	Tomoda, K; Muta, T; Ono, A; Makiyama, C; Hirano, G; Makiyama, A; Aoki, K; Ogawa, R; Umeda, S; Uchiyama, A				Tomoda, Kyoko; Muta, Tsuyoshi; Ono, Ayako; Makiyama, Chinatsu; Hirano, Gen; Makiyama, Akitaka; Aoki, Kenichi; Ogawa, Ryosuke; Umeda, Shuyo; Uchiyama, Akihiko			Significance of hypersensitivity reactions in the outpatient infusion unit: Retrospective study in JCHO Kyushu hospital	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Tomoda, Kyoko; Ono, Ayako] Japan Community Healthcare Org, Kyushu Hosp, Dept Nursing, Tokyo, Japan; [Muta, Tsuyoshi; Makiyama, Chinatsu; Hirano, Gen; Makiyama, Akitaka; Aoki, Kenichi; Ogawa, Ryosuke] Japan Community Healthcare Org, Kyushu Hosp, Dept Hematol Oncol, Tokyo, Japan; [Umeda, Shuyo; Uchiyama, Akihiko] Japan Community Healthcare Org, Kyushu Hosp, Dept Surg, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O1-4-1	79	79				1	Oncology	Oncology	CW7ED	WOS:000365159900168		
J	Ninomiya, K; Hotta, K; Gotoda, H; Morichika, D; Ichihara, E; Sato, A; Tabata, M; Tanimoto, M; Kiura, K				Ninomiya, Kiichiro; Hotta, Katsuyuki; Gotoda, Hiroko; Morichika, Daisuke; Ichihara, Eiki; Sato, Akiko; Tabata, Masahiro; Tanimoto, Mitsune; Kiura, Katsuyuki			Short-term low-volume hydration in cisplatin-based chemotherapy: a feasibility study in lung cancer (OLCSG1201)	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Ninomiya, Kiichiro; Gotoda, Hiroko; Morichika, Daisuke; Ichihara, Eiki; Sato, Akiko; Tabata, Masahiro; Kiura, Katsuyuki] Okayama Univ Hosp, Dept Allergy & Resp Med Thorac Oncol, Okayama, Japan; [Hotta, Katsuyuki; Tanimoto, Mitsune] Okayama Univ Hosp, Dept Hematol & Oncol, Okayama, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O1-5-1	80	80				1	Oncology	Oncology	CW7ED	WOS:000365159900170		
J	Suyama, H; Sumikawa, T; Adachi, N; Nakase, Y; Makima, M; Fujimatsu, Y				Suyama, Hisashi; Sumikawa, Takashi; Adachi, Naomi; Nakase, Yusuke; Makima, Miwako; Fujimatsu, Yoshito			The efficacy of peripherally inserted central catheter in cancer chemotherapy	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Suyama, Hisashi] Tottori Prefectural Cent Hosp, Dept Med Oncol, Tottori, Japan; [Sumikawa, Takashi] Tottori Prefectural Cent Hosp, Dept Respirol, Tottori, Japan; [Adachi, Naomi] Tottori Prefectural Cent Hosp, Dept Outpatient Treatment Unit, Tottori, Japan; [Nakase, Yusuke] Tottori Prefectural Cent Hosp, Dept Pharm, Tottori, Japan; [Fujimatsu, Yoshito] Tottori Prefectural Cent Hosp, Canc Counseling & Support Serv Ctr, Tottori, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O1-5-4	80	80				1	Oncology	Oncology	CW7ED	WOS:000365159900172		
J	Tokumitsu, Y; Motegi, M; Naruse, I; Shoji, H; Takahashi, M; Hanyu, K; Shimizu, T; Ando, Y; Kaira, K; Asao, T				Tokumitsu, Yoko; Motegi, Masahiko; Naruse, Ichiro; Shoji, Hisanori; Takahashi, Mika; Hanyu, Kazue; Shimizu, Tomomi; Ando, Yoshitaka; Kaira, Kyoichi; Asao, Takayuki			Challenge and current status of night outpatient chemotherapy in our institution	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Tokumitsu, Yoko; Motegi, Masahiko; Naruse, Ichiro; Shoji, Hisanori; Takahashi, Mika; Hanyu, Kazue; Shimizu, Tomomi; Ando, Yoshitaka] Hidaka Hosp, Dept Outpatient Chemotherapy, Takasaki, Gumma, Japan; [Kaira, Kyoichi; Asao, Takayuki] Gunma Univ Hosp, Dept Oncol Clin Dev, Maebashi, Gumma, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O1-5-3	80	80				1	Oncology	Oncology	CW7ED	WOS:000365159900171		
J	Uchiike, A; Hayama, T; Miura, K; Tsutsumi, D; Hayasaka, M; Hatta, Y; Takei, M; Yoshida, Y				Uchiike, Akihiro; Hayama, Tatsuya; Miura, Katsuhiro; Tsutsumi, Daisuke; Hayasaka, Masatoshi; Hatta, Yoshihiro; Takei, Masami; Yoshida, Yoshikazu			A clinical prediction model for infusion reaction to rituximab	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Uchiike, Akihiro; Hayama, Tatsuya; Tsutsumi, Daisuke; Hayasaka, Masatoshi; Yoshida, Yoshikazu] Nihon Univ, Itabashi Hosp, Dept Pharm, Tokyo 102, Japan; [Miura, Katsuhiro; Hatta, Yoshihiro; Takei, Masami] Nihon Univ, Sch Medicin, Dept Hematol & Rheumatol, Tokyo 102, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O1-6-3	80	80				1	Oncology	Oncology	CW7ED	WOS:000365159900173		
J	Kiba, T; Okada, Y				Kiba, Takayoshi; Okada, Yuko			Mechanisms of decreasing oxaliplatin-related vascular pain by coadministration of 5% glucose solution and dexamethasone	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Kiba, Takayoshi] Natl Hosp Org Kure Med Ctr, Inst Clin Res, Div Modern Med Technol, Tokyo, Japan; [Kiba, Takayoshi; Okada, Yuko] Chugoku Canc Ctr, Hiroshima, Japan; [Kiba, Takayoshi] Tohoku Pharmaceut Univ Hosp, Dept Clin Oncol, Sendai, Miyagi, Japan; [Okada, Yuko] Natl Hosp Org Kure Med Ctr, Ctr Canc Chemotherapy, Dept Nursing, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O1-6-5	81	81				1	Oncology	Oncology	CW7ED	WOS:000365159900174		
J	Kitayama, H; Tsuji, Y; Sugiyama, J; Kondo, T; Hirayama, M				Kitayama, Hiromitsu; Tsuji, Yasushi; Sugiyama, Junko; Kondo, Tomohiro; Hirayama, Michiaki			Venous thromboembolismin hospitalized cancer patients receiving chemotherapy in Japan: a prospective observational study	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Kitayama, Hiromitsu; Tsuji, Yasushi; Sugiyama, Junko; Kondo, Tomohiro] Tonan Hosp, Dept Med Oncol, Sapporo, Hokkaido, Japan; [Hirayama, Michiaki] Tonan Hosp, Dept Gastroenterol Med, Sapporo, Hokkaido, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O1-7-1	81	81				1	Oncology	Oncology	CW7ED	WOS:000365159900175		
J	Nakahara, T; Takayama, K; Nakanishi, Y; Furue, M				Nakahara, Takeshi; Takayama, Koichi; Nakanishi, Yoichi; Furue, Masutaka			Effective supportive care for patients with physiological changes in various skin regions induced by EGFR inhibitors	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Nakahara, Takeshi] Kyushu Univ, Grad Sch Med Sci, Dept Dermatol, Div Skin Surface Sensing, Fukuoka 812, Japan; [Takayama, Koichi; Nakanishi, Yoichi] Kyushu Univ, Grad Sch Med Sci, Res Inst Dis Chest, Fukuoka 812, Japan; [Furue, Masutaka] Kyushu Univ, Grad Sch Med Sci, Dept Dermatol, Fukuoka 812, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O1-7-4	81	81				1	Oncology	Oncology	CW7ED	WOS:000365159900177		
J	Terazawa, T; Goto, M; Miyamoto, T; Asaishi, K; Shimamoto, F; Kuwakado, S; Nishitani, H; Kii, T; Higuchi, K				Terazawa, Tetsuji; Goto, Masahiro; Miyamoto, Takahiro; Asaishi, Ken; Shimamoto, Fukutaro; Kuwakado, Shin; Nishitani, Hitoshi; Kii, Takayuki; Higuchi, Kazuhide			The efficacy of prophylactic G-CSF for FOLFIRINOX	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Terazawa, Tetsuji; Goto, Masahiro; Miyamoto, Takahiro; Asaishi, Ken; Shimamoto, Fukutaro; Kuwakado, Shin; Nishitani, Hitoshi; Kii, Takayuki] Osaka Med Coll, Ctr Canc Chemotherapy, Osaka, Japan; [Higuchi, Kazuhide] Osaka Med Coll Hosp, Dept Internal Med 2, Osaka, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O1-7-5	81	82				2	Oncology	Oncology	CW7ED	WOS:000365159900178		
J	Nakagawa, K; Mok, TSK; Wu, YL; Rosell, R; Tsuji, F; Wang, T; Sbar, E				Nakagawa, Kazuhiko; Mok, Tony S. K.; Wu, Yi-Long; Rosell, Rafael; Tsuji, Fumito; Wang, Tao; Sbar, Eric			ARCHER 1050: first-line dacomitinib vs gefitinib for advanced NSCLC in patients with EGFR activating mutation(s)	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Nakagawa, Kazuhiko] Kinki Univ, Fac Med, Dept Med Oncol, Higashiosaka, Osaka 577, Japan; [Mok, Tony S. K.] Chinese Univ Hong Kong, Prince Wales Hosp, Hong Kong, Hong Kong, Peoples R China; [Wu, Yi-Long] Guangdong Gen Hosp, Guangzhou, Guangdong, Peoples R China; [Wu, Yi-Long] Guangdong Acad Med Sci, Guangzhou, Guangdong, Peoples R China; [Rosell, Rafael] Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Barcelona, Spain; [Tsuji, Fumito] SFJ Pharma Japan KK, Osaka, Japan; [Wang, Tao] Pfizer Inc, Groton, CT 06340 USA; [Sbar, Eric] Pfizer Inc, Collegeville, PA USA								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O1-9-1	82	82				1	Oncology	Oncology	CW7ED	WOS:000365159900180		
J	Sakai, H; Kishi, K; Seto, T; Kozuki, T; Nishio, M; Imamura, F; Nokihara, H; Satouchi, M; Tahata, T; Nakagawa, K				Sakai, Hiroshi; Kishi, Kazuma; Seto, Takashi; Kozuki, Toshiyuki; Nishio, Makoto; Imamura, Fumio; Nokihara, Hiroshi; Satouchi, Miyako; Tahata, Takashi; Nakagawa, Kazuhiko			Phase II study of erlotinib plus onartuzumab as first-line treatment for patients with MET-positive and EGFR-mutant NSCLC	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Sakai, Hiroshi] Saitama Prefectural Canc Ctr, Dept Resp Dis, Saitama, Japan; [Kishi, Kazuma] Toranomon Gen Hosp, Dept Resp Med, Tokyo, Japan; [Seto, Takashi] Kyushu Natl Canc Ctr, Dept Thorac Oncol, Tokyo, Japan; [Kozuki, Toshiyuki] Natl Hosp Org Shikoku Canc Ctr, Dept Thorac Oncol, Tokyo, Japan; [Nishio, Makoto] JFCR, Canc Inst Hosp, Dept Thorac Med Oncol, Tokyo, Japan; [Imamura, Fumio] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Thorac Oncol, Osaka, Japan; [Nokihara, Hiroshi] Natl Canc Ctr, Dept Thorac Oncol, Tokyo, Japan; [Satouchi, Miyako] Hyogo Canc Ctr, Dept Thorac Oncol, Nishinomiya, Hyogo, Japan; [Tahata, Takashi] Chugai Pharmaceut Co Ltd, Tokyo, Japan; [Nakagawa, Kazuhiko] Kinki Univ, Fac Med, Dept Med Oncol, Higashiosaka, Osaka 577, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O1-8-3	82	82				1	Oncology	Oncology	CW7ED	WOS:000365159900179		
J	Shimizu, T; Nokihara, H; Murakami, H; Seto, T; Nishio, M; Takeda, K; Inoue, A; Kiura, K; Azuma, K; Keating, A; Krivoshik, A; Uegaki, K; Takeda, K; Komatsu, K; Morita, S; Fukuoka, M; Nakagawa, K				Shimizu, Toshio; Nokihara, Hiroshi; Murakami, Haruyasu; Seto, Takashi; Nishio, Makoto; Takeda, Koji; Inoue, Akira; Kiura, Katsuyuki; Azuma, Koichi; Keating, Anne; Krivoshik, Andrew; Uegaki, Koichi; Takeda, Kentaro; Komatsu, Kanji; Morita, Satoshi; Fukuoka, Masahiro; Nakagawa, Kazuhiko			Phase I/II study of ASP8273 in patients with non-small-cell lung cancer (NSCLC) harboring EGFR activating mutations	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Shimizu, Toshio; Nakagawa, Kazuhiko] Kinki Univ, Fac Med, Dept Med Oncol, Higashiosaka, Osaka 577, Japan; [Nokihara, Hiroshi] Natl Canc Ctr, Tokyo, Japan; [Murakami, Haruyasu] Shizuoka Canc Ctr, Fukuoka, Japan; [Seto, Takashi] Natl Hosp Org Kyushu Canc Ctr, Tokyo, Japan; [Nishio, Makoto] Canc Inst Hosp, Tokyo, Japan; [Takeda, Koji] Osaka City Gen Hosp, Osaka, Japan; [Inoue, Akira] Tohoku Univ Hosp, Sendai, Miyagi, Japan; [Kiura, Katsuyuki] Okayama Univ Hosp, Okayama, Japan; [Azuma, Koichi] Kurume Univ Hosp, Kurume, Fukuoka, Japan; [Keating, Anne; Krivoshik, Andrew] Astellas Pharma Global Dev Inc, Yamaguchi, Japan; [Uegaki, Koichi; Takeda, Kentaro; Komatsu, Kanji] Astellas Pharma Inc, Tokyo, Japan; [Morita, Satoshi] Kyoto Univ, Kyoto 6068501, Japan; [Fukuoka, Masahiro] Izumi Municipal Hosp, Osaka, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O1-9-2	82	82				1	Oncology	Oncology	CW7ED	WOS:000365159900181		
J	Atagi, S; Goto, K; Seto, T; Yamamoto, N; Tamura, T; Tajima, K; Inagaki, N				Atagi, Shinji; Goto, Koichi; Seto, Takashi; Yamamoto, Nobuyuki; Tamura, Tomohide; Tajima, Kosei; Inagaki, Naohito			Combined analysis of two Phase II studies evaluating first-line erlotinib in NSCLC with EGFR mutation: JO22903/JO25567	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Atagi, Shinji] Kinki Chuo Chest Med Ctr, Osaka, Japan; [Goto, Koichi] Natl Canc Ctr Hosp East, Tokyo, Japan; [Seto, Takashi] Natl Kyushu Canc Ctr, Tokyo, Japan; [Yamamoto, Nobuyuki] Wakayama Med Univ, Wakasato, Nagano, Japan; [Tamura, Tomohide] St Lukes Int Hosp, Tokyo, Japan; [Tajima, Kosei; Inagaki, Naohito] Chugai Pharmaceut Co Ltd, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O1-10-2	83	83				1	Oncology	Oncology	CW7ED	WOS:000365159900184		
J	Iwama, E; Sakai, K; Azuma, K; Nozaki, K; Harada, D; Hotta, K; Ohyanagi, F; Nakanishi, Y; Nishio, K; Okamoto, I				Iwama, Eiji; Sakai, Kazuko; Azuma, Koichi; Nozaki, Kaname; Harada, Daijiro; Hotta, Katsuyuki; Ohyanagi, Fumiyoshi; Nakanishi, Yoichi; Nishio, Kazuto; Okamoto, Isamu			A prospective biomarker study in afatinib-treated patients with EGFR-mutation positive non-small cell lung	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Iwama, Eiji] Kyushu Univ, Dept Comprehens Clin Oncol, Fac Med Sci, Fukuoka 812, Japan; [Sakai, Kazuko; Nishio, Kazuto] Kinki Univ, Fac Med, Dept Genome Biol, Higashiosaka, Osaka 577, Japan; [Azuma, Koichi] Kurume Univ, Sch Med, Dept Internal Med, Div Respirol Neurol & Rheumatol, Kurume, Fukuoka, Japan; [Nozaki, Kaname] Kyushu Canc Ctr, Natl Hosp Org, Dept Thorac Oncol, Tokyo, Japan; [Harada, Daijiro] NHO Shikoku Canc Ctr, Dept Thorac Oncol & Med, Fukuoka, Japan; [Hotta, Katsuyuki] Okayama Univ Hosp, Dept Resp Med, Okayama, Japan; [Ohyanagi, Fumiyoshi] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Thorac Med Oncol, Tokyo, Japan; [Iwama, Eiji; Nakanishi, Yoichi; Okamoto, Isamu] Kyushu Univ, Grad Sch Med Sci, Res Inst Dis Chest, Fukuoka 812, Japan; [Nakanishi, Yoichi; Okamoto, Isamu] Kyushu Univ Hosp, Ctr Clin & Translat Res, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O1-9-6	83	83				1	Oncology	Oncology	CW7ED	WOS:000365159900182		
J	Mitsudomi, T; Kobayashi, Y; Togashi, Y; Mizuuchi, H; Suda, K; NIshio, K				Mitsudomi, Tetsuya; Kobayashi, Yoshihisa; Togashi, Yosuke; Mizuuchi, Hiroshi; Suda, Kenichi; NIshio, Kazuto			Comparison of various EGFR tyrosine kinase inhibitors (TKIs) for tumors with exon 18 mutations of the EGFR gene	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Mitsudomi, Tetsuya; Kobayashi, Yoshihisa; Mizuuchi, Hiroshi; Suda, Kenichi] Kinki Univ, Thorac Surg, Higashiosaka, Osaka 577, Japan; [Togashi, Yosuke; NIshio, Kazuto] Kinki Univ, Genome Biol, Higashiosaka, Osaka 577, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O1-10-1	83	83				1	Oncology	Oncology	CW7ED	WOS:000365159900183		
J	Takeda, M; Okamoto, I; Nakagawa, K				Takeda, Masayuki; Okamoto, Isamu; Nakagawa, Kazuhiko			Pooled safety analysis of EGFR-TKI treatment for EGFR mutation-positive non-small cell lung cancer	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Takeda, Masayuki; Nakagawa, Kazuhiko] Kinki Univ, Fac Med, Dept Med Oncol, Higashiosaka, Osaka 577, Japan; [Okamoto, Isamu] Kyushu Univ Hosp, Ctr Clin & Translat Res, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O1-10-3	83	84				2	Oncology	Oncology	CW7ED	WOS:000365159900185		
J	Hosono, N; Yamauchi, T; Matsuda, Y; Kishi, S; Urasaki, Y; Yoshida, A; Ueda, T				Hosono, Naoko; Yamauchi, Takahiro; Matsuda, Yasufumi; Kishi, Shinji; Urasaki, Yoshimasa; Yoshida, Akira; Ueda, Takanori			The efficacy of gemtuzumab ozogamicin in patients with acute leukemia: a single center experience	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Hosono, Naoko; Yamauchi, Takahiro; Matsuda, Yasufumi; Kishi, Shinji; Urasaki, Yoshimasa; Yoshida, Akira; Ueda, Takanori] Univ Fukui, Fac Med Sci, Dept Hematol & Oncol, Fukui, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O1-11-2	84	85				2	Oncology	Oncology	CW7ED	WOS:000365159900189		
J	Kishi, H; Endo, C; Sasaki, J; Saeki, S; Iwamoto, N; Inaba, M; Isobe, T; Kourogi, H; Saito, H; Hamada, A				Kishi, Hiroto; Endo, Chihiro; Sasaki, Ji-ichiro; Saeki, Sho; Iwamoto, Norihiro; Inaba, Megumi; Isobe, Takeshi; Kourogi, Hirotsugu; Saito, Hideyuki; Hamada, Akinobu			Effect of genetic polymorphisms on erlotinib pharmacokinetics and toxicity in patients with non-small-cell lung cancer	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Kishi, Hiroto] Kumamoto City Hosp, Dept Resp Med, Kumamoto, Japan; [Endo, Chihiro; Saito, Hideyuki; Hamada, Akinobu] Kumamoto Univ, Kumamoto 860, Japan; [Endo, Chihiro; Hamada, Akinobu] Natl Canc Ctr, Tokyo, Japan; [Endo, Chihiro] Chugai Pharmaceut Co Ltd, Tokyo, Japan; [Sasaki, Ji-ichiro] Kitasato Univ Hosp, Sagamihara, Kanagawa, Japan; [Saeki, Sho; Kourogi, Hirotsugu] Kumamoto Univ Hosp, Kumamoto, Japan; [Iwamoto, Norihiro] Saiseikai Kumamoto Hosp, Fukuoka, Japan; [Inaba, Megumi] Kumamoto City Hosp, Kumamoto, Japan; [Isobe, Takeshi] Shimane Univ Hosp, Matsue, Shimane, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O1-10-5	84	84				1	Oncology	Oncology	CW7ED	WOS:000365159900187		
J	Matsuzawa, R; Yoh, K; Ishii, G; Kirita, K; Umemura, S; Matsumoto, S; Niho, S; Ohmatsu, H; Tsuboi, M; Goto, K				Matsuzawa, Reiko; Yoh, Kiyotaka; Ishii, Genichiro; Kirita, Keisuke; Umemura, Shigeki; Matsumoto, Shingo; Niho, Seiji; Ohmatsu, Hironobu; Tsuboi, Masahiro; Goto, Koichi			Clinicopathological analysis between exon 19 deletion and L858R in EGFR-mutant completely resected lung adenocarcinoma	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Matsuzawa, Reiko; Yoh, Kiyotaka; Kirita, Keisuke; Umemura, Shigeki; Matsumoto, Shingo; Niho, Seiji; Ohmatsu, Hironobu; Goto, Koichi] Natl Canc Ctr Hosp East, Div Thorac Oncol, Tokyo, Japan; [Ishii, Genichiro] Natl Canc Ctr Hosp East, Div Pathol, Tokyo, Japan; [Tsuboi, Masahiro] Natl Canc Ctr Hosp East, Div Thorac Surg, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O1-10-4	84	84				1	Oncology	Oncology	CW7ED	WOS:000365159900186		
J	Nakamura, N; Matsumoto, T; Shibata, Y; Kitagawa, J; Kanemura, N; Hara, T; Tsurumi, H				Nakamura, Nobuhiko; Matsumoto, Takuro; Shibata, Yuhei; Kitagawa, Junichi; Kanemura, Nobuhiro; Hara, Takeshi; Tsurumi, Hisashi			Sarcopenia and adipopenia are independent prognostic factors in patients with acute myeloid leukemia	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Nakamura, Nobuhiko; Matsumoto, Takuro; Shibata, Yuhei; Kitagawa, Junichi; Kanemura, Nobuhiro; Hara, Takeshi; Tsurumi, Hisashi] Gifu Univ, Grad Sch Med, Dept Hematol, Gifu, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O1-11-1	84	84				1	Oncology	Oncology	CW7ED	WOS:000365159900188		
J	Ito, S; Asahi, M; Oyake, T; Izumida, W; Tsukushi, Y; Sugawara, T; Ishida, Y				Ito, Shigeki; Asahi, Maki; Oyake, Tatsuo; Izumida, Wataru; Tsukushi, Yasuhiko; Sugawara, Takeshi; Ishida, Yoji			Efficacy and safety of dose-adjusted lenalidomide therapy in relapsed/refractory myeloma patients with renal impairment	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Ito, Shigeki] Iwate Med Univ, Sch Med, Dept Med Oncol, Iwatsuki, Saitama, Japan; [Asahi, Maki; Oyake, Tatsuo; Ishida, Yoji] Iwate Med Univ, Sch Med, Dept Internal Med, Hematol & Oncol, Iwatsuki, Saitama, Japan; [Izumida, Wataru] Iwate Prefectural Ofunato Hosp, Dept Hematol, Iwatsuki, Saitama, Japan; [Tsukushi, Yasuhiko] Hachinohe Red Cross Hosp, Dept Hematol, Hachinohe, Aomori, Japan; [Sugawara, Takeshi] Morioka Red Cross Hosp, Dept Hematol Oncol, Morioka, Iwate, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O1-12-1	85	85				1	Oncology	Oncology	CW7ED	WOS:000365159900191		
J	Kanemasa, Y; Shimoyama, T; Sasaki, Y; Takeshi, S; Sasaki, E; Omuro, Y; Maeda, Y; Hishima, T; Sasaki, T				Kanemasa, Yusuke; Shimoyama, Tatsu; Sasaki, Yuki; Takeshi, Sawada; Sasaki, Eisaku; Omuro, Yasushi; Maeda, Yoshiharu; Hishima, Tsunekazu; Sasaki, Tsuneo			Central nervous system relapse in diffuse large B-cell lymphoma: analysis of risk factors and a new prognostic model	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Kanemasa, Yusuke; Shimoyama, Tatsu; Takeshi, Sawada; Sasaki, Eisaku; Omuro, Yasushi; Maeda, Yoshiharu; Sasaki, Tsuneo] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Chemotherapy, Komae, Tokyo, Japan; [Sasaki, Yuki] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Clin Res Support, Komae, Tokyo, Japan; [Hishima, Tsunekazu] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Pathol, Komae, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O1-12-5	85	86				2	Oncology	Oncology	CW7ED	WOS:000365159900193		
J	Kitagawa, J; Matsumoto, T; Shibata, Y; Nakamura, N; Kanemura, N; Hara, T; Tsurumi, H				Kitagawa, Junichi; Matsumoto, Takuro; Shibata, Yuhei; Nakamura, Nobuhiko; Kanemura, Nohuhiro; Hara, Takeshi; Tsurumi, Hisashi			Efficacy and safety of denosumab for multiple myeloma	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Kitagawa, Junichi; Matsumoto, Takuro; Shibata, Yuhei; Nakamura, Nobuhiko; Kanemura, Nohuhiro; Hara, Takeshi; Tsurumi, Hisashi] Gifu Univ, Dept Hematol, Gifu, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O1-12-2	85	85				1	Oncology	Oncology	CW7ED	WOS:000365159900192		
J	Yakushijin, K; Minami, H; Uchida, T; Ogura, M; Taniwaki, M; Kobayashi, T; Mori, A; Yonemura, M; Munakata, W; Kobayashi, Y				Yakushijin, Kimikazu; Minami, Hironobu; Uchida, Toshiki; Ogura, Michinori; Taniwaki, Masafumi; Kobayashi, Tsutomu; Mori, Asuka; Yonemura, Masataka; Munakata, Wataru; Kobayashi, Yukio			A phase I b study of panobinostat and 5-azacitidine in Japanese patients with MDS, CMML, or AML	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Yakushijin, Kimikazu; Minami, Hironobu] Kobe Univ Hosp, Dept Med Oncol & Hematol, Kobe, Hyogo, Japan; [Uchida, Toshiki; Ogura, Michinori] Japanese Red Cross Nagoya Daini Hosp, Dept Hematol & Oncol, Nagoya, Aichi, Japan; [Taniwaki, Masafumi; Kobayashi, Tsutomu] Kyoto Prefectural Univ Med, Dept Hematol & Oncol, Univ Hosp, Kyoto 602, Japan; [Mori, Asuka; Yonemura, Masataka] Novartis Pharma KK, Oncol Dev & Med Affairs Dept, Tokyo, Japan; [Munakata, Wataru; Kobayashi, Yukio] Novartis Pharma KK, Oncol Dev & Med Affairs Dept, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O1-11-3	85	85				1	Oncology	Oncology	CW7ED	WOS:000365159900190		
J	Ebata, T; Kodaira, M; Shimoi, T; Hashimoto, J; Yamamoto, H; Yunokawa, M; Yonemori, K; Shimizu, C; Fujiwara, Y; Tamura, K				Ebata, Takahiro; Kodaira, Makoto; Shimoi, Tatsunori; Hashimoto, Jun; Yamamoto, Harukaze; Yunokawa, Mayu; Yonemori, Kan; Shimizu, Chikako; Fujiwara, Yasuhiro; Tamura, Kenji			Clinical characteristics and outcome of ovarian, fallopian tube and peritoneal-like cancer in cancer of unknown primary	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Ebata, Takahiro; Kodaira, Makoto; Shimoi, Tatsunori; Hashimoto, Jun; Yamamoto, Harukaze; Yunokawa, Mayu; Yonemori, Kan; Shimizu, Chikako; Fujiwara, Yasuhiro; Tamura, Kenji] Natl Canc Ctr, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O1-13-2	86	86				1	Oncology	Oncology	CW7ED	WOS:000365159900195		
J	Hayashi, H; Tomida, S; Togashi, Y; Sakai, K; Fujita, Y; Tsurutani, J; Kurahashi, I; Kurata, T; Nakagawa, K; Nishio, K				Hayashi, Hidetoshi; Tomida, Shuta; Togashi, Yosuke; Sakai, Kazuko; Fujita, Yoshihiko; Tsurutani, Junji; Kurahashi, Issei; Kurata, Takayasu; Nakagawa, Kazuhiko; Nishio, Kazuto			Integrative algorithm to determine the metastatic carcinoma tissue of origin using next generation sequencing (NGS)	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Hayashi, Hidetoshi; Tsurutani, Junji; Nakagawa, Kazuhiko] Kinki Univ, Fac Med, Dept Med Oncol, Higashiosaka, Osaka 577, Japan; [Hayashi, Hidetoshi; Tomida, Shuta; Togashi, Yosuke; Sakai, Kazuko; Fujita, Yoshihiko; Nishio, Kazuto] Kinki Univ, Fac Med, Dept Genome Biol, Higashiosaka, Osaka 577, Japan; [Hayashi, Hidetoshi] Kishiwada Municipal Hosp, Dept Med Oncol, Osaka, Japan; [Kurahashi, Issei] iAnalysis, Tokyo, Japan; [Kurata, Takayasu] Kansai Med Univ, Dept Thorac Oncol, Hirakata Hosp, Moriguchi, Osaka, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O1-13-4	86	86				1	Oncology	Oncology	CW7ED	WOS:000365159900197		
J	Kawachi, A; Koudaira, M; Tanabe, Y; Hashimoto, J; Yunokawa, M; Yamamoto, H; Yonemori, K; Shimizu, C; Fujiwara, Y; Tamura, K				Kawachi, Asuka; Koudaira, Makoto; Tanabe, Yuko; Hashimoto, Jyun; Yunokawa, Mayu; Yamamoto, Harukaze; Yonemori, Kan; Shimizu, Chikako; Fujiwara, Yasuhiro; Tamura, Kenji			Clinical feature in adolescent and young adult with suspected carcinoma of unknown primary	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Kawachi, Asuka; Koudaira, Makoto; Tanabe, Yuko; Hashimoto, Jyun; Yunokawa, Mayu; Yamamoto, Harukaze; Yonemori, Kan; Shimizu, Chikako; Fujiwara, Yasuhiro; Tamura, Kenji] Natl Canc Ctr, Dept Breast & Med Oncol, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O1-13-1	86	86				1	Oncology	Oncology	CW7ED	WOS:000365159900194		
J	Kodaira, M; Shimoi, T; Hashimoto, J; Yamamoto, H; Yunokawa, M; Yonemori, K; Shimizu, C; Fujiwara, Y; Tamura, K				Kodaira, Makoto; Shimoi, Tatsunori; Hashimoto, Jun; Yamamoto, Harukaze; Yunokawa, Mayu; Yonemori, Kan; Shimizu, Chikako; Fujiwara, Yasuhiro; Tamura, Kenji			Clinical characteristics of cancer of unknown primary cancer with poorly differentiated carcinoma and adenocarcinoma	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Kodaira, Makoto; Shimoi, Tatsunori; Hashimoto, Jun; Yamamoto, Harukaze; Yunokawa, Mayu; Yonemori, Kan; Shimizu, Chikako; Fujiwara, Yasuhiro; Tamura, Kenji] Natl Canc Ctr, Div Breast & Med Oncol, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O1-13-3	86	86				1	Oncology	Oncology	CW7ED	WOS:000365159900196		
J	Azuma, T; Akashi, Y; Kannno, M; Kobayashi, S; Hiroshi, K; Yukisige, Y				Azuma, Teruhisa; Akashi, Yusaku; Kannno, Masatoshi; Kobayashi, Shinnya; Hiroshi, Koyama; Yukisige, Yamada			Raising awareness of health care providers in Nara for patients' care through multidisciplinary workshop "MAHOLOBA"	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Azuma, Teruhisa] Tenri Hosp, Dept Gen Internal Med, Nairobi, Kenya; [Akashi, Yusaku] Kinki Univ, Nara Hosp, Dept Med Oncol, Higashiosaka, Osaka 577, Japan; [Kannno, Masatoshi] Nara Med Univ Hosp, Oncol Ctr, Nara, Japan; [Kobayashi, Shinnya] Nara Prefecture Gen Med Ctr, Dept Med Oncol, Nara, Japan; [Hiroshi, Koyama] Nara City Hosp, Dept Breast Surg, Nara, Japan; [Yukisige, Yamada] Kokuho Cent Hosp, Dept Gen Surg, Nara, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O1-15-3	87	87				1	Oncology	Oncology	CW7ED	WOS:000365159900201		
J	Kanai, M; Sakuma, T; Yanagisawa, K; Koyanagi, T; Matsumoto, S; Kuroda, T; Morita, S; Kosugi, S; Okuno, Y				Kanai, Masashi; Sakuma, Tomohiro; Yanagisawa, Koji; Koyanagi, Tomoyoshi; Matsumoto, Shigemi; Kuroda, Tomohiro; Morita, Satoshi; Kosugi, Shinji; Okuno, Yasushi			Introduction of clinical sequence using a comprehensive cancer gene panel (OncoPrime) to daily clinical practice	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Kanai, Masashi; Matsumoto, Shigemi] Kyoto Univ Hosp, Dept Clin Oncol, Kyoto, Japan; [Sakuma, Tomohiro; Yanagisawa, Koji] Mitsui Knowledge Ind Co Ltd, Business Dev Div, Personal Genome Business Deparment, Tokyo, Japan; [Koyanagi, Tomoyoshi] Kyoto Univ, Med Sci & Business Liaison Org, Off Promot Med Innovat, Kyoto, Japan; [Kuroda, Tomohiro] Kyoto Univ, Grad Sch Informat, Dept Social Informat, Div Med Informat, Kyoto, Japan; [Morita, Satoshi] Kyoto Univ, Grad Sch Informat, Dept Biomed Stat & Bioinformat, Kyoto, Japan; [Kosugi, Shinji] Kyoto Univ, Grad Sch Med, Dept Med Eth & Med Genet, Kyoto, Japan; [Okuno, Yasushi] Kyoto Univ, Grad Sch Med, Dept Clin Syst Oncoinformat, Kyoto, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O1-13-6	87	87				1	Oncology	Oncology	CW7ED	WOS:000365159900198		
J	Matsumaru, A; Makino, K; Sakata, Y; Hatanaka, K				Matsumaru, Aki; Makino, Kayoko; Sakata, Yukio; Hatanaka, Kzuteru			Study of outpatient oral continued follow-up system in Regorafenib patients treated for colorectal cancer	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Matsumaru, Aki; Makino, Kayoko; Sakata, Yukio; Hatanaka, Kzuteru] Municipal Hakodate Hosp, Hakodate, Hokkaido, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O1-14-6	87	87				1	Oncology	Oncology	CW7ED	WOS:000365159900199		
J	Nakano, K; Tomomatsu, J; Motoi, N; Gokita, T; Ae, K; Tanizawa, T; Shimoji, T; Matsumoto, S; Takahashi, S				Nakano, Kenji; Tomomatsu, Junichi; Motoi, Noriko; Gokita, Tabu; Ae, Keisuke; Tanizawa, Taisuke; Shimoji, Takashi; Matsumoto, Seiichi; Takahashi, Shunji			Management and treatment of soft tissue sarcoma patients by medical oncologists in multidisciplinary center	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Nakano, Kenji; Tomomatsu, Junichi; Takahashi, Shunji] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Med Oncol, Tokyo, Japan; [Motoi, Noriko] Japanese Fdn Canc Res, Inst Canc, Div Pathol, Tokyo, Japan; [Gokita, Tabu; Ae, Keisuke; Tanizawa, Taisuke; Shimoji, Takashi; Matsumoto, Seiichi] Japanese Fdn Canc Res, Inst Canc, Dept Orthoped Surg, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O1-15-1	87	87				1	Oncology	Oncology	CW7ED	WOS:000365159900200		
J	Hasegawa, Y; Tsukuda, H; Iwaya, R; Suzumura, T; Oota, T; Yonesaka, K; Tanaka, T; Kawaguchi, I; Otsuka, M; Fukuoka, M				Hasegawa, Yoshikazu; Tsukuda, Hiroshi; Iwaya, Rikako; Suzumura, Tomohiro; Oota, Takayo; Yonesaka, Kimio; Tanaka, Tomi; Kawaguchi, Izumi; Otsuka, Masatomo; Fukuoka, Masahiro			The role of palliative care unit co-operating with regional medical systems to provide reliable patient care	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Hasegawa, Yoshikazu; Tsukuda, Hiroshi; Suzumura, Tomohiro; Oota, Takayo; Fukuoka, Masahiro] Izumi Municipal Hosp, Dept Med Oncol, Osaka, Japan; [Iwaya, Rikako; Kawaguchi, Izumi] Izumi Municipal Hosp, Dept Nursing, Osaka, Japan; [Yonesaka, Kimio] Kinki Univ, Sch Med, Sakai Hosp, Dept Med Oncol, Higashiosaka, Osaka 577, Japan; [Tanaka, Tomi] Hyogo Univ Hlth Sci, Kobe, Hyogo, Japan; [Otsuka, Masatomo] Kinki Univ, Sch Med, Dept Palliat Care, Higashiosaka, Osaka 577, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O1-16-6	88	88				1	Oncology	Oncology	CW7ED	WOS:000365159900203		
J	Omuro, Y; Ueno, H; Ikeda, M; Ueno, M; Mizuno, N; Ioka, T; Nakajima, T; Furuse, J				Omuro, Yasushi; Ueno, Hideki; Ikeda, Masafumi; Ueno, Makoto; Mizuno, Nobumasa; Ioka, Tatsuya; Nakajima, Takako; Furuse, Junji			Updated analysis of weekly nab-Paclitaxel (P) plus Gemcitabine (G) with metastatic pancreatic cancer (MPC): Phase I/II trial	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Omuro, Yasushi] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Chemotherapy, Tokyo, Japan; [Ueno, Hideki] Natl Canc Ctr, Hepatobiliary & Pancreat Oncol Div, Tokyo, Japan; [Ikeda, Masafumi] Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Tokyo, Japan; [Ueno, Makoto] Kanagawa Canc Ctr, Div Hepatobiliary & Pancreat Med Oncol, Yokohama, Kanagawa, Japan; [Mizuno, Nobumasa] Aichi Canc Ctr Hosp, Dept Gastroenterol, Nagoya, Aichi, Japan; [Ioka, Tatsuya] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Hepatobiliary & Pancreat Oncol, Osaka, Japan; [Nakajima, Takako] St Marianna Univ, Sch Med Hosp, Dept Med Oncol, Kawasaki, Kanagawa, Japan; [Furuse, Junji] Kyorin Univ, Sch Med, Dept Med Oncol, Hachioji, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O1-17-4	88	89				2	Oncology	Oncology	CW7ED	WOS:000365159900205		
J	Shirakawa, T; Hikage, K; Akino, T; Hirata, T; Shigematsu, H; Nagaie, T; Ariyama, H; Kusaba, H; Akashi, K; Baba, E				Shirakawa, Tsuyoshi; Hikage, Keiko; Akino, Terumi; Hirata, Tomoko; Shigematsu, HIroko; Nagaie, Tomoko; Ariyama, Hiroshi; Kusaba, Hitoshi; Akashi, Koichi; Baba, Eishi			Improvement in the awareness of palliative care nursing using STAS-J in an acute care hospital	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Shirakawa, Tsuyoshi] Kyushu Canc Ctr, Natl Hosp Org, Gastrointestinal & Med Oncol, Fukuoka, Japan; [Hikage, Keiko; Akino, Terumi; Hirata, Tomoko; Shigematsu, HIroko; Ariyama, Hiroshi; Kusaba, Hitoshi; Akashi, Koichi; Baba, Eishi] Kyushu Univ Hosp, Fukuoka 812, Japan; [Nagaie, Tomoko] Kyushu Univ, Sch Med, Dept Hlth Sci, Fundamental Nursing, Fukuoka 812, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O1-15-6	88	88				1	Oncology	Oncology	CW7ED	WOS:000365159900202		
J	Watanabe, K; Takahashi, H; Umemoto, K; Okuyama, H; Hashimoto, Y; Ohno, I; Shimizu, S; Mitsunaga, S; Okusaka, T; Ikeda, M				Watanabe, Kazuo; Takahashi, Hideaki; Umemoto, Kumiko; Okuyama, Hiroyuki; Hashimoto, Yusuke; Ohno, Izumi; Shimizu, Satoshi; Mitsunaga, Shuichi; Okusaka, Takuji; Ikeda, Masafumi			Safety and efficacy of modified FOLFIRINOX in patients with metastatic pancreatic cancer	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Watanabe, Kazuo; Takahashi, Hideaki; Umemoto, Kumiko; Okuyama, Hiroyuki; Hashimoto, Yusuke; Ohno, Izumi; Shimizu, Satoshi; Mitsunaga, Shuichi; Ikeda, Masafumi] Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Tokyo, Japan; [Okusaka, Takuji] Natl Canc Ctr, Dept Hepatobiliary & Pancreat Oncol, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O1-17-3	88	88				1	Oncology	Oncology	CW7ED	WOS:000365159900204		
J	Kakiuchi, S; Minami, Y; Fukushima, N; Kiyoi, H; Naoe, T; Matsuoka, H; Minami, H				Kakiuchi, Seiji; Minami, Yosuke; Fukushima, Nobuaki; Kiyoi, Hitoshi; Naoe, Tomoki; Matsuoka, Hiroshi; Minami, Hironobu			Biomarker and gene profiling analyses in acute myeloid leukemia during treatment with Hedgehog signaling inhibitor	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Kakiuchi, Seiji; Matsuoka, Hiroshi; Minami, Hironobu] Kobe Univ Hosp, Div Oncol & Hematol, Kobe, Hyogo, Japan; [Minami, Yosuke] Kobe Univ Hosp, Div Blood Transfus, Kobe, Hyogo, Japan; [Fukushima, Nobuaki; Kiyoi, Hitoshi] Nagoya Univ Hosp, Dept Hematol & Oncol, Nagoya, Aichi, Japan; [Naoe, Tomoki] Natl Hosp Org Nagoya Med Ctr, Nagoya, Aichi, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O1-19-4	89	89				1	Oncology	Oncology	CW7ED	WOS:000365159900209		
J	Nakamura, M; Nakahira, M; Tokunaga, K; Murakami, Y; Kinosita, C; Okino, Y				Nakamura, Masako; Nakahira, Miwa; Tokunaga, Kiyko; Murakami, Yoko; Kinosita, Chiiemi; Okino, Yoshie			Development of online education program for certified chemotherapy nurses regarding molecular targeted therapy	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Nakamura, Masako] Shiga Univ Med Sci, Med Oncol Dept, Otsu, Shiga, Japan; [Nakamura, Masako; Nakahira, Miwa; Tokunaga, Kiyko; Murakami, Yoko; Okino, Yoshie] Kyoto Koka Womens Univ, Kyoto, Japan; [Kinosita, Chiiemi] Hikone Municipal Hosp, Hikone, Shiga, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O1-18-2	89	89				1	Oncology	Oncology	CW7ED	WOS:000365159900207		
J	Okazaki, J; Kimura, T; Miyamoto, H; Mitsui, Y; Fujino, Y; Kitamura, S; Kimura, M; Okamoto, K; Muguruma, N; Takayama, T				Okazaki, Jun; Kimura, Tetsuo; Miyamoto, Hiroshi; Mitsui, Yasuhiro; Fujino, Yasuteru; Kitamura, Shinji; Kimura, Masako; Okamoto, Koichi; Muguruma, Naoki; Takayama, Tetsuji			S-1/oxaliplatin/irinotecan (SOXIRI) for advanced unresectable pancreatic cancer : a dose-finding study	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Okazaki, Jun; Kimura, Tetsuo; Miyamoto, Hiroshi; Mitsui, Yasuhiro; Fujino, Yasuteru; Kitamura, Shinji; Kimura, Masako; Okamoto, Koichi; Muguruma, Naoki; Takayama, Tetsuji] Univ Tokushima, Grad Sch, Dept Gastroenterol & Oncol, Tokushima, Tokushima, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O1-17-5	89	89				1	Oncology	Oncology	CW7ED	WOS:000365159900206		
J	Kashiwagi, S; Asano, Y; Morisaki, T; Noda, S; Kawajiri, H; Takashima, T; Onoda, N; Hirakawa, K				Kashiwagi, Shinichiro; Asano, Yuka; Morisaki, Tamami; Noda, Satoru; Kawajiri, Hidemi; Takashima, Tsutomu; Onoda, Naoyoshi; Hirakawa, Kosei			Clinical verification of a molecular mechanism of antitumor effect of eribulin chemotherapy	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Kashiwagi, Shinichiro; Asano, Yuka; Morisaki, Tamami; Noda, Satoru; Kawajiri, Hidemi; Takashima, Tsutomu; Onoda, Naoyoshi; Hirakawa, Kosei] Osaka City Univ, Dept Surg Oncol, Grad Sch Med, Osaka, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O2-2-5	90	90				1	Oncology	Oncology	CW7ED	WOS:000365159900213		
J	Muto, M; Uneno, Y; Nishikawa, Y; Mori, Y; Kanai, M; Mastumoto, S; Kato, G; Kuroda, T; Morita, S; Okuno, Y				Muto, Manabu; Uneno, Yu; Nishikawa, Yoshitaka; Mori, Yukiko; Kanai, Masashi; Mastumoto, Shigemi; Kato, Genta; Kuroda, Tomohiro; Morita, Satoshi; Okuno, Yasushi			A new approach to collecting biobank and bioinformatics data at Kyoto University Cancer Center	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Muto, Manabu; Uneno, Yu; Nishikawa, Yoshitaka; Mori, Yukiko; Kanai, Masashi; Mastumoto, Shigemi] Kyoto Univ Hosp, Dept Clin Oncol, Kyoto, Japan; [Kato, Genta] Kyoto Univ Hosp, Solut Ctr Hlth Insurance Claims, Kyoto, Japan; [Kuroda, Tomohiro] Kyoto Univ Hosp, Dept Med Informat, Kyoto, Japan; [Morita, Satoshi] Kyoto Univ Hosp, iACT, Dept Data Sci, Kyoto, Japan; [Okuno, Yasushi] Kyoto Univ, Dept Clin Syst Oncol, Kyoto 6068501, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O1-19-5	90	90				1	Oncology	Oncology	CW7ED	WOS:000365159900210		
J	Taguchi, J; Shimizu, Y; Kinoshita, I; Honma, R; Takeuchi, S; Tsuchiya, K; Shirato, H; Homma, A; Fukuda, S; Akita, H				Taguchi, Jun; Shimizu, Yasushi; Kinoshita, Ichiro; Honma, Rio; Takeuchi, Satoshi; Tsuchiya, Kazuhiko; Shirato, Hiroki; Homma, Akihiro; Fukuda, Satoshi; Akita, Hirotoshi			Locally advanced head and neck squamous cell carcinomas treated with TPF(docetaxel, cisplatin, 5-FU) induction chemotherapy	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Taguchi, Jun; Shimizu, Yasushi; Kinoshita, Ichiro; Honma, Rio; Takeuchi, Satoshi; Akita, Hirotoshi] Hokkaido Univ, Dept Med Oncol, Grad Sch Med, Sapporo, Hokkaido 060, Japan; [Tsuchiya, Kazuhiko; Shirato, Hiroki] Hokkaido Univ, Dept Radiat Med, Grad Sch Med, Sapporo, Hokkaido 060, Japan; [Homma, Akihiro; Fukuda, Satoshi] Hokkaido Univ, Dept Otolaryngol Head & Neck Surg, Grad Sch Med, Sapporo, Hokkaido 060, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O2-1-2	90	90				1	Oncology	Oncology	CW7ED	WOS:000365159900212		
J	Tsubata, Y; Nakao, M; Okimoto, T; Sutani, A; Karube, H; Horiguchi, M; Yamashita, C; Ohtsu, H; Isobe, T				Tsubata, Yukari; Nakao, Mika; Okimoto, Tamio; Sutani, Akihisa; Karube, Hiromitsu; Horiguchi, Michiko; Yamashita, Chikamasa; Ohtsu, Hiroshi; Isobe, Takeshi			A Clinical study on activity of NAMPT and SIRT1 gene expression in neutropenia with cancer chemotherapy	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Tsubata, Yukari; Nakao, Mika; Okimoto, Tamio; Sutani, Akihisa; Isobe, Takeshi] Shimane Univ, Div Med Oncol & Resp Med, Dept Internal Med, Sch Med, Matsue, Shimane, Japan; [Karube, Hiromitsu; Horiguchi, Michiko; Yamashita, Chikamasa] Tokyo Univ Sci, Dept Pharmaceut & Drug Delivery, Fac Pharmaceut Sci, Tokyo 162, Japan; [Ohtsu, Hiroshi] Juntendo Univ, Leading Ctr Dev & Res Canc Med, Grad Sch Med, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O1-20-5	90	90				1	Oncology	Oncology	CW7ED	WOS:000365159900211		
J	Ito, R; Miura, S; Maemondo, M; Harada, T; Sugawara, S; Kobayashi, K; Inoue, A; Nakagawa, T; Takiguchi, Y; Yoshizawa, H				Ito, Ryo; Miura, Satoru; Maemondo, Makoto; Harada, Toshiyuki; Sugawara, Shunichi; Kobayashi, Kunihiko; Inoue, Akira; Nakagawa, Taku; Takiguchi, Yuichi; Yoshizawa, Hirohisa			NEJ016: Phase II study of CBDCA and weekly PTX plus BEV for highly selected elderly non-squamous NSCLC patients	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Ito, Ryo] Nagaoka Chuo Gen Hosp, Nagaoka, Niigata, Japan; [Miura, Satoru] Niigata Univ, Med & Dent Hosp, Niigata, Japan; [Maemondo, Makoto] Miyagi Canc Ctr, Natori, Miyagi 9811293, Japan; [Harada, Toshiyuki] JCHO Hokkaido Hosp, Sapporo, Hokkaido, Japan; [Sugawara, Shunichi] Sendai Kousei Hosp, Sendai, Miyagi, Japan; [Kobayashi, Kunihiko] Saitama Med Univ, Int Med Ctr, Hidaka, Japan; [Inoue, Akira] Tohoku Univ Hosp, Sendai, Miyagi, Japan; [Nakagawa, Taku] Omagari Kosei Med Ctr, Akita, Japan; [Takiguchi, Yuichi] Chiba Univ, Grad Sch Med, Chiba, Japan; [Yoshizawa, Hirohisa] Niigata Med Ctr Hosp, Niigata, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O2-3-6	91	91				1	Oncology	Oncology	CW7ED	WOS:000365159900216		
J	Seto, T; Takeda, M; Hayashi, H; Azuma, K; Okada, M; Sugawara, S; Yamanaka, T; Nakagawa, K; Nakanishi, Y; Okamoto, I				Seto, Takashi; Takeda, Masayuki; Hayashi, Hidetoshi; Azuma, Koichi; Okada, Morihito; Sugawara, Shunichi; Yamanaka, Takeharu; Nakagawa, Kazuhiko; Nakanishi, Yoichi; Okamoto, Isamu			Bevacizumab beyond disease progression in advanced non-squamous NSCLC (WJOG 5910L): a randomized phase II trial	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Seto, Takashi] Kyushu Natl Canc Ctr, Dept Thorac Oncol, Fukuoka, Japan; [Takeda, Masayuki; Nakagawa, Kazuhiko] Kinki Univ, Dept Med Oncol, Fac Med, Higashiosaka, Osaka 577, Japan; [Hayashi, Hidetoshi] Kishiwada City Hosp, Dept Med Oncol, Kishiwada, Osaka, Japan; [Azuma, Koichi] Kurume Univ, Div Respirol Neurol & Rheumatol, Dept Internal Med, Sch Med, Kurume, Fukuoka, Japan; [Okada, Morihito] Hiroshima Univ, Dept Surg Oncol, Hiroshima 730, Japan; [Sugawara, Shunichi] Sendai Kousei Hosp, Dept Pulm Med, Sendai, Miyagi, Japan; [Yamanaka, Takeharu] Yokohama City Univ, Dept Biostat, Yokohama, Kanagawa, Japan; [Nakanishi, Yoichi] Kyushu Univ, Res Inst Dis Chest, Grad Sch Med Sci, Sch Med, Fukuoka 812, Japan; [Okamoto, Isamu] Kyushu Univ Hosp, Ctr Clin & Translat Res, Fukuoka, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O2-3-5	91	91				1	Oncology	Oncology	CW7ED	WOS:000365159900215		
J	Watanabe, M; Takashina, T; Asahina, H; Amano, T; Yokouchi, H; Takamura, K; Harada, T; Honjo, O; Morikawa, N; Kinoshita, I				Watanabe, Masahiro; Takashina, Taichi; Asahina, Hajime; Amano, Toraji; Yokouchi, Hiroshi; Takamura, Kei; Harada, Toshiyuki; Honjo, Osamu; Morikawa, Naoto; Kinoshita, Ichiro			Phase II study of carboplatin/pemetrexed/bevacizumab followed by bev/erlotinib maintenance for non-squamous NSCLC with WT EGFR	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Watanabe, Masahiro] Natl Hosp Org Hokkaido Canc Ctr, Dept Resp Med, Sapporo, Hokkaido, Japan; [Takashina, Taichi; Asahina, Hajime] Hokkaido Univ, Dept Med 1, Sch Med, Sapporo, Hokkaido 060, Japan; [Amano, Toraji] Hokkaido Univ Hosp, Clin Res & Med Innovat Ctr, Sapporo, Hokkaido, Japan; [Yokouchi, Hiroshi] Fukushima Med Univ, Dept Pulm Med, Fukushima, Japan; [Takamura, Kei] Obihiro Kosei Gen Hosp, Dept Med 1, Obihiro, Hokkaido, Japan; [Harada, Toshiyuki] JCHO Hokkaido Hosp, Dept Resp Med, Sapporo, Hokkaido, Japan; [Honjo, Osamu] Sapporo Kosei Hosp, Dept Resp Med, Sapporo, Hokkaido, Japan; [Morikawa, Naoto] Iwate Med Univ, Div Pulm Med Allergy & Rheumatol, Sch Med, Morioka, Iwate, Japan; [Kinoshita, Ichiro] Hokkaido Univ, Dept Med Oncol, Grad Sch Med, Sapporo, Hokkaido 060, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O2-4-4	91	92				2	Oncology	Oncology	CW7ED	WOS:000365159900217		
J	Yoh, K; Seto, T; Satouchi, M; Nishio, M; Yamamoto, N; Murakami, H; Nogami, N; Yamanaka, T; Goto, K				Yoh, Kiyotaka; Seto, Takashi; Satouchi, Miyako; Nishio, Makoto; Yamamoto, Noboru; Murakami, Haruyasu; Nogami, Naoyuki; Yamanaka, Takeharu; Goto, Koichi			LURET study: A phase II study of vandetanib, RET inhibitor in patients with advanced RET fusion-positive NSCLC	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Yoh, Kiyotaka; Goto, Koichi] Natl Canc Ctr Hosp East, Thorac Oncol Div, Tokyo, Japan; [Seto, Takashi] Natl Hosp Org Kyushu Canc Ctr, Nagoya, Aichi, Japan; [Satouchi, Miyako] Hyogo Canc Ctr, Akashi, Hyogo, Japan; [Nishio, Makoto] Japanese Fdn Canc Res, Canc Inst Hosp, Tokyo, Japan; [Yamamoto, Noboru] Natl Canc Ctr, Tokyo, Japan; [Murakami, Haruyasu] Shizuoka Canc Ctr, Nagaizumi, Shizuoka, Japan; [Nogami, Naoyuki] Natl Hosp Org Shikoku Canc Ctr, Shikoku, Ehime, Japan; [Yamanaka, Takeharu] Yokohama City Univ, Assoc Med Sci, Yokohama, Kanagawa, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O2-3-2	91	91				1	Oncology	Oncology	CW7ED	WOS:000365159900214		
J	Hayashi, T; Shimokawa, M; Hiraike, M; Toriyama, Y; Yokota, C; Taniguchi, J; Hanada, M; Tsumagari, K; Okubo, N; Koutake, Y				Hayashi, Toshinobu; Shimokawa, Mototsugu; Hiraike, Mikako; Toriyama, Yoko; Yokota, Chiaki; Taniguchi, Jun; Hanada, Masanori; Tsumagari, Kyouichi; Okubo, Noriko; Koutake, Yoshimichi			Low emetic chemotherapy-induced nausea and vomiting: a prospective, multicenter, observational study	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Hayashi, Toshinobu; Hiraike, Mikako] NHO Kyushu Med Ctr, Dept Pharm, Fukuoka, Japan; [Shimokawa, Mototsugu] NHO Kyushu Canc Ctr, Clin Res Inst, Canc Biostat Lab, Fukuoka, Japan; [Toriyama, Yoko] NHO Beppu Med Ctr, Dept Pharm, Beppu, Oita, Japan; [Yokota, Chiaki; Hanada, Masanori] NHO Nagasaki Med Ctr, Dept Pharm, Nagasaki, Japan; [Taniguchi, Jun] NHO Ureshino Med Ctr, Dept Pharm, Ureshino, Japan; [Tsumagari, Kyouichi] NHO Nagasaki Med Ctr, Dept Pharm, Nagasaki, Japan; [Okubo, Noriko] NHO Kumamoto Med Ctr, Dept Pharm, Kumamoto, Japan; [Koutake, Yoshimichi] NHO Fukuoka Natl Hosp, Dept Pharm, Fukuoka, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O2-6-1	92	93				2	Oncology	Oncology	CW7ED	WOS:000365159900221		
J	Onodera, K; Hayashi, Y; Kanno, S; Kawakami, K; Kubo, T; Yamamoto, E; Nousho, K; Yamashita, K; Arimura, Y; Shinomura, Y				Onodera, Kei; Hayashi, Yuki; Kanno, Shinichi; Kawakami, Kentaro; Kubo, Toshiyuki; Yamamoto, Eiichiro; Nousho, Katsuhiko; Yamashita, Kentaro; Arimura, Yoshiaki; Shinomura, Yasuhisa			Retrospective study on complications of upper arm central venous access ports	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Onodera, Kei; Hayashi, Yuki; Kanno, Shinichi; Kawakami, Kentaro; Kubo, Toshiyuki; Yamamoto, Eiichiro; Nousho, Katsuhiko; Yamashita, Kentaro; Arimura, Yoshiaki; Shinomura, Yasuhisa] Sapporo Med Univ, Dept Gastroenterol Rheumatol & Clin Immunol, Sapporo, Hokkaido, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O2-5-5	92	92				1	Oncology	Oncology	CW7ED	WOS:000365159900220		
J	Usui, K; Miyauchi, E; Sugawara, S; Fukuhara, T; Saito, H; Fujita, Y; Kato, T; Suzuki, T; Inoue, A; Ishinose, M				Usui, Kazuhiro; Miyauchi, Eisaku; Sugawara, Shunichi; Fukuhara, Tatsuro; Saito, Heisuke; Fujita, Yuka; Kato, Terufumi; Suzuki, Toshiro; Inoue, Akira; Ishinose, Masakazu			Phase II study of carboplatin plus weekly nab-paclitaxel in elderly patients with NSCLC:NJLCG1301	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Usui, Kazuhiro] NTT Med Ctr Tokyo, Div Respirol, Tokyo, Japan; [Miyauchi, Eisaku; Inoue, Akira; Ishinose, Masakazu] Tohoku Univ Hosp, Dept Resp Med, Sendai, Miyagi, Japan; [Sugawara, Shunichi] Sendai Kousei Hosp, Dept Pulm Med, Sendai, Miyagi, Japan; [Fukuhara, Tatsuro] Miyagi Canc Ctr, Dept Resp Med, Natori, Miyagi, Japan; [Saito, Heisuke] Iwate Med Univ, Div Pulm Med Allergy & Rheumatol, Dept Internal Med, Sch Med, Morioka, Iwate, Japan; [Fujita, Yuka] Natl Hosp Org Asahikawa Med Ctr, Dept Resp Med, Asahikawa, Hokkaido, Japan; [Kato, Terufumi] Kanagawa Cardiovasc & Resp Ctr, Dept Resp Med, Yokohama, Kanagawa, Japan; [Suzuki, Toshiro] Iwate Prefectural Isawa Hosp, Div Resp Med, Mizusawa, Iwate, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O2-4-5	92	92				1	Oncology	Oncology	CW7ED	WOS:000365159900218		
J	Fujiwara, T; Taira, T; Wakuda, K; Ono, A; Kenmotsu, H; Naitou, T; Murakami, H; Mori, K; Endou, M; Takahashi, T				Fujiwara, Takumi; Taira, Tetsuhiko; Wakuda, Kazushige; Ono, Akira; Kenmotsu, Hirotsugu; Naitou, Tateaki; Murakami, Haruyasu; Mori, Keita; Endou, Masahiro; Takahashi, Toshiaki			Association between febrile neutropenia and use of G-CSF in chemotherapy of extensive-disease small-cell lung cancer	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Fujiwara, Takumi; Taira, Tetsuhiko; Wakuda, Kazushige; Ono, Akira; Kenmotsu, Hirotsugu; Naitou, Tateaki; Murakami, Haruyasu; Takahashi, Toshiaki] Shizuoka Canc Ctr, Dept Resp Med, Nagaizumi, Shizuoka, Japan; [Mori, Keita] Shizuoka Canc Ctr, Clin Res Ctr, Nagaizumi, Shizuoka, Japan; [Endou, Masahiro] Shizuoka Canc Ctr, Dept Diagnost Radiol, Nagaizumi, Shizuoka, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O2-7-4	93	94				2	Oncology	Oncology	CW7ED	WOS:000365159900225		
J	Hata, A; Katakami, N; Fujita, S; Kaji, R; Takeshita, J; Morita, S; Fujimoto, D; Nagata, K; Otsuka, K; Tomii, K				Hata, Akito; Katakami, Nobuyuki; Fujita, Shiro; Kaji, Reiko; Takeshita, Jumpei; Morita, Satoshi; Fujimoto, Daichi; Nagata, Kazuma; Otsuka, Kojiro; Tomii, Keisuke			Garenoxacin (GRNX) for secondary prophylaxis against febrile neutropenia (FN) in chemotherapies for advanced lung cancer	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Morita, Satoshi] Kyoto Univ, Dept Biomed Stat & Bioinformat, Grad Sch Med, Kyoto 6068501, Japan; [Fujimoto, Daichi; Nagata, Kazuma; Otsuka, Kojiro; Tomii, Keisuke] Kobe City Med Ctr Gen Hosp, Dept Resp Med, Kobe, Hyogo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O2-7-1	93	93				1	Oncology	Oncology	CW7ED	WOS:000365159900224		
J	Miyabayashi, T; Miura, S; Tanaka, H; Ishida, T; Watanabe, S; Makino, M; Okajima, M; Tanaka, J; Kagamu, H; Yoshizawa, H				Miyabayashi, Takao; Miura, Satoru; Tanaka, Hiroshi; Ishida, Takashi; Watanabe, Satoshi; Makino, Masato; Okajima, Masaaki; Tanaka, Junta; Kagamu, Hiroshi; Yoshizawa, Hirohisa			A randomized phase II trial of triplet or doublet antiemetic therapy in lung cancer patients receiving MEC (NLCTG1002)	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Miyabayashi, Takao] Niigata City Gen Hosp, Dept Resp Med, Niigata, Japan; [Miura, Satoru; Okajima, Masaaki] Niigata Univ, Dept Resp Med, Med & Dent Hosp, Niigata, Japan; [Tanaka, Hiroshi] Niigata Canc Ctr Hosp, Dept Internal Med, Niigata, Japan; [Ishida, Takashi] Niigata Prefectural Cent Hosp, Dept Internal Med, Joetsu, Japan; [Watanabe, Satoshi] Niigata Univ, Biosci Med Res Ctr, Med & Dent Hosp, Niigata, Japan; [Makino, Masato] Niigata Prefectural Shibata Hosp, Dept Internal Med, Shibata, Japan; [Tanaka, Junta] Niigata Univ, Dept Hlth Promot Med, Med & Dent Hosp, Niigata, Japan; [Yoshizawa, Hirohisa] Niigata Med Ctr Hosp, Dept Resp Med, Niigata, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O2-6-2	93	93				1	Oncology	Oncology	CW7ED	WOS:000365159900222		
J	Seki, Y; Mitsuko, O; Miyakoshi, S				Seki, Yoshinobu; Mitsuko, Ooba; Miyakoshi, Syukuko			Analysis of efficacy and safety of aprepitant in R-CHOP or R-TCOP chemotherapy for NHL	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Seki, Yoshinobu; Mitsuko, Ooba; Miyakoshi, Syukuko] Niigata Prefectural Shibata Hosp, Dept Internal Med, Shibata, Niigata, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O2-6-4	93	93				1	Oncology	Oncology	CW7ED	WOS:000365159900223		
J	Naganuma, A; Hoshino, T; Takagi, H; Sato, K; Kakizaki, S; Yamada, M				Naganuma, Atsushi; Hoshino, Takashi; Takagi, Hitoshi; Sato, Ken; Kakizaki, Satoru; Yamada, Masanobu			Randomized controlled trial of epirubicin and miriplatin using together with TACE for hepatocellular carcinoma	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Naganuma, Atsushi; Hoshino, Takashi] Takasaki Gen Med Ctr, Dept Gastroenterol, NHO, Takasaki, Gunma, Japan; [Takagi, Hitoshi] Kusunoki Hosp, Dept Gastroenterol, Yokosuka, Kanagawa, Japan; [Sato, Ken; Kakizaki, Satoru; Yamada, Masanobu] Gunma Univ, Dept Med & Mol Sci, Grad Sch Med, Maebashi, Gunma, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O2-8-5	94	95				2	Oncology	Oncology	CW7ED	WOS:000365159900229		
J	Ogawara, D; Fukuda, M; Ueno, S; Oka, M; Kondo, A; Tomari, S; Nakatomi, K; Nakamura, Y; Ashizawa, K; Kohno, S				Ogawara, Daiki; Fukuda, Minoru; Ueno, Shiro; Oka, Mikio; Kondo, Akira; Tomari, Shinya; Nakatomi, Katsumi; Nakamura, Yoichi; Ashizawa, Kazuto; Kohno, Shigeru			Fever after cancer chemotherapy is affected by drug fever on post-treatment days 3-4	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Ogawara, Daiki; Kondo, Akira; Tomari, Shinya] Isahaya Gen Hosp, Dept Resp Med, Isahaya, Nagasaki, Japan; [Fukuda, Minoru; Ashizawa, Kazuto] Nagasaki Univ Hosp, Clin Oncol Ctr, Nagasaki, Japan; [Ueno, Shiro] Ikeda Hosp, Dept Resp Med, Ikeda, Osaka, Japan; [Oka, Mikio] Kawasaki Med Sch Hosp, Dept Resp Med, Kawasaki, Kanagawa, Japan; [Nakatomi, Katsumi; Nakamura, Yoichi; Kohno, Shigeru] Nagasaki Univ Hosp, Dept Resp Med, Nagasaki, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O2-7-6	94	94				1	Oncology	Oncology	CW7ED	WOS:000365159900227		
J	Ohkawa, S; Okusaka, T; Kudo, M; Hatano, E; Fujii, H; Masumoto, A; Furuse, J; Wada, Y; Ishii, H; Obi, S; Arai, K; Kawazoe, S; Yokosuka, O; Ikeda, M; Ukai, K; Morita, S; Asou, H; Abada, PB; Yang, L; Zhu, AX				Ohkawa, Shinichi; Okusaka, Takuji; Kudo, Masatoshi; Hatano, Etsuro; Fujii, Hirofumi; Masumoto, Akihide; Furuse, Junji; Wada, Yoshiyuki; Ishii, Hiroshi; Obi, Shuntaro; Arai, Kuniaki; Kawazoe, Seiji; Yokosuka, Osamu; Ikeda, Masafumi; Ukai, Katsuaki; Morita, Sojiro; Asou, Hiroya; Abada, Paolo B.; Yang, Ling; Zhu, Andrew X.			Ramucirumab (RAM) as second-line treatment in patients (pts) with advanced hepatocellular carcinoma (HCC): Japanese subgroup analysis of the phase III REACH trial	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Ohkawa, Shinichi] Kanagawa Canc Ctr, Div Hepatobiliary & Pancreat Oncol, Kanagawa, Japan; [Okusaka, Takuji] Natl Canc Ctr Hosp, Chiba, Japan; [Kudo, Masatoshi] Kinki Univ Hosp, Osaka, Japan; [Hatano, Etsuro] Kyoto Univ Hosp, Kyoto, Japan; [Fujii, Hirofumi] Jichi Med Univ Hosp, Shimotsuke, Tochigi, Japan; [Masumoto, Akihide] Aso Corp Iizuka Hosp, Tokyo, Japan; [Furuse, Junji] Kyorin Univ Hosp, Kyoto, Japan; [Wada, Yoshiyuki] Natl Hosp Org Kyushu Med Ctr, Fukuoka, Japan; [Ishii, Hiroshi] Japanese Fdn Canc Res, Canc Inst Hosp, Fukuoka, Japan; [Obi, Shuntaro] Kyoundo Hosp, Sasaki Inst, Fukuoka, Japan; [Arai, Kuniaki] Kanazawa Univ Hosp, Kanazawa, Ishikawa, Japan; [Kawazoe, Seiji] Saga Ken Med Ctr Koseikan, Saga, Japan; [Yokosuka, Osamu] Chiba Univ Hosp, Chiba, Japan; [Ikeda, Masafumi] Natl Canc Ctr Hosp East, Chiba, Japan; [Ukai, Katsuaki] Sendai Med Ctr, Sendai, Miyagi, Japan; [Morita, Sojiro] Kochi Hlth Sci Ctr, Kochi, Japan; [Asou, Hiroya] Eli Lilly & Co, Kobe, Hyogo, Japan; [Abada, Paolo B.] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Yang, Ling] Eli Lilly & Co, Bridgewater, NJ USA; [Zhu, Andrew X.] Harvard Univ, Massachusetts Gen Hosp, Ctr Canc, Sch Med, Boston, MA 02114 USA								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O2-8-1	94	94				1	Oncology	Oncology	CW7ED	WOS:000365159900228		
J	Shibata, Y; Matsumoto, T; Nakamura, N; Kitagawa, J; Morikawa, A; Kanemura, N; Hara, T; Tsurumi, H				Shibata, Yuhei; Matsumoto, Takuro; Nakamura, Nobuhiko; Kitagawa, Junichi; Morikawa, Akemi; Kanemura, Nobuhiro; Hara, Takeshi; Tsurumi, Hisashi			A retrospective study of D-index in acute myeloid leukemia patients undergoing induction chemotherapy	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Shibata, Yuhei; Matsumoto, Takuro; Nakamura, Nobuhiko; Kitagawa, Junichi; Kanemura, Nobuhiro; Hara, Takeshi; Tsurumi, Hisashi] Gifu Univ, Dept Hematol, Grad Sch Med, Gifu, Japan; [Morikawa, Akemi] Gifu Univ, Dept Surg Oncol, Grad Sch Med, Gifu, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O2-7-5	94	94				1	Oncology	Oncology	CW7ED	WOS:000365159900226		
J	Setoyama, T; Miyamoto, S; Horimatsu, T; Funakoshi, T; Nikaido, M; Kodama, Y; Minamiguchi, S; Yamabata, T; Muto, M; Chiba, T				Setoyama, Takashi; Miyamoto, Shin'ichi; Horimatsu, Takahiro; Funakoshi, Taro; Nikaido, Miutsuhiro; Kodama, Yuzo; Minamiguchi, Sachiko; Yamabata, Tomoko; Muto, Manabu; Chiba, Tsutomu			Bioactive insulin-like growth factors as a possible molecular target for non-islet cell tumor hypoglycemia	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Setoyama, Takashi; Miyamoto, Shin'ichi; Nikaido, Miutsuhiro; Kodama, Yuzo; Chiba, Tsutomu] Kyoto Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Kyoto 6068501, Japan; [Horimatsu, Takahiro; Funakoshi, Taro; Muto, Manabu] Kyoto Univ, Dept Therapeut Oncol, Grad Sch Med, Kyoto 6068501, Japan; [Minamiguchi, Sachiko] Kyoto Univ, Dept Diagnost Pathol, Grad Sch Med, Kyoto 6068501, Japan; [Yamabata, Tomoko] Kyoto Kizugawa Hosp, Dept Gastroenterol, Kizugawa, Kyoto, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O2-9-4	95	96				2	Oncology	Oncology	CW7ED	WOS:000365159900233		
J	Umemoto, K; Takahashi, H; Watanabe, K; Ohno, I; Shimizu, S; Mitsunaga, S; Shiba, S; Ueno, H; Okusaka, T; Ikeda, M				Umemoto, Kumiko; Takahashi, Hideaki; Watanabe, Kazuo; Ohno, Izumi; Shimizu, Satoshi; Mitsunaga, Shuichi; Shiba, Satoshi; Ueno, Hideki; Okusaka, Takuji; Ikeda, Masafumi			Modified FOLFIRINOX in pancreatic cancer patients with double variant type of UGT1A1 polymorphism	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Umemoto, Kumiko; Takahashi, Hideaki; Watanabe, Kazuo; Ohno, Izumi; Shimizu, Satoshi; Mitsunaga, Shuichi; Ikeda, Masafumi] Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Tokyo, Japan; [Shiba, Satoshi; Ueno, Hideki; Okusaka, Takuji] Natl Canc Ctr, Dept Hepatobiliary & Pancreat Oncol, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O2-9-2	95	95				1	Oncology	Oncology	CW7ED	WOS:000365159900232		
J	Ikesue, H; Watanabe, H; Hirano, M; Chikamori, A; Suetsugu, K; Ryokai, Y; Egashira, N; Koichi, T; Yoichi, N; Masuda, S				Ikesue, Hiroaki; Watanabe, Hiroyuki; Hirano, Megumi; Chikamori, Ayako; Suetsugu, Kimitaka; Ryokai, Yuriko; Egashira, Nobuaki; Koichi, Takayama; Yoichi, Nakanishi; Masuda, Satohiro			Risk factors for predicting severe neutropenia induced by pemetrexed plus carboplatin therapy in patients with NSCLC	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Ikesue, Hiroaki; Watanabe, Hiroyuki; Hirano, Megumi; Chikamori, Ayako; Suetsugu, Kimitaka; Ryokai, Yuriko; Egashira, Nobuaki; Masuda, Satohiro] Kyushu Univ Hosp, Dept Pharm, Fukuoka, Japan; [Koichi, Takayama; Yoichi, Nakanishi] Kyushu Univ, Res Inst Dis Chest, Grad Sch Med Sci, Fukuoka 812, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O2-10-4	96	96				1	Oncology	Oncology	CW7ED	WOS:000365159900236		
J	Ito, K; Okamoto, M; Ando, M; Ando, Y; Suzuki, E; Okamoto, A; Inaguma, Y; Hayashi, T; Yamada, S; Emi, N				Ito, Kaori; Okamoto, Masataka; Ando, Maiko; Ando, Yosuke; Suzuki, Eri; Okamoto, Akinao; Inaguma, Yoko; Hayashi, Takahiro; Yamada, Shigeki; Emi, Nobuhiko			Influence of rituximab(R) -fludarabine(F) and R-bendamustine(B) therapy on the immune system in relapsed lymphoma	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Ito, Kaori; Ando, Maiko; Ando, Yosuke; Suzuki, Eri; Hayashi, Takahiro; Yamada, Shigeki] Fujita Hlth Univ Hosp, Dept Pharm, Sapporo, Hokkaido, Japan; [Ito, Kaori; Okamoto, Masataka; Okamoto, Akinao; Inaguma, Yoko; Emi, Nobuhiko] Fujita Hlth Univ, Dept Hematol, Sch Med, Sapporo, Hokkaido, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O2-11-3	96	97				2	Oncology	Oncology	CW7ED	WOS:000365159900238		
J	Kataoka, Y; Hosokawa, S; Maehashi, N; Shinomiya, M; Masatoshi, S; Nikaido, J; Horiguchi, R; Hirano, K; Endo, K; Hirabayashi, M				Kataoka, Yuki; Hosokawa, Sawako; Maehashi, Nobuko; Shinomiya, Mariko; Masatoshi, Shimada; Nikaido, Junichi; Horiguchi, Reika; Hirano, Katsuya; Endo, Kazuo; Hirabayashi, Masataka			Predictive values of activity of daily livings score for the identification of worse performance status	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Kataoka, Yuki; Hosokawa, Sawako; Maehashi, Nobuko; Shinomiya, Mariko; Masatoshi, Shimada; Nikaido, Junichi; Horiguchi, Reika; Hirano, Katsuya; Endo, Kazuo; Hirabayashi, Masataka] Hyogo Kenritsu Amagasaki Hosp, Dept Resp Med, Amagasaki, Hyogo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O2-10-2	96	96				1	Oncology	Oncology	CW7ED	WOS:000365159900235		
J	Nishio, M; Takeda, Y; Azusa, M				Nishio, Mitsufumi; Takeda, Yukari; Azusa, Miyauchi			G-CSF after the first cycle of R-CHOP or mini R-CHOP similar to Who needs it as a primary prophylaxis?	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Nishio, Mitsufumi; Takeda, Yukari; Azusa, Miyauchi] NTT East Japan Sapporo Hosp, Dept Hematol & Oncol, Sapporo, Hokkaido, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O2-12-5	97	97				1	Oncology	Oncology	CW7ED	WOS:000365159900241		
J	Tokito, T; Azuma, K; Ishii, H; Yamada, K; Hoshino, T				Tokito, Takaaki; Azuma, Koichi; Ishii, Hidenobu; Yamada, Kazuhiko; Hoshino, Tomoaki			Retrospective analysis between PD-L1 expression and prognosis for stage III non-small cell lung cancer patients	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Tokito, Takaaki; Azuma, Koichi; Ishii, Hidenobu; Yamada, Kazuhiko; Hoshino, Tomoaki] Kurume Univ, Sch Med, Kurume, Fukuoka, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O3-1-3	97	97				1	Oncology	Oncology	CW7ED	WOS:000365159900242		
J	Waki, F; Shumpei, U; Tetsuya, F; Makoto, I; Yoichiro, I; Yasunori, K; Hiroaki, O				Waki, Fusako; Shumpei, Uchida; Tetsuya, Fukumoto; Makoto, Ide; Yoichiro, Izumi; Yasunori, Kawachi; Hiroaki, Ohnishi			Safety and efficacy of R-THP-COP for over 80 years elderly patients with diffuse large B-cell lymphoma	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Waki, Fusako; Shumpei, Uchida; Tetsuya, Fukumoto; Makoto, Ide; Yoichiro, Izumi; Yasunori, Kawachi; Hiroaki, Ohnishi] Takamatsu Red Cross Hosp, Dept Hematol, Takamatsu, Kagawa, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O2-12-3	97	97				1	Oncology	Oncology	CW7ED	WOS:000365159900240		
J	Yamaguchi, T; Kanemasa, Y; Sawada, T; Shimoyama, T; Sasaki, E; Omuro, Y; Hishima, T; Maeda, Y; Sasaki, T				Yamaguchi, Tsukasa; Kanemasa, Yusuke; Sawada, Takeshi; Shimoyama, Tatsu; Sasaki, Eisaku; Omuro, Yasushi; Hishima, Tsunekazu; Maeda, Yoshiharu; Sasaki, Tsuneo			Beta-2 microglobulin as a significant prognostic factor and a new risk model for diffuse large B-Cell lymphoma	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Yamaguchi, Tsukasa; Kanemasa, Yusuke; Sawada, Takeshi; Shimoyama, Tatsu; Sasaki, Eisaku; Omuro, Yasushi; Maeda, Yoshiharu; Sasaki, Tsuneo] Tokyo Metropolitan Canc & Infect Dis Ctr Komagome, Dept Chemotherapy, Tokyo, Japan; [Hishima, Tsunekazu] Tokyo Metropolitan Canc & Infect Dis Ctr Komagome, Dept Pathol, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O2-11-4	97	97				1	Oncology	Oncology	CW7ED	WOS:000365159900239		
J	Murakami, H; Yamamoto, N; Kenmotsu, H; Takahashi, T; Fujiwara, Y; Mizugaki, H; Ishida, Y; Kawakami, T				Murakami, Haruyasu; Yamamoto, Noboru; Kenmotsu, Hirotsugu; Takahashi, Toshiaki; Fujiwara, Yutaka; Mizugaki, Hidenori; Ishida, Yoshimasa; Kawakami, Tomohisa			Phase I study of anti-PD-L1 antibody MPDL3280A in patients with advanced solid tumors	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Murakami, Haruyasu; Kenmotsu, Hirotsugu; Takahashi, Toshiaki] Shizuoka Canc Ctr, Div Thorac Oncol, Nagaizumi, Shizuoka, Japan; [Yamamoto, Noboru; Fujiwara, Yutaka; Mizugaki, Hidenori] Natl Canc Ctr, Dept Expt Therapeut, Exploratory Oncol Res & Clin Trial Ctr, Tokyo, Japan; [Mizugaki, Hidenori] Hokkaido Univ, Dept Med 1, Sch Med, Sapporo, Hokkaido 060, Japan; [Ishida, Yoshimasa; Kawakami, Tomohisa] Chugai Pharmaceut Co LTD, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O3-1-5	98	98				1	Oncology	Oncology	CW7ED	WOS:000365159900243		
J	Sekine, I; Sumi, M; Satouchi, M; Tsujino, K; Nishio, M; Kozuka, T; Niho, S; Nihei, K; Yamamoto, N; Harada, H; Ishikura, S; Tamura, T				Sekine, Ikuo; Sumi, Minako; Satouchi, Miyako; Tsujino, Kayoko; Nishio, Makoto; Kozuka, Takuhiro; Niho, Seiji; Nihei, Keiji; Yamamoto, Nobuyuki; Harada, Hideyuki; Ishikura, Satoshi; Tamura, Tomohide			Long-term results of chemoradiotherapy followed by amrubicin and cisplatin for limited-disease small cell lung cancer	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Sekine, Ikuo] Chiba Canc Ctr, Div Resp Med, Chiba, Japan; [Sumi, Minako] Natl Canc Ctr, Div Radiat Oncol, Tokyo, Japan; [Satouchi, Miyako] Hyogo Canc Ctr, Dept Thorac Oncol, Akashi, Hyogo, Japan; [Tsujino, Kayoko] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Radiat Oncol, Tokyo, Japan; [Nishio, Makoto] Japanese Fdn Canc Res, Canc Inst Hosp, Thorac Oncol Ctr, Tokyo, Japan; [Kozuka, Takuhiro] Japanese Fdn Canc Res, Canc Inst Hosp, Radiat Oncol, Tokyo, Japan; [Niho, Seiji] Natl Canc Ctr Hosp East, Div Thorac Oncol, Tokyo, Japan; [Nihei, Keiji] Natl Canc Ctr Hosp East, Div Radiat Oncol, Tokyo, Japan; [Yamamoto, Nobuyuki] Shizuoka Canc Ctr Hosp, Thorac Oncol Div, Nagaizumi, Shizuoka, Japan; [Harada, Hideyuki] Shizuoka Canc Ctr Hosp, Radiotherapy Div, Nagaizumi, Shizuoka, Japan; [Ishikura, Satoshi] Koshigaya Municipal Hosp, Dept Radiol, Koshigayashi, Saitama, Japan; [Tamura, Tomohide] Natl Canc Ctr, Div Internal Med & Thorac Oncol, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O3-2-1	98	98				1	Oncology	Oncology	CW7ED	WOS:000365159900244		
J	Sudo, J; Fukuizumi, A; Yamane, Y; Kurimoto, F; Sakai, H				Sudo, Junko; Fukuizumi, Aya; Yamane, Yuki; Kurimoto, Futoshi; Sakai, Hiroshi			Hematologic toxicity of amrubicin monotherapy in recurrent small-cell lung cancer	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Sudo, Junko; Fukuizumi, Aya; Yamane, Yuki; Kurimoto, Futoshi; Sakai, Hiroshi] Saitama Canc Ctr, Div Thorac Oncol, Saitama, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O3-2-4	98	98				1	Oncology	Oncology	CW7ED	WOS:000365159900245		
J	Yoshino, R; Tomizawa, Y; Takei, K; Tomizawa, M; Yoshii, A; Kawashima, O; Watanabe, S; Hisada, T; Saitou, R; Yamada, M				Yoshino, Reiko; Tomizawa, Yoshio; Takei, Kousuke; Tomizawa, Mai; Yoshii, Akihiro; Kawashima, Osamu; Watanabe, Satoru; Hisada, Takeshi; Saitou, Ryusei; Yamada, Masanobu			A phase II study of gemcitabine plus carboplatin as adjuvant chemotherapy in patients with resected NSCLC	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Yoshino, Reiko; Tomizawa, Yoshio; Takei, Kousuke; Tomizawa, Mai; Yoshii, Akihiro; Watanabe, Satoru; Saitou, Ryusei] Natl Hosp Org Nishigunma Hosp, Dept Resp Med, Shibukawa, Gunma, Japan; [Hisada, Takeshi; Yamada, Masanobu] Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, Maebashi, Gunma 371, Japan; [Kawashima, Osamu] Natl Hosp Org Nishigunma Hosp, Dept Resp Surg, Shibukawa, Gunma, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O3-3-2	98	98				1	Oncology	Oncology	CW7ED	WOS:000365159900246		
J	Arita, S; Shirakawa, T; Matsushita, Y; Kumagai, H; Hirano, G; Makiyama, A; Shibata, Y; Tamura, S; Kusaba, H; Baba, E				Arita, Shuji; Shirakawa, Tsuyoshi; Matsushita, Yuzo; Kumagai, Hozumi; Hirano, Gen; Makiyama, Akitaka; Shibata, Yoshihiro; Tamura, Shingo; Kusaba, Hitoshi; Baba, Eishi			Trifluridine-tipiracil for multidrug-resistant advanced colorectal cancer: A multicenter retrospective study	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Arita, Shuji; Baba, Eishi] Kyushu Univ, Dept Comprehens Clin Oncol, Fac Med, Fukuoka 812, Japan; [Arita, Shuji; Kumagai, Hozumi; Kusaba, Hitoshi] Kyushu Univ Hosp, Dept Hematol & Med Oncol, Fukuoka, Japan; [Shirakawa, Tsuyoshi] Natl Hosp Org Kyushu Canc Ctr, Dept Gastrointestinal & Med Oncol, Fukuoka, Japan; [Matsushita, Yuzo] Hamanomachi Hosp, Dept Med Oncol, Fukuoka, Japan; [Hirano, Gen; Makiyama, Akitaka] Japan Community Hlth Care Org Kyushu Hosp, Dept Hematol Oncol, Fukuoka, Japan; [Shibata, Yoshihiro] Miyazaki Prefectural Miyazaki Hosp, Dept Chemotherapy, Miyazaki, Japan; [Tamura, Shingo] Kyushu Univ, Dept Internal Med, Beppu Hosp, Fukuoka 812, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O3-6-1	99	100				2	Oncology	Oncology	CW7ED	WOS:000365159900250		
J	Mitsuya, K; Hayashi, N; Hamauchi, S; Tsushima, T; Machida, N; Yamazaki, K; Yasui, H; Harada, H; Nishimura, T; Nakasu, Y				Mitsuya, Koichi; Hayashi, Nakamasa; Hamauchi, Satoshi; Tsushima, Takahiro; Machida, Nozomu; Yamazaki, Kentaro; Yasui, Hirofumi; Harada, Hideyuki; Nishimura, Tetsuo; Nakasu, Yoko			Multidisciplinary treatment in patients with leptomeningeal metastasis from gastric cancer	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Mitsuya, Koichi; Hayashi, Nakamasa; Nakasu, Yoko] Shizuoka Canc Ctr, Div Neurosurg, Nagaizumi, Shizuoka, Japan; [Hamauchi, Satoshi; Tsushima, Takahiro; Machida, Nozomu; Yamazaki, Kentaro; Yasui, Hirofumi] Shizuoka Canc Ctr, Div GI Oncol, Nagaizumi, Shizuoka, Japan; [Harada, Hideyuki; Nishimura, Tetsuo] Shizuoka Canc Ctr, Div Radiat Oncol, Nagaizumi, Shizuoka, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O3-4-4	99	99				1	Oncology	Oncology	CW7ED	WOS:000365159900248		
J	Niibe, Y; Yamashita, H; Yamamoto, T; Katsui, K; Nakagawa, K; Kanazawa, S; Kawamori, J; Takahashi, W; Terahara, A; Jingu, K				Niibe, Yuzuru; Yamashita, Hideomi; Yamamoto, Takaya; Katsui, Kuniaki; Nakagawa, Keiichi; Kanazawa, Susumu; Kawamori, Jiro; Takahashi, Wataru; Terahara, Atsuro; Jingu, Keiichi			Stereotactic body radiotherapy for pulmonary oligometastases with emphasis on the difference in oligometastatic state	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Niibe, Yuzuru; Terahara, Atsuro] Toho Univ, Omori Med Ctr, Dept Radiol, Tokyo, Japan; [Yamashita, Hideomi; Nakagawa, Keiichi; Takahashi, Wataru; Terahara, Atsuro] Tokyo Univ Hosp, Dept Radiol, Tokyo, Japan; [Yamamoto, Takaya; Jingu, Keiichi] Tohoku Univ, Dept Radiat Oncol, Sendai, Miyagi 980, Japan; [Katsui, Kuniaki; Kanazawa, Susumu] Okayama Univ, Dept Radiol, Okayama 7008530, Japan; [Kawamori, Jiro] St Lukes Int Hosp, Div Radiat Oncol, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O3-3-4	99	99				1	Oncology	Oncology	CW7ED	WOS:000365159900247		
J	Uneno, Y; Taneishi, K; Kanai, M; Tamon, A; Okamoto, K; Nishikawa, Y; Brown, JB; Matsumoto, S; Okuno, Y; Muto, M				Uneno, Yu; Taneishi, Kei; Kanai, Masashi; Tamon, Akiko; Okamoto, Kazuya; Nishikawa, Yoshitaka; Brown, J. B.; Matsumoto, Shigemi; Okuno, Yasushi; Muto, Manabu			Establishment of a terminal prognosis prediction model by applying time series analysis to real-world data	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Uneno, Yu; Kanai, Masashi; Nishikawa, Yoshitaka; Matsumoto, Shigemi; Muto, Manabu] Kyoto Univ Hosp, Dept Clin Oncol, Kyoto, Japan; [Taneishi, Kei; Tamon, Akiko; Okuno, Yasushi] RIKEN, Adv Inst Computat Sci, Wako, Saitama, Japan; [Okamoto, Kazuya] Kyoto Univ, Div Med Informat, Dept Social Informat, Grad Sch Informat, Kyoto 6068501, Japan; [Brown, J. B.; Okuno, Yasushi] Kyoto Univ, Dept Clin Syst Oncoinformat, Grad Sch Med, Kyoto 6068501, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O3-5-4	99	99				1	Oncology	Oncology	CW7ED	WOS:000365159900249		
J	Doi, A; Shitara, K; Fukuoka, S; Kuboki, Y; Bando, H; Okamoto, W; Kojima, T; Doi, T; Ohtsu, A; Yoshino, T				Doi, Ayako; Shitara, Kohei; Fukuoka, Shota; Kuboki, Yasutoshi; Bando, Hideaki; Okamoto, Wataru; Kojima, Takashi; Doi, Toshihiko; Ohtsu, Atsushi; Yoshino, Takayuki			Gastrointestinal perforation and fistula formation in colorectal cancer patients during regorafenib treatment	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Doi, Ayako; Shitara, Kohei; Fukuoka, Shota; Kuboki, Yasutoshi; Bando, Hideaki; Okamoto, Wataru; Kojima, Takashi; Doi, Toshihiko; Ohtsu, Atsushi; Yoshino, Takayuki] Natl Canc Ctr East Hosp, Dept Gastrointestinal Oncol, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O3-6-6	100	100				1	Oncology	Oncology	CW7ED	WOS:000365159900253		
J	Sugimoto, N; Yoshinami, T; Yamamoto, S; Yagi, T; Imamura, F				Sugimoto, Naotoshi; Yoshinami, Tetsuhiro; Yamamoto, Sachiko; Yagi, Toshinari; Imamura, Fumio			Both regorafenib and TAS-102 give metastatic colorectal cancer patients survival benefit with different toxicity profile	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Sugimoto, Naotoshi; Yoshinami, Tetsuhiro; Yamamoto, Sachiko; Yagi, Toshinari; Imamura, Fumio] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Clin Oncol, Osaka, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O3-6-5	100	100				1	Oncology	Oncology	CW7ED	WOS:000365159900252		
J	Sugita, K; Kawakami, K; Yokokawa, T; Sugisaki, T; Takiguchi, T; Suenaga, M; Mizunuma, N; Yamaguchi, T; Hama, T				Sugita, Kazuo; Kawakami, Kazuyoshi; Yokokawa, Takashi; Sugisaki, Takahito; Takiguchi, Tomomi; Suenaga, Mitsukuni; Mizunuma, Nobuyuki; Yamaguchi, Toshiharu; Hama, Toshihiro			Self-reported adherence with TAS-102	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Sugita, Kazuo; Kawakami, Kazuyoshi; Yokokawa, Takashi; Sugisaki, Takahito; Takiguchi, Tomomi; Hama, Toshihiro] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Pharm, Tokyo, Japan; [Suenaga, Mitsukuni; Mizunuma, Nobuyuki; Yamaguchi, Toshiharu] Japanese Fdn Canc Res, Canc Inst Hosp, Gastroenterol Ctr, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O3-6-3	100	100				1	Oncology	Oncology	CW7ED	WOS:000365159900251		
J	Tanioka, H; Tsuji, A; Emi, Y; Mototsugu, S; Miyamoto, Y; Oki, E; Akagi, Y; Baba, H; Ogata, Y; Maehara, Y				Tanioka, Hiroaki; Tsuji, Akihito; Emi, Yasunori; Mototsugu, Shimokawa; Miyamoto, Yuji; Oki, Eiji; Akagi, Yoshito; Baba, Hideo; Ogata, Yutaka; Maehara, Yoshihiko			A prospective study of S-1+Irinotecan plus bevacizumab as second-line therapy in metastatic colorectal cancer (KSCC1102)	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Tanioka, Hiroaki] Okayama Rousai Hosp, Dept Med Oncol, Okayama, Japan; [Tsuji, Akihito] Kobe City Med Ctr Gen Hosp, Dept Med Oncol, Kobe, Hyogo, Japan; [Emi, Yasunori] Saiseikai Fukuoka Gen Hosp, Dept Surg, Fukuoka, Japan; [Mototsugu, Shimokawa] Kyushu Natl Canc Ctr, Dept Clin Res, Fukuoka, Japan; [Miyamoto, Yuji; Baba, Hideo] Kumamoto Univ, Grad Sch Med Sci, Dept Gastroenterol Surg, Kumamoto 860, Japan; [Oki, Eiji; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan; [Akagi, Yoshito] Kurume Univ, Sch Med, Dept Surg, Kurume, Fukuoka, Japan; [Ogata, Yutaka] Kurume Univ, Med Ctr, Dept Surg, Kurume, Fukuoka, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O3-7-3	100	100				1	Oncology	Oncology	CW7ED	WOS:000365159900254		
J	Makihara, R; Hashimoto, H; Watanabe, N; Sato, Y; Hatano, S; Ueno, H; Yamada, Y; Okusaka, T; Makino, Y; Hayashi, Y				Makihara, Reiko; Hashimoto, Hironobu; Watanabe, Noriko; Sato, Yoko; Hatano, Sayuri; Ueno, Hideki; Yamada, Yasuhide; Okusaka, Takushi; Makino, Yoshinori; Hayashi, Yoshikazu			A new management model of oral outpatient chemotherapy featured by concerted interventions by physicians and pharmacists	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Makihara, Reiko; Hashimoto, Hironobu; Makino, Yoshinori; Hayashi, Yoshikazu] Natl Canc Ctr, Dept Pharm, Tokyo, Japan; [Watanabe, Noriko] NIHON CHOUZAI Co Ltd, Tokyo, Japan; [Sato, Yoko] Tanabe Pharm Co Ltd, Tokyo, Japan; [Ueno, Hideki; Okusaka, Takushi] Natl Canc Ctr, Hepatobiliary & Pancreat Oncol Div, Tokyo, Japan; [Yamada, Yasuhide] Natl Canc Ctr, Gastrointestinal Med Oncol Div, Tokyo, Japan; [Makino, Yoshinori] Natl Canc Ctr, Med Support & Partnership Div, Ctr Canc Control & Informat Serv, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O3-10-2	101	101				1	Oncology	Oncology	CW7ED	WOS:000365159900257		
J	Murahashi, M; Matsumoto, T; Hamana, H; Katsuya, H; Ikari, Y; Ishitsuka, K; Hara, S; Kishi, H; Takamatsu, Y; Tamura, K				Murahashi, Mutsunori; Matsumoto, Taichi; Hamana, Hiroshi; Katsuya, Hiroo; Ikari, Yosuke; Ishitsuka, Kenji; Hara, Shujji; Kishi, Hiroyuki; Takamatsu, Yasushi; Tamura, Kazuo			Characterization of tumor-infiltrating CD8+T lymphocytes in malignant lymphoma	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Murahashi, Mutsunori; Katsuya, Hiroo; Ikari, Yosuke; Ishitsuka, Kenji; Takamatsu, Yasushi; Tamura, Kazuo] Kyushu Univ Hosp, Dept Adv Cell & Mol Therapy, Fukuoka, Japan; [Matsumoto, Taichi; Hara, Shujji] Fukuoka Univ, Dept Pharmacol, Div Med Informat, Fukuoka, Japan; [Hamana, Hiroshi; Kishi, Hiroyuki] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Immunol, Toyama, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O3-9-2	101	101				1	Oncology	Oncology	CW7ED	WOS:000365159900255		
J	Aihara, S; Hashiguchi, M; Okuma, E; Nishiyama, S; Nakao, Y; Yokoyama, M				Aihara, Satomi; Hashiguchi, Mariko; Okuma, Emi; Nishiyama, Satoshi; Nakao, Yoshifumi; Yokoyama, Masatoshi			Associations between early end of life discussion and care received near death in advanced ovarian cancer patiens	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Aihara, Satomi; Hashiguchi, Mariko; Okuma, Emi; Nishiyama, Satoshi; Nakao, Yoshifumi; Yokoyama, Masatoshi] Saga Univ, Fac Med, Dept Obstet & Gynecol, Saga, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O3-12-6	102	102				1	Oncology	Oncology	CW7ED	WOS:000365159900261		
J	Kitamura, H; Inoue, R; Shindo, T; Nishiyama, N; Masumori, N				Kitamura, Hiroshi; Inoue, Ryuta; Shindo, Tetsuya; Nishiyama, Naotaka; Masumori, Naoya			Dosing schedules and outcomes in patients with first-line sunitinib for advanced renal cell carcinoma	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Kitamura, Hiroshi; Inoue, Ryuta; Shindo, Tetsuya; Nishiyama, Naotaka; Masumori, Naoya] Sapporo Med Univ, Sch Med, Dept Urol, Sapporo, Hokkaido, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O3-11-2	102	102				1	Oncology	Oncology	CW7ED	WOS:000365159900259		
J	Nakano, M; Ariyama, H; Tamura, S; Isobe, T; Miyawaki, K; Okumura, Y; Kusaba, H; Ueki, T; Baba, E; Akashi, K				Nakano, Michitaka; Ariyama, Hiroshi; Tamura, Shingo; Isobe, Taichi; Miyawaki, Kohta; Okumura, Yuta; Kusaba, Hitoshi; Ueki, Takashi; Baba, Eishi; Akashi, Koichi			Epithelial to mesenchymal transition by TGF-beta induced cancer stem-like properties in primary colorectal cancer	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Nakano, Michitaka; Ariyama, Hiroshi; Tamura, Shingo; Miyawaki, Kohta; Okumura, Yuta; Kusaba, Hitoshi; Baba, Eishi; Akashi, Koichi] Kyushu Univ, Dept Med & Biosyst Sci, Fukuoka 812, Japan; [Ueki, Takashi] Kyushu Univ, Dept Surg & Oncol, Fukuoka 812, Japan; [Isobe, Taichi] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O3-13-3	102	103				2	Oncology	Oncology	CW7ED	WOS:000365159900263		
J	Takano, A; Nakamura, Y; Daigo, Y				Takano, Atsushi; Nakamura, Yusuke; Daigo, Yataro			Characterization of LASEP1 as a new serological and prognostic biomarker and a therapeutic target for lung cancer	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Takano, Atsushi; Daigo, Yataro] Univ Tokyo, Inst Med Sci, Ctr Antibody & Vaccine Therapy, Res Hosp, Tokyo 1138654, Japan; [Daigo, Yataro] Shiga Univ Med Sci, Dept Med Oncol, Shiga, Japan; [Daigo, Yataro] Shiga Univ Med Sci, Ctr Canc, Shiga, Japan; [Nakamura, Yusuke] Univ Chicago, Dept Med & Surg, Chicago, IL 60637 USA								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O3-13-1	102	102				1	Oncology	Oncology	CW7ED	WOS:000365159900262		
J	Horiguchi, K; Goto, R; Idera, N; Honda, Y; Miyamoto, H; Aruga, T; Yamashita, T; Kuroi, K				Horiguchi, Kazumi; Goto, Risa; Idera, Nami; Honda, Yayoi; Miyamoto, Hiromi; Aruga, Tomoyuki; Yamashita, Toshinari; Kuroi, Katsumasa			Management of bone metastasis in the patients achieved 10-year survival with recurrence from breast cancer	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Horiguchi, Kazumi; Goto, Risa; Idera, Nami; Honda, Yayoi; Miyamoto, Hiromi; Aruga, Tomoyuki; Yamashita, Toshinari; Kuroi, Katsumasa] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O3-14-5	103	103				1	Oncology	Oncology	CW7ED	WOS:000365159900266		
J	Ito, T; Ono, M; Oba, T; Hanamura, T; Kanai, T; Maeno, K; Hiraguri, M; Shingu, K; Kaneko, G; Ito, K				Ito, Tokiko; Ono, Mayu; Oba, Takaaki; Hanamura, Toru; Kanai, Toshiharu; Maeno, Kazuma; Hiraguri, Manabu; Shingu, Kiyoshi; Kaneko, Gengo; Ito, Ken-ichi			Impairment of renal function in the breast cancer patients with bone metastases treated with zoledronic acid	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Ito, Tokiko; Ono, Mayu; Oba, Takaaki; Hanamura, Toru; Kanai, Toshiharu; Maeno, Kazuma; Ito, Ken-ichi] Shinshu Univ, Sch Med, Div Breast & Endocrine Surg, Matsumoto, Nagano, Japan; [Shingu, Kiyoshi] Iida Municipal Hosp, Div Breast & Endocrine Surg, Nagano, Japan; [Hiraguri, Manabu; Kaneko, Gengo] Iida Municipal Hosp, Div Surg, Nagano, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O3-14-3	103	103				1	Oncology	Oncology	CW7ED	WOS:000365159900265		
J	Narita, Y; Kadowaki, S; Oze, I; Taniguchi, H; Ura, T; Ando, M; Ito, S; Yatabe, Y; Niwa, Y; Muro, K				Narita, Yukiya; Kadowaki, Shigenori; Oze, Isao; Taniguchi, Hiroya; Ura, Takashi; Ando, Masashi; Ito, Seiji; Yatabe, Yasushi; Niwa, Yasumasa; Muro, Kei			Development of nomograms for predicting survival in advanced gastric cancer	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Narita, Yukiya; Kadowaki, Shigenori; Taniguchi, Hiroya; Ura, Takashi; Ando, Masashi; Muro, Kei] Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi, Japan; [Oze, Isao] Aichi Canc Ctr, Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi, Japan; [Ito, Seiji] Aichi Canc Ctr Hosp, Dept Gastroenterol Surg, Nagoya, Aichi, Japan; [Yatabe, Yasushi] Aichi Canc Ctr Hosp, Dept Pathol & Mol Diagnost, Nagoya, Aichi, Japan; [Niwa, Yasumasa] Aichi Canc Ctr Hosp, Dept Endoscopy, Nagoya, Aichi, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O3-15-4	103	104				2	Oncology	Oncology	CW7ED	WOS:000365159900267		
J	Kawai, A; Araki, N; Sugiura, H; Ueda, T; Yonemoto, T; Takahashi, M; Morioka, H; Hiraga, H; Hiruma, T; Takahashi, S				Kawai, Akira; Araki, Nobuhito; Sugiura, Hideshi; Ueda, Takafumi; Yonemoto, Tsukasa; Takahashi, Mitsuru; Morioka, Hideo; Hiraga, Hiroaki; Hiruma, Toru; Takahashi, Shunji			Treatment results of trabectedin (T) in patients (pts) with myxoid-round cell liposarcoma (MRCL)	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Kawai, Akira] Natl Canc Ctr, Div Musculoskeletal Oncol, Tokyo, Japan; [Araki, Nobuhito] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Orthopaed Surg, Osaka, Japan; [Sugiura, Hideshi] Aichi Canc Ctr Hosp, Dept Orthopaed Surg, Nagoya, Aichi, Japan; [Ueda, Takafumi] Osaka Natl Hosp, Dept Orthopaed Surg, Osaka, Japan; [Yonemoto, Tsukasa] Chiba Canc Ctr, Div Orthopaed Surg, Chiba, Japan; [Takahashi, Mitsuru] Shizuoka Canc Ctr Hosp, Div Orthopaed Surg, Shizuoka, Japan; [Morioka, Hideo] Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo 108, Japan; [Hiraga, Hiroaki] Hokkaido Canc Ctr, Dept Orthopaed Surg, Sapporo, Hokkaido, Japan; [Hiruma, Toru] Kanagawa Canc Ctr, Dept Musculoskeletal Tumor Surg, Yokohama, Kanagawa, Japan; [Takahashi, Shunji] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Med Oncol, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O3-16-1	104	104				1	Oncology	Oncology	CW7ED	WOS:000365159900270		
J	Kimbara, S; Sasada, S; Hashimoto, J; Kodaira, M; Yamamoto, H; Yunokawa, M; Yonemori, K; Shimizu, C; Fujiwara, Y; Tamura, K				Kimbara, Shiro; Sasada, Shinsuke; Hashimoto, Jun; Kodaira, Makoto; Yamamoto, Harukaze; Yunokawa, Mayu; Yonemori, Kan; Shimizu, Chikako; Fujiwara, Yasuhiro; Tamura, Kenji			The relationship between time to treatment, disease stage and prognosis in head and neck rhabdomyosarcoma in adults	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Kimbara, Shiro; Sasada, Shinsuke; Hashimoto, Jun; Kodaira, Makoto; Yamamoto, Harukaze; Yunokawa, Mayu; Yonemori, Kan; Shimizu, Chikako; Fujiwara, Yasuhiro; Tamura, Kenji] Natl Canc Ctr, Breast & Med Oncol, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O3-16-2	104	105				2	Oncology	Oncology	CW7ED	WOS:000365159900271		
J	Matsumoto, T; Nishina, T; Nakasya, A; Kajiwara, T; Hino, K; Asagi, A; Hori, S; Nadano, S; Yamashita, N; Iguchi, H				Matsumoto, Toshihiko; Nishina, Tomohiro; Nakasya, Akio; Kajiwara, Takeshi; Hino, Kaori; Asagi, Akinori; Hori, Shinichiro; Nadano, Seijin; Yamashita, Natsumi; Iguchi, Haruo			Prognostic factors in elderly patients with advanced gastric cancer	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Matsumoto, Toshihiko; Nishina, Tomohiro; Nakasya, Akio; Kajiwara, Takeshi; Hino, Kaori; Asagi, Akinori; Hori, Shinichiro; Nadano, Seijin; Iguchi, Haruo] Natl Hosp Org, Shikoku Canc Ctr, Dept Gastroenterol, Matsuyama, Ehime, Japan; [Yamashita, Natsumi; Iguchi, Haruo] Natl Hosp Org, Shikoku Canc Ctr, Clin Res Inst, Matsuyama, Ehime, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O3-15-6	104	104				1	Oncology	Oncology	CW7ED	WOS:000365159900269		
J	Sugimoto, N; Yoshinami, T; Yamamoto, S; Yagi, T; Imamura, F				Sugimoto, Naotoshi; Yoshinami, Tetsuhiro; Yamamoto, Sachiko; Yagi, Toshinari; Imamura, Fumio			What is the best fluoropyrimidine plus platinum for advanced gastric cancer (AGC) ? -the inspect of early tumor shrinkage-	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Sugimoto, Naotoshi; Yoshinami, Tetsuhiro; Yamamoto, Sachiko; Yagi, Toshinari; Imamura, Fumio] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Clin Oncol, Osaka, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O3-15-5	104	104				1	Oncology	Oncology	CW7ED	WOS:000365159900268		
J	Nagatani, Y; Shitara, K; Bando, H; Okamoto, W; Kojima, T; Yoshino, T; Nishida, T; Doi, T				Nagatani, Yoshiaki; Shitara, Kohei; Bando, Hideaki; Okamoto, Wataru; Kojima, Takashi; Yoshino, Takayuki; Nishida, Toshirou; Doi, Toshihiko			Clinical outcomes in 21 patients with gastrointestinal stromal tumor(GIST)treated in phase I trials: the NCCHE Experience	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Nagatani, Yoshiaki; Shitara, Kohei; Bando, Hideaki; Okamoto, Wataru; Kojima, Takashi; Yoshino, Takayuki; Doi, Toshihiko] Natl Canc Ctr Hosp East, Dept GI Oncol, Tokyo, Japan; [Nishida, Toshirou] Natl Canc Ctr Hosp East, Dept Surg, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O3-16-6	105	105				1	Oncology	Oncology	CW7ED	WOS:000365159900273		
J	Sasada, S; Kodaira, M; Hashimoto, J; Yamamoto, H; Yunokawa, M; Yonemori, K; Shimizu, C; Fujiwara, Y; Tamura, K				Sasada, Shinsuke; Kodaira, Makoto; Hashimoto, Jun; Yamamoto, Harukaze; Yunokawa, Mayu; Yonemori, Kan; Shimizu, Chikako; Fujiwara, Yasuhiro; Tamura, Kenji			Peripheral neuropathy of VAC therapy for adult rhabdomyosarcoma	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Sasada, Shinsuke; Kodaira, Makoto; Hashimoto, Jun; Yamamoto, Harukaze; Yunokawa, Mayu; Yonemori, Kan; Shimizu, Chikako; Fujiwara, Yasuhiro; Tamura, Kenji] Natl Canc Ctr, Breast & Med Oncol Dept, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		O3-16-3	105	105				1	Oncology	Oncology	CW7ED	WOS:000365159900272		
J	Abe, Y; Tanio, Y; Takashima, J; Ogawa, K; Akazawa, Y; Ueno, K; Funakoshi, Y; Oomori, K; Shimamoto, S; Fushimi, H				Abe, Yuko; Tanio, Yoshiro; Takashima, Junpei; Ogawa, Koichi; Akazawa, Yuki; Ueno, Kiyonobu; Funakoshi, Yasunobu; Oomori, Kenichi; Shimamoto, Shigetoshi; Fushimi, Hiroaki			Seventy-four lung cancer patients under 50 years old	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Abe, Yuko; Tanio, Yoshiro; Takashima, Junpei; Ogawa, Koichi; Akazawa, Yuki; Ueno, Kiyonobu] Osaka Gen Med Ctr, Dept Resp Med, Osaka, Japan; [Funakoshi, Yasunobu; Oomori, Kenichi] Osaka Gen Med Ctr, Dept Resp Surg, Osaka, Japan; [Shimamoto, Shigetoshi] Osaka Gen Med Ctr, Dept Radiat Oncol, Osaka, Japan; [Fushimi, Hiroaki] Osaka Gen Med Ctr, Dept Pathol, Osaka, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		P1-1-6	106	106				1	Oncology	Oncology	CW7ED	WOS:000365159900275		
J	Nosaki, K; Inamasu, E; Shimamatsu, S; Yoshida, T; Toyokawa, G; Hirai, F; Yamaguchi, M; Seto, T; Takenoyama, M; Ichinose, Y				Nosaki, Kaname; Inamasu, Eiko; Shimamatsu, Shin-ichiro; Yoshida, Tsukihisa; Toyokawa, Goji; Hirai, Fumihiko; Yamaguchi, Masafumi; Seto, Takashi; Takenoyama, Mitsuhiro; Ichinose, Yukito			Systemic chemotherapy for pulmonary pleomorphic carcinoma	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Nosaki, Kaname; Inamasu, Eiko; Shimamatsu, Shin-ichiro; Yoshida, Tsukihisa; Toyokawa, Goji; Hirai, Fumihiko; Yamaguchi, Masafumi; Seto, Takashi; Takenoyama, Mitsuhiro; Ichinose, Yukito] Kyushu Natl Canc Ctr, Dept Thorac Oncol, Fukuoka, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		P1-1-20	106	106				1	Oncology	Oncology	CW7ED	WOS:000365159900276		
J	Ohhara, Y; Isobe, H; Sato, T; Ito, K; Fuke, S; Kojima, T; Saito, H; Nishiura, Y				Ohhara, Yoshihito; Isobe, Hiroshi; Sato, Toshitaka; Ito, Kenichiro; Fuke, Satoshi; Kojima, Tetsuya; Saito, Hiroshi; Nishiura, Yoichi			Prognosis of non-small cell lung cancer patients with brain metastasis	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Ohhara, Yoshihito] Hokkaido Univ, Grad Sch Med, Dept Med Oncol, Sapporo, Hokkaido 060, Japan; [Ohhara, Yoshihito; Isobe, Hiroshi] KKR Sapporo Med Ctr, Dept Med Oncol, Sapporo, Hokkaido, Japan; [Sato, Toshitaka; Ito, Kenichiro; Fuke, Satoshi; Kojima, Tetsuya; Saito, Hiroshi; Nishiura, Yoichi] KKR Sapporo Med Ctr, Dept Resp Med, Sapporo, Hokkaido, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		P1-1-4	106	106				1	Oncology	Oncology	CW7ED	WOS:000365159900274		
J	Hosokawa, S; Kataoka, Y; Maehashi, N; Shinomiya, M; Tomoyasu, T; Hirano, K; Endo, K; Hirabayashi, M; Nakajima, N; Takasu, K				Hosokawa, Sawako; Kataoka, Yuki; Maehashi, Nobuko; Shinomiya, Mariko; Tomoyasu, Takemura; Hirano, Katsuya; Endo, Kazuo; Hirabayashi, Masataka; Nakajima, Naoki; Takasu, Kosyo			How to obtain the raw sample of non-small cell lung cancer for mutation screening in a tertialy hospital	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Hosokawa, Sawako; Kataoka, Yuki; Maehashi, Nobuko; Shinomiya, Mariko; Tomoyasu, Takemura; Hirano, Katsuya; Endo, Kazuo; Hirabayashi, Masataka] Hyogo Kenritsu Amagasaki Hosp, Resp Med, Amagasaki, Hyogo, Japan; [Nakajima, Naoki; Takasu, Kosyo] Hyogo Kenritsu Amagasaki Hosp, Dept Pathol, Amagasaki, Hyogo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		P1-1-72	107	107				1	Oncology	Oncology	CW7ED	WOS:000365159900281		
J	Okamoto, K; Mutsuo, S; Tanaka, T; Fumita, S; Shintani, R; Kiyokawa, H; Kato, G; Hayashi, H				Okamoto, Kunio; Mutsuo, Satoru; Tanaka, Tae; Fumita, Souichi; Shintani, Ryota; Kiyokawa, Hirofumi; Kato, Genichi; Hayashi, Hidetoshi			Safety and yield of real time ultrasound-assisted cutting needle biopsy performed by medical oncologist	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Okamoto, Kunio; Tanaka, Tae; Fumita, Souichi; Hayashi, Hidetoshi] Kishiwada Municipal Hosp, Dept Med Oncol, Kishiwada, Japan; [Mutsuo, Satoru] Kishiwada Municipal Hosp, Cent Clin Lab, Kishiwada, Japan; [Shintani, Ryota; Kiyokawa, Hirofumi; Kato, Genichi] Kishiwada Municipal Hosp, Dept Resp, Kishiwada, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		P1-1-73	107	108				2	Oncology	Oncology	CW7ED	WOS:000365159900282		
J	Shibata, K; Ogawa, K; Kotani, H; Takase, M; Takahashi, M; Yuki, F				Shibata, Kazuhiko; Ogawa, Kohei; Kotani, Hiroshi; Takase, Misae; Takahashi, Miyuki; Yuki, Fujii			Definitive thoraco-systemic therapy plus brain local therapy for ED-SCLC with metastasis only to the brain	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Shibata, Kazuhiko] Koseiren Takaoka Hosp, Dept Med Oncol, Takaoka, Toyama, Japan; [Ogawa, Kohei; Kotani, Hiroshi; Takase, Misae; Takahashi, Miyuki; Yuki, Fujii] Koseiren Takaoka Hosp, Ctr Comprehens Canc, Ambulatory Treatment Ward, Takaoka, Toyama, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		P1-1-54	107	107				1	Oncology	Oncology	CW7ED	WOS:000365159900279		
J	Shigematsu, H; Okazaki, M; Sano, Y				Shigematsu, Hisayuki; Okazaki, Mikio; Sano, Yoshifumi			Clinical significance of SUVmax on PET/CT in c-T1a (less than 20 mm) non-small cell lung cancer	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Shigematsu, Hisayuki; Okazaki, Mikio; Sano, Yoshifumi] Ehime Univ, Grad Sch Med, Dept Cardiovasc & Thorac Surg, Matsuyama, Ehime 790, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		P1-1-70	107	107				1	Oncology	Oncology	CW7ED	WOS:000365159900280		
J	Yamaguchi, S; Shin, T; Kaoru, M; Misa, I; Kayo, M; Chikashi, I; Shunsuke, K				Yamaguchi, Shigeo; Shin, Takahashi; Kaoru, Mogushi; Misa, Imai; Kayo, Miura; Chikashi, Ishioka; Shunsuke, Kato			TP53 mutation signature can predict prognosis of early lung adenocarcinoma	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Yamaguchi, Shigeo; Kayo, Miura; Shunsuke, Kato] Juntendo Univ, Dept Med Oncol, Tokyo, Japan; [Shin, Takahashi; Chikashi, Ishioka] Tohoku Univ, Dept Med Oncol, Sendai, Miyagi 980, Japan; [Kaoru, Mogushi; Misa, Imai] Juntendo Univ, Clin Res Support Ctr, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		P1-1-25	107	107				1	Oncology	Oncology	CW7ED	WOS:000365159900278		
J	Kato, K; Iwashita, N; Matumoto, G; Okabe, T; Nakahara, Y; Ookuma, Y; Hosomi, Y				Kato, Kan; Iwashita, Naoki; Matumoto, Gou; Okabe, Toshihiko; Nakahara, Yoshiro; Ookuma, Yuusuke; Hosomi, Yukio			Role of community based integrated careward in the lung cancer practice-revision of medical treatment fees for 2014	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Kato, Kan; Iwashita, Naoki; Matumoto, Gou] Tokyo Kensei Hosp, Dept Internal Med, Tokyo, Japan; [Kato, Kan; Okabe, Toshihiko] Ooizumi Hlth Cooperat Hosp, Dept Internal Med, Tokyo, Japan; [Nakahara, Yoshiro; Ookuma, Yuusuke; Hosomi, Yukio] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Resp Med, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		P1-1-80	108	108				1	Oncology	Oncology	CW7ED	WOS:000365159900283		
J	Okada, K; Sakai, K; Muranushi, H; Okamoto, Y; Sugiura, H; Sato, A; Sato, T; Maeda, T; Onishi, T; Ueda, Y				Okada, Kazuya; Sakai, Kazuya; Muranushi, Hiroyuki; Okamoto, Yusuke; Sugiura, Hiroyuki; Sato, Aki; Sato, Takayuki; Maeda, Takeshi; Onishi, Tatsuhito; Ueda, Yasunori			DeVIC chemotherapy is effective for patients with refractory or relapsed diffuse large B-cell lymphoma	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Okada, Kazuya; Sakai, Kazuya; Muranushi, Hiroyuki; Okamoto, Yusuke; Sugiura, Hiroyuki; Sato, Aki; Sato, Takayuki; Maeda, Takeshi; Onishi, Tatsuhito; Ueda, Yasunori] Kurashiki Cent Hosp, Dept Haematol Oncol, Kurashiki, Okayama, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		P1-2-4	108	108				1	Oncology	Oncology	CW7ED	WOS:000365159900285		
J	Serizawa, K; Morita, Y; Watatani, Y; Oyama, Y; Hirase, C; Tanaka, H; Miyatake, J; Tatsumi, Y; Ashida, T; Matsumura, I				Serizawa, Kentaro; Morita, Yasuyoshi; Watatani, Yosaku; Oyama, Yasuyo; Hirase, Chikara; Tanaka, Hirokazu; Miyatake, Junichi; Tatsumi, Yoichi; Ashida, Takashi; Matsumura, Itaru			Analysis of gemcitabine therapy for relapsed or refractory malignant lymphoma in one institute	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Serizawa, Kentaro; Morita, Yasuyoshi; Watatani, Yosaku; Oyama, Yasuyo; Hirase, Chikara; Tanaka, Hirokazu; Miyatake, Junichi; Tatsumi, Yoichi; Ashida, Takashi; Matsumura, Itaru] Kinki Univ, Sch Med, Dept Hematol & Rheumatol, Higashiosaka, Osaka 577, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		P1-2-3	108	108				1	Oncology	Oncology	CW7ED	WOS:000365159900284		
J	Takahata, T; Saito, K; Chen, Y; Terui, K; Awatsu, A; Abo, E; Sato, A				Takahata, Takenori; Saito, Kensuke; Chen, Yu; Terui, Kazufumi; Awatsu, Akemi; Abo, Emiko; Sato, Atsushi			Retrospective analysis of primary breast diffuse large B-cell lymphoma cases in our institute	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Takahata, Takenori; Saito, Kensuke; Chen, Yu; Sato, Atsushi] Hirosaki Univ, Grad Sch Med, Dept Med Oncol, Hirosaki, Aomori, Japan; [Terui, Kazufumi] Hirosaki Univ Hosp, Dept Pharm, Hirosaki, Aomori, Japan; [Awatsu, Akemi; Abo, Emiko] Hirosaki Univ Hosp, Dept Nursing, Hirosaki, Aomori, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		P1-2-7	108	109				2	Oncology	Oncology	CW7ED	WOS:000365159900286		
J	Motomura, S; Suda, A; Inoue, M; Takashi, Y; Atsushi, Y; Hiroko, H; Hisashi, T; Junichi, N				Motomura, Sayuri; Suda, Atsuhiro; Inoue, Misato; Takashi, Yoshikawa; Atsushi, Yamamoto; Hiroko, Hidai; Hisashi, Tsutsumi; Junichi, Nagashima			Efficacy of Y-90-ibritumomab tiuxetan treatment for relapsed and refractory low-grade B-cell and mantle cell lymphoma	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Motomura, Sayuri; Hiroko, Hidai; Hisashi, Tsutsumi] Tokyo Metropolitan Hlth & Med Treatment Corp, Tama Hokubu Med Ctr, Dept Hematol, Tokyo, Japan; [Suda, Atsuhiro; Inoue, Misato] Tokyo Metropolitan Hlth & Med Treatment Corp, Tama Hokubu Med Ctr, Dept Pharm, Tokyo, Japan; [Takashi, Yoshikawa; Atsushi, Yamamoto; Junichi, Nagashima] Tokyo Metropolitan Hlth & Med Treatment Corp, Tama Hokubu Med Ctr, Dept Radiol, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		P1-2-12	109	109				1	Oncology	Oncology	CW7ED	WOS:000365159900289		
J	Oyake, T; Asahi, M; Sugawara, N; Suzuki, Y; Okano, Y; Fujishima, Y; Aoki, Y; Kowata, S; Ito, S; Ishida, Y				Oyake, Tatsuo; Asahi, Maki; Sugawara, Norifumi; Suzuki, Yuzo; Okano, Yoshiaki; Fujishima, Yukiteru; Aoki, Yusei; Kowata, Shugo; Ito, Shigeki; Ishida, Yoji			A retrospective analysis about Stenotrophomas maltophiria sepsis in patients with hematological malignancy	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Oyake, Tatsuo; Asahi, Maki; Sugawara, Norifumi; Suzuki, Yuzo; Okano, Yoshiaki; Fujishima, Yukiteru; Aoki, Yusei; Kowata, Shugo; Ito, Shigeki; Ishida, Yoji] Iwate Med Univ, Sch Med, Dept Hematol & Oncol, Internal Med, Morioka, Iwate, Japan; [Ito, Shigeki] Iwate Med Univ, Sch Med, Dept Oncol, Internal Med, Morioka, Iwate, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		P1-2-13	109	109				1	Oncology	Oncology	CW7ED	WOS:000365159900290		
J	Yamada, T; Shibata, Y; Nakamura, N; Kitagawa, J; Kanemura, N; Kasahara, S; Goto, H; Fukuno, K; Sawada, M; Tsurumi, H				Yamada, Toshiki; Shibata, Yuhei; Nakamura, Nobuhiko; Kitagawa, Jun-ichi; Kanemura, Nobuhiro; Kasahara, Senji; Goto, Hideko; Fukuno, Kenji; Sawada, Michio; Tsurumi, Hisashi			Bendamustine therapy for relapsed or refractory low grade B cell lymphoma and mantle cell lymphoma	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Yamada, Toshiki] Gifu Prefectural Gen Med Ctr, Dept Hematol, Gifu, Japan; [Shibata, Yuhei; Nakamura, Nobuhiko; Kitagawa, Jun-ichi; Kanemura, Nobuhiro; Tsurumi, Hisashi] Gifu Univ, Sch Med, Dept Internal Med 1, Gifu, Japan; [Kasahara, Senji; Goto, Hideko] Gifu Municipal Hosp, Dept Hematol, Gifu, Japan; [Fukuno, Kenji; Sawada, Michio] Gifu Red Cross Hosp, Dept Hematol, Gifu, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		P1-2-11	109	109				1	Oncology	Oncology	CW7ED	WOS:000365159900288		
J	Deguchi, A; Kokudo, Y; Masaki, T				Deguchi, Akihiro; Kokudo, Yasutaka; Masaki, Tsutomu			Efficacy and safety of transarterial chemoembolization using drug eluting beads for hepatocellular carcinoma	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Deguchi, Akihiro] Kagawa Rosai Hosp, Dept Hepatol, Marugame, Kagawa, Japan; [Kokudo, Yasutaka] Kagawa Rosai Hosp, Dept Surg, Marugame, Kagawa, Japan; [Masaki, Tsutomu] Kagawa Univ, Sch Med, Dept Gastroenterol & Neurol, Takamatsu, Kagawa 760, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		P1-2-18	110	110				1	Oncology	Oncology	CW7ED	WOS:000365159900292		
J	Murata, S; Inaba, Y; Yamaura, H; Sato, Y; Kato, M; Kawada, H; Hasegawa, T				Murata, Shinichi; Inaba, Yoshitaka; Yamaura, Hidekazu; Sato, Yozo; Kato, Mina; Kawada, Hiroshi; Hasegawa, Takaaki			Embolization therapy with microspheres for liver metastases	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Murata, Shinichi; Inaba, Yoshitaka; Yamaura, Hidekazu; Sato, Yozo; Kato, Mina; Kawada, Hiroshi; Hasegawa, Takaaki] Aichi Canc Ctr Hosp, Dept Diagnost & Intervent Radiol, Aichi, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		P1-2-20	110	110				1	Oncology	Oncology	CW7ED	WOS:000365159900293		
J	Ouchi, A; Sano, K; Tanoue, S; Machishima, T; Katori, M; Masuoka, S; Nishiwaki, K; Usui, N; Aiba, K				Ouchi, Aya; Sano, Koji; Tanoue, Susumu; Machishima, Tomohito; Katori, Mitsuji; Masuoka, Shuichi; Nishiwaki, Kaichi; Usui, Noriko; Aiba, Keisuke			Reversible posterior leukoencephalopathy syndrome during R-ICE therapy for malignant lymphoma	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Ouchi, Aya; Sano, Koji; Tanoue, Susumu; Machishima, Tomohito; Katori, Mitsuji; Masuoka, Shuichi; Nishiwaki, Kaichi] Jikei Univ, Kashiwa Hosp, Dept Hematol & Oncol, Kashiwa, Chiba, Japan; [Usui, Noriko; Aiba, Keisuke] Jikei Univ, Dept Hematol & Oncol, Kashiwa, Chiba, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		P1-2-16	110	110				1	Oncology	Oncology	CW7ED	WOS:000365159900291		
J	Ozeki, K; Tatekawa, S; Adachi, Y; Umemura, K; Kohno, A				Ozeki, Kazutaka; Tatekawa, Shotaro; Adachi, Yoshitaka; Umemura, Koji; Kohno, Akio			Serious bronchiolitis obliterans organizing pneumonia associated with azacitidine in two MDS patients	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Ozeki, Kazutaka; Adachi, Yoshitaka; Umemura, Koji; Kohno, Akio] Konan Kosei Hosp, Dept Hematol & Oncol, Konan, Aichi, Japan; [Tatekawa, Shotaro] Kyoto Prefectural Univ Med, Div Hematol & Oncol, Kyoto 602, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		P1-2-51	110	110				1	Oncology	Oncology	CW7ED	WOS:000365159900294		
J	Ryuge, A; Kamiya, Y; Mizutani, T; Park, JY; Shimizu, K				Ryuge, Akane; Kamiya, Yoshikazu; Mizutani, Takefumi; Park, Ji Young; Shimizu, Kazuyuki			A possible link between ITP developed in a patient with relapsed multiple myeloma and maintenance thalidomide	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Ryuge, Akane; Kamiya, Yoshikazu; Mizutani, Takefumi; Park, Ji Young; Shimizu, Kazuyuki] Higashi Nagoya Natl Hosp, Natl Hosp Org, Dept Hematol & Oncol, Nagoya, Aichi, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		P1-2-59	110	111				2	Oncology	Oncology	CW7ED	WOS:000365159900295		
J	Kiba, T				Kiba, Takayoshi			Bortezomib and dexamethasone for multiple myeloma: AST and LDH levels with significant impacts on overall survival	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Kiba, Takayoshi] Natl Hosp Org, Kure Med Ctr, Inst Clin Res, Div Modern Med Technol, Kure, Hiroshima, Japan; [Kiba, Takayoshi] Chugoku Canc Ctr, Hiroshima, Japan; [Kiba, Takayoshi] Tohoku Pharmaceut Univ Hosp, Dept Clin Oncol, Sendai, Miyagi, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		P1-2-66	111	111				1	Oncology	Oncology	CW7ED	WOS:000365159900297		
J	Sawada, K; Abe, M; Saito, Y; Hasebe, T; Nakajima, S; Ohtake, T; Hasebe, C; Fuiya, M; Kohgo, Y				Sawada, Koji; Abe, Masami; Saito, Yoshinori; Hasebe, Takumu; Nakajima, Shunsuke; Ohtake, Takaaki; Hasebe, Chitomi; Fuiya, Mikihiro; Kohgo, Yutaka			The clinical features of patients with advanced HCC treated with sorafenib who experienced long-term survival	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Sawada, Koji; Hasebe, Takumu; Nakajima, Shunsuke; Ohtake, Takaaki; Fuiya, Mikihiro; Kohgo, Yutaka] Asahikawa Med Univ, Dept Med, Div Gastroenterol & Hematol Oncol, Asahikawa, Hokkaido, Japan; [Abe, Masami; Hasebe, Chitomi] Asahikawa Red Cross Hosp, Dept Gasroentelor, Asahikawa, Hokkaido, Japan; [Saito, Yoshinori] Asahikawa Kosei Gen Hosp, Dept Gasroentelor, Asahikawa, Hokkaido, Japan; [Ohtake, Takaaki] Asahikawa Med Univ, Dept Clin Gastroenterol & Hepatol Cooperat Networ, Asahikawa, Hokkaido, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		P1-2-67	111	111				1	Oncology	Oncology	CW7ED	WOS:000365159900298		
J	Tabayashi, T; Takahashi, Y; Kimura, Y; Tomikawa, T; Sagawa, M; Nemoto, T; Watanabe, R; Tokuhira, M; Mori, S; Kizaki, M				Tabayashi, Takayuki; Takahashi, Yasuyuki; Kimura, Yuta; Tomikawa, Tatsuki; Sagawa, Morihiko; Nemoto, Tomoe; Watanabe, Reiko; Tokuhira, Michihide; Mori, Shigehisa; Kizaki, Masahiro			Therapeutic approach for primary plasma cell leukemia: case reports and a review of the literature	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Tabayashi, Takayuki; Takahashi, Yasuyuki; Kimura, Yuta; Tomikawa, Tatsuki; Sagawa, Morihiko; Nemoto, Tomoe; Watanabe, Reiko; Tokuhira, Michihide; Mori, Shigehisa; Kizaki, Masahiro] Saitama Med Univ, Saitama Med Ctr, Dept Hematol, Moroyama, Saitama, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		P1-2-61	111	111				1	Oncology	Oncology	CW7ED	WOS:000365159900296		
J	Hattori, Y; Takasaki, H; Ishiyama, Y; Aoki, J; Numata, A; Watanabe, R; Motomura, S; Sakai, R				Hattori, Yukako; Takasaki, Hirotaka; Ishiyama, Yasufumi; Aoki, Jun; Numata, Ayumi; Watanabe, Reina; Motomura, Shigeki; Sakai, Rika			Amrubicin therapy for platinum-refractory extrapulmonary neuroendocrine carcinoma: Retrospective single-center analysis	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Hattori, Yukako; Takasaki, Hirotaka; Ishiyama, Yasufumi; Numata, Ayumi; Watanabe, Reina; Motomura, Shigeki; Sakai, Rika] Kanagawa Canc Ctr, Dept Med Oncol, Yokohama, Kanagawa, Japan; [Aoki, Jun] Kanagawa Canc Ctr, Dept Hematol, Yokohama, Kanagawa, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		P1-3-4	112	112				1	Oncology	Oncology	CW7ED	WOS:000365159900301		
J	Jingu, D; Yajima, T; Ubukata, S; Watanabe, H; Takahashi, H				Jingu, Daisuke; Yajima, Takehiro; Ubukata, Satoshi; Watanabe, Hiroshi; Takahashi, Hiroshi			An autopsy case of primary cervical neuroendcrine carcinoma proceeded liver metastasis	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Jingu, Daisuke; Yajima, Takehiro; Ubukata, Satoshi; Watanabe, Hiroshi; Takahashi, Hiroshi] Saka Gen Hosp, Resp Dept, Shiogama, Miyagi, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		P1-3-59	112	112				1	Oncology	Oncology	CW7ED	WOS:000365159900304		
J	Kitamura, H; Kashiwada, T; Komiya, K; Nakayma, Y; Nakazono, T; Takase, Y; Aragane, N; Kimura, S				Kitamura, Hiroaki; Kashiwada, Tomomi; Komiya, Kazutoshi; Nakayma, Yukihiko; Nakazono, Takahiko; Takase, Yukari; Aragane, Naoko; Kimura, Shinya			A case with cancer of unknown primary diagnosed pathologically retroperitoneal squamous cell carcinoma	ANNALS OF ONCOLOGY			English	Meeting Abstract	Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)	JUL 16-18, 2015	Sapporo, JAPAN	Japanese Soc Med Oncol					[Kitamura, Hiroaki; Kashiwada, Tomomi; Komiya, Kazutoshi; Aragane, Naoko; Kimura, Shinya] Saga Univ, Fac Med, Dept Internal Med, Div Hematol Resp Med & Oncol, Saga, Japan; [Nakayma, Yukihiko] Saga Univ, Fac Med, Div Obstet & Gynecol, Saga, Japan; [Nakazono, Takahiko] Saga Univ, Fac Med, Div Radiol, Saga, Japan; [Takase, Yukari] Saga Univ, Fac Med, Dept Pathol & Biodef, Div Pathol, Saga, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	NOV	2015	26			7		P1-3-54	112	112				1	Oncology	Oncology	CW7ED	WOS:000365159900302		
